{"directed": false, "multigraph": false, "graph": {}, "nodes": [{"id": 1391740893804, "note": "{{c1::<b>Levothyroxine</b>}} is a recombinant form of T4 that serves as a thyroxine replacement. It has agonist action at thyroid hormone receptors", "time": null}, {"id": 1405141731050, "note": "<div>{{c1::<b>Aplasia cutis</b>}} is a possible teratogenic complication of <b>methimazole</b> if given in the <u>first</u> trimester</div>", "time": 1660105359147.0}, {"id": 1405141770453, "note": "<i></i><i><div></div></i><div><b>{{c1::Agranulocytosis}}</b> and {{c1::<b>Aplastic</b>}} <b>Anemia </b>are rare <u>hematological</u> complications of <b>propylthiouracil</b> and <b>methimazole</b> use</div>", "time": 1660105359148.0}, {"id": 1405189423019, "note": "On which days following fertilization is the <b>morula</b> formed?<div><br></div><div>{{c1::3-4}}</div>", "time": null}, {"id": 1405189449032, "note": "On which <u>days</u> following fertilization does <b>implantation</b> occur?<div><br></div><div>{{c1::6-10}}</div>", "time": null}, {"id": 1405189616150, "note": "During which week of gestation does the primitive streak appear?<div><br /></div><div>{{c1::3}}</div>", "time": null}, {"id": 1405189748896, "note": "<div><div>What is the <u>embryonic origin</u> of the <b>spinal cord</b>? </div><div><br></div><div>{{c1::Neural tube (neuroectoderm)}}</div></div>", "time": null}, {"id": 1405189766131, "note": "<div><div>What is the <u>embryonic origin</u> of the <b>Alveoli, epithelium of trachea / bronchi</b>? </div><div><br /></div><div>{{c1::Endoderm}}</div></div>", "time": null}, {"id": 1405722949047, "note": "<div><i><div></div></i></div>Which <u>antacid</u> is associated with <b>hyporeflexia, hypotension</b> and <b>cardiac arrest</b> if overused?<div><br></div><div>{{c1::Magnesium hydroxide}}</div>", "time": 1660105359125.0}, {"id": 1461597220648, "note": "<div>The <b>{{c1::nucleus tractus solitarius}}</b>, also known as the <b>vomiting</b> <b>center </b>(located in the medulla) receives main inputs from:<br></div><div> 1. {{c2::GI tract}}</div><div> 2. {{c2::Vestibular system}}</div><div> 3. {{c2::Area postrema (chemoreceptor trigger zone)}}</div>", "time": 1660105351958.0}, {"id": 1461597313002, "note": "<div>The <b>nucleus tractus solitarius</b> projects neurons to other medullary nuclei to coordinate the <b>{{c1::vomiting}} response</b><br></div>", "time": 1660105351966.0}, {"id": 1461597592228, "note": "<div>The <b>vestibular</b> <b>system</b> is responsible for {{c1::vertigo}} and <b>motion sickness </b>(vestibular nausea)<br></div>", "time": 1660105351961.0}, {"id": 1461597624636, "note": "<div>The {{c1::<b>area</b> <b>postrema</b>}} (chemoreceptor trigger zone) is located <i>adjacent</i> to the <b>nucleus tractus solitarius</b> in the <b>{{c2::4th}} ventricle</b><br></div>", "time": 1660105351960.0}, {"id": 1461597712293, "note": "<div>The <b>area postrema</b> (chemoreceptor trigger zone) responds to <b>{{c1::emetogenic}}</b> <b>substances</b> (e.g. chemotherapeutic agents)<br></div>", "time": 1660105351968.0}, {"id": 1461597740971, "note": "<div><b>{{c2::Ondansetron}}</b> <i>antagonizes</i> the {{c1::<b>5-HT<sub>3</sub></b>}} <b>receptor</b> on <u>vagal afferents</u> in the <u>GI tract</u></div>", "time": 1660105351947.0}, {"id": 1461598594612, "note": "<div><b>Ondansetron </b>is used to treat <b>{{c1::chemotherapy}}</b> or <b>{{c1::post-operative}}</b> induced nausea and vomiting<br></div>", "time": 1660105351977.0}, {"id": 1461598623075, "note": "<div><b>Ondansetron</b> may cause {{c1::<b>constipation</b>}} at the gut and {{c1::<b>headache/dizziness</b>}} at the head as possible side effects<br></div>", "time": 1660105351976.0}, {"id": 1461598684331, "note": "<div><b>Ondansetron</b> may cause {{c1::<b>serotonin</b> <b>syndrome</b>}}, which presents with symptoms including rigidity, tremor, hyperthermia, and confusion<br></div>", "time": 1660105351975.0}, {"id": 1461599476879, "note": "<div><b>Diphenhydramine</b> and <b>meclizine</b> (1st generation H1 receptor blockers) may cause significant <b>{{c1::sedation}}</b> and have significant <b>anti-{{c2::muscarinic}}</b> properties<br><i></i></div>", "time": 1660105351989.0}, {"id": 1461599508630, "note": "<div>The <b>vestibular</b> <b>system</b> contains <b>{{c1::M1}}</b>&nbsp;<b>muscarinic</b> <b>receptors</b><br></div>", "time": 1660105351962.0}, {"id": 1461599525155, "note": "<div><b>{{c1::Scopolamine}}</b> is a(n)&nbsp;<b>{{c2::muscarinic (M1)}}</b> <b>antagonist</b> that treats vestibular nausea (motion sickness)<br></div>", "time": 1660105351951.0}, {"id": 1461599540100, "note": "<div><b>Motion sickness</b> (vestibular nausea) is treated with {{c1::1st generation anti-histamines (<b>diphenhydramine</b>, <b>meclizine</b>)}} and <b>{{c1::scopolamine}}</b><br></div>", "time": 1660105351979.0}, {"id": 1461600845716, "note": "<div><b>{{c1::Metoclopramide}}</b> <i>antagonizes</i> <b>{{c2::D2}} receptors </b>in the <b>area postrema</b> (treats chemotherapy induced vomiting)<br></div>", "time": 1660105351953.0}, {"id": 1461600965249, "note": "<div><b>Metoclopramide</b> (D2 antagonist) is contraindicated in patients with {{c1::small bowel obstruction}}<br></div>", "time": 1660105351986.0}, {"id": 1461601445180, "note": "<div>Side effects of <b>metoclopramide</b> include <b>extrapyramidal&nbsp;</b><b>effects</b> such as dystonia, akathisia, and <b>{{c1::parkinsonian}} features</b> as a result of central D2 blockade<br></div>", "time": 1660105351972.0}, {"id": 1461601568244, "note": "<div><b>Metoclopramide</b> may cause elevated <b>{{c1::prolactin}}</b> <b>levels</b>, which can cause galactorrhea, impotence, gynecomastia, and menstrual disorders<br></div>", "time": 1660105351981.0}, {"id": 1461601928376, "note": "<div>Which <b>anti-emetic(s)</b> should be used to treat a patient with nausea/vomiting due to <i>motion sickness</i>?<br></div><div><br></div>{{c1::1. <u>H1 receptor blockers</u>, such as diphenhydramine and meclizine<div><i> </i>2. <u>M1 receptor blockers</u>, such as scopolamine</div><div>}} </div>", "time": 1660105351954.0}, {"id": 1461615074564, "note": "<div><b>Histamine</b>, from ECL cells, activates <b>{{c1::H2}} receptors</b> (coupled to {{c1::G<sub>s</sub>}}) on the <b>basolateral</b> membrane of parietal cells</div>", "time": 1660105351942.0}, {"id": 1461615595492, "note": "<div><b>Vagal</b> <b>stimulation</b> is a potent direct <i>activator</i> of <b>parietal cells</b> (H<sup>+</sup> secretion) via binding of the neurotransmitter <b>{{c1::ACh}}</b> to <b>{{c2::M3}}</b> receptors<br></div>", "time": 1660105351930.0}, {"id": 1461615646774, "note": "<div>What <u>drug class</u> do <b>cimetidine</b>, <b>ranitidine</b>, <b>famotidine</b>, and&nbsp;<b>nizatidine</b> belong to? </div><div><br></div><div>{{c1::H<sub>2</sub> receptor antagonists}}</div>", "time": 1660105351928.0}, {"id": 1461616559615, "note": "<div>By what mechanisms can H<sup>+</sup> secretion still occur in a patient on H<sub>2</sub> receptor blockers?<br></div><div><br></div><div>{{c1::<u>Direct</u> stimulation of parietal cells by <b>vagal</b> <b>stimulation</b> and <b>gastrin stimulation</b>}}</div>", "time": 1660105351945.0}, {"id": 1461616635772, "note": "<div>The H<sub>2</sub> receptor antagonist <b>{{c2::cimetidine}}</b> is a potent {{c3::<u>inhibitor</u>}} of <b>{{c1::cytochrome P-450}}</b> and therefore has multiple drug interactions<br></div>", "time": 1660105351933.0}, {"id": 1461616648667, "note": "<div>The H<sub>2</sub> receptor antagonist <b>{{c2::cimetidine}}</b> has many <b>anti-{{c1::androgenic}}</b> effects (e.g. gynecomastia, impotence, elevated prolactin levels)<br></div>", "time": 1660105351935.0}, {"id": 1461616743909, "note": "<div>Both <b>cimetidine</b> and <b>ranitidine</b> decrease <u>renal excretion</u> of {{c1::creatinine}} </div>", "time": 1660105359138.0}, {"id": 1461624946809, "note": "<div>{{c1::<b>Proton pump inhibitors</b> (PPIs)}} are effective at reducing <i>both&nbsp;</i><b>nocturnal</b> and <b>meal-stimulated</b> secretion of acid and thus suppress H<sup>+&nbsp;</sup>secretion to a <i>greater</i> extent than H<sub>2</sub> receptor blockers<br></div>", "time": 1660105351921.0}, {"id": 1461624955031, "note": "<div>What is the <b>first line treatment</b> for a patient with <b>Zollinger-Ellison Syndrome</b>?<br></div><div><br></div><div>{{c1::Proton pump inhibitors (PPIs)}}</div>", "time": 1660105351926.0}, {"id": 1461624994016, "note": "<div>One adverse effect of <b>proton pump inhibitors (PPIs)</b> is increased risk for <i>{{c1::Clostridioides difficile}}</i> infection (2-3x increased risk)<br></div>", "time": 1660105351940.0}, {"id": 1461625004593, "note": "<div>In addition to increased risk for <i>C. difficile</i> infection, patients on <b>proton pump inhibitors</b> are also at increased risk for {{c1::pneumonia}}<br></div>", "time": 1660105351941.0}, {"id": 1461625020267, "note": "<div><b>Proton pump inhibitors</b> decrease the <u>absorption</u> of {{c1::divalent cations (Ca<sup>2+</sup>, Mg<sup>2+</sup>, and Fe<sup>2+</sup>)}}, which require an <u>acidic</u> environment<br></div>", "time": 1660105351937.0}, {"id": 1461625032072, "note": "<div><b>Reduced</b> <b>calcium</b> <b>absorption</b> as a result of <b>proton pump inhibitors </b>(PPIs)<b> </b>increases risk of worsening {{c1::osteoporosis (e.g. increased osteoporotic hip fractures)}}<br></div>", "time": 1660105351936.0}, {"id": 1461625057796, "note": "<div><b>Decreased</b> <b>magnesium</b> <b>absorption</b> as a result of <b>proton pump inhibitors</b> (PPIs) may cause {{c1::hypomagnesemia}}<br></div>", "time": 1660105351944.0}, {"id": 1461625078700, "note": "<div>When <b>proton pump inhibitors</b> are unable to control gastric acid secretion, <b>{{c1::octreotide}}</b> (a long acting <b>somatostatin</b>&nbsp;analog) may be of use in treating <u>gastrinomas</u><br></div>", "time": 1660105351925.0}, {"id": 1461634577602, "note": "<div><b>{{c1::Osmotic}}</b> <b>laxatives</b> are <i>non-absorbable</i> substances that <b>draw water</b> into the intestinal lumen, causing distention and peristalsis<br></div>", "time": 1660105351857.0}, {"id": 1461634588075, "note": "<div><b>Magnesium hydroxide</b> and <b>magnesium citrate</b> are both examples of <b>{{c1::osmotic}} laxatives</b><br></div>", "time": 1660105351875.0}, {"id": 1461634601250, "note": "<div><b>Polyethylene glycol (PEG)</b> is a <i>non-absorbable sugar</i> that acts as a(n)&nbsp;<b>{{c1::osmotic}} laxative</b><br></div>", "time": 1660105351872.0}, {"id": 1461634613345, "note": "<div><b>Lactulose</b> is a <i>non-absorbable sugar</i> that acts as a(n)&nbsp;<b>{{c1::osmotic}} laxative</b><br></div>", "time": 1660105351876.0}, {"id": 1461634642138, "note": "<div>In addition to its use as an <i>osmotic laxative</i>, <b>{{c2::lactulose}}</b> may be used in the treatment of <b>{{c1::hepatic encephalopathy}}</b><br></div>", "time": 1660105351878.0}, {"id": 1461634716202, "note": "<div><b>Docusate</b> is used medically as a(n) {{c1::stool softener}}<br></div>", "time": 1660105351879.0}, {"id": 1461634763574, "note": "<div><b>{{c1::Loperamide}}</b> is a(n)&nbsp;<b>{{c2::\u03bc-opioid}} agonist</b> that <b>does not</b> <b>cross</b> the BBB, therefore there is no analgesia and low potential for addiction<br></div>", "time": 1660105351860.0}, {"id": 1461634814863, "note": "<div>What <u>GI side effect</u> may be caused by <b>opioid</b> <b>agonists</b>?<br></div><div><br></div><div>{{c1::Constipation}}</div>", "time": 1660105351865.0}, {"id": 1461634826340, "note": "<div><b>VIPoma</b> and <b>carcinoid tumor</b> both cause <b>{{c1::secretory}}</b> <b>diarrhea</b><br></div>", "time": 1660105351866.0}, {"id": 1461634834294, "note": "<div>{{c1::<b>Octreotide</b> (a somatostatin analog)}} may be used to treat the <b>secretory diarrhea</b> caused by <b>VIPoma</b> and <b>carcinoid syndrome</b><br></div>", "time": 1660105351858.0}, {"id": 1461792762468, "note": "<div><b>{{c1::Interferons}}</b> are immunomodulatory <b>{{c2::cytokines}}</b> that are released from <u>virus infected</u> host cells</div>", "time": 1660105351890.0}, {"id": 1461794607480, "note": "<div><b>Interferon {{c2::alpha}}</b> may be used in the treatment of <b>hepatitis</b> {{c1::<b>B</b>}} and {{c1::<b>C</b>}} infections<br></div>", "time": 1660105351909.0}, {"id": 1461794779174, "note": "<div><b>Interferon {{c1::</b><b>\u03b2</b><b>}}</b> may be used to treat <b>{{c2::multiple sclerosis}}</b><br></div>", "time": 1660105351911.0}, {"id": 1461797617523, "note": "<div><b>Ribavirin</b> is a(n) {{c1::guanosine nucleoside}} <b>analog</b><br></div>", "time": 1660105351903.0}, {"id": 1461797629482, "note": "<div><b>Ribavirin</b> must be {{c1::phosphorylated <u>three</u> times::specific}} by intracellular enzymes to reach its <i>activated</i> nucleotide form<br></div>", "time": 1660105351901.0}, {"id": 1461797649771, "note": "<div>A major <u>side effect</u> of <b>ribavirin</b> is that it may cause {{c1::dose-dependent hemolytic anemia (10-20% of patients)}}<br></div>", "time": 1660105351920.0}, {"id": 1461797660332, "note": "<div><b>Ribavirin</b> is <i>contraindicated</i> in {{c1::pregnant women}} due to its {{c1::teratogenic}} effects<br></div>", "time": 1660105351902.0}, {"id": 1461797674252, "note": "<div>In addition to <b>hepatitis C</b>, what other virus is <b>ribavirin</b> classically used to treat?<br></div><div><br></div><div>{{c1::respiratory syncytial virus (RSV)}}</div>", "time": 1660105351915.0}, {"id": 1461797689978, "note": "<div><b>{{c1::Sofosbuvir}}</b> is a <u>nucleotide analog</u> that inhibits the HCV <b>{{c3::NS5B}}</b> <b>{{c2::RNA-dependent RNA polymerase}}</b><br></div>", "time": 1660105351888.0}, {"id": 1461806819909, "note": "<div><b>Misoprostol</b> is a synthetic analog of {{c1::PGE<sub>1</sub>}} </div>", "time": 1660105351854.0}, {"id": 1461806838245, "note": "<div><b>Misoprostol</b> promotes <u>increased</u> production and secretion of a gastric&nbsp;<b>{{c1::mucous}}</b> barrier and <u>decreased</u> {{c1::acid}} production<br></div>", "time": 1660105351851.0}, {"id": 1461806905197, "note": "<div><b>{{c1::Misoprostol}}</b> is a PGE<sub>1</sub> analog that may be used to prevent <b>NSAID-induced {{c2::peptic ulcers}}</b><br></div>", "time": 1660105351849.0}, {"id": 1461806919056, "note": "<div><b>Misoprostol</b> promotes <b>{{c1::uterine}}</b> <b>contraction</b> and therefore may be used for induction of {{c1::labor (ripens cervix)}}<br></div>", "time": 1660105351850.0}, {"id": 1461852697255, "note": "<div>All <b>steroid</b> hormones are derivatives of <b>{{c1::cholesterol}}</b></div>", "time": 1660105361943.0}, {"id": 1461857141003, "note": "In the <i>first</i> step of the <u>adenylyl cyclase</u> and <u>phospholipase C</u> mechanism of signaling, binding of <b>hormone</b> to its <b>receptor</b> causes release of {{c1::GDP}} from its <b>\u03b1 subunit</b> (\u03b1<sub>s</sub>, \u03b1<sub>i</sub>, or a<sub>q</sub>) and replacement by {{c1::GTP}} ", "time": 1660105356757.0}, {"id": 1461857237570, "note": "<div>In the <u>adenylyl cyclase</u> mechanism of cellular signaling, the <b>{{c2::\u03b1<sub>s</sub>-GTP}} complex</b> <i>activates</i> <b>adenylyl cyclase</b>, which then catalyzes the conversion of <b>{{c1::ATP}}</b> to <b>{{c1::cAMP}}</b> </div>", "time": 1660105356834.0}, {"id": 1461857273344, "note": "<div>In the <u>adenylyl cyclase</u> mechanism of cellular signaling, the second messenger <b>{{c1::cAMP}}</b> activates <b>{{c2::protein kinase A}}</b>, which then phosphorylates specific proteins to produce physiologic actions</div>", "time": null}, {"id": 1461857288204, "note": "<div>After its use as a second messenger in the <u>adenylyl cyclase</u> signaling pathway, <b>cAMP</b> is degraded to <b>{{c1::5-AMP}}</b> by <b>{{c2::phosphodiesterase}}</b></div>", "time": null}, {"id": 1461857325591, "note": "<div>In the <u>phospholipase C</u> mechanism of cellular signaling, the <b>{{c3::\u03b1<sub>q</sub>-GTP}} complex</b> activates <b>phospholipase C</b>, which then catalyzes the <u>liberation</u> of<b> {{c1::DAG}}</b> and <b>{{c1::IP<sub>3</sub>}}</b> from <b>{{c2::PIP<sub>2</sub>}}</b></div>", "time": null}, {"id": 1461857362486, "note": "<div>In the <u>phospholipase C</u> mechanism of cellular signaling, the <b>{{c2::IP<sub>3</sub>}}</b> generated from <b>PIP<sub>2</sub></b> causes release of <b>{{c1::Ca<sup>2+</sup>}}</b> from intracellular stores in the <b>endoplasmic</b> or <b>sarcoplasmic</b> <b>reticulum</b></div>", "time": null}, {"id": 1461857387477, "note": "<div>In the <u>phospholipase C</u> mechanism of cellular signaling, <b>{{c1::Ca<sup>2+</sup>}}</b> and <b>{{c1::diacylglycerol (DAG)}}</b> activate <b>{{c2::protein kinase C}}</b>, which phosphorylates specific proteins to produce physiologic actions</div>", "time": null}, {"id": 1461864718849, "note": "What hormone acts through a <b><i>receptor</i> guanylyl cyclase</b>? <div><br /></div><div>{{c1::Atrial natriuretic peptide (ANP)}}</div>", "time": null}, {"id": 1461865790194, "note": "<div>Binding of <b>atrial</b> <b>natriuretic</b> <b>peptide</b> to its <i>receptor</i> guanylyl cyclase causes conversion of {{c1::GTP}} to {{c1::cGMP}}</div>", "time": 1660105361237.0}, {"id": 1461865801747, "note": "<div>Newly synthesized <b>cGMP</b> (<i>from guanylyl cyclase activity</i>) activates <b>{{c1::protein kinase G}}</b>, which <i>phosphorylates</i> specific proteins responsible for physiologic actions</div>", "time": null}, {"id": 1461865838545, "note": "<div>What hormone/chemical acts through a <b><i>cytosolic</i> guanylyl cyclase</b>?</div><div><br /></div><div>{{c1::Nitric Oxide}}</div>", "time": null}, {"id": 1461865844254, "note": "<div><b>{{c1::NO synthase}}</b> cleaves the amino acid <b>{{c2::arginine}}</b> into <b>citrulline</b> and<b> nitric oxide</b></div>", "time": null}, {"id": 1461865849072, "note": "<div>Once <b>nitric oxide</b> diffuses <i>into</i> muscle cells, it activates <i>soluble</i> (cytosolic) guanylyl cyclase, which converts {{c1::GTP}} to {{c1::cGMP}}</div>", "time": 1660105354671.0}, {"id": 1461865862798, "note": "<div>What is the difference between the binding sites of <b>atrial natriuretic peptide (ANP)</b> and <b>nitric oxide</b> (NO) to guanylyl cyclase receptors? </div><div><br></div><div>{{c1::- <u>ANP</u> binds to a <u>receptor</u> guanylyl cyclase<div><br></div><div> - NO binds to a <u>cytoplasmic</u> guanylyl cyclase}}</div></div>", "time": null}, {"id": 1461866207939, "note": "{{c1::<i><b>Receptor</b> </i><b>tyrosine kinases</b>}} have <b><i>intrinsic</i></b>&nbsp;<b>tyrosine kinase</b> <b>activity</b> <i>within</i> the receptor molecule ", "time": 1660105339095.0}, {"id": 1461866913033, "note": "<div>{{c1::Receptor-associated tyrosine kinases}} do <u>not</u> have <i>intrinsic</i> kinase activity, but rather <b><i>associate</i> non-covalently with proteins that do</b> (e.g. JAK)</div>", "time": null}, {"id": 1461866992917, "note": "<div><b>Receptor-associated tyrosine kinases</b> are non-covalently <i>associated </i>with a tyrosine kinase, such as <b>{{c1::JAK}}</b> </div>", "time": null}, {"id": 1461867008556, "note": "<u>Targets</u> of <b>JAK</b> (tyrosine kinase associated-receptor pathway) include <b>{{c1::STATs}}</b>, which cause transcription of new mRNAs and new protein synthesis", "time": 1660105350588.0}, {"id": 1461867010914, "note": "What type of <u>receptor</u> do <b>growth hormones</b> use for their signaling pathways? <div><br /></div><div>{{c1::Receptor associated tyrosine kinases}}</div>", "time": 1660105344771.0}, {"id": 1461867085192, "note": "How do the <u>receptors</u> bound by <b>steroid</b> and <b>thyroid hormones</b> differ from the <u>receptors</u> bound by <b>peptide hormones</b>?<div><br /></div><div>{{c1::Peptide hormones bind <u>extracellular</u> receptors}}</div>", "time": 1660105358127.0}, {"id": 1461867864150, "note": "<div>Once a <b>steroid</b> <b>hormone</b> has bound its receptor in the <i>cytoplasm</i> or <i>nucleus</i>, the <b>hormone-receptor complex</b> then {{c1::dimerizes}}</div>", "time": null}, {"id": 1461867909640, "note": "The <b>pituitary gland</b>, which also is called the <b>{{c1::hypophysis}}</b>, consists of an anterior and posterior lobe", "time": null}, {"id": 1461869987440, "note": "<div>The <b>hypothalamus</b> is connected to the <b>pituitary gland</b> by a thin stalk called the <b>{{c1::infundibulum}}</b></div>", "time": null}, {"id": 1461869991748, "note": "<div>The <b>posterior lobe</b> of the pituitary gland is derived from <b>{{c1::neural}}</b> tissue</div>", "time": null}, {"id": 1461870006406, "note": "<div>The connections between the <b>hypothalamus</b> and the <b>{{c1::posterior}}</b> <b>pituitary</b> are <b>neural </b><i>only</i></div>", "time": null}, {"id": 1461870015336, "note": "<div>The <b>{{c2::posterior}} pituitary</b> is a collection of nerve axons whose <b>cell bodies</b> are located in <b>{{c1::hypothalamic nuclei}}</b></div>", "time": 1660105348882.0}, {"id": 1461870027148, "note": "<div><u>Hypothalamic-Pituitary Relationships Summary Picture</u>: No answer {{c1:::)}}</div><div><br /></div><div><img src=\"paste-426116590338576.jpg\" /></div>", "time": null}, {"id": 1461870077108, "note": "<div>The <b>{{c1::anterior}} lobe</b> of the pituitary gland is primarily composed of <b>{{c2::endocrine}}</b> cells</div>", "time": null}, {"id": 1461870083093, "note": "<div>The <b>hypothalamus</b> and <b>anterior pituitary</b> are linked directly by the <b>{{c1::hypothalamic-hypophysial portal}} system</b></div><div> </div>", "time": 1660105350012.0}, {"id": 1461870088700, "note": "<div><b>Blood</b> from the <b>hypothalamus</b> that contains <i>high concentrations</i> of hypothalamic hormones is delivered <u>directly</u> to the {{c1::anterior pituitary}}</div>", "time": 1660105361190.0}, {"id": 1461870100824, "note": "<div><b>Hypothalamic</b> <b>hormones</b> <i>stimulate</i> or <i>inhibit</i> the release of <b>{{c1::anterior pituitary}}</b> <b>hormones</b></div>", "time": 1660105337850.0}, {"id": 1461870110912, "note": "<div>How does the <u>blood supply</u> of the <b>anterior pituitary</b> differ from that of most other organs?</div><div><br /></div><div>{{c1::Most of its blood supply is <i>venous</i> blood from the hypothalamus}}</div>", "time": null}, {"id": 1461870128102, "note": "<div>The connections between the <b>hypothalamus</b> and <b>{{c1::anterior}} pituitary</b> are both <b>neural</b> and <b>endocrine</b></div>", "time": null}, {"id": 1461870794373, "note": "<div><u>Six</u> major hormones are secreted by the <b>anterior</b> <b>lobe</b> of the pituitary: </div><div>{{c1::<div> 1. FSH</div><div> 2. LH</div><div> 3. ACTH</div><div> 4. TSH</div><div> 5. Prolactin</div><div> 6. Growth hormone</div>}}</div>", "time": 1660105349576.0}, {"id": 1461871639955, "note": "<div>The <b>{{c1::\u03b1}} </b>subunits of the <i>anterior</i> <i>pituitary </i>hormones <b>TSH,</b> <b>FSH</b>, <b>hCG</b> and <b>LH</b> are identical</div>", "time": 1660105348959.0}, {"id": 1461871660443, "note": "<div>The <b>{{c1::\u03b2}} </b>subunits of the <i>anterior pituitary</i> hormones <b>TSH</b>, <b>FSH</b>, and <b>LH</b> are different and are responsible for the <u>unique biologic activity</u> of each hormone</div>", "time": null}, {"id": 1461871685256, "note": "<div>The <i>placental</i> hormone {{c1::<b>human chorionic gonadotropin </b>(hCG)}} is structurally related to the <b>TSH</b>, <b>FSH</b>, and <b>LH</b> family</div><div> - It contains an <u>identical</u> alpha chain and <u>unique</u> beta chain</div>", "time": null}, {"id": 1461871703220, "note": "<div>The <b>{{c1::ACTH}}</b> <b>family</b> of hormones is derived from a single precursor, {{c2::<b>pro-opiomelanocortin</b> (POMC)}}</div>", "time": null}, {"id": 1461871735495, "note": "<div><b>Alpha-MSH</b> and <b>beta-MSH</b> are produced in the {{c1::intermediate}} <b>lobe</b> of the pituitary gland, which is <i>rudimentary</i> in adult humans</div>", "time": null}, {"id": 1461871756747, "note": "<div><b>{{c2::Melanocyte-stimulating hormone (MSH)}}</b> is found in <b>POMC</b> and its fragments, thus, increased levels of POMC and ACTH may lead to <b>{{c1::skin/mucosal pigmentation}}</b> (e.g. Addison disease) </div><div></div>", "time": null}, {"id": 1461871803920, "note": "<b>{{c1::Growth hormone}}</b> is the single most important hormone for <b>normal growth</b> to adult size", "time": 1660105340177.0}, {"id": 1461875768373, "note": "<div><b>Growth hormone</b> is a single-chain polypeptide that is <i>homologous</i> with <b>{{c1::prolactin}}</b> and <u>human placental lactogen</u></div>", "time": null}, {"id": 1461875782791, "note": "<div><b>{{c2::Growth hormone}}</b> is synthesized in the <b>{{c1::somatotrophs::cell type}}</b> of the <b>anterior lobe</b> of the pituitary gland</div>", "time": null}, {"id": 1461875806897, "note": "<div><b>Growth hormone</b> is released in a(n)&nbsp;<b>{{c1::pulsatile}}</b> pattern, with bursts of secretion occurring approximately every 2 hours</div>", "time": 1660105358510.0}, {"id": 1461875813135, "note": "<div>The <i>largest</i> secretory burst of <b>growth hormone</b> occurs within 1 hour of <b>{{c1::falling asleep}}</b></div>", "time": null}, {"id": 1461875836893, "note": "<div>At <b>{{c1::puberty}}</b>, there is an enormous secretory burst of <b>growth hormone</b> induced by estrogen (females) or testosterone (males)</div>", "time": null}, {"id": 1461875856182, "note": "<div>What is the effect of <b>hypoglycemia</b> and <b>starvation</b> on <b>growth hormone secretion</b>?</div><div><br></div><div>{{c1::Increased}}</div>", "time": 1660105346531.0}, {"id": 1461875931305, "note": "<div>What is the effect of <b>sleep</b> on <b>growth hormone secretion</b>?</div><div><br></div><div>{{c1::Increased}}</div>", "time": 1660105346511.0}, {"id": 1461875941713, "note": "<div>What is the effect of <b>obesity</b>, <b>pregnancy</b>, and <b>hyperglycemia&nbsp;</b>on <b>growth hormone secretion</b>?</div><div><br></div><div>{{c1::Decreased}}</div>", "time": 1660105346520.0}, {"id": 1461875953752, "note": "<div>What is the effect of <b>exercise</b> and <b>stress</b> on <b>growth hormone secretion</b>?</div><div><br></div><div>{{c1::Increased}}</div>", "time": 1660105346532.0}, {"id": 1461875965165, "note": "<div>What is the effect of <b>somatostatin</b> on <b>growth hormone secretion</b>?</div><div><br></div><div>{{c1::Decreased}}</div>", "time": null}, {"id": 1461875973910, "note": "<div>The synthesis of<b> growth hormone</b> is <u>stimulated</u> by {{c1::growth-hormone releasing hormone (GHRH)}}, its hypothalamic-releasing hormone</div>", "time": null}, {"id": 1461875983115, "note": "<div>The synthesis of<b> growth hormone</b> is <u>inhibited</u> by {{c1::somatostatin}}, its release-inhibiting hormone</div>", "time": null}, {"id": 1461876028006, "note": "<div>Through which <u>secondary messenger(s)</u> does <b>GHRH</b> initiate its action on somatotrophs?</div><div><br /></div><div>{{c1::<i>Both</i> cAMP (primarily) and IP<sub>3</sub>/Ca<sup>2+</sup>}}</div>", "time": null}, {"id": 1461876075319, "note": "<div>How does <b>GHRH</b> affect its own secretion from the hypothalamus?</div><div><br></div><div>{{c1::Decreases (ultrashort-loop <b>negative</b> feedback)}}</div>", "time": null}, {"id": 1461876115915, "note": "<div><b>{{c1::Somatomedins (IGFs)}}</b> are produced, predominantly by the <u>liver</u>, when <b>growth</b> <b>hormones</b> act on <i>target</i> <i>tissue</i> </div>", "time": null}, {"id": 1461876152346, "note": "<div>How do <b>somatomedins</b> affect the secretion of <b>growth hormone</b> from the anterior pituitary?</div><div><br></div><div>{{c1::Decrease, through both <u>direct</u> and <u>indirect</u> mechanisms}}</div>", "time": null}, {"id": 1461876217426, "note": "<div>How does <b>growth hormone</b> affect its own secretion from the anterior pituitary?</div><div><br></div><div>{{c1::Decreased, <u>indirectly</u>}}</div>", "time": null}, {"id": 1461876244688, "note": "<div><b>Growth hormone</b> inhibits its own secretion by stimulating the secretion of <b>{{c1::somatostatin}}</b> from the hypothalamus</div>", "time": null}, {"id": 1461876367336, "note": "In the <i>liver</i>, <b>growth hormone</b> generates the production of <b>somatomedins</b>, or {{c1::insulin-like growth factors (IGF)}}, which serve as the intermediaries of several physiologic actions", "time": null}, {"id": 1461877961265, "note": "<div>The <b>insulin-like growth factor</b> (IGF) <b>receptor</b> has <b>{{c1::tyrosine kinase}} activity</b>, similar to the insulin receptor </div>", "time": null}, {"id": 1461877968926, "note": "<div>One <i>direct</i> action of <b>growth hormone</b> is {{c1::<u>decreased</u>}} <b>glucose uptake</b> into cells, producing a(n) {{c1::<u>increase</u>}} in <b>glucose blood concentration</b></div>", "time": null}, {"id": 1461877995639, "note": "<div>What <i>direct</i> action does <b>growth hormone</b> have on <b>lipolysis</b>?</div><div><br></div><div>{{c1::Increased}}</div>", "time": null}, {"id": 1461878001216, "note": "<div>How does <u>growth hormone</u> affect <b>protein synthesis</b> and <b>lean body mass</b>?</div><div><br></div><div>{{c1::Increased}}</div>", "time": 1660105358100.0}, {"id": 1461878021280, "note": "<div>What <i>direct</i> action does <b>growth hormone</b> have on production of <b>insulin-like growth factor </b>(IGF)?</div><div><br></div><div>{{c1::Increased}}</div>", "time": null}, {"id": 1461878037901, "note": "<div><b>Growth hormone/IGF-1</b> alters <i>cartilage</i> metabolism to increase <b>{{c1::linear}}</b> growth </div>", "time": 1660105358506.0}, {"id": 1461878049146, "note": "<div>Failure to grow, short stature, mild obesity, and delayed puberty is associated with what <b>hormone deficiency</b>?</div><div><br></div><div>{{c1::Growth hormone deficiency}}</div>", "time": 1660105359334.0}, {"id": 1461878103457, "note": "<div><b>Growth hormone</b> <i>excess</i> is most often due to a(n) {{c1::growth hormone-secreting pituitary adenoma}}</div>", "time": 1660105358511.0}, {"id": 1461878115218, "note": "<div><i>{{c2::Before}}</i> puberty, excessive levels of growth hormone cause {{c1::<b>gigantism</b> (increased linear growth)}}</div>", "time": null}, {"id": 1461878128995, "note": "<div><i>{{c1::After}} </i>puberty, <i>excessive</i> levels of <b>growth hormone</b> cause increased periosteal bone growth, increased organ size, glucose intolerance, and coarsening of facial features</div>", "time": null}, {"id": 1461878157516, "note": "Conditions with <i>excess</i> <b>growth hormone</b> may be treated with <b>{{c1::somatostatin}} analogues</b> such as <b>{{c1::octreotide}}</b>, which inhibit growth hormone secretion ", "time": null}, {"id": 1461878460770, "note": "The most important of the <b>somatomedins</b> is <b>{{c1::somatomedin C}}</b>, also known as <b>{{c1::IGF-1}}</b>", "time": null}, {"id": 1461878628938, "note": "What is the embryonic origin of the <b>anterior pituitary</b>? <div><br /></div><div>{{c1::Oral ectoderm, specifically from Rathkes pouch::very specific}}</div>", "time": null}, {"id": 1461878671855, "note": "<div>What is the <b>source</b> of <u>prolactin</u> and <u>growth hormone</u> secretion?</div><div><br></div><div>{{c1::Anterior pituitary}}</div>", "time": null}, {"id": 1461880415237, "note": "<b>Prolactin</b> is the major hormone responsible for {{c1::<b>milk production</b> (lactogenesis)}} and also participates (with estrogen) in {{c1::breast development}}", "time": null}, {"id": 1461880431253, "note": "<div><b>Prolactin</b> is structurally <i>homologous</i> to <b>{{c1::growth hormone}}</b></div>", "time": 1660105353645.0}, {"id": 1461880437675, "note": "<div><b>Prolactin</b> is synthesized by {{c1::lactotrophs}}, which represent approximately 15% of the tissue in the anterior pituitary</div>", "time": null}, {"id": 1461880451899, "note": "<div><b>Prolactin</b> secretion is <b>{{c2::<i>tonically</i> inhibited}}</b> by {{c1::<b>dopamine</b>}}</div>", "time": null}, {"id": 1461880484814, "note": "<div><b>Prolactin</b> secretion is stimulated via {{c1::thyrotropin-releasing hormone (TRH)}} from the hypothalamus</div>", "time": null}, {"id": 1461880499776, "note": "<div>What effect does <b>prolactin</b> have on its own secretion?</div><div><br></div><div>{{c1::Decreased}}</div>", "time": 1660105347173.0}, {"id": 1461880512032, "note": "<div>{{c1::Breast-feeding}} and {{c1::pregnancy}} are the most important <i>stimuli</i> for <b>prolactin</b> secretion</div>", "time": null}, {"id": 1461880526100, "note": "<div>What is the effect of <b>bromocriptine</b> (a dopamine agonist) on <b>prolactin</b> <b>secretion</b>?</div><div><br></div><div>{{c1::Decreased}}</div>", "time": null}, {"id": 1461880545687, "note": "<div><b>{{c1::Prolactin}}</b> stimulates <b>milk production</b> in the breast by inducing synthesis of milk components including <b>casein</b> and <b>lactose</b></div>", "time": 1660105339165.0}, {"id": 1461880555092, "note": "<div><b>{{c1::Prolactin}}</b> stimulates <b>breast development</b> in a supportive role with estrogen</div>", "time": null}, {"id": 1461880563805, "note": "<div>What effect does <b>prolactin</b> have on <b>ovulation </b>and<b> spermatogenesis</b>?</div><div><br></div><div>{{c1::Decreased / Inhibition}}</div>", "time": null}, {"id": 1461880585745, "note": "<div><b>Prolactin</b> <i>{{c2::inhibits}}</i> ovulation and spermatogenesis by decreasing synthesis and release of <b>{{c1::GnRH}}</b></div>", "time": null}, {"id": 1461880606750, "note": "<div><b>Prolactin</b> deficiency occurs with destruction of the <b>{{c2::anterior pituitary}}</b> and results in the <b>failure to {{c1::lactate}}</b> (females)</div>", "time": null}, {"id": 1461880625384, "note": "<div><u>Destruction of the hypothalamus</u> or <u>interruption of the hypothalamic-hypophysial tract</u> result in <b>prolactin excess </b>by causing loss of {{c1::tonic inhibition by dopamine}}</div>", "time": null}, {"id": 1461880651296, "note": "<div>The major symptoms of <b>prolactin excess</b> are <b>{{c1::galactorrhea}}</b> and <b>{{c2::infertility}}</b></div>", "time": null}, {"id": 1461880672430, "note": "<div>Is <b>libido</b> <i>increased</i> or <i>decreased</i> in patients with <b>excess prolactin</b>?</div><div><br /></div><div>{{c1::Decreased}} </div>", "time": null}, {"id": 1461880683894, "note": "<div>How can <b>prolactin excess</b> be treated? </div><div><br></div><div>{{c1::Dopamine agonists (e.g. bromocriptine)}}</div>", "time": null}, {"id": 1461883823047, "note": "<div>What <u>two</u> hormones are secreted by the <b>posterior lobe</b> of the pituitary gland?</div><div><br></div><div>{{c1::ADH and oxytocin}}</div>", "time": null}, {"id": 1461884702127, "note": "<div>Both <b>ADH</b> and <b>oxytocin</b> are <b>neuropeptides</b>,&nbsp;<i>synthesized</i> in hypothalamic neurons and <i>secreted</i> from nerve terminals in the {{c1::posterior pituitary}}</div>", "time": null}, {"id": 1461884717288, "note": "<div>{{c2::<b>Antidiuretic hormone </b>(ADH)}} and <b>{{c1::oxytocin}}</b> are&nbsp;<i>homologous</i><b><i> </i>nonapeptides</b> (9 AA)</div>", "time": null}, {"id": 1461884723914, "note": "<div>En route to the <i>posterior pituitary, </i><b>ADH</b> and <b>oxytocin</b> are packaged in secretory granules with their respective <b>{{c1::neurophysins}}</b></div>", "time": null}, {"id": 1461884730279, "note": "<div><b>{{c2::Antidiuretic hormone (ADH)}}</b> is packaged with <b>neurophysin {{c1::II}}</b> and glycoprotein</div>", "time": null}, {"id": 1461884747560, "note": "<div><b>{{c2::Oxytocin}}</b> is packaged with <b>neurophysin {{c1::I}}</b></div>", "time": null}, {"id": 1461884755574, "note": "<div>The cell bodies of <b>{{c1::ADH}}-secreting neurons</b> originate primarily in the <b>{{c2::supraoptic}} nuclei</b> of the hypothalamus</div>", "time": null}, {"id": 1461884763062, "note": "<div>The cell bodies of <b>{{c1::oxytocin}}-secreting neurons</b> (from the posterior pituitary) originate primarily in the <b>{{c2::paraventricular}} nuclei</b> of the hypothalamus</div>", "time": null}, {"id": 1461884779583, "note": "<div>The most important physiologic stimulus for <i>increasing</i> <b>antidiuretic hormone</b> (ADH) secretion is <b>{{c1::increased plasma osmolarity}}</b></div>", "time": null}, {"id": 1461884800688, "note": "<div>What receptors sense an increase in <b>plasma osmolarity</b>, providing stimuli to increase <b>ADH</b> secretion?</div><div><br></div><div>{{c1::Osmoreceptors in the anterior hypothalamus::What and where?}}</div>", "time": null}, {"id": 1461884807843, "note": "<div><b>Hypovolemia </b>or <b>volume {{c1::contraction}}</b> is another potent <u>stimulus</u> for <b>ADH secretion</b></div>", "time": null}, {"id": 1461884819979, "note": "<div>What receptors sense a decrease in <b>plasma volume</b>, providing stimuli to <i>increase</i> <b>ADH</b> secretion?</div><div><br /></div><div>{{c1::Baroreceptors}}</div>", "time": null}, {"id": 1461884838662, "note": "<div>What is the effect on <b>ADH secretion</b> if a patient has <u>low volume</u> AND <u>low osmolarity</u>? </div><div><br></div><div>{{c1::Volume trumps osmolarity and ADH <i>is</i> secreted}}</div>", "time": null}, {"id": 1461884846394, "note": "<div>What is the effect on <b>ADH secretion</b> if a patient has <u>high volume</u> AND <u>high osmolarity</u>?</div><div><br></div><div>{{c1::Volume trumps osmolarity and ADH <i>is not</i> secreted (or less is secreted as osmolarity increases)}}</div>", "time": null}, {"id": 1461884855032, "note": "<div>What effect do&nbsp;<b>pain</b>, <b>nausea</b>, <b>hypoglycemia</b>, and <b>opiates</b> have on <u>ADH secretion</u>?</div><div><br></div><div>{{c1::Increased}}</div>", "time": null}, {"id": 1461884861116, "note": "<div>What effect does <b>alcohol</b>, <b>atrial natriuretic peptide</b>, and <b>\u03b1-adrenergic agonists</b> have on <u>ADH secretion</u>?</div><div><br></div><div>{{c1::Decreased}}</div>", "time": null}, {"id": 1461884867388, "note": "<div>The major action of <b>ADH (vasopressin)</b> is to <b>increase {{c1::water permeability (and thus reabsorption)}}</b> of the principal cells in the <b>{{c2::<i>late</i> distal convoluted tubule}}</b> and <b>{{c2::collecting duct}}</b></div>", "time": null}, {"id": 1461884871184, "note": "<div>The <i>receptors</i> for <b>ADH</b> on the <b>principal</b> <b>cells</b> of the late distal tubule and collecting duct are <b>{{c1::V<sub>2</sub>}} receptors</b></div>", "time": null}, {"id": 1461884917022, "note": "<div><div>Through which <u>secondary messenger(s)</u> does the <b>ADH</b>-bound <b>V<sub>2</sub> receptor </b>propagate its signal?</div><div><br /></div><div>{{c1::cAMP}}</div></div>", "time": null}, {"id": 1461884921465, "note": "<div>How does <b>ADH</b> <i>increase H<sub>2</sub>O permeability </i>of the principal cells of the late distal tubule and collecting duct?</div><div><br /></div><div>Increased {{c1::<b>aquaporin 2 (AQP2)</b>}} channels via <u>increased</u> {{c1::cAMP}}</div>", "time": null}, {"id": 1461884927872, "note": "<div>In addition to its actions on serum osmolarity, <b>ADH (vasopressin)</b> may also cause {{c1::contraction of vascular smooth muscle (regulate blood pressure)}}</div>", "time": null}, {"id": 1461884968628, "note": "<div>The receptor for <b>ADH</b> on vascular smooth muscle is a(n)&nbsp;<b>{{c1::V<sub>1</sub>}} receptor</b> </div>", "time": null}, {"id": 1461884982922, "note": "<div><div><div>Through which <u>secondary messenger(s)</u> does the ADH-bound <b>V<sub>1</sub> receptor </b>propagate its signal?</div><div><br /></div><div>{{c1::IP<sub>3</sub>/Ca<sup>2+</sup>}}</div></div></div>", "time": null}, {"id": 1461884987103, "note": "<div>What is the end result of <b>ADH</b> binding to <b>V<sub>1</sub></b> receptors on vascular smooth muscle?</div><div><br></div><div><b>{{c1::Contraction of vascular smooth muscle}}</b></div>", "time": null}, {"id": 1461885006895, "note": "<div>Which receptor does <b>antidiuretic hormone</b> (vasopressin) bind to regulate <u>serum osmolarity</u>?</div><div><br /></div><div>{{c1::V<sub>2</sub> receptors}}</div>", "time": null}, {"id": 1461885010270, "note": "<div>Which receptor does <b>antidiuretic hormone</b> bind to regulate <u>blood pressure</u>?</div><div><br /></div><div>{{c1::V<sub>1</sub> receptors}} </div>", "time": null}, {"id": 1461976397557, "note": "<b>{{c2::<i>Central</i>}}</b> <b>diabetes insipidus </b>is caused by <u>failure</u> of the <i>posterior pituitary</i> to secrete <b>{{c1::ADH}} </b>", "time": 1660105338201.0}, {"id": 1461978083695, "note": "<div>Which <u>ADH disorder</u> is characterized by <u>low levels</u> of circulating <b>ADH</b> and thus <b>large volumes</b> of <b>dilute urine</b>? </div><div><br /></div><div>{{c1::central diabetes insipidus (nephrogenic has <u>high</u> ADH levels)}}</div>", "time": null}, {"id": 1461978094215, "note": "<div><b><i>Central</i></b>&nbsp;<b>diabetes insipidus</b> is treated with a(n)&nbsp;<b>{{c1::ADH}}</b> <b>analogue</b>, such as <b>{{c2::dDAVP (desmopressin)}}</b></div>", "time": null}, {"id": 1461978101467, "note": "<div>In <b>{{c1::<i>nephrogenic</i> diabetes insipidus}}</b>, the <i>principal cells</i> of the collecting duct are <u>unresponsive</u> to <b>{{c2::ADH}}</b> due to a defect in the V<sub>2</sub> receptor, G<sub>s</sub> protein, or adenylyl cyclase</div>", "time": null}, {"id": 1461978108106, "note": "<div>Which type of <b>diabetes insipidus</b> is characterized by an <u>inability</u> of the <u>posterior pituitary</u> to secrete <b>ADH</b>?</div><div><br></div><div>{{c1::Central diabetes insipidus}}</div>", "time": null}, {"id": 1461978112272, "note": "<div>Which type of <b>diabetes insipidus</b> is characterized by a <u>lack of response</u> to the <b>ADH</b> secreted by the <u>posterior pituitary</u>?</div><div><br></div><div>{{c1::Nephrogenic diabetes insipidus}}</div>", "time": null}, {"id": 1461978118121, "note": "<div>Which type of <b>diabetes insipidus</b> is characterized by <b>elevated</b> levels of <b>ADH</b>?</div><div><br></div><div>{{c1::Nephrogenic diabetes insipidus}}</div>", "time": null}, {"id": 1461978145086, "note": "<div><b><i>Nephrogenic</i></b>&nbsp;<b>diabetes insipidus</b> is treated with <b>{{c1::thiazide}} diuretics</b></div>", "time": null}, {"id": 1461978156443, "note": "<div>In <b>syndrome of </b>{{c1::<b>inappropriate ADH</b> (SIADH)}}, <b>excess</b> <b>ADH</b> is secreted from an <b>autonomous site</b></div>", "time": 1660105356843.0}, {"id": 1461978165029, "note": "<div>Which <u>ADH disorder</u> is characterized by<i> </i><u>high</u> levels of circulating <b>ADH</b> and thus&nbsp;<b>inappropriately <u>concentrated</u> urine</b>?</div><div><br></div><div>{{c1::Syndrome of inappropriate ADH (SIADH)}}</div>", "time": null}, {"id": 1461978184061, "note": "<div><b>Syndrome of inappropriate ADH (SIADH)</b> may be treated with <b>{{c1::water</b>::first line treatment<b>}}</b> <b>restriction,&nbsp;</b>with {{c3::<b>conivaptan/tolvaptan</b>}}, or with a <b>tetracycline</b> such as <b>{{c2::demeclocycline}}</b></div>", "time": null}, {"id": 1461978191219, "note": "<div>What endocrine pathology is treated with <b>demeclocycline</b>?</div><div><br /></div><div>{{c1::SIADH}}</div>", "time": null}, {"id": 1461978531598, "note": "<b>{{c2::Oxytocin}}</b> causes <b>{{c1::ejection of milk}}</b> from the breast when stimulated by suckling", "time": null}, {"id": 1461979320393, "note": "<div>What is the <u>major</u> stimulus for <b>oxytocin secretion</b>?</div><div><br /></div><div>{{c1::Suckling of the breast}}</div>", "time": null}, {"id": 1461979329468, "note": "<div>What <u>conditioned responses</u> may stimulate <b>oxytocin secretion</b>?</div><div><br /></div><div>{{c1::Sight, sound, or smell of an infant}}</div>", "time": null}, {"id": 1461979376290, "note": "<div><b>Oxytocin</b> is <i>secreted</i> in response to <b>{{c1::dilation of the cervix}}</b> during <b>labor</b> or <b>orgasm</b></div>", "time": null}, {"id": 1461979481956, "note": "<div><b>Oxytocin</b> causes contraction of <b>{{c1::myoepithelial cells}}</b> in the breast, forcing milk stored in the <b>mammary alveoli </b>into the ducts for ejection </div>", "time": 1660105354440.0}, {"id": 1461979495589, "note": "<div><b>Oxytocin</b> causes powerful rhythmic contractions of <b>{{c1::uterine smooth}} muscle</b></div>", "time": 1660105354439.0}, {"id": 1461979522595, "note": "<div><b>{{c1::Oxytocin}}</b> is a hormone that may be used to <i>induce</i> <b>{{c2::labor}}</b> and <i>reduce</i> <b>{{c3::postpartum bleeding}}</b></div>", "time": null}, {"id": 1461979552822, "note": "<b>{{c1::Cretinism}}</b> is a condition of <b>severely stunted physical and mental growth</b> due to untreated congenital deficiency of <b>{{c2::thyroid}} hormones</b>", "time": 1660105340691.0}, {"id": 1461979698536, "note": "Which <b>thyroid hormone</b> (T<sub>3</sub> or T<sub>4</sub>) is <i>more active</i>?<div><br /></div><div>{{c1::T<sub>3</sub>}}</div>", "time": null}, {"id": 1461984633531, "note": "<div>What is the main <b>thyroid hormone</b> (T<sub>3</sub> or T<sub>4</sub>) that is <i>secreted</i>? </div><div><br /></div><div>{{c1::T<sub>4</sub>}}</div>", "time": null}, {"id": 1461984643617, "note": "<div><b>Thyroid hormones</b> are synthesized by the <b>{{c1::follicular epithelial}} cells</b> of the thyroid gland</div>", "time": 1660105348755.0}, {"id": 1461984665340, "note": "<div>In the <u>first</u> step of <b>thyroid hormone </b>synthesis, <b>{{c1::thyroglobulin}} </b>is synthesized from <b>{{c2::tyrosine}}</b> in the <b>thyroid follicular cells</b> </div>", "time": null}, {"id": 1461984695705, "note": "<div>The glycoprotein <b>thyroglobulin</b> (TG) contains large quantities of the <b>amino acid</b> <b>{{c1::tyrosine}}</b></div>", "time": 1660105350074.0}, {"id": 1461984713642, "note": "<div><b>Thyroglobulin synthesis</b> (as part of <u>thyroid hormone synthesis</u>) occurs in the {{c1::RER}} and {{c1::Golgi apparatus}} of the <b>thyroid follicular cells</b></div>", "time": null}, {"id": 1461984729677, "note": "<div>How does <b>iodine</b> enter the <b>follicular epithelial cell</b> (as part of <u>thyroid hormone synthesis</u>)? </div><div><br /></div><div>{{c1::Through Na<sup>+</sup>-I<sup>-</sup> cotransport, A.K.A the iodine pump}}</div>", "time": 1660105358090.0}, {"id": 1461984744498, "note": "<div>If there are <u>low</u> levels of <b>iodine (I<sup>-</sup>)</b>, the <i>activity</i> of the <b>Na<sup>+</sup>-I<sup>-</sup> cotransport</b> {{c1::increases}}, and vice versa</div>", "time": null}, {"id": 1461984762666, "note": "<div><b>Thiocyanate</b> and <b>perchlorate</b> are competitive <u>inhibitors</u> of the <b>{{c1::Na<sup>+</sup>-I<sup>-</sup> cotransport}} pump</b>, thus interfering with the synthesis of <b>thyroid hormones</b></div>", "time": 1660105337256.0}, {"id": 1461984815252, "note": "<div>Once <b>I<sup>-</sup></b> has been pumped into the cell for <u>thyroid hormone synthesis</u>, it is <b>{{c1::oxidized}}</b> to <b>I<sub>2</sub></b> by the enzyme <b>{{c2::thyroid peroxidase}}</b> in the follicular cell membrane</div>", "time": null}, {"id": 1461984963965, "note": "<div><b>Thyroid peroxidase</b> <i>and</i> <b>deiodinase </b>may be inhibited by <b>{{c1::propylthiouracil (PTU)}}</b>, which is used therapeutically for the treatment of <b>{{c2::hyperthyroidism}}</b> </div>", "time": null}, {"id": 1461985089349, "note": "{{c1::<b>5-Deiodinase</b>}} is inhibited by glucocorticoids, \u03b2-blockers, and PTU", "time": null}, {"id": 1461985157595, "note": "{{c1::Thyroperoxidase}} is inhibited by Methimazole and PTU", "time": null}, {"id": 1461985179436, "note": "<div>At the junction of the follicular cells and the follicular lumen, <b>{{c1::tyrosine}} </b>residues of <b>thyroglobulin&nbsp;</b>react with <b>I<sub>2</sub></b> to form {{c2::<b>monoiodotyrosine</b> (MIT)}} and {{c2::<b>diiodotyrosine</b> (DIT)}}</div>", "time": null}, {"id": 1461985266429, "note": "<div>The <b>{{c1::organification}} </b>of <b>I<sub>2</sub> </b>into <b>thyroglobulin</b> is mediated by the enzyme <b>{{c2::thyroid peroxidase}}</b></div>", "time": 1660105349112.0}, {"id": 1461985304582, "note": "<div>High levels of <b>{{c1::I<sup>-</sup>}}</b> inhibit <b>{{c2::organification}}</b> of <b>I<sub>2</sub></b>, and therefore inhibit synthesis of <u>thyroid hormones</u> (<b>{{c3::Wolff-Chaikoff}} effect</b>)</div>", "time": null}, {"id": 1461985394124, "note": "<div><i>After</i> organification of I<sub>2</sub>, <b>coupling</b> between <b>{{c2::two molecules of DIT}}</b> may combine to form <b>{{c1::thyroxine (T<sub>4</sub>)}}</b></div>", "time": null}, {"id": 1461985436986, "note": "<div><i>After</i> organification of I<sub>2</sub>, <b>coupling</b> between <b>{{c1::a molecule of MIT and a molecule of DIT}}</b> may combine to form <b>{{c2::triiodothyronine (T<sub>3</sub>)}}</b></div>", "time": null}, {"id": 1461985501857, "note": "<div>After <b>iodinated thyroglobulin</b> is synthesized, it is stored in the <b>follicular lumen</b> as <b>{{c1::colloid}}</b> until the thyroid gland is stimulated to secrete thyroid hormones</div>", "time": 1660105362014.0}, {"id": 1461985522739, "note": "<div>Why is much more <b>T<sub>4</sub></b> produced compared to <b>T<sub>3</sub></b>?</div><div><br /></div><div>{{c1::The <b>coupling</b> <b>reaction</b> for T<sub>4</sub> is much faster}}</div>", "time": null}, {"id": 1461985542858, "note": "<div>What <u>three</u> steps does <b>thyroid peroxidase</b> catalyze during the synthesis of thyroid hormones?</div><div><br /></div><div>{{c1::<div> 1. Oxidation (I<sup>-</sup> to I<sub>2</sub>)</div><div> 2. Organification (of I<sub>2</sub> into MIT and DIT)</div><div> 3. Coupling (of MIT and DIT into T<sub>3</sub> and T<sub>4</sub>)</div>}}</div>", "time": 1660105344906.0}, {"id": 1461985573952, "note": "<div>When the thyroid gland is stimulated, <b><i>iodinated</i> thyroglobulin</b> is <b>{{c1::endocytosed}}</b> into the follicular epithelial cells </div>", "time": null}, {"id": 1461985599113, "note": "<div>After <b>iodinated thyroglobulin</b> is <i>endocytosed</i> into the follicular epithelial cells, {{c1::<b>lysosomal</b> <b>proteases</b>}} <b>hydrolyze</b> peptide bonds, releasing T<sub>4</sub>, T<sub>3</sub>, MIT, and DIT</div>", "time": 1660105362015.0}, {"id": 1461985625347, "note": "<div>After release from iodinated thyroglobulin, <b>T<sub>4</sub></b> and <b>T<sub>3</sub></b> enter the {{c1::<b>systemic</b> <b>circulation</b>}}</div>", "time": null}, {"id": 1461985640145, "note": "<div>After release from iodinated thyroglobulin, <b>MIT</b> and <b>DIT</b> are <b>{{c1::deiodinated}}&nbsp;</b>by the enzyme <b>{{c2::thyroid deiodinase}}</b>, reproducing <b>{{c3::I<sup>-</sup></b><b>}} </b>and <b>{{c3::tyrosine}}</b></div>", "time": null}, {"id": 1461985675479, "note": "<div>The <b>{{c1::tyrosine}}</b> and <b>{{c1::I<sup>-</sup>}}</b> that is generated by <b>deiodination of MIT and DIT</b> is recycled and used for further <u>thyroid hormone synthesis</u></div>", "time": null}, {"id": 1461985737790, "note": "<div>A patient with <b>thyroid deiodinase</b> <b>deficiency</b> would mimic which mineral <i>deficiency</i>?</div><div><br></div><div>{{c1::Iodine deficiency, due to inability recycle iodine}}</div>", "time": null}, {"id": 1461985749010, "note": "<div>In the <b>circulation</b>, most of the <b>T</b><sub style=\"font-weight: bold; \">3</sub> and <b>T</b><sub style=\"font-weight: bold; \">4</sub> is bound to {{c1::<b>thyroxine-binding globulin</b> (TBG)}}</div>", "time": null}, {"id": 1461986013689, "note": "<div>Once in <i>target</i> <i>tissues</i>, the enzyme <b>{{c1::5-deiodinase}}</b> converts <b>{{c3::T<sub>4</sub>}} </b>to <b>{{c3::T<sub>3</sub>}}</b> by removing one atom of I<sub>2</sub>; a certain portion is also converted to <b>{{c2::reverse T<sub>3</sub> (rT<sub>3</sub>)}}</b> which is <i>inactive</i> </div>", "time": null}, {"id": 1461986072634, "note": "<div>Which thyroid hormone (T<sub>4</sub> or T<sub>3</sub>) binds to <b>nuclear receptor</b> with <i>greater affinity</i>?</div><div><br></div><div>{{c1::T<sub>3</sub>}}</div>", "time": 1660105341977.0}, {"id": 1462032410674, "note": "<b>Thyrotropin-releasing hormone (TRH)</b> is secreted by the <b>{{c1::paraventricular}} nuclei</b> of the hypothalamus", "time": null}, {"id": 1462037942264, "note": "<div><b>{{c3::Thyrotropin-releasing hormone (TRH)}}</b> acts on <b>thyrotrophs</b> of the <i>anterior pituitary</i> to stimulate the secretion of <b>{{c2::thyroid-stimulating hormone (TSH)}}</b></div>", "time": null}, {"id": 1462038045403, "note": "<div>How does <b>free T<sub>3</sub> </b>cause <u>decreased</u> secretion of <b>thyroid stimulating hormone</b>? </div><div><br /></div><div>{{c1::<u>Down-regulating</u> the TRH receptors on the thyrotrophs of the anterior pituitary}}</div>", "time": null}, {"id": 1462038123541, "note": "<div><div>Through which <u>secondary messenger(s)</u> does <b>TSH</b> exert its actions on the thyroid gland?</div><div><br /></div><div>{{c1::cAMP}}</div></div>", "time": null}, {"id": 1462038128069, "note": "<div>One role of <b>TSH</b> on the thyroid gland is to increase <i>both</i> <b>{{c1::synthesis}}</b> and <b>{{c1::secretion}}</b> of <b>thyroid</b> <b>hormones</b> by the follicular cells </div>", "time": 1660105354585.0}, {"id": 1462038150878, "note": "<div><b>Thyroid-stimulating hormone</b> (TSH) has a <b>trophic </b>effect on the thyroid gland, thus, <u>chronic elevation</u> of TSH causes {{c2::<b>hypertrophy</b>/<b>hyperplasia</b>}} of the thyroid gland</div>", "time": null}, {"id": 1462038188179, "note": "<div>In addition to TSH, the <b>TSH receptor</b> on thyroid glands may be activated by <b>{{c1::Thyrotropin receptor antibodies (TRAb)}}</b> (Graves disease)</div>", "time": null}, {"id": 1462038296160, "note": "<div>What effect does <u>increased TBG levels</u> have on <b>thyroid hormone secretion</b>?</div><div><br /></div><div>{{c1::Increases secretion}}</div>", "time": null}, {"id": 1462038317147, "note": "<div>What effect does <u>excessive I</u><sup>-</sup><u> intake </u> have on <b>thyroid hormone secretion</b>?</div><div><br /></div><div>{{c1::Decreases secretion (Wolff-Chaikoff effect)}}</div>", "time": null}, {"id": 1462038359619, "note": "<div>What effect does <u>I</u><sup>-</sup><u> deficiency</u> have on <b>thyroid hormone secretion</b>?</div><div><br /></div><div>{{c1::Decreases secretion}}</div>", "time": null}, {"id": 1462038445101, "note": "<div>Once <b>T</b><sub style=\"font-weight: bold; \">3</sub> is produced inside its target cell, it enters the <b>{{c1::nucleus}}</b> and binds to a(n)&nbsp;<b>{{c1::nuclear}} receptor</b></div>", "time": null}, {"id": 1462038493029, "note": "<div>After T<sub>3</sub> binds its nuclear receptor, the <b>T<sub>3</sub>-receptor complex</b> binds to a <u>thyroid-regulatory element</u><b> </b>on DNA, where it stimulates {{c1::DNA transcription}}</div>", "time": null}, {"id": 1462038514628, "note": "<div>One major effect of <b>thyroid hormone</b> is <b>increased {{c1::O<sub>2</sub> consumption}} </b>with a resultant <u>increase</u> in <b>{{c2::BMR}}</b> and <b>{{c2::body temperature}}, </b>due to increased {{c3::Na/K+-ATPase}} activity</div>", "time": 1660105354602.0}, {"id": 1462038533263, "note": "<div><b>Thyroid hormones</b> increase <b>oxygen consumption</b> in <i>all </i>tissues EXCEPT the {{c1::brain}}, {{c1::gonads}}, and {{c1::spleen}}</div>", "time": null}, {"id": 1462038554234, "note": "<div>How do <b>thyroid hormones</b> cause an increase in <b>oxygen consumption</b>? </div><div><br /></div><div>{{c1::Via increased <i>synthesis</i> and <i>activity</i> of the Na<sup>+</sup>-K<sup>+</sup>-ATPase pump}}</div>", "time": null}, {"id": 1462038565107, "note": "<div>Thyroid hormone increases the processes of <b>{{c1::glycogenolysis}}</b>, <b>{{c1::gluconeogenesis}}</b>,&nbsp;<b>{{c2::proteolysis}}</b>, and <b>{{c2::lipolysis}}</b>, all of which may provide sources of <b>ATP</b></div>", "time": 1660105348759.0}, {"id": 1462038586217, "note": "<div><b>Thyroid hormone</b> increases <b>{{c1::glucose}}</b> absorption from the GI tract to meet the metabolic demands of increased O<sub>2</sub> consumption</div>", "time": null}, {"id": 1462038610838, "note": "<div>While <b>thyroid hormone</b> increases <i>both</i> protein <u>synthesis</u>&nbsp;and <u>degradation</u>, the <b>overall</b> effect of thyroid hormone is <b>{{c1::catabolic}}</b></div>", "time": null}, {"id": 1462038624500, "note": "<div>What is the effect of <b>thyroid hormone</b> on the <b>cardiovascular</b> and <b>respiratory systems</b>? </div><div><br /></div><div>{{c1::Increased activity}}</div>", "time": 1660105346506.0}, {"id": 1462038633475, "note": "<div>Thyroid hormones <i>increase</i> <b>cardiac</b> <b>output&nbsp;</b>by <u>inducing synthesis</u> (upregulation) of {{c1::<b>\u03b2</b><sub style=\"font-weight: bold;\">1</sub>-<b>adrenergic</b>}} <b>receptors</b> in the heart</div>", "time": null}, {"id": 1462038652698, "note": "<div>The <b>increase </b>in<b> {{c2::cardiac output}}</b> due to thyroid hormone is the result of a combination of <i>increased</i> <b>heart rate</b> and <i>increased</i><b><i> </i>stroke volume (contractility)</b></div>", "time": null}, {"id": 1462038674313, "note": "<div>One potential complication of <b>excess</b> <b>thyroid hormone</b> is high output {{c1::heart failure}}</div>", "time": null}, {"id": 1462038682267, "note": "<div><b>Thyroid hormone</b> works synergistically with <b>growth hormone</b> and <b>somatomedins</b> to promote <b>{{c1::bone formation}}</b></div>", "time": 1660105348756.0}, {"id": 1462038696517, "note": "<div>Thyroid hormones stimulate <b>bone {{c1::maturation}}</b> as a result of ossification and fusion of the growth plates</div>", "time": null}, {"id": 1462038763651, "note": "<div>In the <b>{{c2::perinatal}} period</b>, thyroid hormone is essential for <b>{{c1::CNS maturation}}</b></div>", "time": 1660105356582.0}, {"id": 1462038777530, "note": "<div><b>Hypothyroidism</b> in the <b>perinatal period</b> causes <i>irreversible</i><b><i> </i></b>{{c1::<b>mental retardation</b> (<b>cretinism</b>)}}</div>", "time": 1660105357846.0}, {"id": 1462038815493, "note": "<div>Which <b>thyroid disorder</b> causes hyperexcitability, hyperreflexia, and irritability in <b>adulthood</b>?</div><div><b><br></b></div><div><b>{{c1::Hyperthyroidism}}</b> </div>", "time": null}, {"id": 1462038836551, "note": "<div>A useful <i>adjunct</i> therapy for <b>hyperthyroidism</b> is a(n) {{c1::\u03b2-adrenergic}} blocking agent, such as <b>{{c2::propranolol}}</b></div>", "time": null}, {"id": 1462038854701, "note": "<div><u>Actions of Thyroid Hormone Summary</u>: No answer {{c1:::)}}</div><div><br /></div><div><img src=\"paste-491554712060152.jpg\" /></div>", "time": null}, {"id": 1462038872057, "note": "<div>The <i>most common</i> cause of <b>hyperthyroidism</b> is {{c1::Graves disease}}</div>", "time": null}, {"id": 1462038910568, "note": "<div>In what cases may the levels of <b>TSH</b> be <u>increased</u> during <b>hyperthyroidism</b>? </div><div><br /></div><div>{{c1::When the disorder is in the hypothalamus or anterior pituitary (i.e. excessive TRH or TSH secretion)}}</div>", "time": 1660105356520.0}, {"id": 1462038986297, "note": "<div><b>Hyperthyroidism</b> may be treated <u>surgically</u> via {{c1::thyroidectomy}} or with the <u>drug</u> {{c1::propylthiouracil (PTU)}}, which inhibits <i>both</i> thyroid peroxidase and deiodinase</div>", "time": null}, {"id": 1462039003966, "note": "<div>In which disorder (<b>hyper- or hypothyroidism</b>) may a patient present with a <b>goiter</b>? </div><div><br /></div><div>{{c1::Both!}}</div>", "time": null}, {"id": 1462039023178, "note": "<div>The <i>most common</i> cause of <b>hypothyroidism</b> in iodine replete countries is {{c1::autoimmune or Hashimoto thyroiditis}}</div>", "time": null}, {"id": 1462039030033, "note": "<div><div>What are the levels of <b>TSH</b> in <b>hypothyroidism</b> due to <b>thyroiditis</b> or <b>I<sup>-</sup> deficiency</b>? Why?</div><div><br /></div><div>{{c1::Increased due to negative feedback from decreased level of free T<sub>3</sub>}}</div></div>", "time": 1660105347682.0}, {"id": 1462039045912, "note": "<div><div>In what cases may the levels of <b>TSH</b> be <u>decreased</u> during <b>hypothyroidism</b>? </div><div><br /></div><div>{{c1::When the disorder is in the hypothalamus or anterior pituitary (i.e. insufficient TRH or TSH secretion)}}</div></div>", "time": 1660105356521.0}, {"id": 1462039119063, "note": "<div><div><b>Hypothyroidism</b> may be treated with {{c1::thyroid hormone replacement therapy (e.g. levothyroxine, triiodothyronine)}}</div></div>", "time": null}, {"id": 1462039124289, "note": "<div><u><b>Hyperthyroidism</b> vs <b>Hypothyroidism</b> Summary Table</u>: no answer {{c1:::)}}</div><div><br /></div><div><img src=\"paste-491756575523402.jpg\" /></div>", "time": null}, {"id": 1462039139240, "note": "The <b>adrenal medulla</b> is in the <b>{{c1::inner}}</b> <b>zone</b> of the adrenal gland and composes approximately <b>20%</b> of the glandular tissue ", "time": null}, {"id": 1462043406009, "note": "<div>The <b>adrenal medulla</b> is of <b>{{c1::neural crest}} </b>origin</div>", "time": null}, {"id": 1462043410108, "note": "The&nbsp;<b>adrenal medulla&nbsp;</b>is responsible for the secretion of the&nbsp;<b>catecholamines</b>&nbsp;{{c1::norepinephrine}} and {{c1::epinephrine}}", "time": null}, {"id": 1462043412770, "note": "<div>The <b>adrenal cortex</b> is in the <b>{{c1::outer}} zone</b> of the adrenal gland and composes approximately <b>80%</b> of the glandular tissue</div>", "time": null}, {"id": 1462049653810, "note": "<div>The <b>adrenal cortex</b> has <u>three</u> layers:</div><div> 1. Zona {{c1::reticularis}} (the innermost zone)</div><div> 2. Zona {{c1::fasciculata}} (middle, widest zone)</div><div> 3. Zona {{c1::glomerulosa}} (outermost zone)</div><div></div>", "time": 1660105350483.0}, {"id": 1462049673226, "note": "<div>The <b>zona {{c2::glomerulosa}}</b> secretes <b>{{c1::mineralocorticoids}}</b>, such as {{c1::aldosterone}}</div>", "time": 1660105349342.0}, {"id": 1462049687559, "note": "<div>The <b>zona {{c1::fasciculata}}</b> secretes <b>{{c2::glucocorticoids}}</b>, such as {{c2::cortisol}}</div>", "time": 1660105349344.0}, {"id": 1462049697854, "note": "<div>The <b>zona {{c2::reticularis}}</b> secretes <b>{{c1::androgens}}</b>, such as dehydroepiandrosterone (DHEA) and androstenedione</div>", "time": 1660105349340.0}, {"id": 1462049746964, "note": "<div>What is the <b>rate-limiting enzyme</b> in the biosynthesis of <i>adrenocortical</i> hormones?</div><div><br></div><div>{{c1::Cholesterol desmolase}}</div>", "time": null}, {"id": 1462049756266, "note": "<div>The <i>major</i> <b>glucocorticoid</b> produced in humans is {{c1::<b>cortisol</b> (hydrocortisone)}}</div>", "time": null}, {"id": 1462049766892, "note": "<div>The <i>major</i> <b>mineralocorticoid</b> produced in humans is <b>{{c1::aldosterone}}</b></div>", "time": null}, {"id": 1462049776032, "note": "<div><div>The <u>first</u> step in <i>all</i> pathways of <b>adrenocortical hormone synthesis</b> is the conversion of <b>{{c1::cholesterol}}</b> to <b>{{c1::pregnenolone}}</b> by the enzyme <i>{{c2::<b>cholesterol</b> <b>desmolase</b>}} </i></div></div>", "time": null}, {"id": 1462049892666, "note": "<div><b>Pregnenolone</b> may be converted to <b>{{c1::progesterone}}</b> via the enzyme <b><i>{{c2::3\u03b2-hydroxysteroid dehydrogenase}}</i></b></div>", "time": null}, {"id": 1462049935679, "note": "<div><b>Progesterone</b> may be converted to <b>{{c1::11-deoxycorticosterone (DOC)}}</b> via the enzyme {{c2::<b><i>21</i></b><i><b>\u03b2-hydroxylase</b></i>}}</div>", "time": null}, {"id": 1462049962406, "note": "<div><b>11-deoxycorticosterone (DOC)</b> may be converted to <b>{{c1::corticosterone}}</b> via the enzyme {{c2::<b><i>11</i></b><i><b>\u03b2-hydroxylase</b></i>}}</div>", "time": null}, {"id": 1462050002651, "note": "<div><b>Corticosterone</b> may be converted to <b>{{c1::aldosterone}}</b> via the enzyme <b><i>{{c2::aldosterone synthase}}</i></b></div>", "time": null}, {"id": 1462050158143, "note": "<b>Pregnenolone&nbsp;</b>may be converted to&nbsp;<b>{{c1::17-hydroxypregnenolone}}</b>&nbsp;via the enzyme&nbsp;<b><i>{{c2::17\u03b1-hydroxylase}}</i></b>", "time": null}, {"id": 1462050188336, "note": "<div><b>Progesterone</b> may be converted to <b>{{c1::17-hydroxyprogesterone}}</b> via the enzyme <i><b>{{c2::17\u03b1-hydroxylase}}</b></i></div>", "time": 1660105353660.0}, {"id": 1462050210541, "note": "<div><b>17-hydroxypregnenolone</b> may be converted to <b>{{c1::17-hydroxyprogesterone}}</b> via the enzyme <i><b>{{c2::3\u03b2-hydroxysteroid dehydrogenase}}</b></i></div>", "time": null}, {"id": 1462050232929, "note": "<div><b>17-hydroxyprogesterone</b> may be converted to <b>{{c1::11-deoxycortisol}}</b> via the enzyme <b>{{c2::21<i>\u03b2-hydroxylase</i>}}</b></div>", "time": null}, {"id": 1462050264981, "note": "<div><b>11-deoxycortisol</b> may be converted to <b>{{c1::cortisol}}</b> via the enzyme {{c2::<b>11</b><i><b>\u03b2-hydroxylase</b></i>}}</div>", "time": null}, {"id": 1462050406060, "note": "<div><b>17-hydroxypregnenolone </b>may be converted to {{c1::<b>dehydroepiandrosterone</b> (DHEA)}} via the enzyme <b><i>{{c2::17,20-lyase}}</i></b></div>", "time": 1660105362646.0}, {"id": 1462050444853, "note": "<div><b>17-hydroxyprogesterone</b> may be converted to <b>{{c1::androstenedione}}</b> via the enzyme <b><i>{{c2::17,20-lyase}}</i></b></div>", "time": 1660105362644.0}, {"id": 1462050458149, "note": "<div><b>Dehydroepiandrosterone</b> (DHEA) may be converted to <b>{{c1::androstenedione}}</b> via the enzyme {{c2::<b><i>3\u03b2-hydroxysteroid dehydrogenase</i></b>}}</div>", "time": null}, {"id": 1462050477056, "note": "<div><b>Adrenal {{c1::androgens}}</b>, such as DHEA and androstenedione, have a(n)&nbsp;<b>{{c2::ketone}}</b> group at C-17 and are excreted as <b>{{c3::17-ketosteroids}}</b> in the {{c4::urine}}</div>", "time": null}, {"id": 1462050602375, "note": "<b>{{c1::Ketoconazole}}</b> is a drug that inhibits <b>glucocorticoid</b> <b>biosynthesis</b> via inhibition of the enzyme <i><b>{{c2::cholesterol desmolase}}</b></i>", "time": null}, {"id": 1462051340374, "note": "<div><b>Glucocorticoid </b>(cortisol) <b>secretion</b> is <b>{{c1::pulsatile}}</b> and <b>{{c1::diurnal}}</b> (daily) in nature, oscillating with a <b>circadian rhythm</b></div>", "time": 1660105358618.0}, {"id": 1462053126605, "note": "<div><b>Corticotropin-releasing hormone</b> (CRH) is secreted by cells of the <b>{{c1::paraventricular}}</b> <b>nuclei</b> of the hypothalamus </div>", "time": null}, {"id": 1462053144091, "note": "<div><div>Through which <u>secondary messenger(s)</u> does <b>CRH</b> exert its actions on the anterior pituitary?</div><div><br /></div><div>{{c1::cAMP}}</div></div>", "time": null}, {"id": 1462053147855, "note": "<div><b>Corticotropin-releasing hormone (CRH)</b> binds to <b>corticotrophs</b> on the anterior pituitary, directing them to <i>synthesize</i> <b>{{c2::POMC}}</b> and <i>secrete</i> <b>{{c2::ACTH}}</b> </div>", "time": null}, {"id": 1462053248848, "note": "<div><b>ACTH</b> increases steroid hormone synthesis via stimulation of the enzyme {{c1::<b>cholesterol</b> <b>desmolase</b>}}, thus increasing the conversion of <b>cholesterol</b> to <b>pregnenolone</b> </div>", "time": null}, {"id": 1462053298193, "note": "<div>Chronically <i>elevated</i> levels of <b>ACTH</b> cause {{c1::hypertrophy/hyperplasia}} of the <b>adrenal cortex</b></div>", "time": 1660105360705.0}, {"id": 1462053314382, "note": "<div><div>Through which <u>secondary messenger(s)</u> does <b>ACTH</b> exert its actions on the adrenal cortex?</div><div><br></div><div>{{c1::cAMP}}</div></div>", "time": null}, {"id": 1462053341905, "note": "<div>Chronic <i>excess</i> levels of <b>cortisol</b> (glucocorticoid) result in decreased levels of <b>{{c1::CRH}}</b> and <b>{{c1::ACTH}}</b> via negative feedback</div>", "time": 1660105360748.0}, {"id": 1462053376290, "note": "<div><b>{{c2::Dexamethasone}}</b> is a synthetic <b>{{c1::glucocorticoid}}</b> that mimics the actions of cortisol, including <i>suppression of ACTH</i></div>", "time": 1660105338087.0}, {"id": 1462053392778, "note": "<div>The <b>{{c1::dexamethasone}} </b><b>suppression </b><b>test</b> is useful in patients with <b>{{c2::hypercortisolism}}</b><i> </i></div>", "time": null}, {"id": 1462053424992, "note": "<div>What is the result of the <b>dexamethasone suppression test</b> in a <i>normal</i> patient?</div><div><br /></div><div>{{c1::<u>Low-dose</u> dexamethasone inhibits ACTH secretion and consequently cortisol secretion}}</div>", "time": 1660105345544.0}, {"id": 1462053437992, "note": "<div>What is the result of a <b>dexamethasone suppression test</b> if the cause of <b>hypercortisolism&nbsp;</b>is an <b>ACTH-secreting tumor</b> of the <u>anterior pituitary</u>?</div><div><br></div><div>{{c1::<i>LOW</i> dose of dexamethasone does not suppress cortisol secretion, but <i>HIGH</i> dose does}}</div>", "time": 1660105345549.0}, {"id": 1462053455853, "note": "<div>What is the result of a <b>dexamethasone suppression test</b> if the cause of <b>hypercortisolism&nbsp;</b>is an <b>adrenal cortical tumor</b>?</div><div><br></div><div>{{c1::<u>Neither</u> low <i>nor</i> high dose dexamethasone suppresses cortisol secretion}} </div>", "time": 1660105345548.0}, {"id": 1462054352273, "note": "<b>{{c1::Aldosterone}} secretion</b> (from the zona glomerulosa) is under <b><i>tonic</i></b>, but not exclusive, control by <b>ACTH</b>", "time": null}, {"id": 1462054697841, "note": "<div>The primary regulation of <b>aldosterone</b> secretion occurs through changes in <b>{{c1::ECF volume}}</b> (via the <b>{{c2::renin-angiotensin II-aldosterone}}</b> <b>system</b>) and changes in serum <b>{{c1::potassium}}</b> levels </div>", "time": null}, {"id": 1462054771296, "note": "<div>Decreases in <b>{{c2::ECF volume}}</b> (e.g. hemorrhage or decreased Na<sup>+</sup>) cause a decrease in <b>renal</b> <b>perfusion</b> <b>pressure</b>, which in turn increases <b>secretion</b> of the enzyme <b>{{c1::renin}}</b></div>", "time": null}, {"id": 1462054797990, "note": "<b>{{c1::Renin}}</b>&nbsp;is an enzyme that catalyzes the conversion of&nbsp;<b>{{c2::angiotensinogen}}</b>&nbsp;to&nbsp;<b>{{c2::angiotensin I}}</b>&nbsp;in the plasma", "time": null}, {"id": 1462054808914, "note": "<div><b>{{c2::Angiotensin I}}</b> is converted to <b>{{c2::angiotensin II}}</b> by the enzyme <b>{{c1::angiotensin-converting enzyme (ACE)}}</b></div>", "time": null}, {"id": 1462054825483, "note": "<div><b>{{c1::Angiotensin II}}</b> acts on the zona glomerulosa to <i>stimulate</i> <u>aldosterone synthesis</u> via increased activity of the enzyme <b>{{c2::aldosterone synthase}}</b></div>", "time": null}, {"id": 1462054842563, "note": "<div><b>{{c1::Aldosterone}}</b> is a hormone that <u>increases</u> <b>renal Na<sup>+</sup> reabsorption</b>, thereby restoring ECF volume and blood volume to normal</div>", "time": null}, {"id": 1462054857059, "note": "<div>To what receptor does <b>angiotensin II</b> bind?</div><div><br /></div><div>{{c1::AT<sub>1</sub> receptor}}</div>", "time": null}, {"id": 1462054869905, "note": "<div>Through which <u>secondary messenger(s)</u> does the angiotensin II-bound <b>AT<sub>1</sub> receptor </b>propagate its signal?</div><div><br></div><div>{{c1::IP<sub>3</sub>/Ca<sup>2+</sup>}}</div>", "time": null}, {"id": 1462054872908, "note": "<div>How does <b>hyperkalemia</b> influence <b>aldosterone secretion</b>?</div><div><br /></div><div>{{c1::Increased aldosterone secretion}}</div>", "time": null}, {"id": 1462061124035, "note": "<div>Glucocorticoids <b>increase </b>{{c1::<b>protein catabolism</b> (proteolysis)}} in muscle and decrease protein synthesis, thereby providing more amino acids to the liver for <b>gluconeogenesis</b></div>", "time": null}, {"id": 1462061140097, "note": "<div><b>Glucocorticoids</b> {{c1::<u>decrease</u>}}<b> glucose </b><b>utilization</b> by tissues and {{c1::<u>decrease</u>}} <b>insulin</b> <b>sensitivity </b>of adipose tissue</div>", "time": 1660105358613.0}, {"id": 1462061153036, "note": "<div>Do glucocorticoids increase or decrease <b>insulin resistance</b>?</div><div><br /></div><div>{{c1::Increase (by decreasing insulin sensitivity of adipose tissue)}}</div>", "time": 1660105359937.0}, {"id": 1462061159065, "note": "<div>Glucocorticoids <b>increase peripheral {{c1::lipolysis}}</b>, which provides more <u>glycerol</u> to the liver for <b>gluconeogenesis</b> </div>", "time": null}, {"id": 1462061167732, "note": "<div>Glucocorticoids are a potent stimulator for <b>{{c1::gluconeogenesis}}</b>, thus they are essential for <b>survival during {{c2::fasting}}</b></div>", "time": null}, {"id": 1462061181462, "note": "<div>In <b>hypocortisolism</b>, there is <b>decreased</b> {{c1::gluconeogenesis}} and thus <b>hypoglycemia</b>, and vice versa </div>", "time": 1660105357179.0}, {"id": 1462061188088, "note": "<div>Glucocorticoids may have <b>anti-inflammatory </b>effects by inducing the synthesis of <b>{{c1::lipocortin}}</b>, an inhibitor of {{c2::<b>phospholipase A</b><sub style=\"font-weight: bold; \">2</sub>}} </div>", "time": null}, {"id": 1462061208539, "note": "<div>Glucocorticoids may have <b>anti-inflammatory</b> effects by <i>inhibiting</i> the <i>production</i> of <b>{{c1::interleukin-2 (IL-2)}}</b> and thus <i>inhibiting</i> the <b>proliferation of {{c2::T lymphocytes}}</b></div>", "time": 1660105358616.0}, {"id": 1462061251872, "note": "<div>Glucocorticoids may have <b>anti-inflammatory </b>effects via the inhibition of the <i>release</i> of <b>{{c1::histamine}}</b> and <b>{{c1::serotonin}}</b> from mast cells and platelets </div>", "time": 1660105358614.0}, {"id": 1462061261772, "note": "<div>What is the effect of <b>glucocorticoids</b> on blood <b>neutrophil</b> levels?</div><div><br /></div><div>{{c1::Increased (<u>neutrophilia</u>) due to decreased WBC adhesion}}</div>", "time": null}, {"id": 1462061271080, "note": "<div>Do <b>glucocorticoids</b> cause an increase or decrease in eosinophils?</div><div><br /></div><div>{{c1::Decrease}}</div>", "time": null}, {"id": 1462061287878, "note": "<div>How do glucocorticoids <b>suppress the immune response</b>?</div><div><br></div><div>{{c1::By inhibiting production of IL-2 and subsequent T-cell proliferation}}</div>", "time": null}, {"id": 1462061303113, "note": "<div>Cortisol (glucocorticoids) <b>up-regulates</b> <b>{{c1::\u03b1<sub>1</sub>}}</b> <b>receptors</b> on arterioles, increasing their <b>sensitivity</b> to {{c2::catecholamines (i.e. norepinephrine and epinephrine)}}</div>", "time": 1660105360400.0}, {"id": 1462061338886, "note": "<div>What is the effect of <b>hypocortisolism </b>on <b>blood pressure</b>? </div><div><br /></div><div>{{c1::Decreased (hypotension)}}</div>", "time": null}, {"id": 1462061368360, "note": "<div>Glucocorticoids decrease {{c2::<b>bone</b> <b>formation</b>}} by decreasing <b>{{c1::osteoblast}}</b> activity</div>", "time": null}, {"id": 1462061455299, "note": "<div><b>Cortisol</b> travels in the blood bound to {{c1::corticosteroid-binding globulin (CBG)}}</div>", "time": null}, {"id": 1462061483238, "note": "<div><b>Mineralocorticoids (aldosterone)</b> cause <i>increased</i> renal <b>{{c1::Na<sup>+</sup>}} </b></div><div><b>reabsorption</b> via action on the <b>{{c2::principal}}</b> <b>cells</b> of the late distal tubule and collecting duct</div>", "time": null}, {"id": 1462061496172, "note": "<div><b>Mineralocorticoids (aldosterone)</b> cause <i>increased</i> renal <b>{{c1::K<sup>+</sup>}}</b></div><div><b> secretion</b> via action on the <b>{{c2::principal}}</b> <b>cells</b> of the late distal tubule and collecting duct</div>", "time": null}, {"id": 1462061507179, "note": "<b>Mineralocorticoids (aldosterone)</b> cause <i>increased</i> renal <b>{{c1::H<sup>+</sup>}} secretion</b> via action on the {{c2::<u>\u03b1-intercalated</u>}}<u> cells</u> of the late distal tubule and collecting duct", "time": null}, {"id": 1462062116806, "note": "<b>{{c2::Addison}} disease</b> is most commonly caused by <b>{{c1::autoimmune destruction}} </b>of <u>all three zones</u> of the adrenal cortex, which causes acute <b>adrenal crisis</b>", "time": 1660105338350.0}, {"id": 1462066630531, "note": "<div>One <u>clinical feature</u> of <b>Addison disease</b> is {{c1::hyperkalemia::K<sup>+</sup>&nbsp;levels}}</div>", "time": null}, {"id": 1462066714314, "note": "<div>What classes of steroid hormones are <u>decreased</u> in<b> secondary adrenocortical insufficiency</b>?</div><div><br></div><div>{{c1::Glucocorticoids +/- androgens}}</div>", "time": 1660105343568.0}, {"id": 1462066758910, "note": "<div>What is the level of <b>ACTH</b> in <b>secondary adrenocortical insufficiency</b>? Why?</div><div><br /></div><div>{{c1::Decreased; the disease is a result of decreased ACTH secretion}}</div>", "time": null}, {"id": 1462066777580, "note": "<div><div>How do <u>blood sugar levels</u> change in <b>secondary adrenocortical deficiency</b>? </div><div><br /></div><div>{{c1::Decreased (hypoglycemia)}}</div></div>", "time": null}, {"id": 1462066785696, "note": "<div>Does <b>secondary adrenocortical insufficiency</b> present with hyperpigmentation? Why?</div><div><br /></div><div>{{c1::No, ACTH levels are low therefore there is no increased melanocyte-stimulating hormone (MSH)}}</div>", "time": null}, {"id": 1462066801144, "note": "<div><b>{{c1::Cushing}} syndrome</b> is the result of chronic <b>excess glucocorticoids</b> by: <br><br></div><div> 1. Adrenal gland hyperplasia</div><div> 2. {{c2::Pharmacologic doses of glucocorticoids}} (most common)</div><div> 3. ACTH secreting pituitary adenoma (Cushing <i>disease</i>)</div><div> 4. Ectopic ACTH production (e.g. small cell lung carcinoma)</div>", "time": null}, {"id": 1462066845454, "note": "<div><b>Cushing </b><b>{{c1::disease}}</b> is the result of chronic <b>excess</b> <b>glucocorticoids</b> caused by {{c2::<i>hypersecretion of ACTH</i> from a <b>pituitary adenoma</b>}}</div>", "time": null}, {"id": 1462066866385, "note": "<div><div>What classes of steroid hormones are <u>increased</u> in <b>Cushing syndrome/disease</b>?</div><div><br></div><div>{{c1::Glucocorticoids (cortisol) +/- androgens}}</div></div>", "time": null}, {"id": 1462066906674, "note": "<div><div>What is the level of <b>ACTH</b> in <b>Cushing <i>disease</i></b>? Why?</div></div><div><br /></div><div>{{c1::Increased because the disease is caused by an ACTH-secreting tumor}}</div>", "time": null}, {"id": 1462066978901, "note": "<div><div>What would the result of a <b>dexamethasone suppression test</b> be in a patient with <b>Cushing </b><i style=\"font-weight: bold; \">disease</i>? </div><div><br></div><div>{{c1::Cortisol response WOULD BE suppressed by <i>high</i> dose dexamethasone}}</div></div>", "time": 1660105344660.0}, {"id": 1462066985374, "note": "<div>What is a possible treatment for <b>Cushing </b><i style=\"font-weight: bold; \">syndrome</i>? </div><div><br /></div><div><b>{{c1::Ketoconazole}}</b> or <b>{{c1::metyrapone}}</b>, which block steroid hormone biosynthesis</div>", "time": null}, {"id": 1462067017399, "note": "<div>What is the treatment for <b>Cushing </b><i style=\"font-weight: bold; \">disease</i>?</div><div><br /></div><div>{{c1::Removal of the ACTH-secreting tumor}}</div>", "time": 1660105345371.0}, {"id": 1462067036959, "note": "<div><b>Conn syndrome </b>presents with <b>hypertension</b>, <b>hypokalemia</b>, and <b>metabolic alkalosis</b> due to {{c1::increased}} <u>aldosterone</u> levels</div>", "time": 1660105360431.0}, {"id": 1462067057504, "note": "<div>Treatment of <b>Conn syndrome</b> consists of administration of a(n) {{c1::<u>aldosterone</u>}}<u> antagonist</u>, such as <b>{{c2::spironolactone}}</b>, followed by removal of the aldosterone-secreting tumor</div>", "time": null}, {"id": 1462067070469, "note": "<div><div>What classes of steroid hormones are <u>decreased</u> in <b>21\u03b2-hydroxylase deficiency</b>?</div><div><br></div><div>{{c1::Glucocorticoids and mineralocorticoids::2}}</div></div>", "time": 1660105343574.0}, {"id": 1462067091584, "note": "<div><b>{{c1::21\u03b2-hydroxylase}} deficiency</b> is the <i>most common</i> cause of <b>congenital adrenal hyperplasia</b></div>", "time": null}, {"id": 1462067106848, "note": "<div>What is the level of <b>ACTH</b> in <b>21\u03b2-hydroxylase deficiency</b>? Why?</div><div><br /></div><div>{{c1::Increased, due to decreased feedback inhibition from cortisol}}</div>", "time": null}, {"id": 1462067121558, "note": "<div>What <u>clinical features</u> are seen in <b>21\u03b2-hydroxylase deficiency </b>that are a result of <u>increased</u><b> androgen </b>levels in <b>females</b>? </div><div><br /></div><div>{{c1::Masculinization (<u>clitoral enlargement</u>, early appearance of pubic/axillary hair)}}</div>", "time": null}, {"id": 1462067182134, "note": "<div>What classes of steroid hormones are <u>decreased</u> in <b>17\u03b1-hydroxylase deficiency</b>?</div><div><br></div><div><div><div>{{c1::Glucocorticoids and androgens::2}}</div></div></div>", "time": 1660105343569.0}, {"id": 1462067204039, "note": "<div>What <u>clinical features</u> are seen in <b>17</b><b>\u03b1-hydroxylase</b> deficiency that are a result of <u>decreased</u><b> androgen </b>levels in <b>females</b>? </div><div><br /></div><div>{{c1::Lack of sexual development; e.g. lack pubic and axillary hair}}</div>", "time": 1660105347422.0}, {"id": 1462067218581, "note": "<div>What is the level of <b>aldosterone</b> in <b>17\u03b1-hydroxylase deficiency</b>? </div><div><br /></div><div>{{c1::Decreased!}}</div>", "time": null}, {"id": 1462067231521, "note": "<div>Which <b>adrenal cortex deficiency</b> results in shunting towards the <b>aldosterone synthesis pathway</b>?</div><div><br /></div><div>{{c1::17\u03b1-hydroxylase deficiency}}</div>", "time": 1660105344148.0}, {"id": 1462067240205, "note": "<div>Which <b>adrenal cortex deficiency</b> results in shunting towards the <b>androgen synthesis pathway</b>?</div><div><br /></div><div>{{c1::21\u03b2-hydroxylase deficiency}}</div>", "time": null}, {"id": 1462120796565, "note": "The <b>endocrine</b> cells of the pancreas are arranged in clusters called the <b>{{c1::islets of Langerhans}}</b>, which compose 1% to 2% of the pancreatic mass", "time": 1660105350195.0}, {"id": 1462121444354, "note": "<div>The <b>{{c2::alpha}}</b> <b>cells</b> of the <b>islets of Langerhans</b> compose 20% of the islet and secrete <b>{{c1::glucagon}}</b> </div>", "time": null}, {"id": 1462121459429, "note": "<div>The <b>{{c2::</b><b>\u03b2</b><b>}}</b> <b>cells</b> of the <b>islets of Langerhans</b> compose 65% of the islet and secrete <b>{{c1::insulin}}</b> </div>", "time": null}, {"id": 1462121467886, "note": "<div>The <b>{{c2::delta}}</b> <b>cells</b> of the <b>islets of Langerhans</b> compose 10% of the islet and secrete <b>{{c1::somatostatin}}</b> </div>", "time": null}, {"id": 1462121476788, "note": "<div>The <b>remaining cells</b> (non-alpha, beta, delta) of the <b>islets of Langerhans</b> secrete {{c1::<b>pancreatic</b> <b>polypeptide</b>}} or other peptides</div>", "time": null}, {"id": 1462121485588, "note": "<div><b>{{c1::Gap junctions}}</b> in the <b>islets of Langerhan</b> link \u03b2-cells to each other, \u03b1-cells to each other, and \u03b2-cells to \u03b1-cells, allowing for <b>rapid communication</b> </div>", "time": null}, {"id": 1462121501158, "note": "<div>The portal blood supply of the <b>islets of Langerhans</b> allow blood from the <b>{{c1::beta}} cells</b> to bathe the <b>{{c1::alpha}}</b> and <b>{{c1::delta}} cells</b>, further promoting <b>rapid communication</b> </div>", "time": null}, {"id": 1462121526915, "note": "<div>The<b> {{c2::central core}}</b> of the <b>islet of Langerhans</b> contains mostly <b>{{c1::beta}} cells</b> </div>", "time": null}, {"id": 1462121552008, "note": "<div>The <b>{{c2::outer rim}}</b> of the <u>islet of Langerhans</u> contains mostly <b>{{c1::alpha}} cells</b></div>", "time": 1660105348894.0}, {"id": 1462121565140, "note": "<div>What is location of the<b> delta cells</b> in the <b>islet of Langerhans</b>?</div><div><br /></div><div>{{c1::Interspersed between alpha and beta cells}}</div>", "time": null}, {"id": 1462121573747, "note": "<b>Insulin</b> is a peptide hormone consisting of two straight chains, a(n)&nbsp;<b>{{c1::A}} chain</b> (21 AA) and a(n)&nbsp;<b>{{c1::B}} chain</b> (30 AA), connected by <u>two</u> <b>{{c2::disulfide bridges}}</b>", "time": 1660105356000.0}, {"id": 1462122572408, "note": "<div>mRNA directs ribosomal synthesis of <b>{{c1::preproinsulin}}</b>, which contains a <b>signal</b> <b>peptide</b>, the<b> </b>A and B chains of <b>insulin</b>, and a <b>connecting</b> <b>peptide</b> (insulin synthesis) </div>", "time": null}, {"id": 1462122608618, "note": "<div>The <b>{{c1::signal peptide}}</b> of <b>preproinsulin</b> is cleaved while the peptide chains are being assembled, yielding <b>{{c2::proinsulin}}</b></div>", "time": 1660105349034.0}, {"id": 1462122640848, "note": "<div><b>Proinsulin</b> is packaged in <b>secretory</b> <b>granules</b> in the {{c1::Golgi apparatus}}</div>", "time": 1660105353647.0}, {"id": 1462122652771, "note": "<div>While being packed into <u>secretory granules</u>, <i>proteases</i> cleave the <b>{{c1::connecting peptide}}</b> of <b>proinsulin</b>, yielding <b>{{c1::insulin}}</b> </div>", "time": null}, {"id": 1462122670792, "note": "<div><b>Insulin</b> is packaged in secretory granules of the Golgi apparatus with <b>{{c1::C peptide}}</b></div>", "time": null}, {"id": 1462122681020, "note": "<div>When the&nbsp;<b>\u03b2</b><b>&nbsp;cell</b> is stimulated, exocytosis of <b>insulin</b> and <b>C peptide</b> are released in <b>{{c1::equimolar}} quantities</b> </div>", "time": null}, {"id": 1462122701249, "note": "<div>What peptide is packaged <i>with insulin</i> and may be used to monitor&nbsp;<b>\u03b2</b><b>&nbsp;cell function</b> in patients receiving <b>exogenous insulin</b>?</div><div><br></div><div>{{c1::C peptide (connecting peptide)}}</div>", "time": null}, {"id": 1462122709023, "note": "What may cause <b>increased</b> levels of <i>both </i><b>insulin</b> and <b>C-peptide</b>? <div><br></div><div>{{c1::Insulinoma, sulfonylurea drugs::2}} </div>", "time": 1660105345170.0}, {"id": 1462123239655, "note": "<div><b>{{c1::Glucose}}</b> is the major regulator of <b>insulin release</b></div>", "time": 1660105340225.0}, {"id": 1462127745460, "note": "<div>Transport of <b>glucose</b> from blood into the <u>pancreatic \u03b2-cell</u> occurs via a(n)&nbsp;<b>{{c1::GLUT2}}</b> transporter</div>", "time": null}, {"id": 1462127759504, "note": "<div>Once inside the <u>pancreatic \u03b2-cell</u>, <b>glucose</b> is <b>{{c1::phosphorylated}}</b> by the enzyme <b style=\"font-style: italic; \">{{c2::glucokinase}}</b> </div>", "time": null}, {"id": 1462127781248, "note": "<div>In the <u>pancreatic&nbsp;\u03b2&nbsp;cell</u>, <b>metabolism of glucose </b>generates <b>{{c1::ATP}}</b>, which may cause <u>closure</u> of <i>select</i> <b>K<sup>+</sup> channels</b> with consequent membrane depolarization </div>", "time": null}, {"id": 1462127805913, "note": "<div><b>Increased ATP:ADP ratio</b> in the <b>pancreatic</b>&nbsp;<b>\u03b2</b><b>&nbsp;cell</b> (as a result of glucose metabolism) causes <i>ATP-sensitive</i> <b>{{c1::K<sup>+</sup>}} channels</b> to <b>{{c2::close}}</b>, causing membrane <b>{{c2::depolarization}}</b></div>", "time": null}, {"id": 1462127846011, "note": "<div><b>Depolarization</b> of the pancreatic&nbsp;<b>\u03b2</b><b>&nbsp;cell</b> causes <i>voltage-sensitive</i> <b>{{c1::Ca<sup>2+</sup>}} channels</b> to <b>{{c2::open}}</b>, causing a(n) {{c2::increase}} in intracellular {{c1::Ca<sup>2+</sup>}}</div>", "time": null}, {"id": 1462127869624, "note": "<div>Increased <b>intracellular Ca<sup>2+</sup></b> in the <u>pancreatic \u03b2-cell</u> causes <b>{{c1::exocytosis}} </b>of <b>insulin</b>-containing granules</div>", "time": 1660105356173.0}, {"id": 1462127903018, "note": "<div>What <i>class</i> of drugs acts by <b>closing K<sup>+</sup> channels</b> in <u>pancreatic&nbsp;</u><u style=\"\">\u03b2</u><u>&nbsp;cells</u>, causing <b>increased insulin secretion</b>? </div><div><br></div><div>{{c1::Sulfonylurea drugs (e.g. tolbutamide, glyburide)}}</div>", "time": null}, {"id": 1462127929691, "note": "<div>Why is <b>oral glucose</b> a <i>more</i> <i>powerful</i> stimulant of <b>insulin secretion</b> than <b>IV glucose</b>? </div><div><br></div><div>{{c1::Oral glucose stimulates secretion of GIP and GLP-1}}</div>", "time": null}, {"id": 1462127967528, "note": "<div>How do <b>sulfonylurea drugs</b> (e.g. tolbutamide, glyburde) cause an <b>increased</b> <b>insulin secretion</b>?</div><div><br /></div><div>{{c1::By closing the ATP-dependent K<sup>+</sup> channels, causing depolarization and subsequent insulin release}}</div><div></div>", "time": null}, {"id": 1462128017601, "note": "<div>What effect does <b>somatostatin</b> have on <b>insulin secretion</b>? </div><div><br /></div><div>{{c1::Decreased}}</div>", "time": null}, {"id": 1462128028823, "note": "<div>The <b>insulin receptor</b> is a tetramer consisting of <u>two</u> <b>{{c1::\u03b1}} subunits</b> and <u>two</u> <b>{{c1::\u03b2}} subunits</b> </div>", "time": 1660105349976.0}, {"id": 1462128036872, "note": "<div>The <b>{{c1::alpha}} subunits</b> of the <b>insulin receptor</b> are connected by a disulfide bond and lie in the <b>extracellular domain</b> </div>", "time": null}, {"id": 1462128089182, "note": "<div>The <b>{{c1::</b><b>\u03b2</b><b>}} subunits</b> of the <b>insulin receptor</b> are connected to the alpha subunit by a disulfide bond and <b>span the cell membrane </b></div>", "time": null}, {"id": 1462128108324, "note": "<div>The&nbsp;<b>\u03b2</b><b>&nbsp;subunits</b> of the <b>insulin receptor</b> have <b>{{c1::<i>intrinsic</i> tyrosine kinase}} activity</b></div>", "time": null}, {"id": 1462128120927, "note": "<div>When <b>insulin</b> binds to its receptor, {{c1::<b>tyrosine</b> <b>kinase</b>}} is activated and <b>autophosphorylates</b> the <b>\u03b2</b>-<b>subunits</b> </div>", "time": 1660105344614.0}, {"id": 1462128178981, "note": "<div>What are the <u>three</u> locations that <b>insulin</b> acts on? </div><div><br /></div><div>{{c1::Liver, muscle, and adipose tissue}}</div>", "time": null}, {"id": 1462128186045, "note": "<div>Insulin <b>increases glucose transport</b> to <b>{{c1::muscle}}</b> and <b>{{c1::adipose}} tissue</b> by directing the insertion of the <b>{{c2::GLUT4}}</b> transporter into the cell membranes</div>", "time": 1660105356003.0}, {"id": 1462128205014, "note": "<div><b>Insulin</b> decreases <u>blood glucose concentration</u> by promoting synthesis and storage of <b>{{c1::glycogen}}</b> in the <b>{{c2::muscle}}</b> and <b>{{c2::liver}}</b>, while simultaneously inhibiting <b>{{c1::glycogenolysis}}</b> </div>", "time": null}, {"id": 1462128231420, "note": "<div><b>Insulin</b> decreases <u>blood glucose concentration</u> by decreasing <b>{{c1::gluconeogenesis}}</b> via increased production of <i>fructose-2,6-bisphosphate</i></div>", "time": null}, {"id": 1462128243453, "note": "<div>In <b>adipose</b> tissue, <b>insulin</b> <i>stimulates</i> {{c1::fat deposition (increased triglyceride synthesis)}} and <i>inhibits</i> {{c1::lipolysis}} </div>", "time": null}, {"id": 1462128277353, "note": "<div><b>Insulin</b> stimulates<b> amino acid uptake </b>into cells and {{c1::increases}} <b>protein</b> <b>synthesis</b> in muscles</div>", "time": 1660105355995.0}, {"id": 1462128347237, "note": "<div><b>Insulin</b> results in {{c1::increased}} <b>K<sup>+ </sup>uptake</b> into cells</div>", "time": null}, {"id": 1462128367235, "note": "<div>What is the effect of <b>insulin</b> on <b><i>blood</i></b> <b>K<sup>+</sup> </b>and<b> amino acid concentration</b>?</div><div><br /></div><div>{{c1::Decreased (due to increased uptake into cells)}}</div>", "time": null}, {"id": 1462128384469, "note": "<div>What is the effect of <b>insulin</b> on <b>Na<sup>+</sup> retention</b> in the kidneys?</div><div><br /></div><div>{{c1::Increased retention}}</div>", "time": null}, {"id": 1462128398864, "note": "<div>Does <b>glucose</b> cross the placenta? What about <b>insulin</b>? </div><div><br /></div><div>{{c1::Glucose does; insulin does not}}</div>", "time": 1660105359869.0}, {"id": 1462128449086, "note": "<div>What is the cause of <b>metabolic acidosis</b> in a patient with <b>diabetes mellitus</b>?</div><div><br /></div><div>{{c1::Increased production of ketoacids}}</div>", "time": null}, {"id": 1462128459898, "note": "<div>What is the <i>blood</i> concentration of <b>K<sup>+</sup></b> in a patient with<b> diabetes mellitus</b>?</div><div><br /></div><div>{{c1::Increased (<b>hyperkalemia</b>) due to decreased K<sup>+</sup> uptake into cells}}</div>", "time": null}, {"id": 1462130433532, "note": "<b>{{c1::Glucagon}}</b>, an <b>endocrine</b> <b>hormone</b>, is a member of a family of peptides that includes the GI hormones <b>secretin </b>and <b>GIP</b> ", "time": null}, {"id": 1462131701878, "note": "<div><b>Glucagon</b> acts on the <b>{{c1::liver}}</b> (primarily) and <b>{{c1::adipose}}</b> tissue</div>", "time": 1660105358624.0}, {"id": 1462131726115, "note": "<div>The major factor that stimulates <b>glucagon secretion </b>is {{c1::hypoglycemia}}</div>", "time": null}, {"id": 1462131783153, "note": "<div>What is the effect of <b>insulin</b> on <b>glucagon secretion</b>?</div><div><br /></div><div>{{c1::Decreased}}</div>", "time": 1660105346525.0}, {"id": 1462131799037, "note": "<div><div>Through which <u>secondary messenger(s)</u> does <b>glucagon</b> exert its actions on liver and adipose tissue?</div><div><br></div><div>{{c1::cAMP}}</div></div>", "time": null}, {"id": 1462131802276, "note": "<div><b>Glucagon</b> <i>increases</i> <u>blood glucose concentration</u> by increasing <b>{{c1::glycogenolysis}}</b>, while simultaneously inhibiting <b>{{c1::glycogen}}</b> formation from glucose</div>", "time": null}, {"id": 1462131823875, "note": "<div><b>Glucagon</b> <i>increases</i> <u>blood glucose concentration</u> by increasing <b>{{c1::gluconeogenesis}}</b> via decreased production of <i>fructose-2,6-bisphosphate</i> </div>", "time": 1660105358622.0}, {"id": 1462131831506, "note": "<div><b>Glucagon</b> causes {{c1::decreased}} <b>fatty</b> <b>acid</b> <b>synthesis</b> and {{c1::increased}} <b>lipolysis</b>, which shunts substrates towards gluconeogenesis</div>", "time": null}, {"id": 1462131878424, "note": "<div>What is the effect of <b>somatostatin</b> on <b>insulin</b> and <b>glucagon secretion</b>?</div><div><br /></div><div>{{c1::Decreased}}</div>", "time": 1660105346510.0}, {"id": 1462133663173, "note": "<div>Hyperreflexia, spontaneous twitching, muscle cramping, tingling, and numbness are signs of which <b>calcium imbalance</b>? </div><div><br /></div><div>{{c1::Hypocalcemia}} </div>", "time": 1660105357890.0}, {"id": 1462133670703, "note": "<div>The <b>{{c3::Chvostek}} sign</b> is {{c2::twitching of the facial muscles}} elicited by tapping on the facial nerve; it is an indicator of <b>{{c1::hypocalcemia}}</b> </div>", "time": null}, {"id": 1462133693905, "note": "<div>The <b>{{c3::Trousseau}} sign</b> is {{c1::carpopedal spasm}} upon inflation of a blood pressure cuff; it is an indicator of <b>{{c2::hypocalcemia}}</b> </div>", "time": null}, {"id": 1462133704288, "note": "<div>Why does <b>hypocalcemia</b> cause symptoms such as <b>tingling</b>/<b>numbness</b> and <b>twitching</b>/<b>cramping</b>?</div><div><br></div><div>{{c1::Decreased <u>extracellular</u> Ca<sup>2+</sup> decreases the <u>threshold potential</u> (makes it more negative)}}</div>", "time": null}, {"id": 1462133718268, "note": "<div>Constipation, polyuria, polydipsia, lethargy, and hyporeflexia are signs of which <b>calcium imbalance</b>? </div><div><br /></div><div>{{c1::Hypercalcemia}} </div>", "time": null}, {"id": 1462133746777, "note": "<div>What is the effect of <b>acidemia</b> on free ionized Ca<sup>2+</sup> concentration?</div><div><br /></div><div>{{c1::Increased}}</div>", "time": null}, {"id": 1462133757332, "note": "<div><div>What is the effect of <b>alkalemia</b> on free ionized Ca<sup>2+</sup> concentration?</div><div><br /></div><div>{{c1::Decreased}}</div></div>", "time": null}, {"id": 1462133789803, "note": "<div>Which <u>three</u> hormones are involved in <b>Ca<sup>2+</sup> homeostasis</b>?</div><div><br /></div><div>{{c1::Parathyroid hormone, calcitonin, and vitamin D (1,25-dihydroxycholecalciferol)}}</div>", "time": null}, {"id": 1462135442737, "note": "<div><b>Parathyroid hormone</b> is synthesized and secreted by the <b>{{c1::chief}} cells</b> of the parathyroid glands </div>", "time": null}, {"id": 1462137178939, "note": "<div><b>Parathyroid hormone (PTH)</b> secretion is regulated by plasma {{c1::Ca<sup>2+</sup>}} concentration</div>", "time": 1660105354372.0}, {"id": 1462137188759, "note": "<div>When plasma <b>Ca<sup>2+</sup></b> concentrations <b>{{c1::decrease}}</b>,&nbsp;<b>parathyroid hormone </b>secretion is <b>{{c2::increased}}</b> (and vice versa)</div>", "time": null}, {"id": 1462137205163, "note": "<div>Secretion of <b>PTH</b> is controlled by <u>extracellular</u> (serum) Ca<sup>2+</sup> binding to <b>{{c1::Ca<sup>2+</sup>-sensing}} receptors</b> in the parathyroid cell membrane</div>", "time": 1660105353085.0}, {"id": 1462137262732, "note": "<div><i>Chronic</i> <b>hypocalcemia</b> causes <b>secondary </b>{{c1::hyperparathyroidism}}, which is characterized by increased synthesis and storage of PTH and hyperplasia of the parathyroid glands</div>", "time": 1660105360739.0}, {"id": 1462137282272, "note": "<div>{{c2::<i>Mild</i> <b>decreases</b>}} in serum <b>Mg<sup>2+</sup> </b>concentration cause {{c1::<u>increased</u>}} <b>PTH</b> secretion</div>", "time": null}, {"id": 1462137305372, "note": "<div>{{c2::<i>Severe</i> <b>decreases</b>}} in serum <b>Mg<sup>2+</sup> </b>concentration cause {{c1::<u>decreased</u>}} <b>PTH</b> secretion</div>", "time": null}, {"id": 1462137316417, "note": "<div>What is the effect of <u>increased</u><b> </b>serum <b>PO</b><sub style=\"font-weight: bold; \">4</sub><sup style=\"font-weight: bold; \">3-</sup><b> </b>on <b>PTH secretion</b>?</div><div><br /></div><div>{{c1::Increased}}</div>", "time": null}, {"id": 1462137345946, "note": "<div>The actions of <b>PTH</b> are coordinated to produce an <b>increase</b> in serum {{c1::Ca<sup>2+</sup>}} and a <b>decrease</b> in serum {{c1::phosphate (PO<sub>4</sub><sup>3-</sup>)}}</div>", "time": null}, {"id": 1462137433796, "note": "<div>Through what <u>secondary messenger(s)</u> does <b>PTH</b> exert its actions on bone and kidney tissue?</div><div><br /></div><div>{{c1::cAMP}}</div>", "time": null}, {"id": 1462137441428, "note": "<div>In <i>bone</i>, <b>PTH receptors</b> are located on <b>{{c1::osteoblasts}}</b>, but <u>not</u> on <b>{{c1::osteoclasts}}</b> </div>", "time": null}, {"id": 1462137452070, "note": "<div><i>Initially</i> and <i>transiently</i>, <b>PTH</b> causes an increase in <b>bone {{c1::formation}}</b> by a direct action on {{c1::osteoblasts}}</div>", "time": null}, {"id": 1462137465195, "note": "<div>In <i>bone</i>, the <i>long-term</i> effect of <b>PTH</b> is <b>bone {{c1::resorption}}</b> via <u>indirect</u> action on {{c1::osteoclasts}}</div>", "time": 1660105357414.0}, {"id": 1462137479145, "note": "<div>The action of <b>PTH</b> on <b>osteoclasts</b> is <u>indirect</u> and mediated by <b>cytokines</b> released from <b>{{c1::osteoblasts}}</b> </div>", "time": null}, {"id": 1462137508465, "note": "<div>The <i>overall</i> effect of <b>PTH</b> on <i>bone</i> is to promote <b>bone</b> <b>{{c1::resorption}}</b>, which delivers <i>both</i> {{c2::<b>Ca</b><sup><b>2+</b></sup>}} and <b>{{c2::phosphate}}</b> to extracellular fluid</div>", "time": 1660105349728.0}, {"id": 1462137531146, "note": "<div><b>PTH </b>acts on the kidney to <u>inhibit</u> renal <b>{{c1::phosphate}} reabsorption</b> in the <b>{{c2::proximal convoluted tubule}}</b>, which therefore increases phosphate excretion</div>", "time": null}, {"id": 1462137593301, "note": "<div>The <b>cAMP</b> generated as a result of the action of <b>PTH</b> on the <b>proximal</b> <b>tubule</b> is excreted in the {{c1::urine (<b>urinary cAMP</b>)}}</div>", "time": null}, {"id": 1462137601866, "note": "<div><b>PTH </b>acts on the kidney to <u>increase</u> renal <b>{{c1::calcium}} reabsorption</b> in the <b>{{c2::distal convoluted tubule}}</b></div>", "time": null}, {"id": 1462137618041, "note": "<div><b>PTH</b> stimulates the <b>renal</b> <b>enzyme</b> <b>{{c1::1\u03b1-hydroxylase}}</b>, which converts 25-hydroxycholecalciferol to the active form, <b>1,25-dihydroxycholecalciferol</b> (vitamin D)</div>", "time": null}, {"id": 1462137679566, "note": "<div>How does <b>PTH</b> increase <i>intestinal</i> <b>Ca<sup>2+&nbsp;</sup></b><b>absorption</b>?</div><div><br></div><div>{{c1::<u>Indirectly</u>, by stimulating production of <b>1,25-(OH)<sub>2</sub>D<sub>3</sub> </b>in the kidney}}</div>", "time": 1660105358069.0}, {"id": 1462137711715, "note": "<div><u>PTH Actions Summary Picture</u>: no answer {{c1:::)}}</div><div><br /></div><div><img src=\"paste-563126047080990.jpg\" /></div>", "time": null}, {"id": 1462137714771, "note": "<b>Primary hyperparathyroidism</b> is most commonly caused by a(n) {{c1::<b>parathyroid adenoma</b> (which secretes excess PTH)}}", "time": null}, {"id": 1462140487757, "note": "<div><b>{{c1::Primary hyperparathyroidism}}</b> is characterized by <b>hypercalcemia</b>, <b>hypophosphatemia</b>, and <u>increased</u> circulating levels of <b>PTH</b></div>", "time": 1660105339184.0}, {"id": 1462140496889, "note": "<div>Patients with <b>primary hyperparathyroidism</b> have {{c1::increased}} Ca<sup>2+</sup> excretion due to the high <i>filtered load</i> of calcium on the kidney</div>", "time": null}, {"id": 1462140513830, "note": "<div>What is a possible complication of <b>increased Ca<sup>2+</sup> </b>in the <b>urine</b> (e.g. due to primary hyperparathyroidism)? </div><div><br /></div><div>{{c1::Calcium-oxalate kidney stones}} </div>", "time": null}, {"id": 1462140522357, "note": "<div>Patients with <b>primary</b> <b>hyperparathyroidism</b> have {{c1::increased}} <b>urinary</b> <b>excretion</b> of phosphate, calcium, and cAMP </div>", "time": null}, {"id": 1462140530307, "note": "<div>Which parathyroid disorder is characterized by \"<b>stones</b>, <b>bones</b>, <b>groans</b>, and <b>psychiatric undertones</b>\"? </div><div><br /></div><div>{{c1::Primary hyperparathyroidism}}</div>", "time": 1660105342414.0}, {"id": 1462140537123, "note": "<div>What is the treatment for a patient with <b>primary hyperparathyroidism</b>? </div><div><br /></div><div>{{c1::Parathyroidectomy}}</div>", "time": 1660105345408.0}, {"id": 1462140542758, "note": "<div>In <b>secondary hyperparathyroidism</b>, PTH levels are elevated <i>secondary</i> to {{c1::hypocalcemia (or hyperphosphatemia)}}</div>", "time": 1660105356874.0}, {"id": 1462140548057, "note": "<div><b>Hypoparathyroidism</b> is most commonly a result of <b>{{c1::thyroid surgery}}</b>, or less commonly may be {{c3::<b>autoimmune</b>}} or <b>{{c2::congenital}}</b> </div>", "time": 1660105357853.0}, {"id": 1462140559401, "note": "<div><b>Hypoparathyroidism </b>is characterized by <b>decreased</b> serum {{c1::calcium (hypocalcemia)}} and <b>increased</b> serum {{c1::phosphate (hyperphosphatemia)}} </div>", "time": 1660105357854.0}, {"id": 1462140572238, "note": "<div><b>Pseudohypoparathyroidism type 1a</b>, or <b>Albright hereditary osteodystrophy</b>, is due to a defective <b>{{c1::G<sub>s</sub>}}</b> protein in the <b>kidney</b> and <b>bone</b>, which causes end-organ resistance to <b>{{c2::PTH}}</b> </div>", "time": 1660105353590.0}, {"id": 1462140587560, "note": "<div>{{c1::Pseudohypoparathyroidism type 1a}} is characterized by <b>hypocalcemia</b> and <b>hyperphosphatemia </b>that is <u>not correctable</u> by administration of <b>exogenous PTH</b> </div>", "time": 1660105339144.0}, {"id": 1462140593524, "note": "<div>What is the difference in <b>PTH</b> levels in <b>hypoparathyroidism</b> versus</div><div> <b>pseudohypoparathyroidism</b>?</div><div><br></div><div>{{c1::PTH levels are <i>elevated</i> in pseudohypoparathyroidism due to stimulation by hypocalcemia}}</div>", "time": null}, {"id": 1462140635772, "note": "<div>Some {{c1::<b>malignant</b> <b>tumors</b>}} secrete <b>{{c2::PTH-related peptide (PTH-rp)}}</b>, which is structurally <i>homologous</i> with the PTH secreted by the parathyroid glands</div>", "time": null}, {"id": 1462140680959, "note": "<div>{{c2::<b>Familial hypocalciuric hypercalcemia</b> <b>(FHH)</b>}} is caused by <b>inactivating mutations</b> of the <b>{{c1::Ca<sup>2+</sup>-sensing receptors}}</b> that regulate PTH secretion</div>", "time": 1660105337980.0}, {"id": 1462140694887, "note": "<div>What is the inheritance of <b>familial hypocalciuric hypercalcemia (FHH)</b>? </div><div><br /></div><div>{{c1::Autosomal dominant}}</div>", "time": 1660105346212.0}, {"id": 1462140768683, "note": "<div>What is the effect of <b>chronic renal failure</b> on <b>serum phosphate levels</b>?</div><div><br /></div><div>{{c1::Increased}}</div>", "time": 1660105346544.0}, {"id": 1462140786768, "note": "<div>In <b>chronic renal failure</b>, increased serum phosphate complexes Ca<sup>2+</sup> and leads to <b>decreased</b> {{c1::free, <b>ionized Ca</b><sup style=\"font-weight: bold; \">2+</sup>}} </div>", "time": 1660105357380.0}, {"id": 1462140791464, "note": "<div>In <b>chronic renal failure</b>, decreased <i>production</i> of the active form of <b>vitamin</b> <b>{{c1::D, (1,25-dihydroxycholecalciferol)}}</b> by the kidney contributes to <b>decreased ionized Ca</b><sup style=\"font-weight: bold; \">2+</sup> </div>", "time": 1660105357381.0}, {"id": 1462140817380, "note": "<div>The <u>decreased</u><b> ionized Ca</b><sup style=\"font-weight: bold; \">2+</sup> in <b>chronic renal failure</b> causes <b>{{c1::secondary hyperparathyroidism}}</b>, which is characterized by increased levels of PTH</div>", "time": 1660105350254.0}, {"id": 1462140837741, "note": "In <b>{{c2::CKD}}</b>, the combination of <i>elevated</i> <b>PTH</b> and <i>decreased</i> <b>1,25-(OH)<sub>2</sub>D<sub>3</sub></b> produces <b>{{c1::renal osteodystrophy}}</b>, in which there is <u>increased</u> <b>bone resorption</b> and <b>osteomalacia</b> ", "time": null}, {"id": 1462140850494, "note": "<b>{{c2::Calcitonin}}</b> is secreted by the {{c1::<b>parafollicular cells</b> (C cells)}} of the <b>thyroid</b> <b>gland</b> ", "time": null}, {"id": 1462143914867, "note": "<div>The major <i>function</i> of <b>calcitonin</b> is to <u>inhibit</u><b> bone {{c1::resorption}}</b>, thus decreasing the plasma Ca<sup>2+</sup> concentration </div>", "time": null}, {"id": 1462145992988, "note": "<div><b>Cholecalciferol</b> is converted to {{c1::<b>25-hydroxycholecalciferol</b> (25-OH-cholecalciferol)}} in the <b>{{c2::liver}}</b>; this compound is chemically <b>{{c3::inactive}}</b> </div>", "time": null}, {"id": 1462146092249, "note": "<div>The activity of the renal enzyme <b>1\u03b1-hydroxylase</b> is <u>increased</u> with {{c1::increased}}<b> PTH</b> levels</div>", "time": null}, {"id": 1462146106409, "note": "<div>The activity of the renal enzyme <b>1\u03b1-hydroxylase</b> is <u>increased</u> with {{c1::decreased}} serum <b>phosphate</b> concentration</div>", "time": null}, {"id": 1462146190722, "note": "<div>In addition to <u>calcium</u>, <b>1,25-(OH)<sub>2</sub> D<sub>3 </sub></b>also increases the <b>intestinal absorption</b> of <b>{{c1::phosphate (PO<sub>4</sub><sup>3-</sup>)}}</b></div>", "time": null}, {"id": 1462146204556, "note": "<div>Similar to its action on the <u>intestines</u>, <b>1,25-dihydroxycholecalciferol</b> increases the <b>{{c1::renal}} reabsorption</b> of <b>Ca</b><sup><b>2</b>+</sup> and <b>phosphate</b> </div>", "time": null}, {"id": 1462146232681, "note": "<div>In <i>bone</i>, <b>1,25-(OH)<sub>2</sub> D<sub>3</sub> </b>acts syngergistically with PTH to stimulate <b>{{c1::osteoclast}} activity</b> and <b>bone {{c1::resorption}}</b> </div>", "time": 1660105357415.0}, {"id": 1462146277040, "note": "<div><div>In <b>children</b>, vitamin D deficiency causes <b>{{c1::rickets}}</b></div></div>", "time": null}, {"id": 1462146288515, "note": "<div><div>In <b>adults</b>, vitamin D deficiency causes <b>{{c1::osteomalacia}}</b> </div></div>", "time": null}, {"id": 1462146297915, "note": "<div><b>Vitamin D resistance</b> most commonly occurs due to <b>{{c1::chronic renal failure}}</b></div>", "time": null}, {"id": 1462204521643, "note": "<b>Pituitary </b>{{c1::<b>adenoma</b>}} is a <i>benign</i> tumor of the <b>anterior pituitary cells</b>", "time": 1660105353906.0}, {"id": 1462206107219, "note": "<div><b>Nonfunctional pituitary adenomas</b> present with symptoms due to <b>{{c1::mass effect}}</b></div>", "time": 1660105354805.0}, {"id": 1462206113339, "note": "<div><b>Pituitary adenoma</b> may present with <b>{{c1::bitemporal hemianopsia}}</b> due to compression of the <b>{{c2::optic chiasm}}</b> </div>", "time": null}, {"id": 1462206153513, "note": "<div><b>Pituitary adenoma</b> may present with <b>{{c1::hypopituitarism}}</b> due to compression of normal pituitary tissue</div>", "time": 1660105353914.0}, {"id": 1462206162910, "note": "<div>A <i>non-specific</i> symptom of <b>pituitary adenoma</b> is {{c1::headache}} (due to mass effect)</div>", "time": 1660105362500.0}, {"id": 1462206168906, "note": "<div>What is the <u>most common</u> type of <i>functional</i> <b>pituitary adenoma</b>? </div><div><br /></div><div>{{c1::Prolactinoma}}</div>", "time": null}, {"id": 1462206173395, "note": "<div>In <u>females</u>, <b>prolactinoma</b> presents as <b>{{c1::galactorrhea}}</b> and <b>{{c2::amenorrhea}}</b> </div>", "time": null}, {"id": 1462206536742, "note": "<b>{{c1::Hypopituitarism}}</b> is the insufficient production of hormones by the <b>anterior pituitary gland</b>", "time": 1660105340009.0}, {"id": 1462207418792, "note": "<div>One possible cause of <b>hypopituitarism</b> in adults is {{c1::pituitary adenoma}} (due to <b>mass effect</b>)</div>", "time": null}, {"id": 1462207447904, "note": "<div><b>Hypopituitarism</b> may be caused by <b>{{c1::Sheehan}} syndrome</b>, which is a(n)&nbsp;<b>{{c2::pregnancy}}-related {{c3::infarction}}</b> of the pituitary gland</div>", "time": null}, {"id": 1462207540805, "note": "<div>Pregnancy-related infarction of the pituitary gland (<b>Sheehan syndrome</b>) often occurs following <b>{{c1::postpartum bleeding}}</b></div>", "time": null}, {"id": 1462207566120, "note": "<div>Symptoms of <b>Sheehan syndrome</b> include poor<b> {{c1::lactation}}</b>, loss of <b>{{c1::pubic hair}}</b>, and <b>fatigue</b></div>", "time": 1660105350656.0}, {"id": 1462208336313, "note": "<b><i>{{c1::Central}}</i> diabetes insipidus</b> is characterized by <b>polyuria</b> and <b>polydipsia</b> with an <u>inability</u> to <b>{{c3::concentrate}}</b> urine due to<b> {{c2::<u>lack of ADH</u>}}</b> ", "time": 1660105340886.0}, {"id": 1462209828585, "note": "<b><i>{{c1::Nephrogenic}}</i> diabetes insipidus</b> is characterized by <b>polyuria</b> and <b>polydipsia</b> with an <u>inability</u> to <b>{{c3::concentrate}}</b> urine due to<b> {{c2::lack of <u>response</u> to ADH}}</b>", "time": 1660105339484.0}, {"id": 1462209855035, "note": "<div>Etiologies of <b><i>{{c1::central}}</i> diabetes insipidus</b> include pituitary tumor, autoimmune, trauma, surgery, and ischemic encephalopathy </div>", "time": 1660105359407.0}, {"id": 1462209861777, "note": "<div><b><i>{{c2::Nephrogenic}}</i> diabetes insipidus</b> is often caused by <b>{{c1::ADH receptor}}</b> <b>mutations</b> </div>", "time": 1660105337619.0}, {"id": 1462209877358, "note": "<div><b><i>{{c1::Nephrogenic}}</i> diabetes insipidus</b> may be caused by drugs such as <b>{{c2::lithium}}</b> and <b>{{c3::demeclocycline}}</b> </div>", "time": null}, {"id": 1462209898939, "note": "<div>Both <i style=\"font-weight: bold; \">central</i> and <b><i>nephrogenic</i> diabetes insipidus</b> are characterized by <b>urine specific gravity </b>&lt; {{c1::1.006}}</div>", "time": null}, {"id": 1462210021520, "note": "<div>Both <i style=\"font-weight: bold; \">central</i> and <b><i>nephrogenic</i> diabetes insipidus</b> are characterized by {{c1::low}} <b>urine osmolality</b></div>", "time": 1660105361157.0}, {"id": 1462210030535, "note": "<div>Both <i style=\"font-weight: bold; \">central</i> and <b><i>nephrogenic</i> diabetes insipidus</b> are characterized by <b>serum osmolality</b> {{c1::&gt;}} 290 mOsm/kg</div>", "time": null}, {"id": 1462210050114, "note": "<div>Both <i style=\"font-weight: bold; \">central</i> and <b><i>nephrogenic</i> diabetes insipidus</b> are characterized by blood <b><i>hyperosmotic</i> volume {{c1::contraction}}</b></div>", "time": null}, {"id": 1462210111594, "note": "<div><b><i>Central</i> diabetes insipidus</b> is characterized by {{c1::low}} levels of <b>ADH</b></div>", "time": null}, {"id": 1462210119948, "note": "<div><b><i>Nephrogenic </i>diabetes insipidus</b> is characterized by {{c1::normal}} or {{c1::elevated}} levels of <b>ADH</b></div>", "time": null}, {"id": 1462210128881, "note": "<div>Treatment for <i style=\"font-weight: bold; \">central</i><b> diabetes insipidus</b><i style=\"font-weight: bold; \"> </i>includes <b>hydration</b> and&nbsp;<b>{{c1::desmopressin}}</b>, which is an <b>ADH</b> <i>analog</i></div>", "time": null}, {"id": 1462210181914, "note": "<div>Treatment for <b><i>nephrogenic</i> diabetes insipidus</b> includes <b>hydration</b> and <b>{{c1::HCTZ}}</b>, which is a <b>thiazide</b> <b>diuretic</b></div>", "time": null}, {"id": 1462210183851, "note": "<div>Diagnosis of <b>diabetes insipidus</b> is aided by the <b>{{c1::water deprivation}} test</b> </div>", "time": 1660105360082.0}, {"id": 1462210190761, "note": "<div>In <b>diabetes insipidus</b>, the <b>water deprivation test</b> <i>fails</i> to <b>{{c1::increase}}</b> urine osmolality</div>", "time": 1660105357346.0}, {"id": 1462210209207, "note": "<div>One possible cause of <b>SIADH</b> is <b>{{c1::small cell}} lung carcinoma</b>, which provides a source of <i>ectopic</i> ADH</div>", "time": null}, {"id": 1462210245186, "note": "<div><b>Disease</b> of which <b>organ system</b> is most commonly associated with <b>SIADH</b>?</div><div><br></div><div>{{c1::Pulmonary}} </div>", "time": 1660105360011.0}, {"id": 1462210250618, "note": "<div><b>SIADH</b> may be caused by drugs, such as<b> </b>(<i><b><font color=\"#aa0000\">C</font></b>ant <b><font color=\"#aa0000\">C</font></b>oncentrate <b><font color=\"#aa0000\">S</font></b>erum Sodium)</i></div><div><i><br /></i></div><div><i>- <b><font color=\"#aa0000\">C</font></b>{{c1::arbamazepine}}</i></div><div><i>- <b><font color=\"#aa0000\">C</font></b>{{c2::yclophosphamide}}</i></div><div><i>- <font color=\"#aa0000\" style=\"font-weight: bold; \">S</font></i>{{c3::<i>SRI</i>}}</div>", "time": null}, {"id": 1462210256039, "note": "<div><b>SIADH</b> is characterized by <i>increased</i> <b>{{c1::retention}}</b> of free <b>water</b></div>", "time": null}, {"id": 1462210267018, "note": "<div><b>SIADH</b> is characterized by <b>{{c1::urine}} </b>osmolality &gt; <b>{{c1::serum}}</b> osmolality</div>", "time": 1660105352996.0}, {"id": 1462210280338, "note": "<div><b>SIADH</b> is characterized by <b>{{c1::euvolemic::volume}}</b>&nbsp;<b>{{c1::hyponatremia::Na+ level}}</b> with continued urinary Na<sup>+</sup> excretion</div>", "time": null}, {"id": 1462210386904, "note": "<div>The <i>very low</i> serum <b>Na<sup>+</sup></b> concentration in <b>SIADH</b> can lead to <b>{{c2::cerebral}} {{c1::edema}}</b> and <b>seizures</b> </div>", "time": 1660105349368.0}, {"id": 1462210406620, "note": "<div>In <b>SIADH</b>, serum Na<sup>+</sup> levels must be corrected <b>slowly</b> to prevent <b>{{c1::osmotic demyelination}} syndrome</b> </div>", "time": null}, {"id": 1462210416123, "note": "Treatment of <b>SIADH</b> includes <b>water restriction</b> and <b>{{c1::demeclocycline}}</b>, which is a<b> tetracycline</b>", "time": null}, {"id": 1462210486818, "note": "<div>A(n)&nbsp;<b>{{c2::thyroglossal duct}} cyst</b> presents as a(n)&nbsp;<b>{{c1::anterior, midline::location}}</b> <b>{{c3::neck}}</b> <b>mass</b> that moves with swallowing or protrusion of the tongue</div>", "time": 1660105362370.0}, {"id": 1462211176329, "note": "<div>The <b>thyroid</b> develops at the base of the tongue (primitive pharynx) and then travels along the <b>{{c1::thyroglossal}} duct</b> to the anterior neck <br></div><div><br></div><div><i>Bonus: forms from which arch?</i></div>", "time": null}, {"id": 1462211180559, "note": "<div>The <b>{{c1::foramen cecum}}</b> (of the tongue) is the <u>normal</u> <b>remnant</b> of the <b>thyroglossal</b> <b>duct</b> </div>", "time": null}, {"id": 1462211182904, "note": "<div>A <i>partially</i> involuted <b>thyroglossal</b> <b>duct</b> may present as a(n)&nbsp;<b>{{c1::pyramidal}} lobe</b> on the thyroid</div>", "time": null}, {"id": 1462211192914, "note": "<div>What is the most common site for <b>ectopic thyroid tissue</b>?</div><div><br /></div><div>{{c1::The tongue}} </div>", "time": null}, {"id": 1462218872220, "note": "<div>How does <u>hyperthyroidism</u> cause an <b>increased basal metabolic rate</b>?</div><div><br></div><div>{{c1::Via increased synthesis of Na<sup>+</sup>-K<sup>+</sup> ATPase pumps}}</div>", "time": null}, {"id": 1462219774801, "note": "<div>Which <b>thyroid imbalance</b> presents with <b><u>decreased</u> heat production</b> (<b>cold</b> <b>intolerance</b>) and <b><u>decreased</u> sweating</b>?</div><div><br></div><div>{{c1::Hypothyroidism}} </div>", "time": null}, {"id": 1462219782959, "note": "<div><div>Which <b>thyroid imbalance</b> presents with <b><u>increased</u> heat production</b> (<b>heat</b> <b>intolerance</b>) and <b>increased sweating</b>?</div><div><br></div><div>{{c1::Hyperthyroidism}}</div></div>", "time": null}, {"id": 1462219790083, "note": "<div>Which <b>thyroid imbalance</b> presents with <b>weight </b><u style=\"font-weight: bold; \">loss</u> and <b>increased appetite</b>?</div><div><br></div><div>{{c1::Hyperthyroidism}}</div>", "time": 1660105341973.0}, {"id": 1462219795034, "note": "<div><div>Which <b>thyroid imbalance</b> presents with <b>weight </b><u style=\"font-weight: bold; \">gain</u> and <b>decreased appetite</b>?</div><div><br></div><div>{{c1::Hypothyroidism}}</div></div>", "time": 1660105341974.0}, {"id": 1462219844221, "note": "<div><div>Which <b>thyroid imbalance</b> presents with <b>hyperdefecation / diarrhea</b>?</div><div><br></div><div>{{c1::Hyperthyroidism}}</div></div>", "time": null}, {"id": 1462219845577, "note": "<div><div>Which <b>thyroid imbalance</b> presents with <b>constipation</b>?</div><div><br></div><div>{{c1::Hypothyroidism}}</div></div>", "time": null}, {"id": 1462219856267, "note": "<div><div>Which <b>thyroid imbalance</b> presents with <b><u>decreased</u> reflexes</b>?</div><div><br></div><div>{{c1::Hypothyroidism}}</div></div>", "time": null}, {"id": 1462219862784, "note": "<div><div>Which <b>thyroid imbalance</b> presents with <b>tachycardia</b>, <b>palpitations</b>, and <b>arrhythmias</b>?</div><div><br></div><div>{{c1::Hyperthyroidism}}</div></div>", "time": 1660105341975.0}, {"id": 1462219876107, "note": "<div><div>Which <b>thyroid imbalance</b> presents with <b>bradycardia </b>and <b>dyspnea</b> <b>on exertion</b>?</div><div><br></div><div>{{c1::Hypothyroidism}}</div></div>", "time": 1660105341976.0}, {"id": 1462219894892, "note": "<div><div>Which <b>thyroid imbalance</b> presents with <b>proximal muscle weakness</b> and&nbsp;<b><u>increased</u>&nbsp;</b><b>creatine</b><b>&nbsp;kinase</b>?</div><div><br></div><div>{{c1::Hypothyroidism}}</div></div>", "time": null}, {"id": 1462219903584, "note": "<div>Does <b>hyperthyroidism</b> present with <b>hypo-</b> or <b>hyper-cholesterolemia</b>? Why?</div><div><br></div><div>{{c1::Hypocholesterolemia; due to <u>increased</u> LDL receptor expression}}</div>", "time": null}, {"id": 1462219909563, "note": "<div><div>Does <b>hypothyroidism</b> present with <b>hypo-</b> or <b>hyper-cholesterolemia</b>? Why?</div><div><br></div><div>{{c1::Hypercholesterolemia; due to <u>decreased</u> LDL receptor expression}}</div></div>", "time": null}, {"id": 1462219919701, "note": "<div><div>Does <b>hyperthyroidism</b> present with <b>hypo-</b> or <b>hyper-glycemia</b>? Why?</div><div><br></div><div>{{c1::Hyperglycemia; due to increased gluconeogenesis and glycogenolysis}}</div></div>", "time": null}, {"id": 1462219943721, "note": "<div><b>Graves disease </b>is associated with <b>{{c1::pretibial}} {{c2::myxedema}}</b> which occurs due to activation of <b>dermal {{c3::fibroblasts}}</b></div>", "time": null}, {"id": 1462219961995, "note": "<div><div><b>Graves disease </b>is associated with<b> {{c1::exophthalmos}}</b> which occurs due to activation of <b>retro-orbital {{c2::fibroblasts}}</b></div></div>", "time": null}, {"id": 1462220165879, "note": "<div><b>{{c1::Thyroid storm (Thyrotoxicosis)}}</b> is a serious complication that occurs when <b>hyperthyroidism</b> is <u>untreated</u>&nbsp;and <u>worsened</u> in the setting of <b>acute stress</b> (e.g. infection, trauma, surgery)</div>", "time": null}, {"id": 1462220185774, "note": "<div>What are the \"<b>4 Ps</b>\" used to treat <b>thyroid storm</b>?</div><div><br></div><div> 1. {{c1::<b>P</b>ropranolol}} (a \u03b2-blocker)</div><div> 2. {{c1::<b>P</b>ropylthiouracil}} </div><div> 3. {{c2::<b>P</b>rednisolone}} (a corticosteroid)</div><div> 4. {{c2::<b>P</b>otassium iodide}} (Lugol iodine)  </div>", "time": null}, {"id": 1462220276669, "note": "<div><b>Toxic multinodular goiter</b> is most often due to <b>{{c1::TSH receptor}} mutations</b> (60% of cases) </div>", "time": null}, {"id": 1462220285179, "note": "<div>The <b>{{c1::Jod-Basedow}} phenomenon</b> describes <b>{{c3::thyrotoxicosis (hyperthyroidism)}}</b> in a patient with <b>iodine</b> <b>deficiency</b> who is made <b>iodine</b> <b>replete</b></div>", "time": null}, {"id": 1462220327470, "note": "<div><b>{{c1::Hypothyroidism}}</b> in neonates and infants is known as <b>cretinism</b> </div>", "time": null}, {"id": 1462223715564, "note": "<div>A <b>p</b>ot-bellied, <b>p</b>ale, <b>p</b>uffy-faced child with <u><b>p</b>rotruding umbilicus</u>, <b>p</b>rotuberant tongue, and <u><b>p</b>oor brain development</u> is characteristic of <b>{{c1::cretinism}}</b> </div>", "time": 1660105362468.0}, {"id": 1462223763124, "note": "<div>One cause of <b>cretinism</b> is <b>{{c1::dyshormonogenetic goiter}}</b>, which is due to a congenital defect in thyroid hormone production</div>", "time": 1660105354654.0}, {"id": 1462223781267, "note": "<div>The most common cause of <b>cretinism</b> in the <u>U.S.</u> is <b>{{c1::thyroid dysgenesis}}</b></div>", "time": 1660105349810.0}, {"id": 1462223793144, "note": "<div><div><b>{{c2::Myxedema}}</b> is the accumulation of <b>{{c1::glycosaminoglycans}}</b> in the skin and soft tissue; it is most often associated with&nbsp;<b>{{c3::hypothyroidism}}</b> </div></div>", "time": null}, {"id": 1462223802155, "note": "<div>In <b>hypothyroidism</b> patients, <b>myxedema&nbsp;</b>commonly affects the <b>{{c1::larynx}}</b> (causing deep voice) and <b>{{c1::tongue}}</b> (causing enlargement)</div>", "time": 1660105357177.0}, {"id": 1462223809215, "note": "<div><div>Which <b>thyroid imbalance</b> is associated with <b>dry, cool skin</b> and <b>coarse, brittle hair</b>?</div></div><div><br></div><div>{{c1::Hypothyroidism}}</div>", "time": null}, {"id": 1462223812155, "note": "<div><div><div>Which <b>thyroid imbalance</b> is associated with <b>warm, moist skin</b> and <b>fine hair</b>?</div></div><div><br></div><div>{{c1::Hyperthyroidism}}</div></div>", "time": null}, {"id": 1462223814642, "note": "<div><b>Hashimoto thyroiditis</b> is associated with <b>HLA-{{c1::DR3}}</b> and <b>HLA-{{c1::DR5}}</b></div>", "time": null}, {"id": 1462223819821, "note": "<div>What is the most common cause of <b>hypothyroidism</b> in regions where iodine levels are adequate?</div><div><br /></div><div>{{c1::Hashimoto thyroiditis}}</div>", "time": null}, {"id": 1462223846795, "note": "<div><i>Initially</i>, <b>Hashimoto thyroiditis</b> presents as <b>{{c1::hyperthyroidism}} </b>due to thyrotoxicosis during follicular rupture </div>", "time": 1660105356048.0}, {"id": 1462223862805, "note": "<div>Which <u>two</u> antibodies are associated with <b>Hashimoto thyroiditis</b>? </div><div><br></div><div>{{c1::Anti-thyroglobulin}} and {{c2::anti-thyroid peroxidase (anti-microsomal)}} </div>", "time": null}, {"id": 1462223891730, "note": "<div><u>Histologically</u>, <b>Hashimoto thyroiditis</b> is associated with <b>chronic inflammation</b> with well-developed <b>{{c1::germinal centers}}</b></div>", "time": 1660105358231.0}, {"id": 1462223900918, "note": "<div><u>Histologically</u>, <b>Hashimoto thyroiditis</b> may have <b>{{c1::Hurthle}} cells</b>, which are <b>eosinophilic</b> metaplastic cells that line the follicles</div><div></div>", "time": null}, {"id": 1462223916411, "note": "<div>Patients with <b>Hashimoto thyroiditis</b> have an increased risk for <b>{{c1::B-cell (marginal zone) lymphoma}}</b>; presents as an enlarging thyroid late in disease course</div>", "time": null}, {"id": 1462223924118, "note": "<div>Does <b>Hashimoto thyroiditis</b> present with a <b>tender</b> or <b>nontender</b> thyroid?</div><div><br /></div><div>{{c1::Nontender}}</div>", "time": null}, {"id": 1462223933107, "note": "<div><b>Subacute granulomatous thyroiditis (de Quervain)</b> is a self-limited disease often following <b>{{c1::viral infection}}</b></div>", "time": 1660105350718.0}, {"id": 1462223953253, "note": "<div>Does <b>subacute granulomatous thyroiditis (de Quervain)</b> present with a <b>tender</b> or <b>nontender</b> thyroid?</div><div><br /></div><div>{{c1::**Very tender**}}</div>", "time": null}, {"id": 1462223990721, "note": "<div><b>Subacute granulomatous thyroiditis (de Quervain)</b> may <i>initially</i> present with <b>{{c1::hyperthyroidism}}</b>, which typically is followed by a brief <b>{{c1::hypothyroid}}</b> state</div>", "time": 1660105350717.0}, {"id": 1462224001342, "note": "<div>What <u>histological</u> findings are associated with <b>Subacute thyroiditis (de Quervain)</b>?</div><div><br></div><div>{{c1::Granulomatous inflammation}}</div><div></div>", "time": null}, {"id": 1462224038691, "note": "<div><b>Riedel thyroiditis</b> is characterized by replacement of thyroid by <b>{{c1::fibrous}} tissue</b> with <b>inflammatory infiltrate</b></div>", "time": null}, {"id": 1462224076734, "note": "<div>In <b>Riedel thyroiditis</b>, fibrosis may extend to {{c1::<b>local structures</b> (e.g. airway)}}, thus mimicking <b>{{c2::anaplastic carcinoma}} </b></div>", "time": 1660105356891.0}, {"id": 1462224106274, "note": "<div><b>Riedel thyroiditis</b> presents as a \"<b>{{c1::hard as wood}}</b>\", <b>{{c2::nontender::tender or non-tender}}</b>&nbsp;goiter</div>", "time": 1660105353278.0}, {"id": 1462224134179, "note": "<b>Riedel thyroiditis</b> is considered a manifestation of <b>{{c1::IgG<sub>4</sub>}}-related systemic disease</b>, which includes autoimmune pancreatitis, retroperitoneal fibrosis, and noninfectious aortitis ", "time": null}, {"id": 1462224141565, "note": "<b>Thyroid nodules</b> are more likely to be <b>{{c1::benign::benign or malignant}}</b> than <b>{{c1::malignant::benign or malignant}}</b>&nbsp;", "time": 1660105348754.0}, {"id": 1462228482324, "note": "<div><b>Thyroid nodules</b> may be studied using <b>{{c1::<sup>131</sup>I}} radioactive uptake studies</b> </div>", "time": 1660105348753.0}, {"id": 1462228497868, "note": "<div>If a <b>thyroid nodule</b> has <b><u>increased</u></b> <b>uptake</b> of <b><sup>131</sup>I</b>, it is considered a(n)&nbsp;<b>{{c1::hot}} nodule</b>; seen in Graves disease or nodular goiter</div>", "time": 1660105357728.0}, {"id": 1462228511124, "note": "<div>If a <b>thyroid nodule</b> has <b><u>decreased</u></b> <b>uptake</b> of <b><sup>131</sup>I</b>, it is considered a(n)&nbsp;<b>{{c1::cold}} nodule</b></div>", "time": 1660105357729.0}, {"id": 1462228521890, "note": "<div>What is a <b>cold nodule</b> on <b><sup>131</sup>I radioactive uptake studies</b> indicative of?</div><div><br /></div><div>{{c1::Adenoma or carcinoma; warrants further biopsy}}</div>", "time": null}, {"id": 1462228531057, "note": "<div>How is a <b>biopsy</b> performed for a <b>thyroid nodule</b>? </div><div><br /></div><div>{{c1::Fine needle aspiration (FNA)}}</div>", "time": null}, {"id": 1462228546625, "note": "<div><b>Thyroid {{c1::adenoma}}</b> is a <b>benign</b> solitary growth of the thyroid</div>", "time": null}, {"id": 1462228554222, "note": "<div>Most <b>thyroid adenomas</b> are <b>nonfunctional</b> (\"cold\"), but may rarely cause <b>{{c1::hyperthyroidism}}</b> via autonomous thyroid hormone production (\"hot\" or \"toxic\") </div>", "time": null}, {"id": 1462228578176, "note": "<div>The most common type of <b>thyroid <u>adenoma</u></b> is <b>{{c1::follicular}} adenoma</b></div>", "time": 1660105349792.0}, {"id": 1462228594968, "note": "<div>What is the main <u>distinguishing feature</u> between <b>follicular adenoma</b> and <b>follicular carcinoma</b> of the thyroid?</div><div><br /></div><div>{{c1::Follicular <u>adenoma</u> has a lack of capsular and vascular invasion}}</div>", "time": null}, {"id": 1462228629278, "note": "<div>Thyroid <b>follicular adenoma</b> is a benign tumor of follicles surrounded by a(n)&nbsp;<b>{{c1::fibrous capsule}}</b></div>", "time": 1660105348762.0}, {"id": 1462228661599, "note": "<div>What is the <u>most common</u> type of <b>thyroid carcinoma</b>? </div><div><br></div><div>{{c1::Papillary Carcinoma (80%)}}</div>", "time": null}, {"id": 1462228665661, "note": "<div>Exposure to {{c1::<b>ionizing</b> <b>radiation</b>}} in <b>childhood</b> is a major risk factor for thyroid <b>{{c2::papillary}} carcinoma</b></div>", "time": null}, {"id": 1462228694838, "note": "<div>Thyroid <b>{{c1::papillary}} carcinoma</b> may be lined by cells with clear, <b>{{c2::Orphan Annie eye}}</b> nuclei</div>", "time": null}, {"id": 1462228925054, "note": "<div>In addition to Orphan Annie eye nuclei, thyroid <b>papillary carcinoma</b> may have cells with <b>intranuclear {{c1::grooves}} </b>and <b>inclusions</b></div>", "time": null}, {"id": 1462228968675, "note": "<div>Thyroid <b>{{c2::papillary}} carcinoma</b> may have <b>{{c1::psammoma}} bodies</b> on biopsy, which are characterized by <b>concentric</b> layers of <b>calcification</b> </div>", "time": null}, {"id": 1462228988545, "note": "<div>What is the prognosis of thyroid <b>papillary carcinoma</b>? </div><div><br></div><div>{{c1::Excellent}}</div>", "time": 1660105345579.0}, {"id": 1462228992508, "note": "<div>Thyroid <b>follicular carcinoma</b> is characterized by a malignant proliferation of follicles surrounded by a(n)&nbsp;<b>{{c1::fibrous capsule}}</b> with <b>{{c1::invasion through the capsule}}</b></div>", "time": null}, {"id": 1462229017040, "note": "<div>Can <b>fine needle aspiration</b> distinguish between thyroid <b>follicular adenoma</b> versus <b>carcinoma</b>?</div><div><br /></div><div>{{c1::No; the fibrous capsule cannot be visualized with FNA}}</div>", "time": 1660105361001.0}, {"id": 1462229039299, "note": "<div>What is the most common route of <b>metastasis</b> for a thyroid <b>follicular carcinoma</b>?</div><div><br></div><div>{{c1::Hematogenous}} </div>", "time": null}, {"id": 1462229047807, "note": "<div>Thyroid <b>{{c1::medullary}} carcinoma </b>is a malignant proliferation of <b>{{c2::parafollicular \"C\"}} cells</b> </div>", "time": null}, {"id": 1462229061096, "note": "<div>Thyroid <b>medullary carcinomas</b> secrete <b>{{c1::calcitonin}}</b> </div>", "time": null}, {"id": 1462229067351, "note": "<div>High levels of <b>calcitonin</b> produced by a thyroid <b>medullary carcinoma</b> may lead to <b>{{c1::hypocalcemia}}</b></div>", "time": null}, {"id": 1462229072601, "note": "<div>In thyroid <b>medullary carcinoma</b>, <u>calcitonin</u> often deposits within the tumor as <b>{{c1::amyloid}}</b>, which may be visualized with a(n)&nbsp;<b>{{c2::congo red}} stain</b></div>", "time": null}, {"id": 1462229092555, "note": "<div>Detection of a <i>RET</i> oncogene<b> mutation</b> warrants <b>prophylactic </b><b>{{c1::thyroidectomy}}</b></div>", "time": 1660105360111.0}, {"id": 1462229198876, "note": "<div>What <u>two</u> <b>multiple endocrine neoplasias</b> are associated with thyroid <b>medullary carcinoma</b>?</div><div><br /></div><div>{{c1::MEN 2A and 2B}}</div>", "time": null}, {"id": 1462229233459, "note": "<div>Thyroid <b>{{c1::anaplastic}} carcinoma</b> is an <i>undifferentiated</i> malignant tumor of thyroid</div>", "time": 1660105348750.0}, {"id": 1462229255450, "note": "<div>Thyroid <b>{{c1::anaplastic}} carcinoma</b> often invades <b>local</b> <b>structures</b> leading to dysphagia or respiratory compromise</div>", "time": 1660105348749.0}, {"id": 1462229270613, "note": "<div>What is the prognosis of thyroid <b>anaplastic carcinoma</b>?</div><div><br></div><div>{{c1::Poor}}</div>", "time": null}, {"id": 1462229277074, "note": "<div><div>What type of <b>thyroid carcinoma</b> is illustrated in this histology slide? </div><div><br></div><div>{{c1::Anaplastic carcinoma}} </div></div><div><br></div><div><img src=\"paste-39603893436918.jpg\"></div>", "time": 1660105344757.0}, {"id": 1462229286041, "note": "<div>What is the <u>most common</u> cause of <b>primary hyperparathyroidism</b>?</div><div><br></div><div>{{c1::Parathyroid adenoma (&gt;80%)}}</div>", "time": null}, {"id": 1462232001565, "note": "<div>What is the <b>serum calcium level</b> in <b>primary hyperparathyroidism</b>?</div><div><br /></div><div>{{c1::Increased (due to increased PTH)}}</div>", "time": null}, {"id": 1462232007760, "note": "<div>As a result of <b>hypercalcemia</b>, patients with <b>primary hyperparathyroidism</b> are at increased risk for <b>{{c1::calcium oxalate kidney}} stones</b></div>", "time": null}, {"id": 1462232033989, "note": "<div><b>{{c1::Nephrocalcinosis}}</b> is the deposition of <b>calcium</b> in the tubules of the kidney due to <b>primary hyperparathyroidism</b></div>", "time": 1660105339485.0}, {"id": 1462232060525, "note": "<div><b>Primary hyperparathyroidism</b> may lead to <u>CNS</u> disturbances, such as {{c1::depression}} and seizures</div>", "time": 1660105353692.0}, {"id": 1462232077763, "note": "<div>Is a patient with <b>hyperparathyroidism</b> more likely to present with constipation or diarrhea?</div><div><br /></div><div>{{c1::Constipation}}</div>", "time": null}, {"id": 1462232142704, "note": "<div>What is the serum level of <b>calcium</b> in <b><u>primary</u> hyperparathyroidism</b>?</div><div><br /></div><div>{{c1::Increased (hypercalcemia)}}</div>", "time": 1660105345499.0}, {"id": 1462232161465, "note": "<div><div>What is the serum level of <b>phosphate</b> in <b><u>primary</u> hyperparathyroidism</b>?</div><div><br /></div><div>{{c1::Decreased (hypophosphatemia)}}</div></div>", "time": null}, {"id": 1462232179503, "note": "<div><div>What is the serum level of <b>calcium</b> in <b><u>secondary</u> hyperparathyroidism</b>?</div><div><br /></div><div>{{c1::Decreased (hypocalcemia)}}</div></div>", "time": null}, {"id": 1462232204692, "note": "<div>What is the <u>most common</u> cause of <b>secondary hyperparathyroidism</b>?</div><div><br></div><div>{{c1::Chronic renal failure}}</div>", "time": null}, {"id": 1462232219341, "note": "<div>How does <b>renal insufficiency</b> cause <b>secondary hyperparathyroidism</b>? (sorry) </div><div><br /></div><div>{{c1::<div> 1. Renal insufficiency causes decreased phosphate excretion and thus increased serum phosphate levels</div><div> 2. Increased serum phosphate may bind free, ionized calcium, thus decreasing serum calcium levels</div><div> 3. Decreased free calcium stimulates PTH release from the parathyroid glands</div>}}</div>", "time": null}, {"id": 1462232225257, "note": "<div><b>Chronic {{c1::renal}} disease </b>can cause a <b><u>s</u></b><u style=\"font-weight: bold; \">econdary</u><b> hyperparathyroidism</b> syndrome known as <b>{{c1::Renal Osteodystrophy}}</b>, which is characterized by <b>bone lesions</b> due to increased bone resorption (from elevated PTH) </div>", "time": null}, {"id": 1462232232348, "note": "<div><u style=\"font-weight: bold; \">{{c1::Tertiary}}</u> <b>hyperparathyroidism</b> is refractory (<b>autonomous</b>) hyperparathyroidism resulting from <b>chronic</b> <b>renal</b> <b>disease</b></div>", "time": null}, {"id": 1462232288770, "note": "<div><b>Pseudohypoparathyroidism type 1a</b> or <b>Albright hereditary osteodystrophy</b> is characterized by <u>shortened stature</u> and shortened {{c1::4th}} and {{c1::5th}} digits</div>", "time": null}, {"id": 1462232307555, "note": "<div>What is the inheritance of <b>pseudohypoparathyroidism type 1a</b> (<b>Albright hereditary osteodystrophy</b>)?</div><div><br /></div><div>{{c1::Autosomal dominant}}</div>", "time": 1660105346211.0}, {"id": 1462308715423, "note": "Which endocrine disorder presents with the <b>physical features</b> of <b>Albright hereditary dystrophy</b> but <u>without</u> the end-organ <b>PTH resistance</b>? <div><br></div><div>{{c1::Pseudopseudohypoparathyroidism}}</div>", "time": 1660105343164.0}, {"id": 1462326105448, "note": "<b>Type {{c1::1}} diabetes mellitus</b> is characterized by <b>insulin</b> <b>deficiency</b> ", "time": 1660105348449.0}, {"id": 1462326951145, "note": "<div><b>Type {{c1::2}} diabetes mellitus</b> is characterized by <b>insulin</b> <b>resistance</b></div>", "time": null}, {"id": 1462326961450, "note": "<div><b>Type 1 diabetes mellitus</b> is due to {{c1::autoimmune destruction}} of <u>pancreatic </u>{{c2::<u>\u03b2</u>}}<u> cells</u> by <b>{{c3::anti-glutamic acid decarboxylase}} antibodies</b> </div>", "time": 1660105348461.0}, {"id": 1462326990404, "note": "<div>What type of <b>hypersensitivity</b> is <b>type 1 DM</b>? </div><div><br /></div><div>{{c1::type IV HSR}}</div>", "time": null}, {"id": 1462326996658, "note": "<div>What age group is most commonly affected by <b>type 1 DM</b>? </div><div><br /></div><div>{{c1::&lt; 30 years old}}</div>", "time": 1660105347980.0}, {"id": 1462327011039, "note": "<div><div>What age group is most commonly affected by <b>type 2 DM</b>? </div><div><br /></div><div>{{c1::&gt; 40 years old}}</div></div>", "time": null}, {"id": 1462327016536, "note": "<div>Is <b>type 1 DM</b> characterized by a <u>strong</u> or <u>weak</u> <b>genetic predisposition </b>(compared to type 2)? </div><div><br /></div><div>{{c1::Relatively weak (50% concordance in identical twins)}}</div>", "time": null}, {"id": 1462327023070, "note": "<div>Is <b>type 2 DM</b> characterized by a <u>strong</u> or <u>weak</u> <b>genetic predisposition</b> (compared to type 1)?</div><div><br /></div><div>{{c1::Relatively strong (90% concordance in twin studies)}}</div>", "time": null}, {"id": 1462327031605, "note": "<div>Histology of <b>type 1 diabetes mellitus</b> demonstrates <b>islets</b> with <b>{{c1::leukocytic infiltrate (inflammation)}}</b></div>", "time": null}, {"id": 1462327043159, "note": "<div>Histology of <b>type 2 diabetes mellitus</b> demonstrates <b>islets</b> with <b>{{c1::amyloid deposits}}</b></div>", "time": null}, {"id": 1462327053167, "note": "<div>What is the level of <b>insulin</b> in a patient with <b>type 2 diabetes</b> (elevated, decreased, normal)? </div><div><br></div><div>{{c1::Variable; <u>increased</u> <i>early</i> in disease, but may be <u>decreased</u> later in disease due to&nbsp;\u03b2&nbsp;cell exhaustion}}</div>", "time": 1660105346180.0}, {"id": 1462327061414, "note": "<div><b>Type 1 diabetes </b>is associated with <b>HLA-{{c1::DR3}}</b> and <b>HLA-{{c1::DR4}}</b></div>", "time": null}, {"id": 1462327073683, "note": "<div>Why does <b>type 1 diabetes mellitus</b> present with <b>weight loss</b> and <b>decreased muscle mass?</b></div><div><b><br /></b></div><div>{{c1::increased <u>lipolysis</u> and <u>proteolysis</u> due to unopposed glucagon from lack of insulin}}</div>", "time": 1660105341513.0}, {"id": 1462327089156, "note": "<div>Why do patients with <b>diabetes mellitus</b> present with <b>polyuria</b> and <b>polydipsia</b>? </div><div><br /></div><div>{{c1::Excess glucose is filtered into the urine and pulls water with it}}</div>", "time": 1660105341530.0}, {"id": 1462327127564, "note": "<div>What is the <u>most common</u> type of <b>diabetes mellitus</b>?</div><div><br /></div><div>{{c1::Type 2}}</div>", "time": 1660105345789.0}, {"id": 1462327139204, "note": "<div><div>How does <b>insulin resistance</b> manifest in <b>obese</b> patients, causing <b>type 2 DM</b>?</div><div><br></div><div>{{c1::Obesity causes downregulation of insulin receptors}}</div></div>", "time": 1660105358092.0}, {"id": 1462327161497, "note": "<div>The diagnosis for <b>diabetes mellitus</b> may be made using {{c1::HbA<sub>1c</sub>}} which reflects average blood glucose over <b>3 prior months</b></div>", "time": null}, {"id": 1462327170017, "note": "<div>What is the diagnostic cutoff for <b>HbA</b><sub style=\"font-weight: bold; \">1c</sub> for a diagnosis of <b>diabetes mellitus</b>? </div><div><br></div><div>{{c1::\u22656.5%}}</div>", "time": null}, {"id": 1462327178225, "note": "<div>What is the diagnostic cutoff for <b>fasting plasma glucose</b> for a diagnosis of <b>diabetes mellitus</b>?</div><div><br></div><div>{{c1::\u2265126 mg/dL}}</div>", "time": null}, {"id": 1462327189114, "note": "<div>What is the diagnostic cutoff for the <b>2-hour oral glucose tolerance test</b> for a diagnosis of <b>diabetes mellitus</b>?</div><div><br></div><div>{{c1::\u2265 200 mg/dL}}</div><div></div>", "time": null}, {"id": 1462327203603, "note": "<div>What is the range for <b>normal blood glucose levels</b> (mg/dL)?</div><div><br /></div><div>{{c1::70-120 mg/dL}}</div>", "time": null}, {"id": 1462327211125, "note": "<div>One of the most feared complications of <b>type 1 diabetes</b> is <b>{{c1::diabetic ketoacidosis}}</b></div>", "time": null}, {"id": 1462327224889, "note": "<div><b>Diabetic ketoacidosis</b> often arises with <b>{{c1::stress}}</b> (e.g. infection) </div><div><div></div></div>", "time": null}, {"id": 1462327286091, "note": "<div>In <b>type 1 diabetics</b>, increased <b>{{c2::lipolysis}}</b> leads to an increase in <b>free fatty acids</b> which are converted to <b>{{c1::ketone bodies}}</b> in the <b>liver</b></div>", "time": 1660105356555.0}, {"id": 1462327309654, "note": "<div>What are the <u>two major</u> <b>ketone bodies</b> produced in a <b>type 1 diabetic</b> patient?</div><div><br /></div><div>{{c1::\u03b2-hydroxybutyrate and acetoacetate}}</div>", "time": null}, {"id": 1462327320519, "note": "<div><b>Diabetic ketoacidosis</b> is associated with a(n)&nbsp;<b>{{c1::fruity}}</b> breath odor due to exhaled <b>{{c2::acetone}}</b></div>", "time": null}, {"id": 1462327329868, "note": "<div><b>Diabetic ketoacidosis</b> is associated with<b> {{c1::Kussmaul}}</b> respirations, which is rapid/deep breathing to compensate for <b>metabolic</b> <b>{{c2::acidosis}}</b> </div>", "time": null}, {"id": 1462327341080, "note": "<div>What is the <b><u>serum</u> potassium</b> level in a <b>type 1 diabetic</b> patient? </div><div><br></div><div>{{c1::Increased::increased or decreased}}</div>", "time": null}, {"id": 1462327346466, "note": "<div>What is the <u style=\"font-weight: bold; \">intracellular</u> <b>potassium</b> level in a <b>type 1 diabetic</b> patient?</div><div><br></div><div>{{c1::Decreased::increased or decreased}}</div>", "time": null}, {"id": 1462327363797, "note": "<div>What type of <b>acidosis</b> will a patient with <b>diabetic ketoacidosis</b> experience?</div><div><br></div><div>{{c1::high anion gap metabolic acidosis}}</div>", "time": null}, {"id": 1462327370877, "note": "<div>Will a <b>diabetic ketoacidosis</b> patient present with <b>hyper-</b> or <b>hypo-glycemia</b>?</div><div><br></div><div>{{c1::Hyperglycemia (usually &gt;300 mg/dL)}}</div>", "time": 1660105341490.0}, {"id": 1462327377004, "note": "<div>What <b>fungal infection</b> is a feared complication in a <b>diabetic ketoacidosis</b> patient?</div><div><br></div><div>{{c1::Mucormycosis (usually caused by <i>Rhizopus</i> infection)}}</div>", "time": null}, {"id": 1462327382493, "note": "<div>What is the treatment for <b>diabetic ketoacidosis</b>?</div><div><br /></div><div>IV {{c1::fluids}}, {{c1::insulin}}, and {{c1::K<sup>+</sup> (to replete <b>intracellular</b> stores)}}</div>", "time": 1660105345367.0}, {"id": 1462327389480, "note": "<div>One of the most feared complications of <b>type 2 diabetes</b> is {{c1::hyperosmolar hyperglycemia non-ketotic syndrome}}</div>", "time": null}, {"id": 1462327432810, "note": "<div>What demographic is most commonly associated with <b>hyperosmolar hyperglycemia non-ketotic syndrome</b>? </div><div><br /></div><div>{{c1::Elderly type 2 diabetics, especially with limited ability to drink}}</div>", "time": 1660105347320.0}, {"id": 1462327441833, "note": "<div><b>Hyperosmolar hyperglycemic non-ketotic syndrome</b> often presents with <u>glucose levels</u> &gt; {{c1::600}} mg/dL and <u>increased</u><b> serum osmolarity</b> (&gt; 320 mOsm/kg) </div>", "time": null}, {"id": 1462327461738, "note": "<div>Does <b>hyperosmolar hyperglycemia non-ketotic syndrome</b> present with ketoacidosis? Why? </div><div><br></div><div>{{c1::No, ketone production is inhibited by presence of insulin}}</div>", "time": 1660105359854.0}, {"id": 1462327473707, "note": "<div>What is the treatment for <b>hyperosmolar hyperglycemic non-ketotic syndrome</b>? </div><div><br></div><div>{{c1::Intense IV fluids and insulin therapy}}</div>", "time": 1660105345350.0}, {"id": 1462327481691, "note": "<div>One <u>chronic</u> complication of <b>diabetes mellitus</b> is <b>{{c1::non-enzymatic glycosylation}}</b> of vascular <b>basement membranes</b> </div>", "time": null}, {"id": 1462327545263, "note": "<div><b>{{c2::Non-enzymatic glycosylation}}</b> of medium and large-sized vessels leads to <b>{{c1::atherosclerosis}}</b> in <b>diabetic patients</b></div>", "time": 1660105337600.0}, {"id": 1462327558597, "note": "<div>What is the leading cause of death in a patient with <b>diabetes mellitus</b>?</div><div><br /></div><div>{{c1::Heart attack (MI)}}</div>", "time": null}, {"id": 1462327570500, "note": "<div><b>Non-enzymatic glycosylation</b> of medium and large-sized vessels may cause <b>{{c1::peripheral vascular occlusive disease}}</b>, which is the leading cause of nontraumatic <b>amputation</b> in <b>diabetic patients</b> </div>", "time": 1660105354825.0}, {"id": 1462327588618, "note": "<div><b>Non-enzymatic glycosylation</b> of small vessels may cause <b>nodular {{c1::glomerulosclerosis}}</b> with <b>Kimmelstiel-Wilson nodules</b>; may cause chronic renal failure </div>", "time": 1660105354823.0}, {"id": 1462327605465, "note": "<div><b>Non-enzymatic glycosylation</b> of small vessels can cause <b>hyaline</b> <b>{{c1::arteriolosclerosis}}</b> of the kidney, which may lead to chronic renal failure </div>", "time": 1660105354824.0}, {"id": 1462327641370, "note": "<div><b>Non-enzymatic glycosylation</b> of <b>hemoglobin</b> leads to {{c1::HbA<sub>1c</sub>}}</div>", "time": 1660105354826.0}, {"id": 1462327651340, "note": "<div>In <b>diabetes</b> patients, <b>{{c1::osmotic}} damage</b> may occur when <b>glucose</b> in tissue is converted to <b>{{c2::sorbitol}}</b> by the enzyme {{c3::<i style=\"font-weight: bold; \">aldose reductase</i>}}</div>", "time": 1660105357343.0}, {"id": 1462327670273, "note": "<div>In <b>diabetes </b>patients, <b>{{c1::peripheral neuropathy}}</b>&nbsp;and {{c1::<b>autonomic</b>}}&nbsp;<b>neuropathy&nbsp;</b>occurs as a result of <b>osmotic damage </b>to <b>{{c2::Schwann}} cells</b></div>", "time": null}, {"id": 1462327681826, "note": "<div>In <b>diabetes </b>patients, <b>{{c2::blindness}}</b> occurs as a result of <b>osmotic damage </b>to <b>{{c1::pericytes::cell type}} </b>of retinal blood vessels, weakening the vessel wall and causing <b>aneurysm</b> formation</div>", "time": null}, {"id": 1462327695261, "note": "<div>In <b>diabetes </b>patients, <b>{{c1::cataracts}}</b> occur as a result of <b>osmotic damage </b>to the <b>{{c2::lens::structure}}</b></div>", "time": 1660105357345.0}, {"id": 1462327705715, "note": "<div><b>Glucose</b> is converted to <b>{{c1::sorbitol}}</b> by the enzyme<i> <b>{{c2::aldose reductase}}</b></i></div>", "time": null}, {"id": 1462327732727, "note": "<div>A(n)&nbsp;<b>{{c1::glucagonoma}}</b> is a tumor of <b>pancreatic <u>alpha</u></b> <b>cells</b></div>", "time": null}, {"id": 1462327744491, "note": "<div>Which <b>hormone-secreting tumor</b> is associated with <b>d</b>ermatitis (necrolytic migratory erythema), <b>d</b>iabetes, <b>D</b>VT, <b>d</b>eclining weight, and <b>d</b>epression?</div><div><br/></div><div>{{c1::Glucagonoma}} </div>", "time": 1660105342817.0}, {"id": 1462327755265, "note": "<div>What is the treatment for a <b>glucagonoma</b>?</div><div><br></div><div>{{c1::Octreotide (somatostatin analog) or surgery}}</div>", "time": null}, {"id": 1462327759863, "note": "<div>A(n)&nbsp;<b>{{c1::insulinoma}}</b> is a tumor of <b>pancreatic&nbsp;</b><b><u>\u03b2</u></b>&nbsp;<b>cells</b></div>", "time": null}, {"id": 1462327767445, "note": "<div>The <b>Whipples triad</b> help confirm&nbsp;<b>symptomatic {{c2::hypoglycemia}}</b> </div><div><br></div><div>- low blood <b>{{c1::glucose}}</b></div><div>- {{c1::symptoms}} of hypoglycemia</div><div>- resolution of symptoms after normalization of <b>{{c1::glucose}}</b> levels </div>", "time": 1660105349352.0}, {"id": 1462327792664, "note": "<div>Symptomatic patients with <b>insulinoma</b> have <b>{{c1::low</b>::high/low<b>}}</b> blood glucose and <b>{{c1::high</b>::high/low<b>}}</b> C-peptide levels</div>", "time": 1660105350673.0}, {"id": 1462327808151, "note": "<div>About 10% of cases of <b>insulinoma</b> are associated with <b>{{c1::MEN 1}} syndrome</b> </div>", "time": null}, {"id": 1462327847781, "note": "<div>The <b>{{c1::secretin stimulation}} test</b> may be used to aid in the diagnosis of <b>Zollinger-Ellison syndrome</b> </div>", "time": null}, {"id": 1462327862046, "note": "<div>If a patient has <b>Zollinger-Ellison syndrome</b>, <b>gastrin</b> levels will remain {{c1::elevated}} after administration of <b>secretin</b> (secretin stimulation test) </div>", "time": null}, {"id": 1462327872883, "note": "<div><b>Zollinger-Ellison syndrome</b> is caused by a(n)&nbsp;<b>{{c1::gastrinoma}}</b> of the pancreas or duodenum</div>", "time": null}, {"id": 1462327883792, "note": "<div><div><b>Carcinoid tumors</b> often secrete <b>{{c1::serotonin (5-HT)}}</b>, which is dumped into the portal vein and processed by the <b>liver</b> via <b>{{c2::monoamine oxidase (MAO)}}</b></div></div>", "time": null}, {"id": 1462327891062, "note": "<div>Elevated levels of <b>{{c1::5-HIAA}}</b>, a metabolite of serotonin, in the urine is indicative of a(n)&nbsp;<b>{{c2::carcinoid}} tumor</b></div>", "time": null}, {"id": 1462327899426, "note": "<div>What is the&nbsp;<u>most common</u>&nbsp;<b>malignancy</b>&nbsp;in the&nbsp;<b>small intestine</b>?</div><div><br></div><div>{{c1::Carcinoid tumor (neuroendocrine cells)}}</div>", "time": null}, {"id": 1462327929517, "note": "<div><div><b>Carcinoid</b> <b>syndrome</b> may occur if the carcinoid tumor <b>metastasizes</b> <b>to the {{c1::liver}}</b></div></div>", "time": null}, {"id": 1462327941682, "note": "<div><div><b>Carcinoid syndrome</b> is characterized by bronchospasm (<b>asthmatic</b> <b>wheezing</b>), recurrent diarrhea, and {{c1::flushing of the skin}}</div></div>", "time": null}, {"id": 1462327945336, "note": "<div><div>Carcinoid syndrome may cause <b>carcinoid heart disease</b>, which is characterized by <b>{{c1::right}}-sided</b> valvular fibrosis leading to <b>{{c1::tricuspid}} regurgitation</b> and <b>pulmonary valve stenosis</b></div></div>", "time": null}, {"id": 1462327957226, "note": "<div><div>Why are <b>left-sided valvular lesions</b> not seen in a patient with <b>carcinoid heart disease</b>?</div><div><br /></div><div>{{c1::blood passes through the lung, which contains MAO, thus converting 5-HT to 5-HIAA before reaching the left heart}}</div></div>", "time": null}, {"id": 1462327963475, "note": "<b>{{c1::VIPoma}}</b>&nbsp;is a non-\u03b1, non-\u03b2, non-\u03b4&nbsp;islet cell&nbsp;<u>pancreatic tumor</u>&nbsp;that secretes&nbsp;<b>VIP&nbsp;</b>(also known as WDHA syndrome)", "time": null}, {"id": 1462327969304, "note": "<div>The symptoms of <b>VIPoma</b> are {{c1::Watery Diarrhea}}, {{c1::Hypokalemia}}, and {{c1::Achlorhydria}}</div>", "time": null}, {"id": 1462377691686, "note": "<b>Cushing <i>syndrome</i></b> simply refers to an increase in serum <b>{{c1::cortisol}}</b>", "time": null}, {"id": 1462380546437, "note": "<b>Cushing </b><i><b>disease</b> </i>refers <i>specifically</i> to a(n) {{c1::ACTH-secreting pituitary adenoma}}", "time": null}, {"id": 1462380557261, "note": "<div>What is the <u>most common</u> cause of <b>Cushing syndrome</b>?</div><div><br></div><div>{{c1::Exogenous glucocorticoids}}</div>", "time": null}, {"id": 1462380573238, "note": "<div>What is the most common <u>endogenous</u> cause of <b>Cushing syndrome</b>?</div><div><br /></div><div>{{c1::Cushing disease (i.e. an ACTH-secreting pituitary adenoma)}}</div>", "time": null}, {"id": 1462380580332, "note": "<div>One clinical feature of <b>Cushing syndrome</b> is <b>muscle weakness</b> with <b>{{c1::thin}} extremities </b></div>", "time": 1660105354643.0}, {"id": 1462380591634, "note": "<div>Clinical features of <b>{{c2::Cushing syndrome}}</b> include moon facies, buffalo hump, and truncal obesity due to <b>increased {{c1::fat storage}}</b>, secondary to excess <b>{{c1::insulin}}</b> </div>", "time": 1660105360638.0}, {"id": 1462380612148, "note": "<div>One clinical feature of <b>Cushing syndrome</b> is <b>{{c2::abdominal striae}}</b> which is a result of <u>impaired</u> <b>{{c1::collagen}} synthesis</b>, allowing blood vessels to rupture easily</div>", "time": null}, {"id": 1462380628768, "note": "<div>One clinical feature of <b>Cushing syndrome</b> is <b>{{c1::hypertension}}</b>, which is a result of an upregulation of <b>{{c2::alpha<sub>1</sub>-adrenergic}} receptors</b>, causing increased sensitivity of blood vessels to catecholamines </div>", "time": 1660105354642.0}, {"id": 1462380649800, "note": "<div>One clinical feature of <b>Cushing syndrome</b> is <b>{{c1::immune suppression}}</b>, which is a result of inhibition of phospholipase A<sub>2</sub>, IL-2, and histamine</div>", "time": 1660105354640.0}, {"id": 1462380658695, "note": "<div>One <i>positive</i> <b>screening test</b> for <b>Cushing syndrome</b> is an <u>increased</u> free {{c1::cortisol}} on 24-hour urinalysis </div>", "time": null}, {"id": 1462380664504, "note": "<div>One <i>positive</i> <b>screening test</b> for <b>Cushing syndrome</b> is an <u>increased</u> <b>midnight {{c1::salivary}} cortisol</b></div>", "time": null}, {"id": 1462380676531, "note": "<div>One <i>positive</i> <b>screening test</b> for <b>Cushing syndrome</b> is <b>no {{c1::cortisol suppression}}</b> with overnight <u>low-dose</u> dexamethasone test (1mg) </div>", "time": 1660105354600.0}, {"id": 1462380707702, "note": "<div>What is the state of the <b>adrenal glands</b> in <u>Cushing syndrome</u> due to <b>exogenous corticosteroids</b>? </div><div><br></div><div>{{c1::<u>Atrophy</u> of <u>both</u> adrenal glands::hyperplasia, atrophy; one, both}}</div>", "time": 1660105345458.0}, {"id": 1462380769945, "note": "<div>What is the state of the <b>adrenal glands</b> in <u>Cushing syndrome</u> due to a <b>paraneoplastic (ectopic) ACTH secretion</b>?</div><div><br></div><div>{{c1::<u>Hyperplasia</u> of <u>both</u> adrenal glands::hyperplasia, atrophy; one, both}}</div>", "time": 1660105345460.0}, {"id": 1462380781251, "note": "<div>What is the most common tumor that produces <b>ectopic ACTH</b>?</div><div><br></div><div>{{c1::Small cell lung carcinoma}}</div>", "time": null}, {"id": 1462380786286, "note": "<div>What is the differential diagnosis in a <b>Cushing syndrome </b>patient with <b>suppressed ACTH</b>?</div><div><br></div><div>{{c1::<div> 1. Exogenous glucocorticoids</div><div> 2. Adrenal adenoma (or carcinoma, hyperplasia)</div>::2}}</div>", "time": null}, {"id": 1462380873616, "note": "<div>What is the differential diagnosis in a <b>Cushing syndrome </b>patient with <b>elevated ACTH</b>?</div><div><br></div><div>{{c1::1. Cushing disease (ACTH-secreting pituitary adenoma)<div> 2. Ectopic ACTH secretion</div>::2}}</div>", "time": null}, {"id": 1462380876557, "note": "<div>If a patient with <b>ACTH-dependent Cushing syndrome</b> has <u>adequate cortisol suppression</u> following a <b>high-dose dexamethasone suppression test</b> (8mg), the most likely cause of their syndrome is <b>{{c1::Cushing disease}}</b></div>", "time": null}, {"id": 1462380908389, "note": "<div><div>If a patient with <b>ACTH-dependent Cushing syndrome</b> has <u>no cortisol suppression</u> following a <b>high-dose dexamethasone suppression test</b> (8mg), the most likely cause of their syndrome is <b>{{c1::ectopic ACTH secretion}}</b></div></div>", "time": null}, {"id": 1462380962582, "note": "<div><b>Hyperaldosteronism</b> presents as <b>{{c2::hypertension::blood pressure}}</b>&nbsp;with&nbsp;<b>{{c1::hypernatremia::Na+}}</b>, <b>{{c3::hypokalemia::K+}}</b>, and <b>{{c4::metabolic alkalosis::H+}}</b>&nbsp;</div>", "time": 1660105357917.0}, {"id": 1462381603797, "note": "<div><b>Aldosterone</b> increases {{c1::<b>Na<sup>+</sup></b>}} and H<sub>2</sub>O <u>reabsorption</u> at the <b>distal</b> <b>tubules</b> and <b>collecting</b> <b>duct</b></div>", "time": null}, {"id": 1462381626652, "note": "<div>The most common cause of <b>primary hyperaldosteronism</b> is {{c1::bilateral adrenal hyperplasia}}</div>", "time": 1660105349808.0}, {"id": 1462381638330, "note": "<div>{{c1::<b>Primary</b>}} <b>hyperaldosteronism </b>is characterized by <b>high aldosterone</b> and <b>{{c2::low}}</b> <b>renin</b> </div>", "time": null}, {"id": 1462381654555, "note": "<div><b>{{c1::Secondary}}</b> <b>hyperaldosteronism </b>is characterized by <b>high aldosterone</b> and <b>{{c2::high}} renin</b></div>", "time": 1660105338997.0}, {"id": 1462381664335, "note": "<div><b>Secondary hyperaldosteronism</b> is due to activation of <b>{{c1::renin-angiotensin}} system</b> </div>", "time": 1660105353104.0}, {"id": 1462383708003, "note": "<b>Congenital adrenal {{c1::hyperplasia}}</b> occurs due to loss of one of the four enzymes needed for <u>cortisol synthesis</u>", "time": 1660105360473.0}, {"id": 1462383833553, "note": "<b>Congenital adrenal hyperplasia</b> is a result of <u>decreased</u> levels of <b>{{c1::cortisol}}</b>, causing&nbsp;<u>increased</u> <b>{{c1::ACTH}}</b> secretion via negative feedback", "time": 1660105360474.0}, {"id": 1462383836128, "note": "<div><b>Congenital adrenal hyperplasia</b> affects the adrenal glands on {{c1::both::one or both}} side(s) of the body</div>", "time": 1660105360475.0}, {"id": 1462383838903, "note": "<div>Decreased <b>cortisol</b> production in <b>congenital adrenal hyperplasia</b> may cause life-threatening <b>{{c1::hypotension}}</b> due to decreased <b>{{c1::alpha<sub>1</sub>-adrenergic}} receptors</b></div>", "time": null}, {"id": 1462383841425, "note": "<div>Which steroid synthesis <b>enzyme deficiency</b> results in <b>salt wasting</b> and <b>hyponatremia</b> due to lack of aldosterone? </div><div><br></div><div>{{c1::21\u03b2-hydroxylase deficiency}}</div>", "time": 1660105342099.0}, {"id": 1462383843747, "note": "<div><b>21\u03b2-hydroxylase deficiency</b> presents with <b>{{c1::hyperkalemia::K+}}&nbsp;</b>and <b>{{c2::hypotension::blood pressure}}</b>&nbsp;</div>", "time": null}, {"id": 1462383846293, "note": "<div><b>11\u03b2-hydroxylase deficiency</b> presents with <b>{{c1::hypokalemia::K+}}</b>&nbsp;and <b>{{c2::hypertension::blood pressure}}</b>&nbsp;</div>", "time": null}, {"id": 1462383852650, "note": "<div>What <u>clinical features</u> are seen in <b>11\u03b2-hydroxylase deficiency </b>that are a result of <b>increased androgen levels</b>:</div><div><br></div><div>{{c1::virilization}} (in women)</div>", "time": null}, {"id": 1462383855049, "note": "<b>17\u03b1-hydroxylase deficiency</b> presents with <b>{{c1::hypokalemia::K+}}</b>&nbsp;and <b>{{c2::hypertension::blood pressure}}</b>&nbsp;", "time": 1660105362642.0}, {"id": 1462389760356, "note": "<div><b>{{c1::Adrenal insufficiency}}</b> is the inability of the <b>adrenal</b> <b>glands</b> to generate enough glucocorticoids +/- mineralocorticoids</div>", "time": null}, {"id": 1462390236322, "note": "<div><b>{{c2::Primary}} adrenal insufficiency</b> presents with <b>{{c1::low}} cortisol</b> and <b>{{c1::high}} ACTH</b> </div>", "time": 1660105337493.0}, {"id": 1462390426081, "note": "One cause of <b>acute</b> primary adrenal insufficiency is {{c1::<b>Waterhouse-Friderichsen</b>}} <b>syndrome</b>", "time": 1660105354638.0}, {"id": 1462390432656, "note": "<div><b>Waterhouse-Friderichsen</b> <b>syndrome</b> is the <b>bilateral</b> {{c1::hemorrhagic}} <b>necrosis</b> of the {{c2::adrenal glands}}, causing the gland to look like a \"sack of blood\"</div>", "time": 1660105348145.0}, {"id": 1462390449708, "note": "<b>Waterhouse-Friderichsen</b> <b>syndrome</b> classically follows after <b>DIC</b> in young children with <i>{{c1::N. meningitidis}}</i> infection", "time": 1660105348147.0}, {"id": 1462390476322, "note": "<div><u>Chronic</u> primary adrenal insufficiency, also known as <b>{{c1::Addison}}</b><b> disease</b>, is due to adrenal atrophy or destruction by disease</div>", "time": null}, {"id": 1462390501771, "note": "<div>The most common cause of <b>Addison disease</b> in the West is {{c1::autoimmune destruction}}</div>", "time": null}, {"id": 1462390507327, "note": "<div>The most common cause of <b>Addison disease</b> in the <u>developing</u> world is {{c1::tuberculosis}} </div>", "time": null}, {"id": 1462390512342, "note": "<div>A common cause of <b>Addison disease</b> is metastatic carcinoma, especially from the {{c1::lungs}}</div>", "time": null}, {"id": 1462390533401, "note": "<div>Clinical features of <b>Addison disease</b> include <b>hyponatremia</b>, <b>hypovolemia</b>, and <b>hyperkalemia</b>, due to lack of {{c1::mineralocorticoids}} </div>", "time": 1660105360646.0}, {"id": 1462390543517, "note": "<div>One clinical feature of <b>Addison disease</b> is <b>{{c1::hyperpigmentation}}</b>, due to increased levels of <b>{{c2::MSH}}</b> secondary to elevated ACTH </div>", "time": null}, {"id": 1462390604502, "note": "<div>Does <b>secondary adrenal insufficiency</b> present with skin/mucosal hyperpigmentation?</div><div><br></div><div>{{c1::No, because ACTH levels are decreased}}</div>", "time": 1660105359823.0}, {"id": 1462390609512, "note": "<div>Does <b>secondary adrenal insufficiency</b> present with hyperkalemia?</div><div><br></div><div>{{c1::No, because aldosterone synthesis is preserved}}</div>", "time": 1660105359824.0}, {"id": 1462390622705, "note": "<div><b>{{c2::Tertiary}} adrenal insufficiency</b> is seen in patients with chronic exogenous <b>{{c1::steroid}}</b> use, precipitated by <b>{{c1::abrupt withdrawal}}</b></div>", "time": null}, {"id": 1462390641726, "note": "<div><b>{{c2::Pheochromocytoma}} </b>is the <u>most common</u> tumor of the <b>{{c1::adrenal medulla}}</b> in <b>adults</b></div>", "time": null}, {"id": 1462391904909, "note": "<div>The <b>adrenal medulla</b> is composed of <b>{{c1::chromaffin}} cells</b>, which are derived from {{c2::<b>neural crest</b>}}</div>", "time": null}, {"id": 1462391919306, "note": "The&nbsp;<b>adrenal medulla&nbsp;</b>is responsible for the secretion of the&nbsp;<b>catecholamines</b>&nbsp;{{c1::norepinephrine}} and {{c1::epinephrine}}", "time": null}, {"id": 1462391926278, "note": "<div>A <b>pheochromocytoma</b> is a tumor of <b>{{c1::chromaffin}} cells</b> </div>", "time": null}, {"id": 1462391951908, "note": "<div>Patients with <b>pheochromocytoma</b> experience their symptoms <b>{{c1::episodically}}</b>, rather than continuously</div>", "time": null}, {"id": 1462391963610, "note": "<div>The <u>five</u> <b>episodic hyperadrenergic symptoms</b> of a(n)&nbsp;<b>{{c3::pheochromocytoma}}</b> are:</div><div> 1. {{c1::Pressure (increased BP)}}</div><div> 2. {{c1::Pain (headache)}}</div><div> 3. {{c2::Perspiration}}</div><div> 4. {{c2::Palpitations (tachycardia)}}</div><div> 5. Pallor </div>", "time": 1660105350138.0}, {"id": 1462392011163, "note": "<div><b>{{c2::Pheochromocytoma}}</b> is diagnosed by increased <b>serum</b> and <b>urine</b> levels of <b>catecholamines</b>, or their breakdown products <b>{{c1::metanephrines}}</b> and {{c1::<b>vanillylmandelic acid</b> (VMA)}}</div>", "time": null}, {"id": 1462392039342, "note": "<div>Treatment for a <b>pheochromocytoma</b>&nbsp;is {{c1::surgical excision}}</div>", "time": 1660105348602.0}, {"id": 1462392047911, "note": "<div>Prior to removal of a <b>pheochromocytoma</b>, irreversible <b>{{c1::\u03b1-antagonists}}</b>, such as <b>{{c2::phenoxybenzamine}}</b> are administered, followed by <b>{{c1::</b><b style=\"\">\u03b2</b><b>-blockers}}</b></div>", "time": null}, {"id": 1462808901843, "note": "What is the <b>embryonic origin</b> of <b>thyroid</b> tissue?<div><br /></div><div>{{c1::Endoderm}}</div>", "time": null}, {"id": 1462808976733, "note": "What is the<b> embryonic origin</b> of <b>parafollicular cells </b>(C cells) of the thyroid?<div><br /></div><div>{{c1::Endoderm}}</div>", "time": null}, {"id": 1462809000922, "note": "What is the <b>embryonic origin</b> of the <b>adrenal </b><u style=\"font-weight: bold; \">cortex</u>?<div><br></div><div>{{c1::Mesoderm}}</div>", "time": null}, {"id": 1462809037538, "note": "What is the <b>embryonic origin</b> of the <b>adrenal </b><u style=\"font-weight: bold; \">medulla</u>?<div><br /></div><div>{{c1::Neural crest}}</div>", "time": null}, {"id": 1462809038273, "note": "Which <b>anterior pituitary hormones</b> are <u style=\"font-weight: bold; \">basophilic</u> on histological preparation?<div><br /></div><div>{{c1::FSH, LH, ACTH, TSH}}</div>", "time": 1660105344114.0}, {"id": 1462809195840, "note": "Which <b>anterior pituitary hormones</b> are <u style=\"font-weight: bold; \">acidophilic</u> on histological preparation?<div><br /></div><div>{{c1::GH, Prolactin}} </div>", "time": 1660105344115.0}, {"id": 1462809232452, "note": "<b>Insulin</b> <u>increases</u> expression of the <b>GLUT4</b> transporter on <i>adipose</i> and <i>muscle</i> tissue via the <b>{{c1::PI<sub>3</sub> kinase}} signaling pathway</b>", "time": null}, {"id": 1462809498251, "note": "Which <u>insulin-independent transporter</u> is found in the <b>brain</b>, <b>placenta</b>, <b>cornea</b>, and <b>RBCs</b>?<div><br></div><div>{{c1::GLUT1}}</div>", "time": null}, {"id": 1462809621604, "note": "<div>Which <u>bidirectional</u> <b>insulin-independent transporter</b> is found in the&nbsp;\u03b2-islet cells, liver, kidney, and small intestine?</div><div><br></div><div>{{c1::GLUT2}}</div>", "time": null}, {"id": 1462809735089, "note": "What is the effect of <b>chest wall trauma</b> on prolactin secretion?<div><br /></div><div>{{c1::Increased}}</div>", "time": null}, {"id": 1462809895863, "note": "What is the effect of <b>renal failure</b> on prolactin levels?<div><br /></div><div>{{c1::Increased (due to reduced prolactin elimination)}}</div>", "time": null}, {"id": 1462810051900, "note": "What is the effect of <b>leptin </b>on appetite? <div><br /></div><div>{{c1::Decreased}}</div>", "time": null}, {"id": 1462810342552, "note": "Which steroid hormone enzyme deficiency (21- or 11\u03b2-hydroxylase) presents with <u>decreased</u> <b>renin</b> activity?<div><br /></div><div>{{c1::11\u03b2-hydroxylase}}</div>", "time": null}, {"id": 1462810386376, "note": "Overall, the effect of <b>cortisol</b> is {{c1::catabolic::anabolic, catabolic}}", "time": null}, {"id": 1462810615371, "note": "After <b>PTH</b> binds to <b>{{c1::osteoblasts}}</b>, <b>RANK-L</b> is secreted which binds to <b>RANK</b> on <b>{{c1::osteoclasts}}</b>, <u>increasing</u> bone resorption", "time": null}, {"id": 1462810965063, "note": "Which <u>two</u> <b>endocrine hormones</b> act to <u>increase</u> <b>bone growth</b>? <div><br /></div><div>{{c1::Growth hormone &amp; Thyroid hormone}} </div>", "time": null}, {"id": 1462811101121, "note": "Overall, the effects of <b>thyroid hormones</b> are {{c1::catabolic::anabolic, catabolic}}&nbsp;", "time": null}, {"id": 1462811140825, "note": "The <i>main</i> functions of <b>thyroid hormone</b> can be remembered with the \"7<b>&nbsp;Bs</b>\"?<div style=\"centerbox\"><div class=\"mnemonics\"><div><br></div><div>1. {{c1::Brain maturation}}<div>2. {{c2::Bone growth}}</div><div>3. {{c3::\u03b2<sub>1</sub>-adrenergic effects}} </div><div>4. {{c4::Basal metabolic rate (increased)}} </div></div><div>5. {{c5::Blood sugar}}</div><div>6. {{c6::Break down lipids}}</div><div>7.&nbsp;{{c1::Stimulates surfactant synthesis in Babies}}</div></div></div>", "time": null}, {"id": 1462811217109, "note": "Which<b> hormones</b> use <b>cAMP</b> as their secondary messenger?<div><br></div><div>{{c1::<i>(FLAT ChAMPs CHuGG)</i></div><div style=\"centerbox\"><div class=\"mnemonics\"><div>FSH</div><div>LH</div><div>ACTH</div><div>TSH</div><div><br></div><div>CRH</div><div>hCG</div><div>ADH (V<sub>2</sub>)</div><div>MSH</div><div>PTH</div><div><br></div><div>Calcitonin</div><div>Histamine (H2-receptor)</div><div>Glucagon</div><div>GHRH</div></div>}}</div>", "time": null}, {"id": 1462811651513, "note": "<div>Which<b> hormones</b> use <b>cGMP</b> as their secondary messenger?</div><div><br></div><div>{{c1::ANP, BNP, NO::3}}</div>", "time": null}, {"id": 1462811666951, "note": "<div>Which<b> hormones</b> use <b>IP<sub>3</sub></b> as their secondary messenger?</div><div><br /></div><div>{{c1::GnRH, Oxytocin, ADH (V<sub>1</sub>), TRH, Histamine (H<sub>1</sub>), Angiotensin II, Gastrin}}</div>", "time": null}, {"id": 1462811683463, "note": "<div>In <b>women</b>, <u>decreased</u> levels of <b>sex hormone-binding globulin</b> (SHBG) causes {{c1::hirsutism}} due to {{c1::increased}} <i>free</i> testosterone </div>", "time": null}, {"id": 1462811818195, "note": "In <b>men</b>, <u>increased</u> levels of <b>sex hormone-binding globulin</b> (SHBG) causes {{c1::gynecomastia}} due to {{c1::decreased}} <i>free</i> testosterone ", "time": null}, {"id": 1462812278781, "note": "What are the <u>two</u> main areas that experience <b>hyperpigmentation</b> due to <b>Addison disease</b>? <div><br></div><div>{{c1::Skin and mucous membranes}}</div>", "time": 1660105347619.0}, {"id": 1462812673994, "note": "What is the <u>most common</u> tumor of the <b>adrenal medulla</b> in <b>children</b>? <div><br /></div><div>{{c1::Neuroblastoma}}</div>", "time": null}, {"id": 1462818005716, "note": "<b>Neuroblastoma</b> originates from <b>{{c2::neural crest}} cells </b>and can occur anywhere along the <b>{{c1::sympathetic chain}}</b>", "time": 1660105354897.0}, {"id": 1462818046641, "note": "The most common presentation for a(n)&nbsp;<b>{{c1::neuroblastoma}}</b> is <b>abdominal</b> <b>distention</b> with a firm, <b>{{c2::irregular}}</b> <b>mass</b> that <b>{{c2::can}}</b> cross the midline", "time": 1660105349798.0}, {"id": 1462818125916, "note": "<b>Neuroblastoma</b> may present with <b>{{c1::opsoclonus-myoclonus}} syndrome</b>, sometimes referred to as \"dancing eyes, dancing feet\"", "time": null}, {"id": 1462818332334, "note": "Which oncogene is associated with Neuroblastoma?<div><br /></div><div>{{c1::<i>N-myc</i> overexpression}}</div>", "time": null}, {"id": 1462818499640, "note": "<b>Neuroblastoma</b> is characterized by increased levels of {{c1::homovanillic acid (HVA)}} and {{c1::vanillylmandelic acid (VMA)}} in the urine (<u>catecholamine</u> metabolites)", "time": null}, {"id": 1462818806593, "note": "<b>{{c1::Familial hypocalciuric hypercalcemia}}</b> presents with mild hypercalcemia and hypocalciuria with normal or increased PTH levels ", "time": null}, {"id": 1462831927912, "note": "One complication of <b>{{c2::hyperparathyroidism}}</b> is <b>{{c1::osteitis fibrosa cystica}}</b>, which is characterized by <b>bone pain</b> and <u>cystic bone spaces</u> filled with <b>brown fibrous tissue</b>", "time": null}, {"id": 1462833649683, "note": "What is the inheritance of all <b>multiple endocrine neoplasia (MEN) </b>syndromes?<div><br></div><div>{{c1::Autosomal dominant}}</div>", "time": null}, {"id": 1462834082547, "note": "Which three organs are involved in <b>MEN1</b>?<div><br /></div><div>{{c1::Pituitary, pancreas, and parathyroids}}</div>", "time": null}, {"id": 1462834177306, "note": "<div><b>MEN {{c2::1}}</b> is associated with <b>pituitary</b> <b>tumors</b> that secrete {{c1::prolactin}} or {{c1::GH}}</div>", "time": 1660105355314.0}, {"id": 1462834193700, "note": "<div><b>MEN {{c2::1}}</b> is associated with <b>pancreatic endocrine tumors</b>, such as {{c1::Zollinger-Ellison syndrome (gastrinoma)}}, {{c3::insulinomas}}, VIPomas, and glucagonomas (rare)</div>", "time": null}, {"id": 1462834233055, "note": "<div><b>MEN {{c1::1}} </b>is associated with <b>parathyroid <u>adenomas</u></b> </div>", "time": null}, {"id": 1462834249353, "note": "<b>MEN 1</b> is associated with mutation of the <i>{{c1::MEN1}}</i> gene (menin), which is a <b>tumor</b> <b>suppressor</b> <b>gene</b> found on chromosome {{c2::11}}", "time": null}, {"id": 1462834349642, "note": "Which three organs or diseases are involved in <b>MEN 2A</b>?<div><br></div><div>{{c1::Parathyroid, thyroid (medullary carcinoma) and pheochromocytomas}}</div><div></div>", "time": null}, {"id": 1462834690894, "note": "<div><b>MEN {{c1::2A}}</b> is associated with <b>parathyroid <u>hyperplasia</u></b> </div>", "time": null}, {"id": 1462834697458, "note": "<div><b>MEN {{c2::2A}}</b> and <b>{{c2::2B}}</b> are associated with <b>{{c1::medullary thyroid carcinoma::thyroid}}</b>&nbsp;</div>", "time": null}, {"id": 1462834724504, "note": "<div><b>MEN {{c2::2A}}</b> and <b>{{c2::2B}}</b> are associated with <b>{{c1::pheochromocytoma::adrenal medulla}}</b>&nbsp;</div>", "time": null}, {"id": 1462834732857, "note": "<div>Which three organs or diseases are involved in <b>MEN 2B</b>?</div><div><br></div><div>{{c1::Thyroid (medullary carcinoma), pheochromocytomas, and mucosal neuromas}}</div>", "time": null}, {"id": 1462834769845, "note": "<div><b>MEN 2B</b> is associated with <b>mucosal {{c1::neuromas}}</b> (oral/intestinal ganglioneuromatosis) </div>", "time": null}, {"id": 1462834777985, "note": "<b>MEN {{c3::2B}}</b> is associated with {{c1::<b>marfanoid</b>}} <b>habitus</b> and mutations in the <i>{{c2::RET}}</i> gene", "time": null}, {"id": 1462834810746, "note": "<b>MEN 2A</b> is associated with mutations in the <i>{{c1::RET}} </i>gene, which codes for receptor tyrosine kinase in cells of neural crest origin", "time": null}, {"id": 1462844350121, "note": "<div><i>Activation</i> of which <b>adrenergic receptor</b> increases production of <b>insulin</b>?<br></div><div><br></div><div>{{c1::\u03b2<sub>2</sub>}}</div>", "time": 1660105352020.0}, {"id": 1462844554684, "note": "<div>What is the effect of <b>insulin</b> on <b>Na<sup>+</sup>-K<sup>+</sup>-ATPase</b> activity?<br></div><div><br></div><div>{{c1::Increased (thus causing increased K<sup>+</sup> uptake into cells)}}</div>", "time": 1660105351996.0}, {"id": 1462845596752, "note": "<div>When <b>insulin</b> acts on <b>liver</b> tissue, it causes {{c1::increased}} glycogenesis and {{c1::decreased}} glycogenolysis<br></div>", "time": 1660105352040.0}, {"id": 1462849092193, "note": "<div>When <b>insulin</b> acts on <b>muscle</b> tissue, it causes {{c1::<u>increased</u>}} glycogen storage and {{c2::<u>increased</u>}} protein synthesis<br></div>", "time": 1660105352039.0}, {"id": 1462849100249, "note": "<div>When <b>insulin</b> acts on <b>adipose </b>tissue, it causes {{c1::<u>increased</u>}} triglyceride storage and {{c1::<u>decreased</u>}} lipolysis<br></div>", "time": 1660105351995.0}, {"id": 1462849107376, "note": "<div><b>Insulin Glulisine</b>, <b>Aspart</b>, and <b>Lispro</b> are characterized by <b>{{c1::rapid}}</b> <b>action</b> and <b>duration</b><br></div>", "time": 1660105352069.0}, {"id": 1462849116753, "note": "<div><b>Glulisine</b>, <b>aspart</b>, and <b>lispro</b> (rapid acting insulin) are useful for controlling the <b>{{c1::postprandial}} glucose spike</b><br></div>", "time": 1660105352070.0}, {"id": 1462849123696, "note": "<div><b>Regular insulin</b> is characterized by <b>{{c1::short}} action</b> and<b> duration</b><br></div>", "time": 1660105352002.0}, {"id": 1462849133349, "note": "<div><b>{{c2::Regular}} insulin</b> is the only insulin that can be administered <b>{{c1::IV}}</b><br></div>", "time": 1660105351993.0}, {"id": 1462849140370, "note": "<div><b>IV {{c2::regular}} insulin</b> is useful in management of <b>{{c1::diabetic ketoacidosis}}</b> (T1DM complication)<br></div>", "time": 1660105352009.0}, {"id": 1462849149554, "note": "<div><b>IV regular insulin</b> is useful in the management of <b>{{c1::hyperkalemia}}</b> (K<sup>+</sup> levels)<br></div>", "time": 1660105352010.0}, {"id": 1462849159965, "note": "<div><b>Neutral Protamine Hagedorn (NPH) </b>is characterized by <b>{{c1::intermediate}} action</b> and <b>duration</b><br></div>", "time": 1660105352007.0}, {"id": 1462849196492, "note": "<div><b>Insulin Detemir</b> and <b>Glargine</b> are characterized by <b>{{c1::long}} action</b> and <b>duration</b><br></div>", "time": 1660105352011.0}, {"id": 1462849213386, "note": "<div>The most common complication of <b>insulin</b> <b>therapy</b> is {{c1::hypoglycemia}}; may also experience <b>lipodystrophy</b> and <b>hypersensitivity</b> <b>reaction</b> (rare)<br></div>", "time": 1660105351997.0}, {"id": 1462849233061, "note": "<div>Which type(s) of <b>diabetes</b> may be treated with <b>insulin therapy</b>?<br></div><div><br></div><div>{{c1::T1DM, T2DM, and GDM (exogenous therefore doesnt require&nbsp;\u03b2&nbsp;cell activity)}}</div>", "time": 1660105352034.0}, {"id": 1462849240470, "note": "<div><b>Sulfonylureas</b> are {{c1::sulfa}} drugs and thus may cause <u>adverse</u> reactions in <i>allergic</i> patients<br></div>", "time": 1660105352054.0}, {"id": 1462849248763, "note": "<div>{{c1::<b>Sulfonylureas</b>}}  (and {{c1::<b>meglitinides</b>}}) bind the <b>ATP-dependent {{c2::K<sup>+</sup>}} channels</b> on pancreatic&nbsp;\u03b2&nbsp;cells, causing release of <b>endogenous</b> insulin<br></div>", "time": 1660105352028.0}, {"id": 1462849277484, "note": "<div>What <u>drug class</u> do <b>tolbutamide</b> and <b>chlorpropamide</b> belong to?<br></div><div><br></div><div>{{c1::1st generation sulfonylureas}}</div>", "time": 1660105352045.0}, {"id": 1462849289458, "note": "<div>What <u>drug class</u> do <b>glyburide</b>, <b>glimepiride</b>, and <b>glipizide </b>belong to?<br></div><div><br></div><div>{{c1::2nd generation sulfonylureas}}</div>", "time": 1660105352046.0}, {"id": 1462849297574, "note": "<div><b>{{c1::Glipizide}}</b> has the <u>shortest</u> duration of action of the <b>2nd generation sulfonylureas </b>and thus least risk of hypoglycemia<br></div>", "time": 1660105352033.0}, {"id": 1462849313819, "note": "<div><b>{{c1::Meglitinides}}</b> are short-acting diabetic medications that act similarly to <b>sulfonylureas</b> (same MOA)<br></div>", "time": 1660105352032.0}, {"id": 1462849345929, "note": "<div><b>Meglitinides</b> are <b>not {{c1::sulfa drugs}} </b>and thus may be used to treat a T2DM patients with an <b>allergy</b> to <b>{{c1::sulfonylureas}}</b><br></div>", "time": 1660105352067.0}, {"id": 1462849353569, "note": "<div><b>Sulfonylureas</b> and <b>meglitinides</b> have significant risk of causing {{c1::hypoglycemia}} as a possible side effect<br></div>", "time": 1660105352056.0}, {"id": 1462849360434, "note": "<div><b>Sulfonylureas</b> and <b>meglitinides</b> may cause <b>weight</b> <b>{{c1::gain}}</b> as a side effect<br></div>", "time": 1660105352055.0}, {"id": 1462849367468, "note": "<div><b>{{c2::1st}} generation sulfonylureas</b> (e.g. chlorpropamide, tolbutamide) may cause a(n)&nbsp;<b>{{c1::disulfiram-like}}</b> <b>reaction</b> as a possible side effect when you ingest alcohol while taking these drugs</div>", "time": 1660105352026.0}, {"id": 1462849374890, "note": "<div>What type(s) of <b>diabetes</b> may be treated with <b>sulfonylureas</b> and <b>meglitinides</b>?<br></div><div><br></div><div>{{c1::T2DM <i>only</i>; dependent on some functional&nbsp;\u03b2&nbsp;cells}}</div>", "time": 1660105352041.0}, {"id": 1462849382382, "note": "<div>Patients on <b>sulfonylureas</b> are at <u>increased</u> risk of <b>hypoglycemia</b> if they have <b>{{c1::renal}} failure</b></div>", "time": 1660105359175.0}, {"id": 1462849387815, "note": "<div><b>Exenatide</b> and <b>liraglutide</b> are both examples of {{c1::GLP-1 agonists}}<br></div>", "time": 1660105352075.0}, {"id": 1462849394748, "note": "<div><b>GLP-1 analogs</b> cause <u>increased</u> {{c1::insulin}} release and satiety<br></div>", "time": 1660105352071.0}, {"id": 1462849402751, "note": "<div><b>GLP-1 analogs</b> cause <u>decreased</u> {{c1::glucagon}} release and gastric emptying<br></div>", "time": 1660105352012.0}, {"id": 1462849410036, "note": "<div><b>{{c1::Dipeptidyl peptidase-4 (DPP-4)}} inhibitors</b> act via preventing the breakdown of <b>{{c2::GLP-1}}</b><br></div>", "time": 1660105352082.0}, {"id": 1462849421840, "note": "<div><b>Linagliptin</b>, <b>saxagliptin</b>, and <b>sitagliptin</b> are all examples of {{c1::DPP-4 inhibitors}}<br></div>", "time": 1660105352068.0}, {"id": 1462849428163, "note": "<div><b>DPP-4 inhibitors</b> <u>increase</u> levels of <b>endogenously</b> secreted {{c1::GLP-1}}<br></div>", "time": 1660105352076.0}, {"id": 1462849434995, "note": "<div><b>GLP-1 agonists</b> and <b>DPP-4 inhibitors</b> cause <u>decreased</u> {{c1::glucagon}} secretion<br></div>", "time": 1660105352074.0}, {"id": 1462849442061, "note": "<div><b>GLP-1 agonists</b> and <b>DPP-4 inhibitors</b> cause <i>increased</i> satiety via <i>decreased</i> {{c1::gastric emptying}}<br></div>", "time": 1660105352073.0}, {"id": 1462849448833, "note": "<div><b>DPP-4 inhibitors</b> can increase risk of {{c1::upper respiratory}} tract infection<br></div>", "time": 1660105352077.0}, {"id": 1462849457192, "note": "<div><b>GLP-1 agonists</b> can cause {{c1::pancreatitis}} as a possible side effect, as well as nausea and vomiting<br></div>", "time": 1660105352072.0}, {"id": 1462849475077, "note": "<div>Do <b>GLP-1 agonists</b> and/or <b>DPP-4 inhibitors</b> cause <b>hypoglycemia</b> as a possible side effect?<br></div><div><br></div><div>{{c1::No}}</div>", "time": 1660105352079.0}, {"id": 1462849488980, "note": "<div>What type(s) of <b>diabetes</b> may be treated with <b>GLP-1 agonists</b> and <b>DPP-4 inhibitors</b>?<br></div><div><br></div><div>{{c1::T2DM <i>only</i>; dependent on some functional&nbsp;\u03b2&nbsp;cells}}&nbsp;<br></div>", "time": 1660105352042.0}, {"id": 1462879506170, "note": "The effects of <b>cortisol</b> may be remembered with the mnemonic \"<b>A BIG FIB</b>\": <div style=\"centerbox\"><div class=\"mnemonics\"><div><br/></div><div><b>A</b>: {{c1::increased Appetite}}</div><div><b>B</b>: {{c2::Blood pressure (increased, via alpha<sub>1</sub>)}}</div><div><div><b>I</b>: {{c3::Insulin resistance (increased)}}</div><div><b>G</b>: {{c4::Gluconeogenesis (increased)}}</div><div><b>F</b>: {{c5::Fibroblast activity (decreased)}}</div><div><b>I</b>: {{c6::Inflammatory/Immune response (decreased)}}</div><div><b>B</b>: {{c7::Bone formation (decreased)}}</div></div></div></div>", "time": null}, {"id": 1462913151403, "note": "<div><b>{{c1::Metformin}}</b>, a(n)&nbsp;<b>{{c2::biguanide}}</b>, is the <u>first line</u> oral agent for the management of <b>type {{c3::2}} diabetes</b></div>", "time": 1660105352031.0}, {"id": 1462913162803, "note": "<div><b>Metformin</b> modulates enzyme function to <u>decrease</u> hepatic {{c1::gluconeogenesis}}<br></div>", "time": 1660105352064.0}, {"id": 1462913170662, "note": "<div>One mechanism by which <b>metformin</b> decreases gluconeogenesis is via {{c2::<u>inhibition</u>}} of the mitochondrial enzyme {{c1::<b><i>glycerol-3-phosphate dehydrogenase</i></b> (mGPDH)}}<br></div>", "time": 1660105352061.0}, {"id": 1462913225002, "note": "<div>One mechanism by which <b>metformin</b> decreases gluconeogenesis is via {{c2::<u>activation</u>}} of the enzyme {{c1::<b><i>AMP-activated protein kinase</i></b> (AMPK)}}<br></div>", "time": 1660105352063.0}, {"id": 1462913228518, "note": "<div><b>Metformin</b> causes increased <b>insulin</b> {{c1::sensitivity}}, therefore <u>enhancing glucose uptake</u> in peripheral tissues<br></div>", "time": 1660105352066.0}, {"id": 1462913238244, "note": "<div>The most serious side effect of <b>metformin</b> is {{c1::lactic acidosis}}<br></div>", "time": 1660105352052.0}, {"id": 1462913246058, "note": "<div>Patients with {{c1::renal insufficiency}} have <u>increased</u> risk for <b>metformin-induced lactic acidosis</b> due to metformin accumulation<br></div>", "time": 1660105352059.0}, {"id": 1462913257878, "note": "<div>The <u>most common</u> side effect of <b>metformin</b> is {{c1::GI upset (e.g. nausea, vomiting, anorexia, diarrhea)}}<br></div>", "time": 1660105352053.0}, {"id": 1462913267342, "note": "<div><b>Metformin</b> may cause modest <b>weight</b> {{c1::reduction}}<br></div>", "time": 1660105352065.0}, {"id": 1462913285372, "note": "<div><b>Pioglitazone</b> and <b>rosiglitazone</b> are examples of <b>glitazones</b>, also known as <b>{{c1::thiazolidinediones}}</b><br></div>", "time": 1660105352058.0}, {"id": 1462913300610, "note": "<div><b>Thiazolidinediones</b> cause increased <b>insulin</b> {{c1::sensitivity}}, therefore <u>enhancing glucose uptake</u> in peripheral tissues<br></div>", "time": 1660105352047.0}, {"id": 1462913309820, "note": "<div><b>{{c2::Thiazolidinediones (glitazones)</b><b>}}</b> are ligands of <b>{{c1::PPAR-</b><b>\u03b3</b><b>}}</b>, an <b>intranuclear</b> <b>receptor</b> that regulates gene transcription<br></div>", "time": 1660105352024.0}, {"id": 1462913323101, "note": "<div><b>PPAR-gamma</b>, which is activated by thiazolidinediones, <u>upregulates</u> {{c1::adiponectin}}, which causes <b>increased insulin sensitivity</b> and <b>fatty acid oxidation</b><br></div>", "time": 1660105352057.0}, {"id": 1462913355567, "note": "<div>What is the effect of <b>thiazolidinediones</b> on the <u>differentiation</u> and <u>number</u> of <b>adipocytes</b>?<br></div><div><br></div><div>{{c1::Increased}}</div>", "time": 1660105352044.0}, {"id": 1462913390177, "note": "<div>What is the effect of <b>thiazolidinediones</b> on <b>triglyceride storage</b> and <b>fatty acid oxidation</b>?<br></div><div><br></div><div>{{c1::Increased}}</div>", "time": 1660105352043.0}, {"id": 1462913407963, "note": "<div>Which <b>GLUT</b> receptor is <u>upregulated</u> in peripheral tissue by <b>thiazolidinediones</b>?<br></div><div><br></div><div>{{c1::GLUT4}}</div>", "time": 1660105352035.0}, {"id": 1462913437726, "note": "<div>Do <b>thiazolidinediones</b> act <b>quickly</b> to reduce blood glucose levels? Why?<br></div><div><br></div><div>{{c1::No, because it acts at the level of gene transcription (slow)}}</div><div><br></div><div><i><br></i></div>", "time": 1660105352078.0}, {"id": 1462913442939, "note": "<div><b>Thiazolidinediones</b> (glitazones) can cause <b>weight</b> {{c1::gain}} and increased {{c2::Liver}} Function Tests<br></div>", "time": 1660105352050.0}, {"id": 1462913454503, "note": "<div><b>Thiazolidinediones</b> can cause fluid retention and thus {{c1::peripheral edema}} as a possible side effect in the extremities<br></div>", "time": 1660105352049.0}, {"id": 1462913462613, "note": "<div><b>Thiazolidinedione</b>-induced <b>fluid retention</b> can exacerbate {{c1::heart failure}}<br></div>", "time": 1660105352051.0}, {"id": 1462913505933, "note": "<div><b>Thiazolidinediones</b> can increase the risk of atypical extremity {{c1::fractures}}<br></div>", "time": 1660105352048.0}, {"id": 1462913533718, "note": "<div>What <u>class</u> of <b>diabetic drugs</b> is associated with <b>increased risk of fracture</b> as a possible side effect?<br></div><div><br></div><div>{{c1::Thiazolidinediones (glitazones)}}</div>", "time": 1660105352037.0}, {"id": 1462913541311, "note": "<div>What <u>class</u> of <b>diabetic drugs</b> is associated with <b>increased risk of heart failure</b> as a possible side effect?<br></div><div><div><br></div><div>{{c1::Thiazolidinediones}}</div></div>", "time": 1660105352036.0}, {"id": 1462913552133, "note": "<div>{{c2::<b>Pramlintide</b>}} is an analog of {{c1::<b>amylin</b> (islet amyloid polypeptide, IAPP)}}<br></div>", "time": 1660105352004.0}, {"id": 1462913584874, "note": "<div><b>Amylin</b> <b>analogues</b> (e.g. pramlintide) cause {{c1::decreased}} <b>gastric emptying</b><br></div>", "time": 1660105352016.0}, {"id": 1462913605177, "note": "<div><b>Amylin</b> <b>analogues</b> (e.g. pramlintide) <u>decrease</u> {{c1::glucagon}} secretion<br></div>", "time": 1660105352015.0}, {"id": 1462913613399, "note": "<div>Which type(s) of <b>diabetes</b> may be treated with <b>pramlintide </b>(amylin analogs)?<br></div><div><br></div><div>{{c1::T1DM and T2DM}}</div>", "time": 1660105351994.0}, {"id": 1462913625624, "note": "<div><b>Pramlintide</b> (amylin analog) is used to control the {{c1::postprandial}} <b>glucose</b> <b>spike</b><br></div>", "time": 1660105352005.0}, {"id": 1462913640957, "note": "<div><b>Pramlintide</b> may cause {{c1::hypoglycemia}} as a side effect, especially in the setting of mistimed prandial insulin<br></div>", "time": 1660105352003.0}, {"id": 1462913649966, "note": "<div>A common side effect of <b>pramlintide</b>, an amylin analog, is {{c1::<b>GI upset</b> (<i>e.g. nausea, vomiting, anorexia</i>)}}<br></div>", "time": 1660105352022.0}, {"id": 1462913659830, "note": "<div>How is an <b>amylin analog</b>, such as <b>pramlintide</b>, administered?<br></div><div><br></div><div>{{c1::Subcutaneous injection (usually prior to a meal)}}</div>", "time": 1660105359174.0}, {"id": 1462913664323, "note": "<div><b>Acarbose</b> and <b>miglitol</b> are examples of <b>{{c1::alpha-glucosidase}} inhibitors</b><br></div>", "time": 1660105352080.0}, {"id": 1462913681590, "note": "<div><b>Acarbose</b> and <b>miglitol</b> inhibit <b>alpha-glucosidase enzymes</b> which decreases the <u>conversion</u> of {{c1::disaccharides}} into absorbable {{c1::monosaccharides}}<br></div>", "time": 1660105352021.0}, {"id": 1462913702538, "note": "<div><b>Alpha-glucosidase inhibitors</b> (e.g. acarbose, miglitol) reduce the activity of alpha-glucosidases on the {{c1::intestinal brush border}}, thus <i>delaying</i> carbohydrate hydrolysis and absorption<br></div>", "time": 1660105352017.0}, {"id": 1462913711724, "note": "<div><b>Alpha-glucosidase inhibitors</b> (e.g. acarbose, miglitol) are used to control the {{c1::postprandial}} <b>glucose spike</b><br></div>", "time": 1660105352018.0}, {"id": 1462913732310, "note": "<div><b>Alpha-glucosidase inhibitors</b> (e.g. acarbose, miglitol) are <u>infrequently prescribed</u> due to their ability to cause {{c1::diarrhea}}, {{c1::flatulence}}, and <b>abdominal</b> <b>pain</b> as side effects<br></div>", "time": 1660105352019.0}, {"id": 1462913747084, "note": "<div><b>Canagliflozin</b>, <b>dapagliflozin</b>, and <b>empagliflozin</b> are all examples of {{c1::SGLT2}} <b>inhibitors</b><br></div>", "time": 1660105352013.0}, {"id": 1462913773816, "note": "<div><b>SGLT2 inhibitors</b>, such as canagliflozin, cause <u>increased</u> excretion of <b>urinary</b> {{c1::glucose (glucosuria)}}<br></div>", "time": 1660105351998.0}, {"id": 1462913780255, "note": "<div>At which site do <b>SGLT2 inhibitors</b> block <u>reabsorption</u> of glucose?<br></div><div><br></div><div>{{c1::Proximal tubule of the nephron}}</div>", "time": 1660105352014.0}, {"id": 1462913801840, "note": "<div>One adverse effect of <b>SGLT2 inhibitors</b> is <u>increased</u> risk of {{c1::urinary}} tract infection<br></div>", "time": 1660105352006.0}, {"id": 1462913811151, "note": "<div><b>SGLT2 inhibitors</b> may cause <u>increased</u> risk of vaginal {{c1::candidiasis (yeast infection)}}<br></div>", "time": 1660105351999.0}, {"id": 1462913833610, "note": "<div><b>SGLT2 inhibitors </b>may cause dehydration, and consequently {{c1::orthostatic hypotension}} due to osmotic diuresis<br></div>", "time": 1660105352000.0}, {"id": 1462913839886, "note": "<div><b>SGLT2 inhibitors</b> are <u>contraindicated</u> in patients with {{c1::renal}} <b>insufficiency</b><br></div>", "time": 1660105352001.0}, {"id": 1462932018812, "note": "<div>The <b>germ</b> <b>cells</b> of the <b>male gonads</b> produce {{c1::spermatogonia}}</div>", "time": 1660105350084.0}, {"id": 1462932142648, "note": "<div>The <b>{{c2::theca}} cells</b> of the <b>female gonads </b>synthesize the hormone <b>progesterone</b></div>", "time": null}, {"id": 1462932191528, "note": "<div>The <b>theca cells</b> and <b>granulosa cells</b>, together, synthesize <b>{{c1::estradiol (estrogen)}}</b></div>", "time": null}, {"id": 1462932197787, "note": "<div>Which <u>two</u> hormones (from the testes) are decisive in determining differences between male and female <b>gonads</b>?</div><div><br></div><div>{{c1::Anti-m\u00fcllerian hormone and testosterone (both synthesized in <b>testes</b>)}}</div>", "time": null}, {"id": 1462932210004, "note": "<div><div>Gonadal males have <b>testes</b> that synthesize and secrete <b>{{c1::</b><b>anti-m\u00fcllerian</b><b>&nbsp;hormone}}</b> and <b>{{c1::testosterone}}</b>, which are required for development of the male phenotype</div></div>", "time": null}, {"id": 1462932222605, "note": "<div><div><b>{{c3::Testosterone}}</b> stimulates the <u>growth and differentiation</u> of the <b>{{c1::wolffian}} ducts</b>, which develop into the male <b>{{c2::internal}} genital tract</b> </div></div>", "time": null}, {"id": 1462932252114, "note": "<div><div><b>{{c3::Anti-m\u00fcllerian&nbsp;hormone (</b><b>m\u00fcllerian</b><b>&nbsp;inhibitory factor)}}</b> causes <u>atrophy</u> of the <b>{{c1::m\u00fcllerian}} ducts</b>, which would have developed into the female <b>{{c2::internal}} genital tract</b> </div></div>", "time": null}, {"id": 1462932310717, "note": "<div><div>Without <b>{{c1::testosterone}}</b> (gonadal females), the <b>wolffian ducts</b> do not differentiate into <i>male</i> internal genitalia</div></div>", "time": null}, {"id": 1462932318824, "note": "<div><div>Without <b>{{c1::anti-</b><b>m\u00fcllerian</b><b>&nbsp;hormone}}</b> (gonadal females), the&nbsp;m\u00fcllerian&nbsp;ducts are <u>not suppressed</u> and therefore develop into the <i>female</i> internal genitalia</div></div>", "time": null}, {"id": 1462933136208, "note": "<div><div>In <b>puberty</b> and throughout the <b>reproductive years</b>, <b>FSH</b> levels are <u>{{c1::less}} than</u> <b>LH</b> levels</div></div>", "time": null}, {"id": 1462933166502, "note": "<div><div>The primary event that initiates <b>puberty</b> is the onset of <b><u>{{c2::pulsatile}}</u> secretion</b> of <b>{{c1::GnRH}}</b> from the hypothalamus</div></div>", "time": 1660105349678.0}, {"id": 1462933184944, "note": "<div><div>The pulsatile pattern of <b>GnRH</b> after <b>puberty</b> drives a parallel pulsatile secretion of both <b>{{c1::FSH}}</b> and <b>{{c1::LH}}</b> by the anterior pituitary</div></div>", "time": null}, {"id": 1462933237929, "note": "<div><div>The onset of menstrual cycles in females is referred to as <b>{{c1::menarche}}</b> </div></div>", "time": null}, {"id": 1462935407964, "note": "<div><div><b>{{c1::Germ}} cells</b> (spermatogonia) maintain the germ pool and produce <b>primary spermatocytes </b></div></div>", "time": 1660105340269.0}, {"id": 1462935430927, "note": "<div><div><b>{{c2::Sertoli}} cells</b> secrete <b>{{c1::androgen-binding protein}}</b> which serves to <b>maintain local levels of testosterone</b></div></div>", "time": null}, {"id": 1462935441365, "note": "<div><div><b>{{c1::Tight junctions}}</b> between adjacent <b>{{c3::Sertoli}} cells</b> form the <b>{{c2::blood-testis}} barrier</b>, which isolate gametes from autoimmune attack</div></div>", "time": null}, {"id": 1462935476863, "note": "<div><div>What is the effect of <u>increased</u> temperature on <b>sperm</b> <b>production</b>?</div><div><br></div><div>{{c1::Decreased}}</div></div>", "time": null}, {"id": 1462935563125, "note": "<div>The first stage of <b>spermatogenesis</b> is <b>{{c1::DNA replication</b> <b>(interphase)}}</b> of <b>{{c2::spermatogonia}}</b> to generate the <b>{{c2::primary spermatocyte}}</b> </div>", "time": null}, {"id": 1462935591927, "note": "<div>After the <b>primary spermatocyte</b> has been formed, it undergoes <b>{{c1::meiosis I}}</b> to become a(n)&nbsp;<b>{{c2::secondary spermatocyte}}</b></div>", "time": null}, {"id": 1462935608373, "note": "<div>After the <b>secondary spermatocyte</b> has been formed, it undergoes <b>{{c1::meiosis II}}</b> to become a(n)&nbsp;<b>{{c2::spermatid}}</b></div>", "time": null}, {"id": 1462935620453, "note": "<div>After <b>spermatids</b> have been formed from secondary spermatocytes, they undergo <b>{{c1::spermiogenesis}}</b> to form <b>{{c2::spermatozoa}}</b> </div>", "time": null}, {"id": 1462935633329, "note": "<div>What changes occur during the process of <b>spermiogenesis</b>? </div><div><br /></div><div> - Loss of {{c1::cytoplasmic contents}}</div><div> - Gain of a(n) {{c1::acrosomal}} cap</div><div> - Development of {{c1::flagella}} </div>", "time": 1660105347447.0}, {"id": 1462935652670, "note": "<div>After which stage of <b>spermatogenesis</b> does the <b>diploid</b> sperm become <b>haploid</b>?</div><div><br /></div><div>{{c1::Meiosis I (primary spermatocyte to secondary spermatocyte)}}</div>", "time": null}, {"id": 1462935662591, "note": "<div>One full cycle of <b>spermatogenesis</b> takes <b>{{c1::64}} days</b></div>", "time": null}, {"id": 1462935678981, "note": "<div>What is the <u>pathway</u> of <b>sperm</b> during <b>ejaculation</b>?</div><div><br></div><div>{{c1::Seminiferous tubules<div>Epididymis</div><div>Vas deferens</div><div>Ejaculatory ducts (receives vas deferens and seminal vesicle)</div><div>(Nothing)</div><div>Urethra</div><div>Penis</div><div><img src=\"paste-264874928111814.jpg\"></div>}}</div>", "time": null}, {"id": 1462935686800, "note": "<div>The primary location for the <b>maturation</b> and <b>storage</b> of sperm is the <b>{{c1::epididymis}}</b></div>", "time": null}, {"id": 1462979504741, "note": "<div><b>{{c1::LH}}</b> increases <b>testosterone</b> synthesis by stimulating the enzyme <b>{{c2::cholesterol desmolase}}</b> </div>", "time": null}, {"id": 1462979571197, "note": "<div><b>Androstenedione</b> may be converted to <b>{{c1::testosterone}}</b> via the enzyme <i style=\"font-weight: bold; \">{{c2::17\u03b2-hydroxysteroid dehydrogenase}}</i> </div>", "time": null}, {"id": 1462979605920, "note": "Ninety-eight percent of circulating <b>testosterone</b> is bound to plasma proteins, such as {{c1::<b>sex steroid-binding globulin</b> (SSBG)}} and albumin", "time": null}, {"id": 1462981484465, "note": "<b>Hypothalamic</b> <b>control</b> of <u>spermatogenesis</u> and <u>testosterone secretion</u> are regulated via the hormone {{c1::GnRH}}", "time": null}, {"id": 1462981781486, "note": "<div><b>GnRH</b> is primarily secreted by the Hypothalamic {{c1::Preoptic}} nuclei</div>", "time": null}, {"id": 1462981797259, "note": "<div><u>Pulsatile</u> secretion of <b>GnRH</b> stimulates the <b>anterior pituitary</b> to secrete <b>{{c1::FSH}}</b> and <b>{{c1::LH}}</b> </div>", "time": null}, {"id": 1462981814472, "note": "<div><b>Anterior pituitary control</b> of <u>spermatogenesis</u> and <u>testosterone secretion</u> are regulated via the hormones {{c1::FSH}} and {{c1::LH}}</div>", "time": null}, {"id": 1462981851888, "note": "<div><b>Testosterone</b> acts via an <b>intratesticular</b> <b>{{c1::paracrine}}</b> mechanism to reinforce the spermatogenic effects of FSH in Sertoli cells</div>", "time": 1660105350554.0}, {"id": 1462981887544, "note": "<div>What is the effect of <b>testosterone</b> on <b>GnRH secretion</b>?</div><div><br /></div><div>{{c1::Decreased}}  </div>", "time": null}, {"id": 1462981895638, "note": "<div>What is the effect of <b>testosterone</b> on<b> LH</b> <b>secretion</b>?</div><div><br /></div><div>{{c1::Decreased}}</div>", "time": null}, {"id": 1462981903167, "note": "<div>The <b>Sertoli cells</b> release a substance called <b>{{c1::inhibin B::specific}}</b> which causes <u>decreased</u> secretion of <b>{{c2::FSH}}</b> (negative feedback)</div>", "time": null}, {"id": 1462981916104, "note": "<div>Which hormone <u>directly</u> inhibits the secretion of <b>LH</b> in males? </div><div><br /></div><div>{{c1::Testosterone}}</div>", "time": null}, {"id": 1462981928631, "note": "<div>Which<b> androgen</b> is responsible for the <u>differentiation</u> of the <b>internal</b> <b>male</b> <b>genitalia</b> (epididymis, vas deferens, seminal vesicles)? </div><div><br></div><div>{{c1::Testosterone}}</div>", "time": 1660105344121.0}, {"id": 1462981933728, "note": "<div>Which <b>androgen</b> is responsible for the <b>growth spurt</b>, including growth of the penis, seminal vesicles, sperm, and muscle? </div><div><br></div><div>{{c1::Testosterone}}</div>", "time": 1660105344120.0}, {"id": 1462981937884, "note": "<div>Which <b>androgen</b> is responsible for <b>deepening of the voice</b>?</div><div><br></div><div>{{c1::Testosterone}}</div>", "time": 1660105344123.0}, {"id": 1462981942283, "note": "<div>Which <b><u>androgen</u></b> is responsible for <u>closing</u> of <b>epiphyseal plates</b> (cessation of pubertal growth)?</div><div><br></div><div>{{c1::Testosterone}}</div>", "time": null}, {"id": 1462981954788, "note": "<div>Which <b>androgen</b> is responsible for <b>libido</b>?</div><div><br></div><div>{{c1::Testosterone}}</div>", "time": 1660105344122.0}, {"id": 1462982009231, "note": "<div>In <b>{{c2::5\u03b1-reductase}} deficiency</b>, a person is genotypically <b>XY</b> but has <b>underdeveloped</b> (ambiguous) male {{c1::external}}<i> </i>genitalia with <b>normal</b> {{c1::internal}} genitalia</div>", "time": null}, {"id": 1462982032546, "note": "<div>In males, <b>androgens</b> are converted to <b>estrogen</b> primarily in {{c1::adipose}} tissue and the {{c1::testis}}</div>", "time": null}, {"id": 1462982073243, "note": "<div>In males, <b>exogenous {{c1::testosterone}} </b>causes decreased <b>{{c2::intratesticular}} testosterone</b>, leading to decreased <b>testicular size</b> and <b>azoospermia</b> </div>", "time": null}, {"id": 1462982091710, "note": "<div>Which <b>androgen</b> is the most <b>potent</b>?</div><div><br /></div><div>{{c1::DHT &gt; testosterone &gt; androstenedione}}</div>", "time": null}, {"id": 1462984377331, "note": "<div>The <u>functional unit</u> of the <b>ovaries</b> is the <b>single {{c1::ovarian follicle}}</b>, which comprises <u>one</u> germ cell surrounded by endocrine cells</div>", "time": 1660105350105.0}, {"id": 1462984387058, "note": "<div>In the <i>developing</i> ovaries, primordial germ cells produce <b>{{c1::oogonia}}</b> by <b>{{c2::mitotic}} divisions</b> until <i>gestational</i> weeks {{c3::20}} to {{c3::24}} </div>", "time": null}, {"id": 1462984399517, "note": "<div>{{c1::<b>DNA replication</b> <b>(interphase)</b>}} of <b>oogonia </b>generates the <b>{{c2::primary oocytes}}</b> (arrested in <b>prophase 1</b>)  </div>", "time": null}, {"id": 1462984451980, "note": "<div>Which <b>phase</b> of the cell cycle are <b>primary oocytes</b> arrested in until <u>ovulation</u>?</div><div><br /></div><div>{{c1::Prophase I (of meiosis I)}}</div>", "time": null}, {"id": 1462984460832, "note": "<div>Beginning at <b>ovulation</b>, <b>primary oocytes</b> begin to complete <b>{{c1::meiosis I}}</b> (diploid) to form <b>{{c2::secondary oocytes}}</b> (haploid) </div>", "time": null}, {"id": 1462984486053, "note": "<div>Which <b>phase</b> of the cell cycle are <b>secondary oocytes</b> arrested in until <u>fertilization</u>?</div><div><br /></div><div>{{c1::Metaphase II (of meiosis II)}}</div>", "time": null}, {"id": 1462984495155, "note": "<div>After <b>fertilization</b>, the <b>secondary oocyte</b> completes <b>{{c1::meiosis II}}</b> to form a(n)&nbsp;<b>{{c2::ovum}}</b> </div>", "time": null}, {"id": 1462984508078, "note": "<div><b>Primary oocytes</b> are arrested in <b>prophase I</b> of meiosis I for years until {{c1::ovulation}}</div>", "time": null}, {"id": 1462984522924, "note": "<div><b>Secondary oocytes</b> are arrested in <b>metaphase II</b> of meiosis II until {{c1::fertilization}}</div>", "time": null}, {"id": 1462984641273, "note": "<div>In the <b>ovaries,</b> <b>{{c1::theca}} cells</b> synthesize <b>pregnenolone</b> from cholesterol via the enzyme <b>{{c2::cholesterol desmolase}}</b></div>", "time": null}, {"id": 1462986779904, "note": "<div>In addition to progesterone, <b>theca cells</b> also synthesize&nbsp;<b>{{c1::androstenedione}}</b> which <u>diffuses</u> to nearby <b>granulosa</b> <b>cells</b> </div>", "time": null}, {"id": 1462986796333, "note": "<div>In the <b>{{c2::granulosa}} cells</b> of the <i>ovary</i>, <b>androstenedione</b> is converted to <b>testosterone</b> via the enzyme <b>17\u03b2-hydroxysteroid dehydrogenase</b></div><div></div>", "time": null}, {"id": 1462986834932, "note": "<div>In the <b>{{c1::granulosa}} cells</b> of the ovary, <b>testosterone</b> is converted to <b>{{c2::17\u03b2-estradiol}}</b> via the enzyme <b>{{c3::aromatase}}</b> </div>", "time": null}, {"id": 1462986895220, "note": "<b>Hypothalamic</b> <b>control</b> of <u>oogenesis</u> and&nbsp;<u>progesterone/estradiol secretion</u> are regulated via the hormone {{c1::GnRH}}", "time": null}, {"id": 1462987312318, "note": "Ovarian <b>granulosa cells</b> may produce <b>{{c1::inhibin}}</b>, which <u>inhibits</u> <b>FSH secretion</b> from the anterior pituitary", "time": null}, {"id": 1462989742904, "note": "<div>What is the effect of <b>estrogen</b> on <b>LH</b>, <b>estrogen</b>, and <b>progesterone</b> <b>receptors</b>? </div><div><br></div><div>{{c1::Up-regulation::up- or down-regulation}}</div>", "time": 1660105346562.0}, {"id": 1462989745991, "note": "<div>What is the effect of <b>estrogen</b> on <b>prolactin secretion</b>?</div><div><br /></div><div>{{c1::Increased}}</div>", "time": null}, {"id": 1462989749371, "note": "<div>What form of <b>estrogen</b> is produced in the <b>ovary</b>?</div><div><br></div><div>{{c1::17\u03b2-estradiol}}</div>", "time": 1660105347082.0}, {"id": 1462989752426, "note": "<div>What form of <b>estrogen </b>is produced in the <b>placenta</b>?</div><div><br></div><div>{{c1::Estriol}}</div>", "time": 1660105347081.0}, {"id": 1462989755828, "note": "<div>What form of <b>estrogen </b>is produced in the <b>adipose tissue</b>?</div><div><br></div><div>{{c1::Estrone}}</div>", "time": null}, {"id": 1462989759896, "note": "<div>Rank the forms of <b>estrogen</b> from most to least&nbsp;<b>potent</b>?</div><div><br></div><div>{{c1::17\u03b2-estradiol &gt; estrone &gt; estriol}}</div>", "time": null}, {"id": 1462989763064, "note": "<div>Where are <b>estrogen receptors</b> <i>expressed</i> (cell membrane, cytoplasm, nucleus)? </div><div><br></div><div>{{c1::Cytoplasm; translocate to nucleus when bound by estrogen}}</div>", "time": null}, {"id": 1462989766626, "note": "<div>What is the effect of <b>estrogen</b> on <b>sex hormone-binding globulin</b> (SHBG) levels?</div><div><br></div><div>{{c1::Increased}}</div>", "time": null}, {"id": 1462989771729, "note": "<div>What is the effect of <b>estrogen</b> on levels of <b>HDL</b>? </div><div><br></div><div>{{c1::Increased}}</div>", "time": null}, {"id": 1462989774805, "note": "<div>What is the effect of <b>estrogen</b> on levels of <b>LDL</b>? </div><div><br></div><div>{{c1::Decreased}}</div>", "time": null}, {"id": 1462989824446, "note": "<div><div>What is the effect of <b>progesterone</b> on <b>estrogen</b> <b>receptors</b>? </div><div><br></div><div>{{c1::Downregulation::up- or down-regulation}}</div></div>", "time": 1660105346561.0}, {"id": 1462989833021, "note": "<div><b>Elevated</b> levels of <b>{{c1::progesterone}}</b> in a non-pregnant patient is an indication that&nbsp;<b>{{c2::ovulation}} </b>has occurred</div>", "time": null}, {"id": 1462989855687, "note": "Variation in <b>menstrual cycle length</b> is attributed to the variability in duration of the <b>{{c1::follicular}} phase</b>", "time": null}, {"id": 1462992500901, "note": "By convention, day 0 of the <b>menstrual cycle</b> marks the {{c1::onset of menses}}", "time": null}, {"id": 1462992616794, "note": "<div>During the <b><u>follicular</u> phase </b>of the menstrual cycle, <b>estradiol</b> <b>{{c1::inhibits}}</b> <b>FSH</b> and <b>LH</b> secretion</div>", "time": 1660105359706.0}, {"id": 1462992655373, "note": "<div>During the <b><u>follicular</u> phase</b> of the menstrual cycle, <b>progesterone</b> levels are {{c1::low}}</div>", "time": null}, {"id": 1462992670874, "note": "<div>In the <u>middle</u> of the menstrual cycle <b>{{c1::ovulation}}</b> occurs, which occurs {{c2::14}} days prior to menses </div>", "time": 1660105356702.0}, {"id": 1462992912807, "note": "<div><b>Estradiol</b> levels <u>{{c1::decrease}}</u> just after <b>ovulation</b>, but <u>{{c1::increase}}</u> again during the <b>luteal phase</b> </div>", "time": null}, {"id": 1462993011096, "note": "<div>During the <b>luteal phase</b> of the menstrual cycle, <b>basal body temperature </b><u>{{c1::increases}}</u> due to the effect of <b>progesterone</b> on the hypothalamic temperature set-point</div>", "time": null}, {"id": 1462993044137, "note": "<div>If fertilization does <u>not</u> occur, the <b>corpus luteum regresses</b> and estradiol and progesterone levels <b>{{c1::decrease}}</b> abruptly </div>", "time": null}, {"id": 1462993071890, "note": "<div><b>Abnormal uterine bleeding</b> is characterized as either {{c1::heavy menstrual}} bleeding (AUB/{{c1::HMB}}) or {{c2::intermenstrual}} bleeding (AUB/{{c2::IMB}})</div>", "time": null}, {"id": 1462993208165, "note": "<div><b>Abnormal uterine bleeding </b>is further subcategorized by <u><font color=\"#aa0000\">PALM</font>-COEIN</u>; with <b>Structural </b>causes including<i>:</i></div><div><br /></div><div>- <b><font color=\"#aa0000\">P</font></b>{{c1::olyp}}</div><div>- <b><font color=\"#aa0000\">A</font></b>{{c2::denomyosis}}</div><div>- <b><font color=\"#aa0000\">L</font></b>{{c3::eiomyoma}}</div><div>- <b><font color=\"#aa0000\">M</font></b>{{c4::alignancy / hyperplasia}}</div>", "time": null}, {"id": 1462993212425, "note": "<div><b>Abnormal uterine bleeding </b>is further subcategorized by <u>PALM-<font color=\"#aa0000\">COEIN</font></u>; with <b>Non-structural </b>causes including<i>:</i></div><div><br /></div><div>- <b><font color=\"#aa0000\">C</font></b>{{c1::oagulopathy}}</div><div>- <b><font color=\"#aa0000\">O</font></b>{{c2::vulatory dysfunction}}</div><div>- <b><font color=\"#aa0000\">E</font></b>{{c3::ndometrial}}</div><div>- <b><font color=\"#aa0000\">I</font></b>{{c4::atrogenic}}</div><div>- <b><font color=\"#aa0000\">N</font></b>ot yet classified</div>", "time": null}, {"id": 1462993228629, "note": "In cases of <u>heavy</u> menstrual bleeding, <b>Abnormal uterine bleeding</b> can be treated with {{c1::hormone}} therapy or NSAIDS / {{c2::tranexamic acid}} ", "time": null}, {"id": 1462993233054, "note": "In cases of menstrual bleeding due to <u>ovulatory dysfunction</u>, <b>abnormal uterine bleeding</b> can be treated with {{c1::hormone}} therapy ", "time": null}, {"id": 1462995824386, "note": "<div><b>Fertilization</b> must occur within {{c1::one}} day(s) of <b>ovulation</b> </div>", "time": 1660105359300.0}, {"id": 1462995830556, "note": "<div><b>Fertilization</b> most commonly occurs in the upper end of the fallopian tube called the <b>{{c1::ampulla}}</b> </div>", "time": null}, {"id": 1462995840692, "note": "<div><b>Implantation</b> within the wall of the uterus occurs {{c1::six}} day(s) after <b>ovulation</b> </div>", "time": null}, {"id": 1462995889625, "note": "<div><b>Human chorionic gonadotropin </b>(hCG) is detectable in <b>blood</b> <b>{{c1::1}}</b> <b>week(s)</b> after conception and on home test in <b>urine</b> <b>{{c1::2}} weeks</b> after conception</div>", "time": null}, {"id": 1462995922829, "note": "<div><b>{{c1::Gestational}} age</b> of a fetus is calculated from date of <b>last menstrual period</b></div>", "time": null}, {"id": 1462995934823, "note": "<div><b>{{c1::Embryonic}} age</b> of a fetus is calculated from <b>date of conception</b> (gestational age minus 2 weeks)</div>", "time": null}, {"id": 1462995967981, "note": "<div>The function of <b>hCG</b> is to maintain the <b>{{c1::corpus luteum}}</b> by acting like <b>LH</b> for the first {{c2::8-10}} weeks of pregnancy</div>", "time": 1660105350107.0}, {"id": 1462996151862, "note": "<div>During the <u>second</u> and <u>third trimesters</u>, <b>progesterone</b> is produced by the <b>{{c1::placenta}}</b>, using cholesterol from the mother</div>", "time": 1660105359700.0}, {"id": 1462996238719, "note": "<div><b>{{c1::Human placental lactogen (HPL)}}</b> is a hormone produced throughout pregnancy and has actions similar to those of <b>growth hormone</b> and <b>prolactin</b> </div>", "time": null}, {"id": 1462996297369, "note": "<div>Why does <b>lactation</b> not occur during pregnancy, even though <b>prolactin</b> levels are <u>increasing</u>? </div><div><br></div><div>{{c1::Progesterone and estrogen downregulate prolactin receptors on the breast}}</div>", "time": 1660105341521.0}, {"id": 1462996327469, "note": "<div>As long as <b>lactation</b> continues, <b>{{c1::ovulation}}</b> is <b>suppressed</b>, due to <u>inhibitory</u> effects of <b>prolactin</b> on <b>GnRH</b>, <b>FSH</b>, and <b>LH</b> </div>", "time": 1660105361567.0}, {"id": 1463075650855, "note": "In the development of a <b>female</b>, the {{c1::mesonephric (wolffian)}} duct <b>degenerates</b> and the {{c1::paramesonephric (m\u00fcllerian)}} duct <b>develops</b> ", "time": null}, {"id": 1463078557201, "note": "<div><div>In the <b>male</b>, the <i><b>{{c1::SRY}}</b> </i>gene on the <b>Y</b> chromosome produces <b>{{c2::testis-determining factor}}</b>, which is necessary for testes development</div></div>", "time": null}, {"id": 1463078577289, "note": "<div><div><b>Anti-</b><b>m\u00fcllerian</b><b>&nbsp;hormone</b>, from the Sertoli cells, is also referred to as <b>{{c1::</b><b>m\u00fcllerian</b><b>&nbsp;inhibitory factor}}</b> </div></div>", "time": null}, {"id": 1463078581596, "note": "<div><div>If there is a <u>lack</u> of <b>Sertoli cells</b> or <b>MIF</b> during development of a genotypically <b>XY</b> fetus, there is<b> </b>{{c1::<i>both </i>male and female}} <b>internal</b> <b>genitalia</b> and {{c1::male}} <b>external genitalia</b> </div></div>", "time": 1660105357685.0}, {"id": 1463078620627, "note": "<div><div>The <b>indifferent gonad</b> (testis, ovary) <i>begins</i> development next to the <b>fetal kidney,</b> known as the {{c1::mesonephros}}</div></div>", "time": 1660105349999.0}, {"id": 1463078634375, "note": "<div><div>Which <b>embryologic structure</b> develops into the fallopian tubes, uterus, and <u>upper</u> portion of the vagina (<b>internal</b> <b>female</b> <b>genitalia</b>)?</div></div><div><br></div><div>{{c1::Paramesonephric (m\u00fcllerian) duct}} </div>", "time": null}, {"id": 1463078659617, "note": "<div><b>{{c2::M\u00fcllerian}} agenesis</b>, also known as <b>Mayer-Rokitansky-K\u00fcster-Hauser syndrome</b>, presents as <b>primary</b> {{c1::<b>amenorrhea</b>}} in females with <u>fully developed</u> <b>secondary</b> sexual characteristics</div>", "time": 1660105337656.0}, {"id": 1463078682536, "note": "<div>Which <b>embryologic structure</b> develops into the seminal vesicles, epididymis, ejaculatory duct, and ductus deferens (<b>male internal genitalia</b>, except prostate)? </div><div><br></div><div>{{c1::Mesonephric (wolffian) duct}} </div>", "time": null}, {"id": 1463078721869, "note": "<div><b>{{c1::Septate}} uterus</b> is a common anomaly of the uterus due to <b>incomplete resorption of the septum</b> </div>", "time": null}, {"id": 1463078730041, "note": "<div>What is the treatment for <b>septate uterus</b>?</div><div><br></div><div>{{c1::Septoplasty}}</div>", "time": null}, {"id": 1463078734022, "note": "<div>What is the effect of <b>septate uterus</b> on <b>fertility</b>?</div><div><br /></div><div>{{c1::Decreased}}</div>", "time": null}, {"id": 1463078751694, "note": "<div><b>{{c1::Bicornuate}} uterus</b> is an anomaly of the uterus due to <b>{{c2::incomplete}} lateral fusion </b>of M\u00fcllerian ducts </div>", "time": null}, {"id": 1463078773984, "note": "<div><b>Uterus {{c1::didelphys}}</b> is an anomaly of the uterus due to <b>{{c2::complete failure of}} lateral fusion</b> of the&nbsp;m\u00fcllerian&nbsp;ducts, leading to double uterus, vagina, and cervix</div>", "time": null}, {"id": 1463078784640, "note": "<div>Is <u>pregnancy</u> possible in a patient with <b>uterus didelphys</b>?</div><div><br /></div><div>{{c1::Yes}} </div>", "time": null}, {"id": 1463078795879, "note": "<div>The <i>male</i> <b>{{c1::glans penis}}</b> is homologous to the <i>female</i> <b>{{c2::glans clitoris}}</b>, which both arise from the <b>{{c3::genital tubercle}}</b> </div>", "time": null}, {"id": 1463078810052, "note": "<div>The <i>male</i> <b>{{c1::corpus cavernosum and spongiosum}}</b> are homologous to the <i>female</i> <b>{{c2::vestibular bulbs}}</b>, which both arise from the <b>{{c3::genital tubercle}}</b> </div>", "time": 1660105349859.0}, {"id": 1463078836498, "note": "<div>The <i>male</i> <b>{{c1::bulbourethral glands (of <u>Cowper</u>)}}</b> are homologous to the <i>female</i> <b>{{c2::greater vestibular glands (of <u>Bartholin</u>)}}</b>, which both arise from the <b>{{c3::urogenital sinus}}</b> </div>", "time": null}, {"id": 1463078866733, "note": "<div>The <i>male</i> <b>{{c1::prostate gland}}</b> is homologous to the <i>female</i> <b>{{c2::urethral and paraurethral glands (of <u>Skene</u>)}}</b>, which both arise from the <b>{{c3::urogenital sinus}}</b> </div>", "time": null}, {"id": 1463078878506, "note": "<div>The <i>male</i> <b>{{c1::ventral shaft of penis (penile urethra)}}</b> is homologous to the <i>female</i> <b>{{c2::labia minora}}</b>, which both arise from the <b>{{c3::urogenital folds}}</b> </div>", "time": null}, {"id": 1463078891051, "note": "<div>The <i>male</i> <b>{{c1::scrotum}}</b> is homologous to the <i>female</i> <b>{{c2::labia majora}}</b>, which both arise from the <b>{{c3::labioscrotal swelling}}</b> </div>", "time": null}, {"id": 1463078903785, "note": "<div><b>{{c1::Hypospadias}}</b> is the abnormal opening of the penile urethra on the <b>{{c2::ventral}} surface</b> of the penis due to failure of urethral folds to fuse</div>", "time": null}, {"id": 1463078915955, "note": "<div><b>{{c1::Epispadias}}</b> is the abnormal opening of the penile urethra on the <b>{{c2::dorsal}} surface</b> of the penis due to faulty positioning of the genital tubercle </div>", "time": null}, {"id": 1463078929014, "note": "<div>Which congenital penile abnormality (<b>hypospadias</b> or <b>epispadias</b>) is more common?</div><div><br></div><div>{{c1::Hypospadias}}</div>", "time": 1660105343406.0}, {"id": 1463078936768, "note": "<div>The congenital penile abnormality <b>{{c1::epispadias}}</b> is associated with <b>{{c2::exstrophy of the bladder}}</b></div>", "time": null}, {"id": 1463078942355, "note": "<div>The congenital penile abnormality <b>{{c1::hypospadias}}</b> is associated with&nbsp;<b>{{c2::inguinal}} </b><b>hernia</b> and <b>{{c2::cryptorchidism}}</b></div>", "time": null}, {"id": 1463078958759, "note": "<div>What is the <b>male remnant</b> of the <b>processus vaginalis</b>?</div><div><br></div><div>{{c1::Tunica vaginalis}}</div>", "time": null}, {"id": 1463078965308, "note": "<div>What is the <b>female remnant</b> of the <b>processus vaginalis</b>?</div><div><br></div><div>{{c1::None (obliterated)}}</div>", "time": null}, {"id": 1463078977459, "note": "<div>What is the <b>male remnant </b>of the <b>gubernaculum</b>? </div><div><br /></div><div>{{c1::Scrotal ligament (anchors testes within scrotum)}}</div>", "time": 1660105346107.0}, {"id": 1463078997361, "note": "<div>What is the <b>female remnant </b>of the <b>gubernaculum</b>? </div><div><br></div><div>{{c1::Ovarian ligament + round ligament of uterus::2}}</div>", "time": null}, {"id": 1463081027332, "note": "<b>{{c1::Mittelschmerz}}</b> is transient mid-cycle ovulatory pain that may mimic appendicitis", "time": null}, {"id": 1463081222466, "note": "The <b>{{c1::Apgar score}}</b> is an assessment of newborn vital signs following labor via a 10-point scale evaluated at 1 minute and 5 minutes", "time": null}, {"id": 1463081611935, "note": "What <b>appearance</b> is associated with the following scores using the <b>Apgar score</b>? <div><br /></div><div>0: {{c1::pale or blue}}</div><div>1: {{c1::extremities blue}}</div><div>2: {{c1::pink}}</div>", "time": null}, {"id": 1463081757542, "note": "What <b>pulse</b> is associated with the following scores using the <b>Apgar score</b>?<div><br></div><div>0: {{c1::no pulse}}</div><div>1: {{c1::pulse &lt;100 bpm}}</div><div>2: {{c1::pulse &gt;=100 bpm}}</div>", "time": null}, {"id": 1463081820748, "note": "What <b>grimace</b> is associated with the following scores using the <b>Apgar score</b>? <div><br /></div><div>0: {{c1::no response to stimulation}}</div><div>1: {{c1::grimaces or weak cry}}</div><div>2: {{c1::cries and pulls away}}</div>", "time": null}, {"id": 1463081859526, "note": "What <b>activity</b> is associated with each of the following scores using the <b>Apgar score</b>? <div><br /></div><div>0: {{c1::no movement}}</div><div>1: {{c1::arms, legs flexed}}</div><div>2: {{c1::active movement}}</div>", "time": null}, {"id": 1463081896488, "note": "What <b>respiration</b> is associated with the following scores using the <b>Apgar score</b>?<div><br /></div><div>0: {{c1::no breathing}}</div><div>1: {{c1::slow, irregular}}</div><div>2: {{c1::strong cry}}</div>", "time": null}, {"id": 1463081930386, "note": "If a neonates <b>Apgar score</b> remains low at late time points, there is increased risk the child will develop long-term <b>{{c1::neurologic}} damage</b>", "time": 1660105357737.0}, {"id": 1463081956910, "note": "<b>Low birth weight</b> is defined as <b>less than </b>{{c1::2500}} <b>grams</b> (5.5 pounds)", "time": null}, {"id": 1463082333416, "note": "Breastfeeding <u>reduces</u> <b>maternal risk</b> of {{c1::breast}} and {{c1::ovarian}} cancer", "time": 1660105361112.0}, {"id": 1463082529466, "note": "<u>Very elevated</u> levels of <b>{{c1::FSH}}</b> is specific for <b>menopause</b> ", "time": null}, {"id": 1463082620879, "note": "<b>Menopause</b> is associated with <u>{{c1::increased}}</u> levels of FSH, LH, and GnRH with <u>{{c1::decreased}}</u> levels of estrogen", "time": null}, {"id": 1463082697879, "note": "<b>Menopause</b> <i>before</i> age <b>40</b> suggests {{c1::primary ovarian}} insufficiency", "time": 1660105355297.0}, {"id": 1463082721843, "note": "The <u>symptoms/complications</u> of <b>menopause</b> may be remembered with the mnemonic \"<b>HAVOCS</b>\": <div style=\"centerbox\"><div class=\"mnemonics\"><div><br/></div><div><b>H</b>: {{c1::Hot flashes}}, {{c1::Hirsutism}}</div><div><b>AV</b>: {{c2::Atrophy of the Vagina}}</div><div><b>O</b>: {{c3::Osteoporosis}}</div><div><b>C</b>: {{c4::Coronary artery disease}}</div><div><b>S</b>: {{c5::Sleep disturbances}}</div></div></div>", "time": 1660105349497.0}, {"id": 1463082787001, "note": "The source of <b>{{c1::estrogen}}</b><i> after menopause </i>becomes <b>peripheral conversion of androgens</b>", "time": 1660105349563.0}, {"id": 1463082815704, "note": "<b>Menopause</b> is due to <u>decreased</u> {{c1::estrogen}} production due to age-linked decline in the number of ovarian follicles", "time": 1660105355295.0}, {"id": 1463082847360, "note": "<b>{{c1::Estrogen/progesterone}} replacement therapy</b> may be used to minimize the symptoms of <b>menopause</b>", "time": 1660105340407.0}, {"id": 1463083035387, "note": "<b>{{c1::Menopause}}</b> is usually preceded by 4-5 years of abnormal<b> </b>menstrual cycles", "time": 1660105339641.0}, {"id": 1463083069015, "note": "<b>Menopause</b> is diagnosed by <b>amenorrhea</b> for at least {{c1::12}} months", "time": 1660105355296.0}, {"id": 1463083081562, "note": "The <b>{{c1::Tanner}}</b> <b>stages of sexual development</b> are assigned independently to genitalia, pubic hair, and breast", "time": 1660105349011.0}, {"id": 1463083925825, "note": "In <b>Tanner stage {{c1::I}}</b>, a person is <b>pre-pubertal</b> (childhood) with no pubic hair and a flat chest", "time": 1660105356839.0}, {"id": 1463084161585, "note": "<div><div>In <b>Tanner stage {{c1::II}}</b>, pubic hair appears (pubarche), breast buds form (thelarche), and testicular enlargement occurs</div></div>", "time": null}, {"id": 1463084175199, "note": "<div><div>In <b>Tanner stage {{c1::III}}</b>, the pubic hair coarsens, the penis <b>size</b> increases, and the breast enlarges</div></div>", "time": null}, {"id": 1463084186996, "note": "<div><div>In <b>Tanner stage {{c1::IV}}</b>, the penis <b>width</b> and <b>glans </b>increases and the breast enlarges with <b>raised areola</b> </div></div>", "time": null}, {"id": 1463084244802, "note": "<div><div>In <b>Tanner stage {{c1::V}}</b> (adulthood) the penis and testis enlarge to adult size and the areola <b>flattens</b></div></div>", "time": null}, {"id": 1463094023779, "note": "<div><b>Condyloma {{c1::acuminata}} </b>is caused by <b>HPV</b> <b>types</b> <b>{{c2::6}} </b>and <b>{{c2::11}}</b></div>", "time": null}, {"id": 1463094049348, "note": "<div>What are the <u>three</u> areas that <b>HPV</b> most commonly affects in <u>female genital tract</u>?</div><div><br></div><div>{{c1::Vulva}}, {{c1::vaginal canal}}, and {{c1::cervix}}</div>", "time": null}, {"id": 1463094074203, "note": "<div><b>Condyloma {{c1::latum}}</b> is caused by <i>secondary</i> <b>{{c2::syphilis}}</b> </div>", "time": null}, {"id": 1463094084820, "note": "<div>Histologically, HPV-associated <b>condylomas</b> are characterized by <b>{{c1::koilocytes}}</b> </div>", "time": null}, {"id": 1463094394076, "note": "<div><b>{{c2::Paget}} disease</b> (of the<i> </i>vulva<i> and</i> nipple) is characterized by {{c1::<b>malignant</b> <b>epithelial</b>}} <b>cells</b> in the epidermis</div>", "time": null}, {"id": 1463094505791, "note": "<div>The following image shows <b>large</b> cells in the epidermis with a <b>clear</b> halo, which are characteristic of <b>{{c1::Paget}} disease</b></div><div><b><br /></b></div><div><img src=\"paste-2594160247306.jpg\" /></div>", "time": null}, {"id": 1463101150767, "note": "<div>What <b>embryological structure</b> is the <u>lower (distal) 2/3rd</u> of the <b>vaginal</b> <b>canal</b> derived from?</div><div><br></div><div>{{c1::Urogenital sinus}}</div>", "time": null}, {"id": 1463101160605, "note": "<div>The normal <b><i>fetal</i></b> <b>epithelium</b> of the <b>upper 1/3rd</b> of the <b>vaginal canal</b> is {{c1::columnar}} epithelium </div>", "time": null}, {"id": 1463101171957, "note": "<div><b>Vaginal {{c1::adenosis}}</b> is the focal persistence of {{c2::columnar}} epithelium in the <b>upper 1/3rd of the vagina</b></div>", "time": null}, {"id": 1463101175620, "note": "<div>Increased incidence of <b>vaginal {{c1::adenosis}}</b> is classically seen in females who were exposed to <b>{{c2::diethylstilbestrol (DES)}}</b> in utero</div>", "time": null}, {"id": 1463101179451, "note": "<div>What type of cancer does <b>vaginal adenosis</b> increase risk for? </div><div><br></div><div>{{c1::Clear cell adenocarcinoma}}</div>", "time": null}, {"id": 1463101187418, "note": "<div><b>{{c1::Clear cell adenocarcinoma}}</b>, a rare complication of diethylstilbestrol, is the malignant proliferation of glands in the vagina with <b>clear cytoplasm</b></div>", "time": null}, {"id": 1463101200000, "note": "<div><b>Embryonal rhabdomyosarcoma</b>, also known as <b>sarcoma botryoides</b>, is a <i>rare</i> malignant mesenchymal proliferation of immature <b>{{c1::skeletal muscle}}</b></div>", "time": 1660105359585.0}, {"id": 1463101204259, "note": "<div><b>{{c2::Embryonal rhabdomyosarcoma}}</b>, also known as <b>{{c3::sarcoma botryoides}}</b>, presents with bleeding and a(n) {{c1::<u>grape</u>}}<u>-like mass</u> protruding from the vagina or penis of a <b>child</b></div>", "time": null}, {"id": 1463101220961, "note": "<div>What demographic is most commonly associated with <b>embryonal rhabdomysosarcoma</b> (<b>sarcoma botryoides</b>)? </div><div><br /></div><div>{{c1::Girls &lt; 4 years old}}</div>", "time": null}, {"id": 1463101224904, "note": "<div>The malignant cell of <b>embryonal rhabdomysosarcoma </b>is a(n) {{c1::rhabdomyoblast}}</div>", "time": 1660105349856.0}, {"id": 1463101228831, "note": "<div><b>Rhabdomyoblasts</b> are <b>spindle-shaped cells</b> that sometimes exhibit <b>cytoplasmic</b> {{c1::cross-striations}}</div>", "time": 1660105353325.0}, {"id": 1463101246153, "note": "<div><b>Rhabdomyoblasts</b> are characterized by positive IHC staining for <b>{{c1::desmin}}</b> and <b>{{c1::myogenin}}</b> </div>", "time": 1660105353326.0}, {"id": 1463101266778, "note": "<div><b>Vaginal carcinoma</b> arises from the {{c1::stratified squamous}} epithelium lining the vaginal mucosa</div>", "time": null}, {"id": 1463101295333, "note": "<div><b>Vaginal carcinoma</b> is usually related to which infectious disease?</div><div><br></div><div>{{c1::<b>HPV</b> (high-risk strains)}}</div>", "time": null}, {"id": 1463101300781, "note": "<div>What is the <b>precursor lesion</b> of a <b>vaginal squamous cell carcinoma</b>? </div><div><br></div><div>{{c1::Vaginal intraepithelial neoplasia (VAIN)}}</div>", "time": 1660105345623.0}, {"id": 1463101305391, "note": "<div><b>Vaginal squamous cell carcinoma</b> is usually <i>secondary</i> to {{c1::cervical}} SCC</div>", "time": null}, {"id": 1463101308955, "note": "<div><b>Vaginal carcinoma</b> from the <b>lower 2/3rd of the vagina</b> travels first to the {{c1::inguinal}} nodes</div>", "time": 1660105348335.0}, {"id": 1463101311443, "note": "<b>Vaginal carcinoma</b> from the <b>upper 1/3rd of the vagina</b> travels first to the {{c1::iliac}} nodes", "time": 1660105348334.0}, {"id": 1463105824837, "note": "<div>The <b>{{c1::transformation zone}}</b> is the squamocolumnar junction between the <b>ectocervix</b> and the <b>endocervix</b> </div>", "time": null}, {"id": 1463105840341, "note": "<div><b>HPV</b> is a sexually transmitted <b>DNA</b> <b>virus </b>that infects the lower genital tract, especially the <b>cervix</b> at the <b>{{c1::transformation zone}}</b></div>", "time": null}, {"id": 1463105881914, "note": "<div><i>Persistent</i> <b>HPV</b> infection leads to risk for cervical <i>dysplasia</i>, also known as {{c1::cervical intraepithelial neoplasia (CIN)}}</div>", "time": null}, {"id": 1463105909117, "note": "<div><b>High-risk HPV</b> strains produce <b>{{c2::E6}}</b> protein, which increases destruction of <b>{{c1::p53}}</b> </div>", "time": null}, {"id": 1463105915437, "note": "<div><b>High-risk HPV</b> strains produce <b>{{c1::E7}}</b> protein, which increases destruction of <b>{{c2::Rb}}</b></div>", "time": null}, {"id": 1463105924097, "note": "<div><b>{{c1::Cervical intraepithelial neoplasia (CIN)}}</b> is characterized by koilocytic change, nuclear atypia, and increased mitotic activity of <b>cervical epithelium</b> (<i>dysplasia</i>) </div>", "time": null}, {"id": 1463105947626, "note": "<div><div>What is the extent of <b>epithelial involvement</b> by <b>immature <i>dysplastic cells</i> </b>in <b>cervical carcinoma in situ</b>? </div><div><br /></div><div>{{c1::the <u>entire</u> thickness of the epithelium}}</div></div>", "time": 1660105346465.0}, {"id": 1463105972862, "note": "<div><div><div>What is the percent chance of <i>reversal</i> back to normal cervical epithelium in <b>carcinoma in situ</b>? </div><div><br></div><div>{{c1::<u>Not possible</u>}}</div></div></div>", "time": null}, {"id": 1463105976747, "note": "<div><b>Cervical </b><span style=\"font-weight: bold\">carcinoma</span> may present with abnormal vaginal {{c1::bleeding (often postcoital)}} or cervical discharge</div>", "time": null}, {"id": 1463105983927, "note": "<div>What is the <b>#1</b> <b>risk factor</b> for <b>cervical </b><b>carcinoma</b>? </div><div><br></div><div>{{c1::Multiple sexual partners}}</div>", "time": 1660105346782.0}, {"id": 1463105992062, "note": "<div>Besides for <b>multiple</b> <b>sexual</b> <b>partners</b>, the other major risk factors for <b>cervical carcinoma </b>are:</div><div><br></div><div>- deficiency of the {{c1::immune}} system</div><div>- infection by high-risk {{c2::HPV}} </div><div>- {{c3::tobacco}} use</div><div>- {{c4::early}} onset of sexual activity</div><div>- lack of {{c5::barrier contraception}}</div>", "time": null}, {"id": 1463105999636, "note": "<div><b>Cervical carcinoma</b> is an <b>invasive</b> carcinoma that arises from the cervical epithelium and invades through the {{c1::basement membrane}}</div>", "time": null}, {"id": 1463106003755, "note": "<div>What demographic is most commonly associated with <b>cervical carcinoma</b>? </div><div><br></div><div>{{c1::Middle-aged women (average age is 40-50 years)::age}}</div>", "time": 1660105347352.0}, {"id": 1463106007081, "note": "<div>Which subtype of <b>cervical carcinoma</b> (adenocarcinoma or squamous cell carcinoma) is <b>associated with HPV</b>? </div><div><br></div><div>{{c1::Both :)}}</div>", "time": 1660105342055.0}, {"id": 1463106011070, "note": "<div>The <u>most common</u> type of <b>cervical carcinoma</b> is {{c1::squamous cell carcinoma}} (80%)</div>", "time": null}, {"id": 1463106014708, "note": "<div>The <u>second most common</u> subtype of <b>cervical carcinoma</b> is {{c1::adenocarcinoma}} (15%)</div>", "time": null}, {"id": 1463106018043, "note": "<div><i>Advanced</i> <b>cervical carcinoma tumors</b> often <u>invade</u> through the anterior uterine wall into the <b>bladder</b>, blocking the {{c1::ureters}}</div>", "time": null}, {"id": 1463106021207, "note": "<div><b>{{c2::Hydronephrosis}}</b> with {{c1::post-renal failure}} is a common cause of death in <b>advanced {{c3::cervical}} carcinoma</b> in females</div>", "time": 1660105337876.0}, {"id": 1463106029685, "note": "<div><b>Screening</b> for <b>cervical carcinoma</b> is performed via {{c1::pap smears}}</div>", "time": null}, {"id": 1463106033552, "note": "<div><b>Pap smear</b> screening begins at <b>age {{c1::21}}</b> and are performed every <b>{{c1::three}} year(s)</b></div>", "time": null}, {"id": 1463106055950, "note": "<div>A <b>pap smear</b> is performed by scraping cells at the <b>{{c1::transformation zone}}</b> of the <b>cervix</b> </div>", "time": null}, {"id": 1463106062110, "note": "<div><b>High-grade dysplasia</b> on pap smear is characterized by <b>{{c1::dark::color}}</b> <b>nuclei</b>&nbsp;with a(n)&nbsp;<b>{{c1::high}}</b> <b>nuclear:cytoplasmic ratio</b></div>", "time": 1660105358248.0}, {"id": 1463106074503, "note": "<div>An <b>abnormal pap smear</b> is followed by <i>confirmatory</i> <b>{{c1::colposcopy}}</b> (visualization of cervix with a magnifying glass) and <b>{{c1::biopsy}}</b> </div>", "time": null}, {"id": 1463106081948, "note": "<div>One <u>limitation</u> of <b>pap smears</b> is {{c1::inadequate sampling}} of transformation zone resulting in <b>false negative</b> screening</div>", "time": 1660105354603.0}, {"id": 1463106094001, "note": "<div>One <u>limitation</u> of <b>pap smears</b> is limited efficacy in screening for {{c1::adenocarcinoma}} </div>", "time": 1660105354604.0}, {"id": 1463141251045, "note": "What is the <b>embryonic origin</b> of the <b>posterior pituitary</b>?<div><br></div><div>{{c1::Neuroectoderm}}</div>", "time": null}, {"id": 1463150148468, "note": "What is the <u>most common</u> cause of <b>hematochezia</b> in <b>adults</b>?<div><br></div><div>{{c1::Diverticulosis}}  </div>", "time": null}, {"id": 1463163260222, "note": "<div><i>Growth</i> of <b>endometrium</b> is {{c1::estrogen}} driven (proliferative phase)</div>", "time": null}, {"id": 1463163500200, "note": "<div>Preparation of <b>endometrium</b> for <i>implantation</i> is {{c1::progesterone}} driven (secretory phase)</div>", "time": null}, {"id": 1463163507048, "note": "<div>Shedding of the <b>endometrium</b> occurs with loss of {{c1::progesterone}} support (menstrual phase) </div>", "time": 1660105353019.0}, {"id": 1463172079616, "note": "<b>{{c1::Asherman}} syndrome</b> is <i>secondary</i> {{c2::<b>amenorrhea</b>}} due to loss and scarring of the <b>{{c3::basalis}}</b> <b>layer</b> of the endometrium", "time": null}, {"id": 1463172089555, "note": "<div><div><b>Asherman syndrome</b> is often the result of <b>overaggressive</b> {{c1::dilation and curettage (D&amp;C)}} </div></div>", "time": null}, {"id": 1463172095708, "note": "<div><div><b>Anovulatory cycle</b> is a menstrual cycle that lacks {{c1::ovulation}}</div></div>", "time": 1660105361744.0}, {"id": 1463172100364, "note": "<div><div><b>Anovulatory</b> <b>cycle</b> results in an estrogen-driven proliferative phase, but <b>no {{c1::progesterone}}-driven {{c1::secretory}} phase</b></div></div>", "time": 1660105361743.0}, {"id": 1463172108621, "note": "<div><div><b>Anovulatory cycles</b> lead to the break down and shedding of <b>proliferative glands</b> resulting in abnormal {{c1::uterine bleeding}} </div></div>", "time": 1660105361742.0}, {"id": 1463172112650, "note": "<div><div>When are <b>anovulatory cycles</b> more likely to occur? </div><div><br></div><div>{{c1::during menarche and menopause}}</div></div>", "time": 1660105344649.0}, {"id": 1463172117522, "note": "<div><div><b>{{c1::Acute endometritis}}</b> is due to a bacterial infection of the <b>endometrium</b></div></div>", "time": 1660105341313.0}, {"id": 1463172122482, "note": "<div><div><b>Acute endometritis</b> is associated with <b>retained products </b>of {{c1::conception}} or foreign bodies</div></div>", "time": null}, {"id": 1463172137015, "note": "<div><div><b>Acute endometritis</b> presents as fever, abnormal {{c1::uterine bleeding}}, and {{c1::pelvic}} pain</div></div>", "time": 1660105362165.0}, {"id": 1463172143887, "note": "<div><div><b>{{c1::Chronic endometritis}}</b> is due to chronic inflammation of <b>endometrium</b> </div></div>", "time": null}, {"id": 1463172156994, "note": "<div><div><b>Chronic endometritis</b> is characterized by <b>{{c1::lymphocytes}}</b> and <b>{{c1::plasma cells}}</b> in the <b>endometrium</b> </div></div>", "time": null}, {"id": 1463172169695, "note": "<div><div>The histology image below has <b>lymphocytes</b> and <b>plasma cells</b> in the <b>endometrium</b>, which is indicative of {{c1::chronic endometritis}}</div></div><div><br></div><div><img src=\"paste-51823075393875.jpg\"></div>", "time": null}, {"id": 1463172179641, "note": "<div><div>Common causes of <b>chronic endometritis</b> include retained products of conception, chronic {{c1::pelvic inflammatory disease}} (e.g. from long-standing chlamydia), IUD, and TB</div></div>", "time": 1660105360515.0}, {"id": 1463172186799, "note": "<div><div><b>Chronic endometritis</b> presents with abnormal uterine bleeding, pelvic pain, and&nbsp;<b>{{c1::infertility}}</b></div></div>", "time": 1660105360749.0}, {"id": 1463172198813, "note": "<div><b>{{c1::Endometrial polyp}}</b> is a well-circumscribed, <b>hyperplastic</b> <b>protrusion&nbsp;</b>of <b>endometrial</b> <b>tissue</b></div>", "time": null}, {"id": 1463172225574, "note": "<div><div><b>Endometrial polyps</b> may be asymptomatic or may present with <i>painless</i> abnormal {{c1::uterine bleeding}}</div></div>", "time": 1660105359560.0}, {"id": 1463172226538, "note": "<div><div><b>Endometrial polyps </b>and <b>endometrial hyperplasia </b>can arise as a side effect of the chemotherapeutic drug <b>{{c1::tamoxifen}}</b> </div></div>", "time": null}, {"id": 1463172236433, "note": "<div><div><b>{{c1::Endometriosis}}</b> is the <i>abnormal placement</i> of <b>endometrial {{c2::glands}}</b> <u>and</u> <b>{{c2::stroma}}</b> outside the endometrial lining/cavity</div></div>", "time": null}, {"id": 1463172247043, "note": "<div><div><b>Endometriosis</b> often presents with {{c1::dysmenorrhea}} and cyclic {{c3::pelvic}} pain; it may also cause {{c2::infertility}} </div></div>", "time": 1660105359556.0}, {"id": 1463172253954, "note": "<div><div>What is the most supported theory for the <b>etiology</b> of <b>endometriosis</b>?</div><div><br /></div><div>{{c1::Retrograde menstruation}} </div></div>", "time": null}, {"id": 1463172258965, "note": "<div><div>One theory behind the <b>etiology</b> of <b>endometriosis</b> is {{c1::metaplastic}} transformation of multipotent cells</div></div>", "time": null}, {"id": 1463172263963, "note": "<div><div>One theory behind the <b>etiology </b>of <b>endometriosis</b> is transportation of endometrial tissue via the {{c1::lymphatic}} system</div></div>", "time": null}, {"id": 1463172268325, "note": "<div><div>What is the <u>most common</u> site that <b>endometriosis <i>spreads</i> </b>to? </div><div><br /></div><div>{{c1::Ovary}}</div></div>", "time": null}, {"id": 1463172272323, "note": "<div><div>What is the appearance of an <b>ovarian endometrioma</b>? </div><div><br></div><div>{{c1::Chocolate cyst (blood-filled)}} </div></div>", "time": null}, {"id": 1463172280966, "note": "<div><div>When <b>endometriosis</b> spreads to <b>soft tissue</b>, it appears as \"<b>{{c1::gun-powder}}</b> <b>lesions</b>\" </div></div>", "time": 1660105344629.0}, {"id": 1463172289630, "note": "<div><div><b>Endometriosis</b> spread to the <b>Pouch of Douglas</b> (posterior cul-de-sac) can present with {{c1::dyschezia (pain with defecation)}} and {{c2::painful}} intercourse</div></div>", "time": 1660105359550.0}, {"id": 1463172294631, "note": "<div><div><b>Endometriosis</b> spread to the <b>bladder wall</b> presents with {{c1::dysuria}}</div></div>", "time": 1660105359553.0}, {"id": 1463172298323, "note": "<div><div><b>Endometriosis</b> spread to the <b>bowel serosa</b> presents with {{c1::abdominal}} pain and adhesions</div></div>", "time": 1660105359552.0}, {"id": 1463172301905, "note": "<div><div><b>Endometriosis</b> spread to the <b>fallopian tube mucosa</b> presents with increased risk of {{c1::ectopic tubal}} pregnancy and {{c1::infertility}}</div></div>", "time": 1660105359551.0}, {"id": 1463172307168, "note": "<div><div>The presence of <b>endometrial tissue </b>(endometriosis) in the uterine myometrium is known as <b>{{c1::adenomyosis}}</b> </div></div>", "time": null}, {"id": 1463172319857, "note": "<div><div>Continuous (not pulsatile) {{c1::GnRH}} <i>agonists</i> may be used to treat <b>adenomyosis</b> (endometriosis in the myometrium) </div></div>", "time": 1660105360418.0}, {"id": 1463172327723, "note": "<div><div>There is an <u>increased risk</u> of {{c1::carcinoma}} at the site of <b>endometriosis</b>, especially in the <b>ovary</b></div></div>", "time": 1660105348815.0}, {"id": 1463172336780, "note": "<div><b>{{c1::Endometrial hyperplasia}} </b>is the hyperplasia of endometrial glands relative to the stroma</div>", "time": null}, {"id": 1463172352600, "note": "<div><b>Endometrial hyperplasia</b> is usually caused by <b>unopposed</b> {{c1::estrogen}}</div>", "time": null}, {"id": 1463172359613, "note": "<div><b>Endometrial hyperplasia</b> typically presents as <b>{{c1::postmenopausal::pre- or post-menopausal}}</b> uterine bleeding</div>", "time": null}, {"id": 1463172379407, "note": "<div><b>Endometrial hyperplasia</b> is classified histologically based on&nbsp;<b>{{c1::architectural growth pattern}}</b> (simple or complex) and the presence or absence of <b>{{c1::cellular atypia}}</b></div>", "time": null}, {"id": 1463172386929, "note": "<div>The <u>most important</u> <b>predictor</b> for <b>endometrial hyperplasia</b> progression to <b>carcinoma</b> is {{c1::cellular atypia}}</div>", "time": null}, {"id": 1463172390498, "note": "<div>Which <b>architectural growth pattern</b>&nbsp;of <b>endometrial hyperplasia </b>has higher risk of progression to <b>carcinoma</b>?</div><div><br></div><div>{{c1::Complex::simple or complex}}</div>", "time": null}, {"id": 1463172394153, "note": "<div><b>Endometrial hyperplasia</b> has <u>increased risk</u> for progression to endometrial {{c1::carcinoma}}</div>", "time": null}, {"id": 1463172398226, "note": "<div>What is the <u>most common</u> <b>invasive (malignant) carcinoma</b> of the <b>female</b> <b>genital tract</b>? </div><div><br></div><div>{{c1::Endometrial carcinoma}}</div>", "time": null}, {"id": 1463172401877, "note": "<div>In the <b>{{c1::hyperplasia}} pathway</b> (75%) of <b>endometrial carcinoma</b>, the carcinoma arises from {{c2::endometrial hyperplasia}}</div>", "time": null}, {"id": 1463172406630, "note": "<div>In the <b>{{c1::sporadic}} pathway</b> (25%) of <b>endometrial carcinoma</b>, the carcinoma arises in an atrophic endometrium with no precursor lesion</div>", "time": 1660105356604.0}, {"id": 1463172415056, "note": "<div><b>{{c1::Endometrial carcinoma}}</b> is a <b>malignant</b> proliferation of endometrial glands</div>", "time": null}, {"id": 1463172439331, "note": "<div><b>Endometrial carcinoma</b> often presents as <b>{{c1::post}}-menopausal</b> bleeding</div>", "time": null}, {"id": 1463172445552, "note": "<div><b>Endometrial carcinoma </b>arises via <u>two</u> distinct pathways: {{c1::hyperplasia}} and {{c1::sporadic}}</div>", "time": null}, {"id": 1463172460286, "note": "<div><b>Endometrial carcinoma</b> from the <b>{{c2::hyperplasia}}</b> pathway has a(n) {{c1::<b>endometrioid</b>}} histology </div>", "time": 1660105359569.0}, {"id": 1463172476562, "note": "<div><div><b>Endometrial carcinoma</b> from the <b>{{c2::sporadic}}</b> pathway has a(n) {{c1::<b>serous, papillary</b>}} histology </div></div>", "time": 1660105359567.0}, {"id": 1463172499947, "note": "<div>The average age of presentation of <b>endometrial carcinoma</b> from the <b>hyperplasia</b> pathway is {{c1::60}} years old</div>", "time": 1660105350427.0}, {"id": 1463172503888, "note": "<div>The average age of presentation for <b>endometrial carcinoma</b> from the <b>sporadic</b> pathway is {{c1::70}} years old</div>", "time": 1660105350429.0}, {"id": 1463172506951, "note": "<div>What mutation is common in <b>endometrial carcinoma</b> from the <b>sporadic</b> pathway?</div><div><br></div><div>{{c1::p53 mutations}}</div>", "time": 1660105345129.0}, {"id": 1463172510273, "note": "<div>What is a possible histological finding of <b>serous</b>, <b>papillary</b> <b>endometrial carcinoma</b> (sporadic pathway)? </div><div><br></div><div>{{c1::Psammoma bodies (concentric spherules with <u>dystrophic calcification</u>)}} </div>", "time": 1660105346899.0}, {"id": 1463172517382, "note": "<div>Risk factors of <b>endometrial carcinoma</b> from the <b>hyperplasia</b> pathway are related to <b>{{c1::estrogen}}</b> <b>exposure</b></div>", "time": 1660105353253.0}, {"id": 1463172529545, "note": "<div>Which <i>autosomal dominant</i> syndrome is associated with <u>increased</u> risk for <b>colon</b>, <b>ovarian</b>, and <b>endometrial carcinoma</b>? </div><div><br></div><div>{{c1::Lynch syndrome (HNPCC)}}</div>", "time": null}, {"id": 1463172533352, "note": "<div>What is the <u>most common</u> <b>tumor</b> in <b>females</b>?</div><div><br></div><div>{{c1::Leiomyoma (fibroid)}}</div>", "time": null}, {"id": 1463172536516, "note": "<div>What demographic has <u>increased</u> incidence of <b>leiomyoma</b> (fibroid)? </div><div><br></div><div>{{c1::African Americans (peak occurrence 20-40 years old)}}</div>", "time": null}, {"id": 1463172540111, "note": "<div>{{c1::<b>Leiomyoma (uterine </b><b>fibroid)</b>}} is a <b>benign</b> neoplastic proliferation of <b>smooth</b> <b>muscle</b> arising from <b>myometrium</b></div>", "time": null}, {"id": 1463172544045, "note": "<div><b>Leiomyoma</b> (fibroid) is related to {{c1::estrogen}} exposure</div>", "time": null}, {"id": 1463172547912, "note": "<div><b>Leiomyomas</b> (fibroids) <u>increase</u> with {{c1::pregnancy}} (increased estrogen) and <u>decrease</u> with {{c1::menopause}} (decreased estrogen)</div>", "time": null}, {"id": 1463172572838, "note": "<div>Gross examination of {{c1::<b>leiomyoma</b> (fibroid)}} shows <b>multiple</b>, <b>well-defined</b>, <b>white</b>, <b>whorled</b> <b>masses</b> that may distort the uterus and impinge on pelvic structures</div>", "time": null}, {"id": 1463172594564, "note": "<div>The histology image shows a <b>whorled pattern </b>of <b>smooth muscle bundles</b> with well-dermarcated borders, which is characteristic of <b>{{c1::leiomyoma (fibroid)}}</b></div><div><b><br></b></div><div><img src=\"paste-55435142889809.jpg\"></div>", "time": null}, {"id": 1463172598605, "note": "<div>What is the <u>most common</u> symptom of <b>leiomyoma</b> (fibroids)?</div><div><br></div><div>{{c1::Nothing (asymptomatic)&gt;Heavy menstrual bleeding (when symptomatic)}}</div>", "time": 1660105345809.0}, {"id": 1463172608516, "note": "<div>Severe bleeding from <b>leiomyoma </b>(fibroid) may lead to {{c1::iron deficiency anemia}}</div>", "time": null}, {"id": 1463172618384, "note": "<div><b>{{c1::Leiomyosarcoma}}</b> is a <b>malignant</b> proliferation of <b>smooth</b> <b>muscle</b> arising from the <b>myometrium</b> </div>", "time": null}, {"id": 1463172633135, "note": "<div>What is the precursor lesion for <b>leiomyosarcoma</b>?</div><div><br /></div><div>{{c1::None -- arises <u>de novo</u>; leiomyosarcomas do not arise from leiomyomas***}}</div>", "time": 1660105345624.0}, {"id": 1463172638754, "note": "<div>Gross exam of <b>{{c1::leiomyosarcoma}}</b> often shows a uterus with a <b>single</b> <b>lesion</b> with areas of <b>necrosis</b> and <b>hemorrhage</b></div>", "time": 1660105358527.0}, {"id": 1463174905508, "note": "<div>An <b>ovarian</b> <b>follicle</b> consists of an <b>oocyte</b> surrounded by {{c1::granulosa}} and {{c1::theca}} cells</div>", "time": 1660105361800.0}, {"id": 1463176730505, "note": "<div><b>Hemorrhage</b> into a <b>corpus luteum</b> can result in a(n)&nbsp;<b>{{c1::hemorrhagic corpus luteal cyst}}</b>, especially during early pregnancy</div>", "time": 1660105358366.0}, {"id": 1463176746263, "note": "<div><b>Degeneration</b> of <b>ovarian follicles</b> may result in <b>follicular </b><b>{{c1::cysts}}</b></div>", "time": 1660105360152.0}, {"id": 1463176758271, "note": "<div>{{c1::<b>Polycystic ovarian syndrome </b>(<b>Stein-Leventhal syndrome</b>)::fancy name}} is <b>multiple follicular cysts</b> in the ovary and anovulation due to <b>hormone imbalance</b> </div>", "time": 1660105339251.0}, {"id": 1463176773349, "note": "<div><b>Polycystic ovarian syndrome</b> is characterized by <u>{{c1::high</u>::high/low}} LH and <u>{{c1::low</u>::high/low<u>}}</u> FSH</div>", "time": null}, {"id": 1463176777704, "note": "<div><b>Polycystic ovarian syndrome</b> often has a <b>LH:FSH</b> <b>ratio</b> {{c1::<u>&gt;</u>2}}</div>", "time": 1660105353808.0}, {"id": 1463176780906, "note": "<div>In <b>polycystic ovarian syndrome</b>, <u>increased</u> <b>{{c1::LH}}</b> production causes excess <b>{{c2::androgen}}</b> production (from theca cells), resulting in <b>{{c3::hirsutism}}</b></div>", "time": 1660105356969.0}, {"id": 1463176783939, "note": "<div>In <b>polycystic ovarian syndrome</b>, excess androgen (from theca cells) is converted to <b>{{c1::estrone}}</b> in <b>{{c2::adipose}}</b> <b>tissue</b>, which <u>inhibits</u> <b>{{c3::FSH}}</b> <b>secretion</b> from anterior pituitary</div>", "time": 1660105356972.0}, {"id": 1463176787073, "note": "<div>What demographic is most commonly affected by <b>polycystic ovarian syndrome (Stein-Leventhal syndrome)</b>? </div><div><br></div><div>{{c1::Obese, young women}}</div>", "time": 1660105347325.0}, {"id": 1463176789917, "note": "<div><b>Polycystic ovarian syndrome</b> is a condition characterized by at least 2/3 of the following criteria:</div><div><br></div><div>- clinical signs of {{c1::hyperandrogenism}}</div><div>- {{c3::irregular periods (typically oligomenorrhea)::menstrual finding}}</div><div>- {{c2::polycystic ovaries}} on ultrasound</div>", "time": null}, {"id": 1463176792455, "note": "<div><b>Polycystic ovarian syndrome</b> is associated with <b>{{c1::insulin resistance}}</b>, which may cause <b>{{c1::type II diabetes mellitus}}</b> 10-15 years later</div>", "time": 1660105353809.0}, {"id": 1463176795022, "note": "<div>Patients with <b>polycystic ovarian syndrome</b> have increased risk of <b>{{c1::endometrial}} carcinoma</b>, secondary to <u>unopposed</u> effects of estrogen</div>", "time": 1660105354181.0}, {"id": 1463176802048, "note": "<div><b>{{c1::Polycystic ovarian syndrome}}</b> presents with <b>enlarged, bilateral cystic ovaries</b></div><div><b><br /></b></div><div><b><i><img src=\"paste-61345017889003.jpg\" /></i></b></div>", "time": null}, {"id": 1463176881592, "note": "<b>{{c1::Follicular}} cyst</b> is the <u>most common</u> <b>ovarian <u>mass</u></b> in young women ", "time": null}, {"id": 1463177010540, "note": "<div>A(n)&nbsp;<b>{{c1::follicular}} cyst</b> is a distention of an <b>unruptured graafian follicle</b></div>", "time": null}, {"id": 1463178466775, "note": "<b>Ovarian tumors</b> may arise from <u>three</u> different cell types:<br><br><div> 1. {{c1::surface epithelium}}</div><div> 2. {{c1::germ cells}} (e.g. oocyte) </div><div> 3. {{c1::sex cord stromal tissue}} (e.g. granulosa &amp; theca cells) </div>", "time": null}, {"id": 1463187644766, "note": "<div><div><b>{{c1::Surface epithelial}} tumor</b> is the <u>most common</u> <i>class</i> of ovarian tumor (70%) </div></div>", "time": null}, {"id": 1463187654764, "note": "<div><div><b>Surface epithelial tumors</b> of the ovary are derived from the <b>{{c1::coelomic}}</b> <b>epithelium</b> that lines the ovary (embryologically) </div></div>", "time": null}, {"id": 1463187666186, "note": "<div><div>The two <u>most common</u> subtypes of ovarian <b>surface epithelial tumors</b> are <b>{{c1::serous}}</b> and <b>{{c1::mucinous}}</b>; both usually cystic</div></div>", "time": null}, {"id": 1463187677022, "note": "<div><div><b>Ovarian {{c1::cystadenoma}}</b> is a <b>benign </b>tumor<b> </b>composed of a single cyst with a <b>simple, flat lining</b> of epithelial cells</div></div>", "time": 1660105354462.0}, {"id": 1463187698743, "note": "<div><div><b>Ovarian cystadenomas</b> (surface epithelial tumors) most commonly arise in women aged {{c1::30-40}} years old </div></div>", "time": 1660105354469.0}, {"id": 1463187709198, "note": "<div><div>What is the <u>most common</u> <b><i>benign</i> ovarian tumor</b>? </div><div><br /></div><div>{{c1::Serous cystadenoma}}</div></div>", "time": null}, {"id": 1463187720272, "note": "<div><div><b>{{c1::Serous}}</b> <b>cystadenoma</b> is a <b>benign</b> tumor lined with <b>fallopian tube-like epithelium</b>; often bilateral</div></div>", "time": null}, {"id": 1463187726002, "note": "<div><div>Ovarian <b>{{c1::mucinous}}</b> <b>cystadenoma</b> is a large, multiloculated <b>benign</b> tumor lined by <b>mucus-secreting epithelium</b> </div></div><div><br /></div><div><img src=\"paste-64342905061715.jpg\" /></div>", "time": 1660105354461.0}, {"id": 1463187736885, "note": "<div><div><b>Ovarian {{c1::cystadenocarcinoma}}</b> is a <b>malignant </b>tumor<b> </b>composed of complex <b>cysts</b> with a <b>shaggy lining</b> of epithelium and <i>invasion</i> into the connective tissue </div></div>", "time": 1660105354463.0}, {"id": 1463187744728, "note": "<div><div><b>Ovarian adenocarcinomas</b> (surface epithelial tumor) most commonly arise in women aged {{c1::60-70}} years old </div></div>", "time": 1660105354472.0}, {"id": 1463187754886, "note": "<div><div><b>{{c1::Borderline}} tumors </b>have features <i>in between </i>benign and malignant</div></div>", "time": 1660105341002.0}, {"id": 1463187760102, "note": "<div><div><b>Borderline tumors</b> have {{c1::better}} <b>prognosis</b> than clearly malignant tumors, but still carry {{c1::metastatic}} potential</div></div>", "time": 1660105361169.0}, {"id": 1463187763929, "note": "<div><div><b><i>{{c1::BRCA1}}</i> mutation carriers</b> have increased risk for <b>{{c2::serous}}</b> <b>adenocarcinoma</b> of the <b>{{c3::ovary}}</b> and {{c3::<b>fallopian</b> <b>tube</b>}}</div></div>", "time": null}, {"id": 1463187773649, "note": "<div><div><div>What is the <u>most common</u> <b><i>malignant</i> ovarian neoplasm</b>? </div><div><br /></div><div>{{c1::Serous cystadenocarcinoma}}</div></div></div>", "time": null}, {"id": 1463187806662, "note": "<div><div><b>{{c1::Mucinous}} cystadenocarcinoma</b> may present with <b>{{c2::pseudomyxoma peritonei}}</b>, which is an intraperitoneal accumulation of {{c1::mucinous}} material, usually from a <u>GI</u><i>, </i><u>ovarian</u>, <u>appendiceal</u> tumor</div></div>", "time": null}, {"id": 1463187812239, "note": "<div><div>One type of a <i>rare</i> ovarian surface epithelial tumor is a(n)&nbsp;<b>{{c1::endometrioid}} tumor</b>, which is composed of endometrial-like glands and is usually malignant </div></div>", "time": 1660105354580.0}, {"id": 1463187820455, "note": "<div><div>{{c1::15}}% of ovarian <b>endometrioid tumors</b> are associated with an <u>independent</u> endometrial carcinoma </div></div>", "time": null}, {"id": 1463187827285, "note": "<div><div>One type of a <i>rare</i> ovarian surface epithelial tumor is a(n)&nbsp;<b>{{c1::Brenner}} tumor</b>, which is composed of bladder-like epithelium (<b>{{c2::urothelium}}</b>)</div></div>", "time": null}, {"id": 1463187832044, "note": "<div><div><b>Brenner tumors</b> are solid, encapsulated tumors with a yellow-tan appearance; they have \"{{c1::Coffee bean}}\" nuclei on H&amp;E stain</div></div>", "time": null}, {"id": 1463187844705, "note": "<div><div>Ovarian <b>surface epithelial</b> <b>tumors</b> typically present <b>{{c1::late}}</b> and therefore have <b>{{c1::poor}}</b> prognosis</div></div>", "time": 1660105354466.0}, {"id": 1463187881126, "note": "<div><div>Ovarian <b>surface epithelial</b> <b>tumors</b> typically present with <b>vague</b> {{c1::abdominal}} symptoms (e.g. pain, fullness) and signs of {{c1::compression}} (e.g. urinary frequency)</div></div>", "time": 1660105354467.0}, {"id": 1463187887033, "note": "<div><div>What serum tumor marker is useful for monitoring <b>treatment response</b> and <b>recurrence</b> of <b>ovarian neoplasms</b>? </div><div><b><br /></b></div><div>{{c1::CA-125}}</div></div>", "time": null}, {"id": 1463187894899, "note": "<div><div><b>{{c1::Germ cell}} tumors</b> are the <u>second most common</u> <i>class</i> of <b>ovarian</b> tumor (15%)</div></div>", "time": 1660105340275.0}, {"id": 1463187899305, "note": "<div>What demographic is most commonly affected by <b>ovarian germ cell tumors</b>? </div><div><br></div><div>{{c1::Women of reproductive age (15-30 years old)::age}}</div>", "time": 1660105347353.0}, {"id": 1463187910218, "note": "<div><b>{{c1::Cystic teratoma}}</b> is a <b>cystic tumor</b> composed of <b>fetal tissue</b> derived from two or three embryologic layers (e.g. hair, teeth, bone, skin, gut, thyroid, etc) </div>", "time": null}, {"id": 1463187920919, "note": "<div>What is the <u>most common</u> <b>germ cell tumor</b> in <b>females</b>?</div><div><br></div><div>{{c1::Cystic teratoma}}</div>", "time": 1660105345885.0}, {"id": 1463187929584, "note": "<div>What is the <b>malignant potential</b> of a <u>mature</u> <b>cystic teratoma</b> in <u>females</u>? </div><div><br></div><div>{{c1::Benign}} </div>", "time": null}, {"id": 1463187934796, "note": "<div>What is the <b>malignant potential </b>of an <u>immature</u> <b>cystic teratoma</b>?</div><div><br></div><div>{{c1::Malignancy possible}}</div>", "time": null}, {"id": 1463187938130, "note": "<div>What type of <b>fetal tissue</b> is most commonly seen in an <b>immature teratoma</b>? </div><div><br></div><div>{{c1::Neuroectoderm}}</div>", "time": null}, {"id": 1463187941201, "note": "<div>In addition to <u>immature</u> tissue, <b>cystic teratomas</b> may become malignant via <b>{{c1::somatic}} malignancy</b> </div>", "time": 1660105357523.0}, {"id": 1463187950548, "note": "<div>What is the most common <b>somatic malignancy</b> stemming from a <b>cystic teratoma</b>? </div><div><br></div><div>{{c1::Squamous cell carcinoma of skin}} </div>", "time": null}, {"id": 1463187954433, "note": "<div><b>{{c1::Struma ovarii}} </b>is a <b>cystic</b> <b>teratoma</b> composed primarily of <b>{{c2::thyroid}}</b> <b>tissue</b> and thus may cause <b>{{c2::hyperthyroidism}}</b></div>", "time": null}, {"id": 1463187961223, "note": "<div>What is the most common <i><b>malignant</b></i> <b><u>germ cell</u></b> <b>tumor</b> in females? </div><div><br /></div><div>{{c1::Dysgerminoma}} </div>", "time": 1660105345854.0}, {"id": 1463187968614, "note": "<div>A(n)&nbsp;<b>{{c2::dysgerminoma}}</b> is an <b>ovarian germ cell tumor</b> composed of large cells with clear cytoplasm and central nuclei; described as<b> \"{{c1::fried egg}}\" cells</b></div><div><img src=\"paste-65639985185364.jpg\"></div>", "time": null}, {"id": 1463188002544, "note": "<div><b>Dysgerminoma</b> is equivalent to its male testicular counterpart, termed a(n)&nbsp;<b>{{c1::seminoma}}</b></div>", "time": null}, {"id": 1463188008567, "note": "<div><b>Dysgerminoma </b>has a(n) {{c1::good}} prognosis</div>", "time": 1660105359668.0}, {"id": 1463188017836, "note": "<div>What serum markers may be elevated in <b>dysgerminoma</b>? </div><div><br></div><div>{{c1::LDH and hCG::2}}</div>", "time": null}, {"id": 1463188027127, "note": "<div>What demographic is most commonly associated with <b>dysgerminoma</b>? </div><div><br></div><div>{{c1::Adolescent females}}</div>", "time": null}, {"id": 1463188032640, "note": "<div>What is the <u>most common</u> <b>germ cell tumor</b> in <b>children</b> (esp. male infants)? </div><div><br></div><div>{{c1::Endodermal sinus (yolk sac) tumor}}</div>", "time": null}, {"id": 1463188061833, "note": "<div><b>{{c1::Endodermal sinus (yolk sac)}} tumor</b> is a malignant tumor that mimics the <b>yolk sac</b></div>", "time": null}, {"id": 1463188066226, "note": "<div>What serum marker is characteristically <u>elevated</u> in <b>endodermal sinus (yolk sac) tumor</b>? </div><div><br></div><div>{{c1::Alpha-fetoprotein (AFP)}}</div>", "time": null}, {"id": 1463188070821, "note": "<div><b>Endodermal sinus tumors</b> are characterized by what histological finding (50%)?</div><div><br /></div><div>{{c1::Schiller-Duval bodies (<b>glomeruloid-like structures</b>)}}</div>", "time": null}, {"id": 1463188084024, "note": "<div><b>{{c1::Choriocarcinoma}}</b> is a <i>malignant</i> germ cell tumor composed of mononuclear {{c2::<b>cytotrophoblasts</b>}} and multinuclear {{c2::<b>syncytiotrophoblasts</b>}}, but with <b>absent</b> {{c3::<b>villi</b>}}</div>", "time": 1660105340831.0}, {"id": 1463188088647, "note": "<div><b>Choriocarcinoma</b> is a small, hemorrhagic tumor with <u>early</u>, diffuse {{c1::hematogenous}} spread, especially to the {{c1::lungs}}</div>", "time": null}, {"id": 1463188095823, "note": "<div>What serum marker is characteristically elevated in <b>choriocarcinoma</b>?</div><div><br /></div><div>{{c1::hCG (produced by syncytiotrophoblasts)}} </div>", "time": null}, {"id": 1463188103442, "note": "<div><b>Choriocarcinoma</b> is associated with which <i>type</i> of <b>ovarian</b> <b>cyst</b>?</div><div><br></div><div>{{c1::Theca-lutein cyst}}</div>", "time": null}, {"id": 1463188119098, "note": "<div><b>{{c1::Embryonal}} carcinoma</b> is a <i>malignant</i> germ cell tumor of the ovary or testis composed of <b>large</b> <b>primitive</b> <b>cells</b></div>", "time": null}, {"id": 1463188127235, "note": "<div>What is the <u>most common</u> <i>malignant</i> ovarian <b>sex cord stromal tumor</b>? </div><div><br></div><div>{{c1::Granulosa cell tumor}}</div>", "time": null}, {"id": 1463188130876, "note": "<div><b>{{c1::Granulosa}} cell tumor</b> is an <b>ovarian</b> <b>sex</b> <b>cord</b> <b>stromal tumor </b>that often produces <b>{{c2::estrogen}}</b> and <b>{{c2::inhibin}}</b> </div>", "time": null}, {"id": 1463188165692, "note": "<div><b>Granulosa cell tumor</b> predominantly affects women in their {{c1::50s::age}}&nbsp;</div>", "time": null}, {"id": 1463188169675, "note": "<div>Histologically, <b>{{c2::granulosa}} cell tumors</b> are characterized by <b>{{c1::Call-Exner}} bodies</b>, which are {{c2::granulosa}} cells arranged in follicle / rosette-like collections around <u>eosinophilic fluid</u>, resembling primordial follicles</div><div><br/></div><div><img src=\"paste-67692979552762.jpg\"/></div>", "time": null}, {"id": 1463188185291, "note": "<div><b>{{c1::Thecoma}}</b> is a <b>sex cord stromal tumor</b> that, similarly to granulosa cell tumors, may produce estrogen</div>", "time": null}, {"id": 1463188216971, "note": "<div><b>Sertoli-Leydig cell tumor</b> is a rare <u>ovarian</u> sex cord-stromal cell tumor that may produce androgens, thus causing {{c1::hirsutism/virilization}} in <b>women</b> </div>", "time": null}, {"id": 1463188227727, "note": "<div><b>{{c1::Fibromas}}</b> are <i>benign</i> sex cord stromal tumors of <b>fibroblasts</b> (bundles of spindle-shaped cells)</div>", "time": null}, {"id": 1463188237072, "note": "<div><b>{{c1::Meigs}} syndrome</b> is a triad of {{c2::ovarian fibroma}}, {{c2::ascites}}, and {{c2::hydrothorax (pleural effusion)}}</div>", "time": null}, {"id": 1463188240255, "note": "<div><b>{{c1::Fibroma}}</b> is an ovarian sex cord stromal tumor that may present with a <b>\"pulling\" sensation in the groin</b></div>", "time": 1660105340358.0}, {"id": 1463188251805, "note": "<div><b>Primary</b> <b>mucinous</b> <b>tumors</b> of the <b>ovary</b> (e.g. surface epithelial tumor) are usually {{c1::unilateral::unilateral/bilateral}}, where as <b>Krukenberg tumors</b> are usually {{c1::bilateral}}</div>", "time": 1660105353689.0}, {"id": 1463188255248, "note": "<div><b>{{c1::Pseudomyxoma peritonei}}</b> is massive amounts of mucus in the peritoneum</div>", "time": 1660105339139.0}, {"id": 1463191075841, "note": "<div>Which <b>ovarian neoplasm</b> is characterized histologically by <b>Schiller-Duval bodies</b> (glomeruloid-like structures)?</div><div><br></div><div>{{c1::Endodermal sinus (yolk sac) tumor}}</div><div><br></div><div><img src=\"paste-65670049956435.jpg\" class=\"resizer\"></div>", "time": null}, {"id": 1463279445274, "note": "<div>What is the <u>most common</u> site for an <b>ectopic pregnancy</b>?  (specific)</div><div><br></div><div>{{c1::Ampulla of the fallopian tube}}</div>", "time": null}, {"id": 1463279616645, "note": "<div><b>Ectopic pregnancy</b> is often clinically mistaken for {{c1::appendicitis}}</div>", "time": null}, {"id": 1463279622440, "note": "<b>{{c1::Ectopic pregnancy}} </b>is the implantation of a fertilized ovum at a site other than uterine wall<div><br /><div><img src=\"paste-112266150150542.jpg\" /></div></div>", "time": null}, {"id": 1463279630622, "note": "<div><div>The key risk factor for <b>ectopic pregnancy</b> is {{c1::tubal scarring}}</div></div>", "time": 1660105349954.0}, {"id": 1463279639694, "note": "<div><div>The classic presentation of <b>ectopic pregnancy</b> is {{c1::lower quadrant abdominal}} pain weeks after a missed period (<b>amenorrhea</b>)</div></div>", "time": 1660105350297.0}, {"id": 1463279646698, "note": "<div><b>Ectopic pregnancy</b> may present with a(n)&nbsp;<b>{{c2::lower}} than expected</b> rise in the hormone {{c1::<b>hCG</b>}} based on dates</div>", "time": null}, {"id": 1463279658641, "note": "<div><div><u>Major</u> complications of <b>ectopic pregnancy</b> are {{c1::hematosalpinx (bleeding into the fallopian tube)}} and/or {{c1::rupture}} </div></div>", "time": null}, {"id": 1463279666723, "note": "<div><div><b>Spontaneous abortion</b> is the <i>miscarriage</i> of a fetus before {{c1::20}} weeks gestation</div></div>", "time": null}, {"id": 1463279672655, "note": "<div><div><b>Spontaneous abortion</b> is common and occurs in up to {{c1::1/4}} of recognizable pregnancies</div></div>", "time": null}, {"id": 1463279676639, "note": "<div><div><b>{{c1::Spontaneous abortion}}</b> presents as vaginal bleeding, cramp-like pain, and <b>passage of fetal tissues</b></div></div>", "time": 1660105338891.0}, {"id": 1463279681310, "note": "<div><div><b>Spontaneous abortion</b> is most often due to {{c1::chromosomal}} anomalies, especially {{c1::trisomy 16}}</div></div>", "time": 1660105350848.0}, {"id": 1463279694569, "note": "<div><div><b>Spontaneous abortion</b> is more common in patients in a(n) {{c1::hypercoagulable}} <b>state</b>, such as those with antiphospholipid syndrome </div></div>", "time": 1660105350849.0}, {"id": 1463279705406, "note": "<div><div>What is most commonly the effect of <b>teratogens</b> during the <b>first two weeks</b> of gestation?</div><div><br></div><div>{{c1::Spontaneous abortion}}</div></div>", "time": null}, {"id": 1463279711383, "note": "<div><div><div>What is most commonly the effect of <b>teratogens</b> during the <b>weeks 3-8</b> of gestation?</div><div><br></div></div><div>{{c1::Organ <i>malformation</i>}}</div></div>", "time": null}, {"id": 1463279718206, "note": "<div><div><div><div>What is most commonly the effect of <b>teratogens</b> <b>after week 8 </b>of gestation?</div></div><div><br></div><div>{{c1::Organ <i>hypoplasia</i>}}</div></div></div>", "time": null}, {"id": 1463279724957, "note": "<div><div><b>Placenta {{c1::previa}}</b> is attachment of the placenta to the <b>lower uterine segment </b>over (or &lt; 2 cm from) the {{c2::<b>internal cervical os</b>}}</div></div>", "time": null}, {"id": 1463279745525, "note": "<div><div><b>Placenta previa</b> presents with <i><b>painless</b></i> {{c1::third}} trimester {{c2::bleeding}}</div></div>", "time": null}, {"id": 1463279752475, "note": "<div>Risk factors for <b>placenta previa</b> include {{c1::multiparity}} and prior {{c1::C-section}}</div>", "time": 1660105353256.0}, {"id": 1463279757292, "note": "<div><div><b>Placental {{c1::abruption}}</b> is the premature <b>separation</b> of the placenta from the uterine wall (decidua) prior to delivery of fetus</div></div>", "time": 1660105353893.0}, {"id": 1463279770692, "note": "<div><div><b>Placental abruption</b> may cause <u>fetal distress</u> and thus a(n) {{c1::still birth}}</div></div>", "time": null}, {"id": 1463279774717, "note": "<div><div><b>Placental abruption</b> typically presents with abrupt, <i><b>{{c3::painful}}</b> </i>{{c2::third}} trimester {{c1::bleeding}}</div></div>", "time": null}, {"id": 1463279790203, "note": "<div><div><b>Placenta {{c1::accreta}}</b> is the abnormal <b><i>attachment</i></b> of the placenta to the <b>myometrium</b>, <i>without </i>penetrating it</div></div>", "time": null}, {"id": 1463279800156, "note": "<div><div><b>Placenta</b> <b>{{c1::increta}}</b> is the abnormal <b>penetration</b> of the placenta <i>into</i> the <b>myometrium</b> </div></div>", "time": null}, {"id": 1463279816657, "note": "<div><div><b>Placenta {{c1::percreta}}</b> is the abnormal <b>penetration</b> of the placenta <i>through</i> the <b>myometrium</b> and into the uterine serosa</div></div>", "time": null}, {"id": 1463279826371, "note": "<div><div><b>Placenta accreta</b> (or increta/percreta) presents with <b>no separation</b> of the placenta after delivery and {{c1::heavy post-partum bleeding}}</div></div>", "time": null}, {"id": 1463279835082, "note": "<div><div><b>Placenta accreta</b> often requires {{c1::hysterectomy}} after delivery due to attachment of the placenta to the uterus</div></div>", "time": 1660105353897.0}, {"id": 1463279839010, "note": "<div><div><b>{{c1::Gestational&nbsp;hypertension}}</b> is a blood pressure &gt;140/90 mmHg <b><i>after</i></b> <b>the</b> <b>20th week of gestation</b> with <b>no</b> proteinuria, pre-existing hypertension, nor end-organ damage </div></div>", "time": null}, {"id": 1463279861371, "note": "<div><div><b>{{c1::Preeclampsia}}</b> is pregnancy-induced {{c2::hypertension}} <b>with</b> {{c3::proteinuria}} or {{c3::end-organ dysfunction}} <i>after</i> 20th week of gestation </div></div>", "time": null}, {"id": 1463279871354, "note": "<div><div><b>Preeclampsia</b> typically presents {{c1::after}} the 20th week of gestation</div></div>", "time": null}, {"id": 1463279881373, "note": "<div><div><b>Preeclampsia</b> is caused by abnormal placental {{c1::spiral}} arteries, causing endothelial dysfunction, vasoconstriction, and ischemia </div></div>", "time": null}, {"id": 1463279885403, "note": "<div><div>There is an <u>increased incidence</u> of <b>preeclampsia</b> in patients with pre-existing {{c1::hypertension}}, diabetes, chronic renal disease, and autoimmune disorders</div></div>", "time": null}, {"id": 1463279890224, "note": "<div><div><b>{{c1::Eclampsia}}</b> is defined as <b>preeclampsia</b> with <b>{{c2::seizures}}</b></div></div>", "time": null}, {"id": 1463279901977, "note": "<div><div><b>{{c2::HELLP}}</b> <b>syndrome</b> is a manifestation of severe <b>{{c1::preeclampsia}} </b>that presents with {{c3::hemolysis}}, {{c3::elevated liver enzymes}}, and {{c3::low platelets}} </div></div>", "time": null}, {"id": 1463279905770, "note": "<div><div>What finding on <b>blood smear</b> is characteristic of <b>HELLP syndrome</b>?</div><div><br></div><div>{{c1::Schistocytes (due to thrombotic microangiopathy)}}</div></div>", "time": null}, {"id": 1463279909190, "note": "<div><div><b>HELLP syndrome</b> can lead to hepatic subcapsular {{c1::hematomas}}, which may <u>rupture</u> leading to severe <b>hypotension</b></div></div>", "time": null}, {"id": 1463279912679, "note": "<div><div><b>Eclampsia</b> and <b>HELLP syndrome</b> both warrant immediate {{c1::delivery of the baby}}</div></div>", "time": 1660105359635.0}, {"id": 1463279918927, "note": "<div><b>{{c1::Sudden Infant Death Syndrome}}</b> is the death of a healthy infant (<b>1 month to 1 year old</b>) without obvious cause</div>", "time": 1660105338801.0}, {"id": 1463279926558, "note": "<div>Risk factors of <b>sudden infant death syndrome </b>include sleeping on the {{c1::stomach}}, exposure to {{c1::cigarette smoke}}, and prematurity</div>", "time": 1660105353252.0}, {"id": 1463279930319, "note": "<div><b>{{c2::Hydatidiform mole}}</b> is an abnormal conception characterized by swollen and <b>edematous </b>chorionic <b>{{c1::villi}}</b> with proliferation of <b>{{c1::trophoblasts <i>only</i>}}</b> </div>", "time": 1660105337878.0}, {"id": 1463279938999, "note": "<div><b>Hydatidiform mole</b> presents with <b>uterine</b> {{c1::enlargement}} more than expected for the date of gestation </div>", "time": null}, {"id": 1463279946159, "note": "<div><b>Hydatidiform mole</b> presents with {{c1::higher}} levels of <b>hCG</b> than expected for the date of gestation</div>", "time": null}, {"id": 1463279956478, "note": "<div>In areas with <u>no prenatal care</u>, a <b>hydatidiform mole</b> presents in the 2nd trimester with {{c1::passage of <b>grape-like masses</b> (large, edematous villi) through the vaginal canal}}</div>", "time": 1660105357442.0}, {"id": 1463279967084, "note": "<div>In areas <u>with prenatal care</u>, <b>hydatidiform mole</b> is diagnosed by routine {{c1::ultrasound}} early in the first trimester</div>", "time": 1660105357441.0}, {"id": 1463279978747, "note": "<div>A <b>hydatidiform mole</b> may be detected via the absence of <b>fetal {{c1::heart}} sounds</b></div>", "time": 1660105362539.0}, {"id": 1463279979722, "note": "<div><b>Hydatidiform mole</b> presents with a {{c1::snow-storm}} appearance on ultrasound </div>", "time": null}, {"id": 1463279988164, "note": "<div>A(n)&nbsp;<b>{{c1::complete}} hydatidiform mole</b> is characterized by <b>{{c2::46}} chromosomes</b></div>", "time": null}, {"id": 1463279995059, "note": "<div>A(n)&nbsp;<b>{{c1::partial}} hydatidiform mole</b> is characterized by <b>{{c2::69}} chromosomes</b></div>", "time": null}, {"id": 1463280001660, "note": "<div>A(n)&nbsp;<b>{{c1::partial}} hydatidiform mole</b> most commonly consists of {{c2::2}} <b>sperm</b> with {{c2::1}} <b>egg</b></div>", "time": null}, {"id": 1463280009357, "note": "<div>A(n)&nbsp;<b>{{c1::complete}} hydatidiform mole</b> most commonly consists of {{c2::1}} <b>sperm</b> that {{c2::duplicates}} within a(n) {{c2::<u>enucleated</u>}} <b>egg</b> (85%, karyotype <b>46, XX</b>)</div>", "time": null}, {"id": 1463280027026, "note": "<div>A(n)&nbsp;<b>{{c1::partial}} hydatidiform mole</b> <i>contains</i> fetal tissue</div>", "time": null}, {"id": 1463280032221, "note": "<div>A(n)&nbsp;<b>{{c1::complete}} hydatidiform mole</b> <i>does not contain</i> fetal tissue</div>", "time": null}, {"id": 1463280035157, "note": "<div>A(n)&nbsp;<b>{{c1::complete}} hydatidiform mole</b> is more commonly associated with <u>increased</u> uterine size</div>", "time": null}, {"id": 1463280038717, "note": "<div>A(n)&nbsp;<b>{{c1::complete}} hydatidiform mole</b> is associated with <u style=\"font-weight: bold; \">{{c2::very}} </u><u>increased</u> levels of <b>hCG</b></div>", "time": null}, {"id": 1463280041950, "note": "<div>A(n)&nbsp;<b>{{c1::partial}} hydatidiform mole</b> is associated with <u style=\"font-weight: bold; \">{{c2::mildly}} </u><u>increased</u> levels of <b>hCG</b></div>", "time": null}, {"id": 1463280044881, "note": "<div>A(n)&nbsp;<b>{{c1::complete}} hydatidiform mole</b> is associated with <u>increased</u> risk of <b>choriocarcinoma</b> </div>", "time": null}, {"id": 1463280058681, "note": "<div>A(n)&nbsp;<b>{{c1::partial}} hydatidiform mole</b> is associated with <u>very little increased</u> risk of <b>choriocarcinoma</b></div>", "time": null}, {"id": 1463280070337, "note": "<div>In a(n)&nbsp;<b>{{c1::partial}} hydatidiform mole</b>, only <i>some</i> villi are hydropic, and there is only <u>partial</u> trophoblastic proliferation around the vili</div>", "time": 1660105357554.0}, {"id": 1463280075288, "note": "<div>In a(n)&nbsp;<b>{{c1::complete}} hydatidiform mole</b>, <i>most</i> villi are hydropic and there is <u>circumferential</u> trophoblastic proliferation around the villi</div>", "time": 1660105357555.0}, {"id": 1463280078411, "note": "<div><div>What is the <u>treatment</u> for a <b>hydatidiform mole</b>? </div></div><div><br></div><div>{{c1::Dilatation and curettage}}</div>", "time": null}, {"id": 1463280088789, "note": "<div>After a <b>hydatidiform mole</b>, patients should monitor <b>{{c1::hCG}}</b> levels to ensure adequate mole removal and to screen for development of {{c2::<b>choriocarcinoma</b>}}</div>", "time": 1660105362023.0}, {"id": 1463280093289, "note": "<div><i>Early </i><b>hypertension</b> during pregnancy (<i>before</i> 20 weeks) is associated with a(n)&nbsp;<b>{{c1::hydatidiform mole}}</b></div>", "time": null}, {"id": 1463280096234, "note": "<div>What type of <b>ovarian cyst</b> is associated with a <b>hydatidiform mole</b>? </div><div><br></div><div>{{c1::Theca-lutein cysts}}</div>", "time": null}, {"id": 1463280098824, "note": "<div><b>Choriocarcinoma</b> in <u>females</u> may arise as a complication of <b>{{c1::gestation}}</b> or as a spontaneous <b>{{c2::germ cell tumor}}</b></div>", "time": null}, {"id": 1463280101481, "note": "<div><b>Choriocarcinoma</b> that arises as a(n)&nbsp;<b>{{c1::spontaneous germ cell tumor}}</b> has a(n)&nbsp;<b>{{c2::poor}}</b> response to chemotherapy</div>", "time": 1660105360766.0}, {"id": 1463280103792, "note": "<b>Choriocarcinoma</b> that arises from <b>{{c1::gestation}}</b> has a(n)&nbsp;<b>{{c2::very good}}</b> response to chemotherapy", "time": null}, {"id": 1463280612433, "note": "What <b>chemotherapeutic drug</b> is used in the treatment of a <b>hydatidiform mole</b> if <b>hCG</b> levels remain <u>elevated</u> after D&amp;C?<div><br></div><div>{{c1::Methotrexate}}</div>", "time": null}, {"id": 1463330337199, "note": "<b>Hypospadias</b> is due to failure of {{c1::<b>urethral</b> <b>folds</b>}} to close", "time": null}, {"id": 1463331296522, "note": "<div><b>Epispadias</b> is <u>due to</u> <b>abnormal</b> <b>positioning</b> of the {{c1::genital tubercle}} in men</div>", "time": null}, {"id": 1463331315899, "note": "<div><b>Penile squamous cell carcinoma</b> is associated with a <u>lack</u> of {{c1::circumcision (foreskin can act as a nidus)}}</div>", "time": null}, {"id": 1463331318605, "note": "<div>One precursor lesion of <b>{{c1::penile SCC}}</b> is <b>{{c3::Bowen disease}}</b>, which is the in situ carcinoma of the <b>penile</b> {{c2::<b>shaft</b>}} or scrotum that presents as {{c2::<b>leukoplakia</b>}}</div>", "time": null}, {"id": 1463331321726, "note": "<div>One precursor lesion of <b>{{c1::penile SCC}}</b> is <b>{{c3::Erythroplasia of Queyrat}}</b>, which is the in situ carcinoma of the <b>{{c2::glans}}</b> of the penis that presents as&nbsp;<b>{{c2::erythroplakia}}</b></div>", "time": null}, {"id": 1463331324884, "note": "<div>One precursor lesion of <b>{{c1::penile SCC}}</b> is <b>{{c3::Bowenoid papulosis}}</b>, which is an in situ carcinoma of the penis that presents as <b>{{c2::reddish papules}}</b></div>", "time": null}, {"id": 1463331339443, "note": "<div><b>{{c1::Peyronie}} disease</b> is the <b>abnormal</b> <b>{{c2::curvature}}</b> of the <b>penis</b> due to fibrous plaque within the tunica albuginea</div>", "time": null}, {"id": 1463331360156, "note": "<div><b>Peyronie disease</b> is associated with {{c1::erectile}} dysfunction</div>", "time": 1660105353975.0}, {"id": 1463331364573, "note": "<div><b>{{c1::Ischemic priapism}}</b> is a <i>painful</i> sustained {{c2::<b>erection</b>}} lasting &gt;{{c3::4}} hours</div>", "time": 1660105339916.0}, {"id": 1463331372090, "note": "<div>What <b>blood disorder</b> is associated with <b>ischemic priapism</b>?</div><div><br /></div><div>{{c1::Sickle cell anemia (sickled RBCs get trapped in vascular channels)}}</div>", "time": null}, {"id": 1463331383138, "note": "<b>{{c1::Cryptorchidism}} </b>is the failure of the testicle to descend into the scrotal sac", "time": 1660105340676.0}, {"id": 1463334066900, "note": "<div><div>What is the <u>most common</u> congenital <b>male reproductive abnormality</b>?</div><div><br /></div><div>{{c1::Cryptorchidism}}</div></div>", "time": 1660105345896.0}, {"id": 1463334088123, "note": "<div><div>What is the effect of <b>cryptorchidism</b> on <b>fertility</b>? Why? </div><div><br></div><div>{{c1::Decreased; <u>spermatogenesis is impaired</u> due to increased temperature of testis}}</div></div>", "time": 1660105346538.0}, {"id": 1463334097647, "note": "<div><div><b>Cryptorchidism</b> <u>increases risk</u> for which<b> <i>class</i></b> of <b>testicular tumor</b>?</div><div><br></div><div>{{c1::Germ cells tumors, especially <u>seminoma</u>}}</div></div>", "time": 1660105360318.0}, {"id": 1463334101161, "note": "<div><div><div>What is the effect of <b>cryptorchidism</b> on <b>inhibin B</b> levels?</div><div><br /></div><div>{{c1::Decreased (due to decreased Sertoli cell activity)}}</div></div></div>", "time": null}, {"id": 1463334104014, "note": "<div><div><div>What is the effect of <b>cryptorchidism</b> on <b>FSH</b> levels?</div><div><br></div><div>{{c1::Increased}}</div></div></div>", "time": null}, {"id": 1463334107038, "note": "<div>What is the effect of <b><i>bilateral </i>cryptorchidism</b> on&nbsp;<b>testosterone</b> levels?</div><div><br></div><div>{{c1::Decreased}}<br></div>", "time": null}, {"id": 1463334134563, "note": "<div><div><div>What is a possible <u>viral</u> cause of <b>orchitis</b> in <b>teenage males</b>? </div><div><br></div><div>{{c1::Mumps virus}}</div></div></div>", "time": 1660105346898.0}, {"id": 1463334145617, "note": "<div><div><div><b>{{c1::Testicular torsion}}</b> occurs due to <b>twisting of the spermatic cord</b> over thin-walled veins of the scrotum </div></div></div>", "time": null}, {"id": 1463334152127, "note": "<div><div><div><b>Testicular torsion</b> causes {{c1::hemorrhagic}} infarction of the testicle</div></div></div>", "time": 1660105350558.0}, {"id": 1463334158805, "note": "<div><div><div><b>{{c2::Testicular torsion}}</b> commonly presents in <b>12-18 year olds</b> with <u>sudden</u> testicular pain, {{c3::high-riding}} testis, and <u>absent</u> {{c1::cremasteric reflex}}</div></div></div>", "time": null}, {"id": 1463334161746, "note": "<div><div><div><b>{{c1::Varicocele}}</b> is caused by <b>dilated</b> <b>veins</b> in the <b>pampiniform</b> <b>plexus</b> due to <u>increased</u> venous pressure</div></div></div>", "time": null}, {"id": 1463334164527, "note": "<div><div><div>What is the <u>most common</u> cause of <b>scrotal</b> <b>enlargement</b> in <b>adult</b> males?</div><div><br></div><div>{{c1::Varicocele}}</div></div></div>", "time": null}, {"id": 1463334171326, "note": "<div><div><div><b>{{c2::Varicocele}}</b> presents as <b>scrotal</b> <b>swelling</b> with a palpable \"{{c1::<b>bag of worms</b>}}\" while standing</div></div></div>", "time": 1660105337205.0}, {"id": 1463334174816, "note": "<div><div><div><b>Varicocele</b> most commonly occurs on the <b>{{c1::left}}</b> side of the body </div></div></div>", "time": null}, {"id": 1463334184167, "note": "<div><div><div><b>Varicocele</b> is associated with <b>left-sided</b> {{c1::renal cell}} <b>carcinoma</b> </div></div></div>", "time": null}, {"id": 1463334193640, "note": "<div><div><div>What is the effect of <b>varicocele </b>on fertility? </div><div><br /></div><div>{{c1::Decreased}}</div></div></div>", "time": null}, {"id": 1463334197478, "note": "<div><div><div>Does a <b>varicocele</b> transilluminate?</div><div><br></div><div>{{c1::No}}</div></div></div>", "time": 1660105359891.0}, {"id": 1463334201001, "note": "<div><div><div>What <u>imaging</u> technique may be used to diagnose a <b>varicocele</b>?</div><div><br /></div><div>{{c1::Ultrasound with Doppler}}</div></div></div>", "time": null}, {"id": 1463334207231, "note": "<div><div><div><b>{{c2::Hydrocele}}</b> is due to accumulation of fluid within the {{c1::<b>tunica</b> <b>vaginalis</b>}} surrounding the testis</div></div></div>", "time": null}, {"id": 1463334225957, "note": "<div><div><div><b>Congenital hydrocele (\"communicating hydrocele\") </b>occurs due to <u>incomplete obliteration</u> of the <b>{{c1::processus vaginalis}}</b> (infants)</div></div></div>", "time": null}, {"id": 1463334264578, "note": "<div><div><div>Does a <b>hydrocele</b> transilluminate?</div><div><br></div><div>{{c1::Yes}}</div></div></div>", "time": 1660105359898.0}, {"id": 1463334269994, "note": "<div>A(n)&nbsp;<b>{{c1::spermatocele}}</b> is a scrotal cyst due to a <b>dilated epididymal duct</b> or rete testis</div>", "time": null}, {"id": 1463339050251, "note": "<b>Testicular tumors</b> may arise from either {{c1::germ cells}} or {{c1::sex-cord stroma}}", "time": null}, {"id": 1463339928621, "note": "<div><b>Testicular tumors </b>present as a firm, painless testicular mass that {{c1::cannot}} be transilluminated</div>", "time": null}, {"id": 1463339955533, "note": "<div>Are <b>testicular</b> <b>tumors</b> biopsied? Why or why not?</div><div><br /></div><div>{{c1::No; increased risk of seeding the scrotum}}</div>", "time": null}, {"id": 1463339968803, "note": "<div>What is the <u>most common</u> <i>class</i> of <b>testicular tumor</b> (&gt;95%)? </div><div><br></div><div>{{c1::Germ cell tumors}}</div>", "time": 1660105345904.0}, {"id": 1463339972200, "note": "<div>What is the <u>most common</u> <b>testicular tumor</b>?</div><div><br></div><div>{{c1::Seminoma}}</div>", "time": null}, {"id": 1463339975628, "note": "<div>What age group is associated with <b>testicular germ cell tumors</b>? </div><div><br></div><div>{{c1::Men 15-40 years of age}}</div>", "time": 1660105347982.0}, {"id": 1463339978379, "note": "<div>Risk factors for <b>testicular germ cell tumor</b> include {{c1::cryptorchidism}} and {{c1::Klinefelter syndrome}}</div>", "time": null}, {"id": 1463339983674, "note": "<div>Testicular germ cell tumors that are <b>{{c2::seminomas}}</b> (55%) are <b>{{c1::very}}</b> responsive to radiotherapy, metastasize <b>{{c1::late}}</b>, and have <b>{{c1::excellent}}</b> prognosis</div>", "time": 1660105350562.0}, {"id": 1463339990695, "note": "<div><b>{{c1::Seminoma}}</b> is a <i>malignant</i> <b>testicular</b> <b>tumor</b> comprised of large cells with clear cytoplasm and central nuclei, sometimes described as a <b>\"fried egg\" appearance</b> </div><div><br></div><div><img src=\"paste-155288837554754.jpg\"></div>", "time": null}, {"id": 1463339998840, "note": "<div><b>{{c1::Seminoma}}</b> is a testicular germ cell tumor that forms a <b>homogenous</b> mass with <b>no hemorrhage or necrosis</b></div><div><b><br></b></div><div><img src=\"paste-155301722456650.jpg\"></div>", "time": 1660105338987.0}, {"id": 1463340004334, "note": "<div><div>In rare cases, <b>seminomas</b> may have elevated levels of the <u>hormone</u> {{c1::hCG}}</div></div>", "time": 1660105356924.0}, {"id": 1463340008364, "note": "<div><b>Seminomas</b> are associated with <u>increased</u> levels of <b>placental</b> {{c1::ALP}}</div>", "time": null}, {"id": 1463340056503, "note": "<div><b>{{c1::Embryonal carcinoma}}</b> is a testicular germ cell tumor that forms a <b>hemorrhagic</b> mass with <b>necrosis</b> </div><div><br></div><div><i><img src=\"paste-155482111083079.jpg\"></i></div>", "time": null}, {"id": 1463340062541, "note": "<div>What is the <u>most common</u> <b>testicular</b> <b>tumor</b> in <b>children</b> (&lt; 3 years old)?</div><div><br></div><div>{{c1::Yolk sac (endodermal sinus) tumor}}</div>", "time": null}, {"id": 1463340066021, "note": "<div><div>Which <b>testicular neoplasm</b> is characterized histologically by <b>Schiller-Duval bodies</b> (glomeruloid-like structures)?</div><div><br></div><div>{{c1::Endodermal sinus (yolk sac) tumor}}</div></div>", "time": null}, {"id": 1463340075489, "note": "<div>Elevated levels of <b>hCG</b> (e.g. <b>choriocarcinoma</b>) may cause <b>{{c1::gynecomastia}}</b> (males) or <b>{{c3::hyperthyroidism}} </b>due to homology between hCG and {{c2::TSH}}, {{c2::FSH}}, and {{c2::LH}}</div>", "time": 1660105359616.0}, {"id": 1463340099569, "note": "<div><b>Testicular germ cell tumors</b> often present as a(n) {{c1::mixed}} germ cell tumor;&nbsp;<b>prognosis</b> is based on the {{c1::worst}} component</div>", "time": 1660105350563.0}, {"id": 1463340102943, "note": "<div>Testicular <b>sex cord-stromal tumors</b> are composed of <b>Sertoli</b> <b>cells</b> and/or <b>Leydig</b> <b>cells</b> and are usually {{c1::benign::benign or malignant}}</div>", "time": 1660105350559.0}, {"id": 1463340118784, "note": "<div><b>{{c1::Leydig cell}} tumors</b> are testicular sex cord stromal tumors that produce <b>{{c3::estrogens}}</b> or&nbsp;<b>{{c3::androgens}}</b>, causing <b>{{c2::gynecomastia}}</b> (men) or <b>{{c2::precocious puberty}}</b> (boys)</div>", "time": 1660105339775.0}, {"id": 1463340121839, "note": "<div><b>{{c2::Leydig cell}} tumor</b> is a sex cord-stromal tumor associated with characteristic <b>{{c1::Reinke crystals}}</b> (eosinophilic cytoplasmic inclusion) on histology</div>", "time": null}, {"id": 1463340128491, "note": "<div><b>{{c1::Sertoli cell}} tumor</b> is a testicular sex cord stromal tumor comprised of <b>tubules</b>, usually clinically silent</div>", "time": 1660105338971.0}, {"id": 1463340132352, "note": "<div>What is the <u>most common</u> cause of <b>testicular cancer</b> in <u>older men</u> (&gt;60)? </div><div><br /></div><div>{{c1::Lymphoma}}</div>", "time": null}, {"id": 1463340155475, "note": "<div>What <i>type</i> of <b>lymphoma</b> is usually the cause of <b>testicular cancer</b> in <u>older men</u>?</div><div><br></div><div>{{c1::diffuse large B-cell lymphoma (aggressive)}}</div>", "time": null}, {"id": 1463343838534, "note": "The <b>{{c1::posterior}}</b> aspect of <b>prostate</b> is palpable by <b>digital rectal</b> <b>exam</b> (DRE)", "time": 1660105349086.0}, {"id": 1463345914020, "note": "<div>Common <i>infectious</i> causes of <b>acute prostatitis</b> in <u>young adults</u> include {{c1::<i>Chlamydia trachomatis </i>(D-K)}} and {{c1::<i>Neisseria&nbsp;gonorrhoeae</i>}}</div>", "time": null}, {"id": 1463345919229, "note": "<div>Common <i>infectious</i> causes of <b>acute prostatitis </b>in <u>older adults</u> include <i>{{c1::E. coli}}</i> and&nbsp;<i>{{c1::Pseudomonas}}</i></div>", "time": null}, {"id": 1463345922819, "note": "<div><b>Acute prostatitis</b> often presents with {{c1::dysuria}} and fever/chills</div>", "time": 1660105362126.0}, {"id": 1463345925967, "note": "<div>A patient with <b>acute prostatitis </b>may have a tender, {{c1::boggy}} prostate on DRE</div>", "time": 1660105362488.0}, {"id": 1463345928964, "note": "<div>Prostatic secretions of a patient with <b>{{c2::acute}} prostatitis</b> often contain WBCs with culture <b>showing</b> {{c1::<b>bacteria</b>}}</div>", "time": 1660105353623.0}, {"id": 1463345931564, "note": "<div>Prostatic secretions of a patient with <b>{{c2::chronic}} prostatitis</b> often contain WBCs with culture <b>showing</b> {{c1::<b><u>no</u> bacteria</b>}}</div>", "time": 1660105353621.0}, {"id": 1463345936419, "note": "<div><b>Chronic prostatitis </b>presents as <b>dysuria</b> with pelvic or {{c1::low back}} pain</div>", "time": 1660105360725.0}, {"id": 1463345940337, "note": "<div>{{c1::<b>Benign prostatic hyperplasia</b> (BPH)}} is the age-related <b>hyperplasia</b> of <b>prostatic</b> stroma and glands</div>", "time": 1660105341041.0}, {"id": 1463345947474, "note": "<div>Does <b>benign prostatic hyperplasia</b> <u>increase</u> risk of cancer?</div><div><br></div><div>{{c1::No}}</div>", "time": null}, {"id": 1463345952079, "note": "<div><b>Benign prostatic hyperplasia</b> most commonly occurs in the {{c1::<b>periurethral</b> <b>zone</b> (<i>middle/lateral lobes</i>)}} of the prostate</div>", "time": null}, {"id": 1463345960314, "note": "<div><b>Benign prostatic hyperplasia</b> may present with problems starting and stopping {{c1::urination}}</div>", "time": 1660105361307.0}, {"id": 1463345963883, "note": "<div><b>Benign prostatic hyperplasia</b> may present with impaired {{c1::bladder}} emptying </div>", "time": 1660105361309.0}, {"id": 1463345985953, "note": "<div>One possible <u>complication</u> of <b>benign prostatic hyperplasia</b> is {{c1::hydronephrosis}}, due to backup of fluid into the kidney</div>", "time": 1660105354597.0}, {"id": 1463346003581, "note": "<div><b>Benign prostatic hyperplasia</b> may be treated with a(n)&nbsp;<b>{{c1::<i>selective</i>&nbsp;</b><b>\u03b1</b><b><sub>1A,D</sub>}}</b> antagonist such as <b>tamsulosin</b></div>", "time": null}, {"id": 1463346010918, "note": "<div><b>{{c1::Prostate adenocarcinoma}}</b> is the <u>malignant</u> proliferation of prostatic glands</div>", "time": null}, {"id": 1463346015128, "note": "<div>Which form of cancer is the <u>2nd most common</u> cause of cancer death in <b>men</b>? </div><div><br></div><div>{{c1::Prostate cancer}}</div>", "time": null}, {"id": 1463346018491, "note": "<div>What ethnicity is associated with <u>increased risk</u> for <b>prostate adenocarcinoma</b>? </div><div><br></div><div>{{c1::African Americans &gt; Caucasians &gt; Asians}}</div>", "time": null}, {"id": 1463346024760, "note": "<div><b>Prostatic adenocarcinoma</b> most commonly occurs in the <b>{{c1::posterior periphery}}</b> of the prostate </div>", "time": null}, {"id": 1463346050168, "note": "<div>Screening for <b>prostatic adenocarcinoma</b> begins at 50 with {{c1::digital rectal exam}} and {{c1::PSA}}</div>", "time": null}, {"id": 1463346053358, "note": "<div><b>PSA</b> &gt; {{c1::10}} ng/dl is worrisome at any age and <i>may</i> be indicative of prostatic adenocarcinoma</div>", "time": null}, {"id": 1463346056481, "note": "<div>A <u>decreased %</u> of which <i>form</i> of <b>PSA</b> is suggestive of <b>prostatic adenocarcinoma</b>? </div><div><br></div><div>{{c1::Free-PSA (cancer makes bound-PSA)}}</div>", "time": null}, {"id": 1463346061489, "note": "<div>A(n) {{c1::prostatic biopsy}} is <b>required</b> to confirm the presence of <b>prostatic adenocarcinoma</b> (cannot use PSA levels alone)</div>", "time": 1660105362390.0}, {"id": 1463346071188, "note": "<div><b>Prostatic adenocarcinoma</b> may be graded using the <b>{{c1::Gleason}} grading system</b></div>", "time": null}, {"id": 1463346081917, "note": "<div>A higher score using the <b>Gleason grading system</b> (for prostatic adenocarcinoma) is associated with a(n) {{c1::worse}} <b>prognosis</b></div>", "time": 1660105362541.0}, {"id": 1463346088119, "note": "<div>Which <u>serum marker</u> may be elevated due to metastasis of <b>prostatic adenocarcinoma</b> to bone?</div><div><br></div><div>{{c1::Alkaline phosphatase (ALP)}}</div>", "time": null}, {"id": 1463346091406, "note": "<div><b>Prostatic adenocarcinoma</b> often has {{c1::osteo<u>blastic</u>::type}} metastases, which is indicated by {{c2::lower back}} pain</div>", "time": null}, {"id": 1463346099788, "note": "<div>If <b>prostatic adenocarcinoma</b> has <u>not</u> metastasized (i.e. local disease), it may be treated with {{c1::prostatectomy}}</div>", "time": 1660105357698.0}, {"id": 1463346102353, "note": "<div><b>Prostatic adenocarcinoma</b> may be treated with {{c1::GnRH}} <i>analogs</i> (e.g. <b>leuprolide</b>) and/or {{c1::androgen}} <i>receptor</i> <i>inhibitors</i> (e.g. <b>flutamide</b>)</div>", "time": null}, {"id": 1463349512978, "note": "<div><b>Breast tissue</b> is a modified {{c1::sweat gland}} that is embryologically derived from skin</div>", "time": 1660105361115.0}, {"id": 1463356243674, "note": "<div><b>Breast tissue</b> can develop anywhere along the {{c1::<b>milk</b> <b>line</b>}}, which runs from the axilla to the vulva (e.g. supernumerary nipples)</div>", "time": null}, {"id": 1463356248081, "note": "<div>The <b>{{c1::terminal duct-lobular unit (TDLU)}}</b> is the <b>functional</b> <b>unit</b> of the <b>breast</b>; lobules make milk that drains via ducts to nipple </div>", "time": 1660105349009.0}, {"id": 1463356256794, "note": "<div>The lobules and ducts of <b>breast tissue</b> are lined by <u>{{c1::two::#}}</u> layers of epithelium</div>", "time": null}, {"id": 1463356260645, "note": "<div>The <b>inner</b> cell layer of <b>breast tissue</b> is the {{c1::luminal (epithelial)}} cell layer</div>", "time": 1660105349983.0}, {"id": 1463356264902, "note": "<div>The <b>luminal (epithelial) cell layer</b> of <b>breast tissue</b> is responsible for {{c1::milk production}} in the <b>lobules</b></div>", "time": null}, {"id": 1463356268349, "note": "<div>The <b>outer</b> cell layer of <b>breast</b> is the {{c1::myoepithelial}} cell layer</div>", "time": 1660105349735.0}, {"id": 1463356271940, "note": "<div>The <b>myoepithelial cell layer</b> of <b>breast tissue</b> is responsible for {{c1::propelling milk}} towards the nipple</div>", "time": null}, {"id": 1463356275732, "note": "<div>During <b>pregnancy</b>, breast lobules undergo {{c1::hyperplasia}}</div>", "time": 1660105359718.0}, {"id": 1463356283395, "note": "<div>After <b>menopause</b>, breast tissue undergoes {{c1::atrophy}}</div>", "time": 1660105362011.0}, {"id": 1463356287240, "note": "<div>Lobules and small ducts of <b>breast tissue </b>are present in highest density in the <b>{{c1::upper outer}} quadrant</b></div>", "time": null}, {"id": 1463356293665, "note": "<div>{{c1::Galactorrhea}} refers to<b> milk</b> <b>production</b> <i>outside</i> of lactation</div>", "time": null}, {"id": 1463356301740, "note": "<div>Is <b>galactorrhea</b> a symptom of <b>breast cancer</b>?</div><div><br></div><div>{{c1::No!}}</div>", "time": 1660105355902.0}, {"id": 1463356305554, "note": "<div><b>{{c1::Acute (lactational) mastitis}}</b> is due to a <b>bacterial</b> <b>infection</b> of <b>breast</b>, usually&nbsp;<i>{{c2::Staphylococcus aureus}}</i></div>", "time": null}, {"id": 1463356309150, "note": "<div><b>Acute (lactational) mastitis</b> is associated with {{c1::breast feeding}} </div>", "time": null}, {"id": 1463356317440, "note": "<div><b>Acute (lactational) mastitis</b> presents as a warm, erythematous breast with {{c1::purulent}} nipple discharge</div>", "time": null}, {"id": 1463356325517, "note": "<div>Treatment for <b>acute (lactational) mastitis</b> is {{c1::continued drainage (e.g. feeding)}} plus {{c1::antibiotics (e.g. dicloxacillin)}}</div>", "time": 1660105348601.0}, {"id": 1463356329258, "note": "<div><b>{{c1::Periductal}} mastitis </b>is inflammation of <b>subareolar</b> <b>ducts</b></div>", "time": 1660105339312.0}, {"id": 1463356342414, "note": "<div><b>Periductal mastitis </b>is usually seen in {{c1::smokers}}</div>", "time": null}, {"id": 1463356347799, "note": "<div><b>Periductal mastitis </b>occurs due to a relative vitamin {{c1::A}} deficiency, which results in {{c2::<b>squamous</b>}} <b>metaplasia</b> of <b>lactiferous ducts</b></div>", "time": null}, {"id": 1463356369801, "note": "<div><b>Periductal mastitis </b>presents as a <b>subareolar mass</b> with {{c1::<b>nipple</b> <b>retraction</b>}} due to pull from myofibroblasts during healing</div>", "time": 1660105353998.0}, {"id": 1463356374053, "note": "<div><b>Mammary duct {{c1::ectasia}} </b>is inflammation with {{c2::<u>dilation</u>}} of the <b>subareolar duct</b></div>", "time": 1660105355413.0}, {"id": 1463356377704, "note": "<div><b>{{c2::Mammary duct ectasia}}</b> presents with a <b>periareolar</b> {{c1::<u>green-brown</u>}} <b>nipple</b> <b>discharge</b> (inflammatory debris)</div>", "time": null}, {"id": 1463356381503, "note": "<div><b>Mammary duct ectasia</b> is associated with chronic inflammation with <b>{{c1::plasma}}</b> <b>cells</b> seen on biopsy</div>", "time": 1660105355414.0}, {"id": 1463356385294, "note": "<div><b>Mammary duct ectasia</b> classically arises in {{c1::multiparous}} (parity), {{c1::post}}-menopausal women</div>", "time": 1660105355415.0}, {"id": 1463356394363, "note": "<div><b>Fat necrosis</b> of breast tissue is usually related to <b>{{c1::trauma}}</b>, but a history of such is not always reported</div>", "time": null}, {"id": 1463356413365, "note": "<div><b>Fat necrosis</b> of <b>breast</b> <b>tissue</b> presents as a <i>painless</i> {{c1::mass}} on physical exam</div>", "time": null}, {"id": 1463356420839, "note": "<div><b>Fat necrosis</b> of <b>breast</b> <b>tissue</b> presents as a(n)&nbsp;<b>{{c1::calcified oil cyst::specific}}</b> on mammography</div>", "time": null}, {"id": 1463356429101, "note": "<div>Biopsy of <b>breast</b> <b>tissue</b> with <b>fat necrosis</b> shows necrotic fat with associated <b>calcifications</b> and {{c1::giant}} cells</div>", "time": 1660105361230.0}, {"id": 1463356432441, "note": "<div><b>{{c1::Fibrocystic changes}} </b>are the most common <i>changes</i> in <b>{{c2::pre}}-menopausal breast</b></div>", "time": null}, {"id": 1463356441715, "note": "<div><b>Fibrocystic change</b> presents as a {{c1::lumpy}} breast that <b>may be painful </b></div>", "time": null}, {"id": 1463356453700, "note": "<div><b>Fibrocystic change</b> of the breast presents as cysts with a(n) {{c1::blue-domed}} appearance on gross exam</div>", "time": null}, {"id": 1463356457000, "note": "<div><b>Fibrocystic changes</b> of the breast generally are {{c1::benign::benign or malignant}}</div>", "time": 1660105359271.0}, {"id": 1463356461093, "note": "<div>Some <b>fibrocystic-related changes</b> carry <u>increased risk</u> for <b>invasive</b> <b>carcinoma</b>, which applies to <u>{{c1::both}}</u> breast(s)</div>", "time": 1660105350893.0}, {"id": 1463356464886, "note": "<div>What is the relative <u>risk</u> of developing <u>invasive breast carcinoma</u> with <b>fibrosis</b> and <b>cysts</b> (fibrocystic changes)? </div><div><br></div><div>{{c1::No increased risk}}</div>", "time": 1660105345561.0}, {"id": 1463356469862, "note": "<div><div>What is the relative <u>risk</u> of developing <u>invasive breast carcinoma</u> with <b>apocrine metaplasia</b> (fibrocystic changes)? </div><div><br /></div><div>{{c1::No increased risk**}}</div></div>", "time": 1660105345564.0}, {"id": 1463356483258, "note": "<div><b>{{c1::Sclerosing adenosis}}</b> is an <u>increase</u> in <b>acini</b> (ducts) and <b>stromal</b> <b>fibrosis</b> of breast tissue, which may be seen as <b>{{c2::calcifications}}</b> on mammogram</div>", "time": null}, {"id": 1463356487232, "note": "<div><div>What is the relative <u>risk</u> of developing <u>invasive breast carcinoma</u> with <b>sclerosing adenosis</b> (fibrocystic changes)? </div><div><br></div><div>{{c1::1.5-2x increased risk}}</div></div>", "time": null}, {"id": 1463356491082, "note": "<div><b>Epithelial/ductal {{c1::hyperplasia}}</b> is an <u>increased number</u> of cells in the terminal ductal or lobular epithelium of the breast</div>", "time": null}, {"id": 1463356494886, "note": "<div><div>What is the relative <u>risk</u> of developing <u>invasive breast carcinoma</u> with <b>epithelial hyperplasia</b> (fibrocystic changes)? </div><div><br></div><div>{{c1::1.5-2x increased risk}}</div></div>", "time": 1660105345562.0}, {"id": 1463356498416, "note": "<div><div>What is the relative <u>risk</u> of developing <u>invasive breast carcinoma</u> with <b><i>atypical</i> epithelial hyperplasia</b> (fibrocystic changes)? </div><div><br></div><div>{{c1::5x increased risk}}</div></div>", "time": 1660105345563.0}, {"id": 1463356501464, "note": "<div><b>{{c1::Intraductal papilloma}}</b> is a small <b>papillary</b> <b>proliferation</b> within <b>{{c2::lactiferous}}</b> <b>ducts</b>, typically beneath the areola of the breast </div>", "time": null}, {"id": 1463356505756, "note": "<div>Which type(s) of cells line the fibrovascular projections of an <b>intraductal papilloma</b> of the breast? </div><div><u><br></u></div><div>{{c1::<u>Both</u> epithelial (luminal) and myoepithelial cells}}</div>", "time": null}, {"id": 1463356514499, "note": "<div><b>Intraductal papilloma</b> of the breast typically presents as a(n) {{c1::bloody}} nipple discharge in a(n) {{c1::pre}}-menopausal woman </div>", "time": null}, {"id": 1463356532940, "note": "<div>What is the <u>most common</u> cause of <b>nipple discharge</b> (serous or bloody)? </div><div><br></div><div>{{c1::Intraductal papilloma (often bloody)}}</div>", "time": null}, {"id": 1463356558172, "note": "<div><div>Which type(s) of cells line the fibrovascular projections of a <b>papillary carcinoma</b> of the breast? </div><div><u><br></u></div><div>{{c1::<i>Only</i> epithelial cells; <u>no myoepithelial cells</u>}}</div></div>", "time": 1660105341861.0}, {"id": 1463356564936, "note": "<div><b>Papillary carcinoma</b> of the breast typically presents as a(n) {{c1::bloody}} nipple discharge in a(n) {{c1::post}}-menopausal woman</div>", "time": null}, {"id": 1463356568833, "note": "<div><b>{{c1::Fibroadenoma}}</b> is a <b>benign</b> small, well-defined mobile breast mass composed of <b>fibrous tissue</b> and <b>glands</b> </div>", "time": 1660105340360.0}, {"id": 1463356577083, "note": "<div>What is the <u>most common</u> <b>benign</b> neoplasm of <b>breast</b>? </div><div><br></div><div>{{c1::Fibroadenoma}}</div>", "time": null}, {"id": 1463356589606, "note": "<div><b>Fibroadenoma</b> is most common in women {{c1::under}} 35 years old </div>", "time": null}, {"id": 1463356597398, "note": "<div><u>Size</u> and <u>tenderness</u> of a <b>fibroadenoma</b> of the breast increases with exposure to <b>{{c1::estrogen}}</b></div>", "time": null}, {"id": 1463356606383, "note": "<div>Does <b>fibroadenoma</b> <u>increase</u> risk of <u>breast cancer</u>? </div><div><br></div><div>{{c1::No (benign)}}</div>", "time": null}, {"id": 1463356609999, "note": "<div><b>{{c1::Phyllodes}} tumor</b> is a fibroadenoma-like tumor with overgrowth of the fibrous component, causing <b>{{c2::leaf-like}} projections</b> </div>", "time": null}, {"id": 1463356615982, "note": "<div><b>Phyllodes</b> <b>tumor</b> is most commonly seen in {{c2::post}}-menopausal women </div>", "time": null}, {"id": 1463356622263, "note": "<div>Can <b>Phyllodes tumor</b> <u>increase</u> risk of <u>breast cancer</u>? </div><div><br></div><div>{{c1::Yes, some may be malignant}}</div>", "time": 1660105360996.0}, {"id": 1463442436474, "note": "<div><b>Malignant breast tumors</b> most commonly occur in {{c1::post}}-menopausal women</div>", "time": 1660105355423.0}, {"id": 1463442475910, "note": "<div>What is the most common location for an <b>invasive&nbsp;breast tumor</b>?</div><div><br></div><div>{{c1::Upper-outer quadrant of the breast}}</div>", "time": null}, {"id": 1463442490849, "note": "<div>Risk factors for developing <b>breast cancer</b> are generally associated with <u>increased</u> {{c1::estrogen}} exposure</div>", "time": null}, {"id": 1463442496649, "note": "<div><u>Increased risk</u> of developing <b>breast cancer</b> is associated with a(n) {{c1::older::younger/older}} age at <b>first live birth</b></div>", "time": null}, {"id": 1463442505682, "note": "<div>What is the effect of <b>obesity</b> on risk of developing <b>breast cancer</b>? Why?</div><div><br /></div><div>{{c1::Increased, due to increased <u>estrone</u> production from adipose tissue}}</div>", "time": 1660105346521.0}, {"id": 1463442510727, "note": "<div><u>Increased risk</u> for <b>breast carcinoma</b> is associated with {{c1::early}} <b>menarche</b> and {{c1::late}} <b>menopause</b></div>", "time": 1660105356161.0}, {"id": 1463442521792, "note": "<div>{{c1::<b>Ductal carcinoma in situ</b> (DCIS)}} is the malignant proliferation of cells in the <b>ducts</b> of the <b>breast</b> with <b>{{c2::no invasion}}</b> of the basement membrane</div>", "time": 1660105340508.0}, {"id": 1463442529940, "note": "<div><b>Ductal carcinoma in situ</b> (DCIS) is detected as {{c1::microcalcifications}} on mammography </div>", "time": null}, {"id": 1463442541618, "note": "<div>Mammographic <b>calcifications</b> can be associated with <b>benign</b> conditions such as {{c1::sclerosing adenosis}} (fibrocystic change) and {{c1::fat necrosis}}</div>", "time": null}, {"id": 1463442550257, "note": "<div><b>{{c1::Comedocarcinoma}}</b> is a subtype of <u>DCIS</u> (breast) that is characterized by high-grade cells with <b>{{c2::dystrophic calcification}}</b> in the <u>center of ducts</u> immediately surrounded by <b>central</b> <b>{{c2::necrosis}}</b></div>", "time": null}, {"id": 1463442563224, "note": "<div><b>{{c1::Pagets}} disease</b> is ductal carcinoma in situ that extends up the ducts to the <u>skin of the nipple</u></div>", "time": 1660105339365.0}, {"id": 1463442568414, "note": "<div><b>Pagets disease</b> (of the nipple) presents as nipple {{c1::ulceration}} and {{c1::erythema}} </div>", "time": null}, {"id": 1463442577876, "note": "<div><b>Pagets disease</b> of the <b>nipple</b> is almost always associated with an underlying {{c1::carcinoma (e.g. DCIS)}}</div>", "time": null}, {"id": 1463442582429, "note": "<div>The following image shows <b>malignant epithelial cells</b> in the <u>epidermis</u> of the <b>nipple</b>, which is representative of {{c1::Pagets disease}}</div><div><br /></div><div><img src=\"paste-224983271866961.jpg\" /></div>", "time": null}, {"id": 1463442589618, "note": "<div>What is the <u>most common</u> type of <b>breast cancer</b>? </div><div><br></div><div>{{c1::Invasive ductal carcinoma (~75% of all breast cancers)}}</div>", "time": null}, {"id": 1463442596495, "note": "<div><b>Invasive ductal carcinoma</b> presents on <b>physical exam</b> with a firm, fibrous \"{{c1::rock-hard}}\" <b>mass</b> with sharp margins</div>", "time": 1660105355946.0}, {"id": 1463442600788, "note": "<div><b>Invasive ductal carcinoma </b>classically forms {{c1::duct}}-like structures</div>", "time": 1660105355948.0}, {"id": 1463442609662, "note": "<div><b>Invasive ductal carcinoma</b> presents as <b>mass</b> detected by {{c1::physical exam}} (&gt; 2cm) or {{c1::mammography}} (&gt; 1cm)</div>", "time": 1660105355947.0}, {"id": 1463442614906, "note": "<div><b>Invasive ductal carcinoma</b> may present, grossly, with classic \"{{c1::stellate}}\" infiltration</div>", "time": null}, {"id": 1463442623228, "note": "<div>Advanced <b>invasive ductal carcinoma</b> tumors may result in {{c2::dimpling}} of skin or {{c1::retraction}} of the nipple</div>", "time": 1660105362036.0}, {"id": 1463442627581, "note": "<div>One <i>subtype</i> of invasive ductal carcinoma (breast) is <b>{{c1::tubular}} carcinoma</b>, which produces <b>tubules</b> in a <b>desmoplastic stroma</b> </div>", "time": 1660105354582.0}, {"id": 1463442637836, "note": "<div><b>Tubular carcinoma </b>can be <u>differentiated</u> from <b>normal breast tissue</b> by <u>lack</u> of {{c1::myoepithelial}} cells and <u>presence</u> of {{c1::desmoplastic}} stroma </div>", "time": 1660105348479.0}, {"id": 1463442654763, "note": "<div>What is the <b>prognosis</b> of the <b>tubular carcinoma</b> <i>subtype</i> of invasive ductal carcinoma (breast)? </div><div><br></div><div>{{c1::Good}}</div>", "time": 1660105345580.0}, {"id": 1463442661997, "note": "<div>The following image represents the <b>{{c1::tubular}} carcinoma</b> <i>subtype</i> of <b>invasive ductal carcinoma</b>: </div><div><br></div><div><img src=\"paste-225120710820433.jpg\" style=\"width: var(--w); height: auto; min-width: 650px;\"></div>", "time": null}, {"id": 1463442682381, "note": "<div>One <i>subtype</i> of invasive ductal carcinoma of the breast is <b>{{c1::mucinous}} carcinoma</b>, which is characterized by malignant cells floating in pools of mucus</div>", "time": null}, {"id": 1463442690482, "note": "<div><div>What is the <b>prognosis</b> of the <b>mucinous carcinoma</b> <i>subtype</i> of invasive ductal carcinoma (breast)? </div><div><br></div><div>{{c1::Good}}</div></div>", "time": 1660105345583.0}, {"id": 1463442696094, "note": "<div>What demographic is most commonly associated with the <b>mucinous carcinoma</b> subtype of invasive ductal carcinoma (breast)? </div><div><br></div><div>{{c1::Elderly women (average 70)}}</div>", "time": 1660105347317.0}, {"id": 1463442700607, "note": "<div>The following image represents the <b>{{c1::mucinous}} carcinoma</b> <i>subtype</i> of <b>invasive ductal carcinoma</b>: </div><div><br /></div><div><img src=\"paste-225219495068254.jpg\" /></div>", "time": 1660105350124.0}, {"id": 1463442712804, "note": "<div><div>What is the <b>prognosis</b> of the <b>medullary carcinoma</b> <i>subtype</i> of invasive ductal carcinoma (breast)? </div><div><br></div><div>{{c1::Good}}</div></div>", "time": null}, {"id": 1463442718625, "note": "<div>One <i>subtype</i> of invasive ductal carcinoma (breast) is <b>{{c1::medullary}} carcinoma</b>, which is characterized by large, <u>high</u>-grade malignant cells <u>growing in sheets</u> with {{c2::<b>lymphocytic</b>}}<b> infiltrate</b> </div>", "time": null}, {"id": 1463442730408, "note": "<div>There is an <u>increased incidence</u> of <b>medullary carcinoma</b> of the <b>breast</b> (a subtype of invasive ductal carcinoma) in patients with <i>{{c1::BRCA1}}</i> mutations</div>", "time": null}, {"id": 1463442739985, "note": "<div>One <i>subtype</i> of invasive ductal carcinoma (breast) is <b>{{c1::inflammatory}} carcinoma</b>, which is characterized by an erythematous and swollen breast that <u>does not resolve</u> with <b>{{c2::antibiotics}}</b></div>", "time": null}, {"id": 1463442752880, "note": "<div><b>{{c1::Inflammatory}} carcinoma</b>, a <i>subtype</i> of invasive ductal carcinoma, is characterized by cancer within dermal <b>{{c2::lymphatics}}</b> </div>", "time": null}, {"id": 1463442763210, "note": "<div><div>What is the <b>prognosis</b> of the <b>inflammatory carcinoma</b> <i>subtype</i> of invasive ductal carcinoma (breast)? </div><div><br></div><div>{{c1::Poor (50% survival at 5 years)}}</div></div>", "time": null}, {"id": 1463442771028, "note": "<div>What other clinical pathology is <b>inflammatory carcinoma</b> of the <b>breast</b> often mistaken with? </div><div><br></div><div>{{c1::Acute mastitis}}</div>", "time": null}, {"id": 1463442780091, "note": "<div>The following image represents the <b>{{c1::inflammatory}} carcinoma</b> <i>subtype</i> of <b>invasive ductal carcinoma</b> (breast):</div><div> </div><div><i><br>hint: the circled area is lymphatics</i><br><img src=\"paste-225309689381446.jpg\"></div>", "time": null}, {"id": 1463442789976, "note": "<div>The <b>gross appearance</b> of <b>inflammatory breast cancer</b> is often described as resembling a(n) {{c1::orange peel (Peau dorange)}} (due to <u>invasion of lymphatic spaces</u>) </div><div><br /></div><div><img src=\"paste-227697691197776.jpg\" /></div>", "time": null}, {"id": 1463442802064, "note": "<div>{{c1::<b>Lobular carcinoma in situ</b> (LCIS)}} is the malignant proliferation of cells in the <b>lobules</b> <b>of the</b> <b>breast</b> with {{c2::<u>no invasion</u>}}<b> </b>of the basement membrane</div>", "time": 1660105339745.0}, {"id": 1463442810974, "note": "<div><b>Lobular carcinoma in situ</b> (LCIS) is often discovered {{c1::incidentally}}; does not produce mass or calcification</div>", "time": null}, {"id": 1463442814795, "note": "<div>{{c2::<b>Lobular carcinoma in situ</b> (LCIS)}} is a <i>non-invasive </i>breast cancer characterized by dyscohesive cells due to <b>lack of {{c1::E-cadherin}}</b> protein</div>", "time": null}, {"id": 1463442840892, "note": "<div><b>Lobular carcinoma in situ </b>is treated with {{c1::anti-estrogenic drugs (e.g. <b>tamoxifen</b>)}} to reduce risk of subsequent carcinoma</div>", "time": null}, {"id": 1463442860197, "note": "<div>Which type of <i>invasive</i><b><i> </i>breast carcinoma</b> is characterized as often being <b>bilateral</b> with <b>multiple lesions</b> in the same location?</div><div><br></div><div>{{c1::Invasive lobular carcinoma}}</div>", "time": null}, {"id": 1463442868302, "note": "<div><b>Invasive lobular carcinoma</b> grows in a(n)&nbsp;<b>{{c1::single-file}} pattern</b> due to lack of E-cadherin</div>", "time": null}, {"id": 1463442877717, "note": "<div>The following image represents <b>{{c1::invasive lobular}} carcinoma</b> (breast):</div><div><br></div><div><img src=\"paste-225636106895941.jpg\"></div>", "time": null}, {"id": 1463442895605, "note": "<div>What is the most <u>important</u><i> </i>factor in determining <b>prognosis</b> of <b>breast cancer</b>? </div><div><br></div><div>{{c1::Metastasis}}</div>", "time": null}, {"id": 1463442900258, "note": "<div><div>What is the most <u>useful</u><i> </i>factor in determining <b>prognosis</b> of <b>breast cancer</b>? </div><div><br></div><div>{{c1::Spread to axillary lymph nodes}}</div></div>", "time": null}, {"id": 1463442917303, "note": "<div>How is <b>axillary lymph node </b>involvement assessed when looking for spread of <b>breast cancer</b>?</div><div><br /></div><div>{{c1::Sentinel node biopsy}} </div>", "time": 1660105358033.0}, {"id": 1463442924234, "note": "<div>Presence or absence of which <u>three receptors or genes</u> are most important in predicting <i>response</i> to <b>treatment</b> of&nbsp;<b>breast</b> <b>cancer</b>?</div><div><br></div><div>{{c1::estrogen receptor (ER), progesterone receptor (PR) and Her2/neu amplification}}</div>", "time": null}, {"id": 1463442943662, "note": "<div><b>Breast cancer</b> that is <b>ER+</b> and <b>PR+</b> is most likely to respond to <b>anti-</b>{{c1::estrogenic}} agents such as <b>{{c1::tamoxifen}}</b> </div>", "time": null}, {"id": 1463442971546, "note": "<div><b>Breast cancer</b> that has <b>Her2/neu amplification</b> is associated with good response to {{c1::<b>trastuzumab</b> (herceptin)}}</div>", "time": null}, {"id": 1463442982359, "note": "<div><u>Breast Cancer Assessment</u>: The following is an immunohistochemical stain for the&nbsp;<b>{{c1::estrogen}}</b> <b>receptor,</b> which is located in <b>{{c2::nuclei}}</b></div><div><b><br></b></div><div><img src=\"paste-225846560293462.jpg\"> </div>", "time": 1660105361121.0}, {"id": 1463443025598, "note": "<div><u>Breast Cancer Assessment</u>: The following is an immunohistochemical stain for the <b>{{c1::HER-2 (c-<i>erbB2</i>)}}</b> <b>receptor,</b> which is located on the <b>{{c2::cell membrane}}</b></div><div><b><br /></b></div><div><img src=\"paste-225902394868318.jpg\" /></div>", "time": 1660105361119.0}, {"id": 1463443062226, "note": "<div><b>Triple-Negative breast cancer </b>is negative for ER, PR, and HER2/neu and has a(n) {{c1::poor}} prognosis</div>", "time": null}, {"id": 1463443068528, "note": "<div>What demographic is most commonly associated with <b>triple negative breast cancer</b>? </div><div><br></div><div>{{c1::African American women}}</div>", "time": null}, {"id": 1463443071372, "note": "<div>What are the <u>two</u> single most important <b>gene</b> <b>mutations</b> associated with <b>hereditary breast cancer</b>? </div><div><br /></div><div><i>{{c1::BRCA1 and BRCA2}} </i></div>", "time": null}, {"id": 1463443074631, "note": "<div>Females with <i>BRCA1</i> mutations have <u>increased risk</u> for which types of cancer? </div><div><br></div><div>{{c1::Breast, ovarian, and fallopian tube::3}}</div>", "time": null}, {"id": 1463443078086, "note": "<div><i>BRCA2</i> mutation is associated with <b>breast carcinoma</b> in {{c1::males}}</div>", "time": null}, {"id": 1463443081183, "note": "<div>If a women undergoes <b>prophylactic mastectomy</b>, can she still develop breast cancer?</div><div><br></div><div>{{c1::Yes, there is a small chance due to small amounts of remaining breast tissue}}</div>", "time": 1660105357727.0}, {"id": 1463443083596, "note": "<div><b>Male breast cancer</b> most commonly presents as a(n)&nbsp;<b>{{c1::subareolar}} mass</b> in <b>older</b> males</div>", "time": 1660105355425.0}, {"id": 1463443090416, "note": "<div>What type of <b>breast cancer</b> is most common in <b>males</b>? </div><div><br /></div><div>{{c1::invasive ductal carcinoma}}</div>", "time": 1660105344860.0}, {"id": 1463443100523, "note": "<b>Male breast cancer</b> is associated with <i>{{c1::BRCA2}}</i> mutation and {{c1::Klinefelter}} syndrome ", "time": null}, {"id": 1463520710247, "note": "{{c1::Dizygotic (\u201cfraternal\u201d)}} <b>twins</b> arise from <b>2 eggs</b> that are separately fertilized by <b>2 different sperm</b><br /><div></div>", "time": 1660105340538.0}, {"id": 1463526102619, "note": "<div><div><b>Dizygotic (\u201cfraternal\u201d) twins</b>  will have {{c1::2 separate}} <b>amniotic</b> <b>sacs</b> and {{c1::2 separate}} <b>placentas (chorions)</b></div></div>", "time": 1660105359965.0}, {"id": 1463526113458, "note": "<div>{{c1::Monozygotic (\u201cidentical\u201d)}} <b>twins</b> arise from <b>1 fertilized egg</b> (1 egg + 1 sperm) that <b>splits</b> in early pregnancy</div>", "time": 1660105339560.0}, {"id": 1463526118760, "note": "<div>If the developing embryo <b>splits</b> in the <b>2-cell stage</b> (0-4 days), the twins will be {{c1::di::mono/di}}-chorionic and {{c1::di::mono/di}}-amniotic</div>", "time": null}, {"id": 1463526124762, "note": "<div>If the developing embryo <b>splits</b> in the <b>morula stage</b> (4-8 days), the twins will be {{c1::mono::mono/di}}-chorionic and {{c1::di::mono/di}}-amniotic</div>", "time": null}, {"id": 1463526131353, "note": "<div>If the developing embryo <b>splits</b> in the <b>blastocyst stage</b> (8-12 days), the twins will be {{c1::mono::mono/di}}-chorionic and {{c1::mono::mono/di}}-amniotic</div>", "time": null}, {"id": 1463526137463, "note": "<div>If the developing embryo <b>splits</b> <i>after</i> the <b>embryonic disc</b> is formed (&gt;13 days), the twins will be {{c1::conjoined}}</div>", "time": null}, {"id": 1463526145718, "note": "<div>The <b>umbilical {{c1::vein}}</b> supplies <b>oxygenated blood</b> from the placenta to the fetus</div>", "time": null}, {"id": 1463526209818, "note": "<div>The <b>umbilical {{c1::arteries}}</b> return <b>deoxygenated blood</b> from the fetus to the placenta</div>", "time": null}, {"id": 1463526248482, "note": "<div>During the <b>3rd week of development</b>, the yolk sac forms the {{c1::allantois}}, which extends into the urogenital sinus</div>", "time": 1660105359710.0}, {"id": 1463526252752, "note": "<div>The <b>allantois</b> becomes the <b>{{c1::urachus}}</b>, which is a duct between the <b>{{c2::fetal bladder}}</b> and the <b>{{c2::umbilicus}}</b> </div>", "time": null}, {"id": 1463526258452, "note": "<div>The <b>{{c1::vitelline}} duct</b> is a duct that connects the embryonic <b>yolk sac</b> to the <b>midgut lumen</b></div>", "time": null}, {"id": 1463526262145, "note": "<div>During the <b>{{c1::7th}} week of development</b>, the <b>obliteration</b> of the <b>vitelline duct</b> (omphalo-mesenteric duct) occurs</div>", "time": null}, {"id": 1463526266052, "note": "<div>If the <b>vitelline duct</b> <i>COMPLETELY </i><u>fails to close</u>, a <b>vitelline</b> <b>{{c1::fistula (persistent vitelline duct)}}</b> develops, which is characterized by <b>{{c2::meconium}}</b> <b>discharge</b> from the umbilicus</div>", "time": null}, {"id": 1463526385372, "note": "<div>Which two pathologies are associated with <u>increased</u> <b>temperature</b> of the <b>testis</b>?</div><div><br></div><div>{{c1::Varicocele and cryptorchidism}}</div>", "time": null}, {"id": 1463526393047, "note": "<div><b>{{c1::Polyhydramnios}}</b> is the presence of <u>too much</u> <b>amniotic fluid</b> and may be associated with fetal malformations (e.g. esophageal or duodenal atresia due to <b>inability to swallow</b>)</div>", "time": 1660105339244.0}, {"id": 1463526400180, "note": "<div><b>{{c1::Oligohydramnios}}</b> is <u>too little</u> <b>amniotic fluid</b>, and may be associated with bilateral renal agenesis or posterior urethral valves (males)</div>", "time": null}, {"id": 1463526404611, "note": "<div>What is the <u>most common</u> <b>gynecologic cancer</b> <i>worldwide</i>?</div><div><br></div><div>{{c1::Cervical (due to lack of screening or HPV vaccination)}}</div>", "time": 1660105345883.0}, {"id": 1463526408165, "note": "<div><div>What is the <u>most common</u> <b>gynecologic cancer</b> in the <i>U.S.</i>?</div><div><br></div><div>{{c1::Endometrial}}</div></div>", "time": null}, {"id": 1463526412603, "note": "<div>Which <b>gynecologic cancer</b> (endometrial, cervical, ovarian) has the <b>worst prognosis</b>?</div><div><br></div><div>{{c1::Ovarian}}</div>", "time": 1660105342935.0}, {"id": 1463526446923, "note": "What is the most common <u>mechanism</u> of chromosomal <b>aneuploidy</b>? <div><br></div><div>{{c1::Meiotic nondisjunction}}</div>", "time": null}, {"id": 1463529021317, "note": "<b>{{c2::Klinefelter}} syndrome</b> is <u>most commonly</u> characterized by a(n)&nbsp;<b>{{c1::47}},{{c1::XXY}}</b> <b>karyotype</b>", "time": null}, {"id": 1463529453311, "note": "<div>Which <u>sex chromosome disorder</u> is associated with <b>gynecomastia</b>, <b>female hair distribution</b>, <b>tall/long extremities</b> and <b>eunuchoid body shape</b> in a <b>male</b>? </div><div><br></div><div>{{c1::Klinefelter syndrome (47,XXY)}} </div>", "time": null}, {"id": 1463529461225, "note": "<div>What is the level of <b>testosterone</b> in a patient with <b>Klinefelter syndrome</b>?</div><div><br></div><div>{{c1::Decreased (seminiferous tubule dysgenesis, abnormal Leydig cell function)}}</div>", "time": null}, {"id": 1463529464624, "note": "<div><div>What is the level of <b>estrogen</b> in a patient with <b>Klinefelter syndrome</b>?</div><div><br></div><div>{{c1::Increased}}</div></div>", "time": null}, {"id": 1463529468266, "note": "<div><b>Klinefelter syndrome</b> is associated with <b>testicular</b> {{c1::atrophy::size}}&nbsp;</div>", "time": null}, {"id": 1463529471830, "note": "<div><div>Which <u>sex chromosome disorder</u> is associated with <b>short stature</b>, <b>shield chest</b>, and<b> webbed neck</b> in a <b>female</b>? </div><div><br /></div><div>{{c1::Turner syndrome}}</div></div>", "time": null}, {"id": 1463529479421, "note": "<div>What is the <u>most common</u> cause of <b>primary amenorrhea</b>? </div><div><br /></div><div>{{c1::Turners syndrome}}</div>", "time": null}, {"id": 1463529483683, "note": "<div><div>What is the level of <b>estrogen</b> in a patient with <b>Turner syndrome</b>?</div><div><br></div><div>{{c1::Decreased (due to ovarian dysgenesis)}}</div></div>", "time": null}, {"id": 1463529488559, "note": "<div><b>Turner syndrome</b> is associated with <b>preductal {{c2::coarctation of the aorta}}</b>, which may present as a <b>femoral pulse </b><u>{{c1::less}} than</u> <b>brachial pulse</b></div>", "time": null}, {"id": 1463529510813, "note": "<div><b>Ovotesticular disorder of sex development</b>, also known as true {{c1::hermaphroditism}}, is the presence of both ovarian and testicular tissue</div>", "time": null}, {"id": 1463529514333, "note": "<div><b>Placental {{c1::aromatase}} deficiency</b> is the inability to <i>synthesize</i> <b>estrogens</b> from <b>androgens</b></div>", "time": null}, {"id": 1463529518094, "note": "<div><b>Placental aromatase deficiency</b> results in {{c1::masculinization}} of female (46,XX) infants </div>", "time": 1660105353894.0}, {"id": 1463529526162, "note": "<div><b>Placental {{c2::aromatase}} deficiency</b> can present with<b> maternal {{c1::virilization}} </b>during pregnancy</div>", "time": null}, {"id": 1463529534214, "note": "<div><b>{{c2::Androgen insensitivity}} syndrome</b> is due to a defect in the <u>androgen receptor</u>, which results in a normal-appearing <b>{{c1::female}}</b> that is genotypically <b>{{c1::XY}}</b> </div>", "time": null}, {"id": 1463529538028, "note": "<div>In general, <b>sex chromosome disorders</b> (e.g. Turners, Klinefelter) present with {{c1::decreased}} testosterone <i>and/or</i> estrogen and {{c1::increased}} LH</div>", "time": null}, {"id": 1463529541032, "note": "<div>A <b>defective androgen receptor</b> presents with {{c1::increased}} testosterone and {{c1::increased}} LH</div>", "time": 1660105362564.0}, {"id": 1463529546124, "note": "<div>A <b>testosterone-secreting tumor</b> (or exogenous steroids) presents with {{c1::increased}} testosterone and {{c1::decreased}} LH </div>", "time": 1660105362425.0}, {"id": 1463529568699, "note": "<div><b>Primary hypogonadism</b> presents with {{c1::decreased}} testosterone/estrogen and {{c1::increased}} LH </div>", "time": null}, {"id": 1463529575275, "note": "<div><b>Hypogonadotropic hypogonadism </b>presents with {{c1::decreased}} testosterone/estrogen and {{c1::decreased}} LH &amp; FSH</div>", "time": null}, {"id": 1463529580634, "note": "<div><b>{{c1::Kallmann}} syndrome</b> is a rare <u>genetic disorder</u> characterized by a failure to complete puberty</div>", "time": null}, {"id": 1463529584173, "note": "<div><b>{{c2::Kallmann}} syndrome</b> is characterized by a defective <u>migration</u> of {{c1::GnRH}} cells and defective <u>formation</u> of the {{c1::olfactory bulb}} </div>", "time": null}, {"id": 1463529587147, "note": "<b>Kallmann syndrome</b> presents as {{c1::infertility}} in males and {{c1::amenorrhea}} in females; {{c2::<b>anosmia</b>}} may be present in both sexes", "time": 1660105355812.0}, {"id": 1463530651952, "note": "<b>{{c2::Turner}} syndrome</b> is most commonly characterized by a(n)&nbsp;<b>{{c1::45}},{{c1::XO}}</b> <b>karyotype</b> ", "time": null}, {"id": 1463534046490, "note": "In <b>5-alpha-reductase deficiency</b>, there are {{c1::normal}} levels of <b>testosterone</b> and {{c1::normal/increased}} levels of <b>LH</b>", "time": null}, {"id": 1463671526250, "note": "<div>Alendronate, pamidronate, zoledronate are all examples of&nbsp;<b>{{c2::bisphophonates}}</b>, which are the <u>first line treatment</u> for&nbsp;<b>{{c1::osteoporosis}}</b></div>", "time": 1660105351078.0}, {"id": 1463675323435, "note": "<div><b>Bisphosphonates</b> have a chemical structure similar to {{c1::pyrophosphate}}<br></div>", "time": 1660105351072.0}, {"id": 1463675409153, "note": "<div>Which <u>two drugs</u> are useful in the acute treatment of <b>hypercalcemia of malignancy</b>?<br></div><div><br></div><div>{{c1::Bisphosphonates and calcitonin}}</div><div></div>", "time": 1660105351027.0}, {"id": 1463675416618, "note": "<div><b>{{c2::Bisphosphonates}}</b> and <b>{{c2::calcitonin}}</b> are useful in the management of <b>{{c1::Paget disease}}</b>, which is characterized by uncontrolled osteoclast resorption with secondary <i>disorganized bone formation</i><br></div>", "time": 1660105351003.0}, {"id": 1463675427032, "note": "<div>Oral <b>bisphosphonates</b> may cause {{c1::upper GI}} side effects<br></div>", "time": 1660105351043.0}, {"id": 1463675434980, "note": "<div>What <b>osteoporosis drug</b> has side effects that include <b>acid reflux</b>, <b>esophagitis</b>, and <b>esophageal ulcers</b>?<br></div><div><br></div><div>{{c1::Bisphosphonates (oral)}}</div>", "time": 1660105351029.0}, {"id": 1463675445325, "note": "<div>One rare side effect of <b>{{c1::bisphosphonates}} </b>and<b> {{c2::denosumab}}</b> is {{c3::osteonecrosis of the jaw}} (rare)<br></div>", "time": 1660105351046.0}, {"id": 1463675545974, "note": "<div><b>{{c2::Raloxifene}}</b> is a <b>selective estrogen receptor modulator&nbsp;</b>(SERM) that has estrogen <b>{{c1::agonist}}</b> activity on <b>bone</b><br></div>", "time": 1660105350997.0}, {"id": 1463675562411, "note": "<div><b>{{c2::Raloxifene}}</b> is a <b>selective estrogen receptor modulator </b>(SERM) that has estrogen&nbsp;<b>{{c1::antagonist}}</b> activity on <b>breast</b> and <b>uterus</b></div>", "time": 1660105350995.0}, {"id": 1463675577271, "note": "<div><b>Chronic exposure of PTH</b> stimulates <b>osteoblasts</b> to express {{c1::RANKL}}, which binds to {{c1::RANK}} on <b>osteoclast </b>surfaces to increase activity<br></div><div><br></div>", "time": 1660105351042.0}, {"id": 1463675586235, "note": "<div><b>{{c1::Denosumab}}</b> is a <u>monoclonal antibody</u> against <b>{{c2::RANKL}}</b>, useful in the treatment of <b>osteoporosis</b><br></div>", "time": 1660105351016.0}, {"id": 1463675593790, "note": "<div>{{c1::Calcitonin}} is a peptide hormone that <i>directly</i> <b>inhibits osteoclasts</b>, causing decreased bone resorption<br></div>", "time": 1660105351017.0}, {"id": 1463675621016, "note": "<div><b>Calcitonin</b> promotes <b>Ca</b><sup><b>2+</b></sup> {{c1::excretion}} by the <b>kidney</b><br></div>", "time": 1660105351071.0}, {"id": 1463844501109, "note": "<div><b>ADH</b> activation of the {{c1::V<sub>1</sub>}} receptor on vascular smooth muscle causes <b>vasoconstriction</b> and <u>increased</u> <b>blood pressure</b><br></div><div></div>", "time": 1660105351082.0}, {"id": 1463844524624, "note": "<div>ADH-activated <b>V<sub>2</sub></b> receptors cause translocation of {{c1::aquaporin 2}} channels to the renal <b>apical</b> <b>membrane</b>, causing <u>increased reabsorption</u> of free water<br></div>", "time": 1660105351079.0}, {"id": 1463844549067, "note": "<div>What <b>anti-psychotic</b> drug is a common cause of drug-induced <b>nephrogenic diabetes insipidus</b>?<br></div><div><br></div><div>{{c1::Lithium}} </div>", "time": 1660105351036.0}, {"id": 1463844555620, "note": "<div>One <i>class</i> of drugs that may treat <b>nephrogenic diabetes insipidus</b> is <b>{{c1::thiazide diuretics}}</b>, which enhances the uptake of NaCl and H<sub>2</sub>O in the <b>{{c2::proximal tubule}}</b>&nbsp;<br></div>", "time": 1660105351050.0}, {"id": 1463844566230, "note": "<div><b>{{c1::Amiloride}}</b> is a K<sup>+</sup> sparing <b>diuretic</b> that may be used to treat {{c1::<b>Lithium</b>}} induced <b>{{c2::nephrogenic}}</b> <b>diabetes insipidus</b><br></div>", "time": 1660105351022.0}, {"id": 1463844574977, "note": "<div><b>Amiloride</b> is useful for the treatment of {{c1::lithium}}-induced <b>diabetes insipidus</b><br></div>", "time": 1660105351076.0}, {"id": 1463844595293, "note": "<div><b>NSAIDs</b>, such as <b>{{c1::indomethacin}}</b>, may be used to treat <b>{{c2::nephrogenic}} diabetes</b> <b>insipidus</b><br></div>", "time": 1660105351055.0}, {"id": 1463844954526, "note": "<div><b>Central diabetes insipidus</b> may be treated with <i>exogenous</i> administration of {{c1::ADH}}<br></div>", "time": 1660105351070.0}, {"id": 1463845068497, "note": "<div><b>{{c1::Desmopressin&nbsp;(DDAVP)}}</b>, a long-acting synthetic <u>analog of ADH</u>, may be used to treat <b>{{c2::central}} diabetes insipidus</b><br></div>", "time": 1660105351014.0}, {"id": 1463845088254, "note": "<div>In addition to <b>central diabetes insipidus</b>, <b>desmopressin</b> (DDAVP) may be used to treat <b>{{c1::von Willebrand disease}},</b> which is associated with <u>increased bruisability</u> and <u>mucosal bleeding</u><br></div>", "time": 1660105351058.0}, {"id": 1463845129097, "note": "<div>In addition to <b>central diabetes insipidus</b>, <b>desmopressin</b> (DDAVP) may be used to treat <b>{{c1::hemophilia A}},</b> which is associated with <u>hemarthrosis</u> and <u>prolonged bleeding</u> after minor procedures<br></div>", "time": 1660105351059.0}, {"id": 1463845154729, "note": "<div><b>Desmopressin</b> may be used to treat <b>night</b> {{c1::enuresis (bed wetting)}}<br></div>", "time": 1660105351068.0}, {"id": 1463845174869, "note": "<div>{{c1::-<b>Vaptans</b> (tolvaptan, conivaptan)}} are the <u>first line treatment</u> for treatment of <b>{{c2::SIADH}}</b><br></div>", "time": 1660105351024.0}, {"id": 1463845182983, "note": "<div>What adverse effect may <b>-vaptans</b> (tolvaptan, conivaptan) have on <b>sodium levels</b>?<br></div><div><br></div><div>{{c1::Hypernatremia}}</div>", "time": 1660105351038.0}, {"id": 1463845189086, "note": "<div>What is a serious complication of <b>vaptans</b> (e.g. tolvaptan, conivaptan) that may occur if <b>SIADH-induced</b> <b>hyponatremia</b> is corrected <i>too quickly</i>? </div><div><br></div><div>{{c1::Central pontine myelinolysis (osmotic demyelination syndrome)}}</div>", "time": 1660105351030.0}, {"id": 1463845202003, "note": "<div>Which <b>tetracycline</b> may be used as a <i>second line treatment </i>in the treatment of <b>SIADH</b>?<br></div><div><br></div><div>{{c1::Demeclocycline}}</div>", "time": 1660105351028.0}, {"id": 1463845210814, "note": "<div>Which treatment for <b>SIADH</b> may end up causing <b>nephrogenic diabetes insipidus</b>?<br></div><div><br></div><div>{{c1::Demeclocycline}}</div>", "time": 1660105359149.0}, {"id": 1463875484080, "note": "<div>Which <u>type</u> of <b>receptor</b> is associated with <b>growth hormone</b>?</div><div><br></div><div>{{c1::Receptor associated tyrosine kinase}} </div>", "time": 1660105351025.0}, {"id": 1463875780951, "note": "<div><b>{{c2::Growth hormone}}</b> is a hormone that may be used for treatment of <b>{{c1::Turner}} syndrome</b>, which is characterized by an XO genotype<br></div>", "time": 1660105351001.0}, {"id": 1463875845927, "note": "<div><b>{{c1::Octreotide </b>(somatostatin analog)<b>}} </b>may be used to treat <b>acromegaly</b> and <b>gigantism</b> if symptoms persist <u>after</u> <b>{{c2::trans-sphenoidal resection}}</b><br></div>", "time": 1660105351010.0}, {"id": 1463875853686, "note": "<div>What <u>hormone analog</u> may be used to treat <b>VIPoma</b> and <b>carcinoid syndrome</b>?<br></div><div><br></div><div>{{c1::Octreotide (somatostatin analog)}}</div>", "time": 1660105351032.0}, {"id": 1463875860762, "note": "<div>What <u>hormone analog</u> may be used to treat <b>insulinoma</b>, <b>glucagonoma</b>, and <b>gastrinoma</b>?<br></div><div><br></div><div>{{c1::Octreotide (somatostatin analog)}}</div>", "time": 1660105351033.0}, {"id": 1463875872656, "note": "<div><b>Octreotide</b>, a somatostatin analog, may be useful in the management of {{c1::<b>esophageal</b> <b>variceal</b>}} <b>bleeding</b> by reducing portal blood flow and variceal pressure<br></div>", "time": 1660105351051.0}, {"id": 1463875952548, "note": "Which hormone-secreting <b>pancreatic tumor</b> is associated with <b>necrolytic migratory erythema</b>?<div><br></div><div>{{c1::Glucagonoma}}</div>", "time": null}, {"id": 1463881872804, "note": "<div>Dexamethasone, hydrocortisone, and prednisone are all examples of <b>{{c1::glucocorticoids}}</b> </div>", "time": 1660105351067.0}, {"id": 1463883728414, "note": "<div>When <b>unbound</b>, the <b>glucocorticoid</b> <b>receptor</b> is located in the {{c1::cytoplasm}}<br></div>", "time": 1660105350961.0}, {"id": 1463883738825, "note": "<div>Once <b>bound</b> (activated), the <b>glucocorticoid</b> <b>receptor</b> enters the <b>{{c2::nucleus}}</b> and binds to <b>{{c1::glucocorticoid response elements}}</b> to <u>regulate gene transcription</u><br></div>", "time": 1660105350969.0}, {"id": 1463883746350, "note": "<div>What is the effect of <b>glucocorticoids</b> on <u>production</u> of&nbsp;<b>phospholipase A</b><sub style=\"font-weight: bold;\">2</sub>?</div><div><br></div><div>{{c1::Decreased (inhibition)}}</div>", "time": 1660105350963.0}, {"id": 1463883753623, "note": "<div><b>Glucocorticoids</b> prevent production of {{c1::arachidonic acid}} by <u>inhibiting</u> <b>phospholipase A<sub>2</sub></b><br></div>", "time": 1660105350972.0}, {"id": 1463883777608, "note": "<div><b>Glucocorticoids</b> <u>inhibit</u> {{c1::NF-kB}}, which is a <i>transcription factor</i> that regulates the production of <b>proinflammatory</b> <b>cytokines</b> (e.g. IL-2, TNF-alpha)<br></div>", "time": 1660105350978.0}, {"id": 1463883894010, "note": "<div><b>Glucocorticoids</b> are useful for treating {{c1::inflammatory}} <b>disorders</b> (e.g. gout, rheumatoid arthritis, asthma, IBD)<br></div>", "time": 1660105350986.0}, {"id": 1463883932504, "note": "<div><b>Glucocorticoids</b> are useful in treating <b>{{c1::adrenal}}</b> <b>insufficiency</b>, which may progress to circulatory shock, hypoglycemia, and death<br></div>", "time": 1660105350984.0}, {"id": 1463883941617, "note": "<div><u>Abrupt withdrawal </u>of <b>glucocorticoids</b> may cause <b>{{c1::tertiary}} {{c2::adrenal}}</b> <b>insufficiency</b><br></div>", "time": 1660105350990.0}, {"id": 1463884000084, "note": "<div><b>Chronic</b> <b>glucocorticoid</b> use may cause <b>Iatrogenic</b> {{c1::Cushing}} <b>syndrome</b><br></div>", "time": 1660105350988.0}, {"id": 1463884018201, "note": "<div><b>Glucocorticoids</b> may cause {{c1::osteoporosis}} due to <u>inhibition</u> of <b>osteoblast</b> <b>activity</b><br></div><div><b><br></b></div><div>*<i style=\"\">bonus: what supplements should be taken to prevent this?</i></div>", "time": 1660105350977.0}, {"id": 1463930142523, "note": "<i></i><div>Which two <u>hormones</u> or <u>hormone analogs</u> may be used for the management of <b>esophageal variceal bleeding</b>?</div><div><br></div><div>{{c1::Desmopressin (ADH analog)}} and {{c1::octreotide (somatostatin analog)}} </div>", "time": 1660105351026.0}, {"id": 1463943419326, "note": "How does <b>cardiac output</b> change during <b>pregnancy</b>?<div><br /></div><div>{{c1::Increase (~50%)}}</div><div><br /></div><div><br /></div>", "time": 1660105358108.0}, {"id": 1463944180575, "note": "<div>How does <b>plasma volume</b> and <b>RBC volume</b> change during <b>pregnancy</b>?</div><div><br /></div><div>{{c1::<div><u>Plasma volume</u> increases by 50%</div><div><u>RBC volume</u> increases by 30%</div>}}</div>", "time": null}, {"id": 1463944198038, "note": "<div>What is the result of <u>50% increased</u><b> plasma volume</b> versus <u>30% increased</u><b> RBC volume</b> during <b>pregnancy</b>?</div><div><br></div><div>{{c1::Anemia (decreases viscosity to reduce postpartum bleeding)}}</div>", "time": 1660105345550.0}, {"id": 1463944202361, "note": "<div>How does <b>blood pressure</b> change during <i>early</i> <b>pregnancy</b>?</div><div><br /></div><div>{{c1::Decreased}}</div>", "time": null}, {"id": 1463944209580, "note": "<div>How does <b>minute ventilation</b> change during <b>pregnancy</b>?</div><div><br></div><div>{{c1::Increased}}</div>", "time": null}, {"id": 1463944212861, "note": "<div>How does <u>increased</u> <b>minute ventilation</b> during <b>pregnancy</b>&nbsp;affect <b>blood pH</b>? </div><div><br></div><div>{{c1::Mild respiratory alkalosis}}</div>", "time": null}, {"id": 1463944216868, "note": "<div>How do levels of <b>PCO<sub>2</sub></b> change during <b>pregnancy</b>?</div><div><br></div><div>{{c1::Decreased (due to increased ventilation rate)}}</div>", "time": null}, {"id": 1463944224537, "note": "<div>How does <b>coaguability</b> change during <b>pregnancy</b>?</div><div><br></div><div>{{c1::Increased (hypercoagulability; decreases postpartum bleeding)}}</div>", "time": null}, {"id": 1463944228821, "note": "<div>How does <b>glomerular filtration rate</b> change during <b>pregnancy</b>?</div><div><br /></div><div>{{c1::Increase}}</div>", "time": null}, {"id": 1463944239303, "note": "<div>How does <b>insulin resistance</b> change during <b>pregnancy</b>?</div><div><br /></div><div>{{c1::Increase}}</div>", "time": 1660105358093.0}, {"id": 1463944253517, "note": "<div>When grading a females <b>obstetrical status</b> using <b>GTPAL</b>, what does <b>G</b> represent?</div><div><br></div><div>{{c1::Gravidity (the total # of <u>pregnancies</u>)}}</div>", "time": null}, {"id": 1463944257343, "note": "<div><div>When grading a females <b>obstetrical status</b> using <b>GTPAL</b>, what does <b>T</b> represent?</div><div><br></div><div>{{c1::Term deliveries (the total # of deliveries <u>after 37 weeks</u>)}}</div></div>", "time": null}, {"id": 1463944261135, "note": "<div>When grading a females <b>obstetrical status</b> using <b>GTPAL</b>, what does <b>P</b> represent?</div><div><br></div><div>{{c1::Pre-term deliveries (the total # of deliveries <u>after 20 weeks</u>, <i>but</i> <u>before 37 weeks</u>)}}</div>", "time": null}, {"id": 1463944269114, "note": "<div><div>When grading a females <b>obstetrical status</b> using <b>GTPAL</b>, what does <b>L</b> represent?</div><div><br></div><div>{{c1::Number of living children}}</div></div>", "time": null}, {"id": 1463944272827, "note": "<div>What <b>range of weeks</b> is considered a <b>term gestation</b>?</div><div><br></div><div>{{c1::37-42 weeks}}</div>", "time": null}, {"id": 1463944277580, "note": "<div>The <u>four</u> components of a <b>prenatal quad screen</b> are:</div><div><br /></div><div>1. {{c1::AFP}}</div><div>2. {{c2::hCG}}</div><div>3. {{c3::Estriol}}</div><div>4. {{c4::Inhibin A}}</div>", "time": null}, {"id": 1463944339139, "note": "<div><b>Amniocentesis</b> may be done as early as {{c1::15}} to {{c1::17}} weeks</div>", "time": null}, {"id": 1463944348904, "note": "<div><b>Chorionic villus sampling</b> may be done as early as {{c1::10}} to {{c1::13}} weeks</div>", "time": null}, {"id": 1463944355918, "note": "<div>What is the risk of <b>fetal loss</b> in <b>amniocentesis</b>? What about <b>chorionic villus sampling</b>? </div><div><br></div><div>{{c1::0.5% in amniocentesis versus 1% in CVS}}</div>", "time": null}, {"id": 1463944359553, "note": "<div>What is a possible <u>adverse effect</u> associated with performing <b>chorionic villus sampling</b> <u>before 9 weeks</u>? </div><div><br></div><div>{{c1::Limb defects}}</div>", "time": null}, {"id": 1463944364170, "note": "<div>The <u>inability</u> to detect {{c1::neural tube}} <b>defects</b> is a downside of <b>chorionic villus sampling</b> when compared to <b>amniocentesis</b></div>", "time": null}, {"id": 1463944368984, "note": "<div>What <b>lecithin:sphingomyelin ratio</b> is indicative of a <b>mature fetal lung</b>? </div><div><br></div><div>{{c1::lecithin:sphingomyelin <u>&gt;</u> 2}}</div>", "time": null}, {"id": 1463944377495, "note": "<div>What <b>day</b> of fetal development is characterized by <b>chorion</b> formation?</div><div><br /></div><div>{{c1::Day 4 (thus twins that split after day 4 are <u>monochorionic</u>)}} </div>", "time": null}, {"id": 1463944389120, "note": "<div><div>What <b>day</b> of fetal development is characterized by <b>amnion</b> formation?</div><div><br /></div><div>{{c1::Day 8 (thus twins that split after day 8 are <u>monoamniotic</u>)}}</div></div>", "time": null}, {"id": 1463944398823, "note": "<div>The presence of <b>1 yolk sac</b> with <b>2 fetal poles</b> is indicative of {{c1::monoamniotic}} twins</div>", "time": null}, {"id": 1463944402230, "note": "<div>The presence of <b>cord entanglement</b> is indicative of {{c1::monoamniotic}} twins</div>", "time": null}, {"id": 1463944405911, "note": "<div>What is a possible complication of <b>monochorionic twins</b> as a result of <b>anastamosis</b>? </div><div><br></div><div>{{c1::Twin-twin transfusion syndrome}}</div>", "time": null}, {"id": 1463944408999, "note": "<div>In <b>twin-twin transfusion syndrome,</b> the {{c1::donor}} is anemic, pale, and has restricted growth</div>", "time": null}, {"id": 1463944414541, "note": "<div>In <b>twin-twin transfusion syndrome,</b> the {{c1::recipient}} is polycythemic, overloaded, and at risk for heart failure </div>", "time": null}, {"id": 1463945063263, "note": "A(n)&nbsp;<b>{{c1::patent urachus}}</b> occurs due to <u>total failure</u> of the urachus to obliterate", "time": null}, {"id": 1463945251338, "note": "<div><div>A <b>patent {{c2::urachus}}</b> presents as a <u>straw colored</u> {{c1::<b>urine</b>}} discharge from the umbilicus with {{c3::erythema}} around the area</div></div>", "time": 1660105362495.0}, {"id": 1463945257858, "note": "<div>A(n)&nbsp;<b>{{c1::urachal cyst}}</b> is due to <u>partial failure</u> of the urachus to obliterate, resulting in a fluid-filled cyst</div>", "time": null}, {"id": 1463945263919, "note": "<div>A(n)&nbsp;<b>{{c1::urachal}} cyst</b> presents as a fluid-filled cavity lined with <b>uroepithelium</b>, between the umbilicus and bladder</div>", "time": null}, {"id": 1463945273041, "note": "<div>A(n)&nbsp;<b>{{c1::vesicourachal diverticulum}}</b> is a diverticulum due to a <u>slight failure</u> of the urachus to obliterate</div>", "time": null}, {"id": 1463945278650, "note": "<div><div>A <b>vesicourachal diverticulum</b> presents as outpouching of the {{c1::bladder}} </div></div>", "time": null}, {"id": 1463946079893, "note": "<div>The <b>{{c1::median umbilical ligament}}</b> is a remnant of the <u>obliterated</u> <b>{{c2::urachus}}</b> </div>", "time": null}, {"id": 1463947013821, "note": "<b>Invasive mole</b> is typically the <u>malignant</u> progression of a(n) {{c1::complete}} <b>hydatidiform mole</b>", "time": 1660105355945.0}, {"id": 1463947088822, "note": "<div><b>Invasive moles</b> are diagnosed by histologic evidence of <u>villi</u> invading the {{c1::myometrium}} on a hysterectomy specimen</div>", "time": null}, {"id": 1463947774175, "note": "One <u>risk factor</u> for <b>placental abruption</b> is {{c1::trauma}} (e.g. <b>MVA</b>, spouse abuse)", "time": null}, {"id": 1463947812898, "note": "Causes of <b>{{c1::hypertension}}</b> (e.g. cocaine, smoking, and preeclampsia) all <u>increase the risk</u> for <b>placental {{c2::abruption}}</b>", "time": 1660105360913.0}, {"id": 1463947850134, "note": "One <u>risk factor</u> for <b>placenta accreta</b> is a prior {{c1::C-section}}, which results in a scar that lacks a healthy decidua basalis", "time": null}, {"id": 1463947881893, "note": "<b>Placental {{c2::abruption}}</b> may be diagnosed using the <b>{{c1::Kleihauer-Betke}} test</b>, which looks for fetal RBC in the maternal blood ", "time": null}, {"id": 1463947911732, "note": "How is <b>placenta previa</b> usually <b>diagnosed</b>?<div><b><br></b></div><div>{{c1::Ultrasound}}</div>", "time": null}, {"id": 1463950513482, "note": "<b>{{c1::Vasa previa}}</b> is a complication of <u>pregnancy</u> that occurs when <b>fetal vessels</b> run over, or in close proximity to, the <b>{{c2::cervical os}}</b>", "time": null}, {"id": 1463951406234, "note": "<div><div><b>{{c1::Vasa previa}} </b>is a complication of <u>pregnancy</u> that presents with a <b>triad</b> of membrane rupture, <i>painless</i> vaginal bleeding, and fetal bradycardia (&lt; 110 beats/min)</div></div>", "time": null}, {"id": 1463951418297, "note": "<div>What <b>pregnancy complication</b> is associated with <b>painless</b> third trimester bleeding <u>without fetal bradycardia</u>? </div><div><br></div><div>{{c1::Placenta previa}}</div>", "time": null}, {"id": 1463951426347, "note": "<div><div>What <b>pregnancy complication</b> is associated with <b>painless</b> third trimester bleeding <u>with fetal bradycardia (</u>HR &lt;110bpm)? </div><div><br></div><div>{{c1::Vasa previa}}</div></div>", "time": null}, {"id": 1463951456776, "note": "<div><div>What <b>pregnancy complication</b> is associated with <b>painful</b> third trimester bleeding? </div><div><br></div><div>{{c1::Placental abruption}}</div></div>", "time": null}, {"id": 1463951464989, "note": "<div><b>{{c1::Oligohydramnios}}</b> is the presence of <u>too little</u> <b>amniotic fluid</b> and may be associated with <b>placental insufficiency</b>, bilateral renal agenesis, and posterior urethral valves (<b>inability</b> <b>to</b> <b>excrete urine</b>)</div>", "time": 1660105339414.0}, {"id": 1463951475639, "note": "<div>What is the treatment for <b>preeclampsia</b> or <b>eclampsia</b> to&nbsp;<u>prevent</u> <b>seizures</b>?</div><div><br></div><div>{{c1::IV magnesium sulfate}}</div>", "time": null}, {"id": 1463951480447, "note": "<div><b>Gestational diabetes</b> is a result of <u>increased</u> insulin resistance due to elevated levels of {{c1::human placental lactogen}} during pregnancy</div>", "time": 1660105358665.0}, {"id": 1463951489067, "note": "<div>What level of <b>proteinuria</b> is required to make a diagnosis of <b>preeclampsia</b>?<div><br></div><div>{{c1::\u2265 300 mg/day}}</div></div>", "time": null}, {"id": 1463951492922, "note": "<div>What is the <u>most common</u> cause of <b>postpartum hemorrhage</b>?</div><div><br /></div><div>{{c1::Uterine atony}}</div>", "time": null}, {"id": 1463951500613, "note": "<div>The main causes of <b>post-partum hemorrhage</b> may be remembered with the \"<b>4 Ts</b>\": </div><div style=\"centerbox\"><div class=\"mnemonics\"><div><br></div><div>1. {{c1::Uterine aTony (most common)}}</div><div>2. {{c2::Trauma (lacerations, incisions, uterine rupture)}}</div><div>3. {{c3::Thrombin (coagulopathy)}} </div><div>4. {{c4::Tissue (retained products of conception)}}</div></div></div>", "time": null}, {"id": 1463951509378, "note": "<div>What <b>chemotherapeutic drug</b> is used in the treatment of an <b>ectopic pregnancy</b>?</div><div><br></div><div>{{c1::Methotrexate}}</div>", "time": null}, {"id": 1463954126962, "note": "Is <b>Klinefelter syndrome</b> characterized by the <u>presence</u> of an inactivated X chromosome (<b>Barr body</b>)?<div><br></div><div>{{c1::Yes}}</div>", "time": null}, {"id": 1463955278825, "note": "Is <b>Turner syndrome</b> characterized by the <u>presence</u> of an inactivated X chromosome (<b>Barr body</b>)?<div><br /></div><div>{{c1::No (45,XO)}}</div>", "time": null}, {"id": 1463956522023, "note": "Which <u>two</u> <b>breast pathologies</b>&nbsp;affect the <b>stroma</b> of the breast tissue?<div><br></div><div>{{c1::Fibroadenoma and phyllodes tumor}}</div>", "time": null}, {"id": 1463957692573, "note": "What type of <b>breast cancer</b> may present with <b>signet ring cells</b>?<div><br /></div><div>{{c1::Lobular carcinoma (both in situ and invasive)}}</div>", "time": null}, {"id": 1463957763047, "note": "{{c1::Gynecomastia}} is defined as <b>breast enlargement</b> in <b>males</b> due to <u>increased estrogen</u> compared with androgen activity", "time": null}, {"id": 1463957794588, "note": "<u>Physiologic</u> <b>gynecomastia</b> may occur in {{c1::newborn}}, {{c2::pubertal}}, and {{c3::elderly}} males", "time": null}, {"id": 1463957828496, "note": "What <b>drugs</b> are commonly associated with <b>gynecomastia</b>? <div><br></div><div>{{c1::Spironolactone, Hormones, Cimetidine, and Ketoconazole::4}}</div>", "time": null}, {"id": 1463957933297, "note": "<b>Gynecomastia</b> is associated with increased levels of {{c1::estrogen}} (e.g. {{c3::cirrhosis::liver}}), decreased levels of androgens (ex {{c2::Klinefelter}} syndrome), or testicular tumors (ex. {{c4::Leydig}} cell tumor)", "time": null}, {"id": 1463958394262, "note": "What type of <b>ovarian neoplasm</b> is often described as a <b>yellow, friable (hemorrhagic) solid mass</b>?<div><br /></div><div>{{c1::Yolk sac (endodermal sinus) tumor}}</div>", "time": null}, {"id": 1463958628607, "note": "Which <b>ovarian neoplasm</b> is most commonly associated with an <u>increased</u> <b>LDH</b>?<div><br></div><div>{{c1::Dysgerminoma}}</div>", "time": null}, {"id": 1463958668258, "note": "Which <b>ovarian neoplasm</b> is most commonly associated with an <u>increased</u> <b>AFP</b>?<div><br></div><div>{{c1::Yolk sac (endodermal sinus) tumor}}</div>", "time": null}, {"id": 1463958744601, "note": "<b>Theca-lutein cysts</b> are often associated with {{c1::choriocarcinoma}} and {{c1::hydatidiform moles}}", "time": null}, {"id": 1464061546338, "note": "<div>What is the <b>treatment of choice</b> for a pregnant women with <b>hyperthyroidism</b> in the <u>first trimester</u>?<br><br></div><div>{{c1::Propylthiouracil (PTU)}}</div>", "time": 1660105359152.0}, {"id": 1464061625945, "note": "<div>What is the <b>treatment of choice</b> for a pregnant woman with <b>hyperthyroidism</b> in the <u>second/third trimester</u>?<br></div><div><div><br></div><div>{{c1::Methimazole}}</div></div>", "time": 1660105359151.0}, {"id": 1464300429805, "note": "<div><b>{{c1::Propylthiouracil</b> (PTU)<b>}}</b> is used to treat <b>hyperthyroidism</b> by blocking {{c2::<i>both</i> thyroid peroxidase and 5-deiodinase}}</div>", "time": 1660105359160.0}, {"id": 1464300798101, "note": "<div><div><b>{{c2::Methimazole}} </b>is used to treat <b>hyperthyroidism</b> by blocking {{c1::thyroid peroxidase <i>only</i>}}</div></div>", "time": 1660105359155.0}, {"id": 1464300810389, "note": "<div><div><b>{{c1::Levothyroxine}}</b> is a <b>T<sub>4</sub> hormone analog</b> used to treat hypothyroidism and myxedema</div></div>", "time": 1660105359161.0}, {"id": 1464300847477, "note": "<div>What <u>adverse effects</u>&nbsp;on the <b>heart</b> are associated with <b>thyroid hormone replacement</b> <b>therapy</b> (e.g. levothyroxine and triiodothyronine)?<br></div><div><br></div><div>{{c1::Tachycardia, arrhythmias::2}}</div>", "time": 1660105359171.0}, {"id": 1464300876421, "note": "<div>Which <u>pituitary hormone</u> is useful for <b>stimulating labor</b> via the induction of <b>uterine contractions</b>? </div><div><br /></div><div>{{c1::Oxytocin}}</div>", "time": null}, {"id": 1464300976080, "note": "<div><b>{{c1::Cinacalcet}}</b> may be used in the treatment of primary or secondary <b>{{c2::hyperparathyroidism}}</b> by increasing sensitivity to Ca<sup>2+</sup>-sensing receptors<br></div>", "time": 1660105359165.0}, {"id": 1464371990594, "note": "What <i>enzyme</i> is responsible for metabolizing <b>sorbitol</b> into <b>fructose</b>?<div><br /></div><div>{{c1::sorbitol dehydrogenase}}</div>", "time": null}, {"id": 1464478354579, "note": "<div><i><div></div></i></div><div>Which <u>antacid</u> is associated with <b>constipation</b> if overused?</div><div><br></div><div>{{c1::Aluminum hydroxide}}</div>", "time": 1660105359129.0}, {"id": 1464478365999, "note": "<div><i><div></div></i></div><div>Which <b>antacid</b> is associated with <b>diarrhea</b> if overused?</div><div><br></div><div>{{c1::Magnesium hydroxide}}</div>", "time": 1660105359128.0}, {"id": 1464478389699, "note": "<div><i><div></div></i></div><div>Which <u>antacid</u> is associated with <b>proximal muscle weakness</b> and <b>seizures</b> if overused? </div><div><br></div><div>{{c1::Aluminum hydroxide}}</div>", "time": 1660105359124.0}, {"id": 1464478399061, "note": "<div><i><div></div></i></div><div>Which <u>antacid</u> is associated with <b>hypophosphatemia</b> and <b>osteodystrophy</b> if overused? </div><div><br></div><div>{{c1::Aluminum hydroxide}} </div>", "time": 1660105359126.0}, {"id": 1464478432028, "note": "<div>Which <b>antacid</b> is associated with <b>hypercalcemia</b> (<u>milk-alkali syndrome</u>) and <b>rebound acid increase</b>?<br></div><div><br></div><div>{{c1::Calcium carbonate}}</div>", "time": 1660105359127.0}, {"id": 1464478461799, "note": "<div><i><div></div></i></div><div>What drugs are characterized by <b>binding to an ulcer base</b> and providing <b>physical protection</b>? </div><div><br></div><div>{{c1::Bismuth, sucralfate::2}}</div>", "time": 1660105359123.0}, {"id": 1464478477613, "note": "<div><i><div></div></i></div><div><b>Bismuth </b>and <b>sucralfate</b> may be used to <u>increase</u> {{c1::ulcer}} healing</div><div><br></div><div><i><br></i></div>", "time": 1660105359139.0}, {"id": 1464478493034, "note": "<div><b>{{c2::Sulfasalazine}}</b> is a combination drug that may be used to treat <b>{{c1::ulcerative colitis}}</b> and {{c1::<b>Crohn disease</b> (colitis component)}}<br></div>", "time": 1660105359118.0}, {"id": 1464478523728, "note": "<div>What is the <u>clinical use</u> for <b>orlistat</b>?<br></div><div><br></div><div>{{c1::Weight loss}}</div>", "time": 1660105359142.0}, {"id": 1464478542649, "note": "<div><i><div></div></i></div><div><b>{{c2::Orlistat}}</b> is an inhibitor of gastric and pancreatic <b>{{c1::lipase}}</b>, thus leading to <u>decreased</u> breakdown and absorption of <b>dietary {{c1::fats}}</b></div>", "time": 1660105359120.0}, {"id": 1464524897579, "note": "<div>Which <b>ulcerative colitis drug</b> is associated with <i>reversible</i> <b>oligospermia</b>?<br></div><div><br>{{c1::Sulfasalazine}} </div>", "time": 1660105359122.0}, {"id": 1467680889892, "note": "<div>A(n)&nbsp;<b>{{c1::nucleosome</b> (10 nm chromatin)<b>}}</b> is <i>negatively</i> charged <u>DNA</u> wrapped around the outside of <i>positively</i> charged proteins called {{c2::histones}}</div>", "time": null}, {"id": 1467682100570, "note": "<div><div><div><b>Histones</b> are rich in the amino acids {{c1::lysine}} and {{c1::arginine}}</div></div></div>", "time": null}, {"id": 1467682104886, "note": "<div><div><div>What <u>class</u> of <b>histone</b> is <u>not</u> found as a <b>pair</b> in a nucleosome? </div><div><br /></div><div>{{c1::H1}}</div></div></div>", "time": null}, {"id": 1467682112238, "note": "<div><div><div>What <u>class</u> of <b>histone</b> is found <i>outside</i> the nucleosome and functions to <b>condense</b> <b>the</b> <b>nucleosome</b> together?</div><div><br /></div><div>{{c1::H1}}</div></div></div>", "time": null}, {"id": 1467682119151, "note": "<div><div><div>What <u>classes</u> of <b>histones</b> are found as a <b>pair</b> in the nucleosome?</div><div><br></div><div>{{c1::H2A, H2B, H3, H4::4}} </div></div></div>", "time": null}, {"id": 1467682127205, "note": "<div><div>What is the function of the <b>H1</b> class of <b>histones</b>?</div><div><br /></div><div>{{c1::Condense/link the nucleosomes together}} </div></div>", "time": 1659936973347.0}, {"id": 1467682132293, "note": "<div>A(n) {{c1::nucleosome}} is made up of a <b>strand of DNA</b> wrapped <i>nearly twice</i> around <i>two</i> copies of H2A, H2B, H3, and H4</div>", "time": null}, {"id": 1467682141963, "note": "<div>In {{c1::<b>mitosis::</b>cell cycle phase}}, DNA condenses to form <b>chromosomes</b></div>", "time": 1659936990197.0}, {"id": 1467682151814, "note": "<div><div>What cell cycle phase do DNA and histone <b>synthesis</b> occur?</div><div><br></div><div>{{c1::S phase}}</div></div>", "time": 1659937001282.0}, {"id": 1467682160443, "note": "<div><div>What form of <b>chromatin</b> is <u>highly</u> condensed? </div><div><br></div><div>{{c1::Heterochromatin}}</div></div>", "time": null}, {"id": 1467682164864, "note": "<div><div><div>What form of <b>chromatin</b> is <u>less</u> condensed? </div><div><br></div><div>{{c1::Euchromatin}}</div></div></div>", "time": null}, {"id": 1467682168594, "note": "<div><div><div>What form of <b>chromatin</b> appears <u>darker</u> on EM? </div><div><br /></div><div>{{c1::Heterochromatin}}</div></div></div>", "time": null}, {"id": 1467682176839, "note": "<div><div><div>What form of <b>chromatin</b> appears <u>lighter</u> on EM? </div><div><br /></div><div>{{c1::Euchromatin}}</div></div></div>", "time": null}, {"id": 1467682184880, "note": "<div><div><div>What form of <b>chromatin</b> is transcriptionally <u>inactive</u> and sterically inaccessible? </div><div><br></div><div>{{c1::Heterochromatin}}</div></div></div>", "time": 1659989252623.0}, {"id": 1467682191339, "note": "<div><div><div>What form of <b>chromatin</b> is transcriptionally <u>active</u> and sterically accessible? </div><div><br></div><div>{{c1::Euchromatin}}</div></div></div>", "time": 1659989265369.0}, {"id": 1467682203692, "note": "<div><div>{{c1::Heterochromatin}} is the <u>highest</u> order of packaging of the chromosome</div></div>", "time": null}, {"id": 1467682210281, "note": "<div><div><div>Without <b>H1</b>, the <b>nucleosome</b> exists as {{c1::10}} nm chromatin</div></div></div>", "time": null}, {"id": 1467682218464, "note": "<div><div>With <b>H1</b>, the <b>nucleosome</b> exists as {{c1::30}} nm chromatin</div></div>", "time": null}, {"id": 1467682225986, "note": "<div>What process is used by <b>mismatch repair enzymes</b> to distinguish between <u>old</u> and <u>new</u> <b>DNA strands</b> in prokaryotes?</div><div><br /></div><div>{{c1::DNA methylation}}</div>", "time": null}, {"id": 1467682230375, "note": "<div><b>DNA</b> <b>{{c1::methylation}}</b> at <b>{{c2::CpG}}</b> <b>islands</b> {{c3::represses}} transcription</div>", "time": null}, {"id": 1467682236755, "note": "<div><b>Histone</b> <b>{{c1::methylation}}</b> <i>usually</i> reversibly {{c2::<u>represses</u>}} DNA transcription</div>", "time": null}, {"id": 1467682246440, "note": "<div><b>Histone {{c1::acetylation}}</b> usually {{c2::<u>activates</u>}} DNA transcription</div>", "time": 1659989289817.0}, {"id": 1467682438089, "note": "<div>What process takes <b>DNA</b> and makes more <b>DNA</b>? </div><div><br /></div><div>{{c1::Replication}}</div>", "time": null}, {"id": 1467683632126, "note": "<div><div>What process takes <b>DNA</b> and makes <b>RNA</b>? </div><div><br /></div><div>{{c1::transcription}}</div></div>", "time": null}, {"id": 1467683640354, "note": "<div><div>What process takes <b>RNA</b> and makes <b>protein</b>? </div><div><br /></div><div>{{c1::translation}}</div></div>", "time": null}, {"id": 1467683671375, "note": "<div>How many <u>ring(s)</u> do <b>purines</b> have?</div><div><br /></div><div>{{c1::Two}} </div>", "time": null}, {"id": 1467683685406, "note": "<div><div>How many <u>ring(s)</u> do <b>pyrimidines</b> have?</div><div><br /></div><div>{{c1::One}}</div></div>", "time": null}, {"id": 1467683698106, "note": "<div><div><div>Which <b>bases</b> are <b>purines</b>? </div><div><br></div><div>{{c1::Adenine and guanine}}</div></div></div>", "time": 1659989301037.0}, {"id": 1467683705831, "note": "<div><div><div>Which <b>bases</b> are <b>pyrimidines</b>?</div><div><br></div><div>{{c1::Cytosine, uracil, and thymine}}</div></div></div>", "time": 1659989304235.0}, {"id": 1467683713918, "note": "<div><div><div>Which <b>purine</b> is characterized by an <b>amino group</b> at the 12 oclock position?</div><div><br /></div><div>{{c1::Adenine}}</div></div></div>", "time": null}, {"id": 1467683722745, "note": "<div><div><div><div>Which <b>purine</b> is characterized by <b><u>no</u></b> <b>amino group</b> at the 12 oclock position?</div><div><br /></div><div>{{c1::Guanine}}</div></div></div></div>", "time": null}, {"id": 1467683729345, "note": "<div><div><div>Which <b>pyrimidine</b> is characterized by an <b>amino group</b> at the 12 oclock position?</div><div><br /></div><div>{{c1::Cytosine}}</div></div></div>", "time": null}, {"id": 1467683736978, "note": "<div><div><div><div><div>Which <b>pyrimidine</b> is characterized by <b><u>no</u></b> <b>amino group</b> at the 12 oclock position AND <b style=\"text-decoration: underline; \">no</b> <b>methyl</b> <b>group(s)</b>?</div><div><br /></div><div>{{c1::Uracil}}</div></div></div></div></div>", "time": null}, {"id": 1467683748989, "note": "<div><div><div><div><div>Which <b>pyrimidine</b> is characterized by the presence of <b>methyl groups</b>, but <b><u>no</u></b> <b>amino group</b> at the 12 oclock position?</div><div><br></div><div>{{c1::Thymine}}</div></div></div></div></div>", "time": null}, {"id": 1467683757507, "note": "<div><div><div>{{c1::<b>Deamination</b>}} of <b>cytosine</b> makes {{c2::<b>uracil</b>}}</div></div></div>", "time": null}, {"id": 1467683773187, "note": "<div><div>What is the difference (structurally) between <b>thymine</b> and <b>uracil</b>?</div><div><br /></div><div>{{c1::Thymine has a methyl group, uracil does not}}</div></div>", "time": null}, {"id": 1467683782311, "note": "<div><div>Which <b>pyrimidine</b> is found in <b>DNA </b><i style=\"font-weight: bold; \">only</i>?</div><div><br></div><div>{{c1::Thymine}}</div></div>", "time": 1659989314236.0}, {"id": 1467683785823, "note": "<div><div><div>Which <b>pyrimidine</b> is found in <b>RNA </b><i style=\"font-weight: bold; \">only</i>?</div><div><br></div><div>{{c1::Uracil}}</div></div></div>", "time": 1659989316837.0}, {"id": 1467683821663, "note": "<div><div>Which carbon <u>lacks</u> a <b>hydroxyl </b>group in DNA strands?</div><div><br></div><div>{{c1::2 carbon}}</div></div>", "time": null}, {"id": 1467683827712, "note": "<div><div><div>DNA &amp; RNA are made of <b>{{c1::nucleotide monophosphates}}</b> connected via a(n) {{c2::<b>phosphodiester</b>}} bond</div></div></div>", "time": 1659989347247.0}, {"id": 1467683837488, "note": "<div><div><div>Generally, the <b>5 end</b> of DNA or RNA is a(n) {{c1::phosphate}} group</div></div></div>", "time": null}, {"id": 1467683840789, "note": "<div><div><div>Generally, the <b>3 end</b> of DNA or RNA is a(n) {{c1::hydroxyl}} group</div></div></div>", "time": null}, {"id": 1467683857613, "note": "<div>What <u>amino acids</u>&nbsp;are necessary for <b>purine synthesis</b>? </div><div><br></div><div>{{c1::Glycine, Aspartate, Glutamine::3}}</div>", "time": null}, {"id": 1467771663505, "note": "<div>One feature of the <b>genetic code</b> is that it is {{c1::unambiguous}}: each codon specifies only 1 amino acid</div>", "time": null}, {"id": 1467771674094, "note": "<div>One feature of the <b>genetic code</b> is that it is {{c1::degenerate/redundant}}: most amino acids are coded by <i>multiple</i> codons </div>", "time": null}, {"id": 1467771685074, "note": "<div>One feature of the <b>genetic code</b> is that it is {{c1::commaless, nonoverlapping}}: it is read from a fixed starting point as a continuous sequence of bases</div>", "time": null}, {"id": 1467771694239, "note": "<div>One feature of the <b>genetic code</b> is that it is {{c1::universal}}: genetic code is conserved throughout evolution</div>", "time": null}, {"id": 1467771708980, "note": "<div>Of the 64 possible codons, how many encode amino acids?</div><div><br></div><div>{{c1::61 (3 are stop codons)}}</div>", "time": null}, {"id": 1467771721122, "note": "<div>Which sequence of bases is a <b>start codon</b> (methionine) in <u>mRNA</u>? </div><div><br></div><div>{{c1::AUG}}</div>", "time": null}, {"id": 1467771730067, "note": "<div>What does <b>AUG</b> encode for in <i>eukaryotes</i>?</div><div><br /></div><div>{{c1::Methionine (start codon)}}</div>", "time": null}, {"id": 1467771738865, "note": "<div><div>What does <b>AUG</b> encode for in <i>prokaryotes</i>?</div><div><br /></div><div>{{c1::N-formylmethionine, or fMet (start codon)}}</div></div>", "time": null}, {"id": 1467771753315, "note": "<div>Which <u>three</u> sequences of bases are mRNA <b>stop codons</b>? </div><div><br></div><div>{{c1::<b>UGA</b>, <b>UAA</b>, <b>UAG</b>}}</div>", "time": null}, {"id": 1467771762899, "note": "<div>The {{c1::origin of replication}} is a particular consensus sequence of base pairs in a genome where <b>DNA replication begins</b> </div>", "time": null}, {"id": 1467771772782, "note": "<div>{{c1::AT}}-rich sequences are found in <b>promoters</b> and <b>origins</b> <b>of replication</b></div>", "time": null}, {"id": 1467771777297, "note": "<div>The {{c1::replication fork}} is a Y-shaped region along the DNA template where <b>leading</b> and <b>lagging strands are synthesized</b> </div>", "time": 1660105349054.0}, {"id": 1467771785512, "note": "<div>Which enzyme is responsible for <b>unwinding the DNA template</b> at the replication fork? </div><div><br /></div><div>{{c1::Helicase}} </div>", "time": null}, {"id": 1467771793359, "note": "<div>{{c1::Single-stranded binding}} proteins <u>prevent</u><b> DNA strands from reannealing</b> during replication </div>", "time": null}, {"id": 1467771801123, "note": "<div>Which enzyme is responsible for <b>relaxing the DNA strand</b> by creating single- or double-stranded breaks in the DNA helix to add/remove supercoils? </div><div><br></div><div>{{c1::Topoisomerase}} </div>", "time": null}, {"id": 1467771810893, "note": "<div>What is another name for <i>prokaryotic</i> topoisomerase II? </div><div><br></div><div>{{c1::DNA gyrase}}</div>", "time": null}, {"id": 1467771816667, "note": "<div>What class of drugs inhibits <i>prokaryotic</i> <b>topoisomerase II</b> and <b>topoisomerase IV</b>? </div><div><br></div><div>{{c1::Fluoroquinolones}}</div>", "time": null}, {"id": 1467771829884, "note": "<div><div>What <u>chemotherapeutic </u><u>drugs</u> (2) inhibit <i>eukaryotic</i> <b>topoisomerase II</b>? </div><div><br></div><div>{{c1::etoposide/teniposide}}</div></div>", "time": null}, {"id": 1467771834622, "note": "<div>Which enzyme is responsible for <b>making an RNA primer</b> on which DNA polymerase III can initiate replication (<u>prokaryotes</u>)? </div><div><br></div><div>{{c1::Primase}}</div>", "time": null}, {"id": 1467771842612, "note": "<div>Which enzyme is responsible for <b>elongating the DNA strand</b>? </div><div><br></div><div>{{c1::DNA polymerase (specifically, DNA polymerase III in <u>prokaryotes</u>)}}</div>", "time": null}, {"id": 1467771853847, "note": "<div><div><div><b>{{c2::DNA}} polymerase</b> <i>must</i> see a(n) {{c1::<b>RNA primer</b>}} to bind, which is <b>complementary</b> and <b>antiparallel</b> to the polymerase</div></div></div>", "time": null}, {"id": 1467771862566, "note": "<div><div><div><b>DNA/RNA polymerase</b> always <i>read</i> in the {{c1::3 to 5}} direction</div></div></div>", "time": null}, {"id": 1467771867525, "note": "<div><div><div><b>DNA/RNA polymerase</b> always <i>build</i> in the {{c1::5 to 3}} direction</div></div></div>", "time": null}, {"id": 1467771872364, "note": "<div><div><div><b>DNA polymerase </b>pauses and checks (\"<b>proof-reads</b>\") via {{c1::3 -&gt; 5 exonuclease}} activity</div><div></div></div></div>", "time": null}, {"id": 1467771886505, "note": "<div>Which enzymes are responsible for <b>removing the RNA primer</b> in <i><u>eukaryotes</u></i>? </div><div><br></div><div>{{c1::RNase H and FEN-1::2}}</div>", "time": null}, {"id": 1467771897291, "note": "<div>Which enzyme catalyzes the formation of a phosphodiester bond between <b>Okazaki</b> <b>fragments</b>?</div><div><br></div><div>{{c1::DNA ligase}}</div>", "time": null}, {"id": 1467771904154, "note": "<div>The enzyme which adds {{c2::<u>TTAGGG</u>::sequence}} to 3 ends of chromosomes to <b>avoid loss of genetic material</b> with every duplication is known as {{c1::<b>Telomerase</b>}}</div>", "time": null}, {"id": 1467771911742, "note": "<div><div>Which replication enzyme is a <b>RNA-dependent</b> <b>DNA</b> <b>polymerase</b>, and thus a major example of reverse transcriptase activity, in humans? </div><div><br /></div><div>{{c1::Telomerase}} </div></div>", "time": null}, {"id": 1467771917029, "note": "<div><div><div>Telomerase is a rare example where <b>{{c1::reverse transcriptase::enzyme}}</b> activity occurs <i>endogenously</i> in humans </div></div></div>", "time": null}, {"id": 1467771922095, "note": "<div><div><div>What pathology is associated with <u>increased</u> telomerase activity?</div><div><br /></div><div>{{c1::Cancer}}</div></div></div>", "time": 1660105345074.0}, {"id": 1467771928859, "note": "<div><div><div><div><b>{{c1::RNA}} polymerase</b> <u>doesnt have to</u> see a <b>RNA primer</b> to bind</div><div></div></div></div></div>", "time": null}, {"id": 1467771941535, "note": "<div>Which type of <b>DNA</b> <b>mutation</b> causes the <u>least</u> severe damage? </div><div><br></div><div>{{c1::Silent mutations}}</div>", "time": 1660105341851.0}, {"id": 1467771949843, "note": "<div><div>Which type of <b>DNA</b> <b>mutation</b> causes the <u>most</u> severe damage? </div><div><br /></div><div>{{c1::frameshift mutations}}</div></div>", "time": 1660105341850.0}, {"id": 1467771958669, "note": "<div>A(n) {{c1::transition}} is type of <b>DNA mutation</b> in which a purine is mutated to another purine (or pyrimidine to pyrimidine)</div>", "time": null}, {"id": 1467771962365, "note": "<div>A(n) {{c1::transversion}} is a type of <b>DNA mutation</b> in which a purine is mutated into a pyrimidine, and vice versa</div>", "time": null}, {"id": 1467771965298, "note": "<div>What <u>class</u> of <b>DNA mutations</b> are characterized by a <i>single</i> nucleotide change? </div><div><br></div><div>{{c1::Point mutations}}</div>", "time": null}, {"id": 1467771968226, "note": "<div>A(n)&nbsp;<b>{{c1::silent}} mutation</b> occurs when a nucleotide substitution codes for the <u>same</u> amino acid</div>", "time": null}, {"id": 1467771977177, "note": "<div>A(n)&nbsp;<b>{{c1::missense}} mutation</b> occurs when a nucleotide substitution codes for a <u>different</u> amino acid</div>", "time": null}, {"id": 1467771988825, "note": "<div>A(n)&nbsp;<b>{{c1::nonsense}} mutation</b> occurs when a nucleotide substitution codes for a <b>stop</b> codon</div>", "time": null}, {"id": 1467771998020, "note": "<div>A(n)&nbsp;<b>{{c1::frameshift}} mutation</b> occurs when there is a <u>deletion</u> or <u>insertion</u> of a number of nucleotides <b>not divisible by {{c2::3}}</b>, resulting in misreading of all nucleotides downstream</div>", "time": 1660105362411.0}, {"id": 1467772007821, "note": "<div><div>A mutation at a(n) {{c1::splice site}} results in a <b>retained intron</b> in the mRNA, leading to a protein with impaired or altered function</div></div>", "time": 1660105362505.0}, {"id": 1467818125623, "note": "<div><div>What mutation is induced by <b>UV radiation</b>?</div><div><br></div><div>{{c1::Pyrimidine dimers (e.g. thymine dimers)}}</div></div>", "time": null}, {"id": 1467819685605, "note": "<div><div>What form of <b>DNA repair</b> fixes mutations induced by UV radiation?</div><div><br></div><div>{{c1::Nucleotide excision repair}}</div></div>", "time": null}, {"id": 1467819699712, "note": "<div><div>The enzyme that <u>recognizes</u> and <u>excises</u> <b>pyrimidine dimer</b> mutations is {{c1::excision endonuclease}}</div></div>", "time": null}, {"id": 1467819708854, "note": "<div><div>The enzymes that <u>repair</u> <b>pyrimidine dimer</b> mutations are {{c1::DNA polymerase}} and {{c1::DNA ligase}}</div></div>", "time": null}, {"id": 1467819713749, "note": "<div><div>What phase of the cell cycle do <b><u>nucleotide</u> excision repairs</b> occur?</div><div><br></div><div>{{c1::G<sub>1</sub>}}</div></div>", "time": null}, {"id": 1467819717437, "note": "<b>Xeroderma Pigmentosum</b> is an inherited pathology due to a defective {{c1::Nucleotide Excision Repair}} pathway", "time": null}, {"id": 1467819733331, "note": "<div><div><div>What form of <b>DNA repair</b> fixes mutations due to DNA replication errors?</div><div><br></div><div>{{c1::Mismatch repair}}</div></div></div>", "time": null}, {"id": 1467819736477, "note": "<div><div><u>Recognition</u> and <u>facilitation of excision</u> of <b>{{c2::mismatched nucleotides}}</b> occur via enzymes found on <b>two</b> genes: {{c1::<b>MSH2 (MutS)</b>}} or {{c1::<b>MLH1 (MutL)</b>}} </div></div>", "time": null}, {"id": 1467819747337, "note": "<div><div>The enzymes that <u>repair</u> <b>mismatched base</b> mutations are {{c1::DNA polymerase}} and {{c1::DNA ligase}}</div></div>", "time": null}, {"id": 1467819753003, "note": "<div><div>What pathology is characterized by a deficiency of the <u>enzymes</u> used in <b>mismatch base repair</b>? </div><div><br></div><div>{{c1::Lynch syndrome (hereditary nonpolyposis colorectal cancer [HNPCC])}}</div></div>", "time": null}, {"id": 1467819757446, "note": "<div><div>What phase of the cell cycle do <b>mismatch base repairs</b> <u>predominantly</u> occur?</div><div><br></div><div>{{c1::S}}</div></div>", "time": null}, {"id": 1467819760893, "note": "<div><div>{{c1::Deamination (e.g. cytosine to uracil)}} is a mutation that may occur <u>spontaneously</u> or due to <u>heat</u> or <u>nitrates</u> </div></div>", "time": null}, {"id": 1467819790375, "note": "<div><div><div>What form of <b>DNA repair</b> fixes mutations due to spontaneous/toxic deamination?</div><div><br></div><div>{{c1::Base excision repair}}</div></div></div>", "time": 1660105347083.0}, {"id": 1467819793606, "note": "<div><div>In <b>base excision repair</b>, base-specific {{c1::glycosylases}} <u>remove</u> the altered base and create a(n) {{c2::AP (apurinic/apyrimidinic)}} site </div></div>", "time": null}, {"id": 1467819801792, "note": "<div><div>Which <b>base excision repair </b>enzyme is responsible for <u>removing nucleotides</u> at the <b>5 end</b>?</div><div><br /></div><div>{{c1::AP-endonuclease}} </div></div>", "time": null}, {"id": 1467819810778, "note": "<div><div><div>Which <b>base excision repair </b>enzyme is responsible for <u>removing nucleotides</u> at the <b>3 end</b>?</div><div><br /></div><div>{{c1::Lyase}} </div></div></div>", "time": null}, {"id": 1467819815746, "note": "<div><div>Which <b>base excision repair </b>enzymes are responsible for <u>filling</u> and <u>sealing</u> the gap from the <b>excised</b> <b>bases</b>?</div><div><br></div><div>{{c1::DNA polymerase-\u03b2::specific}} (filling) and {{c1::DNA ligase III::specific}} (sealing)</div></div>", "time": null}, {"id": 1467819819593, "note": "<div><div>What phase of the cell cycle do <b><u>base</u> excision repairs</b> occur?</div><div><br></div><div>{{c1::Throughout the cell cycle}}</div></div>", "time": null}, {"id": 1467819823153, "note": "<div><div>Which forms of <b>DNA repair</b> repairs double-stranded breaks (due to <u>ionizing radiation)</u>?</div><div><br></div><div>{{c1::Nonhomologous end joining}} and {{c2::homologous recombination}}</div></div>", "time": 1660105343022.0}, {"id": 1467819833068, "note": "<div>Mechanisms to repair {{c1::dsDNA}} breaks are defective in Ataxia telangiectasia, Fanconi anemia, and SCID</div>", "time": null}, {"id": 1467819843271, "note": "<div>The <b>{{c2::triphosphate}}</b> <b>bond </b>of DNA is the target of <b>{{c1::3 hydroxyl}} </b>attack (strand elongation) </div>", "time": null}, {"id": 1467833317937, "note": "<div><div>Does <b>reverse transcriptase</b> require a primer?</div><div><br></div><div>{{c1::Yes! Because it is a DNA polymerase (RNA dependent DNA polymerase)}}</div></div>", "time": null}, {"id": 1467833327674, "note": "<div>While DNA polymerase binds to a primer, <b>RNA polymerase</b> binds to a(n) {{c1::<b>promoter</b>}}</div>", "time": null}, {"id": 1467833332774, "note": "<div>The {{c1::template}} strand is the dsDNA strand used for transcription; it is <b>complementary</b> and <b>antiparallel</b> to mRNA</div>", "time": null}, {"id": 1467833342686, "note": "<div>The {{c1::coding}} strand is the strand of dsDNA that is <u>NOT</u> used during transcription, but is <b>identical to mRNA</b> (substitute T/U)</div>", "time": null}, {"id": 1467833373021, "note": "<div>The dsDNA sequence reported in <b>databases</b> is the {{c1::coding}} strand, unless specifically stated otherwise<br></div>", "time": null}, {"id": 1467833376501, "note": "<div><div><u>Practice</u>: If a DNA template sequence is TAGC, what is the mRNA sequence?</div><div><br /></div><div>{{c1::GCUA}}</div></div>", "time": null}, {"id": 1467833390571, "note": "<div>The {{c1::untranslated region (UTR)}} of m<b>RNA </b>is the portion of mRNA which contains no protein information</div>", "time": 1660105348985.0}, {"id": 1467833411276, "note": "<div><div>Does <u>prokaryotic</u> mRNA have introns and exons?</div><div><br></div><div>{{c1::No}}  </div></div>", "time": null}, {"id": 1467833441597, "note": "<div><div>In <i>eukaryotes</i>, each gene has its <i>own</i> {{c1::promoter}}, to which RNA polymerase II may bind </div></div>", "time": null}, {"id": 1467833642875, "note": "<div><div><div>The initial mRNA of <i>eukaryotes</i> contains <b>{{c1::introns}}</b> and <b>{{c1::exons}}</b>, which undergo splicing</div></div></div>", "time": null}, {"id": 1467833651277, "note": "<div>The <b>{{c1::promoter}}</b> is the site where <b>{{c2::RNA polymerase II}}</b> and general transcription factors bind to DNA upstream from a gene locus</div>", "time": null}, {"id": 1467833654903, "note": "<div>The <b>promoter</b> is an AT-rich upstream sequence with {{c1::TATA}} and {{c1::CAAT}} boxes </div>", "time": null}, {"id": 1467833662315, "note": "<div>A <u>mutation</u> in the <b>promoter</b> commonly results in a dramatic {{c1::decrease}} in the level of gene transcription</div>", "time": null}, {"id": 1467833666692, "note": "<div><div><b>Promoters</b> serve as binding sites for {{c1::general::general/specific}} transcription factors&nbsp;</div></div>", "time": null}, {"id": 1467833682877, "note": "<div><div>{{c1::Enhancers}}<b> </b>are stretches of DNA that <b>increase</b> <b>gene</b> <b>expression</b> by binding <i>specific </i>transcription factors</div></div>", "time": null}, {"id": 1467833689549, "note": "<div><div>{{c1::Silencers}} are sites where <b>negative</b> <b>regulators</b> (repressors) bind to DNA</div></div>", "time": null}, {"id": 1467833693475, "note": "<div><div><b>Enhancers</b> increase transcription via enhanced activity of the enzyme {{c1::RNA polymerase II}}</div></div>", "time": null}, {"id": 1467833697927, "note": "<div><div><b>Enhancers</b> serve as binding sites for {{c1::specific::specific/general}} transcription factors</div><div></div></div>", "time": null}, {"id": 1467833712322, "note": "<div><div>Are <b>enhancers</b>/<b>silencers</b> <i>close</i> or <i>far</i> from the gene it regulates?</div><div><br></div><div>{{c1::May be close to, far from, or within the gene (in an intron)}}</div></div>", "time": 1660105361616.0}, {"id": 1467833724957, "note": "<div><div><div>How can <b>enhancers</b> be far away from the gene it regulates?</div><div><u><br /></u></div><div>{{c1::DNA will bend to bring enhancer to promoter}} </div></div></div>", "time": null}, {"id": 1467833758513, "note": "<div><div><div>What <u>class</u> of <b>protein</b> <b>receptor</b> is common to<i> all</i> <b>steroid</b> <b>hormones</b>, <b>thyroid</b> <b>hormones</b>, and <b>vitamins</b> <b>A/D</b>?</div><div>  </div><div><br></div><div>{{c1::Zinc finger}}</div></div></div>", "time": null}, {"id": 1467833798088, "note": "<div><div><div><div>What morning sickness drug (no longer used) <i>inadvertently</i> <u>prevents binding</u>&nbsp;of&nbsp;<b>homeodomain</b> <b>proteins</b> to enhancers, thus causing limb abnormalities? </div><div><br></div><div>{{c1::Thalidomide}}</div></div></div></div>", "time": null}, {"id": 1467833814403, "note": "<div><div><div>What class of drugs acts via <u>activation</u> of <b>PPAR-alpha</b>?</div><div><br /></div><div>{{c1::Fibrates}} </div></div></div>", "time": null}, {"id": 1467833820283, "note": "<div><div><div>{{c1::<b>Nuclear factor kappa B</b> (NF-kB)}} is a <u>specific transcription factor</u> that binds kB elements, which regulates expression of many genes in the <b>immune</b> <b>system</b></div></div></div>", "time": null}, {"id": 1467833823409, "note": "<div><div><div>What class of drugs acts via <u>suppression</u> of <b>NF-kB signaling</b>? </div><div><u><br></u></div><div>{{c1::Glucocorticoids}}</div></div></div>", "time": null}, {"id": 1467833832000, "note": "<div>RNA polymerase {{c1::I}} makes {{c2::r}}RNA </div>", "time": 1660105353235.0}, {"id": 1467833839824, "note": "<div>RNA polymerase {{c1::II}} makes {{c2::m}}RNA  </div>", "time": 1660105353238.0}, {"id": 1467833846822, "note": "<div>RNA polymerase {{c1::III}} makes {{c2::t}}RNA and 5S rRNA </div><div></div>", "time": null}, {"id": 1467833855389, "note": "<div>Which <b>RNA</b> <b>polymerase</b> binds to DNA at a promoter site?</div><div><br></div><div>{{c1::RNA polymerase II}}</div>", "time": null}, {"id": 1467833857831, "note": "<div>In <i>eukaryotes</i>, <b>{{c2::RNA polymerase II}}</b> may be <u>inhibited</u> by {{c1::<b>\u03b1-amanitin</b>}}</div>", "time": null}, {"id": 1467833865131, "note": "<div>What drug is an <u>inhibitor</u> of <i>prokaryotic</i> <b>RNA polymerase</b>? </div><div><br></div><div>{{c1::Rifampin}}</div>", "time": null}, {"id": 1467833873415, "note": "<div><div>What drug is an <u>inhibitor</u> of <i>both </i>prokaryotic AND eukaryotic <b>RNA polymerase</b>? </div><div><br></div></div><div>{{c1::Actinomycin D}}</div>", "time": null}, {"id": 1467927049625, "note": "<div><div><div>How many <i>different</i> <b>RNA polymerases</b> do prokaryotes have? </div><div><br></div><div>{{c1::One (makes all 3 kinds of RNA)}}</div></div></div>", "time": 1660105357981.0}, {"id": 1467927060428, "note": "<div><div><div>The <u>initial</u> (primary) transcript transcribed from <i>eukaryotic</i> DNA is {{c1::heterogenous nuclear RNA (hnRNA)}}</div></div></div>", "time": null}, {"id": 1467927065057, "note": "<div><div><div>Capped, tailed, and spliced <b>hnRNA</b> is called {{c1::mRNA}}</div></div></div>", "time": 1660105360966.0}, {"id": 1467927070095, "note": "<div><div><div>In what part of the cell is <b>mRNA</b> <i>formed</i>?</div><div><br></div><div>{{c1::Nucleus}}</div></div></div>", "time": null}, {"id": 1467927073318, "note": "<div><div><div>In what part of the cell is <b>mRNA</b> <i>translated</i>?</div><div><br></div><div>{{c1::Cytosol}}</div></div></div>", "time": 1660105356517.0}, {"id": 1467927076561, "note": "<div><div><div>One <i>co-transcriptional modification</i> is the addition of a(n)&nbsp;<b>{{c1::7-methylguanosine cap}}</b> at the <b>{{c2::5}} end</b> </div></div></div>", "time": null}, {"id": 1467927083137, "note": "<div><div><div>One <i>post-transcriptional modification</i> is the addition of a(n)&nbsp;<b>{{c1::poly-A tail}}</b> at the <b>3 end</b> </div></div></div>", "time": null}, {"id": 1467927088995, "note": "<div><div><div>One <i>post-transcriptional modification</i> is the <b>{{c2::splicing out}}</b> of <b>{{c1::introns}}</b></div></div></div>", "time": null}, {"id": 1467927092663, "note": "<div><div><div>Does <b>Poly-A polymerase</b> require a <u>template</u> (post-transcriptional processing)? </div><div><br></div><div>{{c1::No}}</div></div></div>", "time": 1660105359832.0}, {"id": 1467927099760, "note": "<div><div><div>What sequence of bases represents a <b>polyadenylation signal</b>?</div><div><br></div><div>{{c1::AAUAAA::6}}</div></div></div>", "time": null}, {"id": 1467927104082, "note": "<div><div><div>mRNA <b>quality control</b> occurs at {{c1::cytoplasmic processing bodies (P-bodies)}}, which contain exonucleases, decapping enzymes, and microRNAs</div></div></div>", "time": null}, {"id": 1467927108504, "note": "<div><div><div>mRNAs may be <b>stored</b> in {{c1::P-bodies}} for future translation</div></div></div>", "time": null}, {"id": 1467927114300, "note": "<div><div><div><div><div>In the <i>first</i> step of <b>alternative</b> <b>splicing</b>, the primary transcript (hnRNA) combines with {{c1::<b>small nuclear ribonucleoproteins</b> (snRNPS)}} and other proteins to form the <b>{{c2::spliceosome}}</b> </div></div></div></div></div>", "time": null}, {"id": 1467927124490, "note": "<div><div><div><div><div>After the <b>spliceosome</b> has been formed in <u>alternative splicing</u>, a(n) {{c1::lariat-shaped (looped)}} intermediate is generated</div></div></div></div></div>", "time": 1660105362006.0}, {"id": 1467927131738, "note": "<div><div><div><div><div>In the <i>final</i> step of <b>alternative splicing</b>, the {{c2::lariat}} is released to precisely remove the {{c1::intron}} and join <u>two</u> {{c1::exons}}</div></div></div></div></div>", "time": 1660105356763.0}, {"id": 1467927138618, "note": "<div><div><div><div><div>Antibodies to <b>spliceosomal snRNPs</b>, also known as <b>{{c2::anti-Smith}} antibodies</b>, are highly specific for {{c1::<b>SLE</b>}}</div></div></div></div></div>", "time": null}, {"id": 1467927142028, "note": "<div><div><div><div><div>Antibodies to <b>U1 RNP</b> are highly associated with {{c1::mixed connective tissue}} disease</div></div></div></div></div>", "time": null}, {"id": 1467927145086, "note": "<div><div><div><div><div><div>Every <i>intron</i> has a <b>5</b> {{c1::donor}} <b>site</b> and a <b>3</b> {{c1::acceptor}} <b>site</b>, which are brought together to form the Lariat-shaped loop</div></div></div></div></div></div>", "time": null}, {"id": 1467927147874, "note": "<div><div><div><div>Which portion of eukaryotic <b>hnRNA</b> contains the actual genetic information <b>coding for protein</b>? </div><div><br></div><div>{{c1::Exons}}</div></div></div></div>", "time": null}, {"id": 1467927150999, "note": "<div><div><div><div><div>Which portion of eukaryotic <b>hnRNA</b> contains intervening <b>noncoding segments</b> of DNA? </div><div><br></div><div>{{c1::Introns}}</div></div></div></div></div>", "time": 1660105342331.0}, {"id": 1467927153960, "note": "<div><div><div><div>Different <i>exons</i> are frequently combined by {{c1::alternative splicing}} to produce a larger number of <u>unique</u> proteins </div></div></div></div>", "time": 1660105360042.0}, {"id": 1467927163875, "note": "<div><div><div><div><div>One <u>hematological pathology</u> that is due to <b>abnormal splicing variants</b> is {{c1::\u03b2-thalassemia}}</div></div></div></div></div>", "time": 1660105354605.0}, {"id": 1467927177492, "note": "<div><div>{{c1::microRNAs}} are small, <i>noncoding</i> <b>RNA</b> <b>molecules</b> that <i>post-transcriptionally</i> regulate <b>protein</b> expression</div></div>", "time": 1660105339601.0}, {"id": 1467927184068, "note": "<div><b>microRNA</b> often leads to the {{c1::silencing/inactivation}} of <i>target</i> <i>mRNA</i>, thus causing {{c1::<u>decreased</u>}} translation into protein</div>", "time": null}, {"id": 1467927195193, "note": "<div><div>{{c1::tRNAs}} are the <i>smallest</i> RNAs and have a <u>clover-leaf structure</u>  </div></div>", "time": 1660105338571.0}, {"id": 1467927201468, "note": "<div><div>At the <u>base</u> of a <b>tRNA molecule</b> is a(n)&nbsp;<b>{{c1::anti-codon loop}}</b>, which base pairs with a codon of mRNA in a <i>complementary</i>, <i>antiparallel</i> fashion</div></div>", "time": null}, {"id": 1467927212415, "note": "<div>At the <b>{{c2::3}} end</b> of a <b>tRNA molecule</b> is a(n)&nbsp;<b>{{c1::5-CCA-3}} sequence</b>, which<i> </i>is the amino acid <i>acceptor stem</i></div>", "time": null}, {"id": 1467927222859, "note": "<div><div>The <b>{{c1::T-arm}}</b> of <b>tRNA</b> contains the <u><b>T\u03a8C</b> </u><u><b>sequence</b></u> (<b>ribothymidine</b>, <b>pseudouridine</b>, <b>cytidine</b>) necessary for tRNA-ribosome binding</div></div>", "time": null}, {"id": 1467927230738, "note": "<div><div>What is the function of the <b>T-arm</b> of <b>tRNA</b>? </div><div><br /></div><div>{{c1::tRNA-ribosome binding}}</div></div>", "time": null}, {"id": 1467927236628, "note": "<div><div>The <b>{{c1::D-arm}}</b> of <b>tRNA</b> contains <u>dihydrouridine</u> residues necessary for tRNA recognition by the correct aminoacyl-tRNA synthetase</div></div>", "time": null}, {"id": 1467927244831, "note": "<div><div><div>What is the function of the <b>D-arm</b> of <b>tRNA</b>? </div><div><br></div><div>{{c1::Recognition of tRNA by the correct aminoacyl-tRNA synthetase}}</div></div></div>", "time": null}, {"id": 1467927248193, "note": "<div><div><div><b>tRNA</b> is joined with its <u>specific</u> amino acid via the enzyme <i>{{c1::aminoacyl-tRNA synthetase}}</i></div></div></div>", "time": null}, {"id": 1467927251462, "note": "<div><div><div><b>Aminoacyl-tRNA synthetase</b> requires {{c1::ATP}} and releases inorganic PP<sub>i</sub></div></div></div>", "time": null}, {"id": 1467927284412, "note": "<div>A(n) {{c1::mischarged}} <b>tRNA</b> <u>reads its usual codon</u> but inserts the <b>wrong</b> <b>amino</b> <b>acid</b></div>", "time": 1660105362394.0}, {"id": 1467927301604, "note": "<div><div>Accurate base pairing is usually required only in the first <b>two</b> nucleotide positions of a <u>mRNA codon</u> because codons differing in the <b>3rd</b> \"{{c1::wobble}}\" position may code for the same amino acid</div></div>", "time": null}, {"id": 1467927310137, "note": "<div><b>Aminoacyl-tRNA synthetase</b> and <b>binding of charged tRNA to the codon</b> are responsible for {{c1::accuracy}} of amino acid selection</div>", "time": 1660105361890.0}, {"id": 1467927337792, "note": "<div><b>Peptide bond formation</b> is facilitated by the <b>ribozyme</b> <i>{{c1::peptidyl transferase}}</i></div>", "time": null}, {"id": 1468086171259, "note": "<div><div><div>What is the <u>smaller</u> <b>ribosomal subunit</b> used in <i>prokaryotic</i> translation? </div><div><br /></div><div>{{c1::30s}}</div></div></div>", "time": null}, {"id": 1468089968464, "note": "<div><div><div>What is the <u>larger</u> <b>ribosomal subunit</b> used in <i>prokaryotic</i> translation? </div><div><br></div><div>{{c1::50s}}</div></div></div>", "time": null}, {"id": 1468089972385, "note": "<div><div><div>What is the <u>total</u> size of the <b>ribosome</b> used in <i>prokaryotic </i>translation?</div><div><br /></div><div>{{c1::70s}}</div></div></div>", "time": null}, {"id": 1468089978978, "note": "<div><div><div>What is the <u>smaller</u> <b>ribosomal subunit</b> used in <i>eukaryotic</i> translation? </div><div><br /></div><div>{{c1::40s}}</div></div></div>", "time": null}, {"id": 1468089987696, "note": "<div><div><div><div>What is the <u>larger</u> <b>ribosomal subunit</b> used in <i>eukaryotic</i> translation? </div><div><br /></div><div>{{c1::60s}}</div></div></div></div>", "time": null}, {"id": 1468089995767, "note": "<div><div><div><div>What is the <u>total</u> size of the <b>ribosome</b> used in <i>eukaryotic </i>translation?</div><div><br /></div><div>{{c1::80s}}</div></div></div></div>", "time": null}, {"id": 1468090003178, "note": "<div><div><i>Eukaryotic</i> {{c1::Initiation Factors}} help <u>assemble</u> the <b>40s</b> <b>ribosomal subunit</b> with the initiator tRNA</div></div>", "time": 1660105359401.0}, {"id": 1468090015858, "note": "<div><div>Which <b>nucleotide</b> <b>triphosphate</b> is used in the <u>charging</u> of tRNA?</div><div><br></div><div>{{c1::ATP}}</div></div>", "time": null}, {"id": 1468090020332, "note": "<div><div>Where in the cell does <b>translation</b> <i>begin</i>?</div><div><br></div><div>{{c1::Cytoplasm}}</div></div>", "time": null}, {"id": 1468090037888, "note": "<div><div><b>Translation</b> is initiated by {{c1::GTP}} hydrolysis  </div></div>", "time": null}, {"id": 1468090041618, "note": "<div><div>At what <u>site</u> of the <i>ribosome</i> does tRNA bind to for translation <b>initiation</b>? </div><div><br /></div><div>{{c1::P site}}</div></div>", "time": 1660105361481.0}, {"id": 1468090047136, "note": "<div><div>Which tRNA binds to the <b>P site</b> of the ribosome to <i>initiate</i> translation? </div><div><br></div><div>{{c1::Methionine-tRNA}}</div></div>", "time": null}, {"id": 1468090054335, "note": "<div><div><div>At what <u>site</u> of the ribosome does tRNA bind to for translation <b>elongation</b>? </div><div><br></div><div>{{c1::A site}}</div></div></div>", "time": null}, {"id": 1468090071594, "note": "<div><div>In the <u>first</u> step of strand <b>elongation</b>, a(n) {{c1::aminoacyl-tRNA}} binds to the <b>A</b> site </div></div>", "time": 1660105356759.0}, {"id": 1468090084627, "note": "<div><div>After aminoacyl-tRNA binds to the A site of the ribosome, {{c1::peptidyl transferase}}, a <b>ribozyme</b>, catalyzes peptide bond formation (translation)</div></div>", "time": null}, {"id": 1468090100922, "note": "<div><div>In the final step of translation <b>elongation</b>, {{c1::translocation}} of the ribosome occurs, advancing the ribosome 3 nucleotides towards the 3 end of mRNA</div></div>", "time": 1660105356761.0}, {"id": 1468090112926, "note": "<div><div><b>Translocation</b> of the ribosome during <i>translation</i> moves peptidyl tRNA from the {{c1::A}} site to the {{c1::P}} site</div></div>", "time": 1660105348623.0}, {"id": 1468090131838, "note": "<div><div>In addition to GTP, <b>translocation</b> of the ribosome during <i>translation</i> also requires eukaryotic {{c1::elongation factor 2 (eEF-2)}}</div></div>", "time": 1660105357526.0}, {"id": 1468090142327, "note": "<div><div><div>The {{c1::E}} site of the ribosome holds empty tRNA as it exits</div></div></div>", "time": 1660105349228.0}, {"id": 1468090145602, "note": "<div><div>In the <i>final</i> step of <b>translation</b>, a stop codon is recognized by {{c1::release factor}} and the completed polypeptide is released from the ribosome</div><div><div><div></div></div></div></div>", "time": 1660105356760.0}, {"id": 1468090162890, "note": "<div>One class of <i>post-translational modifications</i> is {{c1::covalent alterations}}, which include phosphorylation, glycosylation, hydroxylation, methylation, acetylation, and ubiquitination</div>", "time": 1660105354649.0}, {"id": 1468090181130, "note": "<div>A(n)&nbsp;<b>{{c1::chaperone}} protein</b>, is an intracellular protein involved in facilitating and/or maintaining <b>protein</b> <b>{{c2::folding}}</b> </div>", "time": null}, {"id": 1468101648191, "note": "<div><div><div><div><div>What is the <u>shortest</u> phase of the <b>cell cycle</b>?</div><div><br /></div><div>{{c1::M phase (mitosis + cytokinesis)}}</div></div></div></div></div>", "time": 1660105345483.0}, {"id": 1468101677524, "note": "<div><div><div><div><div>Which <b>cell cycle phase</b> is characterized by resting, non-dividing cells?</div><div><br /></div><div>{{c1::G<sub>0</sub>}} </div></div></div></div></div>", "time": null}, {"id": 1468101687731, "note": "<div><div><div><div><div>What <u>cell type</u> remains in G<sub>0</sub> and can only regenerate from stem cells?</div><div><br /></div><div>{{c1::Permanent}}</div></div></div></div></div>", "time": null}, {"id": 1468101697168, "note": "<div><div><div><div><div>What type of cells are the following examples? </div><div><br /></div><div>{{c1::Permanent::Labile, Stable, or Permanent?}} </div></div></div></div></div><div><br /></div><div><img src=\"paste-198547748159489.jpg\" /></div>", "time": null}, {"id": 1468101709109, "note": "<div><div><div><div><div><div>What <u>cell type</u> enters G<sub>1</sub> from G<sub>0</sub> when stimulated?</div><div><br /></div><div>{{c1::Stable (quiescent)}}</div></div></div></div></div></div>", "time": null}, {"id": 1468101717082, "note": "<div><div><div><div><div><div>What type of cells are the following examples? </div></div><div><div><div><div><div><div><div><br /></div><div>{{c1::Stable (Quiescent)::Labile, Stable, or Permanent?}} </div></div></div></div></div><div><br /></div><div><img src=\"paste-200630807298049.jpg\" /></div></div></div></div></div></div></div>", "time": null}, {"id": 1468101721156, "note": "<div><div><div><div><div><div>What <u>cell type</u> <i>never</i> enters G<sub>0</sub> and divides rapidly with a short G<sub>1</sub>?</div><div><br /></div><div>{{c1::Labile}}</div><div></div></div></div></div></div></div>", "time": null}, {"id": 1468101731577, "note": "<div><div><div><div><div>What <u>cell type</u> is affected most by <b>chemotherapy</b>?</div><div><br></div><div>{{c1::Labile (gut epithelium, skin, hair follicles, etc)}}</div></div></div></div></div>", "time": null}, {"id": 1468101734699, "note": "<div><div><div><div><div><div>Which <b>cell cycle phase</b> is characterized by DNA synthesis and replication?</div><div><br /></div><div>{{c1::S}} </div></div></div></div></div></div>", "time": null}, {"id": 1468101742045, "note": "<div><div><div><div><div>Which <b>cell cycle phase(s)</b> are part of <b>interphase</b>? </div><div><br /></div><div>{{c1::G<sub>1</sub>, S, G<sub>2</sub>}}</div></div></div></div></div>", "time": null}, {"id": 1468101754043, "note": "<div><div><div><div><div><div>Which <b>cell cycle phase(s)</b> are <u>NOT</u> part of <b>interphase</b>? </div><div><br /></div><div>{{c1::M}}</div></div></div></div></div></div>", "time": null}, {"id": 1468101760456, "note": "<div><div><div><div><div><div><div><b>Transcription</b> occurs throughout which cell cycle phases?</div><div><br></div><div>{{c1::Interphase (<b>G1, S, G2</b>)}}</div></div></div></div></div></div></div>", "time": null}, {"id": 1468101763616, "note": "<div>Which <b>tumor</b> <b>suppressor</b> protein acts at the G<sub>1</sub> check point?</div><div><br></div><div>{{c1::p53}}</div>", "time": null}, {"id": 1468101766794, "note": "<div>What part of the cell is the site of <u>synthesis</u> of <b>secretory proteins</b>? </div><div><br></div><div>{{c1::Rough endoplasmic reticulum}}</div>", "time": 1660105345088.0}, {"id": 1468101769990, "note": "<div>Where in a cell does <b>N-linked oligosaccharide addition</b> take place?</div><div><br></div><div>{{c1::Rough endoplasmic reticulum}}</div>", "time": null}, {"id": 1468101772387, "note": "<div>The {{c2::RER}} in <b>neurons</b>, known as {{c1::<b>Nissl bodies</b>}}, synthesize peptide neurotransmitters for secretion</div>", "time": null}, {"id": 1468101790635, "note": "<div>What <u>cellular structure</u> are <b>mucus-secreting goblet cells</b> (small intestine) and <b>antibody-secreting plasma cells</b> rich in? </div><div><br></div><div>{{c1::Rough endoplasmic reticulum}}</div>", "time": 1660105347456.0}, {"id": 1468101794395, "note": "<div>{{c1::<b>Free</b>}} <b>ribosomes</b> are unattached to any membrane and are the site of <u>synthesis</u> for <b>cytosolic</b> and <b>organellar </b><b>proteins</b></div>", "time": null}, {"id": 1468101797682, "note": "<div>What part of the cell is the site of <b>steroid synthesis</b> and <b>detoxification </b>of drugs and poisons?</div><div><br /></div><div>{{c1::Smooth endoplasmic reticulum}}</div>", "time": null}, {"id": 1468101807071, "note": "<div>How can the <i>smooth</i> <b>endoplasmic</b> <b>reticulum</b> be distinguished from the <i>rough</i> ER? </div><div><br></div><div>{{c1::Smooth ER lacks surface ribosomes}}</div>", "time": 1660105358143.0}, {"id": 1468101810757, "note": "<div>When proteins are <b>misfolded</b>, multiple {{c1::ubiquitins}} are added, which aids in trafficking to the <i>proteasome</i></div>", "time": null}, {"id": 1468101821842, "note": "<div>The {{c1::proteasome}} is a barrel-shaped protein complex that degrades damaged or <b>ubiquitin-tagged</b> proteins</div>", "time": null}, {"id": 1468101828318, "note": "<u>Defects</u> in the <b>ubiquitin-proteasome system </b>have been implicated in some cases of {{c1::Parkinson}} disease", "time": null}, {"id": 1468101831208, "note": "<div>Inside the <i>proteasome</i>, {{c1::proteases}} cleave <u>ubiqutinated</u> proteins into peptide fragments</div>", "time": null}, {"id": 1468101834431, "note": "<div>Which <u>membrane-bound organelle</u> is involved in the <b>catabolism</b> of <b>very-long-chain</b> <b>fatty acids</b>, <b>branched-chain fatty acids</b>, amino acids, and ethanol? </div><div><br></div><div>{{c1::Peroxisome}}</div>", "time": 1660105342628.0}, {"id": 1468178553079, "note": "<div><div>The {{c1::golgi apparatus}} is the <b>distribution</b> <b>center</b> for proteins and lipids from the endoplasmic reticulum to the vesicles and plasma membrane</div></div>", "time": 1660105349208.0}, {"id": 1468180458898, "note": "<div><div>On the <b>N terminal side</b> of <i>newly synthesized protein</i>, a stretch of 10-15 <b>hydrophobic</b> <b>amino acids</b> forms the {{c1::<b>N-terminal signa</b>l}} <b>sequence</b></div></div>", "time": null}, {"id": 1468180469796, "note": "<div><div>The <b>N-terminal signal</b> <b>sequence</b> of a newly synthesized protein is bound by a(n) {{c1::<b>signal recognition particle (SRP</b>)}}, which attaches the complex to the {{c2::ER}} membrane </div></div>", "time": null}, {"id": 1468180482606, "note": "<div>{{c1::Signal recognition particles (SRPs)}} are abundant, cytosolic <b>ribonucleoproteins</b> that traffic proteins from the <u>ribosome</u> to the <u>RER</u></div>", "time": null}, {"id": 1468180488383, "note": "<div>What would happen if there is <u>absent</u> or <u>dysfunctional</u> <b>signal recognition particles</b> (SRPs)?</div><div><br></div><div>{{c1::proteins accumulate in the cytosol}}</div>", "time": null}, {"id": 1468180493048, "note": "<div><div>In the <b>{{c3::ER}}</b>, <i>co-translational</i> <b>{{c1::N-glycosylation}}</b> adds sugars onto the amino acid <b>{{c2::asparagine}}</b></div></div>", "time": null}, {"id": 1468180496024, "note": "<div><div>In the <b>{{c3::Golgi apparatus}}</b>, <i>post-translational</i> <b>{{c1::O-glycosylation}}</b> adds sugars onto the amino acids <b>{{c2::serine}}</b> and <b>{{c2::threonine}}</b></div></div>", "time": null}, {"id": 1468180498878, "note": "<div><div>Which enzyme <b>phosphorylates</b> <b>mannose</b> in the <u>Golgi apparatus</u>, facilitating protein trafficking? </div><div><br></div><div>{{c1::Phosphotransferase}}</div></div>", "time": null}, {"id": 1468180509631, "note": "<div><div><div>In the <b>Golgi apparatus</b>, {{c1::mannose-6-phosphate}} is added to proteins for trafficking to {{c2::lysosomes}}</div></div></div>", "time": null}, {"id": 1468180513115, "note": "<div><div><div>What pathology is associated with a defect in the enzyme <i style=\"font-weight: bold; \">N-acetylglucosaminyl-1-phosphotransferase</i>?</div><div><br /></div><div>{{c1::I-cell disease (inclusion cell disease/mucolipidosis type II)}}</div></div></div>", "time": null}, {"id": 1468180522245, "note": "<div><div><div><b>{{c1::Endosomes}}</b> are <b>sorting</b> <b>centers</b> for material from outside the cell or from the Golgi, sending it to lysosomes for destruction or back to the membrane/Golgi for further use</div></div></div>", "time": 1660105340445.0}, {"id": 1468180527863, "note": "<div><div><div>Which inherited <u>lysosomal storage disorder</u> is characterized by <b>coarse facial features</b>, <b>clouded</b> <b>corneas</b>, and restricted joint movement with <u>high</u> serum levels of <i>multiple</i> lysosomal enzymes? </div><div><br /></div><div>{{c1::I-cell disease}}</div></div></div>", "time": 1660105342759.0}, {"id": 1468180535736, "note": "<div><div><div><b>I-cell disease</b> is characterized by high plasma levels of {{c1::lysosomal}} enzymes</div></div></div>", "time": null}, {"id": 1468180544636, "note": "<div><div>What differentiates <b>I-cell disease</b> from other inclusion body diseases?</div><div><br></div><div>{{c1::I-cell has a <u>mixed</u> accumulation of junk forming the inclusion bodies}}</div></div>", "time": null}, {"id": 1468180547712, "note": "<div>Which <b>vesicular trafficking protein</b> is responsible for <i><u>retrograde</u> Golgi transport</i> (<i>cis-</i><i>Golgi and ER) and intra-Golgi transport</i>?  </div><div><br /></div><div>{{c1::COPI}}</div>", "time": null}, {"id": 1468180554504, "note": "<div><div>Which <b>vesicular trafficking protein</b> is responsible for <i><u>anterograde</u> Golgi transport</i> (ER to cis Golgi)?</div><div><br /></div><div>{{c1::COPII}}</div></div>", "time": null}, {"id": 1468180562100, "note": "<div><div>Which <b>vesicular trafficking protein</b> is responsible for transport between the <i>trans-Golgi</i> and <i>lysosomes</i>? </div><div><br /></div><div>{{c1::Clathrin}}</div></div>", "time": null}, {"id": 1468180570221, "note": "<div><div>Which <b>vesicular trafficking protein</b> is responsible for transport between the <i>plasma membrane</i> and <i>endosomes</i> (receptor-mediated endocytosis)?</div><div><br /></div><div>{{c1::Clathrin}}</div></div>", "time": null}, {"id": 1468248039828, "note": "{{c1::Cytoskeletal elements}} are a network of <b>protein</b> <b>fibers</b> within the cytoplasm that support cell structure, cell and organelle movement, and cell division", "time": null}, {"id": 1468250019616, "note": "<div>Which type of <u>filament</u> is predominantly involved in <b>muscle contraction</b> and <b>cytokinesis</b>? </div><div><br></div><div>{{c1::Microfilaments (e.g. actin, microvilli)}}</div>", "time": null}, {"id": 1468250023076, "note": "<div><div>Which type of <u>filament</u> is predominantly involved in <b>maintainence of cell structure</b>? </div><div><br /></div><div>{{c1::Intermediate filaments (e.g. desmin, cytokeratin)}}</div></div>", "time": null}, {"id": 1468250033324, "note": "<div><div>Which type of <u>filament</u> is predominantly involved in <b>movement</b> and <b>cell division</b>? </div><div><br /></div><div>{{c1::Microtubules (e.g. cilia, flagella)}}</div></div>", "time": null}, {"id": 1468250042681, "note": "<div>What type of <u>filament</u> are <b>actin</b> and <b>microvilli</b>?</div><div><br></div><div>{{c1::Microfilament}}</div>", "time": null}, {"id": 1468250046217, "note": "<div><div>What type of <u>filament</u> are <b>cytokeratin</b> and <b>desmin</b>?</div><div><br></div><div>{{c1::Intermediate filaments}}</div></div>", "time": null}, {"id": 1468250050173, "note": "<div><div>What type of <u>filament</u> are <b>cilia</b> and <b>flagella</b>?</div><div><br></div><div>{{c1::Microtubule}}</div></div>", "time": null}, {"id": 1468250055072, "note": "<div><b>{{c1::Microtubules}}</b> are a cylindrical outer structure composed of a helical array of polymerized heterodimers of <b>{{c2::\u03b1-}}</b> and <b>{{c2::\u03b2-tubulin}}</b></div>", "time": null}, {"id": 1468250062063, "note": "<div>Each <b>\u03b1-</b> and <b>\u03b2-tubulin</b> heterodimer of a <u>microtubule</u> has 2 {{c1::GTP}} bound</div>", "time": null}, {"id": 1468250066742, "note": "<div><b>Microtubules</b> <u>grow</u> {{c1::slowly::speed}} and <u>collapse</u> {{c1::quickly::speed}}</div>", "time": null}, {"id": 1468250070151, "note": "<div>Which type of <u>filament</u> is involved in <b>slow axoplasmic transport</b> in neurons? </div><div><br></div><div>{{c1::Microtubules}}</div>", "time": null}, {"id": 1468250073774, "note": "<div>Which <b>molecular motor</b> <b>protein</b> is responsible for <i>retrograde</i> transport to the microtubule (+ to -)?</div><div><br /></div><div>{{c1::Dynein}} </div>", "time": null}, {"id": 1468250081218, "note": "<div><div>Which <b>molecular motor</b> <b>protein</b> is responsible for <i>anterograde</i> transport to the microtubule (- to +)?</div><div><br /></div><div>{{c1::Kinesin}} </div></div>", "time": null}, {"id": 1468250087836, "note": "<div> <u>Drugs</u> that act on <b>microtubules</b> may be remembered with the mnemonic \"<i><b>M</b>icrotubules <b>G</b>et <b>C</b>onstructed <b>V</b>ery <b>P</b>oorly</i>\":</div><div style=\"centerbox\"><div class=\"mnemonics\"><div><br></div><div><b>M</b>: {{c1::Mebendazole (antihelminthic)}}<div><b>G</b>: {{c2::Griseofulvin (antifungal)}} </div><div><b>C</b>: {{c3::Colchicine (antigout)}} </div><div><b>V</b>: {{c4::Vincristine/Vinblastine (anticancer)}}</div><div><b>P</b>: {{c5::Palcitaxel (anticancer)}}</div></div></div></div>", "time": null}, {"id": 1468250104716, "note": "<div><b>{{c1::Cilia}}</b> are organized in a(n)&nbsp;<b>{{c2::9+2}} arrangement</b> of microtubule doublets</div><div></div>", "time": null}, {"id": 1468250111962, "note": "<div>The base of a <b>cilium</b> below the cell membrane, called the {{c1::basal body}}, consists of 9 microtubule triplets with no central microtubules</div>", "time": null}, {"id": 1468250119090, "note": "<div><b>Axonemal</b> <b>{{c2::dynein}}</b> is a(n)&nbsp;<b>{{c1::ATPase}}</b> that links peripheral 9 doublets and causes <u>bending of cilium</u> (movement)</div>", "time": null}, {"id": 1468250126050, "note": "<div><b>{{c1::Kartagener}} syndrome</b> is a(n) {{c3::autosomal recessive::inheritance}} disease characterized by <u>immotile cilia</u> due to a(n)&nbsp;<b>{{c2::dynein arm}} defect</b></div>", "time": null}, {"id": 1468250135385, "note": "<div><b>Kartagener syndrome</b> results in <u>decreased</u> male and female {{c1::fertility}}</div>", "time": null}, {"id": 1468250145227, "note": "<div>Which developmental pathology is characterized by <b>bronchiectasis</b>, <b>recurrent sinusitis</b>, and <b>situs inversus</b>? </div><div><br /></div><div>{{c1::Kartagener syndrome}}</div>", "time": null}, {"id": 1468250205492, "note": "<div>What is the <b>most abundant protein</b> in the human body?</div><div><br></div><div>{{c1::Collagen}}</div>", "time": 1660105346005.0}, {"id": 1468250215718, "note": "<div>The function of <b>collagen</b> is to <u>organize</u> and <u>strengthen</u> the {{c1::extracellular matrix}}</div>", "time": 1660105350108.0}, {"id": 1468250231270, "note": "<div>What <u>type</u> of <b>collagen</b> is the most common (90%)? </div><div><br></div><div>{{c1::Type I}}</div>", "time": 1660105344843.0}, {"id": 1468250234549, "note": "<div>What <u>type</u> of <b>collagen</b> makes up <b>bone</b>, <b>skin</b>, and <b>tendon</b>? </div><div><br /></div><div>{{c1::Type I}}</div>", "time": 1660105344842.0}, {"id": 1468250242901, "note": "<div>What <u>type</u> of <b>collagen</b> makes up <b>cartilage</b>? </div><div><br></div><div>{{c1::Type II}}</div>", "time": null}, {"id": 1468250259504, "note": "<div>What <u>type</u> of <b>collagen</b> makes up <b>reticulin fibers</b>?</div><div><br></div><div>{{c1::Type III}}</div>", "time": null}, {"id": 1468250262595, "note": "<div>What <u>type</u> of <b>collagen</b> makes up the <b>basement membrane</b>?</div><div><br /></div><div>{{c1::Type IV}}</div>", "time": null}, {"id": 1468250274117, "note": "<div>What <u>type</u> of collagen is <i>decreased</i> in <b>osteogenesis imperfecta type I</b>?</div><div><br /></div><div>{{c1::Type I}}</div>", "time": null}, {"id": 1468250280385, "note": "<div><div>What pathology is characterized by a <u>defective</u> <b>type IV collagen</b>? </div><div><br /></div><div>{{c1::Alport syndrome}}</div></div>", "time": null}, {"id": 1468250283753, "note": "<div><b>Type {{c1::IV}} collagen</b> is targeted by <u>autoantibodies</u> in <b>{{c2::Goodpasture}} syndrome</b> </div>", "time": null}, {"id": 1468250287632, "note": "<div><div><div><div><div><b>Collagen</b> is a repeat of a <i>tripeptide</i> following the pattern {{c1::Gly-X-Y}}, made by <b>fibroblasts</b></div></div></div></div></div>", "time": null}, {"id": 1468250298127, "note": "<div><div><div><div><div>One third of the <b>collagen</b> <b>strand</b> is made of the amino acid {{c1::glycine}}</div></div></div></div></div>", "time": null}, {"id": 1468250306701, "note": "<div><div><div><div><div>In the first step of <u>collagen synthesis</u>, translation of <b>collagen</b> <b>alpha chains</b> forms {{c1::preprocollagen}}</div></div></div></div></div>", "time": null}, {"id": 1468250310013, "note": "<div><div><div><div><u>Collagen Synthesis</u>: After the collagen alpha chains are synthesized, specific residues of the amino acids <b>{{c1::proline}}</b> and <b>{{c1::lysine}}</b> are <b>{{c2::hydroxylated}}</b> </div></div></div></div>", "time": null}, {"id": 1468250319201, "note": "<div><div><div><div><u>Collagen Synthesis</u>: <b>Hydroxylation</b> of selected <u>prolines</u> and <u>lysines</u> during collagen synthesis requires vitamin {{c1::C}}</div></div></div></div>", "time": null}, {"id": 1468250327871, "note": "<div><div><div><div><u>Collagen Synthesis</u>: Following hydroxylation of proline and lysine, there is {{c1::<b>glycosylation</b>}} of pro-\u03b1-chain {{c2::<b>hydroxylysine</b>}} residues </div></div></div></div>", "time": null}, {"id": 1468250335702, "note": "<div><div><div><div><u>Collagen Synthesis</u>: After <i>hydroxylation</i> and <i>glycosylation</i>, <b><u>hydrogen</u></b> and <b><u>disulfide</u></b> <b>bonds</b> help form a(n) {{c1::<b>triple</b> <b>helix</b>}} of <b>collagen \u03b1 chains</b> (<b>procollagen</b>) </div></div></div></div>", "time": null}, {"id": 1468250346923, "note": "<div><div><div><div><u>Collagen Synthesis</u>: <i>After</i> the <b>triple helix</b> is formed, the procollagen is {{c1::exocytosed}} into the extracellular space</div></div></div></div>", "time": null}, {"id": 1468250370572, "note": "<div><div><div><div>Where in the cell does <b>synthesis</b>, <b>hydroxylation</b>, and <b>glycosylation</b> of <u>preprocollagen</u> occur?</div><div><br /></div><div>{{c1::Rough endoplasmic reticulum}}</div></div></div></div>", "time": null}, {"id": 1468250377043, "note": "<div><div><div><div><u>Collagen Synthesis</u>: Once in the extracellular space, <u>cleavage</u> of disulfide-rich terminal regions of <b>procollagen</b> by {{c2::<u>procollagen peptidase</u>}} forms the <i>insoluble</i> <b>{{c1::tropocollagen}}</b> </div></div></div></div>", "time": null}, {"id": 1468250383192, "note": "<div><div><div><div><u>Collagen Synthesis</u>: Staggered <b>tropocollagen</b> molecules are reinforced by covalent {{c1::lysine-hydroxylysine}} {{c2::cross-linkages}} to make <b>collagen fibrils</b> </div></div></div></div>", "time": null}, {"id": 1468250390306, "note": "<div><div><div><div>Formation of <b>lysine-hydroxylysine cross-linkages</b> (collagen synthesis) requires both {{c1::copper}} and the enzyme <i>{{c1::lysyl oxidase}}</i></div></div></div></div>", "time": null}, {"id": 1468250399707, "note": "<div>Where in the cell does the <b>synthesis</b> and <b>formation</b> of&nbsp;<u>tropocollagen</u> and <u>collagen fibrils</u> occur?</div><div><br></div><div>{{c1::Extracellular space}}</div>", "time": null}, {"id": 1468250408492, "note": "<div>Which <u>collagen synthesis</u> pathologies are associated with <b>problems forming the triple helix</b>?</div><div><br /></div><div>{{c1::Osteogenesis imperfecta and Scurvy}}</div>", "time": null}, {"id": 1468531236213, "note": "What <i>genetic bone disorder</i> is also known as <b>brittle bone disease</b>?<div><br></div><div>{{c1::Osteogenesis imperfecta}}</div>", "time": null}, {"id": 1468531735700, "note": "<div><b>Osteogenesis imperfecta</b> is most commonly caused by gene defects in <i>{{c1::COL1A1}}</i> and <i>{{c1::COL1A2}}</i></div>", "time": null}, {"id": 1468531744239, "note": "<div>What is the<i> inheritance</i> of <b>osteogenesis imperfecta</b> (most common)? </div><div><br></div><div>{{c1::Autosomal dominant}}</div>", "time": null}, {"id": 1468531751986, "note": "<div><b>Osteogenesis imperfecta</b> may be confused with {{c1::child abuse}}</div>", "time": 1660105354517.0}, {"id": 1468531755586, "note": "<div><b>Osteogenesis imperfecta</b> is characterized by multiple recurrent {{c1::fractures}} with <u>minimal</u> trauma </div>", "time": 1660105354518.0}, {"id": 1468531768449, "note": "<div><b>{{c2::Osteogenesis imperfecta}}</b> may present with {{c1::<b>blue</b> <b>sclerae</b>}} due to <i>translucent</i> connective tissue over <u>choroidal</u> veins</div>", "time": null}, {"id": 1468531779548, "note": "<div><b>Osteogenesis imperfecta</b> may present with {{c1::hearing loss}} due to abnormal ossicles</div>", "time": null}, {"id": 1468531784089, "note": "<div>Some forms of <i>osteogenesis</i> <i>imperfecta</i> have <b>tooth</b>&nbsp;<b>abnormalities</b>, including <u>opalescent teeth</u> that wear easily due to lack of {{c1::dentin}}</div>", "time": null}, {"id": 1468531846102, "note": "<div>What is the <i>inheritance</i> of <b>Menkes disease</b>? </div><div><br></div><div>{{c1::X-linked recessive}}</div>", "time": null}, {"id": 1468531853450, "note": "<div><b>{{c1::Menkes}} disease</b> is caused by impaired <b>{{c2::copper}}</b> absorption and transport due to a defect in the <b>ATP7A</b> gene</div>", "time": null}, {"id": 1468531860753, "note": "<div>What gene is defective in <b>Menkes disease</b>? </div><div><br /></div><div>{{c1::ATP7A}} </div>", "time": null}, {"id": 1468531867985, "note": "<div>The defective <b>Menkes protein</b> (Menkes disease) leads to <u>decreased</u> activity of the enzyme <i>{{c1::lysyl oxidase}}</i></div>", "time": null}, {"id": 1468531871497, "note": "<div><b>{{c2::Menkes}} disease</b> results in {{c1::brittle, \"kinky\"}} hair, growth retardation, and hypotonia</div><div></div>", "time": null}, {"id": 1468531878098, "note": "<div>{{c1::Elastin}} is a <b>stretchy protein</b> within skin, lungs, large arteries, elastic ligaments, vocal cords, and ligamentum flava</div>", "time": 1660105340453.0}, {"id": 1468531885671, "note": "<div><b>Elastin</b> is rich in <i>non-hydroxylated</i> {{c1::proline}}, {{c1::glycine}}, and {{c1::lysine}} residues (amino acids)</div>", "time": null}, {"id": 1468531890730, "note": "<div><b>Elastin</b> is broken down by the enzyme <i style=\"font-weight: bold; \">{{c2::elastase}}</i>, which is normally <u>inhibited</u> by <b>{{c1::\u03b1<sub>1</sub>-antitrypsin}}</b></div>", "time": null}, {"id": 1468531898082, "note": "<div><b>Elastin</b> is <i>tropoelastin</i> with {{c1::fibrillin}} scaffolding</div>", "time": null}, {"id": 1468531904527, "note": "<div>What gives <b>elastin</b> its elastic \"rubber-like\" properties?</div><div><br /></div><div>{{c1::Cross-linking}}</div>", "time": null}, {"id": 1468531910983, "note": "<div>Where in the cell does <u>cross-linking</u> of <b>elastin</b> take place? </div><div><br /></div><div>{{c1::Extracellular space}}</div>", "time": null}, {"id": 1468531918216, "note": "<div><b>{{c1::Marfan}} syndrome</b> is caused by a <i>defect</i> in <b>{{c2::fibrillin}}</b>, a glycoprotein that forms a sheath around {{c3::elastin}}</div>", "time": null}, {"id": 1468531923039, "note": "<div>{{c1::Emphysema}} may be caused by a(n)&nbsp;<b>{{c2::\u03b1<sub>1</sub>-antitrypsin}} deficiency</b>, resulting in excess <i>elastase</i> activity in <b>alveoli</b> </div>", "time": null}, {"id": 1468531927104, "note": "{{c1::<b>Wrinkles</b>}}<b> of</b> <b>aging</b> are due to <u>decreased</u> <b>{{c2::collagen}}</b> and <b>elastin</b> production ", "time": null}, {"id": 1468549213267, "note": "<div><div><b>DNA</b> requires {{c1::fragmentation}} for <u>analysis</u>, <b>RNA</b> and <b>proteins</b> do not (analyzed directly)</div></div>", "time": null}, {"id": 1468549216900, "note": "<div><div>All <b>RNA/DNA</b> is {{c1::negatively}} charged</div></div>", "time": null}, {"id": 1468549219948, "note": "<div><div>Most <b>proteins</b> are {{c1::negatively}} charged (except histones)</div></div>", "time": null}, {"id": 1468549222931, "note": "<div><div><b>Gel electrophoresis </b>separates fragments on the basis of {{c1::size}} </div></div>", "time": null}, {"id": 1468549231401, "note": "<div><div>When using <b>blotting procedures</b>, the {{c1::probe}} determines what sequences are detected </div></div>", "time": null}, {"id": 1468549239653, "note": "<div>A(n)&nbsp;<b>{{c2::Southern}} blot</b> is used to analyze {{c1::DNA}}</div>", "time": null}, {"id": 1468549248441, "note": "<div>A(n)&nbsp;<b>{{c2::Northern}} blot</b> is used to analyze {{c1::RNA}}</div>", "time": null}, {"id": 1468549256100, "note": "<div><div>Does a <b>Southern blot</b> require <u>gel electrophoresis</u> before analysis? </div><div><br /></div><div>{{c1::Yes}}</div></div>", "time": 1660105359894.0}, {"id": 1468549263734, "note": "<div><div><div>Does a <b>Northern blot</b> require <u>gel electrophoresis</u> before analysis? </div><div><br></div><div>{{c1::Yes}}</div></div></div>", "time": null}, {"id": 1468549269015, "note": "<div><div>A <b>Northern blot</b> is useful for studying gene {{c1::expression}}</div></div>", "time": null}, {"id": 1468549285757, "note": "<div>A(n)&nbsp;<b>{{c2::Western}} blot</b> is used to analyze {{c1::protein}}</div>", "time": null}, {"id": 1468549288868, "note": "<div><div>What type of <i>probe</i> is used to bind <u>protein</u> when using a <b>Western blot</b>? </div><div><br /></div><div>{{c1::Labeled antibody}}</div></div>", "time": 1660105344773.0}, {"id": 1468549297186, "note": "<div><div><div>What type of <i>probe</i> is used to bind <u>DNA/RNA</u> when using a&nbsp;<b>Southern/Northern blot</b>? </div><div><br></div><div>{{c1::Labeled single stranded DNA / RNA oligonucleotide}}</div></div></div>", "time": 1660105344774.0}, {"id": 1468549304489, "note": "<div><div>Does a <b>Dot (slot) blot</b> require <u>gel electrophoresis</u> before analysis?</div><div><br /></div><div>{{c1::No!}}</div></div>", "time": null}, {"id": 1468549318455, "note": "<div>A(n)&nbsp;<b>{{c1::Southwestern}} blot</b> is used to identify <b>{{c2::DNA-binding}} proteins</b> using labeled oligonucleotide probes</div>", "time": null}, {"id": 1468597206819, "note": "<div><b>{{c1::RFLP}} analysis</b> analyzes DNA using <u>variations</u> in <b>restriction enzyme</b> <b>sites</b> between <i>homologous</i> DNA strands</div>", "time": 1660105339070.0}, {"id": 1468605422972, "note": "<div><div>{{c1::<b>Polymerase Chain Reaction</b> (PCR)}} is a powerful diagnostic tool used to <u>amplify</u> a desired fragment of DNA<br></div></div>", "time": null}, {"id": 1468605428299, "note": "<div><div><div>In the <u>first</u> step of <b>PCR</b>, DNA is {{c1::denatured}} by using {{c2::heat}} to separate the strands</div></div></div>", "time": null}, {"id": 1468605437554, "note": "<div><div><div>In the <u>second</u> step of <b>PCR</b>, {{c2::<u>DNA</u> primers}} <b>{{c1::anneal}}</b> to <i>specific sequences</i> on each DNA strand to be amplified</div></div></div>", "time": null}, {"id": 1468605447110, "note": "<div><div><div>In the <u>final</u> step of <b>PCR</b>, heat-stable {{c2::Taq DNA polymerase}} <b>{{c1::elongates}}</b> the DNA sequence following each primer </div></div></div>", "time": null}, {"id": 1468605460088, "note": "<div><div><div>How <u>many</u> <b>primers</b> are needed for polymerase chain reaction (PCR)? </div><div><br></div><div>{{c1::Two (one for the 3 end of <u>each</u> DNA strand)}}</div></div></div>", "time": null}, {"id": 1468605476084, "note": "<div><div><div>What <u>type</u> of <b>primer</b> is used in a polymerase chain reaction (PCR)?</div><div><br /></div><div>{{c1::DNA primer}}</div></div></div>", "time": null}, {"id": 1468605486456, "note": "<div><div><div>Which end of the DNA strand does the <b>DNA primer</b> bind to during PCR?</div><div><br /></div><div>{{c1::3 end}}</div></div></div>", "time": null}, {"id": 1468605494779, "note": "<div><div><div><b>PCR</b> requires the addition of all <u>four</u> {{c1::deoxynucleotide triphosphates (dNTPs)}} for DNA synthesis</div></div></div>", "time": null}, {"id": 1468605505369, "note": "<div><div><b>{{c1::Flow cytometry}}</b> is a laboratory technique used to assess size, granularity, and protein expression of <u>individual</u> cells in a sample</div></div>", "time": 1660105340345.0}, {"id": 1468605516940, "note": "<div><div>What <u>laboratory technique</u> is useful in determining <b>CD4 cell count</b> in HIV patients? </div><div><br></div><div>{{c1::Flow cytometry}}</div></div>", "time": null}, {"id": 1468605522020, "note": "<div><div>In <b>flow cytometry</b>, cells are tagged with {{c1::antibodies}} specific to surface or intracellular proteins </div></div>", "time": 1660105357271.0}, {"id": 1468605530742, "note": "<div><div>In <b>flow cytometry</b>, <u>antibodies</u> are tagged with a unique {{c1::fluorescent dye}}, which is detected and counted during analysis </div></div>", "time": 1660105357272.0}, {"id": 1468605551769, "note": "<div><div><u>Flow Cytometry Example</u>: Cells in the <b>left lower quadrant</b> are CD3{{c1::-}} and CD8{{c1::-}} </div><div><br /></div><div><img src=\"paste-33135672688869.jpg\" /></div></div>", "time": 1660105358845.0}, {"id": 1468605561743, "note": "<div><div><div><u>Flow Cytometry Example</u>: Cells in the <b>left upper quadrant</b> are CD3{{c1::+}} and CD8{{c1::-}}</div><div><br /></div><div> <img src=\"paste-33135672688869.jpg\" /></div></div></div>", "time": 1660105358844.0}, {"id": 1468605570593, "note": "<div><div><div><u>Flow Cytometry Example</u>: Cells in the <b>right lower quadrant</b> are CD3{{c1::-}} and CD8{{c1::+}} </div><div><br /></div><div><img src=\"paste-33135672688869.jpg\" /></div></div></div>", "time": 1660105358843.0}, {"id": 1468605605193, "note": "<div><div><div><u>Flow Cytometry Example</u>: Cells in the <b>right upper quadrant</b> are CD3{{c1::+}} and CD8{{c1::+}} </div><div><br /></div><div><img src=\"paste-33135672688869.jpg\" /></div></div></div>", "time": 1660105358842.0}, {"id": 1468605614335, "note": "<div><div><div><b>{{c1::Microarrays}}</b> analyze <u>thousands</u> of nucleic acid sequences arranged in <i>grids</i> on glass or silicon</div></div></div>", "time": 1660105339611.0}, {"id": 1468605624923, "note": "<div><div><div><div><b>{{c1::Microarrays}}</b> are a laboratory technique used to profile <b>gene expression</b> levels of <u>thousands</u> of genes <i>simultaneously</i> to study certain diseases and treatments</div></div></div></div>", "time": 1660105339610.0}, {"id": 1468605629127, "note": "<div><div><div><b>Microarrays</b> use a(n) {{c1::labeled DNA/RNA}} probe, which is hybridized to the chip, and a scanner detects the relative amounts of complementary binding</div><div></div></div></div>", "time": 1660105355239.0}, {"id": 1468605635616, "note": "<div><div><div>What <u>two</u> types of variations in DNA are detected when using <b>microarrays</b>? (DNA markers)</div><div><br></div><div>{{c1::<div> - Single nucleotide polymorphisms (SNPs)</div><div> - Copy number variations (CNVs)</div>}}</div></div></div>", "time": 1660105344884.0}, {"id": 1468605640090, "note": "<div>{{c1::Enzyme-linked immunosorbent assay (ELISA)::not Coombs}} is an <u>immunologic test</u> used to detect the presence of either a <i>specific</i> <b>antigen</b> or <b>antibody</b> in a patients blood sample</div>", "time": null}, {"id": 1468605649044, "note": "<div>When using <b>ELISA</b>, detection involves the use of a(n) {{c1::antibody}} linked to a(n) {{c2::enzyme}} </div>", "time": 1660105344574.0}, {"id": 1468605672126, "note": "<div>{{c1::Fluorescence in situ hybridization (FISH)}} uses a <b>fluorescent DNA/RNA probe</b> to bind to a specific gene of interest on chromosomes</div>", "time": 1660105340343.0}, {"id": 1468605679141, "note": "<div>{{c1::Fluoresence in situ hybridization (FISH)}} is a laboratory technique used for specific <u>localization</u> of genes and direct <u>visualization</u> of chromosomal anomalies</div>", "time": 1660105340342.0}, {"id": 1468605683908, "note": "<div>A(n) {{c1::microdeletion}} is detected with <b>FISH</b> as <u>no fluorescence</u> on a chromosome compared to fluorescence at the same locus on the second copy of that chromosome</div>", "time": 1660105362395.0}, {"id": 1468605700819, "note": "<div>A(n) {{c1::translocation}} is detected with <b>FISH</b> as fluorescence <u>outside</u> the original chromosome</div>", "time": 1660105362383.0}, {"id": 1468605710555, "note": "<div>A(n) {{c1::duplication}} is detected with <b>FISH</b> as an <u>extra site</u> of fluorescence on one chromosome relative to its homologous chromosome</div>", "time": 1660105362415.0}, {"id": 1469146604758, "note": "<div>A(n) <b>{{c1::locus}}</b> is the specific <u>location</u> of a gene on a chromosome</div>", "time": null}, {"id": 1469146644218, "note": "<div><b>{{c1::Alleles}}</b> are <u>different forms</u> of a single gene</div>", "time": null}, {"id": 1469146651628, "note": "<div><div>When looking at a <b>pedigree</b>, a <u>square</u> is indicative of a(n) {{c1::male}}</div></div>", "time": null}, {"id": 1469146656814, "note": "<div><div>When looking at a <b>pedigree</b>, a <u>circle</u> is indicative of a(n) {{c1::female}}</div></div>", "time": null}, {"id": 1469146662039, "note": "<div>When looking at a <b>pedigree</b>, a(n) {{c1::shaded}} circle/square is indicative of a <u>diseased</u> individual</div>", "time": null}, {"id": 1469146690171, "note": "<div>If a disease has an <b>autosomal dominant</b> inheritance pattern, it is <i>usually</i> {{c1::<u>doesnt</u>}} skip generations</div>", "time": null}, {"id": 1469146700915, "note": "<div><b>Autosomal dominant</b> diseases are often due to defects in {{c1::structural}} genes</div>", "time": null}, {"id": 1469146704776, "note": "<div>Autosomal {{c1::dominant}} diseases are often <b>pleiotropic</b> and <b>variably expressive</b></div>", "time": null}, {"id": 1469146716026, "note": "<div>If a disease has an <b>autosomal recessive</b> inheritance pattern, it is <i>usually</i> {{c1::does}} skip generations</div>", "time": 1660105357740.0}, {"id": 1469146725917, "note": "<div><b>Autosomal recessive</b> diseases are often due to {{c1::enzyme}} deficiences</div>", "time": null}, {"id": 1469146729264, "note": "<div>There is an <u>increased</u> risk of <b>autosomal recessive</b> diseases in {{c1::consanguineous}} families</div>", "time": 1660105348817.0}, {"id": 1469146736550, "note": "<div>If a disease has an <b>X-linked recessive</b> inheritance pattern, it <i>usually</i> {{c1::does}} skip generations</div>", "time": null}, {"id": 1469146744041, "note": "<div>If a disease has an <b>X-linked recessive</b> inheritance pattern, there is <u>NO</u> {{c1::male-to-male}} transmission</div>", "time": 1660105357739.0}, {"id": 1469146750767, "note": "<div><b>X-linked</b> <b>recessive</b> diseases are commonly more severe in {{c1::males}}</div>", "time": 1660105341447.0}, {"id": 1469146757336, "note": "<div>If a male has an <b>X-linked recessive</b> disease, all of his <u>daughters</u> will be {{c1::carriers}}</div>", "time": null}, {"id": 1469146766774, "note": "<div><div>In <u>females</u>, one of two X-chromosomes is condensed and its genes turned <i>off</i> by {{c1::cytosine methylation::specific action}}, forming heterochromatin (lyonization)</div></div>", "time": null}, {"id": 1469146770793, "note": "<div><div>The formation of <b>Barr bodies</b> (X-chromosome inactivation) is also known as {{c1::lyonization}} </div></div>", "time": null}, {"id": 1469146780202, "note": "<div><div>If a disease has an <b>X-linked dominant</b> inheritance pattern, it <i>usually</i> {{c1::doesnt}} skip generations</div></div>", "time": null}, {"id": 1469146794988, "note": "<div><div>If a disease has an <b>X-linked dominant</b> inheritance pattern, there is <u>NO</u> {{c1::male-to-male}} transmission</div></div>", "time": null}, {"id": 1469146805489, "note": "<div>If a male has an <b>X-linked dominant</b> disease, all of his <u>daughters</u> will be {{c1::affected}}</div>", "time": 1660105357738.0}, {"id": 1469146833164, "note": "<div><div>What is the <u>mode of inheritance</u> of <b>hypophosphatemic rickets </b>(vitamin D-resistant rickets)? </div><div><br></div><div>{{c1::X-linked <i>dominant</i>}}</div></div>", "time": null}, {"id": 1469146882653, "note": "<div>Muscle biopsies of patients with <b>{{c2::mitochondrial}} myopathies</b> often show<b> \"{{c1::ragged red}}\" fibers</b></div>", "time": null}, {"id": 1469146891130, "note": "<div><b>Mitochondrial myopathies</b> often present with myopathy, {{c1::lactic acidosis}}, and {{c2::CNS}} disease </div>", "time": 1660105355209.0}, {"id": 1469146927480, "note": "<div>If a <b>mother</b> has a <b>mitochondrial disease</b>, all her children are {{c1::affected}}</div>", "time": null}, {"id": 1469146935257, "note": "If a <b>father</b> has a <b>mitochondrial disease</b>, all his children are {{c1::unaffected}}", "time": null}, {"id": 1469211731057, "note": "<div><div><div>{{c1::Codominance}} describes an inheritance in which <b>both alleles</b> contribute to the phenotype of the heterozygote </div></div></div>", "time": 1660105340772.0}, {"id": 1469211758510, "note": "<div><div><div>{{c1::Variable expressivity}} describes <b>phenotypic variation</b> among individuals with the <u>same</u> genotype</div></div></div>", "time": null}, {"id": 1469211768096, "note": "<div><div>If some individuals who have the disease <u>genotype</u> <b>do not</b> <b>display</b> the disease <u>phenotype</u>, the disease is said to have {{c1::incomplete penetrance}}</div></div>", "time": null}, {"id": 1469211776297, "note": "<div><div><div>{{c1::Pleiotropy}} describes the contribution of <b>one gene</b> to <i>multiple</i> phenotypic effects</div></div></div>", "time": null}, {"id": 1469211789678, "note": "<div><div><div>What <i>class</i> of diseases is characterized by <b>anticipation</b>?</div><div><br></div><div>{{c1::Trinucleotide repeat diseases (e.g. Huntington disease)}}</div></div></div>", "time": null}, {"id": 1469211793467, "note": "<div><div>If a patient inherits or develops a mutation in a(n) {{c1::<u>tumor suppressor</u>}}<u> gene</u>, the <b>complementary allele</b> must be deleted/mutated before cancer develops</div></div>", "time": 1660105357736.0}, {"id": 1469211821192, "note": "<div><div><div>If mutations at <b>different loci</b> can produce a <b>similar phenotype</b>, a disease has {{c1::<b>locus</b> <b>heterogeneity</b>}}</div></div></div>", "time": 1660105357706.0}, {"id": 1469211866990, "note": "<div><div><div>If <u>different mutations</u> at the <b>same locus</b> produce the <b>same phenotype</b>, a disease has {{c1::<b>allelic</b> <b>heterogeneity</b>}}</div></div></div>", "time": 1660105357714.0}, {"id": 1469211878818, "note": "<div><div><div>{{c1::Uniparental disomy}} is the inheritance of <b>2 copies</b> of a chromosome from <b>one parent</b> and no copies from the other</div></div></div>", "time": null}, {"id": 1469211888271, "note": "<div><div><div>Does a <b>uniparental disomy</b> result in euploidy or aneuploidy? </div><div><br></div><div>{{c1::Euploidy}}</div></div></div>", "time": 1660105359892.0}, {"id": 1469211895990, "note": "<div><div><div>If a <b>uniparental disomy</b> results in a(n)&nbsp;<u>{{c2::heterozygous}}</u> offspring, there may have been a(n) {{c1::<b>meiosis I</b>}} error </div></div></div>", "time": null}, {"id": 1469211901148, "note": "<div>If a <b>uniparental disomy</b> results in a(n)&nbsp;<u>{{c2::homozygous}}</u> offspring, there may have been a(n) {{c1::<b>meiosis II</b>}} error</div>", "time": null}, {"id": 1469211908690, "note": "<div><div><div><b>{{c1::Genetic imprinting}}</b> is the <i>normal</i> differential expression of an allele depending on <u>parental</u> origin (e.g. only <u>one</u> allele is active)</div></div></div>", "time": 1660105340277.0}, {"id": 1469211918414, "note": "<div><div><div>Both <b>Prader-Willi</b> and <b>Angelman</b> <b>syndrome</b> are due to a mutation or deletion of genes on chromosome {{c1::15}}</div></div></div>", "time": null}, {"id": 1469211922943, "note": "<div><div><div>In <b>{{c2::Prader-Willi::Prader-Willi OR Angelman}} syndrome</b>, the {{c1::maternal}} gene is imprinted and the {{c1::paternal}} gene is mutated/deleted </div></div></div>", "time": null}, {"id": 1469211930007, "note": "<div><div><div>In <b>{{c2::Angelman}} syndrome</b>, the {{c1::paternal}} gene is imprinted and the {{c1::maternal}} gene is mutated/deleted </div></div></div>", "time": null}, {"id": 1469211936591, "note": "<div><div><div>25% of cases of <b>Prader-Willi syndrome</b> are due to {{c1::maternal}} uniparental disomy</div></div></div>", "time": null}, {"id": 1469211945421, "note": "<div><div><div><div>5% of cases of <b>Angelman syndrome</b> are due to {{c1::paternal}} uniparental disomy</div></div></div></div>", "time": null}, {"id": 1469211952966, "note": "<div><div><div>What pathology is characterized by <b>insatiable appetite</b> (hyperphagia), obesity, <b>intellectual disability</b>, and <b>hypogonadism</b>? </div><div><br /></div><div>{{c1::Prader-Willi syndrome}}</div></div></div>", "time": 1660105345072.0}, {"id": 1469211959736, "note": "<div><div><div>What pathology is characterized by <b>inappropriate laughter</b>, seizures, ataxia, and severe intellectual disability?</div><div><br></div><div>{{c1::Angelman syndrome}}</div></div></div>", "time": null}, {"id": 1469211963576, "note": "<div><div><div>What pathology is also known as \"<b>happy puppet</b>\" syndrome?</div><div><br></div><div>{{c1::Angelman syndrome}}</div></div></div>", "time": null}, {"id": 1469211967494, "note": "<div><div><div>In both <b>Angelman syndrome </b>and <b>Prader-Willi syndrome</b>, the most common abnormality is a gene {{c1::deletion}} </div></div></div>", "time": null}, {"id": 1469211975821, "note": "<div><div>When using <u>Hardy-Weinberg</u> population genetics, <b>p</b> and <b>q</b> represent {{c1::allelic}} frequencies</div></div>", "time": 1660105344572.0}, {"id": 1469211979735, "note": "<div><div><div><div>When using <u>Hardy-Weinberg</u> population genetics, <b>p<sup>2</sup></b>, <b>2pq</b>, and <b>q<sup>2</sup></b> represent {{c1::genotypic}} frequencies</div></div></div></div>", "time": 1660105344571.0}, {"id": 1469211982873, "note": "<div><div><div>What equation is used to calculate <b>allele frequency</b> when using <u>Hardy-Weinberg</u> population genetics?</div><div><div><u><br></u></div><div>{{c1::p + q = 1}}</div></div></div></div>", "time": 1660105347120.0}, {"id": 1469211985793, "note": "<div><div><div><div>What equation is used to calculate <b>genotypic frequency</b> when using <u>Hardy-Weinberg</u> population genetics?</div><div><br></div><div>{{c1::p<sup>2</sup> + 2pq + q<sup>2</sup> = 1}}</div></div></div></div>", "time": 1660105347119.0}, {"id": 1469211988593, "note": "<div><div><div><div>When using <u>Hardy-Weinberg</u> population genetics, the frequency of an <b>X-linked recessive</b> disease in <b>males</b> is equal to {{c1::q}}</div></div></div></div>", "time": null}, {"id": 1469211992261, "note": "<div><div><div><div>When using <u>Hardy-Weinberg</u> population genetics, the frequency of an <b>X-linked recessive</b> disease in <b>females</b> is equal to {{c1::q<sup>2</sup>}}</div></div></div></div>", "time": null}, {"id": 1469211995409, "note": "<div><div><div><div>When using <u>Hardy-Weinberg</u> population genetics, the frequency of a <b>carrier</b> of a <i>recessive</i> disease is equal to {{c1::2pq}}</div></div></div></div>", "time": null}, {"id": 1469211998842, "note": "<div><div><div><div>One <b>assumption</b> of <u>Hardy-Weinberg</u> population genetics is that there is no net {{c1::migration}}</div></div></div></div>", "time": 1660105354662.0}, {"id": 1469212001931, "note": "<div><div><div><div>One <b>assumption</b> of <u>Hardy-Weinberg</u> population genetics is that there is {{c1::completely random}} mating</div></div></div></div>", "time": 1660105354661.0}, {"id": 1469212006870, "note": "<div><div><div><div>One <b>assumption</b> of <u>Hardy-Weinberg</u> population genetics is that {{c1::natural selection}} is <u>not</u> occurring</div></div></div></div>", "time": 1660105354660.0}, {"id": 1469212015433, "note": "<div><div><div><div>One <b>assumption</b> of <u>Hardy-Weinberg</u> population genetics is that <u>no</u> {{c1::mutations}} have occurred at the locus</div></div></div></div>", "time": 1660105354663.0}, {"id": 1469212036244, "note": "<div><div><div><div>{{c1::Mosaicism}} describes the presence of <b>genetically distinct cell lines</b> in the <u>same</u> individual </div></div></div></div>", "time": 1660105339557.0}, {"id": 1469212039940, "note": "<div><div><div>{{c1::<b>Somatic</b>}} <b>mosaicism</b> occurs when a mutation arises from <b>{{c2::mitotic}} errors</b> after fertilization and propagates through multiple tissues or organs</div></div></div>", "time": 1660105338923.0}, {"id": 1469212046884, "note": "<div><div><div><b>McCune-Albright syndrome</b> is lethal if the mutation occurs before fertilization (affecting all cells), but survivable in patients with {{c1::mosaicism}}</div></div></div>", "time": null}, {"id": 1469212049845, "note": "<div><div><div><b>McCune-Albright syndrome</b> is due to a mutation affecting {{c1::G-protein}} signaling</div></div></div>", "time": null}, {"id": 1469212054829, "note": "<div><div><div>{{c1::<b>McCune-Albright</b>}} <b>syndrome</b> is characterized by <i>unilateral </i><b>{{c2::caf\u00e9-au-lait}} spots</b>, <b>{{c3::precocious}} puberty</b>, and <b>{{c4::polyostotic fibrous}} dysplasia</b></div></div></div>", "time": null}, {"id": 1469212079676, "note": "<div>What <i>type</i> of chromosome is most commonly involved in a <b>robertsonian translocation</b>?</div><div><br></div><div>{{c1::Acrocentric chromosomes}}</div>", "time": null}, {"id": 1469212082998, "note": "<div>A(n)&nbsp;<b>{{c1::Robertsonian translocation}}</b> occurs when the long arms of 2 <i>acrocentric</i> chromosomes fuse at the centromere and the 2 short arms are lost</div>", "time": null}, {"id": 1469212097066, "note": "<div><div>How can a <b>Robertsonian translocation</b> cause chromosomal imbalance in <u>offspring</u>? </div><div><br></div><div>{{c1::A gamete with the mutated chromosome is passed on (e.g. gamete with t(14;21))}}</div></div>", "time": null}, {"id": 1469212105987, "note": "<div><div>Do <b>Robertsonian translocations</b> usually cause pathology in the individual who <u>acquired</u> the mutation?</div><div><br /></div><div>{{c1::No, it usually is a <u>balanced</u> translocation}} </div></div>", "time": 1660105359913.0}, {"id": 1469212128488, "note": "<div><b>{{c1::Cri-du-chat}} syndrome</b> is caused by a congenital <i>microdeletion</i> of chromosome {{c2::5p (short arm)}}</div>", "time": null}, {"id": 1469212132977, "note": "<div>What pathology is associated with <b>microcephaly</b>, intellectual disability, and a <b>high-pitched cry</b>? </div><div><br /></div><div>{{c1::Cri-du-chat syndrome}}</div>", "time": null}, {"id": 1469212140064, "note": "<div><b>{{c1::Williams}} syndrome</b> is caused by a congenital <i>microdeletion</i> of chromosome {{c2::7q (long arm)}} </div>", "time": null}, {"id": 1469212143200, "note": "<div>What pathology is associated with \"<b>elfin</b>\" <b>facies</b>, intellectual disability, and <b>extreme friendliness </b>with strangers?</div><div><br /></div><div>{{c1::Williams syndrome}}</div>", "time": null}, {"id": 1469212160390, "note": "<div><div>{{c1::Linkage disequilibrium}} describes the tendency of alleles at <u>two loci</u> <i>on the same chromosome </i>to be <b>inherited together</b> <i><u>more or less</u></i> often than expected by chance</div></div>", "time": 1660105339761.0}, {"id": 1469212163391, "note": "<div><div><b>Linkage disequlibrium</b> is measured in a(n) {{c1::population}}, not in a family</div></div>", "time": 1660105355613.0}, {"id": 1469212172401, "note": "<div><div>If alleles at two loci are inherited <u>equally</u> as expected by chance, the loci are said to be in {{c1::linkage <u>equilibrium</u>}}</div></div>", "time": 1660105357726.0}, {"id": 1469212174648, "note": "<div><div>The closer the <b>recombination frequency </b>is to {{c1::0}}%, the closer alleles in a haplotype are to each other</div></div>", "time": null}, {"id": 1469212177328, "note": "<div>If two <u>linked</u> genes have a recombination frequency of 15%, approximately how far apart are they?</div><div><br></div><div>{{c1::15 centiMorgans (cM)}}</div>", "time": null}, {"id": 1469212183553, "note": "<div><b>{{c1::LOD}} scores</b> are used to calculate the probability that two loci are linked (linkage disequilibrium) </div>", "time": null}, {"id": 1469212191737, "note": "<div>An LOD score <u>greater</u> than {{c1::3}} indicates <b>linkage</b> </div>", "time": null}, {"id": 1469212200495, "note": "<div>An LOD score <u>less</u> than {{c1::-2}} indicates <b>no</b> <b>linkage</b></div>", "time": null}, {"id": 1470790711337, "note": "<b>{{c1::Marfan}} syndrome</b> is due to a(n)&nbsp;<i>{{c2::FBN1}}</i> gene mutation on chromosome {{c3::15}}", "time": null}, {"id": 1470793765181, "note": "<div>What protein is defective in <b>Marfan syndrome</b>?</div><div><br /></div><div>{{c1::Fibrillin (scaffold for elastin)}}</div>", "time": null}, {"id": 1470793772715, "note": "<div>What pathology is associated with <b>long, tapering fingers and toes </b>(arachnodactyly) and <b>subluxation</b> <b>of lenses</b>?</div><div><br /></div><div>{{c1::Marfan syndrome}}</div>", "time": null}, {"id": 1470793786718, "note": "<div><b>Marfan syndrome</b> typically presents with subluxation of the lenses {{c1::upward::direction}} and {{c1::temporally::direction}}&nbsp;</div>", "time": null}, {"id": 1470793801012, "note": "<div><b>Marfan syndrome</b> is associated with a floppy {{c1::mitral}} valve</div>", "time": null}, {"id": 1470793810006, "note": "<div>What is the <u>mode of inheritance</u> of <b>Marfan syndrome</b>?</div><div><br></div><div>{{c1::Autosomal dominant}}</div>", "time": null}, {"id": 1470793813508, "note": "<div>What is the <u>mode of inheritance</u> of <b>Fragile X syndrome</b>?</div><div><br></div><div>{{c1::X-linked dominant}}</div>", "time": null}, {"id": 1470793816352, "note": "<div>What <i>class</i> of diseases is <b>Fragile X syndrome</b> a part of?</div><div><br /></div><div>{{c1::Trinucleotide repeat expansion diseases}}</div>", "time": null}, {"id": 1470793824126, "note": "<div><b>{{c2::Fragile X}} syndrome</b> is due to a trinucleotide repeat in the <i>{{c1::FMR1}}</i> gene</div>", "time": null}, {"id": 1470793834168, "note": "<div>What pathology is associated with an <u>enlarged</u> <b>jaw</b>, <b>testes</b>, and <b>ears</b>?</div><div><br /></div><div>{{c1::Fragile X syndrome}}</div>", "time": null}, {"id": 1470793844592, "note": "<div>What <u>sequence</u> of nucleotides is repeated in<b> Fragile X syndrome</b>?</div><div><br /></div><div>{{c1::CGG}} </div>", "time": null}, {"id": 1470793854315, "note": "<div>What is the <u>second</u> most common cause of <b><i>genetic</i> intellectual disability</b>? </div><div><br></div><div>{{c1::Fragile X syndrome (#1 is Down syndrome)}}</div>", "time": null}, {"id": 1470793858352, "note": "<div><div>What <i>class</i> of diseases is <b>Huntington disease</b> a part of?</div><div><br /></div><div>{{c1::Trinucleotide repeat expansion diseases}}</div></div>", "time": null}, {"id": 1470793865617, "note": "<div><div>What <i>class</i> of diseases is <b>Friedreich ataxia</b> a part of?</div><div><br /></div><div>{{c1::Trinucleotide repeat expansion diseases}}</div></div>", "time": null}, {"id": 1470793873507, "note": "<div><div>What <i>class</i> of diseases is <b>myotonic dystrophy </b>a part of?</div><div><br /></div><div>{{c1::Trinucleotide repeat expansion diseases}}</div></div>", "time": null}, {"id": 1470793881136, "note": "<div><div>What <u>sequence</u> of nucleotides is repeated in<b> Friedreich ataxia</b>?</div><div><br></div><div>{{c1::GAA}} </div></div>", "time": null}, {"id": 1470793889603, "note": "<div><div>What <u>sequence</u> of nucleotides is repeated in<b> Huntington disease</b>?</div><div><br /></div><div>{{c1::CAG}} </div></div>", "time": null}, {"id": 1470793896802, "note": "<div><div>What <u>sequence</u> of nucleotides is repeated in<b> myotonic dystrophy</b>?</div><div><br /></div><div>{{c1::CTG}} </div></div>", "time": null}, {"id": 1470793906545, "note": "<div>What is the <i>most common cause</i> (95%) of <b>Down syndrome</b>? </div><div><br /></div><div>{{c1::Meiotic nondisjunction}} </div><div></div>", "time": null}, {"id": 1470793913138, "note": "<div>4% of cases of <b>Down syndrome</b> are due to unbalanced {{c1::Robertsonian translocation}}</div>", "time": null}, {"id": 1470793917200, "note": "<div>1% of cases of <b>Down syndrome</b> are due to {{c1::mosaicism}} </div>", "time": null}, {"id": 1470793930160, "note": "<div><div>What is the <u>most common cause</u> of <b><i>genetic</i> intellectual disability</b>? </div><div><br /></div><div>{{c1::Down syndrome}}</div></div>", "time": null}, {"id": 1470793948768, "note": "<div><b>Down syndrome</b> may present with {{c1::increased}} <b>nuchal</b> <b>translucency</b> on ultrasound</div>", "time": null}, {"id": 1470793956764, "note": "<div><b>Down syndrome</b> presents with {{c1::decreased}} serum <b>PAPP-A</b></div>", "time": null}, {"id": 1470793965216, "note": "<div><b>Down syndrome</b> presents with {{c1::<u>increased</u>}} free <b>\u03b2-hCG</b></div>", "time": null}, {"id": 1470793975737, "note": "<div><b>Down syndrome</b> presents with {{c1::<u>increased</u>}} <b>inhibin A</b></div>", "time": null}, {"id": 1470793982266, "note": "<div><b>Down syndrome</b> presents with {{c1::decreased}} <b>estriol</b></div>", "time": null}, {"id": 1470793987719, "note": "<div><b>Down syndrome</b> presents with {{c1::decreased}} free <b>\u03b1-fetoprotein</b> (AFP)</div>", "time": null}, {"id": 1470793994021, "note": "<div>What pathology is associated with <b>intellectual disability</b>, <b>prominent epicanthal folds</b>, and a <u>single</u> palmar crease? </div><div><br /></div><div>{{c1::Down syndrome}}</div>", "time": null}, {"id": 1470794002045, "note": "<div>What <u>chromosomal abnormality</u> is associated with <b>Down syndrome</b>?</div><div><br></div><div>{{c1::Trisomy 21}}</div>", "time": null}, {"id": 1470794005067, "note": "<div><div>What <u>chromosomal abnormality</u> is associated with <b>Edwards syndrome</b>?</div><div><br /></div><div>{{c1::Trisomy 18}}</div></div>", "time": 1660105347443.0}, {"id": 1470794011584, "note": "<div><div>What <u>chromosomal abnormality</u> is associated with <b>Patau syndrome</b>?</div><div><br /></div><div>{{c1::Trisomy 13}}</div></div>", "time": 1660105347442.0}, {"id": 1470794018583, "note": "<div>The findings in Edwards Syndrome may be remembered with <b>PRINCE</b> Edward:</div><div style=\"centerbox\"><div class=\"mnemonics\"><div><br></div> -<b> P</b>{{c2::rominent occiput}}<div>- <b>R</b>ocker-bottom feet</div><div>- <b>I</b>ntellectual disability</div>- <b>N</b>ondisjunction<div>- <b>C</b>{{c3::lenched fists with overlapping fingers}}</div><div>- low-set <b>E</b>{{c1::ars}}</div></div></div>", "time": null}, {"id": 1470794026061, "note": "<div>Patients with <b>Edwards syndrome</b> and <b>Patau syndrome</b> often die within {{c1::1}} year(s) of birth</div>", "time": null}, {"id": 1470794029882, "note": "<div><div><b>Edward syndrome</b> and <b>Patau syndrome</b> present with {{c1::decreased}} serum PAPP-A</div></div>", "time": null}, {"id": 1470794037896, "note": "<div><div><b>Edward syndrome</b> and <b>Patau syndrome</b> present with {{c1::<u>decreased</u>}} free \u03b2-hCG</div></div>", "time": null}, {"id": 1470794041447, "note": "<div><div><b>Edward syndrome</b> presents with {{c1::<u>decreased</u>}} or {{c1::<u>normal</u>}} inhibin A</div></div>", "time": null}, {"id": 1470794054199, "note": "<div><div><b>Edward syndrome</b> presents with {{c1::decreased}} estriol</div></div>", "time": null}, {"id": 1470794058884, "note": "<div><div><b>Edward syndrome</b> presents with {{c1::decreased}} free \u03b1-fetoprotein (AFP)</div></div>", "time": null}, {"id": 1470794061543, "note": "<div><div>The findings in <b>Patau Syndrome</b> may be remembered with the <b>5Ps</b></div></div><div style=\"centerbox\"><div class=\"mnemonics\"><div><b><br></b></div><div>- cleft <b>P</b>alate </div><div>- holo<b>P</b>{{c2::rosencephaly}}</div><div>- <b>P</b>{{c1::olydactyly}}</div><div>-  a<b>P</b>{{c4::lasia cutis}}</div><div>- <b>P</b>{{c3::olycystic Kidney disease}}</div></div></div>", "time": null}, {"id": 1470836378217, "note": "How does the <b>cardiac output</b> of the <i>left</i> heart compare to the <i>right </i>heart?<div><br></div><div>{{c1::Equal (in steady state)}}</div>", "time": null}, {"id": 1470839277805, "note": "<div>The <u>rate</u> at which blood is <b>returned</b> to the atria is called the {{c1::venous return}}</div>", "time": 1660105349646.0}, {"id": 1470839280347, "note": "<div><u>Oxygenated</u> blood flows from the <b>lungs</b> to the <b>{{c2::left atrium}}</b> via the <b>{{c1::pulmonary vein}}</b> </div>", "time": 1660105354443.0}, {"id": 1470839287077, "note": "<div>Blood flows from the <b>left atrium</b> to the <b>left ventricle</b> through the <b>{{c1::mitral (bicuspid)}} valve</b> </div>", "time": 1660105361199.0}, {"id": 1470839294833, "note": "<div>Blood flows from the <b>left ventricle</b> to the <b>{{c1::aorta}}</b> through the <b>{{c2::aortic}} valve</b> </div>", "time": 1660105361198.0}, {"id": 1470839303346, "note": "<div>Blood flows from the <b>{{c1::aorta}}</b> to the systemic arteries and tissues </div>", "time": 1660105361192.0}, {"id": 1470839310425, "note": "<div>Blood flows from the <b>tissues</b> to the systemic veins and ultimately the <b>{{c1::vena cava}}</b> before returning to the right atrium</div>", "time": 1660105361193.0}, {"id": 1470839316273, "note": "<div><u>Deoxygenated</u> blood flows from the <b>vena cava</b> to the <b>{{c1::right atrium}}</b></div>", "time": 1660105360125.0}, {"id": 1470839322331, "note": "<div>Blood flows from the <b>right atrium</b> to the <b>right ventricle</b> through the <b>{{c1::tricuspid}} valve</b></div>", "time": 1660105361195.0}, {"id": 1470839328752, "note": "<div>Blood flows from the <b>right ventricle</b> to the <b>pulmonary artery</b> through the <b>{{c1::pulmonic}} valve</b> </div>", "time": 1660105361194.0}, {"id": 1470839334989, "note": "<div>Blood flows from the <b>pulmonary artery</b> to the <b>{{c1::lungs}}</b> for oxygenation </div>", "time": 1660105361196.0}, {"id": 1470839351508, "note": "<div><b>{{c1::Arterioles}}</b> are a type of blood vessel with the<b> {{c2::<u>highest</u>}} resistance</b> in the cardiovascular system</div>", "time": null}, {"id": 1470839383062, "note": "<div>When activated, <b>\u03b2<sub>2</sub>-adrenergic receptors</b> cause {{c1::relaxation}} of vascular smooth muscle</div>", "time": 1660105344652.0}, {"id": 1470839413539, "note": "<div>What <u>equation</u> may be used to calculate the <b>velocity of blood flow</b> (v) given the flow rate (Q)?</div><div><br /></div><div>{{c1::v = Q/A}} </div>", "time": 1660105347111.0}, {"id": 1470839420946, "note": "<div><b>Velocity</b> <b>of blood</b> (v) is {{c1::inversely}} proportional to the <u>total</u> cross-sectional area </div>", "time": 1660105348298.0}, {"id": 1470839425004, "note": "<div>What <u>type</u> of blood vessel has the <b>lowest flow velocity</b>? </div><div><br /></div><div>{{c1::Capillaries}}</div>", "time": 1660105344862.0}, {"id": 1470840588805, "note": "<div>What <u>equation</u> may be used to calculate the <b>blood flow</b> (Q) given <u>pressure</u> and <u>resistance</u>?</div><div><br /></div><div>{{c1::Q = \u0394P/R}} </div>", "time": 1660105347113.0}, {"id": 1470841597433, "note": "<div><b>Blood flow (Q)</b> is {{c1::inversely}} proportional to the <b>resistance</b> of blood vessels </div>", "time": 1660105361200.0}, {"id": 1470841601855, "note": "<div>The <i>magnitude</i> of <b>blood flow (Q)</b> is {{c1::directly}} proportional to the size of the <b>pressure difference </b>between blood vessels </div>", "time": 1660105349877.0}, {"id": 1470841606399, "note": "<div>The <i>direction</i> of <b>blood flow</b> is determined by the direction of the {{c1::pressure gradient}} and is always from <i>high</i> to <i>low</i> pressure</div>", "time": 1660105350238.0}, {"id": 1470841609507, "note": "<div>The resistance of the <i>entire</i> systemic vasculature is called the <b>{{c1::total peripheral resistance (TPR)}}</b> </div>", "time": 1660105349633.0}, {"id": 1470841612811, "note": "<div>In Poiseulles equation, <b>Resistance</b> is {{c1::<u>directly</u>}} proportional to the <b>{{c2::viscosity (\u03b7)}}</b> of the blood</div>", "time": 1660105353367.0}, {"id": 1470841620766, "note": "<div><b>Resistance</b> is {{c1::<u>directly</u>}} proportional to the <b>{{c2::length}}</b> of the blood vessel </div>", "time": 1660105353369.0}, {"id": 1470841628690, "note": "<div><b>Resistance</b> is {{c1::<u>inversely</u>}} proportional to the <b>{{c3::fourth}} power</b> of the {{c2::radius}} of the blood vessel </div>", "time": 1660105353365.0}, {"id": 1470844049174, "note": "What type of <u>resistance</u> is illustrated by the arrangement of blood vessels <b><i>within</i> a given organ</b>? <div><br /></div><div>{{c1::Series resistance}}</div>", "time": 1660105344767.0}, {"id": 1470849959523, "note": "<div>The equation {{c2::R<sub>total</sub> = R<sub>1</sub> + R<sub>2</sub> ...}} may be used to calculate the <u>total resistance</u> of a system arranged in <b>{{c1::series}}</b></div>", "time": 1660105350180.0}, {"id": 1470849965601, "note": "<div>Which <u>type</u> of blood vessel causes the <b>greatest decrease in pressure</b> in a vascular system arranged in <u>series</u>? </div><div><br /></div><div>{{c1::Arterioles}} </div>", "time": 1660105341881.0}, {"id": 1470849985857, "note": "<div>When resistances are arranged in <b>{{c1::series}}</b>, the total <b>{{c2::flow}}</b> through each level of the system is the <b>same</b> </div>", "time": 1660105344592.0}, {"id": 1470849997969, "note": "<div>What type of <u>resistance</u> is illustrated by the arrangement of blood vessels in <b>systemic circulation</b>? <div><br /></div><div>{{c1::Parallel resistance}}</div></div>", "time": 1660105344768.0}, {"id": 1470850006526, "note": "<div>The equation {{c2::1/R<sub>total</sub> = 1/R<sub>1</sub> + 1/R<sub>2</sub> ...}} may be used to calculate the <u>total resistance</u> of a system arranged in <b>{{c1::parallel}}</b></div>", "time": 1660105350182.0}, {"id": 1470850010829, "note": "<div>When a blood vessel is added to a system in <b>series</b>, the total resistance {{c1::increases}}</div>", "time": null}, {"id": 1470850014562, "note": "<div>When a blood vessel is added to a system in <b>parallel</b>, the total resistance {{c1::decreases}}</div>", "time": null}, {"id": 1470850018953, "note": "<div>When vessels are arranged in <b>{{c1::parallel}}</b>, the <i>total</i> resistance is <u>less</u> than the resistance of any of the <i>individual</i> arteries </div>", "time": 1660105344561.0}, {"id": 1470850028855, "note": "<div>When resistances are arranged in <b>{{c1::parallel}}</b>, the <b>{{c2::pressure}}</b> through each level of the system is the <b>same</b> </div>", "time": 1660105344594.0}, {"id": 1470850036482, "note": "<div>Ideally, blood flow in the cardiovascular system is {{c1::laminar}}, or streamlined</div>", "time": 1660105357746.0}, {"id": 1470850047974, "note": "<div>If blood flow is <b>laminar</b>, the highest velocity occurs at the {{c1::center}} of the blood vessel</div>", "time": 1660105357723.0}, {"id": 1470850056888, "note": "<div><b>{{c1::Reynolds}} number</b> predicts whether blood flow will be laminar or turbulent</div>", "time": null}, {"id": 1470850068583, "note": "<div>When <b>Reynolds number</b> is {{c2::<u>increased</u>}}, there is a greater tendency for {{c1::turbulent}} blood flow</div>", "time": null}, {"id": 1470850073410, "note": "<div><b>Turbulent</b> flow in a blood vessel causes audible vibrations known as {{c1::bruits or murmurs::2}}</div>", "time": 1660105348467.0}, {"id": 1470850077204, "note": "<div>A(n) {{c1::increase}} in <b>velocity</b> of blood causes an <u>increase</u> in <b>Reynolds number</b> </div>", "time": null}, {"id": 1470850085634, "note": "<div>A(n) {{c1::<u>decrease</u>}} in <b>viscosity</b> of blood causes an <u>increase</u> in <b>Reynolds number</b> </div>", "time": null}, {"id": 1470850095408, "note": "<div>What is the effect of blood vessel <u>narrowing</u> (e.g. thrombus) on <b>Reynolds number</b>? </div><div><br></div><div>{{c1::Increased}}</div>", "time": null}, {"id": 1470850104686, "note": "<div><b>Viscosity</b> of blood depends mostly on {{c1::hematocrit}}</div>", "time": null}, {"id": 1470850110081, "note": "<div>What is the effect of <b>anemia</b> on blood <u>viscosity</u>? </div><div><br></div><div>{{c1::Decreased}}</div>", "time": 1660105346553.0}, {"id": 1470850113012, "note": "<div>What is the effect of <b>polycythemia</b> on blood <u>viscosity</u>?</div><div><br></div><div>{{c1::Increased}}</div>", "time": 1660105346516.0}, {"id": 1470850129966, "note": "<div>The {{c1::capacitance (compliance)}} of a blood vessel describes the <b>volume of blood</b> the vessel can hold at a <u>given pressure</u></div>", "time": null}, {"id": 1470850142433, "note": "<div><div>The <u>greater</u> the amount of <b>elastic tissue</b> there is in a blood vessel (elastance), the {{c1::lower}} the <b>compliance</b> is</div></div>", "time": null}, {"id": 1470850169002, "note": "<div>What is the result of <b>aging</b> on the <b>capacitance (</b>compliance) of <u>arteries</u>?</div><div><br /></div><div>{{c1::Decreased (more stiff, less distensible)}}</div>", "time": null}, {"id": 1470850181542, "note": "<div><b>{{c1::Systolic}} pressure</b> is the <u>highest</u> arterial pressure during the cardiac cycle</div>", "time": null}, {"id": 1470850200353, "note": "<div><b>{{c1::Diastolic}} pressure</b> is the <u>lowest</u> arterial pressure during the cardiac cycle</div>", "time": null}, {"id": 1470850208869, "note": "<div>The <b>{{c1::pulse}} pressure</b> is the difference between the <b>systolic</b> and <b>diastolic</b> pressures</div>", "time": null}, {"id": 1470850212324, "note": "<div><b>Pulse pressure</b> is {{c1::<u>directly</u>}} proportional to <b>stroke volume</b></div>", "time": null}, {"id": 1470850222414, "note": "<div><b>Pulse pressure</b> is {{c1::<u>inversely</u>}} proportional to <b>arterial compliance</b> </div>", "time": null}, {"id": 1470850231818, "note": "<div>What <u>equation</u> may be used to calculate <b>mean arterial pressure</b> given a patients blood pressure?</div><div><br></div><div>{{c1::MAP = 2/3 diastolic pressure + 1/3 systolic pressure}}</div>", "time": null}, {"id": 1470875818432, "note": "<div>Action potentials in the <u>heart</u> are usually <i>initiated</i> in the <b>{{c1::SA node}}</b>, which serves as the <b>{{c2::pacemaker}}</b> </div>", "time": 1660105362188.0}, {"id": 1470880127116, "note": "<div>Action potentials spread from the <b>SA node</b> to the {{c1::AV}} node <u>and</u> right/left {{c1::atria}}, <u>simultaneously</u></div>", "time": 1660105362186.0}, {"id": 1470880131797, "note": "<div>Conduction velocity through the <b>AV node</b> is {{c1::slower}} than in the other cardiac tissues </div>", "time": null}, {"id": 1470880140148, "note": "<div>From the <b>AV node</b>, the myocardial action potential enters the {{c1::Bundle of His}}</div>", "time": 1660105358772.0}, {"id": 1470880151989, "note": "<div>From the <b>Bundle of His</b>, the myocardial action potential enters the {{c1::Purkinje fibers}} and ultimately the ventricles </div>", "time": 1660105358771.0}, {"id": 1470880181246, "note": "<div>The <b>resting membrane potential</b> of <u>cardiac</u> cells is determined primarily by {{c1::potassium (K<sup>+</sup>)}} ions</div>", "time": null}, {"id": 1470880187380, "note": "<div>In a <u>cardiac</u> cell, the <b>conductance</b> <b>to K<sup>+</sup></b> at rest is {{c1::high::high/low}}&nbsp;</div>", "time": null}, {"id": 1470880197051, "note": "<div>The Na<sup>+</sup> and K<sup>+</sup> concentration gradients across the <b>cardiac cell</b> are maintained by the {{c1::Na<sup>+</sup>-K<sup>+</sup>-ATPase}} pump</div>", "time": null}, {"id": 1470880209864, "note": "<div><b>Phase {{c1::0}}</b> of the <u>myocardial action potential</u> is characterized by <i>rapid</i> <b>{{c2::upstroke/depolarization}}</b></div>", "time": null}, {"id": 1470880214095, "note": "<div><b>Phase 0</b> of the <u><i>myocardial</i> action potential</u> is caused by opening of voltage-gated {{c1::Na<sup>+</sup>}} channels</div><div></div>", "time": null}, {"id": 1470880221588, "note": "<div><b>Phase {{c1::1}}</b> of the <u>myocardial action potential</u> is characterized by <b>{{c2::<i>initial</i> repolarization}}</b> </div>", "time": null}, {"id": 1470880226184, "note": "<div><b>Phase 1</b> of the <u>myocardial action potential</u> is caused by <b>inactivation</b> of voltage-gated {{c1::Na<sup>+</sup>}} channels and <b>opening</b> of voltage-gated {{c1::K<sup>+</sup>}} channels</div>", "time": null}, {"id": 1470880235448, "note": "<div><b>Phase {{c1::2}}</b> of the <u>myocardial action potential</u> is characterized by <b>{{c2::plateau}}</b></div>", "time": null}, {"id": 1470880238653, "note": "<div><b>Phase 2</b> of the <u>myocardial action potential</u> (plateau) is caused by a <u>balance</u> of {{c1::K<sup>+</sup>}}&nbsp;<b>efflux</b> and {{c1::Ca<sup>2+</sup>}}&nbsp;<b>influx</b> through voltage-gated channels</div>", "time": null}, {"id": 1470880245555, "note": "<div><div>The <u>calcium channels</u> that open during the <b>plateau</b> phase (myocardial action potential) are {{c1::L}}-type channels</div></div>", "time": null}, {"id": 1470880260476, "note": "<div>The influx of calcium during the<b> plateau phase</b> of a <u>myocardial action potential</u> triggers release of Ca<sup>2+</sup> from the {{c1::sarcoplasmic reticulum}}, causing<b> myocyte {{c2::contraction}}</b></div>", "time": null}, {"id": 1470880302437, "note": "<div><b>Phase {{c1::3}}</b> of the <u>myocardial action potential</u> is characterized by <b>{{c2::<i>rapid</i> repolarization}}</b> </div>", "time": null}, {"id": 1470880306206, "note": "<div><b>Phase 3</b> of the <u>myocardial action potential</u> is caused by massive <b>efflux</b> of {{c1::K<sup>+</sup>}} and <b>closure</b> of voltage-gated {{c1::Ca<sup>2+</sup>}} channels</div>", "time": null}, {"id": 1470880314839, "note": "<div><b>Phase {{c1::4}}</b> of the <u>myocardial action potential</u> is characterized by a return to <b>{{c2::resting membrane potential}}</b> </div>", "time": null}, {"id": 1470880328100, "note": "<div>What type of <b>action potential</b> occurs in the ventricles, atria, and Purkinje system?</div><div><br></div><div>{{c1::Myocardial action potentials (phase 0 through phase 4)}}</div>", "time": 1660105344882.0}, {"id": 1470880332043, "note": "<div><b>Phase {{c1::0}}</b> of the <u><i>SA node</i> action potential</u> is characterized by <b>{{c2::upstroke}}</b> </div>", "time": null}, {"id": 1470880335411, "note": "<div><b>Phase 0</b> of the <u><i>SA node</i> action potential</u> is caused by opening of voltage-gated {{c1::Ca<sup>2+</sup>}} channels</div>", "time": null}, {"id": 1470880346050, "note": "<div>How does the rate of <b>upstroke</b> in a <u>SA node</u> action potential compare to that of a <u>myocardial</u> action potential?</div><div><br></div><div>{{c1::SA node is slower}}</div>", "time": null}, {"id": 1470880350208, "note": "<div>What <u>type</u> of calcium channels exist in the <b>SA node</b>?</div><div><br></div><div>{{c1::L-type (primary) and T-type::2}}</div>", "time": 1660105344859.0}, {"id": 1470880353973, "note": "<div>What phases of the <u>myocardial action potential</u> are not present in an <b>SA node action potential</b>?</div><div><br /></div><div>{{c1::Phase 1 &amp; 2 (initial repolarization &amp; plateau)}}</div>", "time": null}, {"id": 1470880356909, "note": "<div><div><b>Phase {{c1::3}}</b> of the <u><i>SA node</i> action potential</u> is characterized by <b>{{c2::repolarization}}</b> </div></div>", "time": null}, {"id": 1470880360279, "note": "<div><div><b>Phase 3</b> of the <u><i>SA node</i> action potential</u> is caused by <b>activation</b> of {{c1::K<sup>+</sup>}} channels and <b>inactivation</b> of {{c1::Ca<sup>2+</sup>}} channels</div></div>", "time": null}, {"id": 1470880367589, "note": "<div><b>Phase {{c2::4}}</b> of the <u><i>SA node</i> action potential</u> is characterized by <b>{{c1::<i>slow</i> depolarization}}</b> </div>", "time": null}, {"id": 1470880383058, "note": "<div>The rate of <b>phase {{c1::4}}</b> in the <b>SA node</b> action potential cycle determines <b>{{c2::heart rate}}</b> </div>", "time": null}, {"id": 1470880386392, "note": "<div>Which <u>phase</u> in the <b>SA node</b> accounts for its pacemaker activity and automaticity?</div><div><br></div><div>{{c1::Phase 4 (slow depolarization)}}</div>", "time": null}, {"id": 1470880389765, "note": "<div><b>Phase 4</b> of the <u><i>SA node</i> action potential</u> is caused by a slow, <i>mixed</i> <b>Na<sup>+</sup>/K<sup>+</sup></b> inward current via {{c1::I<sub>f</sub> (\"funny\")}} channels</div>", "time": 1660105353969.0}, {"id": 1470880397079, "note": "<div>What <u>three</u> cell types are considered <b><i>latent</i> pacemakers</b>?</div><div><br></div><div>{{c1::Cells of the AV node, bundle of His, and Purkinje fibers}}</div>", "time": null}, {"id": 1470926668365, "note": "<div><b>{{c1::Conduction velocity}}</b> is the speed at which action potentials are propagated within the tissue</div>", "time": null}, {"id": 1470929277154, "note": "Where in the heart is <b>conduction velocity</b> the <u>slowest</u>?<div><br /></div><div>{{c1::AV node}} </div>", "time": null}, {"id": 1470929280700, "note": "<div>Where in the heart is <b>conduction velocity</b> the <u>fastest</u>?</div><div><br /></div><div>{{c1::Purkinje fibers}}</div>", "time": null}, {"id": 1470929283601, "note": "<div><b>Conduction velocity</b> depends on the {{c1::<u>size</u> (magnitude)}} of the <b>inward current</b> during the upstroke of an action potential </div>", "time": null}, {"id": 1470929301100, "note": "<div><b>{{c1::Excitability}}</b> is the ability of cardiac cells to initiate action potentials in response to inward, depolarizing current</div>", "time": null}, {"id": 1470929313168, "note": "<div>The <b>{{c1::absolute}} refractory&nbsp;period</b> refers to the period in which <b><u>no</u> action potential can be initiated </b></div>", "time": 1660105349328.0}, {"id": 1470929320966, "note": "<div>In cardiac cells, the <b>absolute refractory period</b> begins with the {{c1::upstroke}} and ends after the {{c2::plateau}} </div>", "time": 1660105357403.0}, {"id": 1470929327082, "note": "<div>The <b>{{c1::effective}} refractory period</b> refers to the period in which a(n)&nbsp;<i><b>{{c2::conductive}}</b></i> action potential <u>cannot</u> be generated</div>", "time": 1660105349242.0}, {"id": 1470929337627, "note": "<div>The <b>{{c1::relative}} refractory period</b> refers to the period in which a second action potential is <u>possible</u>, but requires a <i>greater-than-normal</i> stimulus </div>", "time": 1660105349055.0}, {"id": 1470929344743, "note": "<div>The effects of the autonomic nervous system on <b>heart rate </b>are called <b>{{c1::chronotropic}} </b>effects</div>", "time": null}, {"id": 1470929348967, "note": "<div>A <b>negative chronotropic effect</b> {{c1::decreases}} heart rate </div>", "time": null}, {"id": 1470929360626, "note": "<div><div>A <b>positive chronotropic effect</b> {{c1::increases}} heart rate </div></div>", "time": null}, {"id": 1470929367727, "note": "<div>What is the result of <b>sympathetic stimulation</b> on <b>heart rate</b>?</div><div><br></div><div>{{c1::Increased}}</div>", "time": null}, {"id": 1470929371036, "note": "<div><div>What is the result of <b>parasympathetic stimulation</b> on <b>heart rate</b>?</div><div><br></div><div>{{c1::Decreased}}</div></div>", "time": null}, {"id": 1470929374412, "note": "<div>Through what<b> receptor</b> does the sympathetic nervous system <u>increase</u> <b>heart</b> <b>rate</b>?</div><div><br></div><div>{{c1::\u03b2<sub>1</sub> adrenergic receptor}}</div>", "time": 1660105348774.0}, {"id": 1470929377630, "note": "<div>Activation of <b>\u03b2<sub>1</sub> receptors</b> in the <u>SA node</u> produces an <u>increase</u> in {{c1::I<sub>f</sub>}} channel activity, which increases the rate of phase 4 depolarization and thus heart rate</div>", "time": 1660105362172.0}, {"id": 1470929422314, "note": "<div><div>Through what<b> receptor</b> does the parasympathetic nervous system <u>decrease</u> <b>heart</b> <b>rate</b>?</div><div><br></div><div>{{c1::M<sub>2</sub> muscarinic receptor::specific#}}</div></div>", "time": null}, {"id": 1470929429000, "note": "<div>Activation of <b>M<sub>2</sub> receptors</b> in the <u>SA node</u> produces a <u>decrease</u> in {{c1::I<sub>f</sub>}} channel activity, which decreases the rate of phase 4 depolarization and thus heart rate</div>", "time": null}, {"id": 1470929470761, "note": "<div><div>A <b>negative dromotropic effect</b> {{c1::decreases}} conduction velocity through the AV node</div></div>", "time": null}, {"id": 1470929475929, "note": "<div><div><div>A <b>positive dromotropic effect</b> {{c1::increases}} conduction velocity through the AV node</div></div></div>", "time": null}, {"id": 1470929480095, "note": "<div><div>What is the result of <b>sympathetic stimulation</b> on <b>conduction velocity</b>?</div><div><br /></div><div>{{c1::Increased}}</div></div>", "time": null}, {"id": 1470929487277, "note": "<div><div><div>What is the result of <b>parasympathetic stimulation</b> on <b>conduction velocity</b>?</div><div><br /></div><div>{{c1::Decreased}}</div></div></div>", "time": null}, {"id": 1470944202275, "note": "The <b>{{c1::P wave}} </b>on ECG represents <b>{{c2::atrial depolarization}}</b>", "time": null}, {"id": 1470945292566, "note": "<div><b>Atrial repolarization</b> is not seen on an ECG because it is masked by the {{c1::QRS complex}}</div>", "time": 1660105361441.0}, {"id": 1470945298200, "note": "<div><div>The <i>duration</i> of the <b>P wave</b> correlates with the <b>{{c1::conduction velocity}}</b> through the atria</div></div>", "time": 1660105350227.0}, {"id": 1470945305914, "note": "<div>The <b>{{c1::PR interval}}</b> on<b> ECG</b> is the time from the <b>initial depolarization</b> of the <u>atria</u> to the <b>initial depolarization</b> of the <u>ventricles</u> </div>", "time": 1660105349081.0}, {"id": 1470945329001, "note": "<div>The <b>PR interval</b> on ECG depends on the <b>conduction velocity</b> through the {{c1::AV node}}</div>", "time": 1660105349690.0}, {"id": 1470945336792, "note": "<div>The <b>{{c1::QRS complex}}</b> on ECG represents <b>{{c2::ventricular depolarization}}</b> </div>", "time": null}, {"id": 1470945344201, "note": "<div>The <b>{{c2::T wave}}</b> on ECG represents <b>{{c1::ventricular repolarization}}</b></div>", "time": null}, {"id": 1470945364274, "note": "<div><b>T-wave inversion</b> may indicate recent {{c1::myocardial infarction (MI)}}</div>", "time": null}, {"id": 1470945367685, "note": "<div>The <b>{{c1::QT interval}}</b> on ECG represents the entire period of ventricular depolarization, contraction, and repolarization</div>", "time": 1660105349068.0}, {"id": 1470945381155, "note": "<div>The <b>{{c1::ST segment}}</b> on ECG is an <i>isoelectric</i> period (horizontal line) when the ventricles are depolarized </div>", "time": 1660105349030.0}, {"id": 1470945400750, "note": "<div>The <b>U wave</b> on ECG is prominent in {{c1::hypokalemia}} and {{c2::bradycardia}} </div>", "time": 1660105349409.0}, {"id": 1470945441886, "note": "<div>The <b>{{c1::J point}}</b> on ECG is the junction between the <u>end</u> of <b>QRS complex</b> and <u>start</u> of <b>ST segment</b> </div>", "time": 1660105349186.0}, {"id": 1470945494610, "note": "<div>Which <b>pacemaker</b> in the heart has the <u>fastest</u> rate?</div><div><br /></div><div>{{c1::SA node (hence why it is dominant)}}</div>", "time": 1660105342430.0}, {"id": 1470945501724, "note": "<div>The <b>{{c1::left}} bundle branch</b> of the <b>bundle of His</b> divides into <u>anterior</u> and <u>posterior</u> {{c2::fascicles}} </div>", "time": 1660105349170.0}, {"id": 1470945656630, "note": "<div><u>Slowed</u> conduction through the <b>AV node</b> <i>normally</i> causes a(n) {{c1::100}}<b>-msec</b> <b>delay</b>, allowing time for ventricular filling</div>", "time": 1660105350934.0}, {"id": 1471176273250, "note": "<div><b>Serotonin syndrome</b> as a side effect of <b>ondansetron</b> is more common in patients with concommitant use of drugs that increase levels of {{c2::<b>serotonin</b>}}<br></div>", "time": 1660105351973.0}, {"id": 1471218464015, "note": "The {{c1::sarcomere}} is the <b>contractile</b> <b>unit</b> of the myocardial cell", "time": null}, {"id": 1471224396681, "note": "<div>What part of a <u>myocardial cell</u> is responsible for <b>carrying action potentials into the cell interior</b>?</div><div><br></div><div>{{c1::T tubules}}</div>", "time": null}, {"id": 1471224401820, "note": "<div>What part of a <u>myocardial cell</u> is the site of <b>storage</b> <b>and release of Ca<sup>2+</sup></b> for excitation-contraction coupling?</div><div><br></div><div>{{c1::Sarcoplasmic Reticulum (SR)}}</div>", "time": null}, {"id": 1471224406413, "note": "<div>During the <b>plateau</b> of a <u>myocardial action potential</u>, <b>Ca<sup>2+</sup></b> enters the cell through&nbsp;<b>{{c1::dihydropyridine}}</b> <b>receptors</b> (L-type Ca<sup>2+</sup> channels)</div>", "time": 1660105359704.0}, {"id": 1471224415440, "note": "<div>Entry of Ca<sup>2+</sup> into the myocardial cell during the <u>myocardial action potential</u> triggers <i>further release</i> of Ca<sup>2+</sup> through <b>{{c1::ryanodine}} receptors</b> (Ca<sup>2+</sup> release channels)</div>", "time": null}, {"id": 1471224440268, "note": "<div>The <b>magnitude of the tension</b> that develops during <u>myocardial excitation-contraction coupling</u> is <b>proportional</b> to levels of intracellular {{c1::Ca<sup>2+</sup>}}</div>", "time": null}, {"id": 1471224467806, "note": "<div><b>Relaxation</b> of a myocardial cell occurs when:</div><div>-  Ca<sup>2+</sup> is <i>reaccumulated</i> in the sarcoplasmic reticulum by the action of {{c1::<u>Ca<sup>2+</sup> ATPase (SERCA)</u>}}</div><div>- Ca<sup>2+ </sup>is pumped out of the cell by the {{c2::<u>Na<sup>+</sup>/Ca<sup>2+</sup> exchanger (NCX)</u>}} </div>", "time": null}, {"id": 1471224477196, "note": "<div>{{c1::Gap junctions}} are <b>low-resistance paths</b> between cardiac cells that allow for <u>rapid electrical spread</u> of action potentials</div>", "time": null}, {"id": 1471224490686, "note": "<div>Contractility, or {{c1::inotropism}}, is the intrinsic ability of <u>myocardial cells</u> to <b>develop force at a given muscle length</b></div>", "time": null}, {"id": 1471224508109, "note": "<div>A <b>positive inotropic effect</b> {{c1::increases}} heart contractility</div>", "time": 1660105362476.0}, {"id": 1471224512101, "note": "<div>A <b>negative inotropic effect</b> {{c1::decreases}} heart contractility</div>", "time": 1660105362503.0}, {"id": 1471224515467, "note": "<div><b>Cardiac contractility</b> correlates directly with intracellular {{c1::Ca<sup>2+</sup>}} concentration</div>", "time": null}, {"id": 1471224519538, "note": "<div><b>Sympathetic stimulation</b> <u>increases</u>&nbsp;myocardial contractility via <b>{{c1::\u03b2<sub>1</sub>}}</b> <b>receptors</b></div>", "time": null}, {"id": 1471224536944, "note": "<div><b>Sympathetic stimulation</b> <u>increases</u> the activity of <b>{{c2::Ca<sup>2+</sup> ATPase aka SERCA}}</b> via phosphorylation/inhibition of <b>{{c1::phospholamban}}</b></div>", "time": null}, {"id": 1471224590406, "note": "<div><b>Parasympathetic stimulation</b> <u>decreases</u>&nbsp;<i>{{c3::atrial}}</i> contractility via {{c1::<b>M<sub>2</sub></b>}} <b>receptors</b> </div>", "time": null}, {"id": 1471224663028, "note": "<div>What effect does <b>increased heart rate</b> have on cardiac <u>contractility</u>?</div><div><br /></div><div>{{c1::Increased contractility (to an extent)}}</div>", "time": 1660105347182.0}, {"id": 1471224677046, "note": "<div><div>What effect does <b>decreased heart rate</b> have on cardiac <u>contractility</u>?</div><div><br></div><div>{{c1::Decreased contractility}}</div></div>", "time": 1660105347195.0}, {"id": 1471224680488, "note": "<div><b>Cardiac contractility</b> increases with {{c1::<u>increased</u>::increased or decreased}} <b>catecholamines</b></div>", "time": null}, {"id": 1471224684457, "note": "<div><b>Cardiac contractility</b> <i>increases</i> with {{c1::<u>increased</u>}} <b>intracellular Ca<sup>2+</sup></b></div>", "time": 1660105360939.0}, {"id": 1471224689513, "note": "<div><b>Cardiac contractility</b> <i>increases</i> with {{c1::<u>decreased</u>}} <b>extracellular Na<sup>+</sup></b> </div>", "time": 1660105360940.0}, {"id": 1471224698015, "note": "<div>What is the effect of <b>cardiac glycosides</b> on <u>contractility</u>? </div><div><br /></div><div>{{c1::Increased contractility}}</div>", "time": 1660105346547.0}, {"id": 1471224723342, "note": "<div><b>Increased intracellular [Na<sup>+</sup>]</b> in <u>cardiac myocytes</u> causes <i>decreased</i> activity of the {{c1::Ca<sup>2+</sup>-Na<sup>+</sup>}} <b>exchanger</b> </div>", "time": 1660105356174.0}, {"id": 1471224754332, "note": "<div>{{c1::Stroke volume}} is defined as the <b>volume of blood ejected</b> by <u>one</u> ventricular contraction</div>", "time": null}, {"id": 1471224757056, "note": "<div>{{c1::Ejection fraction}} is defined as the <b>fraction of the end-diastolic volume </b>that is <u>ejected</u> in each stroke volume</div>", "time": null}, {"id": 1471224759732, "note": "<div>The equation {{c1::SV = EDV - ESV}} may be used to calculate <b>stroke volume</b> </div>", "time": 1660105350183.0}, {"id": 1471224766592, "note": "<div>The equation {{c1::ejection fraction = SV/EDV}} may be used to calculate <b>ejection fraction</b></div>", "time": null}, {"id": 1471224770350, "note": "<div><b>Cardiac {{c2::contractility}}</b> can be estimated by the <b>left ventricular {{c1::ejection fraction}}</b></div>", "time": 1660105360929.0}, {"id": 1471224774091, "note": "<div><b>Ejection fraction</b> is normally <u>&gt;</u> {{c1::55}}%</div>", "time": 1660105359621.0}, {"id": 1471224777726, "note": "<div>What equation is used to calculate <b>cardiac output</b> given a patients <u>stroke volume</u> and <u>heart rate</u>?</div><div><br></div><div>{{c1::CO = SV x HR}}</div>", "time": null}, {"id": 1471224780838, "note": "<div>The <b>Frank-Starling relationship</b> states that the force of {{c1::<b>contraction</b>}} is <u>proportional</u> to the <b>{{c2::end-diastolic length}}</b> of the cardiac muscle fiber</div>", "time": 1660105350115.0}, {"id": 1471224803014, "note": "<div>What is the effect of <b>increased venous return</b> on end-diastolic volume (EDV)?</div><div><br></div><div>{{c1::Increased EDV}}</div>", "time": 1660105346528.0}, {"id": 1471224807904, "note": "<div><u>Increases</u> in <b>contractility</b> cause the <b>Starling curve</b> to shift {{c1::upward}}</div>", "time": 1660105356148.0}, {"id": 1471224820932, "note": "<div><u>Decreases</u> in <b>contractility</b> (e.g. heart failure) cause the <b>Starling curve</b> to shift {{c1::downward}} </div>", "time": 1660105360179.0}, {"id": 1471224827913, "note": "<div><b>Exercise</b> causes the <b>Starling curve</b> to shift {{c1::upward}}</div>", "time": 1660105359378.0}, {"id": 1471273372497, "note": "{{c1::Isovolumetric contraction}} is the <i>first</i> phase of a cardiac cycle and represents the period <u>between</u> <b>mitral valve closing</b> and <b>aortic valve opening</b> <div><div></div></div>", "time": 1660105339905.0}, {"id": 1471274287185, "note": "<div>{{c1::Ventricular (systolic) ejection}} is the <i>second</i> phase of a cardiac cycle and represents the period <u>between</u> <b>aortic valve opening</b> and <b>closing</b> </div>", "time": 1660105338498.0}, {"id": 1471274292765, "note": "<div>{{c1::Isovolumetric relaxation}} is the <i>third</i> phase of a cardiac cycle and represents the period <u>between</u> <b>aortic valve closing</b> and <b>mitral valve opening</b> </div>", "time": 1660105339904.0}, {"id": 1471274300627, "note": "<div>{{c1::<u>Rapid</u> ventricular filling}} is the <i>fourth</i> phase of a cardiac cycle and represents the period<b> <u>just after</u> mitral valve <i>opening</i></b> </div>", "time": 1660105339099.0}, {"id": 1471274306843, "note": "<div>{{c1::<u>Reduced</u> filling}} is the <i>fifth</i> phase of a cardiac cycle and represents the period <b><u>just before</u> mitral valve <i>closing</i> </b> </div>", "time": 1660105339094.0}, {"id": 1471274312788, "note": "<div>The {{c2::<b>width</b>}} of a <u>pressure-volume loop</u> is the {{c1::<b>stroke volume</b>}}</div>", "time": 1660105348842.0}, {"id": 1471274319093, "note": "<div><b>Preload</b> is approximated by ventricular {{c1::end-diastolic volume (EDV)}}</div>", "time": 1660105353740.0}, {"id": 1471274322460, "note": "<div>What effect does <b>increased venous return</b> have on <b>preload</b>?</div><div><br></div><div>{{c1::Increased preload}}</div>", "time": 1660105347177.0}, {"id": 1471274325193, "note": "<div><b>Afterload</b> is approximated by {{c1::mean arterial pressure}}</div>", "time": 1660105362004.0}, {"id": 1471274328220, "note": "<div>What effect does <b>increased aortic pressure</b> have on <b>afterload</b>?</div><div><br></div><div>{{c1::Increased afterload}}</div>", "time": 1660105347186.0}, {"id": 1471274331054, "note": "<div><b>Increased {{c2::preload}}</b> results in a(n) {{c1::<b>increased</b>}} <b>width</b> on a <u>pressure-volume loop</u> curve</div>", "time": 1660105356150.0}, {"id": 1471274338690, "note": "<div><b>Increased {{c2::afterload}}</b> results in a(n) {{c1::<b>decreased</b>}} <b>width</b> and {{c1::<b>increased</b>}} <b>height</b> on a <u>pressure-volume loop</u> curve</div>", "time": 1660105356154.0}, {"id": 1471274345796, "note": "<div><b>Increased {{c2::contractility}}</b> results in a(n) {{c1::<b>increased</b>}} <b>width</b> and {{c1::<b>increased</b>}} <b>height</b> on a <u>pressure-volume loop</u> curve </div>", "time": 1660105356152.0}, {"id": 1471274352443, "note": "<div>What effect does <b>increased <i>preload</i></b> have on <b>stroke volume</b>? </div><div><br /></div><div>{{c1::Increased SV}}</div>", "time": 1660105347178.0}, {"id": 1471274358522, "note": "<div><div>What effect does <b>increased <i>afterload</i></b> have on <b>stroke volume</b>? </div><div><br /></div><div>{{c1::Decreased SV}} </div></div>", "time": 1660105347188.0}, {"id": 1471274365484, "note": "<div><div>What effect does <b>increased <i>afterload</i></b> have on <b>end-systolic volume</b>? </div><div><br /></div><div>{{c1::Increased ESV}} </div></div>", "time": 1660105347189.0}, {"id": 1471274371357, "note": "<div><div>What effect does <b>increased <i>contractility</i></b> have on <b>end-systolic volume</b>? </div><div><br /></div><div>{{c1::Decreased ESV}} </div></div>", "time": 1660105347184.0}, {"id": 1471274377554, "note": "<div><div>What effect does <b>increased <i>contractility</i></b> have on <b>stroke volume</b>? </div><div><br /></div><div>{{c1::Increased SV}}</div></div>", "time": 1660105347183.0}, {"id": 1471274390554, "note": "<div><div>What effect does <b>increased <i>preload</i></b> have on <b>ejection fraction</b>? </div><div><br /></div><div>{{c1::Increased EF}}</div></div>", "time": 1660105347179.0}, {"id": 1471276670263, "note": "According to the <b>law of Laplace</b>, cardiac wall stress = {{c1::P*r / 2H}}", "time": 1660105362237.0}, {"id": 1471276934361, "note": "<div><b>Cardiac O<sub>2</sub> consumption</b> is directly related to the amount of {{c1::tension}} developed by the ventricles</div>", "time": null}, {"id": 1471276938496, "note": "<div>What is the effect of <b>increased afterload</b> (increased aortic pressure) on <b>cardiac O<sub>2</sub> consumption</b>? </div><div><br></div><div>{{c1::Increased O<sub>2</sub> consumption}}</div>", "time": null}, {"id": 1471276943049, "note": "<div><div>What is the effect of <u>increased</u><b> ventricular diameter</b> on <b>cardiac O<sub>2</sub> consumption</b>? </div><div><br></div><div>{{c1::Increased O<sub>2</sub> consumption}}</div></div>", "time": null}, {"id": 1471276945706, "note": "<div><div>What is the effect of <u>increased contractility</u> on <b>cardiac O<sub>2</sub> consumption</b>? </div><div><br></div><div>{{c1::Increased O<sub>2</sub> consumption}}</div></div>", "time": null}, {"id": 1471276948595, "note": "<div><div>What is the effect of <b>increased heart rate</b> on <b>cardiac O<sub>2</sub> consumption</b>? </div><div><br></div><div>{{c1::Increased O<sub>2</sub> consumption}}</div></div>", "time": null}, {"id": 1471276953481, "note": "<div>The reasons there is <b>concentric left ventricular hypertrophy</b> in response to <u>systemic hypertension</u><b> </b>is that {{c1::increased}} wall thickness {{c1::decreases}} wall stress by offsetting {{c1::increased}} wall tension </div>", "time": null}, {"id": 1471276964931, "note": "<div>The left ventricle compensates for <u>increased afterload</u> by {{c1::thickening (hypertrophy)}} in order to<b> decrease wall tension</b></div>", "time": 1660105349922.0}, {"id": 1471276982372, "note": "<div>What effect does <b>increased aortic pressure</b> (afterload) have on cardiac <b>wall stress</b>?</div><div><br></div><div>{{c1::Increased wall stress}}</div>", "time": 1660105347187.0}, {"id": 1471276994963, "note": "<div>According to the <b>Fick principle</b>: </div><div>{{c2::Cardiac Output (CO)}} = {{c1::O<sub>2</sub> consumption / (arterial O<sub>2</sub> content - venous O<sub>2</sub> content)}}</div>", "time": null}, {"id": 1471277020049, "note": "<div>The <u>resistance</u> of a vessel may be calculated using <b>Poiseuilles equation</b>, which states R = {{c1::8\u03b7l/\u03c0r<sup>4</sup>}}</div>", "time": 1660105349634.0}, {"id": 1471277046566, "note": "<div>The likelihood of <u>turbulent flow</u> may be calculated using <b>Reynolds number</b>, which states N<sub>R</sub> = {{c1::\u03c1dv/\u03b7}}</div>", "time": null}, {"id": 1471289939766, "note": "The heart sound <b>S1</b>&nbsp;is due to<b> {{c2::mitral}} </b>and<b> {{c2::tricuspid}} valve closure</b>", "time": null}, {"id": 1471294040253, "note": "<div><div>The heart sound <b>{{c1::S2}}</b> is due to <b>{{c2::aortic}} </b>and<b> {{c2::pulmonic}} valve closure </b></div></div>", "time": null}, {"id": 1471294044110, "note": "<div><div>The <i>normal</i> heart sound <b>{{c1::S2}}</b> is <u>loudest</u> at the <b>left upper sternal border</b></div></div>", "time": null}, {"id": 1471294048001, "note": "<div><div><b>Atrial {{c1::systole}}</b> is preceded by the <b>{{c2::P}} wave</b> on ECG, which marks depolarization of the atria</div></div>", "time": null}, {"id": 1471294052806, "note": "<div><div>The increase in atrial pressure caused by <u>atrial systole</u> appears on the <b>venous pulse curve </b>as the <b>{{c1::a}} wave</b> </div></div>", "time": 1660105350004.0}, {"id": 1471294064499, "note": "<div><div>Is the <b>fourth heart sound</b> (S4) <i>normally</i> audible in adults?</div><div><br></div><div>{{c1::No}}</div></div>", "time": null}, {"id": 1471294075331, "note": "<div><div>The heart sound <b>{{c1::S4}}</b> can be associated with <b>ventricular </b>{{c2::<b>noncompliance</b>}}</div></div>", "time": null}, {"id": 1471294080868, "note": "<div>The <i>abnormal </i>heart sounds <b>S3</b> and <b>S4</b> are best heard at the heart <b>{{c1::apex}}</b>, with the patient in <u>left lateral decubitus</u> position</div>", "time": 1660105350489.0}, {"id": 1471294084533, "note": "<div>The <i>abnormal </i>heart sound <b>{{c1::S4}}</b> may be audible during <b>atrial systole</b> (late ventricular diastole)</div>", "time": null}, {"id": 1471294104386, "note": "<div>What phase of the <u>cardiac cycle</u> begins during the <b>QRS complex</b> on ECG?</div><div><br></div><div>{{c1::Isovolumetric ventricular contraction::specific}}</div>", "time": null}, {"id": 1471294113945, "note": "<div>The heart sound <b>{{c1::S1}}</b> may be audible during <b>isovolumetric contraction</b> </div>", "time": null}, {"id": 1471294123323, "note": "<div>When the <b>left ventricle contracts</b>, the left ventricular pressure becomes <u>greater</u> than left atrial pressure and the <b>{{c1::mitral}} valve <u>closes</u></b> </div>", "time": 1660105344580.0}, {"id": 1471294159863, "note": "<div>During <b>rapid ventricular ejection</b>, the ventricular pressure becomes <u>greater</u> than aortic pressure and the <b>{{c1::aortic}} valve <u>opens</u></b> </div>", "time": 1660105359716.0}, {"id": 1471294222786, "note": "<div>The <i>end</i> of <b>rapid ventricular ejection</b> corresponds with the <i>onset</i> of the {{c1::T}} <b>wave</b> on ECG</div>", "time": null}, {"id": 1471294229720, "note": "<div>During <u>right ventricular contraction</u>, the tricuspid valve bulges into the right atrium, which appears as the <b>{{c1::c}} wave</b> on the <b>venous pulse curve</b></div>", "time": 1660105359713.0}, {"id": 1471294240036, "note": "<div>The <i>onset</i> of <b>reduced ventricular ejection</b> corresponds with the onset of the {{c1::T}} <b>wave</b> on ECG</div>", "time": null}, {"id": 1471294257021, "note": "<div>During <u>atrial relaxation</u>, the tricuspid valve returns to its downward position, which appears as the <b>{{c1::x}} descent</b> on the <b>venous pulse curve</b> </div>", "time": 1660105359732.0}, {"id": 1471294272870, "note": "<div><div>The heart sound <b>{{c1::S2}}</b> may be audible during <b>isovolumetric relaxation</b> </div></div>", "time": null}, {"id": 1471294282027, "note": "<div><div><div><div><div>How does <b>ventricular pressure</b> change during <u>isovolumetric relaxation</u>?</div><div><br /></div><div>{{c1::Decrease}}</div></div></div></div></div>", "time": 1660105358044.0}, {"id": 1471294310881, "note": "<div>Increased <u>right atrial pressure</u>, due to filling against a closed tricuspid valve, appears as the <b>{{c1::v}} wave</b> on the <b>venous pulse curve</b> </div>", "time": 1660105356162.0}, {"id": 1471294321159, "note": "<div><b>Isovolumetric {{c1::relaxation}}</b> corresponds to the <i>end</i> of the <b>{{c2::T}} wave</b> on ECG</div>", "time": null}, {"id": 1471294329467, "note": "<div>During <b>isovolumetric relaxation</b>, the ventricular pressure becomes <u>less</u> than aortic pressure and the <b>{{c1::aortic}} valve </b><u style=\"font-weight: bold; \">closes</u> </div>", "time": 1660105359722.0}, {"id": 1471294336923, "note": "<div><u>Inspiration</u> delays closure of the <b>{{c1::pulmonic}} valve</b> which causes <b>{{c2::splitting}}</b> of the <b>S2</b> heart sound</div>", "time": null}, {"id": 1471294340099, "note": "<div>During <b>rapid ventricular filling</b>, the left ventricular pressure becomes <u>less</u> than the left atrial pressure and the <b>{{c1::mitral}} valve </b><u style=\"font-weight: bold; \">opens</u> </div>", "time": 1660105359715.0}, {"id": 1471294355563, "note": "<div>The <i>abnormal</i> heart sound <b>{{c1::S3}}</b> may be audible during <b>rapid ventricular filling</b> (early diastole)</div>", "time": null}, {"id": 1471294363464, "note": "<div>In what <i>demographics</i> may the heart sound <b>S3</b> be <u>normal</u>?</div><div><br></div><div>{{c1::Children, young adults, pregnant women, athletes::4 options}}</div>", "time": null}, {"id": 1471294366999, "note": "<div>The presence of the heart sound <b>S3</b> in middle-aged or older adults indicates <b>volume</b> {{c1::overload}}</div>", "time": null}, {"id": 1471294403135, "note": "<div>During <b>rapid ventricular filling</b>, the right atrium empties into the right ventricle, which appears as the <b>{{c1::y}} descent</b> on the <b>venous pulse curve</b> </div>", "time": 1660105359714.0}, {"id": 1471367445517, "note": "The <b>{{c2::cardiac}} function curve</b> is a plot of the relationship between <b>{{c1::cardiac output}}</b> of the <u>left ventricle</u> and <b>{{c1::pressure}}</b> of the <u>right atrium</u> ", "time": 1660105348944.0}, {"id": 1471373941915, "note": "<div><div>The <b>{{c2::vascular}} function curve</b> is a plot of the relationship between <b>{{c1::pressure}}</b> of the <u>right atrium</u> and <b>{{c1::venous return}}</b> </div></div>", "time": 1660105348844.0}, {"id": 1471373949478, "note": "<div><div>The <b>{{c1::mean systemic pressure}}</b> is the point at which the <u>vascular function curve</u> intersects the x-axis </div></div>", "time": 1660105349142.0}, {"id": 1471373957839, "note": "<div><div>The <b>mean systemic pressure</b> is equal to the <u>right atrial pressure</u> when the <b>venous return</b> is {{c1::zero}}</div></div>", "time": 1660105349843.0}, {"id": 1471373965595, "note": "<div><div>What effect does <b><u>increased</u> blood volume</b> have on <b>mean systemic pressure</b>? </div><div><br /></div><div>{{c1::Increased}} </div></div>", "time": 1660105347185.0}, {"id": 1471373973842, "note": "<div><div>An <u>increase</u> in <b>mean systemic pressure</b> is reflected in a shift of the <b>{{c2::vascular}} function curve</b> to the <b>{{c1::right}}</b> </div></div>", "time": 1660105361816.0}, {"id": 1471373980396, "note": "<div><div><div>A <u>decrease</u> in <b>mean systemic pressure</b> is reflected in a shift of the <b>{{c2::vascular}} function curve</b> to the <b>{{c1::left}}</b> </div></div></div>", "time": 1660105362571.0}, {"id": 1471373987266, "note": "<div><div><div>What effect does <b><u>increased</u> venous tone</b> (decreased compliance) have on <b>mean systemic pressure</b>? </div><div><br /></div><div>{{c1::Increased}}</div></div></div>", "time": 1660105347176.0}, {"id": 1471373995806, "note": "<div><div>What <u>two</u> factors influence the value for <b>mean systemic pressure</b>? </div><div><br></div><div>{{c1::Blood volume, venous tone}}</div></div>", "time": null}, {"id": 1471373999704, "note": "<div><div>The <b>slope</b> of the <u>vascular function curve</u> is determined primarily by <b>{{c1::total peripheral resistance (TPR)}}</b> </div></div>", "time": 1660105349570.0}, {"id": 1471374002850, "note": "<div>A(n)&nbsp;<b>{{c1::positive}} inotropic agent</b> causes the <u>{{c3::cardiac}} function curve</u> to shift <b>{{c2::upwards}}</b></div>", "time": null}, {"id": 1471374017183, "note": "<div>A(n)&nbsp;<b>{{c1::negative}} inotropic agent</b> causes the <u>cardiac function curve</u> to shift <b>{{c2::downwards}}</b></div>", "time": null}, {"id": 1471374026509, "note": "<div><div>The <b>{{c1::intersection}}</b> of the <b>cardiac</b> and <b>vascular function curves</b> is the operating point of the heart</div></div>", "time": 1660105349189.0}, {"id": 1471374038161, "note": "<div><div>A <u>positive inotropic agent</u> causes the <b>cardiac</b> <b>output</b> to {{c1::increase}} and <b>right atrial pressure</b> to {{c1::decrease}}</div></div>", "time": 1660105362477.0}, {"id": 1471374043606, "note": "<div><div>A <u>negative inotropic agent</u> causes the <b>cardiac</b> <b>output</b> to {{c1::decrease}} and <b>right atrial pressure</b> to {{c1::increase}}</div></div>", "time": null}, {"id": 1471374049722, "note": "<div><div>An <u>increased blood volume</u> (or venous tone) causes the <b>cardiac</b> <b>output</b> to {{c1::increase}} and <b>right atrial pressure</b> to {{c1::increase}}</div></div>", "time": 1660105361814.0}, {"id": 1471374056483, "note": "<div><div>A <u>decreased blood volume</u> (or venous tone) causes the <b>cardiac</b> <b>output</b> to {{c1::decrease}} and <b>right atrial pressure</b> to {{c1::decrease}}</div></div>", "time": 1660105362569.0}, {"id": 1471374064088, "note": "<div><div>An <u>increased TPR</u> causes the <b>cardiac</b> <b>output</b> to {{c1::decrease}} and <b><i>venous return</i></b> to {{c1::decrease}}</div></div>", "time": 1660105361813.0}, {"id": 1471374073636, "note": "<div><div>A <u>decreased TPR</u> causes the <b>cardiac</b> <b>output</b> to {{c1::increase}} and <b><i>venous return</i></b> to {{c1::increase}}</div></div>", "time": 1660105362568.0}, {"id": 1471374083626, "note": "<div>A(n) <u>{{c2::decrease}}</u> in <b>TPR</b> causes a(n)&nbsp;<b>{{c1::clockwise}} rotation</b> of the <u>vascular</u> function curve</div>", "time": 1660105362296.0}, {"id": 1471374093096, "note": "<div>A(n) <u>{{c2::increase}}</u> in <b>TPR</b> causes a(n)&nbsp;<b>{{c1::counterclockwise}} rotation</b> of the <u>vascular</u> function curve</div>", "time": 1660105362288.0}, {"id": 1471374102211, "note": "<div><div><div>A(n) <u>{{c2::decrease}}</u> in <b>TPR</b> causes a(n) <b>{{c1::upward}} shift</b> of the <u>cardiac</u> function curve </div></div></div>", "time": 1660105362294.0}, {"id": 1471374108833, "note": "<div><div><div>A(n) <u>{{c2::increase}}</u> in <b>TPR</b> causes a(n) <b>{{c1::downward}} shift</b> of the <u>cardiac</u> function curve </div></div></div>", "time": 1660105362286.0}, {"id": 1471375678230, "note": "<div>What equation is used to calculate <b>mean arterial pressure</b> using a patients <u>cardiac output</u>?</div><div><br></div><div>{{c1::MAP = CO x TPR}}</div>", "time": 1660105347118.0}, {"id": 1471378696248, "note": "<div><b>Mean arterial pressure</b> is maintained at a constant level of approximately {{c1::100}} mmHg</div>", "time": null}, {"id": 1471378707376, "note": "<div><b>Baroreceptors</b> are <u>stretch</u> mechanoreceptors located within the {{c1::carotid <i>sinus</i>}} and the {{c1::aortic arch}}</div>", "time": null}, {"id": 1471378710022, "note": "<div>Which <b>baroreceptors</b> are responsive to <i>both</i> <u>increases</u> and <u>decreases</u> in arterial pressure? </div><div><br /></div><div>{{c1::Carotid sinus receptors}} </div>", "time": null}, {"id": 1471378712791, "note": "<div><div>Which <b>baroreceptors</b> are responsive to <u>increases</u> in arterial pressure <i>only</i>? </div><div><br /></div><div>{{c1::Aortic arch receptors}}</div></div>", "time": null}, {"id": 1471378716219, "note": "<div>Information from the <b>carotid sinus baroreceptor</b> is carried to the <b>{{c2::nucleus tractus solitarius (NTS)}}</b> via the {{c1::<b>glossopharyngeal</b>}} <b>nerve</b> </div>", "time": null}, {"id": 1471378723785, "note": "<div>Information from the <b>aortic arch baroreceptors</b> is carried to the {{c2::<b>nucleus tractus solitarius (NTS)</b>}} via the {{c1::<b>vagus</b>}} <b>nerve</b> </div>", "time": null}, {"id": 1471378777627, "note": "<div>How does <u>decreased</u> <b>efferent parasympathetic firing</b> (e.g. baroreceptor reflex) affect <b>heart rate</b>?</div><div><br /></div><div>{{c1::Increased HR}}</div>", "time": null}, {"id": 1471378785447, "note": "<div><div>How does <u>increased</u> <b>efferent sympathetic firing</b> (e.g. baroreceptor reflex) affect <b>heart rate</b>?</div><div><br /></div><div>{{c1::Increased HR}}</div></div>", "time": null}, {"id": 1471378793470, "note": "<div>How does <u>increased</u> <b>efferent sympathetic firing</b> (e.g. baroreceptor reflex) affect <b>contractility</b>?</div><div><br></div><div>{{c1::Increased contractility}}</div>", "time": null}, {"id": 1471378832213, "note": "<div>The integrity of the <b>{{c2::baroreceptor}} reflex</b> can be tested with the <b>{{c1::Valsalva}} maneuver</b></div>", "time": null}, {"id": 1471447132876, "note": "The <b>a wave</b> on <u>jugular venous pulse</u> corresponds to {{c1::atrial contraction}}", "time": null}, {"id": 1471447242243, "note": "<div>The <b>c wave</b> on <u>jugular venous pulse</u> corresponds to {{c1::right ventricle contraction}}</div>", "time": null}, {"id": 1471447244666, "note": "<div>The <b>x descent</b> on <u>jugular venous pulse</u> corresponds to {{c1::atrial relaxation}}</div>", "time": null}, {"id": 1471447248110, "note": "<div>The <b>v wave</b> on <u>jugular venous pulse</u> corresponds to {{c1::right atrial filling}}</div>", "time": null}, {"id": 1471447254224, "note": "The <b>y descent</b> on <u>jugular venous pulse</u> corresponds to {{c1::right atrial emptying into the right ventricle}}", "time": null}, {"id": 1471456202579, "note": "<div>The <b>{{c1::renin-angiotensin II-aldosterone system}}</b> is a <b>slow, hormonally mediated</b> mechanism of <u>regulating arterial pressure</u></div>", "time": null}, {"id": 1471457755859, "note": "<div>The <b>renin-angiotensin II-aldosterone system</b> regulates <u>mean arterial pressure</u> primarily by adjusting blood {{c1::volume}}</div>", "time": null}, {"id": 1471457759434, "note": "<div>The <b>renin-angiotensin II-aldosterone system</b> is activated in response to a(n) {{c1::decrease}} in <u>mean arterial pressure</u></div>", "time": null}, {"id": 1471457762153, "note": "<div>A <u>decrease</u> in <b>renal perfusion pressure </b>causes the {{c2::juxtaglomerular}} cells of the afferent arterioles to secrete {{c1::<b>renin</b>}}</div>", "time": null}, {"id": 1471457764858, "note": "<div><b>{{c1::Renin}}</b> is an enzyme that catalyzes the conversion of <b>{{c2::angiotensinogen}}</b> to <b>{{c2::angiotensin I}}</b> in the plasma</div>", "time": null}, {"id": 1471457767523, "note": "<div>{{c1::<b>Angiotensin-converting enzyme </b>(ACE)}} catalyzes the conversion of <b>angiotensin I</b> to <b>angiotensin II</b></div>", "time": null}, {"id": 1471457770358, "note": "<div>In which organ does <u>angiotensin-converting enzyme</u> (ACE) catalyze conversion of <b>angiotensin I</b> to <b>angiotensin II</b>? </div><div><br></div><div>{{c1::Lungs (primarily)}}</div>", "time": null}, {"id": 1471457773070, "note": "<div><b>Angiotensin II</b> stimulates the synthesis and secretion of {{c1::aldosterone}} by the adrenal cortex</div>", "time": null}, {"id": 1471457792149, "note": "<div><b>Angiotensin II</b> <u>increases</u> {{c1::Na<sup>+</sup>-H<sup>+</sup>}} <b>exchange</b> in the proximal convoluted tubule</div>", "time": null}, {"id": 1471457806709, "note": "<div><b>Angiotensin II</b> increases {{c1::thirst}} via its action on the hypothalamus </div>", "time": null}, {"id": 1471457814120, "note": "<div><b>Angiotensin II</b> causes {{c1::constriction}} of<i> </i>arterioles</div>", "time": null}, {"id": 1471461030608, "note": "<div>{{c1::<b>Atrial natriuretic peptide </b>(ANP)}} is released from <b>atrial myocytes</b> in response to {{c2::<u>increased</u>}} blood volume and atrial pressure </div>", "time": null}, {"id": 1471461042542, "note": "<div><div>Through which <u>secondary messenger</u> does <b>ANP</b> exert its actions?</div><div><br></div><div>{{c1::cGMP}}</div></div>", "time": null}, {"id": 1471461045449, "note": "<div><b>Atrial natriuretic peptide</b> <i>generally </i>causes {{c1::dilation}} of arterioles</div>", "time": null}, {"id": 1471461048669, "note": "<div>What effect does <b>atrial natriuretic peptide</b> have on <b>Na<sup>+</sup> reabsorption</b> at the renal collecting tubule?</div><div><br></div><div>{{c1::Decreased reabsorption}}</div>", "time": null}, {"id": 1471461053719, "note": "<div><b>Atrial natriuretic peptide</b> <i>dilates</i> <u>afferent</u> renal arterioles and <i>constricts</i> <u>efferent</u> renal arterioles, which {{c1::increases}} excretion of <b>Na<sup>+</sup> </b>and <b>water, </b>along with downregulating <b>{{c2::ENaC}}</b> on the collecting tubules</div>", "time": 1660105361443.0}, {"id": 1471461067682, "note": "<div><b>Atrial baroreceptors</b> respond to <b>{{c2::decreased}} blood volume</b> by <u>increasing</u> release of {{c1::vasopressin (ADH)}} from the posterior pituitary</div>", "time": null}, {"id": 1471461070808, "note": "<div><b>Vasopressin (ADH)</b> causes {{c1::constriction}} of arterioles by activating {{c2::V<sub>1</sub>}} receptors</div>", "time": null}, {"id": 1471461086122, "note": "<div><b>Vasopressin (ADH)</b> causes <u>water reabsorption</u> by the renal distal tubule and collecting ducts by activating {{c2::V<sub>2</sub>}} receptors </div>", "time": null}, {"id": 1471466733838, "note": "<div>The <b>effective osmotic pressure</b> contributed by <u>protein</u> is called the <b>{{c1::oncotic}} pressure</b></div>", "time": 1660105350215.0}, {"id": 1471466751292, "note": "<div>The <b>Starling equation</b> is used to determine fluid flow (J<sub>v</sub>) and states that J<sub>v</sub> = {{c1::K<sub>f</sub> [(P<sub>c</sub> - P<sub>i</sub>) - \u03c3(\u03c0<sub>c</sub> \u2212\u03c0<sub>i</sub>)]}}&nbsp; &nbsp;</div>", "time": 1660105349548.0}, {"id": 1471466801870, "note": "<div>What does <b>K<sub>f</sub> </b>represent in regards to capillary fluid exchange?</div><div><br /></div><div>{{c1::Permeability to fluid (water)}}</div>", "time": null}, {"id": 1471466805806, "note": "<div><div>What does <b>P<sub>c</sub> </b>represent in regards to capillary fluid exchange? </div><div><br></div><div>{{c1::Capillary hydrostatic pressure}}</div></div>", "time": null}, {"id": 1471466824360, "note": "<div><u>Increased</u> capillary hydrostatic pressure (<b>P<sub>c</sub></b>) pushes fluid {{c1::out of}} the capillary</div>", "time": 1660105356182.0}, {"id": 1471466831564, "note": "<div>Capillary hydrostatic pressure (<b>P<sub>c</sub></b>) is <u>highest</u> at the {{c1::arteriolar}} end of the capillary and <u>lowest</u> at the {{c1::venous}} end</div>", "time": 1660105360969.0}, {"id": 1471466834322, "note": "<div><div>What does <b>P<sub>i</sub> </b>represent in regards to capillary fluid exchange?</div><div><br></div><div>{{c1::Interstitial hydrostatic pressure}}</div></div>", "time": null}, {"id": 1471466840948, "note": "<div><u>Increased</u> interstitial hydrostatic pressure (<b>P<sub>i</sub></b>) pushes fluid {{c1::into}} the capillary</div>", "time": 1660105356176.0}, {"id": 1471466846426, "note": "<div><div>What does <b>\u03c0<sub>c</sub> </b>represent in regards to capillary fluid exchange?</div><div><br></div><div>{{c1::Capillary oncotic pressure}}</div></div>", "time": null}, {"id": 1471466849804, "note": "<div><u>Increased</u> capillary oncotic pressure (<b>\u03c0<sub>c</sub></b>) pulls fluid {{c1::into}} the capillary</div>", "time": 1660105356181.0}, {"id": 1471466857351, "note": "<div><div>What does <b>\u03c0<sub>i</sub> </b>represent in regards to capillary fluid exchange?</div><div><br></div><div>{{c1::Interstitial oncotic pressure}}</div></div>", "time": null}, {"id": 1471466860825, "note": "<div><u>Increased</u> interstitial oncotic pressure (<b>\u03c0</b><sub style=\"font-weight: bold; \">i</sub>) pulls fluid {{c1::out of}} the capillary</div>", "time": 1660105356175.0}, {"id": 1471466884199, "note": "<div><b>Edema</b> may be caused by {{c1::increased}} capillary pressure (P<sub>c</sub>) </div>", "time": 1660105359630.0}, {"id": 1471466893190, "note": "<div><b>Edema</b> may be caused by {{c1::decreased}} <u>plasma</u> proteins (\u03c0<sub>c</sub>) </div>", "time": 1660105359632.0}, {"id": 1471466900946, "note": "<div><b>Edema</b> may be caused by {{c1::increased}} capillary permeability (K<sub>f</sub>) </div>", "time": 1660105359631.0}, {"id": 1471466908876, "note": "<div><b>Edema</b> may be caused by {{c1::increased}} interstitial proteins (\u03c0<sub>i</sub>)</div>", "time": 1660105359629.0}, {"id": 1471466918687, "note": "<b>{{c1::Autoregulation}}</b> is the maintenance of a <b>constant blood flow</b> to an organ in the face of <u>changing</u> arterial pressures", "time": 1660105341076.0}, {"id": 1471468263016, "note": "<div><b>{{c1::Active hyperemia}}</b> is the concept that blood flow to an organ is <i>proportional</i> to its <b>metabolic activity</b> </div>", "time": null}, {"id": 1471468280928, "note": "<div>The <b><i>vasodilator</i> metabolites</b> produced by tissues as a result of <u>increased</u> metabolic activity may be remembered using the mnemonic \"<b>CHALK</b>\":</div><div style=\"centerbox\"><div class=\"mnemonics\"><div><br/></div><div><b>C</b>: {{c1::CO<sub>2</sub>}}</div><div><b>H</b>: {{c2::H<sup>+</sup>}}</div><div><b>A</b>: {{c3::Adenosine}}</div><div><b>L</b>: {{c4::Lactate}}</div><div><b>K</b>: {{c5::K<sup>+</sup>}} </div></div></div>", "time": null}, {"id": 1471541327679, "note": "<b>Histamine</b> causes <b>arteriolar {{c1::dilation}}</b> and <b>venous {{c1::constriction}}</b>", "time": null}, {"id": 1471541598687, "note": "<div><b>Bradykinin</b> causes <b>arteriolar {{c1::dilation}}</b> and <b>venous {{c1::constriction}}</b></div>", "time": null}, {"id": 1471541616944, "note": "<div><b>Thromboxane A<sub>2</sub> </b>is a vaso-{{c1::constrictor}}</div>", "time": null}, {"id": 1471541620768, "note": "<div>What is the <u>major factor</u> determining <b>autoregulation</b> of blood flow to the <b>heart</b>?</div><div><br></div><div>{{c1::Local metabolites}}</div>", "time": 1660105346120.0}, {"id": 1471541638699, "note": "<div>The most important <u>local metabolic factors</u> for <b>coronary circulation</b> are {{c1::nitric oxide (NO)}} and {{c1::adenosine}} (<b>vasodilatory</b>) </div>", "time": 1660105349790.0}, {"id": 1471541651238, "note": "<div><div>What is the <u>major factor</u> determining <b>autoregulation</b> of blood flow to the <b>brain</b>?</div><div><br></div><div>{{c1::Local metabolites (vasodilatory)}}</div></div>", "time": 1660105346122.0}, {"id": 1471541666800, "note": "<div><div><div>What is the <u>major factor</u> determining <b>autoregulation</b> of blood flow to the <b>lungs</b>?</div><div><br></div><div>{{c1::Hypoxia (causes <u>vasoconstriction</u>)}}</div></div></div>", "time": 1660105346119.0}, {"id": 1471541670022, "note": "<div>In the <b>{{c2::lungs}}</b>, <u>hypoxia</u> causes <b>vaso-{{c1::constriction}}</b> </div>", "time": 1660105356588.0}, {"id": 1471541699437, "note": "<div><div>What are the <u>major factors</u> determining <b>autoregulation</b> of blood flow to the <b>kidney</b>?</div><div><br></div><div>{{c1::Myogenic and tubuloglomerular feedback::2}}</div></div>", "time": 1660105347807.0}, {"id": 1471541716832, "note": "<div><div>What is the <u>major factor</u> determining <b>autoregulation</b> of blood flow to the <b><i>resting</i> skeletal muscle</b>?</div><div><br></div><div>{{c1::Sympathetic innervation}}</div></div>", "time": null}, {"id": 1471541719710, "note": "<div><i>Sympathetic</i> stimulation of <b>{{c1::\u03b1<sub>1</sub>}} receptors</b> in skeletal muscle causes <b>vaso-{{c2::constriction}}</b></div>", "time": null}, {"id": 1471541722579, "note": "<div><i>Sympathetic</i> stimulation of <b>{{c1::\u03b2<sub>2</sub>}} receptors</b> in skeletal muscle causes <b>vaso-{{c2::dilation}}</b></div>", "time": null}, {"id": 1471541725222, "note": "<div><div>What is the <u>major factor</u> determining <b>autoregulation</b> of blood flow to the <b><i>exercising</i> skeletal muscle</b>?</div><div><br></div><div>{{c1::Local metabolites}}</div></div>", "time": 1660105346121.0}, {"id": 1471541734275, "note": "<div><div>What is the <u>major factor</u> determining <b>autoregulation</b> of blood flow to the<b> skin</b>?</div><div><br></div><div>{{c1::Sympathetic innervation}}</div></div>", "time": 1660105346118.0}, {"id": 1471541737371, "note": "<div>The primary <u>function</u> of <b>autoregulation</b> of blood flow to the <b>skin</b> is {{c1::temperature}} regulation</div>", "time": null}, {"id": 1471541760900, "note": "<div>Exposure to <b>cold temperatures</b> activates centers in the <u>{{c2::posterior}} hypothalamus</u>, which then activate<span class=\"Apple-tab-span\" style=\"white-space: pre\"> </span><b>\u03b1</b> and <b>\u03b3 motoneurons</b> innervating skeletal muscle, causing {{c1::<b>shivering</b>}} </div>", "time": null}, {"id": 1471541806006, "note": "<div>Mechanisms for <b>dissipating heat</b> are coordinated in the <b>{{c1::anterior}} hypothalamus</b></div>", "time": null}, {"id": 1471541811425, "note": "<div><b>Pyrogens</b> induce fever via <u>increased</u> production of <b>{{c1::IL-1}}</b>, which acts on the <i>anterior hypothalamus</i> to increase local production of <b>{{c2::prostaglandins}}</b></div>", "time": null}, {"id": 1471544858459, "note": "How does <u>exercise</u>&nbsp;affect <b>total peripheral resistance</b>? <div><br></div><div>{{c1::Decreased TPR}}</div>", "time": 1660105358102.0}, {"id": 1471547618307, "note": "{{c1::<b>Pulmonary capillary wedge pressure</b> (PCWP)}} is a good approximation of <b>{{c2::left atrial}} pressure</b>", "time": null}, {"id": 1471548037554, "note": "<div>How is <b>pulmonary capillary wedge pressure</b> (PCWP) measured?</div><div><br></div><div>{{c1::Pulmonary artery catheter (Swan-Ganz catheter)}}</div>", "time": 1660105358006.0}, {"id": 1471548040375, "note": "<div>What is the approximate <b>normal</b> <b>pressure</b> in the <b>right atrium</b>? </div><div><br /></div><div>{{c1::&lt; 5 mmHg}}</div>", "time": null}, {"id": 1471548046791, "note": "<div><div>What is the approximate <b>normal</b> <b>pressure</b> in the <b>right ventricle </b>(systolic and diastolic)? </div><div><br /></div><div>{{c1::25/5 mmHg}}</div></div>", "time": null}, {"id": 1471548053272, "note": "<div><div>What is the approximate <b>normal</b> <b>pressure</b> in the <b>left atrium</b>? </div><div><br /></div><div>{{c1::&lt; 12 mmHg}}</div></div>", "time": null}, {"id": 1471548060543, "note": "<div><div>What is the approximate<i> </i><b>normal</b> <b>pressure</b> in the <b>left ventricle </b>(systolic and diastolic)? </div><div><br /></div><div>{{c1::130/10 mmHg}}</div></div>", "time": null}, {"id": 1471548066974, "note": "<div><div>What is the approximate <b>normal</b> <b>pressure</b> in the <b>pulmonary artery </b>(systolic and diastolic)? </div><div><br /></div><div>{{c1::25/10 mmHg}}</div></div>", "time": null}, {"id": 1471548073385, "note": "<div><div>What is the approximate <b>normal</b> <b>pressure</b> in the <b>aorta </b>(systolic and diastolic)? </div><div><br /></div><div>{{c1::130/90 mmHg}}</div></div>", "time": null}, {"id": 1471548079484, "note": "<div>{{c1::<b>B-type</b> <b>(brain)</b> <b>natriuretic peptide</b> (BNP)}} is released from <b>ventricular myocytes</b> in response to <u>increased</u> {{c2::tension}} </div>", "time": null}, {"id": 1471548095656, "note": "<div>A <b>B-type natriuretic peptide</b> (BNP) <b>blood test</b> is used for diagnosing {{c1::heart failure}}</div>", "time": 1660105362593.0}, {"id": 1471551647075, "note": "<b>{{c1::Torsades de pointes}}</b> is a polymorphic ventricular tachycardia with <b>shifting sinusoidal waveforms</b> on ECG", "time": null}, {"id": 1471552222169, "note": "<div><div>A <b>long</b> <b>{{c1::QT interval}}</b> predisposes to <b>torsades de pointes</b></div></div>", "time": null}, {"id": 1471552239888, "note": "<div><div>Treatment for <b>torsades de pointes</b> includes {{c1::magnesium sulfate}}</div></div>", "time": null}, {"id": 1471552244931, "note": "<div><i>Deficiencies</i> of which <u>two</u> <b>cations</b> are associated with <b>torsades de pointes</b>?<b> </b></div><div><b><br></b></div><div>{{c1::K<sup>+</sup> and Mg<sup>2+</sup>}}</div>", "time": null}, {"id": 1471552248534, "note": "<div><b>Congenital long QT syndrome</b> is an inherited disorder of myocardial repolarization, typically due to {{c1::ion channel}} defects</div>", "time": 1660105360466.0}, {"id": 1471552267287, "note": "<div><b>Congenital long QT syndrome</b> has <u>increased</u> risk of sudden cardiac death (SCD) due to {{c1::torsades de pointes}}</div>", "time": 1660105360467.0}, {"id": 1471552293942, "note": "<div><div>What is the <i>inheritance</i> of <b>Jervell and Lange-Nielsen syndrome</b> (a form of long QT syndrome)? </div><div><br></div><div>{{c1::Autosomal <u>recessive</u>}}</div></div>", "time": null}, {"id": 1471552302491, "note": "<div><div>What is the <i>inheritance</i> of <b>Brugada syndrome</b>? </div><div><br></div><div>{{c1::Autosomal dominant}}</div></div>", "time": null}, {"id": 1471552306515, "note": "<div>What <i>demographic</i> is most commonly affected by <b>Brugada syndrome</b>? </div><div><br></div><div>{{c1::Asian males}}</div>", "time": null}, {"id": 1471552310851, "note": "<div><b>{{c3::Brugada}} syndrome</b> presents with an ECG pattern of <b>{{c1::pseudo-right bundle branch block}}</b> and <b>{{c2::ST elevations}}</b> in leads {{c4::V<sub>1</sub> - V<sub>3</sub>}} </div>", "time": null}, {"id": 1471552321632, "note": "<div>Patients with <b>Brugada syndrome</b> are at <u>increased</u> risk of ventricular {{c1::tachyarrhythmias}} and sudden cardiac death (SCD)</div>", "time": null}, {"id": 1471552328358, "note": "<div>Patients with <b>Brugada syndrome</b> may prevent sudden cardiac death with an <b>implantable</b> {{c1::cardioverter-defibrillator (ICD)}}</div>", "time": null}, {"id": 1471552336078, "note": "<div><b>{{c1::Wolff-Parkinson-White}} syndrome</b> is the <u>most common</u> type of <b>ventricular <i>pre-excitation</i> syndrome</b></div>", "time": 1660105338429.0}, {"id": 1471552346413, "note": "<div><b>{{c2::Wolff-Parkinson-White}} syndrome</b> is due to an abnormally fast <u>accessory conduction pathway</u> from the atria to ventricle via the <b>bundle of {{c1::Kent}}</b>, which bypasses the slower AV node</div>", "time": null}, {"id": 1471552353438, "note": "<div><b>Wolff-Parkinson-White syndrome</b> presents with a characteristic {{c1::delta}} wave on ECG</div>", "time": null}, {"id": 1471552359997, "note": "<div><b>Wolff-Parkinson-White syndrome</b> presents with a(n) {{c1::widened}} <b>QRS complex</b> and {{c1::shortened}} <b>PR interval</b> on ECG</div>", "time": null}, {"id": 1471552366885, "note": "<div><b>Wolff-Parkinson-White syndrome</b> may result in <u>re-entry circuit</u>, causing supraventricular {{c1::tachycardia}} </div>", "time": 1660105341456.0}, {"id": 1471552372903, "note": "<div>During <b>inspiration</b> there is a(n) {{c1::decrease}} in <b>intrathoracic pressure</b>, which {{c2::increases}} <b>venous return</b></div>", "time": 1660105359724.0}, {"id": 1471552388799, "note": "<div>Increased <u>venous return</u> during <b>inspiration</b> leads to {{c1::increased}} <b>RV filling</b> and <b>ejection time</b></div>", "time": 1660105356158.0}, {"id": 1471552411732, "note": "<div><b>{{c1::Wide}} splitting</b> is a delayed pulmonic sound, <i>especially on inspiration</i>, seen in conditions that <u>delay</u> <b>{{c2::right ventricle}} emptying </b></div>", "time": null}, {"id": 1471552429751, "note": "<div><b>{{c1::Fixed}} splitting</b> is a delayed pulmonic sound, <b>regardless of inspiration</b> </div>", "time": null}, {"id": 1471552434882, "note": "<div>What pathology is associated with <b>fixed splitting</b>?</div><div><br /></div><div>{{c1::Atrial septal defect (ASD)}}</div>", "time": null}, {"id": 1471552444449, "note": "<div><b>{{c1::Paradoxical}} splitting</b> is heard in conditions that delay&nbsp;<b>{{c2::aortic}} valve</b> closure </div>", "time": null}, {"id": 1471552454947, "note": "<div>In <b>{{c1::paradoxical}} splitting</b>, the P2 sound occurs <i>before</i> a delayed A2 sound</div>", "time": 1660105356324.0}, {"id": 1471554803766, "note": "Does <b>aortic stenosis</b> cause a <u>systolic</u> or <u>diastolic</u> murmur?<div><br /></div><div>{{c1::Systolic murmur}}</div>", "time": null}, {"id": 1471558760048, "note": "<div>What is the <u>shape</u> of a murmur due to <b>aortic stenosis</b>? </div><div><br /></div><div>{{c1::Crescendo-decrescendo}} </div>", "time": null}, {"id": 1471558768276, "note": "<div>Where is a murmur due to <b>aortic stenosis</b> the <u>loudest</u>? </div><div><br /></div><div>{{c1::Heart base (aortic area)}}</div>", "time": null}, {"id": 1471558771660, "note": "<div>A murmur due to <b>{{c2::aortic stenosis}}</b> may radiate to the {{c1::<b>carotid</b>}} <b>arteries</b></div>", "time": 1660105362508.0}, {"id": 1471558774734, "note": "<div>Does <b>mitral/tricuspid regurgitation</b> cause a <u>systolic</u> or <u>diastolic</u> murmur?<div><br /></div><div>{{c1::Holo-systolic murmur}}</div></div>", "time": 1660105359841.0}, {"id": 1471558780451, "note": "<div><div>A <b><i>holosystolic</i> high-pitched \"blowing\" murmur</b> is indicative of what pathology? </div><div><br></div><div>{{c1::Mitral/tricuspid regurgitation}} </div></div>", "time": 1660105362540.0}, {"id": 1471558786536, "note": "<div><div>Where is a murmur due to <b>mitral regurgitation</b> the <u>loudest</u>? </div><div><br /></div><div>{{c1::Apex (mitral area)}}</div></div>", "time": null}, {"id": 1471558789622, "note": "<div>A murmur due to <b>{{c2::mitral regurgitation}}</b> may radiate to the {{c1::<b>axilla</b>}}</div>", "time": null}, {"id": 1471558794566, "note": "<div><div><div>Where is a murmur due to <b>tricuspid regurgitation</b> the <u>loudest</u>? </div><div><br /></div><div>{{c1::Tricuspid area}}</div></div></div>", "time": null}, {"id": 1471558799120, "note": "<div><div>A murmur due to <b>tricuspid regurgitation</b> may radiate to the {{c1::right sternal border}}</div></div>", "time": 1660105362509.0}, {"id": 1471558805917, "note": "<div>Does <b>mitral valve prolapse</b> cause a <u>systolic</u> or <u>diastolic</u> murmur?</div><div><br /></div><div>{{c1::Late systolic (with midsystolic click)}}</div>", "time": 1660105359842.0}, {"id": 1471558813597, "note": "<div><div>A murmur with a <b>midsystolic click</b> is indicative of what pathology? </div><div><br></div><div>{{c1::Mitral valve prolapse}} </div></div>", "time": null}, {"id": 1471558819797, "note": "<div>What causes the <b>midsystolic click</b> in a murmur due to <b>mitral valve prolapse</b>?</div><div><br></div><div>{{c1::Sudden tensing of chordae tendinae}}</div>", "time": null}, {"id": 1471558825957, "note": "<div><div>What is the <u>shape</u> of a murmur due to <b>mitral valve prolapse</b>? </div><div><br /></div><div>{{c1::Late crescendo}}</div></div>", "time": 1660105345496.0}, {"id": 1471558832322, "note": "<div><div>Where is a murmur due to <b>mitral valve prolapse</b> the <u>loudest</u>? </div><div><br /></div><div>{{c1::Apex (mitral area)}}</div></div>", "time": null}, {"id": 1471558836726, "note": "<div>A murmur due to <b>mitral valve prolapse</b> is loudest just <i>before</i> which <u>heart sound</u>? </div><div><br /></div><div>{{c1::S2}}</div>", "time": 1660105362511.0}, {"id": 1471558840954, "note": "<div><div>Does a <b>ventricular septal defect</b> cause a <u>systolic</u> or <u>diastolic</u> murmur?</div><div><br /></div><div>{{c1::Holo-systolic}}</div></div>", "time": null}, {"id": 1471558846888, "note": "<div><div>Where is a murmur due to <b>ventricular septal defect </b>the <u>loudest</u>? </div><div><br /></div><div>{{c1::Tricuspid area}}</div></div>", "time": null}, {"id": 1471558855981, "note": "<div><div>Does <b>aortic regurgitation</b> cause a <u>systolic</u> or <u>diastolic</u> murmur?</div><div><br /></div><div>{{c1::Diastolic}}</div></div>", "time": 1660105359883.0}, {"id": 1471558860873, "note": "<div><div>What is the <u>shape</u> of a murmur due to <b>aortic regurgitation</b>? </div><div><br /></div><div>{{c1::Early decrescendo}}</div></div>", "time": 1660105345497.0}, {"id": 1471558869916, "note": "<div><div>Does <b>mitral stenosis</b> cause a <u>systolic</u> or <u>diastolic</u> murmur?</div><div><br /></div><div>{{c1::Diastolic}}</div></div>", "time": 1660105359843.0}, {"id": 1471558880219, "note": "<div><div>A <b>delayed, <i>rumbling</i> late diastolic murmur</b> is indicative of what pathology? </div><div><br></div><div>{{c1::Mitral stenosis}} </div></div>", "time": 1660105362560.0}, {"id": 1471558889414, "note": "<div><div><div>A murmur with an <b>opening snap</b> is most likely indicative of what pathology? </div><div><br></div><div>{{c1::Mitral stenosis}} </div></div></div>", "time": null}, {"id": 1471558899790, "note": "<div>A <b>continuous, machine-like murmur</b> is indicative of what pathology? </div><div><br /></div><div>{{c1::Patent ductus arteriosus}}</div>", "time": null}, {"id": 1471558905659, "note": "<div><div>A murmur due to <b>patent ductus arteriosus</b> is loudest at which <u>heart sound</u>? </div><div><br /></div><div>{{c1::S2}}</div></div>", "time": 1660105362510.0}, {"id": 1471558916902, "note": "<div>What is the likely cause of this murmur: {{c1::aortic stenosis}}</div><div><br></div><div><img src=\"paste-79710298046535.jpg\"></div>", "time": 1660105346173.0}, {"id": 1471558921194, "note": "<div>What is the likely cause of this <b>high-pitched, \"blowing\"</b> murmur: {{c1::mitral/tricuspid regurgitation}}</div><div><br /></div><div><img src=\"paste-79873506803779.jpg\" /></div>", "time": 1660105346175.0}, {"id": 1471558924603, "note": "<div>What is the likely cause of this murmur: {{c1::mitral valve prolapse}}</div><div><br></div><div><img src=\"paste-79890686672965.jpg\"></div>", "time": 1660105346172.0}, {"id": 1471558930347, "note": "<div>What is the likely cause of this murmur: {{c1::aortic regurgitation}}</div><div><br></div><div><img src=\"paste-79860621901891.jpg\"></div>", "time": 1660105346174.0}, {"id": 1471558932772, "note": "<div>What is the most likely cause of this murmur: {{c1::mitral stenosis}}</div><div><br></div><div><img src=\"paste-79736067850311.jpg\"></div>", "time": 1660105345755.0}, {"id": 1471558934765, "note": "<div>What is the likely cause of this murmur? {{c1::Patent ductus arteriosus}}</div><div><br></div><div><img src=\"paste-79723182948435.jpg\"></div>", "time": 1660105346171.0}, {"id": 1471797120815, "note": "<b>{{c1::Vasculitis}}</b> is defined as inflammation of the blood vessel wall", "time": 1660105338508.0}, {"id": 1471806043495, "note": "The <u>innermost</u> layer of the <b>arterial wall</b> is the <b>{{c1::intima}}</b>, which consists of endothelial cells on a basement membrane", "time": 1660105349980.0}, {"id": 1471806048024, "note": "<div>The <u>middle</u> layer of the <b>arterial wall</b> is the <b>{{c1::media}}</b>, which consists of smooth muscle</div>", "time": 1660105349827.0}, {"id": 1471806052273, "note": "<div>The <u>outer</u> layer of the <b>arterial wall</b> is the <b>{{c1::adventitia}}</b>, which consists of connective tissue surrounding blood vessel</div>", "time": 1660105349733.0}, {"id": 1471806055812, "note": "<div><div><b>Vasculitides</b> often present with symptoms of <b>organ</b> <b>ischemia</b> due to {{c1::<u>thrombosis</u>}} of inflamed vessels or <u>luminal narrowing</u> from {{c2::fibrosis}}</div></div>", "time": 1660105348307.0}, {"id": 1471806065717, "note": "<div><div><b>Giant cell (temporal) arteritis</b> is a form of {{c1::large}}-vessel vasculitis</div></div>", "time": 1660105358655.0}, {"id": 1471806069386, "note": "<div><div><b>{{c2::Giant cell (temporal)}} arteritis</b> is a <i>granulomatous</i> vasculitis that classically involves branches of the {{c1::<b>carotid</b>}} <b>artery</b></div></div>", "time": null}, {"id": 1471806073709, "note": "<div>What <u>demographic</u> is classically affected by <b>giant cell (temporal) arteritis</b>? </div><div><br></div><div>{{c1::Elderly females (&gt; 50)}}</div>", "time": 1660105347335.0}, {"id": 1471806078219, "note": "<div><div><b>Giant cell (temporal) arteritis</b> may present with {{c1::unilateral headache}} due to involvement of the <u>temporal artery</u> </div></div>", "time": 1660105358653.0}, {"id": 1471806086201, "note": "<div><div><b>Giant cell (temporal) arteritis</b> may present with {{c1::jaw}} claudication</div></div>", "time": 1660105358654.0}, {"id": 1471806095511, "note": "<div><div><b>Giant cell (temporal) arteritis</b> may present with {{c1::visual}} disturbances due to involvement of the <u>ophthalmic artery</u></div></div>", "time": 1660105358652.0}, {"id": 1471806099065, "note": "<div><div><b>{{c2::Giant cell (temporal)}} arteritis</b> is associated with {{c1::<b>polymyalgia rheumatica</b>}}, which is characterized by aching/stiffness of the shoulders and hips </div></div>", "time": 1660105337933.0}, {"id": 1471806103006, "note": "<div><div>How does the <b>ESR</b> change in a patient with <b>giant cell (temporal) arteritis</b>?</div></div><div><br></div><div>{{c1::Increased (often &gt;100)}}</div>", "time": null}, {"id": 1471806107034, "note": "<div>Biopsy of a patient with <b>giant cell (temporal) arteritis</b> reveals an inflamed vessel with {{c1::giant}} cells and focal {{c2::<u>granulomatous</u>}} inflammation</div>", "time": 1660105361232.0}, {"id": 1471806114242, "note": "<div>Biopsy of a patient with <b>giant cell (temporal) arteritis</b> reveals {{c1::intimal}} fibrosis</div>", "time": 1660105361226.0}, {"id": 1471806124315, "note": "<div><div>The lesions of <b>giant cell (temporal) arteritis</b> are <u>{{c1::segmental}},</u> therefore diagnosis requires biopsy of a <u>long</u> segment of the vessel</div></div>", "time": 1660105349916.0}, {"id": 1471806132559, "note": "<div><div>What is the <u>treatment</u> for a patient with <b>giant cell (temporal) arteritis</b>? </div><div><br /></div><div>{{c1::High-dose corticosteroids}} and {{c2::tocilizumab}}</div></div>", "time": null}, {"id": 1471806136985, "note": "<div><div>Without treatment, patients with <b>{{c2::giant cell (temporal)}} </b><b>arteritis</b> are at high risk for <b>{{c1::blindness}} </b></div></div>", "time": null}, {"id": 1471806144718, "note": "<div><div><b>Takayasu arteritis</b> is a form of {{c1::large}}-vessel vasculitis</div></div>", "time": 1660105350603.0}, {"id": 1471806149857, "note": "<div><div><b>{{c2::Takayasu}} arteritis</b> is a <i>granulomatous</i> <b>thickening and narrowing</b> of the {{c1::<u>aortic arch</u>}} and proximal great vessels</div></div>", "time": 1660105337310.0}, {"id": 1471806157855, "note": "<div><div>What <u>demographic</u> is classically affected by <b>Takayasu arteritis</b>? </div><div><br></div><div>{{c1::Young Asian females (&lt; 40)}}</div></div>", "time": 1660105347333.0}, {"id": 1471806162437, "note": "<div><div><b>Takayasu arteritis</b> may present with {{c1::visual}} and {{c1::neurologic}} symptoms </div></div>", "time": 1660105350602.0}, {"id": 1471806170265, "note": "<div><div><b>{{c1::Takayasu}} arteritis</b> is associated with a(n) {{c2::<b>weak or absent</b>}} <b>pulse</b> in the <u>upper extremity</u> </div></div>", "time": 1660105338769.0}, {"id": 1471806180799, "note": "<div><div><div><div>How does the <b>ESR</b> change in a patient with <b>Takayasu arteritis</b>?</div></div><div><br></div><div>{{c1::Increased}}</div></div></div>", "time": 1660105358058.0}, {"id": 1471806184543, "note": "<div><div><div>What is the <u>treatment</u> for a patient with <b>Takayasu arteritis</b>? </div><div><br></div><div>{{c1::Corticosteroids}}</div></div></div>", "time": 1660105345407.0}, {"id": 1471806188325, "note": "<div><b>Polyarteritis nodosa</b> is a form of {{c1::medium}}-vessel vasculitis</div>", "time": 1660105353819.0}, {"id": 1471806197883, "note": "<div><div>What <u>demographic</u>&nbsp;is classically affected by <b>polyarteritis nodosa</b>? </div><div><br></div><div>{{c1::Middle-aged men::age group}}</div></div>", "time": 1660105347354.0}, {"id": 1471806201823, "note": "<div><div><b>Polyarteritis nodosa</b> is a necrotizing vasculitis that involves <i>most organs</i>, <u>except</u> the {{c1::lungs}}</div></div>", "time": 1660105353818.0}, {"id": 1471806210220, "note": "<div><div><b>Polyarteritis nodosa</b> may present with {{c1::hypertension}} due to involvement of the <b>renal</b> <b>artery</b> </div></div>", "time": 1660105353815.0}, {"id": 1471806217861, "note": "<div><div><b>Polyarteritis nodosa</b> may present with {{c1::abdominal}} pain and {{c1::melena}} due to involvement of the <b>mesenteric artery</b> </div></div>", "time": 1660105353816.0}, {"id": 1471806231010, "note": "<div><div><b>Polyarteritis nodosa</b> may present with {{c1::neurologic}} disturbances/dysfunction</div></div>", "time": 1660105353814.0}, {"id": 1471806235020, "note": "<div><div><b>Polyarteritis nodosa</b> may present with {{c1::skin}} lesions (e.g. cutaneous eruptions) in up to 1/3 of patients</div></div>", "time": 1660105353813.0}, {"id": 1471806240278, "note": "<div><div><b>{{c2::Polyarteritis nodosa}}</b> is a <u>necrotizing</u> vasculitis that is associated with positive serum {{c1::<b>HBsAg</b>}} in 30% of patients</div></div>", "time": 1660105337506.0}, {"id": 1471806250450, "note": "<div><div><u>Early</u> lesions of <b>polyarteritis nodosa</b> are characterized by <i>transmural inflammation</i> with {{c1::fibrinoid necrosis}}</div></div>", "time": 1660105359652.0}, {"id": 1471806263616, "note": "<div><div><u>Late</u> lesions of <b>polyarteritis nodosa</b> are characterized by {{c1::fibrosis}}, leading to vessel <b>narrowing</b></div></div>", "time": 1660105355719.0}, {"id": 1471806267906, "note": "<div><div>The combination of <b>dilatation</b> (aneurysms) and <b>narrowing</b> (fibrosis) in <b>polyarteritis nodosa</b> gives blood vessels a(n) {{c1::<b>\"string of pearls\"</b>}} appearance on imaging</div></div>", "time": 1660105350282.0}, {"id": 1471806277667, "note": "<div><div><b>Polyarteritis nodosa</b> is characterized by <i>innumerable</i> <u>renal {{c1::microaneurysms}}</u> and spasms on arteriogram </div></div>", "time": 1660105353817.0}, {"id": 1471806287761, "note": "<div><div>What <u>drugs</u> may be used to treat a patient with <b>polyarteritis nodosa</b>? </div><div><br></div><div>{{c1::Corticosteroids, cyclophosphamide::2}}</div></div>", "time": 1660105348103.0}, {"id": 1471806302661, "note": "<div><b>Kawasaki disease</b> (mucocutaneous lymph node syndrome) is a form of {{c1::medium}}-vessel vasculitis</div>", "time": 1660105355807.0}, {"id": 1471806307755, "note": "<div><div><div>What <u>demographic</u> is classically affected by <b>Kawasaki disease</b>? </div><div><br></div><div>{{c1::Asian children &lt; 4 years old}}</div></div></div>", "time": 1660105347334.0}, {"id": 1471806312069, "note": "<div><div>Which&nbsp;<u>artery</u> is commonly affected in <b>Kawasaki disease</b>?</div><div><br></div><div>{{c1::Coronary artery}}</div></div>", "time": 1660105347590.0}, {"id": 1471806318041, "note": "<div><div>Patients with <b>Kawasaki disease</b> may develop coronary artery {{c1::thrombosis}}, which can lead to myocardial infarction</div></div>", "time": 1660105354203.0}, {"id": 1471806325942, "note": "<div><div>Patients with <b>Kawasaki disease</b> may develop coronary artery {{c1::aneurysms}}, which can rupture; therefore, get a(n) {{c1::echo::diagnostic test}}</div></div>", "time": 1660105354204.0}, {"id": 1471806330955, "note": "<div><div>The symptoms of <b>{{c7::Kawasaki}} disease</b> may be remembered with the mnemonic <b>\"CRASH</b> and <b>burn</b>\": </div><div style=\"centerbox\"><div class=\"mnemonics\"><div><br></div><div><span style=\"font-weight: bold\">C:</span> {{c1::Conjunctivitis}}<div><b>R: </b>{{c2::Rash (polymorphous -&gt; desquamating)}}</div><div><b>A:</b> {{c3::Adenopathy (cervical lymph nodes)}}</div><div><b>S: </b>{{c4::Strawberry tongue (oral mucositis)}}</div><div><b>H:</b> {{c5::Hand-foot erythema and edema}}</div><div>&amp;</div><div><b>Burn</b>: {{c6::Fever}}</div></div></div></div></div>", "time": null}, {"id": 1471806351580, "note": "<div><div><u>Treatment</u> for <b>Kawasaki disease</b> includes {{c1::aspirin}} and {{c1::IVIG}}</div></div>", "time": null}, {"id": 1471806359114, "note": "<div><b>Buerger disease</b> (thromboangiitis obliterans) is a form of segmenting {{c1::medium}}-vessel vasculitis that extends into contiguous {{c2::veins}} and {{c2::nerves}}</div>", "time": null}, {"id": 1471806363393, "note": "<div><div><div>What <u>demographic</u> is classically affected by <b>Buerger disease</b>? </div><div><br></div></div></div><div>{{c1::Heavy smokers, males &lt; 40 years old}}<br></div>", "time": 1660105347329.0}, {"id": 1471806368819, "note": "<div><div><div><b>{{c2::Buerger}} disease</b> is a <u>segmental thrombosing vasculitis</u> that commonly involves the {{c1::<b>digits</b>}}</div></div></div>", "time": 1660105338238.0}, {"id": 1471806373361, "note": "<div><div><div><b>Buerger disease</b> often presents with <u>intermittent claudication</u> that may lead to&nbsp;<b>{{c2::gangrene}}</b> and {{c1::<b>autoamputation</b>}} of digits</div></div></div>", "time": 1660105361075.0}, {"id": 1471806381549, "note": "<div><div><div>Patients with <b>Buerger disease </b>often experience {{c1::Raynauds}} phenomenon</div></div></div>", "time": 1660105354273.0}, {"id": 1471806387188, "note": "<div><div><div>What is the <u>treatment</u> for <b>Buerger disease</b>?</div><div><br></div><div>{{c1::Smoking cessation}}</div></div></div>", "time": 1660105345381.0}, {"id": 1471806392633, "note": "<div><div><b>Granulomatosis with polyangiitis</b> (<b>Wegener</b>) is a form of {{c1::small}}-vessel vasculitis</div></div>", "time": 1660105358544.0}, {"id": 1471806409036, "note": "<div><div><b>{{c2::Granulomatosis with polyangiitis (Wegener)}}</b> is a form of <u>necrotizing, granulomatous vasculitis</u> that classically involves the {{c1::<b>nasopharynx</b>}}, {{c1::<b>lungs</b>}}, and {{c1::<b>kidneys</b>}}</div></div>", "time": 1660105337919.0}, {"id": 1471806421346, "note": "<div><div><div><b>Granulomatosis with polyangiitis</b> most commonly affects {{c1::middle aged men}} and these patients commonly have a(n) {{c2::saddle nose}} deformity</div></div></div>", "time": null}, {"id": 1471806426564, "note": "<div><div><div><b>Granulomatosis with polyangiitis</b> often presents with <u><i>upper</i> respiratory tract</u> symptoms, such as {{c1::<b>sinusitis</b>}} or {{c2::<b>nasopharyngeal</b> <b>ulceration}}</b></div></div></div>", "time": null}, {"id": 1471806432657, "note": "<div><div><div><b>Granulomatosis with polyangiitis</b> often presents with <u><i>lower</i> respiratory tract</u> symptoms, such as {{c1::hemoptysis}}, cough, and dyspnea</div></div></div>", "time": null}, {"id": 1471806436773, "note": "<div><div><div><b>Granulomatosis with polyangiitis</b> often presents with <u>kidney-related</u> symptoms, such as {{c1::hematuria}}, red cell casts, and rapidly progressive glomerulonephritis (RPGN) </div></div></div>", "time": null}, {"id": 1471806442258, "note": "<div><div><div>Which <b>vasculitis</b> is characterized by a <u>triad</u> of:</div><div>(1) Focal necrotizing vasculitis</div><div>(2) Necrotizing granulomas in the lung and upper airway</div><div>(3) Necrotizing glomerulonephritis</div><div><br /></div><div>{{c1::Granulomatosis with polyangiitis}}</div></div></div>", "time": null}, {"id": 1471806471000, "note": "<div><div><div>What does a <u>chest X-ray</u> of a patient with <b>Granulomatosis with polyangiitis</b> show?</div><div><br></div><div>{{c1::Bilateral large nodular densities/infiltrates}}</div></div></div>", "time": null}, {"id": 1471806482193, "note": "<div><div><div>What significant <u>laboratory finding</u> is associated with <b>Wegener granulomatosis</b> (granulomatosis with polyangiitis)?</div><div><br></div><div>{{c1::Positive c-ANCA}}</div></div></div>", "time": null}, {"id": 1471806493817, "note": "<div><div><div>What <u>drugs</u> may be used to treat <b>Granulomatosis with polyangiitis?</b></div><div><b><br></b></div><div>{{c1::Cyclophosphamide, corticosteroids::2}}</div></div></div>", "time": 1660105348102.0}, {"id": 1471806497406, "note": "<div><b>Microscopic polyangiitis</b> is a form of {{c1::small}}-vessel vasculitis<br></div>", "time": 1660105355232.0}, {"id": 1471806500932, "note": "<div><div><div><b>Microscopic polyangiitis</b> is a <u>necrotizing vasculitis</u> that commonly involves the {{c1::lungs}}, {{c1::kidneys}}, and skin</div></div></div>", "time": 1660105355231.0}, {"id": 1471806505942, "note": "<div><div><div>How does <b>microscopic polyangiitis</b> present <u>differently</u> from&nbsp;<b>granulomatosis with polyangiitis (Wegener)</b>? </div><div><br></div><div>{{c1::Microscopic polyangiitis <u>lacks</u> nasopharyngeal involvement and granulomas::2}}</div></div></div>", "time": null}, {"id": 1471806519835, "note": "<div><div><div><div>What significant <u>laboratory finding</u> is associated with <b>microscopic polyangiitis</b>?</div><div><br></div><div>{{c1::Positive p-ANCA}}</div></div></div></div>", "time": null}, {"id": 1471806531097, "note": "<div><div><div><div>What <u>drugs</u> may be used to treat <b>microscopic polyangiitis</b>? </div><div><br></div><div>{{c1::Cyclophosphamide, corticosteroids::2}}</div></div></div></div>", "time": 1660105348101.0}, {"id": 1471806534652, "note": "<div><b>Eosinophilic granulomatosis with polyangiitis</b> (Churg-strauss) is a form of {{c1::small}}-vessel vasculitis</div>", "time": null}, {"id": 1471806538201, "note": "<div><div>What type of <u>white blood cell</u> is elevated in <b>Churg-Strauss syndrome</b>? </div><div><br></div><div>{{c1::Eosinophils}}</div></div>", "time": 1660105344715.0}, {"id": 1471806541451, "note": "<div><div>Which serum <u>immunoglobulin</u> is <i>elevated</i> in <b>Churg-Strauss syndrome</b>?</div><div><br></div><div>{{c1::IgE}}</div></div>", "time": null}, {"id": 1471806584678, "note": "<div><div>What <u>vasculitis</u> is a <b>granulomatous</b>, <b>necrotizing</b> vasculitis with <b>eosinophilia</b>?</div><div><br /></div><div>{{c1::Churg-Strauss syndrome (eosinophilic granulomatosis with polyangiitis)}}</div></div>", "time": 1660105344990.0}, {"id": 1471806603801, "note": "<div><div>What <u>two</u> organs are commonly affected by <b>Churg-Strauss syndrome</b>?</div><div><br></div><div>{{c1::Heart and lungs}}</div></div>", "time": 1660105344888.0}, {"id": 1471806621695, "note": "<div><div>What <u>respiratory</u> pathology is commonly associated with <b>Churg-Strauss syndrome</b>? </div><div><br /></div><div>{{c1::Asthma}}</div></div>", "time": 1660105345018.0}, {"id": 1471806636140, "note": "<div><div><div><b>{{c2::Eosinophilic granulomatosis with polyangiitis (Churg-Strauss)}}</b>, a small-vessel vasculitis, commonly presents with <u>asymmetric multifocal neuropathy</u>, typically manifesting with {{c1::wrist drop}} and {{c1::foot drop}}</div></div></div>", "time": null}, {"id": 1471806647224, "note": "<div><div><div>What significant <u>laboratory finding</u> is associated with <b>Churg Strauss syndrome</b> (eosinophilic granulomatosis with polyangiitis)?</div><div><br></div><div>{{c1::Positive p-ANCA}}</div></div></div>", "time": null}, {"id": 1471806659451, "note": "<div><b>Henoch-Schonlein purpura </b>is a form of {{c1::small}}-vessel vasculitis</div>", "time": 1660105358363.0}, {"id": 1471806663894, "note": "<div>What <u>demographic</u>&nbsp;is classically affected by <b>Henoch-Schonlein purpura</b>? </div><div><br></div><div>{{c1::Children::age group}} </div>", "time": 1660105347355.0}, {"id": 1471806671662, "note": "<div><b>{{c2::Henoch-Schonlein purpura}}</b> is a <u>vasculitis</u> that occurs <i>secondary</i> to {{c1::<b>IgA immune complex}} deposition</b></div>", "time": null}, {"id": 1471806675606, "note": "<div>The classic clinical <i>triad</i> of <b>{{c2::Henoch-Schonlein purpura}}</b> is {{c1::<u>palpable</u> purpura}} on the buttocks and legs, {{c3::arthralgias}}, and {{c4::abdominal}} pain</div>", "time": null}, {"id": 1471806684970, "note": "<div><b>Henoch-Schonlein purpura</b> is associated with {{c1::IgA nephropathy}}<b> </b>(<b>{{c2::Berger}}</b> <b>disease</b>)</div>", "time": 1660105358361.0}, {"id": 1471806688179, "note": "<div><b>Henoch-Schonlein purpura</b> often occurs following a(n) {{c1::upper respiratory tract}} infection, which leads to generation of <b>IgA</b></div>", "time": null}, {"id": 1471806691032, "note": "<div>What is the <u>treatment</u> for <b>Henoch-Schonlein purpura</b>?</div><div><br></div><div>{{c1::Disease is self-limited; treat with steroids if severe}}</div>", "time": 1660105345355.0}, {"id": 1471806692855, "note": "<b>Hypertension</b> is defined as persistent systolic BP <u>&gt;</u> {{c1::130}} mmHg and/or diastolic BP <u>&gt;</u> {{c1::80}} mmHg", "time": 1660105357883.0}, {"id": 1471808946236, "note": "<div>What <i>ethnicity</i> has the <u>highest</u> risk of developing <b>hypertension</b>?</div><div><br /></div><div>{{c1::African Americans}}</div>", "time": 1660105347109.0}, {"id": 1471808954153, "note": "<div>What <i>ethnicity</i> has the <u>lowest</u> risk of developing <b>hypertension</b>?</div><div><br /></div><div>{{c1::Asians}}</div>", "time": 1660105347108.0}, {"id": 1471808962781, "note": "<div><b>{{c1::Primary (essential)}} hypertension</b> (90-95% of cases) has no known etiology</div>", "time": 1660105339193.0}, {"id": 1471808998460, "note": "<div><b>Primary hypertension</b> is related to <u>increased</u> <b>{{c1::cardiac output}}</b> and <b>{{c2::TPR}}</b> </div>", "time": 1660105353691.0}, {"id": 1471809005658, "note": "<div><b>Secondary hypertension</b> may be caused by {{c1::<b>renal artery stenosis</b>}}, which leads to <u>increased plasma {{c2::renin}}</u> and unilateral atrophy of the affected kidney</div>", "time": 1660105353102.0}, {"id": 1471809011732, "note": "<div><div>What is a possible cause of <b>secondary hypertension</b> that occurs in <u>young females</u>? </div><div><br /></div><div>{{c1::Fibromuscular dysplasia}}</div></div>", "time": null}, {"id": 1471809020140, "note": "<div><b>Fibromuscular dysplasia</b> results in the irregular thickening of medium/large arteries which manifests as a \"{{c1::string of beads}}\" appearance on imaging</div>", "time": null}, {"id": 1471809042124, "note": "<div><b>Secondary hypertension</b> may be caused by primary {{c1::hyper}}-aldosteronism</div>", "time": 1660105353103.0}, {"id": 1471809045876, "note": "<div><b>Hypertensive {{c1::urgency}}</b> is defined as severe hypertension (<u>&gt;</u>180 / <u>&gt;</u>120 mmHg) <b>without</b> acute end-organ damage</div>", "time": null}, {"id": 1471809049354, "note": "<div><b>Hypertensive {{c1::emergency}}</b> is defined as severe hypertension (<u>&gt;</u>180 / <u>&gt;</u>120 mmHg) <b>with</b> acute end-organ damage </div>", "time": null}, {"id": 1471809055703, "note": "<b>{{c1::Arteriosclerosis}}</b> is defined as the <b>hardening of arteries</b>, with arterial wall thickening and loss of elasticity", "time": 1660105341123.0}, {"id": 1471811875076, "note": "<div><b>{{c1::Atherosclerosis}}</b> is a form of <b>arteriosclerosis</b> that damages <u>large-</u> and <u>medium-sized</u> vessels due to buildup of cholesterol plaques</div>", "time": null}, {"id": 1471811878742, "note": "<div>Which part of the <u>blood vessel wall</u> is affected by <b>atherosclerosis</b>? </div><div><br></div><div>{{c1::Intima}}<br></div>", "time": null}, {"id": 1471811882841, "note": "<div><b>Atherosclerosis</b> is caused by a buildup of <b>intimal</b> <b>{{c1::plaques}}</b> that obstruct blood flow</div>", "time": null}, {"id": 1471811944476, "note": "<div>The <b>intimal plaque</b> that causes <u>atherosclerosis</u> consists of a <b>necrotic lipid core</b> (mostly {{c1::cholesterol}}) with a(n)&nbsp;<b>{{c2::fibromuscular}}</b> <b>cap</b></div>", "time": 1660105349969.0}, {"id": 1471811951779, "note": "<div>The <b>intimal plaque</b> that causes <u>atherosclerosis</u><b> </b>often undergoes dystrophic {{c1::calcification}}</div>", "time": 1660105349967.0}, {"id": 1471811955341, "note": "<div>What <u>four</u> arteries are most commonly affected by <b>atherosclerosis</b>? </div><div><br></div><div>{{c1::Lower abdominal aorta}} <b>&gt;</b> {{c2::coronary}} <b>&gt;</b> {{c3::popliteal}} <b>&gt;</b> {{c4::carotid}} artery</div>", "time": null}, {"id": 1471811960008, "note": "<div>What are the <u>four</u> <b>modifiable</b> risk<b> </b>factors for&nbsp;<b>atherosclerosis</b>?</div><div><br></div><div>{{c1::Hypertension}}, {{c1::hypercholesterolemia (LDL)}}, {{c2::smoking}}, {{c2::diabetes}}</div>", "time": null}, {"id": 1471811965337, "note": "<div>What are the <u>three</u> <b>non-modifiable</b> risk factors for <b>atherosclerosis</b>?</div><div> </div><div><br></div><div>{{c1::Age}}, {{c1::gender}}, {{c1::genetics}}</div>", "time": null}, {"id": 1471811968814, "note": "<div><b>Atherosclerosis</b> begins with <u>endothelial cell dysfunction</u> which allows {{c1::lipids}} to leak into the intima</div>", "time": 1660105361459.0}, {"id": 1471811979298, "note": "<div><u>Lipids</u> in the <b>intima</b> of an artery are <b>{{c1::oxidized}}</b> and then consumed by&nbsp;<b>{{c2::macrophages}}</b> via {{c3::<b>scavenger receptor A</b>}} receptors</div>", "time": 1660105355611.0}, {"id": 1471811989477, "note": "<div>Macrophage consumption of <u>oxidized lipids</u> in the <b>intima</b> results in {{c1::foam}} cell formation and \"<b>fatty streaks</b>\"</div>", "time": 1660105355443.0}, {"id": 1471811997810, "note": "<div>In response to <b>fatty streaks</b> in the <b>intima</b>, there is {{c1::smooth muscle}} cell migration/proliferation and {{c2::extracellular matrix}} deposition</div>", "time": null}, {"id": 1471812008532, "note": "<div><b>Smooth muscle proliferation</b> and <b>ECM deposition</b> in the <u>arterial intima</u> leads to the formation of fibrous {{c1::plaques}} and ultimately <b>complex atheromas</b> </div>", "time": 1660105350911.0}, {"id": 1471812024737, "note": "<div>Symptoms of <b>atherosclerosis</b> generally present when &gt;{{c1::70}}% of a vessel has been occluded (stenosis)</div>", "time": 1660105350667.0}, {"id": 1471812042722, "note": "<div>One complication of <b>atherosclerosis</b> is {{c1::peripheral vascular disease}}, which may result from stenosis of the <u>popliteal</u> artery</div>", "time": 1660105354628.0}, {"id": 1471812048776, "note": "<div>One complication of <b>atherosclerosis</b> is {{c1::angina}}, which may result from stenosis of the <u>coronary</u> artery</div>", "time": 1660105354632.0}, {"id": 1471812052582, "note": "<div>One complication of <b>atherosclerosis</b> is {{c1::chronic mesenteric ischemia}}, which may result from stenosis of the <u>mesenteric</u> artery</div>", "time": 1660105354631.0}, {"id": 1471812055612, "note": "<div>One complication of <b>atherosclerosis</b> is {{c1::myocardial infarction}}, which may result from <u>plaque rupture</u> with <b>{{c2::thrombosis}}</b> of the <u>coronary</u> artery</div>", "time": 1660105354630.0}, {"id": 1471812058036, "note": "<div>One complication of <b>atherosclerosis</b> is {{c1::stroke}}, which may result from <u>plaque rupture</u> with <b>thrombosis</b> of the <u>middle cerebral</u> artery</div>", "time": 1660105354627.0}, {"id": 1471812061940, "note": "<div><b>Plaque rupture</b> from <u>atherosclerosis</u> may result in atherosclerotic <b>{{c1::emboli}}</b>, which are characterized by {{c2::<b>cholesterol clefts</b>}}</div>", "time": 1660105353890.0}, {"id": 1471812074715, "note": "<div><b>Atherosclerosis</b> may cause <u>weakening</u> of the blood vessel wall, which can result in {{c1::aneurysm}}  </div>", "time": 1660105361457.0}, {"id": 1471817954249, "note": "<div><b>{{c1::Arteriolosclerosis}}</b> is a form of <b>arteriosclerosis</b> that damages <u>small arteries</u> and <u>arterioles</u></div>", "time": 1660105341124.0}, {"id": 1471819176314, "note": "<div><b>{{c1::Hyaline}}</b> <b>arteriolosclerosis</b> is caused by <u>proteins leaking into the vessel wall</u>, producing vascular thickening </div>", "time": 1660105340065.0}, {"id": 1471819183136, "note": "<div>What <u>type</u> of <b>arteriolosclerosis</b> is demonstrated in the image below? </div><div><br></div><div>{{c1::Hyaline arteriolosclerosis}}</div><div><br></div><div><img src=\"paste-129604933124497.jpg\"></div>", "time": 1660105344870.0}, {"id": 1471819186977, "note": "<div>What <u>two</u> <i>underlying </i>pathologies are associated with <b>hyaline arteriolosclerosis</b>? </div><div><br></div><div>{{c1::Benign hypertension, diabetes}}</div>", "time": 1660105344883.0}, {"id": 1471819191084, "note": "<div><b>Hyaline arteriolosclerosis</b> results in reduced vessel caliber with <u>end-organ ischemia</u>, which classically produces {{c1::glomerular}} scarring </div>", "time": 1660105357932.0}, {"id": 1471819210293, "note": "<div><b>{{c1::Hyperplastic}}</b> <b>arteriolosclerosis</b> is caused by <u>hyperplasia of smooth muscle</u>, resulting in thickening of the vessel wall </div>", "time": 1660105340032.0}, {"id": 1471819217429, "note": "<div><div>What <u>type</u> of <b>arteriolosclerosis</b> is demonstrated in the image below? </div><div><br></div><div>{{c1::Hyperplastic arteriolosclerosis}}</div></div><div><br></div><div><img src=\"paste-129866926129545.jpg\"></div>", "time": 1660105344869.0}, {"id": 1471819222194, "note": "<div><b>Hyperplastic arteriolosclerosis </b>has an {{c1::onion-skin}} appearance on histology </div>", "time": 1660105357898.0}, {"id": 1471819229180, "note": "<div>What <i>underlying </i>pathology is associated with <b>hyperplastic arteriolosclerosis</b>? </div><div><br></div><div>{{c1::Severe (malignant) hypertension}}</div>", "time": 1660105344710.0}, {"id": 1471819233373, "note": "<div><b>Hyperplastic arteriolosclerosis</b> may lead to <u>{{c1::fibrinoid}} necrosis</u> of the vessel wall with hemorrhage</div>", "time": 1660105357896.0}, {"id": 1471819245705, "note": "<div><b>{{c3::Hyperplastic}} arteriolosclerosis</b> classically causes {{c1::<u>acute kidney injury</u>}} with a {{c2::flea-bitten::gross}} appearance</div>", "time": 1660105337078.0}, {"id": 1471819276926, "note": "<div><b>Monckeberg sclerosis</b> is {{c1::non-obstructive}} and therefore is <u>not</u> clinically significant </div>", "time": null}, {"id": 1471819317034, "note": "<div>Risk of <b>atherosclerosis</b> is <u>increased</u> in men and {{c1::postmenopausal}} women</div>", "time": 1660105353249.0}, {"id": 1471824752378, "note": "<b>{{c1::Aortic dissection}}</b> is a longitudinal <b>intimal tear</b> with transmission of blood through the <u>media</u> of the aortic wall ", "time": null}, {"id": 1471824768225, "note": "<div><div><b>Hyaline arteriolosclerosis</b> of the <b>{{c1::vasa vasorum}}</b> results in <u>atrophy</u> of the <b>aortic</b> <b>media</b> and <i>weakening</i> of the vessel wall</div></div>", "time": null}, {"id": 1471824783780, "note": "<div><div><b>Aortic dissection</b> is associated with inherited {{c1::connective tissue}} disorders </div></div>", "time": null}, {"id": 1471824793615, "note": "<div><div><b>Aortic dissection </b>may present with <i>sudden</i> sharp, tearing {{c1::chest}} pain that <u>radiates</u> to the {{c1::back}}</div></div>", "time": null}, {"id": 1471824801037, "note": "<div><div><u>Chest X-ray</u> of a patient with <b>aortic {{c2::dissection}}</b> shows {{c1::<b>mediastinal</b>}} <b>widening</b></div></div>", "time": null}, {"id": 1471824804069, "note": "<div><div><b>Aortic dissection</b> may lead to obstruction of branching arteries, thus causing end-organ {{c1::ischemia}}</div></div>", "time": null}, {"id": 1471824809572, "note": "<div><div><b>Aortic dissection</b> may result in {{c1::cardiac tamponade}} as a result of backflow into the pericardium</div></div>", "time": null}, {"id": 1471824821986, "note": "<div><div><b>{{c1::Stanford type A (proximal)}}</b> <b>aortic dissection</b> involves the <u>ascending aorta</u></div></div>", "time": null}, {"id": 1471824831028, "note": "<div><div><b>{{c1::Stanford type B (distal)}}</b> <b>aortic dissection</b> involves the <u>descending aorta</u> and/or the <u>aortic arch</u> </div></div>", "time": null}, {"id": 1471824836707, "note": "<div><div>What is the treatment for <u>Stanford type A</u> <b>aortic dissection</b>? </div><div><br></div><div>{{c1::Surgery}}</div></div>", "time": null}, {"id": 1471824839446, "note": "<div><div><div>What is the treatment for <u>Stanford type B</u> <b>aortic dissection</b>? </div><div><br></div><div>{{c1::\u03b2-blockers, then vasodilators}}</div></div></div>", "time": null}, {"id": 1471824842252, "note": "<div><div><b>{{c1::Aortic aneurysm}}</b> is a localized pathologic <u>dilatation</u> of the <b>aorta</b> </div></div>", "time": null}, {"id": 1471824848914, "note": "<div><div><b>Aortic aneurysm</b> may cause {{c1::abdominal}} and/or {{c1::back}} pain, which is a sign of leaking, dissection, or imminent rupture</div></div>", "time": null}, {"id": 1471824852175, "note": "<div><div><b>Thoracic aortic aneurysm</b> is classically seen in patients with {{c1::<b>tertiary</b> <b>syphilis</b>}} due to {{c2::<u>endarteritis</u>}} of the vasa vasorum </div></div>", "time": null}, {"id": 1471824868294, "note": "<div><b>{{c2::Thoracic}} aortic aneurysm</b> is associated with {{c1::<b>cystic medial</b>}} <b>degeneration</b> (e.g. Marfan syndrome)</div>", "time": null}, {"id": 1471824872055, "note": "<div><u>Risk factors</u> for <b>thoracic aneurysm</b> include {{c1::bicuspid}} aortic valve and {{c2::hypertension}}</div>", "time": null}, {"id": 1471824876607, "note": "<div><div><b>Thoracic aneurysm</b> is associated with inherited {{c1::connective tissue}} disorders </div></div>", "time": null}, {"id": 1471824884869, "note": "<div>A major complication of <b>thoracic aneurysm</b> is <u>dilation of the aortic valve root</u> resulting in {{c1::aortic regurgitation (insufficiency)}}</div>", "time": null}, {"id": 1471824895480, "note": "<div><b>Abdominal aortic aneurysm (AAA)</b> usually arises below the {{c1::renal arteries}}, but above the {{c1::aortic birfucation}}</div>", "time": null}, {"id": 1471824901308, "note": "<div>The two <i>underlying </i>pathological processes that are associated with <b>abdominal aortic aneurysm </b>are {{c1::<b>chronic transmural inflammation</b>}} and <b>{{c2::atherosclerosis}}</b></div>", "time": null}, {"id": 1471824910294, "note": "<div>What <u>demographic</u> is commonly associated with <b>abdominal aortic aneurysm</b>? </div><div><br></div><div>{{c1::Males &gt; 60 (usually a smoker with HTN)}}</div>", "time": 1660105347328.0}, {"id": 1471824913480, "note": "<div><b>{{c1::Abdominal aortic aneurysm}}</b> may present as a<b> palpable, pulsatile abdominal mass</b> that grows with time </div>", "time": null}, {"id": 1471824920983, "note": "<div>A major complication associated with <b>abdominal aortic aneurysm</b> is <u>{{c1::rupture}}</u>, especially when &gt;{{c2::5}} cm in diameter</div>", "time": null}, {"id": 1471824932558, "note": "<div><b>Abdominal aortic aneurysm</b> <u>rupture</u><b> </b>presents with a triad of {{c1::hypotension}}, a pulsatile abdominal mass, and {{c2::flank}} pain</div>", "time": 1660105362272.0}, {"id": 1471877601145, "note": "<div>Where is a murmur due to <b>aortic regurgitation</b> the <u>loudest</u>? </div><div><br /></div><div>{{c1::Left sternal border}}</div>", "time": null}, {"id": 1471878007808, "note": "<div><div>Where is a murmur due to <b>atrial septal defect</b> the <u>loudest</u>? </div><div><br /></div><div>{{c1::Pulmonic Area}}</div></div>", "time": null}, {"id": 1471878017218, "note": "<div><div>Where is a murmur due to <b>pulmonic stenosis</b> the <u>loudest</u>? </div><div><br /></div><div>{{c1::Pulmonic area}}</div></div>", "time": null}, {"id": 1471878055898, "note": "<b>Ischemic heart disease</b> is usually due to {{c1::<u>atherosclerosis</u>}} of {{c2::coronary}} arteries", "time": null}, {"id": 1471880376461, "note": "<div><div><b>{{c1::Angina}}</b> is chest pain due to <b>myocardial ischemia</b> (secondary to coronary artery <u>narrowing</u> or <u>spasm</u>)</div></div>", "time": null}, {"id": 1471880379381, "note": "<div><div>Does <u>angina</u> cause <b>myocyte necrosis</b>? </div><div><br></div><div>{{c1::No, damage is <u>reversible</u>}}</div></div>", "time": null}, {"id": 1471880381847, "note": "<div><div><b>{{c1::Stable}} angina</b> is characterized by chest pain that arises with <b>{{c2::exertion}}</b> or <b>emotional stress</b></div></div>", "time": null}, {"id": 1471880384775, "note": "<div><div><b>Stable angina</b> is often due to {{c2::atherosclerosis}} of <u>coronary arteries</u> with &gt;{{c1::70}}% stenosis </div></div>", "time": null}, {"id": 1471880402055, "note": "<div><div><b>Stable angina</b> often presents with chest pain <u>lasting {{c1::&lt; 20}} minutes</u> that radiates to the <b>{{c2::left arm}}</b> or <b>{{c2::jaw}}</b> </div></div>", "time": 1660105350826.0}, {"id": 1471880414063, "note": "<div><div><b>Stable angina</b> is often relieved by {{c1::rest}} or with {{c2::nitroglycerin}}</div></div>", "time": 1660105350828.0}, {"id": 1471880418039, "note": "<div><div>What <u>ECG findings</u> are associated with <b>stable angina</b>? </div><div><br></div><div>{{c1::ST-segment <u>depression</u> (<b>subendocardial</b> ischemia)}}</div></div>", "time": null}, {"id": 1471880428703, "note": "<div><div><b>Unstable angina</b> is characterized by chest pain that occurs during {{c1::rest}}</div></div>", "time": 1660105348378.0}, {"id": 1471880433632, "note": "<div><div><b>{{c3::Unstable}} angina</b> is due to rupture of atherosclerotic plaque with {{c1::<b>thrombosis</b>}} and {{c2::<u>incomplete</u>}} occlusion of a coronary artery </div></div>", "time": 1660105337003.0}, {"id": 1471880441143, "note": "<div><div><div>What <u>ECG findings</u> are associated with <b>unstable angina</b>? </div><div><br></div><div>{{c1::ST-segment <u>depression</u> and/or T-wave inversion::2}}</div></div></div>", "time": null}, {"id": 1471880448151, "note": "<div>What drug may be used to relieve symptoms due to <b>unstable angina</b>?</div><div><br></div><div>{{c1::Nitroglycerin}}</div>", "time": 1660105347221.0}, {"id": 1471880451252, "note": "<div><div><b>Unstable angina</b> has a <u>high</u> risk of progression to {{c1::myocardial infarction}}</div></div>", "time": null}, {"id": 1471880453940, "note": "<div><div><b>{{c1::Vasospastic (variant/prinzmetal)}} angina</b> is characterized by <i>episodic </i>chest pain during {{c2::<u>rest</u>}} due to<b> coronary artery {{c3::spasm}}</b></div></div>", "time": 1660105338506.0}, {"id": 1471880459924, "note": "<div><div><div>What <u>ECG findings</u> are associated with <b>vasospastic angina</b>? </div><div><br></div><div>{{c1::ST-segment <u>elevation</u> (<b>transmural</b> ischemia)}}</div></div></div>", "time": null}, {"id": 1471880462751, "note": "<div><div><b>Vasospastic angina</b> is relieved by {{c1::nitrate}} drugs, {{c2::dihydropyridine Ca<sup>2+</sup>}} channel blockers, and smoke cessation (if applicable) </div></div>", "time": 1660105348300.0}, {"id": 1471880467615, "note": "<div><div>Known <u>triggers</u> of <b>Vasospastic angina</b> include {{c1::<b>tobacco</b>}}, <b>{{c2::cocaine}}</b>, and <b>{{c3::triptans}}</b> </div></div>", "time": null}, {"id": 1471880481754, "note": "<b>{{c2::Coronary steal}} syndrome</b> occurs when administration of <u>{{c3::vasodilators}}</u> shunts blood <i>towards</i> <i>well-perfused areas</i>, increasing ischemia in <b>post-{{c1::stenotic}} regions</b> ", "time": 1660105338150.0}, {"id": 1471880947815, "note": "<div><b>Coronary steal syndrome</b> occurs because <u>distal to coronary stenosis</u>, vessels are maximally {{c1::dilated}} at baseline</div>", "time": 1660105360401.0}, {"id": 1471880956835, "note": "<b>Coronary steal syndrome</b> is the principle behind {{c1::pharmacologic}} stress tests", "time": 1660105360402.0}, {"id": 1471898845279, "note": "<div>Does <u>myocardial infarction</u> cause <b>myocyte necrosis</b>? </div><div><br></div><div>{{c1::Yes, damage is <u>irreversible</u>}}</div>", "time": 1660105359839.0}, {"id": 1471898867686, "note": "<div><b>Myocardial infarction</b> is often due to rupture of atherosclerotic plaque with {{c1::<b>thrombosis</b>}} and {{c2::<u>complete</u>}} occlusion of a coronary artery</div>", "time": 1660105354986.0}, {"id": 1471898879429, "note": "<div><b>Myocardial infarction</b> often presents with severe <i>crushing </i>chest pain <u>lasting {{c1::&gt; 20}} minutes</u> that radiates to the <b>{{c2::left arm}}</b> or <b>{{c2::jaw}}</b> </div>", "time": 1660105354983.0}, {"id": 1471898887090, "note": "<div>One less common cause of <b>myocardial infarction</b> is coronary artery {{c1::vasospasm}} (e.g. vasospastic angina, cocaine use)</div>", "time": null}, {"id": 1471898892065, "note": "<div>One less common cause of <b>myocardial infarction</b> is {{c1::vasculitis}} (e.g. Kawasaki disease)</div>", "time": null}, {"id": 1471898896955, "note": "<div><b>Myocardial infarction</b> may present with {{c1::dyspnea}} due to pulmonary congestion and edema </div>", "time": 1660105354984.0}, {"id": 1471898912568, "note": "<div>What <u>heart chamber</u> is most commonly affected by <b>myocardial infarction</b>? </div><div><br /></div><div>{{c1::Left ventricle}}  </div>", "time": null}, {"id": 1471898932776, "note": "<div><b>Myocardial infarction</b> most commonly involves the {{c1::left anterior descending (LAD)}} artery (45%)</div>", "time": null}, {"id": 1471898945857, "note": "<div>The <u>second</u> most common artery involved in a <b>myocardial infarction</b> is the {{c1::right coronary artery}}</div>", "time": null}, {"id": 1471899020561, "note": "<div>The <u>third</u> most common artery involved in a <b>myocardial infarction</b> is the {{c1::left circumflex artery}}</div>", "time": null}, {"id": 1471899029714, "note": "<div>The <u>initial phase</u> of <b>myocardial infarction</b> leads to {{c1::subendocardial}} necrosis involving &lt; 50% of the myocardial thickness</div>", "time": 1660105349988.0}, {"id": 1471899040750, "note": "<div>The <u>initial phase</u> of <b>myocardial infarction</b> (<i>subendocardial</i> infarcts) shows <b>ST-segment</b> {{c1::depression}} on ECG</div>", "time": 1660105349989.0}, {"id": 1471899048022, "note": "<div>The <u>later phase</u> of <b>myocardial infarction</b> (<i>transmural</i> infarcts) shows <b>ST-segment</b> {{c1::elevation}} and <b>Q waves</b> on ECG </div>", "time": 1660105349942.0}, {"id": 1471899057863, "note": "<div>When suspecting a <b>myocardial infarction</b>, laboratory tests are used to detect <i>elevated</i> {{c1::cardiac}} enzymes</div>", "time": null}, {"id": 1471899068548, "note": "<div>In the <u>first 6 hours</u>, <b>{{c1::ECG}}</b> is the gold standard for diagnosis of <b>myocardial infarction</b></div>", "time": null}, {"id": 1471899071838, "note": "<div>What is the <u>most</u><i> sensitive </i>and <i>specific</i> <b>cardiac biomarker</b> used for diagnosis of myocardial infarction? </div><div><br></div><div>{{c1::Troponin I}}</div>", "time": null}, {"id": 1471899075220, "note": "<div><b>Troponin</b> <b>I</b> levels rise {{c1::2-4}} hours after an MI and peak at {{c2::24}} hours </div>", "time": null}, {"id": 1471899082910, "note": "<div><b>Troponin I</b> levels return to normal {{c1::7-10 days}} after an MI</div>", "time": null}, {"id": 1471899090660, "note": "<div><b>{{c1::CK-MB}}</b> is a <u>cardiac biomarker</u> that is useful for detecting <b>{{c2::reinfarction}}</b> following acute MI</div>", "time": 1660105340798.0}, {"id": 1471899095578, "note": "<div><b>CK-MB</b> levels rise {{c1::6-12}} hours after an MI and peak at {{c2::16-24}} hours</div>", "time": null}, {"id": 1471899134297, "note": "<div><b>CK-MB</b> levels return to normal {{c1::48-72 hours}} after an MI</div>", "time": null}, {"id": 1471899140737, "note": "<div><i>Large</i> <u>myocardial infarctions</u> lead to {{c1::greater}} elevations in <b>troponin I</b> and <b>CK-MB</b></div>", "time": null}, {"id": 1471899144372, "note": "<div><b>CK-MB</b> is <i>predominantly</i> found in <u>myocardium</u>, but can also be released from {{c1::skeletal muscle}}</div>", "time": null}, {"id": 1471899149384, "note": "<div>What <b>anti-coagulation</b> drug is frequently used to treat <u>acute coronary syndromes</u> (e.g. unstable angina, STEMI, NSTEMI)?</div><div><br></div><div>{{c1::Heparin}}</div>", "time": 1660105347968.0}, {"id": 1471899154660, "note": "<div>Treatment of <u>acute coronary syndromes</u> (e.g. unstable angina, STEMI, NSTEMI) often includes <b>antiplatelet therapy</b> such as {{c1::aspirin}}</div>", "time": 1660105348574.0}, {"id": 1471899158974, "note": "<div>Treatment of <u>acute coronary syndromes</u> often includes a(n)&nbsp;<b>{{c1::ADP}} receptor inhibitor</b> such as <b>clopidogrel</b></div>", "time": 1660105348573.0}, {"id": 1471899174061, "note": "<div>Treatment of <u>acute coronary syndromes</u> often includes <b>{{c1::\u03b2-blockers}}</b>, which decrease heart rate and reduces risk of arrhythmia</div>", "time": null}, {"id": 1471899180531, "note": "<div>Treatment of <u>acute coronary syndromes</u> often includes <b>{{c1::ACE}} inhibitors</b> to decrease left ventricular dilation</div>", "time": null}, {"id": 1471899192663, "note": "<div>Treatment of <u>acute coronary syndromes</u> often includes supplemental {{c1::O<sub>2</sub>}} to minimize ischemia</div>", "time": 1660105348572.0}, {"id": 1471899202241, "note": "<div><font color=\"#aa0000\">Initial</font> treatment of <u>acute coronary syndrome</u> includes <i>MONA (<font color=\"#aa0000\">MONA</font> greets <font color=\"#aa0000\">chest pain</font> patients <font color=\"#aa0000\">at the door</font>)</i></div><div><br /></div><div> - <b><font color=\"#aa0000\">M</font></b>{{c1::orphine}}</div><div> - <b><font color=\"#aa0000\">O</font></b>{{c2::xygen}}</div><div> - <b><font color=\"#aa0000\">N</font></b>{{c3::itroglycerin}}</div><div> - <b><font color=\"#aa0000\">A</font></b>{{c4::spirin}}</div>", "time": null}, {"id": 1471899212336, "note": "<div>The most important treatment for <b>STEMI</b> is <b>{{c1::reperfusion}} therapy</b>, such as {{c2::<u>angioplasty</u>}} (preferred) or {{c3::<u>fibrinolysis</u>}}</div>", "time": 1660105349789.0}, {"id": 1471899221722, "note": "<div><b>Reperfusion</b> of irreversibly-damaged cells post-MI may result in {{c1::<b>Ca<sup>2+</sup></b>}} influx, leading to {{c2::<b>hypercontraction</b>}} of myofibrils ({{c3::<u>contraction band necrosis</u>}}) </div>", "time": 1660105353376.0}, {"id": 1471899234512, "note": "<div><b>Reperfusion</b> of irreversibly-damaged cells post-MI may result in {{c1::<b>free</b> <b>radical</b>}} <b>formation</b> (due to O<sub>2</sub>), further damaging myocytes (known as {{c2::<u>reperfusion injury</u>}})</div>", "time": null}, {"id": 1471899256655, "note": "<div>What <b>gross changes</b> occur during the <b>first 4 hours</b> of a <u>myocardial infarction</u>? </div><div><br></div><div>{{c1::None :)}}</div>", "time": null}, {"id": 1471899267904, "note": "<div><div>What <b>microscopic changes</b> occur during the <b>first 4 hours</b> of a <u>myocardial infarction</u>? </div><div><br></div><div>{{c1::None :)}}</div></div>", "time": 1660105345161.0}, {"id": 1471899271006, "note": "<div>One complication that may occur during the <b>first 4 hours</b> post-MI is {{c1::cardiogenic shock}}, which occurs due to lack of blood flow to vital organs</div>", "time": null}, {"id": 1471899275408, "note": "<div>One complication that may occur during the <b>first 4 hours</b> post-MI is {{c1::congestive heart failure}}, which occurs due to inefficient pumping of the left ventricle</div>", "time": null}, {"id": 1471899290606, "note": "<div>One complication that may occur during the <b>first 24 hours</b> post-MI is {{c1::arrhythmia}}, which is an important cause of death before reaching the hospital </div>", "time": 1660105354622.0}, {"id": 1471899319397, "note": "<div><div>What <b>gross changes</b> occur from <b>4 - 24 hours</b> <u>post-MI</u>? </div><div><br /></div><div>{{c1::Dark discoloration}}</div></div>", "time": 1660105347047.0}, {"id": 1471899328126, "note": "<div><div><div>What <b>microscopic changes</b> occur from <b>4 - 24 hours</b> <u>post-MI</u>? </div><div><br /></div><div>{{c1::Coagulative necrosis}}</div></div></div>", "time": 1660105345158.0}, {"id": 1471899336939, "note": "<div><div>What <b>gross changes</b> occur from <b>1 - 3 days</b> <u>post-MI</u>? </div><div><br /></div><div>{{c1::Yellow pallor}}</div></div>", "time": 1660105347048.0}, {"id": 1471899339995, "note": "<div><div>What <b>microscopic changes</b> occur from <b>1 - 3 days</b> <u>post-MI</u>? </div><div><br /></div><div>{{c1::Neutrophils (acute inflammation)}}</div></div>", "time": 1660105345160.0}, {"id": 1471899346321, "note": "<div><b>{{c1::Fibrinous pericarditis}}</b> is an inflammatory <u>post-MI</u> complication that occurs after <b>{{c2::2*}} </b>to<b> {{c2::4*}} days </b></div>", "time": null}, {"id": 1471899349727, "note": "<div><b>{{c1::Fibrinous pericarditis}}</b> is a <u>post-MI complication</u> that presents as chest pain with <b>{{c2::friction}} rub</b> </div>", "time": 1660105340362.0}, {"id": 1471899362336, "note": "<div><div><div>What <b>gross changes</b> occur from <b>4 - 7 days</b> <u>post-MI</u>? </div><div><br /></div><div>{{c1::Yellow pallor}}</div></div></div>", "time": 1660105347046.0}, {"id": 1471899371687, "note": "<div><div><div>What <b>microscopic changes</b> occur from <b>3 - 10 days</b> <u>post-MI</u>? </div><div><br></div><div>{{c1::Macrophage infiltration  (acute inflammation)*}}</div></div></div>", "time": null}, {"id": 1471899376283, "note": "<div>One complication that may occur <b>{{c3::5}} - {{c3::14}} days</b> post-MI is {{c1::<b>ventricular free wall <u>rupture</u></b>}}, which causes {{c2::<b>cardiac tamponade</b>}}</div>", "time": 1660105354616.0}, {"id": 1471899388138, "note": "<div>One complication that may occur <b>{{c2::3}} - {{c2::5}} days</b> post-MI is {{c1::<b>interventricular septal <u>rupture</u></b>}}, which causes a <b>ventricular septal defect</b> (VSD) </div>", "time": 1660105354621.0}, {"id": 1471899395392, "note": "<div>One complication that may occur <b>{{c3::3}} - {{c3::5}} days</b> post-MI is {{c1::<b>papillary muscle <u>rupture</u></b>}}, which often causes {{c2::<b>mitral regurgitation</b>}}</div>", "time": 1660105354619.0}, {"id": 1471899404681, "note": "<div><div><div>At <b>10 - 14 days</b> <u>post-MI</u>, the following <b>gross changes</b> occur: emergence of the {{c1::red border}}; due to {{c2::granulation tissue}} entering from the edge of the {{c2::infarct}}</div></div></div>", "time": null}, {"id": 1471899409106, "note": "<div><div><div><div>What <b>microscopic changes</b> occur from <b>3 - 14 days</b> <u>post-MI</u>? </div><div><br></div><div>{{c1::Granulation tissue*}}</div></div></div></div>", "time": 1660105345159.0}, {"id": 1471899412796, "note": "<div>What <b>gross changes</b> occur<b> months</b> after an MI? </div><div><br></div><div>{{c1::White scar}}</div>", "time": 1660105347045.0}, {"id": 1471899419610, "note": "<div><div>What <b>microscopic changes</b> occur<b> months</b> after an MI? </div><div><br></div><div>{{c1::Fibrosis}}</div></div>", "time": 1660105345157.0}, {"id": 1471899426119, "note": "<div><div>{{c1::<b>True ventricular </b><b>aneurysm</b>}} is a complication that may occur <b><i>months</i></b> <u>after an MI</u> and increases risk for <b>mural {{c2::thrombus}}</b></div></div>", "time": 1660105338563.0}, {"id": 1471899435178, "note": "<div><div><b>{{c1::Dressler}} syndrome</b> is an autoimmune complication that may occur <b>several weeks</b> (6-8) after an MI</div></div>", "time": null}, {"id": 1471899439284, "note": "<div><div><b>{{c1::Dressler}} syndrome</b> is a(n) {{c2::<u>autoimmune</u>}} phenomenon that results in <b>fibrinous pericarditis</b> following an MI (&gt; 1 month)</div></div>", "time": null}, {"id": 1471899450039, "note": "<div><b>{{c1::Sudden cardiac death}}</b> is death from cardiac causes within <u>1 hour</u> of onset of symptoms</div>", "time": null}, {"id": 1471899459296, "note": "<div><b>Sudden cardiac death</b> is most commonly due to a lethal {{c1::arrhythmia (e.g. <u>ventricular fibrillation</u>)}} </div>", "time": null}, {"id": 1471899462236, "note": "<div><b>Sudden cardiac death</b> may be prevented with an implantable {{c1::cardioverter-defibrillator (ICD)}}</div>", "time": null}, {"id": 1471899464553, "note": "<div>90% of patients who suffer <b>sudden cardiac death</b> have pre-existing severe {{c1::atherosclerosis}}</div>", "time": null}, {"id": 1471899472721, "note": "<b>{{c1::Chronic ischemic heart disease}}</b> is the <i>progressive</i> onset of <b>heart failure</b> over <u>many years</u> due to chronic ischemic myocardial damage", "time": null}, {"id": 1471909359002, "note": "<b>Ventricular </b>{{c1::<b>pseudo-aneurysm</b>}} is a <i>contained</i> free wall rupture that may occur <b>{{c2::3}} - {{c2::14}} days</b> <u>post-MI</u>", "time": null}, {"id": 1471909453754, "note": "<div>Which <u>artery</u> is associated with <b>anteroseptal </b>myocardial<b> </b>infarction?</div><div><br /></div><div>{{c1::Left anterior descending (LAD) artery}}</div>", "time": 1660105343980.0}, {"id": 1471910984242, "note": "<div>What <u>leads</u> show <b>ST elevations</b> or <b>Q waves</b> in an <b>anteroseptal</b> myocardial infarction? </div><div><br></div><div>{{c1::V<sub>1</sub> - V<sub>2</sub>::2}}</div>", "time": null}, {"id": 1471910987924, "note": "<div><div>Which <u>artery</u> is associated with <b>anteroapical </b>myocardial<b> </b>infarction?</div><div><br /></div><div>{{c1::<i>Distal</i> left anterior descending (LAD) artery}}</div></div>", "time": 1660105343981.0}, {"id": 1471910994276, "note": "<div><div>What <u>leads</u> show <b>ST elevations</b> or <b>Q waves</b> in an <b>anteroapical</b> myocardial infarction? </div><div><br></div><div>{{c1::V<sub>3</sub> - V<sub>4</sub>::2}}</div></div>", "time": null}, {"id": 1471910997263, "note": "<div><div>Which <u>arteries</u> may be associated with <b>anterolateral </b>myocardial<b> </b>infarction?</div><div><br></div><div>{{c1::LAD or LCX::2}}</div></div>", "time": 1660105344397.0}, {"id": 1471911002718, "note": "<div><div>What <u>leads</u> show <b>ST elevations</b> or <b>Q waves</b> in an <b>anterolateral</b> myocardial infarction? </div><div><br></div><div>{{c1::V<sub>5</sub> - V<sub>6</sub>::2}}</div></div>", "time": null}, {"id": 1471911005725, "note": "<div><div>Which <u>artery</u> is associated with <b>lateral </b>myocardial<b> </b>infarction?</div><div><br /></div><div>{{c1::Left circumflex (LCX) artery}}</div></div>", "time": 1660105343979.0}, {"id": 1471911012149, "note": "<div><div>What <u>leads</u> show <b>ST elevations</b> or <b>Q waves</b> in a <b>lateral</b> myocardial infarction? </div><div><br></div><div>{{c1::I, aVL::2}}</div></div>", "time": null}, {"id": 1471911016577, "note": "<div><div>Which <u>artery</u> is <i>typically</i> associated with <b>inferior </b>myocardial<b> </b>infarction?</div><div><br /></div><div>{{c1::Right coronary artery (RCA)}}</div></div>", "time": 1660105343977.0}, {"id": 1471911022900, "note": "<div>What <u>leads</u>&nbsp;show <b>ST elevations</b> or <b>Q waves</b> in an <b>inferior</b> myocardial infarction? </div><div><br></div><div>{{c1::II, III, aVF::3}}</div>", "time": null}, {"id": 1471911025659, "note": "<div><div>Which <u>artery</u> is associated with <b>posterior </b>myocardial<b> </b>infarction?</div><div><br></div><div>{{c1::Posterior descending artery (PDA)}}</div></div>", "time": 1660105343978.0}, {"id": 1471911032392, "note": "<div><div>What <u>leads</u> show <b>ST elevations</b> or <b>Q waves</b> in a&nbsp;<b>posterior </b>myocardial infarction? </div><div><br></div><div>{{c1::V<sub>7</sub> - V<sub>9</sub>}}</div></div>", "time": 1660105345182.0}, {"id": 1471911062062, "note": "<div><b>{{c1::Heart failure}}</b> is a clinical syndrome of <b>cardiac pump dysfunction</b> which causes <u>congestion</u> and <u>low perfusion</u></div>", "time": null}, {"id": 1471914909206, "note": "<div>How does <b>ejection fraction</b> change in <u>heart failure</u> with <b>systolic dysfunction</b>? </div><div><br></div><div>{{c1::Reduced EF}}</div>", "time": null}, {"id": 1471914912128, "note": "<div><div>How does <b>EDV</b> change in <u>heart failure</u> with <b>systolic dysfunction</b>? </div><div><br></div><div>{{c1::Increased EDV}}</div></div>", "time": null}, {"id": 1471914914774, "note": "<div><b>Systolic dysfunction</b> (heart failure) occurs due to <u>decreased</u> {{c1::contractility}}, often secondary to ischemia/MI or dilated cardiomyopathy</div>", "time": null}, {"id": 1471914917436, "note": "<div><div>How does <b>ejection fraction</b> change in <u>heart failure</u> with <b>diastolic dysfunction</b>? </div><div><br></div><div>{{c1::Preserved EF}}</div></div>", "time": null}, {"id": 1471914919931, "note": "<div><div><div>How does <b>EDV</b> change in <u>heart failure</u> with <b>diastolic dysfunction</b>? </div><div><br></div><div>{{c1::Normal EDV}}</div></div></div>", "time": null}, {"id": 1471914922825, "note": "<div><b>Diastolic dysfunction</b> (heart failure) occurs due to <u>decreased</u> {{c1::compliance}}, often secondary to myocardial concentric hypertrophy</div>", "time": 1660105360052.0}, {"id": 1471914925586, "note": "<div>What is the <u>most common cause</u> of <b>right heart failure</b>?</div><div><br></div><div>{{c1::Left heart failure}}</div>", "time": null}, {"id": 1471914928516, "note": "<div><b>Right heart failure</b> may be caused by a <i>long-standing </i>{{c1::left-to-right}} shunt</div>", "time": null}, {"id": 1471914931976, "note": "<div><b>{{c2::Cor pulmonale}}</b> refers to <i>isolated</i> <b>{{c1::right heart failure}}</b> due to pulmonary cause</div>", "time": null}, {"id": 1471914938644, "note": "<div>Clinical features of <b>left heart failure</b> are due to {{c2::<u>decreased</u>}} forward perfusion with consequent {{c1::pulmonary}} congestion</div>", "time": 1660105360643.0}, {"id": 1471914942128, "note": "<div><b>{{c2::Left::Left or Right}} heart failure</b> may present with {{c1::<b>orthopnea</b>}}, which is shortness of breath when supine</div>", "time": null}, {"id": 1471914954685, "note": "<div><b>{{c2::Left}} heart failure</b> may present with {{c1::<b>paroxysmal nocturnal dyspnea</b>}}, which is breathless awakening from sleep</div>", "time": null}, {"id": 1471914969111, "note": "<div><b>{{c2::Left}} heart failure</b> may present with <b>pulmonary {{c1::edema}}</b> due to <u>increased</u> pulmonary venous pressure</div>", "time": 1660105337789.0}, {"id": 1471914979068, "note": "<div><b>{{c3::Left}} heart failure</b> may present with {{c1::<b>hemosiderin-laden macrophages</b>}}, known as <b>{{c2::heart failure}} cells</b>, in the lungs</div>", "time": null}, {"id": 1471914992993, "note": "<div><b>Left heart failure</b> causes <u>decreased forward perfusion</u> to the kidneys, resulting in activation of the {{c1::renin-angiotensin}} system</div>", "time": null}, {"id": 1471914999950, "note": "<div>Clinical features of <b>right heart failure</b> are due to {{c1::systemic}} congestion</div>", "time": null}, {"id": 1471915003682, "note": "<div><b>{{c2::Right}} heart failure</b> may cause <b>{{c1::jugular venous}} distension</b> due to <u>increased</u> systemic venous pressure</div>", "time": 1660105337420.0}, {"id": 1471915035278, "note": "<div><b>{{c2::Right}} heart failure</b> is associated with a characteristic \"{{c1::<b>nutmeg</b>}}\" appearance of the liver</div>", "time": null}, {"id": 1471915047213, "note": "<div><b>Right heart failure</b> is associated with <b>peripheral</b> {{c1::edema}} due to <u>increased</u> venous pressure and thus fluid transudation</div>", "time": null}, {"id": 1471915101703, "note": "<div><b>Heart failure</b> may present with <i>dependent</i> {{c1::pitting}} <b>edema</b> due to <u>increased</u> hydrostatic pressure</div>", "time": null}, {"id": 1471915155178, "note": "<div>What <i>sound</i> on <u>respiratory exam</u> may be associated with <b>heart failure</b>? </div><div><br></div><div>{{c1::Rales / crackles}}</div>", "time": null}, {"id": 1471989960544, "note": "<div>Defects with <b>left-to-right shunting</b> may be relatively <u>asymptomatic</u> at birth, but the shunt can eventually {{c1::reverse}}</div>", "time": null}, {"id": 1471989967288, "note": "<div><b>Left-to-right shunting</b> results in <u>increased</u> flow through the pulmonary circulation, causing pulmonary {{c1::hypertension}}</div>", "time": null}, {"id": 1471989976175, "note": "<div>The <u>pulmonary hypertension</u> seen with <i>long-standing</i><b> left-to-right shunts</b> causes the <b>right ventricle</b> to {{c1::hypertrophy}}</div>", "time": null}, {"id": 1471989983590, "note": "<div>The combination of <b>right ventricle hypertrophy</b> and <b>pulmonary hypertension</b> in response to <u>left-to-right shunting</u> results in shunt {{c1::reversal}}</div>", "time": 1660105350281.0}, {"id": 1471989989842, "note": "<div>Uncorrected <u>left-to-right shunting</u> eventually results in <i>reversal</i>, which presents with <i>late</i> <b>{{c1::cyanosis}}</b> (<b>{{c2::Eisenmenger}} syndrome</b>)</div>", "time": null}, {"id": 1471990007665, "note": "<div><b>Eisenmenger syndrome</b> is characterized by a triad of {{c1::<i>late</i> cyanosis}}, {{c2::clubbing}}, and {{c3::polycythemia}} </div>", "time": null}, {"id": 1471990027733, "note": "<div>Compared to <u>right-to-left shunts</u>, <b>left-to-right shunts</b> lead to <b>cyanosis</b> at a(n) {{c1::later}} age</div>", "time": null}, {"id": 1471990035729, "note": "<div>Compared to <u>left-to-right shunts</u>, <b>right-to-left shunts</b> lead to <b>cyanosis</b> at a(n) {{c1::earlier}} age</div>", "time": null}, {"id": 1471990069494, "note": "<div><div><b>Ventricular septal defect</b> (VSD) is associated with {{c1::fetal alcohol}} syndrome </div></div>", "time": null}, {"id": 1471990077514, "note": "<div><div><b>Ventricular septal defect</b> (VSD) results in a(n) {{c1::left}}-to-{{c1::right}} shunt</div></div>", "time": null}, {"id": 1471990122978, "note": "<div><div><i>Smaller</i> <b>ventricular septal defects</b> are often {{c1::asymptomatic}} and may close spontaneously, but on physical exam will present with a(n) {{c2::<u>murmur</u>}}</div></div>", "time": 1660105350924.0}, {"id": 1471990129054, "note": "<div><div>How is a <i>large</i> <b>ventricular septal defect</b> <u>treated</u>? </div><div><br></div><div>{{c1::Surgical closure}}</div></div>", "time": 1660105358038.0}, {"id": 1471990184418, "note": "<div><i>Larger</i> <b>ventricular septal defects</b> may lead to left ventricle {{c1::overload}} and, consequently, {{c2::heart failure}}</div>", "time": 1660105355736.0}, {"id": 1471990192539, "note": "<div>What is the most common type of <b>Atrial Septal Defect</b> (ASD)?</div><div><br></div><div>{{c1::Ostium secundum (90%)}}</div>", "time": null}, {"id": 1471990196725, "note": "<div><b>Ostium {{c1::primum}}</b> is a less common type of <u>atrial septal defect</u> that is associated with {{c2::Down}} syndrome</div>", "time": null}, {"id": 1471990231482, "note": "<div><b>Atrial septal defect</b> (ASD) results in a(n) {{c1::left}}-to-{{c1::right}} shunt</div>", "time": null}, {"id": 1471990236088, "note": "<div>What effect does <b>atrial septal defect</b> (ASD) have on <b>S2 splitting</b>? </div><div><br /></div><div>{{c1::Causes a <u>wide, fixed</u> split}}</div>", "time": null}, {"id": 1471990251073, "note": "<div><b>{{c1::Paradoxical}} emboli</b>, an important complication of <u>atrial septal defect</u>, are emboli that arise on the right-side of the body and <i>crossover</i> to lodge on the left side </div>", "time": 1660105339352.0}, {"id": 1471990273033, "note": "<div><b>Patent ductus arteriosus</b> is associated with congenital {{c1::rubella}} infection </div>", "time": null}, {"id": 1471990276789, "note": "<div>In the <u>fetal period</u>, the <b>ductus arteriosus</b> acts as a(n) {{c1::right}}-to-{{c1::left}} shunt</div>", "time": null}, {"id": 1471990316141, "note": "<div>Patency of a <b>patent ductus arteriosus</b> is maintained by {{c1::PGE}} synthesis and low O<sub>2</sub> tension</div>", "time": null}, {"id": 1471990321620, "note": "<div>Uncorrected <b>patent ductus arteriosus</b> may eventually result in <i>late</i> <b>cyanosis</b> in the {{c1::lower}} extremities</div>", "time": 1660105348392.0}, {"id": 1471990336202, "note": "<div>Treatment of a <b>patent ductus arteriosus</b> involves {{c1::indomethacin}}, which <u>decreases PGE</u>, resulting in PDA closure</div>", "time": 1660105348575.0}, {"id": 1471990345570, "note": "<div><b>{{c1::Tetralogy of Fallot}}</b> is a <u>congenital heart disease</u> that is characterized by:<br><br></div><div> 1. {{c2::Pulmonary infundibular stenosis}}</div><div> 2. {{c3::Right ventricular hypertrophy}} </div><div> 3. {{c4::Overriding aorta}}</div><div> 4. {{c5::Ventricular septal defect (VSD)}}</div>", "time": null}, {"id": 1471990360540, "note": "<div><b>Tetralogy of Fallot</b> results in a(n) {{c1::right}}-to-{{c1::left}} shunt with {{c2::<i>early</i>}} cyanosis</div>", "time": 1660105350537.0}, {"id": 1471990372693, "note": "<div>The degree of <u>shunting</u> in <b>Tetralogy of Fallot</b> is determined by the degree of {{c1::right ventricular outflow tract obstruction (from pulmonary stenosis)}}</div>", "time": 1660105350251.0}, {"id": 1471990378964, "note": "<div><b>{{c2::Tetralogy of Fallot}}</b> is characterized by a(n) {{c1::<b>boot</b>}}<b>-shaped heart</b> on CXR</div>", "time": null}, {"id": 1471990386790, "note": "<div>Patients with <b>Tetralogy of Fallot</b> often experience \"{{c1::tet}} spells\" which may be caused by crying, fever, and exercise due to <b>exacerbation of RV outflow obstruction</b> </div>", "time": 1660105354156.0}, {"id": 1471990402261, "note": "<div>Patients with <b>Tetralogy of Fallot</b> may {{c1::<b>squat</b>}} in response to <i>cyanotic spells</i>, which <u>decreases</u> <b>right-to-left shunting</b> by <u>increasing</u> {{c2::<b>systemic vascular resistance</b> (SVR)}} </div>", "time": null}, {"id": 1471990415098, "note": "<div>What is the most common <u>congenital heart defect</u> that causes <i><b>early</b></i><b> cyanosis</b>?</div><div><br></div><div>{{c1::Tetralogy of Fallot}}</div>", "time": null}, {"id": 1471990419337, "note": "<div><b>Tetralogy of Fallot</b> is caused by {{c1::anterosuperior}} displacement of the infundibular septum</div>", "time": null}, {"id": 1471990424324, "note": "<div><b>{{c3::D-transposition of the great vessels}}</b> is characterized by the {{c1::pulmonary artery}} arising from the <u>left ventricle</u> and {{c1::aorta}} from the <u>right ventricle</u></div>", "time": 1660105337111.0}, {"id": 1471990429400, "note": "<div><b>D-transposition of the great vessels </b>and<b> VSD</b> are<b> </b>associated with {{c1::maternal diabetes::endocrine disorder}}</div>", "time": null}, {"id": 1471990434324, "note": "<div><b>D-transposition of great vessels</b> is <u>not</u> compatible with life unless a(n) {{c1::shunt}} is created</div>", "time": 1660105360219.0}, {"id": 1471990439469, "note": "<div><b>D-transposition of great vessels</b> is due to failure of the {{c1::aorticopulmonary septum}} to <u>spiral</u></div>", "time": null}, {"id": 1471990453854, "note": "<div>{{c1::PGE}} may be administered to patients with <b>D-transposition of great vessels</b> to <u>maintain a PDA</u> until definitive surgical repair is performed</div>", "time": 1660105339301.0}, {"id": 1471990482138, "note": "<div><b>D-transposition of great vessels</b> results in {{c1::hypertrophy}} of the <u>right ventricle</u> and {{c1::atrophy}} of the <u>left ventricle</u></div>", "time": null}, {"id": 1471990492863, "note": "<div><b>D-transposition of great vessels</b> is an example of a(n) {{c1::right}}-to-{{c1::left}} shunt</div>", "time": null}, {"id": 1471990497672, "note": "<div><b>{{c1::Persistent truncus arteriosus}}</b> is a <u>congenital heart disease</u> characterized by a <b>single</b> <b>large vessel</b> arising from <i>both</i> ventricles before eventually splitting</div>", "time": null}, {"id": 1471990527868, "note": "<div><b>Truncus arteriosus</b> is an example of a(n) {{c1::right}}-to-{{c1::left}} shunt</div>", "time": null}, {"id": 1471990537720, "note": "<div>Most patients with <b>truncus arteriosus</b> have accompanying {{c1::ventricular septal}} defect</div>", "time": null}, {"id": 1471990555821, "note": "<div><b>{{c1::Tricuspid atresia}}</b> is the <u>failure</u> of the <b>tricuspid valve orifice</b> to develop</div>", "time": 1660105338573.0}, {"id": 1471990559381, "note": "<div><b>Tricuspid atresia</b> leads to <u>right ventricle</u> {{c1::hypoplasia}}</div>", "time": null}, {"id": 1471990562850, "note": "<div><b>Tricuspid atresia</b> requires <i>both</i> {{c1::ASD}} and {{c1::VSD}} for viability</div>", "time": null}, {"id": 1471990568385, "note": "<div><b>Tricuspid atresia </b>is an example of a(n) {{c1::right}}-to-{{c1::left}} shunt</div>", "time": null}, {"id": 1471990572291, "note": "<div><b>{{c1::Coarctation of the aorta}}</b> is the <b>narrowing of the aorta</b> near the <u>insertion</u> of the ductus arteriosus </div>", "time": 1660105340773.0}, {"id": 1471990580271, "note": "<div><div>The <b>{{c2::infantile}} form</b> of <u>coarctation of the aorta</u> is associated with a(n) {{c1::<b>PDA</b>}}</div></div>", "time": null}, {"id": 1471990586601, "note": "<div><div>In the <b>infantile form</b>, <u>coarctation of the aorta</u> lies <i>{{c1::after}}</i> the <b>aortic arch</b>, but <i>{{c1::before}}</i> the <b>PDA</b></div></div>", "time": null}, {"id": 1471990597653, "note": "<div><div><b>Coarctation of the aorta</b> in <b>infants</b> presents as <u>{{c1::lower}} extremity</u> cyanosis, often at <i>birth</i></div></div>", "time": 1660105360543.0}, {"id": 1471990603994, "note": "<div><div>The <b>infantile form</b> of <u>coarctation of the aorta</u> is associated with {{c1::Turner}} syndrome</div></div>", "time": null}, {"id": 1471990607962, "note": "<div>In the <b>adult form</b>, <u>coarctation of the aorta</u> lies <i>{{c2::after}}</i> the <b>aortic arch</b></div>", "time": null}, {"id": 1471990627889, "note": "<div><b>Coarctation of the aorta</b> in <b>adults</b> presents as {{c1::hypertension}} in the <u>upper extremities</u> and {{c1::hypotension}} in the <u>lower extremities</u> </div>", "time": 1660105360544.0}, {"id": 1471990657613, "note": "<div>In the <b>adult form</b> of <b>coarctation of the aorta</b>, <u>collateral circulation</u> develops most notably across the {{c1::intercostal}} arteries</div>", "time": null}, {"id": 1471990672697, "note": "<div>What X-ray finding is associated with the <b>adult form</b> of <b>coarctation of the aorta</b>? </div><div><br></div><div>{{c1::Notching of ribs (due to engorged intercostal arteries)}}</div>", "time": 1660105344659.0}, {"id": 1471990678892, "note": "<div><b>Coarctation of the aorta</b> is associated with a(n) {{c1::<u>bicuspid</u>}}<u> aortic valve</u> and an increased risk of developing {{c2::<u>berry</u>}}<u> aneurysms</u></div>", "time": null}, {"id": 1471990683814, "note": "<div>What <u>congenital heart defect</u> is associated with <b>lithium exposure in utero</b>? </div><div><br></div><div>{{c1::Ebstein anomaly}}</div>", "time": null}, {"id": 1471990688317, "note": "<div><b>{{c1::Ebstein anomaly}}</b> is a <u>congenital heart disease</u> characterized by <b>downward displacement of tricuspid leaflets</b> into the right ventricle </div>", "time": null}, {"id": 1471990692243, "note": "<div><b>Ebstein anomaly</b> is associated with <b>tricuspid {{c2::regurgitation}}</b> and <b>right</b> <b>{{c1::heart failure}}</b> </div>", "time": null}, {"id": 1471990716491, "note": "<div>{{c1::<b>Total anomalous pulmonary venous return</b> (TAPVR)}} is a <u>congenital heart disease</u> characterized by drainage of <b>pulmonary veins</b> into the <b>right circulation</b> </div>", "time": null}, {"id": 1471990724475, "note": "<div><b>Total anomalous pulmonary venous return</b> (TAPVR) is associated with <b>{{c1::ASD}}</b> and sometimes PDA to allow for right-to-left shunting</div>", "time": 1660105348666.0}, {"id": 1471995423922, "note": "<div><b>Class I antiarrhythmics </b>exert their actions by blocking {{c1::Na<sup>+</sup>}} channels</div>", "time": 1660105352368.0}, {"id": 1471999839826, "note": "<div><b>Class I antiarrhythmics</b> {{c3::<u>decrease</u>}} the <b>{{c2::slope}}</b> of&nbsp;<b>phase {{c1::0 (upstroke)}}</b> of the <i>myocardial</i> action potential<br></div>", "time": 1660105352365.0}, {"id": 1471999854180, "note": "<div>What effect do <b>class I antiarrhythmics</b> have on <u>conduction velocity</u> of the myocardial action potential?<br></div><div><br></div><div>{{c1::Decreased CV}}</div>", "time": 1660105352293.0}, {"id": 1471999865945, "note": "<div><b>Class I antiarrhythmics</b> bind to Na<sup>+</sup> channels in their {{c1::open}} or {{c1::inactivated}} state<br></div>", "time": 1660105352369.0}, {"id": 1471999885871, "note": "<div><b>Na<sup>+</sup> channels</b> in <b>rapidly depolarizing</b> tissue (e.g. tachycardia) spend the {{c1::most}} time in <u>open</u> or <u>inactivated</u> states<br></div>", "time": 1660105352315.0}, {"id": 1471999893105, "note": "<div><b>Class I antiarrhythmics</b> have {{c1::<u>use dependence</u>}} and thus selectively depress tissue that is <b>frequently depolarized</b><br></div>", "time": 1660105352367.0}, {"id": 1471999905712, "note": "<div>What effect do <b>class I antiarrhythmics</b> have on the <b>action potentials</b> of the <u>SA</u> and <u>AV nodes</u>?<br></div><div><b><br></b></div><div>{{c1::No effect (only affects Na<sup>+</sup>-dependent action potentials)}}</div>", "time": 1660105352292.0}, {"id": 1471999913609, "note": "<div><b>Class I antiarrhythmics</b> {{c1::widen}} the <u>QRS complex</u> on ECG<br></div>", "time": 1660105352366.0}, {"id": 1471999921983, "note": "<div>What <i>drug class</i> does <b>quinidine </b>belong to?<br></div><div><br></div><div>{{c1::Class IA antiarrhythmics}}</div>", "time": 1660105352294.0}, {"id": 1471999929658, "note": "<div>Toxic doses of <b>{{c4::quinidine}}</b>, an <i>antiarrhythmic</i> drug, may cause <b>{{c1::cinchonism}}</b>, which is a syndrome of {{c2::<b>tinnitus</b>}}, {{c3::<b>headache</b>}}, and {{c5::<b>dizziness</b>}}<br></div>", "time": 1660105352309.0}, {"id": 1471999936258, "note": "<div><b>{{c2::Quinidine}}</b> is an <i>anti-arrhythmic</i>&nbsp;that rarely causes <u>immunologic reactions</u>, resulting in {{c1::<b>thrombocytopenia</b>}}<br></div>", "time": 1660105352259.0}, {"id": 1471999942205, "note": "<div>What <i>drug class</i> does <b>procainamide </b>belong to?<br></div><div><br></div><div>{{c1::Class IA antiarrhythmics}}</div>", "time": 1660105352296.0}, {"id": 1471999949472, "note": "<div><b>{{c2::Procainamide}}</b>, a class IA antiarrhythmic, can cause a <i>reversible</i> <b>{{c1::SLE}}-like syndrome</b> as an adverse effect<br></div>", "time": 1660105352261.0}, {"id": 1471999956293, "note": "<div>What <i>drug class</i> does <b>disopyramide </b>belong to?<br></div><div><div><br></div><div>{{c1::Class IA antiarrhythmics}}</div></div>", "time": 1660105352300.0}, {"id": 1471999991212, "note": "<div>One <u>adverse effect</u> associated with <b>disopyramide</b> is exacerbation of {{c1::heart failure}}, due to its <u>negative inotropic</u> effects<br></div>", "time": 1660105352313.0}, {"id": 1471999998145, "note": "<div><b>Class I{{c3::A}} antiarrhythmics</b> can cause <u>{{c1::QT interval}} prolongation</u> which precipitates {{c2::<b>torsades de pointes</b>}}<br></div>", "time": 1660105352339.0}, {"id": 1472000006974, "note": "<div><b>Class IA antiarrhythmics</b> have a(n) {{c1::intermediate}} binding affinity for the Na<sup>+</sup> channel<br></div>", "time": 1660105352362.0}, {"id": 1472000019446, "note": "<div>In addition to Na<sup>+</sup> channels, <b>Class IA antiarrhythmics</b> also block {{c1::K<sup>+</sup>}} channels<br></div>", "time": 1660105352316.0}, {"id": 1472000027736, "note": "<div>What effect do <b>class <u>IA</u> antiarrhythmics</b> have on <u>action potential duration</u>?<br></div><div><br></div><div>{{c1::Increased duration}}</div>", "time": 1660105352291.0}, {"id": 1472000038292, "note": "<div>What effect do <b>class IA antiarrhythmics</b> have on the <u>effective refractory period</u> in the <b>ventricular tissue</b>?<br></div><div><br></div><div>{{c1::Increased ERP}}</div>", "time": 1660105359220.0}, {"id": 1472000042817, "note": "<div>Are <b>class IA antiarrhythmics</b> used to treat <u>supraventricular</u> or <u>ventricular</u> arrhythmias?<br></div><div><div><div><br></div><div>{{c1::Both :)}}</div></div></div>", "time": 1660105352374.0}, {"id": 1472000056279, "note": "<div><b>Class I{{c1::A}} antiarrhythmics</b> may be used to treat <b>Wolff-Parkinson-White syndrome</b>, a type of SVT<br></div><div></div>", "time": 1660105352344.0}, {"id": 1472000064700, "note": "<div>What <i>drug class</i> does <b>lidocaine </b>belong to?<br></div><div><div><br></div><div>{{c1::Class IB antiarrhythmics}}</div></div>", "time": 1660105352298.0}, {"id": 1472000071465, "note": "<div>What <i>antiarrhythmic drug class</i> does <b>phenytoin </b>belong to?<br></div><div><div><br></div><div>{{c1::Class IB antiarrhythmics (anti-epileptic but has class IB properties)}}</div></div>", "time": 1660105352304.0}, {"id": 1472000097100, "note": "<div>What <i>drug class</i> does <b>mexiletine </b>belong to?<br></div><div><div><br></div><div>{{c1::Class IB antiarrhythmics}}</div></div>", "time": 1660105352297.0}, {"id": 1472000103258, "note": "<div><b>Class IB antiarrhythmics</b> have a(n) {{c1::low}} binding affinity for the Na<sup>+</sup> channel<br></div>", "time": 1660105352361.0}, {"id": 1472000114229, "note": "<div>What effect do <b>class IB antiarrhythmics</b> have on <u>action potential duration</u>?<br></div><div><br></div><div>{{c1::Shortened duration}}</div>", "time": 1660105352290.0}, {"id": 1472000124224, "note": "<div><b>Class {{c3::IB}} antiarrhythmics</b> treat {{c1::ventricular}} arrhythmias, especially in {{c2::ischemic}} tissue (e.g. <b>post-MI</b>)<br></div>", "time": 1660105352330.0}, {"id": 1472000134782, "note": "<div><b>Class I{{c1::B}} antiarrhythmics</b> may be used to treat <i>digitalis-induced </i>arrhythmias<br></div><div><br></div><div><i><br></i></div>", "time": 1660105359224.0}, {"id": 1472000138222, "note": "<div><b>Class I{{c2::B}} antiarrhythmics</b> can cause {{c1::<u>neurological</u>}} side effects (e.g. paresthesias, tremor, convulsions)<br></div>", "time": 1660105352343.0}, {"id": 1472000146226, "note": "<div>What <i>drug class</i> does <b>flecainide </b>belong to?<br></div><div><div><br></div><div>{{c1::Class IC antiarrhythmics}}</div></div>", "time": 1660105352299.0}, {"id": 1472000153006, "note": "<div>What <i>drug class</i> does <b>propafenone </b>belong to?<br></div><div><div><br></div><div>{{c1::Class IC antiarrhythmics}}</div></div>", "time": 1660105352295.0}, {"id": 1472000170602, "note": "<div><b>Class IC antiarrhythmics</b> have a(n) {{c1::strong}} binding affinity for the Na<sup>+</sup> channel<br></div>", "time": 1660105352359.0}, {"id": 1472000179397, "note": "<div>What effect do <b>class IC antiarrhythmics </b>have on <u>action potential duration</u>?<br></div><div><br></div><div>{{c1::No effect}}</div>", "time": 1660105352289.0}, {"id": 1472000189983, "note": "<div>What effect do <b>class IC antiarrhythmics</b> have on the <u>effective refractory period</u> in the <b>AV node</b> and <b>accessory bypass tracts</b>?<br></div><div><br></div><div>{{c1::Significant prolongation of ERP}}</div>", "time": 1660105359219.0}, {"id": 1472000196513, "note": "<div><div>What effect do <b>class IC antiarrhythmics</b> have on the <u>effective refractory period</u> in the <b>Purkinje</b> and <b>ventricular tissue</b>?<br></div><div><br></div><div>{{c1::No effect}}</div></div>", "time": 1660105359218.0}, {"id": 1472000199963, "note": "<div>Are <b>class IC antiarrhythmics</b> used to treat <u>supraventricular</u> or <u>ventricular</u> arrhythmias?<br></div><div><br></div><div>{{c1::Both :)}}</div>", "time": 1660105352373.0}, {"id": 1472000205998, "note": "<div><b>Class I{{c2::C}} antiarrhythmics</b> are <b>especially</b> effective at treating <b>{{c1::atrial}} fibrillation</b> (and flutter)<br></div>", "time": 1660105352341.0}, {"id": 1472000211302, "note": "<div><b>Class IC antiarrhythmics</b> can <i>restore</i> and <i>maintain&nbsp;</i><u>normal sinus <b>rhythm</b></u> in {{c1::atrial}} <b>fibrillation</b> and <b>flutter</b><br></div>", "time": 1660105352360.0}, {"id": 1472000217588, "note": "<div><b>Class I{{c4::C}} antiarrhythmics</b> may have {{c3::<u>proarrhythmic</u>}} effects and are thus <i>contraindicated</i> in patients with {{c1::<b>structural</b>}} <b>heart disease </b>or {{c2::<b>ischemic</b>}} <b>heart disease</b><br></div>", "time": 1660105352336.0}, {"id": 1472058591254, "note": "<b>Acute rheumatic fever</b> is a consequence of pharyngeal infection with {{c1::group A \u03b2-hemolytic streptococci}}", "time": null}, {"id": 1472058599074, "note": "<div><div><b>Acute rheumatic fever</b> most commonly affects children 2 - 3 {{c1::weeks}} after an episode of streptococcal pharyngitis (\"strep throat\")</div></div>", "time": null}, {"id": 1472058602540, "note": "<div><div><b>Acute rheumatic fever</b> is {{c1::immune}}-mediated, <u>not</u> a direct effect of bacteria</div></div>", "time": null}, {"id": 1472058606797, "note": "<div><div><b>Acute rheumatic fever</b> is caused by {{c1::<u>molecular mimicry</u>}} due to resemblance of <b>bacterial {{c2::M}} protein</b> with proteins in human tissue</div></div>", "time": null}, {"id": 1472058609956, "note": "<div><div>Evidence of prior <b>group</b> <b>A \u03b2-hemolytic streptococcal</b> infection includes <u>elevated</u> {{c1::anti-streptolysin O (ASO)}} or anti-{{c2::DNase B}} titers</div></div>", "time": null}, {"id": 1472058617422, "note": "<div><div><i>Minor</i> criteria for <b>rheumatic fever</b> are <u>nonspecific</u> and include {{c1::fever}} and elevated {{c2::ESR}}</div></div>", "time": null}, {"id": 1472058620746, "note": "<div><div>The <i>major</i> criteria for the diagnosis of<b> rheumatic fever</b>&nbsp;are the <b>{{c2::J\u2665NES}}</b> <b>criteria</b> </div></div>", "time": null}, {"id": 1472058624751, "note": "<div><div>What does the <b>J</b> in <u>J\u2665NES criteria</u> represent?</div><div><br /></div><div>{{c1::Joint (migratory polyarthritis)}} </div></div>", "time": null}, {"id": 1472058634105, "note": "<div><div>What does the \u2665 in <u>J\u2665NES criteria</u> represent? </div><div><br></div><div>{{c1::Pancarditis (includes endocarditis, myocarditis, and pericarditis)}}</div></div>", "time": null}, {"id": 1472058638817, "note": "<div><div><div><b>Endocarditis</b> secondary to <u>rheumatic fever</u> most commonly affects the <b>{{c1::mitral}} valve</b>  </div></div></div>", "time": null}, {"id": 1472058647432, "note": "<div><div><div><b>{{c2::Endocarditis}}</b>, secondary to <u>rheumatic fever</u>, is characterized by <b>small vegetations</b> along valvular lines of closure, which cause {{c1::<b>regurgitation</b>}}</div></div></div>", "time": null}, {"id": 1472058667580, "note": "<div><div><div>Severe {{c1::pancarditis}} is the <b>most common cause of death</b> during the acute phase of <u>rheumatic fever</u> </div></div></div>", "time": null}, {"id": 1472058674176, "note": "<div><div><div><b>{{c2::Myocarditis}}</b>, secondary to <u>{{c3::rheumatic fever}}</u>, is associated with <b>{{c1::Aschoff bodies}}</b>, which are <u>granulomas</u> with <b>giant cells</b> and fibrinoid material </div></div></div>", "time": null}, {"id": 1472058685014, "note": "<div><div><div><b>{{c2::Myocarditis}}</b>, secondary to <u>{{c3::rheumatic fever}}</u>, is associated with <b>{{c1::Anitschkow cells}}</b>, which are reactive histiocytes with <i>slender, wavy</i> nuclei </div></div></div>", "time": null}, {"id": 1472058698775, "note": "<div><div><div><b>{{c1::Pericarditis}}</b> most often presents with <b>friction rub </b>and chest pain</div></div></div>", "time": null}, {"id": 1472058703254, "note": "<div><div><div>What does the <b>N</b> in <u>J\u2665NES criteria</u> represent?</div><div><br></div><div>{{c1::Nodules in skin (subcutaneous)}}</div></div></div>", "time": null}, {"id": 1472058706949, "note": "<div><div><div>What does the <b>E</b> in <u>J\u2665NES criteria</u> represent?</div><div><br /></div><div>{{c1::Erythema marginatum}} </div></div></div>", "time": null}, {"id": 1472058715982, "note": "<div><div><div>What does the <b>S</b> in <u>J\u2665NES criteria</u> represent?</div><div><br /></div><div>{{c1::Sydenham chorea}}</div></div></div>", "time": null}, {"id": 1472058725470, "note": "<div><div><b>Acute rheumatic fever</b> attack usually resolves, but may progress to <b>{{c1::chronic rheumatic heart}} disease</b> </div></div>", "time": null}, {"id": 1472058734186, "note": "<div>What&nbsp;<u>drug</u> is used for treatment or prophylaxis of <b>rheumatic fever</b>?</div><div><br></div><div>{{c1::Penicillin}}</div>", "time": null}, {"id": 1472058738488, "note": "<div><div>What is the <u>most common</u> heart valve affected by <b>rheumatic heart disease</b>?</div><div><br /></div><div>{{c1::Mitral valve}}</div></div>", "time": null}, {"id": 1472058744043, "note": "<div><div><div>What is the <u><i>second</i> most common</u> heart valve affected by <b>rheumatic heart disease</b>?</div><div><br></div><div>{{c1::Aortic valve}}</div></div></div>", "time": null}, {"id": 1472058746912, "note": "<div><div><i>Early</i> (<u>acute</u>) lesions of <b>rheumatic heart disease</b> cause mitral {{c1::regurgitation}} </div></div>", "time": null}, {"id": 1472058750504, "note": "<div><div><i>Late</i> (<u>chronic</u>) lesions of <b>rheumatic heart disease</b> cause mitral {{c1::stenosis}}</div></div>", "time": null}, {"id": 1472058753870, "note": "<div><div><b>Chronic rheumatic heart disease</b> results in <u>stenosis</u> with a classic <b>{{c1::fish-mouth}}</b> appearance</div></div>", "time": null}, {"id": 1472058762429, "note": "<div><div>Occasionally, <b>chronic rheumatic heart disease</b> involves the <u>aortic</u> valve, leading to <b>{{c1::fusion}} of the commissures</b> </div></div>", "time": null}, {"id": 1472058770262, "note": "<div><div>Complications of <b>chronic rheumatic heart disease</b> include infectious {{c1::endocarditis}}</div></div>", "time": null}, {"id": 1472058775498, "note": "<div>The most common cause of <b>aortic stenosis</b> is {{c1::degenerative calcification}} from \"wear and tear\"</div>", "time": null}, {"id": 1472058782489, "note": "<div>What <u>demographic</u>&nbsp;is most commonly affected by <b>aortic stenosis</b>? </div><div><br></div><div>{{c1::Older adults (&gt; 60)::age group}}</div>", "time": null}, {"id": 1472058786068, "note": "<div><u>Symptomatic</u>&nbsp;<b>aortic stenosis</b> may present in patients around age <b>50</b> with a(n) {{c1::bicuspid}} aortic valve</div>", "time": null}, {"id": 1472058794493, "note": "<div><div><b>Aortic {{c1::stenosis}}</b> may arise as a consequence of <b>chronic rheumatic valve disease</b></div></div>", "time": null}, {"id": 1472058799078, "note": "<div><div><b>Aortic stenosis</b> due to <u>rheumatic disease</u> may be distinguished from stenosis due to \"<u>wear and tear</u>\" by the presence of: </div><div> 1. {{c1::Coexisting mitral stenosis}}</div><div> 2. {{c2::Fusion of the commissures}}</div></div>", "time": 1660105361654.0}, {"id": 1472058810169, "note": "<div><div>Compensation for <b>aortic stenosis</b> leads to a <u>prolonged</u> {{c1::asymptomatic}} stage  </div></div>", "time": null}, {"id": 1472058817318, "note": "<div><b>Aortic stenosis</b> may present with {{c1::syncope}}, {{c2::angina}}, and {{c3::dyspnea}} on exertion </div>", "time": null}, {"id": 1472058826585, "note": "<div><b>Aortic {{c2::stenosis}}</b> may lead to {{c1::<u>concentric</u>::con/e-centric}} left ventricular hypertrophy, which can further progress to heart failure</div>", "time": null}, {"id": 1472058830036, "note": "<div><b>Aortic {{c2::stenosis}}</b> may cause {{c1::<b>macroangiopathic hemolytic anemia</b>}} as <u>RBCs are damaged</u> while crossing the calcified valve, producing <b>schistocytes</b></div>", "time": null}, {"id": 1472058834697, "note": "<div><b>Aortic {{c1::stenosis}}</b> is associated with \"Pulsus parvus et tardus\", meaning pulses are weak with a delayed peak</div>", "time": null}, {"id": 1472058867617, "note": "<div>Treatment for <b>aortic stenosis</b> is {{c1::valve replacement}} <u>after</u> the onset of complications</div>", "time": 1660105348597.0}, {"id": 1472058871043, "note": "<div>What is the most common cause of <b>aortic regurgitation</b>? </div><div><br /></div><div>{{c1::Isolated aortic root dilation}}</div>", "time": 1660105345976.0}, {"id": 1472058878308, "note": "<div><b>Aortic regurgitation</b> arises due to <u>aortic root dilation</u> (e.g. syphilitic aneurysm, aortic dissection) or {{c1::<u>valve damage</u>}} (e.g. infectious endocarditis)</div>", "time": 1660105361661.0}, {"id": 1472058882618, "note": "<div>One clinical feature of <b>aortic {{c3::regurgitation}}</b> is {{c1::hyperdynamic}} circulation due to <u>increased</u> (widened) {{c2::pulse}} pressure</div>", "time": null}, {"id": 1472058888270, "note": "<div>What is the effect of <b>aortic regurgitation</b> on <b>diastolic pressure</b>? </div><div><br></div><div>{{c1::Decreased pressure}}</div>", "time": null}, {"id": 1472058891600, "note": "<div><div>What is the effect of <b>aortic regurgitation</b> on <b>systolic pressure</b>? </div><div><br></div><div>{{c1::Increased pressure}}</div></div>", "time": null}, {"id": 1472058895186, "note": "<div><b>Aortic {{c2::regurgitation}}</b> may present with a(n)&nbsp;<b>{{c3::bounding}}</b> <b>pulse</b> (Corrigan / Water-hammer pulse), <b>{{c4::pulsating}}</b> <b>nail</b> <b>bed</b> (Quincke pulse), and<b> head {{c1::bobbing}}</b> when severe</div>", "time": null}, {"id": 1472058898774, "note": "<div><b>Aortic {{c2::regurgitation}}</b> may lead to left ventricle <i>dilation</i> with {{c1::<u>eccentric</u>}} hypertrophy, which can progress to left heart failure</div>", "time": 1660105361650.0}, {"id": 1472058901939, "note": "<div>Treatment for <b>aortic regurgitation</b> is {{c1::valve replacement}} <u>before</u> LV dysfunction develops</div>", "time": null}, {"id": 1472058912445, "note": "<div><b>{{c1::Mitral valve prolapse}}</b> is the ballooning of the mitral valve into the left atrium during systole</div>", "time": 1660105339578.0}, {"id": 1472058920968, "note": "<div><b>Mitral valve prolapse</b> is caused by {{c1::myxoid}} <b>degeneration</b> of the valve, making it floppy </div>", "time": null}, {"id": 1472058929720, "note": "<div><div><b>Mitral valve prolapse </b>complications are rare but include <b>infective</b> {{c1::<b>endocarditis</b>}}, arrhythmia, and severe mitral regurgitation </div></div>", "time": null}, {"id": 1472058950915, "note": "<div><div>What is the <u>treatment</u> for <b>mitral valve prolapse</b>? </div></div><div><br></div><div>{{c1::Valve replacement}}</div>", "time": null}, {"id": 1472058957758, "note": "<div><b>Mitral regurgitation</b> usually arises as a complication of mitral valve {{c1::prolapse}}</div>", "time": 1660105355202.0}, {"id": 1472058967059, "note": "<div><b>Mitral regurgitation</b> may be caused by <u>left ventricle</u> {{c1::dilatation}} </div>", "time": 1660105355203.0}, {"id": 1472058981260, "note": "<div><b>Chronic mitral regurgitation</b> may result in volume overload and {{c1::left}}-sided heart failure</div>", "time": null}, {"id": 1472058984977, "note": "<div><b>Mitral stenosis</b> is usually due to {{c1::chronic rheumatic valve}} disease</div>", "time": null}, {"id": 1472058988829, "note": "<div>A(n)&nbsp;<u>{{c2::decreased}}</u> interval between <b>A2</b> (of S2) and the <b>opening snap</b> sounds of a <b>mitral stenosis murmur</b> correlates with {{c1::<u>increased</u>}} <b>disease severity</b></div>", "time": null}, {"id": 1472058992255, "note": "<div>Chronic <b>mitral stenosis</b> may result in <u>left {{c1::atrium}} dilatation</u> due to volume overload</div>", "time": 1660105360732.0}, {"id": 1472058995902, "note": "<div>Increased {{c1::LA}} pressure as a result of <b>mitral stenosis</b> may lead to <u>pulmonary congestion</u> with edema and alveolar hemorrhage</div>", "time": 1660105356155.0}, {"id": 1472058998627, "note": "<div>One possible complication of <b>mitral stenosis</b> is pulmonary {{c1::hypertension}} and eventual {{c2::right}}-sided heart failure</div>", "time": 1660105354596.0}, {"id": 1472059003077, "note": "<div>One possible complication of <b>mitral stenosis</b> is {{c1::atrial fibrillation}} with associated risk for <b>mural thrombi </b></div>", "time": 1660105354594.0}, {"id": 1472068006982, "note": "<b>{{c1::Endocarditis}}</b> is inflammation of <b>endocardium</b> that <u>lines the surface of cardiac valves</u> (usually due to bacterial infection)", "time": null}, {"id": 1472072078325, "note": "<div>What <i>bacteria</i> is the most common cause of <b>subacute endocarditis</b>? </div><div><br></div><div><div>{{c1::Viridans streptococci}}</div></div>", "time": null}, {"id": 1472072081949, "note": "<div><div>What <i>type</i> of <u>heart valve</u> does <span style=\"font-weight: bold\">viridans streptococci</span> infect? </div><div><i><br></i></div><div>{{c1::Previously damaged valves::normal vs damaged}}</div></div>", "time": null}, {"id": 1472072085534, "note": "<div><div><span style=\"font-weight: bold\">viridans streptococci</span> cause <b>{{c1::subacute}} endocarditis</b>, which is characterized by {{c2::<u>small</u>::size}} vegetations that do not destroy the valve</div></div>", "time": null}, {"id": 1472072090577, "note": "<div><div>When the surface of the <b>endocardium</b> is <u>damaged</u>, <b>thrombotic vegetations</b> of {{c1::platelets}} and {{c1::fibrin}} may develop </div></div>", "time": null}, {"id": 1472072097648, "note": "<div><div><b>Subacute endocarditis</b> is often a sequela of {{c1::dental}} procedures </div></div>", "time": null}, {"id": 1472072104808, "note": "<div><div>Prophylactic {{c1::antibiotics}} <u>decrease</u> risk of subacute endocarditis</div></div>", "time": null}, {"id": 1472072107763, "note": "<div>What <i>bacteria</i> is the most common cause of <b>endocarditis</b> in <b>IV drug users</b>?</div><div><br></div><div><i>{{c1::Staphylococcus aureus}}</i></div>", "time": null}, {"id": 1472072110576, "note": "<div>Which heart valve is most frequently involved in <b>bacterial endocarditis</b>?</div><div><br /></div><div>{{c1::Mitral valve}}</div>", "time": null}, {"id": 1472072115600, "note": "<div><div>Which heart valve is most frequently involved in <b>bacterial endocarditis</b> in <b>IV drug users</b>?</div><div><br /></div><div>{{c1::Tricuspid valve}}</div></div>", "time": null}, {"id": 1472072126853, "note": "<div>What <i>type</i> of <u>heart valve</u> does <i style=\"font-weight: bold; \">Staphylococcus aureus</i> infect?</div><div><br></div><div>{{c1::Normal heart valves (undamaged)::damaged vs normal}}</div>", "time": null}, {"id": 1472072130618, "note": "<div><i style=\"font-weight: bold; \">Staphylococcus aureus</i> causes <b>{{c1::acute}} endocarditis</b>, which is characterized by {{c2::<u>large</u>::size}} vegetations that destroy the valve&nbsp;</div>", "time": null}, {"id": 1472072137356, "note": "<div><i><b>{{c2::Staphylococcus epidermidis}}</b></i> infection is associated with&nbsp;<b>endocarditis</b> in patients with <b>{{c1::prosthetic}} valves</b></div>", "time": null}, {"id": 1472072140715, "note": "<div><div>{{c2::<b><i>Streptococcus bovis</i></b> (<i>gallolyticus</i>)}}<i> </i>infection is associated with <b>endocarditis</b> in patients with underlying {{c1::<b>colorectal carcinoma</b>}}</div></div>", "time": null}, {"id": 1472072149708, "note": "<div><b>Endocarditis</b> due to <i>S. aureus</i> is characterized by {{c1::high}} <b>virulence</b> and {{c1::rapid}} <b>onset</b></div>", "time": null}, {"id": 1472072154881, "note": "<div><b>Endocarditis</b> due to <i>viridans streptococci</i> is characterized by {{c1::low}} <b>virulence</b> and {{c1::gradual}} <b>onset</b></div>", "time": null}, {"id": 1472072157675, "note": "<div><div>The <b>HACEK organisms </b>(<i>Haemophilus, Aggregatibacter, Cardiobacterium, Eikenella, </i><i>Kingella</i>) are associated with <b>endocarditis</b> with {{c1::negative}} blood cultures</div></div>", "time": null}, {"id": 1472072164834, "note": "<div>What is the <u>most common symptom</u> of <b>bacterial endocarditis</b>? </div><div><br /></div><div>{{c1::Fever}}</div>", "time": null}, {"id": 1472072173442, "note": "<div>One symptom associated with <b>bacterial endocarditis</b> is <b>{{c1::Roth spots}}</b>, which are round, white spots on the <u>retina</u> surrounded by hemorrhage</div>", "time": null}, {"id": 1472072182113, "note": "<div>One symptom associated with <b>bacterial endocarditis</b> is <b>{{c1::Osler nodes}}</b>, which are <b><i>tender</i></b>, raised lesions on the <b>finger or toe pads</b> </div>", "time": null}, {"id": 1472072190993, "note": "<div>One symptom associated with <b>bacterial endocarditis</b> is <b>{{c1::murmur}}</b>, which occurs as blood flows over vegetations on the heart valve</div>", "time": null}, {"id": 1472072198097, "note": "<div>One symptom associated with <b>bacterial endocarditis</b> is <b>{{c1::Janeway lesions}}</b>, which are small, <b><i>nontender</i></b>, erythematous lesions on the <b>palm or sole</b></div>", "time": null}, {"id": 1472072206743, "note": "<div>One symptom associated with <b>bacterial endocarditis</b> is <b>{{c1::anemia of chronic disease}}</b>, which occurs as a result of <u>increased</u> release of <b>hepcidin</b> </div>", "time": null}, {"id": 1472072219254, "note": "<div>One symptom associated with <b>bacterial endocarditis</b> is <b>{{c1::splinter hemorrhages}}</b> in the nail bed</div>", "time": null}, {"id": 1472072229216, "note": "<div>One symptom associated with <b>bacterial endocarditis</b> is <u>septic arterial</u> or <u>pulmonary</u> {{c1::emboli}}</div>", "time": 1660105354581.0}, {"id": 1472072237422, "note": "<div><b>Bacterial endocarditis</b> requires <i>multiple</i> {{c1::blood}} cultures for diagnosis</div>", "time": null}, {"id": 1472072242222, "note": "<div><b>{{c1::Transesophageal}} echocardiogram</b> may be used to detect <u>lesions on heart valves</u>, which aids in the diagnosis of <b>bacterial endocarditis</b></div>", "time": null}, {"id": 1472072245370, "note": "<div>{{c3::<b>Non-bacterial thrombotic</b>}}<b> endocarditis</b> is due to <u>sterile vegetations</u> that arise in association with a(n)&nbsp;<b>{{c2::hypercoagulable}} state</b> or <b>underlying {{c1::adenocarcinoma}}</b></div>", "time": 1660105337057.0}, {"id": 1472072263603, "note": "<div><div><b>Non-bacterial thrombotic endocarditis</b> often results in sterile vegetations on the <b>{{c1::mitral}} valve </b><u>along lines of closure</u>, which results in regurgitation</div></div>", "time": null}, {"id": 1472072268519, "note": "<div>{{c1::<b>Libman-Sacks</b> (<b>verrucous</b>)}}<b> endocarditis</b> is due to <i>sterile</i> vegetations that arise in association with {{c2::<b>SLE</b>}}</div>", "time": null}, {"id": 1472072271446, "note": "{{c1::<b>Libman-Sacks</b> (<b>verrucous</b>)<b> endocarditis</b>}} is <i>unique</i> in that vegetations typically present on <b>{{c1::both}} side(s)</b> of the {{c2::<u>mitral</u>}} valve, resulting in regurgitation ", "time": null}, {"id": 1472077123190, "note": "<b>{{c1::Dilated}} cardiomyopathy</b> is the dilation of <u>all four chambers</u> of the heart", "time": null}, {"id": 1472078675445, "note": "<div>What is the <u>most common</u> form of <b>cardiomyopathy</b> (90%)? </div><div><br></div><div>{{c1::Dilated cardiomyopathy}}<br></div>", "time": null}, {"id": 1472078681367, "note": "<div><b>Dilated cardiomyopathy</b> results in {{c1::systolic::systolic or diastolic}} dysfunction</div>", "time": null}, {"id": 1472078716563, "note": "<div><b>Systolic dysfunction</b> as a result of <u>dilated cardiomyopathy</u> may lead to <i>biventricular</i> {{c1::congestive heart failure}}</div>", "time": null}, {"id": 1472078731516, "note": "<div>What <i>type</i> of <b>hypertrophy</b> is seen in <b>dilated cardiomyopathy</b>? </div><div><br /></div><div>{{c1::Eccentric hypertrophy (sarcomeres added in series)}}</div>", "time": null}, {"id": 1472078743516, "note": "<div>The cause of <b>dilated cardiomyopathy</b> is most commonly {{c1::idiopathic}}</div>", "time": 1660105350365.0}, {"id": 1472078813364, "note": "<div>Chronic <b>alcohol abuse</b> increases risk for <b>{{c1::dilated}} cardiomyopathy</b></div>", "time": null}, {"id": 1472078821022, "note": "<div><b>Dilated cardiomyopathy</b> may be caused by <b>{{c1::Chagas}} disease</b>, which is the result of a <u>parasitic</u> infection</div>", "time": null}, {"id": 1472078824458, "note": "<div>What <b>anti-neoplastic agent</b> is associated with <b>dilated cardiomyopathy</b>? </div><div><br></div><div>{{c1::Doxorubicin}}</div>", "time": null}, {"id": 1472078827800, "note": "<b>{{c1::Dilated}} cardiomyopathy</b>&nbsp;may be seen during the last&nbsp;<b>month</b>&nbsp;of pregnancy or within&nbsp;<b>five</b>&nbsp;months of childbirth (\"<b>peripartum</b>&nbsp;<b>cardiomyopathy</b>\")", "time": null}, {"id": 1472078831731, "note": "<div><b>Dilated cardiomyopathy</b> may be caused by <b>{{c1::wet beriberi}}</b>, which is the result of a <u>vitamin B1</u> deficiency</div>", "time": null}, {"id": 1472078835137, "note": "<div>What <u>pathologic</u> heart sound may be heard with <b>dilated cardiomyopathy</b>? </div><div><br></div><div>{{c1::S3}}</div>", "time": null}, {"id": 1472078876824, "note": "<div><b>{{c1::Hypertrophic}} cardiomyopathy</b> is characterized by <b>massive ventricular hypertrophy</b>, often with septal predominance</div>", "time": 1660105340025.0}, {"id": 1472078884074, "note": "<div><b>{{c2::Hypertrophic}} cardiomyopathy</b> usually arises due to <u>genetic mutations</u> (60-70%), especially in {{c1::<b>sarcomere</b>}} <b>proteins</b></div>", "time": 1660105337855.0}, {"id": 1472078891926, "note": "<div>Mutations that cause <b>hypertrophic cardiomyopathy</b> most commonly have a(n) {{c1::autosomal dominant}} inheritance pattern</div>", "time": null}, {"id": 1472078900076, "note": "<div><b>{{c2::Hypertrophic}} cardiomyopathy</b> is associated with the <u>trinucleotide repeat expansion disease</u> {{c1::<b>Friedreich ataxia</b>}}</div>", "time": null}, {"id": 1472078903517, "note": "<div><b>Hypertrophic cardiomyopathy</b> causes {{c1::diastolic::systolic or diastolic}} dysfunction&nbsp;</div>", "time": null}, {"id": 1472078910305, "note": "<div><b>Hypertrophic cardiomyopathy</b> leads to {{c1::decreased}} cardiac output due to <u>decreased</u> compliance of the left ventricle</div>", "time": 1660105357868.0}, {"id": 1472078917744, "note": "<div><b>{{c1::Hypertrophic}} cardiomyopathy</b> is associated with <u>sudden death</u> in young athletes due to {{c2::ventricular arrhythmia}}</div>", "time": null}, {"id": 1472078921019, "note": "<div><b>Hypertrophic cardiomyopathy</b> causes {{c1::<b>syncope</b>}} with <u>exercise</u> due to subaortic hypertrophy of the ventricular septum, resulting in functional <b>aortic {{c2::stenosis}}</b></div>", "time": 1660105357870.0}, {"id": 1472078933976, "note": "<div><b>{{c2::Hypertrophic}} cardiomyopathy</b> is characterized by <u>myofibrillar</u> hypertrophy with {{c1::<b>disarray</b>}} and fibrosis on biopsy</div><div><br /></div><div><img src=\"paste-260004435198430.jpg\" /></div>", "time": 1660105337857.0}, {"id": 1472078947637, "note": "<div><div>What <u>pathologic</u> heart sound may be heard with <b>hypertrophic cardiomyopathy</b>? </div><div><br></div><div>{{c1::S4}}</div></div>", "time": 1660105345080.0}, {"id": 1472078951203, "note": "<div><b>Hypertrophic cardiomyopathy</b> may impair {{c1::mitral}} valve closure, thus causing regurgitation</div>", "time": 1660105357867.0}, {"id": 1472078955281, "note": "<div><b>{{c1::Restrictive}} cardiomyopathy </b>is primarily characterized by <u><b>decreased</b></u> <b>compliance</b> of the ventricular endomyocardium</div>", "time": null}, {"id": 1472078958506, "note": "<div>Causes of <b>{{c1::restrictive}} cardiomyopathy</b> include amyloidosis, sarcoidosis, post-radiation fibrosis, and eosinophilic syndromes of the heart (loeffler endocarditis, endomyocardial fibrosis)</div>", "time": null}, {"id": 1472078965806, "note": "<div><b>Restrictive cardiomyopathy</b> causes {{c1::diastolic::systolic or diastolic}} dysfunction</div>", "time": null}, {"id": 1472078969410, "note": "<div><b>{{c3::Restrictive}} cardiomyopathy</b> may be caused by {{c1::<b>endocardial</b> <b>fibroelastosis</b>}}, which is a <u>thick fibroelastic tissue</u> in the endocardium; most commonly affects {{c2::young <b>children</b>}}</div>", "time": null}, {"id": 1472078973457, "note": "<div><b>{{c3::Restrictive}} cardiomyopathy</b> may be caused by <b>{{c1::Loeffler}}</b> <b>syndrome</b>, which is an endomyocardial fibrosis with a prominent {{c2::<u>eosinophilic</u>}} infiltrate</div>", "time": null}, {"id": 1472078981815, "note": "<div><b>{{c3::Restrictive}} cardiomyopathy</b> presents with a(n)&nbsp;<b>{{c1::low-voltage}} ECG</b> with a <u>diminished</u> {{c2::QRS}} amplitude</div>", "time": null}, {"id": 1472079020079, "note": "<div>What is the <u>most common</u> <b>primary</b> <b>cardiac tumor</b> in <i style=\"font-weight: bold; \">adults</i>? </div><div><br /></div><div>{{c1::Myxoma}}</div>", "time": null}, {"id": 1472079023283, "note": "<div><b>Cardiac {{c2::myxomas}}</b> usually form a <u>pedunculated mass</u> in the {{c1::<b>left atrium (80%)</b>}}, which may cause <b>{{c3::syncope}}</b> due to <i>obstruction</i> of the mitral valve </div>", "time": null}, {"id": 1472079064044, "note": "<div><b>{{c1::Rhabdomyomas}}</b> are <u>benign</u> <b>hamartomas</b> of cardiac muscle</div>", "time": null}, {"id": 1472079071768, "note": "<div><div>What is the <u>most common</u> <b>primary</b> <b>cardiac tumor</b> in <i style=\"font-weight: bold; \">children</i>? </div><div><br></div><div>{{c1::Rhabdomyoma}}</div></div>", "time": null}, {"id": 1472079075375, "note": "<div><b>{{c2::Rhabdomyoma}}</b> is a <u>cardiac tumor</u> associated with {{c1::<b>tuberous sclerosis</b>}} </div>", "time": null}, {"id": 1472079078709, "note": "<div>The <u>most common</u> <b>heart</b> <b>tumor</b> is a(n) {{c1::metastasis}} </div>", "time": 1660105349804.0}, {"id": 1472085339918, "note": "<div>What <u>type</u> of drug are <b>class II antiarrhythmics</b>? </div><div><br></div><div>{{c1::\u03b2-blockers}}</div>", "time": 1660105352285.0}, {"id": 1472087000322, "note": "<div><b>Metoprolol</b>, <b>propranolol</b>, and <b>esmolol</b> are all examples of <b>class {{c1::II}} antiarrhythmics</b></div>", "time": 1660105359222.0}, {"id": 1472087004432, "note": "<div><b>Atenolol</b>, <b>timolol</b>, and <b>carvedilol</b> are all examples of <b>class {{c1::II}} antiarrhythmics</b></div>", "time": 1660105359225.0}, {"id": 1472087007504, "note": "<div><b>Class {{c3::II}} antiarrhythmics</b> treat arrhythmias by blocking <u>{{c1::sympathetic}} input</u> to the <b>{{c2::SA}}</b> and <b>{{c2::AV nodes}}</b><br></div>", "time": 1660105352327.0}, {"id": 1472087015704, "note": "<div>What effect do <b>Class II antiarrhythmics </b>(\u03b2-blockers) have on <b>cAMP levels</b>?<br></div><div><br></div><div>{{c1::Decreased cAMP}} </div>", "time": 1660105352288.0}, {"id": 1472087022065, "note": "<div><b>Decreased cAMP</b> as a result of <u>class II antiarrhythmics</u><b> </b>(\u03b2-blockers) leads to the <b>closure</b> of membrane {{c1::Ca<sup>2+</sup>}} channels<br></div>", "time": 1660105352321.0}, {"id": 1472087031632, "note": "<div><b>Class II antiarrhythmics </b>(\u03b2-blockers) suppress abnormal pacemakers by <u>decreasing</u> the {{c1::slope}} of <b>phase {{c2::4}}</b> of the <i>nodal</i> action potential<br></div>", "time": 1660105352355.0}, {"id": 1472087041816, "note": "<div>The <b>{{c1::AV}}</b> <b>node</b> is particularly sensitive to <b>class II antiarrhythmics </b>(\u03b2-blockers)<br></div>", "time": 1660105352310.0}, {"id": 1472087051517, "note": "<div>Are <b>class II antiarrhythmics </b>(\u03b2-blockers) used to treat <u>supraventricular</u> or <u>ventricular</u> arrhythmias?<br></div><div><div><br></div><div>{{c1::Supraventricular}}</div></div>", "time": 1660105352372.0}, {"id": 1472087069469, "note": "<div>{{c1::<b>Intravenous</b>::mode of delivery}} <b>class II antiarrhythmics</b>, such as&nbsp;<b>{{c2::esmolol}}</b>, can be used for intra-operative or other&nbsp;<i>acute&nbsp;</i>supraventricular arrhythmias (<u>very short acting</u>)<br></div>", "time": 1660105352276.0}, {"id": 1472087079663, "note": "<div>One possible adverse effect of <b>class II antiarrhythmics </b>(\u03b2-blockers) is <u>{{c1::heart block}}</u> due to decreased conduction through the AV node<br></div>", "time": 1660105352312.0}, {"id": 1472087092128, "note": "<div><b>Class II antiarrhythmics </b>(\u03b2-blockers) may induce <b>heart (AV) block</b>, which manifests as a <u>prolonged</u> {{c1::PR interval}} on ECG<br></div>", "time": 1660105352356.0}, {"id": 1472087101965, "note": "<div><b>Class II antiarrhythmics </b>(\u03b2-blockers) are useful in the treatment of {{c1::atrial}} fibrillation (and flutter)<br></div>", "time": 1660105352357.0}, {"id": 1472087110025, "note": "<div><b>Class II antiarrhythmics </b>(\u03b2-blockers) are useful in preventing {{c1::rapid ventricular response (RVR)}} in atrial fibrillation and flutter (\"<b>rate control</b>\")<br></div>", "time": 1660105352358.0}, {"id": 1472087115813, "note": "<div>What <u>classes</u> of <b>antiarrhythmics</b> are used for <b>ventricular</b> <b><u>rate</u> control</b> in atrial fibrillation and flutter?<br></div><div><br></div><div>{{c1::Class II and IV::2}}</div>", "time": 1660105352282.0}, {"id": 1472090596497, "note": "<div>What <u>classes</u> of <b>antiarrhythmics</b> are used for <b><u>rhythm</u> control</b> in atrial fibrillation and flutter?<br></div><div><div><br></div><div>{{c1::Class IC and III::2}}</div></div>", "time": 1660105359212.0}, {"id": 1472091023576, "note": "<div>What <u>type</u> of drug are <b>class III antiarrhythmics</b>?<br></div><div><div><br></div><div>{{c1::K<sup>+</sup> channel blockers}}</div></div>", "time": 1660105352284.0}, {"id": 1472091031357, "note": "<div>What effect do <b>class III antiarrhythmics</b> have on <b>action potential duration</b>?<br></div><div><br></div><div>{{c1::Increased AP duration}}</div>", "time": 1660105359217.0}, {"id": 1472091039542, "note": "<div>What effect do <b>class III antiarrhythmics</b> have on <b>effective refractory period</b>?<br></div><div><div><br></div><div>{{c1::Increased ERP}}</div></div>", "time": 1660105359216.0}, {"id": 1472091045601, "note": "<div><b>Class III antiarrhythmics</b> (K<sup>+</sup> channel blockers) exert their effects by <u>prolonging</u> phase {{c1::2}} and {{c1::3}} of the <i>myocardial</i> action potential<br></div>", "time": 1660105352353.0}, {"id": 1472091073131, "note": "<div><b>{{c1::Amiodarone}}</b> is a <i>lipophilic</i> <b>class {{c2::III}} antiarrhythmic</b> that also shares properties with class I, II, and IV antiarrhythmics<br></div>", "time": 1660105352280.0}, {"id": 1472091088106, "note": "<div>What <i>drug class</i> do <b>dofetilide</b> and <b>ibutilide</b> belong to?<br></div><div><br></div><div>{{c1::Class III antiarrhythmics (K<sup>+</sup> channel blockers)}}</div>", "time": 1660105352301.0}, {"id": 1472091094963, "note": "<div><b>{{c3::Sotalol}}</b> is a <b>class {{c1::III}} antiarrhythmic</b> that also has class {{c2::II (\u03b2-blocker)}} activity<br></div>", "time": 1660105352254.0}, {"id": 1472091101662, "note": "<div>Are <b>class III antiarrhythmics</b> used to treat <u>supraventricular</u> or <u>ventricular</u> arrhythmias?<br></div><div><div><br></div><div>{{c1::Both :)}}</div></div>", "time": 1660105352371.0}, {"id": 1472091107732, "note": "<div><b>Class III antiarrhythmics</b> may be used to treat {{c1::atrial}} fibrillation (and flutter)<br></div>", "time": 1660105352351.0}, {"id": 1472091129744, "note": "<div><b>Class III antiarrhythmics</b> can <i>restore</i> and <i>maintain&nbsp;</i><u>normal sinus <b>rhythm</b></u> in {{c1::atrial}} fibrillation and flutter<br></div>", "time": 1660105352352.0}, {"id": 1472091136098, "note": "<div><b>{{c1::Amiodarone}}</b>, a class III antiarrhythmic, has many <b>neurologic</b> <b>side effects</b> (e.g. tremor, ataxia, peripheral neuropathy, sleep disturbances)<br></div>", "time": 1660105352278.0}, {"id": 1472091142763, "note": "<div><b>Amiodarone</b>, a class III antiarrhythmic, can act as a(n)&nbsp;<b>{{c1::hapten}}</b>, resulting in <b>gray {{c2::corneal}} </b>microdeposits</div>", "time": 1660105352378.0}, {"id": 1472091153400, "note": "<div><b>{{c2::Amiodarone}}</b>, a class III antiarrhythmic, can cause <i>both</i> <b>hyper-</b> or <b>hypo-{{c1::thyroidism}}</b><br></div>", "time": 1660105352272.0}, {"id": 1472091162700, "note": "<div><b>Amiodarone</b> can cause <u>pulmonary {{c1::fibrosis}}</u> with progression to <b>{{c2::restrictive lung}} disease</b><br></div>", "time": 1660105352383.0}, {"id": 1472091171892, "note": "<div><b>Amiodarone</b> can cause {{c1::heart block}} as a result of its <u>class II antiarrhythmic</u> activity<br></div>", "time": 1660105352381.0}, {"id": 1472091178381, "note": "<div><b>Amiodarone</b>, a class III antiarrhythmic, can induce heart {{c1::failure}}, especially with rapid IV administration<br></div>", "time": 1660105352375.0}, {"id": 1472091184661, "note": "<div><b>Amiodarone</b>, a class III antiarrhythmic, can cause hypersensitivity {{c1::hepatitis}}<br></div>", "time": 1660105352376.0}, {"id": 1472091193755, "note": "<div><b>Amiodarone</b> may act as a <b>hapten</b> resulting in <b>{{c1::gray-blue}} skin discoloration</b> with <b>{{c2::photodermatitis}}</b><br></div>", "time": 1660105352380.0}, {"id": 1472091209218, "note": "<div><b>{{c2::Amiodarone}}</b>, a class III antiarrhythmic, is a(n) {{c3::<u>inhibitor</u>}} of {{c1::<b>cytochrome P450</b>}} and thus may have many drug interactions<br></div>", "time": 1660105352270.0}, {"id": 1472091220986, "note": "<div>What <u>adverse effect</u> is common to <b>sotalol</b>, <b>dofetilide</b>, and <b>ibutilide</b> (class III antiarrhythmics)?<br></div><div><br></div><div>{{c1::Torsades de pointes}}</div>", "time": 1660105352305.0}, {"id": 1472091227884, "note": "<div><i>All</i> <b>type III antiarrhythmics</b> (K<sup>+</sup> channel blockers) can {{c2::<u>widen</u>}} the {{c1::<b>QT interval</b>}} on ECG<br></div>", "time": 1660105352385.0}, {"id": 1472091234421, "note": "<div><b>{{c2::Amiodarone}}</b> and <b>{{c3::sotalol}}</b> (class III antiarrhythmics) may be used to treat {{c1::<b>ventricular</b>}} <b>tachycardia</b></div>", "time": 1660105359211.0}, {"id": 1472091238059, "note": "<div>What <u>laboratory function tests</u>&nbsp;should be checked when using <b>amiodarone</b>?<br></div><div><br></div><div>{{c1::Pulmonary (PFTs), Liver (LFTs), and Thyroid (TFTs)::3}}</div>", "time": 1660105359214.0}, {"id": 1472091242088, "note": "<div>What <u>adverse effect</u> may <b>amiodarone</b> have on <b>bowel movement</b>?<br></div><div><br></div><div>{{c1::Constipation}}</div>", "time": 1660105359221.0}, {"id": 1472139199092, "note": "During the <u>early</u> stages of exercise, <b>cardiac output</b> is maintained by <u>increased</u> {{c1::heart rate}} and {{c1::stroke volume}}", "time": 1660105359708.0}, {"id": 1472146993792, "note": "<div>During the <u>late</u> stages of exercise, <b>cardiac output</b> is maintained by <u>increased</u> {{c1::heart rate}} <i>only</i> as {{c1::stroke volume}} <u>plateaus</u> </div>", "time": 1660105359705.0}, {"id": 1472146997848, "note": "<div>Which phase of the cardiac cycle (systole or diastole) is <b>preferentially shortened</b> with <u>increased heart rate</u>? </div><div><br /></div><div>{{c1::Diastole}}</div>", "time": null}, {"id": 1472147014014, "note": "<div><div>What is the effect of <b><i>obstructive</i> sleep apnea</b> on <b>pulse pressure</b>?</div><div><br></div><div>{{c1::Increased pulse pressure}}</div></div>", "time": 1660105346519.0}, {"id": 1472147021015, "note": "<div>What is the effect of <b>exercise</b> on <b>pulse pressure</b>? </div><div><br /></div><div>{{c1::Increased pulse pressure, <i>transiently</i>}} </div>", "time": null}, {"id": 1472147029631, "note": "<div><div>{{c1::<u>Decreased</u>}} <b>pulse pressures</b> are seen in conditions that <u>decrease</u> left ventricular stroke volume</div></div>", "time": null}, {"id": 1472147055139, "note": "<div><div>What is the effect of <b>cardiogenic shock</b> on <b>pulse pressure</b>?</div><div><br /></div><div>{{c1::Decreased pulse pressure}}</div></div>", "time": null}, {"id": 1472147062479, "note": "<div><div>What is the effect of <b>advanced heart failure</b> on <b>pulse pressure</b>?</div><div><br></div><div>{{c1::Decreased pulse pressure}}</div></div>", "time": null}, {"id": 1472147065831, "note": "<div>What is the effect of <b>\u03b2<sub>1</sub>-blockade</b> on <b>contractility</b> (and SV)? </div><div><br></div><div>{{c1::Decreased contractility}}</div>", "time": null}, {"id": 1472147111730, "note": "<div><b>{{c1::Vaso}}-dilators</b> (e.g. hydralazine) cause <u>decreased</u> <b>{{c2::after}}-load</b></div>", "time": null}, {"id": 1472147158498, "note": "<div>What is the effect of <b>dilated cardiomyopathy</b> on <b>contractility</b>?</div><div><br /></div><div>{{c1::Decreased (systolic dysfunction)}}</div>", "time": null}, {"id": 1472147168894, "note": "<div><b>Hypertrophic cardiomyopathy</b> may present with a(n) {{c1::systolic::systolic/diastolic}} murmur&nbsp;</div>", "time": null}, {"id": 1472147174414, "note": "<div>Where is a&nbsp;<u>murmur</u> due to <b>hypertrophic cardiomyopathy</b> best heard?</div><div><br></div><div>{{c1::Left sternal border}}</div>", "time": null}, {"id": 1472147180171, "note": "<div>What effect does <b>inspiration</b> have on <b>venous return</b> to the right atrium?</div><div><br></div><div>{{c1::Increased venous return}}</div>", "time": null}, {"id": 1472147244957, "note": "<div><b>Inspiration</b> as a <u>bedside maneuver</u> may be used to <u>increase</u> the<b> intensity</b> of {{c1::right}} heart sounds</div>", "time": null}, {"id": 1472147255373, "note": "<div>The <b>hand grip</b> maneuver is used to {{c1::<u>increase</u>}} <b>{{c2::after}}-load</b></div>", "time": null}, {"id": 1472147261637, "note": "<div>What effect does the <b>hand grip</b> maneuver have on the <u>intensity</u> of <b>MR</b>, <b>AR</b>, and <b>VSD murmurs</b>?</div><div><br /></div><div>{{c1::Increased intensity}}</div>", "time": 1660105347167.0}, {"id": 1472147273188, "note": "<div>What effect does the <b>hand grip</b> maneuver have on the <u>intensity</u> of <b>hypertrophic cardiomyopathy murmurs</b>?</div><div><br /></div><div>{{c1::Decreased intensity}}</div>", "time": 1660105347168.0}, {"id": 1472147290407, "note": "<div><div>What effect does the <b>hand grip</b> maneuver have on the <u>\"click\" onset time</u> of <b>MVP murmurs</b>?</div><div><br /></div><div>{{c1::Later onset of click/murmur}}</div></div>", "time": 1660105347169.0}, {"id": 1472147314850, "note": "<div><div><b>Standing up</b> and the <b>valsalva</b> <b>maneuver</b> are both used to {{c1::<u>decrease</u>}} <b>{{c2::pre}}-load</b></div></div>", "time": null}, {"id": 1472147334578, "note": "<div><div>What effect does <b>standing up</b> or the <b>valsalva</b> <b>maneuver</b> have on the <u>intensity</u> of <b>MR</b>, <b>AR</b>, <b>MS</b>, and <b>AS murmurs</b>?</div><div><br /></div><div>{{c1::Decreased intensity}}</div></div>", "time": 1660105347170.0}, {"id": 1472147355240, "note": "<div><div>What effect does <b>standing up</b> or the <b>valsalva</b> <b>maneuver</b> have on the <u>intensity</u> of <b>hypertrophic cardiomyopathy murmurs</b>?</div><div><br /></div><div>{{c1::Increased intensity}}</div></div>", "time": 1660105347171.0}, {"id": 1472147363872, "note": "<div><div><div>What effect does <b>standing up</b> or the <b>valsalva</b> <b>maneuver</b> have on the <u>\"click\" onset time</u> of <b>MVP murmurs</b>?</div><div><br></div><div>{{c1::Earlier onset of click/murmur}}</div></div></div>", "time": 1660105347172.0}, {"id": 1472147368524, "note": "<div><div><b>{{c1::Rapid squatting}}</b> is a maneuver that is used to {{c2::<u>increase</u>}} <b>preload</b>, <b>afterload</b>, and <b>venous return</b></div></div>", "time": null}, {"id": 1472147376594, "note": "<div><div>What effect does the <b>rapid squatting</b> maneuver have on the <u>intensity</u> of <b>aortic stenosis murmurs</b>?</div><div><br /></div><div>{{c1::Increased intensity}}</div></div>", "time": 1660105347165.0}, {"id": 1472147380828, "note": "<div><div>What effect does the <b>rapid squatting</b> maneuver have on the <u>intensity</u> of <b>hypertrophic cardiomyopathy murmurs</b>?</div><div><br /></div><div>{{c1::Decreased intensity}}</div></div>", "time": 1660105347164.0}, {"id": 1472147388954, "note": "<div><div><div>What effect does the <b>rapid squatting</b> maneuver have on the <u>\"click\" onset time</u> of <b>MVP murmurs</b>?</div><div><br></div><div>{{c1::Later onset of click/murmur}}</div></div></div>", "time": 1660105347166.0}, {"id": 1472147393835, "note": "<div>Where is a <u>murmur</u> due to <b>patent ductus arteriosus</b> best heard?</div><div><br></div><div>{{c1::Left infraclavicular area}}</div>", "time": null}, {"id": 1472147398832, "note": "<div>The <b>Cushing reaction</b> is a <u>triad</u> of {{c1::hypertension}}, {{c2::bradycardia}}, and {{c3::respiratory}} depression<i> </i>due to <u>increased</u> <b>{{c4::intracranial}} pressure</b> </div>", "time": null}, {"id": 1472147442231, "note": "<div>What effect does <b>carotid massage</b> have on <u>conduction</u><b> </b>through the <b>AV node</b>? </div><div><br /></div><div>{{c1::Slowed conduction}}</div>", "time": null}, {"id": 1472147549163, "note": "<div><b>{{c1::Atrial fibrillation}}</b> is characterized by a <u>chaotic</u> and <u>erratic baseline</u> with <b>no discrete {{c2::P}} waves</b> in between <u>irregularly</u> spaced QRS complexes on ECG</div>", "time": 1660105341089.0}, {"id": 1472147564017, "note": "<div><b>Atrial fibrillation</b> is characterized by a(n) {{c1::irregularly}}, {{c1::irregular}} patterned rhythm  </div>", "time": 1660105361447.0}, {"id": 1472147572504, "note": "<div><b>Atrial fibrillation</b> can lead to <u>thromboembolic events</u>, particularly {{c1::stroke}} (brain complication)</div>", "time": 1660105361448.0}, {"id": 1472147594834, "note": "<div>The most common risk factors for <b>atrial fibrillation</b> include {{c1::hypertension}} and {{c2::coronary artery disease (CAD)}}</div>", "time": null}, {"id": 1472147631824, "note": "<div><b>Atrial {{c1::flutter}}</b> is characterized by a rapid succession of <u>identical</u>, back-to-back atrial depolarization waves</div>", "time": 1660105361440.0}, {"id": 1472147658939, "note": "<div><b>Atrial {{c2::flutter}}</b> typically has a <b>4:1 \"{{c1::sawtooth}}\" pattern</b> appearance on ECG</div>", "time": 1660105361439.0}, {"id": 1472147672143, "note": "<div>What is the <u>definitive</u> treatment for <b>atrial flutter</b>?</div><div><br /></div><div>{{c1::Catheter ablation}}</div>", "time": null}, {"id": 1472147679613, "note": "<div><b>{{c1::Ventricular fibrillation}}</b> is characterized by a <b>completely erratic rhythm</b> with <u>no identifiable waves</u> on ECG</div>", "time": 1660105338497.0}, {"id": 1472147692713, "note": "<div><b>{{c1::1st}} degree AV block</b> is characterized by a <b>PR interval</b> <b>&gt; {{c2::200}} msec</b> on ECG</div>", "time": 1660105341374.0}, {"id": 1472147713025, "note": "<div><b>{{c1::2nd degree Mobitz type I (Wenckebach)::(aka)}} AV block</b> is characterized by <u>progressive lengthening</u> of the <b>{{c2::PR}} interval</b> until a beat is \"dropped\"</div>", "time": null}, {"id": 1472147724188, "note": "<div><b>2nd degree Mobitz type I AV block</b> is characterized by a(n) {{c1::regularly}}, {{c1::irregular}} patterned rhythm on ECG</div>", "time": null}, {"id": 1472147731220, "note": "<div><b>{{c1::2nd degree Mobitz type II}} AV block</b> is characterized by <b>dropped beats</b> that are <u>not</u> preceded by a change in length of the PR interval on ECG</div>", "time": null}, {"id": 1472147778461, "note": "<div><b>2nd degree Mobitz type II AV block</b> may progress to {{c1::3rd}}-degree block </div>", "time": null}, {"id": 1472147788517, "note": "<div><b>2nd degree Mobitz type II AV block</b> is often treated with a(n) {{c1::pacemaker}}</div>", "time": null}, {"id": 1472147800542, "note": "<div><b>{{c1::3rd}} degree AV block</b> is characterized by <u>independent beating</u> of the <b>atria </b>and <b>ventricles</b> (P waves and QRS complexes are not rhythmically associated) </div>", "time": null}, {"id": 1472147819483, "note": "<div><b>3rd degree AV block</b> is usually treated with a(n) {{c1::pacemaker}}</div>", "time": null}, {"id": 1472147823286, "note": "<div><b>3rd degree AV block</b> can be caused by {{c1::Lyme}} disease</div>", "time": null}, {"id": 1472147826598, "note": "<div>What pathology is indicated on the ECG below? </div><div><br /></div><div>{{c1::Atrial fibrillation}}</div><div><br /></div><div><img src=\"paste-302318452998310.jpg\" /></div><div></div>", "time": 1660105345070.0}, {"id": 1472147840361, "note": "<div><div>What pathology is indicated on the ECG below? </div><div><br /></div><div>{{c1::Atrial flutter}}</div><div><br /></div><div><img src=\"paste-302717884956875.jpg\" /></div></div>", "time": 1660105345069.0}, {"id": 1472147847318, "note": "<div><div>What pathology is indicated on the ECG below? </div><div><br /></div><div>{{c1::Ventricular fibrillation}}</div><div><br /></div><div><img src=\"paste-303001352798364.jpg\" /></div></div>", "time": 1660105345068.0}, {"id": 1472147853249, "note": "<div><div>What pathology is indicated on the ECG below? </div><div><br /></div><div>{{c1::1st degree AV block}}</div><div><br /></div><div><img src=\"paste-303207511228576.jpg\" /></div></div>", "time": 1660105345071.0}, {"id": 1472147859678, "note": "<div><div>What pathology is indicated on the ECG below? </div><div><br /></div><div>{{c1::2nd degree AV block, Mobitz type I (Wenckebach)}}</div></div><div><br /></div><div><img src=\"paste-303559698546837.jpg\" /></div>", "time": null}, {"id": 1472147916281, "note": "<div><div>What pathology is indicated on the ECG below? </div><div><br></div><div>{{c1::2nd degree AV block, Mobitz type II}}</div></div><div><br></div><div><img src=\"paste-303976310374559.jpg\"></div>", "time": null}, {"id": 1472147925256, "note": "<div><div>What pathology is indicated on the ECG below? </div><div><br /></div><div>{{c1::3rd degree AV block}}</div></div><div><br /></div><div><img src=\"paste-304491706450095.jpg\" /></div>", "time": null}, {"id": 1472160921721, "note": "<div><b>{{c1::Atrial}} septal defect</b> leads to an <u>increased</u> O<sub>2</sub> saturation in the <b>{{c2::RA}}</b>, <b>RV</b> and <b>pulmonary artery</b> </div>", "time": 1660105341087.0}, {"id": 1472160925535, "note": "<div>One sign of <b>hyperlipidemia</b> is <b>{{c1::xanthomas}}</b>, which are plaques or nodules composed of {{c3::<u>lipid-laden histiocytes</u>}} in <b>{{c2::skin}}</b> </div>", "time": null}, {"id": 1472160934383, "note": "<div>When a <b>xanthoma</b> affects the eyelids, it is known as <b>{{c1::xanthelasma}}</b> </div>", "time": null}, {"id": 1472160945385, "note": "<div>One sign of <b>hyperlipidemia</b> is <b>{{c1::tendinous xanthomas}}</b>, which are plaques or nodules composed of <u>lipid-laden histiocytes</u> in <b>{{c2::tendon</b> (especially Achilles)<b>}}</b> </div>", "time": null}, {"id": 1472160960255, "note": "<div>One sign of <b>hyperlipidemia</b> is <b>{{c1::corneal arcus}}</b>, which are <u>lipid</u> deposits in the <b>cornea</b> </div>", "time": null}, {"id": 1472160971843, "note": "<div><b>Corneal arcus</b> is common in the {{c1::<u>elderly</u>}} (arcus senilis), but appears <i>earlier</i> in life in patients with {{c2::<b>hypercholesterolemia</b>}} </div>", "time": null}, {"id": 1472160976855, "note": "<div>Diagnosis of a <i>current</i> or <i>previous</i> <b>myocardial infarction</b> may be aided by the presence of <u>pathologic</u> {{c1::Q}} waves on ECG</div>", "time": null}, {"id": 1472160983526, "note": "<div>There is an <i>increased</i> risk for <b>{{c1::posteromedial}} papillary muscle rupture</b> (post-MI) due to its <u>single</u> blood supply from the <b>{{c2::posterior descending}} artery</b> </div>", "time": null}, {"id": 1472160991017, "note": "<div><b>{{c1::Obstructive}} hypertrophic cardiomyopathy</b> is a subset of <u>hypertrophic cardiomyopathy</u> in which <b>asymmetric septal hypertrophy</b> interferes with the outflow of blood from the left ventricle</div>", "time": 1660105339424.0}, {"id": 1472161006747, "note": "<div>{{c1::Shock}} is defined as <b><i>inadequate</i> organ perfusion</b> and <b>delivery of nutrients</b> necessary for normal tissue and cellular function</div>", "time": null}, {"id": 1472161014695, "note": "<div><b>{{c1::Hypovolemic}} shock</b> may be caused by hemorrhage, dehydration, and burns (volume loss) </div>", "time": null}, {"id": 1472161017955, "note": "<div><b>Hypovolemic shock</b> is characterized by skin that is {{c1::cold}} and {{c1::clammy}}</div>", "time": 1660105357844.0}, {"id": 1472161020896, "note": "<div>How do&nbsp;<b>PCWP</b> and <b>preload</b> change during <b>hypovolemic shock</b>?</div><div><br></div><div>{{c1::<u>Severely</u> decreased}}</div>", "time": 1660105358077.0}, {"id": 1472161027631, "note": "<div><div>How does <b>cardiac output</b> change during <b>hypovolemic shock</b>?</div><div><br /></div><div>{{c1::Decreased}}</div></div>", "time": null}, {"id": 1472161030560, "note": "<div><div>How do&nbsp;<b>SVR</b> and <b>afterload</b> change during <b>hypovolemic shock</b>?</div><div><br></div><div>{{c1::Increased}}</div></div>", "time": null}, {"id": 1472161037446, "note": "<div>What is the <b>treatment</b> for <b>hypovolemic shock</b>? </div><div><br /></div><div>{{c1::IV fluids}}</div>", "time": null}, {"id": 1472161040604, "note": "<div><div><b>{{c1::Cardiogenic}} shock</b> may be caused by acute MI, HF, valvular dysfunction, and arrhythmia (pump failure)</div></div>", "time": null}, {"id": 1472161046165, "note": "<div><div><b>{{c1::Obstructive}} shock</b> may be caused by cardiac tamponade and pulmonary embolism</div></div>", "time": null}, {"id": 1472161049375, "note": "<div><div><b>Cardiogenic</b> and <b>obstructive shock</b> are characterized by skin that is {{c1::cold}} and {{c1::clammy}}</div></div>", "time": 1660105360927.0}, {"id": 1472161052097, "note": "<div><div>How do&nbsp;<b>PCWP</b> and <b>preload</b> change during <b></b><b>cardiogenic</b> and <b>obstructive</b> shock?</div><div><br></div><div>{{c1::Increased or decreased}}</div></div>", "time": 1660105358079.0}, {"id": 1472161054773, "note": "<div><div><div>How does <b>cardiac output</b> change during <b></b><b></b><b>cardiogenic</b> and <b>obstructive</b> shock?</div><div><br /></div><div>{{c1::<u>Severely</u> decreased}}</div></div></div>", "time": null}, {"id": 1472161058426, "note": "<div><div><div>How do&nbsp;<b>SVR</b> and <b>afterload</b> change during <b></b><b></b><b>cardiogenic</b> and <b>obstructive</b> shock?</div><div><br></div><div>{{c1::Increased}}</div></div></div>", "time": null}, {"id": 1472161064901, "note": "<div><div>What is the <b style=\"text-decoration: underline; \">main</b><u> treatment</u> for <b></b><b></b><b>cardiogenic</b> shock? </div><div><br /></div><div>{{c1::IV Inotropes}}</div></div>", "time": null}, {"id": 1472161069279, "note": "<div><div>What is the <b>treatment</b> for <b>obstructive</b> shock? </div><div><br /></div><div>{{c1::Relieve obstruction}}</div></div>", "time": null}, {"id": 1472161073961, "note": "<div><div><b>{{c1::Distributive}} shock</b> may be caused by sepsis, anaphylaxis, or CNS injury (excessive vasodilation)</div></div>", "time": null}, {"id": 1472161083979, "note": "<div><div><b>Distributive shock</b> is characterized by skin that is {{c1::warm}} and {{c1::dry}}</div></div>", "time": null}, {"id": 1472161087300, "note": "<div><div>How do&nbsp;<b>PCWP</b> and <b>preload</b> change during <b>distributive shock</b>?</div><div><br></div><div>{{c1::Decreased}}</div></div>", "time": 1660105358078.0}, {"id": 1472161090368, "note": "<div><div><div>How does <b>cardiac output</b> change during <b>distributive shock</b> due to <u>sepsis</u> and <u>anaphylaxis</u>?</div><div><br /></div><div>{{c1::Increased}}</div></div></div>", "time": null}, {"id": 1472161094503, "note": "<div><div><div>How does <b>cardiac output</b> change during <b>distributive shock</b> due to <u>CNS injury</u>?</div><div><br /></div><div>{{c1::Decreased}}</div></div></div>", "time": null}, {"id": 1472161128581, "note": "<div><div><div>How do&nbsp;<b>SVR</b> and <b>afterload</b> change during <b>distributive shock</b>?</div><div><br></div><div>{{c1::<u>Severely</u> decreased}}</div></div></div>", "time": null}, {"id": 1472161140070, "note": "<div><div>What is the <b>treatment</b> for <b>distributive shock</b>? </div><div><br></div><div>{{c1::IV fluids, pressors::2}}</div></div>", "time": null}, {"id": 1472161149689, "note": "<div>What <u>kidney complication</u> may be associated with <b>bacterial endocarditis</b>?</div><div><br></div><div>{{c1::Glomerulonephritis}}</div>", "time": null}, {"id": 1472161153409, "note": "<div><b>{{c1::Kussmaul}} sign</b> is {{c2::<u>increased</u>}} <b>jugular venous</b> <b>pressure</b> on {{c3::<u>inspiration</u>}}</div>", "time": null}, {"id": 1472161162928, "note": "<div>The <b>Kussmaul sign</b> (increased JVP on inspiration) occurs due to <i>failure</i> of <u>negative intrathoracic pressure</u> to be transmitted to the {{c1::heart}} during inspiration</div>", "time": null}, {"id": 1472161172593, "note": "<div>Failure of <u>negative intrathoracic pressure</u> to be transmitted to the <b>heart</b> results in <b>impaired filling</b> of the {{c1::right}} ventricle, with a consequent back-up of blood into the {{c1::vena cava::one step past the atria}} (Kussmaul sign)</div>", "time": null}, {"id": 1472161182633, "note": "<div><b>Kussmaul sign</b> (increased JVP on inspiration) may be seen with <b>constrictive {{c1::pericarditis}}</b> and <b>{{c2::restrictive}} cardiomyopathies</b></div>", "time": 1660105355774.0}, {"id": 1472161190792, "note": "<div><b>Kussmaul sign</b> (increased JVP on inspiration) may be seen with {{c1::right::left or right}}<b>&nbsp;atrial or ventricular tumors</b> </div>", "time": null}, {"id": 1472161197399, "note": "<div><b>Tertiary syphilis</b> disrupts the {{c1::vasa vasorum}} of the aorta with consequent atrophy of the vessel wall and <b>dilatation of the aorta</b> and valve ring</div>", "time": null}, {"id": 1472161209479, "note": "<div><b>Acute {{c1::pericarditis}}</b> is defined as inflammation of the pericardium</div>", "time": null}, {"id": 1472161218711, "note": "<div><b>Acute {{c3::pericarditis}}</b> commonly presents with <b>sharp pain</b> that is <u>aggravated</u> by {{c1::inspiration}} and <u>relieved</u> by {{c2::sitting up and leaning forward}}</div>", "time": null}, {"id": 1472161223823, "note": "<div><b>Acute pericarditis</b> is often complicated by pericardial {{c1::effusion}}</div>", "time": null}, {"id": 1472161230528, "note": "<div>ECG changes associated with <b>acute {{c4::pericarditis}}</b> include <i>widespread, diffuse</i> <b>{{c1::ST segment}}</b> {{c2::<u>elevation</u>}} and/or <b>{{c1::PR}}</b> {{c2::<u>depression</u>}}</div>", "time": null}, {"id": 1472161233950, "note": "<div>What is the most common cause of <b>acute pericarditis</b>?</div><div><br /></div><div>{{c1::Idiopathic (presumed viral)}}</div>", "time": null}, {"id": 1472161242542, "note": "<div><b>{{c1::Cardiac tamponade}}</b> is defined as <u>compression</u> of the <b>heart</b> by fluid </div>", "time": 1660105340909.0}, {"id": 1472161250447, "note": "<div>What is the effect of <b>cardiac tamponade</b> on <b>cardiac output</b>? </div><div><br></div><div>{{c1::Decreased CO}}</div>", "time": null}, {"id": 1472161253998, "note": "<div><div>What is the effect of <b>cardiac tamponade</b> on <b>heart rate</b>? </div><div><br /></div><div>{{c1::Increased HR}}</div></div>", "time": null}, {"id": 1472161256779, "note": "<div><b>Cardiac tamponade</b> leads to <u>equilibration</u> of {{c1::diastolic}} pressures in <b>all 4</b> chambers</div>", "time": null}, {"id": 1472161263980, "note": "<div><b>{{c4::Cardiac tamponade}}</b> may present with <b>Becks triad</b> of {{c1::hypotension}}, {{c2::distended neck veins}}, and {{c3::distant heart sounds}}</div>", "time": null}, {"id": 1472161271695, "note": "<div>One ECG change associated with <b>cardiac tamponade</b> is a(n) {{c1::low-voltage}} <b>QRS complex</b> </div>", "time": 1660105354610.0}, {"id": 1472161282900, "note": "<div>One ECG change associated with <b>cardiac tamponade</b> is {{c1::electrical alternans}}, which occurs due to \"<b>swinging</b>\" <b>movement</b> of the <u>heart</u> in a large effusion</div>", "time": null}, {"id": 1472161298149, "note": "<div><b>Cardiac tamponade</b> may be associated with <b>{{c1::pulsus paradoxus}}</b>, which is a(n) {{c4::<u>decrease</u>}} in amplitude of <b>systolic BP &gt; {{c3::10}} mmHG</b> during {{c2::inspiration}}</div>", "time": null}, {"id": 1472261539021, "note": "<div>What <u>type</u> of drug are <b>class IV antiarrhythmics</b>?<br></div><div><br></div><div>{{c1::Non-dihydropyridine Ca<sup>2+</sup> channel blockers}} </div>", "time": 1660105352283.0}, {"id": 1472261849467, "note": "<div><b>Class {{c2::IV}} antiarrhythmics</b> block&nbsp;<u>activated</u> and <u>inactivated</u> <b>{{c1::L}}-type calcium channels</b><br></div>", "time": 1660105352332.0}, {"id": 1472261858159, "note": "<div><b>Class IV antiarrhythmics</b> (non-dihydropyridine CCBs) are <u>specific</u> for the<b> L-type calcium channel receptors</b> in the {{c1::heart::<i>overall location in the body</i>}}</div><div><br></div><div><i><br></i></div>", "time": 1660105352350.0}, {"id": 1472261861671, "note": "<div>What <i>drug class</i> do <b>diltiazem</b> and <b>verapamil</b> belong to?<br></div><div><br></div><div>{{c1::Class IV antiarrhythmics (non-dihydropyridine Ca<sup>2+</sup> channel blockers)}}</div>", "time": 1660105352302.0}, {"id": 1472261870063, "note": "<div><b>Class {{c3::IV}} antiarrhythmics</b> treat arrhythmias by <u>directly</u> blocking {{c1::Ca<sup>2+</sup>}} current in the <b>{{c2::SA}}</b> and <b>{{c2::AV nodes}}</b><br></div>", "time": 1660105352324.0}, {"id": 1472261876215, "note": "<div><b>Class IV antiarrhythmics</b> decrease pacemaker activity by <u>decreasing</u> the <b>slope</b> of <b>phase {{c1::0}} </b>of the <i>nodal</i> action potential<br></div>", "time": 1660105352346.0}, {"id": 1472261886034, "note": "<div>What is the effect of <b>class IV antiarrhythmics </b>(non-dihydropyridine Ca<sup>2+</sup> channel blockers) on <b>effective refractory period</b>?<br></div><div><br></div><div>{{c1::Increased ERP}}</div>", "time": 1660105359215.0}, {"id": 1472261890259, "note": "<div><b>Class IV antiarrhythmics</b> (non-dihydropyridine CCBs) {{c1::<u>decrease</u>}} <b>conduction velocity</b> through the AV node<br></div>", "time": 1660105352349.0}, {"id": 1472261896454, "note": "<div><div>Are <b>class IV antiarrhythmics</b> used to treat <u>supraventricular</u> or <u>ventricular</u> arrhythmias?<br></div></div><div><div><div><br></div><div>{{c1::Supraventricular}}</div></div></div>", "time": 1660105352370.0}, {"id": 1472261904555, "note": "<div><b>Class IV antiarrhythmics </b>may <u>prolong</u> the {{c1::PR interval}} on ECG<br></div>", "time": 1660105352345.0}, {"id": 1472261910467, "note": "<div>One possible adverse effect of <b>class IV antiarrhythmics</b> is <u>AV {{c1::block}}</u> due to decreased conduction through the AV node<br></div>", "time": 1660105352311.0}, {"id": 1472261919635, "note": "<div><b>Class IV antiarrhythmics</b> are useful in the treatment of {{c1::atrial}} fibrillation (and flutter)<br></div>", "time": 1660105352347.0}, {"id": 1472261925853, "note": "<div><b>Class IV antiarrhythmics </b>are useful in preventing {{c1::rapid ventricular response (RVR)}} in atrial fibrillation and flutter (\"<b>rate control</b>\")<br></div>", "time": 1660105352348.0}, {"id": 1472264798618, "note": "<div><b>{{c1::Digoxin}}</b> is a <u>cardiac glycoside</u> that has <b>antiarrhythmic</b> properties<br></div>", "time": 1660105352277.0}, {"id": 1472265205487, "note": "<div><b>Digoxin</b> exerts <u>parasympathomimetic effects</u> via direct stimulation of the <b>{{c1::vagus}} nerve</b>, causing <b>{{c2::AV}} nodal inhibition</b><br></div>", "time": 1660105352320.0}, {"id": 1472265213940, "note": "<div><b>Digoxin</b> is useful in the treatment of {{c1::atrial}} fibrillation (and flutter)<br></div>", "time": 1660105352317.0}, {"id": 1472265219508, "note": "<div><b>Digoxin</b> is useful in preventing {{c1::rapid ventricular response (RVR)}} in atrial fibrillation and flutter (\"<b>rate control</b>\")<br></div>", "time": 1660105352318.0}, {"id": 1472265226228, "note": "<div><b>{{c2::Magnesium}}</b> is an <u>ion</u> that may be used as an <b>antiarrhythmic</b> to treat {{c1::<b>torsades de pointes</b>}}<br></div><div></div>", "time": 1660105352263.0}, {"id": 1472265258266, "note": "<div><b>Magnesium</b> may be used as an <b>antiarrhythmic</b> to treat {{c1::digoxin}}<b> toxicity</b></div>", "time": 1660105359223.0}, {"id": 1472265265781, "note": "<div>What changes in <u>potassium levels</u> (hyper- or hypokalemia) can induce <b>arrhythmias</b>?<br></div><div><br></div><div>{{c1::Both hyper- and hypokalemia :)}}</div>", "time": 1660105352303.0}, {"id": 1472265271998, "note": "<div><b>{{c2::Hyper}}-kalemia induced arrhythmias </b>may present on ECG with {{c1::<u>peaked</u>}} T waves and a(n) {{c1::<u>shortened</u>}} QT interval<br></div>", "time": 1660105352267.0}, {"id": 1472265278073, "note": "<div><b>{{c2::Hypo}}-kalemia induced arrhythmias </b>may present on ECG with {{c1::<b>U</b>}} <b>waves</b> at the end of the T wave<br></div>", "time": 1660105352265.0}, {"id": 1472265283602, "note": "<div>{{c1::Adenosine}} is a <u>purine nucleoside</u> with <b>antiarrhythmic</b> properties<br></div>", "time": 1660105352281.0}, {"id": 1472265289730, "note": "<div><b>Adenosine</b> activates <i>inhibitory</i> <b>{{c1::A1}} receptors</b> on the myocardium of the <b>{{c2::SA}}</b> and {{c2::<b>AV</b> <b>nodes</b>}}<br></div>", "time": 1660105352393.0}, {"id": 1472265296216, "note": "<div>Activation of <b>A1 receptors</b> in the <b>myocardium</b> by <b><i>adenosine</i></b> {{c1::<u>increases</u>}} outward {{c2::K<sup>+</sup>}} current<br></div>", "time": 1660105352395.0}, {"id": 1472265318747, "note": "<div>Activation of <b>A1 receptors</b> in the <b>myocardium</b> by adenosine {{c1::<u>decreases</u>}} inward {{c2::Ca<sup>2+</sup>}} current<br></div>", "time": 1660105352397.0}, {"id": 1472265327630, "note": "<div><b>Adenosine</b> {{c1::<u>decreases</u>}} <b>conduction velocity</b> through the AV node<br></div>", "time": 1660105352388.0}, {"id": 1472265335516, "note": "<div>What is the effect of <b>adenosine</b> on <b>effective refractory period</b>?<br></div><div><div><br></div><div>{{c1::Increased ERP}}</div></div>", "time": 1660105352286.0}, {"id": 1472265342000, "note": "<div><b>Adenosine</b> may cause <i>transient</i> high grade {{c1::heart block}} due to direct AV node inhibition<br></div>", "time": 1660105352389.0}, {"id": 1472265350914, "note": "<div><b>Adenosine</b> may be used as a <u>very {{c1::short}} acting</u> <b>antiarrhythmic</b><br></div>", "time": 1660105359226.0}, {"id": 1472265363911, "note": "<div><b>{{c2::Adenosine}}</b> is a <u>first line agent</u> for <b><u>acute</u></b> treatment of {{c1::<b>supraventricular</b>}} <b>arrhythmias</b><br></div>", "time": 1660105352274.0}, {"id": 1472265374376, "note": "<div><b>Adenosine</b> causes <b>coronary {{c1::dilation}}</b> via its action on <b>{{c2::A2}} receptors</b><br></div>", "time": 1660105352391.0}, {"id": 1472265381679, "note": "<div>One <u>adverse effect</u> associated with <b>adenosine</b> is <b>cutaneous {{c1::flushing}}</b><br></div>", "time": 1660105352314.0}, {"id": 1472265388511, "note": "<div><u>Adverse effects</u> associated with <b>adenosine</b> include {{c1::chest}} pain and a sense of {{c2::impending doom}}<br></div>", "time": 1660105352387.0}, {"id": 1472265402899, "note": "<div>What effect may <b>adenosine</b> have on <b>blood pressure</b>?<br></div><div><br></div><div>{{c1::Decreased (hypotension)}}</div>", "time": 1660105352287.0}, {"id": 1472265413515, "note": "<div><b>{{c3::Adenosine}}</b> is an <i>antiarrhythmic</i> that is <u>less effective</u> in the presence of {{c1::<b>theophylline</b>}} and {{c2::<b>caffeine</b>}} (methylxanthines)<br></div>", "time": 1660105352257.0}, {"id": 1472265424130, "note": "<div>What <u><i>pulmonary</i> side effect</u> is associated with <b>adenosine</b>?<br></div><div><br></div><div>{{c1::Bronchospasm}}</div>", "time": 1660105359213.0}, {"id": 1472267102887, "note": "<b>{{c2::Hypertrophic}} cardiomyopathy</b> is commonly due to <b>{{c1::\u03b2-myosin heavy chain}}</b> or <b>{{c3::myosin-binding protein C}}</b> mutations", "time": null}, {"id": 1472267164385, "note": "The <u>heart</u> is <b>maximally softened</b> {{c1::7}} to {{c1::10}} days <b>post-MI</b>", "time": null}, {"id": 1472310814145, "note": "The embryonic <b>{{c1::truncus arteriosus}}</b> gives rise to the <b>{{c2::ascending aorta}}</b> and <b>{{c2::pulmonary trunk}}</b>", "time": null}, {"id": 1472311600246, "note": "<div><div>The embryonic <b>{{c1::bulbus cordis}}</b> gives rise to the <u>{{c3::smooth}} parts</u> (outflow tracks) of the <b>left </b>and<b> right {{c2::ventricles}}</b> </div></div>", "time": null}, {"id": 1472311628946, "note": "<div><div>The embryonic <b>{{c1::primitive atria}}</b> gives rise to the <u>{{c2::trabeculated}} parts</u> of the <b>left </b>and<b> right {{c3::atria}}</b> </div></div>", "time": 1660105350203.0}, {"id": 1472311644323, "note": "<div><div>The embryonic <b>{{c1::primitive ventricle}}</b> gives rise to the <u>{{c3::trabeculated}} parts</u> of the <b>left </b>and<b> right {{c2::ventricles}}</b> </div></div>", "time": null}, {"id": 1472311744141, "note": "<div><div>The embryonic <b>{{c1::<u>right</u> horn of sinus venosus}}</b> gives rise to the <u>{{c2::smooth}} part</u> of the <b>{{c3::right atrium}}</b> </div></div>", "time": null}, {"id": 1472311765491, "note": "<div><div>The embryonic <b>{{c1::<u>left</u> horn of sinus venosus}}</b> gives rise to the <b>{{c2::coronary sinus}}</b> </div></div>", "time": null}, {"id": 1472311783046, "note": "<div><div>The embryonic <b>{{c1::right common cardinal vein}}</b> and <b>{{c1::right anterior cardinal vein}}</b> give rise to the <b>{{c2::superior vena cava}}</b> </div></div>", "time": null}, {"id": 1472311809283, "note": "<div><div>The embryonic <b>{{c1::endocardial cushion}}</b> gives rise to the <b>atrial septum</b> and <b>membranous interventricular septum</b> </div></div>", "time": 1660105350205.0}, {"id": 1472311842456, "note": "<div><div>The embryonic <b>{{c1::endocardial cushion}}</b> gives rise to the <b>AV</b> and <b>semilunar valves</b> </div></div>", "time": 1660105350204.0}, {"id": 1472311914172, "note": "The <b>heart</b> <u>beats spontaneously</u> by week {{c1::4}} of embryonic development ", "time": null}, {"id": 1472312509202, "note": "<div>The <b>primary heart tube</b> {{c1::loops}} to establish <u>left-right polarity</u> beginning in <b>week 4</b> of gestation </div>", "time": 1660105349676.0}, {"id": 1472317574681, "note": "<div>A defect in <b>left-right dynein</b> during <u>heart morphogenesis</u> can result in {{c1::dextrocardia}}</div>", "time": null}, {"id": 1472317585511, "note": "In the <i>first</i> step of <u>atrial partitioning</u>, the <b>{{c1::septum primum}}</b> grows toward the <b>endocardial cushions</b>, forming a narrow <b>{{c2::ostium primum}}</b> ", "time": null}, {"id": 1472317591569, "note": "<div>In the <i>second</i> step of <u>atrial partitioning</u>, the <b>{{c1::ostium secundum}}</b> forms in place of the <b>ostium primum</b></div>", "time": null}, {"id": 1472317600504, "note": "<div>In the <i>third</i> step of <u>atrial partitioning</u>, the <b>sinus venosus</b> is \"pulled\" into the developing right atrium, forming the <b>{{c1::septum secundum}}</b> </div>", "time": null}, {"id": 1472317610340, "note": "<div>In the <i>fourth</i> step of <u>atrial partitioning</u>, the <b>septum secundum</b> expands and covers most of the <b>foramen secundum</b>, leaving the residual <b>{{c1::foramen ovale}}</b> </div>", "time": null}, {"id": 1472317616453, "note": "<div>The remaining portion of the <b>septum primum</b>, following <u>foramen ovale formation</u>, forms the <b>{{c1::valve of foramen ovale}}</b> </div>", "time": null}, {"id": 1472317622098, "note": "<div>Shortly after birth, the <b>septum secundum</b> and <b>septum primum</b> <u>fuse</u> to form the {{c1::atrial septum}}</div>", "time": null}, {"id": 1472317625805, "note": "<div>The <b>foramen ovale</b> usually closes shortly after birth because of <u>increased</u> {{c1::left atrial}} pressure</div>", "time": null}, {"id": 1472317632103, "note": "<div><u>Failure</u> of the <b>septum primum</b> and <b>septum secundum</b> to fuse after birth results in a(n) {{c1::patent foramen ovale}}</div>", "time": null}, {"id": 1472317635740, "note": "<div><b>Patent foramen ovale</b> can lead to <b>{{c1::paradoxical}} emboli</b>, which are venous thromboemboli that enter systemic arterial circulation</div>", "time": null}, {"id": 1472317639354, "note": "<div>In the <i>first</i> step of <u>ventricular partitioning</u>, the <b>{{c1::muscular}} interventricular septum</b> develops and forms the <b>{{c2::interventricular foramen}}</b> </div>", "time": null}, {"id": 1472317652793, "note": "<div>In the <i>second</i> step of <u>ventricular&nbsp;partitioning</u>, the <b>aorticopulmonary septum</b> <u>rotates</u> and <u>fuses</u> with the <b>muscular interventricular septum </b>to form the {{c1::membranous interventricular septum}}, resulting in <u>closure</u> of the interventricular foramen</div>", "time": 1660105356668.0}, {"id": 1472317662259, "note": "<div>In the <i>third </i>step of <u>ventricular&nbsp;partitioning</u>, growth of <b>{{c1::endocardial cushions}}</b> separates atria from ventricles</div>", "time": 1660105356641.0}, {"id": 1472317718259, "note": "<div><b>Ventricular septal defects</b> usually occur in the <u>{{c1::membranous}} portion</u> of the <b>interventricular septum</b></div>", "time": null}, {"id": 1472317725558, "note": "<div>The <b>mitral</b> and <b>tricuspid valves</b> are derived from the fused {{c1::endocardial cushions}} of the <b>common AV canal</b></div>", "time": null}, {"id": 1472317734577, "note": "<b>Outflow tracts</b> from the heart are formed by <u>migrations</u> of <b>{{c1::neural crest}}</b> and <b>{{c2::endocardial}} cells</b>, which spiral and fuse to form the <b>{{c3::aorticopulmonary::long}} septum</b> ", "time": null}, {"id": 1472317743442, "note": "<div>What is the <u>embryonic origin</u> of <b>endocardial cushion </b>cells? </div><div><br></div><div>{{c1::Neural crest cells and lateral plate mesoderm::2}}</div>", "time": null}, {"id": 1472317746227, "note": "<div>What is the <u>embryonic origin</u> of the <b>aorticopulmonary septum</b>? </div><div><br></div><div>{{c1::Neural crest cells}} </div>", "time": null}, {"id": 1472318680807, "note": "Blood in the <b>umbilical vein</b> has a <b>Po<sub>2</sub></b> of approximately {{c1::30}} mmHg", "time": null}, {"id": 1472319906177, "note": "<div>Blood in the <b>umbilical vein</b> has a <b>O<sub>2</sub> saturation</b> of approximately {{c1::80}}%</div>", "time": 1660105361189.0}, {"id": 1472319909035, "note": "<div>Compared to the <u>umbilical vein</u>, the <b>umbilical arteries</b> have {{c1::low}} O<sub>2</sub> saturation</div>", "time": 1660105360501.0}, {"id": 1472319911691, "note": "<div><b>Oxygenated blood</b> from the <u>placenta</u> enters the fetal circulation via the <b>{{c1::umbilical vein}}</b> </div>", "time": null}, {"id": 1472319917363, "note": "<div>From the <b>umbilical vein</b>, blood is conducted into the <b>{{c1::IVC}}</b> via the <b>{{c2::ductus venosus}}</b>, which <u>bypasses</u> <b>{{c3::hepatic}} circulation</b> </div>", "time": 1660105358770.0}, {"id": 1472319923606, "note": "<div><u>Mixed</u> blood in the <i>fetal</i> <b>IVC</b> enters the <b>{{c1::right atrium}}</b> </div>", "time": null}, {"id": 1472319929389, "note": "<div><i>Most</i> of the <b>highly oxygenated blood</b> reaching the heart via the <i>fetal</i> <b>IVC</b> is directed from the RA to the LA via the {{c1::<b>foramen ovale</b>}} and pumped into the aorta to supply the head and body </div>", "time": 1660105355144.0}, {"id": 1472319935401, "note": "<div><i>Most</i> of the <b>deoxygenated</b> <b>blood</b> from the <i>fetal</i> <b>SVC</b> is conducted to the <b>{{c1::descending aorta}}</b> via the <b>{{c2::ductus arteriosus}}</b>, which bypasses the <b>{{c3::lungs}}</b> </div>", "time": 1660105355147.0}, {"id": 1472319948100, "note": "<div><b>Deoxygenated blood</b> is returned to the <u>placenta</u> via the <b>{{c1::umbilical arteries}}</b> </div>", "time": null}, {"id": 1472319954680, "note": "<div>Once the <b>foramen ovale</b> has closed, it is re-named the <b>{{c1::fossa ovalis}}</b></div>", "time": null}, {"id": 1472319957308, "note": "<div><u>Closure</u> of the <b>ductus arteriosus</b> occurs in response to <u>increased</u> {{c1::<b>O<sub>2</sub></b>}} and <u>decreased</u> {{c2::<b>PGE</b>}} (from respiration and placental separation, respectively)</div>", "time": null}, {"id": 1472319983044, "note": "<div>The <u>remnant</u> of the <b>ductus arteriosus</b> is the <b>{{c1::ligamentum arteriosum}}</b>, which connects the aorta and pulmonary artery</div>", "time": null}, {"id": 1472320389702, "note": "The <b>SA </b>node is commonly supplied by the <b>{{c1::right coronary}} artery</b> while the <b>AV</b> node is supplied by the <b>{{c1::Posterior Descending}} Artery</b>", "time": null}, {"id": 1472320579969, "note": "<div>The <b>posterior descending artery </b>(PDA) most commonly arises from the {{c1::right coronary}} artery (85%)</div>", "time": null}, {"id": 1472321222872, "note": "When the {{c1::<b>posterior descending artery</b> (PDA)}} arises from the <b>{{c2::right coronary}} artery</b>, it is referred to as <b>right-dominant circulation</b> (85%) ", "time": null}, {"id": 1472321225527, "note": "<div>When the {{c1::<b>posterior descending artery</b> (PDA)}} arises from the <b>{{c2::left circumflex}} artery</b>, it is referred to as <b>left-dominant circulation</b> (8%)</div>", "time": null}, {"id": 1472321229002, "note": "<div>When the {{c1::<b>posterior descending artery</b> (PDA)}} arises from <i>both </i>the <b>right coronary artery</b> and <b>left circumflex artery</b>, it is referred to as <b>{{c2::codominant}} circulation</b> (7%)</div>", "time": null}, {"id": 1472321235661, "note": "<div><b>Coronary blood flow</b> <u>peaks</u> in early {{c1::diastole::systolic/diastolic}}</div>", "time": 1660105360404.0}, {"id": 1472321238353, "note": "<div>The most <u>posterior</u> part of the heart is the {{c1::left atrium}}</div>", "time": null}, {"id": 1472321253969, "note": "<div>The <u>outermost</u> layer of the <b>pericardium</b> is the {{c1::fibrous pericardium}}</div>", "time": null}, {"id": 1472321256473, "note": "<div>The <u>middle</u> layer of the <b>pericardium</b> is the {{c1::parietal layer of serous pericardium}}</div>", "time": null}, {"id": 1472321259575, "note": "<div>The <u>inner</u> layer of the <b>pericardium</b> is the {{c1::visceral layer of serous pericardium}}</div>", "time": null}, {"id": 1472321262004, "note": "<div>The <b>{{c1::pericardial cavity}}</b> lies between <u>parietal</u> and <u>visceral</u> layers of serous pericardium</div>", "time": null}, {"id": 1472321269968, "note": "<div><div>Which <u>artery</u> supplies the <u>anterior two-thirds</u> of the <b>interventricular septum</b>? </div><div><br></div><div>{{c1::Left anterior descending artery (LAD)}}</div></div>", "time": null}, {"id": 1472321276735, "note": "<div>Which arteries supply the <b>anterolateral papillary muscle</b>? </div><div><br></div><div>{{c1::LCX, LAD::2}}</div>", "time": null}, {"id": 1472426456195, "note": "<div><div>If <b>\u0394G</b> for a reaction is {{c1::<u>less</u>}} than zero, the reaction happens <b>spontaneously</b></div></div>", "time": null}, {"id": 1472426481431, "note": "<div><div>If <b>\u0394G</b> for a reaction is {{c1::<u>greater</u>}} than zero, <b>energy must be added</b> for the reaction to occur</div></div>", "time": null}, {"id": 1472426485090, "note": "<div><div><b>Enzymes</b> exert their effects by <u>decreasing</u> the energy of {{c1::activation}}</div></div>", "time": null}, {"id": 1472426491309, "note": "<div>The <b>rate of a reaction</b> depends on the <u>concentration</u> of <i>both</i> the {{c1::enzyme}} and the {{c1::substrate}}</div>", "time": null}, {"id": 1472426494725, "note": "<div><div><div>The Michaelis-Mentin <i>constant</i>, <b>K</b><sub style=\"font-weight: bold; \">m</sub> is defined as the {{c1::substrate}} concentration at which rate is equal to {{c1::V<sub>max</sub>/2}}</div></div></div>", "time": null}, {"id": 1472426501144, "note": "<div><div>The Michaelis-Mentin constant, <b>K</b><sub style=\"font-weight: bold; \">m</sub> is {{c1::inversely}} proportional to the <b>affinity</b> <b>of the enzyme</b> for its substrate</div></div>", "time": null}, {"id": 1472426513341, "note": "<div><div>The <b>V<sub>max</sub></b> of a reaction is {{c1::directly}} proportional to <b>enzyme concentration</b> </div></div>", "time": null}, {"id": 1472426521266, "note": "<div><div>In <b>{{c1::first}} order kinetics</b>, the <u>rate of reaction</u> is directly proportional to the substrate (drug) concentration</div></div>", "time": null}, {"id": 1472426529103, "note": "<div><div>In <b>{{c1::zero}} order kinetics</b>, the <u>rate of reaction</u> is constant </div></div>", "time": null}, {"id": 1472426537468, "note": "<div><div>If the <b>amount of enzymes doubles</b>, the V<sub>max</sub> {{c1::doubles}}, while K<sub>m</sub> {{c1::remains constant}}</div></div>", "time": null}, {"id": 1472426541101, "note": "<div><div>The <b>{{c1::X}}-intercept</b> of a <u>lineweaver-burke plot</u> represents <b>-1/K<sub>m</sub></b> </div></div>", "time": null}, {"id": 1472426549510, "note": "<div><div>The <b>{{c1::Y}}-intercept</b> of a <u>lineweaver-burke plot</u> represents <b>1/V<sub>max</sub></b> </div></div>", "time": null}, {"id": 1472426560728, "note": "<div>If the <b>Y-intercept</b> <u>increases</u> on a lineweaver-burke plot, the <b>V<sub>max</sub> </b>has {{c1::decreased}}</div>", "time": null}, {"id": 1472426576894, "note": "<div>When using a(n)&nbsp;<b>{{c1::<i>reversible</i> competitive}}</b> inhibitor, the <b>{{c2::K<sub>m</sub>}}</b> changes, while the <b>{{c2::V<sub>max</sub>}}</b> remains the same</div>", "time": null}, {"id": 1472426585896, "note": "<div><div>When using a(n)&nbsp;<b>{{c1::noncompetitive}}</b> inhibitor, the <b>{{c2::V<sub>max</sub>}}</b> changes, while the <b>{{c2::K<sub>m</sub>}}</b> remains the same</div></div>", "time": null}, {"id": 1472426600174, "note": "<div><div>When using an <b><i>irreversible </i>competitive</b> inhibitor, the <b>{{c1::V<sub>max</sub>}}</b> changes, while the <b>{{c1::K<sub>m</sub>}}</b> remains the same</div></div>", "time": null}, {"id": 1472426609949, "note": "<div>Do <b><i>reversible </i>competitive inhibitors</b> resemble the substrate?</div><div><br /></div><div>{{c1::Yes}}</div><div><br /></div><div><div><br /></div></div>", "time": null}, {"id": 1472426614133, "note": "<div><div>Do <b><i>irreversible </i>competitive inhibitors</b> resemble the substrate?</div><div><br /></div><div>{{c1::Yes}}</div></div><div><br /></div><div><div><br /></div></div>", "time": null}, {"id": 1472426616871, "note": "<div><div>Do<b style=\"font-style: italic; \"> </b><b>non</b><b>competitive inhibitors</b> resemble the substrate?</div><div><br /></div><div>{{c1::No}}</div></div><div><br /></div><div><div><br /></div></div>", "time": null}, {"id": 1472426619514, "note": "<div><div>Can <b><i>reversible </i>competitive inhibitors</b> be overcome by <u>increasing</u> the substrate concentration, [S]?</div><div><br /></div><div>{{c1::Yes}}</div></div><div><br /></div><div><div><br /></div></div>", "time": null}, {"id": 1472426621969, "note": "<div><div>Can <b><i>irreversible </i>competitive inhibitors</b> be overcome by <u>increasing</u> the substrate concentration, [S]?</div><div><br /></div><div>{{c1::No}}</div></div><div><br /></div><div><div><br /></div></div>", "time": null}, {"id": 1472426624361, "note": "<div><div>Can<b style=\"font-style: italic; \"> </b><b>non</b><b>competitive inhibitors</b> be overcome by <u>increasing</u> the substrate concentration, [S]?</div><div><br /></div><div>{{c1::No}}</div></div><div><br /></div><div><div><br /></div></div>", "time": null}, {"id": 1472426626716, "note": "<div><div>Do <b><i>reversible </i>competitive inhibitors</b> bind to the active site of the enzyme?</div><div><br /></div><div>{{c1::Yes}}</div><div><br /></div><div><div><br /></div></div></div>", "time": null}, {"id": 1472426629660, "note": "<div><div><div>Do <b><i>irreversible </i>competitive inhibitors</b> bind to the active site of the enzyme?</div><div><br /></div><div>{{c1::Yes}}</div></div><div><br /></div><div><div><br /></div></div></div>", "time": null}, {"id": 1472426631686, "note": "<div><div><div>Do<b style=\"font-style: italic; \"> </b><b>non</b><b>competitive inhibitors</b> bind to the active site of the enzyme?</div><div><br /></div><div>{{c1::No}}</div></div></div><div><br /></div><div><div><br /></div></div>", "time": null}, {"id": 1472426633744, "note": "<div>While most enzymatic reactions follow a <u>hyperbolic</u> curve (Michaelis-Menten kinetics), <b>{{c2::allosteric}} kinetics </b>follow a(n) {{c1::<b>sigmoidal</b>}} curve </div>", "time": null}, {"id": 1472487541747, "note": "<div>One <u>adverse effect</u> associated with <b>digoxin</b> is <b>{{c1::hyperkalemia}}</b>, which is an indicator of {{c2::<u>poor</u>}} prognosis<br></div>", "time": 1660105352185.0}, {"id": 1472487550752, "note": "<div><b>Digitalis toxicity</b> may induce {{c1::arrhythmias}}, such as premature ventricular contractions<br></div>", "time": 1660105352197.0}, {"id": 1472487557798, "note": "<div><u style=\"font-weight: bold;\">Chronic</u> <b>{{c3::digoxin}} use</b> leads to Peaked T wave and QT interval shortening (<i>due to hyperkalemia</i>), and <b>ST {{c1::depression}}</b> with a \"{{c2::scooped}}\" appearance on ECG<br></div>", "time": 1660105352200.0}, {"id": 1472487609656, "note": "<div>One factor that predisposes to <b>digoxin toxicity</b> is {{c1::hypokalemia}}, which <u>increases binding</u> of digoxin to Na<sup>+</sup>-K<sup>+</sup> ATPase<br></div>", "time": 1660105352183.0}, {"id": 1472487655906, "note": "<div><b>Milrinone</b> and <b>inamrinone</b> are <b>{{c1::PDE-3}} inhibitors </b>used in the treatment of <u>acute heart failure</u><br></div>", "time": 1660105352192.0}, {"id": 1472487663906, "note": "<div>What effect does <b>milrinone</b> have on <b>cardiac contractility</b>?<br></div><div><br></div><div>{{c1::Increased contractility}}</div>", "time": 1660105352177.0}, {"id": 1472487670528, "note": "<div><b>Milrinone</b> causes arteriolar {{c1::dilation}} and thus {{c1::<u>decreased</u>}} afterload<br></div>", "time": 1660105352191.0}, {"id": 1472500374903, "note": "<div><b>Calcium channel blockers</b> (CCBs) target voltage-gated {{c1::L}}-type calcium channels<br></div><div><br></div>", "time": 1660105352433.0}, {"id": 1472502461817, "note": "<div><b>{{c2::Dihydropyridine}} CCBs</b> primarily block L-type calcium channels in <b>{{c1::smooth}} muscle</b><br></div>", "time": 1660105352411.0}, {"id": 1472502468924, "note": "<div><b>{{c2::Non-dihydropyridine}} CCBs</b> primarily block L-type calcium channels in <b>{{c1::cardiac}} </b><b>muscle</b><br></div>", "time": 1660105352404.0}, {"id": 1472502477608, "note": "<div><b>Dihydropyridine CCBs</b> cause vaso-{{c1::dilation}}<br></div>", "time": 1660105352429.0}, {"id": 1472502484635, "note": "<div><b>Dihydropyridine CCBs</b> have a(n) {{c1::-dipine}} suffix<br></div>", "time": 1660105352428.0}, {"id": 1472502493911, "note": "<div><b>Verapamil</b> and <b>diltiazem</b> are both examples of {{c1::non-dihydropyridine}} Ca<sup>2+</sup> channel blockers<br></div>", "time": 1660105352419.0}, {"id": 1472502505405, "note": "<div><b>Diltiazem</b> has some vaso-{{c1::dilatory}} activity<br></div>", "time": 1660105352426.0}, {"id": 1472502520244, "note": "<div><b>{{c2::Non-dihydropyridine}} CCBs</b> {{c1::<u>decrease</u>}} cardiac contractility and cardiac output<br></div>", "time": 1660105352402.0}, {"id": 1472502529886, "note": "<div><u>Inhibition</u> of the <b>SA node</b> by <b>non-dihydropyridine CCBs</b> can cause {{c1::bradycardia}}<br></div>", "time": 1660105352425.0}, {"id": 1472502538202, "note": "<div><b>{{c1::Ca<sup>2+</sup>}} channel blockers</b> are useful for treating <b>hypertension</b><br></div>", "time": 1660105352142.0}, {"id": 1472502559313, "note": "<div><b>{{c2::Nifedipine}}</b> is a <u>dihydropyridine CCB</u> that is used to treat <b>{{c3::hypertension}}</b> during {{c1::pregnancy}}<br></div>", "time": 1660105352409.0}, {"id": 1472502565616, "note": "<div><b>Ca<sup>2+</sup> channel blockers</b> may be used to treat {{c1::<u>stable</u> angina}} if \u03b2-blockers/nitrates have not worked or are contraindicated<br></div>", "time": 1660105352434.0}, {"id": 1472502574081, "note": "<div><b>{{c2::Dihydropyridine}} CCBs</b> are useful for treating <b>angina</b> due to their ability to cause <b>coronary</b> <b>vaso-{{c1::dilation}}</b><br></div>", "time": 1660105352415.0}, {"id": 1472502594120, "note": "<div>What effect do <b>dihydropyridine CCBs</b> have on <b>afterload</b>?<br></div><div><br></div><div>{{c1::Decreased afterload (via peripheral vasodilation)}}</div>", "time": 1660105352418.0}, {"id": 1472502605856, "note": "<div><b>Non-dihydropyridine CCBs</b> are useful for treating angina due to their ability to <u>decrease</u> {{c1::myocardial oxygen}} demand<br></div>", "time": 1660105352424.0}, {"id": 1472502616617, "note": "<div><b>{{c2::Ca<sup>2+</sup> channel}} blockers</b> are a <u>first-line treatment</u>&nbsp;for&nbsp;<b>{{c1::Prinzmetal}} angina</b>, due to their ability to prevent vasoconstriction in the coronary vasculature<br></div>", "time": 1660105352141.0}, {"id": 1472502628127, "note": "<div><b>{{c2::Dihydropyridine}} CCBs</b> may be used to treat <b>{{c1::Raynauds phenomenon}}</b>, which is an exaggerated vascular response to cold temperature or emotional stress<br></div>", "time": 1660105352413.0}, {"id": 1472502634353, "note": "<div><b>{{c3::Nimodipine}}</b> is a <u>Ca</u><sup>2+</sup><u> channel blocker</u> that is used to prevent <b>cerebral</b> <b>{{c2::vasospasm}}</b> following a(n) {{c1::<b>subarachnoid</b> <b>hemorrhage</b>}}<br></div>", "time": 1660105352400.0}, {"id": 1472502649352, "note": "<div><b>Calcium channel blockers</b>, such as <u>{{c2::verapamil}}</u>, may be used for {{c1::<b>migraine</b>}} <i>prophylaxis</i><br></div>", "time": 1660105352432.0}, {"id": 1472502659342, "note": "<div>Nonspecific <u>adverse effects</u> of <b>dihydropyridine CCBs</b> include headache, {{c1::dizziness}}, and {{c2::flushing}}<br></div>", "time": 1660105352423.0}, {"id": 1472502678171, "note": "<div>One <u>adverse effect</u> associated with <b>dihydropyridine CCBs</b> is {{c1::<b>peripheral</b> <b>edema</b>}}, secondary to dilation of <u>pre-capillary</u> vessels<br></div>", "time": 1660105352420.0}, {"id": 1472502689964, "note": "<div><b>Dihydropyridine CCBs</b> may cause <u>reflex {{c1::tachycardia::HR}}</u>&nbsp;</div>", "time": 1660105352427.0}, {"id": 1472502698548, "note": "<div>Which <b>Ca<sup>2+</sup> channel blocker</b> is contraindicated in patients with <u>unstable angina</u> or <u>MI</u> due to its ability to <b>exacerbate myocardial ischemia</b>?<br></div><div><br></div><div>{{c1::Nifedipine}}</div>", "time": 1660105352416.0}, {"id": 1472502704876, "note": "<div>What major <u>GI side effect</u> is associated with <b>verapamil</b>?<br></div><div><br></div><div>{{c1::Constipation}}</div>", "time": 1660105352417.0}, {"id": 1472502710529, "note": "<div>One <u>adverse effect</u> associated with <b>Ca<sup>2+</sup> channel blockers</b> (e.g. verapamil) is {{c1::gingival}} hyperplasia<br></div>", "time": 1660105352421.0}, {"id": 1472502721143, "note": "<div><b>{{c2::Non-dihydropyridine}} CCBs</b> are relatively <u>contraindicated</u> in patients with <b>heart</b> {{c1::<b>block</b>}} or <b>heart </b>{{c1::<b>failure</b>}} due to their ability to cause <b>cardiac depression</b><br></div>", "time": 1660105352406.0}, {"id": 1472502750542, "note": "<div><b>Dihydropyridine CCBs </b>can <i>worsen</i> <b>heart failure</b> due to increased <u>{{c1::sympathetic}} activity</u> induced by baroreceptor reflex activation<br></div>", "time": 1660105352430.0}, {"id": 1472502758634, "note": "<div>Which<b> Ca<sup>2+</sup> channel blockers</b> have the <u>most potent</u> effects on <b>vascular smooth muscle</b>?<br></div><div><br></div><div>{{c1::Amlodipine, Nifedipine::2}}</div>", "time": 1660105359231.0}, {"id": 1472502761294, "note": "<div>Which<b> Ca<sup>2+</sup> channel blocker</b> has the <u>most potent</u> effects on <b>cardiac muscle</b>?<br></div><div><br></div><div>{{c1::Verapamil}} </div>", "time": 1660105359232.0}, {"id": 1472611837810, "note": "<div><b>Black</b> and <b>elderly</b> <b>patients</b> respond well to {{c1::hydrochlorothiazide}} and long-acting {{c2::dihydropyridine Ca<sup>2+</sup> channel blockers}} for treatment of <b>primary hypertension</b><br></div>", "time": 1660105352251.0}, {"id": 1472611912290, "note": "<div><b>IV Ca<sup>2+</sup> channel blockers</b> such as {{c1::<u>nicardipine</u>}} and {{c2::<u>clevidipine</u>}} may be used in <b>hypertensive {{c3::emergency}}</b><br></div>", "time": 1660105352235.0}, {"id": 1472611938769, "note": "<div><b>Hydralazine</b> primarily <u>dilates</u> {{c1::<b>arterioles</b>}}, leading to a <u>decreased</u> <b>{{c1::after}}-load</b><br></div>", "time": 1660105352237.0}, {"id": 1472611979581, "note": "<div><b>Hydralazine</b> is often combined with a(n) {{c1::<b>organic nitrate</b>}} to treat <b>{{c2::heart failure}}</b> due to LV systolic dysfunction<br></div>", "time": 1660105352239.0}, {"id": 1472611989012, "note": "<div><b>Hydralazine</b> combined with a(n)&nbsp;<b>{{c2::nitrate}}</b> provides a(n)&nbsp;<u>{{c1::mortality}} benefit</u> for <i>some</i> patients with <b>heart failure</b></div>", "time": 1660105352243.0}, {"id": 1472612013495, "note": "<div><b>Hydralazine</b> can rarely cause {{c1::<b>drug-induced lupus</b>}}, which may manifest as myalgias, arthralgias, and joint swelling<br></div>", "time": 1660105352244.0}, {"id": 1472612051677, "note": "<div><b>Nitroprusside</b> is associated with <b>{{c1::cyanide}} poisoning</b>, which may present as<br></div><div><br></div><div>- {{c2::lactic acidosis}}</div><div>- {{c2::seizures}}</div><div>- altered mental status</div>", "time": 1660105352229.0}, {"id": 1472668144393, "note": "<div>After being absorbed from the GI tract, <b>free cholesterol</b> is packaged into a(n)&nbsp;<b>{{c1::chylomicron}}</b> as&nbsp;<b>cholesterol ester</b></div>", "time": 1660105352543.0}, {"id": 1472668157311, "note": "<div>The <u>main</u> component of <b>chylomicrons</b> is {{c1::triglycerides}}<br></div>", "time": 1660105352484.0}, {"id": 1472668181157, "note": "<div><b>{{c1::Chylomicrons}}</b> deliver <b>triglycerides</b> from the <u>intestine</u> to <b>peripheral tissues</b></div>", "time": 1660105352459.0}, {"id": 1472668189982, "note": "<div><b>Triglycerides</b> in <u>chylomicrons</u> are hydrolyzed by the enzyme <b>{{c1::<i>lipoprotein lipase </i>(LPL)}}</b>, releasing {{c2::<b>free fatty acids</b>}}<br></div>", "time": 1660105352476.0}, {"id": 1472668212125, "note": "<div><b>Free fatty acids</b> can be converted back to {{c1::triglycerides}} and <u>stored</u> in <b>adipose tissue</b><br></div>", "time": 1660105352507.0}, {"id": 1472668221441, "note": "<div>Once <u>depleted</u> of their triglycerides, <b>chylomicron {{c1::remnants}}</b> return to the <b>{{c2::liver}}</b><br></div>", "time": 1660105352495.0}, {"id": 1472668230564, "note": "<div>The <b>remnant&nbsp;receptor</b> on the <u>liver</u> binds to <b>{{c2::ApoE}}</b> of the <b>chylomicron remnant</b>, causing subsequent endocytosis<br></div>", "time": 1660105352477.0}, {"id": 1472668244713, "note": "<div><b>Hepatocytes</b> synthesize <b>{{c2::cholesterol}}</b> using the <u>rate-limiting</u> enzyme <b><i>{{c1::HMG CoA reductase}}</i></b><br></div>", "time": 1660105352504.0}, {"id": 1472668252970, "note": "<div>The first intermediate in <b>cholesterol synthesis</b> is {{c1::mevalonate}} (from HMG CoA)<br></div>", "time": 1660105352487.0}, {"id": 1472668261580, "note": "<div><b>Cholesterol</b> from the <u>liver</u> may be <i>repackaged</i> into the interior of {{c1::VLDLs}}<br></div>", "time": 1660105352527.0}, {"id": 1472668268533, "note": "<div>The main component of <b>VLDL</b> is {{c1::triglycerides}} (60%)<br></div>", "time": 1660105352482.0}, {"id": 1472668276020, "note": "<div><b>Apolipoprotein {{c1::B-100}}</b> is found on the lipoproteins <b>{{c2::LDL}}</b>, <b>{{c2::IDL}}</b>, and <b>{{c2::VLDL}}</b><br></div>", "time": 1660105352539.0}, {"id": 1472668287227, "note": "<div><b>{{c1::VLDLs}}</b> deliver <b>triglycerides</b> <i>directly</i> from the <u>liver</u> to <b>peripheral tissues</b><br></div>", "time": 1660105352441.0}, {"id": 1472668297518, "note": "<div>Depletion of <u>triglycerides</u> from <b>VLDLs</b> produces <b>IDLs</b>, which may undergo further removal of triglycerides via the enzyme <i><b>{{c2::hepatic TG lipase}}</b></i>, forming&nbsp;<b>LDL</b><br></div>", "time": 1660105352525.0}, {"id": 1472668314490, "note": "<div>The <u>main</u> component of <b>LDL</b> is a core of {{c1::cholesterol esters}}<br></div>", "time": 1660105352483.0}, {"id": 1472668322150, "note": "<div><b>{{c1::LDLs}}</b> are the <u>main source</u> of <b>cholesterol delivery</b> to peripheral tissues in the body<br></div>", "time": 1660105352450.0}, {"id": 1472668346297, "note": "<div><b>Nascent HDL</b> is secreted by the {{c1::liver}} and {{c1::intestine}}<br></div>", "time": 1660105352502.0}, {"id": 1472668354811, "note": "<div><b>{{c1::Lecithin cholesterol acyltransferase (LCAT)}}&nbsp;</b>converts&nbsp;<u><i>free&nbsp;</i>cholesterol</u> into&nbsp;<u>cholesterol esters</u> for <b>transport by HDL</b></div>", "time": 1660105352449.0}, {"id": 1472668367901, "note": "<div><b>{{c1::Mature}} HDL</b> particles contain <u>LCAT-generated</u> cholesterol esters<br></div>", "time": 1660105352448.0}, {"id": 1472668380549, "note": "<div><b>HDL</b> transfers <u>cholesterol esters</u> to LDLs, IDLs, and VLDLs&nbsp;via <b>{{c1::cholesterol ester transfer protein (CETP)}}</b> to be transported back to the liver<br></div>", "time": 1660105352506.0}, {"id": 1472668407920, "note": "<div><b>{{c2::HDL}}</b> delivers <b>cholesterol esters</b> <u>directly</u> to the liver via <b>{{c1::scavenger receptor B-1}} </b>receptors<br></div>", "time": 1660105352440.0}, {"id": 1472668415239, "note": "<div>{{c2::<b>Statins</b> (e.g. simvastatin, atorvastatin, rosuvastatin)}} exert their effects by <u>inhibiting</u> the enzyme <i><b>{{c1::HMG CoA reductase}}</b></i>, thus decreasing cholesterol production<br></div>", "time": 1660105352436.0}, {"id": 1472668423640, "note": "<div><b>Statins </b>indirectly cause {{c1::<u>increased</u>}} <b>LDL receptor expression</b> on hepatocytes<br></div>", "time": 1660105352490.0}, {"id": 1472668437183, "note": "<div><b>{{c1::Statins}}</b> <b>significantly</b> reduce <b>{{c2::LDL}}</b> levels (30-60% reductions)<br></div>", "time": 1660105352445.0}, {"id": 1472668445184, "note": "<div>What effect do <b>statins</b> have on <u>triglyceride</u> levels?<br></div><div><br></div><div>{{c1::Mild decrease}}</div>", "time": 1660105352469.0}, {"id": 1472668453090, "note": "<div>What effect do <b>statins</b> have on <u>HDL</u> levels?<br></div><div><br></div><div>{{c1::Mild increase}}</div>", "time": 1660105352470.0}, {"id": 1472668462268, "note": "<div>The <u>first line treatment</u> for <b>hypercholesterolemia</b> (LDL) is with lifestyle modification and {{c1::statins}}<br></div>", "time": 1660105352486.0}, {"id": 1472668470653, "note": "<div><b>{{c1::Statins}}</b> are the <u>most effective</u> lipid lowering medications for&nbsp;<b>preventing future cardiovascular events</b><br></div>", "time": 1660105352443.0}, {"id": 1472668485114, "note": "<div><b>{{c1::Statins}}</b> are the only <b>lipid-lowering drugs</b> consistently proven to&nbsp;<u>reduce</u> risk of atherosclerotic heart disease<br></div>", "time": 1660105352442.0}, {"id": 1472668510022, "note": "<div><b>Statins</b> reduce risk of <u>future vascular events</u> in patients with a history of <b>TIA</b> or {{c1::stroke}}<br></div>", "time": 1660105352488.0}, {"id": 1472668519019, "note": "<div><b>Statins</b> may be {{c1::teratogenic}}, therefore avoid during the first trimester of pregnancy<br></div>", "time": 1660105352492.0}, {"id": 1472668526554, "note": "<div>The most common <u>side effect</u> of <b>statins</b> is {{c1::myopathy}}, which occurs weeks to months after starting therapy<br></div>", "time": 1660105352481.0}, {"id": 1472668552198, "note": "<div><b>Statins</b> may cause mild {{c1::<b>hepato</b>}}<b>-toxicity</b>, and thus mild <u>elevations</u> in <b>{{c1::liver}} function tests</b><br></div>", "time": 1660105352489.0}, {"id": 1472668562134, "note": "<div>All <b>statins</b>, except for <b>{{c2::pravastatin}}</b>, are <u>metabolized</u> by {{c1::<b>cytochrome p450</b>}}<br></div>", "time": 1660105352541.0}, {"id": 1472672275670, "note": "<div>What <i>drug class</i> do <b>cholestyramine</b>, <b>colestipol</b>, and&nbsp;<b>colesevelam</b> belong do?<br></div><div><br></div><div>{{c1::Bile acid resins}}</div>", "time": 1660105352474.0}, {"id": 1472673094113, "note": "<div>{{c1::<b>Bile acid resins</b> (e.g. cholestyramine)}} bind <b>bile acids</b> in the intestinal lumen, <u>preventing</u> absorption and recycling to the liver<br></div>", "time": 1660105352462.0}, {"id": 1472673105758, "note": "<div><b>Bile acid resins</b> (e.g. cholestyramine) <u>interrupt</u> bile acid recycling and <b>promote synthesis of new bile acids</b>, depleting liver {{c1::cholesterol}} stores<br></div>", "time": 1660105352537.0}, {"id": 1472673121602, "note": "<div><b>Bile acid resins</b> indirectly cause {{c1::<u>increased</u>}} <b>LDL receptor expression</b><br></div>", "time": 1660105352532.0}, {"id": 1472673129980, "note": "<div>What effect do <b>bile acid resins</b> have on <u>LDL</u> levels?<br></div><div><div><br></div><div>{{c1::Moderately decreased}}</div></div>", "time": 1660105352472.0}, {"id": 1472673137003, "note": "<div><b>Bile acid resins</b> are used in patients with primary <b>{{c1::hypercholesterolemia}}</b>, usually in <u>conjunction</u> with <b>statins</b><br></div><div><br></div><div><i><br></i></div>", "time": 1660105352535.0}, {"id": 1472673150221, "note": "<div><b>Bile acid resins</b> <u>increase</u> the <i>cholesterol content</i> of bile acids and thus may cause {{c1::cholesterol gallstones}}<br></div>", "time": 1660105352529.0}, {"id": 1472673161686, "note": "<div><b>Bile acid resins</b> frequently cause <u>GI side effects</u>, such as {{c1::constipation}} and {{c2::bloating}}<br></div>", "time": 1660105352531.0}, {"id": 1472673168254, "note": "<div><b>Bile acid resins</b> can lead to <b>{{c1::steatorrhea}}</b>, which may <u>impair</u> the absorption of <b>{{c2::fat-soluble vitamins (A, D, E, K)}}</b><br></div>", "time": 1660105352534.0}, {"id": 1472673197430, "note": "<div><b>{{c1::Ezetimibe}}</b> is a <u>lipid-lowering agent</u> that blocks absorption of <b>{{c2::cholesterol}}</b> at the <b>small intestinal brush border</b><br></div>", "time": 1660105352458.0}, {"id": 1472673210697, "note": "<div><b>Ezetimibe</b> restricts the livers access to <i>exogenous</i> {{c1::cholesterol}}<br></div>", "time": 1660105352519.0}, {"id": 1472673225907, "note": "<div><b>Ezetimibe</b> indirectly causes {{c1::<u>increased</u>}} <b>LDL receptor expression</b><br></div>", "time": 1660105352521.0}, {"id": 1472673233193, "note": "<div>What effect does <b>ezetimibe</b> have on <u>LDL</u> levels?<br></div><div><div><br></div><div>{{c1::Moderately decreased}}</div></div>", "time": 1660105352468.0}, {"id": 1472673237351, "note": "<div>What <u>GI side effect</u> is associated with <b>ezetimibe</b>?<br></div><div><br></div><div>{{c1::Diarrhea/steatorrhea::2}}</div>", "time": 1660105352466.0}, {"id": 1472673244066, "note": "<div><b>Ezetimibe</b> may cause <u>increased</u> {{c1::liver}} <b>function tests</b><br></div>", "time": 1660105352520.0}, {"id": 1472673251212, "note": "<div><b>Evolocumab</b> and <b>alirocumab</b> are <u>lipid-lowering agents</u> that inhibit {{c1::PCSK9::what enzyme?}}<br></div>", "time": 1660105352523.0}, {"id": 1472673261352, "note": "<div><b>{{c2::PCSK9}}</b> is a <u>protease</u> produced by the liver that leads to <u>degradation</u> of <b>{{c3::hepatocyte}} {{c1::LDL}} receptors</b><br></div>", "time": 1660105352438.0}, {"id": 1472673269032, "note": "<div><b>Evolocumab</b> binds <b>PCSK9</b> and {{c1::<u>prevents</u>}} degradation of <b>hepatic</b> <b>LDL receptors</b><br></div>", "time": 1660105352522.0}, {"id": 1472676030952, "note": "<div>What <i>drug class</i> do <b>gemfibrozil</b> and <b>fenofibrate</b> belong to?<br></div><div><br></div><div>{{c1::Fibrates}}</div>", "time": 1660105352473.0}, {"id": 1472676524788, "note": "<div><b>{{c1::Fibrates}}</b> <u>upregulate</u> the enzyme {{c2::<i><b>lipoprotein lipase</b></i> (LPL)}} by <u>activating</u> <b>{{c3::PPAR-\u03b1}}</b><br></div>", "time": 1660105352456.0}, {"id": 1472676532297, "note": "<div><b>Fibrates</b> <u>significantly decrease</u> serum <b>{{c1::triglycerides}}</b> by <u>increasing</u> <b>{{c2::hydrolysis}}</b> of VLDLs and chylomicrons<br></div>", "time": 1660105352516.0}, {"id": 1472676541571, "note": "<div>One way <b>Fibrates</b> <u>decrease</u> serum <b>triglycerides</b> is by decreasing hepatic {{c1::VLDL}} secretion<br></div>", "time": 1660105352517.0}, {"id": 1472676549097, "note": "<div><b>Fibrates</b> lead to {{c1::<i>mild </i><u>decreases</u>}} in<b> serum LDL </b>by reducing VLDL<br></div>", "time": 1660105352513.0}, {"id": 1472676561710, "note": "<div><b>Fibrates</b> may cause <b>{{c1::myopathy}}</b> as an <u>adverse effect</u>, especially when combined with <b>{{c2::statins}}</b><br></div>", "time": 1660105352512.0}, {"id": 1472676568535, "note": "<div><b>Fibrates</b> increase risk of {{c1::cholesterol gallstones}} and thus should be used with caution in patients with biliary tract disease<br></div>", "time": 1660105352514.0}, {"id": 1472676576760, "note": "<div><b>{{c1::Niacin (B<sub>3</sub>)}}</b> is the <u>most effective</u> drug for <b>increasing</b> serum <b>{{c2::HDL}}</b><br></div>", "time": 1660105352447.0}, {"id": 1472676616697, "note": "<div><div><b>{{c1::Fibrates}}</b> are the <u>most effective</u> drugs for <b>decreasing</b> serum&nbsp;<b>{{c2::triglycerides}}</b></div></div>", "time": 1660105359234.0}, {"id": 1472676626963, "note": "<div><b>Niacin</b> <b>(Vitamin B<sub>3</sub>)</b> {{c1::mildly}} <u>decreases</u> serum triglycerides by decreasing hepatic {{c1::VLDL}} secretion<br></div>", "time": 1660105352501.0}, {"id": 1472676636114, "note": "<div><b>Niacin</b> leads to {{c1::<u>moderately</u> <u>decreased</u>}}<b> serum LDL </b>by {{c2::<i>reducing</i> VLDL synthesis}}<br></div>", "time": 1660105352499.0}, {"id": 1472676642388, "note": "<div>A common <u>adverse effect</u> associated with <b>niacin</b> is <b>cutaneous</b> {{c1::<b>flushing</b>}} and {{c2::<b>warmth</b>}} due to increased {{c3::prostaglandin}} activity<br></div>", "time": 1660105352546.0}, {"id": 1472676648720, "note": "<div><b>Flushing</b> and <b>warmth</b>, secondary to <u>niacin</u> use, may be prevented with {{c1::NSAIDs}}<br></div>", "time": 1660105352510.0}, {"id": 1472676654480, "note": "<div>What effect may <b>niacin</b> have on <u>blood glucose levels</u>?<br></div><div><br></div><div>{{c1::Increased (Hyperglycemia)}}</div>", "time": 1660105352467.0}, {"id": 1472676659959, "note": "<div><b>Niacin </b>may cause <b>{{c1::hyperuricemia}}</b> as an <u>adverse effect</u>, which can precipitate {{c2::gout}}<br></div>", "time": 1660105352498.0}, {"id": 1472676674981, "note": "<div><b>{{c1::Fish oil}}</b>, a supplement high in <b>{{c2::omega-3 fatty}} acids</b>, may be used to <u>lower</u> serum <b>{{c3::triglyceride}}</b> levels<br></div>", "time": 1660105352453.0}, {"id": 1472743774495, "note": "<div><b>Organic nitrates</b> are <i>metabolized</i> and release {{c1::nitric oxide}}</div>", "time": 1660105352150.0}, {"id": 1472747773497, "note": "<div><b>Nitric oxide</b> <u>increases</u> levels of {{c1::cGMP}} in vascular smooth muscle cells<br></div>", "time": 1660105352154.0}, {"id": 1472747780684, "note": "<div><u>Increased</u> levels of <b>cGMP</b> cause <b>{{c1::myosin light chain}} {{c2::dephosphorylation}}</b>, <u>preventing</u> its interaction with actin</div>", "time": 1660105352172.0}, {"id": 1472747787801, "note": "<div><b>Nitrates</b> primarily cause {{c1::<b>venous</b>}} <b>dilation</b>, causing <u>decreased</u> <b>{{c1::pre}}-load</b><br></div>", "time": 1660105352157.0}, {"id": 1472747798559, "note": "<div><b>Nitrates</b> may provide symptomatic relief of chronic, stable {{c1::angina}}<br></div>", "time": 1660105352158.0}, {"id": 1472747806470, "note": "<div><b>Nitrates</b> {{c1::<u>reduce</u>}} myocardial oxygen requirements<br></div>", "time": 1660105352155.0}, {"id": 1472747814325, "note": "<div>{{c1::Sublingual}} administration of <b>nitroglycerine</b> <i>avoids</i> <u>first pass metabolism</u>, which is useful for <b>immediate relief</b> of angina<br></div>", "time": 1660105352144.0}, {"id": 1472747820905, "note": "<div>{{c1::Oral}} <b>nitrate</b> preparations have a <u>longer</u> duration of action than sublingual<br></div>", "time": 1660105352145.0}, {"id": 1472747829983, "note": "<div>What <i>drug class</i> do <b>isosorbide mononitrate/dinitrate</b> and <b>nitroglycerin&nbsp;</b>belong to?</div><div><br></div><div>{{c1::Nitrates}}</div>", "time": 1660105352147.0}, {"id": 1472747837737, "note": "<div><i>Oral</i> <b>nitrate</b> preparations require {{c1::<u>large</u>}} dosing due to <b>{{c2::first}} pass metabolism</b><br></div>", "time": 1660105352152.0}, {"id": 1472747844000, "note": "<div><b>Nitrates</b> may be used to treat {{c1::Prinzmetal}} <b>angina</b>, which is characterized by <u>vasospasm</u><br></div>", "time": 1660105352161.0}, {"id": 1472747850067, "note": "<div><b>Nitrates</b> are useful in treatment of <u>acute</u> {{c1::<b>coronary</b>}} <b>syndromes</b><br></div>", "time": 1660105352143.0}, {"id": 1472747857568, "note": "<div><b>Nitrates</b> should be <i>avoided</i> in <u>{{c1::right}}-sided</u> <b>myocardial infarction</b><br></div>", "time": 1660105352156.0}, {"id": 1472747866517, "note": "<div><b>IV nitroglycerine</b> can be used in the treatment of <b>hypertensive</b> {{c1::emergency}}<br></div>", "time": 1660105352166.0}, {"id": 1472747873373, "note": "<div><b>Nitroglycerine</b> may be used as an acute treatment for <b>pulmonary</b> {{c1::edema}}<br></div>", "time": 1660105352153.0}, {"id": 1472747882582, "note": "<div><u>Adverse effects</u> associated with <b>nitrates</b> include {{c1::orthostatic hypotension}} and <b>syncope</b> due to pooling of blood in veins<br></div>", "time": 1660105352173.0}, {"id": 1472747888604, "note": "<div><b>Nitrate-induced</b> <u>hypotension</u> may cause <i>reflex</i> {{c1::tachycardia}}<br></div>", "time": 1660105352165.0}, {"id": 1472747894757, "note": "<div><b>Nitrates</b> are often combined with <b>{{c1::\u03b2-blockers}}</b> to help prevent <i>reflex</i> {{c2::<u>sympathetic</u>}} activation<br></div>", "time": 1660105352163.0}, {"id": 1472747901922, "note": "<div>What <u>calcium channel blocker</u> may be <i>combined</i> with&nbsp;<b>nitrates</b>, producing similar effects to \u03b2-blockers?<br></div><div><br></div><div>{{c1::Verapamil}} </div>", "time": 1660105359203.0}, {"id": 1472747910012, "note": "<div><b>Nitrates</b> may cause <b>throbbing</b> <b>{{c1::headaches}}</b> and&nbsp;<b>cutaneous&nbsp;</b><b>{{c2::flushing}}</b> as possible side effects<br></div>", "time": 1660105352160.0}, {"id": 1472747916455, "note": "<div>What <u>hematological</u> complication is associated with <b>nitrates</b>?<br></div><div><br></div><div>{{c1::Methemoglobinemia}} </div>", "time": 1660105352146.0}, {"id": 1472747925827, "note": "<div>Patients on <b>nitrates</b> have a <u>nitrate-free</u> interval everyday to prevent {{c1::tolerance}}<br></div>", "time": 1660105352149.0}, {"id": 1472747933027, "note": "<div><u>Industrial workers</u> may develop \"<b>{{c3::Monday}} disease</b>\" due to excessive <b>{{c4::nitrate}}</b> <b>exposure</b>, which presents with {{c1::headache}}, {{c2::dizziness}}, and tachycardia<br></div>", "time": 1660105352170.0}, {"id": 1472747945251, "note": "<div>Patients on <b>{{c1::PDE-5 inhibitors}} </b>should <u>avoid</u> <b>nitrate</b> therapy for 24 hours<br></div>", "time": 1660105352148.0}, {"id": 1472747953733, "note": "<div><b>Nitrates</b> are <u>contraindicated</u> in patients with {{c1::hypertrophic obstructive}} <b>cardiomyopathy</b><br></div>", "time": 1660105352164.0}, {"id": 1472782086749, "note": "<div><b>Ranolazine</b> is a drug used to treat <b>{{c1::angina}}</b> <u>refractory</u> to other medical therapies<br></div>", "time": 1660105359190.0}, {"id": 1472782285156, "note": "<div>What effect does <b>ranolazine</b> have on <u>heart rate</u> and <u>blood pressure</u>?<br></div><div><br></div><div>{{c1::No effect}}</div>", "time": 1660105359188.0}, {"id": 1472782289232, "note": "<div><b>Ranolazine</b> <u>inhibits</u> the late phase of {{c1::Na<sup>+</sup>}} current, thereby <u>reducing</u> <b>diastolic wall tension</b> and <b>O<sub>2</sub> consumption</b><br></div>", "time": 1660105359191.0}, {"id": 1472782313881, "note": "<div><b>Ranolazine</b> may cause {{c1::QT}} <u>prolongation</u> on ECG</div>", "time": 1660105359189.0}, {"id": 1472782319515, "note": "<div><u>Adverse effects</u> of <b>ranolazine</b> include {{c1::dizziness}}, headache, and nausea</div>", "time": 1660105359192.0}, {"id": 1472782322699, "note": "<div>What <u>GI side effect</u> may be caused by <b>ranolazine</b>?<br></div><div><br></div><div>{{c1::Constipation}}</div>", "time": 1660105359187.0}, {"id": 1472782338409, "note": "<div>What is the effect of <b>\u03b2-blockers</b> <i>alone</i> on <b>heart rate</b>?<br></div><div><div><br></div><div>{{c1::Decreased}}</div></div>", "time": 1660105359179.0}, {"id": 1472782344403, "note": "<div>What is the effect of <b>nitrates</b> <i>and</i> <b>\u03b2-blockers</b> on <b>heart rate</b>?<br></div><div><div><br></div><div>{{c1::No effect or decreased}}</div></div>", "time": 1660105359182.0}, {"id": 1472782350788, "note": "<div>What is the effect of <b>nitrates</b> <i>alone</i> on <b>ejection time</b>?<br></div><div><div><br></div><div>{{c1::Decreased}}</div></div>", "time": 1660105359186.0}, {"id": 1472782356991, "note": "<div>What is the effect of <b>\u03b2-blockers</b> <i>alone</i> on <b>ejection time</b>?<br></div><div><div><br></div><div>{{c1::Increased}}<br></div></div>", "time": 1660105359180.0}, {"id": 1472782364657, "note": "<div>What is the effect of <b>nitrates</b> <i>and</i> <b>\u03b2-blockers</b> on <b>ejection time</b>?<br></div><div><div><br></div><div>{{c1::Little/no effect}}<br></div></div>", "time": 1660105359183.0}, {"id": 1472782371240, "note": "<div>What is the effect of <b>nitrates</b> <i>alone</i> on <b>myocardial O<sub>2</sub> consumption</b>?<br></div><div><div><br></div><div>{{c1::Decreased}}</div></div>", "time": 1660105359184.0}, {"id": 1472782379809, "note": "<div>What is the effect of <b>\u03b2-blockers</b> <i>alone</i> on <b>myocardial O<sub>2</sub> consumption</b>?<br></div><div><div><br></div><div>{{c1::<u>Mildly</u> decreased}}<br></div></div>", "time": 1660105359178.0}, {"id": 1472782387702, "note": "<div>What is the effect of <b>nitrates</b> <i>and</i> <b>\u03b2-blockers</b> on <b>myocardial O<sub>2</sub> consumption</b>?<br></div><div><div><br></div><div>{{c1::<u>Very</u> decreased}}<br></div></div>", "time": 1660105359181.0}, {"id": 1473283703470, "note": "Which aneurysm, <b>true ventricular aneurysm</b> or <b>pseudo-aneurysm</b>, is more likely to <u>rupture</u>? <div><br></div><div>{{c1::Pseudo-aneurysm}}</div>", "time": null}, {"id": 1473289602247, "note": "<div>The <b>alveolar walls</b> are lined with <u>epithelial cells</u> called {{c1::type I}} and {{c1::type II pneumocytes}} </div>", "time": null}, {"id": 1473289611174, "note": "<div><b>Type {{c1::II}} pneumocytes</b> are responsible for <u>synthesis</u> of <b>pulmonary {{c2::surfactant}}</b> </div>", "time": null}, {"id": 1473289619233, "note": "<div><b>Type {{c1::II}} pneumocytes</b> have <u>regenerative capacity</u> for both type I <i>and</i> type II pneumocytes</div>", "time": null}, {"id": 1473289622374, "note": "<div>The <b>alveoli</b> contain <u>phagocytic</u> cells called <b>{{c1::alveolar macrophages (dust cells)}}</b>, which clear debris and participate in the immune response</div>", "time": 1660105350466.0}, {"id": 1473289801695, "note": "<div>When a person is <i>standing</i>, <b>pulmonary blood flow</b> is <u>highest</u> at the {{c1::base (bottom)}} of the lungs</div>", "time": null}, {"id": 1473289822632, "note": "The volume that moves into the lung with each <b><u>quiet</u> inspiration</b> is the <b>{{c1::tidal volume}}</b> ", "time": null}, {"id": 1473293220506, "note": "<div><div>What is the typical <u>normal</u> value for <b>tidal volume</b> (mL)?</div><div><br /></div><div>{{c1::500 mL}}</div></div>", "time": null}, {"id": 1473293242577, "note": "<div><div>The <u>additional volume</u> that can be <b><i>inspired above</i> tidal volume</b> is the <b>{{c1::inspiratory reserve volume}}</b> </div></div>", "time": null}, {"id": 1473293251581, "note": "<div><div>The <u>additional volume</u> that can be <b><i>expired below</i> tidal volume</b> is the <b>{{c1::expiratory reserve volume}}</b> </div></div>", "time": null}, {"id": 1473293260136, "note": "<div><div>The volume that <u>remains in the lungs</u> after <b>maximal forced expiration</b> is the <b>{{c1::residual volume}}</b> </div></div>", "time": null}, {"id": 1473293268513, "note": "<div><div>Which lung <b><u>volume</u> </b>cannot be measured on <b>spirometry</b>?</div><div><br></div><div>{{c1::Residual volume}}</div></div>", "time": null}, {"id": 1473293272040, "note": "<div><div>The <u>sum</u> of the <b>tidal volume</b> plus the <b>inspiratory reserve volume</b> is known as <b>{{c1::inspiratory capacity}}</b> </div></div>", "time": 1660105349534.0}, {"id": 1473293278261, "note": "<div><div>The <u>sum</u> of the <b>residual volume</b> plus the <b>expiratory reserve volume</b> is known as <b>{{c1::functional residual capacity}}</b> </div></div>", "time": 1660105349535.0}, {"id": 1473293285727, "note": "<div><div>The volume of gas <u>remaining</u> in the lungs <b>after normal expiration</b> is the {{c1::functional residual capacity}}</div></div>", "time": null}, {"id": 1473293294683, "note": "<div><div>The <u>sum</u> of the <b>tidal volume</b>, <b>inspiratory reserve volume</b>, and <b>expiratory reserve volume</b> is known as the {{c1::vital capacity}}</div></div>", "time": 1660105349533.0}, {"id": 1473293303131, "note": "<div><div>The maximum volume of gas that can be <u>expired</u> <b>after maximal inspiration</b> is known as the {{c1::(forced) vital capacity}}</div></div>", "time": null}, {"id": 1473293310827, "note": "<div><div>The <u>sum</u> of the <b>tidal volume</b>, <b>inspiratory reserve volume</b>, <b>expiratory reserve volume</b>, <i>and</i> <b>residual volume</b> is known as the {{c1::total lung capacity}}</div></div>", "time": 1660105349532.0}, {"id": 1473293316303, "note": "<div><div>The volume of gas present in the lungs <u>after</u> a <b>maximal inspiration</b> is known as the {{c1::total lung capacity}}</div></div>", "time": null}, {"id": 1473293322063, "note": "<div><div><div>Which lung <b><u>capacities</u> </b>cannot be measured on <b>spirometry</b>?</div><div><br></div><div>{{c1::Functional residual capacity, Total lung capacity::2}}</div></div></div>", "time": 1660105344286.0}, {"id": 1473293330615, "note": "<div><div><b>Functional residual capacity</b> may be measured using <b>{{c1::helium dilution}}</b> or <b>{{c2::body plethysmograph}}</b></div></div>", "time": null}, {"id": 1473293337113, "note": "<div><div><div>What is the typical <u>normal</u> value for <b>anatomic dead space</b> (mL)?</div><div><br /></div><div>{{c1::150 mL}}</div></div></div>", "time": null}, {"id": 1473293343603, "note": "<div>The volume of the <b>{{c2::anatomic}} dead space</b> <i>plus</i> the <b>{{c2::alveolar}} dead space</b> comprises the \"<b>{{c1::physiologic}} dead space</b>\" </div>", "time": null}, {"id": 1473293347301, "note": "<div>The {{c1::apex}} of a <i>healthy</i> lung is the <u>largest</u> contributor of <b>alveolar dead space</b></div>", "time": null}, {"id": 1473293369230, "note": "<div><b>{{c1::Physiologic dead space}}</b> is the <i>total</i> <u>volume</u> of the lungs that <b>does not</b> <b>participate in gas exchange</b></div>", "time": null}, {"id": 1473293375437, "note": "<div>In <i>healthy</i> lungs, the <b>physiologic dead space</b> is approximately equal to the {{c1::anatomic dead space}}</div>", "time": 1660105357217.0}, {"id": 1473293379509, "note": "<div>In certain <i>pathologic</i> situations, the <b>physiologic dead space</b> may become <u>greater</u> than the <b>anatomic dead space</b>, suggesting a(n)&nbsp;<b>{{c1::ventilation/perfusion (V/Q)}} defect</b></div>", "time": 1660105357391.0}, {"id": 1473293387558, "note": "<div><b><i>Pathologic</i> dead space</b> is when part of the respiratory zone is {{c1::ventilated::perfused/ventilated}}, but not {{c1::perfused::perfused/ventilated}}&nbsp;</div>", "time": null}, {"id": 1473293394920, "note": "<div>What <u>equation</u> may be used to determine the <b>physiologic dead space</b> (V<sub>D</sub>)?</div><div><br /></div><div>{{c1::<img src=\"paste-79796197392649.jpg\" />}}</div>", "time": null}, {"id": 1473297224976, "note": "<div><b>{{c1::Minute}} ventilation</b> is the <b><u>total</u> volume</b> of gas that enters the lungs per unit time</div>", "time": null}, {"id": 1473300336904, "note": "<div><b>{{c1::Alveolar}} ventilation</b> is the <u>volume</u> of gas per unit time that <b>reaches the alveoli</b> (accounts for physiologic dead space) </div>", "time": null}, {"id": 1473300352378, "note": "<div>What <u>equation</u> may be used to calculate <b>minute ventilation</b>? </div><div><br></div><div>Minute Ventilation (<b>V<sub>E</sub></b>) = {{c1::V<sub>T</sub> * Respiratory Rate}}</div>", "time": 1660105347115.0}, {"id": 1473300359071, "note": "<div><div>What <u>equation</u> may be used to calculate <b>alveolar ventilation</b>? </div><div><br /></div><div>Alveolar Ventilation (<b>V<sub>A</sub></b>) = {{c1::(V<sub>T</sub> - V<sub>D</sub>) * Respiratory Rate}}</div></div>", "time": 1660105347116.0}, {"id": 1473300362617, "note": "<div>What is the <u>normal</u> range of <b>respiratory rates</b> for a <i>healthy</i> <b>adult</b> (breaths/min)? </div><div><br></div><div>{{c1::12-20 breaths/min}}</div>", "time": 1660105345688.0}, {"id": 1473300367115, "note": "<div>If <b>CO<sub>2</sub> production</b> is <u>constant</u>, then the <b>arterial</b> <i>and</i> <b>alveolar {{c2::Pco<sub>2</sub>}}</b> is determined by <b>{{c1::alveolar ventilation}}</b> </div>", "time": 1660105357721.0}, {"id": 1473300408446, "note": "<div>What is the effect of <u>increased</u> <b>alveolar ventilation</b> on<b> arteriolar</b> (and alveolar) <b>Pco<sub>2</sub></b>?</div><div><br /></div><div>{{c1::Decreased Pco<sub>2</sub>}}</div>", "time": 1660105346530.0}, {"id": 1473300428992, "note": "<div><div>What is the effect of <u>decreased</u> <b>alveolar ventilation</b> on<b> arteriolar</b> (and alveolar) <b>Pco</b><sub style=\"font-weight: bold; \">2</sub>?</div><div><br /></div><div>{{c1::Increased Pco<sub>2</sub>}}</div></div>", "time": 1660105346537.0}, {"id": 1473300442300, "note": "<div>The <b>alveolar gas equation</b> states that the <b>alveolar Po<sub>2</sub> (P<sub>Ao2</sub>)</b> equals:</div><div><br /></div><div>{{c1::<img src=\"paste-82974473191483.jpg\" />}}</div>", "time": null}, {"id": 1473300454880, "note": "<div>When using the <b>alveolar gas equation</b>, the <b>respiratory quotient (R) </b>is equal to the ratio of {{c1::CO<sub>2</sub> produced}} / {{c1::O<sub>2</sub> consumed}} </div>", "time": 1660105344570.0}, {"id": 1473300651450, "note": "<div>In the <u>steady state</u>, the <b>respiratory quotient</b>, <b>R</b>, is normally equal to {{c1::0.8}}</div>", "time": null}, {"id": 1473300687105, "note": "<div>The approximate <b>Po<sub>2</sub> </b>in <u>inspired, humidified</u> air (PI<sub>O2</sub>) at <u>sea level</u> is {{c1::150}} mmHg</div>", "time": null}, {"id": 1473300694950, "note": "<div>The <u>gradient</u> between <b>PAo<sub>2</sub> - Pa</b><b>o<sub>2</sub></b>&nbsp;is known as the <b>{{c1::A-a gradient}}</b> and is <i>normally</i> <b>{{c2::10}} - {{c2::15}} mmHg</b> </div>", "time": 1660105350063.0}, {"id": 1473300703893, "note": "<div>The total volume of air that can be <b><i>forcibly</i> expired</b> after a <u>maximal inspiration</u> is known as the {{c1::forced vital capacity (FVC)}}</div>", "time": 1660105349441.0}, {"id": 1473300709116, "note": "<div>The volume of air that can be <i style=\"font-weight: bold; \">forcibly </i><span style=\"font-weight: bold\">expired</span> after a <u>maximal inspiration</u> in <b>one second</b> is known as the {{c1::FEV<sub>1</sub>}}</div>", "time": 1660105349364.0}, {"id": 1473300713413, "note": "<div>The <i>normal</i> value for the <u>ratio</u> of <b>FEV<sub>1</sub>/FVC</b> is approximately {{c1::0.8}}</div>", "time": null}, {"id": 1473300721069, "note": "<div>In <b>{{c1::obstructive}} lung disease</b>, the <b>FEV<sub>1</sub>/FVC</b> is {{c2::<u>decreased</u>}}</div>", "time": null}, {"id": 1473300758449, "note": "<div>In <b>{{c1::restrictive}} lung disease</b>, the <b>FEV<sub>1</sub>/FVC</b> is {{c2::<u>normal</u> or <u>increased</u>}}</div>", "time": null}, {"id": 1473303039851, "note": "<div><b>Lung {{c1::compliance}}</b> describes the <u>change</u> in lung <b>volume</b> for a given <u>change</u> in lung <b>pressure</b></div>", "time": null}, {"id": 1473303058193, "note": "<div>The <b>compliance </b>of the lungs and chest wall is {{c1::<u>inversely</u>}} proportional to their <b>elastance</b></div>", "time": null}, {"id": 1473303061719, "note": "<div>The <b>compliance </b>of the lungs and chest wall is {{c1::<u>inversely</u>}} proportional to the <b>wall stiffness</b></div>", "time": null}, {"id": 1473303064461, "note": "<div><b>{{c1::Elastic recoil}}</b> is the force generated due to the tendency for the <b>lungs</b> to collapse <u>inward</u> and the <b>chest wall</b> to spring <u>outward</u></div>", "time": null}, {"id": 1473303068390, "note": "<div><b>Elastic recoil</b> is {{c1::<u>inversely</u>}} proportional to <b>compliance</b> and {{c1::<u>directly</u>}} proportional to <b>elastance</b></div>", "time": null}, {"id": 1473303075690, "note": "A lung with {{c1::low}} <b>compliance</b> is <u>harder</u> to fill ", "time": 1660105362525.0}, {"id": 1473357081053, "note": "The {{c1::<u>slope</u>}} of a respiratory system <b>pressure-volume curve</b> represents lung <b>{{c2::compliance}}</b> ", "time": null}, {"id": 1473359649088, "note": "<div>The <u>slope</u> (compliance) of the <b>pressure-volume loop</b> curves for <u>inspiration</u> and <u>expiration</u> are different due to a phenomenon known as <b>{{c1::hysteresis}}</b> </div>", "time": 1660105349573.0}, {"id": 1473359656628, "note": "<div><b>Hysteresis</b> occurs due to the need to overcome <b>{{c1::surface tension}} </b>forces during lung {{c2::<b>inflation</b> (inspiration)}}</div>", "time": null}, {"id": 1473359664721, "note": "<div>Are the lungs generally <u>more</u> <b>compliant</b> during&nbsp;<b>inspiration</b> or <b>expiration</b>?</div><div><br></div><div>{{c1::Expiration (due to hysteresis)}}</div>", "time": 1660105361596.0}, {"id": 1473359676593, "note": "<div>The <u>intermolecular forces</u><b> between liquid molecules</b> lining the lung are much {{c1::<u>stronger</u>}} than the forces <b>between liquid and air</b></div>", "time": null}, {"id": 1473359681224, "note": "<div>During <i>initial</i> <u>inspiration</u>, <b>liquid molecules</b> are<b> </b>{{c1::close}} together and <b>intermolecular forces</b> are {{c1::high}} </div>", "time": null}, {"id": 1473359694352, "note": "<div>During <u>expiration</u>, the <u>slope</u> of the <b>pressure-volume loop</b> {{c1::increases}} as the <i>density</i> of <b>surfactant</b> <b>molecules</b> rapidly {{c1::increases}} </div>", "time": null}, {"id": 1473359711985, "note": "<div>At FRC, the <b>intrapleural space</b> <i>normally</i> has a(n)&nbsp;<u>{{c1::negative}} pressure</u> relative to the atmosphere</div>", "time": null}, {"id": 1473359718241, "note": "<div>At <b>{{c3::functional residual capacity}}</b>, the {{c1::<u>inward</u>}} pull of the <b>{{c2::lung}}</b> is <i>balanced</i> by the {{c1::<u>outward</u>}} pull of the <b>{{c2::chest}}</b> </div>", "time": null}, {"id": 1473359727133, "note": "<div>If a sharp object <u>punctures</u> the intrapleural space (<b>{{c2::pneumothorax}}</b>), the <u>intrapleural pressure</u> becomes <b>{{c1::equal to atmospheric pressure}}</b> </div>", "time": null}, {"id": 1473359737393, "note": "<div>The <b>compliance</b> of the <b>lung-chest wall system</b> is {{c1::<u>less</u>}} than that of the lungs or chest wall <i>alone</i></div>", "time": null}, {"id": 1473359748313, "note": "<div>At FRC, <b>airway</b> and <b>alveolar pressures</b> are equal to {{c1::0 (atmospheric pressure)}}</div>", "time": 1660105361507.0}, {"id": 1473359754715, "note": "<div>When lung volume is {{c2::<u>less</u>}} than FRC, there is a net <b>{{c1::expanding}} force</b> on the lung-chest wall system </div>", "time": 1660105344597.0}, {"id": 1473359773067, "note": "<div><div>When lung volume is {{c2::<u>greater</u>}} than FRC, there is a net <b>{{c1::collapsing}} force</b> on the lung-chest wall system </div></div>", "time": 1660105344599.0}, {"id": 1473359784908, "note": "<div>At <u>highest</u> lung volumes, <i>both</i> the <b>lungs</b> and the <b>chest wall</b> contribute to <b>{{c1::collapsing}} forces</b> on the lung-chest wall system</div>", "time": null}, {"id": 1473359792359, "note": "<div>What is the effect of <b>emphysema</b> on <b>lung compliance</b>?</div><div><br /></div><div>{{c1::Increased compliance}}</div>", "time": null}, {"id": 1473359800095, "note": "<div>At the <i>original</i> FRC, the tendency of the <b>lung to collapse</b> in a patient with <u>emphysema</u> is {{c1::less}} than the tendency of the <b>chest wall to expand</b></div>", "time": 1660105361494.0}, {"id": 1473359810332, "note": "<div>What is the effect of <b>emphysema</b> on <b>functional residual capacity (FRC)</b>?</div><div><br /></div><div>{{c1::Increased FRC}}</div>", "time": 1660105346535.0}, {"id": 1473359817001, "note": "<div>A patient with <b>{{c2::emphysema}}</b> breathes at a <u>higher lung volume</u> and will thus have a(n)&nbsp;<b>{{c1::barrel}}-shaped</b> <b>chest</b> (increased anterior-posterior diameter)</div>", "time": null}, {"id": 1473359822159, "note": "<div><div>What is the effect of <b>normal aging</b> on <b><u>lung</u> compliance</b>?</div><div><br></div><div>{{c1::Increased compliance}}</div></div>", "time": null}, {"id": 1473359825264, "note": "<div><div>What is the effect of <b>pulmonary fibrosis</b> on <b>lung compliance</b>?</div><div><br /></div><div>{{c1::Decreased compliance}}</div></div>", "time": 1660105346512.0}, {"id": 1473359831675, "note": "<div><div>At the <i>original</i> FRC, the tendency of the <b>lung to collapse</b> in a patient with <u>pulmonary fibrosis</u> is {{c1::greater}} than the tendency of the <b>chest wall to expand</b></div></div>", "time": 1660105361493.0}, {"id": 1473359840004, "note": "<div><div>What is the effect of <b>pulmonary fibrosis</b> on <b>functional residual capacity (FRC)</b>?</div><div><br /></div><div>{{c1::Decreased FRC}}</div></div>", "time": 1660105346513.0}, {"id": 1473359848012, "note": "<div><div>What is the effect of <b>pulmonary edema</b> on <b>lung compliance</b>?</div><div><br></div><div>{{c1::Decreased compliance}}</div></div>", "time": 1660105346514.0}, {"id": 1473359903608, "note": "<div><div>What is the effect of <b>pneumonia</b> on <b>lung compliance</b>?</div><div><br></div><div>{{c1::Decreased compliance}}</div></div>", "time": null}, {"id": 1473359913501, "note": "<div>The <b>law of Laplace</b> states that the <b>collapsing pressure</b> of an alveoli, <b>P</b>, is equal to {{c1::2T / r}}</div>", "time": null}, {"id": 1473359922418, "note": "<div>According to the <b>law of Laplace</b>, a <b>large alveolus</b> will have a(n) {{c1::low}} <b>collapsing pressure</b> </div>", "time": null}, {"id": 1473359929731, "note": "<div>According to the <b>law of Laplace</b>, a <b>small alveolus</b> will have a(n) {{c1::high}} <b>collapsing pressure</b> </div>", "time": null}, {"id": 1473359937703, "note": "<div>{{c1::Surfactant}} is a mixture of phospholipids that <b>line the alveoli</b> and <u>reduce</u> their <b>surface tension</b> </div>", "time": null}, {"id": 1473359947453, "note": "<div><b>Without surfactant,</b> <u>small alveoli</u> are more likely to collapse, which is termed <b>{{c1::atelectasis}}</b></div>", "time": null}, {"id": 1473359951494, "note": "<div><b>Pulmonary</b> <b>surfactant</b> is a mix of <u>lecithins</u>, the most important of which is {{c1::dipalmitoyl phosphatidylcholine (DPPC)}}</div>", "time": null}, {"id": 1473359954555, "note": "<div>In the developing fetus, <b>surfactant synthesis</b> begins as early as gestastional week {{c1::20}}</div>", "time": null}, {"id": 1473359957928, "note": "<div>In the developing fetus, <u>mature</u> levels of <b>surfactant</b> are not achieved until around week {{c1::35}}</div>", "time": null}, {"id": 1473360086947, "note": "<div>The major site of <b>airway resistance</b> is the {{c1::medium-sized bronchi}}</div>", "time": null}, {"id": 1473360178198, "note": "<div>The <b>{{c1::transpulmonary}} pressure</b> across the lungs is calculated as <b>{{c2::alveolar}} pressure</b> <i>minus</i> <b>{{c2::intrapleural}} pressure</b></div>", "time": 1660105348994.0}, {"id": 1473360181189, "note": "<div>How does the <u>volume of breath</u> change during <b>inspiration</b>? </div><div><br /></div><div>{{c1::Increased}}</div>", "time": null}, {"id": 1473360187634, "note": "<div>How does the <u>intrapleural pressure</u> change during <b>inspiration</b> (relative to atmosphere)? </div><div><br /></div><div>{{c1::<u>More negative</u> relative to atmosphere}}</div>", "time": 1660105358050.0}, {"id": 1473360199275, "note": "<div>How does the <u>alveolar pressure</u> change during <b>mid-inspiration</b> (relative to atmosphere)? </div><div><br /></div><div>{{c1::<u>More negative</u> relative to atmosphere}} </div>", "time": 1660105358059.0}, {"id": 1473360208446, "note": "<div>As the <b>alveolar pressure</b> becomes <u>negative</u> relative to the atmosphere (<b>mid-inspiration</b>), air flows <b>{{c1::inwards}}</b> </div>", "time": null}, {"id": 1473360216545, "note": "<div><div>How does the <u>volume of breath</u> change during <b>expiration</b>? </div><div><br /></div><div>{{c1::Decreased}}</div></div>", "time": null}, {"id": 1473360223014, "note": "<div><div>How does the <u>intrapleural pressure</u> change during <b>expiration</b> (relative to atmosphere)? </div><div><br /></div><div>{{c1::<u>Less negative</u> relative to atmosphere}}</div></div>", "time": 1660105358051.0}, {"id": 1473360233264, "note": "<div><div>How does the <u>alveolar pressure</u> change during <b>mid-expiration</b> (relative to atmosphere)? </div><div><br /></div><div>{{c1::<u>More positive</u> relative to atmosphere}} </div></div>", "time": 1660105358060.0}, {"id": 1473360243258, "note": "<div><div>As the <b>alveolar pressure</b> becomes <u>positive</u> relative to the atmosphere (<b>mid-expiration</b>), air flows <b>{{c1::outwards}}</b> </div></div>", "time": null}, {"id": 1473360254783, "note": "<div>In what <i>normal</i> scenario may <b>intrapleural pressure</b> be <u>positive</u> (relative to the atmosphere)? </div><div><br /></div><div>{{c1::Forced expiration::specific}}</div>", "time": null}, {"id": 1473368934391, "note": "<div>Transfer of <b>gases</b> across cell membranes or capillary walls occurs by {{c1::simple diffusion}}</div>", "time": null}, {"id": 1473368940054, "note": "<div>According to <b>Ficks law</b>, the <u>rate of diffusion</u> of a gas (V<sub>gas</sub>) is equal to: <br><br></div><div>{{c1::<img src=\"paste-108452219191360.jpg\">}}</div>", "time": null}, {"id": 1473368992990, "note": "<div>The <u>diffusion coefficient</u> (D<sub>K</sub>) for <b>CO<sub>2</sub></b> is approximately 20x {{c1::higher}} than that of <b>O<sub>2</sub></b> </div>", "time": null}, {"id": 1473369003612, "note": "<div>The <b>lung diffusing capacity</b> (D<sub>L</sub>) is the equivalent of {{c1::permeability}} of the <b>alveolar-pulmonary capillary barrier</b></div>", "time": null}, {"id": 1473369013245, "note": "<div>The <b>lung diffusing capacity</b> (D<sub>L</sub>) can be measured with {{c1::carbon monoxide (CO)}} because it is exclusively <i>diffusion</i>-limited</div>", "time": null}, {"id": 1473369023362, "note": "<div><b>D<sub>LCO</sub></b> may be used to estimate the extent to which {{c1::oxygen}} passes from the air sacs of lungs into blood</div>", "time": null}, {"id": 1473369029753, "note": "<div>The lung diffusing capacity, <b>D<sub>L</sub></b>, is {{c1::<u>directly</u>}} proportional to the <b>surface area</b> available for diffusion </div>", "time": null}, {"id": 1473369083915, "note": "<div>The lung diffusing capacity, <b>D<sub>L</sub></b>, is {{c1::<u>directly</u>}} proportional to the <b>diffusion coefficient</b> of the gas </div>", "time": null}, {"id": 1473369124027, "note": "<div>The lung diffusing capacity, <b>D<sub>L</sub></b>, is {{c1::<u>inversely</u>}} proportional to the <b>alveolar wall thickness</b> </div>", "time": null}, {"id": 1473369137331, "note": "<div>The lung diffusing capacity, <b>D<sub>L</sub></b>, {{c1::<u>decreases</u>}} in <b>emphysema</b> due to <u>decreased</u> <b>{{c2::surface area (A)}}</b> </div>", "time": 1660105349890.0}, {"id": 1473369142474, "note": "<div>The lung diffusing capacity, <b>D<sub>L</sub></b>, {{c1::<u>decreases</u>}} in <b>pulmonary fibrosis</b> due to <u>increased</u> <b>{{c2::wall thickness (\u0394x)}}</b></div>", "time": 1660105349888.0}, {"id": 1473369146920, "note": "<div><div>The lung diffusing capacity, <b>D<sub>L</sub></b>, {{c1::<u>increases</u>}} during <b>exercise</b> due to <u>increased</u> <b>{{c2::surface area (A)}}</b> </div></div>", "time": null}, {"id": 1473369155271, "note": "<div>The <b>Po</b><sub style=\"font-weight: bold; \">2</sub> in <b>dry inspired air</b> is <i>normally</i> approximately {{c1::160}} mmHg</div>", "time": null}, {"id": 1473369165633, "note": "<div><div>The <b>Po</b><sub style=\"font-weight: bold; \">2</sub> in <b>humidified tracheal air</b> is <i>normally</i> approximately {{c1::150}} mmHg</div></div>", "time": null}, {"id": 1473369177431, "note": "<div>The partial pressure of <u>oxygen</u> in the <b>alveolar air</b> (P<sub>AO2</sub>) and <b>arterial blood</b> (P<sub>aO2</sub>) is <i>normally</i> approximately {{c1::100}} mmHg</div>", "time": 1660105349716.0}, {"id": 1473369189318, "note": "<div>The partial pressure of <u>carbon dioxide</u> in the <b>alveolar air</b> (P<sub>ACO2</sub>) and <b>arterial blood</b> (P<sub>aCO2</sub>) is <i>normally</i> approximately {{c1::40}} mmHg</div>", "time": null}, {"id": 1473369196549, "note": "<div><div>The partial pressure of <u>oxygen</u> in the <b>venous blood</b> (P<sub>vO2</sub>) is <i>normally</i> approximately {{c1::40}} mmHg</div></div>", "time": null}, {"id": 1473369204016, "note": "<div><div>The partial pressure of <u>carbon dioxide</u> in <b>mixed</b> <b>venous blood</b> (P<sub>vCO2</sub>) is <i>normally</i> approximately {{c1::46}} mmHg</div></div>", "time": null}, {"id": 1473369219302, "note": "<div><div>The <u>partial pressure</u> of O<sub>2</sub> in <b>arteriolar blood</b> is <i>slightly</i> {{c1::lower}} than <b>alveolar air</b> due to the \"<b>{{c2::physiologic shunt}}</b>\" </div></div>", "time": 1660105349718.0}, {"id": 1473369227483, "note": "<div>The <u>two</u> sources of the <b>physiologic shunt</b> are <b>{{c1::bronchial}} blood flow</b> and a small portion of <b>{{c2::coronary}} venous blood</b> (drains into the left ventricle via the <u>thebesian</u> vein) </div>", "time": null}, {"id": 1473369231234, "note": "<div>The <u>total gas concentration</u> in solution is the <i>sum</i> of the <b>{{c1::dissolved}} gas</b> plus <b>{{c2::bound}} gas</b> plus <b>{{c3::chemically}} modified gas</b> </div>", "time": null}, {"id": 1473369240326, "note": "<div>The <b>{{c1::partial pressure}} gradient</b> is the <b>driving force</b> for the <u>diffusion</u> of a gas </div>", "time": null}, {"id": 1473369251416, "note": "<div><i>Only</i> {{c1::free, dissolved}} <b>gas</b> contributes to the <u>partial pressure</u> of a gas in <b>solution</b></div>", "time": null}, {"id": 1473369278925, "note": "<div>In <b>{{c1::diffusion}}-limited gas exchange</b>, the gas <u>does not equilibrate</u> by the time blood reaches the end of the capillary</div>", "time": null}, {"id": 1473369288604, "note": "<div>In <b>{{c1::perfusion}}-limited gas exchange</b>, the gas <u>equilibrates</u> <i>early</i> along the length of the capillary</div>", "time": 1660105356323.0}, {"id": 1473369295710, "note": "<div>In <b>{{c2::perfusion}}-limited gas exchange</b>, diffusion can be <u>increased</u> only if <b>{{c1::blood flow}}</b> <u>increases</u></div>", "time": 1660105356233.0}, {"id": 1473369299476, "note": "<div>In <u>normal health</u>, <b>O<sub>2</sub></b> exhibits <b>{{c1::perfusion}}-limited </b>gas exchange</div>", "time": null}, {"id": 1473369303496, "note": "<div><b>CO<sub>2</sub></b> exhibits <b>{{c1::perfusion}}-limited </b>gas exchange</div>", "time": null}, {"id": 1473369308294, "note": "<div><b>N<sub>2</sub>O</b> exhibits <b>{{c1::perfusion}}-limited </b>gas exchange</div>", "time": null}, {"id": 1473369312966, "note": "<div><b>CO</b> exhibits <b>{{c1::diffusion}}-limited </b>gas exchange</div>", "time": null}, {"id": 1473369317123, "note": "<div>When patients have <u>diseased lung tissue</u> (e.g. <b>fibrosis/emphysema</b>)  O<sub>2</sub> transfer becomes {{c1::<i>diffusion</i>}}-limited</div>", "time": null}, {"id": 1473369331388, "note": "<div>At {{c1::<u>high</u>}} altitude the <b>partial pressure gradient of O<sub>2</sub> </b>is {{c2::<u>lower</u>}} and thus <b>equilibration</b> takes {{c2::<u>longer</u>}} </div>", "time": null}, {"id": 1473369344215, "note": "<b>O<sub>2</sub></b> is carried in blood in <u>two</u> forms: <b>{{c2::dissolved}}</b> (2%) or <b>{{c1::bound to hemoglobin}}</b> (98%)", "time": 1660105354737.0}, {"id": 1473375478702, "note": "<div><b>Hemoglobin</b> is a globular protein consisting of {{c1::four}} subunits</div>", "time": null}, {"id": 1473375500147, "note": "<div>Each subunit of <u>hemoglobin</u> contains a(n)&nbsp;<b>{{c1::heme}} moiety</b>, which is a(n)&nbsp;<b>{{c2::iron}}-binding porphyrin</b>, and a polypeptide chain</div>", "time": null}, {"id": 1473375503319, "note": "<div><b>Iron</b> in <u>hemoglobin</u> is normally in the {{c1::ferrous (Fe<sup>2+</sup>)}} state</div>", "time": null}, {"id": 1473375506777, "note": "<div>If the iron in <u>hemoglobin</u> is in the {{c1::<b>ferric (Fe<sup>3+</sup>)}} state</b>, it is called <b>{{c2::methemoglobin}}</b></div>", "time": null}, {"id": 1473375535170, "note": "<div><b>Methemoglobin</b> (Fe<sup>3+</sup>) binds O<sub>2</sub> much {{c1::<u>less</u>::more/less}} readily than <b>hemoglobin</b> (Fe<sup>2+</sup>)</div>", "time": null}, {"id": 1473375550384, "note": "<div><b>Methemoglobin</b> has a(n) {{c1::<u>increased</u>}} affinity for <b>{{c2::cyanide}}</b> relative to hemoglobin</div>", "time": null}, {"id": 1473375560175, "note": "<div><b>{{c1::Methemoglobinemia}}</b> may present with <b>{{c3::cyanosis}}</b> and <b>{{c2::chocolate}}-colored blood</b></div>", "time": null}, {"id": 1473375565346, "note": "<div><i>Induced</i>-<b>{{c1::methemoglobinemia}}</b> (i.e. {{c3::<u>nitrites</u>}} followed by {{c3::<u>thiosulfate</u>}}) may be used to treat <b>{{c2::cyanide}} poisoning</b> </div>", "time": null}, {"id": 1473375572544, "note": "<div><b>Methemoglobinemia</b> can be treated with <b>{{c1::methylene blue}}</b> or <b>{{c2::vitamin C}}</b></div>", "time": null}, {"id": 1473375576711, "note": "<div>What <u>two</u> drug <i>classes</i> are associated with <b>methemoglobinemia</b>? </div><div><br></div><div>{{c1::Nitrates (and nitrites) &amp; Sulfa drugs}}</div>", "time": null}, {"id": 1473375599442, "note": "<div><b>Polluted/high altitude H<sub>2</sub>O</b> may contain {{c1::nitrites}}, which can cause <b>methemoglobinemia</b></div>", "time": 1660105353822.0}, {"id": 1473375617796, "note": "<div>{{c1::Benzocaine}} is a <u>local anesthetic</u> that may cause <b>methemoglobinemia</b> in <i>toxic</i> doses</div>", "time": null}, {"id": 1473375621493, "note": "<div><b>Methemoglobinemia</b> is associated with {{c1::<u>decreased</u>}} <b>SaO<sub>2</sub></b>, {{c1::<u>decreased</u>}} <b>O<sub>2</sub> content</b>, and {{c1::<u>normal</u>}} <b>PaO<sub>2</sub></b> </div>", "time": null}, {"id": 1473375631091, "note": "<div><div>Most <b>adult</b> <b>hemoglobin</b> is composed of 2 <b>{{c1::\u03b1}}</b> and 2 <b>{{c1::\u03b2}}</b> subunits; known as <b>{{c2::HbA}}</b></div></div>", "time": null}, {"id": 1473375643425, "note": "<div><div><b>Fetal</b> <b>hemoglobin</b>, known as <b>{{c2::HbF}}</b>, is composed of 2 <b>{{c1::alpha}}</b> and 2 <b>{{c1::gamma}}</b> subunits </div></div>", "time": null}, {"id": 1473375653665, "note": "<div><b>Fetal hemoglobin</b> (HbF) has a much {{c1::<u>higher</u>}} binding affinity for O<sub>2</sub> than <b>adult hemoglobin</b> (HbA)</div>", "time": null}, {"id": 1473375657305, "note": "<div>Why must <b>fetal hemoglobin</b> have a much <u>higher</u> O<sub>2 </sub>binding affinity than <b>HbA</b>? </div><div><br></div><div>{{c1::Drives O<sub>2</sub> diffusion across placenta from mother to fetus}}</div>", "time": 1660105341496.0}, {"id": 1473375660370, "note": "<div>The <u>increased</u> <b>O<sub>2</sub> binding affinity</b> of <b>fetal hemoglobin</b> results from {{c1::<u>decreased</u>}} affinity of HbF for <b>{{c2::2,3-BPG}}</b> </div>", "time": null}, {"id": 1473375666330, "note": "<div><b>Hemoglobin</b> exists in <u>two</u> forms: {{c1::taut}} (deoxygenated) and {{c1::relaxed}} (oxygenated)</div>", "time": 1660105358397.0}, {"id": 1473375670335, "note": "<div>The <b>{{c2::taut}}</b> form of hemoglobin has a(n) {{c1::<u>low</u>}} affinity for O<sub>2</sub> </div>", "time": null}, {"id": 1473375678641, "note": "<div>The <b>{{c2::relaxed}}</b> form of hemoglobin has a(n) {{c1::<u>high</u>}} affinity for O<sub>2</sub> </div>", "time": null}, {"id": 1473375704144, "note": "<div>The <b>{{c1::taut}}</b> form of <u>hemoglobin</u> is found in most <b>tissues</b> </div>", "time": null}, {"id": 1473375731135, "note": "<div>The <b>{{c1::relaxed}}</b> form of <u>hemoglobin</u> is found in the <b>respiratory tract</b></div>", "time": null}, {"id": 1473375752214, "note": "<div><div>Normally 1g of <b>hemoglobin</b> can bind {{c1::1.34}} mL of O<sub>2</sub></div></div>", "time": null}, {"id": 1473375755860, "note": "<div><div>Normally there is ~{{c1::15}} g/dL of <b>hemoglobin</b> in blood</div></div>", "time": null}, {"id": 1473375759207, "note": "<div>The <b>O<sub>2</sub>-binding capacity</b> of blood is {{c1::20.1}} mL O<sub>2</sub>/ 100 mL blood </div>", "time": null}, {"id": 1473375766028, "note": "<div>What <u>equation</u> may be used to calculate the <b>O<sub>2</sub> content</b> of blood?</div><div><br /></div><div>O<sub>2</sub> content = {{c1::(1.34 * Hb * SaO<sub>2</sub>) + (0.003 * PaO<sub>2</sub>)}}</div>", "time": null}, {"id": 1473375774093, "note": "<div><u>Decreased</u> <b>hemoglobin</b> (e.g. anemia) is associated with {{c1::<u>normal</u>}} <b>SaO<sub>2</sub></b>, {{c1::<u>decreased</u>}} <b>O<sub>2</sub> content</b>, and {{c1::<u>normal</u>}} <b>PaO<sub>2</sub></b> </div>", "time": 1660105360183.0}, {"id": 1473375777918, "note": "<div>What <u>equation</u> may be used to calculate <b>O<sub>2</sub> delivery to tissues</b>? </div><div><br /></div><div>O<sub>2</sub> delivery = {{c1::cardiac output * O<sub>2</sub> content of blood}}</div>", "time": 1660105347114.0}, {"id": 1473382505498, "note": "The <b>{{c2::sigmoidal}} shape</b> of the <u>oxygen-hemoglobin dissociation curve</u> is due to <b>{{c1::positive cooperativity}}</b> (increased affinity for each sucessive O<sub>2</sub> bound)", "time": 1660105348856.0}, {"id": 1473384968406, "note": "<div>A(n)&nbsp;<b>{{c2::hemo}}-globin</b> <b>molecule</b> has the potential to bind {{c1::4}} O<sub>2</sub> molecule(s)</div>", "time": null}, {"id": 1473384972708, "note": "<div>A(n)&nbsp;<b>{{c2::myo}}-globin</b> <b>molecule</b> has the potential to bind {{c1::1}} O<sub>2</sub> molecule(s)</div>", "time": 1660105362377.0}, {"id": 1473384976677, "note": "<div><div>The <b>{{c1::P<sub>50</sub>}} </b>of the <u>oxygen-Hb dissociation curve</u> is the <b>Po<sub>2</sub> at which hemoglobin is 50% saturated</b> </div></div>", "time": null}, {"id": 1473384984006, "note": "<div><div>The <u>oxygen-Hb dissociation curve</u> is roughly <b>flat</b> when the <b>Po<sub>2</sub></b> is between {{c1::60}} and {{c1::100}} mmHg</div></div>", "time": null}, {"id": 1473384994044, "note": "<div><div>Does the <b>oxygen-myoglobin dissociation curve</b> have a <u>sigmoidal</u> shape? Why?</div><div><br /></div><div>{{c1::No, myoglobin is monomeric (no positive cooperativity)}}</div></div>", "time": 1660105359808.0}, {"id": 1473385001562, "note": "<div>Shifts of the <b>O<sub>2</sub>-Hb dissociation curve</b> to the {{c1::<u>right</u>}} occur when there is {{c2::<u>decreased</u>}} <b>affinity</b> of hemoglobin for O<sub>2</sub></div>", "time": null}, {"id": 1473385008578, "note": "<div>Shifts of the <b>O<sub>2</sub>-Hb dissociation curve</b> to the {{c1::<u>right</u>}} cause {{c2::<u>increased</u>}} <b>unloading</b> of O<sub>2</sub> at tissues</div>", "time": null}, {"id": 1473385014843, "note": "<div>Increased <b>pCO<sub>2</sub></b> and resulting decrease of <b>pH</b> enhancing the release of O<sub>2</sub>&nbsp;from hemoglobin is called the {{c1::Bohr}} effect</div>", "time": 1660105356164.0}, {"id": 1473385085081, "note": "<div>{{c1::<u>Increases</u>}} in <b>Pco</b><sub style=\"font-weight: bold; \">2</sub> cause the <b>O<sub>2</sub>-hemoglobin dissociation curve</b> to shift to the {{c2::<u>right</u>}}</div>", "time": 1660105339959.0}, {"id": 1473385093236, "note": "<div>{{c1::<u>Decreases</u>}} in <b>pH</b> cause the <b>O<sub>2</sub>-hemoglobin dissociation curve</b> to shift to the {{c2::<u>right</u>}}</div>", "time": 1660105340609.0}, {"id": 1473385100104, "note": "<div>{{c1::<u>Increases</u>}} in <b>temperature</b> cause the <b>O<sub>2</sub>-hemoglobin dissociation curve</b> to shift to the {{c2::<u>right</u>}}</div>", "time": 1660105339955.0}, {"id": 1473385107205, "note": "<div>{{c1::<u>Increases</u>}} in <b>2,3-BPG</b> cause the <b>O<sub>2</sub>-hemoglobin dissociation curve</b> to shift to the {{c2::<u>right</u>}}</div>", "time": 1660105339961.0}, {"id": 1473385120151, "note": "<div><b>2,3-BPG</b> <u>decreases</u>&nbsp;the<b> affinity</b> of hemoglobin for O<sub>2</sub> by binding to hemoglobin<b> {{c2::\u03b2}} chains</b> </div>", "time": null}, {"id": 1473385124486, "note": "<div>How do levels of <b>2,3-BPG</b> change at <b>high altitudes</b>? </div><div><br /></div><div>{{c1::Increased}}</div>", "time": null}, {"id": 1473385132024, "note": "<div><b>2,3-BPG</b> <u>increases</u> under {{c1::hypoxic}} conditions (e.g. high altitude)</div>", "time": null}, {"id": 1473385135804, "note": "<div><b>High altitudes</b> <i>indirectly</i> cause the <b>O<sub>2</sub>-hemoglobin dissociation curve</b> to shift to the {{c2::<u>right</u>}}</div>", "time": null}, {"id": 1473385149693, "note": "<div>Factors that shift the <b>O<sub>2</sub>-Hb dissociation curve</b> to the {{c1::<u>right</u>}} favor the <b>{{c2::taut}}</b> <b>form</b> of hemoglobin</div>", "time": null}, {"id": 1473385162124, "note": "<div><div>Shifts of the <b>O<sub>2</sub>-Hb dissociation curve</b> to the {{c1::<u>left</u>}} occurs when there is {{c2::<u>increased</u>}} <b>affinity</b> of hemoglobin for O<sub>2</sub></div></div>", "time": null}, {"id": 1473385182147, "note": "<div><div>Shifts of the <b>O<sub>2</sub>-Hb dissociation curve</b> to the {{c1::<u>left</u>}} cause {{c2::<u>decreased</u>}} <b>unloading</b> of O<sub>2</sub> at tissues</div></div>", "time": null}, {"id": 1473385189444, "note": "<div><div>{{c1::<u>Decreases</u>}} in <b>Pco</b><sub style=\"font-weight: bold; \">2</sub> cause the <b>O<sub>2</sub>-hemoglobin dissociation curve</b> to shift to the {{c2::<u>left</u>}}</div></div>", "time": 1660105340611.0}, {"id": 1473385207458, "note": "<div><div>{{c1::<u>Increases</u>}} in <b>pH</b> cause the <b>O<sub>2</sub>-hemoglobin dissociation curve</b> to shift to the {{c2::<u>left</u>}}</div></div>", "time": 1660105339957.0}, {"id": 1473385216220, "note": "<div><div><u>Decreases</u>&nbsp;in <b>temperature</b> cause the <b>O<sub>2</sub>-hemoglobin dissociation curve</b> to shift to the {{c2::<u>left</u>}}</div></div>", "time": 1660105340606.0}, {"id": 1473385224779, "note": "<div><div>{{c1::<u>Decreases</u>}} in <b>2,3-BPG</b> cause the <b>O<sub>2</sub>-hemoglobin dissociation curve</b> to shift to the {{c2::<u>left</u>}}</div></div>", "time": 1660105340613.0}, {"id": 1473385231162, "note": "<div>{{c1::<u>Increases</u>}} in <b>hemoglobin F</b> cause the <b>O<sub>2</sub>-hemoglobin dissociation curve</b> to shift to the {{c2::<u>left</u>}}</div>", "time": null}, {"id": 1473385249608, "note": "<div><b>{{c1::Carboxyhemoglobin}}</b> is a form of <u>hemoglobin</u> bound to <b>{{c2::CO}}</b> in place of O<sub>2</sub> </div>", "time": null}, {"id": 1473385253436, "note": "<div><b>Carbon monoxide</b> binds competitively to Hb and with <b>200-250x</b> {{c1::<u>greater</u>}} <b>affinity</b> than O<sub>2</sub></div>", "time": 1660105360955.0}, {"id": 1473385257949, "note": "<div><b>Carboxyhemoglobin</b> causes the <b>O<sub>2</sub>-hemoglobin dissociation curve</b> to shift to the {{c2::<u>left</u>}}</div>", "time": null}, {"id": 1473385267297, "note": "<div><b>Carboxyhemoglobin</b> heme groups <u>not</u> bound by CO have a(n) {{c1::<u>increased</u>}} <b>affinity</b> for <b>O<sub>2</sub></b></div>", "time": null}, {"id": 1473385273967, "note": "<div><b>Carboxyhemoglobin</b> causes {{c2::<u>decreased</u>}} <b>unloading</b> of O<sub>2</sub> at tissues</div>", "time": null}, {"id": 1473385280374, "note": "<div><b>Carboxyhemoglobin</b> causes {{c1::<u>decreased</u>}} <b>O<sub>2</sub>-binding capacity</b></div>", "time": null}, {"id": 1473385283630, "note": "<div><b>Carboxyhemoglobinemia</b> (CO poisoning) may be treated with {{c1::<b>100% O<sub>2</sub></b>}} and {{c2::<b>hyperbaric O<sub>2</sub></b>}}</div>", "time": null}, {"id": 1473385287565, "note": "<div><b>Carboxyhemoglobinemia</b> is associated with {{c1::<u>decreased*</u>}} <b>SaO<sub>2</sub></b>, {{c1::<u>decreased</u>}} <b>O<sub>2</sub> content</b>, and {{c1::<u>normal</u>}} <b>PaO<sub>2</sub></b> </div>", "time": 1660105360948.0}, {"id": 1473385295319, "note": "<div>What is the <u>hemoglobin concentration</u> in <b>carboxyhemoglobinemia</b>?</div><div><br /></div><div>{{c1::Normal}}</div>", "time": 1660105346228.0}, {"id": 1473385302273, "note": "<div><div><b>Anemia</b> is associated with {{c1::<u>normal</u>}} <b>SaO<sub>2</sub></b>, {{c1::<u>decreased</u>}} <b>O<sub>2</sub> content</b>, and {{c1::<u>normal</u>}} <b>PaO<sub>2</sub></b> </div></div>", "time": null}, {"id": 1473385309456, "note": "<div><div>How does the <u>hemoglobin concentration</u> change in <b>anemia</b>?</div><div><br /></div><div>{{c1::Decreased}}</div></div>", "time": 1660105358053.0}, {"id": 1473385326286, "note": "<div><b>{{c1::Erythropoietin (EPO)}}</b> is a <u>hormone</u> synthesized in the <u>kidneys</u> in response to <b>{{c2::hypoxia}}</b></div>", "time": null}, {"id": 1473385338969, "note": "<div><b>Decreased O<sub>2</sub> delivery</b> to the <u>kidneys</u> due to <b>hypoxia</b> causes <i>increased</i> production of {{c1::<b>hypoxia-inducible factor 1\u03b1</b>}}, which then stimulates synthesis of EPO</div>", "time": null}, {"id": 1473385372338, "note": "<div><b>Erythropoietin</b> (EPO) causes differentiation of {{c1::proerythroblasts}}, which undergo further development to form <b>mature erythrocytes</b> </div>", "time": null}, {"id": 1473385383326, "note": "<div><b>Hemoglobin</b> may act as a(n) {{c2::<u>buffer</u>}} for <b>{{c1::H<sup>+</sup>}} ions</b></div>", "time": null}, {"id": 1473388334713, "note": "<div>One way in which <b>CO<sub>2</sub></b> is carried in the blood is as {{c1::dissolved}} CO<sub>2 </sub>(5%)</div>", "time": null}, {"id": 1473388343171, "note": "<div>One way in which <b>CO</b><sub style=\"font-weight: bold; \">2</sub> is carried in the blood is <b>bound to hemoglobin</b>, known as {{c1::carbaminohemoglobin (HbCO<sub>2</sub>)}} (5%)</div>", "time": null}, {"id": 1473388346421, "note": "<div>The majority of <b>CO</b><sub style=\"font-weight: bold; \">2</sub> transported in blood is in the form of <b>{{c1::HCO<sub>3</sub><sup>-</sup> (bicarbonate)}} </b>(90%)</div>", "time": null}, {"id": 1473388349273, "note": "<div><b>CO<sub>2</sub> </b>binding to hemoglobin favors the <b>{{c1::taut}} form</b>, thus {{c1::<u>reducing</u>}} Hb affinity for O<sub>2</sub> </div>", "time": null}, {"id": 1473388363119, "note": "<div><b>CO<sub>2</sub></b> binds to <u>hemoglobin</u> at the N-terminus of <b>{{c1::globin}}</b> (heme or globin)</div>", "time": null}, {"id": 1473388366794, "note": "<div>{{c1::<u>Decreased</u>}} <b>O</b><sub style=\"font-weight: bold; \">2</sub> binding to hemoglobin causes {{c2::<u>increased</u>}} affinity for <b>CO<sub>2</sub> </b>and <b>H+ </b>(<b>Haldane</b> <b>effect</b>)</div>", "time": null}, {"id": 1473388374224, "note": "<div>{{c1::<u>Increased</u>}} <b>O</b><sub style=\"font-weight: bold; \">2</sub> binding to hemoglobin causes {{c2::<u>decreased</u>}} affinity for <b>CO<sub>2</sub> </b>(<b>{{c3::Haldane}}</b> <b>effect</b>)</div>", "time": 1660105339964.0}, {"id": 1473388382342, "note": "<div>In <b>{{c1::red blood}} </b><b>cells</b> (in plasma), <b>{{c2::CO<sub>2</sub>}}</b> is combined with <b>{{c2::H<sub>2</sub>O}}</b> via the enzyme <i>{{c3::carbonic anhydrase}}</i>, forming <b>{{c4::H<sub>2</sub>CO<sub>3</sub>}}</b></div>", "time": null}, {"id": 1473388388973, "note": "<div><b>H<sub>2</sub>CO<sub>3</sub></b>, formed from <b>CO<sub>2</sub> </b>and <b>H<sub>2</sub>O</b> in <u>red blood cells</u>, <i>dissociates</i> into {{c1::H<sup>+</sup>}} and {{c1::HCO<sub>3</sub><sup>-</sup>}}</div>", "time": null}, {"id": 1473388394383, "note": "<div>The <b>{{c2::H<sup>+</sup>}}</b> in <u>red blood cells</u> (from H<sub>2</sub>CO<sub>3</sub>) is <b>buffered</b> by <b>{{c1::deoxyhemoglobin}}</b></div>", "time": null}, {"id": 1473388399336, "note": "<div>The {{c2::<b>HCO</b><sub style=\"font-weight: bold; \">3</sub><sup style=\"font-weight: bold; \">-</sup>}} in <u>red blood cells</u> (from H<sub>2</sub>CO<sub>3</sub>) is transported into the <b>plasma</b> in <b>exchange </b>for<b> {{c1::Cl<sup>-</sup>}}</b></div>", "time": null}, {"id": 1473388404748, "note": "<div>The <b>HCO<sub>3</sub><sup>-</sup></b> transported <i>out</i> of <u>RBCs</u> is carried to the lungs in the {{c1::plasma}} of <b>venous blood</b></div>", "time": null}, {"id": 1473388409501, "note": "<div>In the {{c2::<u>lungs</u>}}, <b>oxygenation</b> of <b>hemoglobin&nbsp;</b>promotes {{c1::<b>H<sup>+</sup></b>}} release from its buffering sites</div>", "time": null}, {"id": 1473388413857, "note": "<div>In the {{c1::<u>lungs</u>}}, <b>{{c2::HCO<sub>3</sub><sup>-</sup>}}</b> <i>enters</i> the <u>red blood cells</u> in exchange for <b>Cl</b><sup>-</sup></div>", "time": null}, {"id": 1473388418050, "note": "In the {{c1::<u>lungs</u>}}, <b>H<sub>2</sub>CO<sub>3</sub></b> in the <u>red blood cell</u> is reconverted to <b>CO<sub>2</sub></b>&nbsp;and <b>H<sub>2</sub>O</b>&nbsp;and expired", "time": null}, {"id": 1473388710737, "note": "The mnemonic <b>FROM JANE</b> describes the <u>symptoms</u> of {{c1::bacterial endocarditis}}", "time": null}, {"id": 1473388953084, "note": "Which <u>two</u> <b>vasculitides</b> are associated with positive serum <b>p-ANCA</b>? <div><br /></div><div>{{c1::Churg-Strauss syndrome and Microscopic polyangiitis}}</div>", "time": null}, {"id": 1473449619050, "note": "The <b>Cl</b><sup style=\"font-weight: bold; \">-</sup><b>-HCO</b><sub style=\"font-weight: bold; \">3</sub><sup style=\"font-weight: bold; \">-</sup> <b>exchange</b> that occurs across the <u>RBC membrane</u> is accomplished by an <b>anion exchange protein</b> called {{c1::band three protein}}", "time": null}, {"id": 1473451548444, "note": "The <b>pulmonary circulation</b> is normally characterized as a(n) {{c1::low::high/low}} <u>resistance</u>, {{c1::high::high/low}} <u>compliance</u> system", "time": null}, {"id": 1473456816180, "note": "<div>A <u>decrease</u> in <b>P</b><sub style=\"font-weight: bold; \">AO2</sub> causes a <b>hypoxic </b><b>{{c1::vasoconstriction}}</b> that shunts blood away from <i>poorly</i> ventilated regions of the lung </div>", "time": null}, {"id": 1473456819619, "note": "<div><b><i>Fetal</i> pulmonary vascular resistance</b> is very {{c1::<u>high</u>}} because of <u>generalized</u> hypoxic vaso-{{c1::constriction}}</div>", "time": 1660105359285.0}, {"id": 1473456823056, "note": "<div><u>Decreased</u> <b>Po<sub>2</sub></b> (hypoxia) causes vaso-{{c1::constriction}} in the <b>pulmonary</b> <b>circulation</b></div>", "time": null}, {"id": 1473456825860, "note": "<div><u>Increased</u> <b>Pco<sub>2</sub></b> (hypercapnia) causes vaso-{{c1::constriction}} in the <b>pulmonary</b> <b>circulation</b></div>", "time": null}, {"id": 1473456828566, "note": "<div><div><u>Decreased</u> <b>Po<sub>2</sub></b> (hypoxia) causes vaso-{{c1::dilation}} in the <b>systemic</b> <b>circulation</b></div></div>", "time": null}, {"id": 1473456831203, "note": "<div><div><u>Increased</u> <b>Pco<sub>2</sub></b> (hypercapnia) causes vaso-{{c1::dilation}} in the <b>systemic</b> <b>circulation</b></div></div>", "time": null}, {"id": 1473456833834, "note": "<div>In <b>zone {{c2::1</b> (apex)<b>}}</b> of the <u>lung</u>, <b>blood flow</b> (Q) is {{c1::lowest}}</div>", "time": null}, {"id": 1473456846940, "note": "<div>In <b>zone {{c2::3</b> (base)<b>}}</b> of the <u>lung</u>, <b>blood flow</b> (Q) is {{c1::highest}}</div>", "time": null}, {"id": 1473456875333, "note": "<div>Rank the following variables for <b>zone 1</b> of the <u>lung</u>: P<sub>A</sub>, P<sub>a</sub>, and P<sub>v</sub> </div><div><br /></div><div>{{c1::P<sub>A</sub> &gt; P<sub>a</sub> &gt; P<sub>v</sub>}}</div>", "time": null}, {"id": 1473456888262, "note": "<div>Rank the following variables for <b>zone 2</b> of the <u>lung</u>: P<sub>A</sub>, P<sub>a</sub>, and P<sub>v</sub> </div><div><br /></div><div>{{c1::P<sub>a</sub> &gt; P<sub>A</sub> &gt; P<sub>v</sub>}}</div>", "time": null}, {"id": 1473456895792, "note": "<div>Rank the following variables for <b>zone 3</b> of the <u>lung</u>: P<sub>A</sub>, P<sub>a</sub>, and P<sub>v</sub> </div><div><br /></div><div>{{c1::P<sub>a</sub> &gt; P<sub>v</sub> &gt; P<sub>A</sub>}}</div>", "time": null}, {"id": 1473456902368, "note": "<div>In <b>zone {{c1::1}}</b> of the lung, <u>high alveolar pressure</u> may <b>compress</b> <b>the capillaries</b> and reduce blood flow in this zone </div>", "time": 1660105356401.0}, {"id": 1473456910717, "note": "<div>In <b>zone 2</b> of the <u>lung</u>, blood flow is driven by the <i>difference</i> between <b>{{c1::arteriolar}}&nbsp;</b>and <b>{{c1::alveolar}}</b> <b>pressure</b></div>", "time": 1660105356403.0}, {"id": 1473456920567, "note": "<div>In <b>zone 3</b> of the <u>lung</u>, blood flow is driven by the <i>difference</i> between <b>{{c1::arteriolar}}</b> and <b>{{c1::venous}} pressure</b></div>", "time": 1660105356402.0}, {"id": 1473456927662, "note": "<div>In <b>{{c1::right}}-to-{{c1::left}}</b> <b>shunts</b>, <b>{{c2::hypoxemia}}</b> <i>always</i> occurs because a significant fraction of the cardiac output is not delivered to the lungs</div>", "time": null}, {"id": 1473456935083, "note": "<div>A defining characteristic of <b>hypoxemia</b> caused by a <b>right-to-left</b> <b>shunt</b> is that it {{c1::<u>cannot</u>}} be corrected with <b>high O<sub>2</sub> gas</b> </div>", "time": 1660105362562.0}, {"id": 1473456943998, "note": "<div>Do <b>left-to-right shunts</b> result in <b>hypoxemia</b>? </div><div><br></div><div>{{c1::No}}</div>", "time": null}, {"id": 1473456949116, "note": "<div>A consequence of <u>pulmonary hypertension</u> is <b>right</b> <b>ventricular hypertrophy</b> with eventual {{c1::cor pulmonale}} </div>", "time": null}, {"id": 1473456958647, "note": "<div>The {{c1::ventilation/perfusion (V/Q)}} <b>ratio</b> is the <u>ratio</u> of <b>alveolar ventilation</b> to <b>pulmonary blood flow</b></div>", "time": 1660105348975.0}, {"id": 1473456964441, "note": "<div>The <i>normal</i> average value for <b>V/Q</b> is <b>{{c1::0.8}}</b></div>", "time": 1660105349758.0}, {"id": 1473456980055, "note": "<div><div>In <b>zone {{c2::1</b> (apex)<b>}}</b> of the <u>lung</u>, <b>alveolar ventilation </b>(V) is {{c1::lowest}}</div></div>", "time": null}, {"id": 1473456999177, "note": "<div><div>In <b>zone {{c2::3</b> (base)<b>}}</b> of the <u>lung</u>, <b>alveolar ventilation</b> (V) is {{c1::highest}}</div></div>", "time": null}, {"id": 1473457013179, "note": "<div><i>Both</i> <b>ventilation</b> and <b>perfusion</b> are {{c1::greater}} at the <u>base</u> of the lung than at the <u>apex</u> of the lung</div>", "time": null}, {"id": 1473457019242, "note": "<div>The <b>V/Q ratio</b> is {{c1::<u>highest</u>}} in <b>zone {{c2::1</b> (apex)<b>}}</b> of the lung</div>", "time": null}, {"id": 1473457024978, "note": "<div>The <b>V/Q ratio</b> is {{c1::<u>lowest</u>}} in <b>zone {{c2::3</b> (base)<b>}}</b> of the lung</div>", "time": null}, {"id": 1473457030849, "note": "<div>The <b>V/Q ratio</b> at the <u>apex</u> of the lung is normally <b>{{c1::3}}</b>, indicating <i>wasted</i> <b>{{c2::ventilation}}</b> </div>", "time": 1660105349384.0}, {"id": 1473457042626, "note": "<div>The <b>V/Q ratio</b> at the <u>base</u> of the lung is normally <b>{{c1::0.6}}</b>, indicating <i>wasted</i> <b>{{c2::perfusion}}</b></div>", "time": 1660105349382.0}, {"id": 1473457052548, "note": "<div>What is the <u>ideal</u> <b>V/Q ratio</b> for adequate gas exchange? </div><div><br></div><div>{{c1::1 (ventilation matches perfusion)}}</div>", "time": null}, {"id": 1473457056485, "note": "<div>If there is a(n) <b>{{c1::blood flow}} obstruction</b>, the <b>V/Q ratio</b> = {{c2::<b>\u221e </b>(dead space)*}}</div>", "time": null}, {"id": 1473457064016, "note": "<div><b>{{c1::Dead space}}</b> is <b>ventilation</b> of lung regions that are <u>not</u> <b>perfused</b> (V/Q = \u221e) </div>", "time": null}, {"id": 1473457082593, "note": "<div>If there is a(n) <b>{{c1::airway}} obstruction</b>, the <b>V/Q ratio</b> = {{c2::<b>0</b> (shunt)}}</div>", "time": null}, {"id": 1473457089774, "note": "<div><b>{{c1::Shunt}}</b> is <b>perfusion</b> of lung regions that are <u>not</u> <b>ventilated</b> (V/Q = 0) </div>", "time": null}, {"id": 1473457103123, "note": "<div>What type of <b>V/Q mismatch</b> occurs due to <b>pulmonary embolus</b>?</div><div><br></div><div>{{c1::Dead space*}} </div>", "time": null}, {"id": 1473457111077, "note": "<div>What type of <b>V/Q mismatch</b> occurs due to <b>airway obstruction</b>? </div><div><br /></div><div>{{c1::Shunt (perfusion but no ventilation)}} </div>", "time": null}, {"id": 1473457119672, "note": "<div>Does <b>100% O</b><sub style=\"font-weight: bold; \">2</sub> improve <b>Pa</b><sub style=\"font-weight: bold; \">O2</sub> in <u>V/Q mismatch</u> due to <b>physiologic dead space</b>? </div><div><br></div><div>{{c1::Yes, assuming &lt; 100% dead space}}</div>", "time": null}, {"id": 1473457123360, "note": "<div><div>Does <b>100% O</b><sub style=\"font-weight: bold; \">2</sub> improve <b>Pa</b><sub style=\"font-weight: bold; \">O2</sub> in <u>V/Q mismatch</u> due to <b>shunt</b>? </div><div><br></div><div>{{c1::No}}</div></div>", "time": null}, {"id": 1473457126772, "note": "<div>Certain organisms that thrive in <b>high O<sub>2</sub> </b>(e.g. TB) flourish in the {{c1::<u>apex</u>}} of the lung</div>", "time": null}, {"id": 1473457135988, "note": "With <b>exercise</b> (increased cardiac output), there is <u>vasodilation</u> of <b>{{c2::apical}} capillaries</b> in the lung, which causes the <b>V/Q ratio</b> to approach a value of {{c1::<b>1</b>}} ", "time": null}, {"id": 1473457167822, "note": "<b>Breathing</b> as an <u>involuntary</u> process is controlled by the <b>{{c1::medulla}}</b> and <b>{{c2::pons}}</b> of the <b>brain stem</b>", "time": null}, {"id": 1473462191670, "note": "<div>The <b>{{c1::medullary}} respiratory center</b> is located in the <b>reticular formation</b> and contains an <u>inspiratory</u> and <u>expiratory</u> center</div>", "time": null}, {"id": 1473462194805, "note": "<div>The <b>dorsal</b> and <b>ventral respiratory groups</b> are located in the {{c1::medulla}} of the brain stem</div>", "time": null}, {"id": 1473462198021, "note": "<div>The <b>{{c1::dorsal}} respiratory group</b> is primarily responsible for <b>{{c2::inspiration}}</b> and generates the <u>basic rhythm</u> for breathing</div>", "time": null}, {"id": 1473462201615, "note": "<div>The <b>dorsal respiratory group</b> receives <i>sensory</i> input from <u>peripheral chemoreceptors</u> via the {{c1::<b>glossopharyngeal</b> (CN IX)}} and {{c1::<b>vagus</b> (CN X)}} <b>nerves</b></div>", "time": null}, {"id": 1473462213152, "note": "<div>The <b>dorsal respiratory group</b> receives <i>sensory</i> input from <u>lung stretch receptors</u> via the {{c1::<b>vagus</b> (CN X)}} <b>nerve</b></div>", "time": null}, {"id": 1473462227997, "note": "<div>The <b>dorsal respiratory group</b> sends its <i>motor</i> output to the <u>diaphragm</u> via the <b>{{c1::phrenic}}</b> <b>nerve</b></div>", "time": null}, {"id": 1473462233981, "note": "<div>The <b>{{c1::ventral}} respiratory group</b> is primarily responsible for <b>{{c2::expiration}}</b> and is <u>not</u> active during normal, quiet breathing</div>", "time": null}, {"id": 1473462237789, "note": "<div>The <b>{{c1::apneustic}} center</b> is located in the <b>lower pons</b> and {{c2::<u>stimulates</u>}} inspiration</div>", "time": null}, {"id": 1473462247915, "note": "<div>The <b>{{c1::pneumotaxic}} center</b> is located in the <b>upper pons</b> and {{c2::<u>inhibits</u>}} inspiration</div>", "time": null}, {"id": 1473462256883, "note": "<div>Commands from the <b>{{c1::cerebral cortex}}</b> can <i>temporarily</i> override the <u>automatic</u> respiratory brain stem centers</div>", "time": null}, {"id": 1473462260997, "note": "<div>Where are the <b>central chemoreceptors</b> located?</div><div><br></div><div>{{c1::Medulla}}</div>", "time": 1660105344541.0}, {"id": 1473462263825, "note": "<div><b>Central chemoreceptors</b> are especially sensitive to the <b>{{c1::pH}}</b> of the <b>{{c2::cerebrospinal fluid}}</b> </div>", "time": null}, {"id": 1473462274943, "note": "<div>In response to {{c2::<u>decreased</u>}} <b>pH</b> sensed by<b> chemoreceptors</b>, the breathing rate {{c1::<u>increases</u> (hyperventilation)}}</div>", "time": null}, {"id": 1473462296454, "note": "<div><b>Central chemoreceptors</b> respond <i>indirectly&nbsp;</i>to <u>increased</u> {{c1::Pco<sub>2</sub>}} and <i>directly</i> to&nbsp;<u>decreased</u> {{c1::pH}}</div>", "time": 1660105360860.0}, {"id": 1473462305431, "note": "<div>Where are the <b>peripheral chemoreceptors</b> located? </div><div><br></div><div>{{c1::Carotid bodies and aortic bodies::2}}</div>", "time": null}, {"id": 1473462316560, "note": "<div><b>Peripheral chemoreceptors</b> respond to <u>decreases</u> in {{c1::Pao<sub>2</sub>}} and {{c1::pH}}</div>", "time": null}, {"id": 1473462323490, "note": "<div><b>Peripheral chemoreceptors</b> respond to <u>increases</u> in {{c1::Pco<sub>2</sub>}}</div>", "time": null}, {"id": 1473462329921, "note": "<div><b>Peripheral chemoreceptors</b> respond to <u>decreased</u> Po<sub>2</sub> when the arterial Po<sub>2</sub> is less than {{c1::60}} mmHg</div>", "time": null}, {"id": 1473462342206, "note": "<div><u>Increases</u> in <b>arterial H<sup>+</sup> </b>stimulate the {{c1::carotid}} <b>body peripheral chemoreceptors</b> <i>only</i>, independent of changes in Pco<sub>2</sub> </div>", "time": null}, {"id": 1473462353971, "note": "<div><b>{{c1::Lung stretch}} receptors</b> are <u>mechanoreceptors</u> located in the <b>smooth muscle</b> of the airways</div>", "time": null}, {"id": 1473462358150, "note": "<div><b>Lung stretch receptors</b> cause a(n) {{c1::<u>decreased</u>}}<b> breathing frequency</b> in response to <b>distention of the lungs</b> (Hering-Breuer reflex)</div>", "time": null}, {"id": 1473462361340, "note": "<div><b>{{c1::Irritant}} receptors</b> are located between the airway epithelial cells and are <u>stimulated</u> by <b>noxious substances</b></div>", "time": null}, {"id": 1473462364075, "note": "<div><b>{{c1::Joint}} and {{c1::muscle}} receptors</b> are <u>activated</u> during <b>movement of the limbs</b> and stimulate <i>early</i> breathing during exercise</div>", "time": null}, {"id": 1473462366827, "note": "<b>{{c1::Juxtacapillary (J)}} receptors</b> are located in the <u>alveolar walls</u> and cause <b>rapid, shallow breathing</b> in response to <b>pulmonary capillary engorgement</b> (e.g. left heart failure) ", "time": null}, {"id": 1473465950356, "note": "In response to <b>exercise</b>, there is {{c1::<u>increased</u>}} <b>CO<sub>2</sub> production</b>", "time": null}, {"id": 1473466696206, "note": "<div>In response to <b>exercise</b>, there is {{c1::<u>increased</u>}} <b>O<sub>2</sub> consumption</b></div>", "time": null}, {"id": 1473466699874, "note": "<div>In response to <b>exercise</b>, there is {{c1::<u>increased</u>}} <b>ventilation rate</b> to meet O<sub>2</sub> demand</div>", "time": null}, {"id": 1473466702995, "note": "<div>In response to <b>exercise</b>, the <b>V/Q ratio</b> from <u>apex</u> to <u>base</u> becomes more {{c1::even}} (even or uneven)</div>", "time": null}, {"id": 1473466705886, "note": "<div>In response to <b>exercise</b>, there is {{c1::<u>increased</u>}} <b>pulmonary blood flow</b>, due to <u>increased</u> <b>{{c2::cardiac output}}</b></div>", "time": 1660105356918.0}, {"id": 1473466716293, "note": "<div>In response to <i>strenuous</i> <b>exercise</b>, there is {{c1::<u>decreased</u>}} <b>pH</b>, secondary to {{c1::lactic acidosis}}</div>", "time": 1660105356908.0}, {"id": 1473466719274, "note": "<div>How does <b>Paco<sub>2</sub></b> change in response to <b>exercise</b>?</div><div><br></div><div>{{c1::No change}}</div>", "time": null}, {"id": 1473466722005, "note": "<div>How does <b>Pao<sub>2</sub></b> change in response to <b>exercise</b>?</div><div><br></div><div>{{c1::No change}}</div>", "time": null}, {"id": 1473466724430, "note": "<div>In response to <b>exercise</b>, there is {{c1::<u>increased</u>}} <b><i>venous</i> CO<sub>2</sub> content</b></div>", "time": null}, {"id": 1473466726760, "note": "<div>In response to <b>exercise</b>, there is {{c1::<u>decreased</u>}} <b><i>venous</i> O<sub>2</sub> content</b></div>", "time": null}, {"id": 1473466729435, "note": "<div>In response to <u>decreased</u> atmospheric oxygen (e.g. <b>high altitude</b>), there is a(n) {{c1::<u>decreased</u>}} <b>Pao<sub>2</sub></b></div>", "time": null}, {"id": 1473466732375, "note": "<div>In response to <u>decreased</u> <b>Pao</b><sub style=\"font-weight: bold; \">2</sub> (e.g. high altitude), there is {{c1::<u>increased</u>}} <b>ventilation</b></div>", "time": null}, {"id": 1473466739900, "note": "<div><u>Increased</u> <b>ventilation</b> (e.g. high altitude) causes {{c1::<u>decreased</u>}} <b>Paco<sub>2</sub></b></div>", "time": null}, {"id": 1473466743100, "note": "<div><b>High altitude</b> initially causes <b>{{c3::respiratory}} {{c2::alkalosis}}</b> and <b>hypoxia</b>, which may cause <b>acute {{c1::altitude}} sickness</b></div>", "time": null}, {"id": 1473466750305, "note": "<div>In response to <b>high altitude</b>, there is a <i>chronic</i> {{c1::<u>increase</u>}} in <b>ventilation</b></div>", "time": null}, {"id": 1473466753404, "note": "<div>The <b>respiratory alkalosis</b> that occurs as a result of ascent to <u>high altitude</u> may be treated with <b>{{c1::carbonic anhydrase}} inhibitors</b> </div>", "time": null}, {"id": 1473466761107, "note": "<div>Living at <b>high altitude</b> chronically causes <u>hypoxia</u> which <u>increases</u> the synthesis of {{c1::<b>erythropoietin</b>}}, causing <b>polycythemia</b> </div>", "time": 1660105355582.0}, {"id": 1473466783990, "note": "<div>In response to <b>high altitude</b>, there is a(n) {{c1::<u>increase</u>}} in <b>2,3-BPG</b></div>", "time": null}, {"id": 1473466790168, "note": "<div>In response to <b>respiratory alkalosis</b> (e.g. due to high altitude), there is <u>increased</u> <b>renal</b> <b>excretion</b> of <b>{{c1::HCO<sub>3</sub><sup>-</sup>}} </b> </div>", "time": null}, {"id": 1473466796836, "note": "<div>In response to <i>high altitude</i>, there is <u>chronic hypoxic pulmonary vasoconstriction</u> which results in <b>pulmonary {{c2::hypertension}}</b> and <b>{{c1::RV}} hypertrophy</b></div>", "time": 1660105356916.0}, {"id": 1473466799950, "note": "<div><b>{{c1::Hypoxemia}}</b> is defined as a <u>decrease</u> in<b> {{c2::Pao<sub>2</sub>}}</b></div>", "time": null}, {"id": 1473466803191, "note": "<div>Is the <b>A - a gradient</b> <u>normal</u>, <u>increased</u>, or <u>decreased</u>, in response to <b>high altitude</b>? </div><div><br /></div><div>{{c1::Normal}}</div>", "time": null}, {"id": 1473466810863, "note": "<div><div>Is the <b>A - a gradient</b> <u>normal</u>, <u>increased</u>, or <u>decreased</u>, in response to <b>hypoventilation</b> (e.g. opioid use, obesity hypoventilation syndrome)? </div><div><br /></div><div>{{c1::Normal}}</div></div>", "time": null}, {"id": 1473466822938, "note": "<div><div>Is the <b>A - a gradient</b> <u>normal</u>, <u>increased</u>, or <u>decreased</u>, in response to <b>diffusion defects</b> (e.g. fibrosis, pulmonary edema)? </div><div><br /></div><div>{{c1::Increased}}</div></div>", "time": null}, {"id": 1473466827229, "note": "<div><div><div>Is the <b>A - a gradient</b> <u>normal</u>, <u>increased</u>, or <u>decreased</u>, in response to <b>V/Q mismatch</b>? </div><div><br /></div><div>{{c1::Increased}}</div></div></div>", "time": null}, {"id": 1473466830217, "note": "<div><div><div>Is the <b>A - a gradient</b> <u>normal</u>, <u>increased</u>, or <u>decreased</u>, in response to <b>right-to-left shunts</b>? </div><div><br /></div><div>{{c1::Increased}}</div></div></div>", "time": null}, {"id": 1473466832973, "note": "<div>What cause of <b>hypoxemia</b> is <u>not</u> greatly helped by <b>supplemental O</b><sub style=\"font-weight: bold; \">2</sub>?</div><div><br /></div><div>{{c1::Right-to-left shunt}}</div>", "time": null}, {"id": 1473466841624, "note": "<div><b>{{c1::Hypoxia}}</b> is defined as a <u>decrease</u> of <b>{{c2::O<sub>2</sub> delivery to tissues}}</b></div>", "time": null}, {"id": 1473466844481, "note": "<div><b>Hypoxia</b> may be caused by a(n) {{c1::<u>decreased</u>}} <b>cardiac output</b> </div>", "time": null}, {"id": 1473466847506, "note": "<div><b>{{c1::Hypoxia}}</b> may be caused by <b>{{c1::hypoxemia::hypoxia or hypoxemia}}</b>&nbsp;</div>", "time": null}, {"id": 1473466854672, "note": "<div><b>Hypoxia</b> may be caused by <b>{{c1::anemia}}</b>, due to <u>decreased</u> levels of hematocrit and Hb</div>", "time": null}, {"id": 1473466860013, "note": "<div><b>Hypoxia</b> may be caused by <b>{{c1::carbon monoxide}}</b> <b>poisoning</b>, which <u>decreases the O<sub>2</sub> content</u> of blood </div>", "time": null}, {"id": 1473466862672, "note": "<b>{{c1::Ischemia}}</b> is a cause of <u>O</u><sub>2</sub><u> deprivation</u> due to a <b>loss of blood flow</b> (e.g. impeded arterial flow, decreased venous drainage) ", "time": null}, {"id": 1473466966183, "note": "What <u>clinical features</u> are seen in <b>21\u03b2-hydroxylase deficiency </b>that are a result of <u>increased</u><b> androgen </b>levels in <b>males</b>? <div><br /></div><div>{{c1::Precocious puberty}}</div>", "time": null}, {"id": 1473536763671, "note": "<div><b>Allergic rhinitis</b> is associated with other <u>atopic</u> disorders, such as <b>{{c1::asthma}}</b> and <b>{{c2::eczema}}</b></div>", "time": null}, {"id": 1473536775019, "note": "<div><b>Nasal polyps</b> are associated with <b>{{c1::aspirin-induced asthma}}</b> in <b>adults</b></div>", "time": 1660105354946.0}, {"id": 1473536778562, "note": "<div><b>{{c1::Aspirin-induced asthma}}</b> is characterized by a <u>triad</u> of <b>asthma</b>, <i><b>aspirin-induced</b></i> <b>bronchospasms</b>, and <b>nasal polyps</b></div>", "time": null}, {"id": 1473536833722, "note": "<div><b>Acute epiglottitis</b> may present with <b>muffled voice</b> and <b>inspiratory</b> {{c1::stridor}}</div>", "time": 1660105362163.0}, {"id": 1473547676650, "note": "<b>{{c1::Pneumonia}}</b> is defined as an <u>infection</u> of the <b>lung parenchyma</b>", "time": 1660105339259.0}, {"id": 1473548355407, "note": "<div><b>Pneumonia</b> often occurs when <u>normal defenses</u> are {{c1::impaired}} </div>", "time": 1660105353841.0}, {"id": 1473548369834, "note": "<div><b>Viral pneumonia</b> may damage the {{c1::mucociliary escalator}}, which consequently <u>predisposes</u> to <b>superimposed bacterial pneumonia</b> </div>", "time": 1660105348257.0}, {"id": 1473548378667, "note": "<div>Clinical features of <b>pneumonia</b> include <u>productive</u> <b>cough&nbsp;</b>with <b>{{c1::yellow-green}}</b> or&nbsp;<b>{{c2::rusty}}-colored</b> <b>sputum</b> (due to pus and blood, respectively)</div>", "time": 1660105360641.0}, {"id": 1473548385834, "note": "<div><b>Pneumonia</b> may present with {{c1::<u>decreased</u>}} <b>breath sounds</b> and {{c2::<u>dullness</u>}} to <b>percussion</b></div>", "time": 1660105353843.0}, {"id": 1473548398439, "note": "<div><b>Pneumonia</b> may present as <b>{{c1::tachypnea}}</b> (respiratory rate) with <b>{{c2::pleuritic}} chest pain</b> </div>", "time": 1660105353846.0}, {"id": 1473548408491, "note": "<div>Diagnosis of <b>pneumonia</b> is made by <b>{{c1::CXR}}</b> and <b>sputum</b> &amp; <b>blood</b> <u>gram stain/</u><u>culture</u></div>", "time": 1660105360076.0}, {"id": 1473548430236, "note": "<div><b>{{c1::Lobar}} pneumonia</b> is characterized by <u>consolidation</u> of an <b><i>entire</i> lobe or lung</b></div>", "time": 1660105339746.0}, {"id": 1473548436921, "note": "<div><b>{{c2::Lobar}} pneumonia</b> is characterized by <b>neutrophils</b> in the <u>air sacs</u> with a(n)&nbsp;<b>{{c1::intra-alveolar::location}}</b> <b>exudate</b>&nbsp;</div>", "time": 1660105337745.0}, {"id": 1473548445520, "note": "<div><b>{{c2::Lobar}} pneumonia</b> is commonly caused by <i>{{c1::Streptococcus pneumoniae}}</i> (95%) and <i>{{c3::Klebsiella pneumoniae}}</i> (5%) </div>", "time": 1660105337743.0}, {"id": 1473548457637, "note": "<div><i>Initially</i>, <b>lobar pneumonia</b> presents with {{c1::congestion}} on <u>gross</u> imaging due to <b>congested vessels</b> and <u>proteinaceous</u> <b>edema</b> in the alveolar airspaces</div>", "time": null}, {"id": 1473548462128, "note": "<div>Following the <u>congestion phase</u>, <b>lobar pneumonia </b>presents <i>grossly</i> with <b>{{c1::red hepatization}}</b>, due to exudate, neutrophils, and hemorrhage filling the alveolar air spaces</div>", "time": 1660105358805.0}, {"id": 1473548472722, "note": "<div>Following <u>red hepatization</u>, <b>lobar pneumonia</b> presents <i>grossly</i> with <b>{{c1::gray hepatization}}</b>, due to degradation of red blood cells within exudate</div>", "time": null}, {"id": 1473548476620, "note": "<div>The <i>final</i> phase of <b>lobar pneumonia</b> is {{c1::<b>resolution</b>}} with <u>regeneration</u> of tissue via <b>type {{c2::II}} pneumocytes</b> </div>", "time": null}, {"id": 1473548483092, "note": "<div><div><i>{{c1::Streptococcus pneumoniae}}</i> is the <u>most common cause</u> of <b>community-acquired pneumonia</b></div></div>", "time": null}, {"id": 1473548494127, "note": "<div><div><i>{{c1::Klebsiella pneumoniae::bug}}</i> is a cause of <b>pneumonia</b> that <i>most commonly</i> affects the <b>elderly</b>, <b>alcoholics</b>, and <b>diabetics</b> (due to <u>aspiration</u>)</div></div>", "time": null}, {"id": 1473548504699, "note": "<div><div>Pneumonia due to <i>Klebsiella pneumoniae</i> is caused by <b>enteric flora </b>that are<b> {{c1::aspirated}}</b></div></div>", "time": null}, {"id": 1473548512472, "note": "<div><div><i>{{c2::Klebsiella pneumoniae}}</i> infection is characterized by a <b>thick mucoid capsule</b> that results in gelatinous, <b>{{c1::currant jelly}} sputum</b></div></div>", "time": null}, {"id": 1473548517793, "note": "<div><div><i>Klebsiella pneumoniae</i> is often <u>complicated</u> by {{c1::abscess}} formation in the <b>lungs</b> and <b>liver</b></div></div>", "time": null}, {"id": 1473548523852, "note": "<div><b>{{c1::Bronchopneumonia}}</b> is characterized by <b>{{c2::scattered, patchy}} </b><u>consolidation</u> centered around <b>{{c3::bronchioles}}</b></div>", "time": 1660105340976.0}, {"id": 1473548530340, "note": "<div><b>Bronchopneumonia</b> is often <u>multifocal</u> and {{c1::<u>bilateral</u>::uni- or bilateral}}&nbsp;</div>", "time": 1660105361095.0}, {"id": 1473548541545, "note": "<div>What type of <b>pneumonia</b> is characterized by <b>acute inflammatory infiltrates</b> from&nbsp;<u>bronchioles</u> into <u>adjacent alveoli</u>?</div><div><br></div><div>{{c1::Bronchopneumonia}}</div>", "time": null}, {"id": 1473548558814, "note": "<div>What type of <b>pneumonia</b> is typically caused by <i>S. pneumoniae</i>, <i>S. aureus</i>, <i>H. influenzae</i>, and <i>Klebsiella</i>?  </div><div><br></div><div>{{c1::Bronchopneumonia}}</div>", "time": 1660105344775.0}, {"id": 1473548565827, "note": "<div><div><i>{{c1::Streptococcus pneumoniae}}</i> is the <u>most common cause</u> of <b>secondary pneumonia</b> </div></div><div><br></div><div><i>2nd and 3rd are...</i></div>", "time": null}, {"id": 1473548575017, "note": "<div><b>Pneumonia</b> due to <i>Staphylococcus aureus</i> is often <u>complicated</u> by <b>{{c1::abscess}}</b> <b>formation</b> or <b>{{c2::empyema}}</b> (pus in the pleural space)</div>", "time": null}, {"id": 1473548585240, "note": "<div><i>{{c1::Haemophilus influenzae}}, </i><i>{{c2::Moraxella catarrhalis}}</i>, and <i>{{c3::Legionella}}</i> are common causes of <b>pneumonia superimposed on {{c4::<u>COPD</u>}}</b></div>", "time": 1660105340167.0}, {"id": 1473548603861, "note": "<div><div><i>{{c1::Legionella pneumophila}}</i> is a cause of <b>pneumonia</b> that is transmitted from <b>{{c2::water}} sources</b></div></div>", "time": null}, {"id": 1473548608652, "note": "<div><i>{{c1::Legionella pneumophila}}</i> is a cause of <b>pneumonia</b> in&nbsp;<u>immunocompetent</u> patients that is best visualized by <b>{{c2::silver}} stain</b></div>", "time": null}, {"id": 1473548613652, "note": "<div><b>{{c1::Interstitial (atypical)}} pneumonia</b> is characterized by <b>diffuse </b><u>interstitial</u><b> infiltrates</b></div>", "time": null}, {"id": 1473548626793, "note": "<div><b>{{c1::Atypical}} pneumonia</b> is characterized by <b>diffuse</b>, <b>patchy </b>inflammation that is localized to <u>{{c2::interstitial}} areas</u> at <b>alveolar walls</b> </div>", "time": 1660105341083.0}, {"id": 1473548638343, "note": "<div>How many <u>lobes</u> does <b>interstitial (atypical) pneumonia</b> typically involve? </div><div><br></div><div>{{c1::<u>&gt;</u> 1}}</div>", "time": 1660105357973.0}, {"id": 1473548642198, "note": "<div><b>{{c1::Interstitial (atypical)}} pneumonia</b> presents with relatively <u>mild</u> <b>upper</b> <b>respiratory</b> <b>symptoms</b> </div>", "time": null}, {"id": 1473548655128, "note": "<div>What type of <b>pneumonia</b> is typically caused by <i>Mycoplasma, Chlamydia, Legionella</i> and viruses (RSV, CMV, influenza, adenovirus)? </div><div><br></div><div>{{c1::Interstitial (atypical) pneumonia}}</div>", "time": 1660105344776.0}, {"id": 1473548659199, "note": "<div><div><i>{{c1::Mycoplasma pneumoniae}} </i>is the <u>most common cause</u> of <b>atypical pneumonia</b> in <b>young adults</b></div></div>", "time": null}, {"id": 1473548663216, "note": "<div><div>What <u>demographic</u> is commonly affected by <i>Mycoplasma </i><i>pneumoniae</i>? </div><div><br></div><div>{{c1::Young adults, especially those <u>living in close quarters</u>}} </div></div>", "time": null}, {"id": 1473548667856, "note": "<div>One complication of <i>Mycoplasma </i><i>pneumoniae</i> is <b>autoimmune {{c1::hemolytic anemia}}</b> due to high concentrations of <b>cold agglutinins</b> (<b>IgM</b>)</div>", "time": null}, {"id": 1473548674277, "note": "<div>What <b>gram stain</b> is <i>Mycoplasma </i><i>pneumoniae&nbsp;</i>characterized by?</div><div><br></div><div>{{c1::No stain (lacks cell wall)}}</div>", "time": null}, {"id": 1473548678001, "note": "<div><i>{{c2::Chlamydia pneumoniae}}</i> is the <b>second</b> <u>most common cause</u> of&nbsp;<b>{{c1::atypical}} pneumonia</b> in <b>young adults</b></div>", "time": null}, {"id": 1473548691306, "note": "<div>{{c1::<i>Respiratory syncytial virus</i> (RSV)}} is the <u>most common cause</u> of <b>atypical</b> <b>pneumonia</b> in <b>infants</b></div>", "time": null}, {"id": 1473548696191, "note": "<div><i>{{c1::Cytomegalovirus (CMV)}}</i> is a common cause of <b>atypical pneumonia</b> in <u>post-transplant</u> patients on <b>immunosuppressive therapy</b></div>", "time": null}, {"id": 1473548706867, "note": "<div><i>{{c1::Influenza}}</i> is a common <u>viral</u> cause of <b>atypical pneumonia</b> in the <b>elderly</b></div>", "time": null}, {"id": 1473548728383, "note": "<div><i>{{c1::Influenza}}</i> virus <u>increases</u> the risk for <b>superimposed bacterial pneumonia</b> (e.g. by <i>S. aureus</i>, <i>H. influenzae</i>) </div>", "time": null}, {"id": 1473548750523, "note": "<div><i>{{c1::Coxiella burnetii}}</i> infection is a cause of <b>atypical pneumonia</b> with <b>high fever</b> (Q fever)</div>", "time": 1660105340703.0}, {"id": 1473548771424, "note": "<div><b>Lung {{c1::abscess}}</b> is a localized collection of <b>pus</b> within the parenchyma</div>", "time": null}, {"id": 1473548777192, "note": "<div><b>Lung abscess</b> is often caused by {{c1::aspiration}} of <b>oropharyngeal contents</b> </div>", "time": 1660105355516.0}, {"id": 1473548780668, "note": "<div><b>Lung abscess</b> commonly occurs in patients predisposed to <b>{{c1::loss of consciousness}}</b> (e.g. alcoholics, epileptics) </div>", "time": null}, {"id": 1473548786106, "note": "<div><b>Lung abscess</b> may occur in patients with <b>{{c1::bronchial obstruction}}</b> (e.g. cancer)</div>", "time": 1660105355515.0}, {"id": 1473548789577, "note": "<div><b>Lung abscesses</b> are commonly due to <u>{{c1::anaerobic}} bacteria</u> such as <i>{{c2::Bacteroides}}</i>, <i>{{c3::Fusobacterium}}</i>, <i>{{c4::Peptostreptococcus}}</i>, and <i>Prevotella </i></div>", "time": 1660105355514.0}, {"id": 1473548800206, "note": "<div><b>Lung abscesses</b> may present with <b>{{c1::air-fluid levels}}</b> on <u>CXR</u>, which suggests <b>{{c2::cavitation}}</b></div>", "time": 1660105355510.0}, {"id": 1473548807864, "note": "<div>What&nbsp;<u>drug</u> is commonly used to treat <b>lung abscesses</b>? </div><div><br></div><div>{{c1::Clindamycin}}</div>", "time": null}, {"id": 1473548811354, "note": "<div><b>Lung abscess</b> <u>secondary</u> to <b>aspiration</b> is most commonly found in the <b>{{c1::right::left/right}} lung</b></div>", "time": 1660105355497.0}, {"id": 1473548850675, "note": "<div><b>Primary TB</b> classically forms a(n)&nbsp;<b>{{c1::Ghon complex}}</b>, which is a <u>calcified</u> <b>granulomatous lesion</b> with <b>hilar lymphadenopathy</b></div>", "time": null}, {"id": 1473548885497, "note": "<div>What <u>type</u> of <b>pneumonia</b> may be caused by <b>tuberculosis</b>?</div><div><br></div><div>{{c1::Tuberculous bronchopneumonia}}</div>", "time": null}, {"id": 1473548941011, "note": "<div>What<b> stain</b> is <i>Mycobacterium </i><i>tuberculosis&nbsp;</i>characterized by?</div><div><br></div><div>{{c1::Acid fast}}<br></div>", "time": null}, {"id": 1473548962473, "note": "<div>Which <b>zone of the lung</b> has the <u>highest</u> <b>Pao</b><sub style=\"font-weight: bold; \">2</sub>? </div><div><br /></div><div>{{c1::Zone 1}}</div>", "time": null}, {"id": 1473609295329, "note": "In<b> paradoxical splitting</b>, the split sound is \"paradoxically\" eliminated with {{c1::<b>inspiration</b>}}", "time": null}, {"id": 1473623659476, "note": "<div><b>Obstructive lung diseases</b> are characterized by <u>obstruction of air flow</u> resulting in <b>air</b> <b>{{c1::trapping}}</b> in lungs</div>", "time": null}, {"id": 1473627804555, "note": "<div><b>{{c2::Obstructive}} lung diseases</b> are characterized by a(n) {{c1::<u>decreased</u>}} <b>FEV<sub>1</sub>/FVC ratio</b> </div>", "time": null}, {"id": 1473627813737, "note": "<div><b>Obstructive lung diseases</b> are characterized by a(n) {{c1::<u>increased</u>}} <b>total lung capacity</b></div>", "time": null}, {"id": 1473627818097, "note": "<div><b>Obstructive lung diseases</b> are characterized by a(n) {{c1::<u>increased</u>}} <b>residual volume</b> and <b>functional residual capacity</b> </div>", "time": null}, {"id": 1473627826312, "note": "<div><b>{{c3::Chronic bronchitis}}</b> is defined as a(n)&nbsp;<u>{{c1::productive cough}}</u> lasting <u>&gt;</u> {{c2::3}} months per year for <u>&gt;</u> {{c2::2}} years</div>", "time": null}, {"id": 1473627834849, "note": "<div><b>Chronic bronchitis</b> is highly associated with <b>{{c1::smoking::risk factor}}</b></div>", "time": null}, {"id": 1473627839070, "note": "<div><b>Chronic bronchitis</b> is characterized by <u>hypertrophy/hyperplasia</u> of <b>bronchial {{c1::mucinous}} glands</b> </div>", "time": null}, {"id": 1473627847403, "note": "<div><b>{{c3::Chronic bronchitis}}</b> leads to an <u>increased</u> <b>{{c1::Reid}} index</b>, which is the <i>thickness</i> of <b>{{c2::mucus glands}}</b> relative to the <b>{{c2::overall bronchial wall}}</b> <i>thickness</i> </div>", "time": null}, {"id": 1473627856119, "note": "<div>In <b>chronic bronchitis</b>, the <b>Reid index</b> is &gt; {{c1::50}}% (normal is &lt; {{c1::40}}%) </div>", "time": null}, {"id": 1473627865232, "note": "<div><b>Chronic bronchitis</b> is associated with {{c1::cyanosis}}, due to <u>early-onset hypoxemia</u> from shunting </div>", "time": null}, {"id": 1473627874563, "note": "<div><b>Chronic bronchitis</b> is associated with <b>{{c1::(hypercapnia) CO<sub>2</sub>}} </b>retention due to <b>mucus plug trapping</b></div>", "time": 1660105360761.0}, {"id": 1473627897399, "note": "<div>What <u>sounds</u> may be heard on <i>respiratory exam</i> in a patient with <b>chronic bronchitis</b>? </div><div><br></div><div>{{c1::Wheezing, crackles::2}}</div>", "time": 1660105348056.0}, {"id": 1473627902758, "note": "<div>Chronic complications of <b>chronic bronchitis</b> include <u>pulmonary hypertension</u> with progression to {{c1::cor pulmonale}}</div>", "time": null}, {"id": 1473627906832, "note": "<div><b>Chronic bronchitis</b> patients have <u>increased</u> risk of acquiring {{c1::infection}}</div>", "time": 1660105360759.0}, {"id": 1473627910628, "note": "<div>What effect may <b>chronic bronchitis</b> <i>secondarily</i> have on <u>RBC levels</u>? </div><div><br /></div><div>{{c1::Increased (polycythemia)}}</div>", "time": null}, {"id": 1473627914429, "note": "<div><b>Chronic bronchitis</b> is associated with {{c1::<u>increased</u>}} <b>Paco<sub>2</sub></b> and {{c1::<u>decreased</u>}} <b>Pao<sub>2</sub></b></div>", "time": null}, {"id": 1473627921275, "note": "<div><b>Chronic bronchitis</b> presents with <b>{{c1::productive cough}}</b> due to <u>excessive mucus production</u> and <b>late-onset</b> {{c2::<b>dyspnea</b>}} </div>", "time": null}, {"id": 1473627929151, "note": "<div><b>Emphysema</b> is characterized by {{c1::<u>enlargement</u>}} of air spaces</div>", "time": 1660105359581.0}, {"id": 1473627940622, "note": "<div><b>{{c3::Emphysema}}</b> is characterized by the {{c1::<u>destruction</u>}} of <b>{{c2::alveolar air sacs}}</b></div>", "time": 1660105337103.0}, {"id": 1473627946233, "note": "<div><b>Emphysema</b> is characterized by <u>loss</u> of <b>{{c1::elastic recoil}}</b>, which <u>inhibits</u> the ability to <b>exhale air</b> from the alveoli (air trapping)</div>", "time": 1660105359582.0}, {"id": 1473627951855, "note": "<div><b>Emphysema</b> is characterized by <u>loss</u> of <b>elastic recoil</b>, which may lead to <b>airway {{c1::collapse}}</b> during exhalation</div>", "time": 1660105359583.0}, {"id": 1473627957778, "note": "<div><b>Emphysema</b> is due to an <u>imbalance</u> of {{c1::proteases}} (e.g. elastase) and {{c1::antiproteases}} (e.g. \u03b1<sub>1</sub>-antitrypsin)</div>", "time": null}, {"id": 1473627965295, "note": "<div>Inflammation in the <u>lung</u> normally leads to release of <b>{{c1::proteases}}</b> by <b>{{c2::neutrophils}}</b> and <b>{{c2::macrophages}}</b></div>", "time": 1660105356096.0}, {"id": 1473627969067, "note": "<div><b>{{c1::\u03b1<sub>1</sub>-antitrypsin}}</b> is an enzyme that <u>neutralizes</u> <b>{{c2::proteases (e.g. elastase)}}</b> in the lung </div>", "time": null}, {"id": 1473627972140, "note": "<div><b>Emphysema</b> may be caused by <u>excessive</u> <b>{{c1::inflammation/proteases::general}}</b> or</div><div> <u>lack</u> of <b>{{c2::\u03b1<sub>1</sub>-antitrypsin}}</b> </div>", "time": null}, {"id": 1473627980218, "note": "<div>The <u>most common cause</u> of <b>emphysema </b>is {{c1::smoking}}</div>", "time": 1660105349809.0}, {"id": 1473627988643, "note": "<div><b>{{c3::Smoking}}</b> results in {{c1::<u>centriacinar</u>}} <b>emphysema</b> that is <i>most severe</i> in the <b>{{c2::upper}} lobes</b> of the lung</div>", "time": null}, {"id": 1473627994933, "note": "<div><b>{{c3::\u03b1<sub>1</sub>-antitrypsin deficiency}}</b> results in {{c1::<u>panacinar</u>}} <b>emphysema</b> that is <i>most severe</i> in the <b>{{c2::lower}} lobes</b> of the lung</div>", "time": null}, {"id": 1473627997824, "note": "<div><b>\u03b1<sub>1</sub>-antitrypsin deficiency</b> is caused by a mutation in the {{c2::<b>SERPINA1</b>}} gene which leads to {{c1::<u>misfolding</u>}} of the mutated protein</div>", "time": null}, {"id": 1473628000924, "note": "<div>What <u>liver pathology</u> is associated with <b>\u03b1<sub>1</sub>-antitrypsin deficiency</b>? </div><div><br /></div><div>{{c1::Cirrhosis}}</div>", "time": null}, {"id": 1473628007883, "note": "<div><i>Mutant</i> <b>\u03b1<sub>1</sub>-antitrypsin</b> polymerizes and accumulates in the {{c1::<u>endoplasmic reticulum</u>}} of <b>hepatocytes</b>, resulting in liver damage (e.g. cirrhosis)  </div>", "time": null}, {"id": 1473628011248, "note": "<div><b>{{c3::\u03b1<sub>1</sub>-antitrypsin}} deficiency</b> is characterized by <b>{{c2::pink/purple}} colored</b>, <b>{{c1::PAS}}-positive globules</b> in <u>hepatocytes</u></div>", "time": 1660105336994.0}, {"id": 1473628016236, "note": "<div>What is the <u>normal</u> allele for <b>\u03b1<sub>1</sub>-antitrypsin</b>? </div><div><br></div><div>{{c1::PiM}}</div>", "time": null}, {"id": 1473628019626, "note": "<div><div>What is the <i>most clinically significant</i> <u>mutant</u> allele for <b>\u03b1<sub>1</sub>-antitrypsin</b>? </div><div><br /></div><div>{{c1::PiZ}}</div></div>", "time": null}, {"id": 1473628022683, "note": "<div>What <u>genotype</u> is associated with an <b>asymptomatic phenotype</b> with <u>decreased</u> <b>\u03b1<sub>1</sub>-antitrypsin</b>? </div><div><br /></div><div>{{c1::PiMZ heterozygotes}}</div>", "time": null}, {"id": 1473628025370, "note": "<div><b>PiMZ heterozygotes</b> (\u03b1<sub>1</sub>-antitrypsin) are at <u>significant</u> risk for <b>emphysema</b> if they {{c1::smoke}} </div>", "time": 1660105353917.0}, {"id": 1473628028243, "note": "<div><div>What <u>genotype</u> is associated with significant risk for <b>panacinar emphysema </b>and <b>liver cirrhosis</b> (\u03b1<sub>1</sub>-antitrypsin)?</div><div><br /></div><div>{{c1::PiZZ homozygotes}}</div></div>", "time": null}, {"id": 1473628031956, "note": "<div>Clinical features of <b>emphysema</b> include <b>dyspnea</b> and <b>cough&nbsp;</b>with {{c1::<u>minimal</u>::quantity}} sputum production</div>", "time": 1660105360644.0}, {"id": 1473628043600, "note": "<div><b>{{c3::Emphysema}}</b> often presents with {{c1::<u>prolonged</u>}} <b>expiration</b> with <b>{{c2::pursed}} lips</b> </div>", "time": 1660105337100.0}, {"id": 1473628051921, "note": "<div><b>Emphysema</b> may present with <b>weight {{c1::loss}}</b> </div>", "time": 1660105359580.0}, {"id": 1473628054935, "note": "<div><b>Emphysema</b> is characterized by <u>increased</u> {{c1::<b>AP</b>}} <b>diameter</b> with a <u>flattened</u> <b>{{c2::diaphragm}}</b> on CXR</div>", "time": null}, {"id": 1473628062986, "note": "<div><b>Emphysema</b> may present with {{c1::<u>increased</u>}} <b>lung field lucency</b> on CXR</div>", "time": null}, {"id": 1473628066058, "note": "<div><u>Chronic</u> complications of <b>emphysema</b> include <b>{{c1::hypoxemia}}</b> (due to destruction of capillaries in the alveolar sac) with eventual <b>cor pulmonale</b></div>", "time": 1660105360753.0}, {"id": 1473628069197, "note": "<div><b>{{c1::Asthma}}</b> is defined as <u>bronchial hyperresponsiveness</u> with <i>reversible</i> <b>airway bronchoconstriction</b> </div>", "time": 1660105341103.0}, {"id": 1473628085810, "note": "<div><b>Asthma</b> is most often due to <b>{{c2::allergic stimuli}}</b> (type {{c1::I}} HSR), but may also be triggered by <b>viral URIs</b> and <b>stress</b></div>", "time": 1660105361519.0}, {"id": 1473628088962, "note": "<div><b>Asthma</b> is often associated with <b>{{c1::allergic rhinitis}}</b>, <b>{{c2::eczema}}</b>, and a family history of <b>{{c3::atopy}}</b></div>", "time": 1660105361517.0}, {"id": 1473628091738, "note": "<div><b>Asthma</b> most commonly presents in {{c1::childhood::age group}}</div>", "time": null}, {"id": 1473628105781, "note": "<div>Re-exposure to an <u>allergen</u> in <b>asthmatics</b> leads to <i>IgE-mediated</i> activation of <b>{{c1::mast}}</b> <b>cells</b></div>", "time": null}, {"id": 1473628107938, "note": "<div>In an <b>asthmatic response</b>, <b>mast cells</b> release <u>preformed</u>&nbsp;{{c1::histamine}} granules (early-phase reaction)</div>", "time": 1660105357473.0}, {"id": 1473628116213, "note": "<div>In an <b>asthmatic response</b>, <b>mast cells</b> lead to <u>generation</u> of <b>leukotrienes&nbsp;</b><b>{{c1::C4}}</b>, <b>{{c1::D4}}</b>, and <b>{{c1::E4}}</b> (early-phase reaction)</div>", "time": null}, {"id": 1473628122928, "note": "<div>One clinical feature of <b>{{c3::asthma}}</b> is a <u>productive cough</u> with <b>{{c1::spiral}}-shaped mucus plugs</b>, known as <b>{{c2::Curschmann spirals}}</b></div>", "time": null}, {"id": 1473628127344, "note": "<div>One clinical feature of <b>{{c3::asthma}} </b>is a <u>productive cough</u> with {{c2::eosinophil}}-derived crystals, known as <b>{{c1::Charcot-Leyden}} crystals</b> </div>", "time": null}, {"id": 1473628137176, "note": "<div><b>Asthma</b> is associated with bronchial <u>smooth muscle</u> {{c1::hypertrophy}}</div>", "time": null}, {"id": 1473628139761, "note": "<div>Clinical diagnosis of <b>asthma</b> may be aided with {{c1::<b>spirometry</b>}} (<i>PFTs</i>) and&nbsp;<b>{{c2::methacholine}} challenge</b></div>", "time": null}, {"id": 1473628142291, "note": "<div><b>Asthma</b> classically presents with <i>episodic</i> <b>cough</b>, <b>dyspnea</b>, and {{c1::wheezing}} (lung sound)</div>", "time": 1660105361522.0}, {"id": 1473628148888, "note": "<div><b>Asthma</b> may present with {{c1::tachypnea::respiratory rate}}&nbsp;</div>", "time": null}, {"id": 1473628151513, "note": "<div>Which form of<b> lung disease</b> is associated with <b>pulsus paradoxus</b>?<div><br></div><div>{{c1::Obstructive::restrictive or obstructive?}}</div></div>", "time": null}, {"id": 1473628154652, "note": "<div><b>Asthma</b> may present with a(n) {{c1::<u>decreased</u>}} <b>inspiratory/expiratory ratio</b> </div>", "time": null}, {"id": 1473628157851, "note": "<div><b>Asthma</b> may cause <u>excessive</u> production of mucus with resultant <b>mucus {{c1::plugging}}</b></div>", "time": 1660105361513.0}, {"id": 1473628163192, "note": "<div><b>Asthma</b> may present with {{c1::peribronchial cuffing}} on CXR</div>", "time": null}, {"id": 1473628168408, "note": "<div>Severe, unrelenting <b>asthma attacks</b> can result in {{c1::<b>status</b> <b>asthmaticus</b>}} and death</div>", "time": 1660105353027.0}, {"id": 1473628171767, "note": "<div><b>{{c1::Bronchiectasis}}</b> is defined as the <u>permanent dilatation</u> of <b>bronchioles</b> and <b>bronchi</b> </div>", "time": 1660105361104.0}, {"id": 1473628182439, "note": "<div><b>Bronchiectasis</b> is due to <i>chronic</i> <b>{{c1::necrotizing}} inflammation</b> or {{c2::obstruction}} which results in <u>permanently</u> dilated airways</div>", "time": 1660105361103.0}, {"id": 1473628185048, "note": "<div><b>{{c1::Bronchiectasis}}</b> is an <u>obstructive lung disease</u> that may be caused by <b>cystic fibrosis</b></div>", "time": null}, {"id": 1473628189728, "note": "<div>Which <u>obstructive lung disease</u> may be caused by <b>Kartagener syndrome</b>? </div><div><br></div><div>{{c1::Bronchiectasis}}</div>", "time": null}, {"id": 1473628192986, "note": "<div><b>Bronchiectasis</b> is associated with bronchial {{c1::obstruction}}, such as a <b>tumor</b> or <b>foreign body</b></div>", "time": 1660105361108.0}, {"id": 1473628195686, "note": "<div><b>Bronchiectasis</b> is associated with <u>poor</u> {{c1::ciliary}} <b>motility</b> (e.g. smoking, Kartagener syndrome)</div>", "time": null}, {"id": 1473628198040, "note": "<div><b>Bronchiectasis</b> is associated with {{c1::allergic bronchopulmonary aspergillosis}}, which is a <b>hypersensitivity</b> <b>reaction</b> to <i>Aspergillus</i></div>", "time": null}, {"id": 1473628200497, "note": "<div>Which <u>obstructive lung disease</u> may be <i>caused</i> by <b>allergic bronchopulmonary aspergillosis</b>? </div><div><br /></div><div>{{c1::Bronchiectasis}} </div>", "time": null}, {"id": 1473628203353, "note": "<div><b>Allergic bronchopulmonary aspergillosis</b> is usually seen in individuals with <b>{{c1::asthma}}</b> or <b>{{c2::cystic fibrosis}}</b></div>", "time": null}, {"id": 1473628206194, "note": "<div><b>Bronchiectasis</b> may present with <b>dyspnea</b> and <b>cough</b> <b>with</b> {{c1::hemoptysis}}</div>", "time": 1660105361101.0}, {"id": 1473628208445, "note": "<div><b>Bronchiectasis</b> is associated with <u>recurrent infections</u> and {{c1::foul}}-smelling, {{c2::purulent}} <b>sputum</b></div>", "time": 1660105361107.0}, {"id": 1473628210480, "note": "<div><b>Bronchiectasis</b> may cause digital {{c1::clubbing}}</div>", "time": null}, {"id": 1473628212871, "note": "<div>Complications of <b>bronchiectasis</b> include <b>secondary&nbsp;</b><b>{{c1::(AA) amyloidosis}}</b> and <u>hypoxemia</u> with&nbsp;<b>cor pulmonale</b></div>", "time": null}, {"id": 1473628215176, "note": "<div>Which <u>obstructive lung disease</u> is associated with <b>secondary (AA) amyloidosis</b>?</div><div><br></div><div>{{c1::Bronchiectasis}}</div>", "time": null}, {"id": 1473636186485, "note": "<b>{{c1::Restrictive}} lung diseases</b> are characterized by a <b>FEV<sub>1</sub>/FVC ratio</b> {{c2::<u>&gt;</u>}} 80% ", "time": null}, {"id": 1473638382739, "note": "<div><div><b>Restrictive lung diseases</b> are characterized by a(n) {{c1::<u>decreased</u>}} <b>total lung capacity</b></div></div>", "time": null}, {"id": 1473638386511, "note": "<div><b>Restrictive lung diseases</b> are characterized by a(n) {{c1::<u>decreased</u>}} <b>residual volume</b> and <b>functional residual capacity</b></div>", "time": null}, {"id": 1473638390443, "note": "<div><b>Restrictive lung diseases</b> are most commonly due to {{c1::interstitial}} diseases of the lung</div>", "time": null}, {"id": 1473638399297, "note": "<div><b>{{c1::Idiopathic pulmonary fibrosis}}</b> is <b>fibrosis of the lung interstitium</b> with <u>unknown</u> cause </div>", "time": null}, {"id": 1473638408068, "note": "<div><b>{{c1::Idiopathic pulmonary fibrosis</b><b>}}</b> is likely related to <u>cyclical lung injury</u>, with <b>{{c2::TGF-\u03b2}}</b> from injured pneumocytes inducing <i>increased</i> <b>collagen deposition</b> and <b>fibrosis</b> </div>", "time": null}, {"id": 1473638411680, "note": "<div><b>Idiopathic pulmonary fibrosis </b>presents clinically with <i>progressive</i> {{c1::dyspnea}}, cough, and digital {{c2::clubbing}}</div>", "time": 1660105357743.0}, {"id": 1473638414516, "note": "<div><b>Idiopathic pulmonary fibrosis</b> is <i>initially</i> seen on CT in <b>{{c1::subpleural}} patches</b></div>", "time": 1660105357744.0}, {"id": 1473638417423, "note": "<div><b>{{c2::Idiopathic pulmonary fibrosis}}</b> eventually results in <i>diffuse</i> fibrosis with end-stage <b>{{c1::honeycomb}}</b> lung on CT </div>", "time": null}, {"id": 1473638423778, "note": "<div>What is the <u>treatment</u> for <b>idiopathic pulmonary fibrosis</b>? </div><div><br></div><div>{{c1::Lung transplant}}</div>", "time": null}, {"id": 1473638435532, "note": "<div><b>{{c1::Pneumoconioses}}</b> are a subset of <u>{{c3::restrictive}} lung diseases</u> characterized by <b><i>interstitial</i> fibrosis</b> due to <b>{{c2::occupational}} exposure</b></div>", "time": null}, {"id": 1473638438470, "note": "<div><b>Pneumoconioses</b> requires <i>chronic</i> exposure to <u>small particles</u> that are {{c1::fibrogenic}}</div>", "time": null}, {"id": 1473638441447, "note": "<div><b>Pneumoconioses</b> are due to release of <u>{{c2::fibrogenic}} factors</u> from <b>{{c1::alveolar macrophages}}</b> that have engulfed foreign, fibrogenic particles</div>", "time": null}, {"id": 1473638444755, "note": "<div><b>Coal workers pneumoconiosis</b> results from <u>prolonged</u> <b>{{c1::coal (carbon) dust}} exposure</b> </div>", "time": 1660105360546.0}, {"id": 1473638448026, "note": "<div><b>{{c2::Coal workers pneumoconiosis}}</b> is also known as \"<b>{{c1::black lung}} disease</b>\" </div>", "time": 1660105338168.0}, {"id": 1473638455081, "note": "<div><i>Mild</i> exposure to <b>carbon</b> (e.g. pollution) results in <b>{{c1::anthracosis}}</b>, which is an <u>asymptomatic condition</u> characterized by collections of <b>carbon-laden macrophages</b> </div>", "time": null}, {"id": 1473638462376, "note": "<div><b>Coal workers pneumoconiosis</b> most commonly affects the <b>{{c1::upper}} lobes </b>of the lung</div>", "time": null}, {"id": 1473638465183, "note": "<div><b>{{c1::Coal workers pneumoconiosis}}</b> is characterized by <b>macrophages laden with {{c2::carbon}}</b>, causing inflammation and fibrosis  </div>", "time": null}, {"id": 1473638467997, "note": "<div><b>Silicosis</b>&nbsp;is a pneumoconiosis that results from <u>prolonged</u> <b>{{c1::silica}} exposure</b></div>", "time": 1660105337374.0}, {"id": 1473638470562, "note": "<div><b>Silicosis</b> is seen in <b>{{c2::sandblasters}}</b>, <b>silica miners</b>, and <b>{{c1::foundries}}</b> </div>", "time": 1660105352952.0}, {"id": 1473638477155, "note": "<div><b>Silica</b> may <u>impair</u> <b>{{c1::macrophages}}</b> and&nbsp;<u>disrupt</u> <b>{{c1::phagolysosome}}&nbsp;</b>formation,&nbsp;<i>increasing</i> <i>susceptibility</i> to <b>{{c2::TB}}</b></div>", "time": null}, {"id": 1473638480163, "note": "<div>What <b>pneumoconiosis</b> has an <u>increased</u> risk for <b>TB</b>? </div><div><br /></div><div>{{c1::Silicosis}}</div>", "time": null}, {"id": 1473638482935, "note": "<div><b>Silicosis</b> presents with <u>fibrotic nodules</u> in the <b>{{c1::upper}} lobes </b>of the lung</div>", "time": null}, {"id": 1473638486962, "note": "<div><b>Silicosis</b> may present with \"<b>{{c1::eggshell}}</b>\" <b>calcification</b> of the {{c2::hilar}} lymph nodes</div>", "time": null}, {"id": 1473638516753, "note": "<div><b>Berylliosis</b> <u>increases</u> risk for {{c1::lung}} cancer</div>", "time": 1660105361299.0}, {"id": 1473638519694, "note": "<div><b>Asbestosis</b> results from <u>prolonged</u> exposure to <b>{{c1::asbestos}}</b> <b>fibers</b></div>", "time": 1660105361553.0}, {"id": 1473638522436, "note": "<div><b>Asbestosis</b> is commonly seen in <b>{{c1::construction}} workers</b>, <b>{{c2::shipyard}} workers</b>, and <b>{{c3::plumbers}}</b></div>", "time": 1660105361556.0}, {"id": 1473638525340, "note": "<div><b>Asbestosis</b>&nbsp;is associated with <u>increased</u> risk for <b>{{c2::lung carcinoma}}</b> and <b>{{c2::mesothelioma}}</b> (cancers)</div>", "time": null}, {"id": 1473638531675, "note": "<div>Which is <u>more common</u> in individuals exposed to <i>asbestos</i>: <b>lung (bronchogenic) carcinoma</b> or <b>mesothelioma</b>? </div><div><br></div><div>{{c1::Lung carcinoma}}</div>", "time": null}, {"id": 1473638538360, "note": "<div><b>{{c1::Asbestosis}}</b> presents with \"<b>Ivory</b> <b>white</b>\", <u>calcified</u>&nbsp;<b>supradiaphragmatic</b> and <b>pleural</b> <b>plaques</b></div>", "time": null}, {"id": 1473638546856, "note": "<div><b>Asbestosis </b>lesions may contain <b>{{c1::Asbestos (ferruginous)}} bodies</b>, which are <b>golden-brown fusiform rods</b> resembling dumbbells </div>", "time": null}, {"id": 1473638553635, "note": "<div><b>Asbestos bodies</b> may be found in an <u>alveolar septum sputum sample</u>, often obtained by {{c1::bronchoalveolar lavage}}</div>", "time": null}, {"id": 1473638557173, "note": "<div><b>Asbestos bodies</b> contain <b>{{c1::iron}}</b> and thus may be visualized using a(n)&nbsp;<b>{{c1::Prussian blue}} stain</b></div>", "time": null}, {"id": 1473638562607, "note": "<div><b>Asbestosis</b> most commonly affects the <b>{{c1::lower}} lobes </b>of the lung</div>", "time": null}, {"id": 1473638564977, "note": "<div><b>{{c1::Caplan}} syndrome</b> is a combination of <b>{{c2::rheumatoid arthritis}}</b> and <b>{{c2::pneumoconiosis}}</b> with intrapulmonary nodules </div>", "time": null}, {"id": 1473638571391, "note": "<div><b>Sarcoidosis</b> is a <i>systemic</i> disease characterized by <u>widespread</u> <b>{{c1::noncaseating}}</b> <b>granulomas</b></div>", "time": null}, {"id": 1473638578406, "note": "<div>What <u>demographic</u> is associated with <b>sarcoidosis</b>? </div><div><br></div><div>{{c1::African American females}}</div>", "time": null}, {"id": 1473638593118, "note": "<div><b>Sarcoidosis</b> is <i>likely</i> due to <b>CD{{c1::4}}<sup>+</sup></b> <b>T-cell</b> <b>response</b> to an <u>unknown</u> antigen</div>", "time": null}, {"id": 1473638595730, "note": "<div><b>Granulomas</b> due to <u>sarcoidosis</u> often have characteristic <b>{{c1::stellate}}-shaped inclusions</b> (<b>{{c2::asteroid}} bodies</b>) within <u>giant</u> cells</div>", "time": null}, {"id": 1473638601304, "note": "<div><b>Granulomas </b>due to <u>sarcoidosis</u> may have <b>{{c1::Schaumann}} bodies</b>, which are <b>calcium</b> and <b>protein inclusions</b> inside of <u>giant</u> cells</div>", "time": null}, {"id": 1473638623505, "note": "<div><u>Granulomas</u> due to <b>sarcoidosis</b> most commonly involve the <b>{{c1::hilar}} lymph nodes </b>and the <b>{{c1::lung}}</b>, leading to <b>{{c2::restrictive}} lung</b> <b>disease</b></div>", "time": null}, {"id": 1473638627379, "note": "<div>What <u>eye</u> pathology is associated with <b>sarcoidosis</b>? </div><div><br></div><div>{{c1::Uveitis}}</div>", "time": null}, {"id": 1473638629779, "note": "<div>What <u>skin</u> pathologies are associated with <b>sarcoidosis</b>? </div><div><br></div><div>{{c1::Cutaneous nodules}}, {{c2::Erythema nodosum}}, {{c3::Lupus Pernio}}</div>", "time": null}, {"id": 1473638633433, "note": "<div><b>Sarcoidosis</b> is associated with <b>{{c1::lupus pernio}}</b>, which are <u>skin lesions on the face</u> <i>resembling</i> <b>lupus</b></div>", "time": null}, {"id": 1473638638181, "note": "<div><b>Sarcoidosis</b> may involve the <u>salivary</u> and <u>lacrimal glands</u>, which mimics <b>{{c1::</b><b>Sj\u00f6grens</b><b>}} syndrome</b> </div>", "time": 1660105353161.0}, {"id": 1473638644560, "note": "<div><b>Sarcoidosis</b> is associated with <b>{{c1::Bell palsy}}</b>, a type of facial paralysis </div>", "time": null}, {"id": 1473638647238, "note": "<div><b>Sarcoidosis</b> is associated with {{c1::<b>hypercalcemia</b>}} due to <u>increased</u> {{c2::<i>1\u03b1-hydroxylase</i>}} activity in <b>epithelioid histiocytes</b><i> </i></div>", "time": null}, {"id": 1473638659728, "note": "<div><b>Sarcoidosis</b> is associated with <u>elevated serum levels</u> of the <i>enzyme</i> {{c1::angiotensin converting enzyme (ACE)::lung}}</div>", "time": null}, {"id": 1473638662414, "note": "<div>What is the <u>treatment</u> for <b>sarcoidosis</b>? </div><div><br /></div><div>{{c1::Steroids (if symptomatic)}}</div>", "time": null}, {"id": 1473638669380, "note": "<div>What are the <u>most common</u> presenting symptoms of <b>pulmonary sarcoidosis</b>? </div><div><br></div><div>{{c1::Dyspnea, Cough::2}}</div>", "time": 1660105347791.0}, {"id": 1473638676765, "note": "<div><b>Sarcoidosis</b> is associated with {{c1::<u>elevated</u>}} CD{{c2::4}}<sup>+</sup>/CD{{c2::8}}<sup>+</sup> ratio in bronchoalveolar lavage fluid</div>", "time": null}, {"id": 1473638685349, "note": "<div><b>Sarcoidosis</b> is often <u>asymptomatic</u> except for <b>enlarged</b> {{c1::lymph nodes}}</div>", "time": 1660105353162.0}, {"id": 1473638690056, "note": "<div><b>Sarcoidosis </b>may be visualized on CXR as {{c1::bilateral hilar lymphadenopathy}} and <b>coarse reticular opacities</b> </div>", "time": null}, {"id": 1473638702772, "note": "<div><b>{{c1::Hypersensitivity pneumonitis}}</b> is an autoimmune reaction that generates <u>{{c2::granulomas}}</u> in response to <b>inhaled <i>organic</i> antigens</b> (e.g. pigeon breeders lung)</div>", "time": null}, {"id": 1473638705750, "note": "<div><b>Hypersensitivity pneumonitis</b> is a mixed type {{c1::III}}/{{c1::IV}} hypersensitivity reaction</div>", "time": null}, {"id": 1473638707900, "note": "<div><b>Hypersensitivity pneumonitis</b> is often seen in {{c1::farmers}} and those exposed to {{c2::birds}}</div>", "time": null}, {"id": 1473638710349, "note": "<div><b>Hypersensitivity pneumonitis</b> presents with {{c1::fever}}, <b>cough</b>, and <b>dyspnea</b> <u>hours</u> after exposure; resolves with removal of exposure </div>", "time": null}, {"id": 1473638717615, "note": "<b>Hypersensitivity pneumonitis</b> can lead to <u><i>interstitial</i> fibrosis</u> and <b>{{c1::restrictive}} lung disease</b> with <i>chronic</i> exposure to the inhaled antigen", "time": 1660105357889.0}, {"id": 1473695370768, "note": "<div>Which <u>dyslipidemia</u> drug is associated with <b>hyperglycemia</b> and <b>hyperuricemia</b> as possible <i>adverse effects</i>?<br><br></div><div>{{c1::Niacin}}</div>", "time": 1660105352464.0}, {"id": 1473697145352, "note": "<div><b>{{c2::Verapamil::Drug}} </b>is a&nbsp;<b>Ca<sup>2+</sup> channel blocker </b>that&nbsp;may cause <b>hyper-{{c1::prolactinemia}}</b> as an <i>adverse effect</i><br></div>", "time": 1660105359230.0}, {"id": 1473699393521, "note": "The <i>normal</i> mean<b> <u>pulmonary</u> artery pressure</b> is between {{c1::10}} and {{c1::14}} mmHg", "time": 1660105349757.0}, {"id": 1473707197132, "note": "<div><b>Pulmonary hypertension</b> is defined as a mean <u>pulmonary artery pressure</u> <u>&gt;</u> {{c1::25}} at rest</div>", "time": 1660105353546.0}, {"id": 1473707200636, "note": "<div><b>Pulmonary hypertension</b> is characterized by {{c1::atherosclerosis}} of the pulmonary trunk</div>", "time": 1660105353551.0}, {"id": 1473707203064, "note": "<div><b>Pulmonary hypertension</b> is characterized by <b>{{c1::smooth muscle (medial)}} {{c2::hypertrophy}}</b> of pulmonary arteries </div>", "time": 1660105353548.0}, {"id": 1473707208537, "note": "<div><b>{{c1::Plexiform}} lesions</b> are <i>small</i>, vascular channels that may be seen with <u>severe</u>, <u>long standing</u> <b>pulmonary </b><b>{{c2::hypertension}}</b> </div>", "time": null}, {"id": 1473707219852, "note": "<div><b>Pulmonary hypertension</b> leads to <b>RV</b> <b>{{c1::hypertrophy}}</b> with eventual <b>{{c2::cor pulmonale}}</b> </div>", "time": null}, {"id": 1473707226820, "note": "<div><b>Pulmonary hypertension</b> may present with <i>exertional</i> {{c1::dyspnea}} and {{c2::right}}-sided heart failure</div>", "time": 1660105353544.0}, {"id": 1473707229598, "note": "<div>What <u>demographic</u> is classically associated with <b><i>primary</i> pulmonary hypertension</b>? </div><div><br></div><div>{{c1::Young adult females}}</div>", "time": 1660105347331.0}, {"id": 1473707232059, "note": "<div><b><i>Heritable</i> {{c3::pulmonary hypertension}}</b> can be due to {{c1::<u>inactivating</u>}} mutations of the <i>{{c2::<b>BMPR2</b>}} </i><b>gene</b> </div>", "time": null}, {"id": 1473707239661, "note": "<div>The <i style=\"font-weight: bold; \">BMPR2</i> <b>gene </b>normally <u>inhibits</u> {{c1::vascular smooth muscle}} proliferation </div>", "time": null}, {"id": 1473707246767, "note": "<div>What is the <u>prognosis</u> of <b><i>heritable</i> pulmonary hypertension</b>? </div><div><br></div><div>{{c1::Poor prognosis}}</div>", "time": null}, {"id": 1473707250397, "note": "<div>The cause of <b><i>primary</i> pulmonary arterial hypertension (PAH)</b> is often {{c1::idiopathic}}</div>", "time": 1660105350363.0}, {"id": 1473707263928, "note": "<div><b>Secondary pulmonary hypertension due to Lung Disease </b>may arise due to {{c1::<b>damage / inflammation</b>}} of lung parenchyma (<i>e.g. COPD / I</i><i>nterstitial lung disease) or </i>{{c2::<b>hypoxic pulmonary vasoconstriction</b>}} <i>(e.g. obstructive sleep apnea, high altitude) </i></div>", "time": 1660105353096.0}, {"id": 1473707272647, "note": "<div><b>Secondary pulmonary hypertension due to Heart Disease</b> may arise due to <u>increased</u> {{c1::<b>volume</b>}} in the pulmonary circuit (e.g. left heart failure, congenital heart disease) </div>", "time": 1660105353097.0}, {"id": 1473707275903, "note": "<div><b>Secondary pulmonary hypertension due to Chronic </b>{{c1::<b>Thromboemboli</b>}} may arise with <u>recurrent</u> pulmonary {{c1::<b>embolism</b>}} or {{c2::<b>microthrombi</b>}}</div>", "time": 1660105353099.0}, {"id": 1473707283021, "note": "<div>Another type of <b>secondary pulmonary hypertension</b> may arise due to {{c1::<b>multifactorial</b>}} causes, such as <b>hematologic</b>, <b>systemic</b>, and <b>metabolic</b> <b>disorders</b> </div>", "time": 1660105361745.0}, {"id": 1473707286558, "note": "<div><b>Acute </b>{{c2::<b>(</b><i style=\"font-weight: bold; \">aka</i><b> </b><i style=\"font-weight: bold; \">Adult</i><b>) respiratory distress syndrome (ARDS)</b>}} is caused by <u>diffuse alveolar damage</u> with impairment of the {{c1::<b>alveolar-capillary</b>}} <b>interface</b></div>", "time": 1660105362105.0}, {"id": 1473707295145, "note": "<div>Damage to the <b>alveolar-capillary interface</b> leads to {{c1::<u>increased</u>}} alveolar-capillary <b>permeability</b> </div>", "time": null}, {"id": 1473707300427, "note": "<div>In <b>ARDS</b>, leakage of <i>protein-rich fluid</i> leads to <u>noncardiogenic</u> <b>pulmonary</b> <b>{{c1::edema}}</b> (normal PCWP) </div>", "time": 1660105357443.0}, {"id": 1473707313998, "note": "<div>In <b>ARDS</b>, leakage of <i>protein-rich fluid</i> leads to formation of <u>intra-alveolar</u> <b>{{c1::hyaline}} membranes</b></div>", "time": 1660105357444.0}, {"id": 1473707322300, "note": "<div>Clinical features of <b>ARDS</b> include <b>hypoxemia</b> and <b>cyanosis&nbsp;</b>with <u>respiratory distress</u> due to a(n) {{c1::thickened}} <b>diffusion barrier</b></div>", "time": 1660105360645.0}, {"id": 1473707340741, "note": "<div>Clinical features of <b>ARDS</b> include <b>hypoxemia</b> and <b>cyanosis&nbsp;</b>with <u>respiratory distress</u> due to {{c1::collapse}} of <b>air sacs</b></div>", "time": null}, {"id": 1473707356801, "note": "<div><b>Acute respiratory distress syndrome</b> presents with a \"{{c1::<b>white-out</b>}}\" appearance on CXR</div>", "time": 1660105362120.0}, {"id": 1473707363543, "note": "<div><b>{{c1::Acute Respiratory Distress Syndrome (ARDS)}}</b> is a clinical syndrome characterized by <u>acute onset respiratory failure</u> with <b>bilateral lung opacities</b> and <b><u>no</u> evidence of HF/fluid overload</b> </div>", "time": 1660105341304.0}, {"id": 1473707387439, "note": "<div><b>ARDS </b>is a diagnosis of exclusion with the following criteria (<i>ARDS</i>)</div><div><b><br /></b></div><div>- <b>A</b>bnormal chest x-ray</div><div>- <b>R</b>espiratory failure within {{c1::1 week}} of insult</div><div>- <b>D</b>ecreased {{c2::Pao<sub>2</sub> / F<sub>IO2</sub>}} ratio </div><div>- <b>S</b>ymptoms of respiratory failure are not due to HF/fluid overload</div>", "time": null}, {"id": 1473707392350, "note": "<div>The causes of <b>{{c8::acute respiratory distress}} syndrome</b> may be remembered with \"<b>SPARTAS</b>\" </div><div style=\"centerbox\"><div class=\"mnemonics\"><div><br/></div><div><b>S</b>: {{c1::Sepsis}}</div><div><b>P</b>: {{c2::Pancreatitis}}, {{c2::Pneumonia}}</div><div><b>A</b>: {{c3::Aspiration}}</div><div><b>R</b>: {{c4::uRemia}} </div><div><b>T</b>: {{c5::Trauma}}</div><div><b>A</b>: {{c6::Amniotic fluid embolism}}</div><div><b>S</b>: {{c7::Shock}}</div></div></div>", "time": null}, {"id": 1473707401320, "note": "<div>In <b>ARDS</b>, <u>activation</u> of <b>{{c2::neutrophils}}</b> by proinflammatory <b>cytokines</b> induces&nbsp;<b>{{c3::free radical}}</b> and<b> {{c3::protease}}-mediated damage</b> of {{c1::<u>both</u> type I <i>and</i> II}} pneumocytes</div>", "time": 1660105357447.0}, {"id": 1473707408559, "note": "<div>Treatment of <b>ARDS</b> includes addressing the {{c1::underlying cause}}</div>", "time": null}, {"id": 1473707412227, "note": "<div>Treatment of <b>ARDS</b> includes <u>mechanical ventilation</u> with <b>{{c2::positive end-expiratory pressure (PEEP)}} </b>and<b> </b>most importantly <b>{{c1::low}} tidal volumes</b> </div>", "time": null}, {"id": 1473707419762, "note": "<div>Recovery of <b>ARDS</b> may be complicated by {{c1::interstitial fibrosis/scarring}} due to <u>loss</u> of <b>type II pneumocytes</b> </div>", "time": 1660105353438.0}, {"id": 1473707426029, "note": "<div><b>{{c2::Neonatal respiratory distress}} syndrome</b> is respiratory distress due to <u>inadequate</u> <b>{{c1::surfactant}} levels</b></div>", "time": null}, {"id": 1473707428913, "note": "<div><b>Surfactant</b> <u>decreases</u> {{c2::surface tension}} in the lung, <u>preventing</u> {{c1::collapse}} of alveolar air sacs after expiration</div>", "time": null}, {"id": 1473707435818, "note": "<div><b>Neonatal respiratory distress syndrome</b> is associated with {{c1::premature}} birth </div>", "time": null}, {"id": 1473707444911, "note": "<div>The <b style=\"font-weight: bold; \">{{c1::lecithin}}:</b><b>{{c2::sphingomyelin}} ratio</b> in amniotic fluid is used to <u>screen</u> for <b>{{c3::lung}} maturity</b> </div>", "time": null}, {"id": 1473707491540, "note": "<div>As <b>surfactant</b> production is increased (fetal lung maturation), {{c1::<b>lecithin</b>}} levels <u>{{c2::increase}}</u>, while <b>{{c1::sphingomyelin}}</b> levels <u>{{c2::remain constant}}</u></div>", "time": null}, {"id": 1473707500365, "note": "<div><div>What <b>lecithin:sphingomyelin ratio</b> is <u>indicative</u> of <b>adequate surfactant production</b>?</div><div><br /></div><div>{{c1::&gt; 2}}</div></div>", "time": null}, {"id": 1473707511363, "note": "<div>What <b>lecithin:sphingomyelin ratio</b> is <u>predictive</u> of <b>NRDS</b>?</div><div><br /></div><div>{{c1::&lt; 1.5}}</div>", "time": null}, {"id": 1473707517311, "note": "<div><b>Neonatal respiratory distress syndrome</b> is associated with <b>{{c1::C-section delivery}}</b> due to <u>decreased</u> <i>stress-induced </i>release of <b>fetal {{c2::glucocorticoids}}</b></div>", "time": null}, {"id": 1473707526525, "note": "<div><b>Neonatal respiratory distress syndrome</b> is associated with <b>{{c1::maternal diabetes}}</b> due to <u>increased</u> levels of <b>fetal</b> <b>{{c2::insulin}}</b></div>", "time": null}, {"id": 1473707532037, "note": "<div>What is the effect of <u>increased</u> <b>fetal insulin</b> on <b>surfactant production</b>? </div><div><br /></div><div>{{c1::Decreased surfactant production}}</div>", "time": null}, {"id": 1473707553199, "note": "<div><b>NRDS</b> presents with {{c1::<u>increased</u>}} <b>respiratory effort </b>after birth </div>", "time": null}, {"id": 1473707561353, "note": "<div><b>NRDS</b> may present with {{c1::tachypnea}} (respiratory rate) with use of <b>accessory</b> <b>muscles</b> and <b>grunting</b> </div>", "time": null}, {"id": 1473707568629, "note": "<div><b>Neonatal respiratory distress syndrome</b> is associated with <u>diffuse granularity</u> of the lung with a \"{{c1::<b>ground</b>-<b>glass</b>}}\" appearance on CXR</div>", "time": null}, {"id": 1473707574858, "note": "<div><b>NRDS</b> increases risk for <u>persistence</u> of a(n)&nbsp;<b>{{c1::patent ductus arteriosus}}</b> due to persistently {{c2::<u>low</u>}} <b>O<sub>2</sub> tension</b> (hypoxemia)</div>", "time": null}, {"id": 1473707579754, "note": "<div>What <u>GI pathology</u> is associated with <b>neonatal respiratory distress syndrome</b> due to hypoxemia? </div><div><br></div><div>{{c1::Necrotizing enterocolitis}}</div>", "time": null}, {"id": 1473707585027, "note": "<div>In patients with <b>neonatal respiratory distress syndrome</b>, {{c2::supplemental O<sub>2</sub>}} therapy <u>increases</u> the risk for <b>{{c1::free radical}} injury</b></div>", "time": null}, {"id": 1473707587717, "note": "<div><b>{{c1::Retinopathy of prematurity}}</b> is an <u>eye complication</u> associated with {{c2::supplemental O<sub>2</sub>}} therapy in <b>NRDS </b>patients (due to neovascularization) </div>", "time": null}, {"id": 1473707595473, "note": "<div><b>{{c1::Bronchopulmonary dysplasia}}</b> is a <u>respiratory complication</u> associated with {{c2::supplemental O<sub>2</sub>}} therapy in <b>NRDS </b>patients</div>", "time": 1660105340973.0}, {"id": 1473707603639, "note": "<div>What <u>treatment</u> may be used to treat <b>neonatal respiratory distress syndrome</b> <i>before birth</i>? </div><div><br></div><div>{{c1::Maternal steroids}}</div>", "time": null}, {"id": 1473707606392, "note": "<div><div>What <u>treatment</u> may be used to treat <b>neonatal respiratory distress syndrome</b> <i>after birth</i>? </div><div><br></div><div>{{c1::Artificial surfactant for the infant}}</div></div>", "time": null}, {"id": 1473707608661, "note": "<div>One test for <u>fetal lung maturity</u> is the <b>{{c2::surfactant}}:</b><b>{{c1::albumin}} ratio</b> in the amniotic fluid</div>", "time": null}, {"id": 1473729868523, "note": "<b>{{c1::Lung}} cancer</b> is the <u>most common cause</u> of cancer <i>mortality</i> in the U.S.", "time": null}, {"id": 1473732867211, "note": "<div>The average age of presentation for <b>lung cancer</b> is {{c1::60}} years old</div>", "time": 1660105350428.0}, {"id": 1473732871582, "note": "<div>The key risk factors for <b>lung cancer</b> are <b>{{c1::cigarette smoke}}</b>, <b>{{c2::radon::not arsenic}}</b>, and <b>{{c3::asbestos}}</b>; family history is also a risk factor</div>", "time": null}, {"id": 1473732879162, "note": "<div><b>{{c1::Polycyclic aromatic hydrocarbons::main}}</b> and <b>{{c2::arsenic}}</b> are particularly <u>mutagenic</u> carcinogens found in <b>cigarette smoke</b></div>", "time": 1660105339253.0}, {"id": 1473732882092, "note": "<div><b>Lung cancer</b> <b>risk</b> is directly related to the <u>duration</u> and the <u>amount</u> of <b>smoking</b>, which is measured in {{c1::pack-years}}</div>", "time": null}, {"id": 1473732886065, "note": "<div><b>{{c1::Radon}}</b> is formed by <u>radioactive decay</u> of <b>uranium</b>, which is present in <b>soil</b></div>", "time": 1660105339105.0}, {"id": 1473732889878, "note": "<div><b>Radon</b> accumulates in <u>closed spaces</u>, such as {{c1::basements}}</div>", "time": 1660105353483.0}, {"id": 1473732893483, "note": "<div><b>{{c1::Radon}}</b> is responsible for <i>most</i> of the <u>public exposure</u> to <b>ionizing radiation</b></div>", "time": null}, {"id": 1473732897393, "note": "<div><b>{{c1::Radon}}</b> exposure is the <u>2nd most frequent cause</u> of <b>lung carcinoma</b> in the U.S.</div>", "time": null}, {"id": 1473732900803, "note": "<div><i>Increased</i> risk of <b>lung cancer</b> is seen in <b>{{c1::uranium}} miners</b>, due to <u>increased</u> exposure to <b>radon</b></div>", "time": 1660105356160.0}, {"id": 1473732904737, "note": "<div>Presenting symptoms of <b>lung cancer</b> are <u>non-specific</u> and include <b>cough</b>, <b>hemoptysis</b>, <b>weight</b> <b>{{c2::loss}}</b>, and <b>post-obstructive {{c1::pneumonia}}</b></div>", "time": 1660105353717.0}, {"id": 1473732908452, "note": "<div><b>Lung cancer</b> often presents on CXR with a \"<b>{{c1::coin}}</b>-<b>lesion</b>\" or on CT with a <u>non-calcified</u> nodule </div>", "time": null}, {"id": 1473732927285, "note": "<div>One <u>benign</u> cause of a <b>coin-lesion</b> on CXR is {{c1::granuloma}} (e.g.TB or fungus)</div>", "time": null}, {"id": 1473732940578, "note": "<div>One <u>benign</u> cause of a <b>coin-lesion</b> on CXR is {{c1::<b>bronchial</b> <b>hamartoma</b>}}, which is benign tumor of <b>{{c2::lung tissue}}</b> and <b>{{c2::cartilage}}</b></div>", "time": null}, {"id": 1473732948560, "note": "<div><b>Lung carcinoma</b> is classically divided into <u>two</u> categories: {{c1::small cell carcinoma}} (15%) and {{c1::non-small cell carcinoma}} (85%)</div>", "time": 1660105355506.0}, {"id": 1473732954556, "note": "<div><b>{{c1::Small}} cell carcinoma</b> of the lung is usually <u>not</u> amenable to <i>surgical resection</i> and is thus treated with <b>{{c2::chemotherapy +/- radiation}}</b></div>", "time": 1660105338932.0}, {"id": 1473732957912, "note": "<div><b>{{c1::Non-small}} cell carcinomas</b> of the lung usually do <u>not</u> respond well to <i>chemotherapy</i> and are thus treated upfront with {{c2::<b>surgical</b> <b>resection</b>}}</div>", "time": null}, {"id": 1473732968862, "note": "<div><b>{{c1::Small (oat) cell}} lung carcinoma</b> arises from {{c2::<b>neuroendocrine (Kulchitsky)::general (specific name)</b>}} cells, which are small, dark blue cells</div>", "time": null}, {"id": 1473732979677, "note": "<div>What <u>demographic</u> is associated with <b>small (oat) cell carcinoma</b>?</div><div><br></div><div>{{c1::Male smokers}}</div>", "time": 1660105347341.0}, {"id": 1473732983559, "note": "<div><b>Small (oat) cell carcinoma</b> is {{c1::centrally}} located </div>", "time": null}, {"id": 1473732987672, "note": "<div><b>Small cell carcinoma</b> is characterized <u>histologically</u> by {{c1::<b>poorly</b>}} <b>differentiated</b> <i>small</i> cells and is thus {{c1::<b>very</b>}} <b>aggressive</b></div>", "time": null}, {"id": 1473732995433, "note": "<div><b>{{c2::Small (oat) cell}} lung carcinoma</b> may produce the <u>anterior pituitary</u> hormone <b>{{c1::ACTH}}</b> leading to <b>{{c1::Cushing syndrome}}</b> </div>", "time": null}, {"id": 1473733000524, "note": "<div><b>{{c2::Small (oat) cell}} lung carcinoma</b> may produce the <u>posterior pituitary</u> hormone <b>{{c1::ADH}}</b> leading to <b>{{c1::SIADH}}</b> </div>", "time": null}, {"id": 1473733003619, "note": "<div><b>{{c3::Small (oat) cell}} lung carcinoma</b> may produce <u>antibodies</u> against <b>{{c1::presynaptic Ca<sup>2+</sup> channels}}</b>, causing <b>{{c2::Lambert-Eaton myasthenic}}</b> <b>syndrome</b> </div>", "time": null}, {"id": 1473733007224, "note": "<div><b>{{c3::Small (oat) cell}} lung carcinoma</b> may produce <u>{{c2::antibodies}}</u> against <b>{{c1::neurons}}</b>, which may cause paraneoplastic myelitis, encephalitis, and subacute cerebellar degeneration </div>", "time": null}, {"id": 1473733010517, "note": "<div><b>Small (oat) cell carcinoma</b> is commonly associated with <u>amplification</u> of the {{c1::<i>myc</i>}} oncogene</div>", "time": null}, {"id": 1473733014124, "note": "<div><b>{{c3::Small (oat) cell}} carcinoma</b> of the lung is characterized by <u>positive</u> staining for <b>{{c1::chromogranin A}}</b>, <b>{{c2::neuron-specific enolase}}</b>, <b>{{c4::synaptophysin}}</b>, and <b>{{c5::NCAM}}</b> (<b>CD56)</b></div>", "time": null}, {"id": 1473733017715, "note": "<div><b>Squamous cell carcinoma</b> of the lung is {{c1::centrally}} located</div>", "time": null}, {"id": 1473733024243, "note": "<div><b>{{c3::Squamous cell}} carcinoma </b>of the lung is characterized <u>histologically</u> by <b>{{c2::keratin pearls}}</b> and <b>{{c1::intercellular bridges}}</b> </div>", "time": 1660105337021.0}, {"id": 1473733036646, "note": "<div><b>{{c1::Squamous cell}} carcinoma</b> of the lung is the <u>most common tumor</u> in {{c2::<b>male smokers</b>}}</div>", "time": null}, {"id": 1473733041796, "note": "<div><b>{{c2::Squamous cell}} carcinoma</b> of the lung may produce <b>{{c1::PTHrP}}</b> leading to <b>hyper-{{c1::calcemia}}</b></div>", "time": null}, {"id": 1473733050108, "note": "<div><b>Squamous cell carcinoma</b> of the lung commonly presents as a <b>hilar mass</b> arising from the {{c1::bronchus}} </div>", "time": null}, {"id": 1473733061158, "note": "<div><b>Adenocarcinoma</b> of the lung is {{c1::peripherally}} located</div>", "time": null}, {"id": 1473733068249, "note": "<div><b>{{c3::Adenocarcinoma}} </b>of the lung is characterized <u>histologically</u> by a(n)&nbsp;<b>{{c1::glandular}} pattern</b> that often stains <u>positive</u> for <b>{{c2::mucin}}</b></div>", "time": null}, {"id": 1473733074371, "note": "<div><b>{{c1::Adenocarcinoma}}</b> of the lung is the <u>most common cancer</u> in <b>nonsmokers</b> and <b>female smokers</b> </div>", "time": null}, {"id": 1473733078186, "note": "<div><b>{{c2::Adenocarcinoma}}</b> of the <u>lung</u> is associated with {{c1::<b>hypertrophic osteoarthropathy</b>}} (clubbing)</div>", "time": null}, {"id": 1473733081498, "note": "<div><b>{{c4::Adenocarcinoma}}</b> of the lung is associated with {{c5::<u>activating</u>}} mutations in the <i>{{c1::KRAS}}</i>, <i>{{c2::EGFR}}</i>, and <i>{{c3::ALK}}</i> genes</div>", "time": null}, {"id": 1473733091369, "note": "<div><b>Large cell carcinoma</b> is characterized <u>histologically</u> by <b>{{c1::poorly}} differentiated</b> <i>large</i> cells</div>", "time": 1660105355740.0}, {"id": 1473733098785, "note": "<div><b>Large cell carcinoma</b> of the lung may present <u>histologically</u> with pleomorphic {{c1::giant}} cells</div>", "time": null}, {"id": 1473733105069, "note": "<div><b>{{c2::Large cell}} carcinoma</b> of the lung may secrete the <u>hormone</u> {{c1::<b>\u03b2-hCG</b>}}</div>", "time": null}, {"id": 1473733108775, "note": "<div><div>Is <b>large cell carcinoma</b> related to <u>smoking</u>? </div><div><br></div><div>{{c1::Yes}}</div></div>", "time": 1660105355892.0}, {"id": 1473733111997, "note": "<div><b>Large cell carcinoma</b> of the lung is {{c1::peripherally}} located</div>", "time": null}, {"id": 1473733119649, "note": "<div><div>What is the <u>prognosis</u> of <b>large cell carcinoma</b>? </div><div><br></div><div>{{c1::Poor}}</div></div>", "time": 1660105345587.0}, {"id": 1473733123279, "note": "<div><b>{{c2::Adenocarcinoma in situ}}</b> is characterized <u>histologically</u> by <b>{{c1::columnar::shape}} cells</b> containing <b>mucus</b> that grow along <i>pre-existing </i>bronchioles and alveoli </div>", "time": 1660105338346.0}, {"id": 1473733134696, "note": "<div><b>{{c2::Adenocarcinoma in situ}}</b> is a <u>subtype</u> of adenocarcinoma that typically <i>arises</i> from <b>{{c1::club (Clara)}} cells</b> </div>", "time": 1660105338348.0}, {"id": 1473733138296, "note": "<div>Is <b>bronchioloalveolar carcinoma</b> related to <u>smoking</u>? </div><div><br></div><div>{{c1::No}}</div>", "time": 1660105355912.0}, {"id": 1473733140777, "note": "<div>In regards to lung neoplasias; <b>adenocarcinoma in situ</b> is {{c1::peripherally}} located</div>", "time": 1660105356923.0}, {"id": 1473733143670, "note": "<div><b>{{c2::Adenocarcinoma in situ}}</b> of the lung presents <i>similarly</i> to {{c1::<b>pneumonia</b>}} on CXR (hazy infiltrates, consolidation)</div>", "time": null}, {"id": 1473733146291, "note": "<div>What is the <u>prognosis</u> of <b>bronchioloalveolar carcinoma</b>? </div><div><br></div><div>{{c1::Excellent}}</div>", "time": 1660105345593.0}, {"id": 1473733149553, "note": "<div><b>Bronchial {{c3::carcinoid}} tumor</b> is characterized <u>histologically</u> by nests of <b>{{c1::well}} </b>differentiated <b>{{c2::neuroendocrine}} cells</b></div>", "time": null}, {"id": 1473733154474, "note": "<div><b>Bronchial carcinoid tumor</b> is characterized by <u>positive</u> staining for <b>{{c1::chromogranin A}}</b></div>", "time": null}, {"id": 1473733160737, "note": "<div><div>Is <b>bronchial carcinoid tumor</b> related to <u>smoking</u>? </div><div><br></div><div>{{c1::No}}</div></div>", "time": 1660105355913.0}, {"id": 1473733164970, "note": "<div><div>What is the <u>prognosis</u> of <b>bronchial carcinoid tumor</b>? </div><div><br /></div><div>{{c1::Excellent (low-grade malignancy; rarely metastasizes)}}</div></div>", "time": 1660105345594.0}, {"id": 1473733173413, "note": "<div><b>Bronchial carcinoid tumor</b> classically forms a <u>polyp-like mass</u> in the {{c1::bronchus}}</div>", "time": null}, {"id": 1473733179458, "note": "<div>Symptoms of <b>bronchial carcinoid tumor</b> are related to <b>{{c2::mass effect}}</b> or <b>{{c1::carcinoid syndrome}}</b> </div>", "time": 1660105350666.0}, {"id": 1473733183165, "note": "<div>What does the <b>T</b> of <u>TNM staging</u> for <b>lung cancer</b> represent?</div><div><br></div><div>{{c1::Tumor size and local extension}}</div>", "time": null}, {"id": 1473733186393, "note": "<div><div>What does the <b>N</b> of <u>TNM staging</u> for <b>lung cancer</b> represent?</div><div><br></div><div>{{c1::Spread to regional lymph nodes (<u>hilar</u> and <u>mediastinal</u>)}}</div></div>", "time": null}, {"id": 1473733189446, "note": "<div><div>What does the <b>M</b> of <u>TNM staging</u> for <b>lung cancer</b> represent?</div><div><br></div><div>{{c1::Metastasis}}</div></div>", "time": null}, {"id": 1473733192635, "note": "<div>The {{c1::adrenal gland}} is a <u>unique site</u> of <b>distant metastasis</b> from <b>lung cancer</b></div>", "time": null}, {"id": 1473733196263, "note": "<div><div><b>Lung cancer</b> has a(n) {{c1::low}} <u>5-year survival rate</u> because the disease often presents {{c1::late}} in its course</div></div>", "time": 1660105355507.0}, {"id": 1473733206246, "note": "<div><div>Which is <u>more common</u>, <b>primary lung tumors</b> or <b>metastasis to the lung</b>? </div><div><br></div><div>{{c1::Metastasis}}</div></div>", "time": 1660105342737.0}, {"id": 1473733209170, "note": "<div><div><b>Metastasis to the lung</b> usually presents as <i>multiple</i> {{c1::cannon ball}} nodules on imaging</div></div>", "time": 1660105355274.0}, {"id": 1473733212850, "note": "<div><div>Does <b>metastasis to the lung</b> typically present as <u>single</u> or <u>multiple</u> <b>lesions</b>? </div><div><br></div><div>{{c1::Multiple}}</div></div>", "time": null}, {"id": 1473733215939, "note": "<div><div><b>Metastasis to the lung</b> is most often from {{c1::breast}}, {{c2::colon}}, prostate, and bladder cancer</div></div>", "time": 1660105355276.0}, {"id": 1473733221545, "note": "<div><div>Common sites of metastasis <u>from</u> <b>lung cancer</b> include the {{c1::adrenal gland}}, {{c2::brain}}, {{c3::bone}}, and {{c4::liver}} </div></div>", "time": null}, {"id": 1473733226192, "note": "<div><div><b>Lung cancer</b> is the <u>most common cause</u> of metastasis to the {{c1::brain}} </div></div>", "time": null}, {"id": 1473733237107, "note": "<div>One <u>complication</u> associated with <b>lung cancer</b> is <b>{{c1::pleural effusion}}</b>, which is classically seen with <b>{{c2::adenocarcinoma}}</b> </div>", "time": 1660105354635.0}, {"id": 1473733243986, "note": "<div><b>{{c1::Superior sulcus}} tumor</b> ({{c3::<b>pancoast</b>}} <b>tumor</b>) is any kind of lung carcinoma that occurs in the {{c2::<u>apex</u>}} of the <b>lung</b></div>", "time": null}, {"id": 1473733249792, "note": "<div><b>Pancoast tumors</b> may cause {{c1::<u>Pancoast</u>}}<u> syndrome</u>, which is characterized by <b>shoulder pain</b>, <b>Horner syndrome</b>, <b>atrophy of hand/arm muscles</b>, and <b>edema</b> (due to vascular compression)</div>", "time": null}, {"id": 1473733256463, "note": "<div><div>One <u>complication</u> associated with <b>lung cancer</b> is {{c1::hoarseness}} due to <i>compression</i> of the <b>recurrent laryngeal nerve</b> </div></div>", "time": 1660105354636.0}, {"id": 1473733260207, "note": "<div><div>One <u>complication</u> associated with <b>lung cancer</b> is {{c1::diaphragmatic paralysis}} due to <i>compression</i> of the <b>phrenic nerve</b>     </div></div>", "time": 1660105354637.0}, {"id": 1473733262505, "note": "<div><div>One <u>complication</u> associated with <b>lung cancer</b> is {{c1::superior vena cava}} <b>syndrome</b> due to <i>compression</i> of the <b>SVC</b> </div></div>", "time": 1660105354633.0}, {"id": 1473733268223, "note": "<div><div>One <u>complication</u> associated with <b>lung cancer</b> is {{c1::<b>Horner</b>}} <b>syndrome</b> due to <i>compression</i> of the <b>{{c2::superior cervical}} </b>or <b>{{c3::stellate}} ganglia</b></div></div>", "time": null}, {"id": 1473733270888, "note": "<div><div><b>{{c2::Horner}} syndrome</b> is a <u>triad</u> of <i>ipsilateral</i> {{c1::ptosis}}, {{c1::miosis}}, and {{c1::anhidrosis}} </div></div>", "time": null}, {"id": 1473733277472, "note": "<div><div><b>SVC syndrome</b> is characterized by <u>impaired drainage</u> of the <b>upper extremities</b>, resulting in {{c1::edema}} and dilated collateral veins in the {{c2::upper torso}}</div></div>", "time": null}, {"id": 1473733280489, "note": "<div><div><b>SVC syndrome</b> is characterized by <u>impaired drainage</u> of the <b>head</b>, resulting in \"<b>facial</b> {{c1::<b>plethora</b>}}\"</div></div>", "time": 1660105350679.0}, {"id": 1473733286454, "note": "<div><div><b>SVC syndrome</b> is characterized by <u>impaired drainage</u> of the<b> neck</b>, resulting in {{c1::jugular venous distention}} </div></div>", "time": 1660105350678.0}, {"id": 1473733289550, "note": "<div><div><b>SVC syndrome</b> can be caused by <b>{{c1::thromboemboli}}</b> from indwelling central venous catheters</div></div>", "time": 1660105350680.0}, {"id": 1473733299333, "note": "<div><div><b>SVC syndrome</b> can <u>raise</u> {{c1::intracranial}} pressure (if obstruction is severe), leading to <b>headaches</b> and <b>dizziness</b> </div></div>", "time": null}, {"id": 1473733352058, "note": "<div><b>{{c1::Pneumothorax}}</b> is defined as the <u>accumulation of air</u> in the <b>pleural space</b> </div>", "time": 1660105339258.0}, {"id": 1473733368795, "note": "<div><b>Pneumothorax</b> presents with {{c1::<u>unilateral</u>::uni- or bilateral}}&nbsp;<b>chest pain</b> and <b>expansion</b>, as well as <b>dyspnea</b></div>", "time": 1660105353838.0}, {"id": 1473733371846, "note": "<div><b>Pneumothorax</b> presents with {{c1::decreased}} <b>tactile</b> <b>fremitus</b> on the <u>affected</u> side</div>", "time": 1660105353840.0}, {"id": 1473733374147, "note": "<div><b>Pneumothorax</b>&nbsp;presents with {{c1::<b>hyper</b>}}-<b>resonance</b> on the <u>affected</u> side</div>", "time": 1660105337510.0}, {"id": 1473733376492, "note": "<div><b>Pneumothorax</b> presents with {{c1::diminished}} <b>breath sounds</b> on the <u>affected</u> side</div>", "time": 1660105353839.0}, {"id": 1473733378847, "note": "<div><b>{{c1::Primary spontaneous}} pneumothorax</b> is due to <u>rupture</u> of apical subpleural blebs or cysts</div>", "time": 1660105339182.0}, {"id": 1473733380981, "note": "<div>What <u>demographic</u> is associated with <b>primary spontaneous pneumothorax</b>? </div><div><br></div><div>{{c1::Tall, thin, young males}}</div>", "time": null}, {"id": 1473733383452, "note": "<div><b>{{c1::Secondary spontaneous}} pneumothorax</b> may be due to <u>diseased lung</u> (e.g. bullae in emphysema, infections) or <u>{{c2::meconium}}</u> aspiration</div>", "time": 1660105339002.0}, {"id": 1473733391294, "note": "<div>In <b>{{c2::tension}} pneumothorax</b>, the trachea +/- mediastinum shifts {{c1::<u>away from</u>}} the side of collapse</div>", "time": null}, {"id": 1473733419784, "note": "<div><b>{{c1::Tension}} pneumothorax</b> arises when air enters the pleural space <b>but cannot exit</b>  </div>", "time": 1660105338761.0}, {"id": 1473733428329, "note": "<div><b>Tension pneumothorax</b> needs immediate <b>needle</b> <b>decompression</b> and {{c1::chest tube}}<b> placement</b></div>", "time": 1660105350575.0}, {"id": 1473733430633, "note": "<div><b>{{c1::Mesothelioma}}</b> is a <u>malignancy</u> of the lung <b>{{c2::pleura}}</b> that is highly associated with <b>{{c3::asbestosis}}</b> </div>", "time": 1660105339639.0}, {"id": 1473733439317, "note": "<div><b>Mesothelioma</b> presents with <u>recurrent</u> {{c1::pleural effusions}}, <b>dyspnea</b>, and <b>chest</b> <b>pain</b></div>", "time": 1660105355286.0}, {"id": 1473733441882, "note": "<div><b>Mesothelioma</b> may result in <b>{{c1::hemorrhagic}} pleural effusion</b> (exudative) and <b>pleural thickening</b></div>", "time": 1660105355287.0}, {"id": 1473733443878, "note": "<div>What <u>histological</u> finding may be associated with <b>mesothelioma</b>?</div><div><br></div><div>{{c1::Psammoma bodies}}</div>", "time": null}, {"id": 1473733445739, "note": "<div>Almost all <b>{{c2::mesotheliomas}}</b> are {{c1::<b>calretinin</b>}} <u>positive</u>, which is <u>negative</u> in <i>most</i> carcinomas</div>", "time": null}, {"id": 1473733448257, "note": "<div>Is <u>smoking</u> a risk factor for <b>mesothelioma</b>? </div><div><br></div><div>{{c1::No}}</div>", "time": null}, {"id": 1473793980276, "note": "<b>{{c1::Adenocarcinoma}}</b> is the <u>most common type</u> of <b><i>primary</i> lung carcinoma</b> (40%) ", "time": null}, {"id": 1473957534401, "note": "<b>Aldosterone</b> increases {{c1::<b>K<sup>+</sup></b>}} and {{c1::<b>H<sup>+</sup></b>}} <u>secretion</u> at the <b>distal</b> <b>tubules</b> and <b>collecting</b> <b>duct</b>", "time": null}, {"id": 1473985980516, "note": "<div><u>Primary hemostasis</u> is mediated by interactions between <b>{{c1::platelets}}</b> and the <b>{{c2::vessel wall}}</b></div>", "time": 1660105353698.0}, {"id": 1473985992028, "note": "<div><u>Secondary hemostasis</u> is mediated by the <b>{{c1::coagulation cascade}}</b> </div>", "time": 1660105353105.0}, {"id": 1473985997545, "note": "<div>The <i>first</i> step of <b>primary hemostasis</b> is {{c1::transient vasoconstriction}} of the damaged vessel; which is <i>mediated by</i> {{c2::<u>reflex neural}} stimulation</u> and {{c3::<u>endothelin-1</u>}} release from endothelial cells</div>", "time": 1660105350145.0}, {"id": 1473986001040, "note": "Aggregation is a balance between pro and anti-aggregation factors:<div><br></div><div><b>Pro-aggregation</b> - {{c2::<u>TXA2</u>}} - released by platelets</div><div><br></div><div><b>Anti-aggregation</b> - {{c1::<u>PGI<sub>2</sub></u>}} and {{c1::<u>NO</u>}} - released by endothelial cells</div>", "time": null}, {"id": 1473986009866, "note": "<div>Following <i>transient vasoconstriction</i><b> </b>(<b>primary hemostasis</b>), there is platelet {{c1::adhesion}} to the surface of the disrupted vessel</div>", "time": 1660105358804.0}, {"id": 1473986015897, "note": "<div>When a <u>blood vessel</u> is <i>injured</i>, <b>{{c1::von Willebrand factor (vWF)}}</b> binds exposed <b>{{c2::subendothelial collagen}} </b></div>", "time": null}, {"id": 1473986020742, "note": "<div>In order to adhere to the damaged endothelium, <b>platelets</b> bind <b>{{c1::vWF}}</b> using the <b>{{c2::GPIb}} receptor </b></div>", "time": null}, {"id": 1473986024573, "note": "<div>One source of <b>von Willebrand factor (vWF)</b> is from the <b>{{c1::Weibel-Palade bodies}}</b> of {{c2::endothelial cells}} </div>", "time": null}, {"id": 1473986028528, "note": "<div>One source of <b>von Willebrand factor (vWF)</b> is from the<span class=\"Apple-tab-span\" style=\"white-space: pre\"> </span><b>{{c1::\u03b1}} granules</b> of {{c2::platelets}}</div>", "time": null}, {"id": 1473986031590, "note": "<div>Following <i>platelet adhesion</i> (<b>primary hemostasis</b>), there is platelet {{c1::degranulation::not aggregation}} </div>", "time": 1660105358806.0}, {"id": 1473986034094, "note": "<div><b>Binding </b>of ADP to the <u>P2Y<sub>12</sub></u> receptor in primary hemostasis causes {{c1::<b>shape</b>}} change by upregulating intracellular {{c2::<u>Ca2<sup>+</sup></u>}}, promoting effective platelet plug formation</div>", "time": 1660105361239.0}, {"id": 1473986036899, "note": "<div>Binding of <b>ADP</b> to the P2Y<sub>12</sub> receptor promotes optimal <u>exposure</u> of the <b>{{c1::GPIIb/IIIa}} receptor</b> on platelets</div>", "time": null}, {"id": 1473986040113, "note": "<div>Binding of <b>ADP </b>to the <u>P2Y<sub>12</sub> </u>receptor leads to {{c2::<u>decreased</u>}} {{c1::cAMP}} formation which favors platelet activation</div>", "time": null}, {"id": 1473986043060, "note": "<div>What <u>ion</u> is released from <b>dense granules</b> of <b>platelets</b> during degranulation? </div><div><br /></div><div>{{c1::Ca<sup>2+</sup>}} </div>", "time": null}, {"id": 1473986052600, "note": "<div><b>Thromboxane A<sub>2</sub> (TXA<sub>2</sub>)</b> is synthesized by the platelet enzyme {{c1::<i>cyclooxygenase-1</i> (COX-1)::specific}} </div>", "time": null}, {"id": 1473986059652, "note": "<div><b>Thromboxane A<sub>2</sub></b> promotes platelet {{c1::aggregation}} </div>", "time": null}, {"id": 1473986065214, "note": "<div><i>Following upregulation of GpIIb/IIIa, </i>platelets <b>aggregate </b>at the site of injury via crosslinking of <u>GpIIb/IIIa</u> receptors with {{c1::fibrinogen}} to make a temporary platelet plug</div>", "time": 1660105358803.0}, {"id": 1473986117229, "note": "<div>Binding between <b>GPIIb/IIIa</b> and <b>fibrinogen</b> results in formation of a(n) {{c1::<b><i>weak</i> platelet plug</b>}} </div>", "time": 1660105361243.0}, {"id": 1473986130048, "note": "<div><i>Disorders</i> of <b>primary hemostasis</b> present with symptoms of <u>mucosal</u> and <u>skin</u> {{c1::bleeding}}</div>", "time": 1660105359999.0}, {"id": 1473986132369, "note": "<div><i>Disorders</i> of <b>primary hemostasis</b> present with symptoms of <u>mucosal bleeding</u>, such as {{c1::<b>epistaxis</b>}} (most common overall symptom) </div>", "time": 1660105359998.0}, {"id": 1473986144525, "note": "<div><b>Quantitative</b><i style=\"font-weight: bold; \"> </i><i>disorders</i> of <b>primary hemostasis</b> present with symptoms of <u>skin bleeding</u>, such as <b>{{c1::petechiae}}</b> (1-2 mm)</div>", "time": 1660105353498.0}, {"id": 1473986166644, "note": "<div><b>Petechiae</b> are a sign of <u>thrombocytopenia</u> and are not usually seen with {{c1::qualitative}} platelet disorders</div>", "time": 1660105353980.0}, {"id": 1473986174744, "note": "<div><b>Bleeding time</b> is normally between {{c1::2}} and {{c1::7}} minutes</div>", "time": 1660105361211.0}, {"id": 1473986177028, "note": "<div><b>{{c2::Bleeding time}}</b> is {{c1::<u>prolonged</u>}} in <i>all</i> <b>platelet disorders</b> (both quantitative and qualitative) </div>", "time": 1660105338250.0}, {"id": 1473986179822, "note": "<div><b>{{c1::Immune thrombocytopenic purpura (ITP)}}</b> is due to <u>autoimmune</u> production of <b>Ig{{c2::G}}</b> against <b>{{c3::GPIIb/IIIa}}</b></div>", "time": 1660105357600.0}, {"id": 1473986197639, "note": "<div>The <u>autoantibodies</u> in <b>ITP</b> are <i>produced</i> by plasma cells in the {{c1::spleen}}</div>", "time": null}, {"id": 1473986200310, "note": "<div>The <u>antibody-bound platelets</u> in <b>ITP</b> are consumed by <b>{{c1::splenic macrophages}}</b>, resulting in thrombocytopenia</div>", "time": null}, {"id": 1473986210187, "note": "<div>What demographic is associated with the <u>chronic</u> form of <b>immune thrombocytopenic purpura</b>? </div><div><br /></div><div>{{c1::Women of childbearing age}}</div>", "time": 1660105347340.0}, {"id": 1473986222009, "note": "<div><b>Immune thrombocytopenic purpura</b> presents with {{c1::<u>increased</u>}} <b>bleeding</b> <b>time / PFA</b></div>", "time": null}, {"id": 1473986243860, "note": "<div>The initial <u>treatment</u> for <b>immune thrombocytopenic purpura</b> is {{c1::corticosteroids}}</div>", "time": 1660105349986.0}, {"id": 1473986262035, "note": "<div>The treatment for <u>refractory</u> cases of <b>ITP</b> is {{c1::splenectomy}}</div>", "time": null}, {"id": 1473986269261, "note": "<div><b>{{c1::Microangiopathic hemolytic}} </b><b>anemia</b> occurs when <u>RBCs</u> are \"sheared\" as they cross <b>{{c2::microthrombi}}</b></div>", "time": 1660105339613.0}, {"id": 1473986274259, "note": "<div><b>Microangiopathic hemolytic anemia</b> is often associated with formation of platelet <b>{{c1::microthrombi}}</b> in small vessels</div>", "time": 1660105355240.0}, {"id": 1473986277129, "note": "<div><b>Microangiopathic hemolytic anemia</b> is seen in {{c1::TTP}}, {{c2::HUS}}, and {{c3::HELLP}} syndrome </div>", "time": null}, {"id": 1473986283695, "note": "<div>What type of <u>red blood cell</u> is associated with <b>microangiopathic hemolytic anemia</b>? </div><div><br /></div><div>{{c1::Schistocytes (\"helmet cells\")}}</div>", "time": 1660105344769.0}, {"id": 1473986289344, "note": "<div><b>{{c2::Thrombotic thrombocytopenic purpura (TTP)}}</b> is due to <u>inhibition</u> or <u>deficiency</u><i> </i>of the <b>{{c1::ADAMTS13 (vWF metalloprotease)}} </b>enzyme</div>", "time": null}, {"id": 1473986295017, "note": "<div>In <b>TTP</b>, large, <u>uncleaved vWF multimers</u> lead to <i>increased</i> <b>platelet {{c1::adhesion}}</b> with consequent <b>{{c2::microthrombi}} formation</b></div>", "time": 1660105356559.0}, {"id": 1473986300420, "note": "<div><u>Decreased</u> <b>ADAMTS13</b> (e.g. TTP) is usually due to an acquired {{c1::autoantibody}}</div>", "time": 1660105360184.0}, {"id": 1473986303656, "note": "<div>The <u>pentad</u> of classical symptoms seen in {{c6::<b>thrombotic thrombocytopenic purpura</b> (TTP)}} may be remembered using the mnemonic <b>FAT RN</b>: </div><div style=\"centerbox\"><div class=\"mnemonics\"><div><br/></div><b>F</b>: {{c1::Fever (<i>1/5 patients</i>)}}<div><b>A*</b>: {{c2::Anemia (Microangiopathic Hemolytic Anemia)}}</div><div><b>T*</b>: {{c3::Thrombocytopenia}}</div><div><br/></div><div><b>R</b>: {{c4::Renal symptoms (<i>1/2 of patients</i>)-<i>More common in HUS</i>}}</div><div><b>N</b>: {{c5::Neurologic symptoms (<i>2/3 of patients</i>)-<i>More common in TTP</i>}}</div></div></div>", "time": null}, {"id": 1473986316038, "note": "<div>What is the <u>treatment</u> (3) for <b>thrombotic thrombocytopenic purpura </b>(TTP)? </div><div><br></div><div>{{c1::plasmapheresis}}, {{c2::corticosteroids}}, {{c3::rituximab}}</div>", "time": null}, {"id": 1473986318863, "note": "<div><b>{{c1::Hemolytic uremic syndrome (HUS)}}</b> is characterized by <b>thrombocytopenia</b>, <b>microangiopathic hemolytic anemia</b>, and <b>{{c2::acute renal failure}}</b> </div>", "time": null}, {"id": 1473986325018, "note": "<div><b>{{c2::Hemolytic uremic}}</b> <b>syndrome</b> is classically seen in&nbsp;<b>{{c3::children}}</b> with <i>{{c1::E. coli O157:H7}}</i> dysentery, which results from exposure to undercooked beef</div>", "time": null}, {"id": 1473986338200, "note": "<div><div><b>TTP</b> and <b>HUS </b>present with {{c1::<u>increased</u>}} <b>bleeding</b> <b>time</b></div></div>", "time": 1660105348482.0}, {"id": 1473986341252, "note": "<div><div><b>TTP</b> and <b>HUS</b> present with {{c1::<u>decreased</u>}} <b>platelet</b> <b>count</b></div></div>", "time": 1660105348483.0}, {"id": 1473986344268, "note": "<div><div><b>TTP</b> and <b>HUS</b> typically present with {{c1::<u>normal</u>}} <b>PT </b>and {{c1::<u>normal</u>}} <b>PTT</b> </div></div>", "time": null}, {"id": 1473986353147, "note": "<div><div>The initial <u>treatment</u> for <b>hemolytic uremic syndrome </b>(HUS) is {{c1::plasmapheresis}}</div></div>", "time": null}, {"id": 1473986356940, "note": "<div><b>{{c2::Bernard-Soulier}} syndrome</b> is a <i>qualitative</i> platelet disorder due to a <u>genetic</u> <b>{{c1::GPIb}} deficiency</b></div>", "time": null}, {"id": 1473986359554, "note": "<div><b>{{c2::Bernard-Soulier}} syndrome</b> is characterized by {{c1::<u>enlarged</u> <b>platelets</b>}} on blood smear</div>", "time": null}, {"id": 1473986362035, "note": "<div>In <b>Bernard-Soulier syndrome</b> there is a <i>defect</i> in platelet {{c1::adhesion}}</div>", "time": 1660105357417.0}, {"id": 1473986370477, "note": "<div><b>{{c2::Glanzmann thrombasthenia}}</b> is a <i>qualitative</i> platelet disorder due to a <u>genetic</u> <b>{{c1::GPIIb/IIIa}} deficiency</b></div>", "time": null}, {"id": 1473986373335, "note": "<div>In <b>Glanzmann thrombasthenia</b> there is a <i>defect</i> in platelet {{c1::aggregation}}</div>", "time": null}, {"id": 1473986381071, "note": "<div><b>Glanzmann thrombasthenia</b> is characterized by <u>no</u> {{c1::platelet}} clumping on blood smear </div>", "time": 1660105358632.0}, {"id": 1473986384164, "note": "<div><b>Bernard-Soulier syndrome</b> presents with {{c1::<u>increased</u>}} <b>bleeding</b> <b>time</b></div>", "time": 1660105361303.0}, {"id": 1473986386705, "note": "<div><div><b>Bernard-Soulier syndrome</b> presents with {{c1::<u>normal</u>}} or {{c1::<u>decreased</u>}} <b>platelet</b> <b>count</b> </div></div>", "time": 1660105361302.0}, {"id": 1473986393277, "note": "<div><div><b>Glanzmann thrombasthenia</b> presents with {{c1::<u>increased</u>}} <b>bleeding</b> <b>time</b></div></div>", "time": 1660105358631.0}, {"id": 1473986396022, "note": "<div><div><b>Glanzmann thrombasthenia</b> presents with {{c1::<u>normal</u>}} <b>platelet</b> <b>count</b></div></div>", "time": null}, {"id": 1473986398130, "note": "<div><b>Aspirin</b> <i>irreversibly</i> inactivates the enzyme {{c1::<b><i>cyclooxygenase</i></b>}}, thus <u>decreasing</u> synthesis of {{c2::<b>TXA<sub>2</sub></b>}} and <u>impairing</u> <b>platelet</b> {{c3::<b>aggregation</b>}}</div>", "time": null}, {"id": 1473995163159, "note": "The <u>coagulation cascade</u> generates <b>{{c1::thrombin (factor IIa)}}</b>, which converts <b>fibrinogen</b> in the platelet plug to <b>{{c2::fibrin (factor Ia)}}</b> <div><br></div><div><i><font color=\"#fc02ff\">*BnB expansion: which 4 factors does this activate (positive feedback)?</font></i></div>", "time": null}, {"id": 1473995444571, "note": "<div>After <b>fibrin</b> is formed from fibrinogen, it is <b>{{c1::cross-linked}} </b>by <b>factor {{c2::XIII}}</b> yielding a <i>stable</i> <b>platelet-fibrin thrombus</b></div>", "time": null}, {"id": 1473995463276, "note": "<div>Factors of the <u>coagulation cascade</u> are produced by the {{c1::liver}} in an <b>inactive</b> state</div>", "time": 1660105359344.0}, {"id": 1473995466091, "note": "<div>Activation of the <u>coagulation cascade</u> requires the <b>{{c1::phospholipid}} surface</b> of platelets</div>", "time": 1660105362180.0}, {"id": 1473995468409, "note": "<div>Activation of the <u>coagulation cascade</u> requires <b>{{c1::Ca<sup>2+</sup>}}</b> ions derived from <b>platelet {{c2::dense}} granules</b> </div>", "time": 1660105362179.0}, {"id": 1473995471069, "note": "<div><i>Disorders</i> of <b>secondary hemostasis</b> typically present with <b>{{c1::deep tissue::location}} bleeding</b>&nbsp;</div>", "time": 1660105359994.0}, {"id": 1473995480416, "note": "<div><div><b>{{c1::Prothrombin time (PT)}}</b> measures the {{c2::<u>extrinsic</u>}} and <u>common</u> pathways of the coagulation cascade</div></div>", "time": 1660105339154.0}, {"id": 1473995486704, "note": "<div><div><b>{{c1::Partial thromboplastin time (PTT)}}</b> measures the {{c2::<u>intrinsic</u>}} and <u>common</u> pathways of the coagulation cascade </div></div>", "time": 1660105339340.0}, {"id": 1473995492923, "note": "<div><b>International normalized ratio (INR)</b> is calculated from <b>{{c1::PT::PT or PTT}}</b>&nbsp;</div>", "time": 1660105355986.0}, {"id": 1473995504794, "note": "<div>Which <u>coagulation factor(s)</u> are part of the <i><b>extrinsic</b> </i><b>coagulation<i> </i>cascade</b>? </div><div><br /></div><div>{{c1::Factor VII}}</div>", "time": 1660105343529.0}, {"id": 1473995508259, "note": "<div><div>Which <u>coagulation factor(s)</u> are part of the&nbsp;<i><b>intrinsic</b>&nbsp;</i><b>coagulation<i> </i>cascade</b>? </div><div><br></div><div>{{c1::Factor 8, 9, 11, 12}}</div></div>", "time": 1660105343528.0}, {"id": 1473995525861, "note": "<div><div>Which <u>coagulation factor(s)</u> are part of the <i><b>common</b> </i><b>coagulation<i> </i>cascade</b>? </div><div><br /></div><div>{{c1::Factor 10, 5, 2 (thrombin), 1 (fibrinogen)}}</div></div>", "time": 1660105343530.0}, {"id": 1473995528007, "note": "<div><b>Factor XI</b> of the <u>coagulation cascade</u> is <i>activated</i> by <b>factor {{c1::XIIa}}</b></div>", "time": 1660105359349.0}, {"id": 1473995532126, "note": "<div><b>Factor IX</b> of the <u>coagulation cascade</u> is <i>activated</i> by <b>factor {{c1::XIa}}</b></div>", "time": 1660105359352.0}, {"id": 1473995552377, "note": "<div><b>Factor X</b> of the <u>coagulation cascade</u> may be <i>activated</i> by <b>factor {{c1::VIIa}}</b> (extrinsic pathway) </div>", "time": null}, {"id": 1473995557603, "note": "<div><b>Factor V</b> of the <u>coagulation cascade</u> is <i>activated</i> by <b>factor {{c1::IIa}}</b></div>", "time": 1660105359350.0}, {"id": 1473995562419, "note": "<div><b>Factor II </b>(prothrombin) is activated to <b>thrombin</b> by <b>factor {{c1::Xa}}</b></div>", "time": null}, {"id": 1473995568285, "note": "<div><div><b>{{c1::Tissue thromboplastin}}</b> activates <b>factor {{c2::VII}}</b>, which initiates the <u>extrinsic pathway</u> of the coagulation cascade</div></div>", "time": 1660105338613.0}, {"id": 1473995572360, "note": "<div><div><b>{{c1::Subendothelial collagen}}</b> activates <b>factor {{c2::XII}}</b>, which initiates the <u>intrinsic pathway</u> of the coagulation cascade</div></div>", "time": 1660105338815.0}, {"id": 1473995574937, "note": "<div><b>Hemophilia {{c1::A}}</b> is a <u>coagulation disorder</u> due to a genetic <b>factor {{c2::VIII}} deficiency</b></div>", "time": null}, {"id": 1473995578050, "note": "<div>What is the <u>mode of inheritance</u> of <b>hemophilia A</b>? </div><div><br></div><div>{{c1::X-linked recessive}}</div>", "time": null}, {"id": 1473995580618, "note": "<div><b>Hemophilia A</b> can arise from a(n) {{c1::new (de novo)}} mutation <u>without</u> any family history (20%)</div>", "time": 1660105358373.0}, {"id": 1473995583272, "note": "<div>Which <u>coagulation disorder</u> presents with <b>recurrent hemarthroses</b>, <b>spontaneous / easy bruising</b>, and <b>bleeding after surgery</b>? </div><div><br /></div><div>{{c1::Hemophilia (A, B, C)}}</div>", "time": 1660105343532.0}, {"id": 1473995592393, "note": "<div><div><b>Hemophilia </b>{{c1::<b>B </b>(Christmas disease)}} is a <u>coagulation disorder</u> due to a genetic <b>factor {{c2::IX}} deficiency</b> </div></div>", "time": null}, {"id": 1473995595810, "note": "<div><div>What is the <u>mode of inheritance</u> of <b>hemophilia B</b>? </div><div><br></div><div>{{c1::X-linked recessive}}</div></div>", "time": null}, {"id": 1473995598601, "note": "<div><div><b>Hemophilia {{c1::C}}</b> is a <u>coagulation disorder</u> due to a genetic <b>factor {{c2::XI}} deficiency</b></div></div>", "time": null}, {"id": 1473995601545, "note": "<div><div>What is the <u>mode of inheritance</u> of <b>hemophilia C</b>? </div><div><br /></div><div>{{c1::Autosomal recessive}}</div></div>", "time": null}, {"id": 1473995604345, "note": "<div>Treatment of <b>hemophilia A</b> involves <b>{{c1::desmopressin}}</b> plus recombinant <b>{{c2::factor VIII}}</b> </div>", "time": null}, {"id": 1473995618552, "note": "<div><div><b>Hemophilia (A, B, C)</b> presents with {{c1::<u>normal</u>}} <b>bleeding time</b></div></div>", "time": null}, {"id": 1473995622762, "note": "<div><div><b>Hemophilia (A, B, C)</b> presents with {{c1::<u>normal</u>}} <b>platelet count</b></div></div>", "time": 1660105358375.0}, {"id": 1473995625622, "note": "<div><div><b>Hemophilia (A, B, C)</b> presents with {{c1::<u>normal</u>}} <b>PT </b>and {{c1::<u>increased</u>}} <b>PTT</b> </div></div>", "time": 1660105358374.0}, {"id": 1473995633243, "note": "<div>A <b>coagulation factor inhibitor</b> is a(n) {{c1::<u>acquired antibody</u>}} against a <b>coagulation factor</b>, resulting in <i>impaired</i> factor function</div>", "time": 1660105362573.0}, {"id": 1473995638003, "note": "<div>What is the <u>most common</u> <b>coagulation factor inhibitor</b>?</div><div><br /></div><div>{{c1::Anti-Factor VIII}}</div>", "time": 1660105345903.0}, {"id": 1473995650654, "note": "<div>In <b>hemophilia A</b>, mixing <i>normal</i> plasma with the patients plasma (mixing study) {{c1::<u>does</u>::does/doesnt}} correct the <b>PTT</b>&nbsp;</div>", "time": null}, {"id": 1473995657596, "note": "<div>With a <b>factor VIII</b> <b>coagulation factor inhibitor</b>, mixing <i>normal</i> plasma with a patients plasma {{c1::<u>doesnt</u>::does/doesnt}} correct the <b>PTT</b>&nbsp;</div>", "time": 1660105341465.0}, {"id": 1473995665744, "note": "<div><b>{{c1::Von Willebrand disease}}</b> is characterized by a genetic <b>vWF deficiency</b></div>", "time": null}, {"id": 1473995668705, "note": "<div>What is the <u>most common</u> <i>inherited</i> <b>bleeding/coagulation disorder</b>? </div><div><br></div><div>{{c1::von Willebrand disease}}</div>", "time": null}, {"id": 1473995671286, "note": "<div><div>What is the <u>mode of inheritance</u> of the <i>most common</i> subtype of <b>von Willebrand disease</b>? </div><div><br></div><div>{{c1::Autosomal dominant}}</div></div>", "time": null}, {"id": 1473995674176, "note": "<div>The <i>most common</i> subtype of <b>von Willebrand disease</b> presents with {{c1::decreased}} vWF levels</div>", "time": null}, {"id": 1473995676873, "note": "<div><b>von Willebrand disease</b> typically presents with <i>mild</i> {{c1::mucosal::locations}} and {{c1::skin}} bleeding</div>", "time": 1660105348173.0}, {"id": 1473995679341, "note": "<div><u>Low</u> vWF in <b>von Willebrand disease</b> impairs platelet {{c1::adhesion}}</div>", "time": 1660105355525.0}, {"id": 1473995681855, "note": "<div><div><b>von Willebrand disease</b> presents with {{c1::<u>increased</u>}} <b>bleeding time</b> </div></div>", "time": null}, {"id": 1473995684086, "note": "<div><div><b>von Willebrand disease</b> presents with {{c1::<u>normal</u>}} <b>platelet count</b></div></div>", "time": null}, {"id": 1473995687424, "note": "<div><div><b>von Willebrand disease</b> presents with {{c1::<u>normal</u>}} <b>PT </b>and {{c1::<u>normal</u>}} or {{c1::<u>increased</u>}} <b>PTT</b> </div></div>", "time": null}, {"id": 1473995695173, "note": "<div>Why may <b>PTT</b> be elevated in <b>von Willebrand disease</b>? </div><div><br></div><div>{{c1::Decreased factor VIII half-life (vWF normally stabilizes factor VIII)}}</div>", "time": null}, {"id": 1473995698255, "note": "<div><b>von Willebrand disease</b> is associated with an <u>abnormal</u> {{c1::Ristocetin}} assay</div>", "time": null}, {"id": 1473995704528, "note": "<div><b>Ristocetin</b> induces <u>platelet aggregation</u> by causing {{c1::<b>vWF</b>}} to bind <b>platelet</b> <b>GPIb</b></div>", "time": null}, {"id": 1473995711586, "note": "<div>What is the <u>treatment</u> for <b>von Willebrand disease</b>?</div><div><br></div><div>{{c1::Desmopressin}}</div>", "time": null}, {"id": 1473995714094, "note": "<div><b>Desmopressin</b> <u>increases</u> release of <b>{{c1::vWF}}</b> from <b>{{c2::Weibel-Palade bodies}}</b></div>", "time": null}, {"id": 1473995720927, "note": "<div><b>Vitamin K </b>is necessary for <b>{{c1::gamma carboxylation}}</b> of factors II, VII, IX, X, and proteins C and S </div>", "time": null}, {"id": 1473995736635, "note": "<div>Which <u>coagulation factors</u>&nbsp;have <b>decreased activity</b> due to <b>vitamin K deficiency</b>? </div><div><br></div><div>{{c1::2, 7, 9, 10::4}}</div>", "time": 1660105343527.0}, {"id": 1473995740705, "note": "<div><div>What <u>proteins</u> have <b>decreased activity</b> due to <b>vitamin K deficiency</b>? </div><div><br></div><div>{{c1::Protein C and protein S::2}}</div></div>", "time": null}, {"id": 1473995743024, "note": "<div><b>Vitamin K deficiency</b> may occur in <b>{{c1::newborns}}</b> due to <u>lack</u> of <b>{{c2::colonic bacteria}}</b> that normally synthesize vitamin K </div>", "time": null}, {"id": 1473995752044, "note": "<div><b>Vitamin K deficiency</b> may occur due to <u>long-term</u> {{c1::antibiotic}} therapy, which disrupts the gut flora</div>", "time": null}, {"id": 1473995754384, "note": "<div><b>Vitamin K deficiency</b> may occur due to {{c1::<u>fat</u>}}<u> malabsorption</u>, which leads to deficiency of fat-soluble vitamins</div>", "time": 1660105348209.0}, {"id": 1473995756839, "note": "<div><div><b>Vitamin K deficiency</b> presents with {{c1::<u>normal</u>}} <b>bleeding time</b></div></div>", "time": 1660105348208.0}, {"id": 1473995759027, "note": "<div><div><b>Vitamin K deficiency</b> presents with {{c1::<u>increased</u>}} <b>PT </b>and {{c1::<u>increased </u>(in severe cases)}} <b>PTT</b> </div></div>", "time": null}, {"id": 1473995761090, "note": "<div><u>Abnormal secondary hemostasis</u> may occur due to <b>{{c1::liver}} failure</b>, which causes <u>decreased</u> <i>production</i> of <b>coagulation factors </b>and <u>decreased</u><b>&nbsp;</b><i>activation</i>&nbsp;of&nbsp;<b>vitamin K</b></div>", "time": 1660105362260.0}, {"id": 1473995763371, "note": "<div><u>Abnormal secondary hemostasis</u> may occur due to <b>{{c1::liver}} failure</b>, which causes <u>decreased</u> <i>activation</i> of <b>vitamin K</b></div>", "time": 1660105362261.0}, {"id": 1473995775866, "note": "<u>Abnormal secondary hemostasis</u> may occur due to {{c1::large-volume transfusion}}, which <b>dilutes coagulation factors</b>, resulting in a <i>relative</i> deficiency", "time": 1660105362262.0}, {"id": 1474056842486, "note": "<div><b>Alpha</b> <b>granules</b> of <u>platelets</u> contain {{c1::vW<font color=\"#fc0280\">F</font>}} and <b><font color=\"#fc0280\">f</font>ibrinogen</b><br></div>", "time": null}, {"id": 1474059949481, "note": "<div><div><b>Dense</b> <b>granules</b> of <u>platelets</u> contain {{c1::<b>Ca<sup>2+</sup></b>}} and {{c2::<b>ADP</b>}}</div></div>", "time": null}, {"id": 1474059951940, "note": "<div><b>Heparin-induced thrombocytopenia</b> is a disorder that results in platelet {{c1::activation}} secondary to <u>heparin</u> therapy</div>", "time": null}, {"id": 1474059954350, "note": "<div><b>Heparin-induced thrombocytopenia</b> occurs due to production of <b>Ig{{c1::G}}</b> <b>antibodies</b> against <b>{{c2::heparin-platelet factor IV}} complexes</b></div>", "time": null}, {"id": 1474059956808, "note": "<div>The <b>antibody-heparin-PF4 complex</b> may <u>activate</u> {{c1::platelets}}, leading to <b>thrombosis</b> and <b>thrombocytopenia</b> </div>", "time": 1660105350452.0}, {"id": 1474059964300, "note": "<div><b>{{c1::Disseminated intravascular coagulation (DIC)}}</b> occurs due to <u><i>pathologic</i> activation</u> of the <b>coagulation cascade</b></div>", "time": 1660105340546.0}, {"id": 1474059967657, "note": "<div><b>Disseminated intravascular coagulation (DIC)</b> is characterized by <i>widespread</i> {{c1::microthrombi}} formation, resulting in <b>ischemia</b> and <b>infarction</b></div>", "time": 1660105359990.0}, {"id": 1474059969452, "note": "<div>In <b>disseminated intravascular coagulation</b>, <i>consumption</i> of&nbsp;<u>platelets</u> and <u>factors</u> results in {{c1::bleeding}}</div>", "time": 1660105357330.0}, {"id": 1474059974027, "note": "{{c8::<b>Disseminated Intravascular Coagulation</b> (DIC)}} is almost always&nbsp;<i>secondary</i> to another disease, which may be remembered with \"<b>STOP</b> <b>M</b>aking <b>N</b>ew <b>T</b>hrombi\"<div><br></div><div style=\"centerbox\"><div class=\"mnemonics\"><div><b>S</b>:{{c1::Sepsis}}, {{c1::Snake bite (rattlesnake)}}<div><div><b>T</b>: {{c2::Trauma}}</div><div><b>O</b>: {{c3::*Obstetric complications}}</div><div><b>P</b>: {{c4::Pancreatitis}} (acute)</div><div><b>M</b>aking: {{c5::Malignancy}}</div><div><b>N</b>ew: {{c6::Nephrotic syndrome}}</div><div><b>T</b>hrombi: {{c7::Transfusion}}</div></div></div></div></div>", "time": null}, {"id": 1474059977107, "note": "<div><div><div><b>Disseminated intravascular coagulation</b> may occur secondary to&nbsp;<u>obstetric complications</u> due to <i>activation</i> <i>of the coagulation cascade</i> by {{c1::tissue thromboplastin}} in the <b>amniotic fluid</b></div></div></div>", "time": null}, {"id": 1474059980809, "note": "<div><b>Disseminated intravascular coagulation</b> may occur secondary to <u>sepsis</u>, especially gram {{c1::negative}} bacteria </div>", "time": null}, {"id": 1474059992945, "note": "<div><b>Disseminated intravascular coagulation</b> may occur secondary to <u>malignancy</u>, such as&nbsp;<b>{{c1::adenocarcinoma}}</b>, due to <i>activation of the coagulation cascade</i> by <b>mucin</b></div>", "time": 1660105359989.0}, {"id": 1474059996043, "note": "<div><b>Disseminated intravascular coagulation</b> may occur secondary to <u>malignancy</u>, such as&nbsp;<b>{{c1::acute promyelocytic leukemia}}</b>, due to <i>activation of the coagulation cascade</i> by&nbsp;<b>primary granules</b></div>", "time": null}, {"id": 1474060008420, "note": "<div><b>DIC</b> typically presents with {{c1::<u>increased</u>}} <b>bleeding time</b></div>", "time": null}, {"id": 1474060012250, "note": "<div><div>What type of <u>red blood cell</u> is associated with <b>disseminated intravascular coagulation</b>? </div><div><br></div><div>{{c1::Schistocytes (due to microangiopathic hemolytic anemia)}}</div></div>", "time": null}, {"id": 1474060020070, "note": "<div><b>D-dimers</b> are derived from <u>splitting</u> of {{c1::cross-linked fibrin}} </div>", "time": 1660105360220.0}, {"id": 1474060025715, "note": "<div>Are <b>D-dimers</b> generated from the <u>splitting</u> of <b>fibrinogen</b>? </div><div><br></div><div>{{c1::No}}</div>", "time": null}, {"id": 1474060032363, "note": "<div><u>Treatment</u> of <b>DIC</b> includes <i>transfusion</i> of&nbsp;<b>blood products</b> and <b>{{c1::cryoprecipitate}}</b> as needed</div>", "time": 1660105348559.0}, {"id": 1474060036899, "note": "<div>In the first step of <u>fibrinolysis</u>, <b>{{c1::plasminogen}}</b> is converted to <b>{{c2::plasmin}}</b> via <b>{{c3::tissue plasminogen activator (tPA)}}</b> </div>", "time": null}, {"id": 1474060042847, "note": "<div>One role of <b>plasmin</b> is {{c1::<u>cleavage</u>}} of <b>fibrin</b> <i>and</i> serum <b>fibrinogen</b></div>", "time": 1660105354587.0}, {"id": 1474060045108, "note": "<div>One role of <b>plasmin</b> is {{c1::<u>destruction</u>}} of <b>coagulation factors</b></div>", "time": 1660105354586.0}, {"id": 1474060049763, "note": "<div><b>Plasmin</b> is <u>inactivated</u> by {{c1::<b>\u03b12-antiplasmin</b>}}, which is produced in the liver</div>", "time": null}, {"id": 1474060051855, "note": "<div><i>Disorders</i> of <b>fibrinolysis</b> are due to {{c1::<b>plasmin</b>}} <u>overactivity</u>, resulting in excessive cleavage of <b>serum {{c2::fibrinogen}}</b></div>", "time": 1660105360008.0}, {"id": 1474060054176, "note": "<div><u>Over-activity</u> of <b>plasmin </b>may<b> </b>occur due to <i>activation</i> by <b>{{c2::urokinase}}</b>, which is released following <b>radical {{c1::prostatectomy}}</b></div>", "time": 1660105354455.0}, {"id": 1474060056086, "note": "<div><u>Over-activity</u> of <b>plasmin</b> may occur due to <i>reduced production</i> of <b>{{c1::\u03b12-antiplasmin}}</b> by the <b>liver</b> (e.g. cirrhosis)</div>", "time": 1660105354453.0}, {"id": 1474060058035, "note": "<div><i>Disorders</i> of <b>fibrinolysis</b> present with <u>increased</u> {{c1::bleeding}} (resembles DIC)</div>", "time": 1660105360006.0}, {"id": 1474060061828, "note": "<div><div><i>Disorders</i> of <b>fibrinolysis</b> typically present with {{c1::<u>increased</u>}} <b>PT</b> and {{c1::<u>increased</u>}} <b>PTT</b> </div></div>", "time": 1660105360003.0}, {"id": 1474060067792, "note": "<div><div><i>Disorders</i> of <b>fibrinolysis</b> typically present with {{c1::<u><i>normal</i></u>}} <b>platelet count</b> </div></div>", "time": 1660105360002.0}, {"id": 1474060070226, "note": "<div><div><i>Disorders</i> of <b>fibrinolysis</b> typically present with {{c1::<u>increased</u>}} <b>bleeding time</b> </div></div>", "time": 1660105360004.0}, {"id": 1474060075606, "note": "<div><div><i>Disorders</i> of <b>fibrinolysis</b> typically present with {{c1::<u>decreased</u>}} <b>fibrinogen</b></div></div>", "time": null}, {"id": 1474060077809, "note": "<div><i>Disorders</i> of <b>fibrinolysis</b> typically present with <u>increased</u> <b>{{c1::fibrinogen}} split products</b></div>", "time": 1660105360005.0}, {"id": 1474060080077, "note": "<div><div>Do <i>disorders</i> of <b>fibrinolysis</b> present with <u>elevated</u> <b>D-dimers</b>? </div><div><br /></div><div>{{c1::No}}</div></div>", "time": 1660105359941.0}, {"id": 1474060088165, "note": "Treatment for <i>disorders</i> of <b>fibrinolysis</b> is&nbsp;<b>{{c1::aminocaproic acid}}</b>, which <u>blocks activation</u> of <b>{{c2::plasminogen}}</b>", "time": 1660105348589.0}, {"id": 1474132397341, "note": "<b>Factor X</b> of the <u>coagulation cascade</u> may be <i>activated</i> by <b>factor {{c1::IX}}</b> with <b>factor {{c1::VIII}}</b> as a <u>cofactor</u> (intrinsic pathway)  ", "time": null}, {"id": 1474132602716, "note": "What type of <u>hypersensitivity reaction</u> occurs in <b>polyarteritis nodosa</b>? <div><br /></div><div>{{c1::Type III (immune-complex mediated)}}</div>", "time": null}, {"id": 1474132844495, "note": "What is the <u>next step</u> if a <b>coin-lesion</b> is identified in a patient on CXR? <div><br /></div><div>{{c1::Review previous CXRs and compare}}</div>", "time": 1660105345707.0}, {"id": 1474306785104, "note": "What <u>clinical features</u> are seen in <b>17</b><b>\u03b1-hydroxylase</b> deficiency in <b>males</b> (sex hormone effects)? <div><br /></div><div>{{c1::Pseudo-hermaphroditism: ambiguous genitalia, undescending testes}} </div>", "time": 1660105347423.0}, {"id": 1474340518305, "note": "<div><div><b>Thrombosis</b> most commonly occurs in the {{c1::deep veins (DVT)}} of the leg below the knee </div></div>", "time": 1660105348780.0}, {"id": 1474340536548, "note": "<div>The <i>three</i> major risk factors for <u>thrombosis</u> are <b>{{c1::disruption in blood flow (stasis)}}</b>, <b>{{c2::hypercoagulability}}</b>, and<b> {{c3::endothelial cell damage}}</b> ({{c4::<u>Virchow</u>}}<u> triad</u>)</div>", "time": null}, {"id": 1474340552038, "note": "<div><b>Endothelial cells</b> <u>prevent</u> thrombosis by <i>producing</i> <b>{{c1::prostacyclin (PGI<sub>2</sub>)}}</b> and <b>{{c2::NO}}</b></div>", "time": 1660105359546.0}, {"id": 1474340554238, "note": "<div><b>Prostacyclin (PGI<sub>2</sub>)</b> and <b>NO</b> from <u>endothelial cells</u> cause <b>vaso-{{c1::dilation}}</b></div>", "time": null}, {"id": 1474340556572, "note": "<div>{{c2::<b>Prostacyclin</b> (PGI<sub>2</sub>)}} and <b>{{c3::NO}}</b> from <u>endothelial cells</u> cause <i>inhibition</i> of <b>platelet {{c1::aggregation}}</b> </div>", "time": 1660105337489.0}, {"id": 1474340559882, "note": "<div><b>Endothelial cells</b> <u>prevent</u> thrombosis by <i>secreting</i> <b>{{c1::heparin-like}} molecules</b>, which <u>augment</u> <b>{{c2::antithrombin III (ATIII)}}</b></div>", "time": 1660105359541.0}, {"id": 1474340567887, "note": "<div><b>Antithrombin III</b> {{c1::<u>inactivates</u>::activates or inactivates}}&nbsp;<b>thrombin</b> and <b>coagulation factors</b></div>", "time": 1660105361676.0}, {"id": 1474340571288, "note": "<div><b>Endothelial cells</b> <u>prevent</u> thrombosis by <i>secreting</i> {{c1::<b>tissue plasminogen activator </b>(tPA)}}, which converts plasminogen to plasmin </div>", "time": null}, {"id": 1474340580166, "note": "<div><b>Endothelial cells</b> <u>prevent</u> thrombosis by producing <b>{{c3::thrombomodulin}}</b>, which <i>redirects</i> <b>{{c1::thrombin}}</b> to <u>activate</u> <b>{{c2::protein C}}</b></div>", "time": 1660105359544.0}, {"id": 1474340588031, "note": "<div>Which <u>amino acid</u> may cause <b>endothelial cell damage</b> when serum levels are <i>elevated</i>? </div><div><br /></div><div>{{c1::Homocysteine}}</div>", "time": null}, {"id": 1474340594888, "note": "<div><b>Vitamin B</b><sub style=\"font-weight: bold; \">12</sub> and <b>folate deficiency</b> result in mildly <i>elevated</i> {{c1::homocysteine}} levels, <u>increasing</u> risk for <b>thrombosis</b> </div>", "time": 1660105348239.0}, {"id": 1474340602053, "note": "<div>Which <u>vitamin deficiencies</u> are associated with <i>increased</i> risk for <b>thrombosis</b>? </div><div><br></div><div>{{c1::Vitamin B<sub>12</sub> and B<sub>9</sub> (folate)::2}}</div>", "time": 1660105341582.0}, {"id": 1474340609370, "note": "<div><b>Cystathionine</b> <b>beta synthase</b> (CBS) deficiency results in <u>high</u> {{c1::homocysteine}} levels, <u>increasing</u> risk for <b>thrombosis</b> </div>", "time": null}, {"id": 1474340622747, "note": "<div>The classic presentation of a <u>hypercoagulable state</u> is {{c1::<b>recurrent DVTs</b>}} or {{c2::<b>DVT at a young age</b>}}</div>", "time": 1660105350299.0}, {"id": 1474340632913, "note": "<div><b>Protein C</b> and <b>S</b> normally {{c2::<u>inactivate</u>}} <b>factors</b> <b>{{c1::Va}}&nbsp;</b>and <b>{{c1::VIIIa}}</b></div>", "time": 1660105353615.0}, {"id": 1474340637819, "note": "<div>{{c3::<b>Protein C</b>}}<b> deficiency</b> causes <u>increased</u> risk of <b>{{c1::thrombotic skin necrosis}}</b> with <u>hemorrhage</u> after <b>{{c2::warfarin}}</b> administration</div>", "time": null}, {"id": 1474340647578, "note": "<div>In the <i>initial</i> stages of <b>warfarin therapy</b>, there is a <i>temporary</i> <u>deficiency</u> of {{c1::protein C}} compared to factors II, VII, IX, and X </div>", "time": null}, {"id": 1474340658912, "note": "<div><b>{{c1::Factor V Leiden}}</b> is a mutated form of factor V that is <u>resistant</u> to <i>degradation</i> by activated <b>{{c2::protein C}}</b></div>", "time": null}, {"id": 1474340665996, "note": "<div><b>Factor V Leiden</b> is due to a <i>point mutation</i> near the {{c1::<b>cleavage</b>}} <b>site</b> of factor V</div>", "time": 1660105359351.0}, {"id": 1474340669130, "note": "<div>What point mutation is the cause of <b>Factor V Leiden</b>? </div><div><br /></div><div>{{c1::Arg506Gln (G -&gt; A point mutation)}} </div>", "time": null}, {"id": 1474340675609, "note": "<div>What is the <u>most common</u> <i>inherited</i> cause of <b>hypercoagulable state</b> in <b>Caucasians</b>? </div><div><br></div><div>{{c1::Factor V Leiden}}</div>", "time": null}, {"id": 1474340678804, "note": "<div><b>{{c2::Prothrombin 20210A}}</b> is an inherited <i>point mutation</i> in the <b>prothrombin gene</b> that results in {{c1::<u>increased</u>}} gene expression</div>", "time": null}, {"id": 1474340685900, "note": "<div><b>Prothrombin 20210 mutation</b> is a <u>point mutation</u> in the {{c1::3 untranslated}} region of the gene</div>", "time": 1660105353607.0}, {"id": 1474340691384, "note": "<div>What drug <u>enhances</u> activity of <b>antithrombin</b>? </div><div><br></div><div>{{c1::Heparin}}</div>", "time": null}, {"id": 1474340700648, "note": "<div><div>What <u>coagulation factors</u>&nbsp;are <u>inhibited</u> by <b>antithrombin</b>? </div><div><br></div><div>{{c1::2, 7, 9, 10, 11, 12::6}}</div></div>", "time": 1660105347411.0}, {"id": 1474340703084, "note": "<div><div>What <u>coagulation factors</u> are the <i>principal</i> targets of <b>antithrombin</b>? </div><div><br></div><div>{{c1::IIa (thrombin) and Xa::2}}</div></div>", "time": null}, {"id": 1474340712036, "note": "<div>What is the effect of <b>oral contraceptives</b> on <b>coagulability</b>? </div><div><br /></div><div>{{c1::Increases coaguability}}</div>", "time": null}, {"id": 1474340718532, "note": "<div>What is the effect of <b>estrogen</b> on <u>production</u> of <b>coagulation factors</b>? </div><div><br></div><div>{{c1::Increased production}}</div>", "time": 1660105346533.0}, {"id": 1474340722065, "note": "<div><b>{{c2::Hyper}}-coagulable states</b> are often complicated by <u>recurrent</u> {{c1::<b>pregnancy</b>}} <b>loss</b> (women)</div>", "time": null}, {"id": 1474340730687, "note": "<div><b>Tissue plasminogen activator</b> (tPA) may be administered clinically as a(n) {{c1::thrombolytic}}</div>", "time": null}, {"id": 1474340733586, "note": "<div>The <i>three</i> major risk factors for <u>thrombosis</u> are <b>{{c1::disruption in blood flow (stasis)}}</b>, <b>{{c2::hypercoagulability}}</b>, and<b> {{c3::endothelial cell damage}}</b> ({{c4::<u>Virchow</u>}}<u> triad</u>)</div>", "time": null}, {"id": 1474340749040, "note": "<div>The imaging test of choice for <b>deep venous thrombosis</b> is {{c1::compression ultrasound}}</div>", "time": null}, {"id": 1474340751953, "note": "<div><b>{{c1::DVT}}</b> is a <u>blood clot</u> within a <b>deep vein</b>, causing swelling, redness, warmth, and pain</div>", "time": 1660105340502.0}, {"id": 1474340754145, "note": "<div>What <u>lab test</u> is used clinically to <i>rule out</i> <b>DVT</b> (high sensitivity, low specificity)? </div><div><br></div><div>{{c1::D-dimer}}</div>", "time": null}, {"id": 1474340756655, "note": "<div>Lower limb <b>{{c3::DVT}}</b> may be associated with <b>{{c1::calf pain}}</b> upon <b>{{c2::dorsiflexion}}</b> of the foot ({{c4::<u>Homan</u>}}<u> sign</u>)</div>", "time": null}, {"id": 1474340758802, "note": "<div>{{c1::Unfractioned or LMW heparin}} is used for prophylaxis and <u>acute management</u> of <b>DVT</b> </div>", "time": 1660105338533.0}, {"id": 1474340761077, "note": "{{c1::Oral anticoagulants (e.g. warfarin)}} are used for treatment and <u>long-term prevention</u> of <b>DVT</b> ", "time": 1660105339402.0}, {"id": 1474426134617, "note": "<div><b>{{c1::Atherosclerotic}} embolus</b> is due to an <u>atherosclerotic plaque</u> that embolizes</div>", "time": null}, {"id": 1474426138087, "note": "<div><b>{{c2::Atherosclerotic}} embolus</b> is characterized by the presence of {{c1::<b>cholesterol</b> <b>clefts</b>}} in the embolus</div>", "time": 1660105338288.0}, {"id": 1474426144108, "note": "<div><b>{{c1::Fat}} embolus</b> is associated with <b>bone {{c3::fractures}}</b>, particularly {{c2::<u>long</u>}} bones and soft tissue trauma</div>", "time": null}, {"id": 1474426146952, "note": "<div>When (chronologically) does a <b>fat embolus</b> typically occur following a <b>bone fracture</b>? </div><div><br></div><div>{{c1::While fracture still present or shortly after repair}}</div>", "time": null}, {"id": 1474426149485, "note": "<div>What <u>surgical procedure</u> is associated with <b>fat embolus</b>? </div><div><br></div><div>{{c1::Liposuction}}</div>", "time": null}, {"id": 1474426151822, "note": "<div><b>{{c4::Fat}} emboli</b> are characterized by a <u>triad</u> of:</div><div><br /></div><div>- <b>{{c1::hypox</b><b>}}</b><b>emia</b></div><div>- <b>{{c2::neurologic</b><b>}}</b><b> abnormalities</b></div><div>- <b>{{c3::petechial rash overlying the chest}}</b> </div>", "time": null}, {"id": 1474426154857, "note": "<div><b>Fat emboli</b> commonly presents with <b>{{c1::dyspnea::symptom}}</b> due to <b>fat</b>, often with bone marrow elements, in the <u>pulmonary vessels</u></div>", "time": 1660105359318.0}, {"id": 1474426179963, "note": "<div><b>{{c1::Amniotic fluid}} emboli</b> enter <u>maternal</u> circulation during labor or delivery</div>", "time": null}, {"id": 1474426182572, "note": "<div><b>Amniotic fluid emboli</b> can lead to <u>massive hemorrhage</u> and {{c1::<b>DIC</b>}}, especially <u>postpartum</u>; due to the <i>thrombogenic</i> nature of amniotic fluid </div>", "time": 1660105361864.0}, {"id": 1474426188868, "note": "<div><b>Amniotic fluid emboli</b> may present with <b>{{c2::neurologic}} symptoms</b> and <b>{{c1::respiratory distress}}</b> </div>", "time": 1660105361863.0}, {"id": 1474426192275, "note": "<div><b>{{c1::Amniotic fluid}} emboli</b> are characterized by <b>{{c2::squamous}} cells</b> and <b>{{c3::keratin}} debris</b> in the embolus</div>", "time": 1660105341231.0}, {"id": 1474426211966, "note": "<div><i>Most</i> <b>pulmonary emboli</b> arise via a <u>thromboembolus</u> from the {{c3::<i>proximal</i>}} <b>{{c1::deep veins}}</b> of the <b>{{c2::lower}} extremity</b> </div>", "time": 1660105355131.0}, {"id": 1474426229341, "note": "<div><div>What is the most common <u>symptom</u> of <b>pulmonary embolus</b>? </div><div><br /></div><div>{{c1::Most often clinically silent}}</div></div>", "time": 1660105345807.0}, {"id": 1474426236322, "note": "<div><div><b>Pulmonary emboli</b> are usually clinically <i>silent</i> due to the <u>dual</u> blood supply of the lungs via the <b>{{c1::pulmonary}}</b> and <b>{{c2::bronchial}} arteries</b></div></div>", "time": 1660105353559.0}, {"id": 1474426238805, "note": "<div><div><b>Pulmonary emboli</b> are usually clinically <i>silent</i> as the embolus is usually {{c1::small::size}} and self-resolves</div></div>", "time": 1660105353560.0}, {"id": 1474426241278, "note": "<div><div><b>Pulmonary {{c1::infarction}}</b> due to <b>PE</b> occurs if a <i>large-</i> or <i>medium-sized</i> artery is obstructed in patients with <i>pre-existing</i> {{c2::<u>cardiopulmonary</u>}} compromise</div></div>", "time": 1660105353533.0}, {"id": 1474426251470, "note": "<div><div><b>Pulmonary infarction</b> due to <u>PE</u> may present with <b>{{c1::pleuritic}} chest pain</b> and<b> pleural effusion</b></div></div>", "time": null}, {"id": 1474426253893, "note": "<div><b>Pulmonary infarction</b> due to <u>PE</u> may present with <b>{{c1::tachypnea::RR}}</b>&nbsp;and <b>{{c2::tachycardia::HR}}</b></div>", "time": 1660105353539.0}, {"id": 1474426256653, "note": "<div><div><b>Pulmonary infarction</b> due to <u>PE</u> may present with hemoptysis and <i>sudden-onset</i> {{c1::<b>dyspnea</b>}} and <b>chest pain</b></div></div>", "time": 1660105353540.0}, {"id": 1474426259158, "note": "<div><div>In a patient with a <u>pulmonary emboli</u>, <b>V/Q lung scan</b> shows <b>mismatch</b> due to <u>abnormal</u> {{c1::perfusion}}</div></div>", "time": 1660105357574.0}, {"id": 1474426261606, "note": "<div>The <b>V/Q mismatch</b> seen in <b>pulmonary embolism</b> <u>can</u> result in {{c1::<u>hypoxemia</u>}}, which causes <b>{{c2::hyper}}-ventilation</b> with consequent <b>respiratory</b> <b>{{c2::alkalosis}}</b> </div>", "time": 1660105349386.0}, {"id": 1474426264636, "note": "<div><div>{{c1::<b>Spiral CT</b> (<b>CT pulmonary angiography</b>)}} is the <u>imaging test of choice</u> for <b>pulmonary embolism</b> </div></div>", "time": 1660105338910.0}, {"id": 1474426282700, "note": "<div><div>What may be seen on <b>spiral CT</b> in a patient with a <b>pulmonary embolism</b>? </div><div><br /></div><div>{{c1::Vascular filling defects}}</div></div>", "time": 1660105345172.0}, {"id": 1474426307667, "note": "<div><div><b>Pulmonary embolism</b> may present with {{c1::<u>elevated</u>}} <b>D-dimer</b> </div></div>", "time": 1660105353556.0}, {"id": 1474426314905, "note": "<div><div>Gross examination of <b>pulmonary infarction</b> due to <u>PE</u> reveals a <i>hemorrhagic</i>, {{c1::wedge}}-shaped infarct </div></div>", "time": 1660105358526.0}, {"id": 1474426326611, "note": "<div><div>The <u>wedge-shaped infarct</u> due to <b>pulmonary embolism</b> points {{c1::towards::towards or away}} the area of occlusion&nbsp;</div></div>", "time": 1660105349355.0}, {"id": 1474426331306, "note": "<div><div><b>{{c1::Large saddle}} pulmonary emboli</b> may cause <u>sudden death</u> </div></div>", "time": 1660105339833.0}, {"id": 1474426382395, "note": "<div><div>Death from a <b>saddle pulmonary emboli</b> is due to {{c1::electromechanical}} dissociation</div></div>", "time": 1660105360188.0}, {"id": 1474426389805, "note": "<b>Pulmonary {{c1::hypertension}}</b> may arise with <u>chronic emboli</u> that are <i>reorganized</i> over time ", "time": 1660105353535.0}, {"id": 1474503563246, "note": "<div><b><i>Interstitial</i> restrictive lung diseases</b> are characterized by {{c1::<u>decreased</u>}} <b>diffusing capacity</b> </div>", "time": null}, {"id": 1474503570416, "note": "<div><b><i>Interstitial</i> restrictive lung diseases</b> are characterized by {{c1::<u>increased</u>}} <b>A-a gradients</b> </div>", "time": null}, {"id": 1474503577858, "note": "<div><b><i>Extrapulmonary</i> restrictive lung diseases</b> are characterized by {{c1::<u>normal</u>}} <b>A-a gradients</b></div>", "time": null}, {"id": 1474503594259, "note": "<div><b><i>Extrapulmonary</i> restrictive lung diseases</b> are associated with <u>hypoventilation</u> of {{c1::peripheral::central or peripheral}} origin</div>", "time": null}, {"id": 1474503597137, "note": "<div><div><b>Acute respiratory distress syndrome</b> is a cause of<i> </i>{{c1::<i>interstitial </i><b>restrictive</b>}}<b> lung disease</b></div></div>", "time": null}, {"id": 1474503600195, "note": "<div><div><b>Neonatal respiratory distress syndrome</b> (hyaline membrane disease) is a cause of<i> </i>{{c1::<i>interstitial </i><b>restrictive</b>}} <b>lung disease</b></div></div>", "time": null}, {"id": 1474503602651, "note": "<div>What <u>vasculitis</u> may cause <i>interstitial</i> <b>restrictive lung disease</b>? </div><div><br></div><div>{{c1::Granulomatosis with polyangiitis (Wegener)}}</div>", "time": null}, {"id": 1474503605052, "note": "<div>What <u>anti-arrhythmic agent</u> may cause <i>interstitial</i> <b>restrictive lung disease</b>? </div><div><br></div><div>{{c1::Amiodarone}}</div>", "time": null}, {"id": 1474503607320, "note": "<div>What <u>anti-neoplastic agents</u> may cause <i>interstitial </i><b>restrictive lung disease</b>? </div><div><br></div><div>{{c1::Bleomycin}}, {{c2::busulfan}}, {{c3::methotrexate}}, and procarbazine</div>", "time": null}, {"id": 1474503614121, "note": "<div><b>{{c3::Restrictive}} lung disease</b> may be caused by <u>poor structural apparatus</u>, such as <b>{{c1::scoliosis}}</b> and <b>{{c2::morbid obesity}}</b></div>", "time": 1660105337029.0}, {"id": 1474503616777, "note": "<div><b>{{c4::Restrictive}} lung disease</b> may be caused by <u>poor muscular effort</u>, such as <b>{{c1::polio}}</b>, <b>{{c2::myasthenia gravis::paraneoplastic syndrome}} </b>and <b>{{c3::Guillain-Barr\u00e9}} syndrome</b></div>", "time": 1660105336962.0}, {"id": 1474503628397, "note": "<div>In <b>{{c2::obstructive::obstructive or restrictive}} lung disease</b>, the <u>flow volume loops</u> shifts to the {{c1::*<b>left</b>}}</div>", "time": 1660105356235.0}, {"id": 1474503640158, "note": "<div>In <b>{{c2::restrictive</b><b>::obstructive or restrictive</b><b>}} lung disease</b>, the <u>flow volume loops</u> shifts to the {{c1::<b>right*</b>}}</div>", "time": 1660105356223.0}, {"id": 1474503645336, "note": "<div><b>{{c1::Sleep apnea}}</b> is defined as repeated (&gt;5x/hr) <u>cessation</u> of <b>breathing</b> &gt; {{c2::10}} seconds during sleep</div>", "time": null}, {"id": 1474503663945, "note": "<div><b>Sleep apnea</b> often presents clinically with <b>daytime {{c1::sleepiness}}</b></div>", "time": 1660105350946.0}, {"id": 1474503668169, "note": "<div><b>Sleep apnea</b> is characterized by a(n) {{c1::<u>normal</u>}} <b>Pao<sub>2</sub></b> and <b>Paco<sub>2</sub> </b>during the <i>day</i> </div>", "time": 1660105350947.0}, {"id": 1474503671817, "note": "<div><b>Sleep apnea</b> is associated with <b>{{c1::pulmonary hypertension}}</b> due to <u>nocturnal</u> <b>{{c2::hypoxia}}</b></div>", "time": 1660105350949.0}, {"id": 1474503674681, "note": "<div><b>Obstructive sleep apnea</b> is associated with difficult to manage <b>{{c1::systemic hypertension}}</b> due to <u>increased</u> <b>{{c2::sympathetic tone}}</b> </div>", "time": null}, {"id": 1474503686803, "note": "<div><b>Sleep apnea</b> is associated with <b>arrhythmias</b>, especially {{c1::atrial fibrillation/flutter}}</div>", "time": 1660105350950.0}, {"id": 1474503699805, "note": "<div><div>What effect may<b> sleep apnea</b> <i>secondarily</i> have on <u>RBC levels</u>? </div><div><br /></div><div>{{c1::Increased (polycythemia)}}</div></div>", "time": null}, {"id": 1474503706819, "note": "<div><b>{{c1::Obstructive}} sleep apnea</b> is caused by respiratory effort <u>against</u> an<b> airway obstruction</b> </div>", "time": null}, {"id": 1474503709638, "note": "<div><b>Obstructive sleep apnea</b> is associated with <b>{{c1::obesity}}, </b> <b>loud {{c2::snoring}}</b> with periods of <b>apnea</b>, and <b>daytime sleepiness</b></div>", "time": 1660105354719.0}, {"id": 1474503712016, "note": "<div><b>Obstructive sleep apnea</b> may be caused by <u>excess</u> <b>{{c1::parapharyngeal}} tissue</b> in <b>{{c2::adults::age group}}</b></div>", "time": null}, {"id": 1474503714558, "note": "<div><b>Obstructive sleep apnea</b> may be caused by <b>{{c1::adenotonsillar}} </b><u>hypertrophy</u> in <b>{{c2::children::age group}}</b></div>", "time": null}, {"id": 1474503716932, "note": "<div>Treatment for <u>obstructive sleep apnea</u> includes <b>{{c2::weight loss}}</b>, <b>surgery</b>, and {{c1::<b>CPAP</b>}}</div>", "time": null}, {"id": 1474503739822, "note": "<div><b>{{c1::Central}} sleep apnea</b> can occur due patients having <u>marginal ventilation</u> when awake (e.g. CNS disease, neuromuscular disease, severe kyphoscoliosis, heavy dose narcotics)</div>", "time": 1660105340883.0}, {"id": 1474503743647, "note": "<div><b>{{c1::Obesity hypoventilation}} syndrome</b> is a condition in which <b>severely overweight</b> people <u>fail</u> to breathe rapidly or deeply enough </div>", "time": 1660105339425.0}, {"id": 1474503746119, "note": "<div><b>Obesity hypoventilation syndrome</b> is characterized by {{c1::<u>decreased</u>}} Pao<sub>2</sub> and {{c1::<u>increased</u>}} Paco<sub>2</sub> during <i>sleep</i> </div>", "time": 1660105354731.0}, {"id": 1474503749896, "note": "<div><b>Obesity hypoventilation (Pickwickian) syndrome</b> is characterized by {{c1::<u>increased</u>}} <b>Paco<sub>2</sub> </b>during <i>waking</i> hours </div>", "time": 1660105354732.0}, {"id": 1474503752869, "note": "<div><b>{{c1::Pleural effusion}}</b> is the excess <b>accumulation</b> <b>of fluid</b> between lung <u>pleural</u> layers</div>", "time": 1660105339271.0}, {"id": 1474503757152, "note": "<div><b>Pleural effusion</b> causes <u>restricted</u> lung {{c1::inspiration::inspiration or expiration}}&nbsp;</div>", "time": null}, {"id": 1474503760222, "note": "<div><b>Pleural effusion</b> can be treated with {{c1::thoracentesis}} to remove fluid</div>", "time": 1660105353862.0}, {"id": 1474503768203, "note": "<div><b>{{c2::Transudative}} pleural effusion</b> may be caused by <u>increased</u> <b>{{c1::hydrostatic}} pressure</b> (e.g. HF)</div>", "time": null}, {"id": 1474503771577, "note": "<div><b>{{c2::Transudative}} pleural effusion</b> may be caused by <u>decreased</u> <b>{{c1::oncotic}} pressure</b> (e.g. nephrotic syndrome, cirrhosis)</div>", "time": null}, {"id": 1474503781327, "note": "<div><b>{{c2::Transudative}} pleural effusion</b> is characterized by {{c1::<u>low</u>}} <b>protein content</b></div>", "time": 1660105337231.0}, {"id": 1474503784942, "note": "<div><b>{{c2::Exudative}} pleural effusion</b> is caused by states of <u>increased</u> <b>{{c1::vascular permeability}}</b> (e.g. malignancy, pneumonia, trauma, collagen vascular disease)</div>", "time": 1660105337986.0}, {"id": 1474503787648, "note": "<div><b>Exudative pleural effusions</b> must be <u>drained</u> due to risk of {{c1::infection}}</div>", "time": 1660105359359.0}, {"id": 1474503790995, "note": "<div>What is an&nbsp;<b>empyema</b>? </div><div><br></div><div>{{c1::Pus in the pleural space}}</div>", "time": null}, {"id": 1474503793223, "note": "<div>A(n)&nbsp;<b>{{c2::lymphatic}} pleural effusion</b> is also known as&nbsp;<b>{{c1::chylothorax}}</b></div>", "time": null}, {"id": 1474503795880, "note": "<div><b>{{c2::Lymphatic}} pleural effusion </b>occurs due to <b>{{c1::thoracic duct}} injury</b> from trauma or malignancy</div>", "time": null}, {"id": 1474503798243, "note": "<div><b>Lymphatic pleural effusion</b> is characterized by a(n) {{c1::<b>milky</b>}}-<b>appearing</b> fluid with <u>increased</u> {{c2::<b>triglycerides</b>}}</div>", "time": null}, {"id": 1474503805629, "note": "<div><b>Pleural effusion</b> presents with {{c1::<u>decreased</u>::increased or decreased}} <b>breath sounds</b>&nbsp;</div>", "time": 1660105353861.0}, {"id": 1474503812564, "note": "<div><b>Pleural effusion</b> presents with {{c1::<u>dullness</u>}} to<b> percussion</b></div>", "time": 1660105353859.0}, {"id": 1474503817940, "note": "<div><b>Pleural effusion</b> presents with {{c1::<u>decreased</u>}}<b> fremitus</b></div>", "time": 1660105353860.0}, {"id": 1474503822233, "note": "<div>In <i>large</i> <b>pleural effusions</b>, the trachea may deviate {{c1::<u>away from</u>}} the side of the lesion</div>", "time": 1660105357147.0}, {"id": 1474503835126, "note": "<div><b>Atelectasis </b>(bronchial / bronchiole obstruction) presents with {{c1::<u>decreased</u>}}<b> fremitus</b></div>", "time": 1660105361461.0}, {"id": 1474503845229, "note": "<div><b>Consolidation</b> (lobar pneumonia, pulmonary edema) may present with {{c1::<u>bronchial</u>}} <b>breath sounds</b> along with: </div><div><br /></div><div>- {{c2::<b>Ego</b>}}<b>phony</b></div><div>- {{c3::<b>Broncho</b>}}<b>phony</b></div><div>- <b>Whispered</b> {{c4::<b>Pectoriloquy</b>}}</div>", "time": 1660105360428.0}, {"id": 1474503853594, "note": "<div><b>Consolidation</b> (lobar pneumonia, pulmonary edema) presents with {{c1::<u>dullness</u>}} to<b> percussion</b></div>", "time": 1660105360424.0}, {"id": 1474503857395, "note": "<b>Consolidation</b> (lobar pneumonia, pulmonary edema) presents with {{c1::<u>increased</u>}}<b> fremitus</b>", "time": 1660105360423.0}, {"id": 1474505838759, "note": "<b>Lung development</b> begins with development of a(n) {{c1::lung bud}} from the <u>distal</u> end of the <b>respiratory diverticulum</b>", "time": 1660105355503.0}, {"id": 1474509336827, "note": "<div>What week does <b>lung development</b> <u>begin</u>? </div><div><br></div><div>{{c1::Week 4}}</div>", "time": null}, {"id": 1474509340674, "note": "<div>The <i>embryonic</i><b> lung bud</b> divides into <u>two</u> <b>{{c1::bronchial}} buds</b> that branch off into <b>{{c2::bronchi}}</b> </div>", "time": 1660105350207.0}, {"id": 1474509356802, "note": "<div>The <b>{{c2::embryonic}} period</b> of <u>lung development</u> occurs from weeks {{c1::4}} to {{c1::7}}</div>", "time": null}, {"id": 1474509362273, "note": "<div>Errors at what stage of <u>lung development</u> can lead to the formation of a <b>Tracheoesophageal Fistula?</b></div><div><b></b><b><br></b></div><div><b></b><b>{{c1::Embryonic Period (Weeks 4-7)}}</b></div>", "time": null}, {"id": 1474509366500, "note": "<div>The <b>{{c2::pseudoglandular}} period</b> of <u>lung development</u> occurs from weeks {{c1::5}} to {{c1::17}}</div>", "time": null}, {"id": 1474509372412, "note": "<div>During the <b>{{c1::<font color=\"#aa0000\">p</font>seudoglandular}} period</b> (lung development), the <b>{{c2::endodermal tubules}}</b> form the <b>{{c3::terminal bronchioles}}</b></div>", "time": 1660105359690.0}, {"id": 1474509377202, "note": "<div>During the <b><font color=\"#aa0000\">p</font>seudoglandular period</b> of lung development, the <u>bronchioles</u> are surrounded by a(n) {{c1::modest}} <b>capillary network</b> </div>", "time": null}, {"id": 1474509380518, "note": "<div>Is <b>respiration possible</b> during the <u>pseudoglandular period</u> of lung development? </div><div><br></div><div>{{c1::No; incompatible with life}}</div>", "time": 1660105355881.0}, {"id": 1474509383752, "note": "<div>The <b>{{c2::canalicular}} period</b> of <u>lung development</u> occurs from weeks {{c1::16}} to {{c1::25}}</div>", "time": null}, {"id": 1474509387818, "note": "<div>During the <b>{{c1::<font color=\"#aa0000\">c</font>analicular}} period</b> (lung development), the <b>{{c2::terminal bronchioles}}</b> form the <b>{{c3::respiratory bronchioles}}</b>, which then form the <b>{{c4::alveolar ducts}}</b></div>", "time": 1660105359694.0}, {"id": 1474509397005, "note": "<div>During the <b><font color=\"#aa0000\">c</font>analicular period</b> of lung development, the <u>bronchioles</u> are surrounded by a(n) {{c1::prominent}} <b>capillary network</b> </div>", "time": null}, {"id": 1474509399773, "note": "<div>During the {{c2::<b><font color=\"#aa0000\">c</font>analicular}} period</b> of lung development, <b>airways</b> {{c1::<u>increase</u>}} in <b>diameter</b></div>", "time": 1660105359709.0}, {"id": 1474509405173, "note": "<div><b>Respiration</b> may be <i>possible</i> at <b>week {{c1::25}}</b> (canalicular period)</div>", "time": null}, {"id": 1474509408245, "note": "<div>The {{c2::<font color=\"#aa0000\"><b>s</b></font><b>accular</b>}}<b> period</b> of <u>lung development</u> occurs from weeks {{c1::26}} to {{c1::birth}}</div>", "time": null}, {"id": 1474509412679, "note": "<div>During the <b>{{c1::<font color=\"#aa0000\">s</font>accular}} period</b> (lung development), the <b>{{c2::alveolar ducts}}</b> form the <b>{{c3::terminal sacs}}</b></div>", "time": 1660105359687.0}, {"id": 1474509416897, "note": "<div>During the <u><font color=\"#aa0000\">s</font>accular period</u> (lung development), <b>terminal sacs</b> are separated by {{c1::primary}} septa</div>", "time": 1660105359701.0}, {"id": 1474509420919, "note": "<div>In which<b> </b><i>period</i> of <u>lung development</u> do <b>pneumocytes develop</b>? </div><div><br></div><div>{{c1::Saccular period (weeks 26 - birth)}}</div>", "time": null}, {"id": 1474509424160, "note": "<div>The <b>{{c2::<font color=\"#aa0000\">a</font>lveolar}} period</b> of <u>lung development</u> occurs from weeks {{c1::36}} to {{c1::8 years}}</div>", "time": null}, {"id": 1474509438311, "note": "<div>During the <b>{{c1::alveolar}} period</b> (lung development), the <b>{{c2::terminal sacs}}</b> form the <b>{{c3::adult alveoli}}</b></div>", "time": 1660105359697.0}, {"id": 1474509445288, "note": "<div><b>Terminal sacs</b> form into <b>adult alveoli</b> due to <u>secondary</u> {{c1::septation}}</div>", "time": 1660105350569.0}, {"id": 1474509452822, "note": "<div>In <u>utero</u>, \"breathing\" occurs via <b>aspiration</b> and <b>expulsion</b> of {{c1::amniotic fluid}}, causing {{c2::<u>increased</u>}} <b>pulmonary</b> <b>vascular&nbsp;</b><b>resistance</b> through gestation</div>", "time": 1660105356542.0}, {"id": 1474509460829, "note": "<div><b>Pulmonary {{c1::hypoplasia}}</b> is characterized by a <u>poorly-developed</u> <b>bronchial tree</b> with <i>abnormal</i> histology</div>", "time": 1660105353534.0}, {"id": 1474509463396, "note": "<div><b>Pulmonary hypoplasia</b> is associated with <b>bilateral </b>{{c1::<b>renal agenesis</b> (Potter sequence)}} and <b>congenital {{c2::diaphragmatic hernia}}</b></div>", "time": 1660105353542.0}, {"id": 1474509466150, "note": "<div>Congenital <b>{{c1::bronchogenic}} cysts</b> are caused by <u>abnormal</u> <b>budding of the {{c2::foregut}}</b> and <u>dilation</u> of terminal or large bronchi</div>", "time": 1660105360440.0}, {"id": 1474509469020, "note": "<div><b>{{c1::Bronchogenic cyst}}</b> is a <u>congenital lung malformation</u> that presents as discrete, round, <b>sharply</b> <b>defined</b> and<b> air-filled densities</b> on CXR </div>", "time": 1660105340978.0}, {"id": 1474509476315, "note": "<div><b>Type {{c1::I}} pneumocytes</b> line the alveoli (97% of alveolar surfaces)</div>", "time": null}, {"id": 1474509478829, "note": "<div><b>Type {{c2::I}} pneumocytes</b> are {{c1::<u>squamous</u>}} cells; thin for optimal gas diffusion</div>", "time": 1660105348412.0}, {"id": 1474509484893, "note": "<div><b>Type {{c2::II}} pneumocytes</b> are clustered, {{c1::<u>cuboidal</u>::shape}} cells</div>", "time": 1660105348415.0}, {"id": 1474509488862, "note": "<div><b>Type {{c1::II}} pneumocytes</b> proliferate during <u>lung damage</u></div>", "time": null}, {"id": 1474509491676, "note": "<div><b>{{c1::Club (Clara)}} cells</b> are <u>non-ciliated</u>, <b>low columnar/cuboidal cells</b> with secretory granules in the <i>lung</i> </div>", "time": 1660105340786.0}, {"id": 1474509493954, "note": "<div><b>Club (clara) cells</b> of the <i>lung</i> secrete a component of {{c1::surfactant}} and act as <u>reserve</u> cells </div>", "time": null}, {"id": 1474509498627, "note": "<b>Club (clara) cells</b> of the <i>lung</i> may <u>degrade</u> {{c1::toxins}}", "time": null}, {"id": 1474509558350, "note": "The <b>right lung</b> has {{c1::<u>three</u>}} lobes", "time": 1660105349617.0}, {"id": 1474511888849, "note": "<div>The <b>left lung</b> has {{c1::<u>two</u>}} lobes</div>", "time": 1660105349925.0}, {"id": 1474511892721, "note": "<div>Which <u>lung</u> (right or left) has a <b>lingula</b>? </div><div><br /></div><div>{{c1::Left}}</div>", "time": null}, {"id": 1474511897736, "note": "<div>The <b>{{c1::right}} lung</b> is the <i>more common site</i> for <u>inhaled foreign bodies</u> because it has a <b>wider</b> and <b>more vertical&nbsp;</b>bronchus</div>", "time": null}, {"id": 1474511912687, "note": "<div>In the <u>right lung</u>, the <b>pulmonary artery</b> is {{c1::anterior}} to the <b>bronchus</b> </div>", "time": null}, {"id": 1474511918491, "note": "<div>In the <u>left lung</u>, the <b>pulmonary artery</b> is {{c1::superior}} to the <b>bronchus</b> </div>", "time": null}, {"id": 1474511925850, "note": "<div>The <b>{{c2::IVC}}</b> perforates the <u>diaphragm</u> at the level of <b>{{c1::T8}}</b> </div>", "time": null}, {"id": 1474511934874, "note": "<div>The <b>{{c2::esophagus}}</b> and <b>{{c3::vagus nerve}}</b> perforate the <u>diaphragm</u> at the level of <b>{{c1::T10}}</b> </div>", "time": null}, {"id": 1474511944771, "note": "<div>The <b>{{c2::aorta}}</b>, <b>{{c3::thoracic duct}}</b>, and <b>{{c4::azygos vein}}</b> perforate the <u>diaphragm</u> at the level of <b>{{c1::T12}}</b> </div>", "time": null}, {"id": 1474511953060, "note": "<div>The <b>diaphragm</b> is innervated by the <b>{{c1::phrenic}} nerve</b> </div>", "time": null}, {"id": 1474511955568, "note": "<div>What are the <u>roots</u> of the <b>phrenic nerve</b>? </div><div><br /></div><div>{{c1::C3, C4, C5}}</div>", "time": null}, {"id": 1474511963068, "note": "<div>Pain from <b>diaphragm irritation</b> can be referred to the <b>{{c1::shoulder}}</b> (C5) or <b>{{c2::trapezius ridge}}</b> (C3, 4)</div>", "time": null}, {"id": 1474512820505, "note": "<div><b>{{c2::Exudative}} pleural effusion</b> is characterized by {{c1::<u>high</u>}} <b>protein content</b></div>", "time": 1660105337984.0}, {"id": 1474563607979, "note": "What is the <u>remnant</u> of the <b>mesonephric (wolffian) duct</b> in females?<div><br /></div><div>{{c1::Gartner duct}}</div>", "time": null}, {"id": 1474571591865, "note": "<div>What <b>G protein</b> is the <b>H<sub>2</sub> histamine receptor</b> coupled to?<br></div><div><div><br></div><div>{{c1::G<sub>s</sub>}}</div></div>", "time": 1660105351177.0}, {"id": 1474571599295, "note": "<div><b>{{c1::H<sub>2</sub>}} histamine receptors</b> are located on <u>gastric parietal cells</u> and mediate <b>gastric acid secretion</b><br></div>", "time": 1660105351158.0}, {"id": 1474571698024, "note": "<div><u>{{c2::1st}} generation</u> <b>{{c1::H<sub>1</sub>}} </b><b>histamine r</b><b>eceptor</b> <b>antagonists</b> may be used to treat vestibular nausea and {{c3::motion}} sickness<br></div>", "time": 1660105351150.0}, {"id": 1474571737889, "note": "<div><b>{{c2::1st}} generation H<sub>1</sub> receptor antagonists</b> may {{c3::<u>antagonize</u>}} <b>{{c1::muscarinic}} receptors</b>, leading to significant anti-cholinergic effects<br></div>", "time": 1660105351153.0}, {"id": 1474580628339, "note": "<div><i>Selective</i> <b>{{c1::\u03b2<sub>2</sub>}} agonists</b>, such as <b>albuterol</b>, treat {{c2::<u>bronchoconstriction</u>}} in asthma<br></div>", "time": 1660105351115.0}, {"id": 1474580639757, "note": "<div><b>Albuterol</b>, <b>pirbuterol</b>, and <b>metaproterenol</b> are {{c1::<u>short</u>}}<u>-acting</u> {{c2::<b>\u03b2<sub>2</sub> agonists</b>}}<br></div>", "time": 1660105351138.0}, {"id": 1474580657593, "note": "<div><b>{{c2::Short}}-acting \u03b2<sub>2</sub> agonists</b> (e.g. albuterol) are administered as metered-dose inhalers for {{c1::<u>acute</u>}} relief of symptoms<br></div>", "time": 1660105351086.0}, {"id": 1474580671870, "note": "<div><b>Inhaled {{c1::corticosteroids}}</b> (e.g. budesonide, fluticasone) can be added as <u>daily maintenance therapy</u> for <i>persistent</i> <b>asthma</b><br></div>", "time": 1660105351128.0}, {"id": 1474580678183, "note": "<div><b>{{c1::Corticosteroids}}</b> treat <u>asthma</u> by <i>blocking&nbsp;</i><b>{{c2::inflammation}}</b> and<b> {{c3::cellular infiltration}}</b><br></div>", "time": 1660105351093.0}, {"id": 1474580686903, "note": "<div><b>Inhaled</b> <b>corticosteroids</b> (e.g. asthma therapy) <u>inhibit</u> the synthesis of virtually all {{c1::cytokines}}<br></div>", "time": 1660105358913.0}, {"id": 1474580694965, "note": "<div><b>Inhaled {{c2::corticosteroids}}</b> <u>inactivate</u> <b>{{c1::NF-\u03baB}}</b>, the <i>transcription factor</i> that induces <u>production</u> of <b>TNF-\u03b1</b> and other inflammatory agents<br></div>", "time": 1660105358912.0}, {"id": 1474580700023, "note": "<div><b>{{c1::Inhaled corticosteroids}}</b> are the <u>first line therapy</u> for <b>chronic asthma</b></div>", "time": 1660105358902.0}, {"id": 1474580710779, "note": "<div>Do <i>inhaled</i> <b>corticosteroids</b> present with the typical <u>adverse effects</u> of corticosteroid therapy?<br></div><div><br></div><div>{{c1::No, minimal systemic absorption}}<br></div>", "time": 1660105351140.0}, {"id": 1474580716506, "note": "<div>What <u>adverse effect</u> is associated with <b>inhaled corticosteroids</b>?<br></div><div><br></div><div>{{c1::Oropharyngeal candidiasis}}<br></div>", "time": 1660105351104.0}, {"id": 1474580722813, "note": "<div>The risk of <b>oropharyngeal candidiasis</b> following <u>inhaled corticosteroids</u> is <i>reduced</i> by {{c1::gargling water and spitting}} after each treatment<br></div>", "time": 1660105351112.0}, {"id": 1474580731345, "note": "<div>What <u>drug class</u> do <b>fluticasone,</b> <b>budesonide, </b>and&nbsp;<b>beclomethasone</b> belong to?<br></div><div><div><br></div><div>{{c1::<u>Inhaled</u> corticosteroids}}<br></div></div>", "time": 1660105351101.0}, {"id": 1474580736503, "note": "<div>A major step in the conversion of <b>Arachidonic acids (AA)</b> to <b>leukotrienes </b>is the conversion to {{c1::<b>5-HPETE</b>}} by the enzyme <i><b>{{c2::5-lipoxygenase}}</b></i><br></div>", "time": 1660105351135.0}, {"id": 1474580780060, "note": "<div>What <u>drug class</u> do <b>montelukast</b> and <b>zafirlukast</b> belong to?<br></div><div><br></div><div>{{c1::Leukotriene D4-receptor antagonists}}<br></div>", "time": 1660105351100.0}, {"id": 1474580787193, "note": "<div>What is the <u>route of administration</u> of <b>leukotriene D4-receptor antagonists</b> (e.g. montelukast, zafirlukast)?<br></div><div><br></div><div>{{c1::Oral administration}}<br></div>", "time": 1660105351096.0}, {"id": 1474580796645, "note": "<div>What is the effect of <u>COX inhibition</u> (e.g. aspirin) on production of <b>leukotrienes</b>?<br></div><div><br></div><div>{{c1::Increased}} <br></div>", "time": 1660105351098.0}, {"id": 1474580803822, "note": "<div><b>Montelukast</b> and <b>zafirlukast</b> are especially effective at treating {{c1::aspirin-induced}} <b>asthma</b><br></div>", "time": 1660105351121.0}, {"id": 1474580819655, "note": "<div>What is the <u>mechanism of action</u> of <b>zileuton</b> (asthma treatment)?<br></div><div><br></div><div>{{c1::5-lipoxygenase inhibitor}}<br></div>", "time": 1660105351097.0}, {"id": 1474580830221, "note": "<div>What <u>adverse effect</u> is associated with <b>zileuton</b>?<br></div><div><br></div><div>{{c1::Hepatotoxicity}}<br></div>", "time": 1660105351103.0}, {"id": 1474580850378, "note": "<div><b>Salmeterol</b> and <b>formoterol</b> are {{c1::<u>long</u>}}<u>-acting</u> {{c2::<b>\u03b2<sub>2</sub> agonists</b>}}<br></div>", "time": 1660105351117.0}, {"id": 1474580865425, "note": "<div><u>Long-acting</u> <b>\u03b2<sub>2</sub> agonists</b> are used for {{c1::prophylaxis}} in <u>moderate</u> or <u>severe persistent</u> <b>asthma</b><br></div>", "time": 1660105351122.0}, {"id": 1474580870148, "note": "<div><u>Long-acting</u> <b>\u03b2<sub>2</sub> agonists</b> (e.g. salmeterol) achieve their long duration due to <u>high</u> {{c1::lipid}} <b>solubility</b><br></div>", "time": 1660105351124.0}, {"id": 1474580874963, "note": "<div><u>Long-acting</u> <b>\u03b2<sub>2</sub> agonists</b> (e.g. salmeterol) are given as a <i>daily inhaler</i> and are always combined with a regimen of {{c1::<b>inhaled</b> <b>corticosteroids</b>}}<br></div>", "time": 1660105351123.0}, {"id": 1474580882205, "note": "<div>Adverse effects of <u>long-acting</u> <b>\u03b2<sub>2</sub> agonists</b> (e.g. salmeterol, formoterol) include <b>{{c1::tremor}}</b> and <b>{{c2::arrhythmia}}</b><br></div>", "time": 1660105358916.0}, {"id": 1474580885688, "note": "<div>An {{c1::<u>increased</u>}} dose of<b> inhaled cortisteroids</b> may be useful for treatment of <u>moderate</u> or <u>severe persistent</u> <b>asthma</b><br></div>", "time": 1660105351136.0}, {"id": 1474580890382, "note": "<div>{{c1::Theophylline}} is a <u>methylxanthine</u> that may be used for <b>asthma</b> therapy<br></div>", "time": 1660105351087.0}, {"id": 1474580895509, "note": "<div><b>Theophylline</b> causes <u>broncho-</u>{{c1::<u>dilation</u>}} by <i>inhibiting</i> <b>{{c2::phosphodiesterase}}</b><br></div>", "time": 1660105351110.0}, {"id": 1474580900802, "note": "<div>What effect does <b>theophylline</b> have on levels of <b>cAMP</b>?<br></div><div><br></div><div>{{c1::Increased cAMP}}<br></div>", "time": 1660105351099.0}, {"id": 1474580908969, "note": "<div>What is the <u>route of administration</u> of <b>theophylline</b> (asthma therapy)?<br></div><div><br></div><div>{{c1::Oral administration}}<br></div>", "time": 1660105351095.0}, {"id": 1474580915632, "note": "<div><b>Theophylline</b> use is <i>limited</i> due to its <u>narrow</u> {{c1::therapeutic index}}<br></div>", "time": 1660105351105.0}, {"id": 1474580923255, "note": "<div><b>Theophylline</b> may have <u>CNS side effects</u> including <b>{{c1::nervousness}}</b> and <b>{{c2::tremor}}</b><br></div>", "time": 1660105351107.0}, {"id": 1474580928334, "note": "<div><b>Theophylline</b> can cause {{c1::tachycardia::HR}}&nbsp;<br></div>", "time": 1660105351111.0}, {"id": 1474580933087, "note": "<div><b>Theophylline</b> is <i>metabolized</i> by {{c1::cytochrome P-450}}<br></div>", "time": 1660105351108.0}, {"id": 1474580937969, "note": "<div><b>Theophylline</b> blocks the actions of {{c1::adenosine}} (local metabolite)<br></div>", "time": 1660105358906.0}, {"id": 1474580948335, "note": "<div><b>{{c1::Omalizumab}}</b> is a <u>monoclonal antibody</u> directed against the&nbsp;<b>{{c2::Fc}}</b> portion of <b>{{c3::IgE}}</b>, preventing <u>mast cell</u> <i>sensitization</i><br></div>", "time": 1660105351090.0}, {"id": 1474580958073, "note": "<div><b>{{c1::Omalizumab}}</b> is used in <u>allergic asthma</u> with <i>increased</i> <b>IgE levels</b> and <i>resistance</i> to <b>inhaled steroids</b> and <b>long-acting \u03b2<sub>2</sub> agonists</b><br></div>", "time": 1660105358901.0}, {"id": 1474580960989, "note": "<div><b>Cromolyn sodium</b> is an asthma therapeutic that <u>inhibits</u> {{c1::mast cell degranulation}}<br></div>", "time": 1660105351130.0}, {"id": 1474580971787, "note": "<div>What is the treatment for an <b>acute, severe asthma exacerbation</b>?<br></div><div><br></div><div>{{c1::Short-acting \u03b2<sub>2</sub> agonist +/- <u>systemic</u> corticosteroids OR Epinephrine}}<br></div>", "time": 1660105351094.0}, {"id": 1474580978865, "note": "<div>In <b>acute, severe asthma exacerbation</b>, <u>corticosteroids</u> are administered {{c1::IV}} or {{c1::orally}}<br></div>", "time": 1660105351129.0}, {"id": 1474580987952, "note": "<div><i>Nebulized</i> <b>{{c1::ipratropium}}</b> is a <u>muscarinic antagonist</u> that may be used to treat <b>acute, severe asthma exacerbation</b><br></div>", "time": 1660105351119.0}, {"id": 1474580993401, "note": "<div><b>Ipratropium</b> is a <i>competitive</i> <b>{{c1::M3}} receptor antagonist</b> that is used to prevent {{c2::<u>bronchoconstriction</u>}} in asthmatic and COPD patients<br></div>", "time": 1660105358910.0}, {"id": 1474580997112, "note": "<div>In addition to <u>asthma</u>, <b>ipratropium</b> may also be used to treat {{c1::COPD}}<br></div>", "time": 1660105358914.0}, {"id": 1474580999867, "note": "<div><b>Tiotropium</b> is a(n) {{c2::<u>long</u>}}<u>-acting</u> <b>{{c1::M3}} antagonist</b><br></div>", "time": 1660105358904.0}, {"id": 1474581002805, "note": "<div>What <u>catecholamine</u> may be administered to treat <b>acute, severe asthma exacerbation</b>?<br></div><div><br></div><div>{{c1::Epinephrine}}<br></div>", "time": 1660105351102.0}, {"id": 1474581007757, "note": "<div><b>Methacoline</b> is a(n)&nbsp;<b>{{c1::M<sub>3</sub>}} receptor <i>agonist</i></b> used in the bronchial challenge to help diagnose asthma</div>", "time": 1660105358908.0}, {"id": 1474581020542, "note": "<div><b>Theophylline</b> causes <b>broncho-</b>{{c1::dilation}}<br></div>", "time": 1660105358905.0}, {"id": 1474581024632, "note": "<div><b>Muscarinic <i>antagonists</i></b> cause <b>broncho-</b>{{c1::dilation}}<br></div>", "time": 1660105358907.0}, {"id": 1474651327123, "note": "<div>What <u>classes</u> of drugs are used to treat <b>asthma</b> by <i>blocking</i> <b>inflammation</b> (late response)? </div><div><br></div><div>{{c1::Inhaled corticosteroids}}, {{c2::anti-leukotrienes}}, and anti-IL-5 monoclonal antibodies</div>", "time": 1660105358920.0}, {"id": 1474651458513, "note": "<div>What <u>classes</u> of drugs are used to treat <b>asthma</b> by <i>blocking</i></div><div> <b>bronchoconstriction</b> (early response)? </div><div><br></div><div>{{c1::\u03b2<sub>2</sub> agonists}}, {{c2::theophylline (methylxanthines)}}, {{c3::muscarinic antagonists}}</div>", "time": 1660105358923.0}, {"id": 1474666007192, "note": "<div><b>{{c1::N-acetylcysteine}}</b> is a(n)&nbsp;<b>{{c2::mucolytic}} agent</b> that <i>liquifies mucus</i> by <i>disrupting</i> {{c4::<b>disulfide</b>}} <b>bonds</b>; useful in <u>{{c3::Chronic Bronchitis / COPD}}</u> and <u>{{c3::Cystic Fibrosis}} patients</u></div>", "time": 1660105358869.0}, {"id": 1474666075079, "note": "<div><b>Pseudoephedrine</b> and <b>phenylephrine</b> are {{c2::<u>\u03b1-adrenergic</u>}}<u> </u>{{c3::<u>agonists</u>}} that may be used as <b>{{c1::nasal decongestants}}</b></div>", "time": 1660105358881.0}, {"id": 1474666078223, "note": "<div><b>Pseudoephedrine</b> and <b>phenylephrine</b> may be used clinically to <u>reduce</u><br></div><div>- {{c1::<b>hyperemia</b>}}</div><div>- {{c2::<b>edema</b>}}</div><div>- {{c3::<b>nasal congestion</b>}}</div>", "time": 1660105358878.0}, {"id": 1474666085564, "note": "<div>What <i>adverse effect</i> may <u>pseudoephedrine</u> and&nbsp;<u>phenylephrine</u> have on <b>blood pressure</b>?</div><div><br></div><div>{{c1::Increased BP (Hypertension)}}</div>", "time": 1660105358871.0}, {"id": 1474666102186, "note": "<div><b>Dextromethorphan</b> may cause {{c1::serotonin syndrome}} if combined with other <u>serotonergic</u> agents<br></div>", "time": 1660105358891.0}, {"id": 1474666104617, "note": "<div><b>{{c4::Bosentan}}</b> is a <i>competitive</i> <b>{{c1::endothelin-1 receptor}} {{c2::antagonist}}</b> used to treat {{c3::<u>pulmonary hypertension</u>}}</div>", "time": 1660105358858.0}, {"id": 1474666115096, "note": "<div><b>Sildenafil </b><u>inhibits</u> {{c1::<b>PDE-5</b>}} and <i>prolongs</i> the <b>vasodilatory</b> <b>effect</b> of {{c2::nitric oxide}}</div>", "time": 1660105358874.0}, {"id": 1474666117993, "note": "<div>In addition to <u>erectile dysfunction</u>, <b>sildenafil</b> may also be used to treat {{c1::pulmonary hypertension}}</div>", "time": 1660105358882.0}, {"id": 1474666128784, "note": "<div><b>Epoprostenol</b> and <b>iloprost</b> may be used to treat <u>pulmonary</u> {{c1::hypertension}}</div>", "time": 1660105358887.0}, {"id": 1474670081186, "note": "What is the <u>mode of inheritance</u> of <b>cystic fibrosis</b>? <div><br></div><div>{{c1::Autosomal recessive}}</div>", "time": null}, {"id": 1474670490438, "note": "<div><b>{{c3::Cystic fibrosis}}</b> is due to a defect in the <i>{{c1::CFTR}} </i>gene on <b>chromosome {{c2::7}}</b></div>", "time": null}, {"id": 1474670493718, "note": "<div><b>Cystic fibrosis </b>most commonly occurs due to a(n) {{c2::<u>in-frame</u>}} <u>deletion</u> of {{c1::Phe508}}</div>", "time": null}, {"id": 1474670495829, "note": "<div>What is the <u>most common</u> <b>lethal, genetic</b> <b>disease</b> in <b>Caucasians</b>?</div><div><br></div><div>{{c1::Cystic fibrosis}}</div>", "time": null}, {"id": 1474670498150, "note": "<div>The <i>CFTR </i>gene encodes a(n)&nbsp;<b>{{c2::ATP}}-gated&nbsp;Cl-&nbsp;channel</b></div>", "time": null}, {"id": 1474670500145, "note": "<div>The <b>CFTR</b> <b>Cl<sup>-</sup> channel</b> {{c1::<u>secretes</u>::secretes or absorbs}} Cl<sup>-</sup> in the <b>{{c2::lungs}}</b> and <b>{{c2::GI tract}}</b></div>", "time": null}, {"id": 1474670502201, "note": "<div>The <b>CFTR</b> <b>Cl<sup>-</sup> channel</b> {{c1::<u>reabsorbs</u>::secretes or absorbs}} Cl<sup>-</sup> in the <b>{{c2::sweat glands}}</b></div>", "time": null}, {"id": 1474670504167, "note": "<div>The <i>most common</i> <b>CFTR gene mutation</b> (cystic fibrosis) results in a <u>misfolded protein</u> that is retained in the {{c1::RER}}</div>", "time": null}, {"id": 1474670506237, "note": "<div>In <b>cystic fibrosis</b>, there is {{c1::<u>decreased</u>}} <b>Cl<sup>-</sup></b> and <b>H<sub>2</sub>O <i>secretion</i> </b>in the <u>lungs</u> and <u>GI tract</u> </div>", "time": null}, {"id": 1474670521374, "note": "<div>In <b>cystic fibrosis</b>, <u>increased</u> <b>intracellular Cl<sup>-</sup> </b>results in <i>compensatory</i> <u>increased</u> <b>Na<sup>+&nbsp;</sup></b><b>{{c1::reabsorption}}</b> via epithelial Na<sup>+</sup> channels</div>", "time": null}, {"id": 1474670530324, "note": "<div><u>Increased</u> <b>Na<sup>+</sup> reabsorption</b> due to <i>decreased Cl<sup>-</sup> secretion</i> (cystic fibrosis) results in <u>increased</u> {{c1::H<sub>2</sub>O}} <b>reabsorption</b> </div>", "time": null}, {"id": 1474670536188, "note": "<div><u>Increased</u> <b>H<sub>2</sub>O reabsorption</b> in CF results in <i>abnormally</i> {{c1::<u>thick</u>}} <b>mucus</b> secreted into the <b>{{c2::lungs}}</b> and <b>{{c3::GI tract}}</b> </div>", "time": null}, {"id": 1474670546156, "note": "<div><u>Increased</u> <b>Na<sup>+</sup> reabsorption</b> in cystic fibrosis causes a more {{c1::<i>negative</i>}} <b>transepithelial potential difference</b> (TEPD)</div>", "time": null}, {"id": 1474670560955, "note": "<div><u>Increased</u> <b>{{c2::Cl<sup>-</sup>}} concentration</b> (&gt; {{c1::60}} meQ/L) in {{c3::<u>sweat</u>}} is diagnostic of <b>cystic fibrosis</b> </div>", "time": null}, {"id": 1474670570161, "note": "<div><b>Cystic fibrosis</b> may present with <b>{{c1::contraction::volume}} </b><b>{{c2::alkalosis::pH}}</b>&nbsp;</div>", "time": null}, {"id": 1474670572492, "note": "<div>How does <b>cystic fibrosis</b> affect <b>K<sup>+</sup> levels</b>? </div><div><br></div><div>{{c1::Decreased (hypokalemia)}}</div>", "time": null}, {"id": 1474670578507, "note": "<div>What <u>newborn screening</u> <i>blood</i> test is used to screen for <b>cystic fibrosis</b>? </div><div><br></div><div>{{c1::Immunoreactive trypsinogen}}</div>", "time": null}, {"id": 1474670581496, "note": "<div>A(n) {{c1::<u>increased</u>}} <b>immunoreactive trypsinogen</b> may be indicative of <b>{{c2::cystic fibrosis}}</b></div>", "time": null}, {"id": 1474670584017, "note": "<div>What organism is responsible for <u>recurrent pulmonary infections</u> in an <b><i>infant</i> cystic fibrosis patient</b>? </div><div><br></div><div><i>{{c1::Staphylococcus aureus}}</i></div>", "time": null}, {"id": 1474670586711, "note": "<div><div>What organism is responsible for <u>recurrent pulmonary infections</u> in an <b><i>adolescent</i> cystic fibrosis patient</b>? </div><div><br></div><div><i>{{c1::Pseudomonas aeruginosa}}</i></div></div>", "time": null}, {"id": 1474670589163, "note": "<div><b>Chronic bronchitis</b> and <b>bronchiectasis</b> in a <u>cystic fibrosis</u> patient leads to a(n) {{c1::<b>reticulonodular</b>}} <b>pattern</b> on CXR</div>", "time": null}, {"id": 1474670595105, "note": "<div><b>Cystic fibrosis</b> may cause {{c1::<u>pancreatic</u>}}<u> insufficiency</u>, resulting in <i>malabsorption</i></div>", "time": 1660105360257.0}, {"id": 1474670598330, "note": "<div><b>Cystic fibrosis</b> may cause <u>malabsorption</u> with {{c1::steatorrhea::bowel condition}} and consequent {{c1::fat-soluble}} <b>vitamin deficiencies</b></div>", "time": null}, {"id": 1474670601646, "note": "<div><b>Cystic fibrosis</b> may cause <b>{{c1::biliary}} cirrhosis</b> and/or <b>{{c2::liver}} disease</b> </div>", "time": 1660105360259.0}, {"id": 1474670612056, "note": "<div><b>Cystic fibrosis</b> may present as {{c1::meconium ileus (10-20% of patients)}} in <u>newborns</u> due to abnormally <i>thick </i>(<i>\"inspissated\"</i>) stool  </div>", "time": null}, {"id": 1474670615748, "note": "<div><b>Cystic fibrosis</b> may cause <b>{{c1::infertility}}</b> in <i>men</i> due to congenital <u>bilateral</u> <u>absence</u> of the <b>{{c2::vas deferens}}</b> </div>", "time": null}, {"id": 1474670618209, "note": "<div>Is <u>spermatogenesis</u> possible in a patient with <b>cystic fibrosis</b>?</div><div><br /></div><div>{{c1::Yes}}</div>", "time": null}, {"id": 1474670620491, "note": "<div><b>Cystic fibrosis</b> may cause <b>{{c1::subfertility}}</b> in <i>women</i> due to abnormally <u>thick</u> <b>{{c2::cervical mucus}}</b> and <b>amenorrhea</b></div>", "time": null}, {"id": 1474670622536, "note": "<div><b>Cystic fibrosis</b> may present with <b>{{c1::nasal}} polyps </b>and <b>nail {{c2::clubbing}}</b></div>", "time": null}, {"id": 1474670625781, "note": "<div>Treatment of <b>cystic fibrosis</b> includes replacement of {{c1::pancreatic}} enzymes</div>", "time": 1660105348561.0}, {"id": 1474670628112, "note": "<div>Treatment of <b>cystic fibrosis</b> includes {{c1::azithromycin}}, which is used as an <b>anti-inflammatory</b> agent</div>", "time": null}, {"id": 1474670632979, "note": "<div>Treatment of <b>cystic fibrosis</b> includes <b>{{c1::hyper}}-tonic saline</b>, which facilitates <u>mucus clearing</u></div>", "time": 1660105348560.0}, {"id": 1474670635112, "note": "<div>Treatment of <b>cystic fibrosis</b> includes aerosolized <b>{{c1::dornase alfa (DNase)}}</b>, which hydrolyzes DNA in mucus causing <u>decreased</u> viscosity</div>", "time": null}, {"id": 1474670637480, "note": "<div>Treatment of <b>cystic fibrosis</b> includes {{c1::albuterol}}, a <b>\u03b2<sub>2</sub> agonist</b></div>", "time": null}, {"id": 1474670639442, "note": "Treatment of <b>cystic fibrosis</b> includes <b>chest {{c1::physiotherapy}}</b>, which aids in <u>mucus clearance</u> ", "time": null}, {"id": 1474684616177, "note": "<div><i><div></div></i></div><div>The site of <u>synthesis</u>, <u>storage</u>, and <u>release</u> of <b>renin</b> is the&nbsp;<b>{{c1::juxtaglomerular apparatus}}</b> of the kidney</div>", "time": 1660105352108.0}, {"id": 1474686171007, "note": "<div><b>Renin</b> is responsible for the conversion of {{c1::<b>angiotensinogen</b>}} to {{c1::<b>angiotensin I</b>}}<br></div>", "time": 1660105352109.0}, {"id": 1474686176874, "note": "<div><b>ACE</b> is primarily located in the <u>vascular endothelium</u> of the <b>{{c1::lungs}}</b><br></div>", "time": 1660105352125.0}, {"id": 1474686182224, "note": "<div><b>Angiotensin I</b> is converted to <b>angiotensin II </b>by <b>{{c1::ACE}}</b> in the <u>lungs</u> (primarily)<br></div>", "time": 1660105352124.0}, {"id": 1474686187282, "note": "<div><b>Angiotensin II</b> is a potent <b>vaso-{{c1::constrictor}}</b><br></div>", "time": 1660105352120.0}, {"id": 1474686197574, "note": "<div>What effect do <i>normal</i> levels of <b>angiotensin II</b> have on <b>GFR</b>?<br></div><div><br></div><div>{{c1::Increased GFR}}</div>", "time": 1660105352100.0}, {"id": 1474686203572, "note": "<div><b>Angiotensin II</b> normally <u>constricts</u>&nbsp;the <b>{{c2::efferent}} arteriole</b> of the kidney<br></div>", "time": 1660105352118.0}, {"id": 1474686213041, "note": "<div><b>Angiotensin II</b> acts <i>directly</i> at the {{c1::<b>PCT</b>::location}} to {{c2::<u>increase</u>}} <b>NaHCO<sub>3</sub></b> reabsorption<br></div>", "time": 1660105352123.0}, {"id": 1474686218949, "note": "<div><b>Angiotensin II</b> <u>increases</u> {{c1::aldosterone}} release from the <i>adrenal cortex</i><br></div>", "time": 1660105352121.0}, {"id": 1474686227756, "note": "<div>What effect does <b>angiotensin II</b> <i>indirectly</i> have on serum <b>potassium</b> levels?<br></div><div><br></div><div>{{c1::Decreased K<sup>+</sup> (via aldosterone)}}</div>", "time": 1660105352099.0}, {"id": 1474686237808, "note": "<div>What <u>drug class</u> do <b>captopril</b>, <b>enalapril</b>, <b>lisinopril</b>, and&nbsp;<b>ramipril</b> belong to?<br></div><div><br></div><div>{{c1::ACE inhibitors}}</div>", "time": 1660105352107.0}, {"id": 1474686246072, "note": "<div>What effect do <b>ACE inhibitors</b> have on levels of <b>angiotensin II</b>?<br></div><div><br></div><div>{{c1::Decreased AT II}}</div>", "time": 1660105352102.0}, {"id": 1474686254735, "note": "<div>What effect do <b>ACE inhibitors</b> <i>and</i> <b>ARBs</b> have on <b>GFR</b>?<br></div><div><br></div><div>{{c1::Decreased GFR}}</div>", "time": 1660105352105.0}, {"id": 1474686260264, "note": "<div><b>ACE inhibitors</b> and <b>ARBs</b> primarily cause <b>{{c1::dilation}}</b> of the <b>{{c2::efferent}} arteriole</b> of the kidney<br></div>", "time": 1660105352139.0}, {"id": 1474686265216, "note": "<div><b>ACE inhibitors </b>and <b>ARBs</b> {{c1::<i>decrease</i>}} <u>sodium and bicarbonate</u> reabsorption at the <b>{{c2::proximal convoluted tubule}}</b><br></div>", "time": 1660105352136.0}, {"id": 1474686269926, "note": "<div><b>ACE inhibitors</b> and <b>ARBs</b> {{c1::<u>decrease</u>}} <b>aldosterone&nbsp;</b>release from the adrenal cortex<br></div>", "time": 1660105352137.0}, {"id": 1474686274500, "note": "<div><b>ACE inhibitors</b> can cause a(n) {{c1::<u>elevation</u>}} in <b>creatinine </b>levels within the first few days of starting treatment<br></div>", "time": 1660105352130.0}, {"id": 1474686279261, "note": "<div><b>ACE inhibitors</b> can cause significant <b>{{c1::hypotension}}</b> which can lead to <b>{{c1::syncope}}</b> in patients with <u>high</u> <b>{{c2::renin}}</b> <b>levels</b> (e.g. heart failure, diuretic use)<br></div>", "time": 1660105352129.0}, {"id": 1474686309779, "note": "<div>What effect do <b>ACE inhibitors</b> have on levels of <b>angiotensin I</b> and <b>renin</b>?<br></div><div><br></div><div>{{c1::Increased levels}}</div>", "time": 1660105352103.0}, {"id": 1474686320085, "note": "<div>What effect may <b>ACE inhibitors</b> have on <b>potassium </b>levels?<br></div><div><br></div><div>{{c1::Increased (hyperkalemia)}}</div>", "time": 1660105352098.0}, {"id": 1474686325582, "note": "<div><b>ACE inhibitors</b> are <u>first line agents</u> in the treatment of <b>heart {{c1::failure}}</b><br></div>", "time": 1660105352131.0}, {"id": 1474686333322, "note": "<div>Do <b>ACE inhibitors</b> <u>reduce</u> mortality in patients with <b>heart</b> <b>failure</b> and <b>MI</b>?<br></div><div><br></div><div>{{c1::Yes}}</div>", "time": 1660105352114.0}, {"id": 1474686338336, "note": "<div><b>{{c2::ACE}} </b><b>inhibitors</b> <u>decrease</u> <b>heart&nbsp;</b><b>{{c1::remodeling}}</b> induced by high levels of angiotensin II (e.g. chronic hypertension)<br></div>", "time": 1660105352094.0}, {"id": 1474686349415, "note": "<div><b>ACE inhibitors</b> are a <u>first line agent</u> in the treatment of primary <b>{{c1::hypertension}}</b><br></div>", "time": 1660105352134.0}, {"id": 1474686354906, "note": "<div><b>{{c2::ACE}} inhibitors</b> <u>slow</u> the progression of <b>diabetic {{c1::nephropathy}}</b><br></div>", "time": 1660105352089.0}, {"id": 1474686363427, "note": "<div>In <u>diabetics</u>, <b>{{c2::ACE}} inhibitors</b> <i>decrease</i> intraglomerular pressure, thus <u>slowing</u> <b>{{c1::glomerular basement membrane}} thickening</b><br></div>", "time": 1660105359198.0}, {"id": 1474686367174, "note": "<div>After checking a patient on urinalysis, patients with <b>{{c1::proteinuria}}</b> should be started on a(n)&nbsp;<b>{{c2::ACE}} inhibitor</b>, especially if they have concommitant BP &gt; 130/80<br></div>", "time": 1660105352111.0}, {"id": 1474686384532, "note": "<div><b>{{c2::ACE}} inhibitors</b> may cause a(n)&nbsp;<b>{{c1::dry cough}}</b> due to <i>lung irritation</i>, secondary to <u>increased</u> <b>{{c3::bradykinin}}</b></div>", "time": 1660105352092.0}, {"id": 1474686391197, "note": "<div>What effect do <b>ACE inhibitors</b> have on <b>bradykinin activity</b>?<br></div><div><br></div><div>{{c1::Increased}}</div>", "time": 1660105352104.0}, {"id": 1474686405380, "note": "<div>What effect do <b>ARBs</b> have on <b>bradykinin activity</b>?<br></div><div><br></div><div>{{c1::No effect}}</div>", "time": 1660105352101.0}, {"id": 1474686417807, "note": "<div><b>{{c3::ACE}} inhibitors</b> are <u>contraindicated</u> in patients with <b>{{c1::hereditary angioedema}}</b>, which is characterized by a(n)&nbsp;<b><i>{{c2::C1 esterase inhibitor}}</i> deficiency</b><br></div>", "time": 1660105352085.0}, {"id": 1474686431809, "note": "<div><b>ACE inhibitors</b> may cause <b>angioedema</b> due to <u>increased</u> <b>{{c1::bradykinin}}</b><br></div>", "time": 1660105359202.0}, {"id": 1474686441354, "note": "<div><b>ACE inhibitors</b> are <u>contraindicated</u> during {{c1::pregnancy}} due to possible {{c1::teratogenic}} effects<br></div>", "time": 1660105352133.0}, {"id": 1474686451558, "note": "<div><i>Coadministration</i> of <b>ACE inhibitors</b> with <b>{{c1::NSAIDs}}</b> can precipitate <u>acute</u> {{c2::<b>kidney</b>}} <b>injury</b><br></div>", "time": 1660105352116.0}, {"id": 1474686460035, "note": "<div><b>NSAIDs</b> <u>decrease</u> <b>prostaglandins</b>, which normally {{c1::<u>dilate</u>}} the <b>{{c2::afferent}}</b> <b>arterioles</b> of the kidney<br></div>", "time": 1660105352113.0}, {"id": 1474686473276, "note": "<div>What effect may <b>NSAIDs</b> have on <b>GFR</b>?<br></div><div><br></div><div>{{c1::Decreased GFR}}</div>", "time": 1660105352095.0}, {"id": 1474686477331, "note": "<div><b>ACE inhibitors</b> are <u>contraindicated</u> in <b><i>bilateral&nbsp;</i></b><b>{{c1::renal artery stenosis}}</b><br></div>", "time": 1660105352132.0}, {"id": 1474686494629, "note": "<div><b>ACE inhibitors</b> may precipitate {{c1::<u>acute renal failure</u>}} in <b>bilateral {{c2::renal}} artery stenosis</b>, causing <i>significantly&nbsp;</i><u>increased</u> serum&nbsp;<b>creatinine</b><br></div>", "time": 1660105352127.0}, {"id": 1474686499750, "note": "<div>What <u>drug class</u> do <b>losartan</b>, <b>candesartan</b>, and <b>valsartan</b> belong to?<br></div><div><br></div><div>{{c1::Angiotensin II receptor blockers (ARBs)}}</div>", "time": 1660105352106.0}, {"id": 1474686508267, "note": "<div><b>ARBs</b> are used to treat <u>hypertension</u>, <u>proteinuria</u>, <u>HF</u>, or <u>diabetic nephropathy</u> in patients <i>intolerant</i> to <b>{{c1::ACE inhibitors}}</b><br></div>", "time": 1660105352117.0}, {"id": 1474686517153, "note": "<div><b>ARBs</b> selectively <u>block</u> binding of <b>angiotensin II </b>to the <b>{{c1::AT<sub>1</sub>}} receptor</b></div>", "time": 1660105359199.0}, {"id": 1474686521925, "note": "<div>What effect may <b>ARBs</b> have on <b>potassium </b>levels?<br></div><div><div><br></div><div>{{c1::Increased (hyperkalemia)}}</div></div>", "time": 1660105352096.0}, {"id": 1474686526636, "note": "<div><b>ARBs</b> are <u>contraindicated</u> during {{c1::pregnancy}} due to possible {{c1::teratogenic}} effects</div>", "time": 1660105359200.0}, {"id": 1474686556381, "note": "<div>What effect may <b>ARBs</b> have on <b>blood pressure</b>?<br></div><div><div><br></div><div>{{c1::Decreased (hypotension)}}</div></div>", "time": 1660105359194.0}, {"id": 1474686559492, "note": "<div><b>{{c2::Aliskiren}}</b> is a <u>direct</u> <b>{{c1::renin}} inhibitor</b><br></div>", "time": 1660105352087.0}, {"id": 1474686569024, "note": "<div>What effect may <b>aliskiren</b> have on <b>potassium </b>levels?<br></div><div><div><br></div><div>{{c1::Increased (hyperkalemia)}}</div></div>", "time": 1660105352097.0}, {"id": 1474686581015, "note": "<div>What effect may <b>aliskiren</b> have on <b>blood pressure</b>?<br></div><div><div><br></div><div>{{c1::Decreased (hypotension)}}</div></div>", "time": 1660105359195.0}, {"id": 1474686586573, "note": "<div>What effect does <b>aliskiren </b>have on <b>GFR</b>?<br></div><div><div><br></div><div>{{c1::Decreased GFR}}</div></div>", "time": 1660105359196.0}, {"id": 1474686590025, "note": "<div><b>Aliskiren</b> is relatively <u>contraindicated</u> in patients already taking <b>{{c1::ACE inhibitors}}</b> or <b>{{c1::ARBs}}</b></div>", "time": 1660105359201.0}, {"id": 1474686599248, "note": "<div>What is the primary clinical use for <b>aliskiren</b>?<br></div><div><br></div><div>{{c1::Treatment of hypertension}}</div>", "time": 1660105359193.0}, {"id": 1474735479535, "note": "The <b>kidneys</b> lie in the {{c1::<u>retroperitoneal</u>}} cavity of the body", "time": null}, {"id": 1474740118606, "note": "<div>The <u>outer</u> region of the <b>kidney</b> is the <b>{{c1::cortex}}</b></div>", "time": 1660105349732.0}, {"id": 1474740124096, "note": "<div>The <u>central</u> region of the <b>kidney</b> is the <b>{{c1::medulla}}</b></div>", "time": 1660105350336.0}, {"id": 1474740128563, "note": "<div>The <u>innermost</u> tip of the kidney <i>medullary pyramid</i><b> </b>is called the&nbsp;<b>{{c1::papilla}}</b></div>", "time": 1660105349979.0}, {"id": 1474740134057, "note": "<div>The <b>medullary pyramids</b> (<b>papillae</b>) of the <u>kidney</u> empty into <b>{{c1::major}}</b> and {{c1::<b>minor</b> <b>calyces</b>}}</div>", "time": 1660105349838.0}, {"id": 1474740138099, "note": "<div>The <b>major </b>and <b>minor calyces</b> of the <u>kidney</u> drain into the <b>{{c1::renal pelvis}}</b>, which is the <i>dilated</i> proximal part of the <b>{{c2::ureter}}</b></div>", "time": 1660105349872.0}, {"id": 1474740154600, "note": "<div>Following <b>Bowmans capsule</b>, <u>glomerular filtrate</u> enters the <b>{{c1::proximal convoluted tubule}}</b></div>", "time": null}, {"id": 1474740165098, "note": "<div>Following the <b>proximal straight tubule</b>, <u>glomerular filtrate</u> enters the <b>{{c1::thin <i>descending</i> limb (loop of Henle)}}</b></div>", "time": null}, {"id": 1474740367558, "note": "<div>Following the <b>thin descending limb</b>, <u>glomerular filtrate</u> enters the <b>{{c1::thin <i>ascending</i> limb (loop of Henle)}}</b></div>", "time": null}, {"id": 1474740373043, "note": "<div>Following the <b>thin ascending limb</b>, the <u>glomerular filtrate</u> enters the <b>{{c1::<i>thick</i> ascending limb (loop of Henle)}}</b></div>", "time": null}, {"id": 1474740377221, "note": "<div>The <u>thin</u> <b>descending</b> <b>limb</b>, <u>thin</u> <b>ascending</b> <b>limb</b>, and <u>thick</u> <b>ascending</b> <b>limb</b> of the <i>kidney</i> form the {{c1::loop of Henle}}</div>", "time": null}, {"id": 1474740381345, "note": "<div>Following the <b>thick ascending limb </b>(loop of Henle), <u>glomerular filtrate</u> enters the <b>{{c1::distal convoluted tubule}}</b></div>", "time": null}, {"id": 1474740385466, "note": "<div><div>At the <i>beginning</i> of the <b>distal convoluted tubule</b>, <u>glomerular filtrate</u> passes the <b>{{c1::macula densa}}</b> </div></div>", "time": null}, {"id": 1474740392746, "note": "<div>Following the <b>distal convoluted tubule</b>, <u>glomerular filtrate</u> enters the <b>{{c2::collecting ducts}}</b></div>", "time": null}, {"id": 1474740410456, "note": "<div>Blood enters the <u>kidney</u> via a(n)&nbsp;<b>{{c1::renal}} artery</b>, which branches into <b>{{c2::segmental}} arteries</b></div>", "time": null}, {"id": 1474740414745, "note": "<div><b>Segmental arteries</b> of the <u>kidney</u> further branch into <b>{{c1::interlobar}} arteries</b></div>", "time": null}, {"id": 1474740420064, "note": "<div><b>Interlobar arteries</b> of the <u>kidney</u> further branch into <b>{{c1::arcuate}} arteries</b></div>", "time": null}, {"id": 1474740424347, "note": "<div><b>Arcuate arteries</b> of the <u>kidney</u> further branch into <b>{{c1::interlobular}} arteries</b> </div>", "time": null}, {"id": 1474740432266, "note": "<div>The <b>interlobular arteries</b> of the <u>kidney</u> divide into the <b>{{c1::afferent arterioles}}</b></div>", "time": null}, {"id": 1474740436322, "note": "<div>Blood <u>enters</u> the <b>glomerular capillaries</b> via the <b>{{c1::afferent}} arterioles</b></div>", "time": 1660105361202.0}, {"id": 1474740440380, "note": "<div>Blood <u>exits</u> the <b>glomerular capillaries</b> via the <b>{{c1::efferent}} arterioles</b></div>", "time": 1660105361201.0}, {"id": 1474740445704, "note": "<div>Blood from the <b>efferent arterioles</b> is delivered to the <b>{{c1::peritubular}} capillaries</b></div>", "time": 1660105361191.0}, {"id": 1474740455628, "note": "<div>Which <u>kidney</u> is taken during <b>donor transplantation</b>? Why? </div><div><br></div><div>{{c1::Left; has a longer renal vein}}</div>", "time": null}, {"id": 1474740478683, "note": "On average, <b>total body water </b>(TBW) is <b>{{c1::60}}% of body weight</b>", "time": null}, {"id": 1474746760064, "note": "<div><div><b>Extracellular fluid</b> is divided into <b>{{c1::interstitial fluid}}</b> ({{c2::75}}% of ECF) and <b>{{c1::plasma}}</b> ({{c2::25}}% of ECF)</div></div>", "time": null}, {"id": 1474746765591, "note": "<div><div>In addition to <u>ICF</u> and <u>ECF</u>, a<i> small</i> <b>{{c1::transcellular}} fluid compartment</b> consists of cerebrospinal, pleural, peritoneal, and digestive fluids</div></div>", "time": null}, {"id": 1474746769550, "note": "<div><div><b>Intracellular fluid</b> comprises {{c1::<u>two-thirds</u>}} of <b>total body <u>water</u></b></div></div>", "time": null}, {"id": 1474746774149, "note": "<div><div>The major <u>cations</u> of <b>{{c3::intracellular}} fluid</b> are {{c1::<b>K<sup>+</sup></b>}} and {{c2::<b>Mg<sup>2+</sup></b>}}</div></div>", "time": null}, {"id": 1474746781048, "note": "<div><div><b>Extracellular fluid</b> comprises {{c1::<u>one-third</u>}} of <b>total body <u>water</u> </b><b> </b></div></div>", "time": null}, {"id": 1474746797999, "note": "<div><b>Plasma </b>constitutes {{c1::55}}% of blood volume, while <b>RBCs</b> constitute the remaining {{c1::45}}%</div>", "time": 1660105353886.0}, {"id": 1474746802754, "note": "<div>The <u>percent of blood volume</u> occupied by <b>RBCs</b> is called the <b>{{c1::hematocrit}}</b>, which averages {{c2::45}}%</div>", "time": null}, {"id": 1474746821687, "note": "<div><b>{{c2::Plasma}} volume</b> can be measured by using <b>{{c1::radiolabeled albumin}}</b> or <b>Evans blue</b></div>", "time": null}, {"id": 1474746837185, "note": "<div><b>{{c2::Extracellular}} fluid volume</b> can be measured using <b>{{c1::inulin}}</b> or <b>mannitol</b></div>", "time": null}, {"id": 1474746842357, "note": "<div>The <b>volume</b> of a <u>body fluid compartment</u> depends on the amount of <b>{{c1::solute}} </b>it contains</div>", "time": null}, {"id": 1474746852860, "note": "<div><b>{{c1::Osmolarity}}</b> is the <u>concentration</u> of <b>osmotically</b> <b>active</b> <b>particles</b>, expressed in mOsm/L</div>", "time": null}, {"id": 1474746855917, "note": "<div><b>Plasma osmolarity</b> may be estimated by <b>P<sub>osm</sub></b> = {{c1::(2 * Na<sup>+</sup>) + (Glucose/18) + (BUN/2.8)}} </div>", "time": null}, {"id": 1474746862902, "note": "<div>In the <u>steady state</u>, <b>intracellular osmolarity</b> is {{c1::equal to}} <b>extracellular osmolarity</b> (less than, greater than, or equal to)</div>", "time": null}, {"id": 1474746866845, "note": "<div>Solutes such as <b>NaCl</b> and <b>mannitol</b> <u>do not</u> cross cell membranes and are thus confined to the <b>{{c1::extracellular}} fluid compartment</b></div>", "time": null}, {"id": 1474746870596, "note": "<div><b>Volume {{c2::contraction}}</b> refers to a <u>decrease</u> in <b>{{c1::ECF}}</b> <b>volume</b></div>", "time": null}, {"id": 1474746873791, "note": "<div><b>Volume {{c2::expansion}}</b> refers to an <u>increase</u> in <b>{{c1::ECF}} volume</b></div>", "time": null}, {"id": 1474746882207, "note": "<div>How does <b>ECF volume</b> change with <b>diarrhea</b>? </div><div><br /></div><div>{{c1::Decreased}}</div>", "time": null}, {"id": 1474746958406, "note": "<div><div><div>How does <b>ICF volume</b> change with <b>hyposmotic volume contraction</b> (e.g. adrenal insufficiency)? </div><div><br /></div><div>{{c1::Increased}}</div></div></div>", "time": null}, {"id": 1474746962963, "note": "<div><div>How does <b>osmolarity</b> change with <b>adrenal insufficiency</b>? </div><div><br /></div><div>{{c1::Decreased (loss of Na<sup>+</sup> due to lack of aldosterone)}}</div></div>", "time": null}, {"id": 1474746967542, "note": "<div><div><b>Adrenal insufficiency</b> is a cause of <u>{{c1::hypo}}-osmotic volume</u><b>&nbsp;contraction</b></div></div>", "time": null}, {"id": 1474746972150, "note": "<div><div>How does <b>plasma protein </b><u>concentration</u> change with <b>hyposmotic volume contraction</b> (e.g. adrenal insufficiency)? </div><div><br /></div><div>{{c1::Increased}}</div></div>", "time": null}, {"id": 1474746977041, "note": "<div><div><div>How does <b>hematocrit</b> change with <b>hyposmotic volume contraction</b> (e.g. adrenal insufficiency)? </div><div><br /></div><div>{{c1::Increased}}</div></div></div>", "time": null}, {"id": 1474747015054, "note": "<div><div>How does <b>ECF volume</b> change with <b>excessive NaCl intake</b>? </div><div><br /></div><div>{{c1::Increased}}</div></div>", "time": null}, {"id": 1474747019160, "note": "<div><div><div>How does <b>ICF volume</b> change with <b>excessive NaCl intake</b>? </div><div><br /></div><div>{{c1::Decreased}}</div></div></div>", "time": null}, {"id": 1474747022806, "note": "<div><div>How does <b>osmolarity</b> change with <b>excessive NaCl intake</b>? </div><div><br /></div><div>{{c1::Increased}}</div></div>", "time": null}, {"id": 1474747026681, "note": "<div><div><b>Excessive NaCl intake</b> is a cause of <u>{{c1::hyper}}-osmotic volume</u><b> {{c2::expansion}}</b></div></div>", "time": 1660105359383.0}, {"id": 1474747042640, "note": "<div>How does <b>ECF volume</b> change with <b>SIADH</b>? </div><div><br /></div><div>{{c1::Increased}}</div>", "time": null}, {"id": 1474747048093, "note": "<div><div>How does <b>ICF volume</b> change with <b>hyposmotic volume expansion</b> (e.g. SIADH)? </div><div><br /></div><div>{{c1::Increased}}</div></div>", "time": null}, {"id": 1474747052320, "note": "<div>How does <b>osmolarity</b> change with <b>SIADH</b>? </div><div><br /></div><div>{{c1::Decreased (hyposmolarity)}}</div>", "time": null}, {"id": 1474747057898, "note": "<div><b>SIADH</b> is a cause of <u>{{c1::hypo}}-osmotic volume</u><b>&nbsp;expansion</b></div>", "time": 1660105352998.0}, {"id": 1474747062216, "note": "<div>How does <b>plasma protein </b><u>concentration</u> change with <b>hyposmotic volume expansion</b> (e.g. SIADH)? </div><div><br /></div><div>{{c1::Decreased}}</div>", "time": null}, {"id": 1474747066410, "note": "<div>How does <b>hematocrit</b> change with <b>hyposmotic volume expansion</b> (e.g. SIADH)? </div><div><br /></div><div>{{c1::No change}}</div>", "time": null}, {"id": 1474758510704, "note": "<div>Normal serum <b>osmolality</b> is ~ {{c1::290}} mOsm/kg H<sub>2</sub>O </div>", "time": null}, {"id": 1474763251887, "note": "<div><div>What <u>type</u> of <i>adrenergic</i> <b>receptor</b> is found on the <b>renal afferent</b> and <b>efferent arterioles</b>? </div><div><br /></div><div>{{c1::\u03b1<sub>1</sub>-adrenergic receptors}}</div></div>", "time": null}, {"id": 1474763274094, "note": "<div><div>In both the <i>afferent</i> and <i>efferent</i> arterioles of the <u>kidney</u>, <b>angiotensin II</b> <b>activity</b> causes <b>vaso-{{c1::constriction}} </b> </div></div>", "time": null}, {"id": 1474763277556, "note": "<div><div>Which <i>arterioles</i> of the <b>kidney</b> (afferent or efferent) are <u>more sensitive</u> to <b>angiotensin II</b>? </div><div><br></div><div>{{c1::Efferent arterioles}}</div></div>", "time": null}, {"id": 1474763284717, "note": "<div><div>{{c2::<u>Low (normal)</u>}}<i> </i>levels of <u>angiotensin II</u> <i>primarily</i> causes&nbsp;<b>vasoconstriction </b>of<b> </b>the renal {{c1::efferent}} arterioles</div></div>", "time": null}, {"id": 1474763288960, "note": "<div><div><div>What effect does <u>angiotensin II activity</u> have on <b>renal blood flow</b>? </div><div><br></div><div>{{c1::Decreased RBF}}</div></div></div>", "time": null}, {"id": 1474763292268, "note": "<div><div><div>What effect does <i>normal </i>levels of <u>angiotensin II</u> have on <b>GFR</b>? </div><div><br></div><div>{{c1::Increased GFR}}</div></div></div>", "time": null}, {"id": 1474763298610, "note": "<div><div>What effect do&nbsp;<i>high </i>levels of <u>angiotensin II</u> have on <b>GFR</b>? </div><div><br></div><div>{{c1::Decreased GFR}}</div></div>", "time": null}, {"id": 1474763305428, "note": "<div><b>Atrial natriuretic peptide</b> causes <u>vaso-</u>{{c2::<u>dilation</u>}} of <b>{{c1::afferent}} arterioles</b> and, to a lesser extent, <u>vaso-</u>{{c2::<u>constriction</u>}} of <b>{{c1::efferent}} arterioles</b></div>", "time": 1660105361445.0}, {"id": 1474763321835, "note": "<div><b>Prostaglandins </b>{{c2::<b>E</b><sub style=\"font-weight: bold; \">2</sub>}} and {{c2::<b>I<sub>2</sub></b>}} cause <u>vaso-</u>{{c1::<u>dilation</u>}} of <i>both</i> <b>afferent</b> and <b>efferent arterioles</b> in the kidney</div>", "time": null}, {"id": 1474763338334, "note": "<div>What <u>drug class</u> <i>inhibits</i> synthesis of <b>prostaglandins</b> and thus interferes with the <u>protective effect</u> of PGs on renal function?</div><div><br></div><div>{{c1::NSAIDs}}</div>", "time": null}, {"id": 1474763341992, "note": "<div>At {{c1::<u>low</u>}} levels, <b>dopamine</b> causes <u>vaso-</u>{{c2::<u>dilation</u>}} of <b>renal arterioles</b> and <b>interlobular arteries</b> </div>", "time": null}, {"id": 1474763351178, "note": "<div><b>Renal blood flow</b> (RBF) remains relatively <u>constant</u> between blood pressure ranges of {{c1::80}} to {{c1::200}} mmHg</div>", "time": null}, {"id": 1474763357561, "note": "<div><b>Renal autoregulation</b> is <i>primarily</i> controlled by changing {{c2::<u>vascular resistance</u>}} of the <b>{{c1::afferent}} arteriole</b></div>", "time": null}, {"id": 1474763361773, "note": "<div>The <b>{{c3::myogenic}} mechanism </b>of <i>renal autoregulation</i> states that <b>renal afferent arterioles</b> {{c2::<u>contract</u>}} in response to <u>increased</u> {{c1::<b>stretch</b>}} on the arterial wall</div>", "time": null}, {"id": 1474763369869, "note": "<div>The <b>{{c2::tubuloglomerular feedback}} mechanism</b> of <i>renal autoregulation</i> states that <b>renal afferent arterioles</b> <u>contract</u> in response to <b>vasoactive substances</b> released by the <b>{{c1::macula densa}}</b></div>", "time": null}, {"id": 1474763375647, "note": "<div><b>{{c2::Para-aminohippuric acid (PAH)}}</b> <b>clearance</b> can be used to calculate <b>{{c1::effective renal plasma flow (eRPF)}}</b> because it is <i>both</i> <u>filtered</u> and <u>secreted</u> </div>", "time": null}, {"id": 1474763386216, "note": "<div><b>Effective RPF (eRPF)</b> {{c1::<u>under</u>}}<u>-estimates</u> <i>true</i> <b>renal plasma flow</b> slightly (~10%) </div>", "time": null}, {"id": 1474763400180, "note": "<div><b>Effective renal plasma flow</b> may be estimated using the <u>equation</u>: </div><div><br /></div><div><b>eRPF</b> = <b>C<sub>{{c1::PAH}}</sub></b> = {{c1::[U]<sub>PAH</sub> * V / [P]<sub>PAH</sub>}} </div>", "time": null}, {"id": 1474763407997, "note": "<div><b>Renal blood flow (RBF)</b> is calculated using the <u>equation</u>: </div><div><br /></div><div><b>RBF</b> = {{c1::RPF / (1 - Hct)}}</div>", "time": null}, {"id": 1474763416138, "note": "<div>The <u>fraction of blood volume</u> occupied by <b>plasma </b>= {{c1::1 - hematocrit}}</div>", "time": null}, {"id": 1474763419291, "note": "<div>The <b>glomerular filtration barrier</b> is responsible for filtering the <u>plasma</u> according to the properties of a compounds {{c1::size}} and {{c1::net charge}}</div>", "time": null}, {"id": 1474763422931, "note": "<div>One component of the <u>glomerular filtration barrier</u> is a(n)&nbsp;<b>{{c2::endothelial}} cell layer</b> with large <b>{{c1::fenestrations}} </b></div>", "time": 1660105354613.0}, {"id": 1474763431029, "note": "<div>One component of the <u>glomerular filtration barrier</u> is a(n)&nbsp;<b>{{c1::basement}} membrane</b></div>", "time": null}, {"id": 1474763437090, "note": "<div>One component of the <u>glomerular filtration barrier</u> is a layer of <b>{{c3::epithelial}} cells</b>, called <b>{{c1::podocytes}}</b>, which attach to the <i>basement membrane</i> by <b>{{c2::foot processes}}</b> </div>", "time": null}, {"id": 1474763450879, "note": "<div><div>Does the <b>basement membrane</b> of the <u>glomerular filtration barrier</u> normally <b>permit plasma proteins</b>? </div><div><br /></div><div>{{c1::No}}</div></div>", "time": null}, {"id": 1474763455361, "note": "<div>The <b>{{c3::basement membrane}}</b> of the <u>glomerular filtration barrier</u> contains <b>{{c1::heparan sulfate}}</b>, which acts as a(n)&nbsp;<b>{{c2::negative}} charge barrier</b></div>", "time": null}, {"id": 1474763467088, "note": "<div>In <b>{{c2::nephrotic}} syndrome</b>, the {{c1::<i>charge</i>}} barrier of the <u>glomerular filtration barrier</u> is lost</div>", "time": null}, {"id": 1474763473389, "note": "<div>Loss of the <i>charge barrier</i> of the <u>glomerular filtration barrier</u> (e.g. nephrotic syndrome) results in <b>{{c1::protein}}-uria</b> </div>", "time": null}, {"id": 1474763499282, "note": "<div>What does <b>P<sub>GC</sub> </b>represent in regards to <b>GFR</b> (fluid exchange)? </div><div><br></div><div>{{c1::Glomerular capillary hydrostatic pressure}}</div>", "time": 1660105347279.0}, {"id": 1474763506441, "note": "<div><div>What does <b>P<sub>BS</sub> </b>represent in regards to <b>GFR</b> (fluid exchange)? </div><div><br /></div><div>{{c1::Bowmans space hydrostatic pressure}}</div></div>", "time": 1660105347280.0}, {"id": 1474763514561, "note": "<div><div>What does <b>\u03c0<sub>GC</sub> </b>represent in regards to <b>GFR</b> (fluid exchange)? </div><div><br></div><div>{{c1::Glomerular capillary oncotic pressure}}</div></div>", "time": 1660105347267.0}, {"id": 1474763550482, "note": "<div>What effect does <b>afferent arteriolar</b> <u>constriction</u> have on <b>RPF</b>?</div><div><br /></div><div>{{c1::Decreased}}</div>", "time": 1660105347199.0}, {"id": 1474763558205, "note": "<div><div>What effect does <b>afferent arteriolar</b> <u>constriction</u> have on <b>GFR</b>?</div><div><br /></div><div>{{c1::Decreased}}</div></div>", "time": 1660105347200.0}, {"id": 1474763565664, "note": "<div><div>What effect does <b>efferent arteriolar</b> <u>constriction</u> have on <b>RPF</b>?</div><div><br /></div><div>{{c1::Decreased}}</div></div>", "time": 1660105347190.0}, {"id": 1474763572604, "note": "<div><div><div>What effect does <b>efferent arteriolar</b> <u>constriction</u> have on <b>GFR</b>?</div><div><br /></div><div>{{c1::Increased}}</div></div></div>", "time": 1660105347191.0}, {"id": 1474763579120, "note": "<div>What effect does <u>increased</u> <b>plasma protein concentration</b> (<b>\u03c0<sub>GC</sub></b>) have on <b>GFR</b>? </div><div><br /></div><div>{{c1::Decreased GFR}}</div>", "time": 1660105347181.0}, {"id": 1474763584176, "note": "<div><div>What effect does <u>increased</u> <b>plasma protein concentration</b> (<b>\u03c0<sub>GC</sub></b>) have on <b>RPF</b>? </div><div><br /></div><div>{{c1::No change}}</div></div>", "time": 1660105347180.0}, {"id": 1474763588567, "note": "<div><div>What effect does <u>decreased</u> <b>plasma protein concentration</b> (<b>\u03c0<sub>GC</sub></b>) have on <b>GFR</b>? </div><div><br /></div><div>{{c1::Increased GFR}}</div></div>", "time": 1660105347194.0}, {"id": 1474763593293, "note": "<div><div>What effect does <u>decreased</u> <b>plasma protein concentration</b> (<b>\u03c0<sub>GC</sub></b>) have on <b>RPF</b>? </div><div><br /></div><div>{{c1::No change}}</div></div>", "time": 1660105347193.0}, {"id": 1474763597673, "note": "<div>What effect does <b>constriction of the ureter</b> have on <b>GFR</b>? </div><div><br /></div><div>{{c1::Decreased GFR}}</div>", "time": 1660105347197.0}, {"id": 1474763604888, "note": "<div><div>What effect does <b>constriction of the ureter</b> have on <b>RPF</b>? </div><div><br /></div><div>{{c1::No change}}</div></div>", "time": 1660105347196.0}, {"id": 1474763614010, "note": "<div><div><b>{{c2::Inulin}}</b> <b>clearance</b> can be used to calculate <b>{{c1::GFR}}</b> because it is <i>freely filtered</i> and is not&nbsp;<u>reabsorbed</u> or <u>secreted</u></div></div>", "time": null}, {"id": 1474763631111, "note": "<div><div><b>Glomerular filtration rate</b> may be estimated using the <u>equation</u>: </div><div><br></div><div><b>GFR</b> = <b>C<sub>inulin</sub></b> = {{c1::[U]<sub>inulin</sub> * V / [P]<sub>inulin</sub>}} </div></div>", "time": null}, {"id": 1474763658246, "note": "<div>In addition to <u>inulin</u>, <b>{{c1::creatinine}} clearance</b> may also be used to <i>estimate</i> <b>GFR</b></div>", "time": null}, {"id": 1474763662554, "note": "<div><b>Creatinine clearance</b> slightly {{c1::<u>over</u>}}<u>-estimates</u> <b>GFR</b> because creatinine is moderately {{c1::<u>secreted</u>}} by renal tubules</div>", "time": null}, {"id": 1474763665591, "note": "<div><b>Volume contraction</b> results in <u>decreased</u> renal perfusion with consequent <u>decreased</u> GFR, thus <i>increasing</i> <b>nitrogenous waste products</b> in the blood ({{c1::prerenal}} azotemia)</div>", "time": null}, {"id": 1474763667904, "note": "<div>In <b>prerenal azotemia</b>, <u>decreased</u> GFR causes {{c1::<u>increased</u>}} levels of <b>BUN</b> and <b>serum creatinine</b></div>", "time": null}, {"id": 1474763670263, "note": "<div>In <b>prerenal azotemia</b>, there is a(n) {{c1::<u>increase</u>}} in the ratio of <b>BUN/creatinine</b> to more than 20</div>", "time": null}, {"id": 1474763686814, "note": "<div>The <b>filtration fraction</b> may be calculated using the <u>equation</u> <b>FF</b> = {{c1::GFR / RPF}}</div>", "time": null}, {"id": 1474763698514, "note": "<div><div><div>What effect does <b>afferent arteriolar</b> <u>constriction</u> have on <b>filtration fraction</b>?</div><div><br /></div><div>{{c1::No change}}</div></div></div>", "time": null}, {"id": 1474763701856, "note": "<div><div><div><div>What effect does <b>efferent arteriolar</b> <u>constriction</u> have on <b>filtration fraction</b>?</div><div><br /></div><div>{{c1::Increased FF}}</div></div></div></div>", "time": null}, {"id": 1474763704210, "note": "<div><div>What effect does <u>increased</u> <b>plasma protein concentration</b> (<b>\u03c0<sub>GC</sub></b>) have on <b>filtration fraction</b>? </div><div><br /></div><div>{{c1::Decreased FF}}</div></div>", "time": null}, {"id": 1474763708724, "note": "<div><div><div>What effect does <u>decreased</u> <b>plasma protein concentration</b> (<b>\u03c0<sub>GC</sub></b>) have on <b>filtration fraction</b>? </div><div><br /></div><div>{{c1::Increased FF}}</div></div></div>", "time": null}, {"id": 1474763713169, "note": "<div><div>What effect does <b>constriction of the ureter</b> have on <b>filtration fraction</b>? </div><div><br /></div><div>{{c1::Decreased FF}}</div></div>", "time": null}, {"id": 1474913501954, "note": "Fluid <u>exits</u> the <b>glomerular capillaries</b> and <u>enters</u> <b>Bowmans space</b> via the process of {{c1::filtration}}", "time": 1660105358839.0}, {"id": 1474922296785, "note": "<div>Fluid <u>exits</u> <b>PCT cells </b>and <u>enters</u> the <b>peritubular capillaries</b> via the process of {{c1::reabsorption}}</div>", "time": 1660105358841.0}, {"id": 1474922302177, "note": "<div>Fluid <u>exits</u> <b><i>peritubular</i> capillaries</b> and <u>enters</u> <b>PCT cells</b> via the process of {{c1::secretion}} </div>", "time": 1660105358840.0}, {"id": 1474922326239, "note": "<div>The <i>sum</i> of <b>filtration</b>, <b>secretion</b>, and <b>reabsorption</b> is {{c1::excretion}}</div>", "time": 1660105349536.0}, {"id": 1474922330649, "note": "<div>The <u>amount</u> of substance filtered in Bowmans space <i>per unit time</i> is called the {{c1::filtered load}}</div>", "time": 1660105350465.0}, {"id": 1474922337108, "note": "<div><b>Filtered load</b> (mg/min) can be calculated using the <u>equation</u>: </div><div><br></div><div>Filtered load = {{c1::GFR (mL/min) * [P<sub>x</sub>] (mg/mL)}} </div>", "time": null}, {"id": 1474922347730, "note": "<div><b>Excretion rate</b> can be calculated using the <u>equation</u>: </div><div><br /></div><div>Excretion rate = {{c1::V * [U]<sub>x</sub>}} </div>", "time": 1660105359379.0}, {"id": 1474922357406, "note": "<div>If the <b>filtered load</b> is {{c2::<u>less</u>}} than the <b>excretion rate</b>, there has been net {{c1::<b>secretion</b>::reabsorption or secretion}}&nbsp;</div>", "time": 1660105357692.0}, {"id": 1474922362704, "note": "<div>If the <b>filtered load</b> is {{c2::<u>greater</u>}} than the <b>excretion rate</b>, there has been net {{c1::<b>reabsorption</b>::reabsorption or secretion}}</div>", "time": 1660105357694.0}, {"id": 1474922367295, "note": "<div>The rate of {{c1::<u>reabsorption</u>}} is equal to <b>filtered load</b> <b>-</b> <b>excretion rate</b></div>", "time": null}, {"id": 1474922371104, "note": "<div>The rate of {{c1::<u>secretion</u>}} is equal to <b>excretion rate - filtered load</b></div>", "time": null}, {"id": 1474922374083, "note": "<div><b>Glucose</b> is <u>reabsorbed</u> in the <b>{{c2::early PCT}}</b> by {{c1::<b>Na<sup>+</sup>/glucose (SGLT)</b>}} <b>cotransporters</b></div>", "time": 1660105358602.0}, {"id": 1474922401297, "note": "<div><b>Glucose</b> in the cells of the <i>PCT</i> enter the <u>peritubular capillary blood</u> through <b>{{c1::GLUT1}}</b> and <b>{{c1::GLUT2}}</b> transporters</div>", "time": null}, {"id": 1474922409905, "note": "<div>What type of <u>transport mechanism</u> is glucose transport through <b>GLUT1 </b>and <b>GLUT2</b>? </div><div><br></div><div>{{c1::Facilitated diffusion}}</div>", "time": null}, {"id": 1474922413517, "note": "<div><b>Glucose</b> at a normal plasma level (60 - 120 mg/dL) is <i>completely</i> {{c1::reabsorbed}} in the <b>PCT</b></div>", "time": null}, {"id": 1474922449467, "note": "<div>In adults, <i>all</i> glucose transporters are <u>fully saturated</u> (<b>T</b><sub style=\"font-weight: bold; \">m</sub>) at a <b>plasma</b> glucose of ~ {{c1::350}} mg/dL </div>", "time": null}, {"id": 1474922506786, "note": "<div>What <u>pathology</u> is commonly associated with <b>glucosuria</b>? </div><div><br></div><div>{{c1::Diabetes mellitus}}</div>", "time": null}, {"id": 1474922509502, "note": "<div>What <u>non-pathologic state</u> is commonly associated with <b>glucosuria</b>? </div><div><br /></div><div>{{c1::Pregnancy}}</div>", "time": null}, {"id": 1474922517443, "note": "<div><div>How does <u>GFR</u> change during <b>pregnancy</b>? </div><div><br /></div><div>{{c1::Increased}}</div></div>", "time": null}, {"id": 1474922524410, "note": "<div>Normal <b>pregnancy</b> may <u>decrease</u> the ability of the PCT to <u>reabsorb</u> <b>{{c1::glucose}}</b> and <b>{{c2::amino acids}}</b> by <u>increasing</u> {{c3::GFR}}</div>", "time": null}, {"id": 1474922538417, "note": "<div>In the {{c1::<b>thin descending limb</b> (Henles loop)}} of the nephron, <b>urea</b> is {{c2::<i>secreted</i>}} by <u>simple diffusion</u> </div>", "time": null}, {"id": 1474922547709, "note": "<div>The <b>thick ascending limb</b>, <b>distal tubule</b>, and <b>cortical/outer medullary collecting ducts </b>are {{c1::<u>impermeable</u>}} to <b>urea</b> (permeable or impermeable)</div>", "time": 1660105349466.0}, {"id": 1474922553494, "note": "<div>In the <b>{{c1::inner medullary collecting ducts}}</b>, 70% of the filtered <b>urea</b> is {{c2::<i>reabsorbed</i>}} via {{c3::<u>facilitated</u>}}<u> diffusion</u> (if ADH is present) </div>", "time": null}, {"id": 1474922639637, "note": "<div><b>Tubular</b> <b>inulin</b> {{c1::<u>increases</u>}} in concentration along the PCT as a result of <b>water reabsorption</b> </div>", "time": null}, {"id": 1474929447261, "note": "<div>The bulk of <b>Na<sup>+</sup> reabsorption</b> occurs in the {{c1::proximal convoluted tubule}} (67%)</div>", "time": 1660105350385.0}, {"id": 1474932384686, "note": "<div>The <b>proximal tubule</b> is characterized by {{c1::<u>iso</u>}}<u>-osmotic</u> reabsorption</div>", "time": null}, {"id": 1474932395460, "note": "<div><div>{{c1::<b>HCO<sub>3</sub><sup>-</sup></b>}} is the major <b>anion</b> <i>reabsorbed</i> in the {{c2::<u>early</u> <b>PCT</b>}}</div></div>", "time": null}, {"id": 1474932398773, "note": "<div>Usually, 100% of <u>glucose</u> and <u>amino acids</u> are <i>reabsorbed</i> in the {{c1::early PCT}}</div>", "time": null}, {"id": 1474932405759, "note": "<div><b>Phosphate</b> is primarily <i>reabsorbed</i> in the {{c1::<u>early</u> <b>PCT</b>}} through {{c2::<b>Na<sup>+</sup>-phosphate</b>}} <i>cotransport</i></div>", "time": 1660105353947.0}, {"id": 1474932426910, "note": "<div><b>H<sup>+</sup></b> is <i>secreted</i> into the lumen of the <u>early PCT</u> via the <b>{{c2::Na<sup>+</sup>-H<sup>+</sup>}} exchanger</b>, where it combines with <i>filtered</i> {{c1::<b>HCO<sub>3</sub><sup>-</sup></b>}}, forming H<sub>2</sub>CO<sub>3</sub></div>", "time": 1660105358495.0}, {"id": 1474932431909, "note": "<div>In the lumen of the <u>early PCT</u>, <b>H<sub>2</sub>CO<sub>3</sub></b> is converted into {{c1::H<sub>2</sub>O}} and {{c1::CO<sub>2</sub>}} via the enzyme <i>carbonic anhydrase</i> </div>", "time": 1660105356722.0}, {"id": 1474932437772, "note": "<div>The <b>H<sub>2</sub>O </b>and <b>CO<sub>2</sub></b> in the <i>lumen</i> of the <u>early PCT</u> (from H<sub>2</sub>CO<sub>3</sub>) is {{c1::<i>reabsorbed</i> into::excreted out or reabsorbed into}} the cell&nbsp;</div>", "time": null}, {"id": 1474932447019, "note": "<div>Inside the cells of the <u>early PCT</u>, H<sub>2</sub>O and CO<sub>2</sub> form <b>H<sub>2</sub>CO<sub>3</sub></b>, which then dissociates into {{c1::H<sup>+</sup>}} and {{c1::HCO<sub>3</sub><sup>-</sup>}} </div>", "time": null}, {"id": 1474932451499, "note": "<div>The<b> HCO<sub>3</sub><sup>-</sup></b> inside the cells of the <u>early PCT</u> (from H<sub>2</sub>CO<sub>3</sub>) is {{c1::<i>reabsorbed</i> (into the blood)}} via facilitated diffusion</div>", "time": 1660105350043.0}, {"id": 1474932460152, "note": "<div>The <b>H<sup>+</sup></b> inside the cells of the <u>early PCT</u> (from H<sub>2</sub>CO<sub>3</sub>) is {{c1::<i>re-secreted</i> (into the lumen)}} by the Na<sup>+</sup>-H<sup>+</sup> exchanger</div>", "time": 1660105350053.0}, {"id": 1474932476571, "note": "<div>{{c1::Cl<sup>-</sup>}} is the major <b>anion</b> <i>reabsorbed</i> in the {{c2::<u>late</u> <b>PCT</b>}} of the nephron</div>", "time": null}, {"id": 1474932479975, "note": "<div><b>Cl<sup>-</sup></b> is partially <i>reabsorbed</i> via the <b>{{c1::Cl<sup>-</sup>-formate<sup>-</sup>}} anion exchanger</b> in the luminal membrane of the <u>late</u> PCT</div>", "time": 1660105360674.0}, {"id": 1474932485458, "note": "<div>In the <u>late</u> PCT, <b>Na<sup>+</sup> reabsorption</b> may occur through the {{c1::<b>Na<sup>+</sup>-H<sup>+</sup></b>}} <b>exchange</b></div>", "time": null}, {"id": 1474932490408, "note": "<div>What is the <u>driving force</u> for reabsorption of <b>NaCl</b> in the <u>late</u> PCT? </div><div><br /></div><div>{{c1::High Cl<sup>-</sup> gradient}} </div>", "time": null}, {"id": 1474932502315, "note": "<div>The major solutes absorbed in the <b>proximal tubule</b> are <b>{{c1::NaCl}}</b> and <b>{{c2::NaHCO<sub>3</sub>}}</b></div>", "time": null}, {"id": 1474932505066, "note": "<div>Does solute follow water reabsorption, or does water follow solute reabsorption?</div><div><br></div><div>{{c1::Water follows solute}}</div>", "time": null}, {"id": 1474932507699, "note": "<div>How is <b>Na<sup>+</sup></b> pumped <i>out</i> of the cell of the <u>proximal tubule</u> and <i>into</i> the <u>blood</u>? </div><div><br /></div><div>{{c1::Na<sup>+</sup>-K<sup>+</sup>-ATPase pump}}</div>", "time": 1660105358010.0}, {"id": 1475023030947, "note": "<div>What component of <u>tubular fluid</u> is sensed at the <b>macula densa</b>? </div><div><br /></div><div>{{c1::Na<sup>+</sup> and Cl<sup>-</sup>}}</div>", "time": null}, {"id": 1475023145072, "note": "The <b>{{c1::thin descending}} limb</b> (loop of Henle) is {{c2::<u>permeable</u>}} to <b>water</b>", "time": 1660105349006.0}, {"id": 1475023148576, "note": "<div>The <b>{{c1::thin descending}} limb</b> (loop of Henle) is {{c2::<u>impermeable</u>}} to <b>Na</b><sup style=\"font-weight: bold; \">+</sup></div>", "time": 1660105349008.0}, {"id": 1475023151338, "note": "<div>In the <b>thin descending limb</b> (loop of Henle), <u>tubular fluid</u> becomes progressively <b>{{c1::hyper}}-osmotic</b> as it descends</div>", "time": 1660105356642.0}, {"id": 1475023156885, "note": "The <u>thin descending limb</u> <i>absorbs</i> <b>water</b> {{c1::passively::actively or passively}}&nbsp;", "time": null}, {"id": 1475023164702, "note": "<div>The <b>{{c1::thin}} </b>and <b>{{c1::thick ascending}} limbs</b> (loop of Henle) are {{c2::<u>impermeable</u>}} to <b>water</b></div>", "time": null}, {"id": 1475023167601, "note": "<div>The <b>{{c1::thin}} </b>and <b>{{c1::thick ascending}} limbs</b> (loop of Henle) are {{c2::<u>permeable</u>}} to <b>Na</b><sup style=\"font-weight: bold; \">+</sup></div>", "time": null}, {"id": 1475023170258, "note": "<div>In the <b>thick ascending limb</b> (loop of Henle), <u>tubular fluid</u> becomes progressively <b>{{c1::hypo}}-osmotic</b> as it ascends</div>", "time": 1660105356643.0}, {"id": 1475023173253, "note": "<div>The <u>thin ascending limb</u> <i>absorbs</i> <b>Na<sup>+</sup></b> {{c1::passively::actively or passively}}&nbsp;</div>", "time": null}, {"id": 1475023179496, "note": "<div>The <u>thick ascending limb</u> <i>absorbs</i> <b>Na<sup>+</sup></b> {{c1::actively::actively or passively}}</div>", "time": null}, {"id": 1475023188432, "note": "<div>The <b>thick ascending limb </b>(of Henle) normally <u>reabsorbs</u> approximately {{c1::10-20}}% of the <b>filtered Na<sup>+</sup></b> </div>", "time": 1660105349467.0}, {"id": 1475023207285, "note": "<div><b>Na<sup>+</sup></b> is <u>reabsorbed</u> in the {{c2::<b>thick ascending limb</b> (of Henle)}} via the <b>{{c1::Na<sup>+</sup>-K<sup>+</sup>-2Cl<sup>-</sup>}} cotransporter</b> in the luminal membrane</div>", "time": 1660105354961.0}, {"id": 1475023212490, "note": "<div>In addition to Na<sup>+</sup>, what two other ions are <i>reabsorbed</i> <u>through the lumen</u> of the <b>thick ascending limb</b>? <br><br></div><div> </div><div>{{c1::K<sup>+</sup>, Cl<sup>-</sup> (Na<sup>+</sup>-K<sup>+</sup>-2Cl<sup>-</sup> cotransporter)}}</div>", "time": null}, {"id": 1475023223476, "note": "<div><div>How is <b>Na<sup>+</sup></b> extruded <i>out</i> of the cell of the <u>thick ascending limb</u> and <i>into</i> the <u>blood</u>? </div><div><br /></div><div>{{c1::Na<sup>+</sup>-K<sup>+</sup>-ATPase pump}}</div></div>", "time": 1660105358012.0}, {"id": 1475023231313, "note": "<div><div>How is <b>Cl<sup>-</sup></b> extruded <i>out</i> of the cell of the <u>thick ascending limb</u> and <i>into</i> the <u>blood</u>? </div><div><br></div><div>{{c1::Diffusion down its electrochemical gradient (via membrane channels)}}</div></div>", "time": 1660105358029.0}, {"id": 1475023236542, "note": "<div><div>How is <b>K<sup>+</sup></b> extruded <i>out</i> of the cell of the <u>thick ascending limb</u> and <i>into</i> the <u>blood</u>? </div><div><br></div><div>{{c1::Diffusion down its electrochemical gradient (via membrane channels)}}</div></div>", "time": 1660105358020.0}, {"id": 1475023241238, "note": "<div>Some {{c1::<b>K<sup>+</sup></b>}} in the cells of the <u>thick ascending limb</u> diffuse <i>back into the lumen</i>, creating a <b>lumen {{c2::positive}} potential difference</b> </div>", "time": null}, {"id": 1475023249022, "note": "<div>The <b>{{c2::thick ascending limb</b> (of Henle)<b>}}</b> is the site of action of <b>{{c1::loop}} diuretics</b></div>", "time": null}, {"id": 1475023267133, "note": "<div>Travel through the <b>thick ascending limb</b> (of Henle) results in {{c1::<u>dilution</u>::concentration or dilution}} of the <b>tubular fluid&nbsp;</b></div>", "time": null}, {"id": 1475023281268, "note": "<div>The <u>early</u> <b>DCT</b> normally <u>reabsorbs</u>&nbsp;approximately {{c1::5}}% of the<b> filtered Na<sup>+</sup></b></div>", "time": null}, {"id": 1475023288799, "note": "<div><div><b>Na<sup>+</sup></b> is <u>reabsorbed</u> in the <b>{{c2::<u>early</u> DCT}}</b> via the <b>{{c1::Na<sup>+</sup>-Cl<sup>-</sup>}} cotransporter</b> in the luminal membrane</div></div>", "time": 1660105354963.0}, {"id": 1475023293960, "note": "<div><div>In addition to Na<sup>+</sup>, what other ion is <i>reabsorbed</i> through the lumen of the <b><u>early</u> DCT</b>? <br><br></div><div> </div><div>{{c1::Cl<sup>-</sup> (Na<sup>+</sup>-Cl<sup>- </sup>cotransporter)}}</div></div>", "time": null}, {"id": 1475023301582, "note": "<div><div><div>How is <b>Na<sup>+</sup></b> extruded <i>out</i> of the cell of the <u>early DCT</u> and <i>into</i> the <u>blood</u>? </div><div><br /></div><div>{{c1::Na<sup>+</sup>-K<sup>+</sup>-ATPase pump}}</div></div></div>", "time": 1660105358013.0}, {"id": 1475023319279, "note": "<div><div><div>How is <b>Cl<sup>-</sup></b> extruded <i>out</i> of the cell of the <u>early DCT</u> and <i>into</i> the <u>blood</u>? </div><div><br /></div><div>{{c1::Diffusion down its electrochemical gradient (via membrane channels)}}</div></div></div>", "time": null}, {"id": 1475023324120, "note": "<div>The {{c1::<b>early</b>}}<b> DCT</b> is always {{c2::<u>impermeable</u>::permeability}} to <b>water</b>&nbsp;</div>", "time": null}, {"id": 1475023348879, "note": "<div>What are the <u>two</u> main cell types of the <b>late distal tubule</b> and <b>collecting duct</b>? </div><div><br></div><div>{{c1::Principal cells, \u03b1-intercalated cells}}</div>", "time": 1660105347617.0}, {"id": 1475023354853, "note": "<div>The <b>{{c2::principal}} cells</b> of the <u>late distal tubule</u> and <u>collecting duct</u> <i>reabsorb</i> {{c1::<b>Na<sup>+</sup></b>}} and {{c1::<b>H<sub>2</sub>O</b>}}</div>", "time": 1660105348878.0}, {"id": 1475023360479, "note": "<div>The <b>{{c2::principal}} cells</b> of the <u>late distal tubule</u> and <u>collecting duct</u> <i>secrete</i> {{c1::<b>K<sup>+</sup></b>}}</div>", "time": null}, {"id": 1475023371223, "note": "<div><div>The <b>{{c2::\u03b1-intercalated}} cells</b> of the <u>late distal tubule</u> and <u>collecting duct</u> <i>secrete</i> {{c1::<b>H<sup>+</sup></b>}}</div></div>", "time": 1660105348840.0}, {"id": 1475023376859, "note": "<div><div>The <u>late</u> <b>distal convoluted tubule</b> and <b>collecting ducts </b>normally <u>reabsorb</u> approximately {{c1::3}}% of the<b> filtered Na<sup>+</sup> </b></div></div>", "time": 1660105349944.0}, {"id": 1475023386260, "note": "<div><b>Na<sup>+</sup></b> is <u>reabsorbed</u> in the <i>principal cells</i> of the <b><u>late</u> DCT</b> and <b>collecting duct</b> via the <b>{{c1::epithelial Na<sup>+</sup>}} channels</b> in the luminal membrane </div>", "time": null}, {"id": 1475023394742, "note": "<div><div>How is <b>Na<sup>+</sup></b> extruded <i>out</i> of the cells of the <u>late DCT</u> &amp; <u>collecting duct</u> and <i>into</i> the <u>blood</u>? </div><div><br /></div><div>{{c1::Na<sup>+</sup>-K<sup>+</sup>-ATPase pump}}</div></div>", "time": 1660105358011.0}, {"id": 1475023399522, "note": "<div><b>Aldosterone</b> leads to {{c1::<u>increased</u>}} <b>epithelial Na<sup>+</sup> channel</b> (ENaC)<b> activity</b></div>", "time": null}, {"id": 1475023402435, "note": "<div><b>Aldosterone</b> leads to {{c1::<u>increased</u>}} <b>apical {{c2::K<sup>+</sup>}} conductance</b> </div>", "time": 1660105361975.0}, {"id": 1475023404978, "note": "<div>In <i>principal cells</i>, <u>increased</u> <b>ENaC</b> <b>activity</b> (due to aldosterone) causes <u>increased</u> lumen {{c1::negativity::charge}}&nbsp;</div>", "time": null}, {"id": 1475023407328, "note": "<div><u>Increased</u> <b>lumen</b> <b>negativity</b> in <i>principal cells</i> causes <u>increased</u> {{c1::K<sup>+</sup>}}<b> secretion</b></div>", "time": null}, {"id": 1475024177732, "note": "In response to <u>increased</u> Na<sup>+</sup> intake (and ECF volume), there is {{c1::<u>decreased</u>}} <b>sympathetic activity</b> ", "time": 1660105356911.0}, {"id": 1475024469081, "note": "<div>In response to <u>increased</u> Na<sup>+</sup> intake (and ECF volume), there is {{c1::<u>increased</u>}} <b>ANP activity</b> </div>", "time": 1660105356910.0}, {"id": 1475024491494, "note": "<div>In response to <u>increased</u> Na<sup>+</sup> intake (and ECF volume), there is {{c1::<u>decreased</u>}}<b> peritubular capillary oncotic pressure</b> </div>", "time": null}, {"id": 1475024501313, "note": "<div>In response to <u>increased</u> Na<sup>+</sup> intake (and ECF volume), there is {{c1::<u>decreased</u>}} <b>renin-angiotensin-aldosterone activity</b> </div>", "time": 1660105356912.0}, {"id": 1475026494378, "note": "<b>Insulin</b> causes <b>K</b><sup style=\"font-weight: bold; \">+</sup> to shift {{c1::<u>into</u>}} cells, causing {{c1::<u>hypokalemia</u>}}", "time": null}, {"id": 1475028551112, "note": "<div>How does <b>insulin</b> cause <b>K</b><sup style=\"font-weight: bold; \">+</sup> to shift <u>into</u> cells?</div><div><br></div><div>{{c1::Increased Na<sup>+</sup>-K<sup>+</sup> ATPase}}</div>", "time": null}, {"id": 1475028554589, "note": "<div><b>Insulin deficiency</b> (e.g. T1DM) causes <b>K</b><sup style=\"font-weight: bold; \">+</sup> to shift {{c1::<u>out of</u>}} cells, causing {{c1::<u>hyperkalemia</u>}}</div>", "time": null}, {"id": 1475028559369, "note": "<div>What <u>acid-base disturbance</u> is associated with <b>hypokalemia</b>? </div><div><br /></div><div>{{c1::Alkalosis}}</div>", "time": null}, {"id": 1475028564158, "note": "<div><div>What <u>acid-base disturbance</u> is associated with <b>hyperkalemia</b>? </div><div><br /></div><div>{{c1::Acidosis}}</div></div>", "time": null}, {"id": 1475028568425, "note": "<div><u>Acid-base disturbances</u> <i>may</i>&nbsp;affect serum <b>K<sup>+</sup></b> levels via altering <i>activity</i> and <i>directionality</i> of the {{c1::H<sup>+</sup>-K<sup>+</sup>}}<b> exchanger</b></div>", "time": null}, {"id": 1475028580006, "note": "<div><b>Alkalosis</b> <i>may</i> cause <b>K</b><sup style=\"font-weight: bold; \">+</sup> to shift {{c1::<u>into</u>}} cells, causing {{c1::<u>hypokalemia</u>}}</div>", "time": null}, {"id": 1475028584708, "note": "<div><b>Acidosis</b> <i>may</i> cause <b>K</b><sup style=\"font-weight: bold; \">+</sup> to shift {{c1::<u>out of</u>}} cells, causing {{c1::<u>hyperkalemia</u>}}</div>", "time": null}, {"id": 1475028595175, "note": "<div><b>{{c2::\u03b2}}-adrenergic </b><i>antagonists</i> cause <b>K</b><sup style=\"font-weight: bold; \">+</sup> to shift {{c1::<u>out of</u>}} cells, causing {{c1::<u>hyperkalemia</u>}}</div>", "time": null}, {"id": 1475028599544, "note": "<div><b>{{c2::\u03b2}}-adrenergic</b> <i>agonists</i> cause <b>K</b><sup style=\"font-weight: bold; \">+</sup> to shift {{c1::<u>into</u>}} cells, causing {{c1::<u>hypokalemia</u>}}</div>", "time": 1660105337162.0}, {"id": 1475028603588, "note": "<div><b>{{c2::\u03b1}}-adrenergic </b><i>antagonists</i> cause <b>K</b><sup style=\"font-weight: bold; \">+</sup> to shift {{c1::<u>into</u>}} cells, causing {{c1::<u>hypokalemia</u>}}</div>", "time": null}, {"id": 1475028611617, "note": "<div><b>{{c2::Hyper}}-osmolarity</b> may cause <b>K</b><sup style=\"font-weight: bold; \">+</sup> to shift {{c1::<u>out of</u>}} cells, causing {{c1::<u>hyperkalemia</u>}}</div>", "time": null}, {"id": 1475028616230, "note": "<div><b>{{c2::Hypo}}-osmolarity</b> may cause <b>K</b><sup style=\"font-weight: bold; \">+</sup> to shift {{c1::<u>into</u>}} cells, causing {{c1::<u>hypokalemia</u>}}</div>", "time": null}, {"id": 1475028620304, "note": "<div><b>Lysis of cells</b> may cause <b>K</b><sup style=\"font-weight: bold; \">+</sup> to shift {{c1::<u>out of</u>}} cells, causing {{c1::<u>hyperkalemia</u>}} </div>", "time": null}, {"id": 1475028718697, "note": "<div><b>Hyperaldosteronism</b> {{c2::increases}} K<sup>+</sup> <u>secretion</u> and causes {{c2::hypo}}-kalemia</div>", "time": null}, {"id": 1475028795710, "note": "<div><b>Hypoaldosteronism</b> {{c2::decreases}} K<sup>+</sup> <u>secretion</u> and causes {{c2::hyper}}-kalemia</div>", "time": null}, {"id": 1475028803355, "note": "<div><b>Aldosterone</b> {{c1::increases}} the number of <u>luminal</u> membrane <b>K<sup>+</sup> channels </b>in the late distal tubule and collecting duct</div>", "time": null}, {"id": 1475028806030, "note": "<div><b>Thiazide</b> and <b>loop diuretics</b> {{c1::<u>increase</u>}} K<sup>+</sup> excretion and cause {{c1::hypo}}-kalemia</div>", "time": null}, {"id": 1475028815097, "note": "<div><u>Increased</u> <b>Na<sup>+</sup> delivery</b> to <i>principal cells</i> (e.g. thiazide and loop diuretics) causes {{c1::<u>increased</u>}} <b>K<sup>+</sup> secretion</b> </div>", "time": null}, {"id": 1475028821432, "note": "<div><b>Thiazide</b> and<b> loop diuretics</b> {{c1::<u>increase</u>}} <u>flow rate</u> through the <i>late DCT</i> and <i>collecting duct</i>, thus {{c2::<u>decreasing</u>}} <b><i>luminal</i> K<sup>+</sup> concentration</b></div>", "time": null}, {"id": 1475028830285, "note": "<div><b>K<sup>+</sup>-sparing diuretics</b> {{c1::<u>decrease</u>}} K<sup>+</sup> secretion and cause {{c1::hyper}}-kalemia</div>", "time": null}, {"id": 1475082776569, "note": "<div>{{c1::<b>PTH</b>}} is a hormone that <u>inhibits</u> <b>{{c2::Na<sup>+</sup>-phosphate}} cotransport</b> in the <i>proximal tubule</i></div>", "time": null}, {"id": 1475082795028, "note": "<div><b>PTH</b> action causes <u>increased</u> urinary {{c1::<b>cAMP</b>}} and <b>{{c2::phosphat}}-uria</b></div>", "time": null}, {"id": 1475082841154, "note": "<div><b>{{c2::Loop}} diuretics</b> <i>indirectly</i> <u>inhibit</u> {{c1::<b>Ca</b><sup style=\"font-weight: bold; \">2+</sup>}} and <b>{{c1::Mg<sup>2+</sup>}}&nbsp;</b>reabsorption in the <u>thick ascending limb</u> (loop of Henle)</div>", "time": null}, {"id": 1475082848928, "note": "<div>What effect do <b>loop diuretics</b> have on <i>serum</i> <b>Ca<sup>2+</sup> levels</b>? </div><div><br></div><div>{{c1::Decreased}}</div>", "time": null}, {"id": 1475082866378, "note": "<div>What is the <u>site of regulation</u> for <b>Ca</b><sup style=\"font-weight: bold; \">2+</sup> <b>reabsorption</b>? </div><div><br /></div><div>{{c1::Distal tubule}}</div>", "time": 1660105345479.0}, {"id": 1475082877166, "note": "<div>{{c1::Parathyroid}} hormone <u>stimulates</u> <b>{{c2::Ca<sup>2+</sup>-Na<sup>+</sup>}} exchange</b> in the <i>basolateral membrane</i> of distal tubule cells</div>", "time": 1660105339347.0}, {"id": 1475082883967, "note": "<div><b>PTH </b>action causes <b>{{c1::hypo}}-calciuria</b></div>", "time": null}, {"id": 1475082893857, "note": "<div><div>What effect do <b>thiazide diuretics</b> have on serum <b>Ca<sup>2+</sup> levels</b>? </div><div><br /></div><div>{{c1::Increased}}</div></div>", "time": null}, {"id": 1475082900558, "note": "<div>The bulk of <b>Mg<sup>2+</sup> reabsorption</b> occurs in the {{c1::thick ascending limb (of Henle)}} (60%)</div>", "time": null}, {"id": 1475082906040, "note": "<div><div><b>Mg<sup>2+</sup> </b>is <i>reabsorbed</i> in the <u>thick ascending limb</u> (on Henle) via a(n) {{c1::paracellular}} route </div></div>", "time": null}, {"id": 1475082921853, "note": "<div><div>What effect do <b>loop diuretics</b> have on serum <b>Mg<sup>2+</sup> levels</b>? </div><div><br></div><div>{{c1::Decreased (hypomagnesemia)}}</div></div>", "time": null}, {"id": 1475101582942, "note": "<div>The {{c1::cortical}} and {{c1::outer medullary}} <b>collecting ducts</b> are <u>permeable</u> to <b>H<sub>2</sub>O&nbsp;</b>and&nbsp;<u>impermeable</u> to <b>urea</b> (ADH present)</div>", "time": 1660105349260.0}, {"id": 1475101596275, "note": "<div>The {{c1::inner medullary}} <b>collecting duct</b> is <u>permeable</u> to <i>both</i> <b>H<sub>2</sub>O</b> and <b>urea</b> (ADH present)</div>", "time": 1660105349192.0}, {"id": 1475101601179, "note": "<div>What effect does the <b>urea cycle</b> have on <b>interstitial fluid osmolarity</b>? </div><div><br /></div><div>{{c1::Increased osmolarity}}</div>", "time": null}, {"id": 1475101605375, "note": "<div><b>ADH</b> {{c1::enhances}} the activity of the <b>urea cycle</b></div>", "time": null}, {"id": 1475101609569, "note": "<div>In the <u>absence</u> of <b>{{c2::ADH}}</b>, the principal cells of the <i>late distal tubule</i> and <i>collecting duct</i> are {{c1::<u>impermeable</u>}} to <b>water</b></div>", "time": null}, {"id": 1475101613908, "note": "<div>In the <u>presence</u> of <b>{{c2::ADH}}</b>, <b>{{c1::aquaporin 2}} channels</b> are inserted in the <u>luminal</u> membrane of {{c3::<b>principal</b>}} <b>cells</b> of the late distal tubule and collecting duct</div>", "time": null}, {"id": 1475101620253, "note": "<div><b>{{c1::Hyper}}-osmotic</b> <b>urine</b> is produced when the circulating levels of <b>ADH</b> are {{c2::<u>high</u>}} </div>", "time": 1660105340021.0}, {"id": 1475101707272, "note": "<div><div><b>{{c1::Hypo}}-osmotic</b> <b>urine</b> is produced when the circulating levels of <b>ADH</b> are {{c2::<u>low</u>}} </div></div>", "time": 1660105340003.0}, {"id": 1475101798210, "note": "<div>{{c1::Free-water clearance (C<sub>H2O</sub>)}} is used to estimate the <i>ability</i> to <u>concentrate</u> or <u>dilute</u> the <b>urine</b></div>", "time": null}, {"id": 1475101822187, "note": "<div>When <b>C</b><sub style=\"font-weight: bold; \">H2O</sub> is {{c1::<u>zero</u>}}, urine is <b>{{c2::iso}}-osmotic</b> relative to plasma</div>", "time": null}, {"id": 1475101835618, "note": "<div>When <b>C</b><sub style=\"font-weight: bold; \">H2O</sub> is {{c1::<u>positive</u>}}, urine is <b>{{c2::hypo}}-osmotic</b> relative to plasma </div>", "time": null}, {"id": 1475101841972, "note": "<div>When <b>C</b><sub style=\"font-weight: bold; \">H2O</sub> is {{c1::<u>negative</u>}}, urine is <b>{{c2::hyper}}-osmotic</b> relative to plasma </div>", "time": null}, {"id": 1475107702619, "note": "<div><b>Cholinomimetic</b> drugs mimic the neurotransmitter {{c1::acetylcholine}}</div>", "time": 1660105352875.0}, {"id": 1475114939718, "note": "<div><b>{{c2::Nicotinic}}</b> <b>acetylcholine</b> <b>receptors</b> are found on <u>autonomic </u>{{c1::<u>ganglia</u>}}<br></div>", "time": 1660105352569.0}, {"id": 1475114947006, "note": "<div><b>{{c2::Nicotinic}}</b> <b>acetylcholine</b> <b>receptors</b> are found on {{c1::<u>motor end plates</u>}} at the <i>NMJ</i> of skeletal muscle<br></div>", "time": 1660105352565.0}, {"id": 1475114951816, "note": "<div><b>{{c2::Nicotinic}}</b> <b>acetylcholine</b> <b>receptors</b> are found on the {{c1::<u>adrenal</u>}}<u> gland</u><br></div>", "time": 1660105352567.0}, {"id": 1475114956456, "note": "<div><b>{{c1::Muscarinic::Muscarinic or Nicotinergic?}} acetylcholine receptors</b> are found in <u>effector tissues</u> (e.g. heart, smooth muscle, brain, glands)<br></div>", "time": 1660105352854.0}, {"id": 1475114962355, "note": "<div><b>{{c2::Nicotinic}}</b> <b>Ach receptors</b> are ligand-gated <b>{{c1::Na<sup>+</sup>/K<sup>+</sup> (ion)}} </b>channels<br></div>", "time": 1660105352563.0}, {"id": 1475114968608, "note": "<div><b>{{c2::Muscarinic}} Ach</b> <b>receptors</b> are {{c1::G-protein coupled}} receptors<br></div>", "time": 1660105352851.0}, {"id": 1475114975445, "note": "<div>What <b>G-protein</b> is the <b>M1</b> muscarinic receptor coupled to?<br></div><div><br></div><div>{{c1::G<sub>q</sub>}}</div>", "time": 1660105352861.0}, {"id": 1475114980575, "note": "<div>What <b>G-protein</b> is the <b>M2</b> muscarinic receptor coupled to?<br></div><div><div><br></div><div>{{c1::G<sub>i</sub>}}</div></div>", "time": 1660105352860.0}, {"id": 1475114985396, "note": "<div>What <b>G-protein</b> is the <b>M3</b> muscarinic receptor coupled to?<br></div><div><div><br></div><div>{{c1::G<sub>q</sub>}}</div></div>", "time": 1660105352859.0}, {"id": 1475114989915, "note": "<div><b>G<sub>q</sub></b> proteins {{c2::<u>activate</u>}} the <b>{{c1::IP<sub>3</sub>-DAG}}</b> signaling cascade<br></div>", "time": 1660105352871.0}, {"id": 1475114999119, "note": "<div><b>{{c3::M1}} muscarinic receptors</b> are found in the<br></div><div><b>- {{c1::CNS}}</b> </div><div>- <b>{{c2::ENS}}</b></div>", "time": 1660105352843.0}, {"id": 1475115012652, "note": "<div>What <u>organ</u> does the <b>M2 receptor</b> primarily effect?<br></div><div><br></div><div>{{c1::Heart}}</div>", "time": 1660105352856.0}, {"id": 1475115054784, "note": "<div><b>{{c2::M2}} muscarinic receptors</b> are found in the {{c1::<u>atria</u>}}, <u>SA node</u>, and <u>AV node</u> of the heart<br></div>", "time": 1660105352853.0}, {"id": 1475115086383, "note": "<div>What is the effect of <b>M2 muscarinic agonists</b> on <u>heart rate</u>?<br></div><div><br></div><div>{{c1::Decreased HR (SA node)}}</div>", "time": 1660105352880.0}, {"id": 1475115092818, "note": "<div>What is the effect of <b>M2 muscarinic agonists</b> on <u>conduction velocity</u>?<br></div><div><div><br></div><div>{{c1::Decreased CV (AV node)}}</div></div>", "time": 1660105352858.0}, {"id": 1475115097360, "note": "<div>What is the effect of <b>M2 muscarinic agonists</b> on <u>heart contractility</u>?<br></div><div><div><br></div><div>{{c1::Decreased <i>atrial</i> contractility}}</div></div>", "time": 1660105352857.0}, {"id": 1475115110904, "note": "<div>The <b>{{c1::M3}} muscarinic receptor</b> is found in glands, the bladder, and smooth muscle<br></div>", "time": 1660105352862.0}, {"id": 1475115136486, "note": "<div>In <i>healthy</i> patients, <b>M3</b> <b>receptor</b> <u>activation</u>&nbsp;<i>indirectly</i> causes <b>vaso-{{c1::dilation}}</b> via release of <b>{{c1::nitric oxide</b><b>}}</b><br></div>", "time": 1660105352868.0}, {"id": 1475115173540, "note": "<div>In <i>atherosclerotic</i><i> </i>patients, <b>M3 receptor</b> <u>activation</u> <i>directly</i> causes <b>vaso-{{c1::constriction}}</b><br></div>", "time": 1660105352869.0}, {"id": 1475115182305, "note": "<div>What <u>drug class</u> does <b>bethanechol</b> belong to?<br></div><div><br></div><div>{{c1::Cholinomimetics (muscarinic agonists)}}</div>", "time": 1660105352593.0}, {"id": 1475115200115, "note": "<b>Bethanechol</b>&nbsp;<u>activates</u>&nbsp;{{c1::bowel}} and {{c2::bladder}}&nbsp;<b>smooth muscle</b>", "time": 1660105352879.0}, {"id": 1475115228977, "note": "<div><b>{{c3::Bethanechol}}</b> is a <u>cholinomimetic agent</u> used to treat <b>{{c2::post-operative}}</b> and <b>{{c4::neurogenic}}</b> <b>{{c1::ileus}}</b><br></div>", "time": 1660105352847.0}, {"id": 1475115245082, "note": "<div><b>{{c3::Bethanechol}}</b> is a <u>cholinomimetic agent</u> used to treat <b>urinary {{c2::retention}}</b><br></div>", "time": 1660105352849.0}, {"id": 1475115252741, "note": "<div>What <u>drug class</u> does <b>pilocarpine</b> belong to?<br></div><div><div><br></div><div>{{c1::Cholinomimetics (muscarinic agonists)}}</div></div>", "time": 1660105352935.0}, {"id": 1475115290102, "note": "<div><b>Pilocarpine</b> is a potent {{c1::<u>stimulator</u>}} of<b> tears</b>, <b>sweat</b>, and <b>salivary secretion</b><br></div>", "time": 1660105352863.0}, {"id": 1475115335100, "note": "<div><b>Pilocarpine</b> <u>contracts</u> <b>{{c1::pupillary sphincter}} muscle</b>, which may be used to treat <b>{{c2::closed}}-angle glaucoma</b><br></div>", "time": 1660105352865.0}, {"id": 1475115343012, "note": "<div><b>Carbachol</b> <u>contracts</u> <b>{{c1::pupillary sphincter}} muscle</b>, which may be used to treat <b>{{c2::closed}}-angle glaucoma</b><br></div>", "time": 1660105352877.0}, {"id": 1475115369043, "note": "<div>Is <b>carbachol</b> a <u>muscarinic</u> or <u>nicotinic</u> <b>Ach agonist</b>?<br></div><div><br></div><div>{{c1::Both :)}}</div>", "time": 1660105352619.0}, {"id": 1475115373568, "note": "<div>What <u>drug class</u> does <b>methacholine</b> belong to?<br></div><div><div><br></div><div>{{c1::Cholinomimetics (muscarinic agonists)}}</div></div>", "time": 1660105352590.0}, {"id": 1475115379443, "note": "<div><b>{{c1::Methacholine}} challenge</b> <i>instigates</i> <u>asthma</u> for pulmonary testing<br></div>", "time": 1660105352855.0}, {"id": 1475177759507, "note": "The normal <u>range</u> for <b>arterial pH</b> is {{c1::7.35}} to {{c1::7.45}}<div><br /></div><div>compatible with life is between {{c1::6.8}} and {{c1::8}}</div>", "time": null}, {"id": 1475178054448, "note": "<div>What is the normal <u>average</u> <b>arterial</b> <b>pH</b>? </div><div><br /></div><div>{{c1::7.4}} </div>", "time": null}, {"id": 1475178058540, "note": "<div>{{c1::<b>CO<sub>2</sub></b>}} is also known as <b>{{c2::volatile}} acid</b></div>", "time": 1660105340775.0}, {"id": 1475178061443, "note": "<div><b>CO<sub>2</sub> </b>combines with <b>H<sub>2</sub>O </b>to form the <i>weak acid</i> <b>H<sub>2</sub>CO<sub>3</sub></b> via the enzyme <b>{{c1::<i>carbonic anhydrase</i>}}</b></div>", "time": null}, {"id": 1475178067413, "note": "<div><b>H<sub>2</sub>CO<sub>3</sub></b> dissociates into {{c1::H<sup>+</sup>}} and {{c1::HCO<sub>3</sub><sup>-</sup>}}</div>", "time": null}, {"id": 1475178073034, "note": "<div><b>Non-volatile acids</b> are also called {{c1::<u>fixed</u>}} acids</div>", "time": 1660105354813.0}, {"id": 1475178078505, "note": "<div>One <b>non-volatile acid</b> is <b>{{c1::sulfuric}} acid</b>, which is generated from metabolism of <u>sulfur-containing amino acids</u> (protein)</div>", "time": null}, {"id": 1475178085760, "note": "<div>One <b>non-volatile acid</b> is <b>{{c1::phosphoric}} acid</b>, which is generated from metabolism of <u>phospholipids</u></div>", "time": null}, {"id": 1475178090922, "note": "<div>What <b>non-volatile acids</b> are commonly elevated in <u>type 1 diabetes</u>? </div><div><br></div><div>{{c1::Acetoacetic acid and \u03b2-hydroxybutyric acid (ketoacidosis)::2}}</div>", "time": null}, {"id": 1475178094848, "note": "<div>What <b>non-volatile acid</b> may be elevated with <u>strenuous exercise</u>? </div><div><br></div><div>{{c1::Lactic acid}}</div>", "time": null}, {"id": 1475178097569, "note": "<div><div><div>What <b>non-volatile acid</b> may be elevated with <u>aspirin overdose</u>? </div><div><br></div><div>{{c1::Salicylic acid}}</div></div></div>", "time": null}, {"id": 1475178100183, "note": "<div><div>What <b>non-volatile acid</b> may be elevated with <u>methanol ingestion</u>? </div><div><br></div><div>{{c1::Formic acid}}</div></div>", "time": 1660105345111.0}, {"id": 1475178102547, "note": "<div><div>What <b>non-volatile acid </b>may be elevated with <u>ethylene glycol ingestion</u>? </div><div><br /></div><div>{{c1::Oxalic acid}}</div></div>", "time": null}, {"id": 1475178112018, "note": "<div>The <b>Henderson-Hasselbalch equation</b> for <i>any</i> <u>buffer</u> states that:</div><div><br></div><div>{{c2::pH}} = {{c1::pK + log [A-]/[HA]}}</div>", "time": null}, {"id": 1475178159080, "note": "<div>The <b>[A<sup>-</sup>]</b> <b>form</b> of the <u>bicarbonate</u> buffer is {{c1::HCO<sub>3</sub><sup>-</sup>}}</div>", "time": null}, {"id": 1475178177038, "note": "<div>The <b>Henderson-Hasselbalch equation</b> for the <u>HCO</u><sub>3</sub><sup>-</sup><u>/CO</u><sub>2</sub><u> buffer</u> states that: </div><div><br></div><div>{{c2::pH}} = {{c1::6.1 + log ([HCO<sub>3</sub><sup>-</sup>] / (0.03 * P<sub>CO2</sub>))}} </div>", "time": 1660105350034.0}, {"id": 1475178204508, "note": "<div>The <u>most significant</u> <b>intracellular</b> <b>buffer</b> for H<sup>+</sup> is {{c1::deoxyhemoglobin}}</div>", "time": 1660105349784.0}, {"id": 1475178208291, "note": "<div>Which is a <i>better</i> <u>intracellular buffer</u> in physiologic pH range,<b> oxy- </b>or <b>deoxyhemoglobin</b>?</div><div><br /></div><div>{{c1::Deoxyhemoglobin}}</div>", "time": null}, {"id": 1475195251454, "note": "<div>In the <i>lumen</i> of the <u>early PCT</u>, H<sub>2</sub>CO<sub>3</sub> is converted to CO<sub>2</sub> and H<sub>2</sub>O by brush border <i style=\"font-weight: bold; \">{{c1::carbonic anhydrase}}</i></div>", "time": null}, {"id": 1475196483035, "note": "<div>In the <i>cells</i> of the <u>early PCT</u>, H<sub>2</sub>CO<sub>3</sub> is converted to CO<sub>2</sub> and H<sub>2</sub>O by intracellular <i style=\"font-weight: bold; \">{{c1::carbonic anhydrase}}</i></div>", "time": null}, {"id": 1475196487814, "note": "<div><b>HCO</b><sub style=\"font-weight: bold; \">3</sub><sup style=\"font-weight: bold; \">-</sup> is transported from the cells of <u>proximal tubule</u> into the <u>blood</u> by <b>{{c1::Na<sup>+</sup>-HCO<sub>3</sub><sup>-</sup>}} cotransport</b> and <b>{{c2::Cl<sup>-</sup>-HCO<sub>3</sub><sup>-</sup>}} exchange</b></div>", "time": 1660105358442.0}, {"id": 1475196524399, "note": "<div><div><b>ECF volume contraction</b> results in {{c1::<u>increased</u>}} <b>HCO<sub>3</sub><sup>-</sup> reabsorption</b> </div></div>", "time": null}, {"id": 1475196531489, "note": "<div><b>Angiotensin II</b> <u>stimulates</u> <b>{{c1::Na<sup>+</sup>-H<sup>+</sup>}} exchange</b> in the <i>proximal tubule</i></div>", "time": null}, {"id": 1475196534698, "note": "<div>What effect does <b>angiotensin II</b> have on <u>HCO</u><sub>3</sub><sup>-</sup><u> reabsorption</u>? </div><div><br></div><div>{{c1::Increased reabsorption}} </div>", "time": null}, {"id": 1475196542262, "note": "<div><u>Increased</u> <b>P</b><sub style=\"font-weight: bold; \">CO2</sub> (respiratory acidosis) results in {{c1::<u>increased</u>}} <b>HCO<sub>3</sub><sup>-</sup> reabsorption</b> </div>", "time": null}, {"id": 1475196548894, "note": "<div><div><u>Decreased</u> <b>P</b><sub style=\"font-weight: bold; \">CO2</sub> (respiratory alkalosis) results in {{c1::<u>decreased</u>}} <b>HCO<sub>3</sub><sup>-</sup> reabsorption</b> </div></div>", "time": null}, {"id": 1475196555715, "note": "<div><b>Fixed</b> <b>H<sup>+</sup></b> (e.g. from <i>protein</i> and <i>phospholipid catabolism</i>) is <u>excreted</u> in the urine as <b>{{c1::titratable acid (e.g. H<sub>2</sub>PO<sub>4</sub><sup>-</sup>)}}</b> and <b>{{c2::NH<sub>4</sub><sup>+</sup>}}</b> </div>", "time": null}, {"id": 1475196558711, "note": "<div><b>Titratable acid</b> is primarily excreted in the {{c1::<u>\u03b1-intercalated</u>}} cells of the <i>late distal tubule</i> and <i>collecting duct</i></div>", "time": null}, {"id": 1475196564387, "note": "<div><b>H<sup>+</sup> <i>secretion</i> </b>from <u>\u03b1-intercalated cells</u> occurs via the <i>luminal</i> membrane <b>{{c1::H<sup>+</sup> ATPase}}</b> </div><div>and <b>{{c2::H<sup>+</sup>-K<sup>+</sup> ATPase}}</b> pumps</div>", "time": null}, {"id": 1475196569576, "note": "<div>The <b>{{c2::H<sup>+</sup> ATPase}}</b> pump in the luminal<i> </i>membrane of the <u>\u03b1-intercalated cells</u> is <i>stimulated</i> by <b>{{c1::aldosterone}}</b> </div>", "time": 1660105348916.0}, {"id": 1475196572668, "note": "<div>In the lumen of <i>late distal tubule</i> and <i>collecting duct</i>, secreted<b> H<sup>+</sup></b> combines with the <b>HPO<sub>4</sub><sup>-</sup></b> to form <b>H<sub>2</sub>PO<sub>4</sub></b>, which is a(n)&nbsp;<b>{{c1::titratable}} acid</b></div>", "time": null}, {"id": 1475196577241, "note": "<div>For each <b>H<sup>+</sup></b> excreted as <u>titratable acid</u>, one new {{c1::HCO<sub>3</sub><sup>-</sup>}} is <i>synthesized</i> and <i>reabsorbed</i></div>", "time": 1660105358800.0}, {"id": 1475196585261, "note": "<div>The amount of <b>H<sup>+</sup></b> <i>excreted</i> as <u>titratable acid</u> depends on the <b>amount of {{c1::urinary buffer}}</b> present and the <b>{{c2::pK}} </b>of the buffer</div>", "time": null}, {"id": 1475196592003, "note": "<div>In the cells of the <u>proximal tubule</u>, the enzyme <b>{{c1::glutaminase}}</b> metabolizes&nbsp;<b>glutamine</b> to <b>glutamate</b> and {{c2::<b>NH</b><sub style=\"font-weight: bold;\">4</sub><sup style=\"font-weight: bold;\">+</sup>}}</div>", "time": 1660105356818.0}, {"id": 1475196615386, "note": "<div>For each <b>NH<sub>4</sub><sup>+</sup></b> generated in the <u>proximal tubule</u>, one new {{c1::HCO<sub>3</sub><sup>-</sup>}} is <i>synthesized</i> and <i>reabsorbed</i></div>", "time": null}, {"id": 1475196625077, "note": "<div>Which form (<b>NH<sub>4</sub><sup>+</sup></b> or <b>NH<sub>3</sub></b>) is <i>secreted</i> into the lumen of the cells of the <u>proximal tubule</u>? </div><div><br /></div><div>{{c1::NH<sub>3</sub>}}</div>", "time": 1660105343060.0}, {"id": 1475196649798, "note": "<div>In the {{c1::<u>\u03b1-intercalated</u>}} cells of the <i>collecting duct</i>, <b>NH<sub>3</sub></b> and <b>H<sup>+</sup></b> are secreted into the lumen</div>", "time": null}, {"id": 1475196678184, "note": "<div>As <b>pH</b> of the tubular fluid {{c1::<u>decreases</u>}}, the excretion of H<sup>+</sup> as <b>NH<sub>4</sub><sup>+</sup></b> {{c2::<u>increases</u>}}</div>", "time": null}, {"id": 1475196684550, "note": "<div>In <i>chronic</i> <b>{{c2::acidosis}}</b>, there is an adaptive {{c1::<u>increase</u>}} in <b>NH<sub>3</sub> synthesis</b> in the cells of the <i>proximal tubule</i> </div>", "time": null}, {"id": 1475196693528, "note": "<div><b>{{c1::Hyper}}-kalemia</b> {{c2::<u>inhibits</u>}} <b>NH<sub>3</sub> synthesis</b> </div>", "time": null}, {"id": 1475200506347, "note": "<div>What is the <i>normal</i> average blood <b>HCO<sub>3</sub><sup>-</sup> concentration</b> (mEq/L)?</div><div><br /></div><div>{{c1::24 mEq/L}} </div>", "time": 1660105345704.0}, {"id": 1475203838374, "note": "<div>The <b>plasma anion gap</b> represents <u>unmeasured ions</u> in serum and is equal to {{c1::[Na<sup>+</sup>] - ([HCO<sub>3</sub><sup>-</sup>] + [Cl<sup>-</sup>])::formula}}</div>", "time": null}, {"id": 1475203846579, "note": "<div>The range of normal values for the <b>plasma anion gap</b> is {{c1::8}} to {{c1::16}} mEq/L</div>", "time": null}, {"id": 1475203856328, "note": "<div>The <b>plasma anion gap</b> is useful primarily in the <u>differential diagnosis</u> of <b>{{c1::metabolic acidosis}}</b></div>", "time": null}, {"id": 1475203858939, "note": "<div>If the \"lost\" HCO<sub>3</sub><sup>-</sup> in <u>metabolic acidosis</u> is replaced by {{c2::<b>Cl<sup>-</sup></b>}}, the <i>anion gap</i> is {{c1::<b>normal</b>}}</div>", "time": null}, {"id": 1475203864870, "note": "<div>If the \"lost\" HCO<sub>3</sub><sup>-</sup> in <u>metabolic acidosis</u> is replaced by <b>{{c2::unmeasured ions}}</b>, the <i>anion gap</i> is {{c1::<b>increased</b>}}</div>", "time": null}, {"id": 1475203871268, "note": "<div><b>{{c1::Osmolar gap}}</b> is the difference between <u>measured</u> plasma osmolarity and <u>estimated</u> plasma osmolarity</div>", "time": null}, {"id": 1475203886147, "note": "<div><div>Which <u>acid-base disturbance</u> is caused by <b>decreased HCO</b><sub style=\"font-weight: bold; \">3</sub><sup style=\"font-weight: bold; \">-</sup>? </div><div><br></div><div>{{c1::Metabolic acidosis}}</div></div>", "time": null}, {"id": 1475203888674, "note": "<div><div>The <i>primary disturbance</i> in <b>metabolic acidosis</b> is a(n) {{c2::<u>decrease</u>}} in {{c1::<b>HCO<sub>3</sub><sup>-</sup></b>}}</div></div>", "time": null}, {"id": 1475203890936, "note": "<div><div><u>Decreased</u> HCO<sub>3</sub><sup>-</sup> (metabolic acidosis) causes a(n) {{c1::<u>decrease</u>}} in <b>arterial</b> <b>pH</b></div></div>", "time": null}, {"id": 1475203892902, "note": "<div><div><u>Decreased</u> arterial pH (metabolic acidosis) causes <i>compensatory</i> <b>{{c1::hyper}}-ventilation</b> with consequent {{c1::<u>decreased</u>}} <b>P<sub>CO2</sub></b></div></div>", "time": null}, {"id": 1475203895050, "note": "<div><div>The <u>arterial blood profile</u> seen in <i>compensated</i> <b>metabolic acidosis</b> is: </div><div><br /></div><div><b>pH</b>: {{c1::decreased}}</div><div><b>[HCO<sub>3</sub><sup>-</sup>]</b>: {{c1::decreased}}</div><div><b>P<sub>CO2</sub></b>: {{c1::decreased}}</div></div>", "time": null}, {"id": 1475203898709, "note": "<div><div><b>Hyperventilation</b> as a <i>respiratory</i> <i>compensation</i> for <u>metabolic acidosis</u> is known as <b>{{c1::Kussmaul}} breathing</b> </div></div>", "time": null}, {"id": 1475203900994, "note": "<div><div><b><i>Respiratory</i> compensation </b>in response to <u>metabolic acidosis</u> or <u>alkalosis</u> is {{c1::immediate::timing}}</div></div>", "time": null}, {"id": 1475203903176, "note": "<div><div><div>Which <u>acid-base disturbance</u> is caused by <b>increased HCO</b><sub style=\"font-weight: bold; \">3</sub><sup style=\"font-weight: bold; \">-</sup>? </div><div><br></div><div>{{c1::Metabolic alkalosis}}</div></div></div>", "time": null}, {"id": 1475203905213, "note": "<div><div><div>The <i>primary disturbance</i> in <b>metabolic alkalosis</b> is a(n) {{c2::<u>increase</u>}} in {{c1::<b>HCO<sub>3</sub><sup>-</sup></b>}} OR a(n) {{c2::<u>decrease</u>}} in {{c1::<b>H<sup>+</sup></b>}}</div></div></div>", "time": null}, {"id": 1475203914725, "note": "<div><div><div><u>Increased</u> HCO<sub>3</sub><sup>- </sup>causes a(n) {{c1::<u>increase</u>}} in <b>arterial</b> <b>pH</b> </div></div></div>", "time": null}, {"id": 1475203917075, "note": "<div><div><div><u>Increased</u> arterial pH (metabolic alkalosis) causes <i>compensatory</i> <b>{{c1::hypo}}-ventilation</b> with consequent {{c1::<u>increased</u>}} <b>P<sub>CO2</sub></b></div></div></div>", "time": null}, {"id": 1475203919206, "note": "<div><div><div>The <u>arterial blood profile</u> seen in <i>compensated</i> <b>metabolic alkalosis</b> is: </div><div><br /></div><div><b>pH</b>: {{c1::increased}}</div><div><b>[HCO<sub>3</sub><sup>-</sup>]</b>: {{c1::increased}}</div><div><b>P<sub>CO2</sub></b>: {{c1::increased}}</div></div></div>", "time": null}, {"id": 1475203933773, "note": "<div><div><div>If <u>metabolic alkalosis</u> is accompanied by <b>ECF volume</b> {{c1::contraction}}, the <i>reabsorption</i> of HCO<sub>3</sub><sup>-</sup> <u>increases</u>, <b>worsening the metabolic alkalosis </b></div></div></div>", "time": null}, {"id": 1475203952057, "note": "<div><div><div>The <i>primary disturbance</i> in <b>respiratory acidosis</b> is {{c1::<u>hypo</u>}}<u>-ventilation</u>, which results in {{c1::<u>increased</u>}} <b>CO<sub>2</sub></b> </div></div></div>", "time": null}, {"id": 1475204000469, "note": "<div><div><div><u>Increased</u> CO<sub>2</sub> causes a(n) {{c1::<u>decrease</u>}} in <b>arterial</b> <b>pH</b> </div></div></div>", "time": null}, {"id": 1475204002830, "note": "<div><div><div><u>Increased</u> CO<sub>2</sub> (respiratory acidosis) causes a(n) {{c1::<u>increase</u>}} in <b>HCO<sub>3</sub><sup>-</sup> </b>by mass action</div></div></div>", "time": null}, {"id": 1475204005291, "note": "<div><div><div><div>The <u>arterial blood profile</u> seen in <i>compensated</i> <b>respiratory acidosis</b> is: </div><div><br /></div><div><b>pH</b>: {{c1::decreased}}</div><div><b>[HCO<sub>3</sub><sup>-</sup>]</b>: {{c1::increased}}</div><div><b>P<sub>CO2</sub></b>: {{c1::increased}}</div></div></div></div>", "time": null}, {"id": 1475204008958, "note": "<div>Renal correction of <b>respiratory</b> <b>acidosis</b> includes <u>increased</u>&nbsp;<i>excretion</i> of excess fixed <b>H<sup>+</sup></b> as {{c1::titratable acid}} and {{c1::NH<sub>4</sub><sup>+</sup>}}</div>", "time": 1660105353392.0}, {"id": 1475204011514, "note": "<div><div><div><div>Renal correction of <b>respiratory acidosis</b> includes <u>increased</u> <i>reabsorption</i> of \"new\" {{c1::HCO<sub>3</sub><sup>-</sup>}}</div></div></div></div>", "time": null}, {"id": 1475204013495, "note": "<div><div><div><b><i>Metabolic</i> compensation </b>in response to <u>respiratory acidosis</u> or <u>alkalosis</u> is {{c1::delayed::timing}}&nbsp;</div></div></div>", "time": null}, {"id": 1475204019349, "note": "<div><div><div>The <i>primary disturbance</i> in <b>respiratory alkalosis</b> is {{c1::<u>hyper</u>}}<u>-ventilation</u>, which results in {{c1::<u>decreased</u>}} <b>CO<sub>2</sub></b> </div></div></div>", "time": null}, {"id": 1475204021869, "note": "<div><div><div><u>Decreased</u> CO<sub>2</sub>, secondary to hyperventilation, causes a(n) {{c1::<u>increase</u>}} in <b>arterial</b> <b>pH</b> </div></div></div>", "time": null}, {"id": 1475204024006, "note": "<div><div><div><u>Decreased</u> CO<sub>2</sub> (respiratory alkalosis) causes a(n) {{c1::<u>decrease</u>}} in <b>HCO<sub>3</sub><sup>-</sup> </b>by mass action</div></div></div>", "time": null}, {"id": 1475204026032, "note": "<div><div><div><div>The <u>arterial blood profile</u> seen in <i>compensated</i> <b>respiratory alkalosis</b> is: </div><div><br /></div><div><b>pH</b>: {{c1::increased}}</div><div><b>[HCO<sub>3</sub><sup>-</sup>]</b>: {{c1::decreased}}</div><div><b>P<sub>CO2</sub></b>: {{c1::decreased}}</div></div></div></div>", "time": null}, {"id": 1475204034580, "note": "<div><div>The <i>compensatory</i> <i>response</i> to an <b>acid-base disturbance</b> is always in {{c1::the <u>same</u>::(same or different)}} direction as the original acid-base disturbance </div></div>", "time": null}, {"id": 1475204042122, "note": "<div><b>Winters formula</b> is used to calculate the predicted <u>respiratory compensation</u> for a <i>simple</i> <b>{{c1::metabolic acidosis}}</b> </div>", "time": null}, {"id": 1475204047599, "note": "<div><b>Winters formula</b> for <i>simple metabolic acidosis</i> states that:</div><div><br></div><div>{{c2::P<sub>CO2</sub>}} = {{c1::1.5[HCO<sub>3</sub><sup>-</sup>] + 8 +/- 2}}</div>", "time": null}, {"id": 1475204055693, "note": "<div>If the measured P<sub>CO2</sub> {{c2::&gt;}} predicted P<sub>CO2</sub> using <b>Winters formula</b>, then the <u>metabolic acidosis</u> has a <i>concomitant</i> {{c1::respiratory acidosis}} </div>", "time": null}, {"id": 1475204057826, "note": "If the P<sub>CO2</sub> {{c2::&lt;}} predicted P<sub>CO2</sub> using <b>Winters formula</b>, then the <u>metabolic acidosis</u> has a <i>concomitant</i> {{c1::respiratory alkalosis}} ", "time": null}, {"id": 1475280574693, "note": "<b>{{c1::Horseshoe kidney}} </b>occurs when the {{c2::<u>inferior</u>}}<u> poles</u> of the kidney are <i>fused together</i>", "time": null}, {"id": 1475287234425, "note": "<div>What is the <u>most common</u> <b>congenital renal anomaly</b>?</div><div><br /></div><div>{{c1::Horseshoe kidney}}</div>", "time": null}, {"id": 1475287241814, "note": "<div><div>As <b>horseshoe kidneys</b> <u>ascend</u> from the <i>pelvis</i> during fetal development, they get trapped under the<b> {{c1::inferior mesenteric}}</b> artery and remain <u>low</u> in the <i>abdomen</i> </div></div>", "time": null}, {"id": 1475287246977, "note": "<div>Is <u>kidney function</u> in <b>horseshoe kidney</b> <i>normal</i> or <i>abnormal</i>? </div><div><br></div><div>{{c1::Normal}}</div>", "time": null}, {"id": 1475287250177, "note": "<div><b>Horseshoe kidney</b> is associated with {{c1::hydronephrosis}} (e.g due to ureteropelvic junction obstruction) </div>", "time": null}, {"id": 1475287252831, "note": "<div><b>Horseshoe kidney</b> is associated with increased risk for kidney {{c1::stones}} and infection</div>", "time": null}, {"id": 1475287255781, "note": "<div>What <u>sex chromosome disorder</u> is associated with <b>horseshoe kidney</b>? </div><div><br></div><div>{{c1::Turner syndrome}}</div>", "time": null}, {"id": 1475287258523, "note": "<div>Which <u>congenital kidney disease</u> is associated with <b>chromosomal aneuploidy</b> (e.g. trisomy 13, 18, 21)? </div><div><br></div><div>{{c1::Horseshoe kidney}}</div>", "time": null}, {"id": 1475287261393, "note": "<div><b>Horseshoe kidney</b> is <i>rarely</i> associated with renal {{c1::cancer}} </div>", "time": null}, {"id": 1475287265217, "note": "<div>What <u>congenital kidney disease</u> is associated with <i>unilateral</i> or <i>bilateral </i><b>absent kidney</b> and <b>ureter formation</b>? </div><div><br></div><div>{{c1::Renal agenesis}}</div>", "time": null}, {"id": 1475287268030, "note": "<div><b>Renal agenesis </b>occurs due to failure of the {{c2::<u>ureteric buds</u>}} to <i>develop</i> and <i>induce</i> <i>differentiation&nbsp;</i>of {{c1::<b>metanephric</b> <b>mesenchyme</b>}}</div>", "time": null}, {"id": 1475287273153, "note": "<div><b>Renal agenesis</b> is often diagnosed <i>prenatally</i> via {{c1::ultrasound}}</div>", "time": 1660105353409.0}, {"id": 1475287276309, "note": "<div><i>Unilateral</i> <b>renal agenesis</b> leads to {{c1::hypertrophy}} of the <b>existing</b> <b>kidney</b></div>", "time": 1660105348384.0}, {"id": 1475287279212, "note": "<div><b>Hyperfiltration</b> of the<i> </i>existing kidney in <i>unilateral</i> <u>renal agenesis</u> increases risk of {{c1::renal failure}} later in life</div>", "time": null}, {"id": 1475287281585, "note": "<div>{{c1::<i>Bilateral</i>}}<i> </i><b>renal agenesis</b> <u>increases</u> risk for <b>{{c2::Potter}} sequence</b></div>", "time": 1660105341019.0}, {"id": 1475287283862, "note": "<div>The <i>primary</i> <u>abnormality</u> in <b>Potter sequence</b> is <b>{{c1::oligo}}-hydramnios</b></div>", "time": null}, {"id": 1475287286742, "note": "<div>In <b>Potter sequence</b>, <u>oligohydramnios</u> leads to <b>pulmonary {{c1::hypoplasia}}</b> </div>", "time": 1660105356954.0}, {"id": 1475287289082, "note": "<div>In <b>Potter sequence</b>, <u>oligohydramnios</u> causes {{c1::compression}} of the developing fetus</div>", "time": null}, {"id": 1475287291157, "note": "<div>In <b>Potter sequence</b>, <u>compression</u> of the developing fetus results in a(n)&nbsp;<b>{{c1::flat}} face</b> with <b>{{c2::low-set}} ears</b></div>", "time": 1660105356957.0}, {"id": 1475287300322, "note": "<div>In <b>Potter sequence</b>, <u>compression</u> of the developing fetus results in <b>limb</b> {{c1::<b>deformities</b>}}</div>", "time": 1660105356955.0}, {"id": 1475287304702, "note": "<div><b>Potter sequence</b> may cause {{c1::retrognathia}}, which is the <u>abnormal positioning</u> of the <b>mandible</b> </div>", "time": null}, {"id": 1475287310437, "note": "<div>What is the <u>cause of death</u> in <b>Potter sequence</b>? </div><div><br></div><div>{{c1::Pulmonary hypoplasia}}</div>", "time": null}, {"id": 1475287312836, "note": "<div>Which form of <b>polycystic kidney disease</b> may cause <u>Potter sequence</u>? </div><div><br></div><div>{{c1::Autosomal recessive PKD}}</div>", "time": 1660105343033.0}, {"id": 1475287315208, "note": "<div><b>Potter sequence</b> may be caused by chronic {{c1::placental}} insufficiency</div>", "time": null}, {"id": 1475287317666, "note": "<div><b>Potter sequence</b> may be caused by {{c1::bladder outlet obstruction}} (e.g. posterior urethral valves)</div>", "time": 1660105353758.0}, {"id": 1475287319984, "note": "<div>Is <b>dysplastic kidney</b> heritable? </div><div><br></div><div>{{c1::No}}</div>", "time": null}, {"id": 1475287322161, "note": "<div>What <i>cystic</i> <b>congenital kidney disease</b> is <u>non-inherited</u>?</div><div><br></div><div>{{c1::(Multicystic) dysplastic kidney}}</div>", "time": null}, {"id": 1475287324745, "note": "<div><b>Dysplastic kidney </b>occurs due to failure of the {{c2::<u>ureteric buds</u>}} to <i>induce</i> <i>differentiation</i> of {{c1::<b>metanephric</b> <b>mesenchyme</b>}}</div>", "time": null}, {"id": 1475287335371, "note": "<div><b>Multicystic dysplastic kidney</b> is often diagnosed <i>prenatally</i> via {{c1::ultrasound}}</div>", "time": null}, {"id": 1475287343372, "note": "<div>In <b>dysplastic kidney</b>, cysts are usually {{c1::uni}}-lateral</div>", "time": null}, {"id": 1475287350418, "note": "<div>In <b>polycystic kidney disease</b>, cysts are usually {{c1::bi}}-lateral</div>", "time": 1660105356973.0}, {"id": 1475287371253, "note": "<div><div>Is <b>polycystic kidney disease</b> heritable? </div><div><br></div><div>{{c1::Yes}}</div></div>", "time": null}, {"id": 1475287374579, "note": "<div>Is <b>polycystic kidney disease</b> associated with <u>enlargement</u> of the kidneys? </div><div><br /></div><div>{{c1::Yes}}</div>", "time": 1660105355886.0}, {"id": 1475287384441, "note": "<div>The {{c2::<u>autosomal recessive</u>}} form of <b>polycystic kidney disease</b> typically presents in {{c1::<b>infants</b>}}</div>", "time": null}, {"id": 1475287386660, "note": "<div><u>Autosomal recessive</u> <b>PKD</b> presents in infants as worsening renal failure and {{c1::hypertension::BP}}&nbsp;</div>", "time": 1660105361410.0}, {"id": 1475287388509, "note": "<div>Which form of <b>PKD</b> (autosomal dominant or recessive) is associated with <b>hepatic cysts</b>? </div><div><br /></div><div>{{c1::Both :)}}</div>", "time": null}, {"id": 1475287390592, "note": "<div><u>Autosomal {{c3::recessive}}</u> <b>PKD</b> is associated with <b>congenital</b> {{c1::<b>hepatic</b> <b>fibrosis</b>}} which may lead to <b>{{c2::portal}} hypertension</b></div>", "time": null}, {"id": 1475287392656, "note": "<div>What <u>congenital renal defect</u> may cause <b>portal</b> <b>hypertension</b> in an <i>infant</i>?</div><div><br></div><div>{{c1::Autosomal recessive PKD}}</div>", "time": null}, {"id": 1475287401222, "note": "<div><u>Autosomal dominant</u> <b>PKD</b> may present in young adults with {{c1::<b>hypertension</b>}} due to <u>increased</u> {{c2::<b>renin</b>}}</div>", "time": null}, {"id": 1475287417725, "note": "<div><u>Autosomal dominant</u> <b>PKD</b> may present in young adults as <i>worsening</i> renal failure and <b>{{c1::hemat}}-uria</b> </div>", "time": 1660105361412.0}, {"id": 1475287434487, "note": "<div><u>Autosomal dominant</u> <b>PKD</b> is associated with {{c1::berry aneurysm}}, which is an important cause of death</div>", "time": null}, {"id": 1475287436376, "note": "<div><u>Autosomal dominant</u> <i>and</i> <u>recessive</u> <b>PKD</b> are associated with {{c1::hepatic}} cysts in addition to renal cysts (benign)</div>", "time": null}, {"id": 1475287438868, "note": "<div>What <u>heart defect</u> is associated with <b>autosomal dominant PKD</b>? </div><div><br></div><div>{{c1::Mitral valve prolapse}}</div>", "time": null}, {"id": 1475287443246, "note": "<div><div><div>Is <b>Autosomal Dominant Tubulointerstitial Kidney Disease (<i>Medullary Cystic Kidney Disease</i>)</b> heritable? </div><div><br></div><div>{{c1::Yes}}</div></div></div>", "time": null}, {"id": 1475287445404, "note": "<div><div>What is the <u>mode of inheritance</u> of <b>medullary cystic kidney disease</b>? </div><div><br></div><div>{{c1::Autosomal dominant}}</div></div>", "time": 1660105346017.0}, {"id": 1475287465054, "note": "<div>What <u>congenital renal defect</u> is a condition of being born with only one <i>functioning</i> kidney (one non-functional)?</div><div><br></div><div>{{c1::Congenital solitary functioning kidney}}</div>", "time": null}, {"id": 1475287469624, "note": "<div><b>Congenital solitary functioning kidney</b> leads to {{c1::hypertrophy}} of the <u>functioning</u> <b>kidney</b> </div>", "time": null}, {"id": 1475287543397, "note": "<i>Fetal</i> <u>kidney</u> development begins with the <b>{{c2::pronephros}}</b>, which develops by week {{c1::4}}", "time": null}, {"id": 1475290028338, "note": "<div>After the <b>pronephros</b> develops, it then {{c1::degenerates}}</div>", "time": null}, {"id": 1475290033702, "note": "<div>The <b>{{c1::mesonephros}}</b> forms after the <u>pronephros</u> and functions as an <i>interim kidney</i> for the <b>1st trimester</b></div>", "time": null}, {"id": 1475290038364, "note": "<div>The <b>mesonephros</b> later contributes to the {{c1::male}} genital system</div>", "time": null}, {"id": 1475290042667, "note": "<div>Which <i>embryologic kidney</i> becomes the <u>permanent</u> kidney? </div><div><br /></div><div>{{c1::Metanephros}}</div>", "time": null}, {"id": 1475290046517, "note": "<div>The <b>metanephros</b> first appears in the {{c1::5th}} week of gestation</div>", "time": null}, {"id": 1475290050454, "note": "<div><b>Nephrogenesis</b> continues through {{c1::32}} to {{c1::36}} weeks of gestation</div>", "time": null}, {"id": 1475290053332, "note": "<div>The <b>{{c1::ureteric}} bud</b> is derived from the <u>caudal end</u> of the <b>{{c2::mesonephric}} duct</b></div>", "time": null}, {"id": 1475290057493, "note": "<div>The <i>embryonic</i> <b>{{c1::ureteric bud}}</b> gives rise to the <b>ureter</b>, <b>pelvises</b>, <b>calyces</b>, and <b>collecting ducts</b></div>", "time": 1660105350200.0}, {"id": 1475290061747, "note": "<div>The <b>ureteric bud</b> is <u>fully canalized</u> by the {{c1::10th}} week of gestation, allowing the metanephros to make urine </div><div><br /></div><div><br /></div>", "time": null}, {"id": 1475290064936, "note": "<div>The <i>embryonic</i> <b>{{c3::metanephric mesenchyme (blastema)}}</b> <u>differentiates</u> into renal structures from the <b>{{c1::glomerulus}}</b> through the <b>{{c2::DCT}}</b></div>", "time": 1660105350199.0}, {"id": 1475290069310, "note": "<div>The <i>embryonic</i> {{c1::<b>metanephric mesenchyme</b>}} interacts via <u>{{c2::reciprocal-inductive signaling}}</u> with the <b>ureteric bud</b>, inducing <i>differentiation</i>&nbsp;of these tissues into their respective parts of the kidney</div>", "time": null}, {"id": 1475290075603, "note": "<div>The <b>{{c1::ureteropelvic junction}}</b> is the <i>last</i> structure of the <u>embryologic kidney</u> to <b>canalize</b></div>", "time": null}, {"id": 1475290081562, "note": "<div>What is the <u>most common site</u> of <b>obstruction</b> (hydronephrosis) in the <b>fetal kidney</b>? </div><div><br /></div><div>{{c1::Ureteropelvic junction}}</div>", "time": 1660105345816.0}, {"id": 1475290083779, "note": "<b>{{c3::Duplex collecting system}}</b> is a <u>congenital renal disease</u> characterized by <b>{{c2::bifurcation}} </b>of the <b>{{c1::ureteric bud}}</b> <i>before</i> it enters the <u>metanephric mesenchyme</u>", "time": null}, {"id": 1475290647432, "note": "<div>What <u>congenital renal disease</u> is characterized by a <b>Y-shaped bifid ureter</b>? </div><div><br></div><div>{{c1::Duplex collecting system}}</div>", "time": null}, {"id": 1475290649782, "note": "<div><b>{{c1::Duplex}} collecting system</b> may occur due to <u>two</u> <b>ureteric</b> <b>buds</b> reaching and interacting with one <b>metanephric</b> <b>mesenchyme</b></div>", "time": null}, {"id": 1475290653474, "note": "<div><b>Duplex collecting system</b> is strongly associated with <u>vesicoureteral </u>{{c2::<u>reflux</u>}} and/or <u>ureteral </u>{{c1::<u>obstruction</u>}}</div>", "time": null}, {"id": 1475290658728, "note": "<b>Duplex collecting system</b> is associated with <u>increased</u> risk for {{c1::urinary}} tract infection", "time": null}, {"id": 1475348251414, "note": "The hallmark of <u>acute kidney injury</u> is <b>{{c1::azotemia}}</b>, often with <b>{{c2::oliguria::urinary change}}</b> ", "time": 1660105350049.0}, {"id": 1475353363846, "note": "<b>Azotemia</b> typically refers to an <u>increase</u> in serum {{c1::BUN}} and {{c1::creatinine}}", "time": 1660105361380.0}, {"id": 1475353497496, "note": "<div>What is the <u>most common cause</u> of <b>acute renal failure</b> in <i>hospitalized</i> patients? </div><div><br></div><div>{{c1::Acute tubular necrosis}}</div>", "time": null}, {"id": 1475353500632, "note": "<div><div>What is the effect of <b>acute tubular necrosis</b> on GFR? </div><div><br /></div><div>{{c1::Decreased GFR}}</div></div>", "time": 1660105346555.0}, {"id": 1475353514062, "note": "<div><div><div>In <b>acute tubular necrosis</b>, the <u>BUN:creatinine ratio</u> is {{c1::&lt;}} 15</div></div></div>", "time": null}, {"id": 1475353547607, "note": "<div><b>Acute tubular necrosis</b> is caused by {{c1::<u>ischemic</u>}} or {{c2::<u>nephrotoxic</u>}} injury</div>", "time": null}, {"id": 1475353550626, "note": "<div><b>Acute tubular necrosis</b> caused by {{c1::ischemia}} is due to <u>decreased</u> renal blood flow </div>", "time": null}, {"id": 1475353557014, "note": "<div><b>Acute tubular necrosis</b> due to <u>ischemic injury</u> is often <i>preceded</i> by {{c1::prerenal azotemia}}</div>", "time": 1660105362116.0}, {"id": 1475353560007, "note": "<div><b>Acute tubular necrosis</b> due to <u>ischemic injury</u> most commonly affects the {{c1::<b>proximal</b> <b>tubule</b>}} and the <i>medullary segment</i> of the <b>{{c2::thick ascending limb}}</b></div>", "time": null}, {"id": 1475353563417, "note": "<div><b>Acute tubular necrosis </b>caused by {{c1::nephrotoxicity}} is due to toxic substances </div>", "time": null}, {"id": 1475353567041, "note": "<div><b>Acute tubular necrosis</b> due to <u>nephrotoxic injury</u> most commonly affects the <b>{{c1::proximal tubule}}</b></div>", "time": null}, {"id": 1475353569831, "note": "<div>What <i>class</i> of <u>anti-microbials</u> is a common cause of <b>acute tubular necrosis</b>? </div><div><br></div><div>{{c1::Aminoglycosides}}</div>", "time": null}, {"id": 1475353572575, "note": "<div><b>Acute tubular necrosis</b> may be caused by <u>heavy metals</u> such as {{c1::lead}}</div>", "time": null}, {"id": 1475353575640, "note": "<div><b>Acute tubular necrosis</b> may be caused by {{c1::myoglobinuria}}, which can occur with <u>crush injuries</u></div>", "time": 1660105362111.0}, {"id": 1475353578336, "note": "<div><b>Acute tubular necrosis</b> may be caused by <i>ingestion</i> of <b>{{c1::ethylene glycol}}</b>, which is associated with {{c2::<u>oxalate</u>}}<u> crystals</u> in the urine </div>", "time": null}, {"id": 1475353585796, "note": "<div><b>Acute tubular necrosis</b> may be caused by {{c1::radio}}-contrast dyes</div>", "time": null}, {"id": 1475353588313, "note": "<div><b>Acute tubular necrosis</b> may be caused by high levels of {{c1::uric acid}} (e.g. tumor lysis syndrome)</div>", "time": 1660105362112.0}, {"id": 1475353590850, "note": "<div>What <u>chemotherapeutic agent</u> may cause <b>acute tubular necrosis</b>? </div><div><br></div><div>{{c1::Cisplatin}}</div>", "time": null}, {"id": 1475353595370, "note": "<div><b>{{c2::Acute tubular necrosis}}</b> is associated with {{c1::<b>granular</b> <b>\"muddy brown\"</b>}} <b>casts</b> in the urine</div>", "time": null}, {"id": 1475353600577, "note": "<div>The <u>first stage</u> of <b>acute tubular necrosis</b> is the {{c1::inciting event}}</div>", "time": null}, {"id": 1475353603518, "note": "<div>The <u>second stage</u> of <b>acute tubular necrosis</b> is the <b>{{c1::maintenance}} phase</b></div>", "time": null}, {"id": 1475353605696, "note": "<div>Does the <u>maintenance phase</u> of <b>acute tubular necrosis</b> present with <i>oliguria</i> or <i>polyuria</i>? </div><div><br></div><div>{{c1::Oliguria}}</div>", "time": null}, {"id": 1475353608030, "note": "<div>How long does the <u>maintenance phase</u> of <b>acute tubular necrosis</b> last?</div><div><br /></div><div>{{c1::1-3 weeks}}</div>", "time": null}, {"id": 1475353615732, "note": "<div>During the <u>maintenance phase</u> of <b>acute tubular necrosis</b>, there is increased risk for <b>{{c1::hyper}}-kalemia</b> and <b>uremia</b> </div>", "time": null}, {"id": 1475353630743, "note": "<div>What <i>acid-base disturbance</i> is associated with the <u>maintenance phase</u> of <b>acute tubular necrosis</b>?</div><div><br /></div><div>{{c1::Metabolic acidosis}}</div>", "time": null}, {"id": 1475353637083, "note": "<div><div>The <u>third (final) stage</u> of <b>acute tubular necrosis</b> is the <b>{{c1::recovery}} phase</b> </div></div>", "time": 1660105349464.0}, {"id": 1475353639796, "note": "<div><div>Does the <u>recovery phase</u> of <b>acute tubular necrosis</b> present with <i>oliguria</i> or <i>polyuria</i>? </div><div><br></div><div>{{c1::Polyuria}}</div></div>", "time": null}, {"id": 1475353642142, "note": "<div>During the <u>recovery phase</u> of <b>acute tubular necrosis</b>, there is increased risk for <b>{{c1::hypo}}-kalemia</b> and renal <u>{{c2::wasting}}</u> of other electrolytes and minerals</div>", "time": null}, {"id": 1475353650203, "note": "<div>During the <u>recovery phase</u> of <b>acute tubular necrosis</b>, BUN and serum creatinine levels {{c1::decrease}}</div>", "time": null}, {"id": 1475353652841, "note": "<div><b>Acute tubular necrosis</b> is <i>reversible</i> but often requires supportive {{c1::dialysis}} due to electrolyte imbalances (e.g. hypokalemia)</div>", "time": 1660105362113.0}, {"id": 1475353660130, "note": "<div><b>Intrarenal azotemia</b> is <i>less commonly</i> due to <u>acute</u> {{c1::<b>glomerulonephritis</b>}} or <u>acute</u> {{c2::<b>interstitial</b> <b>nephritis</b>}} </div>", "time": null}, {"id": 1475353671175, "note": "<div><b>{{c1::Acute interstitial nephritis}}</b> is a <i>drug-induced </i>{{c2::<u>hypersensitivity</u>}}<u> reaction</u> involving the <b>interstitium</b> and <b>tubules</b> of the kidney </div>", "time": null}, {"id": 1475353678694, "note": "<div><b>Acute interstitial nephritis</b> is characterized <i>histologically</i> by&nbsp;<b>{{c1::inflammatory infiltrate}}</b> in the connective tissue between renal tubules</div>", "time": 1660105362153.0}, {"id": 1475353689389, "note": "<div><b>Acute interstitial nephritis</b> may present with <b>{{c1::fever}}</b> and <b>{{c1::rash}}</b>, days to weeks after starting a drug </div>", "time": 1660105362152.0}, {"id": 1475353700927, "note": "<div><b>Acute interstitial nephritis</b> is associated with <b>{{c2::hemat}}-uria</b> and <u>pyuria</u>&nbsp;(classically {{c1::<b>eosinophils</b>}}) </div>", "time": null}, {"id": 1475353703566, "note": "<div>What <u>physical exam finding</u> may be associated with <b>acute interstitial nephritis</b>? </div><div><br></div><div>{{c1::CVA tenderness}}</div>", "time": null}, {"id": 1475353706251, "note": "<div>Drugs that cause <b>acute {{c6::interstitial nephritis}}</b> may be remembered with the 5 \"Ps\" </div><div style=\"centerbox\"><div class=\"mnemonics\"><div><br></div><div>{{c1::<b>P</b>ee (diuretics)}} </div><div>{{c2::<b>P</b>ain-free (NSAIDs)}} </div><div>{{c3::<b>P</b>enicillins (and cephalosporins)}} </div><div>{{c4::<b>P</b>roton pump inhibitors}} </div><div>{{c5::Rifam<b>P</b>in}}</div></div></div>", "time": null}, {"id": 1475353712670, "note": "<div>What is the <u>treatment</u> for drug-induced <b>acute interstitial nephritis</b>? </div><div><br></div><div>{{c1::Cessation of the drug}}</div>", "time": null}, {"id": 1475353717012, "note": "<div><b>Acute interstitial nephritis</b> is <i>less commonly </i>secondary to systemic {{c1::infections}} (e.g. mycoplasma)</div>", "time": null}, {"id": 1475353719884, "note": "<div><b>Acute interstitial nephritis</b> is <i>less commonly</i> secondary to {{c1::autoimmune}} diseases (e.g.&nbsp;Sj\u00f6grens&nbsp;syndrome, SLE, sarcoidosis)</div>", "time": null}, {"id": 1475353722104, "note": "<div><b>Acute interstitial nephritis</b> may <i>progress</i> to <b>renal</b> {{c1::papillary}}&nbsp;<b>necrosis</b></div>", "time": 1660105362151.0}, {"id": 1475353724586, "note": "<div><b>{{c1::Renal papillary necrosis}}</b> is characterized by <i>sloughing </i>of <u>necrotic</u> <b>renal papillae</b></div>", "time": null}, {"id": 1475353729635, "note": "<div><b>Renal papillary necrosis</b> presents with <u>gross</u> <b>{{c1::hemat}}-uria</b> and colicky <b>{{c2::flank}} pain</b> </div>", "time": null}, {"id": 1475353732476, "note": "<div>In addition to <i>hematuria</i>, <b>renal papillary necrosis</b> may also present with <b>{{c1::protein}}-uria</b></div>", "time": null}, {"id": 1475353735142, "note": "<div><b>Renal papillary necrosis</b> may be caused by chronic {{c1::analgesic}} abuse </div>", "time": 1660105353388.0}, {"id": 1475353745252, "note": "<div><b>Renal papillary necrosis</b> may be caused by {{c1::sickle cell}} disease or trait</div>", "time": null}, {"id": 1475353749867, "note": "<div><b>Renal papillary necrosis</b> may be caused by severe acute {{c1::pyelonephritis}}</div>", "time": null}, {"id": 1475353753903, "note": "<div>What endocrine pathology may cause <b>renal papillary necrosis</b>?</div><div><br /></div><div>{{c1::Diabetes mellitus}}</div>", "time": null}, {"id": 1475354642973, "note": "<div><b>{{c3::Nephrotic}} syndrome</b> is a group of <u>glomerular disorders</u> characterized by <b>{{c2::protein}}-uria</b> <b>{{c1::&gt; 3.5}} g/day</b></div>", "time": null}, {"id": 1475363769043, "note": "<div><b>Nephrotic syndrome</b> results in {{c1::<u>hypoalbuminemia</u>}}, which manifests as <b>{{c2::pitting edema}} </b>and {{c3::<b>secondary</b>}} <u>hyperaldosteronism</u></div>", "time": null}, {"id": 1475363772593, "note": "<div><b>Nephrotic syndrome</b> results in {{c1::<u>hypogammaglobulinemia</u>}}, which <i>increases</i> risk of {{c2::<b>infection</b>}}</div>", "time": null}, {"id": 1475363774930, "note": "<div><b>Nephrotic syndrome</b> causes a(n) {{c1::<u>hyper</u>}}<u>-coagulable state</u> due to loss of <b>{{c2::antithrombin III}}</b></div>", "time": null}, {"id": 1475363777148, "note": "<div><b>Nephrotic syndrome</b> is associated with {{c1::<u>hyper</u>}}<u>-</u><u>lipidemia</u> and {{c1::<u>hyper</u>}}<u>-</u><u>cholesterolemia</u></div>", "time": null}, {"id": 1475363783582, "note": "<div><b>{{c2::Nephrotic}} syndrome</b> is associated with <u>frothy urine</u> with <b>{{c1::fatty}} casts</b> </div>", "time": null}, {"id": 1475363791450, "note": "<div><b>{{c1::Minimal change disease (lipoid nephrosis)}}</b> is the <i>most common cause</i> of {{c3::<u>nephrotic</u>}}<u> syndrome</u> in <b>{{c2::children}}</b> </div>", "time": null}, {"id": 1475363800217, "note": "<div>The cause of <b>minimal change disease</b> is often {{c1::idiopathic}} and may be triggered by recent URI, immunization, or immune stimulus (ex. insect bite)</div>", "time": 1660105350364.0}, {"id": 1475363803106, "note": "<div><b>Minimal change disease</b> (lipoid nephrosis) is rarely <i>secondary</i> to <b>{{c1::Hodgkin lymphoma}}</b> </div>", "time": null}, {"id": 1475363809585, "note": "<div><b>Minimal change disease</b> is characterized by {{c1::<u>cytokine</u>}}<u>-mediated</u> damage of <b>{{c2::foot processes}}</b> and loss of {{c3::<b>glomerular basement</b>}} <b>anions</b></div>", "time": null}, {"id": 1475363812524, "note": "<div><b>Minimal change disease</b> is characterized by {{c1::normal}}<b> glomeruli</b> on <u>light microscopy</u>  </div>", "time": 1660105355214.0}, {"id": 1475363817507, "note": "<div>In <b>minimal change disease </b>(lipoid nephrosis), {{c1::<u>lipids</u>}} may be seen in <b>{{c2::proximal tubule}} cells</b> of the nephron (light microscopy)</div>", "time": null}, {"id": 1475363820412, "note": "<div><b>Minimal change disease</b> is characterized by <b>{{c1::effacement}} of {{c2::foot processes}}</b> on <u>electron microscopy</u></div>", "time": 1660105355216.0}, {"id": 1475363825579, "note": "<div>What <u>immunofluorescence</u> findings are associated with <b>minimal change disease</b>? </div><div><br></div><div>{{c1::None (no immune complex deposits)}}</div>", "time": 1660105347025.0}, {"id": 1475363828294, "note": "<div><b>Minimal change disease</b> is characterized by <u>loss</u> of <b>{{c1::albumin}}</b>, but not <b>{{c2::immunoglobulin}}</b> in the urine (selective proteinuria)</div>", "time": null}, {"id": 1475363831349, "note": "<div><b>Minimal change disease</b> has a(n) {{c2::<u>excellent</u>}}<u> response</u> to {{c1::corticosteroids}} </div>", "time": null}, {"id": 1475363838997, "note": "<div><b>{{c1::Focal segmental glomerulosclerosis (FSGS)}}</b> is the <i>most common cause</i> of {{c3::<u>nephrotic</u>}}<u> syndrome</u>&nbsp;in&nbsp;<b>{{c2::Hispanics::ethnicity}}</b> and <b>{{c2::African Americans::ethnicity}}</b>&nbsp;</div>", "time": null}, {"id": 1475363841815, "note": "<div>The cause of <b>focal segmental glomerulosclerosis</b> is usually <u>idiopathic</u>, but may be secondary to:<br><br></div><div>- massive {{c1::obesity}}</div><div>- {{c2::interferon}} treatment</div><div>- congenital {{c3::kidney malformations}} that cause <i>chronic kidney disease</i></div>", "time": null}, {"id": 1475363844810, "note": "<div>What <u>hematologic pathology</u> is associated with increased risk for <b>focal segmental glomerulosclerosis</b>? </div><div><br></div><div>{{c1::Sickle cell disease}}</div>", "time": null}, {"id": 1475363847722, "note": "<div>What <u>infectious disease</u> is associated with <b>focal segmental glomerulosclerosis</b>? </div><div><br></div><div>{{c1::HIV}}</div>", "time": null}, {"id": 1475363849731, "note": "<div><b>{{c2::Focal segmental glomerulosclerosis}}</b> is a type of <u>nephrotic syndrome</u> associated with {{c1::<b>heroin</b>}} <b>abuse</b></div>", "time": null}, {"id": 1475363852586, "note": "<div><b>Focal segmental glomerulosclerosis</b> is characterized by <i>focal</i> and <i>segmental&nbsp;</i><b>{{c1::sclerosis}}</b> and&nbsp;<b>{{c2::hyalinosis}}</b> on <u>light microscopy</u></div>", "time": null}, {"id": 1475363857060, "note": "<div><b>Focal segmental glomerulosclerosis</b> is characterized by <b>{{c1::effacement}} of {{c2::foot processes}}</b> on <u>electron microscopy</u> </div>", "time": null}, {"id": 1475363863959, "note": "<div><div>What <u>immunofluorescence</u> findings are<i> usually</i> associated with <b>focal segmental glomerulosclerosis</b>? </div><div><br /></div><div>{{c1::None (no immune complex deposits)}} </div></div>", "time": null}, {"id": 1475363870196, "note": "<div><b>Focal segmental glomerulosclerosis </b>has a(n) {{c1::<u>poor</u>}}<u> response</u> to corticosteroids</div>", "time": null}, {"id": 1475363877947, "note": "<div><b>Focal segmental glomerulosclerosis</b> ultimately progresses to {{c1::chronic renal failure}}</div>", "time": null}, {"id": 1475363880707, "note": "<div><b>{{c1::Membranous nephropathy}}</b> is the <i>most common cause </i>of {{c3::<u>nephrotic</u>}}<u> syndrome</u> in <b>{{c2::Caucasian adults}}</b> </div>", "time": null}, {"id": 1475363888352, "note": "<div><i>Primary</i> <b>{{c2::membranous nephropathy}} </b>is associated with <u>autoantibodies</u> against the transmembrane {{c1::<b>phospholipase A<sub>2</sub></b>}} <b>receptor </b>found in high concentrations in glomerular podocytes</div>", "time": null}, {"id": 1475363908883, "note": "<div>What type of <u>nephrotic syndrome</u> is a patient with <b>SLE </b>most likely to get? </div><div><br></div><div>{{c1::Membranous nephropathy}}</div>", "time": null}, {"id": 1475363911361, "note": "<div>What <u>infectious diseases</u> is <b>membranous nephropathy</b> associated with?</div><div><br></div><div>{{c1::HBV, HCV::2}}</div>", "time": null}, {"id": 1475363980691, "note": "<div><b>Membranous nephropathy</b> may occur <i>secondary</i> to drugs, such as {{c1::NSAIDs}} and {{c2::penicillamine}}</div>", "time": null}, {"id": 1475363985178, "note": "<div>Which type of <u>nephrotic syndrome</u> is commonly seen <i>secondary</i> to <b>solid tumors</b>? </div><div><br /></div><div>{{c1::Membranous nephropathy}}</div>", "time": 1660105341747.0}, {"id": 1475363987466, "note": "<div><b>Membranous nephropathy</b> is characterized by <b>diffuse capillary</b> and <b>{{c1::GBM}} {{c2::thickening}}</b> on <u>light microscopy</u></div>", "time": 1660105355317.0}, {"id": 1475363999923, "note": "<div><div>What <u>immunofluorescence</u> findings are associated with <b>membranous nephropathy</b>? </div><div><b><br></b></div><div>{{c1::Granular deposits (immune complex deposition)}}</div></div>", "time": null}, {"id": 1475364023607, "note": "<div><b>{{c3::Membranous}} nephropathy</b> is characterized by <b>{{c2::subepithelial}} deposits </b>with a <b>{{c1::spike and dome}}</b> appearance on <u>electron microscopy</u></div>", "time": null}, {"id": 1475364024753, "note": "<div><b>Membranous nephropathy </b>has a(n) {{c1::<u>poor</u>}}<u> response</u> to corticosteroids</div>", "time": null}, {"id": 1475364027546, "note": "<div><b>Membranous nephropathy </b>ultimately progresses to {{c1::chronic renal failure}}</div>", "time": null}, {"id": 1475364030028, "note": "<div>Is <b>membranoproliferative glomerulonephritis (MPGN) </b>a <u>nephritic</u> or <u>nephrotic</u> syndrome?</div><div><br /></div><div>{{c1::Can be either or both}} </div>", "time": null}, {"id": 1475364039224, "note": "<div>The <b>tram-track</b> appearance associated with <u>MPGN</u> is due to <b>basement membrane splitting</b> caused by <b>{{c1::mesangial}} cell ingrowth</b></div>", "time": null}, {"id": 1475364052433, "note": "<div><b>MPGN</b> <u>type {{c2::I}}</u> is associated with <b>{{c1::subendothelial}}</b> immune complex deposits</div>", "time": null}, {"id": 1475364057523, "note": "<div><b>MPGN</b> <u>type {{c2::II}}</u> is associated with <b>{{c1::intramembranous}}</b> immune complex deposits</div>", "time": null}, {"id": 1475364061773, "note": "<div>Which <u>type</u> of <b>MPGN</b> is <i><u>more often</u></i> associated with a <b>tram track</b> appearance on H&amp;E stain? </div><div><br /></div><div>{{c1::Type I}}</div>", "time": null}, {"id": 1475364074152, "note": "<div>What <u>infectious diseases</u> are associated with <b>type I MPGN</b>? </div><div><br></div><div>{{c1::HBV, HCV::2}}</div>", "time": null}, {"id": 1475364079016, "note": "<div><b>Type II MPGN</b> is also known as <b>{{c1::dense deposit}} disease</b></div>", "time": null}, {"id": 1475364082942, "note": "<div><b>Type {{c3::II}}</b> <b>MPGN</b> is associated with <b>{{c1::C3 nephritic factor}}</b>, an <u>autoantibody</u> that <i>stabilizes</i> <b>{{c2::C3 convertase}}</b> </div>", "time": null}, {"id": 1475364095466, "note": "<div><b>Type II MPGN</b> is associated with {{c1::<u>low</u>}} circulating levels of <b>C3</b></div>", "time": null}, {"id": 1475364102374, "note": "<div>In <b>diabetes mellitus</b>, <u>high serum glucose</u> leads to {{c1::non-enzymatic glycosylation}} of the <b>GBM</b> in the kidney </div>", "time": null}, {"id": 1475364107707, "note": "<div><b>Non-enzymatic glycosylation</b> of the <u>GBM</u> results in {{c1::hyaline}} <b>arteriolosclerosis</b></div>", "time": null}, {"id": 1475364110524, "note": "<div>Which <u>renal arteriole</u> is initially affected by <b>non-enzymatic glycation</b>? </div><div><br></div><div>{{c1::Efferent arteriole}}</div>", "time": null}, {"id": 1475364112776, "note": "<div>How does <b>non-enzymatic glycation</b> of the <u>efferent renal arteriole</u>&nbsp;affect GFR?</div><div><br></div><div>{{c1::Increased GFR (hyperfiltration)}}</div>", "time": null}, {"id": 1475364115656, "note": "<div><i>Initially</i>, <u>NEG</u> of the <b>glomerular basement membrane</b> (<u>diabetes mellitus</u>) causes hyperfiltration injury which leads to the development of <b>{{c1::microalbumin}}-uria</b> by promoting production of {{c2::<u>heparanase</u>}}</div>", "time": null}, {"id": 1475364120802, "note": "<div>Does untreated <b>diabetes nephropathy</b> stay at a <u>nephrotic</u> syndrome or can it progress to a <u>nephritic</u> syndrome? </div><div><br></div><div>{{c1::Can progress to nephritic syndrome}}</div>", "time": null}, {"id": 1475364123204, "note": "<div><b>Diabetic glomerulonephropathy</b> is associated with <b>{{c1::mesangial}}</b> <b>proliferation</b> on <u>light microscopy</u>  </div>", "time": null}, {"id": 1475364125638, "note": "<div>The hyperfiltration in <b>diabetic glomerulonephropathy </b>can lead to <u>eosinophilic</u> <b>nodular</b> <b>glomerulosclerosis</b>, known as {{c1::Kimmelstiel-Wilson}}<b> </b>nodules</div>", "time": null}, {"id": 1475364129715, "note": "<div>What <i>drug class</i> is used to slow progression of <b>hyperfiltration-induced damage</b> in <u>diabetic glomerulonephropathy</u>? </div><div><br /></div><div>{{c1::ACE inhibitors}}</div>", "time": 1660105347239.0}, {"id": 1475364137399, "note": "<div>What is the <u>most common cause</u> of <b>end-stage renal disease</b> in the U.S.? </div><div><br></div><div>{{c1::Diabetic glomerulonephropathy}}</div>", "time": null}, {"id": 1475364140189, "note": "<div>What is the <u>first change</u> that occurs in the <b>kidney</b> in a diabetes mellitus patient?</div><div><br></div><div>{{c1::Non-enzymatic glycosylation of GBM}}</div>", "time": null}, {"id": 1475364142714, "note": "<div><b>Nephrotic syndrome</b> may be caused by systemic {{c1::amyloidosis}}</div>", "time": null}, {"id": 1475364147786, "note": "<div>The <i>most commonly</i> involved <u>organ</u> in <b>systemic amyloidosis</b> is the {{c1::kidney}}</div>", "time": null}, {"id": 1475364150468, "note": "<div>Where in the <u>kidney</u> does <b>amyloid</b> deposit, causing <i>nephrotic syndrome</i>? </div><div><br></div><div>{{c1::Mesangium}}</div>", "time": null}, {"id": 1475364152379, "note": "<b>Amyloidosis</b> is characterized by <b>{{c1::apple-green birefringence}}</b> under <u>polarized light</u> after staining with <b>{{c2::Congo red}}</b> ", "time": null}, {"id": 1475375262667, "note": "<div><b style=\"font-weight: bold; \">Nephrotic syndrome</b> occurs due to <u>{{c2::podocyte}} damage</u> disrupting the glomerular filtration {{c1::<i>charge</i>}} barrier </div>", "time": null}, {"id": 1475376381122, "note": "<b>Nephritic syndrome</b> is a group of <u>glomerular disorders</u> characterized by <b>glomerular</b> <b>{{c1::inflammation}}</b> and <b>{{c2::bleeding}}</b>", "time": 1660105354913.0}, {"id": 1475376384474, "note": "<div><b>Nephritic syndrome</b> is characterized by <i>limited</i> <b>{{c2::protein}}-uria</b> <b>{{c1::&lt; 3.5}} g/day</b></div>", "time": null}, {"id": 1475376387061, "note": "<div>How does <b>nephritic syndrome</b> affect <u>urine output</u>? </div><div><br></div><div>{{c1::Decreased (oliguria)}}</div>", "time": 1660105358083.0}, {"id": 1475376389469, "note": "<div><b>Nephritic syndrome</b> is associated with {{c1::increased}} BUN and creatinine </div>", "time": 1660105354911.0}, {"id": 1475376396532, "note": "<div><b>Nephritic syndrome</b> is associated with {{c3::<u>salt</u>}}<u> retention</u> with consequent {{c1::<b>periorbital</b> <b>edema</b>}} and {{c2::<b>hypertension</b>}}</div>", "time": 1660105354910.0}, {"id": 1475376399619, "note": "<div><b>Nephritic syndrome</b> may lead to <u>hematuria</u> and <b>{{c1::RBC}} casts</b> in the urine</div>", "time": null}, {"id": 1475376402452, "note": "<div>Biopsy of <b>nephritic syndrome</b> reveals {{c1::<u>hyper</u>}}<u>-cellular</u>, inflamed glomeruli</div>", "time": null}, {"id": 1475376406771, "note": "<div><b>Nephritic syndrome</b> is typically associated with <u>immune-complex deposition</u>, which activates {{c1::<b>complement</b> (e.g. C5a)}}</div>", "time": 1660105354907.0}, {"id": 1475376412860, "note": "<div><b>{{c1::Post-streptococcal glomerulonephritis (PSGN)}}</b> is a type of <u>nephritic syndrome</u> that arises after a(n)&nbsp;<i>{{c2::group A \u03b2-hemolytic streptococcal}}</i> infection of the {{c3::<b>skin</b> (impetigo)}} or <b>{{c4::pharynx}}</b></div>", "time": null}, {"id": 1475376417766, "note": "<div><b>PSGN</b> occurs with <u>nephritogenic</u> strains of <i>group A \u03b2-hemolytic streptococcus</i>, which carry the {{c1::<b>M protein</b>}} virulence factor and is caused by glomerular deposition of nephritogenic antigens such as {{c2::<b>SpeB</b>}}</div>", "time": 1660105353580.0}, {"id": 1475376425582, "note": "<div><b>PSGN</b> typically presents 2 to 4 {{c1::weeks}} after a <i>group A \u03b2-hemolytic streptococcal</i> infection</div>", "time": null}, {"id": 1475376428519, "note": "<div>What type of <u>hypersensitivity reaction</u> is <b>post-streptococcal glomerulonephritis</b>? </div><div><br></div><div>{{c1::Type III (immune complex-mediated)}}</div>", "time": null}, {"id": 1475376431328, "note": "<div><b>Post-streptococcal&nbsp;glomerulonephritis</b> may present with <b>{{c2::hemat}}-uria</b> and <b>{{c1::cola / tea}}-colored urine</b></div>", "time": null}, {"id": 1475376433919, "note": "<div><b>PSGN</b> may present with <u>peripheral</u> and <u>periorbital</u> <b>{{c1::edema}}</b></div>", "time": null}, {"id": 1475376436296, "note": "<div><b>PSGN</b> may present with {{c1::hypertension::BP}}</div>", "time": null}, {"id": 1475376438517, "note": "<div>What <u>demographic</u>&nbsp;is more commonly associated with <b>PSGN</b>? </div><div><br></div><div>{{c1::Children::age group}} </div>", "time": null}, {"id": 1475376445664, "note": "<div><b>Post-streptococcal&nbsp;glomerulonephritis</b>&nbsp;is characterized by <u>enlarged</u> and <b>{{c1::hyper}}-cellular</b> <b>glomeruli</b> on <u>light microscopy</u></div>", "time": null}, {"id": 1475376486636, "note": "<div><b>{{c3::PSGN}}</b> is characterized by a \"{{c1::<b>lumpy</b> <b>bumpy (granular)</b>}}\" <u>immunofluorescence</u>&nbsp;pattern due to <b>{{c2::immune complex deposition}}</b></div>", "time": null}, {"id": 1475376496099, "note": "<div>The \"<b>lumpy-bumpy</b>\" appearance of <u>PSGN</u> on <i>immunofluorescence</i> is due to <b>deposits</b> with immune complexes consisting of <b>{{c1::IgG}} / {{c1::IgM}}</b> and <b>{{c2::C3}}</b> </div>", "time": null}, {"id": 1475376498638, "note": "<div><b>PSGN</b> is characterized by <b>{{c1::subepithelial}}</b> immune complex<b> </b>\"<b>{{c2::humps}}</b>\" on <u>electron microscopy</u></div>", "time": null}, {"id": 1475376503087, "note": "<div>What is the <u>treatment</u> for <b>post-streptococcal glomerulonephritis</b>? </div><div><br></div><div>{{c1::Supportive (resolves spontaneously)}}</div>", "time": null}, {"id": 1475376506084, "note": "<div><b>Children</b> with <u>PSGN</u> {{c1::rarely (1%)::frequency}} progress to <b>renal failure</b></div>", "time": null}, {"id": 1475376509836, "note": "<div>About 25% of <b>adults</b> with <u>PSGN</u> develop<b> </b>{{c1::rapidly progressive glomerulonephritis}} </div>", "time": null}, {"id": 1475376511780, "note": "<div>Diagnosis of <b>{{c1::post-streptococcal}} glomerulonephritis</b> may be aided by positive strep titers/serologies</div>", "time": null}, {"id": 1475376514149, "note": "<div><b>Post-streptococcal glomerulonephritis</b> is associated with {{c1::<u>decreased</u>}} levels of <b>complement</b> </div>", "time": null}, {"id": 1475376520112, "note": "<div><b>{{c1::Rapidly progressive}} glomerulonephritis</b> is a <u>nephritic syndrome</u> that progresses to <b>renal</b> <b>failure</b> in days to weeks</div>", "time": 1660105339098.0}, {"id": 1475376526888, "note": "<div>What is the <u>prognosis</u> of <b>rapidly progressive glomerulonephritis</b>? </div><div><br></div><div>{{c1::Poor prognosis}}</div>", "time": null}, {"id": 1475376529252, "note": "<div><b>{{c2::Rapidly progressive}} glomerulonephritis</b> is characterized by {{c1::<b>crescents</b>}} in Bowmans space of the glomeruli (<u>light microscopy</u>)</div>", "time": null}, {"id": 1475376545116, "note": "<div>The <b>crescents</b> seen in <u>RPGN</u> are composed of <b>{{c1::fibrin}}</b> and <b>{{c2::macrophages}}</b> </div>", "time": null}, {"id": 1475376552582, "note": "<div><b>{{c2::Goodpasture syndrome}}</b> is a form of <u>RPGN</u> that presents with a(n)&nbsp;<b>{{c1::linear}} pattern</b> on immunofluorescence</div>", "time": null}, {"id": 1475376572176, "note": "<div>What type of <u>hypersensitivity reaction</u> is <b>Goodpasture syndrome</b>? </div><div><br></div><div>{{c1::Type II HSR}}</div>", "time": null}, {"id": 1475376574700, "note": "<div><b>{{c3::Goodpasture}} syndrome</b> occurs due to <u>antibodies</u> against the <b>{{c1::glomerular}}</b> and <b>{{c1::alveolar}} {{c2::basement membranes}}</b> </div>", "time": null}, {"id": 1475376577258, "note": "<div><b>Goodpasture syndrome</b> presents with {{c1::hematuria}} and {{c1::hemoptysis}}</div>", "time": null}, {"id": 1475376579559, "note": "<div>What <u>demographic</u> is associated with <b>Goodpasture syndrome</b>? </div><div><br /></div><div>{{c1::Young adult males}}</div>", "time": 1660105347346.0}, {"id": 1475376581661, "note": "<div>What is the <u>treatment</u> for <b>Goodpasture syndrome</b>? </div><div><br></div><div>{{c1::Emergent plasmapheresis}}</div>", "time": null}, {"id": 1475376583593, "note": "<div><u>RPGN</u> with a <b>granular </b>immunofluorescence pattern is <i>more commonly</i> due to <b>{{c1::post-streptococcal glomerulonephritis}}</b> </div>", "time": null}, {"id": 1475376585950, "note": "<div><u>RPGN</u> with a <b>granular </b>immunofluorescence pattern is <i>less commonly</i> due to&nbsp;<b>{{c1::diffuse proliferative glomerulonephritis}}</b> </div>", "time": null}, {"id": 1475376588139, "note": "<div><div>What type of <u>nephritic syndrome</u> is a patient with <b>SLE </b>most likely to get? </div><div><br /></div><div>{{c1::Diffuse proliferative glomerulonephritis}}</div></div>", "time": null}, {"id": 1475376595559, "note": "<div><b>Diffuse proliferative glomerulonephritis</b> is a common <u>cause of death</u> in patients with {{c1::SLE}}</div>", "time": null}, {"id": 1475376597881, "note": "<div><b>{{c2::Diffuse proliferative}} glomerulonephritis</b> is characterized by \"{{c1::<b>wire</b> <b>looping</b>}}\" of capillaries on <u>light microscopy</u></div>", "time": null}, {"id": 1475376608583, "note": "<div><b>Diffuse proliferative glomerulonephritis</b> is characterized by a(n) {{c1::granular}} pattern on <u>immunofluorescence</u></div>", "time": null}, {"id": 1475376612128, "note": "<div><b>DPGN</b> is characterized by&nbsp;<b>{{c1::subendothelial}}</b> and <i>sometimes&nbsp;</i><b>{{c2::intramembranous}}</b> immune complexes on <u>electron microscopy</u></div>", "time": null}, {"id": 1475376614336, "note": "<div>The <b>immune complexes</b> in <u>DPGN</u> are <u>Ig</u>{{c1::<u>G</u>}}<u>-based</u> and often have <b>{{c2::C3}} deposition</b></div>", "time": null}, {"id": 1475376617622, "note": "<div>If <u>RPGN</u> has <b>no</b> immunofluorescence pattern, it is termed <b>{{c1::pauci-immune}}</b> glomerulonephritis </div>", "time": 1660105357696.0}, {"id": 1475376623320, "note": "<div>Which cause of <b>pauci-immune glomerulonephritis</b> is associated with <u>c-ANCA</u> (PR3-ANCA)? </div><div><br /></div><div>{{c1::Wegener granulomatosis}}</div>", "time": null}, {"id": 1475376628335, "note": "<div>Which causes of <b>pauci-immune glomerulonephritis</b> are associated with <u>p-ANCA</u> (MPO-ANCA)? </div><div><br></div><div>{{c1::Microscopic polyangiitis, Churg-strauss syndrome::2}}</div>", "time": null}, {"id": 1475376633607, "note": "<div>What is the <u>most common</u> <b>nephropathy</b> worldwide? </div><div><b><br></b></div><div>{{c1::IgA nephropathy (Berger disease)}}</div>", "time": null}, {"id": 1475376636033, "note": "<div><b>{{c1::IgA nephropathy (Berger disease)}}</b> is the <u>renal</u> pathology associated with <b>Henoch-Schonlein purpura</b></div>", "time": null}, {"id": 1475376641804, "note": "<div><b>IgA nephropathy</b> typically presents during <u>childhood</u> with <i>episodic</i> gross or microscopic <b>{{c1::hemat}}-uria</b> or&nbsp;<b>{{c2::RBC}} casts</b></div>", "time": 1660105357665.0}, {"id": 1475376644933, "note": "<div><b>IgA nephropathy</b> typically follows a(n) {{c1::respiratory}} or {{c2::GI tract}} infection</div>", "time": null}, {"id": 1475376651770, "note": "<div><b>IgA nephropathy</b> is characterized by <b>{{c1::mesangial}} proliferation</b> on <u>light microscopy</u></div>", "time": null}, {"id": 1475376654031, "note": "<div><b>IgA nephropathy</b> is characterized by {{c1::mesangial::location}} immune complex deposits on <u>electron microscopy</u></div>", "time": null}, {"id": 1475376667877, "note": "<div><b>Berger disease</b> is characterized by <b>Ig{{c1::A}}-based</b> immune complex deposits in the <b>{{c2::mesangium}}</b> (seen with <u>immunofluorescence</u>)</div>", "time": null}, {"id": 1475376674749, "note": "<div><b>IgA nephropathy</b> (Berger disease) may slowly <i>progress</i> to {{c1::renal failure}}</div>", "time": 1660105357667.0}, {"id": 1475376677237, "note": "<div><b>{{c1::Alport}} syndrome</b> is an <u>inherited</u> defect in <b>type {{c2::IV}} collagen</b></div>", "time": null}, {"id": 1475376678987, "note": "<div>What is the <i>most common</i> <u>mode of inheritance</u> of <b>Alport syndrome</b>? </div><div><br></div><div>{{c1::X-linked dominant}}</div>", "time": null}, {"id": 1475376681509, "note": "<div><b>{{c3::Alport}} syndrome</b> is characterized by {{c1::<u>thinning</u>}} and {{c2::<u>splitting</u>}} of the <b>glomerular basement membrane</b> </div>", "time": null}, {"id": 1475376683275, "note": "<div><b>{{c4::Alport}} syndrome</b> often presents with a <u>triad</u> of {{c3::ocular}} disturbances, <i>isolated</i> {{c1::hematuria}}, and sensory {{c2::hearing}} loss</div>", "time": null}, {"id": 1475376695635, "note": "<b>Alport syndrome</b> is associated with a \"{{c1::basket-weave}}\" appearance on <u>electron microscopy</u>", "time": null}, {"id": 1475452920961, "note": "<div><b>UTI</b> most commonly arises due to {{c1::<u>ascending</u>::ascending or descending}} infection</div>", "time": 1660105348344.0}, {"id": 1475452925539, "note": "<div>{{c1::<b>Females</b>::gender}} have <u>increased</u> risk for <b>UTI</b> due to a relatively <b>{{c2::short}} urethra</b></div>", "time": 1660105340370.0}, {"id": 1475452928405, "note": "<div>What <u>endocrine pathology</u> is associated with <b>UTI</b>? </div><div><br></div><div>{{c1::Diabetes mellitus}}</div>", "time": 1660105347156.0}, {"id": 1475452931321, "note": "<div><u>Impaired</u> {{c1::<b>bladder</b>}} <b>emptying</b> <i>increases</i> risk for <b>UTI</b> </div>", "time": null}, {"id": 1475452937544, "note": "<div>One <u>risk factor</u> for <b>UTI</b> is {{c1::sexual}} activity </div>", "time": 1660105354589.0}, {"id": 1475452940682, "note": "<div>One <u>risk factor</u> for <b>UTI</b> is indwelling {{c1::catheters}}</div>", "time": null}, {"id": 1475452943180, "note": "<div><b>{{c2::Cystitis}}</b> is an <u>infection/inflammation</u> of the <b>{{c1::bladder}}</b></div>", "time": null}, {"id": 1475452946092, "note": "<div><b>Cystitis </b>typically presents with {{c1::dys}}-uria, urinary frequency, urgency, and {{c2::suprapubic}} pain</div>", "time": 1660105360248.0}, {"id": 1475452948886, "note": "<div>Does <b>cystitis</b> typically present with <u>systemic signs</u> (e.g. fever)? </div><div><br></div><div>{{c1::No}}</div>", "time": null}, {"id": 1475452951914, "note": "<div><b>Cystitis</b> is characterized by {{c1::<u>cloudy</u>}}<u><b> </b>urine</u> with <b>{{c2::&gt; 10::#}} WBCs/hpf</b> (urinalysis)</div>", "time": 1660105360250.0}, {"id": 1475452960076, "note": "<div><b>Cystitis </b>is characterized by <u>positive</u> <b>{{c1::leukocyte esterase}}</b> due to <b>{{c2::pyuria}}</b> </div>", "time": null}, {"id": 1475452963347, "note": "<div><b>Cystitis</b> is characterized by <u>positive</u> <b>{{c1::nitrites}}</b>, which indicates <b>gram {{c2::negative}} organisms</b></div>", "time": null}, {"id": 1475452971352, "note": "<div>The <i>gold standard</i> for diagnosis of <b>cystitis</b> is culture showing &gt; {{c1::100,000}} colony forming units</div>", "time": 1660105350072.0}, {"id": 1475452975778, "note": "<div>What infectious organism is the <u>most common</u> (80%) cause of <b>cystitis</b>? </div><div><br></div><div><i>{{c1::E. coli}}</i></div>", "time": null}, {"id": 1475452989103, "note": "<div>What <i>urease positive</i>, <u>pneumonia-causing</u> bacteria is a common cause of <b>UTI</b>? </div><div><br></div><div>{{c1::Klebsiella pneumoniae}} </div>", "time": null}, {"id": 1475453004269, "note": "<div><b>{{c1::Sterile}} pyuria</b> is the presence of <u>pyuria</u> (&gt; 10 WBCs/hpf and leukocyte esterase) with a <b>negative urine culture</b></div>", "time": null}, {"id": 1475453007566, "note": "<div><b>UTI</b> with <u>sterile pyuria</u> suggests <b>{{c1::urethritis}}</b> due to <i>{{c3::Chlamydia trachomatis}}</i> or <i>{{c2::Neisseria gonorrhoeae}} </i></div>", "time": null}, {"id": 1475453013894, "note": "<div><b>{{c1::Pyelonephritis}}</b> is an <u>infection</u> of the <b>{{c2::kidney}}</b></div>", "time": null}, {"id": 1475453031438, "note": "<div>One <u>risk factor</u> for <b>pyelonephritis</b> is <b>{{c1::vesicoureteral}}</b> <b>reflux</b></div>", "time": null}, {"id": 1475453035006, "note": "<div>What <u>non-pathologic state</u> is associated with <i>increased risk</i> for <b>pyelonephritis</b>? </div><div><br></div><div>{{c1::Pregnancy}}</div>", "time": null}, {"id": 1475453038069, "note": "<div>One <u>risk factor</u> for <b>pyelonephritis</b> is <b>urinary tract {{c1::obstruction::not infection}}</b> </div>", "time": 1660105354590.0}, {"id": 1475453045695, "note": "<div><div>Does <b>acute pyelonephritis</b> typically present with <u>systemic signs</u> (e.g. fever, chills)? </div><div><br></div><div>{{c1::Yes}}</div></div>", "time": 1660105359889.0}, {"id": 1475453051645, "note": "<div><b>Acute pyelonephritis</b> may present with <b>{{c1::flank}} pain</b> due to <i>sensitization</i> of the nerves of the kidney capsule </div>", "time": null}, {"id": 1475453058518, "note": "<div><b>Acute pyelonephritis</b> may present with <b>{{c1::WBCs}}</b> in the urine +/- <b>{{c2::WBC}} casts</b></div>", "time": null}, {"id": 1475453079620, "note": "<div>One <u>complication</u> of <b>acute pyelonephritis</b> is renal {{c1::papillary}} necrosis</div>", "time": null}, {"id": 1475453091066, "note": "<div><b>{{c1::Chronic pyelonephritis}}</b> is the result of <u>recurrent</u> episodes of <b>acute pyelonephritis</b></div>", "time": null}, {"id": 1475453110289, "note": "<div><b>Chronic {{c3::pyelonephritis}}</b> is characterized by coarse, asymmetric&nbsp;<b>{{c1::corticomedullary}} scarring</b> and <b>{{c2::blunted}} calyces</b> in the kidney</div>", "time": 1660105360708.0}, {"id": 1475453116797, "note": "<div><b>Chronic {{c2::pyelonephritis}}</b> is characterized <i>histologically</i> by renal tubules containing <u>eosinophilic proteinaceous material</u> resembling <b>{{c1::thyroid follicles}}</b> </div>", "time": null}, {"id": 1475453132862, "note": "<div><b>{{c1::Nephrolithiasis}}</b> is the precipitation of a <u>urinary</u> solute as a stone</div>", "time": null}, {"id": 1475453135801, "note": "<div>Risk factors for <b>nephrolithiasis</b> include:<br><br></div><div>- <u>high</u> <b>{{c1::solute}}</b> <b>concentration</b> in the urinary filtrate </div><div>- <u>low</u> <b>{{c2::urine}} volume</b> </div>", "time": null}, {"id": 1475453139770, "note": "<div><b>Nephrolithiasis</b> may present as {{c1::<u>colicky</u>::character}}<u> flank pain</u>&nbsp;that <i>radiates</i> to the <b>groin</b></div>", "time": 1660105354905.0}, {"id": 1475453142267, "note": "<div>An <u>obstructed</u> <b>kidney stone </b>may present with <i>unilateral</i> <b>{{c1::flank}} tenderness</b> that <u>radiates</u> to the <b>{{c2::groin}}</b></div>", "time": null}, {"id": 1475453150219, "note": "<div><b>Kidney stones</b> may be <u>treated</u> and <u>prevented</u> by encouraging {{c1::fluid}} intake </div>", "time": null}, {"id": 1475453157187, "note": "<div>What is the <u>most common</u> type of <b>kidney stone</b>?</div><div><br></div><div>{{c1::Calcium stone (80%)}}</div>", "time": null}, {"id": 1475453160043, "note": "<div>Which type of <b>calcium</b> <u>kidney stone</u> (calcium-oxalate or calcium-phosphate) is more common? </div><div><br></div><div>{{c1::Calcium oxalate}}</div>", "time": null}, {"id": 1475453162870, "note": "<div><b>{{c2::Calcium oxalate}} </b>kidney stones often precipitate due to {{c1::<b>hypocitrat</b>}}<b>-uria</b></div>", "time": null}, {"id": 1475453168385, "note": "<div><b>Calcium {{c2::phosphate}}</b> kidney stones precipitate with {{c1::<u>increased</u>}} <b>urine pH</b></div>", "time": null}, {"id": 1475453171165, "note": "<div>The <u>most common</u> kidney stone presentation is a(n)&nbsp;<b>{{c2::calcium oxalate}} stone</b> in a patient with <b>{{c1::hyper}}-calciuria</b> and <b>{{c1::normo}}-calcemia</b></div>", "time": 1660105349803.0}, {"id": 1475453181509, "note": "<div>What <u>GI pathology</u> is associated with <b>calcium oxalate</b> kidney stones?</div><div><br></div><div>{{c1::Crohns disease}}</div>", "time": null}, {"id": 1475453188699, "note": "<div><b>Crohn disease</b> is associated with <u>calcium oxalate</u> kidney stones due to <i>increased</i> levels of {{c1::oxalate}}</div>", "time": null}, {"id": 1475453191411, "note": "<div>What is the appearance <b>calcium kidney stones</b> on <u>X-ray</u> and <u>CT</u>? </div><div><br></div><div>{{c1::Radiopaque}} </div>", "time": 1660105346763.0}, {"id": 1475453205490, "note": "<div><b>{{c2::Calcium}} kidney stones</b> may be treated with {{c1::thiazide}} diuretics </div>", "time": null}, {"id": 1475453213234, "note": "<div>In addition to <u>thiazides</u>, <b>calcium oxalate</b> kidney stones may be treated with <b>{{c1::citrate}}</b> supplementation and a <b>low-{{c2::sodium}} diet</b></div>", "time": null}, {"id": 1475453216091, "note": "<div>What type of <u>kidney stone</u> may result from <b>ethylene glycol</b> (antifreeze) ingestion? </div><div><br></div><div>{{c1::Calcium oxalate}}</div>", "time": null}, {"id": 1475453220280, "note": "<div><b>{{c2::Calcium oxalate}}</b> kidney stones may result from <b>vitamin {{c1::C}} abuse</b></div>", "time": null}, {"id": 1475453223270, "note": "<div>The <u>second most common</u> type of <i>kidney stone</i> (15%) is a(n) {{c1::<b>ammonium magnesium phosphate</b>}} stone, also known as <b>{{c2::struvite}}</b></div>", "time": null}, {"id": 1475453226283, "note": "<div><b>Ammonium magnesium phosphate </b>kidney stones precipitate with {{c1::<u>high</u>}} <b>urine pH</b></div>", "time": null}, {"id": 1475453229159, "note": "<div><div>What is the appearance of&nbsp;<b>ammonium magnesium phosphate</b> kidney stones on <u>X-ray</u> and <u>CT</u>? </div><div><br></div><div>{{c1::Radiopaque}}</div></div>", "time": 1660105346762.0}, {"id": 1475453236620, "note": "<div><b>Ammonium magnesium phosphate</b> kidney stones are caused by {{c1::urease}} <u>positive</u> organisms </div>", "time": null}, {"id": 1475453243182, "note": "<div><b>Urease </b><u>positive</u> organisms hydrolyze <b>urea </b>to {{c1::<b>ammonia</b>}}, causing <i>urine alkalinization</i></div>", "time": null}, {"id": 1475453246064, "note": "<div><b>Ammonium magnesium phosphate</b> (struvite) kidney stones classically form <b>{{c1::staghorn calculi}}</b> in renal calyces</div>", "time": null}, {"id": 1475453250507, "note": "<div>The <b>staghorn calculi</b> seen in <u>struvite kidney stones</u> may act as a nidus for {{c1::urinary tract}} infection</div>", "time": 1660105349553.0}, {"id": 1475453253604, "note": "<div>What type of <u>kidney stone</u> commonly requires <b>surgical removal</b> due to its size?</div><div><br></div><div>{{c1::Ammonium magnesium phosphate (struvite) stones}}</div>", "time": null}, {"id": 1475453256310, "note": "<div>In addition to <i>surgical removal</i>, <u>treatment</u> of <b>struvite stones</b> involves eradication of underlying {{c1::infection}}</div>", "time": null}, {"id": 1475453259650, "note": "<div><div>The <u>third most common</u> type of <i>kidney stone</i> (5%) is a(n) {{c1::<b>uric acid</b>}} stone</div></div>", "time": null}, {"id": 1475453262176, "note": "<div><div><b>Uric acid</b> kidney stones precipitate with {{c1::<u>low</u>}} <b>urine pH</b></div></div>", "time": null}, {"id": 1475453264320, "note": "<div><div><div>What is the appearance of&nbsp;<b>uric acid</b> kidney stones on <u>X-ray</u>? </div><div><br></div><div>{{c1::Radiolucent}}</div></div></div>", "time": null}, {"id": 1475453266868, "note": "<div><div><div><div>What is the appearance of&nbsp;<b>uric acid</b> kidney stones on <u>CT</u>? </div><div><br></div><div>{{c1::Minimally visible}}</div></div></div></div>", "time": null}, {"id": 1475453274131, "note": "<div>What <u>imaging modality</u> may be used to visualize <b>uric acid</b> <b>kidney stones</b>? </div><div><br></div><div>{{c1::Ultrasound}}</div>", "time": null}, {"id": 1475453276934, "note": "<div><i>Risk factors </i>for <b>{{c3::uric acid}} </b>kidney stones include {{c1::<u>hot/arid</u>}} <b>climates</b> and {{c2::<u>low</u>}} <b>urine</b> <b>volume</b></div>", "time": null}, {"id": 1475453283377, "note": "<div>What type of <u>kidney stone</u> is seen in patients with <b>gout</b>? </div><div><br></div><div>{{c1::Uric acid stone}}</div>", "time": 1660105344809.0}, {"id": 1475453286069, "note": "<div><b>{{c2::Uric acid}} </b>kidney stones are often seen in diseases with <u>increased</u> <b>{{c1::cell turnover}}</b> (e.g. leukemia, myeloproliferative disorders)</div>", "time": 1660105337215.0}, {"id": 1475453294639, "note": "<div>Treatment of <b>uric acid</b> <b>kidney</b> <b>stones</b> involves {{c1::<u>alkalinization</u>}} of urine (e.g. potassium bicarbonate)</div>", "time": null}, {"id": 1475453297299, "note": "<div>Treatment of <b>uric acid kidney</b> <b>stones</b> may include {{c1::allopurinol}}, especially in patients with <b>gout</b></div>", "time": null}, {"id": 1475453301458, "note": "<div><b>{{c1::Cystine}}</b> <b>stones</b> are a <i>rare</i> form of <u>nephrolithiasis</u>, most commonly seen in <b>{{c2::children::age group}}</b></div>", "time": null}, {"id": 1475453303765, "note": "<div><div><b>Cystine </b>kidney stones precipitate with {{c1::<u>low</u>}} <b>urine pH</b></div></div>", "time": null}, {"id": 1475453306198, "note": "<div><div><div>What is the appearance of&nbsp;<b>cystine</b> kidney stones on <u>X-ray</u>? </div><div><br></div><div>{{c1::Faintly radioopaque}}</div></div></div>", "time": 1660105346760.0}, {"id": 1475453308606, "note": "<div><div><div><div>What is the appearance of <b>cystine</b> kidney stones on <u>CT</u>? </div><div><br></div><div>{{c1::Moderately radioopaque (sometimes visible)}}</div></div></div></div>", "time": 1660105346761.0}, {"id": 1475453310825, "note": "<div><div><div><div><b>{{c2::Cystine}} </b>kidney stones are characterized by <u>urine crystals</u> that are {{c1::<b>hexagonal</b>}} in shape</div></div></div></div>", "time": null}, {"id": 1475453318914, "note": "<div>What <u>inherited pathology</u> are <b>cystine kidney stones</b> associated with?</div><div><br /></div><div>{{c1::Cystinuria}}</div>", "time": 1660105347017.0}, {"id": 1475453326357, "note": "<div>Patients with <b>{{c1::cystinuria}}</b> have <u>decreased</u> reabsorption of <b>cystine</b>, <b>ornithine</b>, <b>lysine</b>, and <b>arginine</b></div>", "time": null}, {"id": 1475453340355, "note": "<div><b>Cystine kidney stones</b> may form <b>{{c1::staghorn}}</b> <b>calculi</b> </div>", "time": null}, {"id": 1475453343743, "note": "<div>A <u>positive</u> <b>{{c2::sodium cyanide nitroprusside}}</b> test may help in the diagnosis of<b> {{c1::cystine}} </b>kidney stones</div>", "time": null}, {"id": 1475453348135, "note": "<div>Treatment of <b></b><b>cystine</b> kidney stones involves {{c1::<u>alkalinization</u>}} of urine and a low-{{c2::sodium}} diet</div>", "time": null}, {"id": 1475453356821, "note": "<div><b>Chronic renal failure</b> is most commonly caused by {{c1::diabetes mellitus}}, {{c2::hypertension}}, and {{c3::glomerular}} disease</div>", "time": 1660105360718.0}, {"id": 1475453375270, "note": "<div><b>Renal failure</b> is associated with an <i>inability</i> to <u>make</u> {{c1::urine}} and <u>excrete</u> {{c2::nitrogenous}} wastes</div>", "time": null}, {"id": 1475453378032, "note": "<div>One clinical feature of <b>renal failure</b> is <b>{{c1::uremia}}</b>, which is a <i>symptomatic</i> clinical syndrome marked by <u>increased</u> <b>nitrogenous</b> <b>waste</b> <b>products</b> in the blood (azotemia)</div>", "time": 1660105354639.0}, {"id": 1475453397652, "note": "<div>What <u>cardiac pathology</u> is a consequence of <b>uremia</b> (<b>renal failure</b>)? </div><div><br /></div><div>{{c1::Pericarditis}}</div>", "time": null}, {"id": 1475453400568, "note": "<div><b>Uremia</b>, a consequence of <u>renal failure</u>, may cause {{c1::<b>platelet</b>}} <b>dysfunction</b> in the blood </div>", "time": 1660105348365.0}, {"id": 1475453406023, "note": "<div><b>Uremia</b>, a consequence of <u>renal failure</u>, may cause <b>{{c1::encephalopathy}}</b> with <b>{{c2::asterixis}}</b> </div>", "time": 1660105348367.0}, {"id": 1475453422378, "note": "<div>What <u>GI symptoms</u> are associated with <b>uremia</b> (<b>renal failure</b>)?</div><div><br></div><div>{{c1::Nausea, anorexia::2}}</div>", "time": 1660105348092.0}, {"id": 1475453425482, "note": "<div><b>Uremia</b>, a consequence of <u>renal failure</u>, may cause deposition of <b>{{c1::urea}} crystals</b> in the skin</div>", "time": 1660105348368.0}, {"id": 1475453429411, "note": "<div>What <u>acid-base disorder</u> is a consequence of <b>renal failure</b>? </div><div><br /></div><div>{{c1::Metabolic acidosis}}</div>", "time": 1660105348012.0}, {"id": 1475453432034, "note": "<div>The <u>consequences</u> of <b>{{c9::renal failure}}</b> may be remembered using the mnemonic \"<b>MAD HUNGER</b>\": </div><div style=\"centerbox\"><div class=\"mnemonics\"><div><br/></div><div><b>M</b>.<b>A</b>: {{c1::Metabolic Acidosis}}</div><div><b>D</b>: {{c2::Dyslipidemia}} (especially <u>increased</u> {{c2::triglycerides}})</div><div><b>H</b>: {{c3::Hyperkalemia}}</div><div><b>U</b>: {{c4::Uremia}} </div><div><b>N</b>: {{c5::Na<sup>+</sup> / H<sub>2</sub>O retention}}</div><div><b>G</b>: {{c6::Growth retardation and developmental delay}}</div><div><b>E</b>: {{c7::Erythropoietin failure (anemia)}} </div><div><b>R</b>: {{c8::Renal osteodystrophy}}</div></div></div>", "time": null}, {"id": 1475453434812, "note": "<div>What <u>potassium imbalance</u> is a consequence of <b>renal failure</b>?</div><div><br /></div><div>{{c1::Hyperkalemia}}</div>", "time": 1660105345051.0}, {"id": 1475453437333, "note": "<div>One consequence of <b>renal failure</b> is {{c1::Na<sup>+</sup>}} and {{c1::H<sub>2</sub>O}} <i>retention</i> with resulting hypertension, heart failure, and pulmonary edema </div>", "time": 1660105354611.0}, {"id": 1475453442348, "note": "<div>One consequence of <b>renal failure</b> is <b>{{c1::anemia}}</b> due to <u>decreased</u> <b>{{c2::erythropoietin}}</b> production </div>", "time": null}, {"id": 1475453444576, "note": "<div><b>Erythropoietin</b> is produced by <b>renal</b> {{c1::peritubular interstitial}} <b>cells</b> </div>", "time": null}, {"id": 1475453446887, "note": "<div>What <u>bone pathology</u> is associated with <b>chronic renal failure</b>? </div><div><br></div><div>{{c1::Renal osteodystrophy}}</div>", "time": 1660105347569.0}, {"id": 1475453457502, "note": "<div><b>Chronic renal disease</b> is characterized by <b>{{c1::hypo}}-calcemia </b></div>", "time": 1660105360720.0}, {"id": 1475453463080, "note": "<div><b>Chronic renal disease</b> is characterized by <b>{{c2::hyper}}-phosphatemia</b> </div>", "time": 1660105360719.0}, {"id": 1475453469868, "note": "<div><b>Hypocalcemia</b> in <b>chronic renal disease</b> is caused, in part, by <u>decreased</u> {{c1::1-\u03b1-hydroxylation}} of vitamin D </div>", "time": 1660105357859.0}, {"id": 1475453482604, "note": "<div><div>How do levels of <u>parathyroid hormone</u> change in <b>chronic renal disease</b>? </div><div><br /></div><div>{{c1::Increased (secondary hyperparathyroidism)}}</div></div>", "time": 1660105358137.0}, {"id": 1475453489899, "note": "<div><b>Hyperparathyroidism</b> is characterized by {{c1::subperiosteal}} <u>thinning</u> of bones</div>", "time": null}, {"id": 1475453498841, "note": "<div><u>Treatment</u> of <b>renal failure</b> involves {{c1::dialysis}} or {{c2::renal transplant}}</div>", "time": 1660105348540.0}, {"id": 1475460297979, "note": "<b>{{c1::Angiomyolipoma}}</b> is a renal <u>hamartoma</u> comprised of blood vessels, smooth muscle, and adipose tissues", "time": 1660105341192.0}, {"id": 1475462959571, "note": "<div>There is an <u>increased</u> frequency of <b>renal</b> <b>angiomyolipoma</b> in patients with {{c1::tuberous sclerosis}}</div>", "time": null}, {"id": 1475462966975, "note": "<div>What is the <u>most common</u> <i>primary</i> <b>renal malignancy</b>? </div><div><br /></div><div>{{c1::Renal cell carcinoma}}</div>", "time": 1660105345827.0}, {"id": 1475462971484, "note": "<div><b>Renal cell carcinoma</b> is associated with a classic <u>triad</u> of {{c1::hematuria}}, {{c2::palpable mass}}, and {{c3::flank}} pain</div>", "time": null}, {"id": 1475462978025, "note": "<div><b>Renal cell carcinoma</b> may present with <u>systemic symptoms</u> including <b>{{c1::fever}}</b> and <b>{{c2::weight loss}}</b></div>", "time": null}, {"id": 1475462983332, "note": "<div><b>Renal cell carcinoma</b> is associated with \"<b><font color=\"#aa0000\">PEAR</font></b>-aneoplastic\" syndromes, producing:<br><br></div><div><div>- <b><font color=\"#aa0000\">P</font></b>{{c1::THrP}}</div><div>- <b><font color=\"#aa0000\">E</font></b>{{c2::PO}}</div><div>- <b><font color=\"#aa0000\">A</font></b>{{c3::CTH}}</div><div>- <b><font color=\"#aa0000\">R</font></b>{{c4::enin}}</div></div>", "time": null}, {"id": 1475462988602, "note": "<div><b>Renal cell carcinoma</b> may present with <u>paraneoplastic syndromes</u>, such as <i>secondary</i> {{c1::polycythemia::hematocrit levels}}&nbsp;</div>", "time": 1660105353395.0}, {"id": 1475462995684, "note": "<div><b>Renal cell carcinoma</b> rarely may present with {{c2::<u>left</u>}}<u>-sided</u> <b>{{c1::varicocele}}</b> in males</div>", "time": null}, {"id": 1475463012039, "note": "<div>The <i>most common variant</i> of <b>renal cell carcinoma</b> exhibits {{c1::clear cell}} cytoplasm </div>", "time": null}, {"id": 1475463018940, "note": "<div><b>Renal cell carcinoma</b> often originates from the {{c1::PCT}} cells of the nephron</div>", "time": null}, {"id": 1475463021894, "note": "<div><b>Renal cell carcinoma</b> is associated with <u>loss</u> of the <i><b>{{c1::VHL}}</b></i> tumor suppressor gene on <u>chromosome </u>{{c2::<u>3p</u>}}</div>", "time": null}, {"id": 1475463026584, "note": "<div>Loss of the <i>VHL</i> tumor suppressor gene (renal cell carcinoma) leads to <u>increased</u> <b>{{c1::HIF}} transcription factor</b>, which increases <b>VEGF</b> and <b>PDGF</b></div>", "time": 1660105355543.0}, {"id": 1475463031790, "note": "<div>The {{c3::<u>sporadic</u>}} form of <b>renal cell carcinoma</b> classically arises in adult {{c1::males}} (average age is {{c2::60}})</div>", "time": null}, {"id": 1475463054501, "note": "<div>The major risk factor for <u>sporadic</u> form of <b>renal cell carcinoma</b> is {{c1::cigarette smoke}}</div>", "time": null}, {"id": 1475463065054, "note": "<div>In addition to <u>smoking</u>, what is another <i>modifiable risk factor</i> for <b>renal cell carcinoma</b>? </div><div><br></div><div>{{c1::Obesity}}</div>", "time": null}, {"id": 1475463067676, "note": "<div><b>{{c3::Von Hippel-Lindau}} disease </b>is an <i>inherited</i> disease associated with&nbsp;<u>increased risk</u> for <b>{{c1::renal cell}} carcinoma&nbsp;</b>and&nbsp;<b>{{c2::hemangioblastoma}}</b> of the <u>cerebellum</u></div>", "time": 1660105336997.0}, {"id": 1475463069917, "note": "<div>What is the <u>mode of inheritance</u> of <b>von Hippel Lindau disease</b>? </div><div><br></div><div>{{c1::Autosomal dominant}}</div>", "time": 1660105346013.0}, {"id": 1475463113190, "note": "<div><div>The <b>N</b> of <u>TNM staging</u> for <b>renal cell carcinoma</b> represents spread to <i>regional lymph nodes</i> (i.e. {{c1::<u>retroperitoneal</u>}} nodes)</div></div>", "time": 1660105349771.0}, {"id": 1475463191861, "note": "<div><b>Renal cell carcinoma</b> is referred to as a \"{{c1::silent}}\" cancer because it commonly presents as a <u>metastatic</u> neoplasm</div>", "time": 1660105353396.0}, {"id": 1475463194050, "note": "<div><b>Renal cell carcinoma</b> may invade the <u>renal vein</u>, then <u>IVC</u>, before spreading {{c1::hematogenously}}</div>", "time": null}, {"id": 1475463196563, "note": "<div>What are the top two places <b>renal cell carcinoma</b> typically <u>metastasizes</u> to?</div><div><br /></div><div>1st - {{c1::Lung}}</div><div>2nd - {{c1::Bone}}</div>", "time": null}, {"id": 1475463199257, "note": "<div>Treatment for <u>localized</u> <b>renal cell carcinoma</b> is {{c1::surgical resection}}</div>", "time": 1660105348583.0}, {"id": 1475463201591, "note": "<div>How does <b>renal cell carcinoma</b> respond to <u>chemotherapy</u> and <u>radiation therapy</u>? </div><div><br></div><div>{{c1::Poor response (resistant)}}</div>", "time": 1660105358068.0}, {"id": 1475463212199, "note": "<div>What is the <u>most common</u> <b>renal malignancy</b> of <b>early childhood</b> (ages 2-4)? </div><div><br></div><div>{{c1::Wilms tumor}}</div>", "time": null}, {"id": 1475463214665, "note": "<div><b>{{c2::Wilms}} tumor</b> is a <u>malignant kidney tumor</u> composed primarily of {{c1::<b>blastema</b>}} +/- primitive glomeruli, tubules, and stromal cells</div>", "time": 1660105337180.0}, {"id": 1475463223057, "note": "<div><b>Wilms tumor</b> presents as a large, {{c1::<u>uni</u>}}<u>-lateral</u> <b>{{c2::flank}}</b> <b>mass</b> and/or <b>{{c3::hematuria}}</b></div>", "time": 1660105341478.0}, {"id": 1475463225676, "note": "<div><b>Wilms tumor</b> may present with <b>{{c1::hypertension}}</b> due to <u>increased</u> <b>{{c2::renin}}</b> secretion</div>", "time": 1660105341480.0}, {"id": 1475463227868, "note": "<div><b>Wilms tumor</b> is caused by \"loss of function\" mutations of tumor suppression genes <i style=\"font-weight: bold; \">{{c1::WT1}}</i> or <i style=\"font-weight: bold; \">{{c1::WT2}}</i> on chromosome {{c2::11}} </div>", "time": null}, {"id": 1475463252650, "note": "<div><b>WAGR syndrome</b> is a combination of:<br><br></div><div>-&nbsp;<b>W</b>{{c1::ilms tumor}}</div><div>-&nbsp;<b>A</b>{{c2::niridia (absence of iris)}}</div><div>-&nbsp;<b>G</b>{{c3::enital abnormalities}}</div><div>-&nbsp;<b>R</b>{{c4::etardation (mental or motor)}}</div>", "time": null}, {"id": 1475463257882, "note": "<div><b>{{c3::WAGR}} syndrome</b> is associated with a(n)&nbsp;<i>{{c1::WT1}}</i> gene {{c2::<u>deletion</u>}}</div>", "time": null}, {"id": 1475463260501, "note": "<div><b>{{c5::Beckwith-Wiedemann}} syndrome</b> is a combination of: </div><div><br></div><div> 1. {{c1::Wilms tumor}}</div><div> 2. {{c2::Macroglossia}} </div><div> 3. {{c3::Muscular hemihypertrophy (or hyperplasia)}}</div><div> 4. {{c4::Organomegaly}} </div>", "time": null}, {"id": 1475463272947, "note": "<div><b>{{c1::Transitional cell (urothelial)}} carcinoma</b> is the most common tumor of the <u>urinary tract system</u> </div>", "time": null}, {"id": 1475463297879, "note": "<div>Which part of the <u>urinary tract</u> does <b>transitional cell carcinoma</b> <i>most commonly</i> occur?</div><div><br></div><div>{{c1::Bladder}}</div>", "time": null}, {"id": 1475463318609, "note": "<div><b>Transitional cell </b><b>(urothelial)</b><b> carcinoma</b> classically presents with <i>{{c2::painless}}</i> <b>{{c1::hematuria}}</b> </div>", "time": 1660105348631.0}, {"id": 1475463326724, "note": "<div>What <u>demographic</u>&nbsp;is associated with <b>transitional cell</b><b> carcinoma</b> of the bladder? </div><div><br></div><div>{{c1::Older adults::age group}}</div>", "time": null}, {"id": 1475463329357, "note": "<div>The <u>major risk factor</u> for <b>transitional cell carcinoma</b> is {{c1::cigarette smoke}}</div>", "time": null}, {"id": 1475463344628, "note": "<div>What&nbsp;<i>drugs</i> are <u>risk factors</u> for <b>transitional cell carcinoma</b>? </div><div><br></div><div>{{c1::Cyclophosphamide}}, {{c2::Phenacetin}}</div>", "time": null}, {"id": 1475463348604, "note": "<div><b>{{c2::Transitional (urothelial) cell}} carcinoma</b> is a <u>urinary tract cancer</u> associated with <b>{{c1::aniline (azo)}} dyes</b></div>", "time": null}, {"id": 1475463375703, "note": "<div><b>Transitional cell (urothelial) carcinoma</b> tumors are often <u>multifocal</u> and <u>recur</u> due to a \"{{c1::field}} defect\" </div>", "time": 1660105348628.0}, {"id": 1475463381699, "note": "<div><i>Chronic</i> <u>irritation</u> of the <b>bladder</b> can cause {{c1::<b>squamous</b>}} <b>metaplasia</b>, which may progress to <b>{{c1::squamous}} cell carcinoma</b></div>", "time": null}, {"id": 1475463383859, "note": "<div><div>Which part of the <u>urinary tract</u> does <b>squamous cell carcinoma</b> <i>most commonly</i> occur?</div><div><br></div><div>{{c1::Bladder}}</div></div>", "time": null}, {"id": 1475463386114, "note": "<div><b>Squamous cell carcinoma</b> of the <u>bladder</u> arises in a <i>background</i> of <b>{{c1::squamous}} metaplasia </b></div>", "time": null}, {"id": 1475463392967, "note": "<div>Risk factors for <b>squamous cell carcinoma</b> of the <b>bladder</b> include {{c1::chronic cystitis}} (older women) and <u>smoking</u></div>", "time": null}, {"id": 1475463395276, "note": "<div><i>{{c1::Schistosoma haematobium}}</i> infection is associated with {{c4::<u>squamous cell</u>}}<u> carcinoma</u> of the {{c3::<b>bladder</b>}} in <b>{{c2::Middle eastern::ethnicity}}</b><b> males</b></div>", "time": null}, {"id": 1475463397773, "note": "<div>One <u>risk factor</u> for <b>squamous cell carcinoma</b> of the <b>bladder</b> is <i>long-standing</i> {{c1::nephrolithiasis::kidney}}</div>", "time": null}, {"id": 1475463401818, "note": "<div>Which part of the <u>urinary tract</u> does <b>adenocarcinoma</b> <i>most commonly</i> occur?</div><div><br></div><div>{{c1::Bladder}}</div>", "time": null}, {"id": 1475463404054, "note": "<div><b>{{c2::Adenocarcinoma}}</b> is a cancer of the <u>bladder</u> that usually arises from a(n) <b>{{c1::urachal}} remnant</b></div>", "time": null}, {"id": 1475463406185, "note": "<div><b>Adenocarcinoma</b> arising from a <u>urachal remnant</u> develops at the {{c1::dome}} of the <b>bladder</b></div>", "time": null}, {"id": 1475463407823, "note": "<div><b>Adenocarcinoma</b> of the <u>bladder</u> may arise from <b>{{c1::cystitis glandularis}}</b>, which is a(n)&nbsp;<b>{{c2::columnar}} metaplasia</b> in response to chronic inflammation</div>", "time": 1660105362086.0}, {"id": 1475463409814, "note": "<b>Adenocarcinoma</b> of the <u>bladder</u> may arise from {{c1::exstrophy}}, which is a <i>congenital</i> failure to form the <u>caudal</u> portion of the<b> anterior abdominal</b> and <b>bladder walls</b> ", "time": 1660105362084.0}, {"id": 1475633629850, "note": "<div>Where in the <u>nephron</u> do <b>acetazolamide</b> and <b>mannitol</b> primarily exert their effects? </div><div><br></div><div>{{c1::Proximal convoluted tubule}}</div>", "time": 1660105351275.0}, {"id": 1475636680103, "note": "<div>The <b>Na<sup>+</sup></b><b>-K<sup>+</sup> ATPase</b> is located on the {{c1::<u>basolateral</u>}}<u> membrane</u> of the nephron<br></div>", "time": 1660105351198.0}, {"id": 1475636693655, "note": "<div>The <b>Na<sup>+</sup>-H<sup>+</sup> exchanger</b> is located on the {{c1::<u>apical (luminal)</u>}}<u> membrane</u> in the PCT of the nephron<br></div>", "time": 1660105351199.0}, {"id": 1475636698521, "note": "<div>The <b>H<sup>+</sup></b> <i>secreted</i> into the <u>lumen</u> of the PCT combines with {{c1::HCO<sub>3</sub><sup>-</sup>}} to form <b>carbonic acid</b> (H<sub>2</sub>CO<sub>3</sub>)<br></div>", "time": 1660105351201.0}, {"id": 1475636703092, "note": "<div>What <u>enzyme</u> catalyzes the conversion of <b>H<sub>2</sub>CO<sub>3</sub></b> into <b>CO<sub>2</sub></b> and <b>H<sub>2</sub>O</b> (and its reverse reaction)?<br></div><div><br></div><div>{{c1::Carbonic anhydrase}}</div>", "time": 1660105351193.0}, {"id": 1475636707510, "note": "<div><b>H<sub>2</sub>CO<sub>3</sub></b> is converted into {{c1::H<sub>2</sub>O}} and {{c1::CO<sub>2</sub>}} by <b><i>carbonic anhydrase</i></b><br></div>", "time": 1660105351211.0}, {"id": 1475636718966, "note": "<div><u>Inside</u> the cells of the PCT, <b>H<sub>2</sub>O</b> and <b>CO<sub>2</sub></b> are converted back into {{c1::H<sub>2</sub>CO<sub>3</sub>}}<br></div>", "time": 1660105351208.0}, {"id": 1475636736138, "note": "<div>The <b>H<sub>2</sub>CO<sub>3</sub></b> formed <u>inside</u> the cells of the PCT <i>dissociates</i> into {{c1::H<sup>+</sup>}} and {{c1::HCO<sub>3</sub><sup>-</sup>}}<br></div>", "time": 1660105351200.0}, {"id": 1475636740566, "note": "<div><b>H<sup>+</sup> </b>in the <u>PCT cells</u>, from H<sub>2</sub>CO<sub>3</sub>, is transported into the {{c1::lumen}} of the PCT<br></div>", "time": 1660105351212.0}, {"id": 1475636748549, "note": "<div><b>HCO<sub>3</sub><sup>-</sup> </b>in the <u>PCT cells</u>, from H<sub>2</sub>CO<sub>3</sub>, is transported into the {{c1::interstitium}} of the PCT<br></div>", "time": 1660105351210.0}, {"id": 1475636756999, "note": "<div><b>{{c2::Acetazolamide}}</b> is a <i>diuretic</i> that <u>inhibits</u> the enzyme <b>{{c1::carbonic anhydrase}}</b><br></div>", "time": 1660105351190.0}, {"id": 1475636781037, "note": "<div><b>Acetazolamide</b> <i>primarily</i> prevents&nbsp;<u>reabsorption</u> of {{c1::HCO<sub>3</sub><sup>-</sup>}}<br></div>", "time": 1660105351213.0}, {"id": 1475636789652, "note": "<div><b>Acetazolamide</b> causes urine {{c1::alkalinization::pH}}<br></div>", "time": 1660105351218.0}, {"id": 1475636800490, "note": "<div>In addition to HCO<sub>3</sub><sup>-</sup>, <b>acetazolamide</b> also&nbsp;<i>prevents</i> the <u>reabsorption</u> of {{c1::Na<sup>+</sup>}} and <b>H<sub>2</sub>O</b><br></div>", "time": 1660105351209.0}, {"id": 1475636808667, "note": "<div><b>Acetazolamide</b> causes {{c1::<u>increased</u>::increased or decreased}}&nbsp;<i>excretion</i> of <b>HCO<sub>3</sub><sup>-</sup></b>&nbsp;<br></div>", "time": 1660105351217.0}, {"id": 1475636814661, "note": "<div>Besides a type II RTA, what <u>acid-base disorder</u> may be <i>caused</i> by <b>acetazolamide</b>?<br></div><div><br></div><div>{{c1::<u>Normal</u> anion gap metabolic acidosis}} </div>", "time": 1660105351195.0}, {"id": 1475636822384, "note": "<b>Acetazolamide</b>&nbsp;causes&nbsp;<u>decreased</u>&nbsp;production of&nbsp;<b>{{c2::aqueous humor}}</b>, which is useful in the management of&nbsp;<b>{{c1::glaucoma}}</b>", "time": 1660105351222.0}, {"id": 1475636846425, "note": "<div><b>Acetazolamide</b> causes <u>decreased</u> production of <b>{{c2::CSF}}</b>, which is useful in the management of <b>{{c1::pseudotumor cerebri}}</b><br></div>", "time": 1660105351220.0}, {"id": 1475636854602, "note": "<div><b>Acetazolamide</b> is useful in the <u>treatment</u> and <u>prevention</u> of acute {{c1::<b>altitude</b>}} <b>sickness</b><br></div>", "time": 1660105351215.0}, {"id": 1475636859252, "note": "<div><b>Urinary alkalinization</b> (e.g. acetazolamide) can <u>increase</u> <i>solubility</i> of <b>{{c1::cystine}} </b>and&nbsp;<b>{{c2::uric acid}}</b><b>&nbsp;</b>kidney stones<br></div>", "time": 1660105351197.0}, {"id": 1475636863433, "note": "<div>What effect may <b>acetazolamide</b> have on serum <b>K<sup>+</sup></b> levels?<br></div><div><br></div><div>{{c1::Decreased (hypokalemia)}}</div>", "time": 1660105351194.0}, {"id": 1475636873747, "note": "<div>What type of <u>renal tubular acidosis</u> may be caused by <b>acetazolamide</b>?<br></div><div><br></div><div>{{c1::Type 2 (Proximal)}} </div>", "time": 1660105351192.0}, {"id": 1475636883017, "note": "<div>Which <u>diuretic</u> can cause <b>type 2 renal tubular acidosis</b> as an adverse effect?<br></div><div><br></div><div>{{c1::Acetazolamide}}</div>", "time": 1660105351191.0}, {"id": 1475636887796, "note": "<div><b>Acetazolamide</b> may <i>promote</i> the <u>formation</u> of <b>calcium</b> {{c1::<b>phosphate</b>}} kidney stones OR {{c2::<b>struvite stones</b>}}<br></div>", "time": 1660105351214.0}, {"id": 1475636894121, "note": "<div><b>Acetazolamide</b> is a(n) {{c1::sulfa}} drug and thus may cause <u>adverse</u> reactions in <i>allergic</i> patients<br></div>", "time": 1660105351216.0}, {"id": 1475636899144, "note": "<div>One <u>adverse effect</u> associated with <b>acetazolamide</b> is {{c1::NH<sub>3</sub>::compound}}&nbsp;toxicity</div>", "time": 1660105358928.0}, {"id": 1475636902047, "note": "<div>What <u>neurological</u> <i>adverse effect</i> may be caused by <b>acetazolamide</b>?<br></div><div><br></div><div>{{c1::Paresthesias}}</div>", "time": 1660105358925.0}, {"id": 1475636904715, "note": "<div>What <u>acid-base disorder</u> may be <i>treated</i> with <b>acetazolamide</b>?<br></div><div><br></div><div>{{c1::Metabolic <i>alkalosis</i>}}</div>", "time": 1660105358927.0}, {"id": 1475636907165, "note": "<div><b>{{c2::Mannitol}}</b> is a(n)&nbsp;<b>{{c1::osmotic}}</b> <b>diuretic</b> that acts at the {{c3::<u>proximal tubule</u>}} and {{c3::<u>descending limb</u> (of Henle)::location}}<br></div>", "time": 1660105351188.0}, {"id": 1475636911457, "note": "<div><b>Mannitol</b> may be used to <u>decrease</u> {{c1::<b>intracranial</b>}} and {{c2::<b>intraocular</b>}} <b>pressure</b>&nbsp;<br></div>", "time": 1660105351206.0}, {"id": 1475636920964, "note": "<div>What effect does&nbsp;<b>mannitol</b>&nbsp;have on&nbsp;<u>urine flow</u>?<br></div><div><br></div><div>{{c1::Increased urine flow (diuretic)}}</div>", "time": 1660105358926.0}, {"id": 1475636929548, "note": "<div><b>Mannitol </b>may be used clinically for <b>drug {{c1::overdose}}</b></div>", "time": 1660105358929.0}, {"id": 1475636932784, "note": "<div><b>Mannitol</b> may be used to treat {{c1::<u>elevated</u>}} <b>intracranial</b> and/or <b>intraocular pressure</b><br></div>", "time": 1660105351204.0}, {"id": 1475636941924, "note": "<div><u>Mannitol-induced</u> <i>expanded</i> <b>ECF</b> <b>volume</b> can cause <b>pulmonary</b> {{c1::edema}}<br></div>", "time": 1660105351203.0}, {"id": 1475636949706, "note": "<div><u>Mannitol-induced</u> <i>expanded</i> <b>ECF</b> <b>volume</b> can exacerbate <b>heart</b> {{c1::failure}}<br></div>", "time": 1660105351202.0}, {"id": 1475636960046, "note": "<div>Is <b>mannitol</b> associated with <u>hypernatremia</u> or <u>hyponatremia</u> as a possible adverse effect?<br></div><div><br></div><div>{{c1::Both :)}}</div>", "time": 1660105351207.0}, {"id": 1475636975592, "note": "<div><b>Mannitol</b> is <u>contraindicated</u> in patients with <b>{{c2::anuria}}</b> and/or <b>heart failure</b></div>", "time": 1660105358930.0}, {"id": 1475636978710, "note": "<div>Which <u>osmotic diuretic</u> may cause <b>dehydration</b> as a possible adverse effect?<br></div><div><br></div><div>{{c1::Mannitol}}</div>", "time": 1660105358924.0}, {"id": 1475700465425, "note": "The {{c1::fractional excretion of sodium (FE<sub>Na</sub>)}} is the ratio of the <b>Na<sup>+</sup> excreted/</b> <b>Na<sup>+</sup> filtered</b>", "time": 1660105349218.0}, {"id": 1475703918707, "note": "<div>What equation may be used to calculate the <u>fractional excretion of sodium</u> given the patients <b>GFR</b>? </div><div><br></div><div>FE<sub>Na</sub> = {{c1::(V * U<sub>Na</sub>) / (GFR * P<sub>Na</sub>)}}</div>", "time": null}, {"id": 1475703929983, "note": "<div>What equation may be used to calculate the <u>fractional excretion of sodium</u> using <b>creatinine</b> as an <i>estimate</i> of GFR? </div><div><br></div><div> FE<sub>Na</sub> = {{c1::(P<sub>Cr</sub> * U<sub>Na</sub>) / (U<sub>Cr</sub> * P<sub>Na</sub>)}}</div>", "time": null}, {"id": 1475703937935, "note": "<div>Where in the <u>nephron</u> is <i>reabsorption</i> <b>isotonic</b>? </div><div><br></div><div>{{c1::PCT}}</div>", "time": null}, {"id": 1475703958925, "note": "<div><b>{{c1::Fanconi}} syndrome</b> is a <u>renal tubular defect</u> characterized by a generalized <i>reabsorptive</i> defect in the <b>{{c2::PCT::location}}</b>&nbsp;of the nephron</div>", "time": null}, {"id": 1475703963364, "note": "<div>Which <u>renal tubular defect</u> is associated with <b>increased excretion</b> of nearly all amino acids, glucose, HCO<sub>3</sub><sup>-</sup>, and PO<sub>4</sub><sup>3- </sup> and all substances reabsorbed by the PCT</div><div><br></div><div>{{c1::Fanconi syndrome}}</div>", "time": null}, {"id": 1475703966647, "note": "<div>What <u>acid-base disorder</u> may be seen with <b>Fanconi syndrome</b>? </div><div><br /></div><div>{{c1::Metabolic acidosis}}</div>", "time": null}, {"id": 1475703973341, "note": "<div>Which type of <u>renal tubular acidosis</u> may be caused by <b>Fanconi syndrome</b>? </div><div><br></div><div>{{c1::Type 2 (proximal renal tubular acidosis)}}</div>", "time": null}, {"id": 1475703980557, "note": "<div>Which <u>renal tubular defect</u> may be caused by <b>metabolism</b> <b>disorders</b> (e.g. glycogen storage disease, tyrosinemia, cystinosis)? </div><div><br></div><div>{{c1::Fanconi syndrome}}</div>", "time": 1660105342218.0}, {"id": 1475703984646, "note": "<div>What <u>renal tubular defect</u> may be caused by <b>ischemia</b>, <b>multiple myeloma</b>, or <b>lead poisoning</b>? </div><div><br></div><div>{{c1::Fanconi syndrome}}</div>", "time": null}, {"id": 1475703988155, "note": "<div>What <u>renal tubular defect</u> may be caused by <b>nephrotoxins/drugs</b> (e.g. ifosfamide, cisplatin, tenofovir, expired tetracyclines)?</div><div><br></div><div>{{c1::Fanconi syndrome}}</div>", "time": null}, {"id": 1475703998743, "note": "<div><b>{{c1::Bartter}} syndrome</b> is a <u>renal tubular defect</u> that affects the <b>{{c2::Na<sup>+</sup>/K<sup>+</sup>/2Cl<sup>-</sup>}} cotransporter</b></div>", "time": null}, {"id": 1475704002070, "note": "<div>Which <u>renal tubular defect</u> presents similarly to <b>chronic loop diuretic use</b>? </div><div><br /></div><div>{{c1::Bartter syndrome}} </div>", "time": null}, {"id": 1475704008931, "note": "<div>How do serum <b>K<sup>+</sup> </b>levels change in <b>Bartter syndrome</b>? </div><div><br></div><div>{{c1::Decreased (hypokalemia)}}</div>", "time": null}, {"id": 1475704018591, "note": "<div>What <u>acid-base disorder</u> may be seen with <b>Bartter syndrome</b>? </div><div><br></div><div>{{c1::Metabolic alkalosis}}</div>", "time": null}, {"id": 1475704021775, "note": "<div>How does <u><i>urinary</i> <i>excretion</i></u> of <b>Ca<sup>2+</sup> </b>change in <b>Bartter syndrome</b>?</div><div><br /></div><div>{{c1::Increased (hypercalciuria)}}</div>", "time": null}, {"id": 1475704028171, "note": "<div>How do levels of <u>plasma renin</u> and <u>aldosterone</u> change in <b>Bartter syndrome</b>? </div><div><br /></div><div>{{c1::Increased (due to decreased Na<sup>+</sup> reabsorption)}}</div>", "time": null}, {"id": 1475704041042, "note": "<div><div><b>{{c1::Gitelman}} syndrome</b> is a <u>renal tubular defect</u> that affects the <b>{{c2::Na<sup>+</sup>-Cl<sup>-</sup>}} cotransporter</b></div></div>", "time": null}, {"id": 1475704044425, "note": "<div><div>Which <u>renal tubular defect</u> presents similarly to <b>lifelong thiazide diuretic use</b>? </div><div><br /></div><div>{{c1::Gitelman syndrome}} </div></div>", "time": null}, {"id": 1475704063331, "note": "<div><div>How do serum <b>K<sup>+</sup> </b>levels change in <b>Gitelman syndrome</b>? </div><div><br></div><div>{{c1::Decreased (hypokalemia)}}</div></div>", "time": null}, {"id": 1475704073991, "note": "<div><div>What <u>acid-base disorder</u> may be seen with <b>Gitelman syndrome</b>? </div><div><br /></div><div>{{c1::Metabolic alkalosis}} </div></div>", "time": null}, {"id": 1475704077390, "note": "<div><div>How does <u><i>urinary</i> <i>excretion</i></u> of <b>Ca<sup>2+</sup> </b>change in <b>Gitelman syndrome</b>?</div><div><br /></div><div>{{c1::Decreased (hypocalciuria)}}</div></div>", "time": null}, {"id": 1475704083741, "note": "<div><div>How do levels of <u>plasma renin</u> and <u>aldosterone</u> change in <b>Gitelman syndrome</b>? </div><div><br /></div><div>{{c1::Increased (due to decreased Na<sup>+</sup> reabsorption)}}</div></div>", "time": null}, {"id": 1475704101275, "note": "<div><b>{{c1::Liddle}} syndrome</b> is a <u>renal tubular defect</u> that <b>increases activity</b> of the <b>{{c2::epithelial Na<sup>+</sup>}} channel</b></div>", "time": null}, {"id": 1475704104542, "note": "<div><div>How do serum <b>Na<sup>+</sup> </b>levels change in <b>Liddle syndrome</b>? </div><div><br /></div><div>{{c1::Increased (hypernatremia)}}</div></div>", "time": null}, {"id": 1475704128000, "note": "<div><div>How do serum <b>K<sup>+</sup> </b>levels change in <b>Liddle syndrome</b>? </div><div><br></div><div>{{c1::Decreased (hypokalemia)}}</div></div>", "time": null}, {"id": 1475704130805, "note": "<div><div><div>How does <b>blood pressure</b> change in <b>Liddle syndrome</b>? </div><div><br></div><div>{{c1::Increased (hypertension)}}</div></div></div>", "time": 1660105358111.0}, {"id": 1475704133477, "note": "<div><div>What <u>acid-base disorder</u> may be seen with <b>Liddle syndrome</b>? </div><div><br></div><div>{{c1::Metabolic alkalosis}}</div></div>", "time": null}, {"id": 1475704136294, "note": "<div><div><div>How do serum <b>aldosterone </b>levels change in <b>Liddle syndrome</b>? </div><div><br /></div><div>{{c1::Decreased}}</div></div></div>", "time": null}, {"id": 1475704143410, "note": "<div><div>How do levels of <u>plasma renin</u> change in <b>Liddle syndrome</b>? </div><div><br></div><div>{{c1::Decreased}}</div></div>", "time": null}, {"id": 1475704153938, "note": "<div>What is the <u>treatment</u> for <b>Liddle syndrome</b>? </div><div><br></div><div>{{c1::Amiloride}}</div>", "time": null}, {"id": 1475704157554, "note": "<div><b>{{c1::Syndrome of apparent mineralocorticoid excess}}</b> is a <u>renal tubular defect</u> characterized by a(n) {{c3::autosomal recessive}} inherited deficiency of the enzyme <b><i>{{c2::11\u03b2-hydroxysteroid dehydrogenase}}</i> </b> </div>", "time": null}, {"id": 1475704160922, "note": "<div>In cells containing <u>mineralocorticoid receptors</u>, <b>{{c1::cortisol}}</b> may be converted to <b>{{c2::cortisone}}</b> by the enzyme <i style=\"font-weight: bold; \">{{c3::11\u03b2-hydroxysteroid dehydrogenase}}</i> </div>", "time": null}, {"id": 1475704171437, "note": "<div>Can <b>cortisol</b> <u>activate</u> mineralocorticoid receptors?</div><div><br></div><div>{{c1::Yes}}</div>", "time": null}, {"id": 1475704175095, "note": "<div><div>Can <b>cortisone</b> <u>activate</u> mineralocorticoid receptors?</div><div><br></div><div>{{c1::No}}</div></div>", "time": null}, {"id": 1475704178937, "note": "<div>In<b> syndrome of apparent mineralocorticoid excess</b>, excess {{c1::cortisol}} causes <u>increased</u> mineralocorticoid receptor activity</div>", "time": 1660105356844.0}, {"id": 1475704189323, "note": "<div><div>How do serum <b>K<sup>+</sup> </b>levels change in <b></b><b>syndrome of apparent mineralocorticoid excess</b>? </div><div><br></div><div>{{c1::Decreased (hypokalemia)}}</div></div>", "time": 1660105358128.0}, {"id": 1475704197940, "note": "<div><div><div>How does <b>blood pressure</b> change in <b></b><b>syndrome of apparent mineralocorticoid excess</b>? </div><div><br></div><div>{{c1::Increased (hypertension)}}</div></div></div>", "time": 1660105358110.0}, {"id": 1475704204931, "note": "<div><div>What <u>acid-base disorder</u> may be seen with <b>syndrome of apparent mineralocorticoid excess</b>? </div><div><br></div><div>{{c1::Metabolic alkalosis}}</div></div>", "time": 1660105348008.0}, {"id": 1475704208186, "note": "<div><div><div><div>How do serum <b>aldosterone </b>levels change in <b>syndrome of apparent mineralocorticoid excess</b>? </div><div><br /></div><div>{{c1::Decreased}}</div></div></div></div>", "time": 1660105358129.0}, {"id": 1475704215805, "note": "<div><b>{{c1::Glycyrrhetinic acid}}</b> is a substance present in {{c2::<u>licorice</u>}} that may <i>block</i> activity of the enzyme <i style=\"font-weight: bold; \">{{c3::11\u03b2-hydroxysteroid dehydrogenase}}</i> </div>", "time": null}, {"id": 1475704230009, "note": "<div>Which <u>renal tubular defect</u> may be caused by <b>ingestion of licorice</b>? </div><div><br></div><div>{{c1::Syndrome of apparent mineralocorticoid excess}}</div>", "time": 1660105342219.0}, {"id": 1475704272711, "note": "<div>Which <u>cell type</u> in the nephron <i>secretes </i><b>renin</b>?</div><div><br></div><div>{{c1::Juxtaglomerular cells}}</div>", "time": null}, {"id": 1475704275956, "note": "<div><b>{{c2::Juxtaglomerular (JG)}} cells</b> are <i><b>modified</b></i> {{c1::<b>smooth</b> <b>muscle</b>}} cells of the <u>afferent</u> arteriole </div>", "time": null}, {"id": 1475704278837, "note": "<div>Which cells of the <u>kidney</u> detect <i>changes</i> in <b>blood pressure</b>?</div><div><br /></div><div>{{c1::Juxtaglomerular cells}}</div>", "time": null}, {"id": 1475704282043, "note": "<div>Which cells of the <u>kidney</u> detect <i>changes</i> in <b>Na<sup>+</sup> delivery</b>?</div><div><br></div><div>{{c1::Macula densa cells}}</div>", "time": null}, {"id": 1475704284898, "note": "<div>In response to {{c1::<u>decreased</u>}} <b>blood pressure</b>, the <i>JG cells</i> of the kidney cause <u>increased</u> <b>renin</b> <b>release</b></div>", "time": null}, {"id": 1475704353903, "note": "<!--anki--><!--anki--><div>In response to {{c1::<u>decreased</u>}} <b>Na<sup>+</sup> delivery</b>, the <i>macula densa cells</i> of the kidney cause <u>increased</u> <b>renin</b> <b>release</b></div>", "time": null}, {"id": 1475704392767, "note": "<div>In response to {{c1::<u>increased</u>}} <b>sympathetic tone</b>, there is <u>increased</u> <b>renin release</b></div>", "time": null}, {"id": 1475704403088, "note": "<div><u>Increased</u> <b>sympathetic tone</b> <i>increases</i> <b>renin</b> release via stimulation of the {{c1::\u03b2<sub>1</sub>}} adrenergic receptors of the JGA</div>", "time": null}, {"id": 1475704406483, "note": "<div><b>\u03b2-blockers</b> may <u>decrease BP</u> by <i>inhibiting</i> \u03b2<sub>1</sub> receptors of the JGA, thus decreasing {{c1::renin}} release</div>", "time": null}, {"id": 1475704409635, "note": "<div><b>Angiotensin II</b> causes <u>vaso-</u>{{c1::<u>constriction</u>}} of vascular smooth muscle</div>", "time": null}, {"id": 1475704416680, "note": "<div><b>Angiotensin II</b> acts on the <i>posterior pituitary</i> to <u>increase</u> release of {{c1::ADH}}</div>", "time": null}, {"id": 1475704420146, "note": "<div><b>Angiotensin II</b>&nbsp;affects <u>baroreceptor function</u>, limiting <i>reflex</i> {{c1::bradycardia}} that would normally accompany its pressor effects</div>", "time": null}, {"id": 1475704424077, "note": "<div>Which hormones are released in response to <u>increased</u> <b>volume</b>, and thus act as a \"check\" on the <b>renin-angiotensin-aldosterone system</b>? </div><div><br></div><div>{{c1::ANP, BNP::2}}</div>", "time": null}, {"id": 1475704431337, "note": "<div>{{c1::ADH::aldosterone or ADH}}&nbsp;<i>primarily</i> regulates <b>osmolarity</b>; may also respond to low volume states</div>", "time": 1660105341284.0}, {"id": 1475704434755, "note": "<div>{{c1::Aldosterone::aldosterone or ADH}} <i>primarily</i> regulates <b>ECF volume</b> and <b>Na<sup>+</sup> content</b></div>", "time": 1660105341256.0}, {"id": 1475704437176, "note": "<div>The <b>juxtaglomerular apparatus</b> consists of {{c1::JG}} cells, {{c2::macula densa}}, extraglomerular {{c3::mesangial}} cells</div>", "time": null}, {"id": 1475704439941, "note": "<div>In response to <u>increased</u> <b>Na<sup>+</sup> delivery </b>(e.g. increased GFR/RPF), the<b> macula densa</b> releases {{c1::<b>ATP (adenosine)</b>}}, which <i>constricts</i> the {{c2::<u>afferent</u>}} arterioles</div>", "time": 1660105356914.0}, {"id": 1475704448153, "note": "<div>In response to <u>decreased</u> <b>Na<sup>+</sup> delivery</b>, the <b>macula densa</b> releases {{c1::<b>PGE<sub>2</sub></b>}}, which <i>relaxes</i> the {{c2::<u>afferent</u>}} arterioles </div>", "time": null}, {"id": 1475704456046, "note": "<div>In response to <u>decreased</u> <b>Na<sup>+</sup> delivery</b>, the <b>macula densa</b> causes <u>increased</u> <b>renin</b> release, which ultimately <i>constricts</i> the {{c1::<u>efferent</u>}} arterioles </div>", "time": null}, {"id": 1475704465797, "note": "<div>In response to <u>increased</u> <b>Na<sup>+</sup> delivery</b>, the <b>macula densa</b> causes <u>decreased</u> <b>renin</b> release, which ultimately <i>relaxes</i> the {{c1::<u>efferent</u>}} arterioles  </div>", "time": null}, {"id": 1475704474957, "note": "<div><b>Erythropoietin</b> is often <i>supplemented</i> in chronic {{c1::kidney::organ}} disease</div>", "time": 1660105359440.0}, {"id": 1475704481414, "note": "<div><b>25-OH vitamin D<sub>3</sub></b> is converted to <b>1,25 (OH)<sub>2</sub> vitamin D<sub>3</sub></b> in cells of the {{c1::PCT}} of the nephron</div>", "time": null}, {"id": 1475704502915, "note": "<div><b>Parathyroid hormone</b> is <i>secreted</i> in response to <u>increased</u> plasma {{c1::PO<sub>4</sub><sup>3-</sup>}}</div>", "time": null}, {"id": 1475704505649, "note": "<div><b>Prostaglandins</b> act via a(n) {{c1::paracrine}} mechanism to <b>vaso-{{c2::dilate}}</b> the <u>afferent</u> arterioles</div>", "time": null}, {"id": 1475704511587, "note": "<div><b>{{c1::Dopamine}}</b> is a <u>neurotransmitter</u> that may be secreted by cells of the <b>{{c2::PCT}}</b> of the nephron</div>", "time": null}, {"id": 1475704516937, "note": "<div>What effect do <u>low</u> doses of <b>dopamine</b> have on renal <b>afferent</b> and <b>efferent</b> <b>arterioles</b>?</div><div><br></div><div>{{c1::Dilation::dilation or constriction}}</div>", "time": null}, {"id": 1475704524115, "note": "<div>What effect do <u>low</u> doses of <b>dopamine</b> have on <b>RBF</b>? </div><div><br /></div><div>{{c1::Increased}}</div>", "time": null}, {"id": 1475704531155, "note": "<div>What effect do <u>low</u> doses of <b>dopamine</b> have on <b>GFR</b>? </div><div><br /></div><div>{{c1::Little or no change}}</div>", "time": null}, {"id": 1475704537873, "note": "<div>At <u>higher</u> doses, <b>dopamine</b> acts as a <b>vaso-{{c1::constrictor}}</b> of renal arterioles</div>", "time": null}, {"id": 1475704550752, "note": "<div>Which <u>electrolyte disturbance</u> causes nausea, malaise, stupor, coma, and <b>seizures</b>? </div><div><br /></div><div>{{c1::Low Na<sup>+</sup> (hyponatremia)}}</div>", "time": 1660105343181.0}, {"id": 1475704555994, "note": "<div><div>Which <u>electrolyte disturbance</u> causes <b>irritability</b>, stupor, coma? </div><div><br /></div><div>{{c1::High Na<sup>+</sup> (hypernatremia)}}</div></div>", "time": 1660105343182.0}, {"id": 1475704559983, "note": "<div><div>Which <u>electrolyte disturbance</u> causes <b>U waves</b> and <b>flattened T waves</b> on ECG? </div><div><br /></div><div>{{c1::Low K<sup>+</sup> (hypokalemia)}}</div></div>", "time": null}, {"id": 1475704571141, "note": "<div>Which <u>electrolyte disturbances</u> cause <b>arrhythmias</b>, muscle cramps, spasm, and weakness? </div><div><br></div><div>{{c1::Low and high K<sup>+</sup>::2}}</div>", "time": null}, {"id": 1475704576856, "note": "<div><div>Which <u>electrolyte disturbance</u> causes <b>wide QRS</b> and <b>peaked T waves</b> on ECG? </div><div><br /></div><div>{{c1::High K<sup>+</sup> (hyperkalemia)}}</div></div>", "time": null}, {"id": 1475704581729, "note": "<div><div>Which <u>electrolyte disturbance</u> causes <b>tetany</b>, seizures, QT prolongation, <b>twitching</b>, and <b>spasm</b>? </div><div><br></div><div>{{c1::Low Ca<sup>2+</sup> (hypocalcemia)}}</div></div>", "time": null}, {"id": 1475704590710, "note": "<div>Which <u>electrolyte disturbance</u> causes <b>stones</b>, <b>bones</b>, <b>groans</b>, and <b>psychiatric overtones</b>?</div><div><br></div><div>{{c1::High Ca<sup>2+</sup> (hypercalcemia)}}</div>", "time": null}, {"id": 1475704598208, "note": "<div><div>Which <u>electrolyte disturbance</u> causes tetany, <b>torsades de pointes</b>, and hypokalemia? </div><div><br></div><div>{{c1::Low Mg<sup>2+</sup> (hypomagnesemia)}}</div></div>", "time": 1660105343179.0}, {"id": 1475704604597, "note": "<div><div>Which <u>electrolyte disturbance</u> causes <b>decreased DTRs</b>, <b>cardiac arrest</b>, bradycardia, hypotension, and hypocalcemia? </div><div><br></div><div>{{c1::High Mg<sup>2+</sup> (hypermagnesemia)}}</div></div>", "time": 1660105343183.0}, {"id": 1475704608986, "note": "<div><div>Which <u>electrolyte disturbance</u> causes <b>bone loss</b>, osteomalacia (adults), and rickets (children)? </div><div><br /></div><div>{{c1::Low PO<sub>4</sub><sup>3-</sup>}}</div></div>", "time": 1660105343184.0}, {"id": 1475704613413, "note": "<div><div>Which <u>electrolyte disturbance</u> causes <b>renal stones</b>, metastatic calcifications, and <b>hypocalcemia</b>? </div><div><b><br /></b></div><div>{{c1::High PO<sub>4</sub><sup>3-</sup>}}</div></div>", "time": 1660105343180.0}, {"id": 1475704618623, "note": "<div>The causes of {{c9::<u>high</u>}}<u> anion gap</u> <b>metabolic acidosis</b> may be remembered with the mnemonic <b>MUDPILES</b>: </div><div style=\"centerbox\"><div class=\"mnemonics\"><div><br></div><div><b>M</b>: {{c1::methanol (formic acid)}}</div><div><b>U</b>: {{c2::uremia}}</div><div><b>D</b>: {{c3::diabetic ketoacidosis}}</div><div><b>P</b>: {{c4::propylene glycol}}</div><div><b>I</b>: {{c5::iron tablets}} or {{c5::isoniazid}}</div><div><b>L</b>: {{c6::lactic acidosis}}</div><div><b>E</b>: {{c7::ethylene glycol (-&gt; oxalic acid)}}</div><div><b>S</b>: {{c8::salicylates (late)}}</div></div></div>", "time": 1660105350353.0}, {"id": 1475704621284, "note": "<div>The causes of {{c8::<u>normal</u>}}<u> anion gap</u> <b>metabolic acidosis</b> may be remembered with the mnemonic <b>HARDASS</b>: </div><div style=\"centerbox\"><div class=\"mnemonics\"><div><br></div><div><b>H</b>: {{c1::hyperalimentation (artificial supply of nutrition)}}</div><div><b>A</b>: {{c2::Addison disease}}</div><div><b>R</b>: {{c3::renal tubular acidosis}}</div><div><b>D</b>: {{c4::diarrhea}}</div><div><b>A</b>: {{c5::acetazolamide}}</div><div><b>S</b>: {{c6::spironolactone}} </div><div><b>S</b>: {{c7::saline infusion}}</div></div></div>", "time": 1660105350361.0}, {"id": 1475704667950, "note": "<div>What <u>acid-base disorder</u> may be caused by <b>vomiting</b>? </div><div><br></div><div>{{c1::Metabolic alkalosis}}</div>", "time": null}, {"id": 1475704670335, "note": "<div><b>{{c1::Renal tubular acidosis}}</b> is a <i>group of disorders</i> of the <b>renal</b> <b>tubules</b> that lead to <u>normal anion gap</u> (hyperchloremic) <b>metabolic acidosis</b></div>", "time": null}, {"id": 1475704672372, "note": "<div><b>{{c2::Distal}} renal tubular acidosis</b> is also known as <u>type </u>{{c1::<u>1</u>}} RTA</div>", "time": null}, {"id": 1475704749667, "note": "<div><b>{{c2::Distal}} renal tubular acidosis</b> is characterized by a <u>urine pH</u> {{c1::&gt;}} 5.5</div>", "time": null}, {"id": 1475704753633, "note": "<div><b>{{c2::Distal}} renal tubular acidosis</b> is due to a defect in the ability of <u>\u03b1-intercalated cells</u> to <i>secrete</i> <b>{{c1::H<sup>+</sup>}}</b></div>", "time": null}, {"id": 1475704756049, "note": "<div><i>Inability</i> to <b>secrete H<sup>+</sup></b> by the <u>\u03b1-intercalated cells</u> (distal RTA) results in <u>no</u> new {{c1::HCO<sub>3</sub><sup>-</sup>}} generation </div>", "time": null}, {"id": 1475704764670, "note": "<div><b>Distal renal tubular acidosis</b> is associated with <b>{{c1::hypo}}-kalemia</b></div>", "time": null}, {"id": 1475704766893, "note": "<div><b>{{c1::Distal}} renal tubular acidosis</b> is associated with <i>increased</i> risk for <u>calcium </u>{{c2::<u>phosphate</u>}} kidney stones</div>", "time": null}, {"id": 1475704774908, "note": "<div>Which <u>renal tubular acidosis</u> may be caused by&nbsp;<b>amphotericin&nbsp;B toxicity</b>?</div><div><br></div><div>{{c1::Distal RTA (type 1)}}</div>", "time": null}, {"id": 1475704777400, "note": "<div><div>Which <u>renal tubular acidosis</u> may be caused by&nbsp;<b>analgesic&nbsp;nephropathy</b>?</div><div><br></div><div>{{c1::Distal RTA (type 1)}}</div></div>", "time": null}, {"id": 1475704779656, "note": "<div><div>Which <u>renal tubular acidosis</u> is highly associated with autoimmune diseases?</div><div><br></div><div>{{c1::Distal RTA (type 1)}}</div></div>", "time": null}, {"id": 1475704782078, "note": "<div><div><b>{{c2::Proximal}} renal tubular acidosis</b> is also known as <u>type </u>{{c1::<u>2</u>}} RTA</div></div>", "time": null}, {"id": 1475704784428, "note": "<div><div><b>Proximal renal tubular acidosis</b> is characterized by a <u>urine pH</u> {{c1::&lt;}} 5.5</div></div>", "time": null}, {"id": 1475704791214, "note": "<div><div><b>{{c2::Proximal}} renal tubular acidosis</b> is due to a defect in the ability of <u>PCT cells</u> to <i>reabsorb</i> <b>{{c1::HCO<sub>3</sub><sup>-</sup>}}</b> </div></div>", "time": null}, {"id": 1475704797793, "note": "<div><div>Which <u>renal tubular acidosis</u> is associated with <i>increased</i> urinary excretion of <b>HCO</b><sub style=\"font-weight: bold; \">3</sub><sup style=\"font-weight: bold; \">-</sup>? </div><div><b><br></b></div><div>{{c1::Proximal RTA (type 2)}}</div></div>", "time": null}, {"id": 1475704801446, "note": "<div><b>Proximal renal tubular acidosis</b> is associated with <b>{{c1::hypo}}-kalemia</b> </div>", "time": null}, {"id": 1475704808555, "note": "<div>There is an <i>increased risk</i> for {{c2::<u>hypophosphatemic</u>}}<u> rickets</u> with {{c1::<b>proximal</b>}} <b>renal tubular acidosis</b> due to <i>Fanconi Syndrome</i></div>", "time": 1660105348819.0}, {"id": 1475704810517, "note": "<div><u>{{c1::Fanconi}} Syndrome</u> and <u>Multiple {{c2::Myeloma}}</u> can both cause <b>proximal (type 2) renal tubular acidosis</b></div>", "time": null}, {"id": 1475704812592, "note": "<div><b>{{c2::Proximal}} renal tubular acidosis</b> may be caused by {{c1::<u>carbonic anhydrase</u>}} inhibitors<i>, </i>{{c3::aminoglycosides::antimicrobial}}, and {{c4::lead::metal}}</div>", "time": null}, {"id": 1475704814610, "note": "<div><div><b>{{c2::Hyperkalemic}} renal tubular acidosis</b> is also known as <u>type </u>{{c1::<u>4</u>}} RTA</div></div>", "time": null}, {"id": 1475704820088, "note": "<div><div><b>Hyperkalemic renal tubular acidosis</b> <u>may</u> be characterized by a <u>urine pH</u> {{c1::&lt;}} 5.5</div></div>", "time": null}, {"id": 1475704823914, "note": "<div>In <u>hyperkalemic</u> RTA, {{c1::hypoaldosteronism}} causes <b>hyperkalemia</b></div>", "time": null}, {"id": 1475704826799, "note": "<div>In <u>hyperkalemic</u> RTA, <b>hyperkalemia</b> causes {{c1::<u>decreased</u>}} <b>NH<sub>3</sub> synthesis</b> in the PCT</div>", "time": null}, {"id": 1475704828727, "note": "<div>In <u>hyperkalemic</u> RTA, <i>decreased</i> <b>NH<sub>3&nbsp;</sub></b><b>synthesis</b> in the PCT causes <u>decreased</u> {{c1::NH<sub>4</sub><sup>+</sup>}} excretion</div>", "time": null}, {"id": 1475704834291, "note": "<div>Which <u>renal tubular acidosis</u> may be caused by <i>decreased</i> <b>aldosterone production</b>? </div><div><br></div><div>{{c1::Hyperkalemic (type 4) RTA}}</div>", "time": null}, {"id": 1475704844392, "note": "<div><div>Which <u>renal tubular acidosis</u> may be caused by <b>aldosterone <i>resistance</i></b>? </div><div><br></div><div>{{c1::Hyperkalemic (type 4) RTA}}</div></div>", "time": null}, {"id": 1475713336232, "note": "<div>What <u>pathologies</u> are characterized by <b>hematuria</b> with <b><u>no</u> casts</b>? </div><div><br></div><div>{{c1::Bladder cancer, Kidney stones::2}}</div>", "time": null}, {"id": 1475713346285, "note": "<div><b>{{c2::Fatty}} casts</b> (\"oval fat bodies\") are often associated with the \"<b>{{c1::Maltese cross}}</b>\" sign</div>", "time": null}, {"id": 1475713351153, "note": "<div>What type of <u>cast</u> may be seen in <b>end-stage renal disease</b> and <b>chronic renal failure</b>? </div><div><br></div><div>{{c1::Waxy casts}}</div>", "time": 1660105344851.0}, {"id": 1475713357154, "note": "<div>A \"{{c1::focal}}\" glomerular disorder involves <b>&lt; 50%</b> of glomeruli</div>", "time": 1660105362596.0}, {"id": 1475713382619, "note": "<div><div>Is <b>diffuse proliferative glomerulonephritis (DPGN) </b>a <u>nephritic</u> or <u>nephrotic</u> syndrome?</div><div><br></div><div>{{c1::Can be either or both}}</div></div>", "time": null}, {"id": 1475713386294, "note": "<div>Which <u>two</u> pathologies may present as <b>nephritic </b>and/or <b>nephrotic syndrome</b>? </div><div><br /></div><div>{{c1::DPGN, MPGN}}</div>", "time": null}, {"id": 1475713396454, "note": "<div><b>Hydronephrosis</b> is usually caused by <u>urinary tract </u>{{c1::<u>obstruction</u>}}</div>", "time": null}, {"id": 1475713408598, "note": "<div>Is serum <b>creatinine</b> <i>usually </i>elevated in&nbsp;<u>unilateral</u> <b>hydronephrosis</b>?</div><div><br></div><div>{{c1::No}}</div>", "time": null}, {"id": 1475713435737, "note": "<div><b>{{c1::Diffuse cortical necrosis}}</b> is an <u>acute</u> generalized <b>cortical</b> <b>infarction&nbsp;</b>of both kidneys</div>", "time": null}, {"id": 1475713438166, "note": "<div><b>Diffuse cortical necrosis</b> is likely due to a <u>combination</u> of {{c1::vasospasm}} and {{c1::DIC}}</div>", "time": 1660105360040.0}, {"id": 1475713440191, "note": "<div><b>{{c2::Diffuse cortical}} necrosis</b> is a renal pathology associated with {{c1::<u>obstetric</u>}}<u> catastrophes</u> and <u>septic shock</u> </div>", "time": 1660105338078.0}, {"id": 1475713487440, "note": "<div><b>{{c3::Urgency}} incontinence</b> may be treated with {{c1::<u>M3</u>}} antagonists or {{c2::\u03b23}} agonists</div>", "time": null}, {"id": 1475721654515, "note": "<b>{{c1::Buerger}} disease</b> may also be referred to as <b>thromboangiitis obliterans</b>", "time": null}, {"id": 1475721772882, "note": "<div><b>{{c1::Kawasaki}} disease</b> may also be referred to as <b>mucocutaneous lymph node syndrome</b></div>", "time": null}, {"id": 1475721775046, "note": "<div><b>Granulomatosis with polyangiitis</b> used to be referred to as <b>{{c1::Wegeners granulomatosis}}</b> </div>", "time": null}, {"id": 1475721778747, "note": "<b>Eosinophilic granulomatosis with polyangiitis </b>may present with paranasal <u>sinus</u> abnormalities and skin nodules / palpable {{c1::purpura}}", "time": null}, {"id": 1475723610576, "note": "<b>{{c1::Secondary}} hyperaldosteronism</b> is seen in patients with <b>renovascular</b> <b>hypertension</b> due to <u>independent</u> activation of the RAAS ", "time": 1660105338995.0}, {"id": 1475777525494, "note": "One <u>clinical feature</u> of <b>Addison disease</b> is {{c1::metabolic acidosis::H<sup>+</sup>&nbsp;levels}}", "time": null}, {"id": 1475777624874, "note": "One clinical feature of&nbsp;<b>Addison disease</b>&nbsp;is {{c1::hypotension::BP}}, due to lack of cortisol", "time": 1660105354644.0}, {"id": 1475783631493, "note": "<div><b>{{c1::Loop}} diuretics</b> exert their effects on the<b> {{c2::thick ascending limb of Henle</b>::<b>location}}</b>&nbsp;of the nephron</div>", "time": 1660105351263.0}, {"id": 1475784185212, "note": "<div>The <b>Na<sup>+</sup>-K<sup>+</sup> ATPase</b> is located on the {{c1::<u>basolateral</u>}}<u> membrane</u> of the thick ascending limb (loop of Henle)<br></div>", "time": 1660105351300.0}, {"id": 1475784195387, "note": "<div>The <b>{{c1::Na<sup>+</sup>-K<sup>+</sup>-2Cl<sup>-</sup>}} cotransporter</b> is present on the <u>luminal membrane</u> of the <b>thick ascending limb</b> (of Henle)<br></div>", "time": 1660105351297.0}, {"id": 1475784202796, "note": "<div>The <b>thick ascending limb (of Henle)</b> is {{c1::<u>impermeable</u>}} to water (permeability)<br></div>", "time": 1660105351299.0}, {"id": 1475784210709, "note": "<div>What <i>drug class</i> do <b>furosemide</b>, <b>bumetanide</b>, and&nbsp;<b>torsemide</b> belong to?<br></div><div><br></div><div>{{c1::Loop diuretics}}</div>", "time": 1660105351284.0}, {"id": 1475784215796, "note": "<div><b>{{c2::Loop}} diuretics</b> block the <b>{{c1::Na<sup>+</sup>-K<sup>+</sup>-2Cl<sup>-</sup>}} cotransporter</b> on the <u>luminal membrane</u> of the thick ascending limb<br></div>", "time": 1660105351248.0}, {"id": 1475784338773, "note": "<div>What <i>class</i> of <u>diuretics</u> are the <b>most effective</b>?<br></div><div><br></div><div>{{c1::Loop diuretics}}</div>", "time": 1660105351274.0}, {"id": 1475784344811, "note": "<div>What <i>drug class</i> does <b>ethacrynic</b> <b>acid</b> belong to?<br></div><div><br></div><div>{{c1::Loop diuretics}}</div>", "time": 1660105351283.0}, {"id": 1475784350728, "note": "<div><b>{{c3::Loop}} diuretics</b> <u>decrease</u> the <i>lumen positive potential,</i> thus promoting the {{c2::<u>excretion</u>}} of <b>{{c1::Ca<sup>2+</sup>}}</b> and <b>{{c1::Mg<sup>2+</sup>}}</b><br></div>", "time": 1660105351228.0}, {"id": 1475784355251, "note": "<div><b>Loop diuretics</b> may cause <b>{{c1::hypo}}-magnesemia</b> as an adverse effect<br></div>", "time": 1660105351312.0}, {"id": 1475784363717, "note": "<div><b>Loop diuretics</b> may cause <b>{{c1::hypo}}-calcemia</b> as an adverse effect<br></div>", "time": 1660105351313.0}, {"id": 1475784371054, "note": "<div><b>{{c3::Loop}} diuretics</b> induce expression of {{c1::<u>COX-2</u>}}, which leads to <i>synthesis</i> of <b>{{c2::prostaglandins</b> (e.g. PGE)<b>}}</b><br></div>", "time": 1660105351225.0}, {"id": 1475784382760, "note": "<div><u>Increased</u> <b>prostaglandin</b> (e.g. loop diuretics) causes <b>vaso-{{c1::dilation}}</b> of the {{c2::<u>afferent</u>}} arteriole<br></div>", "time": 1660105351321.0}, {"id": 1475784390789, "note": "<div>What <i>class of drugs</i> may inhibit the renal-protective aspect of <b>loop diuretics</b>?<br></div><div><br></div><div>{{c1::NSAIDs (decreased prostaglandin synthesis)}}</div>", "time": 1660105351285.0}, {"id": 1475784396602, "note": "<div><b>{{c1::Loop}} diuretics</b> are the <u>1st line treatment</u> for the symptomatic treatment of <b>acute decompensated heart failure with fluid overload</b><br></div>", "time": 1660105351264.0}, {"id": 1475784401111, "note": "<div><b>Loop diuretics</b> may be used to treat the symptoms of pulmonary {{c1::edema}} in an <u>acute heart failure&nbsp;exacerbation</u><br></div>", "time": 1660105351315.0}, {"id": 1475784405822, "note": "<div>Do <b>loop diuretics</b> prolong life in <u>heart failure</u>?<br></div><div><br></div><div>{{c1::No}} </div>", "time": 1660105351325.0}, {"id": 1475784411856, "note": "<div><b>Loop diuretics</b> may be used to treat {{c1::ascites}} in <u>liver failure</u> (e.g. cirrhosis)<br></div>", "time": 1660105351314.0}, {"id": 1475784417761, "note": "<div><b>Loop diuretics</b> can be useful in the treatment of {{c1::hypertension}}, especially if other comorbidities are present (e.g. heart failure with edema)<br></div>", "time": 1660105351316.0}, {"id": 1475784424384, "note": "<div><b>Loop diuretics</b> may be used in the treatment of <b>{{c1::hyper}}-calcemia</b></div>", "time": 1660105358946.0}, {"id": 1475784427405, "note": "<div>What <i>class</i> of <u>renal disorders</u> may be treated with <b>loop diuretics</b>?<br></div><div><br></div><div>{{c1::Nephrotic syndrome}} </div>", "time": 1660105358940.0}, {"id": 1475784430813, "note": "<div>What effect may <b>loop diuretics</b> have on serum <b>K<sup>+</sup></b> levels?<br></div><div><div><br></div><div>{{c1::Decreased (hypokalemia)}}</div></div>", "time": 1660105351281.0}, {"id": 1475784439679, "note": "<div><b>{{c2::Loop}} diuretics</b> may cause <b>{{c1::oto}}-toxicity</b> as an adverse effect<br></div>", "time": 1660105351246.0}, {"id": 1475784443986, "note": "<div>Which <u>loop diuretic</u> is <i>more</i> <b>ototoxic</b>, furosemide or ethacrynic acid?<br></div><div><br></div><div>{{c1::Ethacrynic acid}}</div>", "time": 1660105358934.0}, {"id": 1475784447029, "note": "<div><u>Most</u> <b>loop diuretics </b>are {{c1::sulfa}} drugs and thus may cause <u>adverse</u> reactions in <i>allergic</i> patients<br></div>", "time": 1660105351311.0}, {"id": 1475784453952, "note": "<div><b>{{c1::Ethacrynic acid}}</b> is a <b>non-sulfonamide</b> <u>loop diuretic</u><br></div>", "time": 1660105351267.0}, {"id": 1475784458619, "note": "<div>What <u>renal pathology</u> may be <i>caused</i> by <b>loop diuretics</b>?<br></div><div><br></div><div>{{c1::Interstitial nephritis}}</div>", "time": 1660105351277.0}, {"id": 1475784462835, "note": "<div><b>{{c3::Loop}}</b> and <b>{{c4::thiazide}} diuretics</b> can cause <b>{{c1::hyperuricemia}}</b>, which may lead to precipitation of <b>{{c2::gout}}</b><br></div>", "time": 1660105351232.0}, {"id": 1475784475612, "note": "<div>What <u>acid-base disorder</u> may be caused by <b>loop diuretics</b>?<br></div><div><br></div><div>{{c1::Metabolic alkalosis}}</div>", "time": 1660105351288.0}, {"id": 1475784492646, "note": "<div>The <u>potent diuretic effects</u> of <b>loop diuretics</b> may lead to <i>significant volume loss</i> and thus {{c1::dehydration}}</div>", "time": 1660105358945.0}, {"id": 1475784496637, "note": "<div><b>Ethacrynic acid</b> is used for diuresis in patients allergic to {{c1::<u>sulfa</u>}}<u> drugs</u>, who thus <i>cannot</i> tolerate other <b>loop diuretics</b></div>", "time": 1660105358949.0}, {"id": 1475784499514, "note": "<div><b>Loop diuretics</b> cause {{c1::decreased::increased or decreased}} <u>hypertonicity</u> of the <b>renal medulla</b>&nbsp;</div>", "time": 1660105358947.0}, {"id": 1475784501981, "note": "<div><u>Decreased</u> <b>medullary hypertonicity</b> (e.g. due to loop diuretics) results in an <i>inability</i> to {{c1::concentrate}} urine<br></div>", "time": 1660105358950.0}, {"id": 1475791011290, "note": "<div><b>{{c1::Thiazide}} diuretics</b> exert their effects on the<b> {{c2::DCT::location}}</b>&nbsp;of the nephron</div>", "time": 1660105351258.0}, {"id": 1475791111932, "note": "<div>The <b>{{c1::Na<sup>+</sup>-Cl<sup>-</sup>}} cotransporter</b> is present on the <u>luminal membrane</u> of the <b>DCT</b><br></div>", "time": 1660105351298.0}, {"id": 1475791118882, "note": "<div>In the {{c1::DCT}} of the nephron, Ca<sup>2+</sup> is <i>reabsorbed</i> by an <u>apical</u> <b>Ca<sup>2+</sup> channel</b> and a <u>basolateral</u> <b>Na<sup>+</sup>-Ca<sup>2+</sup> exchanger</b><br></div>", "time": 1660105351322.0}, {"id": 1475791126171, "note": "<div>The <i>early</i> <b>distal convoluted tubule</b> is {{c1::<u>impermeable</u>}} to water (permeability)</div>", "time": 1660105351301.0}, {"id": 1475791129554, "note": "<div><b>Thiazide diuretics</b> {{c1::<u>decrease</u>}} the <i>diluting</i> capacity of the nephron</div>", "time": 1660105358943.0}, {"id": 1475791132047, "note": "<div>What <i>drug class</i> does <b>hydrochlorothiazide</b> belong to?<br></div><div><br></div><div>{{c1::Thiazide diuretics}}</div>", "time": 1660105351282.0}, {"id": 1475791136404, "note": "<div>What <i>drug class</i> do <b>chlorthalidone</b>,&nbsp;<b>metolazone </b>and&nbsp;<b>indapamide&nbsp;</b>belong to?<br></div><div><div><br></div><div>{{c1::Thiazide diuretics}}</div></div>", "time": 1660105351185.0}, {"id": 1475791141009, "note": "<div><b>{{c2::Thiazide}} diuretics</b> block the <b>{{c1::Na<sup>+</sup>-Cl<sup>-</sup>}} cotransporter</b> on the <u>luminal membrane</u> of the DCT<br></div>", "time": 1660105351242.0}, {"id": 1475791149563, "note": "<div><b>Thiazide diuretics</b> <u>increase</u> Ca<sup>2+</sup> {{c1::reabsorption}} (excretion or reabsorption)<br></div>", "time": 1660105351292.0}, {"id": 1475791156865, "note": "<div><b>{{c1::Thiazide}} diuretics</b> are a <u>1st line agent</u> for treatment of mild or moderate <b>{{c2::hypertension}}</b><br></div>", "time": 1660105351260.0}, {"id": 1475791163490, "note": "<div><b>Thiazide diuretics</b> can be useful in the symptomatic treatment of <u>heart </u>{{c1::<u>failure</u>}} (loop diuretics are first line)<br></div>", "time": 1660105351293.0}, {"id": 1475791167738, "note": "<div><b>{{c2::Thiazide}} diuretics</b> may be useful in the treatment of <b>{{c1::nephrogenic}} diabetes insipidus</b><br></div>", "time": 1660105351238.0}, {"id": 1475791181523, "note": "<div><b>{{c2::Thiazide}} diuretics</b> can be used to prevent {{c1::<b>calcium</b>}} <b>kidney</b> <b>stones</b><br></div>", "time": 1660105351240.0}, {"id": 1475791191571, "note": "<div><b>{{c1::Thiazide}} diuretics</b> may be useful for <u>attenuating bone loss</u> in patients with <b>osteoporosis</b><br></div>", "time": 1660105351256.0}, {"id": 1475791196190, "note": "<div><b>Thiazide diuretics</b> may be useful in the treatment of <u>idiopathic</u><b> </b>{{c1::hypercalciuria}}<br></div><div><br></div><div><i><br></i></div>", "time": 1660105358944.0}, {"id": 1475791201574, "note": "<div><b>Thiazide diuretics</b> may cause <b>{{c1::hyper}}-calcemia</b> as an adverse effect<br></div>", "time": 1660105351291.0}, {"id": 1475791212125, "note": "<div>What effect may <b>thiazide diuretics</b> have on serum <u>glucose</u> levels?<br></div><div><br></div><div>{{c1::Increased (hyperglycemia)}}</div>", "time": 1660105351280.0}, {"id": 1475791218107, "note": "<div>What effect may <b>thiazide diuretics</b> have on serum <u>lipid</u> levels (e.g. cholesterol, triglycerides)?<br></div><div><br></div><div>{{c1::Increased (hyperlipidemia)}}</div>", "time": 1660105351278.0}, {"id": 1475791231974, "note": "<div><b>{{c2::Thiazide}} diuretics</b> may <u>decrease</u> renal excretion of <b>{{c1::lithium}}</b>, which is commonly used as an <u>anti-psychotic</u> drug<br></div>", "time": 1660105351234.0}, {"id": 1475791241993, "note": "<div>What effect may <b>thiazide diuretics</b> have on serum <b>K<sup>+</sup></b> levels?<br></div><div><div><br></div><div>{{c1::Decreased (hypokalemia)}}</div></div>", "time": 1660105351279.0}, {"id": 1475791264227, "note": "<div><b>{{c2::Thiazide}} diuretics</b> may cause <b>{{c1::hypo}}-natremia</b> as an adverse effect<br></div>", "time": 1660105351236.0}, {"id": 1475791272897, "note": "<div><b>Thiazide diuretics</b> are {{c1::sulfa}} drugs and thus may <i>rarely</i> cause <u>allergic</u> reactions<br></div>", "time": 1660105351294.0}, {"id": 1475791277370, "note": "<div>What <u>acid-base disorder</u> may be caused by <b>thiazide diuretics</b>?<br></div><div><div><br></div><div>{{c1::Metabolic alkalosis}}</div></div>", "time": 1660105351287.0}, {"id": 1475801251542, "note": "<div><b>K+ sparing&nbsp;diuretics</b> exert their effects on the<b> {{c2::<i>cortical</i> collecting tubules::location}}</b>&nbsp;of the nephron</div>", "time": 1660105351265.0}, {"id": 1475803054465, "note": "<div>Which part of the <u>nephron</u> do <b>mineralocorticoids</b> exert their effects?<br></div><div><br></div><div>{{c1::Collecting duct}}</div>", "time": 1660105351273.0}, {"id": 1475803060109, "note": "<div>The <b>{{c1::principal}}</b> <b>cells</b> of the <u>collecting duct</u> are the major site of <b>Na<sup>+</sup></b>, <b>K<sup>+</sup></b>, and <b>H<sub>2</sub>O</b> transport<br></div>", "time": 1660105351296.0}, {"id": 1475803064583, "note": "<div><b>Na<sup>+</sup></b> is <i>reabsorbed</i> on the <u>luminal membrane</u> of the <b>collecting duct</b> through <b>{{c1::epithelial Na<sup>+</sup>}} channels</b><br></div>", "time": 1660105351310.0}, {"id": 1475803069011, "note": "<div><b>K<sup>+</sup> channels</b> on the <u>luminal membrane</u> of the <i>principal cells</i> of the <b>collecting duct</b> {{c1::<i>secrete</i>::<i>absorb/secrete</i>}} <b>K<sup>+</sup></b><br></div>", "time": 1660105351318.0}, {"id": 1475803073708, "note": "<div><i>Reabsorption</i> of <b>Na<sup>+</sup></b> in the <u>collecting duct</u> creates a(n)&nbsp;<b>{{c2::negative}} luminal potential</b> that facilitates <b>{{c1::K<sup>+</sup>}}</b> <i>excretion</i></div>", "time": 1660105351307.0}, {"id": 1475803081654, "note": "<div>The {{c1::\u03b1-intercalated}} <b>cells</b> of <u>collecting duct</u> are the major site of <b>H<sup>+</sup> secretion</b><br></div>", "time": 1660105351295.0}, {"id": 1475803087346, "note": "<div><b>H<sup>+</sup></b> is <i>secreted</i> by {{c1::H<sup>+</sup>-ATPase}} on the <u>luminal membrane</u> of the \u03b1-intercalated cells of the <b>collecting duct</b><br></div>", "time": 1660105351323.0}, {"id": 1475803092399, "note": "<div>Is the <b>mineralocorticoid</b> <b>receptor</b> an&nbsp;<u>intracellular</u> or <u>membrane</u> receptor?<br></div><div><br></div><div>{{c1::Intracellular}}</div>", "time": 1660105351319.0}, {"id": 1475803096851, "note": "<div><b>Aldosterone</b> <u>upregulates</u> <b>{{c1::K<sup>+</sup>}} channels</b> on the <i>apical</i> membranes of the principal cells, increasing <b>K<sup>+</sup> excretion</b><br></div>", "time": 1660105351326.0}, {"id": 1475803101293, "note": "<div><b>Aldosterone</b> <u>upregulates</u> {{c1::ENaCs}} on the <i>apical</i> membrane of the principal cells, increasing <b>Na<sup>+</sup> reabsorption</b><br></div>", "time": 1660105351327.0}, {"id": 1475803107428, "note": "<div><b>Aldosterone</b> <u>upregulates</u> the {{c1::Na<sup>+</sup>-K<sup>+</sup> ATPase}} pump on the <i>basolateral</i> membrane of the principal cells<br></div>", "time": 1660105351328.0}, {"id": 1475803114431, "note": "<div><b>Aldosterone</b> <u>upregulates</u> the {{c1::H<sup>+</sup> ATPase}} pump on the <i>apical</i> membrane of the \u03b1-intercalated cells, increasing <b>H<sup>+</sup> excretion</b><br></div>", "time": 1660105351329.0}, {"id": 1475803118764, "note": "<div><b>{{c1::Triamterene}}</b> and <b>{{c1::amiloride}}</b> are <b>{{c3::K<sup>+</sup> sparing}}&nbsp;</b><b>diuretics</b> that act by <u>blocking</u> Na<sup>+</sup> <i>reabsorption</i> through {{c2::<b>ENaCs</b>}}<br></div>", "time": 1660105351255.0}, {"id": 1475803122988, "note": "<div><b>{{c1::Eplerenone}}</b> and <b>{{c1::spironolactone}}</b> are&nbsp;{{c3::<b>K<sup>+</sup></b><b> sparing</b>}}<b> diuretics </b>that act by&nbsp;<i>competitively&nbsp;</i><u>antagonizing</u>&nbsp;the&nbsp;<b>{{c2::mineralocorticoid}} receptor</b><br></div>", "time": 1660105351270.0}, {"id": 1475803132593, "note": "<div><b>{{c2::K<sup>+</sup> sparing}} diuretics</b> are useful in the treatment of <u>primary</u> and <u>secondary</u> <b>{{c1::hyper}}-</b><b>aldosteronism</b><br></div>", "time": 1660105351250.0}, {"id": 1475803141549, "note": "<div><b>K<sup>+</sup> sparing diuretics </b>(e.g. spironolactone, eplerenone) are useful in the treatment of <u>heart </u>{{c1::<u>failure</u>}}, especially in <i>combination</i> with loop diuretics<br></div>", "time": 1660105351317.0}, {"id": 1475803146531, "note": "<div><b>{{c2::Mineralocorticoid}} receptor antagonists</b> prevent <u>myocardial </u>{{c1::<u>remodeling</u>}} induced by high levels of aldosterone<br></div>", "time": 1660105351244.0}, {"id": 1475803154405, "note": "<div>Do <b>mineralocorticoid receptor antagonists</b> (e.g. spironolactone, eplerenone) prolong life in <u>heart failure</u>?<br></div><div><br></div><div>{{c1::Yes}}</div>", "time": 1660105351324.0}, {"id": 1475803159454, "note": "<div><b>{{c1::Amiloride}}</b>, a <u>K</u><sup>+</sup><u> sparing diuretic</u>, is useful in the treatment of <b>{{c2::Li<sup>+</sup>}}-induced</b> <i>nephrogenic</i> diabetes insipidus<br></div>", "time": 1660105351272.0}, {"id": 1475803165151, "note": "<div><b>{{c2::Amiloride}}</b> and <b>{{c2::triamterene}}</b> are <u>K</u><sup>+</sup><u> sparing diuretics</u> that may be used to treat <b>{{c1::Liddles}} syndrome</b>, which is characterized by&nbsp;<i>overactive</i> ENaCs<br></div>", "time": 1660105351252.0}, {"id": 1475803169856, "note": "<div>Which <u>ion depletion</u> may be treated with <b>K<sup>+</sup> sparing diuretics</b>?<br></div><div><br></div><div>{{c1::K<sup>+</sup> depletion (hypokalemia)}}</div>", "time": 1660105358935.0}, {"id": 1475803172814, "note": "<div><b>{{c2::Spironolactone}}</b>, a K<sup>+</sup> sparing diuretic, may be used in the treatment of <b>hepatic {{c1::ascites}}</b></div>", "time": 1660105358933.0}, {"id": 1475803175228, "note": "<div>One adverse effect of <b>K<sup>+</sup> sparing diuretics </b>is {{c1::<u>hyperkalemia</u>}}, which <i>increases risk</i> for <b>{{c2::arrhythmia}}</b><br></div>", "time": 1660105351309.0}, {"id": 1475803179794, "note": "<div>What <u>acid-base disorder</u> may be caused by <b>K<sup>+</sup>-sparing diuretics</b>?<br></div><div><br></div><div>{{c1::Normal anion gap metabolic acidosis}}</div>", "time": 1660105351289.0}, {"id": 1475803187344, "note": "<div>What type of <u>renal tubular acidosis</u> may be caused by <b>K<sup>+</sup> sparing diuretics</b>?<br></div><div><br></div><div>{{c1::Type 4 RTA}}</div>", "time": 1660105351276.0}, {"id": 1475803191500, "note": "<div><b>Type 4</b> <u>renal tubular acidosis</u> is associated with <b>{{c1::hyper}}-kalemia</b><br></div>", "time": 1660105351290.0}, {"id": 1475803196244, "note": "<div><b>Spironolactone</b> may <u>inhibit</u> <i>{{c1::17\u03b1-hydroxylase}}</i>, an enzyme in the <b>testosterone synthesis pathway</b><br></div>", "time": 1660105351303.0}, {"id": 1475803200843, "note": "<div><b>{{c1::Spironolactone}}</b>, a K<sup>+</sup> sparing diuretic, may be used to treat symptoms of <u>androgen excess</u> in <b>polycystic ovarian syndrome (PCOS)</b><br></div>", "time": 1660105351261.0}, {"id": 1475803205680, "note": "<div>Symptoms of <u>androgen excess</u>, such as {{c1::hirsutism}}, in <b>PCOS</b> may be treated with <b>spironolactone</b><br></div>", "time": 1660105351302.0}, {"id": 1475803210175, "note": "<div><b>Spironolactone</b> may have <u>anti-androgenic effects</u> via direct <i>antagonism</i> of the {{c1::androgen}} receptor<br></div>", "time": 1660105351304.0}, {"id": 1475803214768, "note": "<div>What adverse <u>anti-androgenic effect</u> may be caused by <b>spironolactone</b> use in <b>males</b>?<br></div><div><br></div><div>{{c1::Gynecomastia}}</div>", "time": 1660105351286.0}, {"id": 1475803220048, "note": "<div><b>Spironolactone</b> may cause <u>impotence</u> and <i>decreased</i> {{c1::<u>libido</u>}} as adverse effects<br></div>", "time": 1660105351305.0}, {"id": 1475803224182, "note": "<div>Which <i>diuretics</i> cause an <u>increase</u> in <b>urine NaCl</b>?<br></div><div><br></div><div>{{c1::All diuretics :)}}</div>", "time": 1660105358936.0}, {"id": 1475803236058, "note": "<div>What classes of <i>diuretics&nbsp;</i>are characterized by <u>increased</u> <b>urine K</b><sup style=\"font-weight: bold;\">+</sup>?<br></div><div><br></div><div>{{c1::Loop and thiazide diuretics::2}}</div>", "time": 1660105358938.0}, {"id": 1475803245775, "note": "<div>What classes of <i>diuretics </i>are characterized by <u>decreased</u> <b>blood pH</b> (acidemia)?<br></div><div><br></div><div>{{c1::Carbonic anhydrase inhibitors, K<sup>+</sup> sparing diuretics::2}}</div>", "time": 1660105358939.0}, {"id": 1475803252097, "note": "<div>What classes of <i>diuretics</i>&nbsp;cause <u>increased</u> <b>blood pH</b> (alkalemia)?<br></div><div><br></div><div>{{c1::Loop and thiazide diuretics::2}}</div>", "time": 1660105358937.0}, {"id": 1475803258402, "note": "<div>In a <u>low</u> <b>K<sup>+</sup> state</b>, {{c1::H<sup>+</sup>}} is exchanged for <b>Na<sup>+</sup></b> in the <i>basolateral</i> membrane of <u>cortical collecting tubule</u>, causing <b>alkalosis</b> and \"<b>paradoxical</b> <b>aciduria</b>\"<br></div>", "time": 1660105358948.0}, {"id": 1475803267195, "note": "<div>What class of <i>diuretics</i>&nbsp;is characterized by <u>increased</u> <b>urine Ca</b><sup style=\"font-weight: bold;\">2+</sup>?<br></div><div><br></div><div>{{c1::Loop diuretics}}</div>", "time": 1660105358941.0}, {"id": 1475803274064, "note": "<div>What class of <i>diuretics</i>&nbsp;is characterized by <u>decreased</u> <b>urine Ca</b><sup style=\"font-weight: bold;\">2+</sup>?<br></div><div><div><br></div><div>{{c1::Thiazide diuretics}}</div></div>", "time": 1660105358942.0}, {"id": 1475874265007, "note": "Which type of <u>nephrotic syndrome</u> is most commonly seen in <b>HIV</b> patients?<div><br></div><div>{{c1::Focal segmental glomerulosclerosis}}</div>", "time": null}, {"id": 1475874402725, "note": "<div>Which type of <u>kidney stone</u> is associated with <b>staghorn calculi</b> in <b>children</b>? </div><div><br /></div><div>{{c1::Cystine kidney stones}}</div>", "time": null}, {"id": 1476233142595, "note": "<b>Incremental</b> <u>reductions</u> in {{c1::GFR}} define the stages of <b>chronic kidney disease</b>", "time": 1660105356144.0}, {"id": 1476383467230, "note": "<b>Aortic {{c1::dissection}}</b> may present with markedly <u>unequal</u> <b>blood pressure</b> in the arms ", "time": null}, {"id": 1476487914649, "note": "What is the <u>male remnant</u> of the&nbsp;<b>m\u00fcllerian</b><b>&nbsp;(paramesonephric) duct</b>? <div><br></div><div>{{c1::Appendix testis}}</div><div><br></div><div><i>+bonus</i><br></div>", "time": null}, {"id": 1476487955126, "note": "Which <i>type</i> of <u>lung carcinoma</u> may present with <b>cavitations</b> on CXR? <div><br /></div><div>{{c1::Squamous cell carcinoma}}</div>", "time": null}, {"id": 1476580396674, "note": "<div><div><div><div>Which <u>vitamins</u>&nbsp;are <b>fat-soluble</b>?</div><div><br></div><div>{{c1::A, D, E, K::4}}</div></div></div></div>", "time": null}, {"id": 1476583107452, "note": "<div><div><div><div>Is <u>toxicity</u> more common for <b>water-soluble</b> or <b>fat-soluble</b> vitamins?</div><div><br></div><div>{{c1::Fat-soluble (vitamins can accumulate in fat)}}</div></div></div></div>", "time": null}, {"id": 1476583116285, "note": "<div><div><div><div><b>Fat-soluble vitamin deficiencies</b> may occur with {{c1::mineral oil}} intake, which can be used to treat <u>constipation</u></div></div></div></div>", "time": null}, {"id": 1476583120594, "note": "<div><div><div><div><b>Fat-soluble deficiencies</b> may occur with syndromes that cause {{c1::steatorrhea}} (e.g. cystic fibrosis and sprue)</div></div></div></div>", "time": 1660105359315.0}, {"id": 1476583124449, "note": "<div><div><div><div>Absorption of <b>fat-soluble vitamins</b> is dependent on the {{c1::<b>gut</b>}} and {{c2::<b>pancreas</b>}}</div></div></div></div>", "time": 1660105362252.0}, {"id": 1476583128453, "note": "<div><div><div><div>Vitamin {{c1::A}} is also known as <b>{{c2::retinol}}</b></div></div></div></div>", "time": null}, {"id": 1476583132273, "note": "<div><div><div><div>The <b>{{c1::retinal}}</b> form of <u>vitamin A</u> is a constituent of <b>{{c2::visual}} pigments</b></div></div></div></div>", "time": null}, {"id": 1476583135570, "note": "<div><div><div><div><b>Vitamin {{c2::A}}</b> is a co-factor for the synthesis of the visual pigment {{c1::<b>rhodopsin</b>}}</div></div></div></div>", "time": null}, {"id": 1476583140069, "note": "<div><b>Vitamin {{c1::A}}</b> is essential for <u>normal differentiation</u> of <b>epithelial</b>&nbsp;<b>cells&nbsp;</b>into&nbsp;<b>specialized tissue</b> (e.g. pancreatic cells, mucus secreting cells)</div>", "time": 1660105348198.0}, {"id": 1476583144320, "note": "<div><div><div><div><b>Vitamin {{c2::A}}</b> prevents {{c1::<u>squamous</u>}} <b>metaplasia</b></div></div></div></div>", "time": null}, {"id": 1476583148423, "note": "<div><div><div><div><b>Vitamin {{c3::A}}</b> may be used to treat {{c1::<b>measles</b>}} and {{c2::<b>acute promyelocytic leukemia (APML)</b>}}</div></div></div></div>", "time": null}, {"id": 1476583157140, "note": "<div><div><div><div><b>Vitamin A</b> is found in {{c1::liver}} and {{c2::leafy vegetables}}</div></div></div></div>", "time": null}, {"id": 1476583171440, "note": "<div><div><div><div><b>Oral {{c2::isotretinoin}}</b> (vitamin A) is used to treat severe cystic {{c1::acne}}</div></div></div></div>", "time": null}, {"id": 1476583175080, "note": "<div><div><div><div>What <u>vitamin</u> is used <i>topically</i> for <b>wrinkles</b> and <b>acne</b>? </div><div><br></div><div>{{c1::Vitamin A}}</div></div></div></div>", "time": null}, {"id": 1476583187105, "note": "<div><div><div><div>{{c2::<b><i>All</i>-trans-retinoic acid</b>}} (vitamin A) is used to treat {{c1::<b>acute promyelocytic leukemia</b>}}</div></div></div></div>", "time": null}, {"id": 1476583190763, "note": "<div>One sign of vitamin {{c2::A}} <u>deficiency</u> is <b>night </b>{{c1::<b>blindness</b> (nyctalopia)}}</div>", "time": null}, {"id": 1476583194711, "note": "<div><div><div><div>One sign of vitamin {{c2::A}} <u>deficiency</u> is <b>dry, scaly </b>{{c1::<b>skin</b> (xerosis cutis)}}</div></div></div></div>", "time": null}, {"id": 1476583200157, "note": "<div><div><div><div>One sign of vitamin {{c2::A}} <u>deficiency</u> is <b>corneal degeneration</b>, known as <b>{{c1::keratomalacia}}</b></div></div></div></div>", "time": null}, {"id": 1476583206549, "note": "<div><div><div><div>One sign of vitamin {{c2::A}} <u>deficiency</u> is <b>{{c1::bitot spots}}</b> on <b>conjunctiva</b> due to <b><i>{{c3::squamous}}</i> <i>metaplasia</i></b> of corneal epithelium</div></div></div></div>", "time": null}, {"id": 1476583223750, "note": "<div><div><div><div>What effect does <b>vitamin A </b><u>deficiency</u> have on the <b>immune</b> <b>system</b>?</div><div><br></div><div>{{c1::Immunosuppression}}</div></div></div></div>", "time": null}, {"id": 1476583239260, "note": "<div><div><div><div><i><b>Acute</b></i> <b>vitamin</b> {{c1::<b>A</b>}} <u><b>toxicity</b></u> presents with nausea, vomiting, vertigo, and blurred vision</div></div></div></div>", "time": null}, {"id": 1476583242805, "note": "<div><i>Chronic</i> <b>vitamin</b> {{c2::<b>A</b>}} <u><b>toxicity</b></u> may cause {{c1::<b>alopecia::hair complication</b>}} and <b>dry skin</b></div>", "time": null}, {"id": 1476583246104, "note": "<div><div><div><div><i>Chronic</i> <b>vitamin {{c2::A}} <u>toxicity</u> </b>may cause {{c1::<b>hepatic</b>}} <b>toxicity</b> and <b>enlargement</b></div></div></div></div>", "time": null}, {"id": 1476583249637, "note": "<div><div><div><div><i>Chronic</i> <b>vitamin {{c2::A}} <u>toxicity</u></b> may cause {{c1::<b>pseudotumor cerebri::CNS complication</b>}}</div></div></div></div>", "time": null}, {"id": 1476583253097, "note": "<div><i>Chronic</i> <b>vitamin {{c2::A}} <u>toxicity</u></b> may cause {{c1::<b>arthralgias::joint complication</b>}}</div>", "time": null}, {"id": 1476583258340, "note": "<div>Which <u>vitamin supplement</u> may be <i>contraindicated</i> during&nbsp;<b>pregnancy</b> due to its <b>teratogenic effects</b>?</div><div><br></div><div>{{c1::Vitamin A (isotretinoin)}}<br></div>", "time": null}, {"id": 1476583262023, "note": "<div><div><div><div><b>Teratogenic effects</b> of <u>vitamin A</u> include {{c1::<b>cardiac</b>}} <b>abnormalities</b> and {{c2::<b>cleft</b> <b>palate</b>}}</div></div></div></div>", "time": null}, {"id": 1476583265854, "note": "<div><div><div><div>A <u>negative</u> {{c1::pregnancy}} test and {{c2::<u>two</u>}} forms of contraception are required <i>before</i> <b>isotretinoin</b> (vitamin A) is prescribed</div></div></div></div>", "time": 1660105362502.0}, {"id": 1476583271416, "note": "<div><div><div><div><b>Vitamin A</b> exerts its <u>teratogenic</u> effects by interfering with {{c1::homeobox}} genes</div></div></div></div>", "time": null}, {"id": 1476583275422, "note": "<div><div><div><div>Vitamin {{c1::B<sub>1</sub>}} is also known as <b>{{c2::thiamine}}</b></div></div></div></div>", "time": null}, {"id": 1476583280119, "note": "<div><div><div><div>What is the <i>coenzyme</i> (<b><u>active</u></b>) form of <b>vitamin B</b><sub style=\"font-weight: bold; \">1</sub>? </div><div><br></div><div>{{c1::Thiamine pyrophosphate (TPP)}}</div></div></div></div>", "time": null}, {"id": 1476583284038, "note": "<div><div><div><div><b>Thiamine pyrophosphate</b> (B<sub>1</sub>) is a <u>cofactor</u> for the enzyme <i>{{c1::pyruvate dehydrogenase}}</i> (glycolysis)</div></div></div></div>", "time": null}, {"id": 1476583287550, "note": "<div><div><div><div><b>Thiamine pyrophosphate</b> (B<sub>1</sub>) is a <u>cofactor</u> for the enzyme <i>{{c1::\u03b1-ketoglutarate dehydrogenase}}</i> (TCA cycle)<b> </b></div></div></div></div>", "time": null}, {"id": 1476583290698, "note": "<div><div><div><div><b>Thiamine pyrophosphate</b> (B<sub>1</sub>) is a <u>cofactor</u> for the enzyme <i>{{c1::transketolase}}</i> (HMP shunt)</div></div></div></div>", "time": null}, {"id": 1476583293810, "note": "<div><div><div><div><b>Thiamine pyrophosphate</b> (B<sub>1</sub>) is a <u>cofactor</u> for the enzyme <i>{{c1::branched-chain ketoacid dehydrogenase}}</i> (amino acid metabolism)</div></div></div></div>", "time": null}, {"id": 1476583297365, "note": "<div>Vitamin {{c3::B<sub>1</sub> (thiamine)}}<b> </b><u>deficiency</u>&nbsp;causes <b>impaired {{c1::glucose}} breakdown</b> with consequent <b>{{c2::ATP}} depletion</b></div>", "time": 1660105348187.0}, {"id": 1476583304479, "note": "<div><div><div><div><b>ATP depletion</b> in vitamin B<sub>1</sub> (thiamine) <i>deficiency</i> is <u>worsened</u> by {{c1::glucose}} infusion </div></div></div></div>", "time": null}, {"id": 1476583308513, "note": "<div><div><div><div>Which <u>tissues</u> are affected <i>first</i> in <b>vitamin B<sub>1</sub> (thiamine) deficiency</b>? </div><div><br></div><div>{{c1::Highly aerobic tissue (e.g. brain, heart)}}</div></div></div></div>", "time": 1660105341971.0}, {"id": 1476583312048, "note": "<div><div><div><div><b>Vitamin B<sub>1</sub> deficiency</b> is seen in {{c1::alcoholism}} and {{c2::malnutrition}}</div></div></div></div>", "time": null}, {"id": 1476583315863, "note": "<div><div><div><div>One complication of <b>vitamin {{c2::B<sub>1</sub>}} </b><u>deficiency</u> is <b>{{c1::Wernicke-Korsakoff}} syndrome</b></div></div></div></div>", "time": null}, {"id": 1476583320663, "note": "<div><div><div><div><b>Wernicke-Korsakoff syndrome</b> is characterized by a <u>triad</u> of {{c1::ophthalmoplegia}}, {{c2::ataxia}}, and {{c3::confusion}} </div></div></div></div>", "time": null}, {"id": 1476583335376, "note": "<div><div><div><div>Is the <u>memory loss</u> associated with <b>Wernicke-Korsakoff syndrome&nbsp;</b><i>temporary</i> or <i>permanent? </i></div><div><br></div><div>{{c1::Permanent}}</div></div></div></div>", "time": null}, {"id": 1476583339113, "note": "<div><div><div><div><b>Vitamin {{c2::B<sub>1</sub>}} </b><u>deficiency</u> is associated with <b>wet</b> and <b>dry {{c1::beriberi}}</b></div></div></div></div>", "time": null}, {"id": 1476583342751, "note": "<div><div><div><div>{{c3::<u>Wet</u>}}<u> beriberi</u> is characterized by <b>high-output cardiac failure</b> ({{c1::dilated}} cardiomyopathy) and <b>{{c2::edema}}</b> +/- {{c3::dry}} beriberi symptoms</div></div></div></div>", "time": null}, {"id": 1476583346666, "note": "<div><div><div><div>{{c3::<u>Dry</u>}}<u> beriberi</u> is characterized by <b>{{c1::polyneuritis}}</b> and <b>symmetrical {{c2::muscle wasting}}</b> </div></div></div></div>", "time": null}, {"id": 1476583349919, "note": "<div><div><div><div>Diagnosis of <b>B<sub>1</sub> (thiamine)</b> <u>deficiency</u> is made by measuring <u>increased</u> <b><i>{{c1::transketolase}}</i></b> activity in <b>{{c2::red blood cells}}</b> <u>following thiamine administration</u></div></div></div></div>", "time": null}, {"id": 1476583353894, "note": "<div><div><div><div>Vitamin {{c1::B<sub>2</sub>}} is also known as <b>{{c2::riboflavin}}</b></div></div></div></div>", "time": null}, {"id": 1476583358077, "note": "<div><div><div><div><b>Vitamin B</b><sub style=\"font-weight: bold; \">2</sub> (riboflavin) is a <i>precursor</i> to <b>{{c1::FAD}}</b> and <b>{{c1::FMN}}</b></div></div></div></div>", "time": null}, {"id": 1476583361519, "note": "<div><div><div><div><b>Vitamin B</b><sub style=\"font-weight: bold; \">2</sub> (riboflavin) is involved in many {{c1::redox}} reactions</div></div></div></div>", "time": null}, {"id": 1476583368603, "note": "<div><div><div><div><b>Vitamin {{c3::B<sub>2</sub>}} </b><u>deficiency</u> is characterized by <b>{{c1::cheilosis}}</b> and <b>{{c2::corneal vascularization}}</b></div></div></div></div>", "time": null}, {"id": 1476583374378, "note": "<div><div><div><div><b>Inflammation</b> of the <u>lips</u> with <b>scaling</b> and <b>fissures</b> at the <u>corners of the mouth</u> is known as {{c1::cheilosis}} </div></div></div></div>", "time": null}, {"id": 1476583439941, "note": "<div><div><div><div><b>Vitamin {{c2::B<sub>2</sub>}} </b><u>deficiency</u> may be associated with a(n) {{c1::<b>magenta</b>}}<b>-colored</b> <b>tongue</b></div></div></div></div>", "time": null}, {"id": 1476583445937, "note": "<div><div><div><div><div>Vitamin {{c1::B<sub>3</sub>}} is also known as <b>{{c2::niacin}}</b></div></div></div></div></div>", "time": null}, {"id": 1476583449997, "note": "<div><div><div><div><div><b>Vitamin B</b><sub style=\"font-weight: bold; \">3</sub> (niacin) is a<i> </i>constituent of <b>{{c2::NAD<sup>+</sup>}}</b> and <b>{{c2::NADP<sup>+</sup>}}</b></div></div></div></div></div>", "time": null}, {"id": 1476583453669, "note": "<div><div><div><div><div><i>Synthesis</i> of <b>vitamin B</b><sub style=\"font-weight: bold; \">3</sub> (niacin) requires vitamins {{c1::B<sub>2</sub>}} and {{c2::B<sub>6</sub>}}</div></div></div></div></div>", "time": null}, {"id": 1476583456788, "note": "<div><div><div><div><div><b>Vitamin B</b><sub style=\"font-weight: bold; \">3</sub> (niacin) is involved in many {{c1::redox}} reactions</div></div></div></div></div>", "time": null}, {"id": 1476583459860, "note": "<div><div><div><div>What <u>vitamin</u> is derived from the amino acid <b>tryptophan</b>?</div><div><br></div><div>{{c1::Vitamin B<sub>3</sub> (niacin)}}</div></div></div></div>", "time": null}, {"id": 1476583463074, "note": "<div><div><div><div><b>Vitamin B</b><sub style=\"font-weight: bold; \">3</sub> (niacin) is used to treat <b>{{c1::dyslipidemia}}</b> </div></div></div></div>", "time": null}, {"id": 1476583470387, "note": "<div><div><div><div><i>Mild</i> <u>deficiencies</u> of <b>vitamin B<sub>3</sub> </b>cause <b>{{c1::glossitis}}</b></div></div></div></div>", "time": 1660105355224.0}, {"id": 1476583475548, "note": "<div><div><div><div><i>Severe</i> <u>deficiencies</u> of <b>vitamin </b>{{c2::<b>B</b><sub style=\"font-weight: bold; \">3</sub>}} can lead to <b>{{c1::pellagra}}</b></div></div></div></div>", "time": null}, {"id": 1476583479638, "note": "<div><div><div><div><b>Pellagra</b> (from severe B<sub>3</sub> deficiency) may be caused by <b>{{c1::Hartnup}} disease</b>, <b>{{c2::malignant carcinoid}} syndrome</b>, and <b>{{c3::isoniazid}} therapy</b></div></div></div></div>", "time": null}, {"id": 1476583483635, "note": "<div><div><div><div>What is the <u>mode of inheritance</u> of <b>Hartnup disease</b>? </div><div><br></div><div>{{c1::Autosomal recessive}}</div></div></div></div>", "time": null}, {"id": 1476583487158, "note": "<div><div><div><div><b>{{c2::Hartnup}} disease</b> is due to a <u>deficiency</u> of <b>neutral amino acid transporters</b> (especially {{c1::<u>tryptophan</u>}}) in the proximal renal tubular cells and enterocytes</div></div></div></div>", "time": null}, {"id": 1476583490418, "note": "<div><div><div><div>{{c1::Hartnup}} disease is characterized by <b>neutral aminoaciduria</b> and <u>decreased</u> <b>neutral AA absorption</b> (esp. tryptophan) from the gut</div></div></div></div>", "time": null}, {"id": 1476583493926, "note": "<div><div><div><div><b>Hartnup disease</b> is treated with a high-{{c1::protein}} diet and {{c2::<b>nicotinic</b> <b>acid</b> (niacin)}}</div></div></div></div>", "time": null}, {"id": 1476583497529, "note": "<div><div><div><div><b>Malignant carcinoid syndrome</b> is characterized by <u>increased</u> metabolism of the amino acid {{c1::tryptophan}}</div></div></div></div>", "time": null}, {"id": 1476583501488, "note": "<div><div><div><div><b>Isoniazid therapy</b> <i>indirectly</i> decreases vitamin {{c1::B<sub>3</sub>}} by decreasing levels of vitamin B<sub>6</sub> </div></div></div></div>", "time": null}, {"id": 1476583510666, "note": "<div><div><div><div>What <u>change in bowel movement</u> is associated with&nbsp;<b>pellagra&nbsp;</b>(B<sub>3&nbsp;</sub>deficiency)? </div><div><br></div><div>{{c1::Diarrhea}} </div></div></div></div>", "time": null}, {"id": 1476583519576, "note": "<div><div><div><div><div>What <u>CNS complication</u> is associated with <b>pellagra</b> (B<sub>3</sub> deficiency)? </div><div><br /></div><div>{{c1::Dementia (also hallucinations)}} </div></div></div></div></div>", "time": null}, {"id": 1476583526759, "note": "<div><div><div><div><div><b>{{c3::Pellagra}}</b> is a <u>vitamin deficiency</u> complication associated with <b>{{c1::dermatitis}}</b> in a(n) {{c2::C3/C4}} dermatome distribution</div></div></div></div></div>", "time": null}, {"id": 1476583546693, "note": "<div><div><div><div><div><b>Pellagra</b> (B<sub>3</sub> deficiency) is associated with <b>{{c1::hyper}}-pigmentation</b> of sun-exposed limbs</div></div></div></div></div>", "time": null}, {"id": 1476583557608, "note": "<div><div><div><div><b>Vitamin </b>{{c3::<b>B<sub>3</sub> </b>(niacin)}} <u>excess</u> is characterized by <b>{{c1::facial flushing}}</b>; can be avoided by taking <b>{{c2::NSAIDs}}</b> if given 30-60 minutes before administration</div></div></div></div>", "time": null}, {"id": 1476583565822, "note": "<div><div><div><div>The <b>facial flushing</b> seen with vitamin B<sub>3</sub> <u>excess</u> is mediated by {{c1::prostaglandins}}</div></div></div></div>", "time": null}, {"id": 1476583573298, "note": "<div><div><div><div><b>Vitamin </b>{{c3::<b>B<sub>3</sub> </b>(niacin)}} <u>excess</u> is associated with <b>hyper-{{c1::glycemia}}</b> and <b>hyper-{{c2::uricemia}}</b></div></div></div></div>", "time": null}, {"id": 1476583576619, "note": "<div>Vitamin {{c1::B<sub>5</sub>}} is also known as <b>{{c2::pantothenic acid}}</b></div>", "time": null}, {"id": 1476583580011, "note": "<div><div><div><div><b>Vitamin </b>{{c2::<b>B</b><sub style=\"font-weight: bold; \">5</sub> (pantothenic acid)}} is an essential component of {{c1::<b>coenzyme A</b>}} and fatty acid synthase</div></div></div></div>", "time": null}, {"id": 1476583583262, "note": "<div><div><div><div><b>Vitamin {{c2::B<sub>5</sub>}} deficiency</b> (rare) presents with dermatitis, enteritis, alopecia, and {{c1::adrenal}} insufficiency</div></div></div></div>", "time": null}, {"id": 1476583586358, "note": "<div><div><div><div>Vitamin {{c1::B<sub>6</sub>}} is also known as <b>{{c2::pyridoxine}}</b></div></div></div></div>", "time": null}, {"id": 1476583589562, "note": "<div><div>What is the <i>coenzyme</i> (active) form of <b>vitamin B</b><sub style=\"font-weight: bold; \">6</sub>? </div><div><br></div><div>{{c1::Pyridoxal phosphate (PLP)}}</div></div>", "time": null}, {"id": 1476583592918, "note": "<div>What <u>vitamin</u> is used as a <i>cofactor</i> for <b>transamination</b>, <b>decarboxylation reactions</b>, and <b>glycogen phosphorylase</b>?</div><div><br></div><div>{{c1::B<sub>6</sub> (pyridoxal phosphate)}}<br></div>", "time": null}, {"id": 1476583596111, "note": "<div>What <u>vitamin</u> is used as a <i>cofactor</i> for <i>synthesis</i> of <b>cystathionine</b>, <b>heme</b>, <b>histamine</b>, and <b>neurotransmitters</b>?</div><div><br></div><div>{{c1::B<sub>6</sub> (pyridoxal phosphate)}}<br></div>", "time": null}, {"id": 1476583603375, "note": "<div><div><div><div><b>Vitamin B</b><sub style=\"font-weight: bold; \">6</sub> <u>deficiency</u> may occur with {{c1::isoniazid}} and {{c2::oral contraceptive}} use</div></div></div></div>", "time": null}, {"id": 1476583613878, "note": "<div><div><div><div><b>Vitamin </b>{{c2::<b>B</b><sub style=\"font-weight: bold; \">6</sub>}} <u>deficiency</u> is characterized by <b>{{c1::sideroblastic}} anemia</b> and <b>{{c3::peripheral neuropathy}}</b></div></div></div></div>", "time": null}, {"id": 1476583632124, "note": "<div><div><div><div>Vitamin {{c1::B<sub>7</sub>}} is also known as <b>{{c2::biotin}}</b></div></div></div></div>", "time": null}, {"id": 1476583635491, "note": "<div><div><div><div><b>Vitamin B</b><sub style=\"font-weight: bold; \">7</sub> (biotin) is a cofactor for {{c1::<u>carboxylation</u>}} reactions</div></div></div></div>", "time": null}, {"id": 1476583642059, "note": "<div><div><div><div><b>Vitamin B</b><sub style=\"font-weight: bold; \">7</sub> (biotin) is a cofactor for the enzyme <i>{{c1::pyruvate carboxylase}}</i> (gluconeogenesis) </div></div></div></div>", "time": null}, {"id": 1476583648794, "note": "<div><div><div><div><b>Vitamin B</b><sub style=\"font-weight: bold; \">7</sub> (biotin) is a cofactor for the enzyme <i>{{c1::acetyl-CoA carboxylase}}</i> (fatty acid synthesis)</div></div></div></div>", "time": null}, {"id": 1476583656234, "note": "<div><div><div><div><b>Vitamin B</b><sub style=\"font-weight: bold; \">7</sub> (biotin) is a cofactor for the enzyme <i>{{c1::propionyl-CoA carboxylase}}</i> (propionyl CoA metabolism)</div></div></div></div>", "time": null}, {"id": 1476583663367, "note": "<div><div><div><div><b>Vitamin </b>{{c3::<b>B</b><sub style=\"font-weight: bold; \">7</sub> (biotin)}} <u>deficiency</u> may be caused by excessive ingestion of <b>{{c1::raw eggs}}</b>, which contain <b>{{c2::avidin}}</b> </div></div></div></div>", "time": null}, {"id": 1476583668245, "note": "<div><div><div><div>In addition to ingestion of raw eggs, <b>vitamin B<sub>7</sub> </b>(biotin) <u>deficiency</u> may occur with {{c1::antibiotic}} use or {{c2::biotinidase}} deficiency</div></div></div></div>", "time": null}, {"id": 1476583672286, "note": "<div><div><div><div><b>Vitamin B<sub>7</sub> </b>(biotin) <u>deficiency</u> presents with {{c1::alopecia}}, macular dermatitis, mental status changes, enteritis, and <u>lactic acidosis</u> </div></div></div></div>", "time": null}, {"id": 1476583675506, "note": "<div><div><div><div>Vitamin {{c1::B<sub>9</sub>}} is also known as <b>{{c2::folate}}</b></div></div></div></div>", "time": null}, {"id": 1476583678630, "note": "<div><div><div><div><b>Vitamin B<sub>9</sub> </b>(folate) is converted to {{c1::<b>tetrahydrofolate</b> (THF)}}, a coenzyme for {{c2::<u>1-carbon</u>::#}} transfer/methylation reactions </div></div></div></div>", "time": null}, {"id": 1476583681489, "note": "<div><div><div><div>Which <u>vitamin</u> is important for <i>synthesis</i> of nitrogenous bases in <b>DNA</b> and <b>RNA</b>?</div><div><br></div><div>{{c1::B<sub>9</sub> (folate)}}</div></div></div></div>", "time": 1660105341580.0}, {"id": 1476583684909, "note": "<div><div><div><div><b>Vitamin B</b><sub style=\"font-weight: bold; \">9</sub> (folate) is <i>absorbed</i> in the {{c1::jejunum}} of the small intestine</div></div></div></div>", "time": null}, {"id": 1476583687853, "note": "<div><div><div><div><b>Vitamin B<sub>9</sub> </b>(folate) is found in {{c1::leafy green}} vegetables</div></div></div></div>", "time": null}, {"id": 1476583690602, "note": "<div><div><div><div><b>Vitamin </b>{{c3::<b>B</b><sub style=\"font-weight: bold; \">9</sub> (folate)}} is <i>stored</i> in the {{c2::<u>liver</u>}} for up to 3-4 {{c1::months}}</div></div></div></div>", "time": null}, {"id": 1476583693485, "note": "<div><div><div><div>What is the <u>most common</u> <b>vitamin deficiency</b> in the U.S.?</div><div><br></div><div>{{c1::Folate (vitamin B<sub>9</sub>)}}</div></div></div></div>", "time": null}, {"id": 1476583696264, "note": "<div><div><div><div><b>Vitamin B</b><sub style=\"font-weight: bold; \">9</sub> (folate) <u>deficiency</u> most commonly occurs due to {{c1::pregnancy}}, {{c2::alcoholism}}, or drugs (e.g. phenytoin, sulfonamides, methotrexate)</div></div></div></div>", "time": null}, {"id": 1476583699009, "note": "<div><div><div><div>Supplemental maternal {{c2::<b>folic</b> <b>acid</b>}} in early pregnancy <u>decreases</u> risk of <b>{{c1::neural tube}} defects</b> </div></div></div></div>", "time": null}, {"id": 1476583701831, "note": "<div><div><div><div>What <i>type</i> of <u>anemia</u> is seen with <b>vitamin B</b><sub style=\"font-weight: bold; \">9</sub> (folate) <b>deficiency</b>?</div><div><br></div><div>{{c1::Macrocytic, megaloblastic anemia}}</div></div></div></div>", "time": null}, {"id": 1476583707008, "note": "<div><div><div><div><b>Vitamin B<sub>9</sub> </b>(folate) <u>deficiency</u> is characterized by {{c1::hypersegmented}} <b>polymorphonuclear cells</b> (PMNs)</div></div></div></div>", "time": null}, {"id": 1476583713668, "note": "<div><div><div><div>Does <b>vitamin B</b><sub style=\"font-weight: bold; \">9</sub> (folate) <u>deficiency</u> cause <b>neurologic symptoms</b>? </div><div><br /></div><div>{{c1::No}}</div></div></div></div>", "time": null}, {"id": 1476583726304, "note": "<div><div><div><div><b>Vitamin B<sub>9</sub> </b>(folate) <u>deficiency</u> is characterized by {{c1::normal}} <b>methylmalonic acid</b> levels</div></div></div></div>", "time": null}, {"id": 1476583733748, "note": "<div><div><div><div><b>Vitamin B<sub>9</sub> </b>(folate) <u>deficiency</u> is characterized by {{c1::increased}} <b>homocysteine</b> levels</div></div></div></div>", "time": 1659989420299.0}, {"id": 1476583738293, "note": "<div><div><div><div>A <i>nonspecific</i> symptom of <b>vitamin B<sub>9</sub> </b>(folate) <u>deficiency</u> is {{c1::glossitis::tongue}}</div></div></div></div>", "time": null}, {"id": 1476583741652, "note": "<div><div><div><div>Vitamin {{c1::B<sub>12</sub>}} is also known as <b>{{c2::cobalamin}}</b></div></div></div></div>", "time": null}, {"id": 1476583744866, "note": "<div><div><div><div><b>Vitamin B</b><sub style=\"font-weight: bold; \">12</sub> (cobalamin) is a <u>cofactor</u> for {{c1::<i>methionine synthase</i>}} and {{c2::<i>methylmalonyl-CoA mutase</i>}}</div></div></div></div>", "time": null}, {"id": 1476583753540, "note": "<div><div><div><div><b>Vitamin B<sub>12</sub> </b>(cobalamin) is found in {{c1::animal}} products</div></div></div></div>", "time": null}, {"id": 1476583756773, "note": "<div><div><div><div><b>Vitamin B<sub>12</sub> </b>(cobalamin) is <u>synthesized</u> <i>only</i> by {{c1::microorganisms}} </div></div></div></div>", "time": 1660105348240.0}, {"id": 1476583759387, "note": "<div><div><div><div><b>Vitamin </b>{{c3::<b>B</b><sub style=\"font-weight: bold; \">12</sub> (cobalamin)}} is <i>stored</i> in the {{c2::<u>liver</u>}} for up to 3-4 {{c1::years}}</div></div></div></div>", "time": null}, {"id": 1476583763287, "note": "<div>One cause of&nbsp;<b>{{c1::pernicious}} anemia </b>is<b>&nbsp;</b><i>lack</i>&nbsp;of&nbsp;<b>{{c2::intrinsic&nbsp;factor}},&nbsp;</b>which leads to&nbsp;<b>vitamin </b>{{c3::<b>B</b><sub style=\"font-weight: bold;\">12</sub>}} <u>deficiency</u></div>", "time": null}, {"id": 1476583766716, "note": "<div><div><div><div>{{c1::Anti-intrinsic factor}} <u>antibodies</u> are diagnostic for <b>pernicious anemia</b></div></div></div></div>", "time": null}, {"id": 1476583770861, "note": "<div><div><div><div>One cause of <b>vitamin </b>{{c2::<b>B</b><sub style=\"font-weight: bold; \">12</sub>}} <u>deficiency</u> is <b>{{c1::gastric}} bypass surgery</b> (ex. <u>Roux-en-Y</u>, <u>Sleeve Gastrectomy</u>)</div></div></div></div>", "time": null}, {"id": 1476583774604, "note": "<div><div><div><div>One cause of <b>vitamin </b><b>B</b><sub style=\"font-weight: bold; \">12</sub> <u>deficiency</u> is <b>damage</b> <b>to</b> or <b>resection</b> <b>of</b> the <b>{{c1::terminal ileum}}</b> (e.g. Crohn disease)</div></div></div></div>", "time": null}, {"id": 1476583778314, "note": "<div><div><div><div>One cause of <b>vitamin </b><b>B</b><sub style=\"font-weight: bold; \">12</sub> <u>deficiency</u> is <b>insufficient intake</b>, which may occur with {{c1::vegan}} diets</div></div></div></div>", "time": null}, {"id": 1476583781350, "note": "<div><div><div><div>One cause of <b>vitamin </b><b>B</b><sub style=\"font-weight: bold; \">12</sub> <u>deficiency</u> is <b>{{c1::malabsorption}}</b> (e.g. sprue, enteritis)</div></div></div></div>", "time": null}, {"id": 1476583784272, "note": "<div><div><div><div>What <u>parasite</u> is associated with <b>vitamin B</b><sub style=\"font-weight: bold; \">12</sub> <b>deficiency</b>? </div><div><br></div><div><i>{{c1::Diphyllobothrium latum}}</i></div></div></div></div>", "time": null}, {"id": 1476583793394, "note": "<div><div><div><div>The <b>Schilling test</b> is useful in determining the <i>etiology</i> of <b>vitamin </b>{{c1::<b>B<sub>12</sub></b>}} <u>deficiency</u> </div></div></div></div>", "time": null}, {"id": 1476583796722, "note": "<div><div><div><div><div>What <i>type</i> of <u>anemia</u> is seen with <b>vitamin B</b><sub style=\"font-weight: bold; \">12</sub> (cobalamin) <b>deficiency</b>?</div><div><br></div><div>{{c1::Macrocytic, megaloblastic anemia}}</div></div></div></div></div>", "time": null}, {"id": 1476583799809, "note": "<div><div><div><div><div><b>Vitamin B<sub>12</sub> </b>(cobalamin) <u>deficiency</u> is characterized by {{c1::hypersegmented}} <b>polymorphonuclear cells</b> (PMNs)</div></div></div></div></div>", "time": null}, {"id": 1476583805176, "note": "<div>Does <b>vitamin B</b><sub style=\"font-weight: bold; \">12</sub> (cobalamin) <u>deficiency</u>&nbsp;cause <b>neurologic symptoms</b>?</div><div><br></div><div>{{c1::Yes}}<br></div>", "time": null}, {"id": 1476583812900, "note": "<div><div><div><div><div><b>Vitamin B<sub>12</sub> </b>(cobalamin) <u>deficiency</u> is characterized by {{c1::increased}} <b>methylmalonic acid</b> levels</div></div></div></div></div>", "time": null}, {"id": 1476583821628, "note": "<div><div><div><div><div><b>Vitamin B<sub>12</sub> </b>(cobalamin) <u>deficiency</u> is characterized by {{c1::increased}} <b>homocysteine</b> levels</div></div></div></div></div>", "time": 1659989431237.0}, {"id": 1476583824625, "note": "<div><div><div><div><i>Prolonged</i> <b>vitamin B</b><sub style=\"font-weight: bold; \">12</sub> <u>deficiency</u> causes irreversible {{c1::nerve}} damage</div></div></div></div>", "time": null}, {"id": 1476583827458, "note": "<div><div><div>Vitamin {{c1::C}} is also known as <b>{{c2::ascorbic acid}}</b></div></div></div>", "time": null}, {"id": 1476583830053, "note": "<div><div><div><b>Vitamin {{c2::C}}</b> keeps iron in the {{c1::Fe<sup>2+</sup>}} state which {{c3::<u>increases</u>}} absorption</div></div></div>", "time": null}, {"id": 1476583833764, "note": "<div><div><div><b>Vitamin {{c2::C}}</b> is necessary for {{c1::<u>hydroxylation</u>}} of <b>proline</b> and <b>lysine</b> in collagen synthesis</div></div></div>", "time": null}, {"id": 1476583836527, "note": "<div><div><div><b>Vitamin {{c2::C}}</b> is necessary for the enzyme <i style=\"font-weight: bold; \">dopamine \u03b2-hydroxylase</i>, which converts dopamine to norepinephrine</div></div></div>", "time": null}, {"id": 1476583840567, "note": "<div><div><div><b>Vitamin C</b> is found in {{c1::fruits}} and {{c1::vegetables}}</div></div></div>", "time": null}, {"id": 1476583843502, "note": "<div><div><div><b>Vitamin {{c1::C}}</b> is used as an <u>ancillary treatment</u> for <b>{{c2::methemoglobinemia}}</b></div></div></div>", "time": null}, {"id": 1476583846055, "note": "<div><div><div>What pathology is associated with <b>vitamin C</b> <u>deficiency</u>?</div><div><br /></div><div><b>{{c1::Scurvy}}</b> </div></div></div>", "time": null}, {"id": 1476583848657, "note": "<div><div><div>What vitamin deficiency is <u>commonly</u> characterized by <b>swollen</b> <b>gums</b>, bruising, <b>petechiae</b>, and hemarthrosis? </div><div><br /></div><div>{{c1::Vitamin C deficiency (scurvy)}}</div></div></div>", "time": 1660105344677.0}, {"id": 1476583854343, "note": "<div><div><div><b>Scurvy</b> (vitamin C deficiency) is associated with <u>poor</u> {{c1::<b>wound</b>}} <b>healing</b> </div></div></div>", "time": null}, {"id": 1476583864279, "note": "<div><div><div><b>Scurvy</b> is associated with {{c1::<u>perifollicular</u>}} <b>hemorrhages </b>and {{c2::<u>subperiosteal</u>}} <b>hemorrhages</b></div></div></div>", "time": null}, {"id": 1476583869493, "note": "<div><div><div><b>Scurvy</b> is associated with \"{{c1::corkscrew}}\" hair and loosening of the  teeth</div></div></div>", "time": null}, {"id": 1476583874664, "note": "<div><div><div><div>What effect does <b>vitamin C </b><u>deficiency</u> have on the <b>immune</b> <b>system</b>?</div><div><br></div><div>{{c1::Weakened immune response}}</div></div></div></div>", "time": null}, {"id": 1476583878006, "note": "<div><div><div><b>Vitamin C deficiency</b> is characterized by a(n) {{c1::<u>increased</u>}} <b>bleeding time</b> </div></div></div>", "time": null}, {"id": 1476583887901, "note": "<div><div><div><b>Vitamin C deficiency</b> is characterized by a(n) {{c1::<u>normal</u>}} <b>PT</b> and {{c1::<u>increased</u>}} <b>PTT </b></div></div></div>", "time": null}, {"id": 1476583896012, "note": "<div><div><div><b>Vitamin C</b> <u>excess</u> may cause {{c1::calcium oxalate}} <b>nephrolithiasis</b> </div></div></div>", "time": null}, {"id": 1476583908192, "note": "<div><b>Vitamin {{c2::C}}</b> <u>excess</u> can increase risk of <b>{{c1::iron}} toxicity</b> in <i>predisposed</i> individuals (e.g. those with transfusions, hemochromatosis)</div>", "time": null}, {"id": 1476583926797, "note": "<div><div><div><b>Vitamin </b>{{c1::<b>D</b><sub style=\"font-weight: bold; \">2</sub>}}, known as <u>ergocalciferol</u>, is the form ingested from <b>plants</b>, <b>fungi</b>, and <b>yeasts</b></div></div></div>", "time": null}, {"id": 1476583956651, "note": "<div><div><div>What is the <u>storage form</u> of <b>vitamin D</b>?</div><div><br></div><div>{{c1::25-OH D<sub>3</sub>}}</div></div></div>", "time": null}, {"id": 1476583959014, "note": "<div><div><div><div>What is the <u>active form</u> of <b>vitamin D</b>?</div><div><br></div><div>{{c1::1,25-(OH)<sub>2</sub> D<sub>3</sub>}}</div></div></div></div>", "time": null}, {"id": 1476583961748, "note": "<div><div><div><b>Vitamin D</b> {{c3::<u>increases</u>}} <i>intestinal</i> absorption of {{c1::<b>calcium</b>}} and {{c2::<b>phosphate</b>}}</div></div></div>", "time": null}, {"id": 1476583966601, "note": "<div><div><div>At {{c2::low}} levels, <u>vitamin D</u> increases <b>bone {{c1::mineralization}}</b></div></div></div>", "time": null}, {"id": 1476583969633, "note": "<div><div><div>At {{c2::high}} levels, <u>vitamin D</u> increases <b>bone {{c1::resorption}}</b></div></div></div>", "time": null}, {"id": 1476583972242, "note": "<div><div><div><b>Vitamin D </b><u>deficiency</u> causes {{c1::rickets}} in <b>children</b>; presents as bone pain and deformity</div></div></div>", "time": null}, {"id": 1476583976799, "note": "<div><div><div><b>Vitamin D </b><u>deficiency</u> causes {{c1::osteomalacia}} in <b>adults</b>; presents as bone pain, muscle weakness</div></div></div>", "time": null}, {"id": 1476583979683, "note": "<div><div><div><b>Vitamin {{c2::D}} </b><u>deficiency</u> is associated with <b>hypocalcemic {{c1::tetany}}</b></div></div></div>", "time": null}, {"id": 1476583982749, "note": "<div><div><div>What <u>vitamin</u> should be <i>orally</i> <i>supplemented</i> in <b>breastfed infants</b>? </div><div><br></div><div>{{c1::Vitamin D}}</div></div></div>", "time": null}, {"id": 1476583985260, "note": "<div><div><div><b>Vitamin D </b><u>deficiency</u> is <i>exacerbated</i> by {{c1::low}} sun exposure, {{c2::pigmented}} skin, and prematurity</div></div></div>", "time": null}, {"id": 1476583987989, "note": "<div><div><div><b>Vitamin {{c3::D}}</b> <u>excess</u> presents with <b>{{c1::hyper}}-calcemia</b> and <b>{{c2::hyper}}-calciuria</b></div></div></div>", "time": null}, {"id": 1476583995605, "note": "<div><div><div><b>Vitamin D</b> <u>excess</u> may present with <b>stupor</b> and {{c1::decreased}} <b>appetite</b></div></div></div>", "time": null}, {"id": 1476583999750, "note": "<div><div><div><b>Vitamin D </b><u>excess</u> is seen in {{c1::<b>granulomatous</b>}} diseases due to <u>increased activation of vitamin D</u> by <b>{{c2::epithelioid macrophages}}</b> </div></div></div>", "time": null}, {"id": 1476584002542, "note": "<div><div><div><b>Vitamin {{c1::E}}</b> is also referred to as <b>{{c2::tocopherol}}</b> or <b>tocotrienol</b></div></div></div>", "time": 1660105348195.0}, {"id": 1476584005032, "note": "<div><div><div><b>Vitamin E</b> primarily functions as a(n) {{c1::antioxidant}}; protects RBCs and membranes from free radical damage</div></div></div>", "time": null}, {"id": 1476584009973, "note": "<div><div><div><b>Vitamin {{c1::E}}</b> can <u>enhance</u> the <i>anticoagulant</i> effects of <b>{{c2::warfarin}}</b> </div></div></div>", "time": null}, {"id": 1476584021092, "note": "<div><div><div><b>Vitamin {{c3::E}}</b> <u>deficiency</u> may cause <b>{{c1::hemolytic}} anemia</b> and <b>{{c2::acanthocytosis::cells}}</b> (hematologic complications)</div></div></div>", "time": null}, {"id": 1476584023882, "note": "<div><div><div><b>Vitamin E</b> <u>deficiency</u> may cause muscle {{c1::weakness}}</div></div></div>", "time": null}, {"id": 1476584026341, "note": "<div><div><div>What <u>vitamin deficiency</u> has <i>similar</i> <b>neurologic presentation</b> to B<sub>12</sub> deficiency but lacks megaloblastic anemia? </div><div><br /></div><div>{{c1::Vitamin E deficiency}}</div></div></div>", "time": null}, {"id": 1476584033358, "note": "<div><div><div><b>Vitamin {{c1::K}}</b> is also referred to as <b>phytomenadione</b>, <b>phylloquinone</b>, and <b>phytonadione</b></div></div></div>", "time": null}, {"id": 1476584036426, "note": "<div><div><div><b>Vitamin {{c2::K}}</b> is a <i>cofactor</i> for the <b>{{c1::\u03b3-carboxylation}}</b> of <u>glutamic acid residues</u> on various proteins required for blood clotting</div></div></div>", "time": null}, {"id": 1476584038859, "note": "<div><div><div><b>Vitamin K</b> is <i>synthesized</i> by {{c1::colonic bacteria}}</div></div></div>", "time": null}, {"id": 1476584041597, "note": "<div><div><div><b>Vitamin {{c1::K}}</b> <i>injection</i> is given at <u>birth</u> to prevent <b>hemorrhagic disease of the newborn</b></div></div></div>", "time": null}, {"id": 1476584044171, "note": "<div><div><div>Does <u>breast milk</u> contain <b>vitamin K</b>?</div><div><br></div><div>{{c1::No}}</div></div></div>", "time": null}, {"id": 1476584046114, "note": "<div><div><div><b>Vitamin K</b> <u>deficiency</u> may cause neonatal {{c1::hemorrhage}}</div></div></div>", "time": null}, {"id": 1476584054368, "note": "<div><div><div><div><b>Vitamin K deficiency</b> is characterized by a(n) {{c1::<u>normal</u>}} <b>bleeding time</b> </div></div></div></div>", "time": null}, {"id": 1476584060864, "note": "<div><div><div><div><b>Vitamin K deficiency</b> is characterized by a(n) {{c1::<u>increased</u>}} <b>PT</b> and {{c1::<u>increased</u>}} <b>PTT </b></div></div></div></div>", "time": null}, {"id": 1476584068209, "note": "<div><div><div><b>Vitamin K deficiency</b> can occur after prolonged use of broad-spectrum {{c1::antibiotics}}</div></div></div>", "time": null}, {"id": 1476584071161, "note": "<div>What <u>vitamins</u>&nbsp;function as <b>antioxidants</b>?</div><div><br></div><div>{{c1::Vitamins A, C, and E::3}}</div>", "time": null}, {"id": 1476584073597, "note": "<div><div><div><b>{{c1::Zinc}}</b> is a <u>mineral</u> that is essential for the activity of 100+ enzymes</div></div></div>", "time": null}, {"id": 1476584076865, "note": "<div><b>Zinc</b> is a <u>mineral</u> that is important in the formation of {{c1::zinc fingers::transcription factor motif}}</div>", "time": 1660105341412.0}, {"id": 1476584079267, "note": "<div><div><div><b>Zinc </b><u>deficiency</u> is associated with delayed {{c1::wound}} healing</div></div></div>", "time": null}, {"id": 1476584081608, "note": "<div><div><div><b>{{c2::Zinc}}</b> <b>deficiency</b>&nbsp;is a trace mineral deficiency that is associated with <b>{{c1::hypo}}-gonadism</b></div></div></div>", "time": null}, {"id": 1476584083742, "note": "<div><div><div><b>{{c2::Zinc}} deficiency</b>&nbsp;is a trace mineral deficiency that is associated with {{c1::<i>decreased</i>}} <b>adult</b> <b>hair</b> (axillary, facial, pubic)</div></div></div>", "time": 1660105337170.0}, {"id": 1476584085965, "note": "<div><div><div>What <u>senses</u> are impaired with <b>zinc deficiency</b>?</div><div><br></div><div> <b>{{c1::Taste (dysgeusia)}}</b> and <b>{{c2::smell (anosmia)}}</b></div></div></div>", "time": 1660105345011.0}, {"id": 1476584088411, "note": "<div><div><div>What <u>mineral deficiency</u> is associated with <b>acrodermatitis enteropathica</b>? </div><div><br /></div><div>{{c1::Zinc deficiency}}</div></div></div>", "time": null}, {"id": 1476584099738, "note": "<div><div><div><b>Zinc </b><u>deficiency</u> may <i>predispose</i> to <b>alcoholic {{c1::cirrhosis}}</b></div></div></div>", "time": 1660105341414.0}, {"id": 1476584103099, "note": "<div><b>{{c1::Kwashiorkor}}</b> is a <i>malnutrition</i> disorder that results from a(n)&nbsp;<b>{{c2::protein}}-deficient diet</b></div>", "time": 1660105339857.0}, {"id": 1476584105090, "note": "<div><div>The symptoms of <b>{{c1::Kwashiorkor}}</b> may be remembered with the mnemonic \"<b>MEALS</b>\": <div style=\"centerbox\"><div class=\"mnemonics\"><div><br></div><div><b>M</b>: Malnutrition</div><div><b>E</b>: {{c2::Edema}}</div><div><b>A</b>: {{c3::Anemia}}</div><div><b>L</b>: {{c4::Liver (fatty)}}</div><div><b>S:</b>&nbsp;{{c5::Skin lesions (dyspigmentation, hyperkeratosis, etc)}}</div></div></div></div></div>", "time": null}, {"id": 1476584108843, "note": "<div><div><b>Kwashiorkor</b> may present with <b>edema</b> (due to <u>decreased</u> plasma {{c1::oncotic}} pressure) and <b>skin lesions</b></div></div>", "time": null}, {"id": 1476584154333, "note": "<div><div>What <i>malnutrition</i> disorder presents as a <b>small child</b> with a <b>swollen abdomen</b>? </div><div><br /></div><div>{{c1::Kwashiorkor}}</div></div>", "time": null}, {"id": 1476584161540, "note": "<div><b>{{c1::Marasmus}}</b> is a <i>malnutrition</i> disorder that results from a(n)&nbsp;<b>{{c2::calorie}}-deficient diet</b></div>", "time": null}, {"id": 1476584164425, "note": "<div><div><b>{{c1::Marasmus}}</b> is a <i>malnutrition</i> disorder characterized by <u>emaciation</u> with <b>tissue</b> and <b>muscle wasting</b> and loss of subcutaneous fat +/- edema</div></div>", "time": 1660105339680.0}, {"id": 1476584180434, "note": "<div>The <u>neurologic symptoms</u> seen in <b>vitamin B<sub>12</sub> deficiency</b> are due to <i>abnormal</i> {{c1::myelin}}</div>", "time": 1660105349764.0}, {"id": 1476584182319, "note": "<div><b>Vitamin B</b><sub style=\"font-weight: bold; \">12</sub> <u>deficiency</u> presents with <b>{{c1::paresthesias}}</b> and <b>{{c2::subacute combined degeneration}}</b> (neurologic symptoms)</div>", "time": null}, {"id": 1476584184074, "note": "<div><b>Subacute combined degeneration</b> in <u>vitamin B</u><sub>12</sub><u> deficiency</u> affects the {{c1::dorsal columns}}, {{c2::corticospinal tracts}}, and {{c3::spinocerebellar tracts}}</div>", "time": null}, {"id": 1476584185817, "note": "<b>Vitamin E</b> <u>deficiency</u> may cause {{c1::<b>Posterior (Dorsal)</b> <b>Column</b>}} and {{c2::<b>Spinocerebellar</b> <b>tract</b>}} <b>demyelination</b>", "time": null}, {"id": 1476661073431, "note": "<div><b>Ferrous (Fe<sup>2+</sup>) iron</b> within the <u>duodenal cell</u> is transported into the <i>blood</i> by the&nbsp;<b>{{c1::ferroportin}}</b> transporter</div>", "time": null}, {"id": 1476661087790, "note": "<div>The <b>Fe<sup>3+</sup> iron</b> in the <u>plasma</u> is bound to {{c1::transferrin}} for transport in the blood </div>", "time": null}, {"id": 1476661104838, "note": "<div><b>{{c1::Hepcidin}} </b>binds to the <b>{{c2::ferroportin}}</b> transporter on intestinal mucosal cells and macrophages, thus {{c3::<u>inhibiting</u>}} <b>iron absorption</b></div>", "time": null}, {"id": 1476661113645, "note": "<div>Some of the <b>iron</b> absorbed in the duodenum is taken up by <b>{{c1::hepatocytes}}</b> for <u>storage</u> as <b>{{c2::ferritin}}</b></div>", "time": null}, {"id": 1476661119016, "note": "<div>Some of the <b>iron</b> absorbed in the duodenum is taken up by <u>erythroid precursors</u> in <b>bone marrow</b> to make <b>{{c1::hemoglobin}}</b> for RBCs</div>", "time": 1660105350889.0}, {"id": 1476665733378, "note": "<div>In the <u>first</u> step of <b>heme </b><i>synthesis</i>, <b>{{c1::glycine}}</b> and <b>{{c2::succinyl-CoA}}</b> are combined to form <b>{{c3::\u03b4-aminolevulinic acid}}</b> via the enzyme <i style=\"font-weight: bold; \">{{c4::\u03b4-aminolevulinic acid synthase}}</i> (with {{c5::vitamin B<sub>6</sub>}} as a cofactor)</div>", "time": null}, {"id": 1476666792202, "note": "<div>What is the <u>rate-limiting enzyme</u> of <b>heme synthesis</b>? </div><div><br></div><div>{{c1::\u03b4-aminolevulinic acid synthase (ALAS)}}</div>", "time": null}, {"id": 1476666798893, "note": "<div><b>\u03b4-aminolevulinic acid synthase </b>is regulated via <u>negative feedback</u> by <b>{{c1::glucose}}</b> and <b>{{c2::heme}}</b></div>", "time": null}, {"id": 1476666803925, "note": "Does <b>heme synthesis</b> occur in the <u>cytoplasm</u> or <u>mitochondria</u>? <div><br /></div><div>{{c1::Both :)}} </div>", "time": null}, {"id": 1476666810819, "note": "<div><b>\u03b4-aminolevulinic acid</b> is converted to <b>{{c1::porphobilinogen}}</b> via the enzyme <i style=\"font-weight: bold; \">{{c2::\u03b4-aminolevulinic acid dehydratase}}</i> (heme synthesis)</div>", "time": 1660105336917.0}, {"id": 1476666815134, "note": "<div><b>Porphobilinogen</b> is converted to <b>{{c1::hydroxymethylbilane}}</b> via the enzyme <i style=\"font-weight: bold; \">{{c2::porphobilinogen deaminase}}</i> (heme synthesis)</div>", "time": null}, {"id": 1476666821658, "note": "<div><b>Hydroxymethylbilane</b> is converted to <b>{{c1::uroporphyrinogen III}}</b> via the enzyme <i>uroporphyrinogen III synthase</i> (heme synthesis)</div>", "time": null}, {"id": 1476666825837, "note": "<div><b>Uroporphyrinogen III</b> is converted to <b>{{c1::coproporphyrinogen III}}</b> via the enzyme <i style=\"font-weight: bold; \">{{c2::uroporphyrinogen decarboxylase}}</i> (heme synthesis)</div>", "time": null}, {"id": 1476666829827, "note": "<div><b>Coproporphyrinogen III</b> is converted to <b>{{c1::protoporphyrin}}</b> (heme synthesis)</div>", "time": null}, {"id": 1476666833848, "note": "<div><b>{{c1::Protoporphyrin}}</b> and {{c2::<b>Fe</b><sup style=\"font-weight: bold; \">2+</sup>}} combine to form <b>{{c3::heme}}</b> via the enzyme <b style=\"font-style: italic; \">{{c4::ferrochelatase}}</b></div>", "time": null}, {"id": 1476666837592, "note": "<b>Lead (Pb) poisoning</b> leads to <u>inhibition</u> of the enzymes <i style=\"font-weight: bold; \">{{c1::\u03b4-aminolevulinic acid dehydratase}}</i><i> </i>and <i style=\"font-weight: bold; \">{{c2::ferrochelatase}}</i> (heme synthesis)", "time": null}, {"id": 1476667635005, "note": "In <u>splenic macrophages</u>, <b>heme</b> is metabolized to <b>{{c1::biliverdin}}</b> by the enzyme <i><b>{{c2::heme oxygenase}}</b></i>", "time": null}, {"id": 1476669535017, "note": "<div>In <u>splenic macrophages</u>, <b>biliverdin</b> is reduced to <b>{{c1::(unconjugated) bilirubin}}</b></div>", "time": null}, {"id": 1476669538969, "note": "<div>What <i>type</i> of <b>bilirubin</b> (conjugated or unconjugated) is formed in the <u>splenic macrophages</u>? </div><div><br /></div><div>{{c1::Unconjugated/indirect bilirubin}}</div>", "time": null}, {"id": 1476669544873, "note": "<div><b>Unconjugated bilirubin</b> travels in the <u>blood</u> bound to {{c1::albumin}}</div>", "time": null}, {"id": 1476669549324, "note": "<div><b>Unconjugated bilirubin</b> is removed from the <u>blood</u> by the {{c1::liver::organ}}&nbsp;</div>", "time": null}, {"id": 1476669552837, "note": "<div>In the <u>liver</u>, <b>unconjugated bilirubin</b> is converted to <b>{{c1::conjugated bilirubin}}</b> via the enzyme <i style=\"font-weight: bold; \">{{c2::UDP-glucuronyl transferase}}</i></div>", "time": null}, {"id": 1476669559297, "note": "<div><b>Conjugated (direct) bilirubin</b> is excreted in bile and metabolized by <u><b>bacterial flora</b></u>, producing <b>{{c1::urobilinogen}}</b></div>", "time": null}, {"id": 1476669563594, "note": "<div>Most (80%) of <b>urobilinogen</b> is <i>excreted</i> in&nbsp;<u>feces</u> as <b>{{c1::stercobilin}}</b>, which gives stool its brown color</div>", "time": null}, {"id": 1476669567633, "note": "<div>~ 18% of <b>urobilinogen</b> is returned to the <u>liver</u> via <b>{{c1::enterohepatic}} circulation</b></div>", "time": null}, {"id": 1476669572157, "note": "<div>~ 2% of <b>urobilinogen</b> is <i>excreted</i> in <u>urine</u> as&nbsp;<b>{{c1::urobilin}}</b>, which gives urine its yellow color</div>", "time": null}, {"id": 1476669576211, "note": "<div>Is <b>unconjugated (indirect) bilirubin</b> water <i>soluble</i>?</div><div><br></div><div>{{c1::No (insoluble)}}</div>", "time": null}, {"id": 1476669579159, "note": "<div><div>Is <b>conjugated (direct) bilirubin</b> water <i>soluble</i>?</div><div><br></div><div>{{c1::Yes}}</div></div>", "time": null}, {"id": 1476669580948, "note": "<div>The \"<b>-ogen</b>\" suffix (e.g. urobilinogen) indicates a(n) {{c1::<u>colorless</u>::colored or colorless}} compound</div>", "time": null}, {"id": 1476669582662, "note": "The \"<b>-in</b>\" suffix (e.g. stercobilin) indicates a(n) {{c1::<u>colored</u>::colored or colorless}} compound", "time": null}, {"id": 1476733477668, "note": "What <u>chromosomal abnormality</u> is commonly associated with <b>endocardial cushion defects</b>? <div><br /></div><div>{{c1::Trisomy 21 (Down syndrome)}}</div>", "time": null}, {"id": 1476915318326, "note": "<div>The effects of <b>{{c10::cholinergic}} toxicity</b> may be remembered with the mnemonic \"<b>DUMBBELSS</b>\": </div><div style=\"centerbox\"><div class=\"mnemonics\"><div><br></div><div><b>D</b>: {{c1::diarrhea}}</div><div><b>U</b>: {{c2::urination}}</div><div><b>M</b>: {{c3::miosis}}</div><div><b>B</b>: {{c4::bronchospasm}}</div><div><b>B</b>: {{c5::bradycardia/bradypnea}} </div><div><b>E</b>: {{c6::excitation of skeletal muscle and CNS}}</div><div><b>L</b>: {{c7::lacrimation}}</div><div><b>S</b>: {{c8::salivation}}</div><div><b>S</b>: {{c9::sweating}} </div></div></div>", "time": 1660105352904.0}, {"id": 1476919613381, "note": "<div><b>Anti-muscarinics</b><i> block</i> the action of {{c1::<u>acetylcholine</u>}} at <b>M receptors</b><br></div>", "time": 1660105352928.0}, {"id": 1476919620070, "note": "<div style=\"font-style: italic; \">What <u>drug class</u> does <b>atropine</b> belong to?<br></div><div><div><br></div><div>{{c1::Anti-muscarinics}}<br></div></div>", "time": 1660105352594.0}, {"id": 1476919625787, "note": "<div><b>{{c1::Atropine}}</b> is found in <u>belladona flowers</u> and {{c2::<u>jimson weed</u>}}, which are natural <b>antimuscarinic alkaloids</b><br></div>", "time": 1660105352885.0}, {"id": 1476919634500, "note": "<div>What effect do <b>anti-muscarinics</b> have on <b>pupils</b>?<br></div><div><br></div><div>{{c1::Dilation (mydriasis)::dilation or constriction}}</div>", "time": 1660105352890.0}, {"id": 1476919643870, "note": "<div>What <u>anti-muscarinic</u> is administered as a <i>transdermal patch</i> to treat <b>motion sickness</b> (vestibular nausea)?<br></div><div><br></div><div>{{c1::Scopolamine}}</div>", "time": 1660105352894.0}, {"id": 1476919648352, "note": "<div><b>Scopolamine</b> primarily affects the <b>{{c1::CNS::organ system}}</b>&nbsp;via <u>inhibition</u> of {{c2::<b>M1</b>}} muscarinic receptors</div>", "time": 1660105352906.0}, {"id": 1476919655451, "note": "<div>What effect do <u>anti-muscarinics</u> have on <b>heart rate</b>?<br></div><div><br></div><div>{{c1::Increased HR}} </div>", "time": 1660105352891.0}, {"id": 1476919664478, "note": "<div>What effect do <u>anti-muscarinics</u> have on <b>AV conduction velocity</b>?<br></div><div><div><br></div><div>{{c1::Increased conduction velocity}} </div></div>", "time": 1660105352892.0}, {"id": 1476919674183, "note": "<div>What <u>drug class</u> do <b>ipratropium</b> and <b>tiotropium</b> belong to?<br></div><div><br></div><div>{{c1::Inhaled M3 antimuscarinics}}</div>", "time": 1660105352551.0}, {"id": 1476919680971, "note": "<div><b>Ipratropium</b> and <b>tiotropium</b> primarily affect the <b>{{c1::lungs::organ}}</b>&nbsp;via <u>inhibition</u> of {{c2::<b>M3</b>}} muscarinic receptors</div>", "time": 1660105352918.0}, {"id": 1476919685377, "note": "<div><b>Anti-muscarinics</b> may be used to {{c1::<u>dilate</u>}} bronchial airways and to {{c2::<u>reduce</u>}} secretions<br></div>", "time": 1660105352925.0}, {"id": 1476919693433, "note": "<div>Which <u>anti-muscarinic</u> (tiotropium or ipratropium) is <b>longer-acting</b>?<br></div><div><br></div><div>{{c1::Tiotropium}}</div>", "time": 1660105352886.0}, {"id": 1476919698402, "note": "<div>What <u>drug class</u> do <b>oxybutynin</b>, <b>tolterodine</b>, and <b>solifenacin</b> belong to?<br></div><div><div><br></div><div>{{c1::<b>Oral</b> <b>M3 muscarinic antagonists</b>}}</div></div>", "time": 1660105352595.0}, {"id": 1476919709210, "note": "<div><b>Oxybutynin</b> and <b>tolterodine</b> primarily affect the <b>{{c1::genitourinary system::organ system}}</b>&nbsp;via <u>inhibition</u> of {{c2::<b>M3</b>}} muscarinic receptors</div>", "time": 1660105352908.0}, {"id": 1476919714833, "note": "<div><b>Oxybutynin</b> and <b>tolterodine</b> are primarily used to treat {{c1::urgency incontinence (overactive bladder)}}<br></div>", "time": 1660105352909.0}, {"id": 1476919724945, "note": "<div>What <u>drug class</u> do <b>benztropine</b> and&nbsp;<b>trihexyphenidyl</b> belong to?<br></div><div><div><br></div><div>{{c1::<b>M1 Muscarinic antagonists</b>}}</div></div>", "time": 1660105352552.0}, {"id": 1476919734213, "note": "<div><b>Benztropine</b> and <b>trihexyphenidyl</b> primarily affect the <b>{{c1::CNS::organ system}}</b>&nbsp;via <u>inhibition</u> of {{c2::<b>M1</b>}} muscarinic receptors</div>", "time": 1660105352921.0}, {"id": 1476919744186, "note": "<div><b>{{c3::M1}} muscarinic </b><u>antagonists</u> (e.g. Benztropine) can reduce <i>pill rolling </i>{{c1::<b>tremors</b>}} and <i>cogwheel</i> {{c2::rigidity}} in <b>Parkinsons disease</b><br></div>", "time": 1660105352883.0}, {"id": 1476919757743, "note": "<div><b>Benztropine</b> may be used to treat <u>extrapyramidal</u> side effects caused by {{c1::<b>anti-psychotic</b>}} drugs (e.g. <b>dystonia</b>, akathisia, parkinsonism)<br></div>", "time": 1660105352919.0}, {"id": 1476919769431, "note": "<div>What effect does <b>atropine</b> have on the <u>stomach acid secretion</u>?<br></div><div><br></div><div>{{c1::Decreased acid secretion}}</div>", "time": 1660105352888.0}, {"id": 1476919773069, "note": "<div>What effect does <b>atropine</b> have on the <u>gut motility</u>?<br></div><div><div><br></div><div>{{c1::Decreased motility}}</div></div>", "time": 1660105352889.0}, {"id": 1476919776519, "note": "<div>What effect does <b>atropine</b> have on <u>airway secretions</u>?<br></div><div><div><br></div><div>{{c1::Decreased secretions}}</div></div>", "time": 1660105352588.0}, {"id": 1476919779333, "note": "<div><b>Atropine</b> may be used to <u>decrease</u> urinary {{c1::urgency}} in <b>cystitis</b></div>", "time": 1660105352922.0}, {"id": 1476919782385, "note": "<div>Which \"<b>DUMBBELSS</b>\" symptom is <i>NOT</i> alleviated by <u>atropine administration</u> in <b>cholinesterase inhibitor poisoning</b>?<br></div><div><br></div><div>{{c1::Excitation of skeletal muscle and CNS}}</div>", "time": 1660105352887.0}, {"id": 1476919789412, "note": "<div>One <i>adverse effect</i> of <b>anti-muscarinics </b>(e.g. atropine) is {{c1::tachycardia::HR}}&nbsp;<br></div>", "time": 1660105352916.0}, {"id": 1476919793674, "note": "<div>One <i>adverse effect</i> of <b>anti-muscarinics</b> is <b>{{c1::hyperthermia}}</b>, especially in {{c2::<u>infants</u>}}<br></div>", "time": 1660105352912.0}, {"id": 1476919800993, "note": "<div><b>Anti-muscarinics</b> cause <u>hyperthermia</u> due to inhibition of <b>{{c1::sweat glands}}</b> via antagonism of {{c2::M3}} receptors<br></div>", "time": 1660105352927.0}, {"id": 1476919810379, "note": "<div><i>Adverse effects </i>of <b>anti-muscarinics</b> include {{c2::<u>dry</u>}} <b>{{c1::eyes}}</b> and <b>{{c3::mouth}}</b>&nbsp;<br></div>", "time": 1660105352932.0}, {"id": 1476919819600, "note": "<div>One <i>adverse effect</i> of <b>anti-muscarinics</b> is <u>dry</u>, {{c1::flushed}} <b>skin</b><br></div>", "time": 1660105352915.0}, {"id": 1476919831441, "note": "<div><i>Adverse effects</i> of <b>anti-muscarinics </b>on the eye and its muscles (<i>not including glands</i>) include&nbsp;<b>{{c1::mydriasis}}</b> and <b>{{c2::cycloplegia}}</b><br></div>", "time": 1660105352934.0}, {"id": 1476919839290, "note": "<div>One <i>adverse effect</i> of <b>anti-muscarinics</b> is <b>{{c1::acute angle-closure}} </b><b>glaucoma</b>, especially in {{c2::<u>elderly</u>}} patients<br></div>", "time": 1660105352914.0}, {"id": 1476919841793, "note": "<div><b>Anti-muscarinics</b> may cause <u>acute angle-closure glaucoma</u> due to decreased outflow of aqueous humor, secondary to <b>{{c1::mydriasis}}</b><br></div>", "time": 1660105352923.0}, {"id": 1476919848901, "note": "<div>One <i>adverse effect</i> of <b>anti-muscarinics</b> is {{c1::urinary retention}}, especially in men with <u>prostatic hyperplasia</u><br></div>", "time": 1660105352910.0}, {"id": 1476919851460, "note": "<div><i>Adverse effects</i> of <b>antimuscarinics</b> include<br></div><div> <b>agitation</b>, <b>hallucination</b>, and <b>coma</b>, especially in {{c1::<u>elderly</u>}} patients</div>", "time": 1660105352929.0}, {"id": 1477005434793, "note": "<div>The <b>{{c1::\u03b1<sub>1</sub>}}</b> <b>adrenergic</b> <b>receptor</b> is coupled to <b>{{c2::G<sub>q</sub>}}</b></div>", "time": 1660105352718.0}, {"id": 1477011377426, "note": "<div>The <b>{{c1::\u03b1<sub>2</sub>}}</b> <b>adrenergic</b> <b>receptor</b> is coupled to <b>{{c2::G<sub>i</sub>}}</b><br></div>", "time": 1660105352716.0}, {"id": 1477011384108, "note": "<div>The <b>{{c1::\u03b2<sub>1</sub>}} </b>and <b>{{c1::\u03b2<sub>2</sub>}}</b><b> adrenergic receptors</b> are coupled to <b>{{c2::G<sub>s</sub>}}</b><br></div>", "time": 1660105352714.0}, {"id": 1477011401729, "note": "<div><u>Activation</u> of the <b>{{c2::\u03b1<sub>1</sub>}}</b> adrenergic receptor causes <b>vaso-{{c1::constriction}}</b><br></div>", "time": 1660105352797.0}, {"id": 1477011409317, "note": "<div><u>Activation</u> of the <b>{{c2::\u03b1<sub>1</sub>}}</b> adrenergic receptor {{c1::<u>increases</u>}} <b>mean arterial pressure (MAP)</b><br></div>", "time": 1660105352791.0}, {"id": 1477011414189, "note": "<div><u>Activation</u> of the <b>{{c2::\u03b1<sub>1</sub>}}</b> adrenergic receptor causes <b>veno-{{c1::constriction}}</b><br></div>", "time": 1660105352795.0}, {"id": 1477011423804, "note": "<div><u>Activation</u> of the <b>{{c2::\u03b1<sub>1</sub>}}</b> adrenergic receptor causes <u>contraction</u> of the&nbsp;<b>{{c1::pupillary dilator}} muscle</b>, causing <b>{{c3::mydriasis}}</b><br></div>", "time": 1660105352800.0}, {"id": 1477011431858, "note": "<div><u>Activation</u> of the <b>{{c2::\u03b1<sub>1</sub>}}</b> adrenergic receptor causes {{c1::<u>contraction</u>}} of the <b>intestinal</b> and <b>bladder <i>sphincter</i> muscles</b><br></div>", "time": 1660105352793.0}, {"id": 1477011437200, "note": "<div><u>Activation</u> of the <b>\u03b1<sub>1</sub></b> adrenergic receptor may cause <b>urinary</b> {{c1::retention}}<br></div>", "time": 1660105352785.0}, {"id": 1477011451449, "note": "<div><u>Activation</u> of the <b>{{c2::\u03b1<sub>2</sub>}}</b> adrenergic receptor causes {{c1::<u>decreased</u>}} levels of intracellular <b>cAMP</b><br></div>", "time": 1660105352787.0}, {"id": 1477011456345, "note": "<div><u>Activation</u> of the&nbsp;<i>presynaptic</i>&nbsp;<b>{{c2::\u03b1<sub>2</sub>}}</b> adrenergic receptors can <u>inhibits</u> {{c1::neurotransmitter}} release</div>", "time": 1660105352789.0}, {"id": 1477011463650, "note": "<div><u>Activation</u> of <b>{{c2::\u03b1<sub>2</sub>}}</b> adrenergic receptors on <i>pancreatic islet cells</i> causes {{c1::<u>decreased</u>}} <b>insulin release</b><br></div>", "time": 1660105352782.0}, {"id": 1477011469772, "note": "<div><u>Activation</u> of <b>{{c2::\u03b1<sub>2</sub>}}</b> adrenergic receptors {{c1::<u>inhibits</u>}} <b>lipolysis</b> and <b>release of fatty acids</b><br></div>", "time": 1660105352780.0}, {"id": 1477011480660, "note": "<div><u>Activation</u> of <b>{{c2::\u03b1<sub>2</sub>}}</b> adrenergic receptors on <i>ciliary bodies</i> causes {{c1::<u>decreased</u>}} <b>aqueous humor production</b><br></div>", "time": 1660105352784.0}, {"id": 1477011485721, "note": "<div><u>Activation</u> of <b>{{c2::\u03b1<sub>2</sub>}}</b> adrenergic receptors causes {{c1::<u>increased</u>}} <b>platelet aggregation</b></div>", "time": 1660105359254.0}, {"id": 1477011497450, "note": "<div><u>Activation</u> of <b>{{c2::\u03b2}}</b> adrenergic receptors causes {{c1::<u>increased</u>}} levels of intracellular <b>cAMP</b><br></div>", "time": 1660105352760.0}, {"id": 1477011505650, "note": "<div><u>Activation</u> of <b>{{c2::\u03b2<sub>1</sub>}}</b> adrenergic receptors on the <i>SA node</i> causes {{c1::<u>increased</u>}} <b>heart rate</b><br></div>", "time": 1660105352774.0}, {"id": 1477011511428, "note": "<div><u>Activation</u> of <b>{{c2::\u03b2<sub>1</sub>}}</b> adrenergic receptors on the <i>cardiac myocytes</i> causes {{c1::<u>increased</u>}} <b>cardiac contractility</b><br></div>", "time": 1660105352778.0}, {"id": 1477011516755, "note": "<div><u>Activation</u> of <b>\u03b2<sub>1</sub></b> adrenergic receptors results in {{c1::<u>increased</u>}} <b>cardiac output</b><br></div>", "time": 1660105352758.0}, {"id": 1477011522197, "note": "<div><u>Activation</u> of <b>{{c2::\u03b2<sub>1</sub>}}</b> adrenergic receptors on the <i>juxtaglomerular cells</i> causes {{c1::<u>increased</u>}} <b>renin release</b><br></div>", "time": 1660105352776.0}, {"id": 1477011528602, "note": "<div><u>Activation</u> of <b>{{c2::\u03b2<sub>2</sub>}}</b> adrenergic receptors causes <b>broncho-{{c1::dilation}}</b><br></div>", "time": 1660105352772.0}, {"id": 1477011534590, "note": "<div><u>Activation</u> of <b>{{c2::\u03b2<sub>2</sub>}}</b> adrenergic receptors causes <u>coronary</u> and <u>skeletal muscle</u> <b>vaso-{{c1::dilation}}</b><br></div>", "time": 1660105352770.0}, {"id": 1477011539335, "note": "<div><u>Activation</u> of <b>\u03b2<sub>2</sub></b> adrenergic receptors causes {{c1::<u>decreased</u>}} <b>systemic vascular resistance</b> (SVR)<br></div>", "time": 1660105352756.0}, {"id": 1477011544513, "note": "<div><u>Activation</u> of <b>{{c2::\u03b2<sub>2</sub>}}</b> adrenergic receptors causes {{c1::<u>decreased</u>}} <b>diastolic blood pressure</b><br></div>", "time": 1660105352768.0}, {"id": 1477011550067, "note": "<div><u>Activation</u> of <b>\u03b2</b><b><sub>1</sub> </b>and <b>\u03b2</b><b><sub>2</sub></b> adrenergic receptors {{c1::<u>stimulates</u>}} <b>lipolysis</b> and <b>release of fatty acids</b><br></div>", "time": 1660105352757.0}, {"id": 1477011554587, "note": "<div><u>Activation</u> of <b>{{c2::\u03b2<sub>2</sub>}}</b> adrenergic receptors {{c1::<u>stimulates</u>}} <b>gluconeogenesis</b> in the liver<br></div>", "time": 1660105352762.0}, {"id": 1477011561690, "note": "<div><u>Activation</u> of <b>{{c2::\u03b2<sub>2</sub>}}</b> adrenergic receptors on <i>pancreatic islet cells</i> causes {{c1::<u>increased</u>}} <b>insulin release</b><br></div>", "time": 1660105352764.0}, {"id": 1477011567163, "note": "<div>What effect does <b>\u03b2<sub>2</sub></b> adrenergic <u>activation</u> have on serum <b>K<sup>+</sup> levels</b>?<br></div><div><br></div><div>{{c1::Decreased (hypokalemia)}}</div>", "time": 1660105352709.0}, {"id": 1477011576752, "note": "<div><u>Activation</u> of <b>{{c2::\u03b2<sub>2</sub>}}</b> adrenergic receptors on <i>ciliary bodies</i> causes {{c1::<u>increased</u>}} <b>aqueous humor production</b><br></div>", "time": 1660105352766.0}, {"id": 1477011581106, "note": "<div><b>Phenylephrine</b> is <i>primarily</i> a(n) {{c1::\u03b1<sub>1</sub>::alpha 1 or 2}}&nbsp;<b>agonist</b></div>", "time": 1660105352726.0}, {"id": 1477011611143, "note": "<div><b>Phenylephrine</b> causes {{c1::increased}} <u>systolic</u> pressure<br></div>", "time": 1660105352727.0}, {"id": 1477011616347, "note": "<div><b>Phenylephrine</b> causes {{c1::increased}} <u>diastolic</u> pressure<br></div>", "time": 1660105352728.0}, {"id": 1477011621149, "note": "<div><b>Phenylephrine</b> causes <u>reflex</u> {{c1::bradycardia::HR}}&nbsp;<br></div>", "time": 1660105352729.0}, {"id": 1477011629194, "note": "<div>Rank the following <b>receptors</b> for <b>affinity to norepinephrine</b>, from <u>highest</u> to <u>lowest</u>: \u03b2<sub>1</sub>, \u03b1<sub>1</sub>, \u03b1<sub>2</sub>,<br></div><div><br></div><div>{{c1::\u03b1<sub>1</sub>&gt; \u03b1<sub>2</sub> &gt; \u03b2<sub>1</sub>}}</div>", "time": 1660105352721.0}, {"id": 1477011634030, "note": "<div><b>Norepinephrine</b> may be used to treat {{c1::<u>hypo</u>}}<u>-tension</u><br></div>", "time": 1660105352730.0}, {"id": 1477011641203, "note": "<div><b>Norepinephrine </b>causes {{c1::increased}} <u>systolic</u> pressure<br></div>", "time": 1660105352731.0}, {"id": 1477011649586, "note": "<div><b>Norepinephrine </b>causes {{c1::increased}} <u>diastolic</u> pressure<br></div>", "time": 1660105352733.0}, {"id": 1477011656570, "note": "<div><b>Norepinephrine </b>causes {{c1::increased}} <u>pulse</u> pressure<br></div>", "time": 1660105352732.0}, {"id": 1477011664436, "note": "<div><b>Norepinephrine</b> causes <u>reflex</u> {{c1::bradycardia::HR}}&nbsp;<br></div>", "time": 1660105352734.0}, {"id": 1477011672952, "note": "<div>Unlike phenylephrine, <b>norepinephrine&nbsp;</b>causes <u>increased</u> {{c1::cardiac contractility}} due to <b>\u03b2<sub>1</sub></b> activation which results in increased pulse pressure<br></div>", "time": 1660105352712.0}, {"id": 1477011680427, "note": "<div>What <u>sympathomimetic</u> catecholamine is used to treat <b>septic </b>shock?<br></div><div><br></div><div>{{c1::Norepinephrine}} </div>", "time": 1660105352706.0}, {"id": 1477011688658, "note": "<div>Rank the following <b>receptors</b> for <b>affinity to dobutamine</b>, from <u>highest</u> to <u>lowest</u>: \u03b2<sub>1</sub>, \u03b2<sub>2</sub>, \u03b1<br></div><div><br></div><div>{{c1::\u03b2<sub>1 </sub>&gt; \u03b2<sub>2</sub> &gt; \u03b1}}</div>", "time": 1660105352722.0}, {"id": 1477011693487, "note": "<div>What effect does <b>dobutamine</b> have on <b>HR</b> and <b>contractility</b>?<br></div><div><br></div><div>{{c1::Increased HR/contractility (\u03b2<sub>1</sub> agonist)}}</div>", "time": 1660105352710.0}, {"id": 1477011701404, "note": "<div><b>Dobutamine</b> causes <i>mild</i> <b>vaso-{{c1::dilation}}</b><br></div>", "time": 1660105352750.0}, {"id": 1477011709231, "note": "<div><b>Dobutamine</b> causes {{c1::increased}} <u>pulse</u> pressure<br></div>", "time": 1660105352748.0}, {"id": 1477011718005, "note": "<div><b>Dobutamine</b> causes {{c1::increased}} <u>systolic</u> pressure<br></div>", "time": 1660105352747.0}, {"id": 1477011725670, "note": "<div><b>Dobutamine</b> causes {{c1::decreased}} <u>diastolic</u> pressure<br></div>", "time": 1660105352749.0}, {"id": 1477011732949, "note": "<div>What <u>sympatho<b>mimetic</b></u> is used to treat <b>cardiogenic </b>shock?<br></div><div><br></div><div>{{c1::Dobutamine}} </div>", "time": 1660105352707.0}, {"id": 1477011740581, "note": "<div>Which <u>sympathomimetic</u> is useful for <b>cardiac stress testing</b>?<br></div><div><br></div><div>{{c1::Dobutamine}} </div>", "time": 1660105352705.0}, {"id": 1477011748932, "note": "<div><b>Isoproterenol</b> acts on {{c1::\u03b2<sub>1</sub>}} and {{c1::\u03b2<sub>2</sub>}} adrenergic receptors<br></div>", "time": 1660105352740.0}, {"id": 1477011753866, "note": "<div><b>Isoproterenol</b> causes {{c1::<u>increased</u>}} <b>HR </b>and <b>contractility</b><br></div>", "time": 1660105352736.0}, {"id": 1477011760995, "note": "<div><b>Isoproterenol</b> causes <b>vaso-{{c1::dilation}}</b><br></div>", "time": 1660105352739.0}, {"id": 1477011767340, "note": "<div><b>Isoproterenol</b> causes {{c1::decreased}} <u>diastolic</u> pressure<br></div>", "time": 1660105352738.0}, {"id": 1477011774822, "note": "<div><b>Isoproterenol</b> causes {{c1::<u>decreased</u>}} <b>mean arterial pressure</b><br></div>", "time": 1660105352737.0}, {"id": 1477011782938, "note": "<div><b>Isoproterenol</b> causes {{c1::increased}} <u>pulse pressure</u><br></div>", "time": 1660105352735.0}, {"id": 1477011790487, "note": "<div><b>Terbutaline</b> and <b>ritodrine</b> are {{c2::\u03b2<sub>2</sub>}} receptor <u>agonists</u> that are used to <b>relax</b> <b>{{c1::uterine smooth}} muscle</b><br></div>", "time": 1660105352720.0}, {"id": 1477011798304, "note": "<div>At {{c2::<u>low</u>}} doses, <b>epinephrine</b> primarily activates <b>{{c1::\u03b2}}</b> adrenergic receptors<br></div>", "time": 1660105352753.0}, {"id": 1477011808646, "note": "<div>At {{c2::<u>high</u>}} doses, <b>epinephrine</b> primarily activates <b>{{c1::\u03b1}}</b> adrenergic receptors<br></div>", "time": 1660105352755.0}, {"id": 1477011839741, "note": "<div><b>Epinephrine</b> causes {{c1::<u>increased</u>}} <b>HR</b> and <b>cardiac contractility</b><br></div>", "time": 1660105352744.0}, {"id": 1477011851812, "note": "<div><b>Epinephrine</b> causes {{c1::<u>increased</u>}} <b>mean arterial pressure</b><br></div>", "time": 1660105352743.0}, {"id": 1477011859852, "note": "<div><b>Epinephrine</b> causes {{c1::increased}} <u>systolic</u> pressure<br></div>", "time": 1660105352741.0}, {"id": 1477011869612, "note": "<div><b>Epinephrine</b> causes {{c1::decreased}} <u>diastolic</u> pressure<br></div>", "time": 1660105352745.0}, {"id": 1477011876587, "note": "<div><b>Epinephrine</b> causes {{c1::increased}} <u>pulse</u> pressure<br></div>", "time": 1660105352742.0}, {"id": 1477011883318, "note": "<div>What <u>catecholamine</u> is used to treat <b>anaphylactic shock</b>?<br></div><div><br></div><div>{{c1::Epinephrine}} </div>", "time": 1660105352708.0}, {"id": 1477089705684, "note": "<div>Inside the <u>nerve terminal</u>, <b>tyrosine</b> is converted to <b>{{c1::L-DOPA}}</b> via <i>tyrosine hydroxylase</i><br></div>", "time": 1660105352813.0}, {"id": 1477089715178, "note": "<div>{{c1::Metyrosine}} is a<i> tyrosine analog </i>that <u>prevents</u> conversion of <b>tyrosine</b> to <b>L-DOPA</b><br></div>", "time": 1660105352802.0}, {"id": 1477089726093, "note": "<div><b>Dopamine</b> is converted into {{c1::norepinephrine}} in the vesicle by <i>dopamine \u03b2-hydroxylase</i><br></div>", "time": 1660105352816.0}, {"id": 1477089745741, "note": "<div><b>Cocaine</b> exerts its effects via <u>inhibition</u> of the {{c1::NET}} and {{c1::DAT}} transporters (reuptake inhibitor)<br></div>", "time": 1660105352823.0}, {"id": 1477089750537, "note": "<div><b>Cocaine</b> <u>intoxication</u> can cause agitation, {{c1::hypertension::BP}}, {{c2::tachycardia::HR}}, and pupillary {{c3::dilation}}<br></div>", "time": 1660105352822.0}, {"id": 1477089761426, "note": "<div><b>Cocaine</b> causes vaso-{{c1::constriction::dilation or constriction}}&nbsp;<br></div>", "time": 1660105352824.0}, {"id": 1477089771285, "note": "<div><b>Cocaine</b> may induce coronary {{c1::<u>vasospasm</u>}}, which can cause <b>myocardial ischemia</b> and <b>Prinzmetal angina</b><br></div>", "time": 1660105352819.0}, {"id": 1477089775518, "note": "<div>What <i>class</i> of <u>autonomic drugs</u> are <b>contraindicated</b> in <b>cocaine toxicity</b>?<br></div><div><br></div><div>{{c1::\u03b2-blockers}}</div>", "time": 1660105352804.0}, {"id": 1477089780610, "note": "<div>Administration of <u>\u03b2-blockers</u> for <b>cocaine intoxication</b> causes extreme {{c1::<b>hypertension</b>::BP}} due to <i>unopposed</i> {{c2::\u03b1<sub>1</sub>}} activation</div>", "time": 1660105352840.0}, {"id": 1477089795846, "note": "<div>{{c1::Reserpine}} <u>inhibits</u> <b>VMAT</b>, thus depleting neurotransmitter stores<br></div>", "time": 1660105352801.0}, {"id": 1477089800068, "note": "<div><b>Amphetamines</b> exert their effects by {{c1::<u>displacing</u>}} <b>catecholamines</b> (NE, dopamine) into the synapse<br></div>", "time": 1660105352838.0}, {"id": 1477089830734, "note": "<div>The <b>{{c1::D<sub>1</sub>}} dopamine receptor</b> is coupled to <b>{{c2::G<sub>s</sub>}}</b><br></div>", "time": 1660105352808.0}, {"id": 1477089837439, "note": "<div>The <b>{{c1::D<sub>2</sub>}} dopamine receptor</b> is coupled to <b>{{c2::G<sub>i</sub>}}</b><br></div>", "time": 1660105352806.0}, {"id": 1477089841730, "note": "<div>At {{c1::<i>low</i>}} doses, <u>dopamine</u> stimulates <b>{{c3::D<sub>1</sub>}} receptors</b>, especially in the {{c2::<b>renal</b>}} <b>vasculature</b><br></div>", "time": 1660105352835.0}, {"id": 1477089846070, "note": "<div>What effect do <i>low</i> levels of <b>dopamine</b> have on <u>renal blood flow</u>?<br></div><div><br></div><div>{{c1::Increased RBF}}</div>", "time": 1660105352803.0}, {"id": 1477089852913, "note": "<div>At {{c1::<i>medium</i>}} doses, <u>dopamine</u> stimulates <b>{{c2::\u03b2<sub>1</sub>}} receptors</b><br></div>", "time": 1660105352832.0}, {"id": 1477089867198, "note": "<div>At {{c1::<i>high</i>}} doses, <u>dopamine</u> stimulates <b>{{c2::\u03b1<sub>1</sub>}} receptors</b><br></div>", "time": 1660105352837.0}, {"id": 1477089906455, "note": "<div><b>Dopamine</b> may be used for the treatment of {{c1::heart}} failure and unstable bradycardia<br></div>", "time": 1660105352814.0}, {"id": 1477089913242, "note": "<div><b>Dopamine</b> may be used as a&nbsp;<u>pressor</u> in the treatment of <b>{{c1::shock}}</b> <i>refractory</i> to other agents (e.g. norepinephrine)<br></div>", "time": 1660105352815.0}, {"id": 1477089918154, "note": "<div><b>D<sub>2</sub> dopamine receptors</b> are primarily found in the {{c1::CNS::organ system}}&nbsp;<br></div>", "time": 1660105352818.0}, {"id": 1477432063653, "note": "<div><b>Clonidine</b> is a(n) {{c1::<b>\u03b1<sub>2</sub></b>}}-adrenergic <i>agonist</i> that primary affects the <b>{{c2::CNS::organ system}}</b></div>", "time": 1660105352631.0}, {"id": 1477432855650, "note": "<div>Which <u>adrenergic receptor</u> is <b>sympatholytic</b>?<br></div><div><br></div><div>{{c1::\u03b1<sub>2</sub>}}</div>", "time": 1660105352586.0}, {"id": 1477432861773, "note": "<div>What effect does <b>clonidine</b> have on <u>blood pressure</u>?<br></div><div><br></div><div>{{c1::Decreased (via reduced sympathetic tone)}}</div>", "time": 1660105352701.0}, {"id": 1477432866507, "note": "<div><b>{{c2::Clonidine}}</b> is an <u>\u03b1</u><sub>2 </sub><u>agonist</u> that may be used to treat&nbsp;<b>hypertensive {{c1::urgency}}</b> (limited situations)<br></div>", "time": 1660105352694.0}, {"id": 1477432872252, "note": "<div><b>{{c2::Clonidine}}</b> is an <u>\u03b1</u><sub>2 </sub><u>agonist</u> that may be used to treat&nbsp;<b>{{c1::ADHD}}</b> that is <i>refractory</i> to treatment with stimulants<br></div>", "time": 1660105352692.0}, {"id": 1477432878321, "note": "<div><b>{{c2::Clonidine}}</b> is an <u>\u03b1</u><sub>2 </sub><u>agonist</u> that may be used to treat&nbsp;<b>{{c1::Tourettes}} syndrome</b><br></div>", "time": 1660105352690.0}, {"id": 1477432887267, "note": "<div>Adverse effects of <b>clonidine</b> include <u>CNS</u>&nbsp;and <u>respiratory</u> {{c1::depression}}</div>", "time": 1660105359248.0}, {"id": 1477432891952, "note": "<div>One adverse effect associated with <b>clonidine</b> is {{c1::hypotension::BP}}</div>", "time": 1660105359246.0}, {"id": 1477432895849, "note": "<div>One adverse effect associated with <b>clonidine</b> is {{c1::bradycardia::HR}}</div>", "time": 1660105359247.0}, {"id": 1477432899027, "note": "<div>One adverse effect associated with <b>clonidine</b> is {{c1::miosis::pupil size}}</div>", "time": 1660105359245.0}, {"id": 1477432903955, "note": "<div><b>\u03b1-methyldopa</b> is a(n) {{c1::<b>\u03b1<sub>2</sub></b>}} adrenergic <i>agonist</i> that primary affects the <b>{{c2::CNS::organ system}}</b>&nbsp;</div>", "time": 1660105352561.0}, {"id": 1477432909389, "note": "<div><b>{{c2::\u03b1-methyldopa}}</b> is an <u>\u03b1</u><sub>2 </sub><u>agonist</u> that is primarily used to treat <b>{{c1::gestational hypertension}}</b><br></div>", "time": 1660105352682.0}, {"id": 1477432914191, "note": "<div>Which <u>\u03b1</u><sub>2 </sub><u>agonist</u> may cause a <b>SLE-like syndrome</b> as an adverse effect?<br></div><div><b><br></b></div><div>{{c1::\u03b1-methyldopa}}</div>", "time": 1660105352700.0}, {"id": 1477432920598, "note": "<div>Which <u>\u03b1</u><sub>2 </sub><u>agonist</u> may cause a <b>direct Coombs (+) hemolysis</b> as an adverse effect?<br></div><div><br></div><div>{{c1::\u03b1-methyldopa}}</div>", "time": 1660105359250.0}, {"id": 1477432925746, "note": "<div><b>\u03b1-methyldopa</b> may cause a <u>direct Coombs test</u> {{c1::(+)}} <b>hemolysis</b></div>", "time": 1660105359249.0}, {"id": 1477432936752, "note": "<div><b>{{c2::Tizanidine}}</b> is an <u>\u03b1</u><sub>2 </sub><u>agonist</u> that may be used as a <b>muscle {{c1::relaxant}}</b><br></div>", "time": 1660105352684.0}, {"id": 1477432942049, "note": "<div><b>{{c1::Phentolamine}}</b> is a <i>non-selective</i> <u>reversible</u><i> </i><b>{{c2::\u03b1<sub>1</sub>}}</b> and&nbsp;<b>{{c2::\u03b1<sub>2</sub>}}&nbsp;</b>adrenergic receptor antagonist<br></div>", "time": 1660105352577.0}, {"id": 1477432947868, "note": "<div>Is <b>phentolamine</b> (\u03b1-blocker) <i>reversible</i> or <i>irreversible</i>?<br></div><div><br></div><div>{{c1::Reversible}}</div>", "time": 1660105352616.0}, {"id": 1477432955952, "note": "<div>Is <b>phentolamine</b> (\u03b1-blocker) <i>selective</i> or <i>non-selective</i>?<br></div><div><br></div><div>{{c1::Non-selective}}</div>", "time": 1660105352615.0}, {"id": 1477432963694, "note": "<div><b>Phentolamine</b> causes vaso-{{c1::dilation}}<br></div>", "time": 1660105352555.0}, {"id": 1477432971129, "note": "<div><b>{{c1::Phenoxybenzamine}}</b> is a <i>non-selective</i> <u>irreversible</u> <b>{{c2::\u03b1<sub>1</sub>}}</b> and&nbsp;<b>{{c2::\u03b1<sub>2</sub>}}</b> adrenergic receptor antagonist<br></div>", "time": 1660105352549.0}, {"id": 1477432981161, "note": "<div>Is <b>phenoxybenzamine</b> (\u03b1-blocker) <i>reversible</i> or <i>irreversible</i>?<br></div><div><br></div><div>{{c1::Irreversible}}</div>", "time": 1660105352618.0}, {"id": 1477432989137, "note": "<div>Is <b>phenoxybenzamine</b> (\u03b1-blocker) <i>selective</i> or <i>non-selective</i>?<br></div><div><br></div><div>{{c1::Non-selective}}</div>", "time": 1660105352617.0}, {"id": 1477433000882, "note": "<div><b>\u03b1 antagonists </b>(e.g. phentolamine) can be used to treat {{c1::cocaine::illicit drug}} toxicity<br></div>", "time": 1660105352680.0}, {"id": 1477433005679, "note": "<div><b>Wine</b> and <b>aged</b> <b>cheese</b> contain the <i>sympathomimetic</i> <b>{{c1::tyramine}}</b>, which is metabolized by the enzyme <b><i>{{c2::monoamine oxidase-A}}</i></b><br></div>", "time": 1660105352699.0}, {"id": 1477433010779, "note": "<div><b><i>Monoamine oxidase</i></b> <u>inhibitors</u> can prevent the metabolism of <b>tyramine</b> (e.g. from wine or cheese ingestion), causing a(n)&nbsp;<b>{{c1::hypertensive}} crisis</b></div>", "time": 1660105352703.0}, {"id": 1477433015124, "note": "<div><b>{{c1::Phentolamine}}</b> may be given to patients on <u>MAO inhibitors</u> who eat <b>tyramine containing foods</b> (e.g. wine, cheese)<br></div>", "time": 1660105352695.0}, {"id": 1477433020046, "note": "<div><b>{{c1::Phenoxybenzamine}}</b> is used <u>pre-operatively</u> to prevent <b>hypertensive crisis</b> during removal of a(n) {{c2::<b>pheochromocytoma</b>}}<br></div>", "time": 1660105352697.0}, {"id": 1477433027612, "note": "<div><b>\u03b1-receptor antagonists</b> may cause {{c1::orthostatic hypotension::BP}} as an adverse effect<br></div>", "time": 1660105352678.0}, {"id": 1477433031722, "note": "<div><b>\u03b1-receptor antagonists</b> may cause <i>reflex</i> {{c1::tachycardia::HR}} as an adverse effect<br></div>", "time": 1660105352679.0}, {"id": 1477433035666, "note": "<div>What <i>drug class</i> do <b>prazosin</b>, <b>terazosin</b>,&nbsp;<b>doxazosin</b>, and&nbsp;<b>tamsulosin</b> belong to?</div><div><br></div><div>{{c1::<u>Selective</u> \u03b1<sub>1</sub> antagonists (\"-osins\")}}</div>", "time": 1660105352550.0}, {"id": 1477433039808, "note": "<div><b>{{c2::\u03b1<sub>1</sub>}} adrenergic antagonists</b> may be used to treat urinary symptoms of {{c1::<b>BPH</b>}}<br></div>", "time": 1660105352607.0}, {"id": 1477433048360, "note": "<div><u>Selective</u> <b>\u03b1<sub>1</sub> adrenergic antagonists</b> (except tamsulosin) may be used to treat {{c1::hypertension::BP}}&nbsp;<br></div>", "time": 1660105352702.0}, {"id": 1477433060866, "note": "<div><b>{{c2::Prazosin}}</b> is a <u>selective</u> <b>\u03b1<sub>1</sub> antagonist</b> that may be used to treat <b>{{c1::post-traumatic stress}} disorder</b><br></div>", "time": 1660105352686.0}, {"id": 1477433068590, "note": "<div>One adverse effect associated with <u>selective</u>&nbsp;<b>{{c2::\u03b1<sub>1</sub>}} </b>adrenergic <i>antagonists</i> is <b>1st-dose</b> <b>{{c1::orthostatic hypotension}}</b><br></div>", "time": 1660105352557.0}, {"id": 1477433075625, "note": "<div><b>Mirtazapine</b> is a <u>selective</u> <b>{{c1::\u03b1<sub>2</sub>}} </b>adrenergic <i>antagonist</i><br></div>", "time": 1660105352558.0}, {"id": 1477433079711, "note": "<div>Is <b>mirtazapine</b> (\u03b1-blocker) <i>selective</i> or <i>non-selective</i>?<br></div><div><div><br></div><div>{{c1::Selective}}</div></div>", "time": 1660105352704.0}, {"id": 1477433089246, "note": "<div><b>{{c2::Mirtazapine}}</b> is an <u>\u03b1</u><sub>2</sub><u> antagonist</u> that may be used to treat <b>{{c1::depression}}</b><br></div>", "time": 1660105352688.0}, {"id": 1477433097831, "note": "<div>Adverse effects of <i>selective</i> <b>\u03b1<sub>2</sub> antagonists</b> (e.g. mirtazapine) include <b>sedation</b>, {{c1::<u>increased</u>}} <b>appetite</b>, and <u>increased</u> serum <b>{{c2::cholesterol}}</b><br></div>", "time": 1660105359252.0}, {"id": 1477440510272, "note": "<div><b>\u03b2-blockers</b> all have a \"{{c1::-lol}}\" suffix</div>", "time": 1660105352649.0}, {"id": 1477447015004, "note": "<div><b>\u03b2-blockers </b>{{c1::<u>decrease</u>}} cardiac contractility<br></div>", "time": 1660105352639.0}, {"id": 1477447024779, "note": "<div><b>\u03b2-blockers</b> may cause {{c1::bradycardia::HR}} as a <b>direct </b>adverse effect</div>", "time": 1660105352642.0}, {"id": 1477447031885, "note": "<div><b>\u03b2-blockers</b> can cause or exacerbate {{c1::heart block}} due to excessive <b>AV nodal</b> <u>inhibition</u><br></div>", "time": 1660105352651.0}, {"id": 1477447038671, "note": "<div><b>\u03b2-blockers</b> are useful in the management of chronic, stable {{c1::angina}}<br></div>", "time": 1660105352647.0}, {"id": 1477447048175, "note": "<div><b>\u03b2-blockers</b> treat angina by reducing {{c1::HR}} and {{c1::contractility}}, thus <u>decreasing</u> <b>myocardial O<sub>2</sub> demand</b><br></div>", "time": 1660105352640.0}, {"id": 1477447053586, "note": "<div>What <u>type</u> of <b>\u03b2-blocker</b> is <b>atenolol</b>?<br></div><div><br></div><div>{{c1::Selective \u03b2<sub>1</sub> antagonist (cardioselective)}} </div>", "time": 1660105352666.0}, {"id": 1477447065294, "note": "<div>What <u>type</u> of <b>\u03b2-blocker</b> is <b>betaxolol</b>?<br></div><div><div><br></div><div>{{c1::Selective \u03b2<sub>1</sub> antagonist (cardioselective)}} </div></div>", "time": 1660105352665.0}, {"id": 1477447074073, "note": "<div>What <u>type</u> of <b>\u03b2-blocker</b> is <b>esmolol</b>?<br></div><div><div><br></div><div>{{c1::Selective \u03b2<sub>1</sub> antagonist (cardioselective)}} </div></div>", "time": 1660105352663.0}, {"id": 1477447082664, "note": "<div>What <u>type</u> of <b>\u03b2-blocker</b> is <b>acebutolol</b>?<br></div><div><div><br></div><div>{{c1::Selective \u03b2<sub>1</sub> antagonist (cardioselective)}} </div></div>", "time": 1660105352667.0}, {"id": 1477447100980, "note": "<div>What <u>type</u> of <b>\u03b2-blocker</b> is <b>metoprolol</b>?<br></div><div><div><br></div><div>{{c1::Selective \u03b2<sub>1</sub> antagonist (cardioselective)}} </div></div>", "time": 1660105352661.0}, {"id": 1477447111426, "note": "<div><b>\u03b2<sub>1</sub> selective antagonists</b> primarily suppress <u>adrenergic</u> stimulation of the {{c1::heart (cardioselective)}}<br></div>", "time": 1660105352637.0}, {"id": 1477447115841, "note": "<div>{{c1::Cardioselective}} <b>\u03b2-blockers</b> are useful in the acute treatment of <b>MI</b> and other <b>ACS</b> (e.g. unstable, NSTEMI)<br></div>", "time": 1660105352657.0}, {"id": 1477447120151, "note": "<div>{{c1::Cardioselective}} <b>\u03b2-blockers</b> are useful in the management of <b>chronic heart failure</b><br></div>", "time": 1660105352656.0}, {"id": 1477447131807, "note": "<div>What <i>non-selective</i> <b>\u03b2-blocker</b> may be used in the treatment of <b>CHF</b>?<br></div><div><br></div><div>{{c1::Carvedilol}} </div>", "time": 1660105352668.0}, {"id": 1477447140175, "note": "<div>What <u>type</u> of \u03b2-blocker is <b>carvedilol</b>?<br></div><div><br></div><div>{{c1::Non-selective&nbsp;\u03b2- and \u03b1<sub>1</sub>-antagonist}}</div>", "time": 1660105352664.0}, {"id": 1477447145086, "note": "<div>Do <b>cardioselective \u03b2-blockers</b> <u>reduce mortality</u> in CHF and post-MI?<br></div><div><br></div><div>{{c1::Yes}}</div>", "time": 1660105352674.0}, {"id": 1477447155287, "note": "<div><b>\u03b2-blockers</b> reduce <u>cardiac remodeling</u> by protecting the heart from excess circulating {{c1::catecholamines}}<br></div>", "time": 1660105352641.0}, {"id": 1477447161132, "note": "<div><b>\u03b2-blockers</b> are useful in the treatment of {{c1::hypertension}}, especially in patients with <b>heart failure</b> or <b>post-MI</b><br></div>", "time": 1660105352644.0}, {"id": 1477447170888, "note": "<div><b>\u03b2-blockers</b> {{c1::<u>inhibit</u>}} production of <b>renin</b><br></div>", "time": 1660105352638.0}, {"id": 1477447177436, "note": "<div>What <u>type</u> of <b>\u03b2-blocker</b> is <b>labetalol</b>?<br></div><div><br></div><div>{{c1::Non-selective \u03b1<sub>1</sub>- and \u03b2-antagonist}}</div>", "time": 1660105352662.0}, {"id": 1477447188460, "note": "<div>Which <u>two</u> <b>\u03b2-blockers</b> are <i>non-selective</i> \u03b1<sub>1</sub>- and \u03b2-antagonists?<br></div><div><br></div><div>{{c1::Labetalol and carvedilol}}</div>", "time": 1660105352660.0}, {"id": 1477447196321, "note": "<div><b>Labetalol</b> causes vaso-{{c1::dilation}}<br></div>", "time": 1660105352672.0}, {"id": 1477447205759, "note": "<div>Which <b>\u03b2-blocker</b> is used to treat <u>hypertension</u> during <b>pregnancy</b> (<i>aka gestational hypertension</i>)?<br></div><div><br></div><div>{{c1::Labetalol}}</div>", "time": 1660105352658.0}, {"id": 1477447210587, "note": "<div><b>Labetalol</b> is useful in the treatment of <b>hypertensive</b> {{c1::<b>emergency</b>}}<br></div>", "time": 1660105352671.0}, {"id": 1477447224578, "note": "<div><b>IV \u03b2-blockers</b> (e.g. labetalol, esmolol) are useful in the acute management of <b>aortic</b> {{c1::<b>dissection</b>}}<br></div>", "time": 1660105352673.0}, {"id": 1477447228893, "note": "<div><b>\u03b2-blockers</b> are useful in the management of {{c1::<b>hypertrophic</b> <b>obstructive</b>}} and {{c2::<b>dilated</b>}} <b>cardiomyopathy</b><br></div>", "time": 1660105352646.0}, {"id": 1477447235549, "note": "<div><b>{{c2::\u03b2}}-adrenergic blockers</b> can be used for <b>{{c1::migraine}}</b> <i>prophylaxis</i><br></div>", "time": 1660105352653.0}, {"id": 1477447248845, "note": "<div><b>Propranolol</b> is a <u>\u03b2-blocker</u> that is useful for the treatment of <b>{{c1::thyroid}} storm</b><br></div>", "time": 1660105352670.0}, {"id": 1477447256308, "note": "<div><b>\u03b2-blockers </b>are a <u>first line treatment</u> for essential {{c1::tremor}}<br></div>", "time": 1660105352648.0}, {"id": 1477447260399, "note": "<div>What <i>class</i> of <u>anti-arrhythmic</u> are <b>\u03b2-blockers</b>?<br></div><div><br></div><div>{{c1::Class II antiarrhythmics}} </div>", "time": 1660105352669.0}, {"id": 1477447267775, "note": "<div>Adverse effects of <i>non-selective</i> <b>\u03b2-blockers </b>include <u>exacerbation</u> of <b>{{c1::asthma}}</b> and&nbsp;<b>{{c2::COPD}}</b><br></div>", "time": 1660105352676.0}, {"id": 1477447276445, "note": "<div><b>{{c2::Timolol}}</b> is a topical <i>non-selective</i> <b>\u03b2-blocker</b> that is used to treat <b>{{c1::open angle glaucoma}}</b><br></div>", "time": 1660105352655.0}, {"id": 1477447288622, "note": "<div><b>\u03b2-blockers</b> can cause {{c1::impotence}} in <u>men</u> as an adverse effect<br></div>", "time": 1660105352643.0}, {"id": 1477447295771, "note": "<div>Which <u>two</u> <b>\u03b2-blockers</b> have <b>partial</b> <b>agonist activity</b>?<br></div><div><br></div><div>{{c1::Acebutolol and pindolol}}</div>", "time": 1660105352659.0}, {"id": 1477447306507, "note": "<div><b>Acebutolol</b> and <b>pindolol</b> are {{c1::<u>contraindicated</u>}} in heart failure, MI, and angina<br></div>", "time": 1660105352677.0}, {"id": 1477447313512, "note": "<div><b>\u03b2-blocker</b> <u>toxicity</u> is treated with {{c1::<b>glucagon</b>}},<b> saline</b>, or <b>atropine</b><br></div>", "time": 1660105352650.0}, {"id": 1477447319676, "note": "<div><b>\u03b2-blockers</b> may have {{c1::CNS}} <u>adverse effects</u>, including seizures, sedation, and sleep alterations</div>", "time": 1660105359244.0}, {"id": 1477447324180, "note": "<div><b>{{c2::Metoprolol}}</b> is a <u>\u03b2-blocker</u> that is associated with&nbsp;<b>{{c1::dyslipidemia}}</b> as an adverse effect</div>", "time": 1660105359241.0}, {"id": 1477447327155, "note": "<div><b>\u03b2-blockers</b> may <u>mask the effects</u> of {{c1::hypoglycemia}}</div>", "time": 1660105359237.0}, {"id": 1477447329463, "note": "<div><b>{{c1::Propranolol}}</b> is a <u>\u03b2-blocker</u> that may <i>exacerbate</i> vasospasm in <b>Prinzmetal angina</b></div>", "time": 1660105359242.0}, {"id": 1477447331862, "note": "<div><b>\u03b2-blockers</b> may cause <u>unopposed \u03b1</u><sub>1</sub> <u>agonism</u> if given alone for <b>{{c1::cocaine}}</b> <b>toxicity</b> or <b>{{c2::pheochromocytoma}}</b><br></div>", "time": 1660105359239.0}, {"id": 1477447337864, "note": "<div>Are <b>\u03b2-blockers</b> <u>contraindicated</u> in <b>diabetic patients</b>?<br></div><div><br></div><div>{{c1::No}}</div>", "time": 1660105359243.0}, {"id": 1478644623569, "note": "What type of <u>cardiac tumor</u> is associated with a diastolic \"<b>plop</b>\" sound  (mid-diastolic rumbling murmur best heard at the apex) on auscultation? <div><br></div><div>{{c1::Myxomas}} </div>", "time": null}, {"id": 1478741474828, "note": "What <u>renal pathology</u> is associated with <b>eosinophils</b> in the <b>urine</b>? <div><br /></div><div>{{c1::Acute interstitial nephritis}}</div>", "time": null}, {"id": 1478915661684, "note": "<div>A <u>normal</u> <b>reticulocyte count</b> is between {{c1::1}} to {{c1::2}}% </div>", "time": null}, {"id": 1479248816088, "note": "<div>The levels of <u>TBG</u> and <u>total thyroid hormone</u> are {{c1::<i>decreased</i>}} with <b>{{c2::hepatic}} failure</b>, <b>{{c3::steroid}} use</b>, and <b>{{c4::nephrotic}} syndrome</b></div>", "time": 1660105349911.0}, {"id": 1479248835296, "note": "<div>The levels of <u>TBG</u> and <u>total thyroid hormone</u> are {{c1::<i>increased</i>}} with <b>{{c2::pregnancy}}</b> and <b>{{c3::oral contraceptive}} use</b> </div>", "time": 1660105349907.0}, {"id": 1479267261208, "note": "<div>What is the <u>source of energy</u> in <b>erythrocytes</b>? </div><div><br></div><div>{{c1::Glucose}}</div>", "time": null}, {"id": 1479267263688, "note": "<div>In <u>erythrocytes</u>, <b>90%</b> of <b>glucose</b> is used for {{c1::glycolysis}}</div>", "time": 1660105357304.0}, {"id": 1479267268809, "note": "<div>In <u>erythrocytes</u>, <b>10%</b> of <b>glucose</b> is used for the {{c1::HMP shunt}}</div>", "time": null}, {"id": 1479267275681, "note": "<div>What <u>antiporter</u> is present in the membrane of <b>erythrocytes</b>? </div><div><br /></div><div>{{c1::Cl<sup>-</sup>/HCO<sub>3</sub><sup>-</sup> antiporter}}</div>", "time": null}, {"id": 1479267324516, "note": "<div><b>Platelets</b> (thrombocytes) are small cytoplasmic fragments derived from {{c1::megakaryocytes}}</div>", "time": null}, {"id": 1479267329028, "note": "<div><b>Platelets</b> (thrombocytes) have a life span of {{c1::8}} to {{c1::10}} days</div>", "time": null}, {"id": 1479267335124, "note": "<div>What <u>skin finding</u> is associated with <b>thrombocytopenia</b> and/or <b>decreased platelet function</b>? </div><div><br></div><div>{{c1::Petechiae}}</div>", "time": 1660105344992.0}, {"id": 1479267337680, "note": "<div>The {{c1::<u>dense</u>}}<u> granules</u> of platelets contain <b>ADP</b> and<b> Ca<sup>2+</sup></b></div>", "time": null}, {"id": 1479267340667, "note": "<div>The {{c1::<u>\u03b1</u>}}<u> granules</u> of platelets contain <b>vWF</b>, <b>fibrinogen</b>, and <b>{{c2::fibronectin}}</b></div>", "time": null}, {"id": 1479267358567, "note": "<div>Which <u>leukocyte</u> is most involved in an <b>acute inflammatory response</b>? </div><div><br></div><div>{{c1::Neutrophils}}</div>", "time": null}, {"id": 1479267395454, "note": "<div><b>Macrophages</b> {{c1::phagocytose}} bacteria, cellular debris, and RBCs</div>", "time": null}, {"id": 1479267461227, "note": "<div><b>Mast cells</b> mediate {{c1::allergic}} reactions in local tissues</div>", "time": null}, {"id": 1479267463438, "note": "<div><b>Mast cells</b> can bind the {{c2::<u>Fc</u>}}<u> portion</u> of <b>Ig{{c1::E}}</b></div>", "time": null}, {"id": 1479267465747, "note": "<div>{{c1::<b>Cromolyn sodium</b>}} and {{c2::<b>Nedocromil</b>}} <u>prevent</u> <b>mast cell degranulation</b> (used for asthma prophylaxis)</div>", "time": null}, {"id": 1479267524420, "note": "<div><b>Plasma cells</b> have <u>abundant</u><b> RER </b>and a <u>well-developed</u> <b>{{c1::Golgi apparatus}}</b> (yellow arrows)</div><div><br></div><div><img src=\"paste-196950020325591.jpg\"></div>", "time": null}, {"id": 1480550522376, "note": "<div><b>Anencephaly</b> may result in <b>{{c1::poly}}-hydramnios</b></div>", "time": null}, {"id": 1480563883544, "note": "<div><div><div>A <u>high</u> <b>WBC count</b> (&gt; 10K) is called {{c1::leukocytosis}}</div></div></div>", "time": 1660105362547.0}, {"id": 1480563925641, "note": "<div><div><div><b>Lymphopenia</b> may occur due to a <u>high</u> {{c1::cortisol}} state, which induces <b>apoptosis</b> <b>of</b> <b>lymphocytes</b></div></div></div>", "time": 1660105355469.0}, {"id": 1480563962378, "note": "<div><div><div><b>{{c1::Neutrophilia}}</b> refers to an <u>increased</u> number of circulating <b>neutrophils</b></div></div></div>", "time": 1660105339467.0}, {"id": 1480563965313, "note": "<div>A(n)&nbsp;<b>{{c1::left}} shift</b> is an <u>increase</u> in <b>neutrophil </b><i style=\"font-weight: bold;\">precursors</i>, such as band cells and metamyelocytes, in peripheral blood</div>", "time": 1660105362404.0}, {"id": 1480563969014, "note": "<div><div><div><b>Left shifts</b> are usually seen with <u>neutrophilia</u> in the acute response to <b>{{c1::bacterial infection}}</b> or <b>{{c2::tissue necrosis}}</b></div></div></div>", "time": 1660105355701.0}, {"id": 1480563971359, "note": "<div>When a <u>left shift</u> is seen with <b>immature RBCs</b> it is called a(n)&nbsp;<b>{{c1::leukoerythroblastic}} reaction</b></div>", "time": null}, {"id": 1480563978323, "note": "<div><div><div><b>Immature neutrophils</b> (e.g. left shift) are characterized by <u>decreased</u> <b>{{c1::Fc}} receptors</b> (CD-{{c2::16}})</div></div></div>", "time": 1660105357607.0}, {"id": 1480563995713, "note": "<div><div><div><b>{{c1::Lymphocytosis}}</b> refers to an <u>increased</u> number of circulating <b>lymphocytes</b></div></div></div>", "time": 1660105339726.0}, {"id": 1480563998173, "note": "<div><div><div><b>Lymphocytosis</b> often occurs in response to {{c1::viral}} infections </div></div></div>", "time": 1660105355483.0}, {"id": 1480564003760, "note": "<div><div><div>What <u>bacteria</u> causes <b>lymphocytosis</b> via production of <b>lymphocytosis-promoting factor</b>? </div><div><br /></div><div><i>{{c1::Bordetella pertussis}}</i> </div></div></div>", "time": null}, {"id": 1480564118993, "note": "<div><b>Acute leukemia</b> is defined as a <u>neoplastic proliferation</u> of <b>blasts</b> {{c1::&gt; 20}}% in the bone marrow</div>", "time": 1660105362146.0}, {"id": 1480564133291, "note": "<div><b>Acute leukemia</b> may present <u>acutely</u> with symptoms of <b>{{c1::anemia}}</b>, <b>{{c2::thrombocytopenia}}</b>, and/or <b>{{c3::neutropenia}}</b> </div>", "time": 1660105362144.0}, {"id": 1480564138898, "note": "<div><b>Acute leukemias</b> are typically associated with {{c1::<u>increased</u>}} circulating WBCs </div>", "time": 1660105362141.0}, {"id": 1480564145214, "note": "<div>The <b>blasts</b> seen in <u>acute leukemia</u> are {{c2::large::size}}, immature cells, often with \"<b>punched out</b>\" <b>{{c1::nucleoli}}</b></div>", "time": 1660105350409.0}, {"id": 1480564150230, "note": "<div><b>Acute leukemia</b> is subdivided into {{c1::ALL}} or {{c1::AML}} based on the phenotype of the blasts</div>", "time": 1660105362145.0}, {"id": 1480564153998, "note": "<div><b>ALL</b> is a neoplastic accumulation of {{c1::lymphoblasts}} (&gt;20%) in the bone marrow</div>", "time": 1660105361952.0}, {"id": 1480564160094, "note": "<div><b>{{c2::Lympho}}-blasts</b> are characterized by positive <u>nuclear staining</u> for <b>{{c1::TdT}}</b>, which is a(n) {{c3::<b>DNA</b> <b>polymerase</b>}}</div>", "time": null}, {"id": 1480564165697, "note": "<div>What <u>demographic</u>&nbsp;is most commonly associated with <b>acute lymphoblastic leukemia</b> (ALL)? </div><div><br></div><div>{{c1::Children::age group}}</div>", "time": null}, {"id": 1480564168105, "note": "<div><b>{{c3::Acute lymphoblastic}} leukemia</b> is associated with <b>{{c1::Down}} syndrome</b>; usually arises {{c2::<u>after</u>}} the age of 5 years</div>", "time": 1660105337155.0}, {"id": 1480564170393, "note": "<div><b>Acute lymphoblastic leukemia</b> is subclassified into <b>{{c1::B}}-ALL</b> and <b>{{c1::T}}-ALL</b> based on surface markers</div>", "time": 1660105362138.0}, {"id": 1480564172520, "note": "<div>Which <u>type</u> of <b>ALL</b> (B- or T-ALL) is the <b>most common</b>? </div><div><br></div><div>{{c1::B-ALL}}</div>", "time": null}, {"id": 1480564174659, "note": "<div><b>B-ALL</b> is usually characterized by <u>lymphoblasts</u> (TdT+) that express <b>CD-{{c1::10}}</b>, <b>CD-{{c1::19}}</b>, and <b>CD-{{c1::20}}</b> </div>", "time": 1660105361375.0}, {"id": 1480564182494, "note": "<div><b>B-ALL</b> has a(n) {{c1::<u>excellent</u>}} response to <b>chemotherapy</b></div>", "time": 1660105361376.0}, {"id": 1480564186735, "note": "<div>Treatment of <b>B-ALL</b> requires prophylaxis to the <b>{{c1::scrotum}}</b> and <b>{{c2::CSF}}</b> </div>", "time": 1660105348568.0}, {"id": 1480564193542, "note": "<div><b>B-ALL</b> with t({{c3::12}};{{c3::21}}) has a(n) {{c1::<u>good</u>}} prognosis and is more commonly seen in <b>{{c2::children}}</b></div>", "time": null}, {"id": 1480564195911, "note": "<div><b>B-ALL</b> with t({{c3::9}};{{c3::22}}) has a(n) {{c1::<u>poor</u>}} prognosis and is more commonly seen in <b>{{c2::adults::age group}}</b>&nbsp;</div>", "time": null}, {"id": 1480564207407, "note": "<div><b>T-ALL</b> is characterized by <u>lymphoblasts</u> (TdT+) that express markers ranging from <b>CD-{{c1::2}}</b> to <b>CD-{{c1::8}}</b></div>", "time": 1660105350621.0}, {"id": 1480564210396, "note": "<div>Do the <u>lymphoblasts</u> in <b>T-ALL</b> express <b>CD10</b>?</div><div><br /></div><div>{{c1::No}} </div>", "time": 1660105359907.0}, {"id": 1480564217692, "note": "<div><b>{{c3::T}}-ALL</b> usually presents in {{c1::<u>teenagers</u>::age group}} as a(n)&nbsp;<b>{{c2::mediastinal}}</b> <b><u>mass</u></b>, thus it is often referred to as acute lymphoblastic <i>lymphoma</i></div>", "time": null}, {"id": 1480564222986, "note": "<div><div><b>AML</b> is a neoplastic accumulation of {{c1::myeloblasts}} (&gt;20%) in the bone marrow</div></div>", "time": 1660105361865.0}, {"id": 1480564228511, "note": "<div><b>{{c2::Myeloblasts::-blasts}}</b>&nbsp;are usually characterized by <u>positive cytoplasmic staining</u> for {{c1::myeloperoxidase (MPO)}}</div>", "time": 1660105337643.0}, {"id": 1480564230781, "note": "<div><b>Myeloblasts</b> may have <u>crystal aggregates</u> of <b>{{c2::MPO}}</b>, which are seen on blood smear as {{c1::<b>Auer</b> <b>rods</b>}}      </div>", "time": null}, {"id": 1480564236828, "note": "<div><b>Acute myeloid leukemia</b> (AML) most commonly arises in {{c1::older adults (median onset 65 years)}}</div>", "time": null}, {"id": 1480564239574, "note": "<div>One <u>subtype of AML</u> is <b>{{c1::acute promyelocytic leukemia (APL)}}</b>, which is characterized by t({{c2::15}};{{c2::17}}) </div>", "time": null}, {"id": 1480564244694, "note": "<div>The t(15;17) translocation seen in <b>acute promyelocytic leukemia</b> results in <u>disruption</u> of the <b>{{c1::retinoic acid}} receptor</b> on chromosome 17</div>", "time": null}, {"id": 1480564250886, "note": "<div>The <u>abnormal promyelocytes</u> seen in <b>APML</b> contain numerous primary granules that increase risk for {{c1::DIC}} </div>", "time": null}, {"id": 1480564261082, "note": "<div><b>Acute promyelocytic leukemia</b> is treated with {{c1::all-<i>trans</i>-retinoic acid (ATRA)}}, a vitamin A derivative, as well as {{c2::arsenic}}</div>", "time": null}, {"id": 1480564270476, "note": "<div><b>All-<i>trans</i>-retinoic acid</b> binds the <u>altered retinoic acid receptor</u> in <b>APL</b> and causes blasts to {{c1::mature}}</div>", "time": 1660105361937.0}, {"id": 1480564273556, "note": "<div>One subtype of <u>AML</u> is acute {{c1::monocytic}} leukemia, which presents with <b>proliferation of monoblasts</b></div>", "time": 1660105354583.0}, {"id": 1480564275517, "note": "<div>Do the <b>monoblasts</b> seen in <u>acute monocytic leukemia</u> typically contain <b>myeloperoxidase</b> (MPO)? </div><div><br></div><div>{{c1::No}}</div>", "time": 1660105359905.0}, {"id": 1480564277903, "note": "<div>In <b>acute {{c2::monocytic}} leukemia</b>, blasts characteristically infiltrate the {{c1::<b>gums</b>}}</div>", "time": 1660105357530.0}, {"id": 1480564283123, "note": "<div>One subtype of <u>AML</u> is acute {{c1::megakaryoblastic}} leukemia, which presents with <b>proliferation of megakaryoblasts</b> </div>", "time": 1660105354584.0}, {"id": 1480564288709, "note": "<div><div>Do the <b>megakaryoblasts</b> seen in <u>acute megakaryoblastic leukemia</u> typically contain&nbsp;<b>myeloperoxidase</b> (MPO)? </div><div><br></div><div>{{c1::No}}</div></div>", "time": 1660105359906.0}, {"id": 1480564291439, "note": "<div><b>{{c3::Acute megakaryoblastic}} leukemia</b> is associated with <b>{{c1::Down}} syndrome</b>; usually arises {{c2::<u>before</u>}} the age of 5</div>", "time": 1660105337152.0}, {"id": 1480564293791, "note": "<div><b>AML</b> may arise from <u>pre-existing</u> {{c1::myelodysplastic}} syndromes </div>", "time": null}, {"id": 1480564302943, "note": "<div>Risk factors for <u>acute myeloid leukemia</u> include prior exposure to <b>{{c1::alkylating}} </b><b>chemotherapy</b> and <b>{{c2::radiation}}</b> </div>", "time": 1660105353261.0}, {"id": 1480564318772, "note": "<div><b>Myelodysplastic syndromes</b> usually present with <u>increased</u> blasts {{c1::&lt; 20}}%  </div>", "time": 1660105355002.0}, {"id": 1480564325491, "note": "<div><b>Myelodysplastic syndromes</b> rarely may progress to <b>{{c1::acute myeloid}} leukemia</b> </div>", "time": null}, {"id": 1480645785025, "note": "<div><b>Myelodysplastic syndromes</b> are caused by {{c1::<u>de novo mutations</u>::genetics}} or <u>environmental exposure</u> (e.g. radiation, benzene, chemotherapy)</div>", "time": 1660105355006.0}, {"id": 1480646882826, "note": "<div><b>{{c3::Myelodysplastic}} syndromes</b> may be associated with a(n)&nbsp;<b>{{c1::Pseudo-Pelger-Huet}} anomaly</b>, which are neutrophils with {{c2::<u>bilobed</u>}} nuclei</div>", "time": null}, {"id": 1480646887685, "note": "<div><b>Pseudo-Pelger Huet anomaly</b> is typically seen after {{c1::chemotherapy}}</div>", "time": null}, {"id": 1480646912185, "note": "<div><b>{{c1::Chronic::acute or chronic}} leukemia</b>&nbsp;is a neoplastic proliferation of <u>mature</u> circulating <b>lymphocytes</b></div>", "time": 1660105340808.0}, {"id": 1480646945096, "note": "<div><b>Chronic leukemia </b>is usually <u>insidious</u> in onset and seen in {{c1::older adults::age group}}</div>", "time": 1660105360734.0}, {"id": 1480646959040, "note": "<div><b>{{c2::Chronic lymphocytic}} leukemia</b> is a neoplastic proliferation of <u>naive {{c3::B}} cells</u> that <i>co-express</i> <b>CD-{{c1::5}}</b> and <b>CD-{{c1::20}}</b></div>", "time": null}, {"id": 1480646962226, "note": "<div>What is the <u>most common</u> <b>leukemia</b> in adults? </div><div><br></div><div>{{c1::Chronic lymphocytic leukemia (CLL)}}</div>", "time": null}, {"id": 1480646964715, "note": "<div><b>{{c2::Chronic lymphocytic}} leukemia</b> is associated with <b>{{c1::smudge}} cells</b> and <u>increased lymphocytes</u> on blood smear</div>", "time": null}, {"id": 1480646969997, "note": "<div><b>{{c2::Chronic lymphocytic}} leukemia</b> commonly involves lymph nodes, leading to <u>generalized lymphadenopathy</u>; thus called <b>{{c1::small lymphocytic}} <i>lymphoma</i></b> </div>", "time": 1660105338187.0}, {"id": 1480646976277, "note": "<div>One complication of <b>chronic lymphocytic leukemia</b> is {{c1::<u>hypogammaglobulinemia</u>}}, which predisposes to infection</div>", "time": 1660105354626.0}, {"id": 1480646978863, "note": "<div>What is the most<i> </i>common <u>cause of death</u> in patients with <b>chronic lymphocytic leukemia</b>? </div><div><br></div><div>{{c1::Infection (due to hypogammaglobulinemia)}}</div>", "time": null}, {"id": 1480646982068, "note": "<div>One complication of <b>chronic lymphocytic leukemia</b> is {{c1::<u>autoimmune hemolytic::very specific</u>}} anemia</div>", "time": null}, {"id": 1480646984927, "note": "<div><b>{{c2::Chronic lymphocytic}} leukemia</b> may transform into {{c1::<u>diffuse, large B-cell lymphoma</u> (DLBCL)}} via the <b>{{c3::Richter}} transformation</b></div>", "time": null}, {"id": 1480646987166, "note": "<div>Transformation of <b>CLL</b> into <u>diffuse, large B-cell lymphoma</u> presents clinically as a(n) {{c1::enlarging}} <b>lymph</b> <b>node</b> or <b>spleen</b></div>", "time": 1660105348634.0}, {"id": 1480646989390, "note": "<div><b>{{c1::Hairy cell}} leukemia</b> is a neoplastic proliferation of <u>mature {{c2::B}} cells</u> characterized by <b>hairy cytoplasmic processes</b></div>", "time": null}, {"id": 1480646994730, "note": "<div>The cells in <b>{{c2::hairy cell}} leukemia</b> stain <u>positive</u> for {{c1::<b>tartrate-resistant acid phosphatase </b>(TRAP)}}</div>", "time": null}, {"id": 1480647002481, "note": "<div><u>Positive</u> <b>TRAP</b> <b>stain</b> for diagnosis of <b>hairy cell leukemia</b> has been largely replaced with {{c1::flow cytometry}}</div>", "time": null}, {"id": 1480647005122, "note": "<div>Patients with <b>hairy cell leukemia</b> typically present with <u>massive</u> <b>{{c1::splenomegaly}}</b> due to expansion of the <b>{{c2::red}} pulp</b></div>", "time": null}, {"id": 1480647007606, "note": "<div><b>{{c2::Hairy cell}} leukemia</b> causes <u>marrow fibrosis</u>, which results in a&nbsp; \"<b>{{c1::dry tap}}</b>\" on bone marrow aspiration</div>", "time": null}, {"id": 1480647009765, "note": "<div>Does <u>hairy cell leukemia</u> typically present with <b>lymphadenopathy</b>? </div><div><br></div><div>{{c1::No}}</div>", "time": 1660105359867.0}, {"id": 1480647012122, "note": "<div><b>Hairy cell leukemia</b> has an <u>excellent</u> response to {{c1::cladribine (2-CDA)}}, which is an <b>adenosine deaminase inhibitor</b>  </div>", "time": null}, {"id": 1480647018232, "note": "<div>In addition to <b>cladribine</b> (2-CDA), <u>hairy cell leukemia</u> may also be treated with {{c1::pentostatin}}</div>", "time": null}, {"id": 1480647021973, "note": "<div>What <u>demographic</u> is associated with <b>hairy cell leukemia</b>? </div><div><br></div><div>{{c1::Adult males::age/gender}}</div>", "time": 1660105347345.0}, {"id": 1480647024386, "note": "<div><b>Adult T-cell leukemia/lymphoma</b> (ATLL) is a neoplastic proliferation of <u>mature </u>{{c1::<u>CD4</u><sup>+</sup><u> T</u>::specific}}<u> cells</u></div>", "time": 1660105362044.0}, {"id": 1480647026937, "note": "<div><b>{{c2::Adult T-cell}} leukemia/lymphoma</b> is caused by the <b>{{c1::HTLV-1}} virus</b> </div>", "time": null}, {"id": 1480647032473, "note": "<div>The <b>HTLV-1 virus</b> (cause of ATLL) is associated with {{c1::IV drug}} users</div>", "time": null}, {"id": 1480647044946, "note": "<div>What <u>regions</u> are most commonly affected by <b>adult T-cell leukemia/lymphoma</b>?</div><div><br></div><div>{{c1::Japan}}, {{c2::West Africa}}, and the {{c3::Caribbean}}</div>", "time": null}, {"id": 1480647048466, "note": "<div><b>Adult T-cell leukemia/lymphoma</b> may present with {{c1::<u>cutaneous lesions</u> (rash)}} due to <b>skin</b> <b>infiltration</b> </div>", "time": 1660105362043.0}, {"id": 1480647054826, "note": "<div><b>{{c3::Adult T-cell}} leukemia/lymphoma</b> may present with {{c1::<u>lytic</u> (punched-out)}} <b>{{c2::bone}} lesions</b> and <b>hypercalcemia</b> </div>", "time": null}, {"id": 1480647061759, "note": "<div>How can <b>adult T-cell leukemia/lymphoma</b> be distinguished from <b>multiple myeloma</b>? </div><div><br></div><div>{{c1::ATLL causes a rash}}</div>", "time": 1660105358148.0}, {"id": 1480647079747, "note": "<div><b>Mycosis fungoides</b> is a neoplastic proliferation of <u>mature </u>{{c1::<u>CD4</u><sup>+</sup><u> T</u>::name and type}}<u> cells</u></div>", "time": null}, {"id": 1480647082705, "note": "<div><b>Mycosis fungoides</b> typically presents in <u>adults</u> with {{c1::skin}} patches/plaques </div>", "time": 1660105355010.0}, {"id": 1480647110727, "note": "<div>The aggregates of neoplastic cells in the <b>epidermis</b> seen with <u>mycosis fungoides</u> are called <b>{{c1::Pautrier microabscesses}}</b></div>", "time": null}, {"id": 1480647113251, "note": "<div><b>Mycosis fungoides</b> may spread to involve the <u>blood</u>, producing <b>{{c1::</b><b style=\"color: rgb(32, 33, 36);\">S\u00e9zary</b><b>}} syndrome</b> (T-cell leukemia)</div>", "time": null}, {"id": 1480647115492, "note": "<b>{{c2::</b><span style=\"color: rgb(32, 33, 36);\"><b>S\u00e9zary</b></span><b>}} syndrome</b> is characterized by <u>atypical CD4</u><sup>+</sup><u> cells</u> with <b>{{c1::cerebriform}} nuclei</b> seen on blood smear ", "time": null}, {"id": 1481328893539, "note": "<div><b>{{c1::Myeloproliferative}} disorders</b> are neoplastic proliferations of <u>mature</u> cells of <b>myeloid</b> <b>lineage</b> </div>", "time": 1660105339530.0}, {"id": 1481330544018, "note": "<div><b>Myeloproliferative disorders</b> most commonly present in {{c1::<u>late adulthood</u> (50 - 60 years old)::age group}}</div>", "time": 1660105354989.0}, {"id": 1481330549403, "note": "<div><b>Myeloproliferative disorders</b> may cause {{c1::<b>hyperuricemia</b>}} and {{c2::<b>gout</b>}} due to <u>high turnover</u> of cells</div>", "time": 1660105354992.0}, {"id": 1481330631625, "note": "<div><b>Myeloproliferative disorders</b> may progress to <u>marrow {{c1::fibrosis}}</u> or transform to <u>acute leukemia</u></div>", "time": 1660105354990.0}, {"id": 1481330642022, "note": "<div><b>Chronic myeloproliferative disorders</b> (<u>except CML</u>) are associated with <b>{{c1::V617F <i>JAK2</i>}} mutations</b> </div>", "time": null}, {"id": 1481330666330, "note": "<div><b>{{c1::Chronic myeloid}} leukemia</b> is a neoplastic proliferation of <u>mature myeloid cells</u>, especially <b>{{c2::granulocytes}}</b> and their precursors (<i>basophil, neutrophil, eosinophils)</i></div>", "time": 1660105340817.0}, {"id": 1481330673147, "note": "<div><b>{{c2::Chronic myeloid}} leukemia</b> is defined by the <b>t({{c1::9}};{{c1::22}}) translocation</b></div>", "time": null}, {"id": 1481330725065, "note": "<div><b>Chronic myeloid leukemia*</b> responds well to <u>tyrosine kinase inhibitors</u>, such as {{c1::imatinib}} </div>", "time": null}, {"id": 1481330729767, "note": "<div><b>Chronic myeloid leukemia</b> commonly results in {{c1::spleno}}-megaly</div>", "time": 1660105360730.0}, {"id": 1481330733274, "note": "<div>An <u>enlarging</u> {{c1::spleen}} in <b>CML</b> suggests progression to <b>accelerated disease</b> (\"blast crisis\") </div>", "time": 1660105361828.0}, {"id": 1481330742359, "note": "<div><b>CML</b> may transform to <b>acute {{c1::myeloid}} leukemia</b> (2/3rd of cases)</div>", "time": 1660105360606.0}, {"id": 1481330745789, "note": "<div><b>CML</b> may transform to <b>acute {{c1::lymphoid}} leukemia</b> (1/3rd of transformations) </div>", "time": 1660105360607.0}, {"id": 1481330754322, "note": "<div><b>CML</b> is distinguished from a <b>leukemoid reaction</b> (benign neutrophilia) by presence of <u>increased</u> {{c1::basophils}} </div>", "time": null}, {"id": 1481330763737, "note": "<div><b>CML</b> is distinguished from a <b>leukemoid reaction</b> (benign neutrophilia) by a(n)&nbsp;<u>{{c2::negative}}</u> {{c1::<b>leukocyte alkaline phosphatase</b> (LAP)}} stain</div>", "time": null}, {"id": 1481330777811, "note": "<div><b>{{c1::Polycythemia vera}}</b> is a neoplastic proliferation of <u>mature myeloid cells</u>, especially <b>{{c2::red blood}} cells</b> </div>", "time": 1660105339248.0}, {"id": 1481330821240, "note": "<div><b>Polycythemia vera</b> is a form of {{c1::<u>primary</u>::primary or secondary}} polycythemia&nbsp;</div>", "time": null}, {"id": 1481330825790, "note": "<div><b>Polycythemia vera</b> may present with symptoms of {{c1::<u>hyperviscosity</u>}} of the blood (e.g. <u>blurry vision</u>, <u>headache</u>) </div>", "time": 1660105353801.0}, {"id": 1481330830284, "note": "<div><b>Polycythemia vera</b> increases risk of <u>venous</u>&nbsp;and <u>arterial</u>&nbsp;{{c1::thrombosis}}</div>", "time": null}, {"id": 1481330836353, "note": "<div><b>Polycythemia vera </b>rarely may cause {{c1::<u>erythromelalgia</u>}}, which is characterized by <b>severe</b>, <b>burning</b> <b>pain</b> and <b>red-blood discoloration</b> </div>", "time": null}, {"id": 1481330858659, "note": "<div><b>{{c2::Polycythemia vera}}</b> classically presents with intense {{c1::<u>itching</u>}}, especially after a <b>hot</b> <b>shower</b></div>", "time": null}, {"id": 1481330867563, "note": "<div>The 1st line treatment for <b>polycythemia vera</b> is <b>{{c1::phlebotomy}}</b>; second-line therapy is <b>{{c2::hydroxyurea}}</b> </div>", "time": null}, {"id": 1481330876863, "note": "<div>Patients with <b>polycythemia vera</b> may take <u>low-dose</u> {{c1::aspirin}} to<b> decrease risk of thrombosis</b></div>", "time": null}, {"id": 1481330882808, "note": "<div><b>Polycythemia vera</b> is characterized by <u>{{c1::increased}}</u> <b>plasma volume</b></div>", "time": 1660105353804.0}, {"id": 1481330888341, "note": "<div><b>Polycythemia vera</b> is characterized by <u>{{c1::significantly increased}}</u> <b>RBC mass</b></div>", "time": 1660105353802.0}, {"id": 1481330892847, "note": "<div><b>Polycythemia vera</b> is characterized by <u>{{c1::decreased}}</u> <b>EPO</b> </div>", "time": null}, {"id": 1481330900853, "note": "<div><b>Relative polycythemia</b> is characterized by <u>{{c1::decreased}}</u> <b>plasma volume</b> </div>", "time": null}, {"id": 1481330908501, "note": "<div><b>Relative polycythemia</b> is characterized by <u>{{c1::normal}}</u> <b>RBC mass</b> </div>", "time": null}, {"id": 1481330918238, "note": "<div><b>Relative polycythemia </b>is characterized by <u>{{c1::normal}}</u> <b>EPO</b></div>", "time": null}, {"id": 1481330923869, "note": "<div>Which form of <u>polycythemia</u> is associated with <b>dehydration</b> and <b>burns</b>?  </div><div><br /></div><div>{{c1::Relative polycythemia (<u>relative erythrocytosis / hemoconcentration</u>)}}</div>", "time": null}, {"id": 1481330931835, "note": "<div><b>Appropriate absolute polycythemia</b> is characterized by <u>{{c1::increased}}</u> <b>RBC mass</b></div>", "time": null}, {"id": 1481330936897, "note": "<div><b>Appropriate absolute polycythemia</b> is characterized by <u>{{c1::increased}}</u> <b>EPO</b> </div>", "time": 1660105361634.0}, {"id": 1481330945063, "note": "<div><b>{{c2::Appropriate}} absolute polycythemia</b> is characterized by <u>{{c1::decreased}}</u> <b>O<sub>2</sub> saturation</b> </div>", "time": 1660105338304.0}, {"id": 1481330955321, "note": "<div>Which form of <u>polycythemia</u> is associated with <b>lung disease </b>(ex. COPD / obstructive sleep apnea), <b>congenital heart disease</b>, <b>high altitude, </b>or <b>low birth weight</b>? </div><div><br /></div><div>{{c1::Appropriate absolute polycythemia (<u>appropriate secondary erythrocytosis</u>)}}</div>", "time": null}, {"id": 1481330964938, "note": "<div><div><b>Inappropriate absolute polycythemia</b> is characterized by <u>{{c1::increased}}</u> <b>RBC mass</b></div></div>", "time": null}, {"id": 1481330970263, "note": "<div><div><b>Inappropriate absolute polycythemia</b> is characterized by <u>{{c1::increased}}</u> <b>EPO</b> </div></div>", "time": 1660105356188.0}, {"id": 1481330979815, "note": "<div><div><b>{{c2::Inappropriate}} absolute polycythemia</b> is characterized by <u>{{c1::normal}}</u> <b>O<sub>2</sub> saturation</b> </div></div>", "time": 1660105337840.0}, {"id": 1481330987282, "note": "<div><div>Which form of <u>polycythemia</u> is associated with <b>ectopic EPO production</b> (e.g. malignancy, hydronephrosis &amp; renal cysts) or <b>exogenous EPO</b>? </div><div><br /></div><div>{{c1::Inappropriate absolute polycythemia (innapropriate secondary erythrocytosis)}}</div></div>", "time": null}, {"id": 1481330995569, "note": "<div>{{c1::<b>Essential thrombocythemia </b>(ET)}} is a neoplastic proliferation of <u>mature myeloid cells</u>, especially <b>{{c2::platelets}}</b> </div>", "time": null}, {"id": 1481331004185, "note": "<div>Blood smear of <b>essential {{c1::thrombocythemia}}</b> shows markedly <u>increased</u> number of <b>platelets</b>, which may be <i>large</i> or <i>abnormally</i> <i>formed</i> </div><div><br></div><div><img src=\"paste-201738908860674.jpg\"></div>", "time": 1660105361186.0}, {"id": 1481331011775, "note": "<div>Symptoms of <b>essential thrombocythemia</b> are related to an <u>increased risk</u> of <b>{{c1::bleeding}}</b> and/or <b>{{c2::thrombosis}}</b> </div>", "time": null}, {"id": 1481331037844, "note": "<div>Are patients with <u>essential thrombocythemia</u> (ET) at risk for <b>marrow</b> <b>fibrosis</b> and/or <b>acute</b> <b>leukemia</b>?</div><div><br></div><div>{{c1::No (rare)}}</div>", "time": 1660105361606.0}, {"id": 1481331042288, "note": "<div>Does <u>essential thrombocythemia</u> (ET) present with significant risk for <b>hyperuricemia</b> and <b>gout</b>? </div><div><br /></div><div>{{c1::No}}</div>", "time": 1660105359872.0}, {"id": 1481331070297, "note": "<div>{{c1::<b>Myelofibrosis</b>}} is a neoplastic proliferation of <u>mature myeloid cells</u>, especially <b>{{c2::megakaryocytes}}</b></div>", "time": 1660105339533.0}, {"id": 1481331073466, "note": "<div>In <b>myelofibrosis</b>, <u>megakaryocytes</u> produce excess {{c1::<b>platelet-derived growth factor</b> (PDGF)}} and {{c1::TGF-b}}, causing marrow fibrosis</div>", "time": 1660105357062.0}, {"id": 1481331078662, "note": "<div><b>Myelofibrosis</b> is often associated with massive {{c1::splenomegaly}} due to extramedullary hematopoiesis</div>", "time": null}, {"id": 1481331081640, "note": "<div><b>Myelofibrosis</b> is characterized by a(n)&nbsp;<b>{{c1::leukoerythroblastic}} smear</b> (increased nucleated RBCs <i>and</i> immature granulocytes)</div><div><br></div><div><i>Why?</i></div>", "time": 1660105355000.0}, {"id": 1481331108533, "note": "<div><b>Myelofibrosis</b> causes increased risk of infection, thrombosis, and bleeding due to {{c1::pancytopenia}} </div>", "time": 1660105355001.0}, {"id": 1481331118988, "note": "<div>What <u>pathologic RBC</u> is associated with <b>myelofibrosis</b>? </div><div><br /></div><div>{{c1::\"Tear drop\" cells (dacrocyte)}}</div>", "time": null}, {"id": 1481331123263, "note": "<div><b>Polycythemia vera</b> is characterized by <u>{{c1::increased}}</u> <b>WBCs</b></div>", "time": null}, {"id": 1481331128938, "note": "<div><b>Polycythemia vera</b> is characterized by <u>{{c1::increased}}</u> <b>platelets</b></div>", "time": 1660105353803.0}, {"id": 1481331132964, "note": "<div>Is <u>polycythemia vera</u> associated with <i><b>JAK2</b></i> <b>mutations</b>?</div><div><br /></div><div>{{c1::Yes}}</div>", "time": null}, {"id": 1481331137093, "note": "<div><div>Is <u>essential thrombocythemia</u> associated with <i><b>JAK2</b></i> <b>mutations</b>?</div><div><br /></div><div>{{c1::Yes (30-50%)}}</div></div>", "time": null}, {"id": 1481331141117, "note": "<div><div>Is <u>myelofibrosis</u> associated with <i><b>JAK2</b></i> <b>mutations</b>?</div><div><br /></div><div>{{c1::Yes (30-50%)}}</div></div>", "time": null}, {"id": 1481331145178, "note": "<div>Is <u>chronic myeloid leukemia</u> associated with <i><b>JAK2</b></i> <b>mutations</b>?</div><div><br /></div><div>{{c1::No (associated with Philadelphia chromosome)}}</div>", "time": null}, {"id": 1481335274780, "note": "<div><b>{{c1::Lymphomas::leukemias or lymphomas}}</b>&nbsp;are <u>neoplastic proliferations</u> of lymphoid cells that <b>form a mass</b></div>", "time": 1660105339724.0}, {"id": 1481335285928, "note": "<div><b>{{c1::Follicular}} lymphoma</b> is a neoplastic proliferation of <u>small B cells</u> (CD20<sup>+</sup>) that form <b>follicle-like nodules</b></div>", "time": 1660105340332.0}, {"id": 1481335297272, "note": "<div><b>Follicular lymphoma</b> typically presents in {{c1::late adulthood::age group}}&nbsp;</div>", "time": 1660105358812.0}, {"id": 1481335309127, "note": "<div><b>{{c2::Follicular}} lymphoma</b> is characterized by <i>painless</i> \"<b>{{c1::waxing and waning}}</b>\" <b>lymphadenopathy</b> </div>", "time": null}, {"id": 1481335315008, "note": "<div><b>{{c2::Follicular}} lymphoma</b> is driven by a <b>t({{c1::14}};{{c1::18}}) translocation</b> </div>", "time": null}, {"id": 1481335322052, "note": "<div>What <u>chromosome</u> is <i><b>BCL2</b></i> located on? </div><div><br></div><div>{{c1::Chromosome 18}}</div>", "time": null}, {"id": 1481335336072, "note": "<div>The <b>t({{c3::14}};{{c3::18}}) translocation</b> results in <u>overexpression</u> of <b>{{c1::Bcl2}}</b>, resulting in <b>inhibition of</b> <b>{{c2::apoptosis}}</b> </div>", "time": 1660105349483.0}, {"id": 1481335343183, "note": "<div>Treatment of <b>follicular</b> <b>lymphoma</b> is reserved for <u>symptomatic patients</u> and involves low-dose chemotherapy or {{c1::rituximab}} (anti-CD20 antibody) </div>", "time": 1660105348557.0}, {"id": 1481335391975, "note": "<div><b>Follicular lymphoma</b> is distinguished from <u>reactive follicular hyperplasia</u> by expression of <i>{{c1::Bcl2}}</i> in follicles</div>", "time": 1660105358816.0}, {"id": 1481335403145, "note": "<div><b>Follicular lymphoma</b> is distinguished from <u>reactive follicular hyperplasia</u> by <b>{{c1::mono}}-clonality</b> </div>", "time": 1660105358813.0}, {"id": 1481335444447, "note": "<div>Is <b>follicular</b> <b>lymphoma</b> typically <u>aggressive</u>&nbsp;or <u>indolent</u>?</div><div><br></div><div>{{c1::Indolent}}</div>", "time": null}, {"id": 1481335448184, "note": "<div><b>{{c1::Mantle cell}} lymphoma</b> is a neoplastic proliferation of <u>small B cells</u> (CD20<sup>+ </sup>&amp; CD{{c2::5}}<sup>+</sup>) that expands into the <b>mantle zone</b></div>", "time": 1660105339682.0}, {"id": 1481335461024, "note": "<div>What <u>demographic</u> is associated with <b>mantle cell lymphoma</b>? </div><div><br></div><div>{{c1::Adult males}}</div>", "time": 1660105347344.0}, {"id": 1481335465309, "note": "<div><div><b>{{c2::Mantle cell}} lymphoma</b> is driven by a <b>t({{c1::11}};{{c1::14}}) translocation</b> </div></div>", "time": null}, {"id": 1481335477349, "note": "<div>The <b>t({{c3::11}};{{c3::14}}) translocation</b> results in <u>overexpression</u> of {{c1::<b>Cyclin</b> <b>D1</b>}}, which <i>promotes</i> the <b>{{c2::G1/S}} transition</b> in the cell cycle, facilitating neoplastic proliferation</div>", "time": 1660105349486.0}, {"id": 1481335494405, "note": "<div><b>{{c1::Marginal zone}} lymphoma</b> is a neoplastic proliferation of <u>small B cells</u> (CD20<sup>+</sup>) that expands into the <b>marginal</b> <b>zone</b></div>", "time": 1660105339670.0}, {"id": 1481335499955, "note": "<div><b>{{c1::Marginal zone}} lymphoma</b> is associated with <b><i>chronic</i> inflammatory states</b> (e.g. Hashimoto thyroiditis,&nbsp;Sj\u00f6grens&nbsp;syndrome, <i>H. pylori</i> gastritis)</div>", "time": null}, {"id": 1481335508438, "note": "<div><b>{{c1::MALToma}}</b> is a form of <u>marginal zone lymphoma</u> in <b>mucosal</b> <b>sites</b></div>", "time": 1660105339685.0}, {"id": 1481335519028, "note": "<div><b>Gastric MALTomas</b> may regress with treatment of <i>{{c1::H. pylori}}</i></div>", "time": 1660105358701.0}, {"id": 1481335522400, "note": "<div><b>{{c1::Burkitt}} lymphoma</b> is a neoplastic proliferation of <u>intermediate-sized B cells</u>&nbsp;(CD20<sup>+</sup>) </div>", "time": 1660105340957.0}, {"id": 1481335525711, "note": "<div><b>Endemic Burkitt lymphoma</b> is associated with {{c1::EBV}} infection </div>", "time": null}, {"id": 1481335529915, "note": "<div><b>Burkitt lymphoma</b> classically presents as an <u>extranodal mass</u> in a(n)&nbsp;<b>{{c1::child}}</b> or <b>{{c1::young adult::age group}}</b></div>", "time": 1660105361059.0}, {"id": 1481335541845, "note": "<div><div><b>{{c2::Burkitt}} lymphoma</b> is driven by a <b>t({{c1::8}};{{c1::14}}) translocation</b> </div></div>", "time": null}, {"id": 1481335552189, "note": "<div><div>The <b>t({{c2::8}},{{c2::14}}) translocation</b> results in <u>overexpression</u> of <b>{{c1::<i>c-myc</i>}}</b>, which <b>promotes growth</b>  </div></div>", "time": 1660105349488.0}, {"id": 1481335558657, "note": "<div><b>{{c2::Burkitt}} lymphoma</b> is characterized by a <u>high {{c3::mitotic index}}</u> and \"<b>{{c1::starry-sky}}</b>\" <b>appearance</b> on microscopy </div>", "time": null}, {"id": 1481335568359, "note": "<div><b>{{c1::Diffuse large B-cell}} lymphoma</b> is a neoplastic proliferation of <u>large B cells&nbsp;</u>(CD20<sup>+</sup>) that grow diffusely in sheets</div>", "time": 1660105340569.0}, {"id": 1481335576291, "note": "<div>What is the <u>most common</u> form of <b>non-Hodgkins lymphoma</b>?</div><div><br></div><div>{{c1::Diffuse large B-cell lymphoma (DLBCL)}}</div>", "time": null}, {"id": 1481335589184, "note": "<div>While <b>diffuse large B-cell lymphoma</b> is usually seen in <u>older adults</u>, {{c1::20}}% of cases occur in <b>children</b></div>", "time": null}, {"id": 1481335618613, "note": "<div><b>{{c2::Hodgkin}} lymphoma</b> is a neoplastic proliferation of <b>{{c1::Reed-Sternberg}} cells</b> </div>", "time": null}, {"id": 1481335625688, "note": "<div><b>{{c2::Reed-Sternberg}} cells</b> are <u>large {{c1::B}} cells</u> with <b>multilobed</b> <b>nuclei</b> and <b>prominent</b> <b>nucleoli</b> (\"owl eye\" appearance) </div>", "time": null}, {"id": 1481335636086, "note": "<div><b>Reed-Sternberg cells</b> are classically <u>positive</u> for <b>CD-{{c1::15}}</b> and <b>CD-{{c1::30}}</b> </div>", "time": null}, {"id": 1481335641858, "note": "<div><b>Reed-Sternberg cells</b> secrete {{c1::cytokines}}, which attract other inflammatory cells </div>", "time": null}, {"id": 1481335649637, "note": "<div><b>Reed-Sternberg cells</b> occasionally result in \"{{c1::B}}\" symptoms (fever, chills, weight loss, night sweats) </div>", "time": null}, {"id": 1481335671459, "note": "<div>What is the <i>most common</i> <u>subtype</u> of <b>Hodgkin lymphoma</b> (70%)? </div><div><br></div><div>{{c1::Nodular sclerosis}}</div>", "time": null}, {"id": 1481335674660, "note": "<div>What <u>demographic</u> is classically associated with the <b>nodular sclerosis</b> subtype of Hodgkin lymphoma? </div><div><br></div><div>{{c1::Young adult <u>females</u>::age and gender}}</div>", "time": 1660105347330.0}, {"id": 1481335677363, "note": "<div>The <b>{{c1::nodular sclerosis}}</b> subtype of Hodgkin lymphoma typically presents as an <u>enlarging</u> <b>cervical</b> or <b>{{c2::mediastinal}}</b> <b>lymph</b> <b>node</b> in a <i>female</i></div>", "time": 1660105349117.0}, {"id": 1481335711535, "note": "<div><div>Which <u>subtype</u> of <b>Hodgkin lymphoma</b> has the <b>best prognosis</b>? </div><div><br /></div><div>{{c1::Lymphocyte-rich}}</div></div>", "time": null}, {"id": 1481335718073, "note": "<div><div>Which <u>subtype</u> of <b>Hodgkin lymphoma</b> is often associated with <b>abundant eosinophils</b>? </div><div><br></div><div>{{c1::Mixed-cellularity}}</div></div>", "time": null}, {"id": 1481335728332, "note": "<div><div>Which <u>subtype</u> of <b>Hodgkin lymphoma</b> is the<b> most aggressive</b>? </div><div><br></div><div>{{c1::Lymphocyte-depleted}}</div></div>", "time": null}, {"id": 1481335745043, "note": "<div>Which <i>type</i> of <u>lymphoma</u>&nbsp;is associated with masses composed of <b>lymphoid cells</b>? </div><div><br></div><div>{{c1::Non-Hodgkin lymphoma::Hodgkin or non-Hodgkin}}</div>", "time": null}, {"id": 1481335759164, "note": "<div>Which <i>type</i> of <u>lymphoma</u>&nbsp;is characterized by <b>contiguous spread</b>? </div><div><br></div><div>{{c1::Hodgkin lymphoma::Hodgkin or non-Hodgkin}}</div>", "time": null}, {"id": 1481335777145, "note": "<div><div>Which <i>type</i> of <u>lymphoma</u>&nbsp;is characterized by <b>non-contiguous spread</b>? </div><div><br></div><div>{{c1::Non-Hodgkin lymphoma::Hodgkin or non-Hodgkin}}</div></div>", "time": null}, {"id": 1481335785451, "note": "<div><div>Which <i>type</i> of <u>lymphoma</u>&nbsp;is associated with <b>extranodal involvement</b>? </div><div><br></div><div>{{c1::Non-Hodgkin lymphoma::Hodgkin or non-Hodgkin}}</div></div>", "time": 1660105341761.0}, {"id": 1481335790026, "note": "<div><b>{{c2::Staging}}</b> is important and the <u>strongest predictor of prognosis</u> for <b>{{c1::Hodgkin::Hodgkin or non-Hodgkin}} lymphoma</b></div>", "time": 1660105337353.0}, {"id": 1481335796685, "note": "<div>{{c1::Radiation}} is the mainstay of <u>treatment</u> for <b>Hodgkin lymphoma</b> </div>", "time": 1660105339107.0}, {"id": 1481335799700, "note": "<div><b>Hodgkin lymphoma</b> has a <u>bimodal distribution</u>: common in <b>{{c1::young adulthood}}</b> and <b>{{c2::adults &gt; 55 years}}</b></div>", "time": 1660105358192.0}, {"id": 1481335802501, "note": "<div><b>{{c2::Multiple myeloma}}</b> is a malignant proliferation of <i>{{c3::mono}}-clonal </i><b>{{c1::plasma}} cells</b> in the bone marrow</div>", "time": 1660105337652.0}, {"id": 1481335824161, "note": "<div><b>Multiple myeloma</b> is associated with high serum <b>IL-{{c1::6}}</b>, which stimulates plasma cell growth and immunoglobulin production</div>", "time": null}, {"id": 1481335826686, "note": "<div><b>Multiple myeloma</b> presents with {{c1::<u>lytic</u> (punched-out)}} <b>{{c2::bone}} lesions</b> and <b>hypercalcemia</b> </div>", "time": 1660105355100.0}, {"id": 1481335833182, "note": "<div>The <u>bone lesions</u> seen with <b>multiple myeloma</b> are most common in the <b>{{c1::vertebrae}}</b> and <b>{{c2::skull}}</b></div>", "time": 1660105350401.0}, {"id": 1481335848197, "note": "<div><b>Multiple myeloma</b> is associated with <u>{{c1::M spike}}</u> on <b>serum protein electrophoresis (SPEP)</b> </div>", "time": null}, {"id": 1481335857397, "note": "<div>The <b>M spike</b> seen in <u>{{c3::multiple myeloma}}</u> is most commonly due to <i>monoclonal</i> <b>{{c1::IgG}}</b> (55%) or <b>{{c2::IgA}}</b> (25%) </div>", "time": null}, {"id": 1481335874189, "note": "<div><b>Multiple myeloma</b> is associated with increased risk of <b>{{c1::infection}}</b> due to <u>lack of {{c2::antigenic}} diversity</u> of <i>monoclonal</i> antibodies</div>", "time": 1660105355103.0}, {"id": 1481335878353, "note": "<div>What is the <i>most common</i> <u>cause of death</u> in <b>multiple myeloma</b>? </div><div><br></div><div>{{c1::Infection}}</div>", "time": null}, {"id": 1481335881007, "note": "<div><b>Multiple myeloma</b> is associated with <b>{{c1::Rouleaux formation}}</b> of RBCs on blood smear </div>", "time": null}, {"id": 1481335888586, "note": "<div><b>Multiple myeloma</b> may deposit in tissue, causing <b>{{c1::primary (AL)}} amyloidosis</b> </div>", "time": null}, {"id": 1481335896023, "note": "<div><b>{{c3::Multiple myeloma}}</b> is associated with free <u>{{c1::light chain}}</u> <i>excretion</i> in the urine, known as <b>{{c2::Bence Jones}} proteinuria</b></div>", "time": null}, {"id": 1481335899225, "note": "<div>In <u>multiple myeloma</u>, <b>free</b> <b>light</b> <b>chain</b> (Bence Jones protein) may deposit in <b>kidney</b> <b>tubules</b>, leading to risk for {{c1::renal failure (myeloma kidney)}}</div>", "time": 1660105357072.0}, {"id": 1481335901819, "note": "<div>The <u>signs/symptoms</u> of <b>{{c6::multiple myeloma}}</b> may be remembered with the mnemonic \"<b>CRAB</b>\": </div><div style=\"centerbox\"><div class=\"mnemonics\"><div><br></div><div><b>C</b>: {{c1::hyperCalcemia}}</div><div><b>R</b>: {{c2::Renal involvement, height Reduction}}</div><div><b>A</b>: {{c3::Anemia*}}</div><div><b>B</b>: {{c4::Bone lytic lesions}} / {{c5::Back pain}}</div></div></div>", "time": null}, {"id": 1481335904978, "note": "<div>{{c1::<b>Monoclonal gammopathy of undetermined significance </b>(MGUS)}} is an <b>asymptomatic condition</b> characterized by an <u>M spike on SPEP</u> <i><b>without</b></i> other features of <b>multiple</b> <b>myeloma</b></div>", "time": 1660105339563.0}, {"id": 1481335919116, "note": "<div>1-2% of patients with <b>monoclonal gammopathy of underdetermined significance </b>(MGUS) develop {{c1::multiple myeloma}} per year</div>", "time": null}, {"id": 1481335921954, "note": "<div><b>{{c1::Waldenstrom macroglobulinemia}}</b> is a <u>B-cell lymphoma</u> with <i>monoclonal</i> <b>IgM production</b></div>", "time": 1660105338446.0}, {"id": 1481335924365, "note": "<div>Does <u>Waldenstrom macroglobulinemia</u> present with <b>lytic bone lesions</b>? </div><div><br /></div><div>{{c1::No}} </div>", "time": 1660105359786.0}, {"id": 1481335930440, "note": "<div><div>The <b>M spike</b> seen in <u>{{c2::Waldenstrom macroglobulinemia}}</u> is due to <i>monoclonal</i> <b>Ig{{c1::M}}</b> </div></div>", "time": null}, {"id": 1481335936093, "note": "<div><b>Waldenstrom macroglobulinemia</b> typically presents with <u>{{c1::visual}}</u> and&nbsp;<u>{{c2::neurologic}}</u> deficits&nbsp;<u style=\"\">without</u>&nbsp;CRAB symptoms of multiple myeloma</div>", "time": 1660105348161.0}, {"id": 1481335943404, "note": "<div><b>Waldenstrom macroglobulinemia </b>is associated with symptoms of {{c1::<u>hyperviscosity</u>}} (due to large size of IgM pentamer) </div>", "time": null}, {"id": 1481335953050, "note": "<div>Acute complications of <b>Waldenstrom macroglobulinemia</b> are treated with {{c1::<u>plasmapheresis</u>}}, which removes IgM from the serum</div>", "time": null}, {"id": 1481336059289, "note": "<div><div>Which <u>Langerhans cell histiocytosis</u> presents as <b>scalp rash</b>, <b>lytic skull lesions</b>, <b>diabetes insipidus</b>, and <b>exophthalmos</b>?</div><div><br></div><div>{{c1::Hand-Sch\u00fcller-Christian disease}}</div></div>", "time": 1660105342711.0}, {"id": 1481477106660, "note": "<b>{{c1::Acute lymphoblastic}} leukemia</b> is associated with the <b>t(12;21) translocation</b> ", "time": null}, {"id": 1481477282577, "note": "The <b>t(9;22) translocation</b> (BCR-ABL) is also known as the <b>{{c1::Philadelphia}} chromosome</b> ", "time": null}, {"id": 1482014886764, "note": "The <u>innermost</u> layer of the <b>gut wall</b> is the <b>{{c1::mucosa}}</b>", "time": null}, {"id": 1482021549752, "note": "<div>The <b>mucosa</b> of the <u>gut wall</u> consists of three layers: a(n) {{c1::epithelium}}, {{c2::lamina propria}}, and {{c3::muscularis mucosa}}</div>", "time": null}, {"id": 1482021556058, "note": "<div>External to the <u>mucosal layer</u> of the gut wall is the <b>{{c1::submucosa}}</b></div>", "time": null}, {"id": 1482021561377, "note": "<div>External to the <u>submucosal layer</u> of the gut wall is the <b>{{c1::muscularis externa}}</b></div>", "time": null}, {"id": 1482021567159, "note": "<div>The <b>muscularis externa</b> of the gut wall consists of an <u>inner</u> {{c1::circular}} and an <u>outer</u> {{c1::longitudinal}} muscle layer</div>", "time": null}, {"id": 1482021572867, "note": "<div>The <b>{{c1::myenteric (Auerbach)}} nerve plexus</b> lies between the <u>circular</u> and <u>longitudinal muscles layers</u> of the gut wall</div>", "time": null}, {"id": 1482021579186, "note": "<div>The <b>{{c1::submucosal (Meissner)}} nerve plexus</b> lies between the <u>submucosa</u> and <u>inner circular muscle layer</u> of the gut wall</div>", "time": null}, {"id": 1482021584289, "note": "<div>The <u>outermost</u> layer of the <b>gut wall</b> is the {{c1::serosa}} (when intraperitoneal)</div>", "time": null}, {"id": 1482021589803, "note": "<div>The <u>outermost</u> layer of the <b>gut wall</b> is the {{c1::adventitia}} (when retroperitoneal)</div>", "time": null}, {"id": 1482021594676, "note": "<div>Which <u>gut wall layer</u> contains <b>Meissners plexus</b>? </div><div><br /></div><div>{{c1::Submucosa}}</div>", "time": null}, {"id": 1482021603417, "note": "<div>Which <u>gut wall layer</u> contains <b>Auerbachs plexus?</b> </div><div><br /></div><div>{{c1::Muscularis externa}}</div>", "time": null}, {"id": 1482021663832, "note": "<div><i>Post-ganglionic</i> <u>sympathetic</u> and <i>Pre-ganglionic </i><u>parasympathetic</u> neurons supplying the GI tract synapse in the <b>{{c1::myenteric}}</b> or {{c1::<b>submucosal</b> <b>plexuses</b>}}</div>", "time": null}, {"id": 1482021669311, "note": "<div>The <b>{{c1::enteric}} nervous system</b> can direct all functions of the <b>GI tract</b>, even in the <u>absence</u> of extrinsic innervation (e.g. PNS/SNS)</div>", "time": null}, {"id": 1482021680972, "note": "<div><div>The <b>{{c1::submucosal (Meissners)}} plexus</b> of the <u>gut wall</u> primarily controls <b>secretion</b> and<b> blood flow</b></div></div>", "time": null}, {"id": 1482021684208, "note": "<div><div>The <b>{{c1::myenteric (Auerbach)}} plexus</b> of the <u>gut wall</u> primarily controls <b>motility</b></div></div>", "time": null}, {"id": 1482021686946, "note": "<div><b>{{c4::Gastrin}} </b>is secreted from <b>{{c1::G}} cells</b> in the <u>{{c2::antrum}}</u> of the <b>stomach</b> and the <b>{{c3::duodenum}}</b> </div>", "time": null}, {"id": 1482021696583, "note": "<div>One function of <b>gastrin</b> is to <u>{{c1::increase}}</u> gastric <b>H<sup>+</sup> secretion</b></div>", "time": null}, {"id": 1482021700392, "note": "<div>One function of <b>gastrin</b> is to <u>increase</u> <b>growth</b> <b>of {{c1::gastric mucosa}}</b> and {{c2::<b>parietal cells}}</b></div>", "time": null}, {"id": 1482021707646, "note": "<div>One function of <b>gastrin</b> is to {{c1::<u>increase</u>}} <b>gastric motility</b></div>", "time": null}, {"id": 1482021710999, "note": "<div><b>Gastrin secretion</b> is most&nbsp;<i>stimulated</i> by stomach {{c1::<u>distention</u>}}</div>", "time": null}, {"id": 1482021715220, "note": "<div><b>Gastrin secretion</b> is <i>{{c2::stimulated}}</i> by <u>{{c1::high}}</u> <b>pH</b> of gastric contents</div>", "time": null}, {"id": 1482021723937, "note": "<div><b>Gastrin secretion</b> is <i>stimulated</i> by <u>vagal stimulation</u> via the neuropeptide {{c1::<b>gastrin-releasing peptide</b> (GRP, bombesin)}}</div>", "time": null}, {"id": 1482021728193, "note": "<div>Is the <u>vagal stimulation</u> of <b>G cells</b> (gastrin secretion) <i>inhibited</i> by <b>atropine</b>? </div><div><br /></div><div>{{c1::No}} </div>", "time": null}, {"id": 1482021739745, "note": "<div>Which <u>nutrient</u>&nbsp;<i>stimulates</i> <b>gastrin secretion</b>? </div><div><br></div><div>{{c1::Protein (amino acids)::glucose, fat, protein}}</div>", "time": null}, {"id": 1482021742911, "note": "<div>Of the amino acids,&nbsp;<b>{{c1::phenylalanine}}</b> and <b>{{c2::tryptophan}}</b> are the <u>most potent</u> <i>stimuli</i> for <b>gastrin secretion</b></div>", "time": null}, {"id": 1482021746495, "note": "<div><b>Gastrin secretion</b> is <i>{{c2::inhibited}}</i> by <u>{{c1::low}}</u> <b>pH</b> of gastric contents</div>", "time": null}, {"id": 1482021753483, "note": "<div><b>Gastrin</b> secretion is <u>{{c1::inhibited}}</u> by <b>somatostatin</b></div>", "time": null}, {"id": 1482021756852, "note": "<div>The <u>minimum fragment</u> necessary for <i>biologic activity</i> of <b>gastrin</b> is the <b>{{c1::C-terminal tetrapeptide}}</b></div>", "time": null}, {"id": 1482021762704, "note": "<div>How does <b>gastrin secretion</b> change with <u>chronic</u> <b>PPI use</b>? </div><div><br /></div><div>{{c1::Increased}}</div>", "time": null}, {"id": 1482021770777, "note": "<div><div>How does <b>gastrin secretion</b> change with <b>Zollinger-Ellison syndrome</b>? </div><div><br></div><div>{{c1::<u>Very</u> increased}}</div></div>", "time": null}, {"id": 1482021774604, "note": "<div><b>{{c2::Zollinger-Ellison}} syndrome</b> is caused by a(n)&nbsp;<u>{{c1::gastrinoma}}</u> of the <b>pancreas</b> (non-\u03b2 cells) or <b>duodenum</b></div>", "time": null}, {"id": 1482021777590, "note": "<div><div><b>Zollinger-Ellison syndrome</b> is characterized by acid <u>hypersecretion</u>, causing <i>recurrent</i> {{c1::<b>ulcers</b>}} in the <b>{{c2::duodenum}}</b> and <b>{{c3::jejunum}}</b></div></div>", "time": null}, {"id": 1482021780663, "note": "<div><div><b>Zollinger-Ellison syndrome</b> may present with <u>{{c1::abdominal}} pain</u>, due to <b>peptic ulcer disease</b> and <b>distal ulcers</b></div></div>", "time": null}, {"id": 1482021783566, "note": "<div><div><b>Zollinger-Ellison syndrome</b> may present with {{c1::steatorrhea}} due to <u>inactivation</u> of <i>pancreatic lipases</i></div></div>", "time": null}, {"id": 1482021793271, "note": "<div><div><b>{{c2::Zollinger-Ellison}} syndrome</b> is diagnosed with a <u>positive</u> <b>{{c1::secretin stimulation}} test</b></div></div>", "time": null}, {"id": 1482021814068, "note": "<div><div>A <b>secretin stimulation test</b> is <i>positive</i> if <b>gastrin</b> levels {{c1::<u>increase</u>}} after administration of <b>secretin</b> </div></div>", "time": null}, {"id": 1482021822196, "note": "<div>What <u>endocrine disorder</u> may be associated with <b>Zollinger-Ellison syndrome</b>? </div><div><br /></div><div>{{c1::MEN 1}}</div>", "time": null}, {"id": 1482021827543, "note": "<div><div>{{c4::<b>Cholecystokinin</b> (CCK)}}<b> </b>is secreted from <b>{{c1::I}} cells</b> in the <b>{{c2::duodenum}}</b> and the <b>{{c3::jejunum}}</b> </div></div>", "time": null}, {"id": 1482021831523, "note": "<div><div>One function of <b>cholecystokinin</b> is to <u>increase</u> secretion of {{c1::<b>pancreatic</b>}} <b>enzymes</b> </div></div>", "time": null}, {"id": 1482021838448, "note": "<div><div>One function of <b>cholecystokinin</b> is to <u>increase</u> {{c1::contraction}} of<b> </b>the <b>gallbladder</b> </div></div>", "time": null}, {"id": 1482021846216, "note": "<div><div>One function of <b>cholecystokinin</b> is to <u>increase</u> {{c1::relaxation}} of<b> </b>the <b>sphincter of Oddi</b> </div></div>", "time": null}, {"id": 1482021853417, "note": "<div><div>One function of <b>cholecystokinin</b> is to <u>{{c1::decrease}}</u> <b>gastric emptying</b> </div></div>", "time": null}, {"id": 1482021864452, "note": "<div><div><b>Cholecystokinin secretion</b> is <i>stimulated</i> by {{c1::<u>fatty acids</u>}} and {{c2::<u>amino acids</u>}}</div></div>", "time": null}, {"id": 1482021870350, "note": "<div><div><div>Which <b>cholecystokinin</b> <b>receptor</b> is <u>equally sensitive</u> to <b>gastrin</b> <i>and</i> <b>CCK</b>? </div><div><br /></div><div>{{c1::CCK<sub>B</sub>}}</div></div></div>", "time": null}, {"id": 1482021883479, "note": "<div><b>{{c3::Secretin}}</b> is secreted from <b>{{c1::S}} cells</b> in the <b>{{c2::duodenum}}</b></div>", "time": null}, {"id": 1482021886990, "note": "<div>One function of <b>secretin</b> is to <u>increase</u> secretion of <b>pancreatic</b> {{c1::<b>HCO<sub>3</sub><sup>-</sup></b>}}</div>", "time": null}, {"id": 1482021894404, "note": "<div>One function of <b>secretin</b> is to <u>{{c1::increase}}</u> <b>bile secretion</b></div>", "time": null}, {"id": 1482021903019, "note": "<div>One function of <b>secretin</b> is to {{c1::<u>decrease</u>}} <b>gastric acid secretion</b> and {{c1::<u>increase</u>}} <b>pyloric sphincter contraction</b></div>", "time": null}, {"id": 1482021911657, "note": "<div><b>Secretin </b>is <i>secreted</i> in response to {{c1::<b>H<sup>+</sup></b>}} and {{c2::<b>fatty</b> <b>acids</b>}} in the lumen of the duodenum </div>", "time": null}, {"id": 1482021920866, "note": "<div>{{c4::<b>Glucose-insulinotropic peptide </b>(GIP)}} is secreted from <b>{{c1::K}} cells</b> in the <b>{{c2::duodenum}}</b> and <b>{{c3::jejunum}}</b> </div>", "time": null}, {"id": 1482021939459, "note": "<div>The {{c1::oral::oral or IV?}} form of <u>glucose administration</u>  leads to <b>greater insulin release </b>due to stimulation of {{c2::<b>GIP</b>}} and {{c2::<b>GLP-1</b>}} secretion</div>", "time": null}, {"id": 1482021949414, "note": "<div><b>Motilin</b> is secreted from the <u>small intestine</u> during {{c1::fasting::fed or fasting}} states</div>", "time": null}, {"id": 1482021953235, "note": "<div><b>{{c2::Motilin}}</b> is a hormone that <i>initiates</i> {{c1::<b>migrating motor complexes </b>(MMCs)}} at 90-minute intervals between meals</div>", "time": 1660105337664.0}, {"id": 1482021955784, "note": "<div><b>Motilin receptor</b> <u>agonists</u>, such as {{c1::erythromycin}}, are used to <i>stimulate</i> <b>intestinal peristalsis</b></div>", "time": null}, {"id": 1482021961866, "note": "<div><b>{{c2::Somatostatin}}</b> is secreted from <b>{{c1::D}} cells</b> in the <b>GI mucosa</b> </div>", "time": null}, {"id": 1482021967948, "note": "<div><b>Somatostatin secretion</b> is <i>stimulated</i> by {{c1::<u>low</u>::high or low}} <b>pH</b> in the GI mucosa&nbsp;</div>", "time": null}, {"id": 1482021971578, "note": "<div><div><b>Somatostatin secretion</b> is {{c1::<u>decreased</u>}} in response to <b>vagal stimulation</b></div></div>", "time": null}, {"id": 1482022001682, "note": "<div>What effect does <b>somatostatin</b> have on <b>gastric acid secretion</b>? </div><div><br></div><div>{{c1::Decreased secretion}}</div>", "time": null}, {"id": 1482022005886, "note": "<div><div>What effect does <b>somatostatin</b> have on <b>pancreatic</b>/<b>small intestinal fluid secretion</b>? </div><div><br></div><div>{{c1::Decreased secretion}}</div></div>", "time": null}, {"id": 1482022008299, "note": "<div><div>What effect does <b>somatostatin</b> have on <b>gallbladder contraction</b>? </div><div><br /></div><div>{{c1::Decreased contraction}}</div></div>", "time": null}, {"id": 1482022010871, "note": "<div><div>What effect does <b>somatostatin</b> have on <b>insulin</b> and <b>glucagon secretion</b>? </div><div><br></div><div>{{c1::Decreased secretion}}</div></div>", "time": null}, {"id": 1482022023195, "note": "<div><b>Leptin</b> is secreted by <u>fat cells</u> and acts to <b>{{c1::decrease}} appetite</b></div>", "time": null}, {"id": 1482022027494, "note": "<div><b>Vasoactive intestinal polypeptide</b> (VIP) is secreted from <u>{{c1::parasympathetic}}</u> neurons in the gallbladder, small intestine, and sphincters</div>", "time": 1660105348303.0}, {"id": 1482022030441, "note": "<div><b>Vasoactive intestinal polypeptide</b> (VIP) causes {{c1::<u>relaxation</u>}} of <b>GI smooth muscle</b> and <b>sphincters</b> (including LES) </div>", "time": null}, {"id": 1482022036640, "note": "<div><b>Vasoactive intestinal polypeptide</b> (VIP) causes {{c1::<u>increased</u>}} intestinal <b>H<sub>2</sub>O </b>and <b>electrolyte secretion</b> </div>", "time": 1660105348304.0}, {"id": 1482022044624, "note": "<div><b>{{c1::VIPoma}}</b> is a non-\u03b1, non-\u03b2, non-\u03b4 islet cell <u>pancreatic tumor</u> that secretes <b>VIP&nbsp;</b>(also known as WDHA syndrome)</div>", "time": null}, {"id": 1482022047169, "note": "<div><b>{{c4::VIPoma}}</b> is characterized by a <u>triad</u> of {{c1::watery diarrhea}}, {{c2::hypokalemia}}, and {{c3::achlorhydria}}</div>", "time": null}, {"id": 1482022069057, "note": "<div><b>{{c1::Slow waves}}</b> are <u>oscillating membrane potentials</u> inherent to the <b>smooth muscle cells</b> of some parts of the <b>GI tract</b> </div>", "time": null}, {"id": 1482022076569, "note": "<div>The frequency of <u>slow waves</u> in the <b>stomach</b> is <b>{{c1::3}} waves/minute</b></div>", "time": null}, {"id": 1482022079663, "note": "<div>The frequency of <u>slow waves</u> in the <b>duodenum</b> is <b>{{c1::12}} waves/minute</b></div>", "time": null}, {"id": 1482022081983, "note": "<div>The frequency of <u>slow waves</u> in the <b>ileum</b> is <b>{{c1::8 - 9}} waves/minute</b></div>", "time": null}, {"id": 1482022084524, "note": "<div>Which portion of the <u>GI tract</u> has the <b><i>lowest</i> rate</b> <b>of</b> <b>slow waves</b>?</div><div><br /></div><div>{{c1::Stomach (3 waves/min)}}</div>", "time": null}, {"id": 1482022097240, "note": "<div><div>Which portion of the <u>GI tract</u> has the <b><i>highest</i> rate</b> <b>of</b> <b>slow waves</b>?</div><div><br /></div><div>{{c1::Duodenum (12 waves/min)}}</div></div>", "time": null}, {"id": 1482022105272, "note": "<div><b>Slow waves</b> originate in the <b>{{c1::interstitial cells of Cajal}}</b>, which serve as the <u>pacemaker</u> for GI smooth muscle</div>", "time": null}, {"id": 1482022108336, "note": "<div><b>Slow waves</b> of the GI tract are produced via <u>cyclic opening</u> of <b>{{c1::Ca<sup>2+</sup>}} channels</b> (depolarization), followed by opening of <b>{{c2::K<sup>+</sup>}} channels</b> (repolarization)</div>", "time": null}, {"id": 1482022126258, "note": "<div>The <b>{{c1::upper}} esophageal sphincter</b> prevents <u>air</u> from entering the esophagus</div>", "time": null}, {"id": 1482022129277, "note": "<div>The <b>{{c1::lower}} esophageal sphincter</b> prevents <u>gastric contents</u> from entering the esophagus</div>", "time": null}, {"id": 1482022140828, "note": "<div>The <b>{{c1::orad}} </b>region of the<b> stomach</b> is <u>thin-walled</u> and includes the <b>fundus</b> and <b>proximal body</b></div>", "time": null}, {"id": 1482022147543, "note": "<div>The <b>{{c1::caudad}} </b>region of the <b>stomach</b> is <u>thick-walled</u> and includes the <b>distal body</b> and <b>antrum</b></div>", "time": null}, {"id": 1482022152555, "note": "<div>Which <u>region</u> of the <b>stomach</b> (orad or caudad) is responsible for the <b>strong contractions</b> that mix food with gastric secretions? </div><div><br></div><div>{{c1::Caudad}}</div>", "time": null}, {"id": 1482028018965, "note": "<div><b>Saliva</b> is formed by <u>three</u> major glands: {{c1::parotid}}, {{c2::submandibular}}, and {{c3::sublingual}}</div>", "time": 1660105353193.0}, {"id": 1482030234278, "note": "<div>The <b>{{c2::acinar}} cells</b> of <u>salivary glands</u> secrete the <i>initial</i> saliva, which is <b>{{c1::iso}}-tonic</b> and in similar composition to plasma </div>", "time": 1660105348958.0}, {"id": 1482030242022, "note": "<div>The <b>{{c2::ductal}} cells</b> <i>modify</i> the initial <b>saliva</b> via <u>{{c1::absorption}}</u> of <b>Na<sup>+</sup></b> and <b>Cl<sup>-</sup></b></div>", "time": 1660105348930.0}, {"id": 1482030247113, "note": "<div>The <b>ductal cells</b> <i>modify</i> the initial saliva via <u>{{c1::secretion}}</u> of <b>K<sup>+</sup></b> and <b>HCO<sub>3</sub><sup>-</sup></b></div>", "time": null}, {"id": 1482030251800, "note": "<div><b>Saliva</b> is characterized by <u>{{c1::high}}</u> <b>K<sup>+</sup></b> and <b>HCO<sub>3</sub><sup>-</sup></b> concentration relative to plasma</div>", "time": null}, {"id": 1482030256371, "note": "<div><b>Saliva</b> is characterized by <u>{{c1::low}}</u> <b>Na<sup>+</sup></b> and <b>Cl<sup>-</sup></b> concentration relative to plasma</div>", "time": null}, {"id": 1482030261006, "note": "<div><b>Saliva</b> is <u>{{c1::hypo}}-tonic</u> relative to plasma</div>", "time": null}, {"id": 1482030269123, "note": "<div>What <u>salivary enzyme</u> begins the <i>initial</i> digestion of <b>carbohydrates</b>? </div><div><br></div><div>{{c1::\u03b1-amylase}}</div>", "time": null}, {"id": 1482030273275, "note": "<div><div>What <u>salivary enzyme</u> begins the <i>initial</i> digestion of <b>fats</b>? </div><div><br></div><div>{{c1::Lingual lipase}}</div></div>", "time": null}, {"id": 1482030275598, "note": "<div><div>What <u>salivary enzyme</u> <i>cleaves</i> <b>kininogen</b> into <b>bradykinin</b>, a potent vasodilator? </div><div><br></div><div>{{c1::Kallikrein}}</div></div>", "time": null}, {"id": 1482030278629, "note": "<div>At the <u>{{c1::highest}}</u> flow rates, <b>saliva</b> is most <i>similar</i> to plasma (high Na<sup>+</sup> and Cl<sup>-</sup>, low K<sup>+</sup>)</div>", "time": null}, {"id": 1482030283165, "note": "<div>At the <u>{{c1::lowest}}</u> flow rates, <b>saliva</b> is most <i>dissimilar</i> to plasma (high K<sup>+</sup>, low Na<sup>+</sup> and Cl<sup>-</sup>)</div>", "time": null}, {"id": 1482030287042, "note": "<div>The levels of <i>salivary</i><b> HCO<sub>3</sub><sup>-</sup> </b><u>increase</u> with {{c1::<u>increased</u>}} <b>flow rate</b> </div>", "time": null}, {"id": 1482030295480, "note": "<div>What is the effect of <u>parasympathetic</u> innervation on <b>salivary secretion</b>? </div><div><br /></div><div>{{c1::Increased secretion}}</div>", "time": 1660105346517.0}, {"id": 1482030303363, "note": "<div><div>What is the effect of <u>sympathetic</u> innervation on <b>salivary secretion</b>? </div><div><br /></div><div>{{c1::Increased secretion}}</div></div>", "time": 1660105346509.0}, {"id": 1482030311506, "note": "<div><b>{{c4::Parietal}} cells</b> are located in the <u>{{c3::body}}</u> of the stomach and secrete <b>{{c1::HCl}}</b> and <b>{{c2::intrinsic factor}}</b></div>", "time": null}, {"id": 1482030315536, "note": "<div><b>{{c3::Chief}} cells</b> are located in the <u>{{c2::body}}</u> of the stomach and secrete <b>{{c1::pepsinogen}}</b></div><div><b><br></b></div><div><b>*bonus:</b> also secretes...</div>", "time": null}, {"id": 1482030319798, "note": "<div><b>Pepsinogen</b> (inactive) is converted into <b>{{c1::pepsin}}</b> (active) in the presence of {{c2::<b>H</b><sup style=\"font-weight: bold; \">+</sup>}}</div>", "time": 1660105354007.0}, {"id": 1482030322556, "note": "<div>In the <i>first</i> step of <u>gastric acid secretion</u>, CO<sub>2</sub> and H<sub>2</sub>O combine to form <b>H<sub>2</sub>CO<sub>3</sub></b> via the enzyme <i style=\"font-weight: bold; \">{{c1::carbonic anhydrase}}</i></div>", "time": null}, {"id": 1482030326785, "note": "<div>The <b>H</b><sup style=\"font-weight: bold; \">+</sup> from H<sub>2</sub>CO<sub>3</sub> is <i>secreted</i> from the <u>parietal cell</u> via the <b>{{c1::H<sup>+</sup>-K<sup>+</sup> ATPase}} pump</b></div>", "time": null}, {"id": 1482030330644, "note": "<div><b>Cl</b><sup style=\"font-weight: bold; \">-</sup> in the <u>parietal cell</u> follows H<sup>+</sup> into the lumen by diffusing through <b>{{c1::Cl<sup>-</sup>}} channels</b></div>", "time": null}, {"id": 1482030334468, "note": "<div>The <b>HCO<sub>3</sub></b><sup style=\"font-weight: bold; \">-</sup> from H<sub>2</sub>CO<sub>3</sub> is <i>absorbed</i> from the <u>parietal cell</u> into the blood via the <b>{{c1::Cl<sup>-</sup>-HCO<sub>3</sub><sup>-</sup>}} exchanger</b></div>", "time": null}, {"id": 1482030339793, "note": "<div>The <u>increased</u> <b>{{c2::blood}} pH</b> following <b>gastric acid secretion</b> is referred to as the \"<b>{{c1::alkaline tide}}</b>\" (e.g. after meals, vomiting)</div>", "time": null}, {"id": 1482030348639, "note": "<div><b>{{c2::Histamine}}</b> is released from {{c1::<b>enterochromaffin-like</b> (ECL)}} <b>cells</b> in the gastric mucosa</div>", "time": null}, {"id": 1482030352837, "note": "<div><b>Histamine</b> binds to <b>{{c1::H<sub>2</sub>}} receptors</b> on <u>parietal cells</u>, causing <i>{{c2::increased}}</i> <b>H<sup>+</sup> secretion</b></div>", "time": null}, {"id": 1482030356723, "note": "<div>Vagal stimulation <i>increases</i> <b>H<sup>+</sup> secretion</b> <u>directly</u> via binding of <b>{{c2::acetylcholine}}</b> to <b>{{c1::M<sub>3</sub>}} receptors</b> on parietal cells</div>", "time": null}, {"id": 1482030364936, "note": "<div>{{c2::Vagal}} stimulation <i>increases</i> <b>H<sup>+</sup> secretion</b> <u>indirectly</u> via binding of <b>{{c1::GRP}}</b> to G cells</div>", "time": null}, {"id": 1482030372145, "note": "<div><b>Gastrin</b> <i>increases</i> <b>H<sup>+</sup> secretion</b> <u>directly</u> via binding to <b>{{c1::CCK<sub>B</sub>}} receptors</b> on parietal cells</div>", "time": null}, {"id": 1482030376868, "note": "<div><b>{{c1::Gastrin}}</b> <i>increases</i> <b>H<sup>+</sup> secretion</b> <u>indirectly</u> by causing <b>histamine release</b> from ECL cells </div>", "time": null}, {"id": 1482030383962, "note": "<div><b>Gastrin</b> increases <u>acid secretion</u> <i>primarily</i> through its effects on <b>{{c1::ECL::parietal or ECL}} cells</b>&nbsp;</div>", "time": null}, {"id": 1482030391388, "note": "<div>What type of <u>signaling mechanism</u>&nbsp;does <b>gastrin</b> use to reach <b>parietal cells</b>?</div><div><br></div><div>{{c1::Endocrine (enters systemic circulation)::endocrine or paracrine}}</div>", "time": null}, {"id": 1482030396859, "note": "<div>What type of <u>signaling mechanism</u>&nbsp;does <b>histamine</b> use to reach <b>parietal cells</b>?</div><div><br></div><div>{{c1::Paracrine (locally diffuses)::endocrine or paracrine}}</div>", "time": null}, {"id": 1482114769717, "note": "<div>Which <u>second messenger</u> is released upon binding of <b>gastrin</b> to <b>CCK</b><sub><b>B</b></sub> receptors?</div><div><br /></div><div>{{c1::IP<sub>3</sub>/Ca<sup>2+</sup>}}</div>", "time": 1660105342189.0}, {"id": 1482115195503, "note": "<div><div>Which <u>second messenger</u> is <i>increased</i> upon binding of <b>histamine</b> to <b>H<sub>2</sub></b> receptors?</div><div><br></div><div>{{c1::cAMP}}</div></div>", "time": null}, {"id": 1482115200729, "note": "The <b>{{c1::cephalic}} phase</b> of <u>gastric HCl secretion</u> accounts for 30% of total HCl secreted ", "time": 1660105349278.0}, {"id": 1482115208173, "note": "<div><b>Gastric HCl secretion </b>during the <u>{{c2::cephalic}} phase</u> is mediated by {{c1::<b>vagal stimulation</b>}} <i>only</i></div>", "time": 1660105358703.0}, {"id": 1482115213179, "note": "<div>The <b>{{c1::gastric}} phase</b> of <u>gastric HCl secretion</u> accounts for 60% of total HCl secreted </div>", "time": 1660105349211.0}, {"id": 1482115220459, "note": "<div><b>Gastric HCl secretion </b>during the <u>{{c1::gastric}} phase</u> is mediated by <i>both</i> <b>vagal stimulation</b> and <b>direct</b> <b>gastrin release</b></div>", "time": 1660105358704.0}, {"id": 1482115226227, "note": "<div>What effect does <u>alcohol</u> and <u>caffeine</u> have on <b>gastric HCl secretion</b>? </div><div><br></div><div>{{c1::Increased secretion}}</div>", "time": null}, {"id": 1482115229293, "note": "<div><b>Somatostatin</b> decreases <u>gastric acid secretion</u> by decreasing levels of {{c1::cAMP::second messenger}}</div>", "time": null}, {"id": 1482115237070, "note": "<div><div>What effect do <b>prostaglandins</b> have on <b>gastric acid secretion</b>? </div><div><br></div><div>{{c1::Decreased secretion}}</div></div>", "time": null}, {"id": 1482115240121, "note": "<div><b>Prostaglandins</b> decrease <u>gastric acid secretion</u> by decreasing levels of {{c1::cAMP}} (second messenger)</div>", "time": null}, {"id": 1482115252126, "note": "<div><b>Pepsinogen</b> is secreted in response to <b>{{c1::vagal stimulation}}</b> and {{c2::<b>local H</b><sup style=\"font-weight: bold; \">+</sup>}} </div>", "time": null}, {"id": 1482115268611, "note": "<div><b>Mucus</b> is secreted into the <u>GI tract</u> via <b>{{c1::Brunner}} glands</b> in the duodenum</div>", "time": null}, {"id": 1482115275376, "note": "<div>Are the concentrations of <b>Na</b><sup>+</sup> and<b> K</b><sup>+</sup> in&nbsp;<b>pancreatic</b> <b>secretions</b> <i>similar</i> or <i>dissimilar</i> to plasma?</div><div><br></div><div>{{c1::Similar}}</div>", "time": null}, {"id": 1482115280312, "note": "<div><b>Pancreatic secretions</b> are <u>{{c1::iso}}-tonic</u> relative to <b>plasma</b>, regardless of flow rate</div>", "time": null}, {"id": 1482115284201, "note": "<div>At <u>{{c2::low}}</u> flow rates, the <b>pancreatic secretions</b> have <u>high</u> {{c1::<b>Cl<sup>-</sup></b>}} concentration</div>", "time": null}, {"id": 1482115290110, "note": "<div>At <u>{{c2::high}}</u> flow rates, the <b>pancreatic secretions</b> have <u>high</u> {{c1::<b>HCO<sub>3</sub><sup>-</sup></b>}} concentration</div>", "time": null}, {"id": 1482115296382, "note": "<div>The <u>{{c1::enzymatic}}</u> component of <b>pancreatic secretion</b> is secreted by <b>acinar cells</b></div>", "time": null}, {"id": 1482115305907, "note": "<div><div><div>The <u>{{c1::aqueous}}</u> component of <b>pancreatic</b> <b>secretion</b> is secreted by <b>ductal </b>and <b>centroacinar cells</b></div></div></div>", "time": null}, {"id": 1482115311272, "note": "<div><div>The <b>ductal cells </b>modify the <i>initial</i> <b>pancreatic secretion</b> via {{c1::absorption}} of <b>Cl<sup>-</sup></b></div></div>", "time": null}, {"id": 1482115316095, "note": "<div><div>The <b>ductal cells </b>modify the <i>initial</i> <b>pancreatic secretion</b> via {{c1::secretion}} of <b>HCO<sub>3</sub><sup>-</sup></b></div></div>", "time": null}, {"id": 1482115326502, "note": "<div>Release of the <b>aqueous (HCO<sub>3</sub><sup>-</sup>) component</b> of <u>pancreatic secretion</u> is <i>primarily</i> stimulated by {{c1::<b>secretin</b>}}</div>", "time": null}, {"id": 1482115337224, "note": "<div><div>Which <u>second messenger</u> is released upon binding of <b>cholecystokinin</b> to <b>CCK</b><sub><b>A</b></sub> receptors?</div><div><br /></div><div>{{c1::IP<sub>3</sub>/Ca<sup>2+</sup>}}</div></div>", "time": 1660105342190.0}, {"id": 1482115342571, "note": "<div>{{c1::Bile}} is composed of bile salts, phospholipids, cholesterol, bilirubin, water, and ions</div>", "time": null}, {"id": 1482115345843, "note": "<div><div>One component of <b>bile</b> is {{c1::bilirubin}}, which is the major <b>bile</b> <b>pigment</b></div></div>", "time": null}, {"id": 1482115348463, "note": "<div>In the liver, <b>bile acids</b> are <u>conjugated</u> to the amino acids <b>{{c1::glycine}}</b> or <b>{{c2::taurine}}</b> to form <b>{{c3::bile salts}}</b></div>", "time": null}, {"id": 1482115351278, "note": "<div><div>What is the purpose of <u>conjugating</u> <b>bile acids</b> in the liver? </div><div><br /></div><div>{{c1::Increase water solubility}}</div></div>", "time": null}, {"id": 1482115357618, "note": "<div><div>The <b>bile salts</b> and <b>phospholipids</b> in bile are {{c1::amphipathic}} molecules, which allows for the <u>emulsification</u> and <u>solubilization</u> of <b>lipids</b> in an <i>aqueous</i> environment</div></div>", "time": null}, {"id": 1482115360476, "note": "<div>Which <i>organ</i> is responsible for <u>synthesis</u> of <b>bile</b>? </div><div><br></div><div>{{c1::Liver}}</div>", "time": 1660105342447.0}, {"id": 1482115362763, "note": "<div>Which <i>organ</i> is responsible for the <u>storage</u> and <u>concentration</u> of <b>bile</b>? </div><div><br></div><div>{{c1::Gallbladder}}</div>", "time": 1660105342446.0}, {"id": 1482115365440, "note": "<div>Which <i>hormone</i> provides the <u>major stimulus</u> for<b> bile</b> <b>ejection</b>? </div><div><br /></div><div>{{c1::Cholecystokinin (CCK)}}</div>", "time": null}, {"id": 1482115378077, "note": "<div>Most of the secreted <b>bile</b> <b>salts</b> are <u>recirculated</u> to the <b>liver</b> via <b>{{c1::enterohepatic circulation}}</b></div>", "time": null}, {"id": 1482115382071, "note": "<div>Which portion of the <u>small intestine</u> is responsible for <i>absorption</i> of <b>bile salts</b>? </div><div><br /></div><div>{{c1::Terminal ileum}}</div>", "time": null}, {"id": 1482115388869, "note": "<div>What is the <u>rate-limiting enzyme</u> for <b>bile acid synthesis</b>? </div><div><br></div><div>{{c1::7\u03b1-hydroxylase}}</div>", "time": null}, {"id": 1482115391361, "note": "<div><i style=\"font-weight: bold; \">7\u03b1-hydroxylase</i> is regulated via <u>negative feedback</u> by {{c1::bile salts}}</div>", "time": null}, {"id": 1482115393714, "note": "<div>One function of <b>bile</b> is to aid in the <u>digestion</u> and <u>absorption</u> of <b>{{c1::lipids}}</b> </div>", "time": null}, {"id": 1482115395969, "note": "<div>One function of&nbsp;<b>bile</b> is <u>excretion</u> of <b>{{c1::cholesterol}}</b> </div>", "time": null}, {"id": 1482115403409, "note": "<div>One function of <b>bile</b> is {{c1::<u>anti-microbial</u>}} activity via <b>membrane</b> <b>disruption</b></div>", "time": null}, {"id": 1482115408306, "note": "<div>What is the <i>only</i> type of <u>carbohydrate</u> that can be <b>absorbed by enterocytes</b>?</div><div><br /></div><div>{{c1::Monosaccharides}}</div>", "time": null}, {"id": 1482115420919, "note": "<div><u>Pancreatic</u> and <u>salivary</u> <b><i>{{c1::\u03b1-amylases}}</i></b> hydrolyze 1,4-glycosidic bonds in <b>{{c2::starch}}</b></div>", "time": null}, {"id": 1482115427771, "note": "<div><b>Lactose</b> is a <u>disaccharide</u> that is digested into <b>{{c1::glucose}}</b> and <b>{{c1::galactose}}</b> by <i>lactase</i></div>", "time": null}, {"id": 1482115432496, "note": "<div><b>Sucrose</b> is a <u>disaccharide</u> that is digested into <b>{{c1::glucose}}</b> and <b>{{c1::fructose}}</b> by <i>sucrase</i></div>", "time": null}, {"id": 1482115442644, "note": "<div>Is pancreatic <b>\u03b1-amylase</b> secreted in an <u>active</u> or <u>inactive</u> form? </div><div><br></div><div>{{c1::Active}}</div>", "time": null}, {"id": 1482115445612, "note": "<div><b>Glucose</b> and <b>galactose</b> are transported from the <u>intestinal lumen</u> into the cells by {{c1::<b>Na<sup>+</sup>-dependent cotransport </b>(<b>SGLT1</b>)}}</div>", "time": null}, {"id": 1482115451005, "note": "<div>Which <u>monosaccharide(s)</u> are absorbed from the <i>intestine</i> by <b>Na<sup>+</sup>-dependent cotransport</b> (SGLT1)?</div><div><br></div><div>{{c1::Glucose and galactose}}</div>", "time": null}, {"id": 1482115455383, "note": "<div><b>Glucose,</b>&nbsp;<b>galactose </b>and <b>fructose</b>&nbsp;are extruded from the <u>intestinal cell</u> into the blood by {{c1::<b>GLUT-2</b> (facilitated diffusion)}}</div>", "time": null}, {"id": 1482115460996, "note": "<div><div>Which <u>monosaccharide(s)</u> are absorbed from the <i>intestine</i> by <b>GLUT-5</b>?</div><div><br></div><div>{{c1::Fructose}}</div></div>", "time": null}, {"id": 1482115465581, "note": "<div><b>Fructose</b> is extruded from the <u>intestinal cell</u> into the blood by {{c1::<b>GLUT-2</b> (facilitated diffusion)}}</div>", "time": null}, {"id": 1482115473217, "note": "<div>Which <u>monosaccharide(s)</u> are extruded from the <i>intestinal cell</i> into the blood by <b>GLUT-2</b>? </div><div><br></div><div>{{c1::Glucose, galactose, <i>and</i> fructose}}</div>", "time": null}, {"id": 1482115477908, "note": "<div>The <b>{{c1::D-xylose absorption}} test</b> helps distinguish <b>GI mucosal damage</b> from other causes of <u>malabsorption</u> (e.g. lactose intolerance)</div>", "time": null}, {"id": 1482115481615, "note": "<div><u>{{c1::Decreased}}</u> <i>excretion</i> of <i>urinary</i>&nbsp;<b>D-xylose </b>is indicative of <b>GI mucosal damage</b> or <b>bacterial overgrowth</b> (D-xylose absorption test) </div>", "time": null}, {"id": 1482115484108, "note": "<div>Digestion of <b>protein</b> begins in the <u>stomach</u> with the action of {{c1::pepsin}}</div>", "time": null}, {"id": 1482115490061, "note": "<div>The first step in <u>intestinal</u> <b>protein digestion</b> involves activation of <b>{{c1::trypsinogen}}</b> (inactive) to <b>{{c1::trypsin}}</b> (active)</div>", "time": null}, {"id": 1482115492876, "note": "<div><b>Trypsinogen</b> is converted to <b>trypsin</b> via <b style=\"font-style: italic; \">{{c1::enteropeptidase (enterokinase)}}</b>, a brush<i>-</i>border enzyme on duodenal and jejunal mucosa</div>", "time": null}, {"id": 1482115500165, "note": "<div>Are <b>pancreatic proteases</b> secreted in an <u>active</u> or <u>inactive</u> form? </div><div><br /></div><div>{{c1::Inactive (proenzymes/zymogens)}}</div>", "time": null}, {"id": 1482115504921, "note": "<div>Which <u>pancreatic protease</u> cleaves <b>all pancreatic proenzymes</b> to their active forms? </div><div><br /></div><div>{{c1::Trypsin}}</div>", "time": null}, {"id": 1482115509710, "note": "<div><b>{{c1::Chymotripsinogen}}</b> (inactive) is activated to <b>chymotrypsin</b> (active) via <i>trypsin</i></div>", "time": null}, {"id": 1482115513922, "note": "<div><b>{{c1::Proelastase}}</b> (inactive) is activated to <b>elastase</b> (active) via <i>trypsin</i></div>", "time": null}, {"id": 1482115518484, "note": "<div><b>{{c1::Procarboxypeptidase}}</b> (inactive) is activated to <b>carboxypeptidase</b> (active) via <i>trypsin</i> </div>", "time": null}, {"id": 1482115525140, "note": "<div><b>Trypsin</b> results in <u>{{c1::increased::increased or decreased}}</u> cleavage of <b>trypsinogen</b> to <b>trypsin</b>&nbsp;</div>", "time": 1660105348494.0}, {"id": 1482115541696, "note": "<div><b>Pancreatic </b><i><b>{{c1::lipases}}</b> </i>are responsible for <u>fat digestion</u> in the small intestine</div>", "time": null}, {"id": 1482115547887, "note": "<div><b>Pancreatic </b><i style=\"font-weight: bold; \">lipase</i> is <u>inactivated</u> by {{c1::low::high or low}} duodenal pH</div>", "time": null}, {"id": 1482115554891, "note": "<div>The<i> </i>hydrophobic products of <u>{{c1::lipid}} digestion</u> are <i>solubilized</i> in <b>micelles</b> by <b>bile acids</b> </div>", "time": 1660105350015.0}, {"id": 1482115575316, "note": "<div>The <b>chylomicrons</b> in <u>intestinal epithelial cells</u> enter <b>lymphatic capillaries</b> known as {{c1::lacteals}}</div>", "time": null}, {"id": 1482115579210, "note": "<div>The <b>chylomicrons</b> in the <u>lymphatic capillaries</u> enter the <b>bloodstream</b> via the <b>{{c1::thoracic duct}}</b></div>", "time": null}, {"id": 1482191425845, "note": "<div>What <u>virus</u> is associated with <i>bilateral</i> inflammation of the<b> parotid glands</b>? </div><div><br /></div><div>{{c1::Mumps virus}}</div>", "time": null}, {"id": 1482191438195, "note": "<div>In addition to <u>parotitis</u>, <b>mumps</b> may also present with {{c1::orchitis}}, pancreatitis, and aseptic meningitis</div>", "time": null}, {"id": 1482191440593, "note": "<div>What <u>enzyme</u> is elevated in <b>mumps</b> patients due to involvement of the <b>pancreatic</b> or <b>salivary glands</b>? </div><div><br></div><div>{{c1::\u03b1-amylase}}</div>", "time": null}, {"id": 1482191442957, "note": "<div><b>Orchitis</b> due to <u>mumps infection</u> carries risk of <b>{{c1::sterility}}</b>, especially in <b>teenagers</b> </div>", "time": null}, {"id": 1482191446032, "note": "<div><b>{{c1::Sialadenitis}}</b> is <u>inflammation</u> of a <b>salivary gland</b></div>", "time": null}, {"id": 1482191452207, "note": "<div><b>Sialadenitis</b> most commonly occurs due to <b>{{c1::sialolithiasis}}</b>, which often leads to <i>{{c2::Staphylococcus aureus}} </i>mediated <u>sialadenitis / parotitis </u></div>", "time": null}, {"id": 1482191454667, "note": "<div>Is <b>Warthin tumor</b> <i>typically</i> <u>unilateral</u> or <u>bilateral</u>? </div><div><br></div><div>{{c1::Unilateral}}</div>", "time": null}, {"id": 1482191457090, "note": "<div><b>Salivary gland tumors</b> are most commonly <u>{{c1::benign</u>::benign or malignant<u>}}</u></div>", "time": null}, {"id": 1482191460328, "note": "<div><b>Salivary gland tumors</b> most commonly arise in the <b>{{c1::parotid}} gland</b></div>", "time": null}, {"id": 1482191462733, "note": "<div>If a <b>salivary gland tumor</b> involves a <u>non-parotid gland</u> it is more likely to be {{c1::malignant::benign or malignant}}</div>", "time": null}, {"id": 1482191464785, "note": "<div><b>Salivary gland tumors</b> typically present as a mobile, {{c1::painless::painful or painless}} <b>mass/swelling</b>&nbsp;at the angle of the jaw</div>", "time": null}, {"id": 1482191475157, "note": "<div>What is the <u>most common</u> <b>salivary gland tumor</b>? </div><div><br></div><div>{{c1::Pleomorphic adenoma}}</div>", "time": null}, {"id": 1482191477668, "note": "<div><b>{{c3::Pleomorphic adenoma}}</b> is a <u>salivary gland tumor</u> composed of {{c1::<b>chondromyxoid</b> <b>stroma</b>}} and <b>{{c2::epithelium}}</b> </div>", "time": null}, {"id": 1482191484730, "note": "<div>Is <b>pleomorphic adenoma</b> a <u>benign</u> or <u>malignant</u> salivary gland tumor?</div><div><br /></div><div>{{c1::Benign}}</div>", "time": null}, {"id": 1482191486924, "note": "<div><b>Pleomorphic adenoma</b> is associated with a <u>high</u><u> rate of recurrence</u> due to <b>{{c1::incomplete resection}}</b> or <b>{{c2::intraoperative rupture}}</b> </div>", "time": null}, {"id": 1482191495929, "note": "<div>Which <u>salivary gland tumor</u> is associated with a <b>high rate of recurrence</b> following resection? </div><div><br></div><div>{{c1::Pleomorphic adenoma}}</div>", "time": null}, {"id": 1482191498808, "note": "<div><div>{{c2::<b>Warthin tumor</b>}} is a <b>cystic</b> <u>salivary gland tumor</u> with abundant lymphocytes and <b>{{c1::germinal centers}}</b> </div></div>", "time": null}, {"id": 1482191504196, "note": "<div><div>Is <b>Warthin tumor</b> <i>typically </i>a <u>benign</u> or <u>malignant</u> salivary gland tumor?</div><div><br></div><div>{{c1::Benign}}</div></div>", "time": null}, {"id": 1482191506425, "note": "<div><div><b>{{c3::Mucoepidermoid carcinoma}}</b> is a <b>malignant</b> <u>salivary gland tumor</u> composed of {{c1::<b>mucinous</b>}} and <b>{{c2::squamous}} cells</b></div></div>", "time": null}, {"id": 1482191508179, "note": "<div><div><div>What is the <u>most common</u> <i>malignant</i> <b>salivary gland tumor</b>? </div><div><br></div><div>{{c1::Mucoepidermoid carcinoma}}</div></div></div>", "time": null}, {"id": 1482191509975, "note": "<div><u>Malignant</u> <b>salivary gland tumors</b> present with signs of <b>{{c1::facial}} nerve damage</b> </div>", "time": null}, {"id": 1482203633368, "note": "{{c1::<b>Tracheoesophageal fistula</b> (TEF)}} is a <i>congenital defect</i> resulting in a <u>connection</u> between the <b>esophagus</b> and <b>trachea</b>", "time": null}, {"id": 1482203653741, "note": "<div>The <u><i>most </i>common</u> <b>tracheoesophageal anomaly </b>(85%) is <b>proximal</b> {{c1::esophageal atresia}} with <b>distal</b> {{c1::tracheoesophageal fistula}}</div>", "time": null}, {"id": 1482203658544, "note": "<div><b>Esophageal atresia</b> with <b>distal TEF</b> presents with {{c1::<u>polyhydramnios</u>}} in utero</div>", "time": null}, {"id": 1482203661732, "note": "<div><b>Esophageal atresia</b> with <b>distal TEF</b> presents as <b>drooling</b>, <b>choking</b>, and <u>{{c1::vomiting}}</u> with the <b>first feeding</b> </div>", "time": null}, {"id": 1482203664232, "note": "<div><b>Esophageal atresia</b> with <b>distal TEF</b> may present with <u>abdominal distention</u> due to {{c1::air}} in the stomach (visible on CXR)</div>", "time": null}, {"id": 1482203666996, "note": "<div><b>Esophageal atresia</b> with <b>distal TEF</b> may present with <b>{{c1::cyanosis}}</b>, secondary to <u>{{c2::laryngospasm}}</u> to <b>avoid aspiration</b></div>", "time": 1660105359438.0}, {"id": 1482203669616, "note": "<div><b>Esophageal atresia</b> with <b>distal TEF</b> is characterized by <u>failure</u> to pass a(n) {{c1::nasogastric}} tube into the stomach</div>", "time": null}, {"id": 1482203671978, "note": "<div><div>Which <u>tracheoesophageal anomaly</u> <b>resembles the letter H</b>? </div><div><br /></div><div>{{c1::Pure TEF (\"H-type\")}}</div></div>", "time": null}, {"id": 1482203676681, "note": "<div>Which <u>tracheoesophageal anomaly</u> is associated with a <b>gasless abdomen</b> on CXR? </div><div><br /></div><div>{{c1::Pure esophageal atresia}}</div>", "time": null}, {"id": 1482203680744, "note": "<div><b>{{c1::Esophageal web}}</b> is a <u>thin protrusion</u> of <b>esophageal mucosa</b>, most often in the <i>upper</i> esophagus</div>", "time": null}, {"id": 1482203684060, "note": "<div><b>Esophageal web</b> presents with <u>dysphagia</u> for <b>{{c1::poorly chewed}} food</b></div>", "time": null}, {"id": 1482203686941, "note": "<div><b>{{c1::Plummer-Vinson}} syndrome</b> is characterized by a <u>triad</u> of iron deficiency anemia, esophageal web, and a beefy-red tongue (atrophic glossitis) </div>", "time": null}, {"id": 1482203693998, "note": "<div><b>{{c1::Zenker}} diverticulum</b> is an outpouching of <u>pharyngeal mucosa</u> through an acquired defect in the muscular wall (<b>false</b> <b>diverticulum</b>) caused by <u>{{c2::cricopharyngeal motor}} dysfunction</u></div>", "time": null}, {"id": 1482203696957, "note": "<div>Is <b>Zenker diverticulum</b> a <u>true</u> or <u>false</u> diverticulum?</div><div><br /></div><div>{{c1::False (only involves mucosa and submucosa)}}</div>", "time": null}, {"id": 1482203703271, "note": "<div><b>{{c4::Zenker}} diverticulum</b> classically arises at <b>{{c1::Killians triangle}}</b>, between the <u>{{c2::thyropharyngeal}}</u> and <u>{{c3::cricopharyngeal}}</u> parts of the <b>inferior pharyngeal constrictor</b> </div>", "time": null}, {"id": 1482203712090, "note": "<div><b>Zenker diverticulum</b> often presents with <u>oropharyngeal</u> <u>dysphagia</u>, obstruction, and {{c1::halitosis (bad breath)}}</div>", "time": null}, {"id": 1482203718520, "note": "<div>What <u>demographic</u> is most commonly affected by <b>Zenker diverticulum</b>? </div><div><br></div><div>{{c1::Elderly males}}</div>", "time": null}, {"id": 1482203721241, "note": "<div><b>{{c2::Mallory-Weiss}} syndrome</b> is a <i>linear</i> <u>{{c1::mucosal}}</u> laceration at the <b>gastroesophageal (GE) junction</b> </div>", "time": 1660105337728.0}, {"id": 1482203723630, "note": "<div>The tears in <b>Mallory-Weiss syndrome</b> are caused by a rapid increase in {{c1::intraabdominal}} pressure (ex. retching, vomiting)</div>", "time": null}, {"id": 1482203725950, "note": "<div><b>Mallory-Weiss syndrome</b> is usually seen in <b>{{c1::alcoholics}}</b> and <b>{{c2::bulimics}}</b> </div>", "time": null}, {"id": 1482203728689, "note": "<div><b>Mallory-Weiss syndrome</b> presents with <b>{{c1::hematemesis}}</b> that can be <i>painful</i></div>", "time": 1660105355420.0}, {"id": 1482203731228, "note": "<div>Is the <u>hematemesis</u> seen with <b>Mallory-Weiss syndrome</b> typically <i>painful</i> or <i>painless</i>? </div><div><br /></div><div>{{c1::Painful}}</div>", "time": null}, {"id": 1482203737378, "note": "<div><b>{{c2::Boerhaave}} syndrome</b> is a(n) {{c1::<u>transmural</u>}} laceration of the <b>distal esophagus</b></div>", "time": null}, {"id": 1482203740366, "note": "<div><b>Boerhaave syndrome</b> presents as <u>esophageal rupture</u> with {{c1::pneumomediastinum (air in the mediastinum)}} and subcutaneous emphysema </div>", "time": null}, {"id": 1482203748553, "note": "<div><b>Boerhaave syndrome</b> is usually due to <b>violent</b> <b>{{c1::retching}}</b></div>", "time": null}, {"id": 1482203751576, "note": "<div><b>{{c1::Esophageal varices}}</b> are dilated <u>submucosal veins</u> in the <b>lower 1/3rd</b> of the<b> esophagus</b></div>", "time": null}, {"id": 1482203756188, "note": "<div><b>Esophageal varices</b> arise secondary to <b>{{c1::portal hypertension}}</b> </div>", "time": null}, {"id": 1482203764406, "note": "<div>In <u>portal hypertension</u>, the <b>{{c1::left gastric}} vein</b><i> backs up </i>into the <b>esophageal</b> <b>vein</b>, resulting in <b>varices</b></div>", "time": null}, {"id": 1482203769705, "note": "<div><b>Esophageal varices</b> may rupture, which presents with <i>painless</i> <b>{{c1::hematemesis}}</b></div>", "time": 1660105359427.0}, {"id": 1482203772064, "note": "<div><div>Is the <u>hematemesis</u> seen with <b>esophageal varices</b> typically <i>painful</i> or <i>painless</i>? </div><div><br /></div><div>{{c1::Painless}}</div></div>", "time": null}, {"id": 1482203779331, "note": "<div><b>Esophageal </b><b>{{c2::varices}}</b> are a<i> </i>common<i> </i>cause of <u>death</u> in patients with {{c1::<b>cirrhosis</b>}} </div>", "time": null}, {"id": 1482203787030, "note": "<div><b>{{c2::Achalasia}}</b> is characterized by <u>disordered esophageal motility</u> due to <i>inability</i> to relax the <b>{{c1::lower}} esophageal sphincter</b> </div>", "time": null}, {"id": 1482203793099, "note": "<div><b>Primary achalasia</b> is due to an <u>autoimmune</u> destruction of ganglion cells in the&nbsp;<b>{{c1::myenteric (Auerbach)}} plexus</b> </div>", "time": null}, {"id": 1482203795669, "note": "<div><b>Achalasia</b> may be <u>idiopathic</u> or <u>secondary</u> to a known insult, such as <b>{{c1::Chagas}} disease</b> and <b>extraesophageal malignancies</b> </div>", "time": null}, {"id": 1482203801315, "note": "<div>Does <b>achalasia</b> present with <u>dysphagia</u> for <b>solids</b> or <b>liquids</b>? </div><div><br></div><div>{{c1::Both solids and liquids :)}}</div>", "time": null}, {"id": 1482203808143, "note": "<div><b>Achalasia</b> is characterized by <u>{{c1::high}}</u> <b>LES pressure</b> on esophageal manometry </div>", "time": 1660105362220.0}, {"id": 1482203810412, "note": "<div><b>Achalasia</b> is characterized by <u>uncoordinated</u> or <u>absent</u> {{c1::peristalsis}} in the esophagus</div>", "time": 1660105362221.0}, {"id": 1482203812587, "note": "<div><b>{{c2::Achalasia}}</b> is characterized by the \"<b>{{c1::Birds beak}}</b>\" sign on barium swallow </div>", "time": null}, {"id": 1482203821480, "note": "<div>{{c1::<b>Gastroesophageal reflux disease</b> (GERD)}} is caused by reflux of acid from the stomach due to transiently <u>decreased</u> <b>{{c2::LES}} tone</b> </div>", "time": null}, {"id": 1482203823643, "note": "<div>What type of <u>hernia</u> increases risk of developing <b>GERD</b>? </div><div><br /></div><div>{{c1::Sliding hiatal hernia}}</div>", "time": null}, {"id": 1482203830526, "note": "<div><b>Gastroesophageal reflux disease</b> (GERD) often presents with <b>{{c1::heartburn}}</b>, which can <u>mimic</u> <b>cardiac chest pain</b></div>", "time": 1660105358683.0}, {"id": 1482203833062, "note": "<div><b>Gastroesophageal reflux disease</b> (GERD) may present with <b>chronic cough</b> and <u>adult-onset</u> <b>{{c1::asthma}}</b> </div>", "time": null}, {"id": 1482203843738, "note": "<div><b>Gastroesophageal reflux disease</b> (GERD) may damage the {{c1::enamel}} of teeth</div>", "time": 1660105358684.0}, {"id": 1482203845945, "note": "<div>Late complications of <u>GERD</u> include:</div><div>- <b>{{c2::Barrett}} esophagus</b> </div><div>- <i><b>ulcerations</b></i> followed by <b>esophageal {{c1::strictures}}</b> </div>", "time": 1660105355721.0}, {"id": 1482203852076, "note": "<div><b>Esophageal strictures</b> are associated with <b>{{c1::caustic ingestion}}</b> and <b>{{c2::GERD}}</b></div>", "time": 1660105359430.0}, {"id": 1482203855096, "note": "<div><b>{{c1::Barretts esophagus}}</b> is characterized by <u>specialized intestinal metaplasia</u> of the <b>lower esophageal mucosa</b></div>", "time": null}, {"id": 1482203859036, "note": "<div>In <u>Barretts esophagus</u>, <b>{{c1::non-keratinized stratified squamous epithelium}}</b> is <i>replaced</i> with <b>{{c2::non-ciliated columnar epithelium with goblet cells}}</b> (metaplasia) </div>", "time": 1660105357428.0}, {"id": 1482203866292, "note": "<div><b>Barretts esophagus</b> is seen in 10% of patients with {{c1::GERD}}</div>", "time": 1660105361343.0}, {"id": 1482203868576, "note": "<div>Which type of <u>esophageal cancer</u>&nbsp;is associated with <b>obesity</b>, <b>GERD</b> and<b> Barretts esophagus</b>? </div><div><br></div><div>{{c1::Adenocarcinoma::SCC or adenocarcinoma}}</div>", "time": null}, {"id": 1482203956292, "note": "<div><b>Adenocarcinoma </b>of the <u>esophagus</u> most commonly arises from pre-existing {{c1::Barrett esophagus}}</div>", "time": 1660105362083.0}, {"id": 1482203977242, "note": "<div><div><div><div>Which type of <u>esophageal cancer</u> (SCC or adenocarcinoma) is associated with <b>esophageal web</b> (e.g. Plummer-Vinson syndrome)? </div><div><br /></div><div>{{c1::Squamous cell carcinoma}}</div></div></div></div>", "time": null}, {"id": 1482203979595, "note": "<div><div><div><div>Which type of <u>esophageal cancer</u> (SCC or adenocarcinoma) is associated with <b>achalasia</b>? </div><div><br /></div><div>{{c1::Both :)}}</div></div></div></div>", "time": null}, {"id": 1482203981622, "note": "<div><div><div>Which type of <u>esophageal cancer</u> (SCC or adenocarcinoma) is associated with <b>very hot tea</b>? </div><div><br /></div><div>{{c1::Squamous cell carcinoma}}</div></div></div>", "time": 1660105341843.0}, {"id": 1482203983569, "note": "<div><div><div>Which type of <u>esophageal cancer</u> (SCC or adenocarcinoma) is associated with <b>esophageal injury</b> (e.g. lye/caustic ingestion)? </div><div><br /></div><div>{{c1::Squamous cell carcinoma}}</div></div></div>", "time": null}, {"id": 1482255441749, "note": "<b>Barrett esophagus </b>is characterized by extension of the <u>{{c1::squamocolumnar}} junction</u> (<b>Z-line</b>) into the esophageal mucosa ", "time": null}, {"id": 1482255679162, "note": "<div><b>{{c1::Eosinophilic esophagitis}}</b> is characterized by <u>eosinophilic infiltration</u> of the <b>esophagus</b>, often in {{c2::<b>atopic</b>}} <b>patients</b> </div>", "time": 1660105340435.0}, {"id": 1482255682101, "note": "<div><b>{{c2::Eosinophilic esophagitis}}</b> presents with <b>esophageal {{c1::rings}}</b> and linear furrows, often seen on endoscopy</div>", "time": 1660105338010.0}, {"id": 1482255686225, "note": "<div><b>Eosinophilic esophagitis</b> classically presents with <u>dysphagia</u> and <u>food impaction</u> in response to {{c1::food allergens}}</div>", "time": 1660105359511.0}, {"id": 1482255688470, "note": "<div>Does <b>eosinophilic esophagitis</b> respond to <b>GERD therapy</b> (e.g. PPIs)?</div><div><br></div><div>{{c1::No}}</div>", "time": null}, {"id": 1482255690220, "note": "<div>What <i>infectious</i> cause of <u>esophagitis</u> presents as <b>punched-out ulcers</b>? </div><div><br /></div><div>{{c1::HSV-1}}</div>", "time": null}, {"id": 1482255696148, "note": "<div><div>What <i>infectious</i> cause of <u>esophagitis</u> presents as <b>linear ulcers</b>? </div><div><br /></div><div>{{c1::CMV}}</div></div>", "time": null}, {"id": 1482255701661, "note": "<div><div>What <i>infectious</i> cause of <u>esophagitis</u> presents as <b>white pseudomembranes</b>? </div><div><br></div><div>{{c1::Candida}}</div></div>", "time": null}, {"id": 1482255704031, "note": "<div><b><i>Infectious</i> esophagitis</b> is typically seen in {{c1::<u>immunocompromised</u>}} patients </div>", "time": null}, {"id": 1482255713833, "note": "<div><b>Sclerodermal esophageal dysmotility</b> is characterized by <u>{{c1::low}}</u> <b>LES pressure</b> on esophageal manometry</div>", "time": null}, {"id": 1482273060226, "note": "<div><b>{{c1::Gastroschisis}}</b> is a <i>congenital malformation</i> characterized by <b>extrusion of abdominal contents</b> through the <u>anterior abdominal wall</u> </div>", "time": null}, {"id": 1482274957988, "note": "<div><div>Which <i>congenital</i> <u>abdominal wall defect</u> <b>IS NOT</b> covered by <b>peritoneum</b>?</div><div><br /></div><div>{{c1::Gastroschisis}}</div></div>", "time": null}, {"id": 1482274965376, "note": "<div><div><div><b>Omphalocele</b> is a <u>persistent {{c2::herniation}}</u> of <b>bowel into umbilical cord</b></div></div></div>", "time": null}, {"id": 1482274971453, "note": "<div><div><div><b>{{c1::Omphalocele}}</b> is caused by <u>failure</u> of the <b>herniated intestines</b> to <i>return</i> to the body cavity during embryologic development</div></div></div>", "time": null}, {"id": 1482274978199, "note": "<div><div><div><div>Which <i>congenital</i> <u>abdominal wall defect</u> <b>IS</b> covered by <b>peritoneum</b>?</div><div><br /></div><div>{{c1::Omphalocele}} </div></div></div></div>", "time": null}, {"id": 1482274990793, "note": "<div><div><div><b>{{c2::Gastroschisis}}</b> and <b>{{c2::omphalocele}}</b> occur due to <u>failure</u> of <b>{{c1::lateral}} fold closure</b> of the anterior abdominal wall</div></div></div>", "time": 1660105337935.0}, {"id": 1482274999896, "note": "<div><div><b>{{c2::Bladder exstrophy}}</b> occurs due to <u>failure</u> of <b>{{c1::caudal}} fold closure</b> of the anterior abdominal wall</div></div>", "time": 1660105338254.0}, {"id": 1482275004042, "note": "<div><div><b>{{c1::Pyloric stenosis}}</b> is a <i>congenital</i> <u>hypertrophy</u> of the<b> pyloric smooth muscle</b></div></div>", "time": 1660105339121.0}, {"id": 1482275007962, "note": "<div><div>What is the <u>most common</u> cause of <b>gastric outlet obstruction</b> in <b>infants</b>? </div><div><br></div><div>{{c1::Pyloric stenosis (1:600)}}</div></div>", "time": 1660105345945.0}, {"id": 1482275017818, "note": "<div><div>What <u>demographic</u> is associated with <b>pyloric stenosis</b>? </div><div><br></div><div>{{c1::First-born males}}</div></div>", "time": null}, {"id": 1482275085375, "note": "<div><div>How soon after birth does <b>pyloric stenosis</b> typically present? </div><div><br /></div><div>{{c1::~ 2 - 6 weeks}}</div></div>", "time": null}, {"id": 1482275190191, "note": "<div><div><b>Pyloric stenosis</b> typically presents with <b>{{c1::nonbilious::bilious or nonbilious}}</b>, <b><i>projectile</i></b> <b>vomiting</b> </div></div>", "time": null}, {"id": 1482275198622, "note": "<div><div><b>{{c2::Pyloric stenosis}}</b> often presents with a palpable \"{{c1::<b>olive</b>}}<b>-like</b>\" <b>mass</b> in the epigastric region of the abdomen</div></div>", "time": null}, {"id": 1482275209765, "note": "<div><div><b>Pyloric stenosis</b> may present with <b>visible {{c1::peristalsis}}</b></div></div>", "time": null}, {"id": 1482275213721, "note": "<div><div>What <u>drug class</u> is associated with <b>pyloric stenosis</b>? </div><div><br /></div><div>{{c1::Macrolides (antibiotics)}}</div></div>", "time": null}, {"id": 1482275221585, "note": "<div><div>What <u>acid-base disturbance</u> is associated with <b>pyloric stenosis</b>? </div><div><br /></div><div>{{c1::Hypokalemic, hypochloremic metabolic alkalosis}}</div></div>", "time": null}, {"id": 1482275230016, "note": "<div><div><div>What is the <u>treatment</u> for <b>pyloric stenosis</b>? </div><div><br /></div><div>{{c1::Surgical excision (pyloromyotomy)}}</div></div></div>", "time": 1660105345312.0}, {"id": 1482275713023, "note": "<div><div><b>{{c1::Acute}} gastritis</b> occurs due to <u>acidic damage</u> to the stomach mucosa </div></div>", "time": null}, {"id": 1482275724899, "note": "<div><b>{{c1::Acute}} gastritis</b> arises due to <u>imbalance</u> between <b>mucosal defenses</b> and <b>acidic environment</b></div>", "time": 1660105341301.0}, {"id": 1482275730166, "note": "<div><b>Mucosal defenses</b> include secretion of <b>{{c1::mucus}}, </b><b>{{c2::HCO<sub>3</sub><sup>-</sup>}}, prostaglandins,&nbsp;</b>and {{c3::<b>normal blood supply</b>}}</div>", "time": null}, {"id": 1482275734722, "note": "<div><b>Mucosal defenses</b> include <u>normal</u> <b>{{c1::blood supply}}</b>, which provides nutrients and picks up leaked acids</div>", "time": null}, {"id": 1482275738780, "note": "<div><b>Acute gastritis</b> may arise with <b>severe {{c1::burns}}</b> due to <u>hypovolemia</u>, which causes <b>mucosal</b> {{c2::<b>ischemia</b>}} </div>", "time": null}, {"id": 1482275742402, "note": "<div>What type of <u>gastric ulcer</u> is caused by <b>severe burns</b>? </div><div><br /></div><div>{{c1::Curling ulcer}}</div>", "time": null}, {"id": 1482275748424, "note": "<div><b>Acute gastritis</b> may arise with <b>{{c1::NSAID}} use </b>due to <u>decreased</u> {{c2::<b>PGE</b><sub style=\"font-weight: bold; \">2</sub>}} </div>", "time": null}, {"id": 1482275755769, "note": "<div><b>Acute gastritis</b> may arise with <b>increased {{c1::ICP}},</b> which to <u>increases {{c2::vagal stimulation}}</u>, which<b> increases H<sup>+</sup> production</b></div>", "time": null}, {"id": 1482275763392, "note": "<div><div>What type of <u>gastric ulcer</u> is caused by <b>increased intracranial pressure</b>? </div><div><br /></div><div>{{c1::Cushing ulcer}}</div></div>", "time": null}, {"id": 1482275770410, "note": "<div><b>Acute gastritis</b> may arise with <b>{{c1::shock}}</b>, which presents as <i>multiple</i> <u>stress</u> ulcers secondary to ischemia</div>", "time": 1660105362161.0}, {"id": 1482275773896, "note": "<div><b>{{c2::Acute}} gastritis</b> is especially common among <b>{{c1::alcoholics}}</b> and <b>patients taking daily NSAIDs</b> (e.g. rheumatoid arthritis patients)</div>", "time": null}, {"id": 1482275776638, "note": "<div><b>Gastric {{c1::erosions::erosions or ulcers}}</b> involves loss of the <u>{{c2::mucosal}} layer</u> <i>only</i></div>", "time": null}, {"id": 1482275780185, "note": "<div><b>Gastric {{c1::ulcers::erosions or ulcers}}</b>&nbsp;may extend <i>into</i> and <i>beyond</i> the <b>{{c2::submucosa}}</b></div>", "time": null}, {"id": 1482275786649, "note": "<div><b>{{c1::Chronic}} gastritis</b> occurs due to <u>chronic inflammation</u> of the stomach mucosa</div>", "time": null}, {"id": 1482275789570, "note": "<div><b>Chronic gastritis</b> is associated with <u>{{c1::atrophy::hypertrophy or atrophy}}</u> of the gastric mucosa</div>", "time": 1660105360746.0}, {"id": 1482275792478, "note": "<div><b>Chronic gastritis</b> is associated with <b>{{c1::intestinal}} metaplasia</b> </div>", "time": null}, {"id": 1482275800941, "note": "<div>What is the effect of <u>chronic gastritis</u> on <b>gastric HCl secretion</b>? </div><div><br /></div><div>{{c1::Decreased (achlorhydria or hypochlorhydria)}}</div>", "time": 1660105346546.0}, {"id": 1482275848739, "note": "<div><div>What is the effect of <u>chronic gastritis</u> on <b>gastrin secretion</b>? </div><div><br /></div><div>{{c1::Increased (hypergastrinemia)}}</div></div>", "time": 1660105346545.0}, {"id": 1482275855469, "note": "<div><b>{{c3::Chronic}} gastritis</b> is divided into <u>two</u> types based on etiology: {{c1::<b>autoimmune</b>}} and {{c2::<i><b>H. pylori</b></i>}} <b>gastritis</b></div>", "time": null}, {"id": 1482275866688, "note": "<div><b>Chronic autoimmune gastritis</b> is also referred to as <b>type {{c1::A}} gastritis</b> </div>", "time": null}, {"id": 1482275879352, "note": "<div><div><b>Chronic <i>H. pylori</i> gastritis</b> is also referred to as <b>type {{c1::B}} gastritis</b> </div></div>", "time": null}, {"id": 1482275885978, "note": "<div><b>Chronic <u>autoimmune</u> gastritis</b> is due to <i>autoimmune destruction</i> of <b>{{c1::parietal}} cells</b></div>", "time": null}, {"id": 1482275889027, "note": "<div>Which <u>areas</u> of the stomach are affected in <b>chronic <u>autoimmune</u> gastritis</b>? </div><div><br></div><div>{{c1::body and fundus}}</div>", "time": 1660105344398.0}, {"id": 1482275895589, "note": "<div><b>Chronic <u>autoimmune</u> gastritis</b> is associated with antibodies against <b>{{c1::parietal cells}}</b> and/or <b>{{c2::intrinsic factor}}</b> </div>", "time": null}, {"id": 1482275928004, "note": "<div>What type of <u>hypersensitivity reaction</u> is <b>chronic autoimmune gastritis</b>? </div><div><br /></div><div>{{c1::Type IV (T-cell mediated)}}</div>", "time": 1660105344815.0}, {"id": 1482275937923, "note": "<div>{{c2::<b>Chronic <u>autoimmune</u></b>}}<b> gastritis</b> is associated with increased risk for <b>{{c1::pernicious}} anemia</b> </div>", "time": 1660105338189.0}, {"id": 1482275947242, "note": "<div>What is the <u>most common</u> (90%) form of <b>chronic</b> <b>gastritis</b>? </div><div><br></div><div>{{c1::Chronic <i>H. pylori</i> gastritis}}</div>", "time": null}, {"id": 1482275950328, "note": "<div><div>Which <u>area</u> of the stomach is <i>initially</i> affected by <b>chronic <i>H. pylori</i> gastritis</b>? </div><div><br></div><div>{{c1::Antrum}}</div></div>", "time": null}, {"id": 1482275966286, "note": "<div><b>Chronic <i>H. pylori</i> gastritis</b> causes <u>increased</u> risk for <b>{{c1::peptic ulcer}} disease</b></div>", "time": null}, {"id": 1482275969327, "note": "<div><b>Chronic {{c2::<i>H. pylori</i>}} gastritis</b> causes <u>increased</u> risk for <b>{{c1::MALT}} lymphoma</b> </div>", "time": null}, {"id": 1482275980698, "note": "<div>What <u>cytotoxin</u> released by <b><i>H. pylori</i></b> breaks down the <b>protective mucus barrier</b>? </div><div><br></div><div>{{c1::CagA toxin}}</div>", "time": null}, {"id": 1482275983368, "note": "<div><i style=\"font-weight: bold; \">H. pylori</i> produces {{c1::urease}}, which <u>alkalinizes</u> the local environment, enabling bacterial survival</div>", "time": null}, {"id": 1482275986228, "note": "<div><i><b>H. pylori</b> </i>infection may be diagnosed using the <b>{{c1::urea}} breath test</b> </div>", "time": null}, {"id": 1482275993431, "note": "<div>Is the <u>intestinal metaplasia</u> seen with <b><i>H. pylori </i>gastritis</b> <i>reversible</i>? </div><div><br></div><div>{{c1::Yes (resolves with treatment of infection)}}</div>", "time": null}, {"id": 1482275998890, "note": "<div><b>Duodenal ulcers</b> are <u>almost always</u> due to {{c1::<i><b>H. pylori</b></i>}} (~ 90%) </div>", "time": 1660105359740.0}, {"id": 1482276001326, "note": "<div><b>Duodenal ulcers</b> <i>rarely</i> may be due to <b>{{c1::Zollinger-Ellison}} syndrome</b></div>", "time": null}, {"id": 1482276003791, "note": "<div><b>{{c2::Duodenal}} ulcers</b> present with <u>epigastric pain</u> that <b>{{c1::improves}}</b> with meals </div>", "time": null}, {"id": 1482276009311, "note": "<div><b>{{c2::Duodenal}} ulcers</b> are diagnosed via <u>endoscopic biopsy</u>, which shows an ulcer with <b>hypertrophy of</b> <b>{{c1::Brunner glands}}</b></div>", "time": null}, {"id": 1482276012228, "note": "<div><b>Duodenal ulcers</b> usually arise in the <u>{{c1::anterior::anterior or posterior}}</u> duodenum&nbsp;</div>", "time": null}, {"id": 1482276015731, "note": "<div><b>Duodenal ulcers</b> located in the <u>{{c1::posterior}} duodenum</u> may <i>rupture</i>, leading to bleeding from the <b>{{c2::gastroduodenal}} artery</b> </div>", "time": null}, {"id": 1482276022637, "note": "<div><b>Gastric ulcers</b> are <u>usually</u> due to {{c1::<i><b>H. pylori</b></i>}} (~ 70%) </div>", "time": 1660105358697.0}, {"id": 1482276026606, "note": "<div>Less common causes of <b>gastric ulcers</b> include {{c1::NSAIDs}} and bile reflux</div>", "time": 1660105355646.0}, {"id": 1482276029805, "note": "<div><b>{{c2::Gastric}} ulcers</b> present with <u>epigastric pain</u> that <b>{{c1::worsens}}</b> with meals</div>", "time": null}, {"id": 1482276032069, "note": "<div>What is the <u>most common</u> location for a <b>gastric ulcer</b>? </div><div><br></div><div>{{c1::Lesser curvature of stomach}}</div>", "time": null}, {"id": 1482276034749, "note": "<div><b>Gastric ulcers</b> on the <u>lesser curvature</u> of the stomach may <i>rupture</i>, leading to bleeding from the <b>{{c1::left gastric}} artery</b> </div>", "time": null}, {"id": 1482276036848, "note": "<div>Which type of <u>ulcer</u> (gastric or duodenal) is more likely to be <b>malignant</b>? </div><div><br></div><div>{{c1::Gastric}}</div>", "time": 1660105341686.0}, {"id": 1482276044316, "note": "<div><b>{{c1::Benign::Benign or Malignant}} gastric ulcers</b> are usually small (&lt; 3 cm), sharply demarcated (\"<b>punched-out</b>\"), and surrounded by <b>radiating folds of mucosa</b></div>", "time": 1660105341039.0}, {"id": 1482276059851, "note": "<div><b>{{c1::Gastric::gastric or duodenal}} ulcers</b>&nbsp;should be <u>biopsied</u> at the margins to rule out malignancy</div>", "time": null}, {"id": 1482276062753, "note": "<div>What is the <u>most common</u> <b>ulcer complication</b> (both gastric and duodenal)?</div><div><br></div><div>{{c1::Hemorrhage}}</div>", "time": null}, {"id": 1482276069472, "note": "<div>Which type of <u>duodenal ulcer</u>&nbsp;is more commonly associated with<b> perforation</b>? </div><div><br></div><div>{{c1::Anterior::anterior or posterior}}</div>", "time": null}, {"id": 1482276071848, "note": "<div><b>{{c1::Perforation}}</b> of an <u>anterior duodenal ulcer</u> is characterized by <b>free air</b> <b>under the diaphragm</b> (pneumoperitoneum) </div>", "time": null}, {"id": 1482276076924, "note": "<div><b>Perforation</b> of an <u>anterior duodenal ulcer</u> may present with <i>referred pain</i> to the <b>{{c1::shoulder}}</b> via the <b>phrenic nerve</b> </div>", "time": null}, {"id": 1482276113524, "note": "<div>What is the <i>most common</i> classification of <b>gastric carcinoma</b> (e.g. SCC, lymphoma, adenocarcinoma, etc.)? </div><div><br></div><div>{{c1::Adenocarcinoma}}</div>", "time": null}, {"id": 1482276121561, "note": "<div><b>Gastric carcinoma</b> is subclassified into <b>{{c1::intestinal}}</b> and <b>{{c2::diffuse}} types</b></div>", "time": null}, {"id": 1482276124111, "note": "<div>Which type of <u>gastric carcinoma</u> (intestinal or diffuse) is <b>more</b> <b>common</b>? </div><div><br></div><div>{{c1::Intestinal}}</div>", "time": null}, {"id": 1482276126544, "note": "<div>The <b>intestinal type</b> of <u>gastric carcinoma</u> most commonly arises on the {{c1::lesser curvature of the antrum}} </div>", "time": null}, {"id": 1482276131945, "note": "<div>Which type of <u>gastric carcinoma</u> (intestinal or diffuse) is associated with <i><b>H. pylori</b> </i><b>infection</b>? </div><div><br></div><div>{{c1::Intestinal}}</div>", "time": null}, {"id": 1482276134378, "note": "<div><div>Which type of <u>gastric carcinoma</u> (diffuse or intestinal) is associated with <b>chronic gastritis</b>? </div><div><br /></div><div>{{c1::Intestinal}}</div></div>", "time": null}, {"id": 1482276145668, "note": "<div>The <b>{{c2::intestinal}} type</b> of <u>gastric carcinoma</u> is associated with <b>{{c1::nitrosamines}}</b>, which are found in <b>smoked foods</b> (common in Japan)</div>", "time": null}, {"id": 1482276148696, "note": "<div>The <b>{{c2::intestinal}} type</b> of <u>gastric carcinoma</u> is associated with <b>blood type {{c1::A}}</b></div>", "time": null}, {"id": 1482276151528, "note": "<div>The <b>{{c2::diffuse}} type</b> of <u>gastric carcinoma</u> is characterized by <b>{{c1::signet ring}} cells</b> that infiltrate the gastric wall </div>", "time": null}, {"id": 1482276167916, "note": "<div>The <b>{{c2::diffuse}} type</b> of <u>gastric carcinoma</u> may cause <b>{{c1::linitis plastica}}</b>, which is a grossly <b>thickened</b> and <b>leathery</b> stomach wall </div>", "time": null}, {"id": 1482276174562, "note": "<div><b>Gastric carcinoma</b> typically presents {{c1::<u>late</u>::timing}} with <b>weight loss</b>, <b>early satiety</b>, abdominal pain, and anemia</div>", "time": 1660105358705.0}, {"id": 1482276177874, "note": "<div><b>Gastric {{c2::adenocarcinoma}}</b> rarely may present with <b>{{c1::acanthosis nigricans}}</b>, which is <u>hyperpigmented</u> velvety plaques in the <b>axilla</b> and <b>neck</b> </div>", "time": null}, {"id": 1482276182309, "note": "<div><b>{{c2::Gastric}} adenocarcinoma</b> rarely may present with the <b>{{c1::</b><b>Leser-Tr\u00e9lat</b><b>}} sign</b>, which is <u>sudden onset</u> of multiple <b>{{c3::seborrheic keratoses}}</b></div>", "time": null}, {"id": 1482276186550, "note": "<div><b>Gastric carcinoma</b> may spread and involve the <u>{{c1::left supraclavicular}} node</u>, also known as <b>{{c2::Virchows node}}</b></div>", "time": null}, {"id": 1482276188994, "note": "<div><b>Distant metastasis</b> of <u>gastric adenocarcinoma</u> <i>most commonly</i> involves the {{c1::liver}}</div>", "time": null}, {"id": 1482276190926, "note": "<div><b>Gastric carcinoma</b> may spread and involve the <u>{{c1::periumbilical}} region</u>, also known as a(n)&nbsp;<b>{{c2::Sister Mary Joseph nodule}}</b></div>", "time": null}, {"id": 1482276192890, "note": "<div><div>Which type of <u>gastric carcinoma</u> (diffuse or intestinal) is associated with a <b>Sister Mary Joseph nodule</b>? </div><div><br></div><div>{{c1::Intestinal}}</div></div>", "time": 1660105341835.0}, {"id": 1482276194946, "note": "<div><b>Gastric carcinoma</b> may spread and involve the <u>{{c1::bilateral ovaries}}</u>, also known as a(n)&nbsp;<b>{{c2::Krukenberg tumor}}</b></div>", "time": null}, {"id": 1482276209786, "note": "<div><b>M\u00e9n\u00e9trier&nbsp;disease</b> is characterized by {{c1::<u>hyperplasia</u>}} of the gastric mucosa and {{c1::<u>atrophy</u>}} of the parietal / chief cells</div>", "time": null}, {"id": 1482276212675, "note": "<div><b>{{c1::M\u00e9n\u00e9trier}} disease</b> is characterized by <u>hypertrophied gastric rugae</u> that resemble <b>brain gyri</b></div>", "time": null}, {"id": 1482276216481, "note": "<div><b>M\u00e9n\u00e9trier&nbsp;disease</b> is characterized by <u>excess</u> <b>mucus production</b> with resultant <b>{{c1::protein}} loss,&nbsp;</b>leading to&nbsp;<u>edema</u></div>", "time": null}, {"id": 1482276224000, "note": "<div><b>M\u00e9n\u00e9trier&nbsp;disease</b> is characterized by <b>{{c1::parietal}} cell atrophy</b> with <u>decreased</u> acid production</div>", "time": null}, {"id": 1482276226091, "note": "<div>Does <u>m\u00e9n\u00e9trier&nbsp;disease</u> increase risk for <b>gastric cancer</b>? </div><div><br></div><div>{{c1::Yes (pre-cancerous lesion)}}</div>", "time": 1660105359844.0}, {"id": 1482284296442, "note": "<div><b>Intestinal atresia</b> presents with <u>abdominal distention</u> and <b>{{c1::bilious::bilious or nonbilious}}</b> <b>vomiting</b>&nbsp;</div>", "time": null}, {"id": 1482289458987, "note": "<div><div><div>How soon after birth does <b>intestinal atresia</b> typically present? </div><div><br /></div><div>{{c1::~ 1 - 2 days}}</div></div></div>", "time": null}, {"id": 1482289465469, "note": "<b>Duodenal {{c1::atresia}}</b> is a <i>congenital </i><u>failure</u> of the duodenum to <b>canalize</b>", "time": null}, {"id": 1482289468295, "note": "<div><b>{{c2::Duodenal}} atresia</b> is associated with <b>{{c1::Down}} syndrome</b></div>", "time": null}, {"id": 1482289470259, "note": "<div><b>Duodenal atresia</b> presents with {{c1::<u>polyhydramnios</u>}} in utero</div>", "time": 1660105359743.0}, {"id": 1482289473221, "note": "<div><b>{{c2::Duodenal atresia}}</b> is characterized by <u>dilation</u> of the stomach and <i>proximal</i> duodenum with a \"{{c1::<b>double</b> <b>bubble</b>}}\" sign on X-ray </div>", "time": null}, {"id": 1482289480639, "note": "<div><b>Jejunal</b> and <b>ileal atresia</b> occur due to <u>disruption</u> of {{c1::mesenteric}} vessels during development, which causes <b>ischemic</b> <b>necrosis</b> and <b>segmental</b> <b>resorption</b> </div>", "time": null}, {"id": 1482289483439, "note": "<div><b>Jejunal</b> and <b>ileal atresia</b> are associated with an \"<b>{{c1::apple peel}}</b>\" appearance of the bowel</div>", "time": null}, {"id": 1482289491610, "note": "<div><b>{{c1::Meckel}} diverticulum</b> is an outpouching of <u>all three layers</u> of the <b>bowel wall</b> (<b>true diverticulum</b>)</div>", "time": null}, {"id": 1482289494494, "note": "<div><div>Is <b>Meckel diverticulum</b> a <u>true</u> or <u>false</u> diverticulum?</div><div><br /></div><div>{{c1::True (outpouching of all layers)}}</div></div>", "time": null}, {"id": 1482289502594, "note": "<div><b>Meckel diverticulum</b> arises due to <u>persistence</u> of the <b>{{c1::vitelline (omphalomesenteric) duct}}</b></div>", "time": null}, {"id": 1482289505425, "note": "<div>What is the <u>most common</u> <b>congenital anomaly </b>of the <b>GI tract</b>? </div><div><br /></div><div>{{c1::Meckel diverticulum}}</div>", "time": null}, {"id": 1482289510964, "note": "<div><b>Meckel diverticulum</b> is associated with the \"rule of {{c1::2s}}\"</div>", "time": null}, {"id": 1482289515105, "note": "<div><b>Meckel diverticulum</b> is <u>two times</u> more likely to occur in {{c1::males::gender}}</div>", "time": null}, {"id": 1482289518360, "note": "<div><b>Meckel diverticulum</b> is typically <u>two</u> {{c1::inches}} <b>long</b></div>", "time": null}, {"id": 1482289520748, "note": "<div><b>Meckel diverticulum </b>is typically located in the small bowel, <u>two</u> {{c1::feet}} from the <b>ileocecal valve</b></div>", "time": null}, {"id": 1482289524478, "note": "<div><b>Meckel diverticulum</b> typically presents during the first <u>two</u> {{c1::years}} of life</div>", "time": null}, {"id": 1482289539018, "note": "<div><b>Meckel diverticulum</b> may contain <b>ectopic</b> <u>acid-secreting</u> <b>{{c1::gastric mucosa}}</b> and/or <b>{{c2::pancreatic}}</b> <b>tissue</b></div>", "time": null}, {"id": 1482289546088, "note": "<div><b>{{c2::Meckel}} diverticulum</b> is diagnosed using a(n)&nbsp;<u>{{c1::<sup>99m</sup>Tc-pertechnetate}} study</u> for uptake by <b>heterotopic gastric mucosa</b></div>", "time": null}, {"id": 1482289549128, "note": "<div><b>Meckel diverticulum</b> is typically {{c1::asymptomatic}} but may present with volvulus, intussusception, melena/hematochezia, RLQ pain, or obstruction </div>", "time": 1660105355361.0}, {"id": 1482289554846, "note": "<div><div>The <b>{{c2::vitelline}} duct</b> connects the <b>yolk sac</b> to the <b>{{c1::midgut}} lumen</b> </div></div>", "time": null}, {"id": 1482289557764, "note": "<div><div>What <u>week</u> does the <b>vitelline duct</b> <i>normally</i> <b>obliterate</b>? </div><div><br></div><div>{{c1::Week 7}}</div></div>", "time": null}, {"id": 1482289560054, "note": "<div>What <i>congenital anomaly</i> is caused by <u>complete failure</u> of the <b>vitelline duct to close</b>? </div><div><br /></div><div>{{c1::Vitelline fistula}}</div>", "time": null}, {"id": 1482289564582, "note": "<div><div>What <i>congenital anomaly</i> is caused by only <u><i>partial</i> closure</u> of the <b>vitelline duct</b>? </div><div><br /></div><div>{{c1::Meckel diverticulum}}</div></div>", "time": null}, {"id": 1482289568991, "note": "<div><div>What <i>congenital anomaly</i> is caused by <u>cystic dilation</u> of the <b>vitelline duct</b>? </div><div><br /></div><div>{{c1::Vitelline cyst (enterocyst)}}</div></div>", "time": null}, {"id": 1482289579274, "note": "<div><b>{{c1::Volvulus}}</b> is caused by <u>twisting</u> of a portion of <b>bowel </b>around its <b>mesentery</b>       </div>", "time": null}, {"id": 1482289593587, "note": "<div><b>Volvulus</b> can lead to <b>{{c1::obstruction}}</b> and <b>{{c2::infarction}}</b> of the affected bowel region</div>", "time": 1660105348179.0}, {"id": 1482289603147, "note": "<div><b>Volvulus</b> of the <u>{{c1::sigmoid colon}}</u> is more commonly seen in {{c2::the elderly::age group}}&nbsp;</div>", "time": null}, {"id": 1482289610928, "note": "<div><b>{{c1::Intussusception}}</b> is <b>telescoping</b> of a(n)&nbsp;<u>{{c2::proximal::proximal or distal}}</u> bowel segment <i>into&nbsp;</i>a(n)&nbsp;<u>{{c2::distal::proximal or distal}}</u> segment</div>", "time": null}, {"id": 1482289615950, "note": "<div>In <b>children</b>, the most common cause of <u>intussusception</u> is <b>{{c1::lymphoid hyperplasia}}</b> (e.g. due to rotavirus or adenovirus)</div>", "time": null}, {"id": 1482289623508, "note": "<div>What is the <i>most common</i> <u>pathologic</u> lead point for <b>intussusception</b> in <b>children <u>over 2</u></b>? </div><div><br /></div><div>{{c1::Meckel diverticulum}}</div>", "time": null}, {"id": 1482289625777, "note": "<div><div>What is the <i>most common</i> lead point for <b>intussusception</b> in <b>adults</b>? </div><div><br /></div><div>{{c1::Intraluminal mass or tumor}}</div></div>", "time": null}, {"id": 1482289634672, "note": "<div>Where in the <u>GI tract</u> does <b>intussusception</b> most commonly occur?</div><div><br></div><div>{{c1::Ileocecal junction}}</div>", "time": null}, {"id": 1482289637050, "note": "<div><b>Intussusception</b> results in compromised blood supply, which causes {{c2::<u>intermittent</u>::frequency}} <b>abdominal</b> <b>pain&nbsp;</b>with \"{{c1::<b>currant</b> <b>jelly</b>}}\" <b>stool</b> </div>", "time": null}, {"id": 1482289647560, "note": "<div><b>{{c2::Acute}} mesenteric ischemia</b> may occur due to a <u>thrombotic</u> or <u>embolic occlusion</u> of the <b>{{c1::superior mesenteric}} artery</b></div>", "time": null}, {"id": 1482289650424, "note": "<div><b>{{c2::Acute}} mesenteric ischemia</b> may occur due to a <u>thrombosis</u> of the <b>{{c1::mesenteric}} vein</b></div>", "time": 1660105338352.0}, {"id": 1482289652565, "note": "<div><b>Acute mesenteric ischemia</b> is associated with <u>transmural</u>&nbsp;<b>infarction </b>and <b>perforation</b>, which&nbsp;may cause {{c1::<b>septic&nbsp;</b><b>shock</b>}}</div>", "time": 1660105362137.0}, {"id": 1482289654584, "note": "<div><b>{{c1::Acute mesenteric ischemia}}</b> is associated with small bowel necrosis and <u>abdominal pain</u> <b>out of proportion</b> <b>to physical findings</b> </div>", "time": 1660105341310.0}, {"id": 1482289659677, "note": "<div><b>Acute mesenteric ischemia</b> may present with \"{{c1::currant jelly}}\" stool</div>", "time": null}, {"id": 1482289661873, "note": "<div><b>{{c2::Chronic}} mesenteric ischemia</b> may occur due to <u>severe hypotension</u> or <u>{{c1::atherosclerosis}}</u> of the <b>celiac artery</b>, <b>SMA</b>, or <b>IMA</b> </div>", "time": null}, {"id": 1482289667898, "note": "<div><b>Chronic mesenteric ischemia</b> is associated with {{c1::<u>mucosal</u>::mucosal or transmural}} <b>infarction</b></div>", "time": 1660105360733.0}, {"id": 1482289670432, "note": "<div><b>{{c1::Chronic}} mesenteric ischemia</b> is typically caused by <b>intestinal</b> <b>hypoperfusion</b> as a result of<b> </b><u>narrowed</u> vasculature<i> </i></div>", "time": null}, {"id": 1482289672114, "note": "<div><b>Chronic mesenteric ischemia</b> presents with <b>epigastric pain</b> that occurs {{c1::after::before or after}} eating&nbsp;</div>", "time": null}, {"id": 1482342409102, "note": "What <u>risk factor</u> is associated with <b>Warthin tumors</b>? <div><br></div><div>{{c1::Smoking}}</div>", "time": null}, {"id": 1482342465607, "note": "<b>Boerhaave syndrome</b> may present with <u>subcutaneous {{c1::emphysema}}</u>, which is characterized by <b>crepitus</b> felt in the neck region or chest wall ", "time": null}, {"id": 1482342792702, "note": "<b>Esophagitis</b> may occur with <u>medications</u> such as {{c1::bisphosphonates}}, tetracyclines, NSAIDs, iron, and potassium chloride ", "time": null}, {"id": 1482343170021, "note": "Loss of which <u>hormones/neurotransmitters</u> are implicated in the pathogenesis of <b>achalasia</b>? <div><br></div><div>{{c1::NO and VIP::2}}</div>", "time": null}, {"id": 1482343779218, "note": "What <u>GI pathology</u> is associated with the <b>rotavirus </b><i style=\"font-weight: bold; \">vaccine</i>? <div><br /></div><div>{{c1::Intussusception}}</div>", "time": null}, {"id": 1482355178454, "note": "<b>Lactose intolerance</b> is caused by <u>decreased</u> function of the <b>{{c1::<i>lactase</i>}} enzyme</b> found in brush border enterocytes", "time": null}, {"id": 1482359254980, "note": "<div><b>{{c1::Lactose}} intolerance</b> presents with <u>abdominal distention</u> and <u>diarrhea</u> upon consumption of <b>milk</b> <b>products</b></div>", "time": null}, {"id": 1482359266484, "note": "<div><b>Lactose intolerance</b> is <i>typically</i> characterized by <b>{{c1::normal}}-appearing villi</b> </div>", "time": null}, {"id": 1482359303783, "note": "<div><b>Lactose intolerance</b> is characterized by a(n)<u>{{c1::decreased}}</u> <b>stool pH</b></div>", "time": null}, {"id": 1482359312751, "note": "<div><b>Lactose intolerance</b> may be diagnosed using the <b>{{c1::lactose hydrogen}} breath test</b></div>", "time": null}, {"id": 1482359318969, "note": "<div><b>{{c2::Celiac}} disease</b> is <u>immune-mediated</u> damage of small bowel villi due to <b>{{c1::gluten}} exposure</b> </div>", "time": null}, {"id": 1482359326233, "note": "<div><b>Celiac disease</b> is associated with <b>HLA-{{c1::DQ2}}</b> and <b>HLA-{{c1::DQ8}}</b></div>", "time": null}, {"id": 1482359329829, "note": "<div>What <u>malabsorption disorder</u> is associated with <b>HLA-DQ2 </b>and <b>HLA-DQ8</b>? </div><div><br></div><div>{{c1::Celiac disease}}</div>", "time": null}, {"id": 1482359348837, "note": "<div>What is the <u>most pathogenic</u> component of <b>gluten</b> (celiac disease)?</div><div><br></div><div>{{c1::Gliadin}}</div>", "time": null}, {"id": 1482359355658, "note": "<div>In <u>Celiac disease</u>, <b>{{c1::deamidated gliadin}}</b> is presented by <u>APCs</u> via <b>MHC class II</b></div>", "time": 1660105357395.0}, {"id": 1482359358577, "note": "<div>Which <u>immune cell</u> mediates the tissue damage in <b>Celiac disease</b>? </div><div><br></div><div>{{c1::Helper T cells}}</div>", "time": null}, {"id": 1482359361688, "note": "<div><b>Celiac disease</b> in <u>{{c1::children::age group}}</u>&nbsp;classically presents as abdominal distention, <b>steatorrhea</b>, and <b>failure to thrive</b></div>", "time": 1660105360870.0}, {"id": 1482359364200, "note": "<div><b>Celiac disease</b> in <u>{{c1::adults::age group}}</u>&nbsp;classically presents with <b>chronic steatorrhea</b> and <b>bloating</b></div>", "time": 1660105360871.0}, {"id": 1482359382839, "note": "<div><b>Celiac disease</b> is classically seen in people of {{c1::northern European}} descent</div>", "time": null}, {"id": 1482359386135, "note": "<div><b>{{c2::Celiac}} disease</b> is associated with <b>{{c1::dermatitis herpetiformis}}</b>, which are small, herpes-like vesicles on the skin </div>", "time": null}, {"id": 1482359389310, "note": "<div>The <b>dermatitis herpetiformis</b> that arises with <u>celiac disease</u> is due to <b>{{c1::IgA}}</b> <b>deposition</b> at the <i>tips</i> of the <b>dermal papillae</b> </div>", "time": null}, {"id": 1482359407331, "note": "<div><b>{{c4::Celiac}} disease</b> is classically associated with <u>Ig{{c5::A}} antibodies</u> against <b>{{c1::endomysium}}</b>, {{c2::<b>tissue transglutaminase </b>(tTG)}}, and/or <b>{{c3::deamidated gliadin}}</b></div>", "time": null}, {"id": 1482359431570, "note": "<div><b>Celiac disease</b> is characterized <i>histologically</i> by <u>{{c1::flattening}}</u> of <b>{{c2::villi}}</b> </div>", "time": null}, {"id": 1482359449381, "note": "<div><b>Celiac disease</b> is characterized <i>histologically</i> by <u>{{c1::hyperplasia}}</u> of <b>{{c2::crypts}}</b> </div>", "time": null}, {"id": 1482359464147, "note": "<div><b>Celiac disease</b> is characterized <i>histologically</i> by <u>increased</u>&nbsp;<b>intraepithelial </b><b>{{c1::lymphocytes}}</b></div>", "time": null}, {"id": 1482359472741, "note": "<div><b>Celiac disease</b> primarily affects the <u>distal</u> {{c1::duodenum}} or <u>proximal</u> {{c1::jejunum}} </div>", "time": null}, {"id": 1482359478387, "note": "<div>Which type of <u>sprue</u> (celiac or tropical) primarily affects the <b>proximal small bowel</b>? </div><div><br></div><div>{{c1::Celiac sprue}}</div>", "time": null}, {"id": 1482359486208, "note": "<div><b>Celiac disease</b> is associated with <u>increased risk</u> for <b>small bowel carcinoma</b> and <b>{{c1::T-cell}} lymphoma</b> <i> </i></div>", "time": null}, {"id": 1482359500680, "note": "<div>What is the <u>treatment</u> for <b>celiac disease</b>? </div><div><br></div><div>{{c1::Gluten-free diet}}</div>", "time": null}, {"id": 1482359512506, "note": "<div><b>{{c1::Tropical}} sprue</b> is characterized by damage to <u>small bowel villi</u> due to an <i><b>unknown</b></i> <b>organism</b>, resulting in malabsorption</div>", "time": null}, {"id": 1482359538706, "note": "<div>Which <u>malabsorption disorder</u> is more common in <b>tropical regions</b>? </div><div><br></div><div>{{c1::Tropical sprue}}</div>", "time": null}, {"id": 1482359541727, "note": "<div><b>Tropical sprue</b> classically arises after infectious {{c1::diarrhea}}</div>", "time": null}, {"id": 1482359544432, "note": "<div><div>Which type of <u>sprue</u> (celiac or tropical) can affect <b>any</b> <b>part</b> of the<b> small bowel</b>? </div><div><br></div><div>{{c1::Tropical sprue}}</div></div>", "time": null}, {"id": 1482359552377, "note": "<div><b>{{c1::Tropical sprue}}</b> presents similarly to <u>celiac disease</u> but responds to <b>{{c2::antibiotics}}</b></div>", "time": null}, {"id": 1482359555074, "note": "<div><b>Tropical sprue</b> may be associated with <b>{{c1::megaloblastic}} anemia</b> </div>", "time": null}, {"id": 1482359564811, "note": "<div><div>Is <b>tropical sprue</b> associated with <u>normal</u> or <u>decreased</u> <i>urinary excretion</i> of <b>D-xylose</b> (D-xylose test)? </div><div><br /></div><div>{{c1::Decreased}} </div></div>", "time": null}, {"id": 1482359572977, "note": "<div><b>{{c2::Whipple}} disease</b> is characterized by systemic tissue damage with <u>macrophages</u> loaded with <b><i>{{c1::Tropheryma whipplei}} </i></b>organisms </div>", "time": null}, {"id": 1482359576029, "note": "<div><b><i>Tropheryma whipplei</i></b> is an <u>intracellular</u>, <b>gram {{c1::positive}}</b> organism </div>", "time": null}, {"id": 1482359578671, "note": "<div>The granules in <u>macrophages</u> in <b>Whipple disease</b> stain <i>positive</i> for {{c1::PAS}} and are {{c2::diastase}} resistant</div>", "time": null}, {"id": 1482359589330, "note": "<div>Which <u>malabsorption syndrome</u> is associated with <b>PAS positive</b>, <b>foamy macrophages</b>? </div><div><br /></div><div>{{c1::Whipple disease}}</div>", "time": null}, {"id": 1482359593949, "note": "<div><b>Whipple disease</b> classically involves the <u>{{c1::lamina propria::mucosal layer}}</u>&nbsp;of the <b>small bowel</b> </div>", "time": null}, {"id": 1482359601319, "note": "<div><b>Whipple disease</b> may present with <u>fat malabsorption</u> and <u>{{c2::steatorrhea}}</u> due to <i>compression</i> of <b>{{c1::lacteals}}</b> by macrophages</div>", "time": null}, {"id": 1482359607083, "note": "<div>What <u>lymph nodes</u> are commonly affected in <b>Whipple disease</b>? </div><div><br></div><div>{{c1::Mesenteric nodes}}</div>", "time": null}, {"id": 1482359609528, "note": "<div>The symptoms of <b>Whipple disease</b> may be remembered with the mnemonic \"<b>Foamy Whipp</b>ed cream in a <b>CAN</b>\": </div><div style=\"centerbox\"><div class=\"mnemonics\"><div><br/></div><div><b>C</b>: {{c1::cardiac symptoms}}</div><div><b>A</b>: {{c2::arthralgias}}</div><div><b>N</b>: {{c3::neurologic symptoms}} </div></div></div>", "time": null}, {"id": 1482359618134, "note": "<div>What <u>demographic</u> is most commonly affected by <b>Whipple disease</b>? </div><div><br></div><div>{{c1::Older men}}</div>", "time": null}, {"id": 1482359621598, "note": "<div><b>Pancreatic insufficiency</b> causes <u>malabsorption</u> of fat, fat-soluble vitamins, and vitamin {{c1::B<sub>12</sub>}}</div>", "time": 1660105354398.0}, {"id": 1482359631696, "note": "<div><b>Pancreatic insufficiency</b> is associated with <u>{{c1::decreased}}</u> excretion of <b>fecal elastase</b></div>", "time": null}, {"id": 1482359635387, "note": "<div><b>Pancreatic insufficiency</b> is associated with <u>{{c1::decreased}}</u> <b>duodenal pH</b> </div>", "time": null}, {"id": 1482359642469, "note": "<div><div>Is <b>pancreatic insufficiency</b> associated with <u>normal</u> or <u>decreased</u> <i>urinary excretion</i> of <b>D-xylose</b> (D-xylose test)? </div><div><br /></div><div>{{c1::Normal}} </div></div>", "time": null}, {"id": 1482359650137, "note": "<div>What <u>stain</u> is used to screen for <b>fecal fat</b>? </div><div><br /></div><div>{{c1::Sudan stain}}</div>", "time": null}, {"id": 1482359656396, "note": "<div><b>{{c2::Abetalipoproteinemia}}</b> is characterized by a <u>deficiency</u> of <b>apolipoprotein {{c1::B-48}}</b> and<b> {{c1::B-100}}</b></div>", "time": null}, {"id": 1482359666657, "note": "<div><b>Abetalipoproteinemia</b> is a(n) {{c1::autosomal recessive}} inherited malabsorption disorder that is caused by a mutation in the <b>{{c2::microsomal triglyceride transfer}} protein</b></div>", "time": null}, {"id": 1482359668798, "note": "<div><b>Abetalipoproteinemia</b> is associated with <u>malabsorption</u> due to defective {{c1::<b>chylomicron</b>}} <b>formation</b>, which <i>requires</i> apoB-48</div>", "time": 1660105362266.0}, {"id": 1482359671335, "note": "<div><b>{{c1::Abetalipoproteinemia}}</b> is associated with <u>absent</u> <b>plasma</b> <b>VLDL</b> and <b>LDL</b>, which <i>require</i> apoB-100</div>", "time": null}, {"id": 1482359673641, "note": "<div><b>Carcinoid tumor</b> is a malignant proliferation of {{c1::neuroendocrine}} cells; <u>low-grade</u> malignancy</div>", "time": null}, {"id": 1482359685945, "note": "<div>What is the&nbsp;<u>most common</u>&nbsp;<b>malignancy</b>&nbsp;in the&nbsp;<b>small intestine</b>?</div><div><br></div><div>{{c1::Carcinoid tumor (neuroendocrine cells)}}</div>", "time": 1660105345856.0}, {"id": 1482359694412, "note": "<div>What <u>neurotransmitter</u> is often secreted by <b>carcinoid tumors</b>? </div><div><b><br></b></div><div>{{c1::Serotonin}}</div>", "time": null}, {"id": 1482359699735, "note": "<div>The <b>serotonin</b> released from <u>carcinoid tumors</u> in the <b>small bowel</b> is metabolized in the <b>{{c1::liver}}</b> by {{c2::<b><i>monoamine oxidase</i> </b>(MAO)}}, producing <b>{{c3::5-HIAA}}</b> </div>", "time": null}, {"id": 1482359707088, "note": "<div><b>Carcinoid tumors</b> are characterized by <u>increased</u> excretion of <b>{{c1::5-HIAA}}</b> in the urine </div>", "time": null}, {"id": 1482359719029, "note": "<div>Metastasis of <b>carcinoid tumor</b> to the <u>liver</u> allows <b>serotonin</b> to <i>bypass</i> <b>{{c1::first-pass}} metabolism</b> and enter systemic circulation </div>", "time": 1660105355278.0}, {"id": 1482359724826, "note": "<div>The symptoms of <b>{{c5::carcinoid}} syndrome</b> may be remembered with the mnemonic \"<b>B</b>e <b>FDR</b>\": </div><div style=\"centerbox\"><div class=\"mnemonics\"><div><br></div><div><b>B</b>e: {{c1::bronchospasm}}</div><div><b>F</b>: {{c2::flushing}}</div><div><b>D</b>: {{c3::diarrhea}}</div><div><b>R</b>: {{c4::right-sided heart disease}}</div></div></div>", "time": 1660105349508.0}, {"id": 1482359729870, "note": "<div><b>Carcinoid syndrome</b> may cause <u>right-sided valvular heart lesions</u> such as <b>{{c1::tricuspid regurgitation}}</b> and <b>{{c2::pulmonic stenosis}}</b></div>", "time": 1660105360943.0}, {"id": 1482359732401, "note": "<div>Why are <b><i>left</i>-sided heart valve lesions</b> NOT seen with <u>Carcinoid syndrome</u>? </div><div><br /></div><div>{{c1::Lung contains MAO, which metabolizes serotonin}}</div>", "time": null}, {"id": 1482359734855, "note": "<div>Does <b>carcinoid </b><i style=\"font-weight: bold; \">syndrome</i> occur with <u>carcinoid tumors</u> that are <i>limited</i> to the <b>GI tract</b>? </div><div><br></div><div>{{c1::No}}</div>", "time": null}, {"id": 1482359737045, "note": "<div>What <u>vitamin deficiency</u> may be caused by <b>malignant carcinoid syndrome</b>? </div><div><br /></div><div>{{c1::Niacin (B<sub>3</sub>) deficiency}}</div>", "time": null}, {"id": 1482359742565, "note": "<div><b>Carcinoid syndrome</b> may be treated with <u>surgical resection</u> or with a(n) {{c1::somatostatin}} analog </div>", "time": null}, {"id": 1482359750696, "note": "<b>Carcinoid syndrome</b> is associated with the \"<b>rule of {{c1::1/3s}}</b>\"", "time": null}, {"id": 1482361493392, "note": "<b>{{c1::Appendicitis}}</b> is defined as acute <u>inflammation</u> of the <b>appendix</b>", "time": null}, {"id": 1482361852062, "note": "<div><b>Appendicitis</b> is related to <u>obstruction</u> of the appendix by <b>{{c1::lymphoid hyperplasia}}</b> (children)</div>", "time": null}, {"id": 1482361855147, "note": "<div><b>Appendicitis</b> in <i>adults </i>is typically related to <u>obstruction</u> of the appendix by a(n)&nbsp;<b>{{c1::fecalith}}</b></div>", "time": null}, {"id": 1482361859692, "note": "<div><b>{{c2::Appendicitis}}</b> presents with <u>diffuse</u> <b>periumbilical pain</b> that eventually localizes to <b>{{c1::McBurneys point}}</b> </div>", "time": null}, {"id": 1482361866370, "note": "<div><b>Appendicitis</b> may lead to <u>rupture</u>, resulting in <b>peritonitis</b> with guarding and <b>{{c1::rebound tenderness}}</b> on physical exam</div>", "time": 1660105361635.0}, {"id": 1482361886695, "note": "<div>What <u>other pathologies</u> should be on a differential when considering <b>appendicitis</b>?<div><br></div><div>{{c1::<b>Diverticulitis</b>}} (elderly) and {{c2::<b>ectopic pregnancy</b>}}</div></div>", "time": null}, {"id": 1482369554930, "note": "<b>Inflammatory bowel disease</b> classically presents in <u>young</u> {{c1::women::gender}} with <i>recurrent</i> <b>bloody diarrhea</b> and <b>abdominal</b> <b>pain</b>  ", "time": 1660105356090.0}, {"id": 1482374179075, "note": "<div><div><b>Inflammatory bowel disease</b> is more prevalent in the <u>West</u>, particularly in <b>{{c1::caucasians}}</b> and <b>{{c2::Eastern European Jews}}</b></div></div>", "time": 1660105356089.0}, {"id": 1482374185613, "note": "<div><div><b>Inflammatory bowel disease</b> is subclassified as <b>{{c1::ulcerative colitis}}</b> or <b>{{c2::Crohn disease}}</b></div></div>", "time": null}, {"id": 1482374188222, "note": "<div>Which form of <u>IBD</u> involves <i>only</i> <b>mucosal&nbsp;</b>and <b>submucosal ulcers</b>?</div><div><br></div><div>{{c1::Ulcerative colitis}}</div>", "time": null}, {"id": 1482374191830, "note": "<div><div>Which form of <u>IBD</u> involves <b>transmural inflammation</b> with \"<b>knife-like</b>\" <b>fissures</b>? </div><div><br></div><div>{{c1::Crohn disease}}</div></div>", "time": null}, {"id": 1482374194811, "note": "<div><b>{{c1::Ulcerative colitis}}</b> (IBD) is characterized by <i>continuous</i><b> colonic lesions</b> that <u>always</u><b> </b>involve the<b> rectum</b></div>", "time": null}, {"id": 1482374199572, "note": "<div><b>Ulcerative colitis</b> always involves the <u>{{c1::rectum}}</u> and can extend <i>proximally</i> up to the <b>{{c2::cecum}}</b> </div>", "time": null}, {"id": 1482374205403, "note": "<div><b>{{c2::Crohn disease}}</b> (IBD) is characterized by <b>{{c1::skip}} lesions</b>, which can occur <i>anywhere</i> from the mouth to the anus</div>", "time": null}, {"id": 1482374207721, "note": "<div><b>Crohn disease</b> most commonly involves the {{c1::terminal ileum}}</div>", "time": null}, {"id": 1482374210189, "note": "Which form of&nbsp;<u>inflammatory bowel disease</u>&nbsp;typically&nbsp;<b>spares the rectum</b>?<div><br></div><div>{{c1::Crohn disease}}</div>", "time": null}, {"id": 1482374212224, "note": "<div>Which form of <u>IBD</u> <i>always </i>causes <b>bloody diarrhea</b>? </div><div><br></div><div>{{c1::Ulcerative colitis}}</div>", "time": null}, {"id": 1482374214379, "note": "<div><div>Which form of <u>IBD</u><i> </i>may cause <b>bloody </b><i>or</i> <b>non-bloody diarrhea</b>? </div><div><br></div><div>{{c1::Crohn disease}}</div></div>", "time": null}, {"id": 1482374216336, "note": "<div><b>Ulcerative colitis</b> is typically characterized by {{c1::<u>left::left or right</u>}} <b>lower</b> <b>quadrant pain&nbsp;</b></div>", "time": null}, {"id": 1482374223031, "note": "<div><b>Crohn disease</b> is typically characterized by {{c1::<u>right</u>::left or right}} <b>lower</b> <b>quadrant pain&nbsp;</b></div>", "time": null}, {"id": 1482374229026, "note": "<div><b>{{c2::Ulcerative colitis::IBD}}</b>&nbsp;is characterized <i>histologically</i> by <b>{{c1::crypt abscesses}}</b> with neutrophils, ulcers, and bleeding</div>", "time": null}, {"id": 1482374233392, "note": "<div><b>{{c2::Crohn disease}}</b> (IBD) is characterized <i>histologically</i> by lymphoid aggregates with <b>{{c1::noncaseating granulomas}}</b></div>", "time": null}, {"id": 1482374237153, "note": "<div><b>{{c2::Ulcerative colitis</b>::<b>IBD}}</b>&nbsp;is <b>Th{{c1::2}} mediated</b></div>", "time": null}, {"id": 1482374240195, "note": "<div><b>{{c2::Crohn disease}}</b> (IBD) is <b>Th{{c1::1}} mediated</b></div>", "time": null}, {"id": 1482374241957, "note": "<div><b>{{c2::Crohn disease}}</b> (IBD) appears <i>grossly</i> with <b>{{c1::cobblestone}} mucosa</b></div>", "time": null}, {"id": 1482374247553, "note": "<div><b>Crohn disease</b> (IBD) appears <i>grossly</i> with \"<b>creeping</b>\" <b>{{c1::fat}}</b></div>", "time": null}, {"id": 1482374264661, "note": "<div><b>Crohn disease</b> appears <i>grossly</i> with <b>{{c1::strictures}}</b> (lumen size) and <b>bowel wall thickening</b></div>", "time": 1660105360334.0}, {"id": 1482374270272, "note": "<div><b>{{c2::Crohn disease}}</b> (IBD) is associated with the \"<b>{{c1::string}}</b>\"<b> sign</b> on <u>imaging</u>, secondary to <b>strictures</b></div>", "time": null}, {"id": 1482374274606, "note": "<div><b>{{c2::Ulcerative colitis</b>::<b>IBD}}</b>&nbsp;appears <i>grossly</i> with <b>friable mucosal {{c1::pseudopolyps}}</b> </div>", "time": null}, {"id": 1482374278670, "note": "<div><b>{{c3::Ulcerative colitis</b>::<b>IBD}}</b>&nbsp;is associated with the \"<b>{{c1::lead pipe}}</b>\" sign on <u>imaging</u>, secondary to <b>loss of {{c2::haustra}}</b> </div>", "time": null}, {"id": 1482374290962, "note": "<div>Complications of <i>both</i> <u>ulcerative colitis</u> and <u>Crohn disease</u> include <b>malabsorption</b> and&nbsp;<b>{{c1::colorectal}}</b> <b>cancer</b> </div>", "time": null}, {"id": 1482374300933, "note": "<div>Complications of <b>ulcerative colitis </b>include {{c1::<b>toxic</b> <b>megacolon</b>}}, which may <u>perforate</u>, and <b>fulminant colitis</b></div>", "time": null}, {"id": 1482374303437, "note": "<div>Complications associated with {{c2::<u>Crohn disease</u>}} (IBD) include <b>gallstones</b> and <b>{{c1::calcium oxalate}} nephrolithiasis</b> </div>", "time": null}, {"id": 1482374309968, "note": "<div>Which form of <u>IBD</u> is associated with <b>fistula formation</b>? </div><div><br></div><div>{{c1::Crohn disease}}</div>", "time": null}, {"id": 1482374312007, "note": "<div>One complication of <u>Crohn disease</u> is a(n)&nbsp;<b>{{c1::enterovesical}} fistula</b>, which can cause <b>UTI</b> and <b>pneumaturia</b></div>", "time": null}, {"id": 1482374315198, "note": "<div>Which form of <u>IBD</u> is associated with <b>perianal</b> <b>disease</b>, <b>phlegmon</b>/<b>abscess formation</b>, and <b>strictures</b>? </div><div><br /></div><div>{{c1::Crohn disease}}</div>", "time": null}, {"id": 1482374319570, "note": "<div><b>Extraintestinal</b> <b>manifestations</b> of <u>IBD</u> include <b>{{c1::rash}}</b>, such as <b>erythema nodosum</b> and <b>pyoderma gangrenosum</b></div>", "time": null}, {"id": 1482374325812, "note": "<div><b>{{c1::Ulcerative colitis::IBD}}</b>&nbsp;is associated with <b>primary sclerosing cholangitis</b></div>", "time": null}, {"id": 1482374327719, "note": "<div>What <u>biliary tract disease</u> is associated with <b>ulcerative colitis</b>? </div><div><br></div><div>{{c1::Primary sclerosing cholangitis}}</div>", "time": null}, {"id": 1482374332046, "note": "<div><b>{{c2::Ulcerative colitis::IBD}}</b>&nbsp;may be associated with <u>positive</u> serum {{c1::<b>p-ANCA</b>}}</div>", "time": null}, {"id": 1482374334033, "note": "<div><b>{{c2::Crohn disease}}</b> (IBD) may be associated with <u>positive</u> serum {{c1::<b>anti-<i>Saccharomyces cervisiae</i> antibodies (ASCA)</b>}}</div>", "time": null}, {"id": 1482374336057, "note": "<div>Treatment for <u>acute exacerbation</u> of <b>Crohn disease</b> often involves {{c1::corticosteroids}}</div>", "time": 1660105348600.0}, {"id": 1482374337911, "note": "<div>What <u>5-aminosalicylic preparations</u> are useful in the management of <b>ulcerative colitis</b> and <b>Crohn disease</b>? </div><div><br></div><div>{{c1::Mesalamine and sulfasalazine::2}}</div>", "time": 1660105348018.0}, {"id": 1482374341463, "note": "<div>Treatment of <b>IBD</b> (Crohns, UC) may involve <u>TNF-\u03b1 inhibitors</u>, such as <b>{{c1::infliximab}}</b> and <b>{{c2::adalimumab}}</b></div>", "time": 1660105348554.0}, {"id": 1482374343955, "note": "<div>Treatment of <b>IBD</b> (Crohns, UC) may involve <u>immunosuppressors</u>, such as&nbsp;<b>{{c1::azathioprine}}</b> and <b>{{c2::6-mercaptopurine}}</b></div>", "time": null}, {"id": 1482374345667, "note": "<div>What <u>treatment</u> is <b>curative</b> for <b>ulcerative colitis</b>? </div><div><br></div><div>{{c1::Colectomy}}</div>", "time": 1660105344898.0}, {"id": 1482374347418, "note": "<div><b>Smoking</b> is <u>protective</u> against {{c1::ulcerative colitis::IBD}}</div>", "time": null}, {"id": 1482374349436, "note": "<b>Smoking</b> <u>increases risk</u> for {{c1::Crohn disease::IBD}}", "time": null}, {"id": 1482878964408, "note": "<b>{{c1::Hirschsprung}} disease</b> is characterized by <i>defective</i> <u>relaxation</u> and <u>peristalsis</u> of the <b>rectum</b> and <b>distal sigmoid colon</b>", "time": null}, {"id": 1482886562931, "note": "<div><b>{{c2::Hirschsprung}} disease</b> is a <u>congenital megacolon</u> associated with <b>{{c1::Down}} syndrome</b></div>", "time": null}, {"id": 1482886567135, "note": "<div><b>{{c2::Hirschsprung}} disease</b> occurs due to a <u>congenital failure</u> of <b>{{c1::ganglion}}</b> <b>cells</b> to descend into the myenteric and submucosal plexus</div>", "time": null}, {"id": 1482886572434, "note": "<div>The <b>ganglion cells</b> that fail to descend in <u>Hirschsprung disease</u> are derived from {{c1::neural crest}}</div>", "time": null}, {"id": 1482886579365, "note": "<div><b>Hirschsprung disease</b> is characterized by <u>failure</u> to {{c1::pass meconium}} within 48 hours and <b>chronic</b> <b>constipation</b></div>", "time": null}, {"id": 1482886582123, "note": "<div><b>Hirschsprung disease</b> may present with abdominal distention and {{c1::<u>bilious</u>::bilious or nonbilious}} <b>vomiting</b></div>", "time": null}, {"id": 1482886587921, "note": "<div><b>Hirschsprung</b> <b>disease</b> is characterized by <u>massive dilation</u> of the bowel {{c1::<i>proximal</i>::proximal or distal}} to the <b>aganglionic segment</b>, resulting in a \"<b>transition</b> <b>zone</b>\"</div>", "time": null}, {"id": 1482886599402, "note": "<div><b>{{c2::Hirschsprung}} disease</b> is diagnosed by <u>absence</u> of <b>ganglionic cells</b> on <b>{{c1::rectal <i>suction</i></b><b>}}&nbsp;</b><b>biopsy</b></div>", "time": null}, {"id": 1482886603327, "note": "<div>Treatment of <b>Hirschsprung disease</b> involves {{c1::<u>resection</u>}} of the involved bowel</div>", "time": null}, {"id": 1482886606125, "note": "<div><b>Colonic {{c1::diverticula}}</b> are \"<b>blind</b> <b>pouches</b>\" that communicate with the lumen of the gut</div>", "time": null}, {"id": 1482886616052, "note": "<div>Which <u>gut wall layers</u> are involved in a <b>false diverticulum</b> (pseudodiverticulum)?</div><div><br></div><div>{{c1::Mucosa and submucosa}}</div>", "time": null}, {"id": 1482886621730, "note": "<div><div>Which <u>gut wall layers</u> are involved in a <b>true diverticulum</b>?</div><div><br /></div><div>{{c1::All three (mucosa, submucosa, muscularis externa)}}</div></div>", "time": 1660105342936.0}, {"id": 1482886631055, "note": "<div><b>GI tract diverticula</b> classically arise where the <b>{{c1::vasa recta}}</b> perforates the <b>{{c2::muscularis externa}}</b> (weak point in colonic wall)</div>", "time": null}, {"id": 1482886634613, "note": "<div><b>{{c1::Diverticulosis}}</b> is characterized by <i>many</i> <u>false diverticula</u> in the <b>colon</b></div>", "time": null}, {"id": 1482886637639, "note": "<div><div>What is the <u>most common location</u> for <b>diverticulosis</b>? </div><div><br></div><div>{{c1::Sigmoid colon}}</div></div>", "time": null}, {"id": 1482886640351, "note": "<div><b>Diverticulosis</b> is related to wall {{c1::stress <b>(pulsion diverticulosis</b>)}} (e.g. constipation, straining, low fiber diet) and {{c2::obesity}}</div>", "time": 1660105359968.0}, {"id": 1482886642816, "note": "<div><b>Diverticulosis</b> is associated with <u>low</u> {{c1::fiber}} diets</div>", "time": 1660105359969.0}, {"id": 1482886645144, "note": "<div>What <u>demographic</u>&nbsp;is commonly associated with <b>diverticulosis</b>? </div><div><br></div><div>{{c1::Older adults (risk increases with age)::age group}} </div>", "time": null}, {"id": 1482886650853, "note": "<div><b>Diverticulosis</b> is usually {{c1::asymptomatic}} or associated with vague discomfort</div>", "time": 1660105359966.0}, {"id": 1482886656445, "note": "<div><b>{{c1::Diverticulitis}}</b> is a complication of <u>diverticulosis</u> due to <b>inflammation of diverticula</b></div>", "time": null}, {"id": 1482886658640, "note": "<div><b>Diverticulitis</b> classically presents with a <i>triad</i> of {{c1::<b>LLQ</b>}} <b>pain</b>, <b>fever</b>, and&nbsp;<b>{{c2::leukocytosis}}</b></div>", "time": null}, {"id": 1482886661006, "note": "<div>What <u>GI tract pathology</u> presents with <b>appendicitis-like symptoms</b> in the <b>LLQ</b>? </div><div><br></div><div>{{c1::Diverticulitis}}</div>", "time": null}, {"id": 1482886663862, "note": "<div><b>Diverticulitis</b> may lead to a(n) {{c1::colovesical fistula}}, which presents with <b>pneumaturia</b> (e.g. air or stool in the urine)</div>", "time": null}, {"id": 1482886666544, "note": "<div>Complications of <u>diverticulitis</u> include <b>{{c1::abscess}}</b>, <b>perforation</b>, and <b>obstruction&nbsp;</b>(inflammatory stenosis)</div>", "time": 1660105360488.0}, {"id": 1482886670766, "note": "<div>What is the <u>general treatment</u> for <b>diverticulitis?</b> </div><div><br></div><div>{{c1::Antibiotics}}</div>", "time": 1660105346336.0}, {"id": 1482886682972, "note": "<div><b>Angiodysplasia</b> usually arises in the <u>cecum</u> and <u>{{c1::right::right or left}} colon</u>&nbsp;due to <b>high wall tension</b></div>", "time": null}, {"id": 1482886689929, "note": "<div><b>Angiodysplasia</b> classically presents as {{c1::<u>hematochezia</u>}} in an <b>older adult</b> </div>", "time": null}, {"id": 1482886692839, "note": "<div><b>Angiodysplasia</b> is confirmed by {{c1::angiography}}</div>", "time": null}, {"id": 1482886696163, "note": "<div><b>{{c2::Hereditary hemorrhagic telangiectasia}}</b> is a(n)&nbsp;<u>{{c1::autosomal dominant::inheritance}}</u>&nbsp;disorder resulting in <b>thin-walled blood vessels</b>, especially in the mouth and GI tract</div>", "time": null}, {"id": 1482886699064, "note": "<div><div><b>{{c1::Hereditary hemorrhagic telangiectasia}}</b> is also known as <b>Osler-Weber-Rendu syndrome</b></div></div>", "time": null}, {"id": 1482886706398, "note": "<div><b>{{c1::Hereditary hemorrhagic telangiectasia}}</b> presents with <b>blanching skin lesions</b>, <b>AV malformations</b>, recurrent epistaxis, skin discoloration, GI bleeding, and hematuria</div>", "time": null}, {"id": 1482886711096, "note": "<div><b>{{c1::Ischemic colitis}}</b> is caused by <u>ischemic</u> damage to the <b>colon</b> </div>", "time": 1660105339917.0}, {"id": 1482886714520, "note": "<div><b>Ischemic colitis</b> usually occurs at the <b>{{c1::splenic}} flexure (griffiths point),</b> which is the <u>watershed area</u> of the <b>{{c2::SMA}}</b> and the {{c2::<b>IMA</b>}} </div>", "time": null}, {"id": 1482886717185, "note": "<div><b>Ischemic colitis</b> is most commonly due to {{c1::<u>atherosclerosis</u>}} of the <b>SMA</b> </div>", "time": null}, {"id": 1482886719758, "note": "<div><b>Ischemic colitis</b> presents with <u>{{c1::post}}-prandial</u> <b>abdominal</b> <b>pain</b> followed by <b>{{c2::hematochezia}}</b> </div>", "time": 1660105355854.0}, {"id": 1482886726114, "note": "<div><b>Ischemic colitis</b> may present with the \"{{c1::thumbprint}}\" sign on imaging due to <b>mucosal edema/hemorrhage</b></div>", "time": 1660105355855.0}, {"id": 1482886730980, "note": "<div><b>{{c1::Irritable bowel}} syndrome</b> is <i>recurrent</i> abdominal pain with <u>&gt;</u> 2 of the following:</div><div> - Pain {{c2::related}} to defecation</div><div> - Change in stool {{c3::frequency}} </div><div> - Change in stool {{c4::consistency}}</div>", "time": null}, {"id": 1482886738291, "note": "<div>What <u>demographic</u> is most commonly associated with <b>irritable bowel syndrome</b>? </div><div><br></div><div>{{c1::Middle-aged women}}</div>", "time": 1660105347319.0}, {"id": 1482886740929, "note": "<div>The chronic symptoms of <b>irritable bowel syndrome</b> may be {{c1::diarrhea}}-predominant, {{c2::constipation}}-predominant, or mixed</div>", "time": 1660105350306.0}, {"id": 1482886747788, "note": "<div>Is <u>irritable bowel syndrome</u> related to <b>structural abnormalities</b>? </div><div><br></div><div>{{c1::No}}</div>", "time": 1660105355894.0}, {"id": 1482886766452, "note": "<div><b>Colonic {{c1::polyps}} </b>are raised protrusions of colonic mucosa</div>", "time": null}, {"id": 1482886768778, "note": "<div><b>Colonic polyps</b> are grossly characterized as <b>flat</b>, <b>{{c1::sessile}}</b>, or {{c2::<b>pedunculated</b> (on a stalk)}}</div>", "time": null}, {"id": 1482886771508, "note": "<div><b>{{c1::Hyperplastic}}</b> <b>colonic polyps</b> are due to <u>hyperplasia</u> of <b>glands</b> </div>", "time": 1660105340031.0}, {"id": 1482886774073, "note": "<div><b>Hyperplastic</b> <b>colonic</b> <b>polyps</b> classically show a \"{{c1::serrated}}\" appearance on microscopy</div>", "time": null}, {"id": 1482886776621, "note": "<div>What is the <u>most common</u> type of <b>colonic</b> <b>polyp</b>? </div><div><br /></div><div>{{c1::Hyperplastic polyp}} </div>", "time": null}, {"id": 1482886779367, "note": "<div><b>Hyperplastic colonic polyps</b> are usually {{c2::<u>small</u>::size}} and located in the&nbsp;<b>{{c1::rectosigmoid}} region</b> </div>", "time": 1660105357894.0}, {"id": 1482886781952, "note": "<div><b>Hyperplastic colonic polyps</b> are <u>benign</u> with {{c1::no}} <b>malignant potential</b> </div>", "time": 1660105357895.0}, {"id": 1482886790385, "note": "<div>What type of <u>colonic polyp</u> is <b>small</b> (&lt; 5 mm) and resembles <b>normal mucosa</b>? </div><div><br></div><div>{{c1::Mucosal polyps (clinically insignificant)}}</div>", "time": null}, {"id": 1482886798598, "note": "<div><b>{{c1::Adenomatous}} colonic polyps</b> are due to a <u>neoplastic proliferation</u> of <b>glands</b></div>", "time": null}, {"id": 1482886802591, "note": "<div><b>Adenomatous colonic polyps</b> are <u>benign</u> with {{c1::<b>some</b>}} <b>malignant</b> <b>potential</b></div>", "time": 1660105362081.0}, {"id": 1482886805436, "note": "<div><b>Adenomatous colonic polyps</b> may progress to <u>adenocarcinoma</u> via the {{c1::adenoma-carcinoma}} sequence</div>", "time": null}, {"id": 1482886811614, "note": "<div>The <b>adenoma-carcinoma sequence</b> <i>begins</i> with {{c1::APC}} gene mutations</div>", "time": null}, {"id": 1482886819280, "note": "<div>Which <u>adenoma-carcinoma sequence</u> mutation results in <b>increased risk for polyp formation</b>? </div><div><br /></div><div>{{c1::APC mutation}}</div>", "time": null}, {"id": 1482886825934, "note": "<div>Following <i>APC</i> mutation (adenoma-carcinoma sequence), <b><i>{{c1::KRAS}} </i>mutations</b> lead to {{c2::<b>polyp formation</b> (adenoma)}}</div>", "time": null}, {"id": 1482886835161, "note": "<div>Progression of <u>colonic adenoma</u> to <u>carcinoma</u> occurs with <u>mutations</u> in the <b>{{c1::p53}}</b> or <u>loss of heterozygosity</u> in the region that encodes for {{c2::<b>SMAD</b>}} 2 / 4</div>", "time": null}, {"id": 1482886841409, "note": "<div>Progression of <u>colonic adenoma</u>&nbsp;to <u>carcinoma</u> is associated with <b>overexpression</b> of {{c1::COX-2}} </div>", "time": null}, {"id": 1482886851249, "note": "<div><b>{{c1::Sessile serrated}} colonic polyps</b> have a \"<u>saw-tooth</u>\" pattern <i>similar</i> to hyperplastic polyps, but <b>extend to the crypts</b> and involve <b>lateral crypt growth</b> </div>", "time": null}, {"id": 1482886858693, "note": "<div><b>Serrated colonic polyps</b> are <u>benign</u> with {{c1::<b>some</b>}} <b>malignant</b> <b>potential</b> </div>", "time": null}, {"id": 1482886861200, "note": "<div><b>Serrated colonic polyps</b> may develop into <u>CRC</u> via <b>{{c1::CpG}} hypermethylation</b> with microsatellite instability and mutations in <b><i>{{c2::BRAF}}</i></b></div>", "time": 1660105353054.0}, {"id": 1482886867250, "note": "<div>Screening for <b>colorectal polyps/carcinoma</b> is performed by <u>{{c1::colonoscopy}}</u> and testing for <b>{{c2::fecal occult blood (stool guaiac test)}}</b> </div>", "time": 1660105353121.0}, {"id": 1482886874458, "note": "<div>Can an <b>adenomatous polyp</b> be distinguished from a <b>hyperplastic polyp</b> on gross examination (e.g. colonoscopy)? </div><div><br></div><div>{{c1::No (thus remove all polyps)}}</div>", "time": null}, {"id": 1482886876931, "note": "<div><div>Which type of <u>polyp</u> has greater malignant potential, <b>sessile</b> or <b>pedunculated</b>? </div><div><br></div><div>{{c1::Sessile}}</div></div>", "time": null}, {"id": 1482886879171, "note": "<div><div><b>Colonic polyps</b> have a <u>greater</u> risk of progression to carcinoma if they are <b>{{c1::&gt; 2}} cm</b> in size</div></div>", "time": 1660105360522.0}, {"id": 1482886882093, "note": "<div><b>Adenomatous polyps</b> with a(n)&nbsp;<b>{{c1::tubular}} </b>histology have <u>{{c2::less}}</u> <i>malignant potential</i> than <b>{{c1::villous}} </b>histology (tubular or villous)</div>", "time": 1660105362080.0}, {"id": 1482886888524, "note": "<div>{{c2::<b>Familial adenomatous polyposis</b> (FAP)}}<b> </b>is a(n)&nbsp;<u>{{c1::autosomal dominant::inheritance}}</u>&nbsp;disorder characterized by <b>100s</b> to <b>1000s</b> <b>of adenomatous colonic polyps</b></div>", "time": null}, {"id": 1482886892911, "note": "<div>{{c3::<b>Familial adenomatous polyposis</b> (FAP)}} is due to an <u>inherited</u> mutation in the <i style=\"font-weight: bold; \">{{c1::APC}}</i> gene on chromosome {{c2::5q::arm}} </div>", "time": null}, {"id": 1482886895750, "note": "<div><b>Colorectal cancer</b> arises in patients with <u>familial adenomatous polyposis</u><b> </b>via the \"<b>{{c1::2-hit}} hypothesis</b>\"</div>", "time": null}, {"id": 1482886898188, "note": "<div><b>Familial adenomatous polyposis</b> is <u>pancolonic</u> and always involves the {{c1::rectum}}</div>", "time": null}, {"id": 1482886900348, "note": "<div><b>Familial adenomatous polyposis</b> is treated with {{c1::prophylactic colectomy}}, or else 100% of patients progress to CRC </div>", "time": null}, {"id": 1482886906383, "note": "<div><b>{{c4::Gardner}} syndrome</b> is a combination of <b>{{c1::familial adenomatous polyposis}}</b> with <b>{{c2::osteomas}}</b> and <b>{{c3::fibromatosis}}</b> </div>", "time": null}, {"id": 1482886913645, "note": "<div><b>{{c3::Turcot}} syndrome</b> is a combination of <b>{{c1::familial adenomatous polyposis}}</b> with {{c2::<b>malignant CNS tumors</b> (e.g. medulloblastoma, glioma)}}</div>", "time": null}, {"id": 1482886915797, "note": "<div><b>{{c1::Juvenile}} polyps</b> usually present in childhood as a <u>solitary rectal polyp</u> that <b>prolapses</b> and <b>bleeds</b></div>", "time": 1660105339896.0}, {"id": 1482886917754, "note": "<div><b>{{c2::Juvenile polyposis}} syndrome</b> is characterized by <i>numerous&nbsp;</i>{{c1::<u>hamartomatous</u>}}<u> </u><u>polyps</u> <b>WITHOUT</b> <b>hyperpigmentation</b></div>", "time": null}, {"id": 1482886920226, "note": "<div>What <u>demographic</u>&nbsp;is associated with <b>juvenile polyposis syndrome</b>? </div><div><br></div><div>{{c1::Children &lt; 5 years old::age group- specific}}</div>", "time": null}, {"id": 1482886922545, "note": "<div><b>{{c1::Juvenile polyposis}} syndrome</b> is characterized by <u>many</u> <b>juvenile polyps</b> in the stomach, colon, and small bowel</div>", "time": null}, {"id": 1482886924531, "note": "<div><b>Juvenile polyposis syndrome</b> is associated with <u>increased</u> risk for {{c1::colorectal}} carcinoma</div>", "time": null}, {"id": 1482886927273, "note": "<div><b>{{c2::Peutz-Jeghers}} syndrome</b> is characterized by <i>numerous</i> {{c1::<u>harmartomatous</u>}}<u> </u><u>polyps</u>&nbsp;<b>WITH</b>&nbsp;<b>hyperpigmentation</b> of the lips, mouth, hands, and genital skin</div>", "time": null}, {"id": 1482886932317, "note": "<div><b>Peutz-Jeghers syndrome</b> is associated with <u>increased</u> risk of {{c1::breast}}, {{c2::GI}}, and gynecologic cancers </div>", "time": null}, {"id": 1482959670270, "note": "<div><div><b>FAP</b> and <i>most</i> <u>sporadic</u> <b>colorectal</b> <b>carcinomas</b> arise via the {{c1::chromosomal}} instability pathway </div></div>", "time": null}, {"id": 1482959678760, "note": "<div><b>Lynch syndrome</b> and <i>some</i> <u>sporadic</u><b> colorectal carcinomas</b> arise via the {{c1::microsatellite}} instability pathway </div>", "time": null}, {"id": 1482959684979, "note": "<div><b>Microsatellites</b> are repeating sequences of <u>{{c1::non-coding</u>::coding/non-coding<u>}}</u> <b>DNA</b></div>", "time": null}, {"id": 1482959688086, "note": "<div><div>The <b>{{c2::microsatellite}} instability pathway</b> of <u>colorectal cancer</u> is characterized by <i>mutations</i> or <i>methylation</i> of {{c1::<b>mismatch</b> <b>repair</b>}} <b>genes</b> </div></div>", "time": null}, {"id": 1482959695838, "note": "<div><b>{{c1::Lynch}} syndrome</b> is due to an <i>inherited</i> defect in <b>{{c2::DNA mismatch repair}} enzymes</b>, resulting in microsatellite instability</div>", "time": null}, {"id": 1482959698585, "note": "<div><b>Lynch syndrome</b> was previously known as {{c1::hereditary nonpolyposis colorectal cancer (HNPCC)}}</div>", "time": null}, {"id": 1482959701217, "note": "<div>What is the <u>mode of inheritance</u> of <b>Lynch syndrome</b> (HNPCC)? </div><div><br></div><div>{{c1::Autosomal dominant}}</div>", "time": null}, {"id": 1482959705416, "note": "<div><b>Lynch syndrome</b> progresses to <u>{{c1::colorectal}} cancer</u> in ~ 80% of patients</div>", "time": null}, {"id": 1482959710127, "note": "<div><b>Lynch syndrome</b> is usually <u>right-sided</u> and <i>always</i> involves the {{c1::<b>proximal</b>::proximal or distal}} <b>colon</b></div>", "time": null}, {"id": 1482959713090, "note": "<div><b>Lynch syndrome</b> is associated with <u>increased</u> risk for {{c1::colorectal}}, {{c2::endometrial}}, {{c3::ovarian}}, and skin cancers</div>", "time": null}, {"id": 1482959736746, "note": "<div>Risk factors for <u>colorectal carcinoma</u> include {{c1::<b>adenomatous</b>}} and {{c2::<b>serrated</b>}} polyps</div>", "time": null}, {"id": 1482959764813, "note": "<div><b>{{c1::Left}}-sided</b> <u>colorectal carcinoma</u> usually arises as a result of the <b>adenoma-carcinoma sequence</b></div>", "time": null}, {"id": 1482959775157, "note": "<div><b>{{c1::Right}}-sided</b> <u>colorectal carcinoma</u> usually arises as a result of the <b>microsatellite instability pathway</b></div>", "time": null}, {"id": 1482959777469, "note": "<div><b>{{c2::Iron deficiency}} anemia</b> in <u>males</u> (especially &gt; 50) and <u>postmenopausal females</u> raises suspicion of <b>{{c1::colorectal}} carcinoma</b> </div>", "time": null}, {"id": 1482959816004, "note": "<div><b>{{c1::Adhesions}}</b> are <u>fibrous bands of scar tissue</u> that commonly form after <b>GI {{c2::surgery}}</b> </div>", "time": null}, {"id": 1482959837664, "note": "<div>What is the <u>most common cause</u> of <b>small bowel obstruction</b>? <div><br /></div><div>{{c1::Adhesion}}</div></div>", "time": null}, {"id": 1482959842224, "note": "<div><b>{{c1::Ileus}}</b> is an <u>intestinal hypomotility</u> <b><i>without</i> obstruction </b>that results in <b>constipation</b> and <b>decreased flatus</b> </div>", "time": 1660105339979.0}, {"id": 1482959849039, "note": "<div><b>Ileus</b> is associated with a <u>distended/tympanic</u> abdomen and {{c1::<i>decreased</i>}} <b>bowel</b> <b>sounds</b> </div>", "time": 1660105357616.0}, {"id": 1482959859744, "note": "<div>{{c1::<b>Meconium</b> <b>ileus</b>}} is characterized by a <u>meconium plug</u> that obstructs the intestine, <b>preventing stool passage at birth</b> </div>", "time": 1660105339659.0}, {"id": 1482959865798, "note": "<div><b>{{c2::Necrotizing enterocolitis}}</b> is a <i>GI pathology</i> seen in <u>premature</u>, <b>{{c1::formula}}-fed infants</b> with immature immune systems </div>", "time": null}, {"id": 1482959868268, "note": "<div><b>{{c2::Necrotizing enterocolitis (NEC)}}</b> is characterized by necrosis of intestinal mucosa with possible <u>perforation</u>, which can lead to:</div><div><br /></div><div>- <u>free air in the bowel wall</u> ({{c1::<b>pneumatosis</b> <b>intestinalis</b>}})</div><div>- <u>free air in the abdomen</u> ({{c2::<b>pneumoperitoneum</b>}}) </div><div>- portal venous gas on imaging</div>", "time": null}, {"id": 1482959873096, "note": "<div><b>{{c2::Malrotation}}</b> is a <i>congenital anomaly</i> of <b>{{c1::midgut}} rotation</b> during fetal development</div>", "time": null}, {"id": 1482959885274, "note": "<div><b>Malrotation</b> results in <u>improper positioning</u> of the <b>bowel</b> with improper formation of fibrous, \"<b>{{c1::Ladds}} bands</b>\"</div>", "time": null}, {"id": 1482959890209, "note": "<b>Malrotation</b> can lead to {{c1::volvulus}} and <b>duodenal</b> <b>obstruction</b>", "time": null}, {"id": 1482965424718, "note": "<div>Which <u>embryological structure</u> develops into the <b>pancreas</b>? </div><div><div><br /></div><div>{{c1::Foregut}}</div></div>", "time": null}, {"id": 1482971213105, "note": "<div>Which <i>embryological</i> <u>pancreatic bud(s)</u> contribute to the <b>main pancreatic duct</b>?<div><br /></div><div>{{c1::Ventral pancreatic buds}}</div></div>", "time": null}, {"id": 1482971220318, "note": "<div>Which <i>embryological</i> <u>pancreatic bud(s)</u> contribute to the <b>uncinate process</b>?<div><br /></div><div>{{c1::Ventral pancreatic buds}}</div></div>", "time": null}, {"id": 1482971225208, "note": "<div>Which <i>embryological</i> <u>pancreatic bud(s)</u> contribute to the <b>body</b>, <b>tail</b>, and <b>isthmus</b> of the pancreas?<div><br /></div><div>{{c1::Dorsal pancreatic buds}}</div></div>", "time": null}, {"id": 1482971231424, "note": "<div>Which <i>embryological</i> <u>pancreatic bud(s)</u> contribute to the <b>accessory pancreatic duct</b>?<div><br /></div><div>{{c1::Dorsal pancreatic buds}}</div></div>", "time": null}, {"id": 1482971236131, "note": "<div>Which <i>embryological</i> <u>pancreatic bud(s)</u> contribute to the <b>head</b> of the pancreas?<div><br /></div><div>{{c1::Both ventral AND dorsal pancreatic buds :)}}</div></div>", "time": null}, {"id": 1482971243363, "note": "<div><b>{{c1::Annular}} pancreas</b> is a <i>congenital malformation</i> in which the <b>{{c3::ventral}}</b> <b>pancreatic</b> <b>bud</b> <u>forms a ring</u> around the <b>{{c2::2nd}} part of the duodenum</b></div>", "time": null}, {"id": 1482971253882, "note": "<div><b>Annular pancreas</b> may cause {{c1::duodenal}} obstruction and {{c2::bilious::bilious/non-bilious}} vomiting</div>", "time": null}, {"id": 1482971258399, "note": "<div><b>Pancreas</b> <b>{{c1::divisum}}</b> is a <i>congenital malformation</i> in which the <u>ventral</u> and <u>dorsal parts</u> <b>fail to fuse</b> at {{c2::8}} weeks </div>", "time": null}, {"id": 1482971261818, "note": "<div><b>Pancreas divisum</b> is mostly <u>asymptomatic</u>, but may cause <b>chronic abdominal pain</b> and/or <b>{{c1::pancreatitis}}</b></div>", "time": null}, {"id": 1482971264299, "note": "<div><div>Which <u>embryological structure</u> develops into the <b>spleen</b>? </div><div><div><br /></div><div>{{c1::Mesoderm}}</div></div></div>", "time": null}, {"id": 1482971271910, "note": "<div>What is the <u>embryonic gut region</u> of the <b>blood supply</b> to the <b>spleen</b> (e.g. foregut, midgut, hindgut)? </div><div><br /></div><div>{{c1::Foregut (celiac trunk gives rise to the splenic artery)}}</div>", "time": 1660105346499.0}, {"id": 1482971281074, "note": "<div><b>{{c1::Acute pancreatitis}}</b> is due to <u>{{c2::autodigestion}}</u> of pancreatic parenchyma by <b>pancreatic</b> <b>enzymes</b></div>", "time": 1660105341307.0}, {"id": 1482971291518, "note": "<div>In <b>acute</b> <b>pancreatitis</b>, {{c1::trypsin}} is <i>prematurely</i> <u>activated</u>, which leads to activation of other pancreatic enzymes</div>", "time": null}, {"id": 1482971294770, "note": "<div><b>Acute pancreatitis</b> results in <u>{{c1::liquefactive}} necrosis</u> of the <b>pancreas</b></div>", "time": null}, {"id": 1482971299269, "note": "<div><b>Acute pancreatitis</b> results in <u>{{c1::fat}} necrosis</u> of the <b>peripancreatic</b> <b>fat</b></div>", "time": null}, {"id": 1482971305143, "note": "<div><b>Acute pancreatitis</b> is most commonly due to {{c1::<b>alcohol</b>}} or {{c2::<b>gallstones</b>}}</div>", "time": null}, {"id": 1482971311075, "note": "<div>The causes of <b>{{c14::acute pancreatitis}} </b>may be remembered with the mnemonic \"<b>I GET PP SMASHED</b>\"<a href=\"https://www.ankingmed.com/congratulations\"><font color=\"#333333\">:</font></a></div><div><br></div><div style=\"centerbox\"><div class=\"mnemonics\"><div><b>I</b>: {{c1::Idiopathic}} </div><div><br></div><div><b>G</b>: {{c2::Gallstones}} </div><div><b>E</b>: {{c3::Ethanol}} </div><div><b>T</b>: {{c4::Trauma (e.g. automobile accident in children - seatbelt injury)}}</div><div><br></div><div><b>P</b>: {{c13::Posterior duodenal ulcer rupture}} </div><div><b>P: </b>{{c15::Pancreas Divisum}}</div><div><br></div><div><b>S</b>: {{c5::Steroids}}</div><div><b>M</b>: {{c6::Mumps}}</div><div><b>A</b>: {{c7::Autoimmune disease}}</div><div><b>S</b>: {{c8::Scorpion sting}} </div><div><b>H</b>: {{c9::HYPERcalcemia}} or {{c10::Hypertriglyceridemia/Hyperchylomicronemia}}</div><div><b>E</b>: {{c11::ERCP (endoscopic retrograde cholangiopancreatography)}}</div><div><b>D</b>: {{c12::Drugs (e.g. sulfa drugs, NRTIs, protease inhibitors)}} </div></div></div>", "time": null}, {"id": 1482971320837, "note": "<div><b>Acute {{c1::pancreatitis}}</b> is diagnosed by 2 of 3 criteria: </div><div><br /></div><div> - Acute <b>epigastric</b> <b>pain</b> that <u>radiates</u> to the <b>back</b></div><div> - <u>Increased</u> <b>serum</b> <b>amylase</b> or <b>lipase</b> to 3x upper limit of normal</div><div> - Characteristic imaging findings </div>", "time": 1660105362106.0}, {"id": 1482971324970, "note": "<div>One criteria for diagnosis of <b>acute pancreatitis</b> is acute <b>{{c1::epigastric}} abdominal</b> <b>pain</b> that <u>radiates</u> to the <b>{{c2::back}}</b></div>", "time": null}, {"id": 1482971327560, "note": "<div>One criteria for diagnosis of <b>acute pancreatitis</b> is <u>increased</u> serum <b>{{c1::amylase}}</b> or <b>{{c2::lipase}}</b></div>", "time": null}, {"id": 1482971330625, "note": "<div>Which pancreatic enzyme is <u>more specific</u> for <b>acute</b> <b>pancreatitis</b>?</div><div><br></div><div>{{c1::Lipase::amylase or lipase}}</div>", "time": null}, {"id": 1482971339275, "note": "<div><b>Acute</b> <b>pancreatitis</b> may present with {{c1::<b>hypo</b>}}<b>-calcemia</b><b>/magnesemia</b></div>", "time": null}, {"id": 1482971345397, "note": "<div><b>Acute pancreatitis</b> may progress to <u>{{c1::shock}}</u>, due to <b>pancreatic hemorrhage</b> and <b>fluid sequestration</b></div>", "time": 1660105362132.0}, {"id": 1482971357054, "note": "<div><b>Acute pancreatitis</b> may be complicated by <u>{{c1::pancreatic pseudocysts}}</u>, which are formed by <b>fibrous tissue</b> surrounding liquefactive necrosis and pancreatic enzymes </div>", "time": null}, {"id": 1482971374440, "note": "<div><b>Pancreatic pseudocyst</b> presents as an <u>abdominal mass</u> with <i>persistently </i><b>elevated</b> <b>serum {{c1::amylase}}</b> </div>", "time": 1660105354396.0}, {"id": 1482971413468, "note": "<div><b>Pancreatic pseudocysts</b> may <u>{{c1::rupture}}</u>, causing <b>hemorrhage</b> and <b>release of enzymes</b> into the abdominal cavity</div>", "time": 1660105354395.0}, {"id": 1482971425744, "note": "<div>Complications of <b>acute pancreatitis</b> include <u>{{c1::DIC}}</u> due to <i>activation</i> of <b>coagulation</b> <b>factors</b></div>", "time": null}, {"id": 1482971428188, "note": "<div>Complications of <b>acute pancreatitis</b> include <u>{{c1::ARDS}}</u> due to <i>damage</i> to the <b>alveolar capillary interface</b></div>", "time": null}, {"id": 1482971431015, "note": "<div><b>{{c1::Chronic}} pancreatitis</b> is characterized by <u>fibrosis</u> of pancreatic parenchyma</div>", "time": 1660105340807.0}, {"id": 1482971433304, "note": "<div><b>Chronic pancreatitis</b> is most often secondary to <i>recurrent</i> acute {{c1::pancreatitis}}</div>", "time": 1660105360728.0}, {"id": 1482971435786, "note": "<div>What are the <u>major causes</u> of <b>chronic pancreatitis</b> in <b>adults</b>? </div><div><br></div><div>{{c1::Alcohol}} and {{c2::genetic predisposition (ex. Cystic Fibrosis)}}</div>", "time": null}, {"id": 1482971438364, "note": "<div><div>What is the <u>most common</u> cause of <b>chronic pancreatitis</b> in <b>children</b>? </div><div><br></div><div>{{c1::Cystic fibrosis}}</div></div>", "time": null}, {"id": 1482971441031, "note": "<div><b>Pancreatitis</b> (acute and chronic) may present with <b>{{c1::epigastric}} abdominal</b> <b>pain</b> that <u>radiates</u> to the <b>{{c2::back}}</b>  </div>", "time": 1660105354392.0}, {"id": 1482971466635, "note": "<div><b>Chronic pancreatitis</b> may present with <u>{{c1::pancreatic insufficiency}}</u>, which results in <b>malabsorption</b> with <b>steatorrhea</b> and fat-soluble vitamin deficiences </div>", "time": 1660105360727.0}, {"id": 1482971514575, "note": "<div><b>{{c2::Chronic}} pancreatitis</b> is characterized by <u>atrophy</u> and <u>dystrophic </u>{{c1::<u>calcification</u>}} of pancreatic parenchyma on imaging</div>", "time": null}, {"id": 1482971533067, "note": "<div><b>Chronic pancreatitis</b> results in <u>increased</u> risk for <b>{{c1::pancreatic}} carcinoma</b></div>", "time": null}, {"id": 1482971536512, "note": "<div>What <u>type of cancer</u> (e.g. SCC, adenocarcinoma, etc.) is <b>pancreatic carcinoma</b>? </div><div><br></div><div>{{c1::Adenocarcinoma}}</div>", "time": null}, {"id": 1482971548645, "note": "<div>The major <u>risk factors</u> for <b><u>pancreatic</u> adenocarcinoma</b> are </div><div>- {{c2::smoking}} </div><div>- {{c1::<b>chronic pancreatitis</b> (especially &gt; 20 years)}}</div>", "time": null}, {"id": 1482971561533, "note": "<div><b>{{c3::Pancreatic adenocarcinoma}}</b> often presents as <u>obstructive {{c1::jaundice}}</u> with a(n)&nbsp;<i>{{c2::painless}}</i>, <b>palpable</b> <b>gallbladder</b></div>", "time": null}, {"id": 1482971569395, "note": "<div>A <b><i>painless</i>, palpable gallbladder</b> in <u>pancreatic adenocarcinoma</u> is also known as the <b>{{c1::Courvoisier}} sign</b></div>", "time": null}, {"id": 1482971572502, "note": "<div><b>Pancreatic adenocarcinoma</b> most commonly arises in the {{c1::<u>head</u>}} of the pancreas</div>", "time": null}, {"id": 1482971578611, "note": "<div><b>Pancreatic adenocarcinoma</b> in the <u>body</u> or <u>tail</u> may present with secondary {{c1::diabetes mellitus}}</div>", "time": 1660105354406.0}, {"id": 1482971585507, "note": "<div><b>Pancreatic adenocarcinoma</b> may present with <u>{{c1::migratory thrombophlebitis}}</u>, which is <b>redness</b> and <b>tenderness</b> in the <b>extremities</b> </div>", "time": null}, {"id": 1482971593747, "note": "<div><b>Migratory thrombophlebitis</b> in <u>pancreatic adenocarcinoma</u> is also known as the <b>{{c1::Trousseau}} syndrome</b></div>", "time": null}, {"id": 1482971596285, "note": "<div><b>{{c3::Pancreatic}} adenocarcinoma</b> is associated with the serum <u>tumor markers</u> <b>{{c1::CA 19-9}}</b> and <b>{{c2::CEA}}</b> (less specific)</div>", "time": null}, {"id": 1482971607268, "note": "<div>What is the <u>prognosis</u> of <b>pancreatic adenocarcinoma</b>? </div><div><br /></div><div>{{c1::Very poor (1-year survival &lt; 10%)}}</div>", "time": 1660105345586.0}, {"id": 1482976984253, "note": "<b>Biliary {{c1::atresia}}</b> is a <u>failure to form</u> or <u>early destruction</u> of the extrahepatic <b>biliary tree</b>", "time": 1660105361249.0}, {"id": 1482978349044, "note": "<div><b>Biliary atresia</b> typically leads to <u>biliary obstruction</u> within the first 2 {{c1::months}} of life</div>", "time": 1660105361252.0}, {"id": 1482978351848, "note": "<div><b>Biliary atresia</b> presents with <u>{{c1::jaundice (CB)}}</u> and progresses to <b>cirrhosis</b> </div>", "time": 1660105361253.0}, {"id": 1482978360365, "note": "<div>{{c1::<b>Cholelithiasis</b> (gallstones)}} are solid, round <u>stones</u> in the <b>gallbladder</b> </div>", "time": null}, {"id": 1482978396966, "note": "<div>There are <u>two</u> types of <b>gallstones</b>: {{c1::cholesterol}} and {{c2::pigmented}} </div>", "time": 1660105348827.0}, {"id": 1482978405717, "note": "<div>Are <b>cholesterol gallstones</b> typically <u>radiolucent</u> or <u>radiopaque</u>? </div><div><br></div><div>{{c1::Radiolucent}}</div>", "time": null}, {"id": 1482978433575, "note": "<div>Risk factors for <b>{{c5::cholesterol}} gallstones</b> may be remembered with the \"<b>4 Fs</b>\": </div><div style=\"centerbox\"><div class=\"mnemonics\"><div><br></div><div>1. {{c1::Fat}}</div><div>2. {{c2::Female (estrogen increases activity of HMG-CoA reductase)}}</div><div>3. {{c3::Fertile (pregnant)}}</div><div>4. {{c4::Forty}}</div></div></div>", "time": null}, {"id": 1482978436457, "note": "<div>What <i>classes</i> of <u>lipid lowering drugs</u> are associated with <b>cholesterol gallstone</b> formation? </div><div><br></div><div>{{c1::Fibrates and bile acid resins::2}}</div>", "time": null}, {"id": 1482978465432, "note": "<div><b>{{c2::Cholesterol}} gallstones</b> are more common in people of {{c1::<b>Native American</b>}} descent</div>", "time": null}, {"id": 1482978479026, "note": "<div><div>Which form of <u>IBD</u> has increased risk for <b>gallstones</b> (both cholesterol and pigment)? </div></div><div><br></div><div>{{c1::Crohn disease}}</div>", "time": 1660105343044.0}, {"id": 1482978481610, "note": "<div><b>{{c1::Black::color}} pigment gallstones</b>&nbsp;are <u>radio-{{c2::opaque}}</u> and composed of <b>{{c3::calcium bilirubinate}}</b></div>", "time": null}, {"id": 1482978486307, "note": "<div><b>{{c1::Brown::color}} pigment gallstones</b>&nbsp;are <u>radio-{{c2::lucent}}</u> and arise with biliary tract <b>{{c3::infection}}</b></div>", "time": 1660105340971.0}, {"id": 1482978489497, "note": "<div><b>Biliary tract infections</b> may cause <u>pigment gallstones</u> by {{c1::deconjugating}} <b>bilirubin</b>, which increases risk of precipitation</div>", "time": null}, {"id": 1482978492202, "note": "<div>Which type of <u>gallstone</u> is associated with <b>extravascular hemolysis</b>? </div><div><br /></div><div>{{c1::Bilirubin (pigment) stones}}</div>", "time": null}, {"id": 1482978497438, "note": "<div><i>{{c1::Clonorchis sinensis}}</i> is a <u>liver fluke</u> that infects the biliary tract, increasing the risk for <b>gallstones</b>, <b>cholangitis</b>, and <b>cholangiocarcinoma</b>  </div>", "time": null}, {"id": 1482978507215, "note": "<div>Which type of <u>gallstone</u> is associated with <b>alcoholic cirrhosis</b>? </div><div><br></div><div>{{c1::Pigment stones}}</div>", "time": null}, {"id": 1482978510390, "note": "<div><div>Which type of <u>gallstone</u> is associated with <b>total parenteral nutrition </b>(TPN)? </div><div><br /></div><div>{{c1::Cholesterol stones}}</div></div>", "time": 1660105341840.0}, {"id": 1482978530310, "note": "<div>The most common <u>gallstone complication</u> is <b>{{c1::cholecystitis}}</b> </div>", "time": null}, {"id": 1482978542274, "note": "<div><b>Gallstones</b> may be treated with elective {{c1::<u>cholecystectomy</u>}} if <b>symptomatic</b> </div>", "time": 1660105358729.0}, {"id": 1482978566629, "note": "<div><b>Biliary {{c2::colic}}</b> is a <u>waxing and waning</u> <b>{{c1::right upper}} quadrant pain</b> associated with gallstones; may also have nausea and vomiting</div>", "time": 1660105361246.0}, {"id": 1482978569217, "note": "<div><b>Biliary {{c1::colic}}</b> occurs due to <u>gallbladder contraction</u> against a <b>stone</b> lodged in the <b>{{c2::cystic}}</b> <b>duct</b> </div>", "time": 1660105361248.0}, {"id": 1482978576781, "note": "<div><b>{{c1::Cholecystitis}}</b> is an acute or chronic <u>inflammation</u> of the <b>gallbladder</b> with gallbladder wall thickening  </div>", "time": null}, {"id": 1482978588423, "note": "<div><div>Is <b>cholecystitis</b> typically <u>calculous</u> or <u>acalculous</u>? </div><div><br /></div><div>{{c1::Calculous}}</div></div>", "time": null}, {"id": 1482978622860, "note": "<div><div><b>{{c1::Acalculous}} cholecystitis</b> is due to gallbladder stasis, hypoperfusion, or infection (<u>no obstruction</u>); seen in critically ill patients</div></div>", "time": null}, {"id": 1482978625107, "note": "<div><div>What <u>infection</u> is associated with <b>acalculous cholecystitis</b>? </div><div><br></div><div>{{c1::CMV}}</div></div>", "time": null}, {"id": 1482978629409, "note": "<div><b>Acute {{c2::cholecystitis}}</b> presents with <u>RUQ pain</u> that often radiates to the {{c1::<b>right</b> <b>scapula</b>}} </div>", "time": null}, {"id": 1482978658105, "note": "<div><b>Cholecystitis</b> may present with <u>elevated</u> serum {{c1::alkaline phosphatase}} if the <b>bile</b> <b>duct</b> is involved</div>", "time": null}, {"id": 1482978661462, "note": "<div><b>{{c2::Cholecystitis}}</b> is associated with a positive <b>{{c1::Murphys}} sign</b>, which is <u>inspiratory arrest</u> on <b>RUQ</b> <b>palpation</b> due to pain</div>", "time": null}, {"id": 1482978704303, "note": "<div><b>Cholecystitis</b> is diagnosed with {{c1::ultrasound}} or {{c2::HIDA scan}} </div>", "time": 1660105360782.0}, {"id": 1482978710341, "note": "<div><b>{{c1::Porcelain gallbladder}}</b> is a <u>calcified gallbladder</u> that results from <b>chronic {{c2::cholecystitis}}</b> </div>", "time": null}, {"id": 1482978770329, "note": "<div><b>Porcelain gallbladder</b> is a <u>shrunken</u>, <u>hard gallbladder</u> due to chronic inflammation, fibrosis, and dystrophic {{c1::calcification}} </div>", "time": null}, {"id": 1482978790539, "note": "<div><b>Porcelain gallbladder</b> is treated with <i>prophylactic</i> {{c1::cholecystectomy}} due to high rates of gallbladder cancer (mostly adenocarcinoma)</div>", "time": null}, {"id": 1482978793159, "note": "<div><b>{{c1::Ascending cholangitis}}</b> is a <u>bacterial infection</u> of the <b>{{c2::bile ducts}}</b></div>", "time": null}, {"id": 1482978795501, "note": "<div><b>Ascending cholangitis</b> is usually due to <u>ascending infection</u> with enteric gram-{{c1::negative}} bacteria</div>", "time": 1660105361550.0}, {"id": 1482978797522, "note": "<div><b>{{c4::Ascending cholangitis}}</b> classically presents with the <u>Charcot triad</u> of {{c1::<b>jaundice</b>}}, {{c2::<b>fever</b>}}, and {{c3::<b>RUQ pain</b>}}</div>", "time": null}, {"id": 1482978799790, "note": "<div>In addition to the <u>Charcot triad</u>, <b>Ascending cholangitis</b> may also present with {{c1::altered mental status}} and {{c2::shock}} (Reynolds pentad)</div>", "time": null}, {"id": 1482978801797, "note": "<div>There is an <u>increased</u> incidence of <b>ascending cholangitis</b> with {{c1::choledocholithiasis}} (stones in the biliary ducts)</div>", "time": 1660105348820.0}, {"id": 1482978803774, "note": "<b>{{c1::Choledocholithiasis}}&nbsp;</b>is the presence of&nbsp;<u>gallstones</u>&nbsp;is the&nbsp;<b>{{c2::common bile}} duct</b>, often leading to&nbsp;<i>elevated</i>&nbsp;ALP, GGT, direct bilirubin, and/or AST/ALT", "time": null}, {"id": 1482978805608, "note": "<div><b>{{c1::Gallstone}} ileus</b> <i>typically</i> involves <u>obstruction</u> of the <b>{{c2::ileocecal}} valve</b> by a gallstone </div>", "time": null}, {"id": 1482978807812, "note": "<div><b>{{c1::Gallstone}} ileus</b> occurs secondary to <i>cholecystitis</i> with <u>fistula formation</u> between the <b>{{c2::gallbladder}}</b> and <b>{{c3::small bowel}}</b> </div>", "time": null}, {"id": 1482978812166, "note": "<div><div>What <u>type of cancer</u> (e.g. SCC, adenocarcinoma, etc.) is <b>gallbladder carcinoma</b>? </div><div><br /></div><div>{{c1::Adenocarcinoma}} </div></div>", "time": 1660105344858.0}, {"id": 1482978820391, "note": "<div>The major risk factor for <u>gallbladder carcinoma</u> is <b>{{c1::gallstones}}</b>, especially when complicated by <b>porcelain gallbladder</b></div>", "time": null}, {"id": 1482978823034, "note": "<div><b>Gallbladder {{c3::carcinoma}}</b> classically presents as new-onset <u>{{c2::cholecystitis}}</u> in an <b>elderly</b> <b>{{c1::woman::gender}}</b></div>", "time": 1660105358735.0}, {"id": 1482978825065, "note": "<div>What is the <u>prognosis</u> of <b>gallbladder carcinoma</b>? </div><div><br /></div><div>{{c1::Poor}} </div>", "time": 1660105345590.0}, {"id": 1483491954571, "note": "{{c1::LTB4}} is an arachidonic acid pathway metabolite that causes neutrophil chemotaxis", "time": null}, {"id": 1483491997459, "note": "The effects of <b>thromboxane A2(TXA2) </b>are <u>increased platelet</u>&nbsp;{{c1::<b>aggreggation</b>}} and <b>vaso</b>{{c2::<b>constriction</b>}}", "time": null}, {"id": 1483492000077, "note": "Leukotrienes are synthesized from arachidonic acid by {{c1::5-Lipoxygenase}}", "time": null}, {"id": 1483492003622, "note": "PGI2, PGE1, PGE2, PGF2-alpha, and thromboxane A2 are synthesized from arachidonic acid by {{c1::COX-1 and COX-2}}", "time": null}, {"id": 1483492118063, "note": "The effect of aspirin on coagulation studies is {{c1::increased bleeding time, no change in PT and PTT}}", "time": null}, {"id": 1483492134876, "note": "Acute adverse effects of aspirin use are {{c1::gastric ulceration}} and {{c1::tinnitus (CN VIII) (ears ringing)}}", "time": null}, {"id": 1483492137748, "note": "Adverse effects of <b>chronic aspirin use</b> include:<div><br><div>- {{c1::acute renal}} injury</div><div>- {{c2::acute interstitial}} nephritis</div><div>- {{c3::GI}} bleeding</div></div>", "time": null}, {"id": 1483825140079, "note": "<b>{{c2::Goodpasture}} syndrome</b> is an <u>autoimmune disease</u> that is associated with exposure to {{c1::<b>hydrocarbon</b> <b>solvents</b>}} (e.g. dry-cleaning, paints, dyes) and <b>cigarette smoke</b> ", "time": null}, {"id": 1483825263574, "note": "What is the <u>mode of inheritance</u> of <b>juvenile polyposis syndrome</b>? <div><br /></div><div>{{c1::Autosomal dominant}}</div>", "time": null}, {"id": 1483825588255, "note": "What is the <u>mode of inheritance</u> of <b>Peutz-Jeghers syndrome</b>? <div><br /></div><div>{{c1::Autosomal dominant}}</div>", "time": null}, {"id": 1483826505573, "note": "<b>Hodgkin lymphoma</b> is associated with {{c1::<b>EBV</b>}} infection ", "time": null}, {"id": 1484768430296, "note": "<div><b>Benzodiazepines</b> exert their effects via binding to an <u>allosteric site</u> on the <b>{{c1::GABA<sub>A</sub>}} receptor</b><br></div>", "time": 1660105351443.0}, {"id": 1484768435794, "note": "<div><b>Benzodiazepines</b> {{c1::<u>enhance</u>::enhance or inhibit}} the action of <b>GABA<sub>A</sub></b>&nbsp;<br></div>", "time": 1660105351438.0}, {"id": 1484768489461, "note": "<div>Non-specific symptoms of <u>alcohol withdrawal</u>, such as anxiety, insomnia, and tremors, typically occur after <b>{{c1::3}} - {{c1::36}} hours</b><br></div>", "time": 1660105351407.0}, {"id": 1484768496791, "note": "<div><b>{{c2::Seizures}}</b> secondary to <u>alcohol withdrawal</u> typically occur after <b>{{c1::6}} - {{c1::48}} hours</b><br></div>", "time": 1660105351334.0}, {"id": 1484768504506, "note": "<div><b>{{c2::Delirium tremens}}</b>, secondary to <u>alcohol withdrawal</u>, typically occurs after <b>{{c1::48}} - {{c1::96}} hours</b><br></div>", "time": 1660105351341.0}, {"id": 1484768528915, "note": "<div><u>Long-acting</u> <b>{{c1::benzodiazepines}}</b> are useful in the treatment of <b>{{c2::alcohol}}</b> <b>withdrawal</b> (if no cirrhosis or {{c2::alcoholic}} hepatitis)<br></div>", "time": 1660105351415.0}, {"id": 1484768542523, "note": "<div><b>IV benzodiazepines</b>, such as {{c1::<u>lorazepam</u>}} and {{c2::<u>diazepam</u>}}, are the 1st-line agents for treatment for <i>acute</i> <b>status</b> <b>epilepticus</b><br></div>", "time": 1660105351418.0}, {"id": 1484768546903, "note": "<div>Which type of <u>generalized seizure</u> is <b>acutely</b> treated with&nbsp;<b>benzodiazepines</b>?<br></div><div><br></div><div>{{c1::Status epilepticus}}</div>", "time": 1660105351366.0}, {"id": 1484768555637, "note": "<div><b>IV benzodiazepines</b> (e.g. midazolam) may be used to create a state of <u>{{c1::conscious sedation}}</u> for <i>minor</i> procedures and surgeries (e.g. colonoscopy, endoscopy)<br></div>", "time": 1660105351420.0}, {"id": 1484768625035, "note": "<div><b>Benzodiazepines</b> may have <u>additive</u> <b>CNS depression effects</b> with {{c1::alcohol}}, barbiturates, 1st generation antihistamines, and neuroleptics<br></div>", "time": 1660105351439.0}, {"id": 1484768629105, "note": "<div><b>{{c1::Flumazenil}}</b> is a <u>competitive antagonist</u> at the {{c2::<b>benzodiazepine site</b>}}<b> </b>of<b> the {{c1::GABA-A}} receptor</b>, which is used to treat overdose or reverse sedative effects of {{c2::<b>benzodiazepines AND nonbenzodiazepine hypnotics::2</b>}}<br></div>", "time": 1660105351358.0}, {"id": 1484768634230, "note": "<div><b>Flumazenil</b> can precipate {{c1::<u>seizures</u>}} by causing acute <b>benzodiazepine</b> <b>withdrawal</b><br></div>", "time": 1660105351425.0}, {"id": 1484768639953, "note": "<div>The <b>benzodiazepines</b> that are safe to use in patients with <u>liver disease</u> may be remembered with the mnemonic \"<b>LOT</b>\":<br></div><div style=\"centerbox\"><div class=\"mnemonics\"><div><br></div><div><b>L</b>: {{c1::Lorazepam}}</div><div><b>O</b>: {{c2::Oxazepam}}</div><div><b>T</b>: {{c3::Temazepam}} </div></div></div>", "time": 1660105351384.0}, {"id": 1484778037232, "note": "<div>What <u>drug class</u> do <b>phenobarbital</b>, <b>pentobarbital</b>, and <b>secobarbital</b> belong to?<br></div><div><br></div><div>{{c1::Barbiturates}}</div>", "time": 1660105351370.0}, {"id": 1484778142057, "note": "<div>What <u>drug class</u> does <b>thiopental</b> belong to?<br></div><div><br></div><div>{{c1::Barbiturates}}</div>", "time": 1660105351369.0}, {"id": 1484778145187, "note": "<div><b>Barbiturates</b> exert their effects via binding to an <u>allosteric site</u> on the <b>{{c1::GABA<sub>A</sub>}} receptor</b><br></div>", "time": 1660105351449.0}, {"id": 1484778149500, "note": "<div><b>Barbiturates</b> {{c1::<u>enhance</u>::enhance or inhibit}} the action of <b>GABA<sub>A</sub></b>&nbsp;<br></div>", "time": 1660105351447.0}, {"id": 1484778153479, "note": "<div><b>{{c2::Barbiturates}} </b>increase Cl<sup>-</sup> conductance by increasing the {{c1::<u>duration</u>::frequency or duration}} of channel opening<br></div>", "time": 1660105351345.0}, {"id": 1484778174517, "note": "<div><b>Thiopental</b> is a <u>barbiturate</u> with a <i>rapid</i> onset and duration of action due to high potency and high {{c1::lipid}} solubility<br></div>", "time": 1660105351375.0}, {"id": 1484778178394, "note": "<div>Plasma levels of <b>thiopental</b> decrease <u>rapidly</u> due to <i>redistribution</i> to <b>{{c1::skeletal muscle}}</b> and <b>{{c2::adipose}}</b><br></div>", "time": 1660105351390.0}, {"id": 1484778220705, "note": "<div><b>Primidone</b> is a <u>barbiturate</u> used to treat <b>seizures</b> and <b>{{c1::essential}}</b> <b>tremor</b><br></div>", "time": 1660105351388.0}, {"id": 1484778229455, "note": "<div>Besides CNS depression, side effects of <b>barbiturates </b>include {{c1::cardiac}} and {{c1::respiratory}} <u>depression</u>, which can be fatal<br></div>", "time": 1660105351385.0}, {"id": 1484778241451, "note": "<div>Do <u>barbiturates</u> have <b>addictive potential</b>?<br></div><div><br></div><div>{{c1::Yes}}</div>", "time": 1660105351431.0}, {"id": 1484778245242, "note": "<div><b>Barbiturates</b> are a(n) {{c2::<u>inducer</u>}} of {{c1::<b>cytochrome P450</b>}} and thus may have many drug interactions<br></div>", "time": 1660105351452.0}, {"id": 1484778257280, "note": "<div><b>Barbiturates</b> are <u>contraindicated</u> in patients with {{c1::porphyrias::hematologic pathology}}&nbsp;<br></div>", "time": 1660105359003.0}, {"id": 1484862200866, "note": "<div>Is <b>propofol</b> used for the <u>induction</u> or <u>maintenance</u> of anesthesia?</div><div><br></div><div>{{c1::Both :)}}</div>", "time": 1660105351746.0}, {"id": 1484862393206, "note": "<div><b>{{c2::Propofol}}</b> and <b>{{c3::etomidate}}</b> are <i>IV anesthetics</i> that exert their effects via <u>potentiation</u> of the <b>{{c1::GABA<sub>A</sub>}} receptor</b> complex<br></div>", "time": 1660105351483.0}, {"id": 1484862427507, "note": "<div>Is <b>etomidate</b> used for the <u>induction</u> or <u>maintenance</u> of anesthesia?<br></div><div><br></div><div>{{c1::Induction}}</div>", "time": 1660105351751.0}, {"id": 1484862432889, "note": "<div>Which <u>IV anesthetic</u> preserves cardiovascular stability?<br></div><div><b><br></b></div><div>{{c1::Etomidate}} </div>", "time": 1660105351537.0}, {"id": 1484862441642, "note": "<div>Is <b>ketamine</b> used for the <u>induction</u> or <u>maintenance</u> of anesthesia?<br></div><div><br></div><div>{{c1::Induction}}</div>", "time": 1660105351750.0}, {"id": 1484862446206, "note": "<div><b>{{c2::Ketamine}}</b> is an <i>IV anesthetic</i> that exerts its effect via <u>inhibition</u> of <b>{{c1::NMDA}}</b> <b>receptors</b><br></div>", "time": 1660105351497.0}, {"id": 1484862452178, "note": "<div><b>Ketamine</b> (an arylcyclohexylamine) is a <u>PCP analog</u> that causes \"<b>{{c1::dissociative}}</b> <b>anesthesia</b>\"<br></div>", "time": 1660105351742.0}, {"id": 1484862461322, "note": "<div><b>{{c1::Ketamine}}</b> is an <i>IV anesthetic</i> that can cause disorientation, hallucinations, and unpleasant dreams<br></div>", "time": 1660105351521.0}, {"id": 1484862490045, "note": "<div><b>Ketamine</b> causes <u>cardiovascular</u> {{c1::stimulation::depression or stimulation}}<br></div>", "time": 1660105351741.0}, {"id": 1484862500798, "note": "<div><b>{{c1::Midazolam}}</b> is a <u>benzodiazepine</u> that may be used as an <b>IV anesthetic</b><br></div>", "time": 1660105351516.0}, {"id": 1484862510434, "note": "<div><b>Benzodiazepines</b> (e.g. midazolam) can cause severe <u>post-operative</u> <b>respiratory</b> {{c1::<b>depression</b>}} and <b>{{c2::hypo}}-tension</b></div>", "time": 1660105359098.0}, {"id": 1484862527140, "note": "<div><b>Thiopental</b> causes <u>{{c1::decreased}}</u> <b>cerebral blood flow</b><br></div>", "time": 1660105359061.0}, {"id": 1484879626510, "note": "<div>What <u>drug class</u> do <b>halothane</b>, <b>enflurane</b>, <b>methoxyflurane</b> belong to?<br></div><div><br></div><div>{{c1::Inhaled anesthetics}}</div>", "time": 1660105351584.0}, {"id": 1484879636730, "note": "<div>Inhaled anesthetics with <u>{{c1::higher}}</u><b> solubility in blood</b> have a(n)&nbsp;<u>{{c2::slower}}</u> <b>onset of action</b></div>", "time": 1660105351758.0}, {"id": 1484879643351, "note": "<div>Inhaled anesthetics with <u>higher</u><b> solubility in blood</b> have a(n)&nbsp;<u>{{c1::slower}}</u> <b>recovery</b></div>", "time": 1660105351760.0}, {"id": 1484879655591, "note": "<div>Inhaled anesthetics with <u>{{c1::lower}}</u><b> solubility in blood</b> have a(n)&nbsp;<u>{{c2::faster}}</u> <b>onset of action</b></div>", "time": 1660105351756.0}, {"id": 1484879664445, "note": "<div>Inhaled anesthetics with <u>lower</u><b> solubility in blood</b> have a(n)&nbsp;<u>{{c1::faster}}</u> <b>recovery</b></div>", "time": 1660105351759.0}, {"id": 1484879673290, "note": "<div>The <b>{{c2::solubility}}</b> of an <i>inhaled anesthetic</i> may also be referred to as the <b>{{c1::blood:gas partition}} coefficient</b><br></div>", "time": 1660105351655.0}, {"id": 1484879678492, "note": "<div>Does the <u>blue</u> curve represent an inhaled anesthetic with a <b><i>high</i> or <i>low</i> blood solubility</b>?<br></div><div><br></div><div>{{c1::Low (quickly saturated, e.g. N<sub>2</sub>O)}}</div><div><br></div><div><img src=\"paste-398388281475156.jpg\"></div>", "time": 1660105351782.0}, {"id": 1484879684118, "note": "<div>Does the <u>red</u> curve represent an inhaled anesthetic with a <b><i>high</i> or <i>low</i> blood solubility</b>?<br></div><div><div><br></div><div>{{c1::High (slowly saturated, e.g. halothane)}}</div></div><div><br></div><div><img src=\"paste-398383986507860.jpg\"></div>", "time": 1660105351781.0}, {"id": 1484879690560, "note": "<div>{{c1::<b>Minimal alveolar concentration</b> (MAC)}} is the dose of <u>inhaled anesthetic</u> that causes 50% of patients to become <b>unresponsive to noxious stimuli</b><br></div>", "time": 1660105351515.0}, {"id": 1484879694825, "note": "<div>Drugs with <u>increased</u> <b>solubility in {{c2::lipids}}</b> have <u>{{c1::increased}}</u> <b>potency</b><br></div><div><br></div><div><i><br></i></div>", "time": 1660105359086.0}, {"id": 1484879697741, "note": "<div><b>Potency</b> is <u>{{c1::inversely}}</u> proportional to <b>minimal alveolar concentration</b> (MAC)<br></div>", "time": 1660105351710.0}, {"id": 1484879701855, "note": "<div><b>Halothane</b> is an example of an <i>inhaled anesthetic</i> with <u>{{c1::high}}</u> <b>lipid</b> and <b>blood solubility</b><br></div>", "time": 1660105359084.0}, {"id": 1484879727067, "note": "<div><b>Nitrous oxide</b> (N<sub>2</sub>O) is an example of an <i>inhaled anesthetic</i> with <u>{{c1::low}}</u> <b>lipid</b> and <b>blood solubility</b><br></div>", "time": 1660105359067.0}, {"id": 1484879734307, "note": "<div><b>Inhaled anesthetics</b> can cause <u>myocardial</u> {{c1::depression::stimulation or depression}}&nbsp;<br></div>", "time": 1660105351763.0}, {"id": 1484879741939, "note": "<div><b>Inhaled anesthetics</b> can cause <u>respiratory</u> {{c1::depression::stimulation or depression}}&nbsp;<br></div>", "time": 1660105351762.0}, {"id": 1484879749641, "note": "<div><b>Inhaled anesthetics</b> can cause <u>{{c1::increased}}</u> <b>cerebral blood flow</b><br></div>", "time": 1660105351761.0}, {"id": 1484879756877, "note": "<div>The <u>inhaled anesthetic</u> <b>{{c2::halothane}}</b> is <i>most commonly</i> associated with <b>{{c1::hepatotoxicity}}</b> as an adverse effect<br></div>", "time": 1660105351688.0}, {"id": 1484879771973, "note": "<div>The <u>inhaled anesthetic</u> <b>methoxyflurane</b> is associated with <b>{{c1::nephrotoxicity}}</b> as an adverse effect<br></div>", "time": 1660105359063.0}, {"id": 1484879782041, "note": "<div><b>{{c1::Malignant hyperthermia}}</b> is a skeletal muscle <u>hypersensitivity</u> to <b>volatile anesthetics</b><br></div>", "time": 1660105351517.0}, {"id": 1484879785546, "note": "<div>In addition to inhaled anesthetics, <b>malignant hyperthermia</b> may also be caused by {{c1::succinylcholine}} (muscle relaxant)<br></div>", "time": 1660105351768.0}, {"id": 1484879789460, "note": "<div><b>Malignant hyperthermia</b> is usually related to a <i>defect</i> in <b>{{c1::ryanodine}} receptors</b>, which causes <u>{{c2::increased}}</u> <b>Ca<sup>2+</sup> release</b> from the SR<br></div>", "time": 1660105351732.0}, {"id": 1484879797391, "note": "<div><b>Excessive heat production</b> in <u>malignant hyperthermia</u> induces <b>fever</b> and {{c1::<b>muscle</b> <b>damage</b> (e.g. rhabdomyolysis)}}<br></div>", "time": 1660105351773.0}, {"id": 1484879804223, "note": "<div><b>Malignant hyperthermia</b> is treated by {{c1::<u>dantrolene</u>}}, which is a(n)&nbsp;<b>{{c2::ryanodine}} receptor </b><i style=\"font-weight: bold;\">antagonist</i> that prevents release of Ca<sup>2+</sup> from the SR</div>", "time": 1660105351734.0}, {"id": 1484879811416, "note": "<div>What is the <u>mode of inheritance</u> of <b>malignant hyperthermia</b>?<br></div><div><br></div><div>{{c1::Autosomal dominant}}</div>", "time": 1660105359043.0}, {"id": 1484950235435, "note": "<div>The <b>{{c1::\u03bc}}-opioid receptor</b> mediates <i>most</i> of the clinical and adverse effects<br></div>", "time": 1660105351376.0}, {"id": 1484950241378, "note": "<div><b>Opiate receptor</b> <i>activation</i> causes <u>{{c1::opening}}</u> of <b>{{c2::K<sup>+</sup>}} channels</b><br></div>", "time": 1660105351396.0}, {"id": 1484950257380, "note": "<div><b>Fentanyl</b> and <b>morphine</b> are <u>opioid agonists</u> that may be used for <b>{{c1::pain}} relief</b><br></div>", "time": 1660105351426.0}, {"id": 1484950290832, "note": "<div><b>Opioid analgesics</b> may be used to treat <b>acute pulmonary {{c1::edema}}</b></div>", "time": 1660105358986.0}, {"id": 1484950294343, "note": "<div><b>Opioid analgesics</b> are associated with <b>CNS {{c1::depression}}</b> as an adverse effect<br></div>", "time": 1660105351394.0}, {"id": 1484950302359, "note": "<div><b>Opioid analgesics</b> may cause significant dose-dependent <b>respiratory {{c1::depression::depression or stimulation}}</b>&nbsp;<br></div>", "time": 1660105351393.0}, {"id": 1484950307243, "note": "<div><i>Most</i> <b>opioid analgesics </b>cause <b>{{c1::miosis::pupil size}}</b>&nbsp;</div>", "time": 1660105351411.0}, {"id": 1484950312081, "note": "<div>What <u>opioid analgesic</u> causes <b>mydriasis</b>?<br></div><div><br></div><div>{{c1::Meperidine}}</div>", "time": 1660105358973.0}, {"id": 1484950316241, "note": "<div>What <u>change in bowel movement</u> is associated with <i>activation</i> of <b>\u03bc-opioid receptors</b>?<br></div><div><div><br></div><div>{{c1::Constipation}} </div></div>", "time": 1660105351372.0}, {"id": 1484950323983, "note": "<div>What <u>biliary tree</u> complication may be caused by <b>opiates</b>?<br></div><div><br></div><div>{{c1::Biliary colic}} or <b>Sphincter of Oddi Spasm</b></div>", "time": 1660105351373.0}, {"id": 1484950334879, "note": "<div>Does chronic <u>opiate</u> use lead to <b>tolerance</b>?<br></div><div><br></div><div>{{c1::Yes}}</div>", "time": 1660105351427.0}, {"id": 1484950340052, "note": "<div>What <i>adverse effects</i> of <u>opiates</u> persist even <b>after tolerance develops</b>?<br></div><div><br></div><div>{{c1::Miosis}} and {{c1::constipation}}</div>", "time": 1660105351374.0}, {"id": 1484950370258, "note": "<div><b>{{c1::Methadone}}</b> is a <i>long-acting</i> <u>\u03bc-receptor agonist</u> used to <b>attenuate opioid withdrawal symptoms</b><br></div>", "time": 1660105351353.0}, {"id": 1484950376874, "note": "<div><b>Methadone</b> and <b>buprenorphine</b> are useful for <u>opioid detoxication</u> due to their {{c1::long}} <b>half lives</b><br></div>", "time": 1660105351412.0}, {"id": 1484950383414, "note": "<div><b>{{c1::Buprenorphine}}</b> is a long-acting <u><i>partial</i> \u03bc-opioid agonist</u> used to <b>attenuate opioid withdrawal symptoms</b><br></div>", "time": 1660105351361.0}, {"id": 1484950408050, "note": "<div><b>Buprenorphine</b>, and&nbsp;<b>butorphanol</b>&nbsp;are <u>\u03bc-opioid</u> {{c1::<i>partial</i> agonists}}<br></div>", "time": 1660105351437.0}, {"id": 1484950415236, "note": "<div>{{c1::<i><b>Partial</b></i> <b>opioid</b>}}<b> agonists</b> can cause <u>{{c2::opioid withdrawal}} symptoms</u> if the patient is also taking a <b>full opioid agonist</b><br></div>", "time": 1660105351349.0}, {"id": 1484950422509, "note": "<div><b>{{c1::Naloxone}}</b> is a <u>\u03bc-opioid <i>inverse agonist</i></u> used to treat<b> acute opioid toxicity</b> (can precipitate withdrawal)<br></div>", "time": 1660105351352.0}, {"id": 1484950427352, "note": "<div><b>{{c1::Naltrexone}}</b> is a <u>\u03bc-opioid <i>antagonist</i></u> that helps <b>maintain abstinence</b> in opioid addicts once detoxified<br></div>", "time": 1660105351351.0}, {"id": 1484950509959, "note": "<div>What <i>type</i> of <u>local anesthetic</u> are <b>procaine</b>, <b>cocaine</b>, <b>tetracaine</b>, and <b>benzocaine</b>?<br></div><div><br></div><div>{{c1::Esters}}</div>", "time": 1660105358967.0}, {"id": 1484950512131, "note": "<div>What <i>type</i> of <u>local anesthetic</u> are <b>lidocaine</b>, <b>mepivacaine</b>, and <b>bupivacaine</b>?<br></div><div><br></div><div>{{c1::Amides}} </div>", "time": 1660105358968.0}, {"id": 1484950518844, "note": "<div><b>Local anesthetics</b>&nbsp;exert their actions by&nbsp;<u>blocking</u>&nbsp;<b>{{c1::Na<sup>+</sup>}} channels</b>&nbsp;(via binding to&nbsp;specific receptors on the <i>inner</i> portion of the channel)</div>", "time": 1660105358987.0}, {"id": 1484950540514, "note": "<div>What <u>vasoconstrictor</u> is often given with <b>local anesthetics</b>?<br></div><div><br></div><div>{{c1::Epinephrine}}</div>", "time": 1660105358965.0}, {"id": 1484950562122, "note": "<div>What <u>size of nerve fiber</u>, small or large diameter, is affected <i>first</i> by <b>local anesthetics</b>?<br></div><div><br></div><div>{{c1::Small-diameter fibers}}</div>", "time": 1660105358969.0}, {"id": 1484950565258, "note": "<div>What <u>type of nerve fiber</u>, myelinated or unmyelinated, is affected <i>first</i> by <b>local anesthetics</b>?<br></div><div><div><br></div><div>{{c1::Myelinated fibers}}</div></div>", "time": 1660105358966.0}, {"id": 1484950567327, "note": "<div>Which <u>nerve fibers</u> (size, myelination) are affected <i>first</i> by <b>local anesthetics</b>?<br></div><div><br></div><div>{{c1::Small, myelinated fibers}}</div>", "time": 1660105358964.0}, {"id": 1484950569362, "note": "<div>Would a <b>small, unmyelinated</b> or <b>large, myelinated fiber</b> be affected <i>first</i> by <u>local anesthetics</u>?<br></div><div><br></div><div>{{c1::Small, unmyelinated}}</div>", "time": 1660105358961.0}, {"id": 1484950576373, "note": "<div>What <u>sensation</u> is lost <i>first</i> with <b>local anesthetics</b>?<br></div><div><br></div><div>{{c1::Pain}}</div>", "time": 1660105358971.0}, {"id": 1484950582585, "note": "<div><b>Local anesthetics</b> are often used for <u>minor</u> surgical procedures and {{c1::spinal}} anesthesia</div>", "time": 1660105358989.0}, {"id": 1484950587301, "note": "<div><b>{{c2::Bupivacaine}}</b> is a <u>local anesthetic</u> that is associated with&nbsp;<b>severe {{c1::cardiovascular}} toxicity</b></div>", "time": 1660105358955.0}, {"id": 1484950589278, "note": "<div><b>{{c1::Cocaine}}</b> is a <u><b>local</b> anesthetic</u> that is commonly associated with <b>cardiac arrhythmias</b></div>", "time": 1660105358960.0}, {"id": 1484950591778, "note": "<div><b>{{c2::Benzocaine}}</b> is a <u>local anesthetic</u> that is associated with&nbsp;<b>{{c1::methemoglobinemia}}</b> as an adverse effect</div>", "time": 1660105358957.0}, {"id": 1484950599425, "note": "<div><b>Dantrolene</b> is a muscle relaxant that is used to treat <b>{{c1::malignant hyperthermia}}</b> and <b>{{c2::neuroleptic malignant syndrome}}</b><br></div>", "time": 1660105359000.0}, {"id": 1485036804882, "note": "<div>What <u>drug class</u> do <b>fluoxetine</b> and <b>paroxetine</b> belong to?</div><div><br></div><div>{{c1::SSRIs}}</div>", "time": 1660105351586.0}, {"id": 1485037133108, "note": "<div>What <u>drug class</u> do <b>sertraline</b> and <b>fluvoxamine</b> belong to?<br></div><div><div><br></div><div>{{c1::SSRIs}}</div></div>", "time": 1660105351580.0}, {"id": 1485037139844, "note": "<div>What <u>drug class</u> do <b>citalopram</b> and <b>escitalopram</b> belong to?<br></div><div><div><br></div><div>{{c1::SSRIs}}</div></div>", "time": 1660105351588.0}, {"id": 1485037144597, "note": "<div>What <u>drug class</u> do <b>venlafaxine</b> and <b>desvenlafaxine</b> belong to?<br></div><div><div><br></div><div>{{c1::SNRIs}}</div></div>", "time": 1660105351578.0}, {"id": 1485037149846, "note": "<div>What <u>drug class</u> does <b>duloxetine</b> belong to?<br></div><div><div><br></div><div>{{c1::SNRIs}}</div></div>", "time": 1660105351575.0}, {"id": 1485037154999, "note": "<div>What <u>drug class</u> do <b>milnacipran</b> and <b>levomilnacipran</b> belong to?<br></div><div><div><br></div><div>{{c1::SNRIs}}</div></div>", "time": 1660105359049.0}, {"id": 1485037158388, "note": "<div><b>SSRIs</b> <u>inhibit</u> the pre-synaptic <i>reuptake</i> of {{c1::serotonin (5-HT)}}<br></div>", "time": 1660105351699.0}, {"id": 1485037163106, "note": "<div><b>SNRIs</b> <u>inhibit</u> the pre-synaptic <i>reuptake</i> of {{c1::norepineprine}} and {{c1::serotonin}}<br></div>", "time": 1660105351703.0}, {"id": 1485037181746, "note": "<div>What are the <i>first-line</i> <u>pharmacologic</u> treatments for <b>panic disorder</b>?<br></div><div><br></div><div>{{c1::SSRIs <i>or</i> SNRIs::2}}</div>", "time": 1660105351597.0}, {"id": 1485037195286, "note": "<div>What is the <i>first-line</i> <u>pharmacologic</u> treatment for <b>obsessive-compulsive disorder</b> (OCD)?<br></div><div><br></div><div>{{c1::SSRIs}}</div>", "time": 1660105351560.0}, {"id": 1485037215079, "note": "<div>What <u>sexual dysfunction</u> may be <i>treated</i> with <b>SSRIs</b>?<br></div><div><br></div><div>{{c1::Premature ejaculation}}</div>", "time": 1660105359037.0}, {"id": 1485037217772, "note": "<div><b>{{c1::SSRIs}}</b> may be used to treat <b>{{c2::premenstrual dysphoric}} disorder</b>, a severe form of premenstrual syndrome (PMS)</div>", "time": 1660105359017.0}, {"id": 1485037220962, "note": "<div>What <u>diabetes complication</u> can be treated with <b>SNRIs</b>?<br></div><div><br></div><div>{{c1::Diabetic neuropathy}}</div>", "time": 1660105351592.0}, {"id": 1485037225784, "note": "<div><b>SNRIs</b> may be used to treat <u>chronic pain</u> (e.g. {{c1::neuropathic}} pain)<br></div>", "time": 1660105351702.0}, {"id": 1485037230598, "note": "<div><b>{{c2::Duloxetine}}</b> is an <u>SNRI</u> that is indicated for the treatment of&nbsp;<b>{{c1::fibromyalgia::musculoskeletal pathology}}</b>&nbsp;</div>", "time": 1660105351507.0}, {"id": 1485037235169, "note": "<div>How long do <b>SSRIs</b> and <b>SNRIs</b> take to <u>achieve maximum effect</u>?<br></div><div><br></div><div>{{c1::1 - 2 months}}</div>", "time": 1660105351771.0}, {"id": 1485037239547, "note": "<div>What <u>endocrine pathology</u> is rarely <i>caused</i> by <b>SSRIs</b>?<br></div><div><br></div><div>{{c1::SIADH}}</div>", "time": 1660105351568.0}, {"id": 1485037244915, "note": "<div><b>SSRIs</b> can cause <u>sexual dysfunction</u>, such as <b>{{c1::anorgasmia}}</b> and <b>decreased libido</b><br></div>", "time": 1660105351701.0}, {"id": 1485037249011, "note": "<div><b>SSRIs</b> can cause <b>weight</b> <b>{{c1::gain}}</b><br></div>", "time": 1660105351700.0}, {"id": 1485037254163, "note": "<div><b>{{c1::Serotonin syndrome}}</b> is a <u>potentially lethal</u> adverse effect associated with any drug that <b>increases 5-HT</b><br></div>", "time": 1660105351513.0}, {"id": 1485037267655, "note": "<div>What <u>anti-emetic</u> can increase risk for <b>serotonin syndrome</b>?<br></div><div><br></div><div>{{c1::Ondansetron}}</div>", "time": 1660105351602.0}, {"id": 1485037272604, "note": "<div>What <u>anti-tussive</u> can increase risk for <b>serotonin syndrome</b>?<br></div><div><div><br></div><div>{{c1::Dextromethorphan}}</div></div>", "time": 1660105359053.0}, {"id": 1485037275907, "note": "<div>What <u>antibiotic</u> can increase risk for <b>serotonin syndrome</b>?<br></div><div><div><br></div><div>{{c1::Linezolid}}</div></div>", "time": 1660105359052.0}, {"id": 1485037278052, "note": "<div>The symptoms of <b>{{c4::serotonin}} syndrome</b> can be remembered with the \"<b>3 As</b>\":<br></div><div><br></div><div>1. {{c1::<b>neuromuscular hyperActivity</b> (clonus, hyperreflexia, hypertonia, tremor, seizure)}} </div><div>2. {{c2::<b>Autonomic stimulation</b> (hyperthermia, diaphoresis, diarrhea)}}</div><div>3. {{c3::<b>Agitation</b>}}</div>", "time": 1660105351677.0}, {"id": 1485037287564, "note": "<div>What <u>abnormal movement</u> is associated with <b>serotonin syndrome</b>?<br></div><div><br></div><div>{{c1::Clonus}}</div>", "time": 1660105351605.0}, {"id": 1485037294850, "note": "<div><b>Serotonin syndrome</b> is associated with <b>{{c1::hyper}}-reflexia</b><br></div>", "time": 1660105351705.0}, {"id": 1485037302273, "note": "<div><b>{{c3::Cyproheptadine}}</b> is a(n) {{c2::<u>5-HT</u><sub>2</sub>}}<u> receptor <i>antagonist</i></u> used to treat <b>{{c1::serotonin}} syndrome</b><br></div>", "time": 1660105351459.0}, {"id": 1485037306763, "note": "<div>What is the <u>most common</u> side effect of <b>SNRIs</b>?<br></div><div><br></div><div>{{c1::Hypertension}}</div>", "time": 1660105351557.0}, {"id": 1485037314388, "note": "<div><b><i>Sudden</i> discontinuation</b> of <u>SSRIs</u> or <u>SNRIs</u> can cause <b>{{c1::flu}}-like symptoms</b><br></div>", "time": 1660105351697.0}, {"id": 1485042171728, "note": "<div>What <u>drug class</u> do <b>amitriptyline</b> and <b>nortriptyline</b> belong to?</div><div><br></div><div>{{c1::Tricyclic antidepressants (TCAs)}}</div>", "time": 1660105351590.0}, {"id": 1485042550553, "note": "<div>What <u>drug class</u> do <b>imipramine</b>, <b>desipramine</b>, and <b>clomipramine</b> belong to?<br></div><div><div><br></div><div>{{c1::Tricyclic antidepressants (TCAs)}}</div></div>", "time": 1660105351582.0}, {"id": 1485042556613, "note": "<div>What <u>drug class</u> do <b>doxepin</b> and <b>amoxapine</b> belong to?<br></div><div><div><br></div><div>{{c1::Tricyclic antidepressants (TCAs)}}</div></div>", "time": 1660105359050.0}, {"id": 1485042559919, "note": "<div><b>TCAs</b> <u>inhibit</u> the pre-synaptic <i><b>reuptake</b></i> of {{c1::norepineprine}} and {{c1::serotonin}}<br></div>", "time": 1660105351694.0}, {"id": 1485042569716, "note": "<div><b>Tricyclic antidepressants</b> (TCAs) may be used for&nbsp;<u>treatment-resistant</u><b> {{c1::depression}}</b><br></div>", "time": 1660105351635.0}, {"id": 1485042574055, "note": "<div>What <u>diabetes complication</u> can be treated with <b>TCAs</b>?<br></div><div><br></div><div>{{c1::Diabetic neuropathy}}</div>", "time": 1660105351591.0}, {"id": 1485042578061, "note": "<div><b>TCAs</b> may be used to treat <u>peripheral neuropathy</u> and <u>chronic pain</u> (e.g. {{c1::neuropathic}} pain)<br></div>", "time": 1660105351693.0}, {"id": 1485042581970, "note": "<div><b>TCAs</b>, such as <u>{{c2::amitryptiline}}</u>, may be used for <b>{{c1::migraine}} prophylaxis</b><br></div>", "time": 1660105351691.0}, {"id": 1485042585717, "note": "<div><b>Clomipramine</b> is a <u>TCA</u> that may be used in the treatment of<b> {{c1::obsessive-compulsive}} disorder</b><br></div>", "time": 1660105351792.0}, {"id": 1485042589665, "note": "<div><b>Imipramine</b> is a <u>TCA</u> that is <i>rarely</i> used to treat <b>nocturnal {{c1::enuresis}}</b></div>", "time": 1660105359080.0}, {"id": 1485042592432, "note": "<div>Are <b>tricyclic antidepressants</b> (TCAs) associated with <u>sexual dysfunction</u>?<br></div><div><div><br></div><div>{{c1::Yes}} </div></div>", "time": 1660105351815.0}, {"id": 1485042600488, "note": "<div><b>TCAs</b> may cause <u>{{c1::anti-cholinergic}}</u> side effects, such as <b>tachycardia</b>, <b>urinary retention</b>, <b>dry mouth</b>, and <b>confusion</b><br></div>", "time": 1660105351692.0}, {"id": 1485042610619, "note": "<div>Which <u>tricyclic antidepressant</u> has the <i>most</i> <b>anti-cholinergic effects</b>?<br></div><div><br></div><div>{{c1::Amitriptyline (tertiary amine)}}</div>", "time": 1660105351529.0}, {"id": 1485042614659, "note": "<div>Which <u>tricyclic antidepressants</u>&nbsp;have the <i>least</i> <b>anti-cholinergic effects</b>?<br></div><div><br></div><div>{{c1::Nortriptyline::secondary amine}} and {{c2::desipramine::secondary amine}}</div>", "time": 1660105351528.0}, {"id": 1485042620859, "note": "<div><b>TCAs</b> are relatively <i>contraindicated</i> in <b>{{c1::elderly}} patients</b> due to severe <u>anticholinergic</u> and <u>antihistamine</u> effects<br></div>", "time": 1660105351696.0}, {"id": 1485042636608, "note": "<div><b>Tricyclic antidepressants</b> <u>antagonize</u> the {{c1::<b>H<sub>1</sub></b>}} <b>histamine</b> <b>receptor</b><br></div>", "time": 1660105351634.0}, {"id": 1485042644988, "note": "<div><b>Tricyclic antidepressants</b> <u>antagonize</u> the {{c1::<b>\u03b1<sub>1</sub></b>}} <b>adrenergic</b> <b>receptor</b><br></div>", "time": 1660105351633.0}, {"id": 1485042649443, "note": "<div>What <u>adverse effect</u> is associated with <b>TCAs</b> due to <b>\u03b1<sub>1 </sub>antagonism</b>?<br></div><div><br></div><div>{{c1::Orthostatic hypotension}}</div>", "time": 1660105351603.0}, {"id": 1485042653577, "note": "<div>What is the most common <u>cause of death</u> in <b>tricyclic antidepressant overdose</b>?<br></div><div><br></div><div>{{c1::Fatal cardiac arrhythmia}}</div>", "time": 1660105351558.0}, {"id": 1485042659288, "note": "<div><b>TCAs</b> can cause <u>arrhythmias</u> due to <b>{{c1::fast Na<sup>+</sup>}} channel inhibition</b> in the myocardium<br></div>", "time": 1660105351695.0}, {"id": 1485042663916, "note": "<div><b>{{c3::TCAs}}</b> are a class of<b> antidepressants</b> that can cause <u>{{c1::QT interval}} prolongation</u>, which precipitates {{c2::<b>torsades de pointes</b>}}<br></div>", "time": 1660105351456.0}, {"id": 1485042672407, "note": "<div><b>Arrhythmia</b> secondary to <u>tricyclic antidepressants</u> is prevented with {{c1::NaHCO<sub>3</sub>}}<br></div>", "time": 1660105351813.0}, {"id": 1485042676367, "note": "<div><b>Tricyclic antidepressants</b> are associated with the \"<b>Tri-C</b>\" <b>side effects</b>: {{c1::Convulsions}}, {{c2::Coma}}, {{c3::Cardiotoxicity}}<br></div>", "time": 1660105351632.0}, {"id": 1485042680339, "note": "<div>Adverse effects of <b>tricyclic antidepressants</b> (TCAs) include <u>respiratory</u> {{c1::depression}} and hyperpyrexia<br></div>", "time": 1660105359104.0}, {"id": 1485047130408, "note": "<div>What <u>drug class</u> does <b>tranylcypromine</b> belong to?<br></div><div><div><br></div><div>{{c1::Monoamine oxidase inhibitors (MAOIs)}}</div></div>", "time": 1660105351570.0}, {"id": 1485048768062, "note": "<div>What <u>drug class</u> does <b>phenelzine</b> belong to?<br></div><div><div><br></div><div>{{c1::Monoamine oxidase inhibitors (MAOIs)}}</div></div>", "time": 1660105351572.0}, {"id": 1485048774787, "note": "<div>What <u>drug class</u> does <b>isocarboxazid</b> belong to?<br></div><div><div><br></div><div>{{c1::Monoamine oxidase inhibitors (MAOIs)}}</div></div>", "time": 1660105351574.0}, {"id": 1485048790993, "note": "<div>What <u>drug class</u> does <b>selegiline</b> belong to?<br></div><div><div><br></div><div>{{c1::<i>Selective</i> MAO-B inhibitor}}</div></div>", "time": 1660105351571.0}, {"id": 1485048795602, "note": "<div>Which <u>MAO inhibitors</u> are <i>selective</i> <b>MAO-B inhibitors</b>?<br></div><div><br></div><div>{{c1::Selegiline and rasagiline::2}}</div>", "time": 1660105351536.0}, {"id": 1485048800051, "note": "<div>Which <u>neurotransmitter(s)</u> are broken down by <b>monoamine oxidase A</b> (MAO-A)?<br></div><div><br></div><div>{{c1::Serotonin, norepinephrine, and dopamine}}</div>", "time": 1660105351534.0}, {"id": 1485048804453, "note": "<div>Which <u>neurotransmitter(s)</u> are metabolized by <b>monoamine oxidase B</b> (MAO-B)?<br></div><div><br></div><div>{{c1::Dopamine}}</div>", "time": 1660105351533.0}, {"id": 1485048808436, "note": "<div>Are <b>MAO inhibitors</b> <i>reversible</i> or <i>irreversible</i>?<br></div><div><br></div><div>{{c1::Irreversible}}</div>", "time": 1660105351816.0}, {"id": 1485048812402, "note": "<div>Do <u>MAO inhibitors</u> <i>typically</i> inhibit <b>MAO-A</b> or <b>MAO-B</b>?<br></div><div><br></div><div>{{c1::Both :) (non-selective)}}</div>", "time": 1660105351783.0}, {"id": 1485048818628, "note": "<div><b>MAO inhibitors</b> may be used to treat anxiety and <i>treatment-resistant</i> <u>{{c1::atypical}}</u> depression (not first line)<br></div>", "time": 1660105351730.0}, {"id": 1485048822971, "note": "<div><b>Selegiline</b> is a(n)&nbsp;<u>MAO-B inhibitor</u> used to treat <b>{{c1::Parkinson}} disease</b><br></div>", "time": 1660105351706.0}, {"id": 1485048831798, "note": "<div><b>{{c1::Tyramine}}</b> is a substance found in many <u>aged</u> foods (e.g. cheese, meats, alcohol)<br></div>", "time": 1660105351512.0}, {"id": 1485048836271, "note": "<div><b>Tyramine</b> is metabolized by the enzyme {{c1::MAO-A}} in the GI tract<br></div>", "time": 1660105351616.0}, {"id": 1485048840582, "note": "<div>In the presence of <u>MAO inhibitors</u>, <b>tyramine</b> enters the circulation and acts as a(n)&nbsp;<b>{{c1::sympathomimetic}}</b> <b>agent</b></div>", "time": 1660105351764.0}, {"id": 1485048847611, "note": "<div><b>Tyramine</b> <b>toxicity</b> in patients on <u>MAO inhibitors</u> can precipitate <b>{{c1::hypertensive}} crisis</b><br></div>", "time": 1660105351615.0}, {"id": 1485048854935, "note": "<div><b>{{c1::Phentolamine}}</b> is an <b>\u03b1<sub>1</sub></b> and <b>\u03b1<sub>2</sub> <i>antagonist</i></b> that can be used to manage the <u>hypertensive</u> symptoms of <b>tyramine toxicity</b><br></div>", "time": 1660105351514.0}, {"id": 1485048858768, "note": "<div><b>MAO inhibitors</b> may cause <u>CNS</u> {{c1::stimulation::stimulation or depression}}</div>", "time": 1660105359074.0}, {"id": 1485048861175, "note": "<div><b>MAO inhibitors</b> are <i>contraindicated</i> in patients taking {{c1::St. Johns wort}}, which is a <u>medicinal herb</u> with <b>antidepressant activity</b><br></div>", "time": 1660105359075.0}, {"id": 1485048869407, "note": "<div><b>MAO inhibitors</b> are <i>contraindicated</i> in patients taking the <u>anti-tussive</u> {{c1::dextromethorphan}}<br></div>", "time": 1660105359077.0}, {"id": 1485048874704, "note": "<div><b>MAO inhibitors</b> are <i>contraindicated</i> in patients taking the <u>opioid analgesic</u> {{c1::meperidine}}<br></div>", "time": 1660105359076.0}, {"id": 1485048880722, "note": "<div>Patients must wait {{c1::2 weeks}} <i>after</i> <u>stopping MAO inhibitors</u> before <b>starting serotonergic drugs</b> and/or <b>stopping dietary restrictions</b><br></div>", "time": 1660105359066.0}, {"id": 1485053499537, "note": "<div>What <u>drug class</u> does <b>bupropion</b> belong to?<br></div><div><div><br></div><div>{{c1::Atypical antidepressants}}</div></div>", "time": 1660105351576.0}, {"id": 1485053638174, "note": "<div><b>Bupropion</b> <u>inhibits</u> the reuptake of {{c1::norepinephrine}} and {{c1::dopamine}}<br></div>", "time": 1660105351808.0}, {"id": 1485053644033, "note": "<div>What <u>sleep disturbance</u> is associated with <b>bupropion</b> use?<br></div><div><br></div><div>{{c1::Insomnia}} </div>", "time": 1660105351553.0}, {"id": 1485053652441, "note": "<div><b>Bupropion </b>may be used for {{c1::smoking}} cessation<br></div>", "time": 1660105351807.0}, {"id": 1485053657195, "note": "<div><b>Bupropion</b> may cause <u>{{c1::seizures}}</u>, especially in <b>{{c2::anorexic}}</b> or <b>{{c2::bulimic}}</b> <b>patients</b><br></div>", "time": 1660105351806.0}, {"id": 1485053661725, "note": "<div>Which <u>atypical antidepressant</u> may cause <b>seizures</b> in anorexic/bulimic patients?<br></div><div><br></div><div>{{c1::Bupropion}}</div>", "time": 1660105351542.0}, {"id": 1485053679920, "note": "<div>What <u>drug class</u> does <b>mirtazapine</b> belong to?<br></div><div><div><br></div><div>{{c1::Atypical antidepressants}}</div></div>", "time": 1660105351573.0}, {"id": 1485053683098, "note": "<div><b>Mirtazapine</b> is a(n) {{c1::<u>\u03b1</u><sub>2</sub>}}<u>-adrenergic antagonist</u>, which <i>increases</i> pre-synaptic <b>release</b> of <b>{{c2::serotonin}}</b> and <b>{{c2::norepinephrine}}</b><br></div>", "time": 1660105351726.0}, {"id": 1485053688514, "note": "<div>Which <u>serotonin receptors</u> are <i>inhibited</i> by <b>mirtazapine</b>?<br></div><div><br></div><div>{{c1::5-HT<sub>2</sub> and 5-HT<sub>3</sub> receptors::2}}</div>", "time": 1660105351530.0}, {"id": 1485053698756, "note": "<div><b>Mirtazapine</b> is a(n) {{c1::H<sub>1</sub>}} histamine receptor <u>antagonist</u><br></div>", "time": 1660105351727.0}, {"id": 1485053703584, "note": "<div><b>Mirtazapine</b> can cause <u>sedation</u>, which may be <i>desirable</i> in <b>depressed patients with {{c1::insomnia}}</b><br></div>", "time": 1660105351729.0}, {"id": 1485053707855, "note": "<div>Which <u>atypical antidepressant</u> is useful for treating <b>depressed patients with</b> <b>insomnia</b>?&nbsp;<br></div><div><br></div><div>{{c1::Mirtazapine}}</div>", "time": 1660105351543.0}, {"id": 1485053712014, "note": "<div><b>Mirtazapine</b> causes <u>{{c1::increased}}</u> <b>appetite</b> and <b>weight</b> <b>{{c1::gain}}</b><br></div>", "time": 1660105351728.0}, {"id": 1485053716394, "note": "<div>Which <u>atypical antidepressant</u> is useful for treating <b>anorexic</b> or <b>elderly depressed patients</b>?<br></div><div><div><br></div><div>{{c1::Mirtazapine}}</div></div>", "time": 1660105351544.0}, {"id": 1485053720833, "note": "<div>Is <b>mirtazapine</b> use associated with <u>sexual dysfunction</u>?<br></div><div><br></div><div>{{c1::No}}</div>", "time": 1660105351747.0}, {"id": 1485053725170, "note": "<div><b>Mirtazapine</b> may cause {{c1::<u>dry</u>}} <b>mouth</b> as an adverse effect</div>", "time": 1660105359072.0}, {"id": 1485053727919, "note": "<div>What <u>drug class</u> does <b>trazodone</b> belong to?<br></div><div><div><br></div><div>{{c1::Atypical antidepressants}}</div></div>", "time": 1660105351569.0}, {"id": 1485053731302, "note": "<div><b>Trazodone</b> is a(n) {{c1::<u>\u03b1</u><sub>1</sub>}}<u>-adrenergic</u> <i>antagonist</i><br></div>", "time": 1660105351637.0}, {"id": 1485053736113, "note": "<div>Which <u>serotonin receptor</u> is <i>inhibited</i> by <b>trazodone</b>?<br></div><div><br></div><div>{{c1::5-HT<sub>2</sub>}}<br></div>", "time": 1660105351531.0}, {"id": 1485053741166, "note": "<div><b>Trazodone</b> is a(n) {{c1::H<sub>1</sub>}} histamine receptor <u>antagonist</u><br></div>", "time": 1660105351638.0}, {"id": 1485053745807, "note": "<div><b>Trazodone</b> <i>weakly</i> <u>inhibits</u> the pre-synaptic reuptake of {{c1::serotonin (5-HT)}}<br></div>", "time": 1660105351636.0}, {"id": 1485053753326, "note": "<div><b>{{c2::Trazodone}}</b> is an <u>atypical antidepressant</u> that can cause <b>{{c1::priapism}}</b> in men&nbsp;<br></div>", "time": 1660105351470.0}, {"id": 1485053760622, "note": "<div><b>Trazodone</b> can cause {{c1::<u>orthostatic hypotension</u>::BP}} as an adverse effect<br></div>", "time": 1660105351639.0}, {"id": 1485053767451, "note": "<div><b>{{c2::Trazodone}}</b> is an <u>atypical antidepressant</u> that is primarily used to treat <b>{{c1::insomnia}}</b><br></div>", "time": 1660105351468.0}, {"id": 1485053774666, "note": "<div>Is <b>trazodone</b> use associated with <u>sexual dysfunction</u>?<br></div><div><div><br></div><div>{{c1::Yes}}</div></div>", "time": 1660105351744.0}, {"id": 1485053779530, "note": "<div>What <u>drug class</u> does <b>vilazodone</b> belong to?<br></div><div><div><br></div><div>{{c1::Atypical antidepressants}}</div></div>", "time": 1660105359048.0}, {"id": 1485053782197, "note": "<div><b>Vilazodone</b> <u>inhibits</u> the pre-synaptic <i>reuptake</i> of {{c1::serotonin (5-HT)}}</div>", "time": 1660105359059.0}, {"id": 1485053784465, "note": "<div><b>Vilazodone</b> is a(n)&nbsp;<b>{{c1::5-HT<sub>1A</sub>}} receptor </b><i style=\"font-weight: bold;\">{{c2::partial agonist}}</i></div>", "time": 1660105359058.0}, {"id": 1485053794810, "note": "<div>What <u>drug class</u> does <b>vortioxetine</b> belong to?<br></div><div><div><br></div><div>{{c1::Atypical antidepressants}}</div></div>", "time": 1660105359047.0}, {"id": 1485053797165, "note": "<div><b>Vortioxetine</b> <u>inhibits</u> the pre-synaptic <i>reuptake</i> of {{c1::serotonin (5-HT)}}</div>", "time": 1660105359054.0}, {"id": 1485053799258, "note": "<div><b>Vortioxetine</b> is a(n)&nbsp;<b>{{c1::5-HT<sub>1A</sub>}} receptor </b><i style=\"font-weight: bold;\">{{c2::agonist}}</i></div>", "time": 1660105358980.0}, {"id": 1485053801271, "note": "<div><b>Vortioxetine</b> is a(n)&nbsp;<b>{{c1::5-HT<sub>3</sub>}} receptor </b><i style=\"font-weight: bold;\">{{c2::antagonist}}</i></div>", "time": 1660105358978.0}, {"id": 1485126703491, "note": "<div>What is the <u>general treatment</u> for <b>bipolar disorder</b>?<br></div><div><br></div><div>{{c1::Mood stabilizers}} <br></div>", "time": 1660105351559.0}, {"id": 1485126718528, "note": "<div><b>{{c1::Lithium}}</b> is an <i>ion</i> that is used as a <u>mood stabilizer</u> for <b>{{c2::bipolar}} disorder</b><br></div>", "time": 1660105351519.0}, {"id": 1485126742965, "note": "<div>The mechanism of action of <b>lithium</b> may be related to <u>inhibition</u> of the <b>{{c1::IP<sub>3</sub>}} signaling pathway</b></div>", "time": 1660105351683.0}, {"id": 1485126747494, "note": "<div><b>Lithium</b> has a <u>narrow</u> {{c1::therapeutic index}}<br></div>", "time": 1660105351735.0}, {"id": 1485126756268, "note": "<div><i>Acute</i> <b>lithium</b> <b>toxicity</b> presents with {{c1::<b>GI</b>}} <b>symptoms</b><br></div>", "time": 1660105351829.0}, {"id": 1485126765245, "note": "<div><i>Chronic</i> <b>lithium</b> <b>toxicity</b> causes <u>neurologic symptoms</u>, such as <b>{{c1::tremor}}</b> and <b>{{c2::ataxia}}</b><br></div>", "time": 1660105351794.0}, {"id": 1485126788211, "note": "<div><b>{{c2::Lithium}}</b> is a <u>mood stabilizer</u> that may cause <b>{{c1::hypo}}-thyroidism</b> as an adverse effect<br></div>", "time": 1660105351495.0}, {"id": 1485126797804, "note": "<div>What <u>type</u> of <b>diabetes</b> is associated with <b>lithium use</b>?<br></div><div><br></div><div>{{c1::Nephrogenic diabetes insipidus}} <br></div>", "time": 1660105351549.0}, {"id": 1485126807025, "note": "<div><i>Renal clearance</i> of <b>lithium</b> is <u>reduced</u> in patients taking <b>{{c1::thiazide}}</b> <b>diuretics</b> or other nephrotoxic agents (e.g. <b>NSAIDs</b>, <b>ACE inhibitors</b>)<br></div>", "time": 1660105351708.0}, {"id": 1485126830237, "note": "<div>What <u>teratogenic effect</u> is associated with <b>maternal lithium use</b>?<br></div><div><br></div><div>{{c1::Ebstein anomaly}}<br></div>", "time": 1660105351552.0}, {"id": 1485126835875, "note": "<div>Which <u>mood stabilizer</u> is associated with <b>ebstein anomaly</b> in newborns?<br></div><div><br></div><div>{{c1::Lithium}}<br></div>", "time": 1660105351535.0}, {"id": 1485126841513, "note": "<div><b>Lithium</b> is almost exclusively <u>excreted</u> by the {{c1::kidneys}}</div>", "time": 1660105359078.0}, {"id": 1485126851799, "note": "<div>What part of the <u>nephron</u> is <b>lithium</b> primarily <i>reabsorbed</i>?<br></div><div><br></div><div>{{c1::PCT (with Na<sup>+</sup>)}}</div>", "time": 1660105359039.0}, {"id": 1485126956476, "note": "<div><b>Valproic acid</b> is a(n) {{c1::broad}} spectrum <b>anti-epileptic</b><br></div>", "time": 1660105351831.0}, {"id": 1485126970109, "note": "<div>What <u>type(s)</u> of <b>seizures </b>(partial, tonic-clonic, or absence) may be treated with <b>valproic acid</b>?<br></div><div><br></div><div>{{c1::All three (partial, tonic-clonic, absence)}}</div>", "time": 1660105359030.0}, {"id": 1485126983586, "note": "<div><b>Valproic acid</b> exerts its effects by <u>increasing</u> <b>{{c1::Na<sup>+</sup>}} channel {{c2::<i>inactivation</i>}}</b> and <u>inhibiting</u> <i style=\"font-weight: bold;\">{{c3::GABA transaminase}}</i><br></div>", "time": 1660105351612.0}, {"id": 1485126989139, "note": "<div><b>Valproic acid</b> {{c1::<u>increases</u>}} levels of <b>GABA</b> in the CNS via <u>inhibition</u> of <i>GABA transaminase</i><br></div>", "time": 1660105351608.0}, {"id": 1485126995875, "note": "<div><b>{{c2::Valproic acid}}</b> is an <u>anti-epileptic</u> that may cause <b>GI distress</b> and <b>{{c1::pancreatitis}}</b> as adverse effects<br></div>", "time": 1660105351466.0}, {"id": 1485127007445, "note": "<div><b>Valproic acid</b> causes {{c1::<u>increased</u>}} <b>appetite</b> and <b>weight</b> <b>{{c1::gain}}</b><br></div>", "time": 1660105351613.0}, {"id": 1485127013968, "note": "<div><b>Valproic acid</b> can cause <u>neurologic side effects</u>, such as {{c1::tremor}}<br></div>", "time": 1660105351614.0}, {"id": 1485127038618, "note": "<div><b>{{c2::Valproic acid}}</b> is an <u>anti-epileptic</u> that rarely causes a <i>fatal</i> <b>{{c1::hepatotoxicity}}</b><br></div>", "time": 1660105351464.0}, {"id": 1485127050894, "note": "<div>What <u>teratogenic effect</u> is associated with <b>valproic acid</b>?<br></div><div><br></div><div>{{c1::Neural tube defects (e.g. spina bifida)}}</div>", "time": 1660105351550.0}, {"id": 1485127079406, "note": "<div><b>{{c2::Valproic acid}}</b> and <b>{{c3::topiramate}}</b> are <u>anti-epileptics</u> that are useful for <b>{{c1::migraine}} prophylaxis</b><br></div>", "time": 1660105359009.0}, {"id": 1485127104969, "note": "<div><b>Topiramate</b> exerts its effects by <u>increasing</u> <b>{{c1::Na<sup>+</sup>}} channel {{c2::<i>inactivation</i>}}</b><br></div>", "time": 1660105351645.0}, {"id": 1485127109814, "note": "<div><b>Topiramate</b> <u>increases</u> <b>GABA action</b> via allosterically binding to the <b>{{c1::GABA<sub>A</sub>}} receptor</b><br></div>", "time": 1660105351642.0}, {"id": 1485127122076, "note": "<div><b>Topiramate</b> <u>increases</u> GABA action and thus may cause {{c1::sedation}} and fatigue as adverse effects<br></div>", "time": 1660105351643.0}, {"id": 1485127127238, "note": "<div><b>Topiramate</b> may cause <u>confusion</u> and <u>cognitive </u>{{c1::<u>slowing</u>}} as adverse effects<br></div>", "time": 1660105351640.0}, {"id": 1485127132019, "note": "<div><b>{{c2::Topiramate}}</b> is an <u>anti-epileptic</u> associated with <b>weight {{c1::loss}}</b><br></div>", "time": 1660105351474.0}, {"id": 1485127136888, "note": "<div>What <u>renal complication</u> may be caused by <b>topiramate</b>?<br></div><div><br></div><div>{{c1::Kidney stones}}</div>", "time": 1660105351554.0}, {"id": 1485127158928, "note": "<div><b>Lamotrigine</b> exerts its effects by <u>increasing</u> <b>{{c1::Na<sup>+</sup>}} channel {{c2::<i>inactivation</i>}}</b><br></div>", "time": 1660105351740.0}, {"id": 1485127168406, "note": "<div>What is the <u>most serious</u> adverse effect associated with <b>lamotrigine </b>use?<br></div><div><br></div><div>{{c1::Stevens-Johnson syndrome}} </div>", "time": 1660105351555.0}, {"id": 1485127177693, "note": "<div><b>Levetiracetam</b> is a(n) {{c1::broad}} spectrum <b>anti-epileptic</b><br></div>", "time": 1660105351737.0}, {"id": 1485127183182, "note": "<div>What <u>type(s)</u> of <b>seizures </b>(partial, tonic-clonic, or absence) may be treated with <b>levetiracetam</b>?<br></div><div><div><br></div><div>{{c1::Partial and tonic-clonic}}</div></div>", "time": 1660105359033.0}, {"id": 1485127191097, "note": "<div>Adverse effects associated with <b>levetiracetam</b> use include {{c1::<b>somnolence</b>}} and <b>neuropsychiatric</b> <b>symptoms</b> (e.g. behavioral change)<br></div>", "time": 1660105351828.0}, {"id": 1485127201063, "note": "<div><b>Carbamazepine</b> is a(n) {{c1::narrow}} spectrum <b>anti-epileptic</b><br></div>", "time": 1660105351803.0}, {"id": 1485127213919, "note": "<div>What is the <u>first line</u> treatment for <b>partial (focal) seizures</b>?<br></div><div><br></div><div>{{c1::Carbamazepine}}</div>", "time": 1660105359044.0}, {"id": 1485127225427, "note": "<div><b>Carbamazepine</b> exerts its effects by <u>blocking</u> <b>{{c1::Na<sup>+</sup>}} channels</b><br></div>", "time": 1660105351804.0}, {"id": 1485127234705, "note": "<div>What is the <u>first line</u> treatment for <b>trigeminal neuralgia</b>?<br></div><div><br></div><div>{{c1::Carbamazepine}}</div>", "time": 1660105351563.0}, {"id": 1485127252070, "note": "<div>Non-specific <u>adverse effects</u> associated with <b>carbamazepine</b> include <b>{{c1::diplopia}}</b> and <b>{{c2::ataxia}}</b><br></div>", "time": 1660105351722.0}, {"id": 1485127261259, "note": "<div>What <u>endocrine pathology</u> may be caused by&nbsp;<b>carbamazepine</b> use?<br></div><div><br></div><div>{{c1::SIADH}}</div>", "time": 1660105351567.0}, {"id": 1485127267582, "note": "<div><b>{{c3::Carbamazepine}}</b> is an <u>anti-epileptic</u> associated with <i>blood dyscrasias</i>, such as <b>{{c1::aplastic anemia}}</b> and <b>{{c2::agranulocytosis}}</b><br></div>", "time": 1660105351462.0}, {"id": 1485127272816, "note": "<div><b>Carbamazepine</b> is a(n) {{c2::<u>inducer</u>}} of {{c1::<b>cytochrome P450</b>}} and thus may have many drug interactions<br></div>", "time": 1660105351802.0}, {"id": 1485127291177, "note": "<div>Is <b>carbamazepine</b> use associated with <u>teratogenic</u> effects?<br></div><div><br></div><div>{{c1::Yes}} </div>", "time": 1660105351753.0}, {"id": 1485127300673, "note": "<div>What <u>dermatologic</u> complication is associated with <b>carbamazepine</b> use?<br></div><div><br></div><div>{{c1::Stevens-Johnson syndrome}}</div>", "time": 1660105351594.0}, {"id": 1485127316123, "note": "<div><b>Carbamazepine</b> is associated with <u>{{c1::liver}} toxicity</u> as an adverse effect<br></div><div><br></div><div><i><br></i></div>", "time": 1660105351800.0}, {"id": 1485127319429, "note": "<div><b>Phenytoin</b> is a(n) {{c1::narrow}} spectrum <b>anti-epileptic</b><br></div>", "time": 1660105351714.0}, {"id": 1485127348698, "note": "<div><b>Phenytoin</b> exerts its effects by <u>blocking</u> <b>{{c1::Na<sup>+</sup>}} channels</b><br></div>", "time": 1660105351715.0}, {"id": 1485127367254, "note": "<div>Adverse effects associated with <b>phenytoin</b> include <b>diplopia</b> and {{c1::<b>nystagmus</b>}} (eye complications)<br></div>", "time": 1660105351827.0}, {"id": 1485127371710, "note": "<div><b>Phenytoin</b> may cause <u>neurologic</u> side effects, such as <b>peripheral neuropathy</b> and <b>{{c1::ataxia}}</b><br></div>", "time": 1660105351711.0}, {"id": 1485127376385, "note": "<div>What <u>hematologic</u> complication is associated with <b>phenytoin</b>?<br></div><div><br></div><div>{{c1::Megaloblastic anemia}}</div>", "time": 1660105351566.0}, {"id": 1485127384075, "note": "<div><b>{{c2::Phenytoin}}</b> is an <u>anti-epileptic</u> associated with <b>{{c1::gingival}} hyperplasia</b><br></div>", "time": 1660105351493.0}, {"id": 1485127389322, "note": "<div><b>{{c2::Phenytoin}}</b> is an <u>anti-epileptic</u> associated with {{c1::<b>hirsutism</b>}} in women<br></div>", "time": 1660105351491.0}, {"id": 1485127393577, "note": "<div>What <u>dermatologic</u> complication is associated with <b>phenytoin</b> use?<br></div><div><div><br></div><div>{{c1::Stevens-Johnson syndrome}}</div></div>", "time": 1660105351593.0}, {"id": 1485127398074, "note": "<div>What <u>teratogenic effect</u> is associated with maternal <b>phenytoin</b> use?<br></div><div><br></div><div>{{c1::Fetal hydantoin syndrome}} </div>", "time": 1660105351551.0}, {"id": 1485127406267, "note": "<div><b>Phenytoin</b> is a(n) {{c2::<u>inducer</u>}} of {{c1::<b>cytochrome P450</b>}} and thus may have many drug interactions<br></div>", "time": 1660105351713.0}, {"id": 1485127427576, "note": "<div><b>{{c2::Phenytoin}}</b> is an <u>anti-epileptic</u> associated with <b>{{c1::osteopenia</b>::bone complication<b>}}</b></div>", "time": 1660105351489.0}, {"id": 1485127433105, "note": "<div>Which <u>anti-epileptic</u> is <i>most</i> associated with <b>drug-induced lupus</b>?<br></div><div><br></div><div>{{c1::Phenytoin}}</div>", "time": 1660105351547.0}, {"id": 1485127504259, "note": "<div><b>{{c2::Phenytoin}}</b> is <u>first line</u> for <i>prophylaxis</i> of <b>{{c1::status epilepticus}}</b><br></div>", "time": 1660105351487.0}, {"id": 1485127512595, "note": "<div><b>Stevens-Johnson syndrome</b> in patients taking <u>carbamazepine</u> or <u>phenytoin</u> is associated with <b>HLA-{{c1::B1502}}</b>, which is typically seen in those of Asian ancestry</div>", "time": 1660105351698.0}, {"id": 1485127520616, "note": "<div><b>Gabapentin</b> is a(n) {{c1::narrow}} spectrum <b>anti-epileptic</b><br></div>", "time": 1660105351772.0}, {"id": 1485127537767, "note": "<div><b>{{c2::Gabapentin}}</b> is an <i>anti-epileptic</i> that exerts its effects by <u>blocking</u> voltage-gated <b>{{c1::Ca<sup>2+</sup>}} channels</b><br></div>", "time": 1660105351501.0}, {"id": 1485127541726, "note": "<div>What <u>type(s)</u> of <b>seizures </b>(partial, tonic-clonic, or absence) may be treated with <b>gabapentin</b>?<br></div><div><div><br></div><div>{{c1::Partial}}</div></div>", "time": 1660105359035.0}, {"id": 1485127545269, "note": "<div>Which <u>anti-epileptic</u> may be used to treat <b>peripheral</b> <b>neuropathy</b> and <b>fibromyalgia</b> (chronic pain)?<br></div><div><br></div><div>{{c1::Gabapentin}}</div>", "time": 1660105351546.0}, {"id": 1485127554282, "note": "<div><b>{{c2::Gabapentin}}</b> is an <u>anti-epileptic</u> that may be used to treat <b>post-{{c1::herpetic}} neuralgia</b><br></div>", "time": 1660105351499.0}, {"id": 1485127559293, "note": "<div><u>Adverse effects</u> of <b>gabapentin</b> include <b>{{c1::sedation}}</b> and <b>{{c2::ataxia}}</b><br></div>", "time": 1660105351826.0}, {"id": 1485127567796, "note": "<div><b>Vigabatrin</b> is an <i>anti-epileptic</i> that exerts its effects via <u>inhibition</u> of the enzyme <b><i>{{c1::GABA transaminase}}</i></b><br></div>", "time": 1660105351606.0}, {"id": 1485127624016, "note": "<div><b>{{c2::Ethosuximide}}</b> is the <u>first line</u> treatment for <b>{{c1::absence seizures}}</b><br></div>", "time": 1660105351503.0}, {"id": 1485127628996, "note": "<div><b>Ethosuximide</b> exerts its effects by <u>blocking</u> <b>{{c1::T-type Ca<sup>2+</sup>::specific}} channels</b> in the <b>{{c2::thalamus}}</b><br></div>", "time": 1660105351775.0}, {"id": 1485127633487, "note": "<div>The <u>side effects</u> of <b>ethosuximide</b> may be remembered with the letters of the alphabet \"<b>EFGHIJ</b>\":<br></div><div style=\"centerbox\"><div class=\"mnemonics\"><div><br></div><div><b>E</b>: Ethosuximide </div><div><b>F</b>: {{c1::Fatigue}}</div><div><b>G</b>: {{c2::GI distress}}</div><div><b>H</b>: {{c3::Headache}}</div><div><b>I</b>: {{c4::Itching/urticaria}} </div><div><b>J</b>: {{c5::Stevens-Johnson syndrome}} </div></div></div>", "time": 1660105351682.0}, {"id": 1485127643105, "note": "<div>In addition to <u>ethosuximide</u>, <b>absence</b> <b>seizures</b> may also be treated with <b>{{c1::valproic acid}}</b> and <b>{{c2::lamotrigine}}</b><br></div>", "time": 1660105351770.0}, {"id": 1485195927119, "note": "<div>What <u>drug class</u> do <b>haloperidol</b> and <b>pimozide</b> belong to?</div><div><br></div><div>{{c1::Typical antipsychotics (1st generation)}}</div>", "time": 1660105351585.0}, {"id": 1485197156148, "note": "<div><div>What <u>drug class</u> do <b>trifluoperazine</b>, <b>fluphenazine</b>, <b>thioridazine</b>, and <b>chlorpromazine</b> belong to?</div><div><br></div><div>{{c1::Typical antipsychotics (1st generation)}}</div></div>", "time": 1660105351579.0}, {"id": 1485197167577, "note": "<div><b>Typical antipsychotics</b> exert their effects by <u>blocking</u> the {{c1::D<sub>2</sub> dopamine}} receptor<br></div>", "time": 1660105351620.0}, {"id": 1485197173976, "note": "<div><b>Typical antipsychotics</b> result in <u>increased</u> <b>{{c1::cAMP::second messenger}}</b>&nbsp;</div>", "time": 1660105359060.0}, {"id": 1485197183364, "note": "<div>The <u>{{c1::high}} potency</u> <i>typical antipsychotics</i> are <b>{{c2::trifluoperazine}}</b>, <b>{{c3::fluphenazine}}</b>, and <b>{{c4::haloperidol}}</b><br></div>", "time": 1660105351662.0}, {"id": 1485197196524, "note": "<div>The <u>{{c1::low}} potency</u> typical antipsychotics are <b>{{c2::chlorpromazine}}</b> and <b>{{c3::thioridazine}}</b><br></div>", "time": 1660105351658.0}, {"id": 1485197204480, "note": "<div>Are <u>typical antipsychotics</u> effective at treating the <i><b>positive</b> </i>or <i style=\"font-weight: bold;\">negative</i> symptoms of <b>schizophrenia</b>?<br></div><div><br></div><div>{{c1::Positive}}</div>", "time": 1660105351814.0}, {"id": 1485197240608, "note": "<div>In addition to schizophrenia, <b>typical antipsychotics</b> are used to treat {{c1::psychosis}} in many conditions (e.g. bipolar disorder, delirium)<br></div>", "time": 1660105351766.0}, {"id": 1485197255331, "note": "<div><b>Typical</b> <i>and</i> <b>atypical antipsychotics</b> may be used to treat intractable or distressing <u>tics</u> associated with <b>{{c1::Tourettes}} syndrome</b><br></div>", "time": 1660105351627.0}, {"id": 1485197266380, "note": "<div><b>Typical antipsychotics </b>are associated with <u>anti-cholinergic effects</u>, such as <b>{{c1::dry mouth}}</b> and <b>{{c2::constipation}}</b><br></div>", "time": 1660105351626.0}, {"id": 1485197270482, "note": "<div>Are <u>anti-cholinergic effects</u> more common with <i style=\"font-weight: bold;\">high</i> or <i style=\"font-weight: bold;\">low</i> <b>potency typical antipsychotics</b>?<br></div><div><br></div><div>{{c1::Low potency}}</div>", "time": 1660105351822.0}, {"id": 1485197279658, "note": "<div><b>Typical antipsychotics </b>are associated with <u>anti-histamine effects</u>, such as <b>{{c1::sedation}}</b><br></div>", "time": 1660105351624.0}, {"id": 1485197284770, "note": "<div>Are <u>anti-histamine effects</u> more common with <i style=\"font-weight: bold;\">high</i> or <i style=\"font-weight: bold;\">low</i> <b>potency typical antipsychotics</b>?<br></div><div><div><br></div><div>{{c1::Low potency}}</div></div>", "time": 1660105351821.0}, {"id": 1485197289010, "note": "<div><b>Typical antipsychotics </b>are associated with {{c1::\u03b1<sub>1</sub><u>}}-adrenergic blockade</u>, which may cause <b>{{c2::orthostatic hypotension}}</b><br></div>", "time": 1660105351622.0}, {"id": 1485197293102, "note": "<div>Are <u>anti-\u03b1</u><sub>1</sub><u> effects</u> more common with <i style=\"font-weight: bold;\">high</i> or <i style=\"font-weight: bold;\">low</i> <b>potency typical antipsychotics</b>?<br></div><div><div><br></div><div>{{c1::Low potency}}</div></div>", "time": 1660105351820.0}, {"id": 1485197319661, "note": "<div><b>Typical antipsychotics</b> are associated with {{c1::<u>extrapyramidal symptoms</u>}}, such as acute dystonia, akathisia, and Parkinsonism<br></div>", "time": 1660105351623.0}, {"id": 1485197324724, "note": "<div><div>Are <u>extrapyramidal symptoms</u> more common with <i style=\"font-weight: bold; \">high</i> or <i style=\"font-weight: bold; \">low</i> <b>potency typical antipsychotics</b>? </div><div><br></div><div>{{c1::High potency}}</div></div>", "time": 1660105351817.0}, {"id": 1485197328694, "note": "<div>Which <u>extrapyramidal symptoms</u> (e.g. due to antipsychotic use) occur within <b>minutes to days</b>?<br></div><div><div><br></div><div>{{c1::Acute dystonia}}</div></div>", "time": 1660105351540.0}, {"id": 1485197342483, "note": "<div>Which <u>extrapyramidal symptoms</u> (e.g. due to antipsychotic use) occur within <b>days to months</b>?<br></div><div><br></div><div>{{c1::Akathisia (restlessness) and parkinsonism}}</div>", "time": 1660105351541.0}, {"id": 1485197356773, "note": "<div>Which <u>extrapyramidal symptoms</u> (e.g. due to antipsychotic use) occur within <b>months to years</b>?<br></div><div><div><br></div><div>{{c1::Tardive dyskinesia}}</div></div>", "time": 1660105351539.0}, {"id": 1485197367877, "note": "<div>The <b>extrapyramidal symptoms</b> of <u>antipsychotics</u> may be managed with an <b>M<sub>1</sub> antagonist</b> such as {{c1::<b>benztropine</b>}}<br></div>", "time": 1660105351689.0}, {"id": 1485197376704, "note": "<div><b>Typical antipsychotics</b> may cause symptoms of <b>{{c1::prolactin}} excess</b> (e.g. galactorrhea, amenorrhea, gynecomastia)<br></div>", "time": 1660105351617.0}, {"id": 1485197383550, "note": "<div>What is the <u>most serious</u> adverse effect associated with <b>antipsychotics</b>?<br></div><div><br></div><div>{{c1::Neuroleptic malignant syndrome (NMS)}}</div>", "time": 1660105351556.0}, {"id": 1485197389304, "note": "<div>The symptoms of <b>{{c7::neuroleptic malignant}} syndrome</b> may be remembered with the mnemonic \"<b>M</b>alignant <b>FEVER</b>\":<br></div><div style=\"centerbox\"><div class=\"mnemonics\"><div><br></div><div><b>M</b>: {{c1::Myoglobinuria}}</div><div><b>F</b>: {{c2::Fever}}</div><div><b>E</b>: {{c3::Encephalopathy (altered mental status)}}</div><div><b>V</b>: {{c4::unstable Vitals (autonomic instability)}}</div><div><b>E</b>: {{c5::increased Enzymes (e.g. CK)}} </div><div><b>R</b>: {{c6::muscle Rigidity}}</div></div></div>", "time": 1660105351673.0}, {"id": 1485197406891, "note": "<div><b>Neuroleptic malignant syndrome</b> is often characterized by a generalized \"{{c1::<b>lead</b>-<b>pipe</b>}}\" <b>rigidity</b><br></div>", "time": 1660105351723.0}, {"id": 1485197412342, "note": "<div><b>Neuroleptic malignant syndrome</b> may be treated with <b>{{c1::dantrolene*}}</b> or a(n)&nbsp;<b>{{c2::D<sub>2</sub>}} agonist</b></div>", "time": 1660105359071.0}, {"id": 1485197420808, "note": "<div>What <u>adverse cardiac effect</u> is associated with <i>both</i> <b>typical </b>and <b>atypical antipsychotics</b>?<br></div><div><br></div><div>{{c1::QT interval prolongation}}</div>", "time": 1660105351604.0}, {"id": 1485197432205, "note": "<div>The <u>typical antipsychotic</u> <b>{{c2::chlorpromazine}}</b> is associated with <b>{{c1::corneal}} deposits</b><br></div>", "time": 1660105351666.0}, {"id": 1485197436210, "note": "<div>The <u>typical antipsychotic</u> <b>{{c2::thioridazine}}</b> is associated with <b>{{c1::retinal}} deposits</b>&nbsp;&nbsp;<br></div>", "time": 1660105351664.0}, {"id": 1485216299549, "note": "<div><div>What <u>drug class</u> do <b>asenapine</b>, <b>clozapine</b>, <b>olanzapine</b>, and <b>quetiapine</b> belong to?</div><div><br></div><div>{{c1::Atypical antipsychotics (2nd generation)}}</div></div><div></div>", "time": 1660105351589.0}, {"id": 1485218502063, "note": "<div><div><div>What <u>drug class</u> do <b>iloperidone</b>, <b>paliperidone</b>, and&nbsp;<b>risperidone</b> belong to?</div><div><br></div><div>{{c1::Atypical antipsychotics (2nd generation)}}</div></div></div>", "time": 1660105351583.0}, {"id": 1485219964898, "note": "<div><div><div>What <u>drug class</u> do <b>lurasidone</b> and <b>ziprasidone</b> belong to?</div><div><br></div><div>{{c1::Atypical antipsychotics (2nd generation)}}</div></div></div>", "time": 1660105351581.0}, {"id": 1485219972311, "note": "<div><div><div>What <u>drug class</u> does <b>aripiprazole</b> belong to?</div><div><br></div><div>{{c1::Atypical antipsychotics (2nd generation)}}</div></div></div>", "time": 1660105351577.0}, {"id": 1485219977212, "note": "<div><i>Most</i> <b>atypical</b> <b>antipsychotics</b> exert their effects by <u>blocking</u> the {{c1::D<sub>2</sub>}} dopamine receptor<br></div>", "time": 1660105351724.0}, {"id": 1485219981783, "note": "<div>Which <u>atypical antipsychotic</u> is a <b>D</b><sub style=\"font-weight: bold;\">2</sub><b> </b><i style=\"font-weight: bold;\">partial agonist</i>?<br></div><div><br></div><div>{{c1::Aripiprazole}}</div>", "time": 1660105359027.0}, {"id": 1485219985329, "note": "<div>Which <u>serotonin receptor</u> is <i>antagonized</i> by many <b>atypical antipsychotics</b>?<br></div><div><br></div><div>{{c1::5-HT<sub>2A</sub>}}</div>", "time": 1660105351532.0}, {"id": 1485219990010, "note": "<div>Are <u>atypical antipsychotics</u> effective at treating the <i><b>positive</b> </i>or <i style=\"font-weight: bold;\">negative</i> symptoms of <b>schizophrenia</b>?<br></div><div><div><br></div><div>{{c1::Both :)}}</div></div>", "time": 1660105351818.0}, {"id": 1485220015721, "note": "What is the&nbsp;<i>treatment of choice</i>&nbsp;for&nbsp;<u>treatment-resistant</u>&nbsp;<b>schizophrenia</b>&nbsp;and&nbsp;<b>schizoaffective disorder</b>?<div><br></div><div>{{c1::Clozapine}}</div>", "time": 1660105359025.0}, {"id": 1485220018582, "note": "<div>Which <u>atypical antipsychotic</u> is used for <b>suicidality in schizophrenia</b>?<br></div><div><div><br></div><div>{{c1::Clozapine}}</div></div>", "time": 1660105359026.0}, {"id": 1485220020967, "note": "<div>Compared to typical antipsychotics, <b>atypical antipsychotics</b> cause <u>{{c1::less</u>::more/less<u>}}</u> <b>anti-cholinergic side effects</b><br></div>", "time": 1660105351786.0}, {"id": 1485220028997, "note": "<div>Compared to typical antipsychotics, <b>atypical antipsychotics</b> cause <u>{{c1::less</u>::more/less<u>}}</u> <b>anti-histamine side effects</b></div>", "time": 1660105351785.0}, {"id": 1485220035986, "note": "<div>Compared to typical antipsychotics, <b>atypical antipsychotics</b> cause <u>{{c1::less</u>::more/less<u>}}</u> <b>anti-\u03b1<sub>1</sub> side effects</b></div>", "time": 1660105351784.0}, {"id": 1485220042805, "note": "<div>Compared to typical antipsychotics, <b>atypical antipsychotics</b> are <u>{{c1::more</u>::more/less<u>}}</u> likely to cause <b>metabolic syndrome</b></div>", "time": 1660105351787.0}, {"id": 1485220045231, "note": "<div><b>Atypical antipsychotics</b> may cause <u>metabolic syndrome</u>, which is characterized by <b>{{c1::weight gain}}</b>, <b>{{c2::dyslipidemia}}</b>, and <b>{{c3::hyperglycemia}}</b><br></div>", "time": 1660105351812.0}, {"id": 1485220060480, "note": "<div>Which <u>atypical antipsychotics</u> are <i>most</i> associated with <b>metabolic syndrome</b>?<br></div><div><br></div><div>{{c1::\"-pines\" (esp. clozapine and olanzapine)}}</div>", "time": 1660105359024.0}, {"id": 1485220063037, "note": "<div><b>{{c2::Clozapine}}</b> is an <u>atypical antipsychotic</u> that may cause&nbsp;<b>{{c1::agranulocytosis</b>::<b>hematologic complication}}</b></div>", "time": 1660105351509.0}, {"id": 1485220069870, "note": "<div><b>Clozapine</b> is an <u>atypical antipsychotic</u> that may cause <b>{{c1::myocarditis}}</b> and <b>cardiomyopathy</b> (cardiac complications)<br></div>", "time": 1660105351791.0}, {"id": 1485220074250, "note": "<div><b>{{c2::Clozapine}}</b> is an <u>atypical antipsychotic</u> associated with a <i>dose dependent</i> risk for <b>{{c1::seizures::neurologic complication}}</b>&nbsp;</div>", "time": 1660105351511.0}, {"id": 1485220077925, "note": "<div><b>{{c2::Risperidone}}</b> is an <u>atypical antipsychotic</u> that often causes <b>{{c1::hyperprolactinemia::endocrine complication}}</b><br></div>", "time": 1660105351480.0}, {"id": 1485220084231, "note": "<div>Compared to typical antipsychotics, <b>atypical antipsychotics</b> are <u>{{c1::less</u>::more/less<u>}}</u> likely to cause <b>extrapyramidal symptoms </b>(EPS)</div>", "time": 1660105351789.0}, {"id": 1485220091213, "note": "<div>Compared to typical antipsychotics, <b>atypical antipsychotics</b> are <u>{{c1::less</u>::more/less<u>}}</u> likely to cause <b>neuroleptic malignant syndrome</b></div>", "time": 1660105351788.0}, {"id": 1485225174374, "note": "<div>{{c1::<b>Levodopa</b> (L-DOPA)}} is a <u>precursor of dopamine</u> that <i>does</i> cross the <b>blood-brain-barrier</b></div>", "time": 1660105351520.0}, {"id": 1485226866177, "note": "<div>Once in the CNS, <b>L-DOPA</b> may be converted to <b>{{c2::dopamine}}</b> via the enzyme <i style=\"font-weight: bold;\">{{c1::DOPA decarboxylase}}</i><br></div>", "time": 1660105351720.0}, {"id": 1485226875275, "note": "<div><u>Peripheral conversion</u> of <b>levodopa</b> may cause <b>{{c1::GI}} distress</b><br></div>", "time": 1660105351717.0}, {"id": 1485226887033, "note": "<div><u>Peripheral conversion</u> of <b>levodopa</b> may cause {{c1::<b>orthostatic</b> <b>hypotension</b>::BP}}&nbsp;<br></div>", "time": 1660105351716.0}, {"id": 1485226891209, "note": "<div><b><i>Chronic</i> levodopa</b> use can cause a \"{{c1::<b>wearing-off</b>}} <b>reaction</b>\", with akinesia re-emerging at <i>end</i> of each dose<br></div>", "time": 1660105351796.0}, {"id": 1485226895684, "note": "<div><b><i>Chronic</i> levodopa</b> use can cause an \"<b>{{c1::on-off}} phenomenon</b>\", with periods of akinesia <i>alternating</i> with periods of improved mobility<br></div>", "time": 1660105351795.0}, {"id": 1485226901711, "note": "<div><b><i>Chronic</i> levodopa</b> therapy can cause {{c1::dyskinesias}}, such as <u>choreoathetosis</u> of the <b>face</b> and <b>distal</b> <b>extremities</b><br></div>", "time": 1660105351797.0}, {"id": 1485226910732, "note": "<div><b>{{c1::Carbidopa}}</b> is a <u>peripheral</u> <b><i>{{c2::DOPA decarboxylase}}</i> inhibitor</b> used to <i>increase </i>the bioavailability of <b>levodopa</b><br></div>", "time": 1660105351523.0}, {"id": 1485226918038, "note": "<div><b>Carbidopa</b> <i>{{c1::decreases}}</i> the <u>peripheral side effects</u> of <b>levodopa</b><br></div>", "time": 1660105351799.0}, {"id": 1485226922398, "note": "<div><b>Carbidopa</b> <i>{{c1::exacerbates}}</i> the <u>neuropsychiatric side effects</u> of <b>levodopa</b><br></div>", "time": 1660105351798.0}, {"id": 1485226927627, "note": "<div><b>Dopamine</b> in the <b>CNS</b> may be <u>degraded</u> to {{c2::<b>3-methoxytyramine</b> (3-MT)}} via the enzyme {{c1::<i><b>catechol-O-methyltransferase</b> </i>(COMT)}}<br></div>", "time": 1660105351780.0}, {"id": 1485226943316, "note": "<div><b>{{c2::Tolcapone}}</b> is a peripheral <i>and</i> central <b><i>{{c1::COMT}}</i></b> <b>inhibitor</b> used to <u>increase</u> the bioavailability of <b>levodopa</b><br></div>", "time": 1660105351476.0}, {"id": 1485226947581, "note": "<div><b>{{c2::Entacapone}}</b> is a peripheral<b><i> {{c1::COMT}}</i></b> <b>inhibitor</b> used to <u>increase</u> the bioavailability of <b>levodopa</b><br></div>", "time": 1660105351505.0}, {"id": 1485226951657, "note": "<div><b>Tolcapone</b> {{c1::<u>increases</u>}} <b>dopamine</b> levels in the <b>CNS</b><br></div>", "time": 1660105351646.0}, {"id": 1485226959311, "note": "<div><b>Tolcapone</b> can cause <b>{{c1::hepatic}}</b> <b>failure</b> as an adverse effect<br></div>", "time": 1660105351647.0}, {"id": 1485226964020, "note": "<div><b>Dopamine</b> in the CNS may be <u>degraded</u> to <b>{{c2::DOPAC}}</b> via the enzyme <i style=\"font-weight: bold;\">{{c1::MAO-B}}</i><br></div>", "time": 1660105351778.0}, {"id": 1485226969948, "note": "<div><b>Selegiline</b> and <b>rasagiline</b> may <i>{{c1::exacerbate}}</i> the <u>adverse effects</u> of <b>levodopa</b></div>", "time": 1660105351707.0}, {"id": 1485226973026, "note": "<div><b>{{c1::Bromocriptine}}</b> is an <u>ergot</u> <b>dopamine</b> <b><i>agonist</i></b> that is rarely used to treat <b>Parkinson disease</b></div>", "time": 1660105351524.0}, {"id": 1485226975107, "note": "<div><b>{{c2::Ropinirole}}</b> is a <u>non-ergot</u> <b>{{c1::D<sub>2</sub>}} receptor <i>agonist</i></b> that is used in initial treatment of <b>Parkinson disease</b><br></div>", "time": 1660105351478.0}, {"id": 1485226983749, "note": "<div><b>{{c2::Pramipexole}}</b> is a <u>non-ergot</u> <b>{{c1::D<sub>3</sub>}} receptor <i>agonist</i></b> that is used in initial treatment of <b>Parkinson disease</b><br></div>", "time": 1660105351485.0}, {"id": 1485226992623, "note": "<div>What is the <u>first line</u> treatment for <b>restless leg syndrome</b>?<br></div><div><br></div><div>{{c1::Dopamine receptor agonists (ropinirole, pramipexole)}}</div>", "time": 1660105351564.0}, {"id": 1485227000677, "note": "<div>Which <u>anti-influenza agent</u> is useful in the management of<b> Parkinson disease</b>?<br></div><div><br></div><div>{{c1::Amantadine}}</div>", "time": 1660105351545.0}, {"id": 1485227004646, "note": "<div><b>Amantadine</b> <i>increases</i> <b>dopamine</b> synthesis and {{c1::release}}<br></div>", "time": 1660105351824.0}, {"id": 1485227008690, "note": "<div><b>Amantadine</b> <i>inhibits</i> <b>dopamine</b> {{c1::reuptake}}<br></div>", "time": 1660105351823.0}, {"id": 1485227020903, "note": "<div><b>{{c1::Benztropine}}</b> and <b>{{c2::trihexyphenidyl}}</b> are <u>antimuscarinic agents</u> used to treat <b>Parkinsonism</b><b>,&nbsp;</b>especially&nbsp;<u>tremor and rigidity</u><br></div>", "time": 1660105351526.0}, {"id": 1485227034713, "note": "<div><b>Trihexyphenidyl</b> and <b>benztropine</b> are useful for treating the <u>{{c1::tremor}}</u><b> </b>and <u>{{c1::rigidity}}</u> of <b>Parkinson</b> <b>disease</b><br></div>", "time": 1660105351628.0}, {"id": 1485227039136, "note": "<div><b>Trihexyphenidyl</b> and <b>benztropine</b> are NOT useful for treating the <u>{{c1::bradykinesia}}</u><b> </b>of <b>Parkinson</b> <b>disease</b><br></div>", "time": 1660105351629.0}, {"id": 1485373632124, "note": "<div><b><i>Indirect</i> cholinomimetics</b> exert their effects via <u>inhibition</u> of the enzyme {{c1::<b><i>acetylcholinesterase</i></b> (AChE)}}</div>", "time": 1660105352620.0}, {"id": 1485382064127, "note": "<div><b><i>Acetylcholinesterase</i> inhibitors</b> lead to {{c1::<u>increased</u>}} levels of <b>acetylcholine</b><br></div>", "time": 1660105352635.0}, {"id": 1485382069799, "note": "<div>What <u>drug class</u> do <b>neostigmine</b>, <b>physostigmine</b>, and <b>pyridostigmine</b> belong to?<br></div><div><br></div><div>{{c1::Acetylcholinesterase inhibitors}}</div>", "time": 1660105352596.0}, {"id": 1485382077657, "note": "<div>What <u>drug class</u> does <b>edrophonium</b> belong to?<br></div><div><br></div><div>{{c1::Acetylcholinesterase inhibitor}}</div>", "time": 1660105352591.0}, {"id": 1485382082442, "note": "<div>Do <u>acetylcholinesterase inhibitors</u> <i>enhance</i> ACh activity at <b>muscarinic</b> or <b>nicotinic</b> <b>receptors</b>?<br></div><div><b><br></b></div><div>{{c1::Both :)}}</div>", "time": 1660105352628.0}, {"id": 1485382087191, "note": "<div><b>{{c2::Myasthenia gravis}}</b> is an <u>autoimmune</u> disease due to production of <i>antibodies</i> against <b><i>post-synaptic</i> {{c1::nicotinic ACh}} receptors</b> at motor end plates<br></div>", "time": 1660105352571.0}, {"id": 1485382112355, "note": "<div><b>{{c1::Edrophonium}}</b> is an <i>acetylcholinesterase inhibitor</i> that was historically used to <u>diagnose</u> <b>myasthenia gravis</b><br></div>", "time": 1660105352582.0}, {"id": 1485382151977, "note": "<div><b>Pyridostigmine</b>, <b>neostigmine</b>, and <b>edrophonium</b> are <u>{{c1::quaternary}} amines</u> and thus <b>{{c1::do NOT}}</b> penetrate the CNS<br></div>", "time": 1660105352608.0}, {"id": 1485382157192, "note": "<div>What&nbsp;<u>drug class</u> is used to <i>reverse</i> the effects of <b>neuromuscular junction blockade</b>?<br></div><div><br></div><div>{{c1::Acetylcholinesterase inhibitors (e.g. neostigmine)}}</div>", "time": 1660105352584.0}, {"id": 1485382166758, "note": "<div><b>Acetylcholinesterase inhibitors</b> may be used to treat <u>post-operative</u> and <u>neurogenic</u> <b>{{c1::ileus}}</b><br></div>", "time": 1660105352634.0}, {"id": 1485382170346, "note": "<div><b>Acetylcholinesterase inhibitors</b> may be used to treat <b>urinary</b> <b>{{c1::retention}}</b><br></div>", "time": 1660105352633.0}, {"id": 1485382175324, "note": "<div><b>Physostigmine</b> is a(n)&nbsp;<u>{{c1::tertiary}} amine</u> and thus <b>{{c1::DOES}}</b> penetrate the CNS</div>", "time": 1660105352609.0}, {"id": 1485382179934, "note": "<div><b>{{c1::Physostigmine}}</b> is an <u>acetylcholinesterase inhibitor</u> that may be used to treat <b>{{c2::atropine}} overdose</b><br></div>", "time": 1660105352575.0}, {"id": 1485382187439, "note": "<div><b>Acetylcholinesterase inhibitor <i>poisoning</i></b> causes <u>{{c1::flaccid paralysis}}</u> due to <b>NMJ nicotinic ACh receptor {{c1::<i>overactivation</i>}}</b><br></div>", "time": 1660105352636.0}, {"id": 1485382192161, "note": "<div><b>{{c1::Organophosphates}}</b> are a type of <u>{{c3::acetylcholinesterase}} inhibitor</u> found in many <b>{{c2::insectisides}}</b><br></div>", "time": 1660105352580.0}, {"id": 1485382199836, "note": "<div><b>Parathion</b>, <b>malathion</b>, and <b>echothiophate</b> are all examples of {{c1::organophosphates}}<br></div>", "time": 1660105352610.0}, {"id": 1485382205594, "note": "<div>Do <u>organophosphates</u> (e.g. parathion) <i>reversibly</i> or <i>irreversibly</i> <b>inhibit AChE</b>?<br></div><div><br></div><div>{{c1::Irreversibly (with time)}}</div>", "time": 1660105352627.0}, {"id": 1485382210373, "note": "<div>What <u>demographic</u> is associated with <b>organophosphate poisoning</b>?<br></div><div><br></div><div>{{c1::Farmers}}</div>", "time": 1660105352598.0}, {"id": 1485382213384, "note": "<div><b>Organophosphate<i> toxicity</i></b> may be treated with <b>{{c1::pralidoxime}}</b>, which <u>regenerates AChE</u> at muscarinic <i>and</i> nicotinic receptors<b> if given early</b><br></div>", "time": 1660105352612.0}, {"id": 1485382218297, "note": "<div>Does <b>pralidoxime</b> <i>reverse</i> the <u>flaccid paralysis</u> associated with <b>cholinesterase inhibitor poisoning</b>?<br></div><div><br></div><div>{{c1::Yes}} </div>", "time": 1660105352625.0}, {"id": 1485382222368, "note": "<div><b>Organophosphate<i> toxicity</i></b> may be treated with <b>{{c1::atropine}}</b>, which is a <u>competitive inhibitor</u> at {{c2::muscarinic}} receptors <i>only</i><br></div>", "time": 1660105352614.0}, {"id": 1485382227392, "note": "<div>Does <b>atropine</b> <i>reverse</i> the <u>flaccid paralysis</u> associated with <b>cholinesterase inhibitor poisoning</b>?<br></div><div><div><br></div><div>{{c1::No, <u>only</u> effective at muscarinic receptors}}</div></div>", "time": 1660105352626.0}, {"id": 1485382232847, "note": "<div>Which <u>cholinesterase inhibitor poisoning</u> <b>antidote</b> reverses the <b><i>central</i> muscarinic effects</b>?<br></div><div><br></div><div>{{c1::Atropine}} </div>", "time": 1660105352585.0}, {"id": 1485382239959, "note": "<div><i>Aging</i> of the <b>organophosphate-cholinesterase complex</b> leads to {{c1::<u>irreversible</u>}} binding<br></div>", "time": 1660105352632.0}, {"id": 1485382248027, "note": "<div>What is a <i>lethal</i> complication of <b>cholinesterase inhibitor poisoning</b> if&nbsp;<u>untreated</u>?<br></div><div><br></div><div>{{c1::Respiratory failure}}</div>", "time": 1660105352587.0}, {"id": 1485382251441, "note": "<div>What <u>drug class</u> do <b>galantamine</b> and <b>tacrine</b> belong to?<br></div><div><br></div><div>{{c1::Acetylcholinesterase inhibitors}}</div>", "time": 1660105352597.0}, {"id": 1485382278118, "note": "<div>What <u>drug class</u> does <b>rivastigmine</b> belong to?<br></div><div><div><br></div><div>{{c1::Acetylcholinesterase inhibitor}}</div></div>", "time": 1660105352589.0}, {"id": 1485382282570, "note": "<div>What <u>drug class</u> does <b>donepezil</b> belong to?<br></div><div><div><br></div><div>{{c1::Acetylcholinesterase inhibitor}}</div></div>", "time": 1660105352592.0}, {"id": 1485382286527, "note": "<div>What is the <u>clinical use</u> for <b>galantamine</b>,&nbsp;<b>rivastigmine</b>, <b>donepezil</b> and <b>tacrine</b>?<br></div><div><br></div><div>{{c1::Alzheimers disease}}</div>", "time": 1660105359045.0}, {"id": 1485382294582, "note": "<div><b>{{c2::Memantine}}</b> is a(n)&nbsp;<u>{{c1::NMDA}} receptor <i>antagonist</i></u> used to treat <b>{{c3::Alzheimers}} disease</b><br></div>", "time": 1660105359012.0}, {"id": 1485382304579, "note": "<div><b>Memantine</b> helps prevent {{c1::excitotoxicity}} (mediated by Ca<sup>2+</sup>) in <b>Alzheimers disease</b></div>", "time": 1660105359073.0}, {"id": 1485382309642, "note": "<div><b>Huntington disease</b> may be treated with <b>{{c1::tetrabenazine}}</b> or <b>{{c2::reserpine}}</b>, which <u>inhibit {{c3::VMAT}}</u>, decreasing dopamine vesicle packaging and release</div>", "time": 1660105359083.0}, {"id": 1485382311895, "note": "<div>What <u>D</u><sub>2</sub><u> receptor antagonist</u> is used to treat <b>Huntington disease</b>?<br></div><div><br></div><div>{{c1::Haloperidol (typical antipsychotic)}}</div>", "time": 1660105359051.0}, {"id": 1485382321484, "note": "<div><b>Neuromuscular blocking drugs</b> are <i>selective</i> for {{c1::N<sub>M</sub>}} nicotinic receptors<br></div>", "time": 1660105359069.0}, {"id": 1485382329569, "note": "<div>Which <u>neuromuscular blocking drug</u> is characterized as <b>depolarizing</b>?<br></div><div><br></div><div>{{c1::Succinylcholine}}</div>", "time": 1660105352583.0}, {"id": 1485382335147, "note": "<div><b>Succinylcholine</b> is a <i>strong</i> <b>ACh receptor </b>{{c1::<b>agonist</b>}} that produces sustained <u>depolarization</u> and <b>prevents muscle {{c2::contraction}}</b><br></div>", "time": 1660105352554.0}, {"id": 1485382339718, "note": "<div><b>Phase {{c1::I}}</b> of <u>succinylcholine-induced</u> neuromuscular blockade is characterized as <b>prolonged depolarization</b><br></div>", "time": 1660105359064.0}, {"id": 1485382351047, "note": "<div>What is used to <i>reverse</i> <u>phase I</u> of <b>succinylcholine-induced&nbsp;</b>neuromuscular blockade?<br></div><div><br></div><div>{{c1::No antidote}} </div>", "time": 1660105359041.0}, {"id": 1485382362549, "note": "<div><div>Complications of <b>succinylcholine</b> include <b>{{c2::hyper}}-calcemia</b>, <b>{{c2::hyper}}-kalemia</b>, and {{c1::<b>malignant</b> <b>hyperthermia</b>}}</div></div>", "time": 1660105359093.0}, {"id": 1485382365415, "note": "<div><b>Atracurium</b> and <b>mivacurium</b> are {{c1::<u>non-depolarizing</u>::depolarizing or non-depolarizing}} <b>neuromuscular blocking agents</b><br></div>", "time": 1660105352559.0}, {"id": 1485382369795, "note": "<div><b>Pancuronium</b>, <b>vecuronium</b>, and <b>rocuronium</b> are {{c1::<u>non-depolarizing</u>::depolarizing or non-depolarizing}} <b>neuromuscular blocking agents</b><br></div>", "time": 1660105352611.0}, {"id": 1485382373819, "note": "<div><b>Tubocurarine</b> is a(n) {{c1::<u>non-depolarizing</u>::depolarizing or non-depolarizing}}&nbsp;<b>neuromuscular blocking agent</b><br></div>", "time": 1660105352602.0}, {"id": 1485382377464, "note": "<div>The <u>non-depolarizing</u> <b>neuromuscular</b>&nbsp;<b>blocking</b> <b>agents</b> are <i>competitive</i> <b>{{c1::ACh}} receptor {{c2::antagonists}}</b><br></div>", "time": 1660105352605.0}, {"id": 1485389788956, "note": "<div><u>Acute</u> management of <b>{{c3::migraine}} headaches</b> includes {{c1::NSAIDs}}, {{c2::triptans}}, or <b>dihydroergotamine</b><br></div>", "time": 1660105351844.0}, {"id": 1485389816164, "note": "<div><b>Triptans</b> may cause <b>coronary</b> <b>{{c1::vasospasm}}</b> as an <u>adverse</u> effect<br></div>", "time": 1660105351833.0}, {"id": 1485389822615, "note": "<div><b>Triptans</b> are <u>contraindicated</u> in patients with <b>{{c1::CAD}}</b> or {{c2::<b>Prinzmetal</b> <b>angina</b>}}<br></div>", "time": 1660105351837.0}, {"id": 1485389832478, "note": "<div>What treatment for <u>headaches</u> is associated with <b>serotonin</b> <b>syndrome</b>?<br></div><div><br></div><div>{{c1::Triptans}}</div>", "time": 1660105359107.0}, {"id": 1485389837206, "note": "<div><u>Acute</u> management of <b>{{c3::cluster}} headaches</b> includes {{c1::<b>sumatriptan</b>}} and {{c2::<b>100% O<sub>2</sub></b>}}<br></div>", "time": 1660105351847.0}, {"id": 1485389845221, "note": "<div>What drug is used for <u>chronic pain</u> in <b>tension headaches</b>?<br></div><div><br></div><div>{{c1::Amitriptyline}} </div>", "time": 1660105359109.0}, {"id": 1486519322563, "note": "<b>{{c1::Jaundice}}</b> is a <b>yellow discoloration</b> of the skin and/or sclera", "time": null}, {"id": 1486522380118, "note": "<div>What is the <u>earliest</u> sign of <b>jaundice</b>?</div><div><br /></div><div>{{c1::Scleral icterus}}</div>", "time": null}, {"id": 1486522390591, "note": "<div><b>Jaundice</b> is due to <u>increased</u> serum {{c1::bilirubin}}, typically <b>&gt; 2.5 mg/dL</b> </div>", "time": null}, {"id": 1486522395177, "note": "<div>Does <b>hemolysis</b> result in <u>unconjugated</u> or <u>conjugated</u> <b>hyperbilirubinemia</b>? </div><div><br /></div><div>{{c1::Unconjugated}} </div>", "time": null}, {"id": 1486522403872, "note": "<div><b>{{c2::Hemolysis}}</b> is associated with <u>dark urine</u> due to <i>increased</i> <b>urine</b> <b>{{c1::urobilinogen}}</b> </div>", "time": null}, {"id": 1486522418951, "note": "<div><b>Physiological neonatal jaundice</b> occurs due to <u>transiently low</u> <b><i>{{c1::UDP-glucuronyl transferase}}</i></b> activity at birth </div>", "time": null}, {"id": 1486522422740, "note": "<div><div>Does <b>physiological neonatal jaundice</b> result in <u>unconjugated</u> or <u>conjugated</u><i style=\"\">&nbsp;</i><b>hyperbilirubinemia</b>? </div><div><br></div><div>{{c1::Unconjugated}} </div></div>", "time": null}, {"id": 1486522426162, "note": "<div>In <b>physiological neonatal jaundice</b>, <u>unconjugated bilirubin</u> deposits in the <b>brain</b>, especially in the <b>{{c1::basal ganglia}}</b> </div>", "time": null}, {"id": 1486522430052, "note": "<div><b>{{c1::Kernicterus}}</b> is the <u>deposition of bilirubin</u> in the <b>brain</b>, especially basal ganglia, causing neurologic deficits and possibly death</div>", "time": null}, {"id": 1486522451470, "note": "<div>What is the <u>treatment</u> for <b>physiologic neonatal jaundice</b>? </div><div><br></div><div>{{c1::Non-UV phototherapy}}</div>", "time": null}, {"id": 1486522459317, "note": "<div>How does <u>phototherapy</u> treat <b>neonatal jaundice</b>?</div><div><br /></div><div>{{c1::Isomerize UCB to water-soluble form}}</div>", "time": null}, {"id": 1486522466249, "note": "<div><div>What is the <u>mode of inheritance</u> of <b><i>hereditary</i> hyperbilirubinemias</b> (e.g. Gilbert, Crigler-Najjar, Dubin-Johnson)? </div><div><br /></div><div>{{c1::Autosomal recessive}}</div></div>", "time": null}, {"id": 1486522470445, "note": "<div><b>{{c1::Gilbert}} syndrome</b> is due to {{c2::<u>mildly low</u>}} <b><i>UDP-glucuronyl transferase</i></b> activity</div>", "time": null}, {"id": 1486522473729, "note": "<div><b>{{c1::Gilbert}} syndrome</b> presents with <u>jaundice</u> during <b>stress</b>, <b>illness</b>, or <b>fasting</b></div>", "time": null}, {"id": 1486522477137, "note": "<div><div>Does <b>Gilbert syndrome</b> result in <u>unconjugated</u> or <u>conjugated</u> <b>hyperbilirubinemia</b>? </div><div><br /></div><div>{{c1::Unconjugated}}</div></div>", "time": null}, {"id": 1486522482841, "note": "<div><b>{{c1::Crigler-Najjar}} syndrome</b> is due to <u>{{c2::absent}}</u> <b><i>UDP-glucuronyl transferase</i></b> activity </div>", "time": null}, {"id": 1486522486856, "note": "<div><div>Does <b>Crigler-Najjar syndrome</b> result in <u>unconjugated</u> or <u>conjugated</u> <b>hyperbilirubinemia</b>? </div><div><br /></div><div>{{c1::Unconjugated}}</div></div>", "time": null}, {"id": 1486522491958, "note": "<div><b>{{c1::Crigler-Najjar}} syndrome</b> causes <u>jaundice</u> and <u>kernicterus</u> early in life; patients often die within a few years </div>", "time": null}, {"id": 1486522498103, "note": "<div>Which form of <b>Crigler-Najjar syndrome</b> is more <u>severe</u>? </div><div><br /></div><div>{{c1::Type I}}</div>", "time": null}, {"id": 1486522501087, "note": "<div>What are the <u>treatments</u> for <b>Crigler-Najjar syndrome type I</b>? </div><div><br></div><div>{{c1::Plasmapheresis and phototherapy::2}}</div>", "time": null}, {"id": 1486522504599, "note": "<div><b>Crigler-Najjar syndrome type {{c1::II}}</b> is <u>less</u> severe and responds to <b>{{c2::phenobarbital}}</b>, which increases liver enzyme synthesis </div>", "time": null}, {"id": 1486522508003, "note": "<div><b>{{c1::Dubin-Johnson}} syndrome</b> is due to a <u>deficiency</u> of <b>{{c2::bilirubin canalicular transport}} protein</b> </div>", "time": 1660105340512.0}, {"id": 1486522515284, "note": "<div><div>Does <b>Dubin-Johnson syndrome</b> result in <u>unconjugated</u> or <u>conjugated</u> <b>hyperbilirubinemia</b>? </div><div><br /></div><div>{{c1::Conjugated}}</div></div>", "time": null}, {"id": 1486522521355, "note": "<div><b>{{c1::Dubin-Johnson}} syndrome</b> presents with a <b>grossly black liver</b>, but is otherwise <u>not</u> clinically significant </div>", "time": 1660105340510.0}, {"id": 1486522525618, "note": "<div><b>{{c1::Rotor}} syndrome</b> is similar to <u>Dubin-Johnson syndrome</u>, but milder and <b>WITHOUT</b> <b>black liver</b></div>", "time": null}, {"id": 1486522528709, "note": "<div><div>Does <b>Rotor syndrome</b> result in <u>unconjugated</u> or <u>conjugated</u> <b>hyperbilirubinemia</b>? </div><div><br /></div><div>{{c1::Conjugated}}</div></div>", "time": null}, {"id": 1486522534230, "note": "<div>What type of <u>jaundice</u> is associated with <b>gallstones</b>, <b>parasites</b>, and <b>liver</b> <b>fluke</b>? </div><div><br></div><div>{{c1::Obstructive jaundice}}</div>", "time": null}, {"id": 1486522543509, "note": "<div>Does <b>biliary tract obstruction</b> (obstructive jaundice) result in <u>unconjugated</u> or <u>conjugated</u>&nbsp;<b>hyperbilirubinemia</b>? <div><br></div>{{c1::Conjugated}} </div>", "time": null}, {"id": 1486522549639, "note": "<div><b>Obstructive jaundice</b> is associated with <u>dark urine</u> due to <i>increased</i> <b>urine {{c1::conjugated bilirubin}}</b> </div>", "time": null}, {"id": 1486522556268, "note": "<div><b>Obstructive jaundice</b> is associated with <u>{{c1::decreased}}</u> <b>urine urobilinogen</b> </div>", "time": 1660105354726.0}, {"id": 1486522563815, "note": "<div><b>Obstructive jaundice</b> is associated with {{c1::<u>pale</u>}} <b>stools</b> </div>", "time": 1660105354724.0}, {"id": 1486522566796, "note": "<div><b>Obstructive jaundice</b> is associated with <i>increased</i> serum {{c2::<u>bile acids</u>}}, which may cause <b>{{c1::pruritus}}</b> </div>", "time": null}, {"id": 1486522573745, "note": "<div><b>Obstructive jaundice</b> is associated with <u>{{c1::hypercholesterolemia}}</u>, which may cause {{c2::<b>xanthomas</b>::skin finding}}</div>", "time": 1660105354725.0}, {"id": 1486522580002, "note": "<div><b>Obstructive jaundice</b> is associated with {{c1::<u>steatorrhea</u>::GI symptom}}, with <i>malabsorption</i> of <b>fat-soluble vitamins</b> </div>", "time": 1660105354723.0}, {"id": 1486522586117, "note": "Does <b>viral hepatitis</b> result in <u>unconjugated</u> or <u>conjugated</u> <b>hyperbilirubinemia</b>? <div><br /></div><div>{{c1::Both :)}}</div>", "time": 1660105359789.0}, {"id": 1486522593205, "note": "<div><b>Viral hepatitis</b> is associated with <u>dark urine</u> due to <i>increased</i> <b>urine {{c1::conjugated bilirubin}}</b> </div>", "time": 1660105348262.0}, {"id": 1486522596363, "note": "<div><b>Viral hepatitis</b> is associated with {{c1::<u>normal</u>}} or {{c1::<u>decreased</u>}} <b>urine urobilinogen</b> </div>", "time": 1660105348261.0}, {"id": 1486522599412, "note": "<div>In addition to <u>hepatitis virus</u>, <b>viral</b> <b>hepatitis</b> may also be caused by <b>{{c1::EBV}}</b> and <b>{{c2::CMV}}</b> </div>", "time": 1660105357525.0}, {"id": 1486522611061, "note": "<div><b>Viral hepatitis</b> is characterized by <u>elevated</u> <b>liver enzymes</b> with <b>ALT</b> {{c1::&gt;}} <b>AST</b> </div>", "time": 1660105348260.0}, {"id": 1486522618128, "note": "<div><b>{{c1::Acute}} hepatitis</b> is associated with <u>inflammation</u> that involves the <b>lobules of the liver</b> <i>and</i> <b>portal tracts</b>; characterized by apoptosis of hepatocytes </div>", "time": 1660105341298.0}, {"id": 1486522630094, "note": "<div><b>{{c1::Chronic}} hepatitis</b> is associated with <u>inflammation</u> that primarily involves the <b>{{c2::portal tracts}}</b>  </div>", "time": 1660105340810.0}, {"id": 1486522637384, "note": "<div><b>Cirrhosis</b> is characterized by <u>disruption</u> of normal hepatic parenchyma by <b>bands</b> <b>of {{c1::fibrosis}} </b>and <b>{{c2::regenerative nodules}} of hepatocytes</b> </div>", "time": 1660105360686.0}, {"id": 1486522654540, "note": "<div>The <b>fibrosis</b> seen in <u>cirrhosis</u> is mediated by <b>{{c2::TGF-\u03b2}}</b> from <b>{{c1::stellate (ito)}}</b> <b>cells</b></div>", "time": null}, {"id": 1486522662626, "note": "<div><b>Alcoholic cirrhosis</b> may be associated with <b>{{c1::sclerosis}}</b> <b>around</b> <b>central veins</b> in <u>early</u> disease</div>", "time": null}, {"id": 1486522667060, "note": "<div><b>Cirrhosis</b> is often complicated by <b>{{c1::portal}}</b> <b>hypertension</b> </div>", "time": 1660105360684.0}, {"id": 1486522670366, "note": "<div>Does <b>cirrhosis</b> result in <u>unconjugated</u> or <u>conjugated</u> <b>hyperbilirubinemia</b>? <div><br /></div><div>{{c1::Both :)}}</div></div>", "time": null}, {"id": 1486522673379, "note": "<div>What is the <u>most common cause</u> of <b>portal hypertension</b> in <b>Western countries</b>? </div><div><br /></div><div>{{c1::Cirrhosis}}</div>", "time": null}, {"id": 1486522676151, "note": "<div><b>Portal</b> <b>hypertension</b> may be caused by <u>vascular obstruction</u>, such as <b>portal vein {{c1::thrombosis}}</b> and <b>{{c2::Budd-Chiari}} syndrome</b> </div>", "time": 1660105353777.0}, {"id": 1486522681611, "note": "<div><b>Portal hypertension</b> can lead to {{c1::ascites}}, which is fluid in the peritoneal cavity </div>", "time": 1660105353778.0}, {"id": 1486522684741, "note": "<div><b>Portal {{c2::hypertension}}</b> may lead to <b>{{c1::portosystemic}} shunts</b>, which can result in esophageal varices, gastric varices, anorectal varices, and caput medusae</div>", "time": 1660105353775.0}, {"id": 1486522690115, "note": "<div><b>Portal hypertension</b> may lead to congestive {{c1::splenomegaly}} and hypersplenism </div>", "time": null}, {"id": 1486522693430, "note": "<div><b>{{c1::Hepatorenal}} syndrome</b> is a complication of <u>portal hypertension</u> characterized by <b>rapidly developing renal failure</b>, secondary to cirrhosis</div>", "time": 1660105340118.0}, {"id": 1486522695665, "note": "<div><b>Cirrhosis</b> may present with <u>neuropsychiatric symptoms</u> due to <i>increased</i> serum <b>{{c1::ammonia (NH<sub>3</sub>)}}</b> </div>", "time": null}, {"id": 1486522702734, "note": "<div><b>Neuropsychiatric symptoms</b> of <u>cirrhosis</u> include <b>hepatic</b> <b>{{c1::encephalopathy}}</b> and {{c2::<b>asterixis</b> (\"flapping tremor\")}}</div>", "time": null}, {"id": 1486522729229, "note": "<div>What <u>osmotic laxative</u> is used to treat <b>hepatic encephalopathy</b>? </div><div><br /></div><div>{{c1::Lactulose}}</div>", "time": null}, {"id": 1486522744760, "note": "<div><b>Dermatologic</b> <b>symptoms</b> of <u>cirrhosis</u> include {{c1::jaundice}}, <b>spider angiomas</b>, <b>palmar erythema</b>, and <b>petechiae/purpura</b></div>", "time": null}, {"id": 1486522750998, "note": "<div>How do levels of <u>estrogen</u> change in <b>cirrhosis</b>? </div><div><br /></div><div>{{c1::Increased}}</div>", "time": null}, {"id": 1486522758122, "note": "<div><i>Increased</i> <b>{{c1::estrogen}}</b> in <u>cirrhosis</u> may lead to {{c2::<b>spider</b> <b>angiomas</b>}} and {{c3::<b>palmar</b> <b>erythema</b>}} (dermatologic symptoms)</div>", "time": null}, {"id": 1486522762686, "note": "<div><i>Increased</i> <b>estrogen</b> in <u>cirrhosis</u> may lead to {{c1::gynecomastia}}, <b>testicular</b> <b>atrophy</b>, and <b>amenorrhea</b> (reproductive symptoms) </div>", "time": null}, {"id": 1486522767302, "note": "<div><b>Cirrhosis</b> may present with <u>peripheral edema</u>, secondary to {{c1::<b>hypoalbuminemia</b>}} </div>", "time": null}, {"id": 1486522771132, "note": "<div><b>Cirrhosis </b>may present with {{c1::coagulopathies}} due to <u>decreased synthesis</u> of <b>clotting</b> <b>factors</b> </div>", "time": 1660105360683.0}, {"id": 1486522786197, "note": "<div>What is the <u>most common cause</u> of <b>liver disease</b> in the <b>West</b>? </div><div><br /></div><div>{{c1::Alcohol consumption}}</div>", "time": null}, {"id": 1486522799728, "note": "<div>Which <u>alcoholic liver disease</u> is characterized by <b>macrovesicular</b> <b>fatty</b> <b>change</b> with a heavy, greasy liver? </div><div><br /></div><div>{{c1::Hepatic steatosis}}</div>", "time": null}, {"id": 1486522804267, "note": "<div><b>Hepatic</b> <b>{{c2::steatosis}}</b> is characterized by <u>{{c1::macro}}-vesicular</u> <b>fatty change</b> </div>", "time": 1660105358348.0}, {"id": 1486522813431, "note": "<div><b>Alcoholic {{c2::hepatitis}}</b> is characterized by {{c1::<u>swelling</u>}} of hepatocytes with <b>necrosis</b> and <b>neutrophilic infiltration</b></div>", "time": 1660105361984.0}, {"id": 1486522818318, "note": "<div><b>{{c3::Alcoholic hepatitis</b><b>}}&nbsp;</b>is characterized histologically by <b>{{c1::mallory bodies}}</b>, which are intracytoplasmic <u>eosinophilic</u> inclusions of <b>damaged {{c2::keratin (intermediate)}} filaments</b></div>", "time": null}, {"id": 1486522822101, "note": "<div>The <u>liver damage</u> in <b>alcoholic</b> <b>hepatitis</b> is mediated by {{c1::acetaldehyde}} </div>", "time": null}, {"id": 1486522825676, "note": "<div><b>Alcoholic hepatitis</b> may present with <u>{{c1::painful::painful or painless}}</u> <b>hepatomegaly</b>&nbsp;</div>", "time": null}, {"id": 1486522828840, "note": "<div><div><b>{{c2::Alcoholic}} hepatitis</b> is characterized by <u>elevated</u> <b>liver enzymes</b> with <b>ALT</b> {{c1::<b>&lt;</b>}} <b>AST</b> </div></div>", "time": 1660105338326.0}, {"id": 1486522836510, "note": "<div><b>{{c1::Non-alcoholic fatty}} liver disease</b> is associated with <b>obesity</b> and <b>metabolic syndrome</b> </div>", "time": 1660105339446.0}, {"id": 1486522847427, "note": "<div><b>Nonalcoholic fatty liver disease</b> is characterized by <u>elevated</u> <b>liver enzymes</b> with <b>ALT</b> {{c1::<b>&gt;</b>}} <b>AST</b> </div>", "time": null}, {"id": 1486589932110, "note": "<b>{{c1::Hemochromatosis}}</b> is characterized by organ damage, secondary to <u>excess</u> <b>iron</b> ", "time": null}, {"id": 1486590791883, "note": "<div><div>The <u>tissue damage</u> in <b>hemochromatosis</b> is mediated by the generation of {{c1::free radicals}} </div></div>", "time": 1660105349444.0}, {"id": 1486590795841, "note": "<div><div><b>Hemochromatosis</b> may be <u>primary</u>; due to {{c1::autosomal recessive::inheritance pattern}} mutations in <b>iron absorption</b></div></div>", "time": null}, {"id": 1486590798588, "note": "<div><div><b>Hemochromatosis</b> typically presents <u>{{c1::after}}</u><b> age 40</b>, when total body iron <b>&gt;</b> <b>20g</b></div></div>", "time": null}, {"id": 1486590801692, "note": "<div><div><b>Hemochromatosis</b> has a <u>slowed</u> progression in {{c1::women::gender}}</div></div>", "time": null}, {"id": 1486590804231, "note": "<div><div>Why does <u>hemochromatosis</u> have a <i>slowed</i> progression in <b>women</b>? </div><div><br></div><div>{{c1::Iron loss through menstruation}}</div></div>", "time": null}, {"id": 1486590807272, "note": "<div><div><div><b>Hemochromatosis</b> may be <u>secondary</u>; due to chronic {{c1::transfusions}} </div></div></div>", "time": null}, {"id": 1486590815608, "note": "<div><div><b>Primary</b> <b>{{c3::hemochromatosis}}</b> is due to mutations in the <i>{{c1::HFE}}</i> gene on chromosome {{c2::6}}, leading to increased expression of {{c4::<u>DMT1</u>}} and decreased synthesis of <u>{{c5::Hepcidin}}</u></div></div>", "time": null}, {"id": 1486590827098, "note": "<div><div><b>{{c2::Hemochromatosis}}</b> is associated with <b>HLA-{{c1::A3}}</b></div></div>", "time": null}, {"id": 1486590830745, "note": "<div><div>What <u>point mutations</u> in the <i>HFE </i>gene are typically seen with <b>primary hemochromatosis</b>? </div><div><br /></div><div>{{c1::<b>C282Y</b>}} (more common) and {{c2::<b>H63D</b>}} </div></div>", "time": null}, {"id": 1486590838863, "note": "<div><div><b>{{c4::Hemochromatosis}}</b> classically presents with a <u>triad</u> of <b>{{c1::cirrhosis}}</b>, <b>{{c2::diabetes mellitus}}</b>, and <b>{{c3::bronze skin}}</b> </div></div>", "time": null}, {"id": 1486590846162, "note": "<div><div><b>Hemochromatosis</b> can cause <u>{{c1::restrictive}}</u> <b>cardiomyopathy</b> or <u>{{c1::dilated}}</u> <b>cardiomyopathy</b> </div></div>", "time": null}, {"id": 1486590946128, "note": "<div><div><b>Hemochromatosis</b> may cause <u>gonadal dysfunction</u> in males due to <b>{{c1::testicular}} atrophy</b></div></div>", "time": 1660105358400.0}, {"id": 1486590949959, "note": "<div><div><b>Hemochromatosis</b> may cause <u>arthropathy</u>, especially in {{c1::<b>metacarpophalangeal</b> (MCP)::specific hand}} <b>joints</b></div></div>", "time": null}, {"id": 1486590953002, "note": "<div><div>The <u>arthropathy</u> in <b>hemochromatosis</b> occurs due to {{c1::calcium pyrophosphate}} deposition </div><div><br /></div><div><br /></div></div>", "time": null}, {"id": 1486590955789, "note": "<div><div>What is a common <u>cause of death</u> in <b>hemochromatosis</b>? </div><div><br></div><div>{{c1::Hepatocellular carcinoma}}</div></div>", "time": null}, {"id": 1486590958876, "note": "<div><div><b>Hemochromatosis</b> is characterized by <u>{{c1::increased}}</u> <b>ferritin</b></div></div>", "time": null}, {"id": 1486590962252, "note": "<div><div><b>Hemochromatosis</b> is characterized by <u>{{c1::decreased}}</u> <b>TIBC</b></div></div>", "time": null}, {"id": 1486590965296, "note": "<div><div><b>Hemochromatosis</b> is characterized by <u>{{c1::increased}}</u> <b>serum iron</b></div></div>", "time": null}, {"id": 1486590968007, "note": "<div><div><b>Hemochromatosis</b> is characterized by <u>{{c1::increased}}</u> <b>% saturation</b></div></div>", "time": null}, {"id": 1486590976651, "note": "<div><div>The coarse <u>yellowish-brown pigment</u> in hepatocytes / kupffer cells from <b>hemochromatosis</b> may be <i>distinguished</i> from <b>lipofuscin</b> by staining with {{c1::Prussian blue}}</div></div>", "time": null}, {"id": 1486590985316, "note": "<div><div><b>{{c1::Lipofuscin}}</b> is a <u>yellow-brown</u> \"<b>wear</b> <b>and tear</b>\" <b>pigment</b> associated with <b>normal aging</b> </div></div>", "time": null}, {"id": 1486590994020, "note": "<div><div>Which <u>part</u> of the cell does <b>lipofuscin</b> accumulate? </div><div><br /></div><div>{{c1::Lysosomes}}</div></div>", "time": null}, {"id": 1486590997246, "note": "<div><div>Deposits of <b>lipofuscin</b> are commonly found in the {{c1::liver}}, <b>heart</b>, <b>colon</b>, <b>kidney</b>, and <b>eye</b> of <u>elderly</u> individuals; and are caused by {{c2::lipid peroxidation}}</div></div>", "time": null}, {"id": 1486591001987, "note": "<div><div>Treatment for <b>hemochromatosis</b> may include repeated {{c1::phlebotomy}}</div></div>", "time": null}, {"id": 1486591020624, "note": "<div>What <u>GI disorder</u> may be treated with <b>deferasirox</b>, <b>deferoxamine</b>, and oral&nbsp;<b>deferiprone</b>?  </div><div><br></div><div>{{c1::Hemochromatosis}}</div>", "time": null}, {"id": 1486591023980, "note": "<div><b>{{c2::Wilson}} disease</b> is caused by a(n) {{c1::<u>autosomal recessive</u>::inheritance}} defect in <b>ATP-mediated hepatocyte {{c3::copper}} transport</b></div>", "time": null}, {"id": 1486591026992, "note": "<div><div><b>{{c3::Wilson disease}}</b> is due to mutations in the <i>{{c1::<b>ATP7B</b>}}</i> gene on chromosome {{c2::13}} </div></div>", "time": null}, {"id": 1486591033652, "note": "<div><b>Wilson disease</b> results in <i>lack</i> of <u>copper transport</u> into <b>{{c1::bile}}</b> and <i>lack</i> of <u>incorporation</u> into <b>{{c2::ceruloplasmin}}</b> </div>", "time": null}, {"id": 1486591040947, "note": "<div><b>Wilson disease</b> is also known as {{c1::hepatolenticular degeneration}}</div>", "time": null}, {"id": 1486591044900, "note": "<div><b>Wilson disease</b> is characterized by <u>accumulation of copper</u>, especially in the <b>{{c1::liver}}</b>, <b>brain</b>, <b>cornea</b>, and <b>kidneys</b> </div>", "time": null}, {"id": 1486591055752, "note": "<div><b>Wilson disease</b> often presents with {{c1::<u>cirrhosis</u>}}, due to copper accumulation in the <b>liver</b> </div>", "time": 1660105341470.0}, {"id": 1486591059081, "note": "<div><b>{{c2::Wilson}} disease</b> often presents with <u>neuropsychiatric manifestations</u>, due to copper deposition and resultant cystic degeneration in the <b>{{c1::putamen}}</b> and other adjacent structures</div>", "time": null}, {"id": 1486591065991, "note": "<div><b>{{c3::Wilson}} disease</b> presents with <b>{{c1::Kayser-Fleischer rings}}</b> due to copper deposits in <u>{{c2::Descemets membrane}}</u><b> </b>of the <b>cornea</b>  </div>", "time": null}, {"id": 1486591074378, "note": "<div><b>Wilson disease</b> is characterized by <u>{{c1::decreased}}</u> serum <b>ceruloplasmin</b> </div>", "time": null}, {"id": 1486591077740, "note": "<div><b>Wilson disease</b> is characterized by <u>{{c1::increased}}</u> <b>urinary</b> <b>{{c2::copper}}</b> </div>", "time": null}, {"id": 1486591083934, "note": "<div><b>{{c2::Wilson}} disease</b> may be treated with <b>oral {{c1::zinc}}</b> or <u>chelating agents</u> (e.g. <b>penicillamine</b>, <b>trientine</b>) </div>", "time": null}, {"id": 1486591086855, "note": "<div><b>Biliary tract diseases</b> (e.g. PSC, PBC) present with features of <u>{{c1::obstructive}} jaundice</u> </div>", "time": null}, {"id": 1486591093197, "note": "<div>Does <b>biliary tract disease</b> (e.g. PBC, PSC) result in <u>unconjugated</u> or <u>conjugated</u>&nbsp;<b>hyperbilirubinemia</b>? </div><div><br></div>{{c1::Conjugated}} ", "time": null}, {"id": 1486591099796, "note": "<div><div><b>{{c3::Primary biliary cholangitis}}</b> is a(n)&nbsp;<u>{{c1::autoimmune}}</u> granulomatous destruction of <b>{{c2::intra}}-hepatic bile ducts</b> </div></div>", "time": null}, {"id": 1486591119547, "note": "<div><div><b>Primary biliary cholangitis</b> is associated with other {{c1::<u>autoimmune</u>}} diseases </div></div>", "time": null}, {"id": 1486591132401, "note": "<div><div>Which <u>biliary tract disease</u> is caused by <b><i>extrahepatic</i> biliary obstruction</b>? <br><br></div></div><div> </div><div>{{c1::Secondary biliary cholangitis}}</div>", "time": 1660105343869.0}, {"id": 1486591144511, "note": "<div><b>Secondary biliary cholangitis</b> may be complicated by ascending {{c1::cholangitis}}</div>", "time": null}, {"id": 1486591147885, "note": "<div><b>{{c1::Primary sclerosing}} cholangitis</b> is characterized by inflammation and fibrosis of<i> both</i> <b>intra- </b>and<b> extrahepatic bile ducts</b></div>", "time": 1660105339183.0}, {"id": 1486591150476, "note": "<div><div>Does <u>primary sclerosing cholangitis</u> (PSC) affect<b> intra- </b>or <b>extrahepatic bile ducts</b>? </div><div><br></div><div>{{c1::Both :)}}</div></div>", "time": null}, {"id": 1486591153191, "note": "<div>{{c2::<b>Primary sclerosing</b>}}<b> cholangitis</b> causes <u>periductal fibrosis</u> with an \"<b>{{c1::onion-skin}}</b>\" appearance histologically</div>", "time": null}, {"id": 1486591157840, "note": "<div><b>Primary sclerosing cholangitis</b> is characterized by a \"{{c1::beading}}\" appearance of <b>intra-</b> and<b> extrahepatic bile ducts </b>on ERCP and MRCP </div>", "time": null}, {"id": 1486591167720, "note": "<div><div>What <u>demographic</u> is classically affected by <b>primary sclerosing cholangitis</b> (PSC)? </div><div><br></div><div>{{c1::Middle-aged men (classically with IBD)}}</div></div>", "time": null}, {"id": 1486591173784, "note": "<div><b>{{c2::Primary sclerosing}} cholangitis</b> is associated with <b>{{c1::p-ANCA}} antibody</b></div>", "time": null}, {"id": 1486591176052, "note": "<div><b>Primary sclerosing cholangitis</b> and <b>primary biliary cholangitis</b> are associated with <u>increased</u> serum <b>Ig{{c1::M}}</b> </div>", "time": 1660105353687.0}, {"id": 1486591222024, "note": "<div><b>Primary sclerosing cholangitis</b> is associated with <u>increased</u> risk for <b>{{c1::cholangiocarcinoma}}</b> and <b>gallbladder cancer</b> </div>", "time": null}, {"id": 1486591227249, "note": "<div>What is a <u>late complication</u> associated with <b>biliary tract disease</b> (e.g. PBC, PSC)? </div><div><br /></div><div>{{c1::Cirrhosis}} </div>", "time": 1660105346924.0}, {"id": 1486591239941, "note": "<div><b>{{c2::Reye}} syndrome</b> is <u>fulminant liver failure</u> and <u>encephalopathy</u> in <b>children</b> with <i>viral illness</i> who take <b>{{c1::aspirin}}</b> </div>", "time": null}, {"id": 1486591245629, "note": "<div><b>Reye syndrome</b> may occur due to <i>decreased</i> {{c1::<b>\u03b2-oxidation</b>}} secondary to reversible <u>inhibition</u> of <b>{{c2::mitochondrial}}</b> <b>enzymes</b> in hepatocytes by <b>aspirin metabolites</b></div>", "time": null}, {"id": 1486591248468, "note": "<div><b>Reye syndrome</b> presents with <u>{{c1::micro}}-vesicular</u> <b>fatty change</b> in the liver, hypoglycemia, vomiting, hepatomegaly, and eventually coma/death</div>", "time": 1660105353327.0}, {"id": 1486591251230, "note": "<div>What <u>viruses</u> classically cause <b>Reye syndrome</b> when treated with <b>aspirin</b>?</div><div><br></div><div>{{c1::Influenza B}} and {{c2::VZV}}</div>", "time": null}, {"id": 1486591253645, "note": "<div><b>Hepatic {{c2::adenomas}}</b> are <i>rare</i>, <u>benign</u> tumors associated with <b>{{c1::OCP}}</b> and <b>{{c1::anabolic steroid}}</b> use; regress upon cessation of drug </div>", "time": null}, {"id": 1486591255795, "note": "<div><b>Hepatic adenomas</b> may <u>rupture</u>, causing <b>intraperitoneal</b> <b>bleeding</b>, especially during {{c1::pregnancy}}</div>", "time": 1660105358354.0}, {"id": 1486591262323, "note": "<div><b>Hepatic adenomas</b> are <u>subcapsular</u> tumors and grow with exposure to {{c1::estrogen}}</div>", "time": null}, {"id": 1486591265100, "note": "<div><b>Hepatic {{c1::angiosarcoma}}</b> is a <u>malignant tumor</u> associated with exposure to <b>arsenic</b> and <b>vinyl chloride</b> </div>", "time": null}, {"id": 1486591267339, "note": "<div><b>{{c1::Cavernous hemangiomas}}</b> are <i>common</i>, <u>benign</u><b> tumors </b>involving the <u>deeper tissues of the body</u> (ex. liver, brain) that typically occur from <b>age 30 - 50 years</b></div>", "time": null}, {"id": 1486591272185, "note": "<div><b>Cavernous hemangiomas </b>should <u>NOT</u> be {{c1::biopsied}} due to risk of fatal hemorrhage </div>", "time": null}, {"id": 1486591276598, "note": "<div>{{c1::<b>Hepatocellular carcinoma</b> (hepatoma)}} is the <u>most common</u> <b><i>primary</i> malignant liver tumor</b> in <b>adults</b> </div>", "time": null}, {"id": 1486591284504, "note": "<div>Risk factors for <b>{{c1::hepatocellular}} carcinoma</b> include <b>chronic</b> <b>hepatitis</b> (e.g. HBV, HCV) </div>", "time": null}, {"id": 1486591287399, "note": "<div>Risk factors for <b>hepatocellular carcinoma</b> include causes of <b>{{c1::cirrhosis}} </b>(e.g. alcohol, NAFLD, hemochromatosis, Wilson disease, A1AT deficiency) </div>", "time": 1660105353258.0}, {"id": 1486591295606, "note": "<div><b>{{c1::Hepatocellular}} carcinoma</b> <u>increases</u> risk for <b>Budd-Chiari syndrome</b></div>", "time": null}, {"id": 1486591298584, "note": "<div>In addition to HCC, <b>Budd-Chiari syndrome</b> may also be seen with <b>hypercoagulable</b> and <b>post-{{c1::partum}} states</b></div>", "time": null}, {"id": 1486591301294, "note": "<div>What <u>myeloproliferative disorder</u> is associated with <b>Budd-Chiari syndrome</b>? </div><div><br /></div><div>{{c1::Polycythemia vera}} </div>", "time": null}, {"id": 1486591304104, "note": "<div><b>{{c1::Budd-Chiari}} syndrome</b> is <u>liver infarction</u> <i>secondary</i> to <b>{{c2::hepatic vein}} obstruction</b></div>", "time": null}, {"id": 1486591314813, "note": "<div><b>Budd-Chiari syndrome</b> presents with <u>{{c1::painful::painful or painless}}</u> <b>hepatomegaly</b>, <b>ascites</b>, varices, and liver failure</div>", "time": 1660105361078.0}, {"id": 1486591317696, "note": "<div><b>Budd-Chiari syndrome</b> results in <u>congestion</u> and <u>necrosis</u> of the <b>{{c1::centrilobular}} zone</b> of the liver</div>", "time": null}, {"id": 1486591320386, "note": "<div>Does <u>Budd-Chiari syndrome</u> present with <b>jugular venous distention</b> (JVD)?</div><div><br /></div><div>{{c1::No}} </div>", "time": 1660105359880.0}, {"id": 1486591326494, "note": "<div><b>{{c2::Budd-Chiari}} syndrome</b> is associated with a characteristic \"{{c1::<b>nutmeg</b>}}\" appearance of the liver</div>", "time": 1660105338242.0}, {"id": 1486591329503, "note": "<div>How does <b>hepatocellular carcinoma</b> spread? </div><div><br></div><div>{{c1::Hematogenously}}</div>", "time": null}, {"id": 1486591331907, "note": "<div>What is the <u>serum tumor marker</u> for <b>hepatocellular carcinoma</b>?</div><div><br></div><div>{{c1::Alpha-fetoprotein}}</div>", "time": null}, {"id": 1486591357720, "note": "<div><b>{{c1::Spontaneous (primary) bacterial peritonitis}}</b> is a common, potentially fatal <u>bacterial infection</u> in patients with <b>cirrhosis</b> and <b>ascites</b> </div>", "time": null}, {"id": 1486591369680, "note": "<div><b>Spontaneous bacterial peritonitis</b> is commonly caused by <i><b>aerobic</b></i>, <b>gram negative</b> organisms, especially <i>{{c1::E. coli}}</i> and <i>{{c1::Klebsiella}}</i></div>", "time": null}, {"id": 1486591372327, "note": "<div><b>{{c2::Spontaneous bacterial peritonitis}}</b> is diagnosed by <u>paracentesis</u> with ascitic fluid <b>absolute neutrophil count</b> &gt; {{c1::250}} cells/mm<sup>3</sup></div>", "time": null}, {"id": 1486591374938, "note": "<div><b>AST {{c1::&gt;}} ALT</b> in <u>nonalcoholic</u> liver disease suggests progression to <b>advanced fibrosis</b> or <b>cirrhosis</b></div>", "time": null}, {"id": 1486591387909, "note": "<div>Which <u>liver enzyme</u> is <i>increased</i> in <b>cholestasis</b> (e.g. biliary obstruction), <b>infiltrative</b> <b>disorders</b>, <i>and</i> <b>bone</b> <b>disease</b>? </div><div><br /></div><div>{{c1::Alkaline phosphatase}}</div>", "time": null}, {"id": 1486591392171, "note": "<div><div>Which <u>liver enzyme</u> is <i>increased</i> in various <b>liver/biliary diseases</b>, but <i>NOT</i> in <b>bone</b> <b>disease</b>? </div><div><br /></div><div>{{c1::\u03b3-glutamyl transpeptidase (GGT)}}</div></div>", "time": null}, {"id": 1486591396296, "note": "<div><b><i>\u03b3-glutamyl transpeptidase</i></b> (GGT) is associated with <b>{{c1::alcohol}} use</b></div>", "time": null}, {"id": 1486591400578, "note": "<div>How does <u>prothrombin time</u><b> </b>(PT) <i>change</i> with <b>advanced liver disease</b>? </div><div><br></div><div>{{c1::Increased}}</div>", "time": 1660105358070.0}, {"id": 1486596640365, "note": "<div>Which <u>embryological structure</u> develops into the GI tract from the <b>lower esophagus</b> to the <b>proximal duodenum</b>? </div><div><br /></div><div>{{c1::Foregut}}</div>", "time": null}, {"id": 1486596665570, "note": "<div><div>Which <u>embryological structure</u> develops into the GI tract from the <b>distal duodenum</b> to the <b>proximal <sup>2</sup>/<sub>3</sub> of the transverse colon</b>? </div><div><br /></div><div>{{c1::Midgut}}</div></div>", "time": null}, {"id": 1486596668900, "note": "<div><div>Which <u>embryological structure</u> develops into the GI tract from the <b>distal <sup>1</sup>/<sub>3</sub> of the transverse colon</b> to the <b>anal canal above the pectinate line</b>? </div><div><br /></div><div>{{c1::Hindgut}}</div></div>", "time": null}, {"id": 1486596671662, "note": "<div>Which <u>embryological structure</u> develops into the <b>liver </b>and <b>gallbladder</b>? </div><div><br /></div><div>{{c1::Foregut}}</div>", "time": 1660105343175.0}, {"id": 1486596675590, "note": "<div>During the <u>{{c2::6th}} week</u> of gestation, the <b>{{c1::midgut}}</b> <i>herniates</i> through the <b>umbilical ring</b> </div>", "time": null}, {"id": 1486596678532, "note": "<div>During the <u>{{c2::10th}} week</u> of gestation, the<b> midgut </b><i>returns</i> to the abdominal cavity<b> </b>and <u>rotates {{c3::270}}\u00b0 counterclockwise</u><b> </b>around the <b>{{c1::superior mesenteric}} artery</b> <b> </b></div>", "time": null}, {"id": 1486596683598, "note": "<div><b>Congenital {{c1::umbilical hernia}}</b> is a <u>failure of umbilical ring to close</u> after physiologic herniation of the intestines</div>", "time": null}, {"id": 1486596689685, "note": "<div>The <b>main pancreatic duct</b> drains into the<b> {{c1::major}} duodenal papilla</b></div>", "time": null}, {"id": 1486596693761, "note": "The <b>accessory pancreatic duct</b> drains into the<b> {{c1::minor}} duodenal papilla</b>", "time": null}, {"id": 1486605111359, "note": "The <b>retroperitoneal</b> <b>structures</b> of the <u>GI tract</u> may be remembered with the mnemonic \"<b>SAID</b> <b>PUCKER</b>\": <div style=\"centerbox\"><div class=\"mnemonics\"><div><br></div><div><b>S</b>: {{c1::Suprarenal (adrenal) glands}}</div><div><b>AI</b>: {{c2::Aorta and IVC}} </div><div><b>D</b>: {{c3::Duodenum (2<sup>nd</sup> through 4<sup>th</sup> part)}}  </div><div><br></div><div><b>P</b>: {{c4::Pancreas (except tail)::except...}} </div><div><b>U</b>: {{c5::Ureters}} </div><div><b>C</b>: {{c6::Colon (ascending and descending) <i>*surgeons consider these intraperitoneal</i>}} </div><div><b>K</b>: {{c7::Kidney}}</div><div><b>E</b>: {{c8::Esophagus (thoracic portion)}} </div><div><b>R</b>: {{c9::Rectum (partially)}} </div></div></div>", "time": 1660105349629.0}, {"id": 1486605702844, "note": "<div>Which <u>GI ligament</u> connects the <b>liver</b> to the <b>anterior abdominal wall</b>?</div><div><br /></div><div>{{c1::Falciform ligament}}</div>", "time": null}, {"id": 1486605708937, "note": "<div>What <u>structure</u> is contained within the <b>falciform ligament</b>?</div><div><br></div><div>{{c1::Ligamentum teres hepatis (derivative of fetal umbilical vein)}} </div>", "time": null}, {"id": 1486605712112, "note": "<div>Which <u>GI ligament</u> is a derivative of <b>ventral mesentery</b>?</div><div><br /></div><div>{{c1::Falciform ligament}}</div>", "time": null}, {"id": 1486605714923, "note": "<div><div>Which <u>GI ligament</u> connects the <b>liver</b> to the <b>duodenum</b>?</div><div><br /></div><div>{{c1::Hepatoduodenal ligament}}</div></div>", "time": 1660105342980.0}, {"id": 1486605719941, "note": "<div><div>What <u>structure</u> is contained within the <b>hepatoduodenal ligament</b>?</div><div><br></div><div>{{c1::Portal triad (proper hepatic artery, portal vein, common bile duct)}}</div></div>", "time": 1660105344959.0}, {"id": 1486605724453, "note": "<div><div>The <b>{{c2::Pringle}} maneuver</b> involves <i>compression</i> of the <u>{{c1::hepatoduodenal}} ligament</u> to <b>control</b> <b>liver</b> <b>bleeding</b> </div></div>", "time": null}, {"id": 1486605727740, "note": "<div>The <b>{{c2::hepatoduodenal}}</b> <b>ligament</b> borders the <u>{{c1::omental}} foramen</u>, which <i>connects</i> the <b>greater</b> and <b>lesser</b> <b>sacs</b> </div>", "time": null}, {"id": 1486605759797, "note": "<div>The <u>lesser omentum</u> is formed by the <b>{{c1::gastrohepatic}}</b> and <b>{{c2::hepatoduodenal}}</b> <b>ligaments</b></div>", "time": 1660105349914.0}, {"id": 1486605773525, "note": "<div><div>Which <u>GI ligament</u> connects the <b>greater curvature</b> <b>of the stomach</b> to the <b>spleen</b>?</div><div><br></div><div>{{c1::Gastrosplenic ligament}}</div></div>", "time": null}, {"id": 1486605777827, "note": "<div><div>What <u>structures</u> are contained within the <b>gastrosplenic ligament</b>?</div><div><br></div><div>{{c1::Short gastric arteries}} and {{c2::left gastroepiploic vessels}} </div></div>", "time": null}, {"id": 1486605781009, "note": "<div>The <b>{{c2::gastrosplenic}} ligament</b> <i>separates</i> the <b>greater</b> and <b>lesser</b> <b>sacs</b> on the <u>{{c1::left::left or right}}</u>&nbsp;</div>", "time": null}, {"id": 1486605785335, "note": "<div>The <u>greater omentum</u> is formed by the <b>{{c1::gastrocolic}}</b> and <b>{{c2::gastrosplenic}}</b> <b>ligaments</b></div>", "time": 1660105350059.0}, {"id": 1486605789747, "note": "<div><div>Which <u>GI ligament</u> connects the <b>spleen</b> to the <b>posterior abdominal wall</b>?</div><div><br></div><div>{{c1::Splenorenal ligament}}</div></div>", "time": 1660105342979.0}, {"id": 1486605794937, "note": "<div><div>What <u>structures</u> are contained within the <b>splenorenal ligament</b>?</div><div><br></div><div>{{c1::Splenic artery/vein}} and the {{c2::tail of the pancreas}} </div></div>", "time": null}, {"id": 1486608389324, "note": "What type of <u>epithelium</u> lines the <b>esophagus</b>? <div><br /></div><div>{{c1::Non-keratinized stratified squamous epithelium}}</div>", "time": null}, {"id": 1486608728772, "note": "<div>The surface of the <u>stomach</u> is marked <i>histologically</i> by closely spaced grooves called <b>gastric {{c1::pits}}</b>, into which several gastric glands secrete</div>", "time": 1660105349524.0}, {"id": 1486608734803, "note": "<div>The <b>gastric {{c1::glands}}</b> of the <u>stomach</u> contain the <b>mucous cells</b>, <b>chief</b> <b>cells</b>, and <b>parietal cells</b></div>", "time": 1660105350096.0}, {"id": 1486608739171, "note": "<div>The <b>{{c2::chief::chief or parietal}} cells</b>&nbsp;of the <u>stomach</u> stain <b>{{c1::baso}}-philic</b></div>", "time": null}, {"id": 1486608745216, "note": "<div>The {{c2::<b>parietal</b>::chief or parietal}} <b>cells</b> of the <u>stomach</u> stain <b>{{c1::eosino}}-philic</b></div>", "time": null}, {"id": 1486608749626, "note": "<div>What type of <u>epithelium</u> lines the <b>small</b> and <b>large intestine</b>?</div><div><br /></div><div>{{c1::Simple columnar epithelium}}</div>", "time": null}, {"id": 1486608754106, "note": "<div><i>All</i> three parts of the <b>small intestine</b> contain <b>{{c1::villi}}</b> and <b>{{c1::microvilli}}</b>, which <u>increase</u> <b>absorptive surface area</b></div>", "time": 1660105361942.0}, {"id": 1486608758394, "note": "<div><i>All</i> three parts of the <b>small intestine</b> contain <b>crypts of {{c1::Lieberk\u00fchn}}</b></div>", "time": 1660105344539.0}, {"id": 1486608763486, "note": "<div><div>Where are the <b>stem cells</b> of the <u>small intestine</u> located?</div><div><br></div><div>{{c1::Crypts of Lieberk\u00fchn::specific name}}</div></div>", "time": null}, {"id": 1486608768857, "note": "<div>The <b>crypts of Lieberk\u00fchn</b> contain <u>{{c1::Paneth}} cells</u>, which secrete <b>defensins</b>, <b>lysozyme</b>, and <b>TNF</b> </div>", "time": null}, {"id": 1486608774946, "note": "<div>What <u>histologic feature</u> distinguishes the <b>duodenum</b> from other parts of the small intestine?</div><div><br /></div><div>{{c1::Brunner glands (in <u>submucosa</u>)}}</div>", "time": 1660105347037.0}, {"id": 1486608779650, "note": "<div><b>Brunner glands</b> secrete a <u>mucus-rich</u> secretion that contains {{c1::HCO<sub>3</sub><sup>-</sup>}}</div>", "time": null}, {"id": 1486608782562, "note": "<div><div>What <u>histologic feature</u> distinguishes the <b>jejunum</b> from other parts of the small intestine?</div><div><br /></div><div>{{c1::Plicae circulares}}</div></div>", "time": 1660105347035.0}, {"id": 1486608789738, "note": "<div><div>What <u>histologic feature</u> distinguishes the <b>ileum</b> from other parts of the small intestine?</div><div><br></div><div>{{c1::Peyer patches}} </div></div>", "time": 1660105347036.0}, {"id": 1486608796832, "note": "<div>Which part of the <u>small intestine</u> contains the <b><i>largest</i></b> number of <b>goblet cells</b>? </div><div><br /></div><div>{{c1::Ileum}}</div>", "time": null}, {"id": 1486608800197, "note": "<div>Does the <b>large intestine</b> contain <b>crypts of Lieberk\u00fchn</b>? </div><div><br /></div><div>{{c1::Yes}} </div>", "time": null}, {"id": 1486608805821, "note": "<div><div>Does the <b>large intestine</b> contain <b>villi</b>? </div><div><br /></div><div>{{c1::No}}</div></div>", "time": 1660105359809.0}, {"id": 1486608813182, "note": "The <b>large intestine</b> is characterized <i>histologically</i> by <u>abundant</u> <b>{{c1::goblet}} cells</b>", "time": 1660105349947.0}, {"id": 1486767143966, "note": "<div><div>What <u>vertebral level</u> does the <b>superior mesenteric artery</b> branch off the aorta? </div><div><br /></div><div>{{c1::L1}}</div></div>", "time": 1660105344695.0}, {"id": 1486767150807, "note": "<div><div>What <u>vertebral level</u> does the <b>inferior mesenteric artery</b> branch off the aorta? </div><div><br /></div><div>{{c1::L3}}</div></div>", "time": 1660105344697.0}, {"id": 1486767159823, "note": "<div>Which <u>artery</u> supplies the regions of the <b>foregut</b>? </div><div><br /></div><div>{{c1::Celiac trunk}}</div>", "time": 1660105343975.0}, {"id": 1486767163689, "note": "<div><div>Which <u>artery</u> supplies the regions of the <b>midgut</b>? </div><div><br /></div><div>{{c1::Superior mesenteric artery}}</div></div>", "time": 1660105343973.0}, {"id": 1486767179344, "note": "<div><div>Which <u>artery</u> supplies the regions of the <b>hindgut</b>? </div><div><br /></div><div>{{c1::Inferior mesenteric artery}}</div></div>", "time": 1660105343974.0}, {"id": 1486767185215, "note": "<div>What <u>vertebral level</u> does the <b>renal artery</b> branch off the aorta? </div><div><br /></div><div>{{c1::L1/L2}}</div>", "time": 1660105344696.0}, {"id": 1486767214155, "note": "<div><div>Which <u>parasympathetics</u> innervate the regions of the <b>foregut</b> and <b>midgut</b>? </div><div><br></div><div>{{c1::Vagus nerve}}</div></div>", "time": 1660105342416.0}, {"id": 1486767222611, "note": "<div>Which <u>sympathetics</u> innervate the regions of the <b>foregut</b> and <b>midgut</b>? </div><div><br></div><div>{{c1::Greater and lesser splanchnics (T5 - T12)::2}}</div>", "time": 1660105342036.0}, {"id": 1486767231234, "note": "<div><b>Superior mesenteric artery syndrome</b> occurs due to <u>compression</u> of the <b>{{c1::3rd (transverse) part of the duodenum}}</b> between the <b>SMA</b> and <b>aorta</b></div>", "time": null}, {"id": 1486767235675, "note": "<div><b>SMA syndrome</b> is characterized by <u>intermittent</u> obstruction symptoms; primarily <b>{{c1::postprandial}}</b> <b>pain</b> </div>", "time": null}, {"id": 1486767238872, "note": "<div><b>SMA syndrome</b> typically occurs in conditions associated with <u>diminished</u> {{c1::<b>mesenteric</b> <b>fat</b>}} (e.g. low body weight, malnutrition)</div>", "time": null}, {"id": 1486767243259, "note": "<div>The <u>foregut</u><b> </b>develops into structures from the {{c1::<b>lower</b> <b>esophagus</b>}} to the {{c2::<b>proximal</b> <b>duodenum</b>}} </div>", "time": null}, {"id": 1486767250072, "note": "<div>The <u>midgut</u> develops into structures from the <b>{{c1::distal duodenum}}</b> to the {{c2::<b>proximal <sup>2</sup>/<sub>3</sub> of the transverse colon</b>}}</div>", "time": null}, {"id": 1486767254523, "note": "<div>The <u>hindgut</u> develops into structures from the {{c1::<b>distal <sup>1</sup>/<sub>3</sub> of the transverse colon</b>}} to the <b>{{c2::anal canal above the pectinate line}}</b></div>", "time": null}, {"id": 1486767263733, "note": "<div>The <u>three</u> branches of the <b>celiac trunk</b> are the <b>{{c1::common hepatic}}</b>, <b>{{c2::splenic}}</b>, and <b>{{c3::left gastric}}</b> arteries</div>", "time": null}, {"id": 1486767268255, "note": "<div>The <b>{{c1::left gastric}} artery</b> gives off <b>esophageal branches</b></div>", "time": null}, {"id": 1486767276770, "note": "<div>The <b>common hepatic artery</b> <u>bifurcates</u> into the <b>{{c1::proper hepatic}}</b> and <b>{{c2::gastroduodenal}} arteries</b></div>", "time": null}, {"id": 1486767287058, "note": "<div>The <b>{{c1::proper hepatic}} artery</b> gives rise to the <b>{{c2::right}} gastric artery</b> </div>", "time": null}, {"id": 1486767295417, "note": "<div>The <b>{{c1::gastroduodenal}} artery</b> gives rise to the <b>{{c2::right}} gastroepiploic artery</b></div>", "time": null}, {"id": 1486767304293, "note": "<div>The <b>{{c1::gastroduodenal}} artery</b> gives rise to the <u>anterior superior</u> and <u>posterior superior</u><b> pancreaticoduodenal arteries</b></div>", "time": null}, {"id": 1486767314237, "note": "<div>The <b>{{c3::splenic}} artery</b> gives rise to the <b>{{c1::left gastroepiploic}}</b> and <b>{{c2::short gastric}} arteries</b></div>", "time": null}, {"id": 1486767323251, "note": "<div><b>ID Artery</b>: {{c1::Left gastroepiploic}} </div><div><br /></div><div><img src=\"paste-455240763572686.jpg\" /></div>", "time": null}, {"id": 1486767327881, "note": "<div><b>ID Artery</b>: {{c1::Splenic}}</div><div><br /></div><div><img src=\"paste-455386792460750.jpg\" /></div>", "time": null}, {"id": 1486767330571, "note": "<div><b>ID Artery</b>: {{c1::Right gastroepiploic}}</div><div><br /></div><div><img src=\"paste-455412562264523.jpg\" /></div>", "time": null}, {"id": 1486767333068, "note": "<div><b>ID Artery</b>: {{c1::Left gastric}}</div><div><br /></div><div><img src=\"paste-455438332068304.jpg\" /></div>", "time": null}, {"id": 1486767335503, "note": "<div><b>ID Artery</b>: {{c1::Right gastric}}</div><div><br /></div><div><img src=\"paste-455464101872082.jpg\" /></div>", "time": null}, {"id": 1486767337959, "note": "<div><b>ID Artery</b>: {{c1::Common hepatic}}</div><div><br /></div><div><img src=\"paste-455502756577753.jpg\" /></div>", "time": null}, {"id": 1486767341284, "note": "<div><b>ID Artery</b>: {{c1::Gastroduodenal}}</div><div><br /></div><div><img src=\"paste-455537116316122.jpg\" /></div>", "time": null}, {"id": 1486767346792, "note": "<div><b>ID Artery</b>: {{c1::Short gastric arteries}}</div><div><br /></div><div><img src=\"paste-456215721148886.jpg\" /></div>", "time": null}, {"id": 1486767395683, "note": "The <b>fundus</b> and <u>upper portion</u> of the <b>greater</b> <b>curvature</b> of the stomach are supplied by the {{c1::<b>short gastric</b>}}<b> arteries</b>", "time": null}, {"id": 1486770898373, "note": "<b>{{c2::Esophageal varices}}</b> result from <u>portosystemic shunting</u> between the <b>{{c1::left gastric}}</b> (portal) and <b>{{c1::esophageal branch of the azygos}}</b> (systemic)<b> veins</b><div></div>", "time": null}, {"id": 1486771285047, "note": "<div><div><b>{{c2::Caput medusae}}</b> results from <u>portosystemic shunting</u> between the <b>{{c1::paraumbilical}} veins</b> (portal) and small <b>{{c1::epigastric}} veins</b> of the abdominal wall (systemic)</div></div>", "time": null}, {"id": 1486771299461, "note": "<div><div><b>{{c2::Anorectal varices}}</b> result from <u>portosystemic shunting</u> between the <b>{{c1::superior rectal}}</b> (portal) and <b>{{c1::middle/inferior rectal}}</b> (systemic)<b> veins</b></div></div>", "time": null}, {"id": 1486771310689, "note": "<div><div><b>Portosystemic shunts</b> may be treated with <u>{{c1::TIPS}}</u> between the <b>portal</b> and <b>{{c2::hepatic}}</b> <b>veins</b> </div></div>", "time": null}, {"id": 1486771318902, "note": "<div><div>Treatment of <b>portosystemic shunts</b> with <b>TIPS</b> can <u>precipitate</u> {{c1::hepatic encephalopathy}} in cirrhotic patients </div></div>", "time": 1660105348545.0}, {"id": 1486771325323, "note": "<div><div>The <b>{{c1::pectinate (dentate)}} line</b> is formed where <b>anal</b> <b>endoderm</b> (hindgut) meets <b>ectoderm</b> </div></div>", "time": 1660105349098.0}, {"id": 1486771334237, "note": "<div>Which type of <u>hemorrhoids</u> are found <b>above the pectinate line</b>?<div><br /></div><div>{{c1::Internal hemorrhoids}}</div></div>", "time": null}, {"id": 1486771339520, "note": "<div><div><div>Which type of <u>carcinoma</u> forms <b>above</b> <b>the</b> <b>pectinate</b> <b>line</b>?</div></div><div><br /></div><div>{{c1::Adenocarcinoma}}</div></div>", "time": null}, {"id": 1486771343412, "note": "<div>Which <u>artery</u> supplies the rectum <b>above the pectinate line</b>?<div><br /></div><div>{{c1::Superior rectal artery (from the IMA)}}</div></div>", "time": null}, {"id": 1486771346144, "note": "<div>The <b>superior rectal artery</b> is a branch of the <b>{{c1::inferior mesenteric}} artery</b> </div>", "time": null}, {"id": 1486771351448, "note": "<div>Which <u>lymph nodes</u> drain the rectum <b>above the pectinate line</b>? </div><div><br /></div><div>{{c1::Internal iliac nodes}}</div>", "time": null}, {"id": 1486771357327, "note": "<div>Which type of <u>hemorrhoid</u> is <b>NOT painful</b>? </div><div><br /></div><div>{{c1::Internal hemorrhoids}}</div>", "time": null}, {"id": 1486771359798, "note": "<div>Does the rectum <u>ABOVE the pectinate line</u> drain into the <b>portal </b>or <b>systemic circulation</b>? </div><div><br /></div><div>{{c1::Portal}} </div>", "time": null}, {"id": 1486771365392, "note": "<div>Which type of <u>hemorrhoids</u> are found <b>below the pectinate line</b>?<div><br /></div><div>{{c1::External hemorrhoids}}</div></div>", "time": null}, {"id": 1486771369403, "note": "<div><div><div>Which type of <u>carcinoma</u> forms <b>below</b> <b>the</b> <b>pectinate</b> <b>line</b>?</div></div><div><br /></div><div>{{c1::Squamous cell carcinoma}}</div></div>", "time": null}, {"id": 1486771372707, "note": "<div>Which <u>artery</u> supplies the rectum <b>below the pectinate line</b>?<div><br></div><div>{{c1::Inferior rectal artery (from the internal pudendal artery)}}</div></div>", "time": null}, {"id": 1486771374861, "note": "<div><div>The <b>inferior rectal artery</b> is a branch of the <b>{{c1::internal pudendal}} artery</b> </div></div>", "time": null}, {"id": 1486771380083, "note": "<div>Which <u>lymph nodes</u> drain the rectum <b>below the pectinate line</b>? </div><div><br></div><div>{{c1::Superficial inguinal nodes}}</div>", "time": null}, {"id": 1486771387643, "note": "<div><div>Which type of <u>hemorrhoid</u> <b>IS painful</b>? </div><div><br /></div><div>{{c1::External hemorrhoids}}</div></div>", "time": null}, {"id": 1486771390217, "note": "<div><div>Does the rectum <u>BELOW the pectinate line</u> drain into the <b>portal </b>or <b>systemic circulation</b>? </div><div><br /></div><div>{{c1::Systemic}} </div></div>", "time": null}, {"id": 1486771396183, "note": "<div><div><b>Anal {{c2::fissures}}</b> are described as <b>tears</b> in the anal mucosa <u>{{c1::below}}</u> the <b>pectinate line</b> </div></div>", "time": null}, {"id": 1486775502282, "note": "The <u>portal triad</u> consists of the <b>{{c1::bile duct}}</b>, <b>{{c2::hepatic artery proper}}</b>, and <b>{{c3::portal vein}}</b>", "time": null}, {"id": 1486776235726, "note": "<div><u>Terminal branches</u> of <b>portal veins</b> connect with hepatic <b>sinusoids</b> that <i>converge</i> toward a(n)&nbsp;<b>{{c1::terminal hepatic (central)}} vein</b></div>", "time": 1660105350570.0}, {"id": 1486776242882, "note": "<div>{{c1::Blood::blood or bile}} flows from the <b>portal triad</b> <u>towards</u> the <b>central vein</b></div>", "time": 1660105341006.0}, {"id": 1486776248771, "note": "<div>{{c1::Bile::blood or bile}} flows from the <b>central vein</b> <u>towards</u> the <b>portal triad</b></div>", "time": 1660105341015.0}, {"id": 1486776254440, "note": "<div><div>What is at the <b>center</b> of each <u>hexagon</u> (liver)?</div><div><br /></div><div>{{c1::Terminal Hepatic Venule (Central veins)}}</div><div><br /></div><div><img src=\"paste-357929689547088.jpg\" /></div></div>", "time": null}, {"id": 1486776257809, "note": "<div><div>What are the darker areas on the <b>corner</b> of each <u>hexagon</u> (liver)? </div><div><br /></div><div>{{c1::Portal triads}}</div><div><br /></div><div><img src=\"paste-357933984514384.jpg\" /></div></div>", "time": null}, {"id": 1486776304662, "note": "<div>The <u>{{c1::apical}}</u> surface of <b>hepatocytes</b> faces <b>bile canaliculi</b></div>", "time": null}, {"id": 1486776314995, "note": "<div>The <u>{{c1::basolateral}}</u> surface of <b>hepatocytes</b> faces <b>sinusoids</b></div>", "time": null}, {"id": 1486776332176, "note": "<div><b>{{c1::Kupffer}} cells</b> are specialized <u>{{c2::macrophages}}</u> that form the <i>lining</i> of <b>hepatic sinusoids</b> </div>", "time": 1660105339862.0}, {"id": 1486776358379, "note": "<div>Which <u>liver cell</u> is the major mediator of <b>fibrosis</b> in response to <b>tissue</b> <b>damage</b> (e.g. cirrhosis)? </div><div><br /></div><div>{{c1::Stellate (Ito cells)}}</div>", "time": null}, {"id": 1486776364876, "note": "<div><b>Zone {{c2::I}}</b> of the <u>liver</u> is the <b>{{c1::periportal}} zone</b></div>", "time": null}, {"id": 1486776370260, "note": "<div><b>Zone II</b> of the <u>liver</u> is the <b>{{c1::intermediate}} zone</b></div>", "time": null}, {"id": 1486776374938, "note": "<div><b>Zone {{c2::III}}</b> of the liver is the {{c1::<b>centrilobular</b> (pericentral vein)}} <b>zone</b></div>", "time": null}, {"id": 1486776378880, "note": "<div>Which <u>liver zone</u> is affected <i>first</i> by <b>viral hepatitis</b>? </div><div><br /></div><div>{{c1::Zone I (periportal)}}</div>", "time": null}, {"id": 1486776382915, "note": "<div><div>Which <u>liver zone</u> is affected <i>first</i> by <b><i>ingested</i> toxins</b> (e.g. cocaine)? </div><div><br /></div><div>{{c1::Zone I (periportal)}}</div></div>", "time": null}, {"id": 1486776386641, "note": "<div><div>Which <u>liver zone</u> is affected by <b>yellow fever</b>? </div><div><br /></div><div>{{c1::Zone II (intermediate)}}</div></div>", "time": null}, {"id": 1486776390497, "note": "<div><div>Which <u>liver zone</u> is affected <i>first</i> by<b> ischemia</b>? </div><div><br /></div><div>{{c1::Zone III (centrilobular)}}</div></div>", "time": null}, {"id": 1486776394241, "note": "<div>Which <u>liver zone</u> contains the <b>cytochrome P-450 system</b>? </div><div><br /></div><div>{{c1::Zone III (centrilobular)}}</div>", "time": null}, {"id": 1486776399210, "note": "<div><div>Which <u>liver zone</u> is affected <i>first</i> by <b><i>metabolic</i> toxins</b> (e.g. alcohol, tylenol, ethanol, CCl4, halothane, rifampin)? </div><div><br /></div><div>{{c1::Zone III (centrilobular)}}</div></div>", "time": null}, {"id": 1486776403243, "note": "<div>Which <u>liver zone</u> is the site of <b>alcoholic hepatitis</b>? </div><div><br /></div><div>{{c1::Zone III (centrilobular)}}</div>", "time": null}, {"id": 1486777451032, "note": "The <u>common bile duct</u> is formed by the <b>{{c1::cystic duct}}</b> and the <b>{{c2::common hepatic duct}}</b>", "time": null}, {"id": 1486777651171, "note": "<div>The <b>{{c1::common bile}} duct</b> and <b>{{c2::main pancreatic}} duct</b> join at the <b>ampulla of Vater</b></div>", "time": null}, {"id": 1486777654795, "note": "<div>What <u>sphincter</u> controls the release of digestive juices from the <b>common</b> <b>bile</b> and <b>pancreatic</b> <b>ducts</b>? </div><div><br /></div><div>{{c1::Sphincter of Oddi}}</div>", "time": null}, {"id": 1486777658795, "note": "<div>Gallstones that reach the <u>confluence</u> of the <i>common bile</i> and <i>pancreatic ducts</i> at the&nbsp;<b>{{c1::ampulla of Vater::name of hole}}</b> can block <u>both ducts</u> (double duct sign) causing&nbsp;<b>cholangitis</b> and <b>pancreatitis</b></div>", "time": 1660105358728.0}, {"id": 1486778497083, "note": "The organization of the <b>femoral region</b> from <u>lateral to medial</u> is the {{c1::nerve-artery-vein-lymphatics (<b>NAVeL</b>)}}", "time": null}, {"id": 1486778696654, "note": "<div>What are the contents of the <b>femoral triangle</b>? </div><div><br /></div><div>{{c1::Femoral nerve, artery, and vein}}</div>", "time": null}, {"id": 1486778702275, "note": "<div><div>What are the contents of the <b>femoral sheath</b>? </div><div><br /></div><div>{{c1::Femoral artery, vein, and canal (deep inguinal lymph nodes)}}</div></div>", "time": null}, {"id": 1486778710282, "note": "<div>The <b>femoral</b> {{c1::<b>sheath</b>}} is a <u>fascial tube</u> found 3-4 cm below the <b>inguinal ligament</b> </div>", "time": null}, {"id": 1486778716772, "note": "<div>What is the <u>superior border</u> of the <b>femoral triangle</b>?</div><div><br /></div><div>{{c1::Inguinal ligament}}</div>", "time": null}, {"id": 1486778720937, "note": "<div>What is the <u>lateral border</u> of the <b>femoral triangle</b>?</div><div><br /></div><div>{{c1::Sartorius muscle}}</div>", "time": null}, {"id": 1486778725100, "note": "<div>What is the <u>medial border</u> of the <b>femoral triangle</b>?</div><div><br /></div><div>{{c1::Adductor longus muscle}}</div>", "time": null}, {"id": 1486780884702, "note": "The <b>{{c2::external oblique}}</b> gives rise to the <u>{{c1::external spermatic fascia}}</u> of the <b>spermatic cord</b> ", "time": 1660105348926.0}, {"id": 1486781809597, "note": "<div>The <b>{{c2::internal oblique muscle}}</b> gives rise to the <u>{{c1::cremasteric muscle/fascia}}</u> of the <b>spermatic cord</b> </div>", "time": 1660105348910.0}, {"id": 1486781824679, "note": "<div>The <b>{{c2::transversalis fascia}}</b> gives rise to the <u>{{c1::internal spermatic fascia}}</u> of the <b>spermatic cord</b> </div>", "time": 1660105348846.0}, {"id": 1486781853443, "note": "<div>A(n) {{c1::hernia}} is a <b>protrusion of peritoneum</b> through an <u>opening</u>, usually at a site of weakness</div>", "time": null}, {"id": 1486781856708, "note": "<div><b>Herniated contents</b> may be at risk for {{c1::<u>incarceration</u>}}, which is the <b>inability to reduce contents back into the abdomen/pelvis</b> </div>", "time": null}, {"id": 1486781859461, "note": "<div><b>Herniated contents</b> may be at risk for {{c1::<u>strangulation</u>}}, which is characterized by <b>ischemia and necrosis</b> </div>", "time": null}, {"id": 1486781865305, "note": "<div>Which type of <u>inguinal hernia</u> involves protrusion of the bowel through<b> </b>the<b> internal inguinal ring, external inguinal ring </b>and<b> into the scrotum</b>?<div><br /></div><div>{{c1::Indirect inguinal hernia}}</div></div>", "time": null}, {"id": 1486781873705, "note": "<div>What is the <u>site of protrusion</u> in an <b>indirect inguinal hernia</b>?<div><br /></div><div>{{c1::Internal (deep) inguinal ring}}</div></div>", "time": null}, {"id": 1486781877894, "note": "<div><b>{{c2::Indirect}} inguinal hernias</b> herniate <u>{{c1::lateral}}</u> to the <b>inferior epigastric vessels</b></div>", "time": null}, {"id": 1486781885770, "note": "<div><b>Indirect inguinal hernias</b> occur in <u>infants</u> due to failure of the {{c1::<b>processus</b> <b>vaginalis</b>}} to close </div>", "time": null}, {"id": 1486781908212, "note": "<div><b>Indirect inguinal hernias</b> are more common in {{c1::<u>males</u>::gender}}&nbsp;</div>", "time": null}, {"id": 1486781913076, "note": "<div>Which <u>layer(s) of spermatic fascia</u> cover an <b>indirect inguinal hernia</b>? </div><div><br /></div><div>{{c1::All three :)}}</div>", "time": null}, {"id": 1486781921099, "note": "<div><div>Which type of <u>inguinal hernia</u> involves protrusion of the bowel through<b> </b>the<b> superficial inguinal ring <i>only</i></b>?<div><br /></div><div>{{c1::Direct inguinal hernia}}</div></div></div>", "time": null}, {"id": 1486781925444, "note": "<div><div>What is the <u>site of protrusion</u> in a&nbsp;<b>direct inguinal hernia </b>and through what anatomical landmark?<div><br></div><div>{{c1::Abdominal wall (through Hesselbach triangle)}}</div></div></div>", "time": null}, {"id": 1486781932848, "note": "<div><div><b>{{c2::Direct}} inguinal hernias</b> herniate <u>{{c1::medial}}</u> to the <b>inferior epigastric vessels</b></div></div>", "time": null}, {"id": 1486781953253, "note": "<div><div>What <u>demographic</u>&nbsp;is more commonly affected by <b>direct inguinal hernias</b>?<b> </b></div><div><b><br></b></div><div>{{c1::Older men::age, gender}}</div></div>", "time": null}, {"id": 1486781957705, "note": "<div><div>Which <u>layer(s) of spermatic fascia</u> cover a <b>direct inguinal hernia</b>? </div><div><br /></div><div>{{c1::External spermatic fascia}}</div></div>", "time": null}, {"id": 1486781960267, "note": "<div><b>Direct inguinal hernias</b> are usually due to an <u>acquired weakness</u> in the <b>{{c1::transversalis}} fascia</b> </div>", "time": null}, {"id": 1486781963213, "note": "<div>What is the <u>medial border</u> of the <b>inguinal (Hesselbach) triangle</b>? </div><div><br /></div><div>{{c1::Lateral border of rectus abdominis}}</div>", "time": null}, {"id": 1486781967050, "note": "<div><div>What is the <u>lateral border</u> of the <b>inguinal (Hesselbach) triangle</b>? </div><div><br /></div><div>{{c1::Inferior epigastric vessels}}</div></div>", "time": null}, {"id": 1486781970730, "note": "<div>What is the <u>inferior border</u> of the <b>inguinal (Hesselbach) triangle</b>? </div><div><br /></div><div>{{c1::Inguinal (Poupart) ligament}}</div>", "time": null}, {"id": 1486830193952, "note": "Which type of <u>hernia</u> protrudes <b>below the inguinal ligament</b>, lateral to the pubic tubercle? <div><br /></div><div>{{c1::Femoral hernia}}</div>", "time": null}, {"id": 1486831365896, "note": "<div><div>Which type of <u>hernia</u> is most likely to present with <b>incarceration</b> or <b>strangulation</b>?</div><div><br /></div><div>{{c1::Femoral hernia}}</div></div>", "time": null}, {"id": 1486831370373, "note": "<div><b>{{c2::Femoral}} hernias</b> are more common in {{c1::<u>females</u>::gender}}&nbsp;</div>", "time": null}, {"id": 1486831373970, "note": "<div>Which type of <u>hernia</u> involves protrusion of <b>abdominal structures into the thorax</b>? <div><br /></div><div>{{c1::Diaphragmatic hernia}}</div></div>", "time": null}, {"id": 1486831380213, "note": "<div><b>Congenital {{c2::diaphragmatic}} hernias</b> occur due a <u>defect</u> in the {{c1::<b>pleuroperitoneal</b> <b>membrane</b>}}</div>", "time": null}, {"id": 1486831385390, "note": "<div><b>Congenital diaphragmatic hernia</b> is associated with <b>lung</b> {{c1::hypoplasia}} and a(n)&nbsp;<b>{{c2::scaphoid</b>::shape<b>}} </b>abdomen</div>", "time": null}, {"id": 1486831388932, "note": "<div><b>Diaphragmatic hernias</b> typically occur on the <u>{{c1::left::left or right}}</u> side&nbsp;</div>", "time": null}, {"id": 1486831395587, "note": "<div>What is the <u>most common</u> type of <b>diaphragmatic hernia</b>? </div><div><br /></div><div>{{c1::Sliding hiatal hernia}}</div>", "time": null}, {"id": 1486831402485, "note": "<div>What type of <b>diaphragmatic</b> <b>hernia</b> involves <u>upward displacement</u> of the <b>gastroesophageal</b> <b>junction</b>?</div><div><br /></div><div>{{c1::Sliding hiatal hernia}}</div>", "time": null}, {"id": 1486831407877, "note": "<div><b>{{c2::Sliding hiatal}} hernias</b> are characterized by an \"{{c1::<b>hourglass</b>}}\" <b>stomach</b> appearance on imaging</div>", "time": null}, {"id": 1486831412480, "note": "<div><div>What type of <b>hiatal hernia</b> involves <u>NO displacement</u> of the <b>gastroesophageal</b> <b>junction</b>?</div><div><br></div><div>{{c1::Paraesophageal hernia}}</div></div>", "time": null}, {"id": 1486831418335, "note": "<div><b>{{c2::Paraesophageal}} hiatal hernias</b> occur due to protrusion of the {{c1::<u>fundus</u>}} of the stomach into the <b>thorax</b></div>", "time": null}, {"id": 1486831422868, "note": "<div><b>Paraesophageal hernias</b> are associated with {{c1::<u>bowel sounds</u>}} in <b>lung fields</b></div>", "time": null}, {"id": 1486831427477, "note": "<div>What type of <u>hernia</u> is associated with <b>abdominal trauma</b>? </div><div><br /></div><div>{{c1::Traumatic diaphragmatic hernia}}</div>", "time": null}, {"id": 1486831445995, "note": "<div><b>Peyer patches</b> are <i>unencapsulated lymphoid tissue</i> found in the <u>{{c1::lamina propria}}</u> and <u>{{c1::submucosa}}</u> of the <b>{{c2::ileum}}</b> </div>", "time": null}, {"id": 1486831448616, "note": "<div><b>Peyer patches</b> contain specialized {{c1::<u>M cells</u>}} that sample and <b>present antigens</b> to immune cells </div>", "time": 1660105353976.0}, {"id": 1486857214573, "note": "<b>{{c1::Lamellar bodies}}</b> are <i>secretory</i> organelles found in <u>type II pneumocytes</u> that release <b>surfactant</b> ", "time": null}, {"id": 1486857369632, "note": "The best way to visualize <b>Kayser-Fleischer rings</b> in <u>Wilson disease</u> is via <b>{{c1::slit-lamp}} examination</b>", "time": null}, {"id": 1486857456886, "note": "<div><b>{{c2::Non-dihydropyridine}} CCBs</b> may cause <u>excessive AV block</u> when combined with <b>{{c1::\u03b2}}-adrenergic antagonists</b> </div>", "time": 1660105359228.0}, {"id": 1486866351517, "note": "<div>Which type of <u>immunity</u>&nbsp;includes <b>T cells</b> and <b>B cells</b>? </div><div><br></div><div>{{c1::Adaptive immunity::innate or adaptive}}</div>", "time": 1660105341783.0}, {"id": 1486867490403, "note": "<div>Which type of <u>immunity</u>&nbsp;includes <b>circulating antibodies</b>? </div><div><br></div><div>{{c1::Adaptive immunity::innate or adaptive}}</div>", "time": null}, {"id": 1486867495023, "note": "<div>Which type of <u>immunity</u>&nbsp;includes <b>macrophages</b> and <b>monocytes</b>? </div><div><br></div><div>{{c1::Innate immunity::innate or adaptive}}</div>", "time": 1660105341786.0}, {"id": 1486867499358, "note": "<div>Which type of <u>immunity</u>&nbsp;includes <b>neutrophils</b> and <b>dendritic cells</b>? </div><div><br></div><div>{{c1::Innate immunity::innate or adaptive}}</div>", "time": 1660105341785.0}, {"id": 1486867503989, "note": "<div>Which type of <u>immunity</u>&nbsp;includes <b>NK cells</b>? </div><div><br></div><div>{{c1::Innate immunity::innate or adaptive}}</div>", "time": null}, {"id": 1486867509134, "note": "<div>Which type of <u>immunity</u>&nbsp;includes <b>complement</b>? </div><div><br></div><div>{{c1::Innate immunity::innate or adaptive}}</div>", "time": 1660105341787.0}, {"id": 1486867513384, "note": "<div>Is <u>innate immunity</u> <b>specific</b> or <b>nonspecific</b>? </div><div><br /></div><div>{{c1::Non-specific}}</div>", "time": 1660105355895.0}, {"id": 1486867518070, "note": "<div>Does <u>innate immunity</u> have a <b>memory response</b>?</div><div><br /></div><div>{{c1::No}}</div>", "time": 1660105359850.0}, {"id": 1486867532110, "note": "<div>Which type of <u>immunity</u> <b>occurs rapidly</b>, over minutes to hours?</div><div><br></div><div>{{c1::Innate immunity::innate or adaptive}}</div>", "time": null}, {"id": 1486867606359, "note": "<div>Which type of <u>immunity</u>&nbsp;has <b><i>limited</i> diversity</b>?</div><div><br></div><div>{{c1::Innate immunity::innate or adaptive}}</div>", "time": null}, {"id": 1486867612235, "note": "<div><div>Is <u>adaptive immunity</u> <b>specific</b> or <b>nonspecific</b>? </div><div><br /></div><div>{{c1::Highly specific}}</div></div>", "time": 1660105355917.0}, {"id": 1486867618953, "note": "<div><div>Does <u>adaptive immunity</u> have a <b>memory response</b>?</div><div><br /></div><div>{{c1::Yes}}</div></div>", "time": 1660105359888.0}, {"id": 1486867623104, "note": "<div>Which type of <u>immunity</u>&nbsp;<b>develops over long periods</b>?</div><div><br></div><div>{{c1::Adaptive immunity::innate or adaptive}}</div>", "time": 1660105341788.0}, {"id": 1486867628723, "note": "<div>Which type of <u>immunity</u>&nbsp;has <b><i>extensive</i> diversity</b>?</div><div><br></div><div>{{c1::Adaptive immunity::innate or adaptive}}</div>", "time": null}, {"id": 1486867633025, "note": "<div>Which type of <u>immunity</u>&nbsp;includes <i>physical</i> barriers, such as <b>skin</b> and <b>mucous membranes</b>? </div><div><br></div><div>{{c1::Innate immunity::innate or adaptive}}</div>", "time": 1660105341784.0}, {"id": 1486867644687, "note": "<div>Which type of <u>immunity</u>&nbsp;includes <i>physiologic</i> barriers, such as <b>temperature</b> and <b>pH</b>? </div><div><br></div><div>{{c1::Innate immunity::innate or adaptive}}</div>", "time": null}, {"id": 1486867649389, "note": "<div>Which type of <u>immunity</u>&nbsp;includes <i>chemical</i> barriers, such as <b>lysozyme</b> and <b>defensins</b>? </div><div><br></div><div>{{c1::Innate immunity::innate or adaptive}}</div>", "time": null}, {"id": 1486867654077, "note": "Which <u>immunoglobulin isotypes</u> are expressed by <b>mature, <i>naive</i> B-cells</b>?<div><br /></div><div>{{c1::IgM and IgD}}</div>", "time": null}, {"id": 1486867658485, "note": "<div><div>The antigen receptors of <b>B lymphocytes</b> have <u>two</u> <b>{{c1::heavy}}</b> and <b>{{c1::light}}</b> <b>chains</b> (bivalent)</div></div>", "time": 1660105350448.0}, {"id": 1486867662727, "note": "<div>The antigen receptors of <b>{{c2::B}} lymphocytes</b> have a(n)&nbsp;<u>{{c1::hinge}} region</u>, which allows for <b>flexibility</b></div>", "time": null}, {"id": 1486867667014, "note": "<div><div>The <u>signal transduction region</u> of <b>B lymphocytes</b> includes a <i>heterodimer</i> of <b>{{c1::Ig-\u03b1}}</b> and <b>{{c1::Ig-\u03b2}}</b> </div></div>", "time": null}, {"id": 1486867676959, "note": "<div><div><div><div>The <u>{{c2::idio}}-type</u> of an antibody is determined by the <b>{{c1::Fab</b>::<b>Fc or Fab}} region</b></div></div></div></div>", "time": null}, {"id": 1486867685826, "note": "<div>The <u>{{c2::iso}}-type</u> of an antibody is determined by the <b>{{c1::Fc</b>::<b>Fc or Fab}} region</b>&nbsp;</div>", "time": null}, {"id": 1486867696248, "note": "<div><div><div>The <u>{{c1::heavy}} chain</u> contributes to the <b>Fab</b> <i>and</i> <b>Fc</b> <b>region</b> of an antibody</div></div></div>", "time": null}, {"id": 1486867700749, "note": "<div><div><div>The <u>{{c1::light}} chain</u> <i>only</i> contributes to the <b>Fab region</b> of an antibody</div></div></div>", "time": null}, {"id": 1486867704942, "note": "<div><div>The <b>mature, <i>naive</i> T cell</b> expresses a <u>single</u> <b>{{c1::T-cell}} receptor</b> on its surface</div></div>", "time": 1660105349853.0}, {"id": 1486867708925, "note": "<div><div>The antigen receptors of <b>T lymphocytes</b> have <u>one</u> <b>{{c1::\u03b1}}</b> and <b>{{c1::\u03b2}} chain</b> (monovalent)</div></div>", "time": 1660105350447.0}, {"id": 1486867712651, "note": "<div>The <u>signal transduction region</u> of <b>T lymphocytes</b> consists of a multi-chain structure known as {{c1::CD3}}</div>", "time": null}, {"id": 1486867718130, "note": "<div>Is the <u>T-cell antigen receptor</u> <b>mobile</b> or <b>rigid</b>?</div><div><br /></div><div>{{c1::Rigid (no hinge region)}}</div>", "time": null}, {"id": 1486945028810, "note": "<div>Antigen-<i>independent</i> <u>antibody diversity</u> in <b>{{c1::heavy}}</b> <b>chains</b> is generated by <b>{{c2::V(D)J}} gene recombination</b></div>", "time": null}, {"id": 1486945095844, "note": "<div><b>V(D)J recombination</b> in <u>heavy chains</u> begins with {{c1::<b>D-J</b>}} <b>joining</b>, followed by {{c2::<b>V-D/J</b>}} <b>joining</b></div>", "time": null}, {"id": 1486945100917, "note": "<div>Antigen-<i>independent</i> <u>antibody diversity</u> in <b>{{c1::light}}</b> <b>chains</b> is generated by <b>{{c2::VJ}} gene recombination</b></div>", "time": null}, {"id": 1486945105493, "note": "<div><div>The enzymes responsible for <b>gene recombination</b> in <u>heavy</u> and <u>light chains</u> are encoded by the genes <i><b>{{c1::RAG1}}</b></i> and <i><b>{{c1::RAG2}}</b></i> </div></div>", "time": null}, {"id": 1486945114357, "note": "<div><div>Antigen-<i>independent</i> <u>antibody diversity</u> is generated via <b>insertion of random nucleotides</b> during <b>V(D)J recombination</b> by the enzyme {{c1::<b><i>terminal deoxyribonucleotidyl transferase</i></b> (Tdt)}} </div></div>", "time": null}, {"id": 1486945119290, "note": "<div>Antigen-<i>{{c1::independent}}</i> <u>antibody diversity</u> is generated via random combination of <b>heavy</b> and <b>light chains</b> </div>", "time": 1660105361703.0}, {"id": 1486945122632, "note": "<div><div>Which <u>primary lymphoid organ</u> is the site for <b>immune cell production</b>? </div><div><br></div><div>{{c1::Bone marrow}}</div></div><div><br></div><div><i>*bonus: whats the survival signal?</i></div>", "time": null}, {"id": 1486945125504, "note": "<div><div><div>Which <u>primary lymphoid organ</u> is the site of <b>B-cell maturation</b>? </div><div><br /></div><div>{{c1::Bone marrow}}</div></div></div>", "time": 1660105342303.0}, {"id": 1486945128758, "note": "<div><div><div>Which <u>primary lymphoid organ</u> is the site of <b>T-cell differentiation</b> and <b>maturation</b>? </div><div><br /></div><div>{{c1::Thymus}}</div></div></div>", "time": 1660105342302.0}, {"id": 1486945131833, "note": "<div><div>The {{c1::secondary}} <u>lymphoid organs</u> allow <b>immune cells to react with antigen</b> </div></div>", "time": 1660105349038.0}, {"id": 1486945137995, "note": "<div><b>Antigens</b> are brought into a <u>lymph node</u> via <b>{{c1::afferent}}</b> <b>lymphatics</b> </div>", "time": 1660105361689.0}, {"id": 1486945149721, "note": "<div><div>The <u>outer cortex</u> of a <b>lymph node</b> contains aggregates of cells called {{c1::follicles}}</div></div>", "time": 1660105349734.0}, {"id": 1486945155220, "note": "<div><div>Where in the <u>lymph node</u> do<b> B-cells</b> <b>localize</b> and <b>proliferate</b>? </div><div><br /></div><div>{{c1::Follicles (outer cortex)}}</div></div>", "time": null}, {"id": 1486945159596, "note": "<div>In lymph nodes, <u>{{c1::primary}} follicles</u> are <b>dense</b> and <b><i>dormant</i></b></div>", "time": null}, {"id": 1486945164044, "note": "<div>In lymph nodes, <u>{{c1::secondary}} follicles</u> have <b>pale, central {{c2::germinal centers}}</b> and are <b><i>active</i></b></div>", "time": 1660105357126.0}, {"id": 1486945168998, "note": "<div>The {{c1::paracortex}} is the region of a <u>lymph node</u> between <b>follicles</b> and <b>medulla</b></div>", "time": 1660105349107.0}, {"id": 1486945173671, "note": "<div><div>Where in the <u>lymph node</u> do<b> T-cells</b> <b>localize</b> and <b>proliferate</b>? </div><div><br /></div><div>{{c1::Paracortex}}</div></div>", "time": null}, {"id": 1486945178237, "note": "<div>The lymph node <u>{{c2::paracortex}}</u> contains {{c1::<b>high endothelial venules</b> (HEV)}}, through which <b>T</b> and <b>B cells enter from the blood</b> </div>", "time": null}, {"id": 1486945186009, "note": "<div>Which region of the <i>lymph node</i> is <u>not well developed</u> in <b>DiGeorge syndrome</b>?</div><div><br /></div><div>{{c1::Paracortex}} </div>", "time": null}, {"id": 1486945189088, "note": "<div><div>Which region of the <i>lymph node</i> <u>enlarges</u> during an <b>extreme cellular immune reponse</b> (e.g. viral infection)?</div><div><br /></div><div>{{c1::Paracortex}}</div></div>", "time": null}, {"id": 1486945192340, "note": "<div>The <u>inner layer</u> of lymph nodes is the {{c1::medulla}}, which consists of <b>medullary cords</b> and <b>sinuses</b></div>", "time": null}, {"id": 1486945196492, "note": "<div><b>Medullary sinuses</b> within <u>lymph nodes</u> communicate with the <b>{{c1::efferent}} lymphatics</b></div>", "time": 1660105355342.0}, {"id": 1486945200481, "note": "<div>The <b>medullary</b> <b>{{c1::sinuses}}</b> within <u>lymph nodes</u> contain <b>reticular</b> <b>cells</b> and <b>macrophages</b></div>", "time": null}, {"id": 1486945204408, "note": "<div>The <b>medullary {{c1::cords}}</b> within <u>lymph nodes</u> contain closely-packed <b>lymphocytes</b> and <b>plasma cells</b></div>", "time": null}, {"id": 1486945209483, "note": "<div>Which <u>lymph node cluster</u> drains the <b>head </b>and <b>neck</b>? </div><div><br /></div><div>{{c1::Cervical}}</div>", "time": null}, {"id": 1486945213450, "note": "<div>Which <u>lymph node cluster</u> drains the <b>lungs</b>? </div><div><br /></div><div>{{c1::Hilar}} </div>", "time": null}, {"id": 1486945217222, "note": "<div><div>Which <u>lymph node cluster</u> drains the <b>trachea</b> and <b>esophagus</b>? </div><div><br /></div><div>{{c1::Mediastinal}} </div></div>", "time": null}, {"id": 1486945222161, "note": "<div><div>Which <u>lymph node cluster</u> drains the <b>upper limb</b> and <b>breast</b>? </div><div><br /></div><div>{{c1::Axillary}} </div></div>", "time": null}, {"id": 1486945227191, "note": "<div><div>Which <u>lymph node cluster</u> drains the <b>skin above the umbilicus</b>? </div><div><br /></div><div>{{c1::Axillary}} </div></div>", "time": null}, {"id": 1486945231564, "note": "<div><div><div>Which <u>lymph node cluster</u> drains the <b>stomach</b>, <b>spleen</b>, <b>liver</b>, and <b>pancreas</b>? </div><div><br /></div><div>{{c1::Celiac}} </div></div></div>", "time": null}, {"id": 1486945235222, "note": "<div><div><div>Which <u>lymph node cluster</u> drains the <b>upper duodenum</b>? </div><div><br /></div><div>{{c1::Celiac}} </div></div></div>", "time": null}, {"id": 1486945239368, "note": "<div><div><div>Which <u>lymph node cluster</u> drains the <b>lower duodenum</b>? </div><div><br /></div><div>{{c1::Superior mesenteric}}</div></div></div>", "time": null}, {"id": 1486945243332, "note": "<div><div><div>Which <u>lymph node cluster</u> drains the <b>jejunum</b> and <b>ileum</b>? </div><div><br /></div><div>{{c1::Superior mesenteric}}</div></div></div>", "time": null}, {"id": 1486945247167, "note": "<div><div><div>Which <u>lymph node cluster</u> drains the&nbsp;<b>proximal colon up to the splenic flexure</b>? </div><div><br></div><div>{{c1::Superior mesenteric}}  </div></div></div>", "time": null}, {"id": 1486945252224, "note": "<div><div><div>Which <u>lymph node cluster</u> drains the <b>colon from splenic flexure to upper rectum</b>? </div><div><br /></div><div>{{c1::Inferior mesenteric}} </div></div></div>", "time": null}, {"id": 1486945256449, "note": "<div><div><div>Which <u>lymph node cluster</u> drains the <b>bladder</b>? </div><div><br /></div><div>{{c1::Internal iliac}}</div></div></div>", "time": null}, {"id": 1486945260294, "note": "<div><div><div>Which <u>lymph node cluster</u> drains the <b>prostate</b>? </div><div><br /></div><div>{{c1::Internal iliac}} </div></div></div>", "time": null}, {"id": 1486945264004, "note": "<div><div><div>Which <u>lymph node cluster</u> drains the <b>cervix</b>? </div><div><br /></div><div>{{c1::Internal iliac}}   </div></div></div>", "time": null}, {"id": 1486945267724, "note": "<div><div><div>Which <u>lymph node cluster</u> drains the <b>testes</b> and <b>ovaries</b>? </div><div><br /></div><div>{{c1::Para-aortic}} </div></div></div>", "time": null}, {"id": 1486945272965, "note": "<div><div><div>Which <u>lymph node cluster</u> drains the <b>kidney</b>? </div><div><br /></div><div>{{c1::Para-aortic}}</div></div></div>", "time": null}, {"id": 1486945280637, "note": "<div><div><div>Which <u>lymph node cluster</u> drains the <b>uterus</b>? </div><div><br /></div><div>{{c1::Para-aortic}}  </div></div></div>", "time": null}, {"id": 1486945284156, "note": "<div><div><div>Which <u>lymph node cluster</u> drains the <b>scrotum</b> and <b>vulva</b>? </div><div><br /></div><div>{{c1::Superficial inguinal}} </div></div></div>", "time": null}, {"id": 1486945288206, "note": "<div><div><div>Which <u>lymph node cluster</u> drains the <b>skin below the umbilicus</b>? </div><div><br /></div><div>{{c1::Superficial inguinal}} </div></div></div>", "time": null}, {"id": 1486945292519, "note": "<div><div>Which <u>lymph node cluster</u> drains the <b>dorsolateral foot</b>? </div><div><br /></div><div>{{c1::Popliteal}}</div></div>", "time": null}, {"id": 1486945297046, "note": "<div><div>Which <u>lymph node cluster</u> drains the <b>posterior calf</b>? </div><div><br /></div><div>{{c1::Popliteal}}</div></div>", "time": null}, {"id": 1486945301523, "note": "<div>The <b>{{c1::right lymphatic}} duct </b>drains <i>lymph</i> from the <u>right side</u> of the body <b>above the diaphragm</b></div>", "time": null}, {"id": 1486945306178, "note": "<div>The <b>{{c2::thoracic}}</b> <b>duct</b> drains <i>most</i> lymph into the <u>junction</u> of the <b>{{c1::left subclavian}}</b> and <b>{{c1::left internal jugular veins}}</b></div>", "time": null}, {"id": 1486945310167, "note": "<div>The <b>spleen</b> is located in the <u>LUQ</u> of the abdomen, behind the {{c1::9th}} - {{c1::11th}} <b>ribs</b></div>", "time": null}, {"id": 1486945314023, "note": "<div><div>Within the <u>spleen</u>, <b>central arterioles</b> are <i>surrounded</i> by {{c1::<b>periarterial lymphatic sheaths</b> (PALS)}}</div></div>", "time": null}, {"id": 1486945318448, "note": "<div><div>The <b>PALS</b> and <b>lymphoid</b> <b>follicles</b> of the <u>spleen</u> constitute the <b>{{c1::white}} pulp</b></div></div>", "time": null}, {"id": 1486945322037, "note": "<div><div>Where in the <u>spleen</u> are <b>T-cells</b> found?</div><div><br /></div><div>{{c1::Periarterial lymphatic sheath (white pulp)}}</div></div>", "time": null}, {"id": 1486945327076, "note": "<div><div>Where in the <u>spleen</u> are <b>B-cells</b> found?</div><div><br /></div><div>{{c1::Follicles (white pulp)}} </div></div>", "time": null}, {"id": 1486945331281, "note": "<div><div><b>Splenic sinusoids</b> are long, vascular channels with <u>fenestrated basement membranes</u> that constitute the <b>{{c1::red}} pulp</b></div></div>", "time": null}, {"id": 1486945335969, "note": "<div><div><i>In between</i> the <b>red</b> and <b>white pulp</b> of the <u>spleen</u> is the {{c1::marginal zone}}, which contains <b>macrophages</b> and <b>specialized B cells</b></div></div>", "time": 1660105357416.0}, {"id": 1486945340214, "note": "<div><div>Where in the <u>spleen</u> do <b>Splenic Macrophages </b>capture blood-borne antigens for recognition by lymphocytes? </div><div><br /></div><div>{{c1::Marginal zone}}</div></div>", "time": null}, {"id": 1486945344711, "note": "<div>How do <u>platelet levels</u> change <b>post-splenectomy</b>? </div><div><br /></div><div>{{c1::Increased (thrombocytosis)}}</div>", "time": null}, {"id": 1486945351084, "note": "<div><div>How do <u>lymphocyte levels</u> change <b>post-splenectomy</b>? </div><div><br /></div><div>{{c1::Increased (lymphocytosis)}}</div></div>", "time": null}, {"id": 1486945360655, "note": "<div>What <u>RBC abnormalities</u> are seen on blood smear <b>post-splenectomy</b>? </div><div><br></div><div>{{c1::Howell-Jolly bodies and target cells::2}}</div>", "time": null}, {"id": 1486945363228, "note": "<div>Patients undergoing <b>splenectomy</b> should be <u>vaccinated</u> against {{c1::encapsulated}} organisms </div>", "time": null}, {"id": 1486945368306, "note": "<div>Which <u>immunoglobulin</u> is <i>decreased</i> with <b>splenic dysfunction</b>? </div><div><br /></div><div>{{c1::IgM}}</div>", "time": null}, {"id": 1486952361607, "note": "<div>The {{c1::thymus}} is an encapsulated <u>lymphoid organ</u> located in the <b>anterosuperior mediastinum</b></div>", "time": null}, {"id": 1486952565694, "note": "<div>What <u>branchial pouch</u> develops into the <b>thymus</b>?</div><div><br /></div><div>{{c1::Third branchial pouch (ventral wing)}}</div>", "time": null}, {"id": 1486952569377, "note": "<div>What is the <u>embryonic origin</u> of<b> lymphocytes</b> in the <b>thymus</b>? </div><div><br /></div><div>{{c1::Mesenchymal origin}}</div>", "time": null}, {"id": 1486952572343, "note": "<div>The<b> {{c1::cortex}}</b> of the <u>thymus</u> is <b>dense</b> and comprised of <b><i>{{c2::immature}}</i> T cells</b></div>", "time": null}, {"id": 1486952576797, "note": "<div>The <b>{{c1::medulla}}</b> of the <u>thymus</u> is <b>pale</b> and comprised of <b><i>{{c2::mature}} </i>T cells</b> and <b>Hassall corpuscles</b></div>", "time": null}, {"id": 1486952580934, "note": "<div>{{c1::Hassalls corpuscles}} are <u>eosinophilic areas</u> in the <b>thymus</b> composed of <b>epithelial reticular cells</b></div>", "time": null}, {"id": 1486952585000, "note": "<div><b>Thymoma</b> is a <u>benign</u> neoplasm of thymus associated with <b>{{c1::myasthenia gravis</b>::<b>immune}}</b>, <b>{{c2::SVC syndrome</b>::<b>lung/vascular}}</b>, <b>{{c3::pure red cell}} aplasia </b>and <b>Good syndrome</b>  </div>", "time": null}, {"id": 1486952589995, "note": "<div>The <b><i>{{c1::progenitor}}</i> B cell</b> <u>lacks</u> <b>cytoplasmic \u03bc</b> and <b>surface IgM/IgD</b></div>", "time": null}, {"id": 1486952594655, "note": "<div>The <b><i>{{c1::precursor}}</i> B cell</b> is characterized by <b>cytoplasmic \u03bc</b></div>", "time": null}, {"id": 1486952598683, "note": "<div>The <b><i>{{c1::immature}}</i> B cell</b> is characterized by <b>surface IgM</b>, but <u>no</u> <b>surface IgD</b></div>", "time": null}, {"id": 1486952603043, "note": "<div><b>{{c1::Plasma}} cells</b> are mature, <u>differentiated B cells</u> characterized by <b>cytoplasmic Ig</b></div>", "time": null}, {"id": 1486952607566, "note": "<div><b>{{c1::Memory B}} cells</b> are mature, <u>differentiated B cells</u> characterized by <b>surface IgG</b>, <b>IgA</b>, or <b>IgE</b></div>", "time": 1660105339644.0}, {"id": 1486952612312, "note": "<div><b>B-cells</b> with <i>self-reactivity</i> in the <u>bone marrow</u> are destroyed by <b>clonal</b> <b>{{c1::deletion}}</b> </div>", "time": null}, {"id": 1486952615115, "note": "<div><b>T-cells</b> that are <i>self-reactive</i> in the <u>periphery</u> are inactivated by <b>clonal</b> <b>{{c1::anergy}}</b> </div>", "time": null}, {"id": 1486952617561, "note": "<div>{{c1::<b>Major histocompatibility complexes</b> (MHCs)}} <u>present antigen fragments</u> to <b>T cells</b> and <b>bind T-cell receptors</b> (TCRs) </div>", "time": 1660105339710.0}, {"id": 1486952620697, "note": "<div><b style=\"font-weight: bold; \">Major histocompatibility complexes</b><b> </b>(MHCs) are encoded by {{c1::HLA}} genes </div>", "time": 1660105355430.0}, {"id": 1486952623418, "note": "<div>Which <u>MHC class</u> is associated with the gene products of <b>HLA-A</b>, <b>HLA-B</b>, and <b>HLA-C</b>? </div><div><br /></div><div>{{c1::MHC I}}</div>", "time": null}, {"id": 1486952630150, "note": "<div>Which <u>MHC class</u> is expressed on <b><u>all</u> nucleated cells</b> and <b>platelets</b>? </div><div><br /></div><div>{{c1::MHC I}} </div>", "time": null}, {"id": 1486952638474, "note": "<div><b>MHC {{c2::I}}</b> binds to the <u>T-cell receptor</u> (TCR) and <b>CD-{{c1::8}}</b> </div>", "time": null}, {"id": 1486952644614, "note": "<div>Which <u>MHC class</u> is formed by <b>1 long chain</b> and <b>1 short chain</b>? </div><div><br /></div><div>{{c1::MHC I}}</div>", "time": null}, {"id": 1486952649215, "note": "<div><div>Which <u>MHC class</u> has a <i><b>smaller</b></i> <b>peptide binding groove</b> (8 - 10 AA)? </div><div><br /></div><div>{{c1::MHC I}}</div></div>", "time": null}, {"id": 1486952653362, "note": "<div>What <u>protein</u> is associated with <b>MHC I</b>? </div><div><br /></div><div>{{c1::\u03b2<sub>2</sub>-microglobulin}}</div>", "time": null}, {"id": 1486952657292, "note": "<div><div>Which <u>MHC class</u> is associated with the gene products of <b>HLA-DP</b>, <b>HLA-DQ</b>, and <b>HLA-DR</b>? </div><div><br /></div><div>{{c1::MHC II}}</div></div>", "time": null}, {"id": 1486952664370, "note": "<div><div>Which <u>MHC class</u> is expressed on <b>antigen presenting cells (APCs)</b>, <i>only</i>? </div><div><br /></div><div>{{c1::MHC II}} </div></div>", "time": null}, {"id": 1486952670744, "note": "<div><div><b>MHC {{c2::II}}</b> binds to the <u>T-cell receptor</u> (TCR) and <b>CD-{{c1::4}}</b> </div></div>", "time": null}, {"id": 1486952677289, "note": "<div><div>Which <u>MHC class</u> is formed by <b>2 equal length chains</b>? </div><div><br /></div><div>{{c1::MHC II}}</div></div>", "time": null}, {"id": 1486952681913, "note": "<div>Which <u>MHC class</u> has a <i><b>larger</b></i> <b>peptide binding groove</b> (13 - 17 AA)? </div><div><br /></div><div>{{c1::MHC II}}</div>", "time": null}, {"id": 1486952685707, "note": "<div><div>What <u>protein</u> is associated with <b>MHC II</b>? </div><div><br></div><div>{{c1::Invariant chain}}</div></div>", "time": null}, {"id": 1486952689393, "note": "<div><div>How many <u>classes</u> of <b>MHC I</b> are expressed on a single cell?</div><div><br /></div><div>{{c1::Six}}</div></div>", "time": null}, {"id": 1486952695243, "note": "<div>Which <u>CD markers</u> (CD4, CD8) does the <b>T-cell <i>precursor</i></b> express in the <b>bone marrow</b>? </div><div><br /></div><div>{{c1::None :)}}</div>", "time": null}, {"id": 1486952700865, "note": "<div>Which <u>CD marker(s)</u> (CD4, CD8) does the<b> T-cell</b> express in the <b>thymic cortex</b>? </div><div><br /></div><div>{{c1::Both CD4 <i>and</i> CD8}}</div>", "time": null}, {"id": 1486952708867, "note": "<div><div>Which <u>CD marker(s)</u> (CD4, CD8) does the<b> T-cell</b> express in the <b>thymic medulla</b>? </div><div><br /></div><div>{{c1::Either CD4 <i>or</i> CD8}}</div></div>", "time": null}, {"id": 1486952713234, "note": "<div>In the {{c1::<b>thymic medulla</b>}}, the <b>T cell</b> <u>differentiates</u> into a CD4<sup>+</sup> <i>or</i> CD8<sup>+</sup> T cell</div>", "time": null}, {"id": 1486952717741, "note": "<div>Which type of <u>selection</u> allows <i>survival</i> of T cells expressing TCRs<b> capable of binding self-MHC</b> on cortical epithelial cells? </div><div><br /></div><div>{{c1::Positive selection}} </div>", "time": null}, {"id": 1486952720521, "note": "<div>Where does <u>positive selection</u> of <b>T cells</b> occur? </div><div><br /></div><div>{{c1::Thymic cortex}}</div>", "time": null}, {"id": 1486952724628, "note": "<div>Which type of <u>selection</u> causes T cells expressing TCRs with<b> high affinity for self antigens</b> on cortical epithelial cells to either undergo <u>apoptosis</u> or become <u>regulatory T cells</u></div><div><br /></div><div>{{c1::Negative selection}} </div>", "time": null}, {"id": 1486952730716, "note": "<div>The <b>tissue-restricted self-antigens</b> expressed in the <u>thymus</u> for <b>negative selection</b> are due to the action of {{c1::autoimmune regulator (AIRE)}}</div>", "time": 1660105349443.0}, {"id": 1486952733427, "note": "<div><u>Deficiency</u> of {{c2::<b>autoimmune regulator</b> (AIRE)}} protein causes <b>{{c1::autoimmune polyendocrine syndrome-1}}</b> </div>", "time": null}, {"id": 1486952739648, "note": "<div>Where does <u>negative selection</u> of <b>T cells</b> occur? </div><div><br /></div><div>{{c1::Thymic medulla}}</div>", "time": null}, {"id": 1486956337697, "note": "What <u>non-nucleated cell</u> expresses <b>MHC class I</b>? <div><br /></div><div>{{c1::Platelets}}</div>", "time": null}, {"id": 1487115889320, "note": "<div><b>MHC {{c2::I}}</b> presents <u>{{c1::endogenously}}</u> synthesized antigens to <b>CD8<sup>+</sup> cytotoxic T cells</b></div>", "time": null}, {"id": 1487116826422, "note": "<div><u>Antigen loading</u> onto <b>MHC I</b> occurs in the <b>RER</b> after breakdown of <i>endogenous antigen</i> by the {{c1::proteasome}} in the cytosol, and delivery to the RER via {{c2::TAP (transporter associated with antigen processing)}}</div>", "time": null}, {"id": 1487116831797, "note": "<div><b>MHC {{c2::II}}</b> presents <u>{{c1::exogenously}}</u> synthesized antigens to <b>CD4<sup>+</sup> helper T cells</b> </div>", "time": null}, {"id": 1487116836334, "note": "<div><u>Antigen loading</u> onto <b>MHC II</b> occurs following <i>release</i> of the&nbsp;<b>{{c2::invariant chain}}</b> in a(n) {{c1::<u>acidified</u> <b>endosome</b>}}</div>", "time": null}, {"id": 1487116841407, "note": "<div>The <u>first signal</u> for <b>T-cell activation</b> is binding between the <b>{{c1::TCR}}</b> and <b>{{c1::MHC/peptide complex}}</b> </div>", "time": 1660105350146.0}, {"id": 1487116849895, "note": "<div>The <u>second signal</u> for <b>T-cell activation</b> is a <i>costimulatory</i> <i>signal</i> via interaction between <b>{{c1::B7}}</b> (APC) and <b>{{c1::CD28}}</b> (T cell) </div>", "time": null}, {"id": 1487116858814, "note": "<div><div>Differentiation of <u>helper T cells</u> to <b>{{c2::Th<sub>2</sub>}}</b> is <i>induced</i> by <b>{{c1::IL-2}}</b> and <b>{{c1::IL-4}}</b></div></div>", "time": null}, {"id": 1487116864321, "note": "<div><div>Differentiation of <u>helper T cells</u> to <b>{{c2::Th<sub>2</sub>}}</b> is <i>inhibited</i> by {{c1::<b>IFN-\u03b3</b>}}</div></div>", "time": null}, {"id": 1487116869316, "note": "<div><div>What <i>class</i> of <u>helper T cell</u> secretes <b>IL-4</b>, <b>-5</b>, <b>-6</b>, <b>-10</b>, and <b>-13</b>? </div><div><br /></div><div>{{c1::Th<sub>2</sub>}} </div></div>", "time": null}, {"id": 1487116873670, "note": "<div><div>What <i>class</i> of <u>helper T cell</u> <b>recruits eosinophils for parasite defense</b>?</div><div><br /></div><div>{{c1::Th<sub>2</sub>}}</div></div>", "time": null}, {"id": 1487116878738, "note": "<div><div><div>What <i>class</i> of <u>helper T cell</u> <b>promotes IgE production by B cells</b>?</div><div><br /></div><div>{{c1::Th<sub>2</sub>}}</div></div></div>", "time": null}, {"id": 1487116883398, "note": "<div><div><div>What <i>class</i> of <u>helper T cell</u> <b>promotes humoral immunity</b>?</div><div><br /></div><div>{{c1::Th<sub>2</sub>}}</div></div></div>", "time": null}, {"id": 1487116888778, "note": "<div><div><div><div>Differentiation of <u>helper T cells</u> to <b>{{c2::Th<sub>1</sub>}}</b> is <i>induced</i> by <b>{{c1::IFN-<b>\u03b3<b>}}</b> and <b>{{c1::IL-12}}</b></b></b></div></div></div></div>", "time": null}, {"id": 1487116895205, "note": "<div><div><div><div>Differentiation of <u>helper T cells</u> to <b>{{c2::Th<sub>1</sub>}}</b> is <i>inhibited</i> by {{c1::<b>IL-4</b>}} and {{c1::<b>IL-10</b>}} (from Th2 cells)</div></div></div></div>", "time": null}, {"id": 1487116917001, "note": "<div><div><div><div>What <i>class</i> of <u>helper T cell</u> secretes <b>IFN-</b><b>\u03b3</b> and <b>IL-2</b>? </div><div><br /></div><div>{{c1::Th<sub>1</sub>}}</div></div></div></div>", "time": null}, {"id": 1487116922978, "note": "<div><div><div><div><b>Th<sub>1 </sub>cells</b> secrete {{c1::<b>IFN-\u03b3</b>}} and <b>{{c2::IL-2}}</b></div></div></div></div>", "time": null}, {"id": 1487116928027, "note": "<div><div><div><div>What <i>class</i> of <u>helper T cell</u> <b>activates macrophages</b> and <b>cytotoxic T cells</b>?</div><div><br /></div><div>{{c1::Th<sub>1</sub>}} </div></div></div></div>", "time": null}, {"id": 1487116948156, "note": "<div><div><div><div><div>What <i>class</i> of <u>helper T cell</u> <b>promotes cell-mediated immunity</b>?</div><div><br /></div><div>{{c1::Th<sub>1</sub>}}</div></div></div></div></div>", "time": null}, {"id": 1487116955601, "note": "<div><div>Differentiation of <u>helper T cells</u> to <b>{{c2::T<sub>reg</sub>}}</b> is <i>induced</i> by <b>{{c1::TGF-\u03b2}} </b>and<b>&nbsp;{{c1::IL-2}}; </b>inhibited by<b>&nbsp;{{c2::IL-6}}</b></div></div>", "time": null}, {"id": 1487116960234, "note": "<div><div>What <i>class</i> of <u>helper T cell</u> helps maintain specific immune tolerance by <b><i>suppressing</i> CD4</b> and <b>CD8 T-cell effector functions</b>? </div><div><br /></div><div>{{c1::Regulatory T (T<sub>Reg</sub>) cells}}</div></div>", "time": null}, {"id": 1487116967325, "note": "<div><div><b>{{c3::Regulatory T}} cells</b> are identified by expression of CD3, CD4, <b>{{c1::CD25}}</b>, and <b>{{c2::FOXP3}}</b> </div></div>", "time": null}, {"id": 1487116971703, "note": "<div><div><div>Activated <b>regulatory T cells</b> produce <b>{{c1::IL-10}}</b> and <b>{{c2::TGF-\u03b2}}</b> (anti-inflammatory cytokines)  </div></div></div>", "time": null}, {"id": 1487116975048, "note": "<div><div>Differentiation of <u>helper T cells</u> to <b>{{c2::Th<sub>17</sub>}}</b> is <i>induced</i> by <b>{{c2::IL-1}}</b>,&nbsp;<b>{{c1::IL-6}}</b> and <b>{{c1::TGF-\u03b2}}</b> </div></div>", "time": null}, {"id": 1487116982311, "note": "<div><div><div>What <i>class</i> of <u>helper T cell</u> are believed to play a role in <b>tissue damage</b> associated with <b>autoimmune disease</b>? </div><div><br /></div><div>{{c1::Th<sub>17</sub> cells}}</div></div></div>", "time": 1660105343579.0}, {"id": 1487116986135, "note": "<div>Which type of <u>immunity</u>&nbsp;responds to antigens with <b>antibodies</b> from plasma cells? </div><div><br></div><div>{{c1::Humoral immunity::humoral or cell-mediated}}</div>", "time": null}, {"id": 1487116989319, "note": "<div><b>Humoral immunity</b> is used to defend against <u>{{c1::extra}}-cellular</u> agents </div>", "time": null}, {"id": 1487116993218, "note": "<div>Is <u>humoral immunity</u> <i>primarily</i> mediated by <b>B-cells</b> or <b>T-cells</b>?</div><div><br /></div><div>{{c1::B-cells}}</div>", "time": null}, {"id": 1487116998408, "note": "<div><b>B-cell activation</b> <i>begins</i> with presentation of <u>foreign antigen</u> on <b>{{c1::MHC II}}</b>, which is recognized by a <b>T-cell receptor</b> </div>", "time": 1660105361374.0}, {"id": 1487117002637, "note": "<div><b>B-cell activation</b> requires a <i>costimulatory</i> <i>signal </i>from binding between the <b>{{c1::CD40 receptor}}</b> (B cell) and <b>{{c1::CD40 ligand}}</b> (Th2 cell) </div>", "time": null}, {"id": 1487117011573, "note": "<div>Antigens that <u>lack</u> a(n)&nbsp;<b>{{c1::peptide}} component</b> are not recognizable by T cells and thus <b>stimulate B cells <i>directly</i></b></div>", "time": 1660105361688.0}, {"id": 1487117018684, "note": "<div>Do <u>thymus-independent antigens</u> result in <b>immunologic memory</b>? </div><div><br /></div><div>{{c1::No}} </div>", "time": 1660105359904.0}, {"id": 1487117025756, "note": "<div>What is the <i>only</i> <u>immunoglobulin</u> that can be secreted in response to <b>thymus-independent antigens</b>? </div><div><br /></div><div>{{c1::IgM}}</div>", "time": null}, {"id": 1487117038124, "note": "<div>One example of a <u>thymus-independent antigen</u> is {{c1::<b>lipopolysaccharides</b> (LPS)}} from <b>gram negative bacteria</b> </div>", "time": 1660105354609.0}, {"id": 1487117045399, "note": "<div><div>Do <u>thymus-dependent antigens</u> result in <b>immunologic memory</b>? </div><div><br /></div><div>{{c1::Yes}} </div></div>", "time": null}, {"id": 1487117055356, "note": "<div>Which type of <u>antibody digestion</u> results in <b>2 monovalent Fab regions</b> and <b>1 Fc</b> <b>region</b>? </div><div><br /></div><div>{{c1::Papain cleavage}}</div>", "time": null}, {"id": 1487117063416, "note": "<div><div>Which type of <u>antibody digestion</u> results in <b>1 bivalent Fab</b> <b>region</b> and <b>1 Fc</b> <b>region</b>? </div><div><br /></div><div>{{c1::Pepsin cleavage}}</div></div>", "time": null}, {"id": 1487117070760, "note": "<div>Which <u>immunoglobulin isotypes</u> can exist as a <b>monomer</b>? </div><div><br /></div><div>{{c1::All Ig types}}</div>", "time": null}, {"id": 1487117074086, "note": "<div><b>IgM </b>exists as a(n)&nbsp;<u>{{c1::monomer}}</u> on the surface of <b>B cells</b></div>", "time": null}, {"id": 1487117077263, "note": "<div><b>Ig{{c2::M}}</b> exists as a(n)&nbsp;<u>{{c1::pentamer}}</u> held by a<b> J chain</b> when <b>secreted</b></div>", "time": null}, {"id": 1487117081885, "note": "<div>How many <u>identical antigens</u> can a <i>single</i> <b>IgM molecule bind</b>?</div><div><br></div><div>{{c1::10}}</div>", "time": 1660105357979.0}, {"id": 1487117090100, "note": "<div>Does <b>IgM </b>fix complement?</div><div><br /></div><div>{{c1::Yes}}</div>", "time": null}, {"id": 1487117096735, "note": "<div>Does <b>IgM</b> cross the placenta?</div><div><br /></div><div>{{c1::No}}</div>", "time": 1660105359851.0}, {"id": 1487117100809, "note": "<div><div>Which <u>immunoglobulin</u> is <b>produced </b><i style=\"font-weight: bold; \">first</i> in response to an infection?</div><div><br /></div><div>{{c1::IgM}}</div></div>", "time": null}, {"id": 1487117104655, "note": "<div>Which <u>immunoglobulin</u> is the main antibody produced during the <b><i>primary</i> response</b> to antigen? </div><div><br /></div><div>{{c1::IgM}}</div>", "time": 1660105342781.0}, {"id": 1487117108862, "note": "<div><div><div>The <b>{{c1::valence}}</b> of an antibody refers to the <b>number of sites available</b> to bind epitopes </div></div></div>", "time": null}, {"id": 1487117112350, "note": "<div>The <b>{{c1::affinity}}</b> of an antibody refers to the <b>binding strength</b> for an epitope</div>", "time": null}, {"id": 1487117115624, "note": "<div><div>Which <u>immunoglobulin</u> has the <i>highest</i> <b>avidity</b>? </div><div><br /></div><div>{{c1::IgM}} </div></div>", "time": null}, {"id": 1487117118637, "note": "<div>Which <u>immunoglobulin</u> has the <i>highest</i> <b>affinity</b>? </div><div><br /></div><div>{{c1::IgG}} </div>", "time": null}, {"id": 1487117121383, "note": "<div>Generation of <u>antibody specificity</u> occurs via {{c1::<b>somatic</b> <b>hypermutation</b>}} with {{c2::<b>affinity</b> <b>maturation</b>}} </div>", "time": null}, {"id": 1487117143873, "note": "<div><div><div>Where does <u>class switching</u> of <b>IgM</b> take place?</div><div><br /></div><div>{{c1::Germinal centers of lymph nodes}}</div></div></div>", "time": 1660105344524.0}, {"id": 1487117152018, "note": "<div><u>Class switching</u> of <b>IgM</b> is mediated by <b>CD40L</b> and <b>cytokines</b> from {{c1::Th2::specific}} cells</div>", "time": 1660105360666.0}, {"id": 1487117156031, "note": "<div><div><u>Class switching</u> to <b>Ig{{c2::A}}</b> is promoted by {{c1::<b>IL-5</b>}} and <b>TGF-\u03b2</b></div></div>", "time": null}, {"id": 1487117161213, "note": "<div><div>Class switching to <b>Ig{{c2::E}}</b> is promoted by {{c1::<b>IL-4</b>}} and <b>{{c1::IL-13}}</b></div></div>", "time": null}, {"id": 1487117165317, "note": "<div><div>Which <u>immunoglobulin</u> is the main antibody produced during the <b><i>secondary </i>response</b> to antigen? </div><div><br /></div><div>{{c1::IgG}}</div></div>", "time": null}, {"id": 1487117169828, "note": "<div>What is the <u>most abundant</u> <b>immunoglobulin isotype</b> in<b> <i>serum</i></b>?</div><div><br /></div><div>{{c1::IgG}}</div>", "time": 1660105346006.0}, {"id": 1487117174952, "note": "<div>Does <b>IgG</b> fix complement?</div><div><br /></div><div>{{c1::Yes}}</div>", "time": null}, {"id": 1487117179318, "note": "<div>Does <b>IgG</b> cross the placenta? </div><div><br /></div><div>{{c1::Yes}}</div>", "time": null}, {"id": 1487117187498, "note": "<div>Which <u>immunoglobulin(s)</u> <b>fix complement</b>? </div><div><br /></div><div>{{c1::IgM and IgG}}</div>", "time": 1660105342780.0}, {"id": 1487117191334, "note": "<div>Which <u>immunoglobulin(s)</u> <b>cross the placenta</b>? </div><div><br /></div><div>{{c1::IgG}}</div>", "time": null}, {"id": 1487117197858, "note": "<div><div>Which <u>immunoglobulin</u> <b>opsonizes bacteria</b>? </div><div><br /></div><div>{{c1::IgG}}</div></div>", "time": null}, {"id": 1487117209824, "note": "<div>Which <u>immunoglobulin</u> is the <b>most <i>produced</i> antibody overall</b>? </div><div><br /></div><div>{{c1::IgA}}</div>", "time": null}, {"id": 1487117216624, "note": "<div><b>IgA </b>exists as a(n)&nbsp;<u>{{c1::monomer}}</u> in <b>circulation</b></div>", "time": 1660105357669.0}, {"id": 1487117219869, "note": "<div><b>Ig{{c2::A}}</b> exists as a(n)&nbsp;<u>{{c1::dimer}}</u> held by a<b> J chain</b> when <b>secreted</b></div>", "time": null}, {"id": 1487117223955, "note": "<div><b>IgA</b> crosses epithelial cells by {{c1::transcytosis}}</div>", "time": 1660105357671.0}, {"id": 1487117227757, "note": "<div>Which <u>immunoglobulin</u> is produced in the <b>GI tract</b> and <b>protects against gut infections</b>? </div><div><br /></div><div>{{c1::IgA}}  </div>", "time": null}, {"id": 1487117234083, "note": "<div>Which <u>immunoglobulin</u> is released into <b>breast milk</b> (colostrum)? </div><div><br /></div><div>{{c1::IgA}}</div>", "time": null}, {"id": 1487117238120, "note": "<div>Which <u>immunoglobulin</u> is released into <b>secretions</b> (tears, saliva, mucus)? </div><div><br /></div><div>{{c1::IgA}}</div>", "time": null}, {"id": 1487117240890, "note": "<div>Does <b>IgA</b> fix complement?</div><div><br /></div><div>{{c1::No}}</div>", "time": 1660105359852.0}, {"id": 1487117247126, "note": "<div>Does <b>IgA</b> cross the placenta? </div><div><br /></div><div>{{c1::No}}</div>", "time": null}, {"id": 1487117251418, "note": "<div><b>IgA</b> is transported through the mucosa via <u>binding</u> between the <b>{{c1::J chain}}</b> of IgA and the <b>{{c2::polymeric Ig}} receptor</b> on epithelial cells</div>", "time": null}, {"id": 1487117255825, "note": "<div>When <b>IgA</b> is released into the <u>mucosa</u>, the <b>poly Ig receptor</b> becomes the <b>{{c1::secretory component}}</b>, which <i>protects</i> IgA from luminal proteases</div>", "time": null}, {"id": 1487117260690, "note": "<div>Which <u>immunoglobulin</u> binds directly to <b>mast cells</b> and <b>basophils</b>? </div><div><br /></div><div>{{c1::IgE}}</div>", "time": null}, {"id": 1487117263860, "note": "<div><b>IgE</b> <i>cross-links</i> when exposed to <u>allergen</u>, mediating <b>type {{c1::I}} hypersensitivity reactions</b> </div>", "time": null}, {"id": 1487117266817, "note": "<div>Which <u>immunoglobulin</u> contributes to <b>immunity to worms</b> by <b>activating eosinophils</b>?</div><div><br /></div><div>{{c1::IgE}}</div>", "time": null}, {"id": 1487117269713, "note": "<div><div>What is the <u>least abundant</u> <b>immunoglobulin isotype</b> in<b> <i>serum</i></b>?</div><div><br /></div><div>{{c1::IgE}} </div></div>", "time": null}, {"id": 1487117272282, "note": "<div>Which <u>immunoglobulin(s)</u> can be secreted by <b>plasma cells</b>? </div><div><br /></div><div>{{c1::IgA, IgG, or IgE (one type per plasma cell)}}</div>", "time": null}, {"id": 1487117286060, "note": "<div>Which type of <u>immunity</u>&nbsp;responds to antigens with <b>activated cytotoxic T-cells</b>? </div><div><br></div><div>{{c1::Cell-mediated immunity::humoral or cell-mediated}}</div>", "time": null}, {"id": 1487117288751, "note": "<div><div><b>Cell-mediated immunity</b> is used to defend against <u>{{c1::intra}}-cellular</u> agents</div></div>", "time": null}, {"id": 1487117291271, "note": "<div><div>Is <u>cell-mediated immunity</u> <i>primarily</i> mediated by <b>B-cells</b> or <b>T-cells</b>?</div><div><br></div><div>{{c1::T-cells}}</div></div>", "time": null}, {"id": 1487117293576, "note": "<div><div><b>Cytotoxic</b> (<b>CD8</b><sup style=\"font-weight: bold; \">+</sup>) <b>T-cells</b> kill virus infected, neoplastic, and donor graft cells by inducing {{c1::apoptosis}}</div></div>", "time": null}, {"id": 1487117295752, "note": "<div><b>Cytotoxic T cells</b> may <u>induce apoptosis</u> of target cells via release of <b>{{c1::perforins}}</b> and <b>{{c1::granzymes}}</b>, which leads to <b>activation of caspases</b></div>", "time": null}, {"id": 1487117300306, "note": "<div><b>Cytotoxic T cells</b> may <u>induce apoptosis</u> of target cells via binding of <b>{{c1::Fas ligand}}</b> to <b>{{c1::Fas}}</b>, which causes release of <b>TNF</b></div>", "time": null}, {"id": 1487117304665, "note": "<div>Which <u>immune cell</u> is a <b>lymphocyte </b>member of the <b>innate immune system</b>? </div><div><br /></div><div>{{c1::Natural killer (NK) cells}}</div>", "time": null}, {"id": 1487117308213, "note": "<div><b>Natural killer cells</b> may <u>induce apoptosis</u> of <b>virally infected cells</b> and <b>tumors cells</b> via release of <b>{{c1::perforins}}</b> and <b>{{c1::granzymes}}</b></div>", "time": null}, {"id": 1487117310594, "note": "<div>Which <u>interferons</u> <i>enhance</i> activity of <b>natural killer cells</b>? </div><div><br></div><div>{{c1::Interferon-\u03b1 and Interferon-\u03b2}}</div>", "time": null}, {"id": 1487117312582, "note": "<div><div>Which <u>interleukins</u> <i>enhance</i> activity of <b>natural killer cells</b>? </div><div><br></div><div>{{c1::IL-2 and IL-12}}</div></div>", "time": null}, {"id": 1487117314403, "note": "<div><b>{{c2::Natural killer}} cells</b> are induced to kill cells that have an <u>absence</u> of {{c1::<b>MHC I</b>}} on their cell surface </div>", "time": null}, {"id": 1487117321802, "note": "<div><b>Natural killer cells</b> may kill cells via binding between <b>{{c1::CD16}}</b> (NK cells) and the <b>{{c2::Fc}} region</b> of <b>IgG-bound antigen</b>  </div>", "time": null}, {"id": 1487117328797, "note": "<div>Which <u>immunoglobulin</u><b> </b><i>typically</i> mediates <b>antibody-dependent cellular cytotoxicity</b> (ADCC)?</div><div><br></div><div>{{c1::IgG*}} </div>", "time": null}, {"id": 1487117336631, "note": "<div><div><b>{{c1::Superantigens}}</b> are antigens that {{c2::cross-link}} the <u>\u03b2 region</u> of <b>T-cell receptors</b> to <b>MHC II</b> on <u>APCs</u> <i>outside</i> the normal peptide-binding groove </div></div>", "time": 1660105338793.0}, {"id": 1487117356804, "note": "<div><div><b>{{c1::Superantigens}}</b> can activate <i>any</i> <b>CD4<sup>+</sup> T-cell</b>, resulting in <u>massive release</u> of <b>cytokines</b></div></div>", "time": 1660105338791.0}, {"id": 1487117363961, "note": "<div><b>{{c1::Anergy}}</b> refers to a state in which an immune cell <b>cannot become activated</b> by exposure to its antigen </div>", "time": null}, {"id": 1487117366290, "note": "<div><b>T-cells</b> and <b>B-cells</b> become <u>{{c1::anergic}}</u> when exposed to their <b>antigen <i>without</i> a costimulatory signal</b></div>", "time": null}, {"id": 1487121752455, "note": "<div>Which type of <u>immunization</u> is acquired by <b>receiving <i>preformed</i> antibodies</b>? </div><div><br /></div><div>{{c1::Passive immunization}}</div>", "time": 1660105341780.0}, {"id": 1487121953944, "note": "<div>Which type of <u>immunization</u> has a <b>rapid onset</b>? </div><div><br /></div><div>{{c1::Passive immunization}}</div>", "time": 1660105341782.0}, {"id": 1487121958371, "note": "<div>Which type of <u>immunization</u> has a <b>short span of duration</b>? </div><div><br /></div><div>{{c1::Passive immunization}}</div>", "time": 1660105341781.0}, {"id": 1487121965148, "note": "<div>Consumption of <b>IgA in breast milk</b> is an example of {{c1::<u>passive</u>}} immunization</div>", "time": null}, {"id": 1487121969591, "note": "<div><b>Maternal IgG crossing the placenta</b> is an example of {{c1::<u>passive</u>}} immunization</div>", "time": 1660105355384.0}, {"id": 1487121973551, "note": "<div>Administration of <b>antitoxin</b> or <b>monoclonal antibody</b> is an example of {{c1::<u>passive</u>}} immunization</div>", "time": null}, {"id": 1487121978005, "note": "<div><div>One risk of <u>passive immunotherapy</u> is <b>IgE production</b> and <b>anaphylaxis</b>, especially in patients with <b>selective {{c1::IgA}} deficiency </b></div></div>", "time": null}, {"id": 1487121984540, "note": "<div><div>Toxins that require <b>passive immunity</b> in exposed, unvaccinated patients may be remembered with the mnemonic \"<b>T</b>o <b>B</b>e <b>H</b>ealed <b>V</b>ery <b>R</b>apidly\": </div><div style=\"centerbox\"><div class=\"mnemonics\"><div><br/></div><div><b>T</b>: {{c1::Tetanus toxin}}</div><div><b>B</b>: {{c2::Botulinum toxin}}</div><div><b>H</b>: {{c3::HBV}}</div><div><b>V</b>: {{c4::Varicella}}</div><div><b>R</b>: {{c5::Rabies virus}}</div></div></div></div>", "time": null}, {"id": 1487121991618, "note": "<div><div>Which type of <u>immunization</u> is acquired by <b>exposure to foreign antigens</b>? </div><div><br /></div><div>{{c1::Active immunization}}</div></div>", "time": null}, {"id": 1487121995626, "note": "<div><div>Which type of <u>immunization</u> has a <b>slow onset</b>? </div><div><br /></div><div>{{c1::Active immunization}}</div></div>", "time": null}, {"id": 1487121999722, "note": "<div><div>Which type of <u>immunization</u> has a <b>long-lasting protection</b> (memory)? </div><div><br /></div><div>{{c1::Active immunization}}</div></div>", "time": null}, {"id": 1487122003310, "note": "<div><b>Natural infection</b> is an example of {{c1::<u>active</u>}} immunization</div>", "time": null}, {"id": 1487122006764, "note": "<div>Administration of <b>toxoid</b> is an example of {{c1::<u>active</u>}} immunization</div>", "time": null}, {"id": 1487122010297, "note": "<div>Administration of <b>vaccines</b> is an example of {{c1::<u>active</u>}} immunization</div>", "time": null}, {"id": 1487122014689, "note": "<div>Which type of <u>vaccine</u> induces a <b>strong</b>, <b>often</b> <b>lifelong immunity</b>? </div><div><br /></div><div>{{c1::Live, attenuated vaccines}}</div>", "time": 1660105341679.0}, {"id": 1487122020805, "note": "<div>Which type of <u>vaccine</u> has the potential to <b>revert to a virulent form</b>? </div><div><br /></div><div>{{c1::Live, attenuated vaccines}} </div>", "time": null}, {"id": 1487122023570, "note": "<div><b>Live attenuated vaccines</b> are often <u>contraindicated</u> in <b>{{c1::pregnancy}}</b> and <b>{{c2::immunodeficiency}}</b> </div>", "time": null}, {"id": 1487122030428, "note": "<div><b>{{c2::MMR}}</b> and <b>{{c3::varicella}}</b> are <u>live vaccines</u> that can be given to <b>HIV patients</b> with CD4 counts &gt; {{c1::200}}/mm<sup>3</sup> </div>", "time": null}, {"id": 1487122032935, "note": "<div>Do <b>live attenuated vaccines</b> induce <u>cellular</u> or <u>humoral</u> responses?</div><div><br /></div><div>{{c1::Both cellular and humoral :)}} </div>", "time": null}, {"id": 1487122035576, "note": "<div>What <u>type of vaccine</u> is the <b>MMR vaccine</b>? </div><div><br /></div><div>{{c1::Live attenuated}}</div>", "time": null}, {"id": 1487122042028, "note": "<div><div>What <u>type of vaccine</u> is the <b>rotavirus vaccine</b>? </div><div><br /></div><div>{{c1::Live attenuated}}</div></div>", "time": null}, {"id": 1487122045686, "note": "<div><div>What <u>type of vaccine</u> is the <b>yellow fever vaccine</b>? </div><div><br /></div><div>{{c1::Live attenuated}}</div></div>", "time": null}, {"id": 1487122048949, "note": "<div><div>What <u>type of vaccine</u> is the <b>varicella vaccine</b>? </div><div><br /></div><div>{{c1::Live attenuated}}</div></div>", "time": null}, {"id": 1487122053213, "note": "<div><div>What <u>type of vaccine</u> is the <b>BCG vaccine</b>? </div><div><br /></div><div>{{c1::Live attenuated}}</div></div>", "time": null}, {"id": 1487122056375, "note": "<div><div>What <u>type of vaccine</u> is the <b><i>intranasal</i> influenza vaccine</b>? </div><div><br /></div><div>{{c1::Live attenuated}}</div></div>", "time": null}, {"id": 1487122060289, "note": "<div>Which <u>polio vaccine</u> is a <b>live attenuated (oral) vaccine</b>? </div><div><br /></div><div>{{c1::Sabin}}</div>", "time": null}, {"id": 1487122064154, "note": "<div>Which type of <u>vaccine</u> is a pathogen that has been <b>inactivated by heat or chemicals</b>? </div><div><br /></div><div>{{c1::Inactivated/killed vaccine}}</div>", "time": 1660105341678.0}, {"id": 1487122067345, "note": "<div>What is an <u>advantage</u> of <b>inactivated vaccines</b> compared to live attenuated? </div><div><br /></div><div>{{c1::Inactivated vaccines are safer}} </div>", "time": null}, {"id": 1487122070185, "note": "<div><div>Which types of <u>vaccine</u> induce a <b>relatively <i>weak</i> immune response</b>? </div><div><br /></div><div>{{c1::Inactivated/killed vaccines and Subunit vaccine::2}}</div></div>", "time": 1660105344219.0}, {"id": 1487122077594, "note": "<div><div>Do <b>killed/inactivated vaccines</b> induce <u>cellular</u> or <u>humoral</u> responses?</div><div><br /></div><div>{{c1::Humoral}} </div></div>", "time": null}, {"id": 1487122080060, "note": "<div>What part of an antigen should be <u>preserved</u> to <b>elicit an immune response</b> when given as an <b>inactivated/killed vaccine</b>? </div><div><br /></div><div>{{c1::Epitope}} </div>", "time": null}, {"id": 1487122086575, "note": "<div><div><div>What <u>type of vaccine</u> is the<b> rabies vaccine</b>? </div><div><br /></div><div>{{c1::Inactivated/killed}}</div></div></div>", "time": null}, {"id": 1487122089996, "note": "<div><div><div>What <u>type of vaccine</u> is the <b><i>injected</i> influenza vaccine</b>? </div><div><br /></div><div>{{c1::Inactivated/killed}}</div></div></div>", "time": null}, {"id": 1487122093207, "note": "<div><div><div>Which <u>polio vaccine</u> is an <b>inactivated/killed vaccine</b>? </div><div><br /></div><div>{{c1::Salk}}</div></div></div>", "time": null}, {"id": 1487122099697, "note": "<div><div>What <u>type of vaccine</u> is the<b> hepatitis A vaccine</b>? </div><div><br /></div><div>{{c1::Inactivated/killed}}</div></div>", "time": null}, {"id": 1487122104176, "note": "<div>What is the <u>first</u> type of <b>immunoglobulin</b> produced in a <b>neonate</b>? </div><div><br /></div><div>{{c1::IgM}}</div>", "time": null}, {"id": 1487122107982, "note": "<div>By <b>age 1</b>, the <u>total antibody level</u> is approximately {{c1::60}}% of <b>adult</b> <b>levels</b></div>", "time": null}, {"id": 1487122111408, "note": "<div>By <b>age 1</b>, the <u>total IgA level</u> is approximately {{c1::20}}% of <b>adult</b> <b>levels</b> </div>", "time": null}, {"id": 1487122118000, "note": "<div>What is the only useful <u>immunoglobulin</u> for diagnosing <b>neonatal infections</b>? </div><div><br /></div><div>{{c1::IgM}}</div>", "time": null}, {"id": 1487122124336, "note": "<div>Some <u>killed vaccines</u> are <b>conjugated</b> to a(n) {{c1::<b>protein</b>}} to elicit a <b>stronger immune response</b> (e.g. immunologic memory) </div>", "time": 1660105350892.0}, {"id": 1487207079363, "note": "<div><div><b>Type I HSR</b> occurs due to <u>cross-linking</u> of <b>Ig{{c1::E}}</b> on <i>presensitized</i> <b>{{c3::mast cells}}</b> and <b>{{c3::basophils}}</b> by antigen</div></div>", "time": null}, {"id": 1487207084334, "note": "<div><div>The <u>immediate</u> response of <b>mast cell</b> and <b>basophil</b> activation is release of <b><i>preformed</i> {{c1::histamine}} granules</b> and <b>{{c2::tryptase</b>::marker of activation<b>}}</b></div></div>", "time": null}, {"id": 1487207091819, "note": "<div><div>The <u>delayed</u> response of <b>mast cell </b>and <b>basophil</b> activation involves production of<b> </b>{{c2::<b>chemokines}} </b>(ex. to attract eosinophils) and <b>cytokines</b> (particularly<b> </b>{{c1::<b>leukotrienes</b>}})</div></div>", "time": null}, {"id": 1487207094725, "note": "<div><div><div>Which type of <u>hypersensitivity</u> mediates <b>anaphylaxis</b> (e.g. food, drug, or bee sting allergies)?</div><div><br /></div><div>{{c1::Type I}} </div></div></div>", "time": null}, {"id": 1487207097572, "note": "<div><div><div>Which type of <u>hypersensitivity</u> mediates <b>atopic reactions</b> (e.g. asthma, allergic rhinitis)?</div><div><br /></div><div>{{c1::Type I}} </div></div></div>", "time": null}, {"id": 1487207100136, "note": "<div><div>{{c1::Skin Pinprick}} tests or {{c2::Blood (ELISA)}} tests for allergen-specific IgE are typically used to diagnose <b>type I hypersensivity reactions</b></div></div>", "time": null}, {"id": 1487207102783, "note": "<div>Which type of <u>hypersensitivity reaction</u> is mediated by binding of <b>antibodies</b> to <b>cell-surface antigens</b>? </div><div><br /></div><div>{{c1::Type II HSR}} </div>", "time": null}, {"id": 1487207105743, "note": "<div><u>Type II HSRs</u> can cause pathology by inducing {{c1::cellular destruction}} by opsonizing the target with antibodies</div>", "time": null}, {"id": 1487207112553, "note": "<div><u>Type II HSRs</u> can cause pathology by inducing {{c1::cellular dysfunction}}, causing <i>abnormal</i><b> blockade</b> or <b>activation/inactivation</b> of downstream cellular processes  </div>", "time": null}, {"id": 1487207119666, "note": "<div><div><u>Type II HSRs</u> can cause pathology by inducing {{c1::inflammation}} by antibodies depositing on cell surfaces, which in turn activates complement</div></div>", "time": null}, {"id": 1487207122541, "note": "<div>Which <u>immunoglobulins</u> mediate <b>type II hypersensivity reactions</b>? </div><div><br /></div><div>{{c1::IgM and IgG}}</div>", "time": null}, {"id": 1487207141168, "note": "<div><div>What <u>test</u> is used to diagnose <b>type II hypersensitivity reactions </b>against RBCs? </div></div><div><div><br /></div><div>{{c1::Coombs test}}</div></div>", "time": null}, {"id": 1487207142388, "note": "<div><div>What type of <u>hypersensitivity reaction</u> are <b>immune thrombocytopenic purpura </b>and <b>autoimmune-hemolytic anemia?</b></div><div><br></div><div>{{c1::Type II HSR (cellular destruction)}}</div></div>", "time": null}, {"id": 1487207145930, "note": "<div><div>What type of <u>hypersensitivity reaction</u> are <b>hemolytic disease of the newborn </b>and <b>transfusion reactions</b>? </div><div><br /></div><div>{{c1::Type II HSR (cellular destruction)}}</div></div>", "time": null}, {"id": 1487207151765, "note": "<div><div>What type of <u>hypersensitivity reaction</u> is <b>Goodpasture syndrome</b>? </div><div><br /></div><div>{{c1::Type II HSR (inflammation)}}</div></div>", "time": null}, {"id": 1487207154426, "note": "<div><div>What type of <u>hypersensitivity reaction</u> is <b>rheumatic fever</b>? </div><div><br></div><div>{{c1::Type II HSR (inflammation)}}</div></div>", "time": null}, {"id": 1487207156353, "note": "<div><div>What type of <u>hypersensitivity reaction</u> is <b><i>hyperacute</i> transplant rejection</b>? </div><div><br></div><div>{{c1::Type II HSR (inflammation)}}</div></div>", "time": null}, {"id": 1487207158134, "note": "<div><div>What type of <u>hypersensitivity reaction</u> is <b>Graves disease </b>and <b>Myasthenia Gravis</b>? </div><div><br /></div><div>{{c1::Type II HSR (cellular dysfunction)}}</div></div>", "time": null}, {"id": 1487207160372, "note": "<div><div>What type of <u>hypersensitivity reaction</u> is <b>Pemphigus Vulgaris</b>? </div><div><br /></div><div>{{c1::Type II HSR (cellular dysfunction)}}</div></div>", "time": null}, {"id": 1487207162179, "note": "<div><div>Which type of <u>hypersensitivity reaction</u> is characterized by <i><b>circulating</b></i> <b>immune complexes</b>? </div><div><br /></div><div>{{c1::Type III HSR}} </div></div>", "time": null}, {"id": 1487207167794, "note": "<div>In <u>type III HSRs</u>, <b>antigen-antibody complexes</b> activate <b>{{c1::complement}}</b>, which attracts <b>{{c2::neutrophils}}</b> </div>", "time": null}, {"id": 1487207175248, "note": "<div><b>{{c1::Serum sickness}}</b> is an <u>immune complex</u> disease in which <b>antibodies</b> to <b>foreign serum proteins</b> are produced </div>", "time": 1660105338969.0}, {"id": 1487207181602, "note": "<div><b>Serum sickness-like reactions</b> are associated with some <u>drugs</u> acting as {{c1::haptens (ex. penicillin)}} and {{c2::infections (ex. HBV)}} </div>", "time": null}, {"id": 1487207184256, "note": "<div>A(n)&nbsp;<b>{{c1::hapten}}</b> is a <u>small antigen</u> that may <b>conjugate with larger proteins</b> to elicit an immune response</div>", "time": 1660105362409.0}, {"id": 1487207190223, "note": "<div><u>Serum sickness</u> presents with <b>fever</b>, <b>urticaria</b>, <b>arthralgia</b>, <b>proteinuria</b>, and <b>lymphadenopathy</b> {{c1::1}} - {{c1::2}} weeks after antigen exposure </div>", "time": null}, {"id": 1487207192567, "note": "<div>What type of <u>hypersensitivity reaction</u> is <b>serum sickness</b>? </div><div><br></div><div>{{c1::Type III HSR}}</div>", "time": null}, {"id": 1487207194698, "note": "<div><b>{{c1::Arthus reaction}}</b> is a local subacute <u>antibody-mediated HSR</u> to antigen in <b>intradermal injection</b> </div>", "time": 1660105341122.0}, {"id": 1487207200447, "note": "<div><b>Arthus reaction</b> leads to <u>immune complex formation</u> in the <b>{{c1::skin}}</b>; characterized by <b>edema</b>, <b>necrosis</b>, and <b>activation of complement</b>  </div>", "time": 1660105361574.0}, {"id": 1487207203586, "note": "<div>What type of <u>hypersensivitity reaction</u> is the <b>Arthus reaction</b>? </div><div><br /></div><div>{{c1::Type III HSR}} </div>", "time": null}, {"id": 1487207210931, "note": "<div>Which is <u>more common</u>, <b>serum sickness</b> or <b>arthus reaction</b>? </div><div><br></div><div>{{c1::Serum sickness}}</div>", "time": null}, {"id": 1487207213102, "note": "<div>What type of <u>hypersensitivity reaction</u> is <b>polyarteritis nodosa</b>? </div><div><br></div><div>{{c1::Type III}}</div>", "time": null}, {"id": 1487207216546, "note": "<div><div>What type of <u>hypersensitivity reaction</u> is <b>post-streptococcal glomerulonephritis</b> (PSGN)? </div><div><br></div><div>{{c1::Type III}}</div></div>", "time": null}, {"id": 1487207218837, "note": "<div>Which type of <u>hypersensitivity reaction</u> is <b>T-cell mediated</b>? </div><div><br></div><div>{{c1::Type IV}}</div>", "time": null}, {"id": 1487207220752, "note": "<div><b>Type {{c2::IV}} HSRs</b> may occur via <u>direct cell cytotoxicity</u>, which involves <b>CD8<sup>+</sup> T cells </b></div>", "time": null}, {"id": 1487207229813, "note": "<div><b>Type {{c2::IV}} HSRs</b> may occur via <u>delayed-type hypersensitivity</u>, which involves <b>CD4<sup>+</sup> T-cells</b> </div>", "time": 1660105348413.0}, {"id": 1487207236838, "note": "<div><div>What type of <u>hypersensitivity reaction</u> is <b>type I diabetes mellitus</b>? </div><div><br></div><div>{{c1::Type IV HSR (direct cell cytotoxicity)}}</div></div>", "time": null}, {"id": 1487207238825, "note": "<div><div><div>What type of <u>hypersensitivity reaction</u> is <b>contact dermatitis</b> (e.g. poison ivy, nickel allergy)? </div><div><br /></div><div>{{c1::Type IV HSR (CD4 &amp; CD8 Mediated)}}</div></div></div>", "time": null}, {"id": 1487207240713, "note": "<div><div><div>What type of <u>hypersensitivity reaction</u> is <b>graft-versus-host-disease</b>? </div><div><br></div><div>{{c1::Type IV HSR (delayed-type hypersensitivity)}}</div></div></div>", "time": null}, {"id": 1487207242473, "note": "<div><div><div>What type of <u>hypersensitivity reaction</u> is <b>tuberculin skin test</b> (PPD)? </div><div><br></div><div>{{c1::Type IV HSR (Th<sub>1&nbsp;</sub>Mediated*)}}</div></div></div>", "time": null}, {"id": 1487207244285, "note": "<div><div>What type of <u>hypersensitivity reaction</u> is <b>patch test</b>? </div><div><br /></div><div>{{c1::Type IV HSR (CD4 Mediated)}}</div></div>", "time": null}, {"id": 1487207248593, "note": "<div>Which type(s) of <u>hypersensitivity reactions</u> are <b>antibody-mediated</b>? </div><div><br /></div><div>{{c1::I, II, and III}}</div>", "time": null}, {"id": 1487208643200, "note": "<div>What type of <u>graft</u> is from<b> self</b>? </div><div><br /></div><div>{{c1::Autograft}}</div>", "time": null}, {"id": 1487214787212, "note": "<div><div>What type of <u>graft</u> is from an<b> identical twin or clone</b>? </div><div><br /></div><div>{{c1::Syngeneic graft (isograft)}}</div></div>", "time": null}, {"id": 1487214790550, "note": "<div><div>What type of <u>graft</u> is from a<b> non-identical individual of the same species</b>? </div><div><br /></div><div>{{c1::Allograft}}</div></div>", "time": null}, {"id": 1487214792960, "note": "<div><div>What type of <u>graft</u> is from<b> </b>a<b> different species</b>? </div><div><br /></div><div>{{c1::Xenograft}}</div></div>", "time": null}, {"id": 1487214863091, "note": "<div><b>Chronic</b> <u>kidney</u> transplant rejection typically presents as {{c1::<b>chronic allograft nephropathy</b>}} </div>", "time": null}, {"id": 1487292580228, "note": "<div>What <u>skin appearance</u> is classically seen in <b>carbon monoxide poisoning</b>? </div><div><br /></div><div>{{c1::Cherry-red appearance}}</div>", "time": null}, {"id": 1487458829921, "note": "Which <u>cellular change</u> is characterized by an <b>increased <i>number</i> of cells</b>? <div><br /></div><div>{{c1::Hyperplasia}}</div>", "time": null}, {"id": 1487460256729, "note": "<div>Which <u>cellular change</u> is characterized by an <b>increased <i>size</i> of cells</b>? <div><br></div><div>{{c1::Hypertrophy}}</div></div>", "time": null}, {"id": 1487460262238, "note": "<div><b>{{c1::Hypertrophy</b>::(hypertrophy or hyperplasia)<b>}}</b> involves <b>gene activation</b>, <b>protein synthesis</b>, and <b>production of organelles</b> </div>", "time": 1660105340024.0}, {"id": 1487460265531, "note": "<div><b>{{c1::Hyperplasia</b>::(hypertrophy or hyperplasia)<b>}}</b> involves the <u>controlled</u> proliferation of stem cells and differentiated cells</div>", "time": 1660105340035.0}, {"id": 1487460268378, "note": "<div>Do <b>permanent tissues</b> (e.g. cardiac muscle, skeletal muscle, nerve) undergo <u>hypertrophy</u> and/or <u>hyperplasia</u>?</div><div><br /></div><div>{{c1::Hypertrophy, <i>only</i>}} </div>", "time": null}, {"id": 1487460276914, "note": "<div>Which <u>cellular change</u> is characterized by a <b>decrease in tissue mass</b> due to decrease in <i>size</i> or <i>number</i> of cells? </div><div><br /></div><div>{{c1::Atrophy}}</div>", "time": 1660105343685.0}, {"id": 1487461041752, "note": "<div><b>Atrophy</b> via <u>decrease</u> in <b>cell <u>number</u></b> occurs via {{c1::apoptosis}} </div>", "time": 1660105361429.0}, {"id": 1487461046220, "note": "<div><b>Atrophy</b> via <u>decrease</u> in <b>cell <u>size</u></b> may occur via <b>{{c1::ubiquitin-proteasome}} degradation</b> of <b>cytoskeleton</b></div>", "time": 1660105361427.0}, {"id": 1487461053514, "note": "<div><b>Atrophy</b> via <u>decrease</u> in <b>cell <u>size</u></b> may occur via <b>{{c1::autophagy}}</b> of cellular components </div>", "time": 1660105361428.0}, {"id": 1487461060183, "note": "<div>Which <u>cellular change</u> is characterized by <b>replacement of one cell type by another</b>? </div><div><br /></div><div>{{c1::Metaplasia}}</div>", "time": null}, {"id": 1487461064842, "note": "<div>Which <u>cellular change</u> typically occurs after <b>chronic exposure to an irritant</b>, such as gastric acid or smoke? </div><div><br /></div><div>{{c1::Metaplasia}}</div>", "time": null}, {"id": 1487461072030, "note": "<div><b>Metaplasia</b> occurs via <u>reprogramming</u> of <b>{{c1::stem}} cells</b>, which then produce the new cell type</div>", "time": null}, {"id": 1487461075476, "note": "<div>Is <b>metaplasia</b> reversible or irreversible? </div><div><br /></div><div>{{c1::Reversible}}</div>", "time": null}, {"id": 1487461083189, "note": "<div>Under <u>persistent stress</u>, <b>metaplasia</b> can progress to <b>dysplasia</b> and eventually <b>{{c1::cancer}}</b> </div>", "time": null}, {"id": 1487461089160, "note": "<div>Which <b>metaplasia</b> carries <u>no increased risk</u> for <b>malignancy</b>? </div><div><br></div><div>{{c1::Apocrine metaplasia of breast}}</div>", "time": null}, {"id": 1487461096732, "note": "<div><b>Vitamin {{c1::A}} deficiency</b> can result in <b>metaplasia</b></div>", "time": null}, {"id": 1487461107256, "note": "<div>What <u>musculoskeletal disorder</u> is characterized by <b>metaplasia</b> of <b>skeletal muscle to bone</b>? </div><div><br /></div><div>{{c1::Myositis ossificans}}</div>", "time": null}, {"id": 1487461112379, "note": "<div><div>Which <u>cellular change</u> is characterized by <b>disordered</b>, <b>non-neoplastic cellular growth</b>? </div><div><br /></div><div>{{c1::Dysplasia}} </div></div>", "time": null}, {"id": 1487462195051, "note": "<div>Which <u>mitochondrial membrane</u> contains the <b>electron transport chain</b>? </div><div><br /></div><div>{{c1::Inner mitochondrial membrane}}</div>", "time": null}, {"id": 1487463879752, "note": "<div><b>Cellular injury</b> is characterized by {{c1::<i>decreased</i>}} activity of the <b>Na<sup>+</sup>-K<sup>+</sup></b> and <b>Ca<sup>2+</sup> pumps</b> </div>", "time": 1660105360861.0}, {"id": 1487463887140, "note": "<div>What is the hallmark of <u>reversible</u> <b>cellular injury</b>?</div><div><br /></div><div>{{c1::Swelling}} </div>", "time": null}, {"id": 1487463894466, "note": "<div><u>{{c2::Reversible}}</u> cellular injury is characterized ultrastructurally by <b>membrane</b> <b>{{c1::blebbing}}</b> and <b>loss of <u>microvilli</u></b></div>", "time": null}, {"id": 1487463900987, "note": "<div><u>{{c2::Reversible}}</u> cellular injury is characterized ultrastructurally by <b>{{c1::ribosomal}} detachment</b> and {{c3::<b>polysomal</b>}} <b>detachment</b>, leading to <u>decreased protein synthesis</u></div>", "time": null}, {"id": 1487463907439, "note": "<div>What is the hallmark of <u>irreversible</u> <b>cellular injury</b>? </div><div><br /></div><div>{{c1::Membrane damage}}</div>", "time": null}, {"id": 1487463918664, "note": "<div><b><i>Plasma</i> membrane damage</b> in <u>irreversible</u> cellular injury results in&nbsp;<i>entry</i> of {{c1::Ca<sup>2+</sup>}} ions into the cell </div>", "time": null}, {"id": 1487463922315, "note": "<div><b>Mitochondrial</b> <b>{{c1::vacuolization}} </b>signifies irreversible cellular injury</div>", "time": 1660105355207.0}, {"id": 1487463924702, "note": "<div><b>{{c1::Lysosome}} membrane damage</b> in <u>irreversible</u> cell injury results in <b>hydrolytic enzymes</b> leaking into the cytosol</div>", "time": null}, {"id": 1487467497291, "note": "<div>What is the end result of <u>irreversible</u> <b>cell injury</b>?</div><div><br /></div><div>{{c1::Cell death}}</div>", "time": null}, {"id": 1487469733350, "note": "<div>The morphologic hallmark of <u>cell death</u> is <b>loss of the {{c1::nucleus}}</b></div>", "time": null}, {"id": 1487469750801, "note": "<div>Which feature of <u>cell death</u> is characterized by <b>nuclear condensation</b>? </div><div><br /></div><div>{{c1::Pyknosis}}</div>", "time": null}, {"id": 1487469755479, "note": "<div><div>Which feature of <u>cell death</u> is characterized by <b>nuclear fragmentation</b>? </div><div><br /></div><div>{{c1::Karyorrhexis}}</div></div>", "time": null}, {"id": 1487469759701, "note": "<div><div>Which feature of <u>cell death</u> is characterized by <b>nuclear dissolution</b>? </div><div><br /></div><div>{{c1::Karyolysis}}</div></div>", "time": null}, {"id": 1487469763555, "note": "<div>The <u>two</u> <b>MAIN</b> mechanisms of <b>cell death</b> are <b>{{c1::necrosis}}</b> and <b>{{c2::apoptosis}}</b> </div>", "time": null}, {"id": 1487469766823, "note": "<div>Which mechanism of <u>cell death</u> is never<b> physiologic*</b>? </div><div><br /></div><div>{{c1::Necrosis}}</div>", "time": null}, {"id": 1487469774152, "note": "<div>Which mechanism of <u>cell death</u> is an <b>inflammatory process</b>? </div><div><br /></div><div>{{c1::Necrosis}}</div>", "time": null}, {"id": 1487469778711, "note": "<div>Which mechanism of <u>cell death</u> involves death of a <b>large group of cells</b>? </div><div><br /></div><div>{{c1::Necrosis}}</div>", "time": null}, {"id": 1487469783753, "note": "<div>Which type of <u>necrosis</u> is characterized by <b>preserved cell shape</b> and <b>organ structure</b>? </div><div><br /></div><div>{{c1::Coagulative necrosis}}</div>", "time": null}, {"id": 1487469807276, "note": "<div><b>Coagulative necrosis</b> is characterized by <u>preserved</u> <b>cell</b> <b>architecture</b> (cell {{c2::outlines}} are seen) but the {{c1::nucleus}} disappears </div>", "time": null}, {"id": 1487469816961, "note": "<div><b>{{c1::Coagulative}} necrosis</b> is characteristic of <b>{{c2::ischemic infarction}}</b> of <i>any</i> organ <u>except</u> the <b>{{c3::brain}}</b> </div>", "time": null}, {"id": 1487469825199, "note": "<div>In <i>coagulative</i> necrosis, injury denatures {{c1::<u>proteolytic</u> <u>enzymes</u>}}</div>", "time": null}, {"id": 1487469864434, "note": "<div>Which type of <u>necrosis</u> is characterized by <b>enzymatic lysis of cells</b> <b>and protein</b>? </div><div><br></div><div>{{c1::Liquefactive necrosis}}</div>", "time": 1660105341748.0}, {"id": 1487469868022, "note": "<div>In the late phase of liquefactive necrosis of the {{c1::brain}}, cystic spaces and cavitation may be seen</div>", "time": null}, {"id": 1487469877849, "note": "<div>What type of&nbsp;<u>necrosis</u> is seen with <b>brain infarcts</b> and <b>abscess</b>? </div><div><br></div><div>{{c1::Liquefactive necrosis}} </div>", "time": null}, {"id": 1487469880635, "note": "<div><div>Which cells release <u>proteolytic enzymes</u> in response to <b>brain</b> <b><i>infarction</i></b>, causing <b>liquefactive necrosis</b>?</div><div><br /></div><div>{{c1::Microglial cells}} </div></div>", "time": null}, {"id": 1487469883647, "note": "<div><div>Which cells release <u>proteolytic enzymes</u> in response to <b>brain</b> <b><i>abscess</i></b>, causing <b>liquefactive necrosis</b>?</div><div><br /></div><div>{{c1::Neutrophils}} </div></div>", "time": null}, {"id": 1487469886411, "note": "<div>In addition to the <u>brain</u>, what other organ may undergo <b>liquefactive necrosis</b>? </div><div><br /></div><div>{{c1::Pancreas}}</div>", "time": null}, {"id": 1487469894582, "note": "<div>Which type of <u>necrosis</u> resembles <b>mummified tissue</b>?</div><div><br /></div><div>{{c1::Gangrenous (dry)}}</div>", "time": null}, {"id": 1487469931164, "note": "<div><b>{{c1::Gangrenous}} necrosis</b> is characteristic of <u>chronic</u> <u>ischemia</u> of the <b>{{c2::lower limb}}</b> and <b>{{c3::GI tract}}</b> </div>", "time": null}, {"id": 1487469935766, "note": "<div><b>Gangrenous necrosis</b> is a form of <u>{{c1::coagulative}}</u> necrosis</div>", "time": 1660105358718.0}, {"id": 1487469938790, "note": "<div>What type of <u>necrosis</u> may be seen <b><i>with</i></b> <b>gangrenous necrosis</b> if <b>superinfection</b> occurs?  </div><div><br /></div><div>{{c1::Liquefactive necrosis (\"wet gangrene\")}}</div>", "time": null}, {"id": 1487469944925, "note": "<div>Which type of <u>necrosis</u> is characterized by <b>soft</b>, <b>friable necrotic tissue</b> with a \"<b>cottage cheese-like</b>\" appearance? </div><div><br /></div><div>{{c1::Caseous necrosis}}</div>", "time": null}, {"id": 1487469959674, "note": "<div><b>Caseous</b> <b>necrosis</b> is a <u>combination</u> of <b>{{c1::coagulative}}</b> and <b>{{c1::liquefactive}}</b> <b>necrosis</b></div>", "time": null}, {"id": 1487469962274, "note": "<div>Which type of <u>necrosis</u> is characteristic of <b>tuberculous</b> and <b>fungal infections</b>? </div><div><br /></div><div>{{c1::Caseous necrosis}}</div>", "time": null}, {"id": 1487469968141, "note": "<div>Which type of <u>necrosis</u> is characterized by <b>fragmented cells/debris</b> <i>surrounded</i> by <b>lymphocytes</b> and <b>macrophages</b>? </div><div><br /></div><div>{{c1::Caseous necrosis}}</div>", "time": null}, {"id": 1487469971218, "note": "<div>Which type of <u>necrosis</u> is characterized by a <b>chalky-white appearance</b> due to <b>deposition of Ca</b><sup style=\"font-weight: bold; \">2+</sup>? </div><div><br /></div><div>{{c1::Fat necrosis}}</div>", "time": 1660105341749.0}, {"id": 1487469975903, "note": "<div><b>Fat necrosis</b> is characteristically due to <b>{{c2::acute pancreatitis}}</b> or {{c1::<b>trauma</b> (e.g. breast)}} </div>", "time": null}, {"id": 1487469981667, "note": "<div>In <u>fat necrosis</u>, <b>fatty</b> <b>acids</b> bind to <b>Ca<sup>2+</sup></b> via a process called <b>{{c1::saponification}}</b> </div>", "time": null}, {"id": 1487469993914, "note": "<div><b>Saponification</b> <b>of fat</b> appears {{c1::dark blue::color}} on H&amp;E stain</div>", "time": 1660105353169.0}, {"id": 1487470008820, "note": "<div><div>Which type of <u>calcification</u>&nbsp;occurs in <b>abnormal</b>, <b>necrotic tissues</b>? </div><div><br></div><div>{{c1::Dystrophic::dystrophic or metastatic}}</div></div>", "time": null}, {"id": 1487470017343, "note": "<div><div><div>Which type of <u>calcification</u>&nbsp;occurs secondary to <b>injury</b> or<b> necrosis</b>? </div><div><br></div><div>{{c1::Dystrophic::dystrophic or metastatic}}</div></div></div>", "time": null}, {"id": 1487470065053, "note": "<div><div><div>Which type of <u>calcification</u>&nbsp;tends to be <b>localized</b>? </div><div><br></div><div>{{c1::Dystrophic::dystrophic or metastatic}}</div></div></div>", "time": null}, {"id": 1487470068885, "note": "<div><div><div><div>Are patients with <u>dystrophic calcifications</u> usually <b>normocalcemic</b>? </div></div><div><br /></div><div>{{c1::Yes}}</div></div></div>", "time": null}, {"id": 1487470072763, "note": "<div><div><div>Which type of <u>calcification</u>&nbsp;occurs in <b>normal</b>, <b>non-necrotic tissues</b>? </div><div><br></div><div>{{c1::Metastatic::dystrophic or metastatic}}</div></div></div>", "time": null}, {"id": 1487470077436, "note": "<div><div><div><div>Which type of <u>calcification</u>&nbsp;occurs secondary to <b>hypercalcemia</b> or<b> hyperphosphatemia</b>? </div><div><br></div><div>{{c1::Metastatic::dystrophic or metastatic}}</div></div></div></div>", "time": null}, {"id": 1487470084914, "note": "<div><div><div><div>Which type of <u>calcification</u>&nbsp;tends to be <b>widespread</b>? </div><div><br></div><div>{{c1::Metastatic::dystrophic or metastatic}}</div></div></div></div>", "time": null}, {"id": 1487470094124, "note": "<div><div><b>Metastatic calcification</b> predominantly occurs in the <b>{{c1::kidney}}</b>, <b>{{c2::lung}}</b>, and <b>gastric mucosa</b> </div></div>", "time": null}, {"id": 1487470100826, "note": "<div>Which type of <u>necrosis</u> is characterized by <b>necrotic damage to blood vessel walls</b>? </div><div><br /></div><div>{{c1::Fibrinoid necrosis}}</div>", "time": null}, {"id": 1487470105872, "note": "<div><b>Fibrinoid necrosis</b> is characteristic of <b>{{c1::malignant}}</b> <b>hypertension</b>, {{c2::<b>vasculitis</b> (e.g. PAN)}}, and <b>{{c3::preeclampsia}}</b> </div>", "time": null}, {"id": 1487470115450, "note": "<div><b>Fibrinoid necrosis</b> is characterized <i>histologically</i> by <b>thick</b>, {{c1::<b>bright</b> <b>pink</b>::color}} <b>staining</b>&nbsp;of vessel walls</div>", "time": null}, {"id": 1487470119549, "note": "<div><div>Which mechanism of <u>cell death</u> is an <b>ATP-dependent programmed cell death</b>? </div><div><br></div><div>{{c1::Apoptosis}}</div></div>", "time": 1660105342634.0}, {"id": 1487470122628, "note": "<div><div>Which mechanism of <u>cell death</u> is NOT followed by <b>inflammation</b>? </div><div><br></div><div>{{c1::Apoptosis}}</div></div>", "time": 1660105342633.0}, {"id": 1487470125519, "note": "<div><div>Which mechanism of <u>cell death</u> involves death of <b>single cells</b> or <b><i>small</i> groups of cells</b>? </div><div><br></div><div>{{c1::Apoptosis}}</div></div>", "time": 1660105342635.0}, {"id": 1487470128060, "note": "<div><b>Apoptosis</b> is characterized <i>morphologically</i> by cell {{c1::<u>shrinkage</u>::size}}, chromatin condensation, and membrane blebbing  </div>", "time": null}, {"id": 1487470134272, "note": "<div>The <u>nucleus</u> of <b>apoptotic cells</b> stains deeply <b>{{c1::baso}}-philic</b> </div>", "time": null}, {"id": 1487470141075, "note": "<div><b>Apoptosis</b> results in the formation of <u>apoptotic bodies</u>, which are subsequently <b>phagocytosed</b> by {{c1::macrophages}}</div>", "time": null}, {"id": 1487470148526, "note": "<div><b>Apoptosis</b> is mediated by {{c1::<u>caspases</u>}}, which <i>activate</i> <b>proteases</b> and <b>endonucleases</b></div>", "time": null}, {"id": 1487470154743, "note": "<div>What <i>class</i> of <u>enzymes</u> <b>breaks down DNA</b> in <b>apoptosis</b>?</div><div><br></div><div>{{c1::Endonucleases}}</div>", "time": null}, {"id": 1487470156809, "note": "<div>What <i>class</i> of <u>enzymes</u> <b>breaks down the cytoskeleton</b> in <b>apoptosis</b>? </div><div><br></div><div>{{c1::Proteases}}</div>", "time": null}, {"id": 1487470158626, "note": "<div>The <u>mitochondrial (intrinsic) pathway</u> of <b>apoptosis</b> occurs via <i>inactivation</i> of <b>{{c1::Bcl2}}</b> </div>", "time": null}, {"id": 1487470164855, "note": "<div><b>Bcl-2</b> normally keeps the<b> </b>mitochondrial outer membrane <u>impermeable</u>, thus preventing {{c1::<b>cytochrome</b> <i><b>c</b></i>}} release from the <b>intermembrane space</b></div>", "time": null}, {"id": 1487470180854, "note": "<div>Are the Bcl-2 related proteins <b>BAX</b> and <b>BAK</b> <u>pro</u><i>-</i> or <u>anti-apoptotic</u>? </div><div><br /></div><div>{{c1::Pro-apoptotic}}</div>", "time": null}, {"id": 1487470201031, "note": "<div>The <u>extrinsic (death receptor) pathway</u> of <b>apoptosis</b> can occur via <i>receptor binding</i> between <b>{{c1::Fas-L}}</b>-(receptor: CD{{c3::95}}) or <b>{{c2::TNF-\u03b1}}</b> and their respective receptors </div>", "time": null}, {"id": 1487470208377, "note": "<div>The <u>extrinsic pathway</u> of <b>apoptosis</b> can occur via a <b>CD-{{c1::8</b><b>}}</b><b><sup>+</sup> T-cell pathway</b> </div>", "time": 1660105350169.0}, {"id": 1487470217383, "note": "<div><u>Defective</u> <b>{{c2::Fas-FasL}} interactions</b> can cause <b>{{c1::autoimmune lymphoproliferative}} syndrome</b></div>", "time": 1660105360171.0}, {"id": 1487470222716, "note": "<div><b>DNA laddering</b> in <i>multiples</i> of <u>180 BP</u> is a sensitive indicator of <b>{{c1::apoptosis}}</b></div>", "time": null}, {"id": 1487470225207, "note": "<div><b>{{c1::Free radicals}}</b> are chemical species with an <u>unpaired electron</u> in their outer orbit</div>", "time": 1660105340320.0}, {"id": 1487470227188, "note": "<div>If <b>O<sub>2</sub></b> <i>accepts</i> <u>one</u> electron, it forms {{c1::superoxide (O<sub>2</sub><sup>-</sup>)}}</div>", "time": 1660105357703.0}, {"id": 1487470229408, "note": "<div>If <b>O<sub>2</sub> </b><i>accepts</i> <u>two</u> electrons, it forms {{c1::hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>)}}</div>", "time": 1660105357701.0}, {"id": 1487470231445, "note": "<div>If <b>O<sub>2</sub> </b><i>accepts</i> <u>three</u> electrons, it forms {{c1::hydroxyl anion (OH<sup>-</sup>)}}</div>", "time": 1660105357702.0}, {"id": 1487470234455, "note": "<div><i>Pathologic</i> generation of <u>free radicals</u> arises with <b>ionizing radiation</b>, which hydrolyzes <b>H<sub>2</sub>O</b> to {{c1::<b>OH</b><sup><b>-</b></sup>}}</div>", "time": 1660105354348.0}, {"id": 1487470236560, "note": "<div>Which <i>oxygen</i>-derived <u>free radical</u> is the <b>most damaging</b>?</div><div><br></div><div>{{c1::OH<sup>-</sup>}}</div>", "time": 1660105342432.0}, {"id": 1487470238614, "note": "<div><i>Pathologic</i> generation of <u>free radicals</u> arises with<b> metals</b> (e.g. copper and iron) via the <b>{{c1::Fenton}} reaction</b> </div>", "time": 1660105354347.0}, {"id": 1487470244885, "note": "<div><b>Free radicals</b> cause cellular injury via {{c1::<u>peroxidation</u>}} of <b>lipids</b> and {{c2::<u>oxidation</u>}} of <b>DNA</b> and <b>proteins</b></div>", "time": 1660105358783.0}, {"id": 1487470250734, "note": "<div><b>Free radicals</b> may be <i>eliminated</i> via {{c1::<u>antioxidants</u>}} (e.g. reduced glutathione and vitamins A, C, and E)</div>", "time": null}, {"id": 1487470252945, "note": "<div>What <u>mitochondrial enzyme</u> reduces <b>superoxide</b> (<b>O<sub>2</sub></b><sup>-</sup>) to <b>H<sub>2</sub>O<sub>2</sub></b>? </div><div><br /></div><div>{{c1::Superoxide dismutase}}</div>", "time": null}, {"id": 1487470255062, "note": "<div><div>What <u>enzymes</u> reduce <b>hydrogen peroxide </b>(<b>H<sub>2</sub>O<sub>2</sub></b>) to <b>O<sub>2</sub> </b>and <b>H<sub>2</sub>O</b>? </div><div><br></div><div>{{c1::Catalase}} and {{c1::glutathione peroxidase}}</div></div>", "time": null}, {"id": 1487470260293, "note": "<div><b>Free radicals</b> may be <i>eliminated</i> via <u>metal carrier proteins</u>, such as {{c1::<b>transferrin</b> (Fe<sup>2+</sup>)}} and {{c2::<b>ceruloplasmin</b> (Cu<sup>2+</sup>)}}</div>", "time": 1660105358780.0}, {"id": 1487470262097, "note": "<div>What <u>organic solvent</u> used in the <b>dry cleaning industry</b> is converted to <b><i>free radicals</i></b> in the <b>liver</b>? </div><div><br /></div><div>{{c1::Carbon tetrachloride (CCl<sub>4</sub>)}}</div>", "time": 1660105345098.0}, {"id": 1487470267945, "note": "<div><b>CCl<sub>3</sub> </b>free radical damage in the <b>liver</b> results in <u>decreased</u><b> apolipoprotein synthesis</b> with resultant {{c1::<b>fatty</b>}} <b>change </b>and <b>{{c2::centrilobular::location}} necrosis</b></div>", "time": null}, {"id": 1487470274721, "note": "<div>What cause of <u>free radical injury</u> occurs following <b>thrombolytic therapy</b>? </div><div><br /></div><div>{{c1::Reperfusion injury}}</div>", "time": 1660105347546.0}, {"id": 1487470280583, "note": "<div>Which <b>layer</b> of the <u>heart wall</u> is <i>most vulnerable</i> to <b>hypoxia/ischemia</b>? </div><div><br /></div><div>{{c1::Subendocardium (LV)}}</div>", "time": null}, {"id": 1487470289670, "note": "<div>Which regions of the <u>colon</u> are <i>most vulnerable</i> to <b>hypoxia/ischemia</b>? </div><div><br></div><div>{{c1::Splenic flexure}} and {{c2::rectosigmoid junction}}</div>", "time": null}, {"id": 1487547577420, "note": "<b>{{c1::Amyloid}}</b> is a <u>misfolded protein</u> that deposits in the <b>extracellular space</b>, resulting in <b>cellular damage</b> and <b>apoptosis</b> ", "time": null}, {"id": 1487550474201, "note": "<div>What is the shared <u>structural feature</u> of <b>amyloid</b>? </div><div><br /></div><div>{{c1::\u03b2-pleated sheet}}</div>", "time": 1660105345484.0}, {"id": 1487550483703, "note": "<div><b>Amyloid</b> may be visualized using <b>{{c1::Congo red}} staining</b></div>", "time": 1660105361843.0}, {"id": 1487550493244, "note": "<div><b>Amyloid</b> may be visualized as {{c1::<u>apple-green birefringence</u>}} under <b>polarized light</b></div>", "time": 1660105361844.0}, {"id": 1487550496659, "note": "<div><b>{{c3::Primary}} amyloidosis</b> is characterized by <u>systemic</u> deposition of <b>{{c1::AL amyloid}}</b>, which is derived from <b>{{c2::Ig light chain}}</b> </div>", "time": null}, {"id": 1487550501974, "note": "<div><b>{{c3::Secondary}} amyloidosis</b> is characterized by <u>systemic</u> deposition of <b>{{c1::AA amyloid}}</b>, which is derived from {{c2::<b>serum amyloid-associated protein </b>(SAA)}}</div>", "time": null}, {"id": 1487550504664, "note": "<div><b>Serum amyloid-associated protein</b> (SAA) is an <u>acute phase reactant</u> that is increased in <b>chronic</b> <b>inflammatory</b> <b>states</b>, <b>malignancy</b>, and {{c1::<b>Familial Mediterranean fever</b> (FMF)}} </div>", "time": null}, {"id": 1487550507064, "note": "<div><b>Familial Mediterranean Fever</b> is due to <u>dysfunction</u> of <b>{{c1::neutrophils::cell type}}</b> </div>", "time": null}, {"id": 1487550515135, "note": "<div><b>Familial Mediterranean fever</b> is characterized by {{c1::<u>AA amyloid</u>}} <b>deposits</b> in tissues during attacks </div>", "time": null}, {"id": 1487550521082, "note": "<div>What organ is <u>most commonly</u> affected by <b>systemic amyloidosis</b>? </div><div><br /></div><div>{{c1::Kidney}}</div>", "time": 1660105345099.0}, {"id": 1487550527095, "note": "<div>Diagnosis of <b>amyloidosis</b> requires {{c1::<u>tissue biopsy</u>}}; the <b>abdominal</b> <b>fat pad</b> and <b>rectum</b> are easily accessible targets</div>", "time": 1660105360083.0}, {"id": 1487550534131, "note": "<div><b>{{c2::Senile cardiac}} amyloidosis</b> is characterized by deposition of <u>non-mutated</u> {{c1::<b>transthyretin</b> (TTR)}} protein</div>", "time": 1660105337388.0}, {"id": 1487550541119, "note": "<div><b>{{c2::Familial amyloid}} cardiomyopathy</b> / <b>polyneuropathies </b>are characterized by deposition of <u>mutated</u> {{c1::<b>transthyretin</b> (TTR)}} protein in the heart and nerves</div>", "time": 1660105337982.0}, {"id": 1487550547055, "note": "<div>What type of <u>cardiomyopathy</u> is caused by <i>mutated</i> <b>transthyretin</b> <b>deposits</b> (familial amyloid cardiomyopathy)?  </div><div><br /></div><div>{{c1::Restrictive cardiomyopathy}}</div>", "time": 1660105344852.0}, {"id": 1487550549393, "note": "<div><b>Type {{c2::II}} diabetes mellitus</b> is associated with deposition of {{c1::<b>amylin</b> (islet amyloid polypeptide)}} in the <b>islets of the pancreas</b> </div>", "time": 1660105348417.0}, {"id": 1487550555569, "note": "<div><b>Alzheimer disease</b> is characterized by deposition of {{c1::<u>A\u03b2-amyloid</u>}} in the <b>brain</b>, which forms <b>amyloid</b> <b>plaques</b> </div>", "time": null}, {"id": 1487550566447, "note": "<div><b>{{c2::Dialysis}}-associated amyloidosis</b> is characterized by deposition of {{c1::<u>\u03b22-microglobulin</u>}} in <b>{{c3::joints}}</b> </div>", "time": 1660105338083.0}, {"id": 1487550571778, "note": "<div>Which <u>amyloidosis</u> may present as <b>carpal tunnel syndrome</b>? </div><div><br></div><div>{{c1::Any amyloidosis*}}</div>", "time": null}, {"id": 1487550585393, "note": "<div><b>Medullary carcinoma of the thyroid</b> is characterized by deposition of {{c1::<u>calcitonin</u>}} within the tumor</div>", "time": 1660105355344.0}, {"id": 1487982311235, "note": "What <u>HLA subtype</u> is associated with <b>hemochromatosis</b>? <div><br /></div><div>{{c1::A3}}</div>", "time": null}, {"id": 1487983915856, "note": "<div>What <u>HLA subtypes</u> are associated with <b>Addison disease</b>? </div><div><br /></div><div>{{c1::B8}}, {{c2::DR3}}, and {{c3::DR4}}</div>", "time": null}, {"id": 1487983919927, "note": "<div><div>What <u>HLA subtypes</u> are associated with <b>Graves disease</b>? </div><div><br /></div><div>{{c1::B8}} and {{c2::DR3}}</div></div>", "time": null}, {"id": 1487983926461, "note": "<div><div>What <u>HLA subtype</u> is associated with <b>seronegative arthropathies</b>? </div><div><br></div><div>{{c1::B27}} </div></div>", "time": null}, {"id": 1487983938140, "note": "<div><div>What <u>HLA subtype</u> is associated with <b>multiple sclerosis</b>? </div><div><br /></div><div>{{c1::DR2}}</div></div>", "time": null}, {"id": 1487983941570, "note": "<div><div>What <u>HLA subtype</u> is associated with <b>hay fever</b>? </div><div><br /></div><div>{{c1::DR2}}</div></div>", "time": null}, {"id": 1487983947972, "note": "<div><div>What <u>HLA subtypes</u> are associated with <b>SLE</b>? </div><div><br /></div><div>{{c1::DR2}} and {{c1::DR3}} </div></div>", "time": null}, {"id": 1487983954783, "note": "<div><div>What <u>HLA subtype</u> is associated with <b>Goodpasture syndrome</b>? </div><div><br /></div><div>{{c1::DR2}} </div></div>", "time": null}, {"id": 1487983956917, "note": "<div><div>What <u>HLA subtypes</u> are associated with <b>type I diabetes mellitus</b>? </div><div><br /></div><div>{{c1::DR3}} and {{c1::DR4}} </div></div>", "time": null}, {"id": 1487983958998, "note": "<div><div>What <u>HLA subtype</u> is associated with <b>Rheumatoid arthritis</b>? </div><div><br /></div><div>{{c1::DR4}}</div></div>", "time": null}, {"id": 1487983965276, "note": "<div><div>What <u>HLA subtypes</u> are associated with <b>Hashimoto thyroiditis</b>? </div><div><br /></div><div>{{c1::DR3}} and {{c1::DR5}}</div></div>", "time": null}, {"id": 1487983968953, "note": "<div>What <u>HLA subtype</u> is associated with <b>pernicious anemia</b>? </div><div><br /></div><div>{{c1::DR5}}</div>", "time": null}, {"id": 1487986335122, "note": "<div>What is <u>another name</u> for the <b>p-ANCA antibody</b>? </div><div><br></div><div>{{c1::Myeloperoxidase (MPO)-ANCA}}</div>", "time": null}, {"id": 1487986370184, "note": "<div>What is <u>another name</u> for the <b>c-ANCA antibody</b>? </div><div><br></div><div>{{c1::Proteinase 3 (PR3)-ANCA}}</div>", "time": null}, {"id": 1487988649958, "note": "<b>{{c2::Anti-smooth muscle}}</b> <u>autoantibodies</u> are associated with <b>{{c1::autoimmune hepatitis type 1}}</b> ", "time": null}, {"id": 1488153925598, "note": "<div><div>What is the <u>penetrance</u> of <b>achondroplasia</b>? </div><div><br></div><div>{{c1::100%}}</div></div>", "time": 1660105345643.0}, {"id": 1488153943084, "note": "<div><b>Achondroplasia</b> is characterized by {{c2::<u>short (rhizomelic)</u>}} <b>extremities</b> with a <i>relatively</i> {{c1::<u>large</u>}} <b>head</b> </div>", "time": 1660105362216.0}, {"id": 1488153977297, "note": "<div><b>{{c2::Osteopetrosis}}</b> is caused by an inherited <u>defect</u> in <b>bone</b> {{c1::<b>resorption</b>}} </div>", "time": null}, {"id": 1488153980776, "note": "<div><b>Osteopetrosis</b> is due to <i>poor</i> <u>osteo-</u>{{c1::<u>clast</u>}} function, impairing the ability to <u>{{c2::remodel}}</u> bone</div>", "time": null}, {"id": 1488153984198, "note": "<div>What <u>MSK pathology</u> is characterized by <b>thick</b>, <b>heavy bone</b> that <b>fractures </b><b style=\"font-style: italic; \">easily</b> due to <b>failure of bone resorption</b>? </div><div><br></div><div>{{c1::Osteopetrosis}}</div>", "time": 1660105347018.0}, {"id": 1488153987056, "note": "<div><div><b>Osteopetrosis</b> is characterized by diffuse, symmetric <b>skeletal</b> <b>{{c1::sclerosis}}</b> on X-ray</div></div>", "time": 1660105354497.0}, {"id": 1488153992586, "note": "<div><b>{{c2::Osteopetrosis}}</b> may occur due to mutations in&nbsp;<b>{{c1::<i>carbonic anhydrase II</i>}}</b>, which leads to <u>loss</u> of the <b>acidic</b> <b>environment</b> necessary for <b>bone</b> <b>resorption</b> </div>", "time": null}, {"id": 1488153999516, "note": "<div><b>Osteopetrosis</b> is associated with {{c1::pancytopenia}} and <u>extramedullary hematopoiesis</u> due to <b>bony</b> <b>replacement</b> of the <b>marrow</b> (myelophthisic process)</div>", "time": null}, {"id": 1488154002188, "note": "<div><b>Osteopetrosis</b> may present with <u>vision</u> and <u>hearing</u> impairment due to <b>{{c1::cranial nerve}} impingement</b></div>", "time": 1660105354495.0}, {"id": 1488154005344, "note": "<div><b>Osteopetrosis</b> may present with <b>hydrocephalus</b> due to <u>narrowing</u> of the {{c1::<b>foramen</b> <b>magnum</b>}}</div>", "time": 1660105354496.0}, {"id": 1488154008256, "note": "<div>What is the <u>treatment</u> for <b>osteopetrosis</b>? </div><div><br></div><div>{{c1::Bone marrow transplant (osteoclasts are derived from monocytes)}}</div>", "time": null}, {"id": 1488154011659, "note": "<div>{{c2::<b>Osteomalacia</b> (<b>Rickets</b>)}} is due to <u>defective</u> <b>mineralization</b> of <b>{{c1::osteoid}}</b> </div>", "time": null}, {"id": 1488154018652, "note": "<div>What is the <u>most common cause</u> of <b>osteomalacia/rickets</b>? </div><div><br /></div><div>{{c1::Vitamin D deficiency}}</div>", "time": null}, {"id": 1488154025451, "note": "<div>What <u>MSK pathology</u> is caused by <b>low vitamin D </b>in <b>children</b>? </div><div><br></div><div>{{c1::Rickets}}</div>", "time": 1660105345140.0}, {"id": 1488154036143, "note": "<div><b>Rickets</b> may present with {{c1::<b>rachitic rosary</b>}} due to <u>osteoid deposition</u><b> </b>at the <b>costochondral</b> <b>junction</b> </div>", "time": 1660105353291.0}, {"id": 1488154044058, "note": "<div><b>Rickets</b> may present with <u>frontal bossing</u> and {{c1::<u>craniotabes</u>}} (soft skull)</div>", "time": 1660105353293.0}, {"id": 1488154051712, "note": "<div><b>Rickets</b> may present with pathologic {{c1::<u>bow</u>}}<u> legs</u> (genu varum)</div>", "time": 1660105353292.0}, {"id": 1488154057387, "note": "<div>What <u>MSK pathology</u> is associated with <b>metaphyseal cupping/fraying</b>?</div><div><br /></div><div>{{c1::Rickets}} </div>", "time": 1660105345142.0}, {"id": 1488154063767, "note": "<div><div>What <u>MSK pathology</u> is caused by <b>low vitamin D </b>in <b>adults</b>? </div><div><br></div><div>{{c1::Osteomalacia}}</div></div>", "time": 1660105345141.0}, {"id": 1488154067058, "note": "<div>What <u>MSK pathology</u> is associated with \"<b>Looser zones</b>\" (pseudofractures) on X-ray? </div><div><br /></div><div>{{c1::Osteomalacia}}</div>", "time": 1660105345145.0}, {"id": 1488154072070, "note": "<div><b>Osteomalacia/rickets</b> is characterized by {{c1::<u>decreased</u>}} serum <b>Ca</b><sup style=\"font-weight: bold; \">2+</sup> </div>", "time": 1660105354505.0}, {"id": 1488154079433, "note": "<div><b>Osteomalacia/rickets</b> is characterized by {{c1::<u>decreased</u>}} serum <b>PO<sub>4</sub></b><sup style=\"font-weight: bold; \">3-</sup> </div>", "time": 1660105354504.0}, {"id": 1488154087019, "note": "<div><b>Osteomalacia/rickets</b> is characterized by {{c1::<u>increased</u>}} serum <b>PTH</b> </div>", "time": null}, {"id": 1488154095903, "note": "<div><b>Osteomalacia/rickets</b> is characterized by {{c1::<u>increased</u>}} serum <b>alkaline phosphatase</b> </div>", "time": 1660105354503.0}, {"id": 1488154103442, "note": "<div>What <u>MSK pathology</u> is characterized by a <i><b>reduction</b></i> in <b>trabecular</b> and <b>cortical bone mass</b> and <b>interconnections</b>? </div><div><br /></div><div>{{c1::Osteoporosis}}</div>", "time": 1660105345139.0}, {"id": 1488154106594, "note": "<div><b><u>Peak</u> bone mass</b> is achieved by {{c1::30}} years of age </div>", "time": 1660105354042.0}, {"id": 1488154123080, "note": "<div><b>Osteoporosis</b> is most commonly due to <u>decreased</u> <b>{{c1::estrogen}}</b> <b>levels</b> or <u>increased</u> <b>{{c2::age}}</b>  </div>", "time": 1660105354488.0}, {"id": 1488154130432, "note": "<div><b>Osteoporosis</b> may be <u>secondary</u> to <b>{{c1::hyper}}-thyroidism</b> </div>", "time": null}, {"id": 1488154132833, "note": "<div><b>Osteoporosis</b> may be <u>secondary</u> to <b>{{c1::hyper}}-parathyroidism</b></div>", "time": null}, {"id": 1488154134900, "note": "<div><b>Osteoporosis</b> is diagnosed by <u>DXA scan</u> with a <b>T-score</b> of <u>&lt;</u> {{c1::- 2.5}} <i>or </i>a <b>fragility</b> <b>fracture</b> of the hip or vertebrae </div>", "time": null}, {"id": 1488154141116, "note": "<div><u>Prophylaxis</u> for <b>osteoporosis</b> includes regular {{c1::<b>weight-bearing</b>}} <b>exercise</b> and <b>adequate Ca<sup>2+</sup> / vitamin D</b> intake throughout adulthood</div>", "time": 1660105353636.0}, {"id": 1488154151078, "note": "<div>What <u>ethnicity</u> is associated with <i>decreased</i> risk for <b>osteoporosis</b>?</div><div><br></div><div>{{c1::African Americans}}</div>", "time": null}, {"id": 1488154155508, "note": "<div><b>Osteoporosis</b> can lead to <u>{{c1::vertebral}} compression fractures</u>, which result in <b>loss of height</b> and <b>kyphosis</b> </div>", "time": 1660105354493.0}, {"id": 1488154158429, "note": "<div><b>Osteoporosis</b> may present with fracture of the <u>femoral neck</u> or <u>distal {{c1::radius}}</u> (<b>Colles fracture</b>)</div>", "time": 1660105354486.0}, {"id": 1488154162983, "note": "<div>What is test used to measure <u>bone density</u>? </div><div><br></div><div>{{c1::DEXA scan}}</div>", "time": 1660105346783.0}, {"id": 1488154165735, "note": "<div><div><b>Osteoporosis</b> is characterized by {{c1::<u>normal</u>}} serum <b>Ca</b><sup style=\"font-weight: bold; \">2+</sup> </div></div>", "time": 1660105354490.0}, {"id": 1488154172718, "note": "<div><div><b>Osteoporosis</b> is characterized by {{c1::<u>normal</u>}} serum <b>PO<sub>4</sub></b><sup style=\"font-weight: bold; \">3-</sup> </div></div>", "time": 1660105354489.0}, {"id": 1488154179748, "note": "<div><div><b>Osteoporosis</b> is characterized by {{c1::<u>normal</u>}} serum <b>PTH</b> </div></div>", "time": null}, {"id": 1488154186768, "note": "<div><div><b>Osteoporosis</b> is characterized by {{c1::<u>normal</u>}} serum <b>alkaline phosphatase</b> </div></div>", "time": 1660105354491.0}, {"id": 1488154194187, "note": "<div><div>What <u>MSK pathology</u> is characterized by <b>thick</b>, <b>heavy bone</b> that <b>fractures </b><b style=\"font-style: italic; \">easily</b> due to <b>imbalance of osteoblast and osteoclast function</b>? </div><div><div><br></div><div>{{c1::Paget disease of bone (osteitis deformans)}}</div></div></div>", "time": 1660105345138.0}, {"id": 1488154197821, "note": "<div><div>Is <b>Paget disease of bone</b> a <u>localized</u> or <u>diffuse</u> process? </div><div><br /></div><div>{{c1::Localized}} </div></div>", "time": 1660105355889.0}, {"id": 1488154203814, "note": "<div><div>What <u>demographic</u>&nbsp;is associated with <b>Paget disease of bone</b>? </div><div><br></div><div>{{c1::Late adulthood (age &gt; 60)::age group}}</div></div>", "time": 1660105347356.0}, {"id": 1488154205844, "note": "<div>What is the <u>first stage</u> of <b>Paget disease of bone</b> (osteitis deformans)? <div><br /></div><div>{{c1::Osteoclastic (lytic)}}</div></div>", "time": null}, {"id": 1488154207969, "note": "<div><div>What is the <u>second stage</u> of <b>Paget disease of bone</b> (osteitis deformans)? <div><br /></div><div>{{c1::Mixed osteoblastic-osteoclastic}}</div></div></div>", "time": null}, {"id": 1488154209988, "note": "<div><div>What is the <u>third stage</u> of <b>Paget disease of bone</b> (osteitis deformans)? <div><br /></div><div>{{c1::Osteoblastic (sclerotic)}}</div></div></div>", "time": null}, {"id": 1488154212025, "note": "<div><div>What is the <u>fourth stage</u> of <b>Paget disease of bone</b> (osteitis deformans)? <div><br></div><div>{{c1::Quiescent (minimal osteoclast/osteoblast activity)}}</div></div></div>", "time": null}, {"id": 1488154214573, "note": "<div><div>What <u>MSK pathology</u> is characterized <i>histologically</i> by a<b> mosaic pattern</b> of <b>woven</b> and <b>lamellar</b> <b>bone</b>? </div><div><br /></div><div>{{c1::Paget disease of bone}}</div></div>", "time": null}, {"id": 1488154222514, "note": "<div><div><b>Paget disease of bone</b> may present with <u>bone {{c1::pain}}</u> due to <b>microfractures</b> or <b>long</b> <b>bone</b> \"chalk stick\" <b>fractures</b></div></div>", "time": 1660105354426.0}, {"id": 1488154239414, "note": "<div><div>What <u>MSK pathology</u> is associated with an <b>increasing hat size</b> due to skull thickening? </div><div><br /></div><div>{{c1::Paget disease of bone}}</div></div>", "time": 1660105345144.0}, {"id": 1488154244383, "note": "<div><div><b>Paget disease of bone</b> often presents with {{c1::<u>hearing</u>}}<u> loss</u> due to <b>CN impingement</b> from foramen narrowing</div></div>", "time": null}, {"id": 1488154250806, "note": "<div><div><b>Paget disease of bone</b> is characterized by {{c1::<u>normal</u>}} serum <b>Ca</b><sup style=\"font-weight: bold; \">2+</sup></div></div>", "time": null}, {"id": 1488154254526, "note": "<div><div><b>Paget disease of bone</b> is characterized by {{c1::<u>normal</u>}} serum <b>PO<sub>4</sub></b><sup style=\"font-weight: bold; \">3-</sup></div></div>", "time": null}, {"id": 1488154260436, "note": "<div><div><b>Paget disease of bone</b> is characterized by {{c1::<u>normal</u>}} serum <b>PTH</b></div></div>", "time": null}, {"id": 1488154264011, "note": "<div><div><b>Paget disease of bone</b> is characterized by {{c1::<u>elevated</u>}} serum <b>alkaline phosphatase</b> </div></div>", "time": null}, {"id": 1488154271167, "note": "<div><div>Treatment for <b>Paget disease of bone</b> includes {{c1::calcitonin}} and {{c2::bisphosphonates}}</div></div>", "time": null}, {"id": 1488154273351, "note": "<div><div>One complication of<b> {{c3::Paget disease of bone}}</b> is <u>{{c1::high-output heart failure}}</u> due to formation of <b>{{c2::AV shunts}}</b> in <b>bone</b></div></div>", "time": null}, {"id": 1488154275283, "note": "<div><div>What <u>malignancy</u> is associated with <b>Paget disease of bone</b> (osteitis deformans)? </div><div><br></div><div>{{c1::Osteosarcoma}}</div></div>", "time": null}, {"id": 1488154310043, "note": "<div><div><div>What cause of <u>osteomyelitis</u> is more common in <b>dog</b> and <b>cat bites</b>? </div><div><br /></div><div>{{c1::<i>Pasteurella multocida</i>}}</div></div></div>", "time": 1660105347545.0}, {"id": 1488154346725, "note": "<div><div>What is the <u>most common site</u> for <b>osteonecrosis</b> (avascular necrosis)?</div><div><br /></div><div>{{c1::Femoral head}}</div></div>", "time": null}, {"id": 1488154358646, "note": "<div><b>{{c1::Teriparatide}}</b> is a <u>recombinant form</u> of <b>{{c2::PTH}}</b> used to treat <b>osteoporosis</b><br></div>", "time": 1660105359158.0}, {"id": 1488156362804, "note": "<b>Osteoma</b> is a <u>benign</u> tumor of <b>{{c1::bone::what overall type of structure?}}</b> that is seen in {{c2::middle}} age", "time": 1660105354508.0}, {"id": 1488158468885, "note": "<div><b>Osteomas</b> most commonly arise on the surface of {{c1::facial}} bones</div>", "time": 1660105354502.0}, {"id": 1488158472215, "note": "<div>What <u>GI pathology</u> is associated with <b>osteomas</b>? </div><div><br /></div><div>{{c1::Gardner syndrome}}</div>", "time": null}, {"id": 1488158478382, "note": "<div><b>Osteoid osteoma</b> is a <u>benign</u> tumor of {{c1::<b>osteoblasts</b> (which make osteoid)}}, surrounded by a rim of reactive bone</div>", "time": null}, {"id": 1488158483806, "note": "<div>What <u>demographic</u>&nbsp;is associated with <b>osteoid osteoma</b>? </div><div><br></div><div>{{c1::Males &lt; 25 years old::age, gender}}</div>", "time": 1660105347351.0}, {"id": 1488158491025, "note": "<div><b>Osteoid osteoma</b> typically arises in the <u>{{c1::cortex}}</u> of the {{c2::<u>diaphysis</u>}} of <b>long bones</b> (e.g. femur) </div>", "time": null}, {"id": 1488158498635, "note": "<div><b>Osteoid osteoma</b> presents with <u>bone pain</u> that is worse at {{c2::<u>night</u>}} and {{c1::<b>DOES</b>}} resolve with <b>aspirin</b> </div>", "time": null}, {"id": 1488158505167, "note": "<div>Imaging of <b>osteoid osteoma</b> reveals a <b>bony</b> <b>mass</b>, {{c1::&lt;}} 2 cm, with a <u>radiolucent</u> core (osteoid)</div>", "time": null}, {"id": 1488158509358, "note": "<div><b>Osteoblastoma</b> is <u>benign</u> tumor of <b>osteoblasts</b>, typically {{c1::&gt;}} 2 cm</div>", "time": null}, {"id": 1488158515445, "note": "<div><b>Osteoblastoma</b> presents with <u>bone pain</u>, especially at&nbsp;<i>night</i>, that {{c1::DOES NOT}} resolve with <b>aspirin</b></div>", "time": null}, {"id": 1488158521582, "note": "<div><b>Osteoblastoma</b> typically arises in {{c1::<b>vertebrae</b>::body location}}</div>", "time": null}, {"id": 1488158587363, "note": "<div><b>{{c1::Osteochondroma}}</b> is a <u>benign</u> <b>bone</b>&nbsp;tumor with an <b>overlying cartilage cap</b> </div>", "time": null}, {"id": 1488158592417, "note": "<div>What is the <i>most common</i> <u>benign</u> tumor of <b>bone</b>? </div><div><br></div><div>{{c1::Osteochondroma}}</div>", "time": null}, {"id": 1488158594625, "note": "<div><b>Osteochondroma</b> arises as a <u>lateral projection</u> of the {{c1::growth plate (metaphysis)}}</div>", "time": null}, {"id": 1488158604836, "note": "<div>The <u>overlying cartilage</u> in <b>osteochondroma</b> <i>rarely</i> transforms to&nbsp;<b>{{c1::chondrosarcoma}}</b></div>", "time": 1660105349726.0}, {"id": 1488158607454, "note": "<div><div>What <u>demographic</u>&nbsp;is associated with <b>osteochondroma</b>? </div><div><br></div><div>{{c1::Males &lt; 25 years old::age, gender}}</div></div>", "time": null}, {"id": 1488158609741, "note": "<div><b>Osteosarcoma</b> is a <u>malignant</u> proliferation of {{c1::<b>osteoblasts</b>}} </div>", "time": null}, {"id": 1488158616564, "note": "<div>The <u>peak incidence</u> for <i>primary</i> <b>osteosarcoma</b> is in {{c1::teenagers (10-20 years old)::specific}}</div>", "time": null}, {"id": 1488158618692, "note": "<div>The <u>peak incidence</u> for <i>secondary</i> <b>osteosarcoma</b> is in {{c1::the elderly (&gt;65 years old)}}</div>", "time": null}, {"id": 1488158624515, "note": "<div>What <u>MSK pathology</u> predisposes to <b>osteosarcoma</b>? </div><div><br></div><div>{{c1::Paget disease of bone}}</div>", "time": null}, {"id": 1488158626909, "note": "<div><b>Osteosarcoma</b> is associated with {{c1::<u>radiation</u>}} exposure</div>", "time": null}, {"id": 1488158629480, "note": "<div>What <u>inherited cancers</u> are associated with <b>osteosarcoma</b>? </div><div><br></div><div>{{c1::Li-Fraumeni syndrome and familial retinoblastoma::2}}</div>", "time": null}, {"id": 1488158632507, "note": "<div><b>Osteosarcoma</b> arises in the {{c1::<u>metaphysis</u>}} of <b>long</b> <b>bones</b>, often around the <b>{{c2::knee::body location}}</b></div>", "time": null}, {"id": 1488158639613, "note": "<div><b>Osteosarcoma</b> typically presents as a <u>pathologic</u> <b>{{c1::fracture}}</b> or <b>bone</b> <b>pain</b> <b>with</b> <b>swelling</b></div>", "time": 1660105354479.0}, {"id": 1488158642264, "note": "<div>Imaging of <b>osteosarcoma</b> may reveal a(n) \"{{c1::sunburst}}\" pattern on X-ray</div>", "time": null}, {"id": 1488158647681, "note": "<div>Imaging of <b>osteosarcoma</b> may reveal <u>elevation of periosteum</u>, which is known as <b>{{c1::Codman triangle}}</b></div>", "time": null}, {"id": 1488158653008, "note": "<div>What <u>bone tumor</u> is characterized by a \"<b>sunburst</b>\" <b>pattern</b> and <b>Codman triangle</b> on X-ray?</div><div><br /></div><div>{{c1::Osteosarcoma}}</div>", "time": null}, {"id": 1488158657810, "note": "<div>Biopsy of <b>osteosarcoma</b> reveals <u>pleomorphic</u> cells that produce {{c1::osteoid}}</div>", "time": 1660105361227.0}, {"id": 1488158661194, "note": "<div>What is the <u>treatment</u> for <b>osteosarcoma</b>?</div><div><br></div><div>{{c1::En bloc resection}} and {{c1::chemotherapy}}</div>", "time": null}, {"id": 1488158663647, "note": "<div><b>Giant cell tumor</b> is a bone tumor comprised of <u>multinucleated giant</u> cells and <u>stromal</u> cells that express {{c1::RANKL}}</div>", "time": null}, {"id": 1488158666195, "note": "<div><div>What <u>demographic</u>&nbsp;is associated with <b>giant cell tumor</b> of bone? </div><div><br></div><div>{{c1::Young adults (20 - 40 years old)::age group}}</div></div>", "time": null}, {"id": 1488158668157, "note": "<div><div><b>Giant cell tumor</b> arises in the <u>{{c1::epiphysis}}</u> of <b>long bones</b>, often in the <b>knee region</b></div></div>", "time": null}, {"id": 1488158671971, "note": "<div>Which <u>bone tumor</u> arises in the <b>epiphysis</b> of <b>long bones</b>?</div><div><br /></div><div>{{c1::Giant cell tumor}}</div>", "time": null}, {"id": 1488158675153, "note": "<div><b>Giant cell tumor</b> usually arises at the <u>distal</u> <b>{{c1::femur}}</b> or <u>proximal</u> <b>{{c2::tibia}}</b></div>", "time": 1660105358649.0}, {"id": 1488158677710, "note": "<div><b>Giant cell tumor</b> is associated with a(n) \"<b>{{c1::soap bubble}}</b>\" appearance on X-ray</div>", "time": null}, {"id": 1488158679387, "note": "<div>Which <u>bone tumor</u> is associated with a \"<b>soap-bubble</b>\" appearance on X-ray? </div><div><br></div><div>{{c1::Giant cell tumor}}</div>", "time": null}, {"id": 1488158681260, "note": "<div><b>Giant cell tumor</b> is a locally <u>aggressive</u> {{c1::benign::benign or malignant}} tumor</div>", "time": 1660105358650.0}, {"id": 1488158684257, "note": "<div><b>Ewing sarcoma</b> is a <u>malignant</u> proliferation of <i>poorly</i>-differentiated cells derived from <b>{{c1::neuroectoderm}}</b></div>", "time": null}, {"id": 1488158686006, "note": "<div><b>Ewing sarcoma</b> arises in the <u>{{c1::diaphysis}}</u> of <b>long bones</b> (particularly the <u>femur</u>); other locations include pelvic {{c2::flat bones}}, scapula, and ribs </div>", "time": 1660105359394.0}, {"id": 1488158689770, "note": "<div><div>What <u>demographic</u>&nbsp;is associated with <b>Ewing sarcoma</b>? </div><div><br></div><div>{{c1::Boys &lt; 15 years old::age, gender}}</div></div>", "time": null}, {"id": 1488158691886, "note": "<div><b>Ewing sarcoma</b> is associated with a(n) \"<b>{{c1::onion-skin}}</b>\" appearance on X-ray</div>", "time": null}, {"id": 1488158694088, "note": "<div>Which <u>bone tumor</u> is characterized by <b>small</b>, <b>round blue cells</b> that <b>resemble lymphocytes</b>? </div><div><br /></div><div>{{c1::Ewing sarcoma}}</div>", "time": 1660105343829.0}, {"id": 1488158700582, "note": "<div><b>{{c2::Ewing sarcoma}}</b> is a <u>bone tumor</u> that is associated with <b>t({{c1::11}};{{c1::22}}) translocation</b> </div>", "time": null}, {"id": 1488158706465, "note": "<div>What is the <u>treatment</u> for <b>Ewing sarcoma</b>?</div><div><br /></div><div>{{c1::Chemotherapy}}</div>", "time": 1660105345362.0}, {"id": 1488158711866, "note": "<div><b>{{c1::Chondroma}}</b> is a <u>benign</u> tumor of <b>cartilage</b></div>", "time": null}, {"id": 1488158715215, "note": "<div>Which <u>cartilage tumor</u> arises in the <b>medulla</b> of the <b>small bones </b>in the <b>hands and feet</b>? </div><div><br /></div><div>{{c1::Chondroma (benign)}}</div>", "time": 1660105343773.0}, {"id": 1488158719240, "note": "<div><b>{{c1::Chondrosarcoma}}</b> is a <u>malignant</u> <b>cartilage-forming tumor</b> </div>", "time": null}, {"id": 1488158721404, "note": "<div><div>Which <u>cartilage tumor</u> arises in the <b>medulla</b> of the <b>pelvis</b> or<b> central skeleton</b>? </div><div><br></div><div>{{c1::Chondrosarcoma (malignant)}}</div></div>", "time": 1660105343774.0}, {"id": 1488158723205, "note": "<div><div>Which is <u>more common</u>, <b>primary bone tumors</b> or <b>metastasis to the bone</b>?</div><div><br></div><div>{{c1::Metastasis}}</div></div>", "time": 1660105342739.0}, {"id": 1488158724693, "note": "<div><b>Metastatic bone tumors</b> <i>usually</i> result in {{c1::<u>osteolytic</u> (punched-out)}} lesions</div>", "time": 1660105355273.0}, {"id": 1488158726384, "note": "<b>Prostatic carcinoma</b> with <u>bone metastasis</u> classically produces {{c1::osteoblastic}} lesions ", "time": null}, {"id": 1488247922730, "note": "<div><u>Pain management</u> for <u>osteoarthritis</u> includes <b>acetaminophen</b>, <b>{{c1::NSAIDs}}</b>, <b>{{c3::Celecoxib}}</b> and/or <b>intra-articular {{c2::glucocorticoids}}</b> </div>", "time": 1660105354421.0}, {"id": 1488247975880, "note": "<div><div>Which <u>arthritis</u> is characterized by <b>joint space narrowing</b>, <b>erosions</b>, and <b>periarticular&nbsp;osteopenia</b> on imaging? </div><div><br></div><div>{{c1::Rheumatoid arthritis}}</div></div>", "time": 1660105343969.0}, {"id": 1488248086324, "note": "<div><b>Reactive arthritis</b> is characterized by a <u>triad</u> of <b>{{c1::conjunctivitis}}</b>, <b>{{c2::urethritis}}</b>, and <b>{{c3::arthritis}}</b>, with patients often also having <u>{{c4::diarrhea::GI}}</u></div>", "time": null}, {"id": 1488409952800, "note": "<b>{{c1::Dermato}}-myositis</b> in an <u>inflammatory</u> disorder of the<b> skin</b> <i>and</i> <b>skeletal muscle</b> ", "time": 1660105340588.0}, {"id": 1488418087875, "note": "<div><div><b>{{c2::Dermato}}-myositis</b> is characterized by <u>{{c1::peri}}-mysial</u> inflammation with <b>perifascicular atrophy</b> on biopsy</div></div>", "time": null}, {"id": 1488418093751, "note": "<div><div>Inflammation in <b>{{c2::dermato}}-myositis</b> is mediated by <b>CD-{{c1::4}}<sup>+</sup> T cells</b></div></div>", "time": null}, {"id": 1488418096970, "note": "<div><div><div><b>{{c2::Dermatomyositis}}</b> may present with a \"<u>{{c1::heliotrope}}\" rash</u>, which is an <b>erythematous</b> <b>periorbital</b> <b>rash</b> </div></div></div>", "time": null}, {"id": 1488418099220, "note": "<div><b>{{c2::Dermatomyositis}}</b> may present with a(n)&nbsp;<u>{{c1::malar}} rash</u> that is <i>similar</i> to <b>SLE</b></div>", "time": 1660105338095.0}, {"id": 1488418106813, "note": "<div><div><div><b>{{c1::Dermatomyositis}}</b> may present with a \"<b>shawl and face</b>\" <b>rash</b> </div></div></div>", "time": null}, {"id": 1488418224075, "note": "<div><div><div><b>{{c2::Dermatomyositis}}</b> may present with <b>{{c1::Gottron papules}}</b>, which are <u>red papules</u> on the <b>elbows</b>, <b>knuckles</b>, and <b>knees</b></div></div></div>", "time": 1660105338093.0}, {"id": 1488418271395, "note": "<div><div><b>{{c2::Dermato}}-myositis</b> is associated with <u>increased</u> risk for <b><i>occult</i> {{c1::malignancy}}</b> </div></div>", "time": null}, {"id": 1488418278945, "note": "<div><div><b>{{c1::Poly}}-myositis</b> is an <u>inflammatory</u> disorder of <b>skeletal muscle</b> <i>only</i> </div></div>", "time": 1660105339243.0}, {"id": 1488418284913, "note": "<div><div><div><b>{{c2::Poly}}-myositis</b> is characterized by <u>{{c1::endo}}-mysial</u> inflammation with <b>necrotic muscle fibers</b> on biopsy</div></div></div>", "time": null}, {"id": 1488418289795, "note": "<div><div><div>Inflammation in <b>{{c2::poly}}-myositis</b> is mediated by <b>CD-{{c1::8}}<sup>+</sup> T cells</b> </div></div></div>", "time": null}, {"id": 1488418293440, "note": "<div><b>Dermatomyositis</b> and <b>polymyositis</b> present with <u>bilateral</u> {{c1::proximal::proximal or distal}} <b>muscle <i>weakness</i>&nbsp;</b></div>", "time": null}, {"id": 1488418299612, "note": "<div>What <u>enzyme</u> is elevated in <i>both</i> <b>dermatomyositis</b> and <b>polymyositis</b>?</div><div><br /></div><div>{{c1::Creatine kinase (CK)}}</div>", "time": null}, {"id": 1488418305850, "note": "<div><b>Polymyositis</b> and <b>dermatomyositis</b> may have <b>ANA</b>, <b>{{c1::anti-Jo-1}}</b>, <b>{{c2::anti-Mi-2}}</b>, and/or <b>{{c3::anti-SRP}}</b> antibodies</div>", "time": null}, {"id": 1488418308296, "note": "<div>What is the <u>treatment</u> for <b>dermatomyositis</b> and <b>polymyositis</b>? </div><div><br></div><div>{{c1::Corticosteroids, followed by immunosuppressant therapy}}</div>", "time": null}, {"id": 1488418310891, "note": "<div><b>{{c1::Polymyalgia rheumatica}}</b> is characterized by sudden onset <u>pain</u> and <u>stiffness</u> in the {{c2::<u>proximal</u>}} muscles (i.e. <b>shoulders and hips</b>), {{c2::<i>without</i>::with or without}} muscular weakness </div>", "time": null}, {"id": 1488418318763, "note": "<div>What <u>demographic</u>&nbsp;is associated with <b>polymyalgia rheumatica</b>?</div><div><br></div><div>{{c1::Women &gt; 50 years old::age, gender}}</div>", "time": null}, {"id": 1488418321113, "note": "<div>What <u>vasculitis</u> is associated with <b>polymyalgia rheumatica</b>? </div><div><br></div><div>{{c1::Giant cell (temporal) arteritis}}</div>", "time": null}, {"id": 1488418324096, "note": "<div><b>Polymyalgia rheumatica</b> is associated with a(n) <u>{{c1::normal}}</u> serum <b>creatine kinase</b> (CK)</div>", "time": null}, {"id": 1488418330232, "note": "<div><b>Polymyalgia rheumatica</b> is associated with a(n) <u>{{c1::elevated}}</u> serum <b>CRP</b> and <b>ESR</b></div>", "time": null}, {"id": 1488418347812, "note": "<div>What is the <u>treatment</u> for <b>polymyalgia rheumatica</b>?</div><div><br></div><div>{{c1::Low-dose corticosteroids}}</div>", "time": null}, {"id": 1488418351291, "note": "<div><b>{{c1::Fibromyalgia}}</b> presents with chronic, <u>widespread</u> <b>musculoskeletal pain</b> associated with \"<b>tender points</b>\" </div>", "time": 1660105340357.0}, {"id": 1488418358285, "note": "<div><div><b>Fibromyalgia</b> is associated with a(n) <u>{{c1::normal}}</u> serum <b>creatine kinase</b> (CK)</div></div>", "time": 1660105359270.0}, {"id": 1488418385131, "note": "<div><div><b>Fibromyalgia</b> is associated with a(n) <u>{{c1::normal}}</u> serum <b>CRP</b> and <b>ESR</b> </div></div>", "time": 1660105359269.0}, {"id": 1488418414137, "note": "<div>Non-pharmacologic treatment for <b>fibromyalgia</b> may include <u>regular</u> {{c1::exercise}}</div>", "time": 1660105354818.0}, {"id": 1488418416727, "note": "<div>Pharmacologic treatment for <b>fibromyalgia</b> may include anti-{{c1::convulsants}} or anti-{{c1::depressants}}  </div>", "time": null}, {"id": 1488418426461, "note": "<div>What <u>classes</u> of <b>antidepressant</b> are useful for treating <b>fibromyalgia</b>? </div><div><br></div><div>{{c1::TCAs and SNRIs::2}}</div>", "time": null}, {"id": 1488418428735, "note": "<div><b>X-linked muscular dystrophy</b> is characterized by <u>muscle wasting</u> and <i>replacement</i> of <b>skeletal muscle</b> by <b>{{c1::adipose}}</b> <b>tissue</b> </div>", "time": 1660105341448.0}, {"id": 1488418436183, "note": "<div>What <u>gene</u> is <i>defective</i> in <b>X-linked muscular dystrophy</b> (e.g. Duchenne, Becker)? </div><div><br></div><div>{{c1::Dystrophin (<i>DMD</i>) gene}}</div>", "time": null}, {"id": 1488418438908, "note": "<div><b>Dystrophin</b> normally <u>anchors</u> the <b>muscle</b> <b>{{c1::cytoskeleton}}</b> to the <b>{{c2::extracellular matrix}}</b>; primarily in skeletal and cardiac muscle</div>", "time": null}, {"id": 1488418445475, "note": "<div><u>Loss</u> of <b>dystrophin</b> (e.g. X-linked muscular dystrophy) results in <b>myo-{{c1::necrosis}}</b></div>", "time": null}, {"id": 1488418447737, "note": "<div>Why is the <u>dystrophin</u> (DMD) gene <b>prone to <i>spontaneous</i> mutations</b>? </div><div><br></div><div>{{c1::Largest protein-coding human gene}}</div>", "time": 1660105341500.0}, {"id": 1488418449967, "note": "<div>What is the <u>mode of inheritance</u> of <b>Duchenne</b> and <b>Becker muscular dystrophy</b>? </div><div><br /></div><div>{{c1::X-linked}}</div>", "time": null}, {"id": 1488418455323, "note": "<div><b>{{c1::Duchenne}} muscular dystrophy</b> is typically due to <u>frameshift</u> or <u>non-sense</u> mutations, resulting in a <b>truncated</b> or <b>absent dystrophin protein</b> </div>", "time": null}, {"id": 1488418461029, "note": "<div><b>{{c1::Becker}} muscular dystrophy</b> is typically due to a <u>non-frameshift</u> deletion, resulting in a <b>partially functional dystrophin protein</b> </div>", "time": null}, {"id": 1488418466511, "note": "<div>Which is <u>more severe</u>, <b>Duchenne</b> or <b>Becker muscular dystrophy</b>? </div><div><br></div><div>{{c1::Duchenne}}</div>", "time": null}, {"id": 1488418468638, "note": "<div><b>Duchenne muscular dystrophy</b> presents with <i>weakness</i> in the {{c1::pelvic girdle}} muscles and progresses <u>superiorly</u></div>", "time": null}, {"id": 1488418470779, "note": "<div><b>{{c2::Duchenne muscular dystrophy}}</b> classically presents with <u>{{c1::pseudohypertrophy}}</u> of <b>calf muscles</b></div>", "time": null}, {"id": 1488418478717, "note": "<div><b>{{c1::Duchenne}} </b><u>muscular dystrophy</u> typically presents <b>before 5 years of age</b></div>", "time": null}, {"id": 1488418480898, "note": "<div><b>Duchenne muscular dystrophy</b> is associated with <u>increased</u> serum <b>{{c1::CK}}</b> and <b>{{c2::aldolase}}</b></div>", "time": null}, {"id": 1488418482714, "note": "<div>What is a common <u>cause of death</u> in <b>Duchenne muscular dystrophy</b>? </div><div><br /></div><div>{{c1::Dilated cardiomyopathy}}</div>", "time": null}, {"id": 1488418489582, "note": "<div><b>{{c1::Becker}} </b><u>muscular dystrophy</u> typically presents in <b>adolescence</b> or <b>early adulthood</b> </div>", "time": null}, {"id": 1488418495512, "note": "<div><b>Duchenne muscular dystrophy</b> classically presents with the <u>{{c1::Gower}} sign</u>, in which a patient <b>uses their upper extremities</b> <b>to help stand up</b> </div>", "time": null}, {"id": 1488418502329, "note": "<div>{{c1::<b>Myotonic dystrophy</b> (type 1)}} is due to <b>CTG</b> <u>trinucleotide repeat</u> expansion in the <b><span style=\"font-style: italic; \">{{c2::DMPK}}</span><i> </i>gene</b></div>", "time": null}, {"id": 1488418515177, "note": "<div>What is the <u>mode of inheritance</u> of <b>myotonic dystrophy</b>?</div><div><br></div><div>{{c1::Autosomal dominant}}</div>", "time": null}, {"id": 1488418518286, "note": "<div><b>Myotonic dystrophy</b> is due to <u>abnormal expression</u> of the enzyme <b><i>{{c1::myotonin protein kinase}}</i></b></div>", "time": null}, {"id": 1488418521622, "note": "<div>The symptoms of <b>{{c4::myotonic dystrophy}}</b> may be remembered with the mnemonic \"<b>CTG</b>\": </div><div style=\"centerbox\"><div class=\"mnemonics\"><div><br></div><div><b>C</b>: {{c1::Cataracts}}</div><div><b>T</b>: {{c2::Toupee (early balding in men)}}</div><div><b>G</b>: {{c3::Gonadal atrophy}}</div></div></div><div><br></div><div>Other symptoms include <b>myotonia</b>, <b>muscle wasting</b>, and <b>arrhythmias</b></div>", "time": null}, {"id": 1488418525490, "note": "<div><b>{{c2::Myasthenia gravis}}</b> is caused by <u>autoantibodies</u> to <b>{{c1::post}}-synaptic</b> <b>{{c1::ACh receptors}}</b> at the NMJ</div>", "time": null}, {"id": 1488418535769, "note": "<div>What <u>gender</u> is more commonly affected by <b>myasthenia gravis</b>? </div><div><br></div><div>{{c1::Females}}</div>", "time": 1660105347070.0}, {"id": 1488418538322, "note": "<div><b>Myasthenia gravis</b> presents with muscle <i>weakness</i> that <u>{{c1::worsens}}</u> with <b>muscle use</b></div>", "time": null}, {"id": 1488418541862, "note": "<div><b>Myasthenia gravis</b> classically involves the <u>eyes</u>, leading to <b>{{c1::ptosis}}</b> and <b>{{c2::diplopia}}</b></div>", "time": null}, {"id": 1488418545172, "note": "<div>Do the symptoms of <b>myasthenia gravis</b> <u>improve</u> with administration of an <b>AChE inhibitor</b> (e.g. edrophonium)? </div><div><br /></div><div>{{c1::Yes}}</div>", "time": null}, {"id": 1488418548933, "note": "<div>What <u>malignancy</u> is associated with <b>myasthenia gravis</b>?</div><div><br /></div><div>{{c1::Thymoma (also may have thymic hyperplasia)}}</div>", "time": null}, {"id": 1488418555043, "note": "<div><b>{{c2::Lambert-Eaton myasthenic syndrome (LEMS)}}</b> is caused by <u>autoantibodies</u> to <b>{{c1::pre}}-synaptic</b> <b>{{c1::VDCCs}}</b> at the NMJ </div>", "time": null}, {"id": 1488418562282, "note": "<div><b>Lambert-Eaton myasthenic syndrome</b> presents with muscle <i>weakness</i> that <u>{{c1::improves}}</u> with <b>muscle use</b></div>", "time": null}, {"id": 1488418565940, "note": "<div><div>What <u>malignancy</u> is associated with <b>Lambert-Eaton myasthenic syndrome</b>?</div><div><br /></div><div>{{c1::Small cell lung cancer}}</div></div>", "time": null}, {"id": 1488418572449, "note": "<div><div>Is the <b>tensilon</b> test (administration of edrophonium) <u>very</u> useful in diagnosis of <b>Lambert-Eaton</b>?</div></div><div><div><br></div><div>{{c1::No}}</div></div>", "time": null}, {"id": 1488418576187, "note": "<div>Which is <u>more common</u>, <b>myasthenia gravis</b> or <b>Lambert-Eaton myasthenic syndrome</b>?</div><div><br /></div><div>{{c1::Myasthenia gravis}}</div>", "time": null}, {"id": 1488418638300, "note": "<div><b>{{c1::Liposarcoma}}</b> is a <u>malignant</u> tumor of <b>adipose tissue</b> </div>", "time": 1660105339754.0}, {"id": 1488418643668, "note": "<div><b>{{c1::Rhabdomyoma}}</b> is a <u>benign</u> tumor of <b>striated muscle</b></div>", "time": null}, {"id": 1488418645713, "note": "<div><b>{{c1::Rhabdomyosarcoma}}</b> is a <u>malignant</u> tumor of <b>skeletal muscle</b> </div>", "time": 1660105339067.0}, {"id": 1488418653159, "note": "<div><div>What <u>cell type</u> is characteristic of a <b>rhabdomyosarcoma</b>?</div><div><br /></div><div>{{c1::Rhabdomyoblast}}</div></div>", "time": 1660105347467.0}, {"id": 1488680746086, "note": "<div>What <u>vascular tumor</u> is associated with <b>HHV-8 </b>and <b>HIV</b>? </div><div><br /></div><div>{{c1::Kaposi sarcoma}}</div>", "time": null}, {"id": 1488763721560, "note": "<b>Vitamin {{c1::K}}</b> is a <u>cofactor</u> for the <i>enzymatic</i> activation of <b>clotting</b> <b>factors</b>", "time": 1660105348192.0}, {"id": 1488765214688, "note": "<div><b>Vitamin K</b> promotes {{c1::\u03b3-carboxylation}} of <b>factors</b> <b>II</b>, <b>VII</b>, <b>IX</b>, <b>X</b> and <b>protein C</b>/<b>S</b> </div>", "time": 1660105348205.0}, {"id": 1488765219096, "note": "<div><b>Vitamin K</b> promotes <u>\u03b3-carboxylation</u> at {{c1::glutamic acid::amino acid}} residues</div>", "time": 1660105348204.0}, {"id": 1488765222541, "note": "<div>What <u>enzyme</u> <i>activates</i> <b>vitamin K</b>? </div><div><br /></div><div>{{c1::Epoxide reductase}}</div>", "time": 1660105347154.0}, {"id": 1488765226036, "note": "<div>What is the <u>mechanism of action</u> of <b>warfarin</b>?</div><div><br /></div><div>{{c1::Epoxide reductase inhibitor}}</div>", "time": 1660105346054.0}, {"id": 1488765231664, "note": "<div><b>{{c2::Warfarin}}</b> is an <i>anti-coagulant</i> that intereferes with <u>{{c1::\u03b3-carboxylation}}</u> of <b>vitamin K-dependent clotting factors</b> (II, VII, IX, X)</div>", "time": 1660105337186.0}, {"id": 1488765233649, "note": "<div>What is the <u>first</u> <b>clotting</b> <b>factor</b> to be <i>reduced</i> when starting <b>warfarin</b> therapy?</div><div><br /></div><div>{{c1::Factor VII}}</div>", "time": 1660105346433.0}, {"id": 1488765239779, "note": "<div><b>Warfarins</b> onset of action is {{c1::8}} - {{c1::12}} <b>hours</b> (slow)</div>", "time": 1660105348152.0}, {"id": 1488765243586, "note": "<div><div>What is the <u>route of administration</u> of <b>warfarin</b>? </div><div><br /></div><div>{{c1::Oral}} </div></div>", "time": 1660105345540.0}, {"id": 1488765248074, "note": "<div><b>Warfarin</b> has a(n) {{c1::long}} half-life</div>", "time": 1660105348154.0}, {"id": 1488765251203, "note": "<div><div>What <u>laboratory assay</u> is used to follow the effects of <b>warfarin</b>?</div><div><br /></div><div>{{c1::PT/INR}}</div></div>", "time": 1660105345188.0}, {"id": 1488765255379, "note": "<div>The <u>goal</u> <b>INR</b> for <b>warfarin therapy</b> is typically between {{c1::2}} - {{c1::3}}</div>", "time": 1660105350073.0}, {"id": 1488765259902, "note": "<div><div>Which <i>anticoagulant</i>, <b>warfarin</b> or <b>heparin</b>, is used for <b>chronic anticoagulation</b>? </div><div><br></div><div>{{c1::Warfarin}}</div></div>", "time": 1660105344043.0}, {"id": 1488765273230, "note": "<div><div>Does <b>warfarin</b> cross the placenta?</div><div><br /></div><div>{{c1::Yes (lipid soluble)}}</div></div>", "time": 1660105359785.0}, {"id": 1488765277192, "note": "<div><b>Warfarin</b> can cause <u>hemorrhage</u> and abnormal {{c1::bone}} formation <b>in utero</b></div>", "time": 1660105348155.0}, {"id": 1488765280375, "note": "<div>The <u>anti-coagulants</u> {{c1::<b>protein</b> <b>C</b>}} and {{c1::<b>S</b>}} are <i>reduced</i> early in <b>warfarin</b> <b>therapy</b>, leading to a(n)&nbsp;<b>{{c2::hyper}}-coagulable</b> <b>state</b></div>", "time": 1660105350457.0}, {"id": 1488765287344, "note": "<div>What <b>warfarin</b> <u>complication</u> presents a few days after beginning treatment due to an <b>early</b> <b>transient <i>hypercoagulable</i></b> <b>state</b>?</div><div><br></div><div>{{c1::Warfarin-induced skin necrosis}}</div>", "time": 1660105344674.0}, {"id": 1488765290929, "note": "<div><u>Coadministration</u> of <b>{{c1::heparin}}</b> when starting <b>warfarin</b> <b>therapy</b> <i>prevents</i> the <b>early</b> <b>hypercoagulable</b> <b>state</b> </div>", "time": 1660105360550.0}, {"id": 1488765296661, "note": "<div><b>Warfarin</b> anti-coagulation can be <u>reversed</u> with {{c1::vitamin K}} (delayed effect)</div>", "time": 1660105348156.0}, {"id": 1488765299956, "note": "<div>For <u>rapid reversal</u> of <b>warfarin</b>, {{c1::<b>fresh frozen plasma</b> (FFP)}} or {{c2::<b>prothrombin complex concentrates</b> (PCC)}} should be administered</div>", "time": 1660105358798.0}, {"id": 1488765303577, "note": "<div><b>Warfarin</b> is {{c1::<u>metabolized</u>}} by <b>cytochrome P450</b> and thus has many drug interactions </div>", "time": 1660105348153.0}, {"id": 1488765308661, "note": "<div>Metabolism of <b>warfarin</b> is affected by <i>polymorphisms</i> in the genes for {{c1::<b>vitamin K epoxide reductase complex</b> (<i>VKORC1</i>)}} and {{c2::<b>CYP2C9::specific</b>}}<b>&nbsp;(</b><i>p450 enzyme which metabolizes warfarin</i><b>)</b></div>", "time": 1660105355284.0}, {"id": 1488765310513, "note": "<div><div>Which <i>anticoagulant</i>, <b>warfarin</b> or <b>heparin</b>, has a <b><i>slow</i> onset of action</b> (days)? </div><div><br /></div><div>{{c1::Warfarin}}</div></div>", "time": 1660105344044.0}, {"id": 1488765314397, "note": "<div>What is the <u>site&nbsp;of action</u> of <b>warfarin</b>?</div><div><br></div><div>{{c1::Liver::organ}}</div>", "time": 1660105345481.0}, {"id": 1488767760913, "note": "{{c1::Unfractionated heparin}} is the <u>largest</u> <b><i>indirect</i> thrombin inhibitor</b>", "time": 1660105338534.0}, {"id": 1488767918819, "note": "<div><b>Heparin</b> exerts its effects by <u>activating</u> {{c1::antithrombin III}}</div>", "time": 1660105358357.0}, {"id": 1488767923559, "note": "<div>Which <u>clotting factors</u> are <i>inactivated</i> by <b>unfractionated heparin</b>? </div><div><br></div><div>{{c1::Thrombin (IIa) and factor Xa}}</div>", "time": 1660105343546.0}, {"id": 1488767931946, "note": "<div>What <u>laboratory assay</u> is used to follow <b>heparin</b> activity?</div><div><br /></div><div>{{c1::aPTT}}</div>", "time": 1660105345189.0}, {"id": 1488767936242, "note": "<div>Which <i>anticoagulant</i>, <b>warfarin</b> or <b>heparin</b>, is used for <b><u>immediate</u> anticoagulation</b>? </div><div><br /></div><div>{{c1::Heparin}}</div>", "time": 1660105344042.0}, {"id": 1488767948376, "note": "<div>Which <i>anticoagulant</i>, <b>warfarin</b> or <b>heparin</b>, may be used in the setting of an <b>acute MI</b>? </div><div><br /></div><div>{{c1::Heparin}}</div>", "time": 1660105344041.0}, {"id": 1488767952273, "note": "<div>What are the <u>routes of administration</u> of <b>heparin</b>? </div><div><br></div><div>{{c1::IV::acute}}&nbsp;or {{c1::subcutaneous::prophylaxis}}</div>", "time": 1660105347660.0}, {"id": 1488767955829, "note": "<div>What is the cause of a <u>hypercoagulable state</u> in a patient on <b>heparin </b>therapy?</div><div><br></div><div>{{c1::Heparin-induced thrombocytopenia (HIT)}}</div>", "time": 1660105346725.0}, {"id": 1488767964396, "note": "<div>What effect may <u>heparin</u> have on <b>K<sup>+</sup> levels</b>?</div><div><br></div><div>{{c1::Increased (hyperkalemia; secondary to hypoaldosteronism)}}</div>", "time": 1660105347163.0}, {"id": 1488767968330, "note": "<div>What <u>MSK pathology</u> is associated with <b>heparin</b> use? </div><div><br /></div><div>{{c1::Osteoporosis}}</div>", "time": 1660105345143.0}, {"id": 1488767971727, "note": "<div>What treatment is used for <u>reversal</u> of <b>heparin therapy</b>? </div><div><br /></div><div>{{c1::Protamine sulfate}} </div>", "time": 1660105344897.0}, {"id": 1488767980272, "note": "<div><b>Unfractionated heparin</b> has a relatively {{c1::<u>short</u>}} half-life</div>", "time": 1660105348385.0}, {"id": 1488767982990, "note": "<div>What <u>drug class</u> do <b>enoxaparin</b> and <b>dalteparin</b> belong to? </div><div><br /></div><div>{{c1::Low molecular weight heparin (LMWH)}}</div>", "time": 1660105347258.0}, {"id": 1488767991453, "note": "<div>Which <u>clotting factors</u> are <i>inactivated</i> by the <b>low molecular weight heparin</b> (LMWH)?  </div><div><br /></div><div><i>Mostly</i><b> </b>{{c1::<b>Factor Xa</b>}}, but also {{c2::<b>Thrombin</b>}}, {{c2::<b>Factor XIa</b>}}, and {{c2::<b>Factor IXa</b>}}</div>", "time": 1660105343547.0}, {"id": 1488767999794, "note": "<div>How is <b>low molecular weight heparin</b> (LMWH) <u>eliminated</u> from the body?</div><div><br /></div><div>{{c1::Renal excretion}}</div>", "time": 1660105358016.0}, {"id": 1488768006143, "note": "<div>Does <b>heparin</b> cross the placenta?</div><div><br /></div><div>{{c1::No (water soluble)}}</div><div><br /></div>", "time": 1660105359864.0}, {"id": 1488768009809, "note": "<div><div><div>Which <i>anticoagulant</i>, <b>warfarin</b> or <b>heparin</b>, has a <b><i>fast</i> onset of action</b> (hours)?</div><div><br /></div><div>{{c1::Heparin}}</div></div></div>", "time": 1660105344045.0}, {"id": 1488768013791, "note": "<div><div><div>What is the <u>site of action</u> of <b>heparin</b>?</div><div><br /></div><div>{{c1::Blood}}</div></div></div>", "time": 1660105345482.0}, {"id": 1488768017315, "note": "<div><b>{{c2::Fondaparinux}}</b> is an <u>anticoagulant</u> that acts <i>only</i> on <b>factor {{c1::Xa}}</b> </div>", "time": 1660105337957.0}, {"id": 1488768020833, "note": "<div><div><div>Is <b>protamine</b> <b>sulfate</b> effective at <u>reversing</u> the effects of <b>LMWH</b> and <b>fondaparinux</b>? </div><div><br /></div><div>{{c1::No}}</div></div></div>", "time": 1660105355884.0}, {"id": 1488768024175, "note": "<div><div><div>Compared to heparin, <b>LMWH</b> and <b>fondaparinux</b> have {{c1::<u>longer</u>}} half-lives</div></div></div>", "time": 1660105360502.0}, {"id": 1488768028936, "note": "<div><div>One advantage of <b>LMWH</b> and<b> fondaparinux</b> is that they do <u>not</u> require routine {{c1::monitoring}}</div></div>", "time": 1660105354666.0}, {"id": 1488768031507, "note": "<div>Compared to unfractionated heparin, <b>LMWH</b> and <b>fondaparinux</b> are <u>{{c1::less}}</u> likely to cause <b>HIT</b></div>", "time": 1660105360503.0}, {"id": 1488768038717, "note": "<div>What <u>drug class</u> does<b> bivalirudin</b> belong to? </div><div><br /></div><div>{{c1::Direct thrombin inhibitor}} </div>", "time": 1660105347251.0}, {"id": 1488768047036, "note": "<div>What <u>drug class</u> do&nbsp;<b>argatroban</b> and <b>dabigatran</b> belong to?</div><div><br></div><div>{{c1::Direct thrombin inhibitors}}</div>", "time": 1660105347252.0}, {"id": 1488768050748, "note": "<div>Which <b>direct thrombin inhibitor</b> is administered <u>orally</u>? </div><div><br></div><div>{{c1::Dabigatran}}</div>", "time": 1660105343328.0}, {"id": 1488768053179, "note": "<div>Do <b>direct thrombin inhibitors</b> require <u>lab monitoring</u>?</div><div><br /></div><div>{{c1::No}}</div><div><br /></div><div><br /></div>", "time": 1660105359942.0}, {"id": 1488768055086, "note": "<div>What class of <u>anticoagulants</u> are used to treat <b>heparin-induced thrombocytopenia</b> (HIT)?</div><div><br /></div><div>{{c1::Direct thrombin inhibitors}}</div>", "time": 1660105347441.0}, {"id": 1488768061994, "note": "<div>What drug is used to <u>reverse</u> the effects of <b>dabigatran</b>? </div><div><br /></div><div>{{c1::Idarucizumab}} </div>", "time": 1660105347222.0}, {"id": 1488768067383, "note": "<div><div>What <u>drug class</u> does <b>rivaroxaban</b> and <b>apixaban</b> belong to?</div><div><br /></div><div>{{c1::Direct Xa inhibitors}}</div></div>", "time": 1660105347244.0}, {"id": 1488768070741, "note": "<div>What is the <u>route of administration</u> of <b>direct factor Xa inhibitors</b> (apixaban, rivaroxaban)? </div><div><br /></div><div>{{c1::Oral}}</div>", "time": 1660105345541.0}, {"id": 1488768080149, "note": "<div>Do <b>direct factor Xa inhibitors</b> (apixaban, rivaroxaban) require <u>lab monitoring</u>?</div><div><br /></div><div>{{c1::No}} </div><div><br /></div><div><b><br /></b></div>", "time": 1660105359943.0}, {"id": 1488768082952, "note": "<div><b>Direct factor Xa inhibitors</b> may be used for <b>stroke</b> <u>prophylaxis</u> in patients with {{c1::atrial fibrillation}} </div>", "time": 1660105360015.0}, {"id": 1488768088581, "note": "<div>Are the effects of <b>direct factor Xa inhibitors</b> easily <u>reversible</u>?</div><div><br></div><div>{{c1::No}}</div>", "time": 1660105361598.0}, {"id": 1488768090306, "note": "<div>What <u>adverse effect</u> is common to all <b>anticoagulants</b> (heparin, direct thrombin inhibitors, direct Xa inhibitors, etc.) </div><div><br></div><div>{{c1::Bleeding}}</div>", "time": 1660105347990.0}, {"id": 1488843272212, "note": "<div>Binding between <b>vWF</b> and <b>platelets</b> occurs via the <b>{{c1::GPIb}} receptor</b></div>", "time": 1660105361242.0}, {"id": 1488847654792, "note": "<div><b>ADP</b> is released upon <u>platelet degranulation</u> and binds to <b>{{c1::P2Y<sub>12</sub>}} receptors</b> on platelets, resulting in platelet <b>aggregation</b></div>", "time": 1660105362047.0}, {"id": 1488847659723, "note": "<div><b>Thromboxane A<sub>2</sub></b> is released upon <u>platelet degranulation</u> and causes platelet <b>{{c1::aggregation}}</b> and <b>activation</b></div>", "time": 1660105348777.0}, {"id": 1488847667802, "note": "<div><b>Thromboxane A<sub>2</sub></b> is synthesized within <u>platelets</u> by the enzyme<i> </i><b>COX-{{c1::1}}</b></div>", "time": 1660105348776.0}, {"id": 1488847671701, "note": "<div><i style=\"font-weight: bold; \">Cyclooxygenase-2</i> expression is {{c2::<u>induced}}</u> by {{c1::inflammation}}</div>", "time": 1660105360283.0}, {"id": 1488847674991, "note": "<div>What is the <u>precursor</u> molecule of <b>thromboxane A</b><sub style=\"font-weight: bold; \">2</sub>?</div><div><br /></div><div>{{c1::Arachidonic acid}}</div>", "time": 1660105345622.0}, {"id": 1488847679422, "note": "<div><b>TXA<sub>2</sub></b> causes vaso-{{c1::constriction}}</div>", "time": 1660105348464.0}, {"id": 1488847683296, "note": "<div>Does <b>aspirin</b> inhibit <i>COX-1</i> or <i>COX-2</i>?</div><div><br /></div><div>{{c1::Both :)}}</div>", "time": 1660105359882.0}, {"id": 1488847688890, "note": "<div>Is <b>aspirin</b> a <u>reversible</u> or <u>irreversible</u> inhibitor of <b>COX-1</b> and<b> COX-2</b>?</div><div><br /></div><div>{{c1::Irreversible}} </div>", "time": 1660105355915.0}, {"id": 1488847696894, "note": "<div><b>Aspirin</b> inhibits <i>cyclooxygenase</i> via irreversible covalent {{c1::acetylation}} </div>", "time": 1660105361531.0}, {"id": 1488847719405, "note": "<div><div><b>Aspirin</b> may cause a \"pseudo-allergy\" due to excess {{c1::leukotriene}} synthesis</div></div>", "time": 1660105361530.0}, {"id": 1488847725986, "note": "<div>What <u>ADP receptor inhibitor</u> is <i>reversible</i>?</div><div><br></div><div>{{c1::Ticagrelor}}</div>", "time": 1660105347260.0}, {"id": 1488847733019, "note": "<div><b>ADP receptor inhibitors</b> (e.g. clopidogrel) <u>prevent</u> expression of <b>{{c1::GPIIb/IIIa}} receptors</b> on the platelet surface</div>", "time": 1660105362046.0}, {"id": 1488847735973, "note": "<div>Do <b>ADP receptor inhibitors</b> reduce <i>risk</i> of future <b>cardiovascular</b> <b>events</b>? </div><div><br /></div><div>{{c1::Yes}}</div>", "time": 1660105359947.0}, {"id": 1488847739545, "note": "<div>Do <b>ADP receptor inhibitors</b> reduce <i>symptoms</i> of <u>claudication</u> in <b>peripheral artery disease</b>? </div><div><br /></div><div>{{c1::No}} </div>", "time": 1660105359946.0}, {"id": 1488847742908, "note": "<div>In the setting of <u>acute MI</u>, <b>aspirin</b> should be administered in a(n) {{c1::chewable}} form</div>", "time": 1660105356659.0}, {"id": 1488847747227, "note": "<div><b>Dual-platelet therapy</b> with <u>aspirin</u> and <u>ADP receptor inhibitors</u> is used to prevent <b>coronary</b> <b>stent</b> <b>{{c1::thrombosis}}</b></div>", "time": 1660105359754.0}, {"id": 1488847752152, "note": "<div>What <u>drug class</u> does <b>ticlopidine</b> belong to? </div><div><br /></div><div>{{c1::ADP receptor inhibitor}}</div>", "time": 1660105347242.0}, {"id": 1488847755836, "note": "<div><b>{{c2::Ticlopidine}}</b> is an <u>ADP receptor antagonist</u> associated with <b>{{c1::granulocytopenia}}</b> as an adverse effect</div>", "time": 1660105337250.0}, {"id": 1488847759567, "note": "<div>Platelet <u>aggregation</u> occurs via binding between the <b>{{c1::GPIIb/IIIa}} receptor</b> and <b>fibrinogen</b></div>", "time": 1660105353879.0}, {"id": 1488847763094, "note": "<div>What <u>drug class</u> does <b>abciximab</b> belong to? </div><div><br /></div><div>{{c1::GPIIb/IIIa inhibitor}}</div>", "time": 1660105347253.0}, {"id": 1488847766303, "note": "<div><b>{{c1::Abciximab}}</b> is a monoclonal <u>IgG antibody</u> against the <b>GPIIb/IIIa receptor</b> </div>", "time": 1660105341352.0}, {"id": 1488847772054, "note": "<div>What <u>drug class</u> do <b>eptifibatide</b> and <b>tirofiban</b> belong to?</div><div><br /></div><div>{{c1::GPIIb/IIIa inhibitors}}</div>", "time": 1660105347257.0}, {"id": 1488847776527, "note": "<div>What <u>adverse hematologic effect</u> is associated with <b>GPIIb/IIIa inhibitors</b>? </div><div><br /></div><div>{{c1::Thrombocytopenia}}</div>", "time": 1660105347987.0}, {"id": 1488847779733, "note": "<div>What <u>laboratory assay</u> is <i>increased</i> with <b>anti-platelet therapy</b>? </div><div><br /></div><div>{{c1::Bleeding time}}</div>", "time": 1660105345190.0}, {"id": 1488847783222, "note": "<div>What <u>drug class</u> does <b>dipyridamole </b>belong to?</div><div><br></div><div>{{c1::Nonspecific PDE inhibitor}}</div>", "time": 1660105347248.0}, {"id": 1488847786464, "note": "<div><div>What <u>drug class</u> does <b>cilostazol</b> belong to?</div><div><br></div><div>{{c1::Antiplatelet PDE-3 inhibitor}} </div></div>", "time": 1660105347249.0}, {"id": 1488847795901, "note": "<div><b>PDE inhibitors</b> (e.g. cilostazol, dipyridamole) {{c1::<u>increase</u>}} <b>cAMP</b>, which {{c2::<u>inhibits</u>}} <b>platelet</b> <b>aggregation</b></div>", "time": 1660105354051.0}, {"id": 1488847800266, "note": "<div>In addition to preventing platelet aggregation, <b>cilostazol</b> and <b>dipyridamole</b> also cause vaso-{{c1::dilation}}</div>", "time": 1660105357519.0}, {"id": 1488847803714, "note": "<div>Can <b>PDE inhibitors</b> reduce <i>symptoms</i> of <u>claudication</u> in <b>peripheral artery disease</b>? </div><div><br /></div><div>{{c1::Yes (e.g. cilostazol)}}</div>", "time": 1660105360997.0}, {"id": 1488847807658, "note": "<div><b>Cilostazol</b> causes coronary artery <u>vasodilation</u>, which may result in <b>{{c1::coronary steal}} syndrome</b> </div><div><br></div>", "time": 1660105360697.0}, {"id": 1488847813320, "note": "<div>What class of <u>anti-platelet</u> drugs may cause <b>facial flushing</b> and <b>abdominal pain</b> as adverse effects?</div><div><br></div><div>{{c1::PDE inhibitors (cilostazol, dipyridamole)}}</div>", "time": 1660105343606.0}, {"id": 1488847815337, "note": "<div>What class of <u>anti-platelet</u> drugs may cause <b>TTP</b> as an adverse effect?</div><div><br></div><div>{{c1::ADP receptor inhibitors}}</div>", "time": 1660105343604.0}, {"id": 1488847817311, "note": "<div>What class of <u>anti-platelet</u> drugs may cause <b>thrombocytopenia</b> as an adverse effect?</div><div><br /></div><div>{{c1::GPIIb/IIIa inhibitors}}</div>", "time": 1660105343605.0}, {"id": 1488847818071, "note": "<div>What <u>drug class</u> do <b>alteplase</b>, <b>reteplase</b>, <b>tenecteplase </b>belong to? </div><div><br /></div><div>{{c1::Thrombolytics (recombinant tPA)}}</div>", "time": 1660105347262.0}, {"id": 1488850148851, "note": "<div>What <u>drug class</u> does <b>streptokinase </b>belong to?</div><div><br /></div><div>{{c1::Thrombolytics}}</div>", "time": 1660105347243.0}, {"id": 1488850153355, "note": "<div><b>Thrombolytics</b> exert their effects via direct or indirect <u>conversion</u> of <b>plasminogen</b> to <b>{{c1::plasmin}}</b> </div>", "time": 1660105348787.0}, {"id": 1488850156616, "note": "<div>Activated {{c1::plasmin}} <u>degrades</u> <b>fibrin</b> <b>clots</b></div>", "time": 1660105362183.0}, {"id": 1488850159719, "note": "<div><b>Thrombolytics</b> result in a(n)&nbsp;<u>{{c1::elevated}}</u> <b>PT</b> and <u>{{c1::elevated}}</u> <b>PTT</b></div>", "time": 1660105348786.0}, {"id": 1488850164208, "note": "<div>What effect do <u>thrombolytics</u> have on <b>platelet count</b>?</div><div><br></div><div>{{c1::No effect}}</div>", "time": 1660105347202.0}, {"id": 1488850166683, "note": "<div>What type of <u>stroke</u> (hemorrhagic, ischemic) may be treated with&nbsp;<b>thrombolytics</b>, and in what time frame? </div><div><br></div><div>{{c1::Ischemic::type?}} ({{c1::if within 3 - 4.5 hours::timeframe?}})</div>", "time": 1660105344761.0}, {"id": 1488850174871, "note": "<div><b>IV</b> {{c1::<b>thrombolytics</b>}} can be used for direct <u>thrombolysis</u> of severe <b>PE</b> and <b>DVT</b></div>", "time": 1660105355830.0}, {"id": 1488850179982, "note": "<div>What <i>class</i> of drugs may be used for <u>reperfusion therapy</u> for <b>STEMI</b> when <b>PCI is not available</b>? </div><div><br /></div><div>{{c1::Thrombolytics}}</div>", "time": 1660105347425.0}, {"id": 1488850183623, "note": "<div>What is the <i>preferred</i> <u>reperfusion therapy</u> for <b>STEMI</b>? </div><div><br /></div><div>{{c1::Percutaneous coronary intervention (PCI)}}</div>", "time": 1660105345613.0}, {"id": 1488850186903, "note": "<div><b>PCI</b> is ideally performed within <u>{{c1::2}} hours</u> in the setting of <b>acute</b> <b>STEMI</b></div>", "time": 1660105354058.0}, {"id": 1488850191723, "note": "<div>What is the main <u>adverse effect</u> of <b>thrombolytics</b>? </div><div><br /></div><div>{{c1::Bleeding}} </div>", "time": 1660105346161.0}, {"id": 1488850198140, "note": "<div><b>Thrombolytics</b> are <u>contraindicated</u> in patients with <b>recent</b> <b>{{c1::surgery}}</b> or <b>head</b> <b>trauma</b></div>", "time": 1660105348789.0}, {"id": 1488850201821, "note": "<div><b>Thrombolytics</b> are <u>contraindicated</u> in patients with any signs of active <b>{{c1::bleeds}}</b> </div>", "time": 1660105348790.0}, {"id": 1488850205070, "note": "<div><b>Thrombolytics</b> are <u>contraindicated</u> in patients with <b>severe</b> <b>{{c1::hypertension::BP}}</b></div>", "time": 1660105348788.0}, {"id": 1488850208041, "note": "<div>What <u>adverse effect</u> is <i>rarely</i> associated with <b>streptokinase</b> use?</div><div><br></div><div>{{c1::Allergic reaction and anaphylaxis}}</div>", "time": 1660105347989.0}, {"id": 1488850212066, "note": "<div>What drugs are used to <u>reverse</u> the effects of <b>thrombolytics</b>?</div><div><br></div><div>{{c1::Aminocaproic acid}} and {{c2::Tranexamic acid}}</div>", "time": 1660105347215.0}, {"id": 1488850223642, "note": "<u>Reversal</u> of <b>thrombolytic</b> therapy may involve platelet transfusions or {{c1::<b>factor</b>}}<b> corrections</b> (e.g. FFP, cryoprecipitate, PCC)", "time": 1660105353332.0}, {"id": 1488854891621, "note": "What is the <u>precursor</u> molecule to <b>prostanoids</b> and <b>leukotrienes</b>?<div><br /></div><div>{{c1::Arachidonic acid}}</div>", "time": 1660105345621.0}, {"id": 1488854917707, "note": "<div>{{c1::Phospholipase A<sub>2</sub>}} <i>hydrolyzes</i> <b>arachidonic acid</b> from the cell membrane</div>", "time": 1660105339287.0}, {"id": 1488854939810, "note": "<div><b>Prostacyclin</b> (PGI<sub>2</sub>) is synthesized by <b>COX-{{c1::2}}</b></div>", "time": 1660105353630.0}, {"id": 1488854944270, "note": "<div><b>Prostacyclin</b> (PGI<sub>2</sub>) is a potent vaso-{{c1::dilator}}</div>", "time": 1660105353631.0}, {"id": 1488854949157, "note": "<div><b>PGI<sub>2</sub></b> {{c1::<u>inhibits</u>}} platelet <b>aggregation</b></div>", "time": 1660105353973.0}, {"id": 1488854955037, "note": "<div>Which <u>form(s)</u> of <i><b>cyclooxygenase</b></i> synthesize prostaglandins that <b>dilate the afferent arteriole</b>? </div><div><br /></div><div>{{c1::Both COX-1 and COX-2 :)}}</div>", "time": 1660105343025.0}, {"id": 1488854972928, "note": "<div>Do <i>most</i> <u>NSAIDs</u> inhibit <b>COX-1</b> or <b>COX-2</b>?</div><div><br /></div><div>{{c1::Both :)}}</div>", "time": 1660105359930.0}, {"id": 1488854977018, "note": "<div>Do <i>most</i> <b>NSAIDs</b> <u>reversibly</u> or <u>irreversibly</u> inhibit <b>COX-1</b> and<b> COX-2</b>?</div><div><br /></div><div>{{c1::Reversibly (except aspirin)}}</div>", "time": 1660105359929.0}, {"id": 1488854981835, "note": "<div>What <u>drug class</u> do <b>diclofenac</b> and <b>ketorolac</b> belong to?</div><div><br /></div><div>{{c1::NSAIDs}}</div>", "time": 1660105347259.0}, {"id": 1488854985772, "note": "<div>What <u>drug class</u> does <b>indomethacin</b> belong to? </div><div><br /></div><div>{{c1::NSAIDs}}</div>", "time": 1660105347246.0}, {"id": 1488854994112, "note": "<div><div>What <u>drug class</u> does <b>naproxen</b> belong to? </div><div><br /></div><div>{{c1::NSAIDs}}</div></div>", "time": 1660105347245.0}, {"id": 1488855002412, "note": "<div><i>Most</i> <b>NSAIDs</b> increase risk of <u>GI</u> <u>bleeding</u> due to inhibition of {{c1::<b>TXA</b><sub style=\"font-weight: bold; \">2</sub> (platelet aggregator)::not COX}}</div>", "time": 1660105355150.0}, {"id": 1488855006967, "note": "<div><u>Inhibition</u> of <b>COX-1</b> by <b>NSAIDs </b>leads to {{c1::increased}} <b>bleeding time</b></div>", "time": 1660105356069.0}, {"id": 1488855011000, "note": "<div><b>NSAIDs</b> can {{c1::<u>increase</u>}} <b>blood</b> <b>pressure</b> </div>", "time": 1660105354752.0}, {"id": 1488855018926, "note": "<div><b>NSAIDs</b> can cause {{c1::<b>acute</b> <b>interstitial</b>}} <b>nephritis</b> as an adverse effect</div>", "time": 1660105354754.0}, {"id": 1488855030418, "note": "<div><b>NSAIDs</b> can cause <b>{{c1::renal papillary::kidney}} necrosis&nbsp;</b>as an adverse effect</div>", "time": 1660105354753.0}, {"id": 1488855034510, "note": "<div><b>NSAIDs</b> may <u>reduce excretion</u> of {{c1::lithium}}, which is commonly used as an antipsychotic drug</div>", "time": 1660105354748.0}, {"id": 1488855057580, "note": "<div>What <u>vasculitis</u> is treated with <b>aspirin</b>?  </div><div><br /></div><div>{{c1::Kawasaki disease}}</div>", "time": 1660105344701.0}, {"id": 1488855061452, "note": "<div>What<i> adverse effect</i> may be caused by <b>aspirin</b> administration to a <b>child with a viral infection</b>? </div><div><br /></div><div>{{c1::Reyes syndrome}}</div>", "time": 1660105347988.0}, {"id": 1488855069021, "note": "<div>What <u>acid-base disorder</u> is seen with <b><i>early</i></b> phases of <b>aspirin toxicity</b>? </div><div><br></div><div>{{c1::Respiratory alkalosis}}</div>", "time": 1660105348010.0}, {"id": 1488855073013, "note": "<div>What <u>acid-base disorder</u> is seen with <b><i>late</i></b> phases of <b>aspirin toxicity</b>? </div><div><br /></div><div>{{c1::High anion gap metabolic acidosis}}</div>", "time": 1660105348009.0}, {"id": 1488855076686, "note": "<div><b>{{c2::Aspirin}}</b> is an <u>NSAID</u> that is associated with <b>{{c1::tinnitus::ear}}</b>&nbsp;as an adverse effect</div>", "time": 1660105338292.0}, {"id": 1488855106673, "note": "<div>What <u>drug class</u> does <b>celecoxib</b> belong to?</div><div><br /></div><div>{{c1::Selective COX-2 inhibitor}}</div>", "time": 1660105347250.0}, {"id": 1488855114769, "note": "<div>What <u>adverse effect</u> is associated with <b>celecoxib </b>use?</div><div><br /></div><div>{{c1::Increased risk of thrombosis}}</div>", "time": 1660105347991.0}, {"id": 1488855129317, "note": "<div>Are <u>NSAIDs</u> useful as <b>antipyretics</b> and <b>analgesics</b>?</div><div><br></div><div>{{c1::Yes}}</div>", "time": 1660105361608.0}, {"id": 1488855131940, "note": "<div><div>Are <u>NSAIDs</u> useful as <b>anti-inflammatory</b> agents?</div><div><br></div><div>{{c1::Yes}}</div></div>", "time": 1660105361609.0}, {"id": 1488855193129, "note": "<div>What <u>toxic intermediate</u> is formed in small amounts by <i>metabolism</i> of <b>acetaminophen</b>? </div><div><br></div><div>{{c1::NAPQI}}</div>", "time": 1660105344904.0}, {"id": 1488855196597, "note": "<div><b>Acetaminophen</b> <b>toxicity</b> results in <u>depletion</u> of hepatic {{c1::glutathione}} stores by NAPQI</div>", "time": 1660105362230.0}, {"id": 1488855200902, "note": "<div><u>Overdose</u> of <b>acetaminophen</b> causes {{c1::hepatic}} <b>necrosis</b></div>", "time": 1660105354449.0}, {"id": 1488855204009, "note": "<div>In the setting of <b>acute</b> <b>acetaminophen</b> <b>toxicity</b>, {{c1::<u>activated charcoal</u>}} can be used to <b>absorb acetaminopen</b></div>", "time": 1660105356661.0}, {"id": 1488855207253, "note": "<div>What is the <u>antidote</u> for <b>acetaminophen</b> <b>poisoning</b>? </div><div><br /></div><div>{{c1::N-acetylcysteine}}</div>", "time": 1660105346764.0}, {"id": 1488855211120, "note": "<div><b>N-acetylcysteine</b> helps <i>restore</i> {{c1::<u>reduced</u> glutathione}} stores in the setting of <b>acetaminophen</b> <b>toxicity</b> </div>", "time": 1660105354968.0}, {"id": 1489112130810, "note": "Which <u>gene of embryogenesis</u> is involved in patterning along the <b>anteroposterior axis</b> and <b>CNS development</b>?<div><br /></div><div>{{c1::Sonic hedgehog gene}}</div>", "time": null}, {"id": 1489112814280, "note": "<div>Which <u>gene of embryogenesis</u> is produced at the <b>base of limbs</b> at the <b>zone of polarizing activity</b>? </div><div><br /></div><div>{{c1::Sonic hedgehog gene}}</div>", "time": null}, {"id": 1489112819759, "note": "<div><u>Mutation</u> in the <b>sonic hedgehog gene</b> can cause {{c1::holoprosencephaly::specific/head}}</div>", "time": null}, {"id": 1489112822671, "note": "<div>Which <u>genes of embryogenesis</u> are produced at the <b>apical ectodermal ridge</b> (thickened ectoderm at <b>distal end</b> of each developing limb)? </div><div><br></div><div>{{c1::Wnt-7 and FGF genes::2}}</div>", "time": null}, {"id": 1489112827721, "note": "<div>Which <u>gene of embryogenesis</u> is responsible for proper<b> </b>organization along the <b>dorsal-ventral axis</b>? </div><div><br /></div><div>{{c1::Wnt-7}}</div>", "time": null}, {"id": 1489112834939, "note": "<div>Which <u>gene of embryogenesis</u> is responsible for <b>lengthening of limbs</b>? </div><div><br /></div><div>{{c1::FGF (stimulates mitosis of underlying mesoderm)}}</div>", "time": null}, {"id": 1489112839753, "note": "<div>Which <u>gene of embryogenesis</u> is involved in segmental organization of the embryo in a <b>craniocaudal direction</b>? </div><div><br /></div><div>{{c1::Homeobox (Hox) genes}}</div>", "time": null}, {"id": 1489112844796, "note": "<div><u>Mutations</u> in <b>{{c1::hox}}</b> genes cause <b>appendages </b>to be placed in <b>wrong locations</b> </div>", "time": null}, {"id": 1489112849260, "note": "<div>What do <u>homeobox genes</u> code for? </div><div><br></div><div>{{c1::Transcription factors}}</div>", "time": null}, {"id": 1489112860211, "note": "<div>Which <u>gene of embryogenesis</u> malfunctioned if a patient develops <b>syndactyly</b> and/or <b>polydactyly</b>? </div><div><br></div><div>{{c1::Homeobox (hox) genes}}</div>", "time": null}, {"id": 1489112863785, "note": "<div>Which <u>gene of embryogenesis</u> is affected by <b>vitamin A</b>? </div><div><br></div><div>{{c1::Homeobox (hox) genes}}</div>", "time": null}, {"id": 1489112866359, "note": "<div>Within which <u>week of embryogenesis</u> does the <b>bilaminar disc</b> (epiblast, hypoblast) form? </div><div><br /></div><div>{{c1::Week 2 (2 layers)}}</div>", "time": null}, {"id": 1489112870762, "note": "<div><div>Within which <u>week of embryogenesis</u> does the <b>trilaminar disc</b> (endoderm, mesoderm, ectoderm) form? </div><div><br /></div><div>{{c1::Week 3 (3 layers)}}</div></div>", "time": null}, {"id": 1489112874704, "note": "<div><div>Within which <u>week of embryogenesis</u> does the <b>neural tube close</b>? </div><div><br /></div><div>{{c1::Week 4}}</div></div>", "time": null}, {"id": 1489112879936, "note": "<div>Which <u>weeks of embryogenesis</u> are <b>most susceptible to teratogens</b>? </div><div><br /></div><div>{{c1::Weeks 3-8 (embryonic period)}}</div>", "time": null}, {"id": 1489112884330, "note": "<div><div>In which <u>week of embryogenesis</u> does the <b>heart begin to beat</b>? </div><div><br /></div><div>{{c1::Week 4 (4 weeks = 4 heart chambers)}}</div></div>", "time": null}, {"id": 1489112888493, "note": "<div><div>In which <u>week of embryogenesis</u> do the <b>upper</b>/<b>lower limb buds form</b>? </div><div><br></div><div>{{c1::Week 4 (4 weeks = 4 limbs)}}</div></div>", "time": null}, {"id": 1489112893990, "note": "<div><div>In which <u>week of embryogenesis</u> is <b>fetal cardiac activity</b> detectable by <b>transvaginal ultrasound</b>? </div><div><br /></div><div>{{c1::Week 6}}</div></div>", "time": null}, {"id": 1489112898394, "note": "<div>In which <u>week of embryogenesis</u> do <b>fetal movements start</b>?</div><div><br /></div><div>{{c1::Week 8 (gait at week 8)}}</div>", "time": null}, {"id": 1489112902130, "note": "<div>In which <u>week of embryogenesis</u> do <b>genitalia</b> begin to <b>develop</b> <b>male/female characteristics</b>? </div><div><br /></div><div>{{c1::Week 10 (\"<u>Ten</u>italia\")}}</div>", "time": null}, {"id": 1489112908133, "note": "<div>What is the <u>embryonic origin</u> of the <b>lens of the eye</b>? </div><div><br /></div><div>{{c1::Surface ectoderm}}</div>", "time": null}, {"id": 1489112912399, "note": "<div><div>What is the <u>embryonic origin</u> of the <b>sweat</b> and <b>mammary glands</b>? </div><div><br /></div><div>{{c1::Surface ectoderm}}</div></div>", "time": null}, {"id": 1489112916155, "note": "<div><div>What is the <u>embryonic origin</u> of the <b>sensory organs of the ear</b>? </div><div><br /></div><div>{{c1::Surface ectoderm}}</div></div>", "time": null}, {"id": 1489112920379, "note": "<div><div>What is the <u>embryonic origin</u> of the <b>retina</b>? </div><div><br /></div><div>{{c1::Neural tube (neuroectoderm)}}</div></div>", "time": null}, {"id": 1489112939263, "note": "<div><div><div><div>What is the <u>embryonic origin</u> of the <b>odontoblasts</b> and <b>bones of the skull</b>? </div><div><br /></div><div>{{c1::Neural crest}}</div></div></div></div>", "time": null}, {"id": 1489112946562, "note": "<div><div>What is the <u>embryonic origin</u> of the <b>endocardial cushion</b> and the <b>aorticopulmonary septum</b>? </div><div><br /></div><div>{{c1::Neural crest}}</div></div>", "time": null}, {"id": 1489112951090, "note": "<div><div>What is the <u>embryonic origin</u> of the <b>myenteric</b> (<b>Auerbach</b>) <b>plexus</b>? </div><div><br /></div><div>{{c1::Neural crest}}</div></div>", "time": null}, {"id": 1489112954716, "note": "<div><div>What is the <u>embryonic origin</u> of the <b>muscle</b>, <b>bone</b>, and <b>connective tissue</b>? </div><div><br /></div><div>{{c1::Mesoderm}}</div></div>", "time": null}, {"id": 1489112958770, "note": "<div><div>What is the <u>embryonic origin</u> of the <b>ovaries</b>/<b>testis</b>? </div><div><br></div><div>{{c1::Mesoderm}}</div></div>", "time": null}, {"id": 1489112961336, "note": "<div><div>What is the <u>embryonic origin</u> of the <b>blood</b> and <b>lymphatics</b>? </div><div><br /></div><div>{{c1::Mesoderm}}</div></div>", "time": null}, {"id": 1489112968862, "note": "<div><div>What is the <u>embryonic origin</u> of the <b>peritoneum</b> (serous lining of cavities)? </div><div><br /></div><div>{{c1::Mesoderm}}</div></div>", "time": null}, {"id": 1489112976992, "note": "<div><div>What is the <u>embryonic origin</u> of the <b>spleen </b>and <b>kidneys</b>? </div><div><br /></div><div>{{c1::Mesoderm}}</div></div>", "time": null}, {"id": 1489112981171, "note": "<div><div>What is the <u>embryonic origin</u> of the <b>gut tube epithelium</b> and <i>most</i> major <b>organs</b> (e.g. lungs, liver, gallbladder, pancreas)? </div><div><br /></div><div>{{c1::Endoderm}}</div></div>", "time": null}, {"id": 1489112985969, "note": "<div><div>What is the <u>embryonic origin</u> of the <b>parathyroid gland</b> and <b>parafollicular C cells</b>? </div><div><br /></div><div>{{c1::Endoderm*}}</div></div>", "time": null}, {"id": 1489112989862, "note": "<div><div>What is the <u>embryonic origin</u> of the <b>thymus</b>? </div><div><br /></div><div>{{c1::Endoderm}}</div></div>", "time": null}, {"id": 1489112993482, "note": "<div>Which <u>error in morphogenesis</u> is characterized by <b>absent organ</b> due to <b>absent primordial tissue</b>?</div><div><br /></div><div>{{c1::Agenesis}}</div>", "time": null}, {"id": 1489112996871, "note": "<div><div>Which <u>error in morphogenesis</u> is characterized by <b>absent organ</b> despite the <b>presence of</b><b> primordial tissue</b>?</div><div><br /></div><div>{{c1::Aplasia}}</div></div>", "time": null}, {"id": 1489113000682, "note": "<div><div>Which <u>error in morphogenesis</u> is characterized by <b><i>incomplete</i> organ development</b> (primordial tissue present)?</div><div><br /></div><div>{{c1::Hypoplasia}}</div></div>", "time": null}, {"id": 1489113004877, "note": "<div><div>Which <u>error in morphogenesis</u> is characterized by <b><i>secondary</i> breakdown</b> of <b>previously normal tissue</b>?</div><div><br /></div><div>{{c1::Disruption (e.g. amniotic band syndrome)}}</div></div>", "time": null}, {"id": 1489113010886, "note": "<div><div>Which <u>error in morphogenesis</u> is characterized by <b>extrinsic disruption</b> (after the embryonic period)? </div><div><br /></div><div>{{c1::Deformation}}</div></div>", "time": null}, {"id": 1489113019621, "note": "<div><div>Which <u>error in morphogenesis</u> is characterized by<b>&nbsp;intrinsic&nbsp;disruption</b> (during embryonic period)?</div><div><br></div><div>{{c1::Malformation}}</div></div>", "time": null}, {"id": 1489113024476, "note": "<div>Which <u>recreational drug</u> causes <b>low birth weight</b>, <b>preterm birth</b>, <b>IUGR</b>, and <b>placental abruption</b>?</div><div><br></div><div>{{c1::Cocaine}}</div>", "time": 1660105342240.0}, {"id": 1489113028145, "note": "<div>What is the <u>major risk factor</u> for <b>sudden infant death syndrome</b> (SIDS)? </div><div><br /></div><div>{{c1::Second-hand smoke (nicotine, CO)}}</div>", "time": 1660105346112.0}, {"id": 1489113031112, "note": "<div>What is the <u>leading cause</u> of <b>low birth weight</b> in developed countries?</div><div><br /></div><div>{{c1::Smoking (nicotine, CO)}}</div>", "time": null}, {"id": 1489113038495, "note": "<div>What compound in <b>swordfish</b>, <b>shark</b>, and <b>king mackarel</b> causes <u>neurotoxicity</u> in the fetus? </div><div><br></div><div>{{c1::Methylmercury}}</div>", "time": null}, {"id": 1489113042237, "note": "<div><b>Vitamin {{c1::A}} excess</b> during <u>pregnancy</u> poses an extremely high risk for <b>spontaneous abortion</b></div>", "time": 1660105348199.0}, {"id": 1489113044939, "note": "<div><b>{{c2::Maternal diabetes}}</b> may lead to <u>{{c1::Caudal regression}} syndrome</u> in infants, which ranges from <b>anal atresia</b> to <b>sirenomelia</b></div>", "time": null}, {"id": 1489113049381, "note": "<div>In addition to <u>caudal regression syndrome</u>, <b>maternal diabetes</b> may result in <b>congenital</b> {{c1::<b>heart</b>}} <b>defects</b>, <b>neural tube defects</b>, <b>macrosomia</b>, and <b>neonatal hypoglycemia</b> in newborns</div>", "time": null}, {"id": 1489113051598, "note": "<div>What is the <i>leading cause</i> of <u>intellectual disability</u> in the <b>US</b>? </div><div><br></div><div>{{c1::Fetal alcohol syndrome}}</div>", "time": null}, {"id": 1489113053591, "note": "<div>What is the <u>mechanism</u> by which <b>fetal alcohol syndrome</b> manifests?</div><div><br></div><div>{{c1::Failure of <u>neuronal</u>&nbsp;and <u>glial</u>&nbsp;cell migration}}</div>", "time": 1660105346101.0}, {"id": 1489113055432, "note": "<div>What <u>teratogen</u> causes a <b>smooth philtrum</b> and <b>thin upper lip</b> in newborns?</div><div><br /></div><div>{{c1::Alcohol (fetal alcohol syndrome)}}</div>", "time": null}, {"id": 1489113063884, "note": "In its most severe form, <u>fetal alcohol syndrome</u> may cause {{c1::<b>heart-lung</b>}} <b>fistulas</b> and <b>holoprosencephaly</b> ", "time": null}, {"id": 1489113530157, "note": "The <b>{{c2::maxillary}} artery</b> is a derivative of the <b>{{c1::1st}}</b> <b>aortic arch</b>", "time": null}, {"id": 1489115490800, "note": "<div>The <b>{{c2::stapedial}} artery</b> and <b>hyoid artery</b> are derivatives of the <b>{{c1::2nd}}</b> <b>aortic arch</b></div>", "time": null}, {"id": 1489115495506, "note": "<div>The <b>{{c2::common carotid}} artery</b> and <u>proximal part</u> of the <b>{{c2::internal carotid}} artery</b> are derivatives of the <b>{{c1::3rd}}</b> <b>aortic arch</b></div>", "time": null}, {"id": 1489115545454, "note": "<div>The <b>{{c2::true aortic arch::left}}</b>&nbsp;and <u>proximal part</u> of the <b>{{c3::right subclavian artery::right}}</b>&nbsp;are derivatives of the <b>{{c1::4th}}</b> <b>aortic arch</b></div>", "time": null}, {"id": 1489115551467, "note": "<div>The <b>{{c2::ductus arteriosus}}</b> and <u>proximal part</u> of <b>{{c3::pulmonary}} arteries</b> are derivatives of the <b>{{c1::6th}}</b> <b>aortic arch</b></div>", "time": null}, {"id": 1489115559922, "note": "<div>The <b>branchial {{c1::clefts/grooves}}</b> are derivatives of <b>ectoderm</b></div>", "time": null}, {"id": 1489115563908, "note": "<div>The <b>branchial {{c1::arches}}</b> are derivatives of <b>mesoderm </b>+ <b>neural crest</b> </div>", "time": null}, {"id": 1489115567302, "note": "<div>The <b>branchial {{c1::pouches}}</b> are derivatives of <b>endoderm</b></div>", "time": null}, {"id": 1489115575905, "note": "<div>The <b>{{c2::1st}} branchial cleft</b> develops into the <b>{{c1::external auditory meatus}}</b></div>", "time": null}, {"id": 1489115591365, "note": "<div>The <b>{{c1::2nd}} - {{c1::4th}} branchial clefts</b> form <u>temporary</u> <b>cervical</b> <b>sinuses</b>, which are <b>obliterated</b></div>", "time": null}, {"id": 1489115594180, "note": "<div>A <b>persistent {{c1::cervical sinus}}</b> is a <u>branchial cleft cyst</u> within the <b>{{c2::lateral}} neck</b> (anterior to SCM muscle)</div>", "time": null}, {"id": 1489115596258, "note": "<div>Does a <b>branchial cleft cyst</b> <u>move</u> during <b>swallowing</b>?</div><div><br></div><div>{{c1::No (immobile)}}</div>", "time": null}, {"id": 1489115598560, "note": "<div>Which <u>branchial arch</u> gives rise to the <b>maxillary process</b> and <b>mandibular process</b>? </div><div><br /></div><div>{{c1::1st arch}}</div>", "time": null}, {"id": 1489115602387, "note": "<div><div>Which <u>branchial arch</u> gives rise to the <b>malleus</b> and <b>incus</b>? </div><div><br /></div><div>{{c1::1st arch}}</div></div>", "time": null}, {"id": 1489115607905, "note": "<div><div>Which <u>branchial arch</u> gives rise to the <b><i>anterior</i> belly of digastric</b>? </div><div><br /></div><div>{{c1::1st arch}}</div></div>", "time": null}, {"id": 1489115611968, "note": "<div><div>Which <u>branchial arch</u> gives rise to the <b>tensor tympani</b>? </div><div><br /></div><div>{{c1::1st arch}}</div></div>", "time": null}, {"id": 1489115615390, "note": "<div><div>Which <u>branchial arch</u> gives rise to the <b>muscles of mastication</b>? </div><div><br /></div><div>{{c1::1st arch}}</div></div>", "time": null}, {"id": 1489115619593, "note": "<div>What <u>cranial nerve(s)</u> are associated with the <b>1st branchial arch</b>? </div><div><br></div><div>{{c1::V<sub>3</sub>::specific}}</div>", "time": null}, {"id": 1489115623221, "note": "<div><div><div>Which <u>branchial arch</u> gives rise to the <b>stapes</b> and <b>stapedius m.</b>? </div><div><br /></div><div>{{c1::2nd arch}}</div></div></div>", "time": null}, {"id": 1489115626516, "note": "<div><div><div>Which <u>branchial arch</u> gives rise to the <b><i>posterior</i> belly of digastric</b>? </div><div><br /></div><div>{{c1::2nd arch}}</div></div></div>", "time": null}, {"id": 1489115630036, "note": "<div><div><div>Which <u>branchial arch</u> gives rise to the <b>stylohyoid m.</b> and <b>stylohyoid ligament</b>? </div><div><br /></div><div>{{c1::2nd arch}}</div></div></div>", "time": null}, {"id": 1489115633644, "note": "<div><div><div>Which <u>branchial arch</u> gives rise to the <b>muscles of facial expression</b>? </div><div><br /></div><div>{{c1::2nd arch}}</div></div></div>", "time": null}, {"id": 1489115637266, "note": "<div><div><div>Which <u>branchial arch</u> gives rise to the <b><i>lesser</i> horn of hyoid</b>? </div><div><br /></div><div>{{c1::2nd arch}}</div></div></div>", "time": null}, {"id": 1489115640609, "note": "<div><div>What <u>cranial nerve(s)</u> are associated with the <b>2nd branchial arch</b>? </div><div><br /></div><div>{{c1::VII}}</div></div>", "time": null}, {"id": 1489115644530, "note": "<div><div><div>Which <u>branchial arch</u> gives rise to the <b>stylopharyngeus muscle</b>? </div><div><br /></div><div>{{c1::3rd arch}}</div></div></div>", "time": null}, {"id": 1489115648711, "note": "<div><div><div>Which <u>branchial arch</u> gives rise to the <b><i>greater</i> horn of hyoid</b>? </div><div><br /></div><div>{{c1::3rd arch}}</div></div></div>", "time": null}, {"id": 1489115652171, "note": "<div><div>What <u>cranial nerve(s)</u> are associated with the <b>3rd branchial arch</b>? </div><div><br /></div><div>{{c1::IX}}</div></div>", "time": null}, {"id": 1489115655836, "note": "<div><div>Which <u>branchial arch/es</u> gives rise to the <b>arytenoid</b>, <b>cricoid</b>, <b>corniculate</b>, <b>cuneiform</b>, and <b>thyroid cartilages</b>? </div><div><br /></div><div>{{c1::4th-6th arches}}</div></div>", "time": null}, {"id": 1489115659200, "note": "<div>Which <u>branchial arch</u> gives rise to the <b>cricothyroid m.</b>? </div><div><br /></div><div>{{c1::4th arch}}</div>", "time": null}, {"id": 1489115664354, "note": "<div><div>Which <u>branchial arch</u> gives rise to the <b>levator veli palatini</b>? </div><div><br /></div><div>{{c1::4th arch}}</div></div>", "time": null}, {"id": 1489115667759, "note": "<div><div>Which <u>branchial arch</u> gives rise to <b>most pharyngeal constrictors</b>? </div><div><br /></div><div>{{c1::4th arch}}</div></div>", "time": null}, {"id": 1489115671098, "note": "<div><div>Which <u>branchial arch</u> gives rise to <b>all intrinsic muscles of the larynx</b>, <b><i>except</i> the cricothyroid</b>? </div><div><br /></div><div>{{c1::6th arch}}</div></div>", "time": null}, {"id": 1489115675284, "note": "<div><div>What <u>cranial nerve(s)</u> are associated with the <b>4th branchial arch</b>? </div><div><br /></div><div>{{c1::X (<u>superior laryngeal</u> br.)}} </div></div>", "time": null}, {"id": 1489115678326, "note": "<div><div>What <u>cranial nerve(s)</u> are associated with the <b>6th branchial arch</b>? </div><div><br /></div><div>{{c1::X (<u>recurrent laryngeal</u> br.)}}</div></div>", "time": null}, {"id": 1489115681641, "note": "<div>What <u>branchial arch abnormality</u> is characterized by <b>cleft palate</b>, <b>airway obstruction</b>, <b>micrognathia</b>, and <b>glossoptosis</b>?</div><div><br /></div><div>{{c1::Pierre Robin sequence}}</div>", "time": null}, {"id": 1489115685280, "note": "<div><div>What <u>branchial arch abnormality</u> is characterized by <b>mandibular hypoplasia</b> and <b>facial abnormalities</b>?</div><div><br /></div><div>{{c1::Treacher Collins syndrome}}</div></div>", "time": null}, {"id": 1489115689647, "note": "<div><b>Treacher Collins syndrome</b> is due to {{c1::neural crest::cell type}} dysfunction</div><div><br></div><div><i>*bonus-failure of migration to which arch?</i></div>", "time": 1660105348603.0}, {"id": 1489115692629, "note": "<div>Which <u>branchial pouch</u> gives rise to the <b>middle ear cavity</b>, <b>eustachian tube</b>, and <b>mastoid air cells</b>?</div><div><br></div><div>{{c1::1st branchial pouch (<u>endoderm</u>-lined structures of the ear)}}</div>", "time": null}, {"id": 1489115697533, "note": "<div><div>Which <u>branchial pouch</u> gives rise to the <b>epithelial lining </b>of the <b>palatine tonsil</b>?</div><div><br /></div><div>{{c1::2nd branchial pouch}}</div></div>", "time": null}, {"id": 1489115700761, "note": "<div><div>Which <u>branchial pouch</u> (wings) gives rise to the <b><i>inferior</i> parathyroids</b>?</div><div><br /></div><div>{{c1::3rd pouch (<u>dorsal</u> wings)}}</div></div>", "time": null}, {"id": 1489115704079, "note": "<div><div>Which <u>branchial pouch</u> (and wing) gives rise to the<b> thymus</b>?</div><div><br /></div><div>{{c1::3rd pouch (<u>ventral</u> wings)}}</div></div>", "time": null}, {"id": 1489115708123, "note": "<div><div>Which <u>branchial pouch</u> (and wings) gives rise to the <b><i>superior</i> parathyroids</b>?</div><div><br /></div><div>{{c1::4th pouch (<u>dorsal</u> wings)}}</div></div>", "time": null}, {"id": 1489115711910, "note": "<div><div>Which <u>branchial pouch</u> (and wing) gives rise to the<b> ultimobranchial body</b> (<b>parafollicular cells of thyroid</b>)?</div><div><br /></div><div>{{c1::4th pouch (<u>ventral</u> wings)}}</div></div>", "time": null}, {"id": 1489115715080, "note": "<div>What <i>congenital abnormality</i> arises due to <u>failure of fusion</u> of the <b>two lateral palatine shelves</b>? </div><div><br></div><div>{{c1::Cleft palate}}</div>", "time": null}, {"id": 1489115717318, "note": "<div><div>What <i>congenital abnormality</i> arises due to <u>failure of fusion</u> of the <b>maxillary</b> and <b>medial nasal processes</b>? </div><div><br></div><div>{{c1::Cleft lip}}</div></div>", "time": null}, {"id": 1489115719007, "note": "<div><div>What <i>congenital abnormality</i> arises due to <u>failure of fusion</u> of the <b>lateral palatine shelf</b> with the <b>nasal septum</b> and/or <b>median palatine shelf</b>? </div><div><br></div><div>{{c1::Cleft palate}}</div></div>", "time": null}, {"id": 1489115720740, "note": "<div>What is the <u>mode of inheritance</u> of <b>cleft lip and palate</b>?</div><div><br /></div><div>{{c1::Multifactorial}}</div>", "time": null}, {"id": 1489873889112, "note": "<b>Fidaxomicin</b> is a macrocyclic antibiotic that works by inhibiting the {{c2::sigma}} subunit of {{c1::RNA polymerase}}", "time": null}, {"id": 1489959879323, "note": "<b>Leuprolide</b><b>, Goserelin<u>,</u>&nbsp;</b>and <b>Buserelin</b>&nbsp;are {{c1::<b>GnRH</b>}} <b>analogues</b>", "time": null}, {"id": 1489959933371, "note": "<b>Leuprolide</b><b>, Goserelin<u>,</u>&nbsp;</b>and <b>Buserelin</b>&nbsp;are&nbsp;<u>GnRH analogues</u>&nbsp;with {{c1::<i>agonist</i>}} properties when used in a <b>pulsatile fashion</b> ", "time": null}, {"id": 1489959955843, "note": "<b>Leuprolide, Goserelin<u>,</u>&nbsp;</b>and <b>Buserelin</b>&nbsp;are&nbsp;<u>GnRH analogues</u> with {{c1::<i>antagonist</i>}} properties when used in a <b>continuous fashion</b> ", "time": null}, {"id": 1489959968219, "note": "What <u>cancer</u> may be treated with <i>continuous</i> <b>leuprolide</b>?<div><br /></div><div>{{c1::Prostate Carcinoma}}</div>", "time": null}, {"id": 1489960158679, "note": "<b>Ethinyl estradiol</b>, <b>DES,</b> and <b>mestranol</b> are examples of {{c1::estrogen}} analogs", "time": 1660105359409.0}, {"id": 1489960223722, "note": "<b>Estrogen analogs</b> induce a(n)&nbsp;<u>{{c1::hyper}}-coagulable</u> state ", "time": 1660105359416.0}, {"id": 1489960388465, "note": "<b>{{c2::Clomiphene}}</b> is used to treat <u>{{c1::infertility}}</u> due to&nbsp;<b>anovulation</b> (e.g. <b>PCOS</b>)", "time": 1660105338172.0}, {"id": 1489960412415, "note": "<b>{{c1::Tamoxifen}}</b> is an ER {{c2::<u>antagonist</u>}}&nbsp;at <b>breast </b>and a(n) {{c2::<u>agonist</u>}}&nbsp;at <b>bone and uterus</b> ", "time": 1660105338766.0}, {"id": 1489960574435, "note": "<b>Tamoxifen</b> <u>increases</u> the risk of <b>thromboembolic</b> <b>events</b> and {{c1::<b>endometrial</b>}} <b>cancer</b> ", "time": 1660105350599.0}, {"id": 1489960590736, "note": "<b>Tamoxifen</b> is used to treat and prevent recurrence of {{c1::ER/PR}} positive <b>breast cancer</b> ", "time": 1660105350598.0}, {"id": 1489960648168, "note": "<b>{{c1::Raloxifene}}</b> is an <u>antagonist</u> at <b>breast and uterus</b> and an <u>agonist</u> at <b>bone </b>", "time": null}, {"id": 1489960668479, "note": "Does <u>raloxifene</u> <i>increase</i> risk for <b>endometrial cancer</b>?<div><br></div><div>{{c1::No (estrogen antagonist at uterus)}}</div>", "time": 1660105359829.0}, {"id": 1489960697759, "note": "<b>Raloxifene</b> is primarily used to treat {{c1::post-menopausal osteoporosis}}", "time": 1660105353482.0}, {"id": 1489960770811, "note": "What <u>drug class</u> do <b>anastrozole and </b><b>letrozole</b> belong to?<div><br /></div><div>{{c1::Aromatase inhibitors}}</div>", "time": 1660105347261.0}, {"id": 1489960782243, "note": "What <u>drug class</u> does <b>exemestane</b> belong to?<div><br /></div><div>{{c1::Aromatase inhibitor}}</div>", "time": 1660105347247.0}, {"id": 1489960803160, "note": "<b>Aromatase inhibitors</b>&nbsp;are used to treat <u>ER positive</u> breast<b> </b>cancer in <b>{{c1::post}}-menopausal women</b> ", "time": 1660105361586.0}, {"id": 1489961021618, "note": "What <u>drug class</u> do <b>levonorgestrel</b>, <b>etonogestrel</b>, and <b>megestrol</b> belong to?<div><br /></div><div>{{c1::Progestins}}</div>", "time": 1660105347256.0}, {"id": 1489961117310, "note": "The presence of <i>withdrawal bleeding</i> with a(n)&nbsp;<u>{{c1::progestin}} challenge</u> excludes <b>anatomic defects</b> (e.g. Asherman syndrome) and <b>chronic anovulation without estrogen</b> ", "time": 1660105349681.0}, {"id": 1489961443667, "note": "What is the <u>mechanism</u> by which <b>progestins</b><i>, alone</i>, act as a <b>contraceptive</b>? <div><br /></div><div>{{c1::Thicken cervical mucus}}</div>", "time": 1660105346099.0}, {"id": 1489961592450, "note": "What is the <u>clinical use</u> of <b>ulipristal</b>?<div><br /></div><div>{{c1::Emergency contraception (anti-progestin)}}</div>", "time": 1660105346609.0}, {"id": 1489961629334, "note": "<b>{{c2::Mifepristone}}</b> is an <u>anti-progestin</u> used to <b>terminate pregnancy</b> when combined with {{c1::<b>misoprostol</b> (PGE<sub>1</sub> analog)}}", "time": 1660105337681.0}, {"id": 1489961756380, "note": "What is the <u>mechanism</u> by which <b>combined contraceptives </b>(progestins + estradiol) act as a <b>contraceptive</b>? <div><br /></div><div>{{c1::Inhibit ovulation}}</div>", "time": 1660105346102.0}, {"id": 1489961819194, "note": "<b>Combined contraceptives</b> are <u>contraindicated</u> in patients <b>&gt; 35</b> years old who {{c1::smoke}} ", "time": 1660105360518.0}, {"id": 1489961987539, "note": "<b>Combined contraceptives</b> are <u>contraindicated</u> in patients with <i>increased</i> risk for <b>{{c1::cardiovascular}} disease</b> ", "time": 1660105360516.0}, {"id": 1489962009550, "note": "<b>Combined contraceptives</b> are <u>contraindicated</u> in patients who have <b>migraines</b> or <b>{{c1::breast}} or {{c1::endometrial}} cancer</b>", "time": 1660105360517.0}, {"id": 1489962071630, "note": "What is the <u>mechanism of action</u> of <b>copper intrauterine devices</b>? <div><br></div><div>{{c1::Local inflammatory response}}</div>", "time": 1660105346087.0}, {"id": 1489962489701, "note": "<b>Terbutaline</b> and <b>ritodrine</b> are {{c1::\u03b2<sub>2</sub>}}-agonists that <u>relax the uterus</u>, thus <i>decreasing</i> <b>contraction</b> <b>frequency</b> during <b>labor</b>", "time": 1660105350572.0}, {"id": 1489962636797, "note": "<b>Danazol</b> is used to treat {{c1::<b>endometriosis</b>}} and <b>hereditary angioedema</b> ", "time": 1660105360208.0}, {"id": 1489962921146, "note": "<i>Exogeneous</i> <b>testosterone</b> results in <u>decreased</u> {{c1::intratesticular}} testosterone", "time": 1660105359377.0}, {"id": 1489962998004, "note": "<i>Exogenous</i> <b>testosterone</b> causes {{c1::<u>increased</u>}} <b>LDL</b> and {{c1::<u>decreased</u>}} <b>HDL</b> ", "time": 1660105359376.0}, {"id": 1489963051870, "note": "What is the <u>mechanism of action</u> of <b>finasteride</b>?<div><br /></div><div>{{c1::5\u03b1-reductase inhibitor}}</div>", "time": 1660105346079.0}, {"id": 1489963073192, "note": "<b>Finasteride</b> is used to treat {{c1::BPH}} and {{c2::male-pattern baldness}}", "time": 1660105359258.0}, {"id": 1489963125560, "note": "<b>Flutamide</b> is used for {{c1::prostate}} carcinoma", "time": 1660105358827.0}, {"id": 1489963136856, "note": "What <i>steroidogenesis</i> enzymes are <u>inhibited</u> by <b>ketoconazole</b> and <b>spironolactone</b>?<div><br></div><div>{{c1::17\u03b1-hydroxylase}} and {{c2::cholesterol desmolase}}</div>", "time": 1660105344980.0}, {"id": 1489963378120, "note": "<b>Ketoconazole</b> and <b>spironolactone</b> may be used to <i>reduce</i> <u>androgenic symptoms</u> in {{c1::PCOS}}", "time": 1660105355801.0}, {"id": 1489963412373, "note": "Side effects of <b>spironolactone</b> and <b>ketoconazole</b> include <u>amenorrhea</u> (females) and {{c1::gynecomastia}} (males)", "time": 1660105352970.0}, {"id": 1489963471375, "note": "<b>{{c2::Tamsulosin}}</b> is a(n)&nbsp;<b>{{c1::<i>selective</i> \u03b1<sub>1A/D</sub>}} receptor</b> <u>antagonist</u> used to treat <b>BPH</b> ", "time": 1660105337306.0}, {"id": 1489963587014, "note": "What <u>drug class</u> do <b>vardenafil</b>, <b>tadalafil</b>, and <b>sildenafil</b> belong to?<div><br /></div><div>{{c1::PDE-5 inhibitors}}</div>", "time": 1660105347254.0}, {"id": 1489963603993, "note": "<b>PDE-5 inhibitors</b> result in <u>increased</u> <b>blood flow</b> in the {{c1::corpus cavernosum}} of the <b>penis</b> ", "time": 1660105354047.0}, {"id": 1489963707884, "note": "Side effects of <u>PDE-5 inhibitors</u> include <b>headache</b>, <b>flushing</b>, {{c2::<b>dyspepsia}}</b>, and {{c1::cyanopia}} ({{c1::blue}}-tinted vision)", "time": 1660105352971.0}, {"id": 1489963760474, "note": "<b>PDE-5 inhibitors</b> may cause <i>life-threatening</i> {{c1::hypotension}} in patients taking <b>nitrates</b> ", "time": 1660105354048.0}, {"id": 1489963793297, "note": "Which <u>PDE-5 inhibitor</u> may be used to treat <b>BPH</b>?<div><br /></div><div>{{c1::Tadalafil}}</div>", "time": 1660105342391.0}, {"id": 1489963845288, "note": "Clinical uses of <b>minoxidil</b> include {{c1::male-pattern baldness}} and severe refractory <b>hypertension</b> ", "time": 1660105360636.0}, {"id": 1489966658123, "note": "<div>Which <u>calcineurin inhibitor</u> binds to <b>cyclophilin</b>? </div><div><br></div><div>{{c1::<b>Cyclosporine</b>}}</div>", "time": null}, {"id": 1489966869972, "note": "<div>Which <u>calcineurin inhibitor</u> binds to <b>FK506 binding protein</b> (FKBP)? </div><div><br></div><div>{{c1::<b>Tacrolimus (FK506)</b>}}</div>", "time": null}, {"id": 1489966899449, "note": "<div><div><b>Cyclosporine</b> and <b>Tacrolimus</b> are <u>{{c2::<b>calcineurin</b>}} inhibitors</u> that <i>block</i> <b>T cell </b>activation by <u>preventing </u><b>{{c1::IL-2}} </b><u>transcription</u> </div></div><div><br /></div>", "time": null}, {"id": 1489966943274, "note": "<div>Are <b>cyclosporine</b> and <b>tacrolimus</b> <u>nephrotoxic</u>?</div><div><br></div><div>{{c1::Yes (highly)}}</div>", "time": null}, {"id": 1489966986129, "note": "<div>Which <u>calcineurin inhibitor</u> is associated with <b>gingival hyperplasia </b>and <b>hirsutism</b>? </div><div><br></div><div>{{c1::<b>Cyclosporine</b>}}</div>", "time": null}, {"id": 1489967019558, "note": "<div>In addition to <u>nephrotoxicity</u>, <b>cyclosporine</b> and <b>tacrolimus</b> may also have <b>{{c1::neuro}}-toxicity</b> (<i>especially</i> {{c2::<i>Tacrolimus</i>}})</div>", "time": 1660105357520.0}, {"id": 1489967103370, "note": "<div>Which <u>calcineurin inhibitor</u> is associated with an even greater risk for <b>diabetes </b>vs the other calcineurin inhibitors?</div><div><br></div><div>{{c1::<b>Tacrolimus</b>}}</div>", "time": 1660105343797.0}, {"id": 1489967393730, "note": "<div><div><b>Sirolimus</b> (<b>rapamycin</b>) is an immunosuppressant that <i>blocks</i> <b>{{c2::T}} cell </b>activation via blocking a step in the <b>{{c1::IL-2 </b><b>receptor</b><b>}} </b>signaling pathway</div></div>", "time": null}, {"id": 1489967395455, "note": "<div>Is <b>sirolimus</b> (<b>rapamycin</b>) <u>nephrotoxic</u>?</div><div><br></div><div>{{c1::No}}</div>", "time": null}, {"id": 1489967499767, "note": "<div>{{c1::<b>Sirolimus (rapamycin)</b>}} is an <u>immunosuppressant</u> that can be used in <b>drug-eluting stents</b></div>", "time": null}, {"id": 1489967613940, "note": "<b><div></div></b><div><u>Azathioprine</u> is an <b>immunosuppressant</b>&nbsp;<u>antimetabolite</u> <i>precursor</i> of {{c1::6-mercaptopurine}}, which inhibits the enzyme {{c2::PRPP amidotransferase}}</div>", "time": null}, {"id": 1489967649130, "note": "<b>6-mercaptopurine</b> (and thus <b>azathioprine</b>) are degraded by the enzyme {{c1::<i>xanthine oxidase</i>}}", "time": null}, {"id": 1489967671487, "note": "<div>The enzyme {{c1::<b>PRPP amidotransferase</b>}} is an important enzyme for <u>de novo</u> purine production, which converts <b>PRPP</b> to an intermediate used in the generation of {{c2::<b>IMP</b>}}</div>", "time": null}, {"id": 1489967703514, "note": "<div><div>Because the <u>bone marrow </u>is a rapidly proliferating population, use of <b>6-mercaptopurine</b> (and thus <b>azathioprine</b>) is associated with {{c1::<b>Myelosuppression</b>}}</div></div>", "time": null}, {"id": 1489968369893, "note": "<div><b>Adalimumab</b> is a <u>monoclonal antibody</u> against<b> {{c1::TNF-\u03b1}}</b></div>", "time": null}, {"id": 1489968431221, "note": "<div><b>Certolizumab</b> is a <u>monoclonal antibody</u> against <b>{{c1::TNF-\u03b1}}</b><br></div><div><b><br></b></div>", "time": null}, {"id": 1489968436766, "note": "<div><b>Golimumab</b> is a <u>monoclonal antibody</u> against <b>{{c1::TNF-\u03b1}}</b></div>", "time": null}, {"id": 1489968442057, "note": "<div><b>Infliximab</b> is a <u>monoclonal antibody</u> against <b>{{c1::TNF-\u03b1}}</b></div>", "time": null}, {"id": 1489968446315, "note": "<div><b>{{c2::Etanercept}}</b> is a <u>decoy</u><b> soluble receptor</b> that binds <b>{{c1::TNF-a}}</b></div>", "time": null}, {"id": 1489968578286, "note": "<div><div><b>Abciximab</b> is a <u>monoclonal antibody</u> against<b> </b>the <b>platelet </b><b>{{c1::GpIIb/IIIa}} </b>cell surface receptor</div></div>", "time": null}, {"id": 1489968613360, "note": "<!--anki--><div><b>Ranibizumab</b> and <b>Bevacizumab</b> are <u>monoclonal antibodies</u> against <b>{{c1::Vascular Endothelial Growth Factor (VEGF)}} </b>which prevents the growth of <b>blood vessel</b></div>", "time": null}, {"id": 1489969950421, "note": "Which <u>interleukin</u> is primarily responsible for <b>fever</b> and <b>acute inflammation</b>?<div><br /></div><div>{{c1::IL-1}}</div>", "time": null}, {"id": 1489970022577, "note": "<div>Which <u>immune cell(s)</u> secretes <b>IL-1</b>?</div><div><br /></div><div>{{c1::Macrophages}} </div>", "time": null}, {"id": 1489970026548, "note": "Which <u>interleukin</u> is primarily responsible for <b>acute-phase reactant production</b>?<div><br /></div><div>{{c1::IL-6}}</div>", "time": null}, {"id": 1489970054827, "note": "<div>Which <u>immune cell(s)</u> secretes <b>IL-6</b>?</div><div><br /></div><div>{{c1::Macrophages}} </div>", "time": null}, {"id": 1489970060543, "note": "Which <u>interleukin</u> is a <b>major chemotactic for neutrophils</b>?<div><br /></div><div>{{c1::IL-8}} </div>", "time": null}, {"id": 1489970091921, "note": "Which <u>immune cell(s)</u> secretes <b>IL-8</b>?<div><br /></div><div>{{c1::Macrophages}} </div>", "time": null}, {"id": 1489970103277, "note": "Which <u>interleukin</u> is responsible for <i>activating</i><b> NK cells</b> and <i>inducing</i><b> </b><i>differentiation</i><b> </b>of<b> T cells </b>into<b> Th<sub>1</sub> cells</b>?<div><br /></div><div>{{c1::IL-12}}</div>", "time": null}, {"id": 1489970137869, "note": "<div>Which <u>immune cell(s)</u> secretes <b>IL-12</b>?</div><div><br /></div><div>{{c1::Macrophages}} </div>", "time": null}, {"id": 1489970181312, "note": "<b>TNF-\u03b1</b> is a <u>cytokine</u> released from {{c1::macrophages}} that mediates <b>cachexia</b> and <b>shock</b> ", "time": 1660105348714.0}, {"id": 1489970247629, "note": "Which <u>cytokine</u> is responsible for <b>maintaining granulomas</b> in <b>TB infection</b>? <div><br /></div><div>{{c1::TNF-\u03b1 (from macrophages)}}</div>", "time": null}, {"id": 1489970288745, "note": "Which <u>interleukin</u> is primarily responsible for <b>stimulating T cells</b> (all) and <b>NK cells</b>?<div><br></div><div>{{c1::IL-2}}</div>", "time": null}, {"id": 1489970329566, "note": "<div><div>Which <u>immune cells</u> secrete <b>IL-2</b>?</div><div><br></div><div>{{c1::T cells (both Th<sub>1</sub> and Th<sub>2</sub>)}} </div></div>", "time": null}, {"id": 1489970333367, "note": "Which <u>interleukin</u> is primarily responsible for <b>stimulating growth and differentiation of bone marrow</b>?<div><br /></div><div>{{c1::IL-3 (similar to GM-CSF)}}</div>", "time": null}, {"id": 1489970360784, "note": "<div><div>Which <u>immune cell(s)</u> secretes <b>IL-3</b>?</div><div><br /></div><div>{{c1::T cells (both Th<sub>1</sub> and Th<sub>2</sub>)}} </div></div>", "time": null}, {"id": 1489970364081, "note": "Which <u>cytokine</u> is primarily responsible for <b>stimulating monocytes / macrophages</b> to kill the microbes they ingest (<u>macrophage-lymphocyte interaction</u>)?<div><br /></div><div>{{c1::IFN-\u03b3}}</div>", "time": null}, {"id": 1489970456186, "note": "<div><div>Which <u>immune cells</u> secretes <b>IFN-\u03b3</b>?</div><div><br></div><div>{{c1::NK cells and Th<sub>1</sub> cells::2}} </div></div>", "time": null}, {"id": 1489970516941, "note": "Which <u>cytokine</u> <b>increases MHC expression</b> and <b>antigen presentation</b> on all cells?<div><br /></div><div>{{c1::IFN-\u03b3}}</div>", "time": 1660105343370.0}, {"id": 1489970519207, "note": "Which <u>interleukin</u> is primarily responsible for <b>stimulating IgE production</b>?<div><br /></div><div>{{c1::IL-4}}</div>", "time": null}, {"id": 1489970582544, "note": "<div><div>Which <u>immune cell(s)</u> secretes <b>IL-4</b>?</div><div><br /></div><div>{{c1::Th<sub>2</sub> cells}} </div></div>", "time": null}, {"id": 1489970595226, "note": "Which <u>interleukin</u> is primarily responsible for <b>stimulating IgA production</b>?<div><br /></div><div>{{c1::IL-5}}</div>", "time": null}, {"id": 1489970609617, "note": "<div><div>Which <u>immune cell(s)</u> secretes <b>IL-5</b>?</div><div><br /></div><div>{{c1::Th<sub>2</sub> cells}} </div></div>", "time": null}, {"id": 1489970615786, "note": "Which <u>interleukin</u> is primarily responsible for <b>attenuating the inflammatory response</b>?<div><br /></div><div>{{c1::IL-10}}</div>", "time": null}, {"id": 1489970693302, "note": "<b>{{c1::Interferon-\u03b1}}</b> and <b>{{c1::-\u03b2}}</b> are glycoproteins synthesized by <u>virus-infected</u> cells that act locally on <b><i>uninfected</i> cells</b>, \"priming\" them for viral defense ", "time": null}, {"id": 1489970862017, "note": "Which <u>immune cell</u> has the cell surface protein <b>CD28</b>? <div><br /></div><div>{{c1::T cells}}</div>", "time": null}, {"id": 1489970960324, "note": "Which <u>immune cell</u> has the cell surface protein <b>CXCR4</b>? <div><br></div><div>{{c1::T cells (late HIV infection)}}</div>", "time": null}, {"id": 1489970973404, "note": "Which <u>immune cell</u> has the cell surface protein <b>CD40L</b>? <div><br /></div><div>{{c1::Helper T cells}}</div>", "time": null}, {"id": 1489970994844, "note": "Which <u>immune cell</u> has the cell surface protein <b>CD4</b> <i>and</i> <b>CD25</b>? <div><br /></div><div>{{c1::Regulatory T cells}}</div>", "time": null}, {"id": 1489971004003, "note": "Which <u>immune cell</u> has the cell surface protein <b>CD19</b>, <b>CD20,</b> and <b>CD21</b>? <div><br /></div><div>{{c1::B cells}}</div>", "time": 1660105342804.0}, {"id": 1489971019097, "note": "Which <u>immune cell</u> has the cell surface protein <b>B7</b> (CD80/86)? <div><br /></div><div>{{c1::APCs (B cells, macrophages, dendritic cells)}}</div>", "time": null}, {"id": 1489971106127, "note": "Which <u>immune cell</u> has the cell surface protein <b>CD16</b> and <b>CD56</b>? <div><br /></div><div>{{c1::NK cells}}</div>", "time": null}, {"id": 1489971140322, "note": "Which <u>immune cell</u> has the cell surface protein <b>CCR5</b>? <div><br /></div><div>{{c1::Macrophages (early HIV infection)}}</div>", "time": null}, {"id": 1489971265225, "note": "Which <u>blood transfusion reaction</u> presents with <b>urticaria</b>, <b>pruritus</b>, <b>hypotension</b>, and <b>shock</b>? <div><br /></div><div>{{c1::Allergic/anaphylactic reaction}}</div>", "time": null}, {"id": 1489972334508, "note": "<div>Which <u>blood transfusion reaction</u> is a reaction against <b>plasma proteins in transfused blood</b>? </div><div><br /></div><div>{{c1::Allergic/anaphylactic reaction}}</div>", "time": null}, {"id": 1489972338045, "note": "<div>What type of <u>hypersensitivity</u> is <b>allergic transfusion reaction</b>?</div><div><br /></div><div>{{c1::Type I HSR}}</div>", "time": null}, {"id": 1489972341669, "note": "<div>Which <u>blood transfusion reaction</u> presents with <b>fever</b>, <b>headaches</b>, <b>chills</b>, and <b>flushing</b>? <div><br /></div><div>{{c1::Febrile nonhemolytic transfusion reaction}}</div></div>", "time": null}, {"id": 1489972344892, "note": "<div><div>Which <u>blood transfusion reaction</u> can be caused by <b><i>host</i></b> <b>antibodies</b> against <b>donor HLA antigens</b> and <b>donor WBCs</b>? </div><div><br /></div><div>{{c1::Febrile nonhemolytic transfusion reaction}}</div></div>", "time": null}, {"id": 1489972348185, "note": "<div><div>A <b>febrile nonhemolytic transfusion reaction </b>can exhibit what type of <u>hypersensitivity</u> reaction?</div><div><br></div><div>{{c1::Type II HSR}}</div></div>", "time": null}, {"id": 1489972355594, "note": "<div>Which <u>blood transfusion reaction</u> presents with <b>fever</b>, <b>hypotension</b>, <b>tachypnea</b>,&nbsp;<b>hemoglobinuria*</b>, and <b>jaundice</b>? <div><br></div><div>{{c1::Acute hemolytic transfusion reaction}}</div></div>", "time": null}, {"id": 1489972384117, "note": "<div><div>Which <u>blood transfusion reaction</u> is caused by <b><i>host</i></b> <b>antibodies</b> against <b>donor</b> <b>ABO blood groups</b> or foreign antigen on donor RBCs? </div><div><br /></div><div>{{c1::Acute hemolytic transfusion reaction}}</div></div>", "time": null}, {"id": 1489972385073, "note": "<div><div>What type of <u>hypersensitivity</u> is <b>acute hemolytic transfusion reaction</b>?</div><div><br /></div><div>{{c1::Type II HSR}}</div></div>", "time": null}, {"id": 1489972389668, "note": "Which <u>blood transfusion reaction</u> presents with <b>respiratory distress</b> and <b>noncardiogenic pulmonary edema</b>? <div><br /></div><div>{{c1::Transfusion-related acute lung injury (TRALI)}}</div>", "time": null}, {"id": 1489972393455, "note": "<div>Which <u>blood transfusion reaction</u> is caused by <b><i>donor</i> anti-leukocyte antibodies</b> against <i><b>recipient</b></i> neutrophils and <b>pulmonary endothelial cells</b>? </div><div><br /></div><div>{{c1::Transfusion-related acute lung injury (TRALI)}}</div>", "time": null}, {"id": 1489973170226, "note": "Which <u>hemoglobin type</u><b> </b>migrates the <b>furthest</b> from the negative electrode on electrophoresis? <div><br /></div><div>{{c1::HbA}}</div>", "time": null}, {"id": 1489973370208, "note": "<div>Which <u>hemoglobin type</u><b> </b>migrates the <b><i>second</i> furthest</b> from the negative electrode on electrophoresis? <div><br /></div><div>{{c1::HbF}}</div></div>", "time": null}, {"id": 1489973375825, "note": "<div>Which <u>hemoglobin type</u><b> </b>migrates the <b>third furthest</b> from the negative electrode on electrophoresis? <div><br /></div><div>{{c1::HbS}}</div></div>", "time": null}, {"id": 1489973382717, "note": "Which <u>hemoglobin type</u><b> </b>migrates the <b>least far</b> from the negative electrode on electrophoresis? <div><br /></div><div>{{c1::HbC}}</div>", "time": null}, {"id": 1489973497370, "note": "<u>Failure of aggregation</u> with <b>ristocetin assay</b> occurs in {{c1::<b>von Willebrand</b>}} <b>disease</b> and {{c1::<b>Bernard-Soulier</b>}} <b>syndrome</b> ", "time": null}, {"id": 1489973764289, "note": "What <u>pathologic RBC</u> is seen in <b>liver disease</b> and <b>abetalipoproteinemia </b>(states of cholesterol dysregulation)?<div><br></div><div>{{c1::Acanthocytes}}</div>", "time": null}, {"id": 1489974240036, "note": "<b>Basophilic stippling</b> in RBCs is a result of <u>aggregation</u> of {{c1::residual ribosomes}}", "time": null}, {"id": 1489974306219, "note": "What <u>pathologic RBC</u> is seen with <b>G6PD deficiency</b>?<div><br></div><div>{{c1::Degmacyte (\"bite cell\")::2 names}}</div>", "time": null}, {"id": 1489974326402, "note": "What <u>pathologic RBC</u> is seen with <b>end-stage renal disease</b>, <b>pyruvate kinase deficiency</b>, and <b>liver disease</b>?<div><br></div><div>{{c1::Echinocyte (\"burr cell\")::2 names}}</div>", "time": null}, {"id": 1489974984676, "note": "What <u>glycolysis enzyme deficiency</u> causes <b>hemolytic anemia in a newborn</b>?<div><br /></div><div>{{c1::Pyruvate kinase deficiency}}</div>", "time": null}, {"id": 1489975359321, "note": "<b>{{c2::Acute intermittent porphyria}}</b> is due to <u>deficiency</u> of the enzyme <i style=\"font-weight: bold; \">{{c1::porphobilinogen deaminase}}</i> ", "time": null}, {"id": 1489976304767, "note": "<div><div>What is the <u>mode of inheritance</u> of <b>acute intermittent porphyria</b>?</div><div><br></div><div>{{c1::Autosomal dominant}}</div></div>", "time": null}, {"id": 1489976307289, "note": "<div>The symptoms of <u>{{c4::acute intermittent porphyria}}</u> may be remembered with the \"<b>5 Ps</b>\": </div><div><br /></div><div>1. {{c1::Painful abdomen}}</div><div>2. {{c2::Port wine-colored urine}}</div><div>3. {{c3::Polyneuropathy}}</div><div>4. Psychological disturbances</div><div>5. Precipitated by <b>drugs</b> (e.g. <u>cytochrome P-450 {{c5::inducers}}</u>), <b>alcohol</b>, and <b>starvation</b> </div>", "time": null}, {"id": 1489976310507, "note": "<div>Does <u>acute intermittent porphyria (AIP)</u> present with <b>photosensitivity</b>?</div><div><br></div><div>{{c1::No}}</div>", "time": null}, {"id": 1489976313229, "note": "<div>Treatment for <u>acute intermittent porphyria</u> include <b>{{c1::heme}}</b> and <b>{{c1::glucose}}</b>, which<b> <i>inhibit</i> ALA synthesis</b></div>", "time": null}, {"id": 1489976320594, "note": "<div><b>{{c2::Porphyria cutanea tarda}}</b> is due to <u>deficiency</u> of the enzyme <i style=\"font-weight: bold; \">{{c1::uroporphyrinogen decarboxylase}}</i></div>", "time": null}, {"id": 1489976327304, "note": "<div><div>Which <u>porphyrea</u> presents with <b>blistering cutaneous <i>photosensitivity</i></b> and&nbsp;<b>hyperpigmentation</b>? </div><div><br></div><div>{{c1::Porphyria cutanea tarda}}</div></div>", "time": null}, {"id": 1489976330654, "note": "<div><div>What is the <u>most common</u> <b>porphyria</b>?</div><div><br /></div><div>{{c1::Porphyria cutanea tarda}}</div></div>", "time": null}, {"id": 1489976334964, "note": "<div><b>Porphyrea cutanea tarda</b> is <u>exacerbated</u> by {{c1::alcohol}} consumption</div>", "time": null}, {"id": 1489976337608, "note": "<div><b>Iron poisoning</b> causes <u>cell death</u> due to {{c1::peroxidation}} of <b>membrane lipids</b> </div>", "time": null}, {"id": 1489976344162, "note": "<div>Which <u>blood transfusion therapy</u> is used to <b>increase Hb </b>and <b>O<sub>2</sub> carrying capacity</b>?</div><div><br /></div><div>{{c1::Packed RBCs}}</div>", "time": 1660105343852.0}, {"id": 1489976366312, "note": "<div><div>Which <u>blood transfusion therapy</u> is used to <b>increase platelet count</b>?</div><div><br /></div><div>{{c1::Platelets}}</div></div>", "time": 1660105343851.0}, {"id": 1489976373103, "note": "<div><div>Which <u>blood transfusion therapy</u> is used to <b>increase coagulation factor levels</b>?</div><div><br></div><div>{{c1::Fresh frozen plasma (FFP) or prothrombin complex concentrate (PCC)::2}}</div></div>", "time": 1660105343853.0}, {"id": 1489976379576, "note": "<div><div>Which <u>blood transfusion therapy</u> contains <b>fibrinogen (factor I)</b>, <b>factor VIII </b>and <b>XIII</b>, <b>vWF</b>, and <b>fibronectin</b>?</div><div><br /></div><div>{{c1::Cryoprecipitate}}</div></div>", "time": null}, {"id": 1489976392823, "note": "<b>Blood transfusions</b> may result in <u>{{c1::hyperkalemia}}</u> due to <b>RBC lysis</b> in <i>old</i> blood units", "time": null}, {"id": 1490061652098, "note": "What <u>pharmokinetic term</u> describes the theoretical <b>volume occupied by <i>total</i> amount of drug in the body</b> relative to its <b>plasma concentration</b>? <div><br /></div><div>{{c1::Volume of distribution (V<sub>d</sub>)}}</div>", "time": null}, {"id": 1490066159100, "note": "<div>What <u>formula</u> is used to estimate <b>volume of distribution</b> (V<sub>d</sub>)?</div><div><br /></div><div>{{c1::<img src=\"paste-380130375499846.jpg\" />}}</div>", "time": null}, {"id": 1490066162567, "note": "<div>What is the <i>relative</i> <u>volume of distribution</u> (V<sub>d</sub>) of a <b>large</b>/<b>charged molecule</b>? </div><div><br /></div><div>{{c1::Low}}</div>", "time": null}, {"id": 1490066166158, "note": "<div><div>What is the <i>relative</i> <u>volume of distribution</u> (V<sub>d</sub>) of a <b>plasma protein-bound molecule</b>? </div><div><br /></div><div>{{c1::Low}}</div></div>", "time": null}, {"id": 1490066171169, "note": "<div><div>What is the <i>relative</i> <u>volume of distribution</u> (V<sub>d</sub>) of a <b>small <i>hydrophilic</i> molecule</b>? </div><div><br /></div><div>{{c1::Medium}}</div></div>", "time": null}, {"id": 1490066174929, "note": "<div><div>What is the <i>relative</i> <u>volume of distribution</u> (V<sub>d</sub>) of a <b>small <i>lipophilic</i> molecule</b>, especially if it can bind to <b>tissue protein</b>? </div><div><br /></div><div>{{c1::High}}</div></div>", "time": null}, {"id": 1490066178586, "note": "<div>What <u>compartment</u> is the majority of a drug with <b>low V</b><sub style=\"font-weight: bold; \">d</sub> found in? </div><div><br /></div><div>{{c1::Intravascular (e.g. plasma)}}</div>", "time": null}, {"id": 1490066181877, "note": "<div><div>What <u>compartment</u> is the majority of a drug with <b>medium V</b><sub style=\"font-weight: bold; \">d</sub> found in? </div><div><br /></div><div>{{c1::Extracellular fluid}}</div></div>", "time": null}, {"id": 1490066185604, "note": "<div><div>What <u>compartment</u> is the majority of a drug with <b>high V</b><sub style=\"font-weight: bold; \">d</sub> found in? </div><div><br /></div><div>{{c1::All tissues including fat}}</div></div>", "time": null}, {"id": 1490066192922, "note": "<div>What <u>formula</u> is used to calculate <b>clearance</b>?</div><div><br /></div><div>{{c1::<img src=\"paste-380456793014345.jpg\" />}}</div>", "time": null}, {"id": 1490066195477, "note": "<div>What <u>formula</u> is used to calculate <b>half-life</b> in <b>first-order elimination</b> kinetics? </div><div><br /></div><div>{{c1::<img src=\"paste-380516922556501.jpg\" />}}</div>", "time": null}, {"id": 1490066198198, "note": "<div>In <u>first-order kinetics</u>, a drug infused at a constant rate takes {{c1::4}} - {{c1::5}} <b>half-lives</b> to reach <b>steady state</b> </div>", "time": null}, {"id": 1490066204599, "note": "<div>What <u>formula</u> is used to calculate <b>loading dose</b>? </div><div><br /></div><div>{{c1::<img src=\"paste-380800390398214.jpg\" />}}</div>", "time": null}, {"id": 1490066207488, "note": "<div><div>What <u>formula</u> is used to calculate <b>maintenance dose</b>? </div><div><br></div><div>{{c1::<img src=\"paste-380800390398214.jpg\">}}</div></div>", "time": null}, {"id": 1490066209783, "note": "<div>How should <u>loading dose</u> be adjusted in patients with <b>renal</b> or <b>liver disease</b>? </div><div><br></div><div>{{c1::Unchanged}}</div>", "time": null}, {"id": 1490066212502, "note": "<div><div>How should <u>maintenance dose</u> be adjusted in patients with <b>renal</b> or <b>liver disease</b>? </div><div><br></div><div>{{c1::Decreased}}</div></div>", "time": null}, {"id": 1490066214478, "note": "<div>What type of <u>drug interaction</u> is the effect of substance A and B together is <i><b>equal</b></i> to the <b>sum of their individual products</b>?</div><div><br /></div><div>{{c1::Additive (e.g. aspirin and acetaminophen)}}</div>", "time": null}, {"id": 1490066217772, "note": "<div><div>What type of <u>drug interaction</u> is the <b>presence of A</b> is <i style=\"font-weight: bold; \">required</i> for the <b>full effects of substance B</b>?</div><div><br /></div><div>{{c1::Permissive (e.g. cortisol on catecholamine responsiveness)}}</div></div>", "time": null}, {"id": 1490066222678, "note": "<div><div>What type of <u>drug interaction</u> is the effect of substance A and B together being&nbsp;<i><b>greater than</b></i> the <b>sum of their individual products</b>?</div><div><br></div><div>{{c1::Synergistic (e.g. clopidogrel with aspirin)}}</div></div>", "time": null}, {"id": 1490066226073, "note": "<div>What type of <u>drug interaction</u> is an <b>acute <i>decrease</i></b> in response to a drug after <b>initial</b>/<b>repeated administration</b>?</div><div><br /></div><div>{{c1::Tachyphylactic (e.g. nitrates, niacin, phenylephrine, LSD, MDMA)}}</div>", "time": null}, {"id": 1490066229194, "note": "<div>What&nbsp;<u>drug elimination</u> is characterized by a <b>constant </b><i style=\"font-weight: bold; \">amount</i> of drug eliminated per unit time?</div><div><br></div><div>{{c1::Zero-order elimination}}</div>", "time": null}, {"id": 1490066232397, "note": "<div>What&nbsp;<u>drug elimination</u> is characterized by a <b>constant </b><i style=\"font-weight: bold; \">fraction</i> of drug eliminated per unit time?</div><div><br></div><div>{{c1::First-order elimination}}</div>", "time": null}, {"id": 1490066236446, "note": "<div>What&nbsp;<u>drug elimination</u> is characterized by a <b><i>linear</i> curve</b>?</div><div><br></div><div>{{c1::Zero-order elimination}}</div>", "time": null}, {"id": 1490066239613, "note": "<div>What&nbsp;<u>drug elimination</u> is characterized by an <b><i>exponential</i> curve</b>?</div><div><br></div><div>{{c1::First-order elimination}}</div>", "time": null}, {"id": 1490066244440, "note": "<div>Examples of drugs eliminated by <u>zero-order elimination</u> include <b>{{c1::phenytoin}}</b>, <b>{{c2::ethanol}}</b>, and <b>aspirin</b> (high concentrations)</div>", "time": null}, {"id": 1490066246680, "note": "<div>Which type of drug, <b>ionized</b> or <b>uncharged</b>, is <u>cleared more </u><i style=\"text-decoration: underline; \">quickly</i>?</div><div><br /></div><div>{{c1::Ionized (trapped in urine)}}</div>", "time": null}, {"id": 1490066253471, "note": "<div>What is the treatment for <u>overdose</u> of drugs that act as <b>weak acids</b> (e.g. phenobarbital, methotrexate, aspirin)?</div><div><br /></div><div>{{c1::Bicarbonate (alkalinize urine)}}</div>", "time": null}, {"id": 1490066257140, "note": "<div><div>What is the treatment for <u>overdose</u> of drugs that act as <b>weak bases</b> (e.g. amphetamines, TCAs)?</div><div><br /></div><div>{{c1::Ammonium chloride (acidify urine)}}</div></div>", "time": null}, {"id": 1490066261471, "note": "<div>What <u>phase of drug metabolism</u> includes <b>reduction</b>, <b>oxidation</b>, and <b>hydrolysis</b>? </div><div><br></div><div>{{c1::Phase I}}</div>", "time": null}, {"id": 1490066263554, "note": "<div><b>Phase {{c1::I}}</b> <u>drug metabolism</u> usually yields <i><b>slightly </b></i><b>polar</b>, water-soluble metabolites (often still <b>active</b>)</div>", "time": null}, {"id": 1490066265387, "note": "<div><div>What <u>phase of drug metabolism</u> includes <b>methylation</b>, <b>glucuronidation</b>, <b>acetylation</b>, and <b>sulfation</b> (i.e. conjugation)? </div><div><br></div><div>{{c1::Phase II}}</div></div>", "time": null}, {"id": 1490066268966, "note": "<div><div><b>Phase {{c1::II}}</b> <u>drug metabolism</u> usually yields <i><b>very </b></i><b>polar</b>, water-soluble metabolites (<b>inactive</b>)</div></div>", "time": null}, {"id": 1490066271518, "note": "<div>Patients who are <b>slow</b> {{c1::acetylators}} have <u>increased side effects</u> from certain drugs due to <b>decreased rate of metabolism</b></div>", "time": null}, {"id": 1490066273472, "note": "<div>Which <u>phase of drug metabolism</u> is lost first in <b>geriatric patients</b>? </div><div><br></div><div>{{c1::Phase I}}</div>", "time": null}, {"id": 1490066276769, "note": "<div><b>{{c1::Efficacy}}</b> is the <u>maximal effect</u> a drug can produce</div>", "time": null}, {"id": 1490066280055, "note": "<div><b>V</b><sub style=\"font-weight: bold; \">max</sub> of a drug is indicative of <b>{{c1::efficacy::potency or efficacy}}</b>&nbsp;</div>", "time": null}, {"id": 1490066286562, "note": "<div>Compared to <u>full agonists</u>, <b>partial agonists</b> have {{c1::less}} <b>efficacy</b> </div>", "time": null}, {"id": 1490066290359, "note": "<div><b>{{c1::Potency}}</b> is the <u>amount of drug needed</u> for a given effect</div>", "time": null}, {"id": 1490066293330, "note": "<div><b>EC</b><sub style=\"font-weight: bold; \">50</sub> of a drug is indicative of <b>{{c1::potency::potency or efficacy}}</b>&nbsp;</div>", "time": null}, {"id": 1490066300391, "note": "<div>What effect does a <u>competitive antagonist</u> have on <b>potency</b>?</div><div><br /></div><div>{{c1::Decrease (curve shifts right)}}</div>", "time": null}, {"id": 1490066305390, "note": "<div><div>What effect does a <u>competitive antagonist</u> have on <b>efficacy</b>?</div><div><br /></div><div>{{c1::No change}}</div></div>", "time": null}, {"id": 1490066308677, "note": "<div><div>What effect does a <u>non-competitive antagonist</u> have on <b>potency</b>?</div><div><br /></div><div>{{c1::No change}}</div></div>", "time": null}, {"id": 1490066311609, "note": "<div><div>What effect does a <u>non-competitive antagonist</u> have on <b>efficacy</b>?</div><div><br /></div><div>{{c1::Decrease (curve shifts down)}}</div></div>", "time": null}, {"id": 1490066314616, "note": "<div><div>What effect does a <u>partial agonist</u> have on <b>efficacy</b>?</div><div><br /></div><div>{{c1::Decrease (curve shifts down)}}</div></div>", "time": null}, {"id": 1490066320396, "note": "<div>The <b>therapeutic index</b> is calculated by {{c1::<b>TD</b><sub style=\"font-weight: bold; \">50</sub>}}/{{c1::<b>ED</b><sub style=\"font-weight: bold; \">50</sub>}}</div>", "time": null}, {"id": 1490066323578, "note": "<div><b>Safer</b> <b>drugs</b> have a(n) {{c1::<u>higher</u>}} <b>therapeutic index value</b></div>", "time": null}, {"id": 1490066326802, "note": "<div>Drugs with a <u>low</u> <b>therapeutic index</b> may be remembered with the mnemonic \"<b>W</b>arning! <b>T</b>hese <b>D</b>rugs are <b>L</b>ethal\": </div><div style=\"centerbox\"><div class=\"mnemonics\"><div><br/></div><div><b>W</b>: {{c1::Warfarin}}</div><div><b>T</b>: {{c2::Theophylline}}</div><div><b>D</b>: {{c3::Digoxin}}</div><div><b>L</b>: {{c4::Lithium}}</div></div></div>", "time": null}, {"id": 1490137213363, "note": "What <u>toxin</u> is found in <b>pufferfish</b>?<div><br /></div><div>{{c1::Tetrodotoxin}}</div>", "time": null}, {"id": 1490137861396, "note": "<div><b>Tetrodotoxin</b> binds fast <i>voltage-gated</i> {{c1::<b>Na<sup>+</sup></b>}} <b>channels</b> in cardiac/nerve tissue, <u>preventing</u> <b>depolarization</b></div>", "time": null}, {"id": 1490137865783, "note": "<div>Does <b>tetrodotoxin</b> <i>cause</i> or <i>prevent</i> <u>depolarization</u>? </div><div><br /></div><div>{{c1::Prevent}}</div>", "time": null}, {"id": 1490137911734, "note": "<div><b><i>Chronic</i> alcohol use</b> leads to <u>{{c1::induction}}</u> of <b>CYP-450</b></div>", "time": null}, {"id": 1490137920397, "note": "<div><b>Griseofulvin</b> is a(n)&nbsp;<u>{{c1::inducer}}</u> of <b>CYP-450</b></div>", "time": null}, {"id": 1490137924125, "note": "<div><b>Rifampin</b> is a(n)&nbsp;<u>{{c1::inducer}}</u> of <b>CYP-450</b></div>", "time": null}, {"id": 1490137930957, "note": "<div><b>Isoniazid</b> is a(n)&nbsp;<u>{{c1::inhibitor}}</u> of <b>CYP-450</b></div>", "time": null}, {"id": 1490137935086, "note": "<div><b>-Azoles</b> (antifungals) are <u>{{c1::inhibitors}}</u> of <b>CYP-450</b></div>", "time": null}, {"id": 1490137960049, "note": "<div><b>Valproate</b> is a(n)&nbsp;<u>{{c1::inhibitor}}</u> of <b>CYP-450</b></div>", "time": null}, {"id": 1490137963044, "note": "<div><b>Phenytoin</b> is a(n)&nbsp;<u>{{c1::inducer}}</u> of <b>CYP-450</b></div>", "time": null}, {"id": 1490137966107, "note": "<div><b>Phenobarbital</b> is a(n)&nbsp;<u>{{c1::inducer}}</u> of <b>CYP-450</b></div>", "time": null}, {"id": 1490137969292, "note": "<b>Carbamazepine</b> is a(n)&nbsp;<u>{{c1::inducer}}</u> of <b>CYP-450</b>", "time": null}, {"id": 1401387108466, "note": "{{c1::DiGeorge Syndrome}} is a 22q11 deletion syndrome that presents with {{c2::<b>thymic</b>}}<b> aplasia</b>,  {{c2::<b>parathyroid</b>}}<b> aplasia</b> and  {{c2::<b>cardiac</b>}}<b> defects</b>", "time": null}, {"id": 1401384439188, "note": "{{c1::Patau Syndrome (Trisomy 13)}} is an autosomal trisomy that is associated with {{c2::<b>cleft lip</b>::face}} and {{c2::<b>cleft palate</b>::face}}", "time": null}, {"id": 1401383464593, "note": "{{c1::Patau Syndrome (Trisomy 13)}} is an autosomal trisomy that is associated with  rocker-bottom feet and  {{c2::<b>microphthalmia</b>}}", "time": null}, {"id": 1493070807467, "note": "<b>SVC syndrome</b> is commonly caused by <b>malignancy</b>, such as:<div>- #1 {{c1::mediastinal mass}}</div><div>- #2 {{c2::superior sulcus tumor}}</div>", "time": null}, {"id": 1493667013610, "note": "The TSH receptor on the thyroid follicular cells may be stimulated by {{c1::TSI (thyroid-stimulating immunoglobulin)}} in Graves Disease", "time": null}, {"id": 1493667164347, "note": "TRH acts on which signalling cascade? {{c1::IP3}}", "time": null}, {"id": 1493667650847, "note": "<b>Thyroid Peroxidase</b> is involved in the first part of T4 synthesis, specifically by catalyzing the addition of {{c2::<u>iodine</u>}} to tyrosine residues on {{c1::<u>thyroglobulin</u>}}", "time": null}, {"id": 1493667933442, "note": "Thyroid hormones (T3/T4) play a role in development of the {{c1::CNS}}", "time": null}, {"id": 1493668150043, "note": "Thyroid hormone increases <u>basal metabolic rate (BMR)</u> via increased activity of {{c1::Na/K-ATPase}}", "time": null}, {"id": 1493668310033, "note": "How does Thyroxine-Binding Globulin (TBG) change with <u>hepatic failure</u> and <u>steroids</u>?<div><br /></div><div>{{c1::Decrease}}</div>", "time": null}, {"id": 1493668383937, "note": "How does Thyroxine-Binding Globulin change in <u>pregnancy</u> and with <u>OCPs</u>?<div><br /></div><div>{{c1::Increase}}</div>", "time": null}, {"id": 1493668504290, "note": "{{c1::Reverse T3 (rT3)}} is an isomer of T3 that mirrors T4 levels", "time": null}, {"id": 1493668592362, "note": "TSH increases which 2nd messenger?<div><br /></div><div>{{c1::cAMP}}</div>", "time": null}, {"id": 1493669075416, "note": "{{c1::Hashimotos Thyroiditis}} is an autoimmune disorder that initially causes a hyperthyroidism that then becomes a hypothyroidism", "time": null}, {"id": 1493669227162, "note": "{{c1::Cretinism}} is a form of congenital hypothyroidism that presents with developmental delay, protruding umbilicus, pot belly, and protruding tongue", "time": null}, {"id": 1493669357997, "note": "Levothyroxine = {{c1::synthetic T4}}<div>Triiodothyronine = {{c2::synthetic T3}}</div>", "time": null}, {"id": 1493669552068, "note": "<u>Levothyroxine and Triiodothyronine</u> are {{c1::thyroid replacement}} medications that are used to treat <i>hypothyroidism and myxedema</i>", "time": null}, {"id": 1493669920128, "note": "<div>{{c1::Propylthiouracil}} is a thioamide that works by inhibiting <u>Thyroid peroxidase</u> <b>AND</b> <u>5-Deiodinase</u></div>", "time": null}, {"id": 1493670305294, "note": "{{c1::<b>Propylthiouracil</b>}} and {{c2::<b>methimazole</b>}} are thionamides used to treat {{c3::hyperthyroidism}}", "time": null}, {"id": 1493670479272, "note": "What kind of hair texture is associated with hypothyroidism?<div><br /></div><div>{{c1::Dry, brittle hair}}</div>", "time": null}, {"id": 1493670550338, "note": "{{c1::Levothyroxine}} is a synthetic T4 hormone replacement that can <i>cause</i> <b>hyperthyroidism</b>", "time": null}, {"id": 1493670587112, "note": "Which thioamide is contraindicated in the first trimester of pregnancy?<div><br /></div><div>{{c1::Methimazole, so need to use PTU}}</div>", "time": null}, {"id": 1493670643676, "note": "Which thyroid medications can cause <b>agranulocytosis?</b><div><b><br></b></div><div>{{c1::PTU and Methimazole}}</div>", "time": null}, {"id": 1493670833040, "note": "Which thyroid medications are associated with drug-induced lupus?<div><br /></div><div>{{c1::Propylthiouracil (PTU), methimazole}}</div>", "time": null}, {"id": 1493670899237, "note": "{{c1::Propylthiouracil (PTU)}} is a thioamide associated with <b>severe hepatotoxicity</b>", "time": null}, {"id": 1493670936385, "note": "<u>Propylthiouracil</u> (PTU) and <u>Methimazole</u> are associated with a(n) {{c1::<b>maculopapular skin}} rash</b>", "time": null}, {"id": 1493673847368, "note": "The {{c2::Wolff-Chaikoff}} effect is the inhibition of <u><i><b>thyroperoxidase</b></i></u> by excess {{c1::iodine}}", "time": null}, {"id": 1493674159991, "note": "<u>Lugols iodine</u> is a large dose of {{c1::Potassium Iodide}} given to evoke the <b><i>Wolff-Chaikoff effect</i></b>", "time": null}, {"id": 1493674222596, "note": "The {{c1::<b>Jod-Basedow</b>}} <b>phenomenon</b> is a condition where a patient develops <b><u>thyrotoxicosis</u></b> after a period of being administered <b>Iodine</b>", "time": null}, {"id": 1493674452979, "note": "{{c1::Jod-Basedow phenomenon}} occurs when a patient being given high dose potassium iodide (Lugols solution) develops thyrotoxicosis as an adverse effect", "time": null}, {"id": 1493675054335, "note": "<b>Radioactive (<i>I<sup>131</sup></i>)</b> <b>Iodine</b> is a <i>last</i> resort treatment of <u>Hyperthyroidism / Graves disease</u> that works by {{c1::ablating}} the Thyroid", "time": null}, {"id": 1493675300258, "note": "Patients who undergo radioactive iodine (I<sup>131</sup>)  treatment can develop {{c1::hypothyroidism}}", "time": null}, {"id": 1493675532373, "note": "<div>\u03b2-Blockers are used to treat {{c1::Thyrotoxicosis (thyroid storm)}} by blocking the <u>hyperadrenergic</u> symptoms</div>", "time": null}, {"id": 1493675721609, "note": "<b>\u03b2-blockers</b> (ex <i>propranolol</i>) can block <u>peripheral conversion</u> of T4 into T3 by inhibiting {{c1::5-deiodinase}}", "time": null}, {"id": 1493675950331, "note": "<b>Glucocorticoids</b> are <i>anti-inflammatory </i>agents that can be used to <u>inhibit peripheral conversion</u> of T4 to T3 by inhibiting {{c1::5-deiodinase}}", "time": null}, {"id": 1493676625806, "note": "<u>Graves ophthalmopathy</u> can be treated with {{c1::Glucocorticoids}}", "time": null}, {"id": 1493676957977, "note": "{{c1::Amiodarone}} is a class III anti-arrhythmic that can produce <b>hyper or hypothyroidism</b>", "time": null}, {"id": 1493677691853, "note": "{{c1::Lithium}} is a mood stabilizer associated with development of <b>hypothyroidism</b>", "time": null}, {"id": 1494985583129, "note": "<div><div><i>Low serum </i>Ca2+ levels<i> </i>will<i> </i><u style=\"font-style: italic; \"><b>{{c1::increase}}</b></u><i> </i>PTH levels in the blood stream</div></div>", "time": null}, {"id": 1494985784198, "note": "The parathyroid glands have <u>{{c1::Ca2+ sensing </u><u>(CaSR)</u>}} receptors that {{c2::negatively}} regulate secretion of PTH", "time": null}, {"id": 1494986039913, "note": "<u>Chronic</u> PTH exposure stimulates <i>osteoblasts</i> to <b><u>express</u> as well as <u>secrete</u> </b><u>{{c1::RANKL}}</u><div><br></div>", "time": null}, {"id": 1494986156445, "note": "<i>RANKL</i> binds to {{c1::<b>RANK</b>}} on <u>Osteoclast precursors / Osteoclast</u> surfaces causing {{c2::<b>activation</b>}} of these cells", "time": null}, {"id": 1494987311932, "note": "Intermittent PTH <u>stimulates</u> <b>maturation of osteoblasts</b>, thus {{c1::<u>increasing</u>}}<u> bone formation</u>", "time": null}, {"id": 1494987409779, "note": "PTH <u>increases Ca2+ {{c1::reabsorption}}</u> by the <b>kidney</b>", "time": null}, {"id": 1494987503240, "note": "PTH <u>increases phosphate {{c1::excretion}}</u> by the <b>kidney</b>", "time": null}, {"id": 1494988042360, "note": "<u>Teriparatide</u> is a(n)&nbsp;<i>{{c1::PTH analog}}</i> used to treat <b>{{c2::osteoporosis}}, </b>wherein the goal is to increase bone density and formation", "time": null}, {"id": 1494988372076, "note": "Does <b>Teriparatide</b> have the exact same activity as <u>endogenous PTH</u>?<div><br /></div><div>{{c1::Yes}}</div>", "time": null}, {"id": 1494988814923, "note": "<b>{{c1::1-alpha-hydroxylase}}</b> converts <u>25-hydroxyvitamin D</u> (calcidiol) into <u>{{c2::1,25-dihydroxyvitamin D (aka calcitriol)}}</u>", "time": null}, {"id": 1494988913959, "note": "<b>Calcitriol</b> stimulates increased <u>{{c1::reabsorption}} of Ca2+</u> and <u>{{c2::reabsorption}} of phosphate</u> by the <i>kidney</i>", "time": null}, {"id": 1494989429488, "note": "<b>Calcitriol</b> increases <u>{{c2::absorption}} of Ca2+</u> and <u>{{c1::absorption}} of phosphate</u> in the <i>intestine</i>", "time": null}, {"id": 1494989545970, "note": "<b>Calcitriol</b> <u>{{c1::increases}}</u> <i>Ca2+</i> and <i>phosphate</i> release into the bloodstream by <u>{{c2::stimulating}} osteoblasts</u> to {{c2::activate}} osteoclasts", "time": null}, {"id": 1494989779751, "note": "Both <u>Calcitriol</u> and <u>Vitamin D</u> can be used to <b>prophylactically </b><u>treat</u> and <i>mitigate</i> symptoms of <u>{{c1::osteoporosis}}</u><div><div><br></div></div>", "time": null}, {"id": 1494989899824, "note": "<u>Vitamin D deficiency</u> can cause <b>{{c1::rickets}}</b> in children and <b>{{c2::osteomalacia}}</b> in adults", "time": null}, {"id": 1494989968462, "note": "<div>Patients with <u>renal insufficiency</u> can be given <b>{{c1::Calcitriol}} </b>to correct their hypocalcemia</div>", "time": null}, {"id": 1494990443406, "note": "<div><b>Calcitriol</b> is useful in the <u>long term management</u> of {{c1::hypocalcemia}} due to chronic disorders</div>", "time": null}, {"id": 1494990648090, "note": "<div>Patients who have undergone <u>{{c1::Thyroid}} surgery</u> can sometimes manifest with symptoms of <b>hypoparathyroidism</b> and <b>hypocalcemia</b></div>", "time": null}, {"id": 1494990718449, "note": "<b><i>H</i></b><b style=\"font-style: italic; \">ypo</b><i>calcemia</i> can lead to {{c1::<b>tetany</b>}} and in <u>severe</u> cases lead to <u>{{c2::seizures}}</u>", "time": null}, {"id": 1494990866419, "note": "<u>Teriparatide</u> and <u>Vitamin D</u> therapy can cause <b>{{c1::hypercalcemia::adverse effect}}</b>", "time": null}, {"id": 1494990914793, "note": "<b>{{c2::Cinacalcet}} </b>is an <u>allosteric</u> activator of the&nbsp;<u>{{c1::Ca2+ sensing (CaSR)}} receptor</u> on the <b>Parathyroid Gland</b>", "time": null}, {"id": 1494991061174, "note": "<u>Cinacalcet</u> is used to treat <b>hypercalcemia</b> secondary to <b>{{c1::hyperparathyroidism}}</b>", "time": null}, {"id": 1494991141787, "note": "{{c2::<b>Sevelamer</b>}} is a compound that <u>binds </u><u><b>free</b></u> <u>{{c1::phosphate}}</u> in the <b><i>gastrointestinal tract</i></b> ", "time": null}, {"id": 1494991205221, "note": "<b>Sevelamer</b> is used to treat {{c1::<b>hyperphosphatemia</b>}} due to <u>{{c2::chronic kidney}} disease</u>", "time": null}, {"id": 1495595300874, "note": "<div>{{c1::<b>Ubiquitin</b>}}-ation of proteins recruits the {{c2::<b>proteasome</b>}} to degrade them</div>", "time": null}, {"id": 1495633577748, "note": "<div>Adverse effects of <b>sirolimus (</b><i>rapamycin</i><b>)</b> include {{c1::<b>pancytopenia</b>}} and {{c2::<b>insulin</b>}} <b>resistance</b></div>", "time": null}, {"id": 1495634939970, "note": "<div><i><div></div></i></div><div><b>Sirolimus</b> is primarily used to treat <u>{{c2::transplant rejection}} prophylaxis</u> in patients who have received a(n) {{c1::<b>kidney</b>}} transplant</div>", "time": null}, {"id": 1495635392036, "note": "<div><b>Sirolimus</b> works by binding <b>{{c1::FKBP}}</b>, which <u>inhibits</u> the {{c2::<b>mTOR::specific signal</b>}} signalling complex involved in cell growth</div>", "time": null}, {"id": 1495635688466, "note": "<div><u>mTOR</u> is a(n)&nbsp;<b>{{c1::protooncogene::protooncogene or tumorsuppressor?}}</b></div>", "time": null}, {"id": 1495731198988, "note": "<div><i><div></div><div></div></i></div><div><b>Denosumab</b> prevents {{c1::osteoclast}} activation by binding {{c2::RANKL}} expressed on <u>osteoblasts</u></div>", "time": null}, {"id": 1495734114619, "note": "<div>Because <b>denosumab </b>impairs osteoclast activity (like <u>bisphosphonates</u>), these drugs can cause {{c1::<b>osteonecrosis of the jaw</b>}} </div>", "time": null}, {"id": 1495734704148, "note": "<div><div>All biologics (ex <u>monoclonal antibodies</u>) carry the risk of eliciting a(n) {{c1::<b>infusion reaction</b>}} within the first hour of administration</div></div>", "time": null}, {"id": 1495734830497, "note": "<div><div>Is the heart failure associated with Trastuzumab reversible with treatment discontinuation?</div></div><div><br /></div><div>{{c1::Yes}}</div>", "time": null}, {"id": 1495735188904, "note": "<div><b>Trastuzumab</b> is contraindicated with {{c1::<b>anthracycline</b>}} <b>usage</b></div>", "time": null}, {"id": 1495735796199, "note": "<div><div><b>Trastuzumab</b> is indicated for {{c1::Her2}}-positive cancers, the most important example being {{c2::<b>breast</b>}} <b>cancer</b></div></div>", "time": null}, {"id": 1495735940631, "note": "<div><div><div><b>Busulfan</b>s use as an&nbsp;<u>antineoplastic</u><b> </b>comes from its ability to be a(n) {{c1::<b>alkylating</b>}} agent</div></div></div>", "time": null}, {"id": 1495736131793, "note": "<div><div><div><b>Busulfan</b> mediated alkylation of <u>DNA</u> leads to {{c1::cross-linking}} of strands, which DNA repair mechanisms cannot fix</div></div></div>", "time": null}, {"id": 1495736987476, "note": "<div><div><div><b>\"Busulfan Lung\" </b>is the term for the {{c1::<b>fibrotic</b>}} pattern of lung damage which can be caused by <b>Busulfan</b></div></div></div>", "time": null}, {"id": 1495737138512, "note": "<div><div><div><b>Busulfan</b> chemotherapy is associated with a(n)&nbsp;<b>{{c1::hyperpigmentation::skin}} </b>reaction</div><b></b></div><b></b></div><div><br></div>", "time": null}, {"id": 1495737396886, "note": "<div><div><div><div><div><div><b>Busulfan</b> is used to treat {{c1::<b>Chronic Myelogenous</b>}} <b>Leukemia</b></div></div></div></div></div></div>", "time": null}, {"id": 1495737442417, "note": "<div>Prior to a bone marrow transplant, <b>Busulfan</b> can be used as a(n)&nbsp;<b>{{c1::conditioning}} </b>agent</div>", "time": null}, {"id": 1495737635396, "note": "<div><div><b>Nitrosureas</b> are chemotherapeutics which can be recognized by the suffixes {{c1::<b>-mustine</b>}} and {{c2::<b>-zotocin</b>}}</div></div>", "time": null}, {"id": 1495737981969, "note": "<div><div><b>Nitrosureas</b> work by {{c1::<b>crosslinking</b>}} <b>DNA</b></div></div>", "time": null}, {"id": 1495738163681, "note": "<div><div><div><b>Nitrosureas</b> requires bioactivation by {{c1::<b>cytochrome p450</b>}} enzymes to be effective</div></div></div>", "time": null}, {"id": 1495738313876, "note": "<div><div><b>Nitrosureas</b> are able to penetrate the {{c1::<b>Blood Brain Barrier</b>}}, making them especially useful for tumors of the {{c2::<b>Central Nervous System</b>}}</div></div>", "time": null}, {"id": 1495738392776, "note": "<div><div><div><b>-Phosphamide</b> chemotherapeutics are {{c1::<b>alkylating</b>}} agents that work by {{c2::<b>crosslinking</b>}} DNA strands</div></div></div>", "time": null}, {"id": 1495738626939, "note": "<div><b>Cyclophosphamide</b> must be bioactivated by the <b>{{c1::liver}} </b>in order to function</div>", "time": null}, {"id": 1495738972701, "note": "<div><b style=\"font-weight: bold; \">Cyclophosphamide</b> is selective for cells that express <u>low / no levels</u> of <b>{{c1::Aldehyde Dehydrogenase}}</b></div><div><b><br /></b></div>", "time": null}, {"id": 1495739124907, "note": "<div>In the process of bioactivating<b> -phosphamides</b>, a highly cytotoxic side product known as <b>{{c1::Acrolein}} </b>is released which can cause <b>{{c2::Hemorrhagic Cystititis}}</b></div>", "time": null}, {"id": 1495739747156, "note": "<div><div>To treat the <u>Hemorrhagic Cystitis </u>induced by <b>cyclophosphamide</b>, the compound {{c1::<b>MESNA</b>}} can be administered</div></div><div><div><br /></div></div>", "time": null}, {"id": 1495740017108, "note": "<div><div><b>Cyclophosphamide </b>and<b> Ifosfamide</b> are especially suited for neoplasias of {{c2::<b>immune</b>}} cells as well as {{c1::<b>solid</b>}} malignancies</div></div>", "time": null}, {"id": 1495740310438, "note": "<div><div><b>Cyclophosphamide</b> can be used as an immunosuppressant for the treatment of {{c1::<b>lupus</b>}} <b>nephritis</b>, as well as for <b>systemic</b> {{c2::<b>vasculitides</b>}} </div></div>", "time": null}, {"id": 1495740615760, "note": "<div><b>Cyclophosphamide</b> can cause a congenital syndrome (<i>remember with the mnemonic <b><font color=\"#aa0000\">conGEAL</font>) - <font color=\"#aa0000\">con</font></b>genital:</i></div><div style=\"centerbox\"><div class=\"mnemonics\"><div style=\"font-weight: bold; \"><br></div><div><i>-&nbsp;</i><i><b><font color=\"#aa0000\">G</font></b></i><i>{{c1::rowth Restriction}}</i></div><div><i>-&nbsp;</i><i><b><font color=\"#aa0000\">E</font></b></i><i>{{c2::ar and facial abnormalities}}</i></div><div><i>-&nbsp;</i><i><b><font color=\"#aa0000\">A</font></b></i><i>{{c3::bsence of digits}}</i></div><div><i>-&nbsp;</i><i><b><font color=\"#aa0000\">L</font></b></i><i>{{c4::imb hypoplasia}}</i></div></div></div>", "time": null}, {"id": 1495741163975, "note": "<div><b>Cyclophosphamide</b> can stimulate {{c1::<b>ADH</b>}} secretion, resulting in a euvolemic hyponatremia</div>", "time": null}, {"id": 1495741324392, "note": "<div>As a result of <b>Cyclophosphamide</b> metabolites accumulating in the {{c2::<b>bladder</b>}}, it is associated with {{c1::<b>transitional cell</b>}} <b>carcinoma</b></div>", "time": null}, {"id": 1495741480727, "note": "<div><div><b>Ifosfamide </b>can cause a generalized reabsorptive defect in the <b>{{c1::proximal convoluted}} tubule</b></div></div>", "time": null}, {"id": 1495812512415, "note": "<div><div><b style=\"font-weight: bold; \">Imatinib</b> is the gold standard for patients with <b style=\"font-weight: bold; \">{{c1::Chronic Myelogenous</b><b style=\"font-weight: bold; \">}} Leukemia </b>that have a(n)&nbsp;<span style=\"font-weight: bold;\">{{c2::<b>Bcr-Abl</b>}} </span>fusion receptor tyrosine kinase</div></div>", "time": null}, {"id": 1495812700726, "note": "<div><div><b>Imatinib</b> can inhibit the receptor tyrosine kinase <b>{{c1::c-Kit}}</b>, making it useful for <b>GI</b> <b>{{c2::Stromal Tumors (GIST)}}</b></div></div>", "time": null}, {"id": 1495812852349, "note": "<div>Patients being treated with <b>Imatinib</b> can experience side effects of <b>{{c1::fluid}} retention</b></div>", "time": null}, {"id": 1495818993477, "note": "<div><b>Tyrosine Kinase inhibitors</b> work by targeting downstream signaling pathways involved in growth - the most important being:</div><div><br><div>- {{c1::<b>PI3K/Akt</b>}} leads to increased {{c2::<b>Bcl-2</b>}} expression (anti-apoptosis)</div><div>- {{c2::<b>JAK/STAT</b>}} which wouldve led to increased cell {{c5::<b>proliferation</b>}}</div><div>- {{c3::<b>Ras/MAPK</b>}} which wouldve led to increased cell {{c6::<b>growth</b>}}</div><div>- {{c4::<b>Src/FAK}}</b> which wouldve led to increased cell {{c7::<b>motility (invasion)</b>}} and decreased cell <b>{{c8::adhesion (migration)}}</b></div></div>", "time": null}, {"id": 1495823589233, "note": "<!--anki--><div>{{c3::<b>Hydroxyurea</b>}} is an antimetabolite that inhibits <u>pyrimidine</u> synthesis by inhibiting {{c1::<b>Ribonucleotide Reductase</b>}}, thus blocking {{c2::<b>Thymidine</b>}} synthesis</div>", "time": null}, {"id": 1495823891256, "note": "<!--anki--><div>In patients with <u>Sickle Cell Anemia</u>, <b>Hydroxyurea</b> is used<i> prophylactically</i> to <b><u>reduce</u></b> {{c1::<b>veno-occlusive crises</b>}}</div>", "time": null}, {"id": 1495824428159, "note": "<!--anki--><div>Patients taking <b>hydroxyurea</b> can develop a(n) {{c1::<b>megaloblastic</b>}} anemia</div>", "time": null}, {"id": 1495824863345, "note": "<!--anki--><div><b>Hydroxyurea</b> is used in the treatment of hematological malignancies, particularly {{c1::myeloproliferative}} disorders<i></i></div>", "time": null}, {"id": 1495997958989, "note": "<div><b>Irinotecan, </b>a(n) {{c2::<b>Topoisomerase I</b>}} <b>inhibitor</b>, is used to treat {{c1::<b>Colon</b>}} <b>Cancer</b></div>", "time": null}, {"id": 1496006981334, "note": "<div><b>Platinum</b> based antineoplastics can cause side effects which might make ya say <b><font color=\"#aa0000\">NOPE</font></b></div><div><b><br></b><div><i>-&nbsp;</i><i><b><font color=\"#aa0000\">N</font></b></i><i>{{c1::</i><i><b>ephrotoxicity</b>}}</i></div><div><i>-&nbsp;</i><i><b><font color=\"#aa0000\">O</font></b></i><i>{{c2::<b>totoxicity</b>}}</i></div><div><i>-&nbsp;</i><i><b><font color=\"#aa0000\">P</font></b></i><i>{{c3::<b>eripheral Neuropathy</b>}}</i></div><div><i>-&nbsp;</i><i><b><font color=\"#aa0000\">E</font></b></i><i>{{c4::<b>mesis</b>}}</i></div></div>", "time": null}, {"id": 1496007126465, "note": "<div>To prevent cisplatin-induced nephrotoxicity, you can administer <b>Amifostine</b>&nbsp;or IV {{c2::<b>Saline</b>}} diuresis</div><div><br></div>", "time": null}, {"id": 1496007192285, "note": "<div><div><b>Vinca Alkaloids</b> are antineoplastics that prevent cell cycle progression at the {{c2::<b>M</b>}} <b>phase</b></div></div>", "time": null}, {"id": 1496007393595, "note": "<div><div><b>Vinca Alkaloids</b> bind {{c2::<b>B-Tubulin</b>}}, inhibiting the <b>assembly</b> of microtubules</div></div>", "time": null}, {"id": 1496007679100, "note": "<div>As two classes of antineoplastic agents that modulate microtubule structure, the distinction lies in that<b> vinca-alkaloids </b>prevent microtubule {{c1::<b>assembly</b>}} whereas <b>taxanes</b> prevent microtubule {{c1::<b>disassembly</b>}}</div>", "time": null}, {"id": 1496008326942, "note": "<div><div><b>Vincristine</b> can cause a(n) {{c1::peripheral sensory}} neuropathy</div></div>", "time": null}, {"id": 1496008463840, "note": "<div><div><b>Taxanes (-taxel) </b>are antineoplastics that prevent cell cycle progression at the {{c1::<b>M</b>}}<b>-Phase</b></div></div>", "time": null}, {"id": 1496008597519, "note": "<div><div><div><div><b>Taxanes</b> work by preventing the {{c1::<b>disassembly</b>}} of microtubules</div></div></div></div>", "time": null}, {"id": 1496008817614, "note": "<div><b>Taxanes </b>can cause a <b>peripheral sensory&nbsp;neuropathy</b><span style=\"\"> as well as induce </span><b>{{c2::hypersensitivity</b>}} reactions</div>", "time": null}, {"id": 1496008854211, "note": "<div><b>Taxanes </b>are used to treat for {{c1::<b>breast</b>}} and {{c1::<b>ovarian</b>}} carcinomas</div>", "time": null}, {"id": 1496029410295, "note": "<div>Patients taking <b>Erlotinib </b>can get a(n) {{c1::<b>papulopustular acneiform</b>}} <b>rash</b></div>", "time": null}, {"id": 1496029620681, "note": "<div>The abbreviation <b>RTK</b> stands for {{c1::<b>Receptor Tyrosine Kinase</b>}}</div>", "time": null}, {"id": 1496032276945, "note": "<div><div>A common side effect of all alkylating agents is {{c1::<b>myelosuppression</b>}}</div></div>", "time": null}, {"id": 1496032306714, "note": "<div><div><div>A general rule of chemotherapeutic side effects is that they will affect all {{c1::rapidly}} dividing cells</div></div></div>", "time": null}, {"id": 1496032495928, "note": "<div><div><b>Cyclophosphamide</b> can target germ cells, resulting in {{c1::<b>infertility</b>}} and <b>premature </b><b>menopause</b></div></div>", "time": null}, {"id": 1496033290669, "note": "<div><div>Because Her2/Neu is expressed on the {{c1::<b>Heart</b>}}, Trastuzumab can cause {{c1::<b>Heart</b>}} failure</div></div>", "time": null}, {"id": 1496078911270, "note": "The {{c1::anterior cruciate ligament (ACL)}} extends from the {{c2::lateral femoral condyle}} to the {{c3::anterior tibia}}", "time": null}, {"id": 1496079030878, "note": "The {{c1::posterior cruciate ligament (PCL)}} extends from the {{c2::medial femoral condyle}} to the {{c3::posterior tibia}}", "time": null}, {"id": 1496079065704, "note": "A knee exam should be performed with the patient in the {{c1::supine}} position", "time": null}, {"id": 1496079084819, "note": "The {{c1::anterior drawer test}} and {{c1::lachman}} test are used to test for {{c2::ACL injury}}", "time": null}, {"id": 1496079121879, "note": "The {{c2::anterior drawer}} test is performed with the knee at a(n) {{c1::90}} degree angle to test for ACL injury", "time": null}, {"id": 1496079183047, "note": "A positive anterior drawer sign demonstrates <b>increased {{c1::anterior gliding}}</b> of the {{c1::tibia}}", "time": 1660105362479.0}, {"id": 1496079235885, "note": "The {{c2::Lachman}} test is similar to the anterior drawer test, but the knee is at a(n) {{c1::30}} degree angle", "time": null}, {"id": 1496079298796, "note": "The {{c3::posterior drawer}} test is performed with the knee at a(n) {{c1::90}} degree angle to test for {{c2::PCL injury}}", "time": null}, {"id": 1496079360132, "note": "A positive posterior drawer sign shows increased {{c1::posterior gliding}} of the {{c1::tibia}}", "time": 1660105362475.0}, {"id": 1496079390352, "note": "The {{c1::Valgus}} test is <u>most commonly</u> used to identify {{c2::MCL}} injury", "time": null}, {"id": 1496079472104, "note": "The {{c1::Valgus}} test is performed with the knee at a(n) {{c2::30}} degree angle while a(n) {{c3::lateral}} {{c1::(valgus)}} force is applied", "time": null}, {"id": 1496079535070, "note": "An abnormal {{c1::<b>Valgus</b>}} test shows increased {{c2::<b>medial space widening</b>}} of the tibia", "time": 1660105361837.0}, {"id": 1496079584387, "note": "The {{c1::Varus}} test is used to identify {{c2::LCL}} injury", "time": null}, {"id": 1496079654765, "note": "The {{c1::Varus}} test is performed with the knee at a(n) {{c2::30}} degree angle while a(n) {{c3::medial}} {{c1::(varus)}} force is applied", "time": null}, {"id": 1496079698921, "note": " An abnormal {{c1::<b>Varus</b>}} test shows increased {{c2::<b>lateral space widening</b>}} of the tibia", "time": 1660105362690.0}, {"id": 1496079737499, "note": "The {{c1::McMurray}} test is used to identify injury to the {{c2::meniscus (of the knee)}}", "time": null}, {"id": 1496079792660, "note": "The {{c1::<b>McMurray</b>}} <b>test</b> is performed by<div><br /></div><div>1) {{c2::<b>full flexion</b>}} of the knee</div><div>2) followed by {{c2::<u>extension</u>}} of the knee with {{c3::<b>rotation of the tibia</b>}} and <u>pressure</u> on the {{c3::<b>opposite</b>}} side of the knee you want to test</div>", "time": 1660105349145.0}, {"id": 1496079916740, "note": "In a positive McMurray test, pain and \"popping\" on {{c1::external}} rotation indicates a(n) {{c2::medial}} meniscus tear", "time": null}, {"id": 1496080025321, "note": "In a positive McMurray test, pain and \"popping\" on {{c1::internal}} rotation indicates a(n) {{c2::lateral}} meniscal tear", "time": null}, {"id": 1496080042295, "note": "A positive McMurray test is characterized by {{c1::pain and \"popping\"}} on extension (with rotation and side of the knee pressure)", "time": null}, {"id": 1496080089180, "note": "A(n)&nbsp;{{c1::<b>greenstick</b>}} fracture is a(n) {{c2::incomplete}} fracture through the width of the bone following {{c3::bending stress}}", "time": null}, {"id": 1496095496392, "note": "{{c2::<b>Greenstick</b>}} fractures and {{c3::<b>torus</b>}} fractures are both common fractures in {{c1::pediatric}} populations", "time": null}, {"id": 1496095543376, "note": "A(n)&nbsp;{{c1::<b>torus</b>}} fracture occurs when {{c2::axial}} force is applied to immature bone, leading to a(n) {{c3::simple buckle}} fracture of the {{c4::cortex}}", "time": null}, {"id": 1496105405364, "note": "<div><div><b>Actinomycin D</b> (aka Dactinomycin)<b>&nbsp;</b>is&nbsp;an antineoplastic antibiotic that works by preventing {{c1::<b>transcription</b>}} through the process of <b>DNA {{c2::intercalation}}</b></div></div>", "time": null}, {"id": 1496105536532, "note": "<div><div><b>Dactinomycin</b> is used to treat for numerous malignancies that affect the {{c1::pediatric}} age group</div></div><div><br /></div>", "time": null}, {"id": 1496107918481, "note": "<div><div><b>Anthracycline </b>associated Dilated Cardiomyopathy can be prevented with {{c1::<b>dexrazoxane</b>}}, a(n) {{c1::<b>iron</b>}} chelating agent</div></div>", "time": null}, {"id": 1496109644674, "note": "<div><b>Bleomycin</b> is an antineoplastic antibiotic indicated for {{c1::<b>lymphoma</b>}} as well as cancers of the {{c2::<b>reproductive</b>}} system</div><div><br /></div>", "time": null}, {"id": 1496109782853, "note": "<div><b>Bleomycin</b> can have severe effects at the <u>lung</u>, which over time can cause {{c2::<b>pulmonary fibrosis</b>}}</div>", "time": null}, {"id": 1496110017365, "note": "<div>In the setting of lung cancer / mesothelioma, <b>Bleomycin</b> can be used to prevent <u>recurrent</u> {{c1::pleural effusions}}</div>", "time": null}, {"id": 1496110133728, "note": "<div>Patients taking <b>Bleomycin</b> can experience {{c1::<b>hyperpigmentation</b>}} of the skin</div>", "time": null}, {"id": 1496110442979, "note": "<div><b>Cytarabine </b>and <b>Gemcitabine</b> are examples of {{c1::<b>pyrimidine</b>}} <b></b><b>nucleoside analogs</b> that block cell cycle progression at {{c2::<b>S</b>}} phase</div><div><br /></div>", "time": null}, {"id": 1496110895116, "note": "<div><u>Pyrimidine</u> nucleoside analogs (<i>ex <b>Cytarabine</b> and <b>Gemcitabine</b></i>) work by inhibiting {{c1::<b>DNA polymerase A/B</b>}}</div>", "time": null}, {"id": 1496111092713, "note": "<div>Because <b>Cytarabine </b>targets <u>lymphocytes</u>, it is indicated for {{c1::<u>leukemias</u>}} as well as {{c2::<b>non-Hodgkins</b>}}<b> Lymphoma</b></div>", "time": null}, {"id": 1496111134927, "note": "<div>All antineoplastic nucleoside analogs (including <u>cladribine, cytarabine, gemcitabine</u>) can cause {{c1::myelo}}suppression</div>", "time": null}, {"id": 1496182184553, "note": "The {{c1::\"unhappy triad\"}} is a common {{c2::knee}} injury in {{c3::contact}} sports due to {{c4::lateral}} force applied to a(n) {{c5::planted}} leg", "time": null}, {"id": 1496182685275, "note": "The {{c1::\"unhappy triad\"}} <i>classically</i> consists of damage to the {{c2::ACL}}, {{c3::MCL}}, and {{c4::medial meniscus* (attached to MCL)}}", "time": null}, {"id": 1496182766150, "note": "Although the classic presentation for the \"unhappy triad\" involves {{c1::medial meniscus}} injury, the {{c1::lateral meniscus}} is more commonly injured", "time": 1660105361905.0}, {"id": 1496182848127, "note": "The \"unhappy triad\" presents with acute {{c1::knee pain}} and {{c2::signs of joint injury/instability}}", "time": null}, {"id": 1496182886253, "note": "{{c1::Prepatellar}} bursitis is an inflammation of the {{c1::prepatellar}} bursa in front of the kneecap", "time": 1660105339199.0}, {"id": 1496182934811, "note": "Prepatellar bursitis can be caused by {{c1::repeated trauma}} or pressure from {{c2::excessive kneeling}}", "time": null}, {"id": 1496182963245, "note": "{{c1::Prepatellar bursitis}} is also known as {{c2::\"housemaids knee\"}}", "time": null}, {"id": 1496182982505, "note": "A(n) {{c1::Baker cyst}} is a collection of {{c2::synovial fluid}} in the {{c3::popliteal fossa}} in the {{c4::gastrocnemius-semimembranosus}} bursa", "time": null}, {"id": 1496183168055, "note": "Baker cyst forms in the setting of {{c1::chronic degenerative or inflammatory joint}} disease", "time": 1660105341061.0}, {"id": 1496183230856, "note": "A(n)&nbsp;{{c3::Baker cyst}} presents with {{c1::posterior knee pain/stiffness}} and detection of a swelling/mass in the {{c2::popliteal fossa}}", "time": 1660105362363.0}, {"id": 1496183277033, "note": "The rotator cuff muscles are innervated primarily by {{c1::C5-C6::(nerve roots)}}", "time": null}, {"id": 1496183407992, "note": "The rotator cuff muscles are:<div>1. {{c1::supraspinatus}}</div><div>2. {{c2::infraspinatus}}</div><div>3. {{c3::teres minor}}</div><div>4. {{c4::subscapularis}}</div>", "time": null}, {"id": 1496183466501, "note": "The {{c1::supraspinatus}} and {{c1::infraspinatus}} (rotator cuff muscles) are innervated by the {{c2::suprascapular (C5-C6)::roots}} nerve", "time": null}, {"id": 1496183537336, "note": "The {{c1::teres minor}} (rotator cuff muscle) is innervated by the {{c2::axillary}} nerve", "time": null}, {"id": 1496183572876, "note": "The {{c1::subscapularis::rotator cuff muscle}} is innervated by the {{c2::upper and lower}} {{c3::subscapular (C5-C6)}} nerves", "time": null}, {"id": 1496183610893, "note": "The {{c1::supraspinatus}} {{c3::a<b>B</b>ducts}} the arm initially (from {{c2::0 to 15}}\u00b0)", "time": null}, {"id": 1496183699185, "note": "The {{c1::supraspinatus}} is the most commonly injured rotator cuff muscle, due to {{c2::trauma}} or {{c3::degeneration and impingement}} which leads to {{c4::tendinopathy or tear}}", "time": null}, {"id": 1496183761507, "note": "Function of the {{c1::supraspinatus}} muscle may be assessed using the {{c2::\"empty/full can\"}} test", "time": null}, {"id": 1496183985115, "note": "The {{c1::infraspinatus::rotator cuff muscle}} and {{c1::teres minor::rotator cuff muscle}} {{c2::laterally (<i>external</i>) rotate::action}} the arm", "time": null}, {"id": 1496184039415, "note": "Injury to the {{c1::infraspinatus}} (rotator cuff muscle) is classically seen in {{c2::baseball pitchers}}", "time": null}, {"id": 1496184112410, "note": "The {{c1::teres minor}} (rotator cuff muscle) does the following actions<div> - {{c2::a<b>D</b>ducts}} the arm </div><div> -  {{c2::laterally (externally) rotates}} the arm</div>", "time": null}, {"id": 1496184163665, "note": "The {{c1::subscapularis}} (rotator cuff muscle) {{c2::a<b>D</b>ducts and medially (<i>internally</i>) rotates}} the arm (action)", "time": null}, {"id": 1496184249316, "note": "The {{c1::supraspinatus}} abducts the arm from {{c2::0 to 15}}\u00b0 and is innervated by the {{c1::suprascapular}} nerve", "time": null}, {"id": 1496184367512, "note": "The {{c1::deltoid}} abducts the arm from {{c2::15}} to {{c2::100}}\u00b0 and is innervated by the {{c3::axillary}} nerve", "time": null}, {"id": 1496184402000, "note": "The {{c1::trapezius}} abducts the arm {{c2::&gt;90}}\u00b0 and is innervated by the {{c3::Spinal Accessory (CNXI)}} nerve", "time": 1660105348992.0}, {"id": 1496184441665, "note": "The {{c1::serratus anterior}} abducts the arm {{c2::&gt;100}}\u00b0 and is innervated by the {{c3::long thoracic}} nerve", "time": null}, {"id": 1496351444482, "note": "<b>Medial epicondylitis (aka golfers elbow</b>) is an elbow injury that may be due to repetitive {{c2::<u>flexion</u>}} ({{c2::forehand}} shots) that causes tendinosis of the {{c1::<b>pronator teres</b>}} and {{c1::<b>flexor carpi radialis</b>}}", "time": null}, {"id": 1496351602377, "note": "<b>Lateral epicondylitis (aka tennis elbow)</b> is an elbow injury that may be due to repetitive {{c1::<u>extension</u>}} ({{c1::backhand}} shots) that causes microtrauma of the <b>{{c2::extensor carpi radialis brevis}}</b> tendon at its origin", "time": null}, {"id": 1496351643415, "note": "The bones of the wrist can be remembered by the mnemonic \"So Long To Pinky, Here Comes The Thumb\":<br><br><div><b>S</b>o: {{c1::<b>s</b>caphoid}}</div><div><b>L</b>ong: {{c2::<b>l</b>unate}}</div><div><b>T</b>o: {{c3::<b>t</b>riquetrum}}</div><div><b>P</b>inky: {{c4::<b>p</b>isiform}}</div><div><b>H</b>ere: {{c5::<b>h</b>amate}}</div><div><b>C</b>omes: {{c6::<b>c</b>apitate}}</div><div><b>T</b>he: {{c7::<b>t</b>rapezoid}}</div><div><b>T</b>humb: {{c7::<b>t</b>rapezium}}</div>", "time": null}, {"id": 1496351847486, "note": "The {{c1::scaphoid}} (bone) (palpable in the {{c2::anatomic snuff box}}) is the most commonly fractured carpal bone", "time": null}, {"id": 1496351900511, "note": "The {{c1::scaphoid}} (bone) is typically injured due to {{c2::a fall on an outstretched hand}}", "time": null}, {"id": 1496351944625, "note": "Complications of {{c1::proximal}} scaphoid fractures include {{c2::avascular necrosis}} and {{c3::nonunion}} due to {{c4::retrograde blood supply}}", "time": null}, {"id": 1496351983459, "note": "Dislocation of the {{c1::lunate}} (bone) may cause acute {{c2::carpal tunnel}} syndrome", "time": null}, {"id": 1496352026512, "note": "Carpal tunnel syndrome is due to entrapment of the {{c2::<b>median</b>}} nerve between the {{c1::transverse carpal}} ligament and the {{c1::carpal}} bones", "time": null}, {"id": 1496352086585, "note": "Nerve compression in carpal tunnel syndrome presents as {{c1::paresthesia}}, {{c2::pain}}, and {{c3::numbness}} in the distribution of the {{c4::median}} nerve", "time": 1660105354902.0}, {"id": 1496352128311, "note": "{{c1::Carpal tunnel}} syndrome leads to atrophy of the {{c2::<b>thenar</b> eminence}}, but spares {{c3::sensation}} because the {{c4::<b>palmar cutaneous branch</b>}} enters the hand external to the carpal tunnel", "time": null}, {"id": 1496352237286, "note": "<b>Carpal tunnel syndrome</b> is associated with <div>- {{c1::pregnancy::reproductive circumstance}} (due to edema)</div><div>- {{c2::rheumatoid arthritis::inflammatory disorder}}</div><div>- {{c3::hypothyroidism::thyroid disorder}}</div><div>- {{c4::diabetes mellitus::endocrine disorder}}</div><div>- {{c5::acromegaly::pituitary disorder}}</div><div>- {{c6::dialysis-related amyloidosis::inflammatory disorder}}</div><div><br></div><div>It <b>may</b> also be associated with {{c7::repetitive use}}</div>", "time": null}, {"id": 1496352355479, "note": "A positive {{c1::Tinel}} sign and {{c2::Phalen}} maneuver are suggestive of {{c3::carpal tunnel}} syndrome", "time": null}, {"id": 1496352395527, "note": "A positive {{c1::Tinel}} sign is when {{c2::percussion of the wrist causes tingling}}", "time": null}, {"id": 1496352430998, "note": "A positive {{c1::Phalen}} maneuver is when {{c2::90 degree flexion of the wrist causes tingling}}", "time": null}, {"id": 1496352456455, "note": "{{c1::<b>Guyon canal</b>}} <b>syndrome</b> is due to compression of the {{c2::ulnar}} nerve at the {{c3::wrist}} or {{c3::hand}}", "time": null}, {"id": 1496352500581, "note": "Guyon canal syndrome is classically seen in {{c1::cyclists}} due to {{c1::pressure from handlebars}}", "time": null}, {"id": 1496511618237, "note": "Treating an organophosphate poisoning is two fold; {{c1::<b>Atropine</b>}} which inhibits all subtypes of {{c1::<b>muscarinic receptors</b>}}, and {{c2::<b>Pralidoxime</b>}}, which if given early - regenerates {{c2::<b>AChE</b>}}", "time": null}, {"id": 1496598817658, "note": "Injury to the {{c1::axillary}} nerve ({{c2::C5-C6::(nerve roots)}}) is commonly due to:<div><br></div><div>- fracture at {{c3::the surgical neck of the humerus}} </div><div>-  {{c4::anterior dislocation}} of the humerus</div>", "time": null}, {"id": 1496599021042, "note": "Injury to the {{c1::axillary (C5-C6)::roots}} nerve presents as: <div>1. {{c2::flattened deltoid}} (appearance)</div><div>2. loss of {{c3::arm abduction at shoulder (&gt;15\u00b0)}} (action)&nbsp;</div><div>3. loss of {{c4::sensation over the deltoid muscle and lateral arm}} (sensation)</div>", "time": 1660105356043.0}, {"id": 1496599147883, "note": "Injury to the {{c1::musculocutaneous}} nerve ({{c2::C5-C7}} (nerve roots)) is commonly due to {{c3::upper trunk compression}}", "time": null}, {"id": 1496599296288, "note": "Injury to the {{c1::musculocutaneous (C5-7)::roots}} nerve presents as:<div>1. loss of {{c2::forearm flexion}} and {{c2::forearm supination}} (action)</div><div>2. loss of {{c3::sensation over the lateral forearm}} (sensation)</div>", "time": 1660105356030.0}, {"id": 1496599433184, "note": "Injury to the {{c1::radial}} nerve ({{c2::C5-T1::(nerve roots)}}) can be caused by<div>- {{c3::midshaft}} fracture of the humerus</div><div>- compression of the {{c4::axilla}}</div><div>- \"{{c5::nursemaids}} elbow\"<br /></div><div>- \"{{c6::finger}}\" drop</div>", "time": null}, {"id": 1496599521790, "note": "Compression of the axilla (resulting in radial nerve injury) can occur due to improper use of {{c1::crutches}} or {{c2::sleeping with an arm over a chair (aka Saturday night palsy)}}", "time": null}, {"id": 1496599851964, "note": "{{c1::Radial}} nerve injury presents with:<div>1. {{c2::wrist drop, including loss of elbow, wrist, and finger extension}} (action)</div><div>2. {{c3::decreased grip strength (due to loss of wrist extension)}} (strength)</div><div>3. {{c4::loss of sensation over posterior arm/forearm and dorsal hand}} (sensation)</div>", "time": 1660105339111.0}, {"id": 1496599885855, "note": "{{c2::Median}} nerve ({{c1::C5-T1::nerve roots}}) injury is commonly due to:<div><br /></div><div>- {{c6::anteromedial}} {{c3::supracondylar}} fracture of the humerus ({{c3::proximal::proximal or distal?}} lesion)</div><div>- {{c4::carpal tunnel}} syndrome ({{c4::distal::proximal or distal?}} lesion)</div><div>- {{c5::wrist}} laceration ({{c5::distal::proximal or distal?}} lesion)</div>", "time": null}, {"id": 1496600043781, "note": "Special findings in a(n) {{c1::<b>median</b>}} nerve injury include \"{{c1::Median}} Claw\" ({{c3::<i>distal lesion</i>}}) and \"{{c2::Popes blessing}}\" ({{c3::<i>proximal lesion</i>}})", "time": 1660105350883.0}, {"id": 1496602297377, "note": "Loss of muscle action in a(n) {{c5::median}} nerve injury includes loss of:<div>1. {{c1::wrist flexion (weakened-ulnar nerve contributes)}}</div><div>2. {{c2::flexion of lateral fingers (2nd and 3rd digits)}}</div><div>3. {{c3::thumb opposition and thumb flexion}}</div><div>4. {{c4::lateral 2 lumbricals (2nd and 3rd digits)}}</div>", "time": 1660105355553.0}, {"id": 1496602403049, "note": "In a(n) {{c1::median}} nerve injury, sensation is lost over the:<br />1. {{c2::thenar eminence}}<div>2. {{c3::dorsal aspects of lateral 3 1/2 fingers (with proximal lesion)}}</div><div>3. {{c4::palmar aspects of lateral 3 1/2 fingers (with proximal lesion)}}</div>", "time": null}, {"id": 1496602511480, "note": "Injury to the {{c1::ulnar}} nerve ({{c2::C8-T1}} (nerve roots)) commonly occurs due to:<div><br /></div><div>- {{c3::fracture of the medial epicondyle of humerus}} {{c5::\"funny bone\"}} ({{c6::proximal}} lesion) </div><div><br /></div><div>- {{c4::fractured hook of hamate}} ({{c7::distal}} lesion) (from fall on outstretched hand - \"FOOSH\")</div>", "time": null}, {"id": 1496602982182, "note": "A special finding in a(n) {{c1::distal ulnar}} nerve injury is \"{{c2::ulnar claw}}\" on {{c3::digit <b>extension</b>}}", "time": 1660105362439.0}, {"id": 1496603035538, "note": "The wrist will deviate {{c1::radially}} upon {{c2::flexion}} in a(n) {{c3::proximal}} {{c4::ulnar}} nerve lesion", "time": null}, {"id": 1496603132543, "note": "Loss of muscle action in a(n) {{c1::ulnar}} nerve injury includes loss of:<div>1. {{c2::wrist flexion}}</div><div>2. {{c3::flexion of medial fingers (4th and 5th digits)}}</div><div>3. {{c4::abduction AND adduction of fingers (interossei)}}</div><div>4. {{c5::medial 2 lumbricals (4th and 5th digits)}}</div>", "time": 1660105355558.0}, {"id": 1496603266265, "note": "In a(n) {{c1::ulnar}} nerve injury, sensation is lost over the {{c2::medial 1 1/2 fingers}}, including the {{c3::hypothenar eminence}}", "time": null}, {"id": 1496603308878, "note": "Injury to the {{c1::<b>recurrent branch of the median</b>}} <b>nerve</b> ({{c2::<b>C5-T1</b>::nerve roots}}) is commonly due to {{c3::<b>superficial laceration of the palm</b>}}", "time": 1660105356022.0}, {"id": 1496603354258, "note": "Injury to the {{c4::recurrent branch of the median}} nerve results in:<div>1. \"{{c1::ape hand / median claw}}\" (appearance)</div><div>2. {{c2::loss of thenar muscles}} (action)</div><div>3. {{c3::no loss of sensation}} (sensation)</div>", "time": 1660105356017.0}, {"id": 1496604023388, "note": "<div>A lesion to #{{c2::1 (upper trunk injury)}} would result in {{c1:: Erb palsy (\"waiters tip\")}}</div><img src=\"paste-165145787498497.jpg\">", "time": null}, {"id": 1496604104524, "note": "A lesion to #{{c2::2}} would result in {{c1::Klumpke palsy (<u>total</u> claw hand)}}<div><img src=\"paste-165141492531201.jpg\" /></div>", "time": null}, {"id": 1496604136916, "note": "A lesion to the #{{c1::3 - posterior}} cord would result in {{c2::wrist drop}}, paralysis of the {{c3::deltoid}}, and impairment of {{c4::internal}} rotation of the humerus<div><img src=\"paste-165141492531201.jpg\" /></div>", "time": null}, {"id": 1496604155753, "note": "A lesion to #{{c1::4 (long thoracic nerve injury)}} ({{c3::C5-C7::root}}) would result in {{c2::winged scapula}}<div><img src=\"paste-165141492531201.jpg\"></div>", "time": null}, {"id": 1496604196287, "note": "A lesion to #{{c1::5 (axillary nerve injury)}} would result in {{c2::deltoid paralysis}}<div><img src=\"paste-165141492531201.jpg\"></div>", "time": null}, {"id": 1496604209709, "note": "A lesion to #{{c1::6 (radial nerve injury)}} would result in \"Saturday night palsy\" ({{c2::wrist drop}})<div><img src=\"paste-165141492531201.jpg\"></div>", "time": null}, {"id": 1496604284088, "note": "A lesion to #{{c1::7 (musculocutaneous nerve injury)}} would result in {{c2::difficulty flexing elbow::muscular deficit}} and {{c2::variable loss of sensation::sensory deficit}}<div><img src=\"paste-165141492531201.jpg\" /></div>", "time": null}, {"id": 1496604372859, "note": "A <b>proximal</b> lesion to #{{c1::<b>8</b> (proximal median nerve injury)}} presents with {{c2::\"Popes blessing\"}} and a loss of sensation in the {{c1::median}} nerve distribution<div><img src=\"paste-165141492531201.jpg\"></div>", "time": null}, {"id": 1496604490473, "note": "A(n)&nbsp;{{c1::distal::Proximal or Distal?}} lesion to #{{c1::9 (distal ulnar nerve lesion)}} would result in {{c2::loss of intrinsic muscles of the hand and ulnar claw hand}}<div><img src=\"paste-165141492531201.jpg\"></div>", "time": null}, {"id": 1496607698945, "note": "<div>{{c1::Erb palsy::condition}} is due to traction or tear of {{c2::the<b> upper trunk</b>}} ({{c2::C5-C6}} roots)</div>", "time": null}, {"id": 1496607841823, "note": "Erb palsy is commonly caused by:<div><br></div><div>- {{c1::lateral traction}} on neck during {{c1::delivery}} (in infants) </div><div>- {{c2::trauma}} (in adults)</div>", "time": 1660105359464.0}, {"id": 1496607898058, "note": "Muscles lost in Erb palsy include: <div>1. {{c1::deltoid}}</div><div>2. {{c1::supraspinatus}}</div><div>3. {{c2::infraspinatus}}</div><div>4. {{c2::biceps brachii}}</div>", "time": null}, {"id": 1496608039683, "note": "Loss of the {{c1::deltoid}} and {{c1::supraspinatus}} in Erb palsy result in {{c2::a<b>D</b>duction}} of the arm", "time": null}, {"id": 1496608084837, "note": "Loss of the {{c1::infraspinatus}} (muscle) in Erb palsy results in {{c2::medial rotation}} of the arm", "time": 1660105361433.0}, {"id": 1496608174130, "note": "Loss of the {{c1::biceps brachii}} in Erb palsy results in {{c2::extension and pronation}} of the forearm", "time": 1660105361435.0}, {"id": 1496608251089, "note": "{{c1::Klumpke palsy::condition}} is due to traction or tear of {{c2::the lower trunk}} ({{c3::C8-T1}} roots)", "time": null}, {"id": 1496608357490, "note": "Klumpke palsy is commonly caused by {{c1::upward force}} on the arm during {{c1::delivery}} (in infants) or {{c2::trauma}}, such as {{c2::grabbing}} a tree branch while {{c2::falling (in adults)}}", "time": 1660105355783.0}, {"id": 1496608419803, "note": "Muscles lost in <b>Klumpke palsy</b> include the {{c1::<u>intrinsic hand muscles}}:</u><div>1. {{c2::lumbricals}}</div><div>2. {{c3::interossei}}</div><div>3. {{c3::hypothenar}}</div><div>4. {{c4::thenar}}</div>", "time": 1660105355082.0}, {"id": 1496608483471, "note": "Loss of the {{c1::lumbricals::specific muscle group}} in {{c2::Klumpke palsy}} results in {{c3::total claw hand}}", "time": null}, {"id": 1496608604412, "note": "{{c1::<b>Thoracic outlet syndrome</b>::condition}} is due to <u>compression</u> of the {{c2::<i>lower trunk</i>}} (roots {{c2::C8-T1}}) and {{c3::<i>subclavian</i>}} vessels", "time": null}, {"id": 1496608680946, "note": "{{c1::Thoracic outlet syndrome}} (condition) is commonly caused by:<div>- presence of a(n) {{c2::cervical}} rib </div><div>- {{c3::Pancoast}} tumor</div><div>- {{c4::scalene}} muscular abnormalities / hypertrophy / trauma (ex repetitive overhead arm movements)</div>", "time": null}, {"id": 1496608737895, "note": "Muscles lost in <b>thoracic outlet syndrome</b> include the {{c1::intrinsic hand muscles}}:<div>1. {{c2::lumbricals}}</div><div>2. {{c3::interossei}}</div><div>3. {{c4::thenar}}</div><div>4. {{c5::hypothenar}}</div>", "time": null}, {"id": 1496608819674, "note": "<b>Thoracic outlet syndrome</b> presents with:<div><br /></div><div>- {{c2::<u>atrophy of intrinsic hand muscles</u>}} (due to loss of lower trunk nourishment)</div><div>- {{c3::<u>ischemia and pain</u>}} (due to artery compression)</div><div>- {{c4::<u>edema</u>}} (due to venous compression)</div><div>- and <u>Klumpke Palsy</u> (due to lower trunk compression)</div>", "time": 1660105348796.0}, {"id": 1496609031353, "note": "{{c1::Winged scapula}} (condition) is due to a lesion of the long thoracic nerve that supplies the {{c2::serratus anterior}}", "time": null}, {"id": 1496609065391, "note": "Winged scapula is commonly caused by:<div>- {{c1::axillary node}} dissection after {{c1::mastectomy}} </div><div>- {{c2::stab wounds}}</div>", "time": null}, {"id": 1496609138175, "note": "Winged scapula is due to loss of action of the {{c1::serratus anterior}} muscle", "time": null}, {"id": 1496609204321, "note": "<div>A long thoracic nerve lesion presents with: </div><div>#1 - inability to abduct arm above {{c1::horizontal position}}</div><div>#2 - inability to anchor {{c2::scapula}} to thoracic cage</div>", "time": null}, {"id": 1496620320182, "note": "Clawing of the hand is best seen with {{c1::<u>distal</u>::proximal or distal}} lesions of the {{c2::median}} or {{c2::ulnar}} nerves", "time": null}, {"id": 1496620388047, "note": "Clawing of the hand is characterized by {{c1::<u>extension</u>::flexion/extension}} at the {{c2::MCP}} joint, {{c1::<u>flexion</u>::flexion/extension}} at the {{c2::PIP}} joint, and {{c1::<u>flexion</u>::flexion/extension}} at the {{c2::DIP}} joint", "time": null}, {"id": 1496620614167, "note": "Claw hand deficits are {{c2::less::(more/less)}} pronounced in {{c1::proximal::(proximal/distal)}}  lesions", "time": null}, {"id": 1496620665242, "note": "{{c1::\"Ulnar claw\" hand}} (<i>distortion of the hand</i>) is most apparent when {{c2::<u>extending</u> fingers or at rest}}, and is due to a(n) {{c3::<u>distal ulnar</u>}} nerve lesion", "time": 1660105341381.0}, {"id": 1496620776631, "note": "{{c1::\"Popes blessing\" hand (aka hand of benediction)}} (<i>distortion of the hand) </i>is most apparent when {{c2::<u>making a fist</u>}}, and is due to a(n) {{c3::<u>proximal median</u>}} nerve lesion", "time": 1660105341384.0}, {"id": 1496620827971, "note": "{{c1::\"Median claw\" hand}} (<i>distortion of the hand</i>) is most apparent when {{c2::<u>extending</u> fingers or at rest}}, and is due to a(n) {{c3::<u>distal median</u>}} nerve lesion", "time": 1660105341390.0}, {"id": 1496620859698, "note": "{{c1::\"OK gesture\" hand}} is most apparent when {{c2::<u>making a fist</u>}}, and is due to a(n) {{c3::<u>proximal ulnar</u>}} nerve lesion", "time": 1660105341387.0}, {"id": 1496620892610, "note": "Atrophy of the {{c1::thenar}} eminence is seen in {{c2::median}} nerve lesions, while atrophy of the {{c1::hypothenar}} eminence is seen in {{c2::ulnar}} nerve lesions", "time": 1660105361431.0}, {"id": 1496621109895, "note": "Muscles of the thenar eminence:<div>1. {{c1::Opponens pollicis}}</div><div>2. {{c2::Abductor pollicis brevis}}</div><div>3. {{c3::Flexor pollicis brevis}}</div>", "time": null}, {"id": 1496621207173, "note": "Muscles of the hypothenar eminence:<div>1. {{c1::Opponens digiti minimi}}</div><div>2. {{c2::Abductor digiti minimi}}</div><div>3. {{c3::Flexor digiti minimi brevis}}</div>", "time": null}, {"id": 1496621247538, "note": "Muscles of the {{c1::thenar}} eminence are innervated by the {{c2::median}} nerve", "time": null}, {"id": 1496621272603, "note": "Muscles of the {{c1::hypothenar}} eminence are innervated by the {{c2::ulnar}} nerve", "time": null}, {"id": 1496621295705, "note": "The {{c1::dorsal}} interossei {{c2::a<b>B</b>duct}} the fingers; the {{c1::palmar}} interossei {{c2::a<b>D</b>duct}} the fingers", "time": null}, {"id": 1496621546579, "note": "The lumbricals {{c1::flex}} at the {{c2::MCP}} joint and {{c1::extend}} at the {{c2::PIP and DIP::2}} joints", "time": null}, {"id": 1496700685629, "note": "The {{c1::iliohypogastric}} nerve ({{c2::T12-L1::nerve roots}}) provides:<div><br /><div>- <u>sensory</u> innervation to the {{c3::<b>suprapubic</b> <b>region</b>}} </div><div>- <u>motor</u> innervation to the {{c4::<b>transversus</b> <b>abdominis</b>}} and {{c4::<b>internal</b> <b>oblique</b>}}</div></div>", "time": null}, {"id": 1496700900655, "note": "The iliohypogastric nerve is commonly injured due to <b>post abdominal surgery {{c1::sutures}}</b>", "time": null}, {"id": 1496700975215, "note": "Injury to the iliohypogastric nerve often presents as burning or tingling pain at the {{c1::surgical incision site}} radiating to the inguinal and suprapubic region", "time": 1660105356045.0}, {"id": 1496701039754, "note": "The {{c1::genitofemoral}} nerve ({{c2::L1-L2::(nerve roots)}}) provides:<div><br /><div>- sensory innervation to the {{c3::scrotum/labia majora::genital area}} and {{c3::upper anterior thigh::femoral area}} </div><div>- motor innervation to the {{c4::cremaster}}</div></div>", "time": null}, {"id": 1496701112919, "note": "The genitofemoral nerve is commonly injured due to <b>laparoscopic surgeries </b>for {{c1::<b>inguinal</b> <b>hernias</b>}} or by <b>{{c2::retractor blades}}</b> used in abdominal surgery", "time": 1660105350086.0}, {"id": 1496701138350, "note": "Injury to the {{c1::genitofemoral}} nerve presents as decreased sensation of {{c2::upper anterior thigh}} and an absent {{c3::cremasteric reflex}}", "time": null}, {"id": 1496701201756, "note": "The {{c1::lateral femoral cutaneous}} nerve ({{c2::L2-L3}} (nerve roots)) provides sensory innervation to the {{c3::anterior and lateral thigh}} and motor innervation to the {{c4::<b>none</b>}}", "time": null}, {"id": 1496701381425, "note": "The lateral femoral cutaneous nerve is commonly injured (<b>meralgia paresthetica</b>) due to {{c1::tight clothing}}, {{c1::obesity}} or {{c1::pregnancy}}", "time": null}, {"id": 1496701430117, "note": "Injury to the {{c1::lateral femoral cutaneous}} nerve presents as {{c2::decreased anterior and lateral thigh sensation}}", "time": null}, {"id": 1496701553014, "note": "The {{c1::Obturator}} nerve ({{c2::L2-L4}} (nerve roots)) provides:<div>- sensory innervation to the {{c3::distal medial thigh::very specific}} </div><div>- motor innervation to the thigh {{c4::adductor}} muscles</div>", "time": null}, {"id": 1496701661112, "note": "The obturator nerve is commonly injured due to <b>surgery </b>of the {{c1::<b>posterior</b>}} <b>pelvis</b> using a <u>trocar</u>", "time": null}, {"id": 1496701677325, "note": "Injury to the {{c1::obturator}} nerve presents as {{c2::decreased medial thigh sensation and adduction}}", "time": 1660105356027.0}, {"id": 1496701710041, "note": "The {{c1::femoral}} nerve ({{c2::L2-L4}} (nerve roots)) provides:<br>- sensory innervation to the {{c3::anterior thigh and medial leg}}<div>- motor innervation to the {{c4::quadriceps}}, {{c4::iliopsoas}}, {{c5::pectineus}}, and {{c5::sartorius}}</div>", "time": null}, {"id": 1496701796676, "note": "The femoral nerve is commonly injured due to {{c1::pelvic fracture}}", "time": null}, {"id": 1496701812693, "note": "Injury to the {{c1::femoral}} nerve presents as <b>decreased</b> <u>thigh</u> {{c2::flexion}} and <u>leg</u> {{c2::extension}}", "time": 1660105356036.0}, {"id": 1496701847029, "note": "The {{c1::sciatic}} nerve ({{c2::L4-S3}} (nerve roots)) provides:<div><br><div>- sensory innervation to the {{c3::none}} </div><div>- motor innervation to the {{c4::semitendinosus}}, {{c4::semimembranosus}}, {{c5::biceps femoris}}, and {{c5::hamstring portion of the adductor magnus}}</div></div>", "time": null}, {"id": 1496702069894, "note": "The <b>sciatic nerve i</b>s commonly injured due to:<div>- {{c1::a herniated disc}}</div><div>- {{c2::posterior hip dislocation}}</div><div>- {{c3::piriformis syndrome}}</div>", "time": null}, {"id": 1496702221940, "note": "The {{c1::sciatic}} nerve splits into the {{c2::common peroneal/fibular}} nerve and the {{c2::tibial}} nerve", "time": null}, {"id": 1496702292763, "note": "The {{c1::<u><b>common</b></u> peroneal}} nerve ({{c2::L4-S2}} (nerve roots)) provides:<div><br></div><div>- <u>sensory innervation</u> to the {{c3::dorsum of the foot}} </div><div>- <u>motor innervation</u> to the {{c4::short head of the biceps femoris::proximal}}, {{c4::tibialis anterior}}, and {{c5::extensor muscles of the digits}}</div>", "time": null}, {"id": 1496702407111, "note": "The {{c1::common peroneal}} nerve is commonly injured due to<div><br></div><div>- {{c2::trauma}} </div><div>- {{c3::compression of the lateral aspect of the leg (ex Cast)}} </div><div>- a(n) {{c4::fibular neck}} fracture</div>", "time": null}, {"id": 1496702476086, "note": "Injury to the {{c1::common peroneal}} nerve presents as loss of sensation on {{c2::the dorsum of the foot}} and {{c3::foot drop::motor}}", "time": 1660105356039.0}, {"id": 1496702526966, "note": "Foot drop is characterized by a foot that is {{c1::inverted}} and {{c1::plantarflexed}} at rest", "time": null}, {"id": 1496702617032, "note": "Foot drop is characterized by loss of {{c1::eversion}} and {{c1::dorsiflexion}} (movements) of the foot", "time": null}, {"id": 1496702661944, "note": "Foot drop results in a \"{{c1::steppage}} gait\"", "time": null}, {"id": 1496702679664, "note": "The {{c1::tibial}} nerve ({{c2::L4-S3::nerve roots}}) provides:<div>- sensory innervation to the {{c3::sole of foot}} </div><div>- motor innervation to the {{c4::triceps surae (soleus)}}, {{c4::plantaris}}, {{c5::popliteus}}, {{c5::flexor muscles of the foot}}, and {{c6::tibialis posterior}}</div>", "time": null}, {"id": 1496702925212, "note": "The tibial nerve is commonly injured due to:<div>- {{c1::knee}} trauma</div><div>- {{c2::Baker cyst}} (proximal lesion) </div><div>- {{c3::tarsal tunnel syndrome}} (distal lesion)</div>", "time": null}, {"id": 1496702960191, "note": "Distal tibial nerve lesions present with:<div><br /></div><div>- sensory loss over the {{c1::sole}} of the foot</div><div>- weakness of {{c2::intrinsic}} muscles of the foot</div>", "time": 1660105359978.0}, {"id": 1496766684762, "note": "The {{c1::superior gluteal}} nerve ({{c2::L4-S1::(nerve roots)}}) provides:<div><br><div>- sensory innervation to the {{c3::<b>none</b>}} </div><div>- motor innervation to the {{c4::gluteus medius}}, {{c4::gluteus minimus}}, and {{c5::tensor fascia latae}}</div></div>", "time": null}, {"id": 1496766876963, "note": "The superior gluteal nerve is commonly injured due to {{c1::intramuscular}} injection to the {{c1::upper medial}} gluteal region (iatrogenic)", "time": null}, {"id": 1496766930062, "note": "Injury to the<b> superior gluteal nerve</b> presents with {{c7::trendelenburg sign}} and a gluteus medius {{c8::lurch}} ", "time": null}, {"id": 1496767001191, "note": "Trendelenburg sign is characterized by {{c2::tilting of the pelvis}} <i>{{c1::contralateral}}</i> to the lesion", "time": null}, {"id": 1496767187973, "note": "Intramuscular injections in the buttocks should be given in the {{c1::anterolateral}} quadrant (specifically the {{c2::von Hochstetter}} triangle) to avoid injury to the superior gluteal nerve", "time": null}, {"id": 1496767287691, "note": "The {{c1::inferior gluteal}} nerve ({{c2::L5-S2::(nerve roots)}}) provides:<div><br></div><div>- sensory innervation to the <b>{{c3::none}}</b> </div><div>- motor innervation to the {{c4::gluteus maximus}}</div>", "time": null}, {"id": 1496767480804, "note": "The inferior gluteal nerve is commonly injured due to {{c1::posterior hip dislocation}}", "time": null}, {"id": 1496767510858, "note": "Injury to the {{c1::inferior gluteal}} nerve presents as difficulty {{c2::climbing stairs}} and {{c2::rising from a seated position}} due to {{c3::loss of hip extension}}", "time": 1660105356033.0}, {"id": 1496767587979, "note": "The {{c1::pudendal}} nerve ({{c2::S2-S4}} (nerve roots)) provides:<div>- sensory innervation to the {{c3::perineum}} </div><div>- motor innervation to the {{c4::external urethral}} and {{c4::anal sphincters}}</div>", "time": null}, {"id": 1496767683204, "note": "The pudendal nerve can be injured due to:<div>- stretching during {{c1::childbirth}}</div><div>- {{c2::saddle}} injury seen in cyclists</div>", "time": null}, {"id": 1496767707806, "note": "Injury to the {{c1::pudendal}} nerve presents as:<div>- decreased sensation in the {{c2::perineal and genital area}} (sensory)</div><div>- {{c3::fecal or urinary incontinence}} (motor)</div>", "time": 1660105356025.0}, {"id": 1496767830867, "note": "The {{c1::<b>pudendal</b>}} <b>nerve</b> can be <u>blocked with local anesthetic</u> during childbirth / minor surgeries of the vagina and perineum using the {{c2::<b>ischial spine}</b>} and {{c3::<b>sacrospinous ligament</b>}} as landmarks for injection", "time": null}, {"id": 1496767941258, "note": "<div>What action do the following muscles allow the hip to do?</div><div><br /></div><div>{{c1::Hip abduction}}</div><div><br /></div><div><font color=\"#aa0000\">Gluteus medius</font></div><div><font color=\"#aa0000\">Gluteus minimus</font></div>", "time": null}, {"id": 1496768101304, "note": "<div>What action do the following muscles allow the hip to do?</div><div><br /></div><div>{{c1::Hip <u>ad</u>duction}}</div><div><br /></div><div><font color=\"#aa0000\">Adductor magnus</font></div><div><font color=\"#aa0000\">Adductor longus</font></div><div><font color=\"#aa0000\">Adductor brevis</font></div>", "time": 1660105348006.0}, {"id": 1496768851595, "note": "<div>What kind of rotation do the following muscles allow the hip to do?</div><div><br /></div><div>{{c1::Internal rotation}}</div><div><br /></div><div><font color=\"#aa0000\">Gluteus medius</font></div><div><font color=\"#aa0000\">Gluteus minimus</font></div><div><font color=\"#aa0000\">Tensor fascia lata</font></div>", "time": 1660105345194.0}, {"id": 1496768984202, "note": "<div>What kind of rotation do the following muscles allow the hip to do?</div><div><br /></div><div>{{c1::External rotation}}</div><div><br /></div><div><font color=\"#aa0000\">Iliopsoas</font></div><div><font color=\"#aa0000\">Gluteus maximus</font></div><div><font color=\"#aa0000\">Piriformis</font></div><div><font color=\"#aa0000\">Obturator</font></div>", "time": 1660105345195.0}, {"id": 1496772731140, "note": "In a <b>cervical</b> or <b>lumbar</b> disc herniation, the disc typically herniates into the {{c1::<u>vertebral</u> canal}}, affecting the {{c2::inferior}} nerve", "time": null}, {"id": 1496775770544, "note": "<b>Intervertebral discs</b> generally herniate {{c1::<u>posterolaterally</u>::direction}} due to the <i>thin</i> {{c2::posterior longitudinal}} ligament and <i>thicker</i> {{c2::anterior longitudinal}} ligament", "time": null}, {"id": 1496775862689, "note": "An intervertebral disc herniation at the {{c1::<b>L3-L4</b>}} level will result in:<div>- weakness of {{c2::<u>leg}} extension</u>  and {{c2::<u>thigh}} flexion</u> (action) </div><div>- decreased {{c3::<u>patellar</u>}}<u> reflex</u></div><div>- decreased sensation of {{c4::anterior}} / medial thigh</div>", "time": 1660105361808.0}, {"id": 1496775957800, "note": "An intervertebral disc herniation at the {{c1::<b>L4-L5</b>}} level will result in:<div>- weakness of {{c2::<u>dorsiflexion</u>}} (action) </div><div>- difficulty in {{c3::<u>heel-</u>}}<u>walking</u></div>", "time": null}, {"id": 1496776101268, "note": "An intervertebral disc herniation at the {{c1::<b>L5-S1</b>}} level will result in:<div>- weakness of {{c2::<u>plantar flexion</u>}} (action)</div><div>- difficulty in {{c3::<u>toe-</u>}}<u>walking</u> </div><div>- decreased {{c4::<u>achilles (ankle jerk)</u>}}<u> reflex</u></div>", "time": null}, {"id": 1496776223147, "note": "The {{c1::long thoracic}} nerve travels with the {{c2::lateral thoracic}} artery through the {{c3::axilla/lateral thorax}}", "time": null}, {"id": 1496776398551, "note": "The {{c1::<b>axillary</b>}} <b>nerve</b> travels with the {{c2::<u>posterior circumflex humeral</u>}}<u> artery</u> around the {{c3::surgical neck of the humerus}}", "time": null}, {"id": 1496776445185, "note": "The {{c1::<b>radial</b>}} nerve travels with the {{c2::<u>deep brachial</u>}}<u> artery</u> around the {{c3::<u>midshaft of the humerus</u>}}", "time": null}, {"id": 1496776632236, "note": "The {{c1::median}} nerve travels with the {{c2::brachial}} artery around the {{c3::distal humerus/cubital fossa}}", "time": null}, {"id": 1496776718708, "note": "The {{c1::tibial}} nerve travels with the {{c2::popliteal}} artery through the {{c3::popliteal fossa}}", "time": null}, {"id": 1496776770417, "note": "The {{c1::tibial}} nerve travels with the {{c2::posterior tibial}} artery posterior to the {{c3::medial malleolus}}", "time": 1660105348999.0}, {"id": 1496864057677, "note": "<div>Due to its anti-<u>angiogenic</u> effect, <b>Bevacizumab </b>poses an increased risk of {{c1::<b>bleeding</b>}} and impairs {{c2::<b>wound healing</b>}}</div><div><br /></div>", "time": null}, {"id": 1496864352035, "note": "<div><b>Rituximab</b> targets B cells by binding {{c1::<b>CD20</b>}} surface antigen </div>", "time": null}, {"id": 1496864658353, "note": "<div><div>Patients who are being treated with<b> Rituximab</b> should be watched for <u>reactivation</u> of the {{c1::<b>Hepatitis B or JC</b>::2}} <b>Virus</b></div></div>", "time": null}, {"id": 1496864694059, "note": "<div><div>Because the skin has abundant <b>EGFR</b>, patients undergoing <b>Cetuximab</b> treatment can experience a(n) {{c1::<b>Papulopustular acneiform}} rash</b></div></div>", "time": null}, {"id": 1496870175137, "note": "<div>In physiological homeostasis, {{c1::<b>purines</b>}} are excreted by way of metabolism to {{c2::<u>uric acid</u>}} </div>", "time": null}, {"id": 1496870429879, "note": "<div>In <u>Purine metabolism</u>, <b>purines</b> end up being converted to {{c1::hypoxanthine}}, a substrate for <u>xanthine oxidase</u></div>", "time": null}, {"id": 1496870508969, "note": "<div>In <u>Purine metabolism</u>, {{c1::<b>xanthine oxidase</b>}} first converts {{c2::<b>hypoxanthine</b>}} to {{c2::<b>xanthine</b>}}, and then converts {{c3::<b>xanthine</b>}} to {{c3::<b>uric</b> <b>acid</b>}}</div>", "time": null}, {"id": 1496870788981, "note": "<div><b>Colchicine </b>is used to treat {{c1::acute::acute or chronic?}} gout</div>", "time": null}, {"id": 1496871132816, "note": "<div><div>The treatments for <u>prophylactic</u> treatment of <i>chronic </i><b>gout</b>&nbsp;can be remembered by the mnemonic \"<b>Prevent A Painful Flare</b>\":</div></div><div><br></div><div>-&nbsp;<b><font color=\"#aa0000\">Pr</font></b>{{c2::<b>obenecid</b>}}</div><div>-&nbsp;<b><font color=\"#aa0000\">A</font></b>{{c1::<b>llopurinol</b>}}</div><div>-&nbsp;<b><font color=\"#aa0000\">P</font></b>{{c3::<b>egloticase</b> (recombinant uricase)}}</div><div>-&nbsp;<b><font color=\"#aa0000\">F</font></b>{{c4::<b>ebuxostat</b>}}</div>", "time": null}, {"id": 1496871875707, "note": "<div><div>{{c1::<b>Allopurinol</b>}} and {{c1::<b>Febuxostat</b>}} are used to inhibit {{c2::<b>xanthine oxidase</b>}} in the management of Chronic Gout</div></div>", "time": null}, {"id": 1496872303888, "note": "<div><div>The symptoms of <b>Lesch-Nyhan</b> syndrome can be managed with {{c1::Xanthine Oxidase}} inhibitors</div></div>", "time": null}, {"id": 1496872585684, "note": "<div><div>Drugs metabolized by <b>xanthine oxidase</b> (<i>like the immunosuppressant&nbsp;{{c1::Azathioprine and 6MP}}</i>) will have serum levels boosted by administration of <b>Allopurinol/Febuxostat</b></div></div>", "time": null}, {"id": 1496872912455, "note": "<div><div>{{c1::<b>Probenecid</b>}} and<b> </b><u>{{c3::high}}-dose</u> <b>Aspirin</b> decrease renal <b>tubular&nbsp;</b>{{c2::<b>reabsorption</b>}} of <u>uric acid</u></div></div>", "time": null}, {"id": 1496872960311, "note": "<div><div><b><i>Probenecid</i></b> may increase the risk of forming {{c2::<b>renal stones</b>}} due to <u>increased</u> uric acid <b>{{c1::excretion}}</b></div></div>", "time": null}, {"id": 1496873123942, "note": "<div><div><u>Uricosurics</u> (<i>like </i><b style=\"font-style: italic; \">Probenecid</b>) are only for {{c1::under excretors::over producers / under excretors}} of uric acid</div></div>", "time": null}, {"id": 1496873297074, "note": "<div><div><i><u>Probenecid</u> </i>is a(n) {{c2::Sulfa}} drug and thus in susceptible patients can cause symptoms ranging from <i>Fever</i> to <i>UTI</i> to <i>Stevens Johnson Syndrome</i></div></div>", "time": null}, {"id": 1497058728715, "note": "<div><b>Cladribine </b>is an antineoplastic <b>purine&nbsp;nucleoside analog</b> that prevents cell cycle progression at the <b>{{c2::S*}} phase</b></div>", "time": null}, {"id": 1497058899081, "note": "<div><div><b>Cladribine </b>is primarily indicated for {{c1::<b>Hairy Cell</b>}} <b>Leukemia</b> </div></div>", "time": null}, {"id": 1497059151626, "note": "<div><b>Cladribine</b> is activated primarily in {{c1::<b>lymphocytes</b>}}, and works by inhibiting the enzyme {{c2::<b>adenosine deaminase (ADA)</b>}}</div>", "time": null}, {"id": 1497060843469, "note": "<div>Can <b>Allopurinol</b> cause <b>sloughing of skin</b> at the <b>dermal-epidermal junction</b>? </div><div><div><br /></div><div>{{c1::Yes}}</div></div>", "time": null}, {"id": 1497061073470, "note": "<div><b>Xanthine Oxidase </b>inhibitors can be used for prophylaxis of {{c1::<b>Uric Acid</b>}} <b>stones</b></div>", "time": null}, {"id": 1497061915081, "note": "<div>The massive onset of hyperuricemia in <b>Tumor Lysis Syndrome</b> can lead to {{c1::acute renal failure}}  </div>", "time": 1660105359114.0}, {"id": 1497062011770, "note": "<div><div><b>Azathioprine/6MP</b> are metabolized by the enzyme {{c1::xanthine oxidase}}, thus inhibitors of that enzyme can boost serum levels of these drugs</div></div>", "time": null}, {"id": 1497066613995, "note": "<div><b>6-mercaptopurine </b>is bioactivated into its <u>active metabolites</u> via the enzyme {{c1::HGPRT}}</div>", "time": null}, {"id": 1497067317568, "note": "<div><div>Cells generate <b>purines</b> for cell growth through either {{c1::<b><i>de novo</i></b>}} production or through the {{c2::<b>salvage</b>}} pathway</div></div>", "time": null}, {"id": 1496110237401, "note": "<div><b>Bleomycin </b>acts as an antineoplastic by inducing <b>{{c1::single and double strand breaks}}</b> in DNA </div>", "time": null}, {"id": 1497103900248, "note": "<div><div>Because {{c1::<b>Lymphocytes</b>}} are a cell population that proliferate rapidly, <u>Azathioprine / 6MP</u> work especially well for the treatment of {{c1::<b>Lymphocyte</b>}} mediated inflammatory diseases</div></div>", "time": null}, {"id": 1497104700095, "note": "<div><div><b>Azathioprine / 6MP</b> can cause {{c1::Hepatitis}}, thus must monitor <b><u>liver</u></b> function tests</div></div>", "time": null}, {"id": 1497106587707, "note": "<div><b>Sulfasalazine</b> can cause a <b>hemolytic anemia </b>in patients with {{c1::<b>G6PD</b>}} <b>deficiency</b></div>", "time": null}, {"id": 1497107684861, "note": "<div><b>Mesalamine </b>(<u>5ASA</u>) works by inhibiting the synthesis of proinflammatory <b>{{c1::eicosanoids}}</b> and <b>{{c2::cytokines}}</b></div>", "time": null}, {"id": 1497190430173, "note": "<div><div><b>{{c1::Mycophenolate Mofetil}}</b> inhibits the enzyme <b>Inosine Monophosphate Dehydrogenase (IMP dehydrogenase)</b></div></div>", "time": null}, {"id": 1497192238111, "note": "<div><b>Immunosuppressants&nbsp;</b>are frequently used for suppression of {{c1::cellular}} immunity to help prevent acute {{c2::transplant rejection}}</div>", "time": null}, {"id": 1497194200908, "note": "<div><b>5-Fluorouracil (5FU) </b>is an cytotoxic {{c2::<b>pyrimidine</b>}} <b>analog</b> that prevents cell cycle progression at the {{c1::<b>S</b>}} <b>phase</b></div>", "time": null}, {"id": 1497194465060, "note": "<div>Upon <u>bioactivation</u>, <b>5FU</b> (<i>now</i> <i>5-FdUMP</i><u>)</u><b> </b>covalently complexes with {{c1::<b>thymidylate synthase</b>}} and {{c3::<b>folic acid</b>}}, reducing {{c2::<b>DNA</b>}} synthesis</div>", "time": null}, {"id": 1497194736626, "note": "<div>When injected intravenously, <b>5FU</b> can be used to treat {{c1::<b>colon</b>}} <b>cancer </b>and {{c2::<b>pancreatic</b>}} <b>cancer</b></div>", "time": null}, {"id": 1497195019610, "note": "<div>The effects of <b>5FU </b>can be <b>potentiated</b> with {{c1::<b>Leucovorin</b>}}</div>", "time": null}, {"id": 1497195076845, "note": "<div>As a topical cream, <b>5FU</b> can be used to treat {{c1::<b>basal cell</b>}} <b>carcinoma</b></div>", "time": null}, {"id": 1497195266866, "note": "<div>Patients taking <b>5FU</b> <u>intravenously</u> can experience {{c1::Hand-Foot::skin}} syndrome</div>", "time": null}, {"id": 1497195404174, "note": "<div>Patients taking <b>5FU</b> as a <u>topical cream</u> can have complications of {{c1::<b>hyperpigmentation</b>}} and {{c2::<b>photosensitivity</b>}}</div>", "time": null}, {"id": 1497195561019, "note": "<div><b>Hydroxyurea</b> can also be used to treat <b>malignant {{c1::melanoma}}</b></div>", "time": null}, {"id": 1497195651522, "note": "Because the highly proliferative cell population at the bone marrow is very dependent on <b>DNA</b> synthesis, all antimetabolites (ex <u>MTX, 5FU, Hydroxyurea</u>) can cause {{c1::<b>myelo</b>suppression}}", "time": null}, {"id": 1497195751879, "note": "<div><b>{{c3::Methotrexate}}</b> is a(n)&nbsp;<b>{{c2::folic acid}}</b> analogue that blocks <u>pyrimidine synthesis</u> by competitively inhibiting <b>{{c1::dihydrofolate reductase}}</b></div>", "time": null}, {"id": 1497196077139, "note": "<div>If taken during pregnancy, <u>Methotrexate</u> can cause {{c1::<b>neural tube</b>}} <b>defects</b>, most commonly <b>{{c2::spina bifida}}</b> or <b>{{c3::anencephaly}}</b></div>", "time": null}, {"id": 1497196361185, "note": "<div>If&nbsp;<i style=\"\">\u03b2</i><i>-hCG </i>levels are still high after a <u>D&amp;C</u> of a molar pregnancy, the remaining&nbsp;<b>Hydatidiform mole </b>can be treated with {{c1::<b>methotrexate</b>}}</div>", "time": null}, {"id": 1497196451810, "note": "<div><u>Methotrexate</u> can cause {{c1::<b>pulmonary fibrosis</b>}}, resulting in restrictive lung disease</div>", "time": null}, {"id": 1497196510573, "note": "<div><b>Methotrexate </b>can cause a(n) {{c1::<b>folate / Vitamin B9</b>::<b>vitamin</b>}}&nbsp;deficiency</div>", "time": null}, {"id": 1497197031696, "note": "<div>Since <b>methotrexate</b> is a(n) {{c2::<b>weak acid</b>}}, a <b>methotrexate</b> overdose can be treated with {{c1::<b>Bicarbonate</b>}} in order to {{c1::<b>alkalinize</b>}} urine</div>", "time": null}, {"id": 1497197274253, "note": "<div>Treatment of <b>Polymyositis / Dermatomyositis</b> involves {{c2::<b>corticosteroids</b>}} followed by long-term {{c1::<b>methotrexate</b>}} therapy</div>", "time": null}, {"id": 1497197397389, "note": "<div><b>Methotrexate </b>can be used as a <u>disease modifying agent</u> in the treatment of {{c1::Lymphocyte::cell type}} mediated disorders </div>", "time": null}, {"id": 1497197449113, "note": "<div><b>Choriocarcinomas </b>and <b>Trophoblastic Tumors</b> can be treated with {{c1::<b>Methotrexate</b>}}</div>", "time": null}, {"id": 1497197625933, "note": "<div>As an <b>antineoplastic, Methotrexate</b> is primarily indicated for cancers of <u>lymphocytes</u>, particularly {{c1::<b>leukemias</b>}} and {{c2::<b>lymphomas</b>}}</div>", "time": null}, {"id": 1497197748300, "note": "<div>During pregnancy, <b>Methotrexate </b>can be used as a(n) {{c1::<b>abortifacent</b>}} (<i>with Misoprostol</i>) as well as in the treatment of {{c2::<b>ectopic pregnancy</b>}}</div><div><br></div>", "time": null}, {"id": 1497197947379, "note": "<div>Because <b>methotrexate</b> affects all rapidly dividing cells, this can affect the oral mucosa resulting in a(n) {{c1::<b>mucositis</b>}}</div>", "time": null}, {"id": 1497198087623, "note": "<div><u>Myelosuppression</u> induced by <b>Methotrexate</b> / <u>overdose</u> can be reserved using the drug {{c1::<b>Leucovorin</b>}}</div>", "time": null}, {"id": 1497198981442, "note": "<div><b>Etanercept</b> is used primarily for the treatment of {{c1::<b>Rheumatoid</b>}} <b>Arthritis</b></div>", "time": null}, {"id": 1497199116233, "note": "<div><div><b>Etanercept </b>works by complexing with TNF-a and inducing <b>{{c1::phagocytosis}} </b>of the complex</div></div>", "time": null}, {"id": 1497199647386, "note": "<div><b>Cyclosporine </b>can cause <i><u>arthropathy</u></i> by causing <b>hyper</b>{{c1::<b>uricemia</b>}} </div><div><br /></div>", "time": null}, {"id": 1497199809850, "note": "<div><b>{{c1::Cyclosporine}} </b>and {{c2::<b>antithymocyte globulin</b>}}<b> </b>can be used in the immunosuppressive treatment of immune mediated <b>Aplastic Anemia</b></div>", "time": null}, {"id": 1497199947288, "note": "<div><div><b>Cyclosporine</b> can cause a(n) {{c1::<b>Type 4</b>}}<b> Renal Tubular Acidosis</b></div></div><div><b><br /></b></div>", "time": null}, {"id": 1497200014755, "note": "<div><b>Tacrolimus </b>can cause a(n) {{c1::<b>hyper</b>}}<b>glycemia</b></div>", "time": null}, {"id": 1497200095459, "note": "<div><div><b>Azathioprine</b> can cause {{c1::<b>pancreatitis</b>}} resulting in elevated <b>amylase </b>and <b>lipase</b> levels</div></div>", "time": null}, {"id": 1497200296622, "note": "<div>Important to its use as an antineoplastic, <b>Azathioprine / 6MP </b>prevent cell cycle progression at {{c1::<b>S</b>}} phase</div>", "time": null}, {"id": 1497200375971, "note": "<div><b>Azathioprine/6MP </b>are used to <u>wean</u> patients off of {{c1::<b>corticosteroids</b>}} in the treatment of chronic inflammatory diseases</div>", "time": null}, {"id": 1497200675738, "note": "<div><div><b>Azathioprine/6MP </b>are used to treat chronic inflammatory diseases that are refractory to {{c1::<b>corticosteroids</b>}}</div></div>", "time": null}, {"id": 1497202218758, "note": "<div>Athletes with <b>polycythemia </b>should be tested for {{c1::exogenous <b>erythropoetin</b>}} injection</div>", "time": null}, {"id": 1497202892232, "note": "<div>Recombinant <b>IFN-\u03b2</b> can be used to treat {{c1::<b>Multiple Sclerosis</b>}} (<i>Type IV HS disease</i><b>)</b></div>", "time": null}, {"id": 1497203002753, "note": "<div><div><b>Interferons </b>stimulate <u>antitumor activity</u><b> </b>by activating {{c1::<b>Natural Killer</b>}} <b>Cells</b></div></div>", "time": null}, {"id": 1497203185934, "note": "<div><b>Rituximab</b> is indicated for {{c1::<b>immune thrombocytopenic</b>}} <b>purpura</b></div>", "time": null}, {"id": 1497203886624, "note": "<div>In the treatment of Multiple Sclerosis<b>, Natalizumab</b> works by preventing extravasation of autoreactive <b>{{c1::CD8+::CD4 or CD8?}} T Cells</b></div>", "time": null}, {"id": 1497205206181, "note": "<div>Because <b>Abciximab</b> is a monoclonal antibody that binds <u>platelets</u>, patients can develop side effects of {{c1::<b>bleeding</b>}} and {{c1::<b>thrombocyto</b>}}<b>penia</b></div>", "time": null}, {"id": 1497205397644, "note": "<div><b>Palivizumab&nbsp;</b>is indicated for <u>RSV prophylaxis</u> in high-risk infants, and works by binding RSV {{c2::<b>Fusion</b>}} protein</div>", "time": null}, {"id": 1497205776676, "note": "<div>In treating patients with <u>RSV</u>, <b>{{c2::Ribavirin}} </b>is preferred in adults, whereas <b>{{c1::palivizumab}} </b>is perferred in children</div>", "time": null}, {"id": 1497205982738, "note": "<div><u>PCSK9</u> Inhibitors ({{c1::<b>alirocumab</b>}} and {{c1::<b>evolocumab</b>}}) work by inactivating <b>{{c2::LDL}}-receptor degradation</b><b>, </b>resulting in a dramatic decrease in <b>{{c2::LDL</b>}}</div>", "time": null}, {"id": 1497209375497, "note": "<div><b>Tumor Lysis Syndrome</b> results from the <i>fulminant</i> release of tumor cell contents into the plasma, resulting in the following problems</div><div><br /><div>- {{c1::<b>Hyper</b>}}<b>kalemia</b></div><div>- {{c2::<b>Hyper</b>}}<b>phosphatemia</b></div><div>- {{c3::<b>Hypo</b>}}<b>calcemia</b> </div><div>- {{c4::<b>hyper</b>}}<b>uricemia</b> due to increased {{c4::<b>nucleic</b>}} acid breakdown</div></div>", "time": null}, {"id": 1497210532542, "note": "<b><div></div></b><div><u>Tumor Lysis Syndrome</u> can be prevented / treated with <b>aggressive </b>{{c1::<b>hydration</b>}}<b>, {{c2::xanthine oxidase}} inhibitors</b><b>, </b>or<b> </b><b>{{c3::rasburicase}}</b></div>", "time": null}, {"id": 1497212066546, "note": "<div>Recombinant <b>IFN-y</b> can be used to treat {{c1::<b>Chronic Granulomatous Disease</b>}}</div>", "time": null}, {"id": 1497306717842, "note": "<div><div><u>Enzyme Replacement Therapy</u> for {{c1::<b>Fabry Disease</b>}} requires replacement of {{c2::<b>alpha-galactosidase A</b>}}</div></div>", "time": null}, {"id": 1497306842176, "note": "<div><!--anki--><div><div><u>Enzyme Replacement Therapy</u> for {{c1::<b>Gaucher</b>}} disease requires replacement of <u>IV</u> {{c2::<b>Glucocerebrosidase</b>}}</div></div></div>", "time": null}, {"id": 1497307004297, "note": "<!--anki--><div><div><u>Enzyme Replacement Therapy</u> for {{c1::<b>Hurler Syndrome</b>}} requires replacement of {{c2::<b>alpha-L-iduronidase</b>}}</div></div>", "time": null}, {"id": 1497307127909, "note": "<div><div><u>Enzyme Replacement Therapy</u> for {{c1::<b>Hunter Syndrome</b>}} requires replacement of {{c2::<b>Iduronate Sulfatase</b>}}</div></div>", "time": null}, {"id": 1497307205371, "note": "<div><div><u>Enzyme Replacement Therapy</u> for {{c1::<b>Pompe</b>}} disease requires replacement of {{c2::<b>alpha-1,4-glucosidase </b><i>(aka acid maltase)</i>}}</div></div>", "time": null}, {"id": 1497309558948, "note": "<div><b>Colchicine</b> works by inhibiting intracellular {{c1::<b>microtubule</b>}} polymerization through binding and stabilizing {{c1::<b>tubulin</b>}}</div><div><br /></div>", "time": null}, {"id": 1497310034167, "note": "<div>By interfering with <i>tubulin</i> function, <b>Colchicine</b> disrupts the {{c2::<u>cytoskeleton</u>::cellular element}} of <b>{{c1::neutrophils}}</b></div><div><br /></div>", "time": null}, {"id": 1497310570418, "note": "<div><b>Colchicine</b> is primarily used for treatment of diseases that involve dysfunction of {{c1::<b>neutrophils</b>}}</div>", "time": null}, {"id": 1497310670150, "note": "<div><b>Colchicine</b> can irritate the GI tract, resulting in {{c1::<b>diarrhea</b>}}</div><div><br /></div>", "time": null}, {"id": 1497366822289, "note": "<div><div><u>Phosphoribosyl Pyrophosphate (PRPP)</u> is a precursor to {{c1::<b>IMP</b>}}</div></div>", "time": null}, {"id": 1497366871349, "note": "<div><div><b>IMP</b> is an intermediate <b>purine</b>&nbsp;nucleotide precursor to {{c1::<b>AMP</b>}} and {{c1::<b>GMP</b>}}</div></div>", "time": null}, {"id": 1497367283882, "note": "<div><div>Patients taking <b>Azathioprine / 6MP</b> are predisposed to reactivation of {{c1::<b>Herpes Zoster</b>}} or exacerbation of chronic viral {{c2::<b>Hepatitis</b>}}</div></div>", "time": null}, {"id": 1497369123409, "note": "<div><div>Because <b>Cladribine, Cytarabine, Gemcitabine</b> all target immune cells, this can cause patients to be at an <u>increased</u> risk for {{c1::<b>infection</b>}}</div></div>", "time": null}, {"id": 1497369809745, "note": "<div><b>Gemcitabine </b>is active against hematologic malignancies and {{c1::<b>solid</b>}} <b>tumors</b></div>", "time": null}, {"id": 1497370604817, "note": "<div>The suffix of anthracyclines is {{c1::-<b>rubicin</b>}}</div>", "time": null}, {"id": 1497371447076, "note": "{{c1::T-tubules}} are extensions of plasma membrane found in {{c2::striated}} muscle", "time": 1660105338781.0}, {"id": 1497371660910, "note": "T-tubules allow for {{c1::coordinated}} contraction of muscles", "time": 1660105350615.0}, {"id": 1497371691198, "note": "A(n)&nbsp;{{c1::triad}} is a structure found in {{c2::skeletal}} muscle which contains 1 {{c3::T-tubule}} with 2 {{c3::terminal cisternae}}", "time": 1660105362382.0}, {"id": 1497371847593, "note": "A(n)&nbsp;{{c1::dyad}} is a structure found in {{c2::cardiac}} muscle which contains 1 {{c3::T-tubule}} with 1 {{c3::terminal cisterna}}", "time": 1660105362414.0}, {"id": 1497372323184, "note": "<div>An {{c1::<b>IL-12 Receptor</b>}} <b>Deficiency </b>may present after administration of the <b>BCG vaccine</b></div>", "time": null}, {"id": 1497371909985, "note": "<div><div>The first step of muscle contraction occurs when the {{c1::somatic motor}} neuron depolarizes, opens {{c2::Ca<sup>2+</sup>}} channels and {{c3::<b>ACh}}</b> is released into the motor end plate</div></div>", "time": null}, {"id": 1497373274959, "note": "The second step of muscle contraction occurs after {{c1::ACh}} has been released by the motor neuron and binds to {{c2::nicotinic cholinergic}} receptors, depolarizing the {{c3::muscle}} cell", "time": null}, {"id": 1497374236198, "note": "In muscle contraction, after the muscle cell is depolarized, the action potential travels down the {{c1::T-tubule}} and to the {{c2::dihydropyridine receptor::long name}}", "time": null}, {"id": 1497374410076, "note": "Once a(n) {{c1::conformational}} change is induced in the {{c2::dihydropyridine receptor::long name}}, it opens the {{c3::ryanodine receptor}} which releases {{c4::Ca<sup>2+</sup>}}", "time": null}, {"id": 1497374547981, "note": "After the {{c1::<b>ryanodine</b>}} receptor is opened, the Ca<sup>2+</sup> that is released binds to {{c2::<b>troponin C</b>}}. This induces a conformational change that moves {{c3::<b>tropomyosin</b>}} out of the myosin-binding groove on {{c4::<b>actin</b>}} filaments, allowing {{c5::actin-myosin}} binding", "time": null}, {"id": 1497374668330, "note": "In muscle contraction, the {{c1::power stroke}} occurs when myosin binds to actin after releasing P<sub>i</sub>", "time": null}, {"id": 1497375563385, "note": "During muscle contraction:<div>- the {{c1::H}} and {{c1::I}} bands, and distance between Z bands, are shortened</div><div>- the {{c2::A}} band remains the same length</div>", "time": null}, {"id": 1497375666132, "note": "After the power stroke in muscle contraction, binding of a new {{c1::ATP}} molecule causes {{c2::detachment}} of the {{c3::myosin head}} from the actin filament", "time": null}, {"id": 1497375793588, "note": "After myosin binds a new ATP molecule in muscle contraction, hydrolysis of the new ATP molecule to ADP allows the myosin head to adopt a(n) {{c1::high-energy, \"cocked\"}} position, ready for a new contraction cycle", "time": null}, {"id": 1497375956453, "note": "Type {{c1::I}} muscle fibers are also known as <u>slow twitch</u> muscle fibers", "time": null}, {"id": 1497375984494, "note": "<u>Slow twitch</u> muscle fibers are {{c1::red::color}} due to {{c2::increased}} myoglobin concentration", "time": 1660105350940.0}, {"id": 1497376022921, "note": "<div><u>Fast twitch</u> muscle fibers are {{c1::white::color}} due to {{c2::decreased}} myoglobin concentration</div>", "time": 1660105359323.0}, {"id": 1497376040736, "note": "<b>Slow twitch</b> muscle fibers perform <u>more</u> {{c1::oxidative phosphorylation}} due to increased {{c2::mitochondria}}", "time": 1660105350938.0}, {"id": 1497376071663, "note": "<b>Fast twitch</b> muscle fibers perform <u>less</u> {{c1::oxidative phosphorylation}} due to decreased {{c2::mitochondria}}", "time": 1660105359321.0}, {"id": 1497376103826, "note": "Type {{c1::II}} muscle fibers are also known as <u>fast twitch</u> muscle fibers", "time": null}, {"id": 1497376126592, "note": "<b>Type {{c1::I}} </b>muscle fibers are increased in proportion after <u>endurance training</u>", "time": null}, {"id": 1497376183041, "note": "Type {{c1::II}} muscle fibers are increased in proportion after <u>weight/resistance training</u> and <u>sprinting</u>", "time": null}, {"id": 1497372723105, "note": "<div>Chronic PTH stimulates Osteoblasts to upregulate {{c1::<b>RANKL</b>}}</div><div><br /></div>", "time": null}, {"id": 1497376209411, "note": "{{c1::<b>Acetylcholine</b>}} and {{c2::<b>bradykinin</b>}} are stimuli for {{c3::<u>NO</u>}} production in endothelial cells", "time": null}, {"id": 1497378092823, "note": "{{c1::NO}} is synthesized from {{c2::L-arginine}} via {{c3::NO synthase}}", "time": null}, {"id": 1497378148913, "note": "{{c4::Ca<sup>2+</sup>}} enters smooth muscle cells via {{c3::L}}-type {{c4::Ca<sup>2+</sup>}} channels and binds to {{c1::<u>calmodulin</u>}}, leading to smooth muscle {{c2::contraction}}", "time": 1660105336983.0}, {"id": 1497378335881, "note": "NO upregulates {{c1::guanylyl cyclase}}, which converts GTP to cGMP", "time": null}, {"id": 1497378395390, "note": "cGMP stimulates {{c1::myosin-light-chain <b>phosphatase</b>}}, which {{c2::dephosphorylates}} myosin and {{c2::relaxes}} smooth muscle", "time": null}, {"id": 1497378477763, "note": "The Ca<sup>2+</sup>-calmodulin complex upregulates {{c1::myosin-light-chain <b>kinase</b>}}, which {{c2::phosphorylates}} myosin and {{c2::contracts}} smooth muscle", "time": null}, {"id": 1497378575778, "note": "Bones of the {{c1::axial}} skeleton, {{c2::appendicular}} skeleton, and {{c3::base of the skull}} are formed via {{c4::<b>endochondral}} ossification</b>", "time": null}, {"id": 1497378642558, "note": "In {{c1::endochondral}} ossification, a(n) {{c2::hyaline cartilage::specific}} model is first made by chondrocytes", "time": 1660105356368.0}, {"id": 1497378692922, "note": "In {{c1::endochondral}} ossification, osteoblasts and osteoclasts replace cartilage with a matrix of {{c2::woven}} bone and then remodel to {{c3::lamellar}} bone", "time": 1660105356366.0}, {"id": 1497378883453, "note": "In adults, woven bone is seen {{c1::after fractures}} and in {{c2::Paget disease}}", "time": null}, {"id": 1497378912089, "note": "{{c1::Endochondral}} ossification is defective in {{c2::achondroplasia}}", "time": null}, {"id": 1497378973098, "note": "Bones of the {{c2::calvarium}}, {{c3::facial bones}}, and {{c4::clavicle}} are formed via {{c1::membranous}} ossification", "time": null}, {"id": 1497379005837, "note": "In {{c3::membranous}} ossification, {{c1::woven}} bone is formed <b>{{c4::directly, without cartilage::how?}}</b>. It is then later remodeled to {{c2::lamellar}} bone", "time": 1660105356199.0}, {"id": 1497379168285, "note": "Osteo-{{c1::blasts}} build bone by secreting {{c2::collagen}}, and catalyze {{c3::mineralization}} via secretion of {{c4::ALP}}", "time": null}, {"id": 1497379370911, "note": "Osteo-{{c3::blasts}} differentiate from {{c1::mesenchymal stem}} cells in the {{c2::periosteum}}", "time": null}, {"id": 1497379444722, "note": "Osteoblastic activity is measured by: {{c1::ALP}}, {{c2::osteocalcin}}, and {{c3::propeptides of type I procollagen}}", "time": 1660105354528.0}, {"id": 1497379531634, "note": "Osteo-{{c1::clasts}} dissolve bone by secreting {{c2::H<sup>+</sup>}} and {{c3::collagenases}}", "time": 1660105354537.0}, {"id": 1497379561184, "note": "Osteo-{{c1::clasts}} differentiate from a fusion of {{c2::monocyte/macrophage lineage precursors}}", "time": null}, {"id": 1497379643141, "note": "At {{c1::low, intermittent}} levels, {{c2::PTH}} exerts {{c3::anabolic}} effects on osteoblasts and osteoclasts", "time": 1660105361474.0}, {"id": 1497379783371, "note": "When chronically {{c1::elevated}}, {{c2::PTH}} has {{c3::catabolic}} effects on bone, known as {{c4::osteitis fibrosa cystica}}", "time": null}, {"id": 1497379834486, "note": "{{c1::Estrogens::hormone}} {{c2::inhibit}} apoptosis in osteoblasts and {{c2::induce}} apoptosis in osteoclasts", "time": null}, {"id": 1497379898641, "note": "Estrogens (hormone) cause {{c2::closure}} of the epiphyseal growth plate (bone structure) during {{c1::puberty}}", "time": null}, {"id": 1497379939080, "note": "Estrogen deficiency leads to increased cycling of {{c2::bone remodeling and resorption}}, increasing risk of {{c1::osteoporosis}}", "time": null}, {"id": 1497381706399, "note": "<div><b>Rituximab</b> is indicated for disorders of {{c1::<b>B</b>}} lymphocytes </div>", "time": null}, {"id": 1497381915590, "note": "<!--anki--><div><b>Rituximab</b> is associated with a <u>rapidly fatal</u> neuropathology known as <b>Progressive Multifocal Leukoencephalopathy</b>&nbsp;due to reactivation of the {{c2::<b>JC</b>}} virus</div>", "time": null}, {"id": 1497382264588, "note": "<div>In patients with cardiovascular disease history, <b>Bevacizumab</b> is contraindicated due to the increased risk of {{c1::<b>Thrombotic</b>}} events</div>", "time": null}, {"id": 1497383292545, "note": "<div><b>Dihydrofolate Reductase</b> converts {{c1::<b>DHF</b>}} to {{c1::<b>THF</b>}}</div><div><br /></div>", "time": null}, {"id": 1497383561163, "note": "<div><b>Thymidylate Synthase</b> is an enzyme that catalyzes the <u>methylation</u> of {{c1::<b>dUMP</b>}}<b> </b>to <b>{{c1::dTMP}},</b> utilizing the methyl group from a(n) {{c2::<b>methylated-THF</b>}} </div>", "time": null}, {"id": 1497383843374, "note": "<div>The main importance of the cofactor <b>THF (Tetrahydrofolate)</b> is that it can be given a(n) {{c1::methyl}} group for use in {{c1::methyl}}ation reactions</div>", "time": null}, {"id": 1497383992830, "note": "<div>Inhibiting <u>Dihydrofolate Reductase</u> results in increased levels of {{c1::<b>DHF</b>}}</div>", "time": null}, {"id": 1497384216002, "note": "<div>Besides&nbsp;<u>Thymidine</u> production, <b>THF</b> is also involved in the formation of {{c1::<b>purine nucleosides</b>}}, as well as some {{c2::<b>amino acids</b>}} </div><div><br></div>", "time": null}, {"id": 1497384375909, "note": "<div><div>Antimetabolites (<b>Methotrexate, 5FU, Hydroxyurea</b>) blocks the progression of {{c1::<b>S</b>}} phase</div></div>", "time": null}, {"id": 1497384877982, "note": "<div>As <b>methotrexate</b> affects all rapidly dividing cells, this can affect a patients <i>scalp</i> and cause {{c1::<b>alopecia</b>}}</div>", "time": null}, {"id": 1497385088901, "note": "<div>As a result of inhibition of <u>Thymidylate Synthase</u>, there are increased levels of {{c1::<b>dUMP</b>}}</div>", "time": null}, {"id": 1497385527399, "note": "<div>As a result of <b>5FU </b>targeting <i>rapidly</i> dividing cells, it can affect the <u>gut mucosa</u> resulting in {{c1::<b>diarrhea</b>}}</div>", "time": null}, {"id": 1497385631398, "note": "<div><span style=\"font-weight: 800;\">Ribonucleotide reductase </span>is used to convert<span style=\"font-weight: normal;\"> {{c1::<b>UDP</b>}} to {{c1::<b>dUDP</b>}}</span></div>", "time": null}, {"id": 1497385969520, "note": "<div><b>Etanercept</b> is contraindicated in patients with an allergy to {{c1::<b>sulfa</b>}} <b>drugs</b></div>", "time": null}, {"id": 1497494664062, "note": "<div>Because antimetabolites (<b><i>methotrexate, 5FU, Hydroxyurea</i></b>) suppress the <u>immune system</u>, patients taking these are at an increased risk of {{c1::<b>infection</b>}}</div>", "time": null}, {"id": 1497494695202, "note": "<div><b>Methotrexate</b> can cause {{c1::<b>hepatotoxicity</b>}}, which results in increased <u>ALT and AST</u> levels</div>", "time": null}, {"id": 1497495357753, "note": "<div><div><b>Anthracyclines </b>act as antineoplastics by producing {{c1::<b>free radicals</b>}} and causing <b>DNA {{c2::intercalation}}</b></div></div>", "time": null}, {"id": 1499356681125, "note": "<div><u>Alprostadil</u> is used to maintain a(n)&nbsp;<b>{{c1::Patent Ductus Arteriosus}} </b>in the setting of certain types of<i> congenital</i> heart disease</div>", "time": null}, {"id": 1499356681150, "note": "<div>{{c1::<b>COX-1</b>}} and {{c1::<b>COX-2</b>}} are enzymes that produce prostanoids (e.g. <u>prostaglandins</u>) </div>", "time": null}, {"id": 1499356681173, "note": "<div>If <u>neonatal ductus arteriosus</u> is not closing properly, this can be treated with {{c1::<b>Indomethacin</b>}}</div>", "time": null}, {"id": 1499356681269, "note": "<div><b>Alprostadil</b> and&nbsp;<b>Misoprostol&nbsp;</b>are analogues of {{c1::PGE<sub>1</sub>}}</div>", "time": null}, {"id": 1499356681293, "note": "<div><b>Misoprostol</b> can be used to prevent <u>NSAID</u>-induced {{c1::peptic ulcers}}</div>", "time": null}, {"id": 1499356681316, "note": "<div><div>Because <b>PGE1</b> is involved in <i>physiological</i> responses of the <u>gut mucosa</u> and the <u>uterine smooth muscle</u>, <b>Misoprostol</b> can cause {{c1::<b>diarrhea</b>}} as well as uterine {{c2::<b>contractions</b>}}</div></div>", "time": null}, {"id": 1499356681339, "note": "<div><b>Misoprostol</b> can be clinically used to treat <u>gastric ulcers</u> as at {{c2::<u><b>high</b></u>}} doses it inhibits <b><u>secretion</u></b>&nbsp;of <u>gastric acid</u></div>", "time": null}, {"id": 1499356681362, "note": "<div><b>Misoprostol</b> is a <i>PGE1</i> mimic which can be used to promote {{c2::<b>uterine</b>}} <b>contraction </b>for the purpose of <b>terminating pregnancy</b></div>", "time": null}, {"id": 1499356681385, "note": "<div><b>{{c2::Sildenafil}}</b> and <b>{{c2::tadalafil}}</b> are examples of {{c1::<b>PDE-5</b>}} inhibitors</div>", "time": null}, {"id": 1499356681502, "note": "<div><b>PDE-5</b> inhibitors work by <b>preventing breakdown of </b>{{c1::<b>cGMP</b>}} to produce prolonged {{c2::<b>smooth muscle</b>}} relaxation</div>", "time": null}, {"id": 1499356681525, "note": "<div><b>Iloprost</b> and <b>Epoprostenol</b> are {{c1::<b>prostacyclin (PGI2)</b>}} analogues that can be used to treat {{c2::<b>Pulmonary Hypertension</b>}} </div>", "time": null}, {"id": 1499356681548, "note": "<div>{{c1::<b>Bosentan</b>}} is an agent used to treat pulmonary hypertension that works by blocking the&nbsp;<b>{{c2::Endothelin-1 (ET-1)}} receptor</b></div>", "time": null}, {"id": 1499358257645, "note": "<div>PDE-5 inhibitors (e.g. <b>sildenafil</b>, <b>tadalafil</b>) are indicated for {{c1::<b>Erectile Dysfunction</b>}}<b> </b>by way of increasing blood flow in the {{c2::<b>corpus cavernosum</b>}} of the penis<br></div>", "time": null}, {"id": 1499358446751, "note": "<div>PDE-5 inhibitors (e.g. <b>sildenafil</b>, <b>tadalafil</b>) are indicated for {{c1::<b>pulmonary</b>}} <b>hypertension</b></div>", "time": null}, {"id": 1500229455013, "note": "<div><div>Pharmacology: Cholestatic Drugs</div></div><div><br></div><div>The rate limiting step of bile acid synthesis is done via {{c1::cholesterol 7a-hydroxylase}}</div>", "time": null}, {"id": 1500230234909, "note": "<div><div>Pharmacology: Cholestatic Drugs</div></div><div><br /></div><div>In patients with <b>Cystic Fibrosis, </b><i>Ursodiol</i> can be used to treat {{c1::<b>biliary stasis</b>}} </div>", "time": null}, {"id": 1500763927138, "note": "<div><b style=\"font-weight: bold; \">Hydrogen peroxide</b> works via a(n) {{c1::free radical oxidation}} mechanism</div>", "time": null}, {"id": 1501511684746, "note": "<div>What type of <u>hypersensitivity reaction</u> is <b>Pernicious anemia</b>? </div><div><br></div><div>{{c1::Type II HSR}}</div>", "time": null}, {"id": 1501555295479, "note": "<div><b>Colchicine</b> is indicated for {{c1::pericarditis}}, a condition that manifests with positional sharp chest pain</div>", "time": null}, {"id": 1502086858589, "note": "<div><div><b>Ivabradine</b> is indicated for <b>chronic</b> {{c1::<b>stable angina</b>}} in patients who cannot take {{c2::<b>\u03b2-blockers</b>}}<br></div><b></b></div><b></b>", "time": null}, {"id": 1502086944102, "note": "<div><b>Ivabradine</b> is indicated for <b>chronic</b> {{c1::<b>Heart Failure</b>}} with {{c2::<b>reduced</b>}} ejection fraction<br></div>", "time": null}, {"id": 1502086979437, "note": "<div><b>{{c2::Ivabradine}}</b> works by inhibiting the {{c1::funny sodium (I<sub>f</sub>)}} channels, prolonging phase {{c1::4}} of the nodal action potential<br></div>", "time": null}, {"id": 1502087058246, "note": "<div>What does<b> Ivabradine </b>do to:<br></div><div><br></div><div>Chronotropy = {{c1::Negative Effect}}</div><div>Inotropy = {{c1::No effect}}</div>", "time": null}, {"id": 1502087136496, "note": "<div>What does<b> Ivabradine </b>do to MvO2?<br></div><div><br></div><div>{{c1::Decrease}}</div>", "time": null}, {"id": 1502087323174, "note": "<div><b>Ivabradine</b> can manifest visual side effects of {{c1::luminous phenomena}}<br></div>", "time": null}, {"id": 1502087343188, "note": "<div><b>Ivabradine</b> is contraindicated in {{c1::sick sinus syndrome::rhythm problem}}<br></div>", "time": null}, {"id": 1502087562746, "note": "<div><b>Ivabradine </b>can cause cardiac side effects of {{c1::bradycardia}} and {{c2::hypertension}}<br></div>", "time": null}, {"id": 1502301024958, "note": "<div><b>Mirabegron</b> is a sympathomimetic that {{c1::<b>stimulates</b>}} {{c2::<b>\u03b23</b>}} receptors<br></div>", "time": null}, {"id": 1502301446592, "note": "<div>At the <u>bladder</u>, stimulation of <b>\u03b23 receptors</b> results in {{c1::bladder relaxation}}<br></div>", "time": null}, {"id": 1502301498513, "note": "<div>In the <u>skeletal muscle</u>, stimulation of&nbsp;<b>\u03b2</b><b>3 receptors</b> results in {{c1::increased thermogenesis}}<br></div>", "time": null}, {"id": 1502301522582, "note": "<div>In <u>fat</u>, stimulation of&nbsp;<b>\u03b2</b><b>3 receptors</b> results in {{c1::increased lipolysis}}<br></div>", "time": null}, {"id": 1502301670964, "note": "<div>{{c4::<b>Midodrine</b>}} is a(n) {{c3::\u03b11}} agonist indicated for {{c2::postural hypotension}} and {{c1::autonomic insufficiency}}<br></div>", "time": null}, {"id": 1502301735723, "note": "<div><b>Midodrine </b>may exacerbate {{c1::supine}} hypertension<br></div>", "time": null}, {"id": 1502302124791, "note": "<div><b>Guanfacine </b>is a(n) {{c2::alpha-2}} agonist that acts analogous to {{c2::<b>Clonidine</b>}}<br></div>", "time": null}, {"id": 1502302298317, "note": "<div><b>Guanfacine </b>differs from Clonidine in that it is {{c1::metabolized::metabolized or not metabolized?}} by cytochrome p450<br></div>", "time": null}, {"id": 1502302569404, "note": "<div><b>Guanfacine </b>is {{c1::more::more/less}} effective than Clonidine in the treatment of ADHD<br></div>", "time": null}, {"id": 1502303951839, "note": "<div><b>Fomepizole</b> is used as an antidote for overdoses of {{c2::<b>methanol</b>}} or {{c1::<b>ethylene glycol</b>}}</div>", "time": null}, {"id": 1502304299735, "note": "<div><b>Fomepizole </b>works as an antidote for <u>methanol/ethylene glycol</u> poisoning by <b>inhibiting</b> {{c1::Alcohol Dehydrogenase}}</div>", "time": null}, {"id": 1502305079611, "note": "<div><b>Disulfiram </b>is used to discourage {{c1::<b>alcohol</b>}} consumption</div>", "time": null}, {"id": 1502306084477, "note": "<div><i></i><div><u><i>Methemoglobinemia</i></u> can be treated by {{c1::<b>methylene blue</b>}} and {{c2::<b>vitamin C</b>}}</div></div>", "time": null}, {"id": 1502306590401, "note": "<div><b>Methylene Blue </b>works for the treatment of <u>methemoglobinemia</u> by {{c1::reducing Fe3+ to Fe2+}}</div>", "time": null}, {"id": 1502344726854, "note": "<div>The main advantage <b>pregabalin </b>has over gabapentin is that it is {{c1::more::more/less?}} bioavailable</div>", "time": null}, {"id": 1502407946079, "note": "<div><b>Dornase Alfa</b> is an aerolized medication used in the treatment of <i><u>Cystic Fibrosis</u></i> that is a recombinant {{c1::DNase I}}</div>", "time": null}, {"id": 1502408261996, "note": "<div><b>Dornase Alfa</b> works by cleaving {{c1::<b>DNA</b>}} present in the mucus of <u>Cystic Fibrosis</u> patients thus <b>reducing the </b>{{c2::<b>viscosity</b>}} of lung secretions</div>", "time": null}, {"id": 1502409162952, "note": "<div>In the treatment of <u>Cystic Fibrosis</u>, <b>Azithromycin</b> is used as a(n) {{c1::anti-inflammatory}} agent</div>", "time": null}, {"id": 1502409507103, "note": "<div>In the treatment of <u>Cystic Fibrosis</u>, <b>Creon (pancrelipase)</b> is a mix of {{c1::pancreatic}} enzymes used to restore {{c1::pancreatic}} function</div>", "time": null}, {"id": 1502409605020, "note": "<div>In the treatment of <u>Cystic Fibrosis</u>, the combination drug {{c1::<b>lumacaftor/ivacaftor</b>}} is indicated for patients who have {{c2::<b>two</b>}} copies of the F508del mutation in the CFTR gene</div>", "time": null}, {"id": 1502409764224, "note": "<div>In the treatment of <u>Cystic Fibrosis</u>, <b>{{c2::Lumacaftor}}</b> works by {{c1::facilitating proper folding}} of the CFTR protein</div>", "time": null}, {"id": 1502409864610, "note": "<div>In the treatment of <u>Cystic Fibrosis</u>, <b>{{c2::Ivacaftor}}</b> works by {{c1::stimulating activity}} of the CFTR protein</div>", "time": null}, {"id": 1502410275869, "note": "<div><b>Saline</b> is a solution of {{c1::sodium chloride}}</div>", "time": null}, {"id": 1502411653744, "note": "<div>In treating SIADH, {{c1::<b>hyper</b>}}tonic saline is given when treating a patient with severe symptoms, and {{c1::<b>iso</b>}}tonic saline is given for mild symptoms </div>", "time": null}, {"id": 1502412510405, "note": "<div>{{c2::<b>Iso</b>}}<b>tonic</b> Saline can cause a(n) {{c1::<b>normal</b>}} anion gap metabolic acidosis</div>", "time": null}, {"id": 1502413141027, "note": "<div>In the treatment of <i><u>hypovolemic</u></i> or <i><u>distributive</u></i> shock, IV {{c1::<b>iso</b>}}tonic saline or {{c1::<b>ringers lactate</b>}} is indicated, but only in {{c2::<b>distributive shock</b>}} <u>pressors</u> are indicated</div>", "time": null}, {"id": 1502414496794, "note": "<div>In the treatment of <u><i>Diabetic Ketoacidosis</i></u> and <u><i>Hyperosmolar Hyperglycemia State</i></u>, aggressive {{c1::iso}}tonic saline fluids are indicated</div>", "time": null}, {"id": 1512516717343, "note": "<div>What is the likely&nbsp;<i>diagnosis</i>&nbsp;in a&nbsp;<u>chronic smoker</u>&nbsp;that develops&nbsp;<b>hypertension</b>,&nbsp;<b>hyperglycemia</b>, and&nbsp;<b>weight gain</b>?<div><br></div><div>{{c1::Cushings syndrome (likely ectopic production of&nbsp;<b>ACTH</b>&nbsp;due to small cell lung carcinoma)}}</div></div><div></div>", "time": 1660105350928.0}, {"id": 1514419633547, "note": "<b>Polymixin B, Bacitracin</b>, and <b>Neomycin</b> are used as a <u>triple</u> antibiotic combination used to treat {{c1::superficial skin}} infections", "time": null}, {"id": 1514420605938, "note": "The suffix {{c1::-<b>penem</b>}} is associated with the <b>Carbapenem</b> class of <u>antimicrobials</u>", "time": null}, {"id": 1514420887416, "note": "<b>Carbapenems</b> are {{c2::<b>broad</b>::broad or narrow}}-spectrum <i>last resort </i>antibiotics useful for bacteria that are <i>resistant</i> against {{c1::<b>\u03b2-lactam drugs</b>}}", "time": null}, {"id": 1514421809620, "note": "<b>Carbapenems</b> are associated with <u>significant</u> side effects, including <b>{{c3::GI distress}}</b>, {{c2::<b>skin rash</b>}}, and {{c1::<b>seizures*</b>}}", "time": null}, {"id": 1514422215928, "note": "Most <u>Carbapenems</u> are <b>very</b> useful against <i>Pseudomonas aeruginosa</i>, except {{c1::<b>Ertapenem</b>}} which has <i>limited coverage</i>", "time": null}, {"id": 1514422659811, "note": "<b>Aztreonam</b>, a&nbsp;<u>\u03b2-lactam</u> based <b>monobactam</b>, prevents cross-linking by binding to <b>{{c1::Penicillin-binding protein 3}}</b>", "time": null}, {"id": 1514423519338, "note": "Does Aztreonam have any <b>cross-allergenicity</b> with <u>penicillins</u>?<div><br /></div><div>{{c1::No}}</div>", "time": null}, {"id": 1514423999681, "note": "Which <u>anti-microbial class</u> is Aztreonam particularly <b>synergistic</b> with?<div><br /></div><div>{{c1::<b>Aminoglycosides</b>}}</div>", "time": null}, {"id": 1514424401527, "note": "<b>Aztreonam</b> is used only for {{c1::Gram negative Rods::gram stain and shape}}", "time": null}, {"id": 1514424617556, "note": "<b>Carbapenems</b> work by by binding bacterial {{c1::transpeptidases}}, inhibiting cell wall synthesis", "time": null}, {"id": 1514425801856, "note": "<b>Vancomycin</b> is antibacterial that is indicated for <u>multi-drug resistant</u> Gram-{{c1::positive}} bugs <u>only</u>", "time": null}, {"id": 1514426162645, "note": "<b>Vancomycin</b> inhibits cell wall synthesis by binding the {{c1::<b>D-ala-D-ala</b>}} portion of cell wall precursors, thus preventing {{c2::<u>transpeptidation</u>}} ", "time": null}, {"id": 1514426584201, "note": "<div>Resistance to <b>Vancomycin</b> is encoded via modifying the bacterias<b> D-Ala-D-Ala</b> subunit to {{c1::D-ala-D-lac}}</div>", "time": null}, {"id": 1514427712564, "note": "<b>Vancomycin</b> is especially suitable for <u>Clostridioides difficile</u> infections when it is prescribed {{c1::orally::IV or Orally?}}", "time": null}, {"id": 1514430258982, "note": "<b>Vancomycin</b> causes <u>Red Man Syndrome</u> due to stimulating release of {{c1::Histamine}}", "time": null}, {"id": 1514430526440, "note": "The following drugs are what class of <u>antimicrobial</u>?<div><br></div><div>{{c1::\u03b2-Lactamase Inhibitors}}</div><div><br></div><div><img src=\"paste-256096014958593.jpg\"></div>", "time": null}, {"id": 1514430905153, "note": "Which group of modified Penicillins does <b>NOT </b>need to be prescribed with&nbsp;\u03b2-lactamase (<b style=\"text-decoration: underline; \">penicillinase</b>) inhibitors?<div><br></div><div>{{c1::Right::Left or Right?}}</div><div><br></div><div><img src=\"paste-257058087632897.jpg\"></div>", "time": null}, {"id": 1514431283782, "note": "Which group of modified penicillins is especially useful for <b>Pseudomonas</b> and <b>Gram Negative Rods </b>(<i>ex. Bacteroides</i>)?<div><br /></div><div>{{c1::Piperacillin, Ticarcillin}}</div><div><br /></div><div><img src=\"paste-279937378418689.jpg\" /></div>", "time": null}, {"id": 1514431666907, "note": "<div>Which group of modified penicillins is associated with <b>Hypersensitivity reactions</b>?</div><div><br /></div><div>{{c1::All :)}}</div><div><br /></div><div><img src=\"paste-279933083451393.jpg\" /></div>", "time": null}, {"id": 1514431768534, "note": "<div>Which group of <u>modified penicillins</u> is <i>especially</i> associated with<b> Acute</b> <b>Interstitial Nephritis (AIN)?</b></div><div><br /></div><div>{{c1::Dicloxacillin, Nafcillin, Oxacillin}}</div><div><br /></div><div><img src=\"paste-279933083451393.jpg\" /></div>", "time": null}, {"id": 1514432045338, "note": "<div>Which group of <u>modified penicillins</u> is associated with the following <b>rash</b>? </div><div><br></div><div>{{c1::Amoxicillin, Ampicillin, Aminopenicillins}}<br></div><div><img src=\"paste-290189465354241.jpg\"></div><div><br></div><div><img src=\"paste-279933083451393.jpg\"></div>", "time": null}, {"id": 1514432711133, "note": "<div>What infection when <i>mistakenly </i>treated with <b>Amoxicillin / Ampicillin</b> will very frequently manifest a <b>maculopapular / morbilliform rash?</b></div><div><br></div><div>{{c1::Infectious Mononucleosis (EBV infection)}}</div>", "time": null}, {"id": 1514433076091, "note": "Which has greater <u>oral</u> bioavailability?<div><br /></div><div>{{c1::Amoxicillin::Ampicillin OR Amoxicillin?}}</div>", "time": null}, {"id": 1514433987345, "note": "To remember the coverage of <b>Amoxicillin, Ampicillin, </b>and <b>Aminopenicillins</b>, use the mnemonic<font color=\"#aa0000\">: <i>Am-cillin <b>HHELPSS</b> kill <b>enterococci</b></i></font><div style=\"centerbox\"><div class=\"mnemonics\"><div><b><br></b></div><div><i><b><font color=\"#aa0000\">H</font></b></i>{{c7::<i>aemophilus influenzae</i>}}</div><div><i><b><font color=\"#aa0000\">H</font></b></i>{{c6::<i>elicobacter pylori</i>}}</div><div><i><b><font color=\"#aa0000\">E</font></b></i>{{c5::<i>scherchia coli</i>}}</div><div><i><b><font color=\"#aa0000\">L</font></b>{{c4::isteria monocytogenes}}</i></div><div><i><b><font color=\"#aa0000\">P</font></b>{{c3::roteus mirabilis}}</i></div><div><i><b><font color=\"#aa0000\">S</font></b>{{c2::almonella spp.}}</i></div><div><i><b><font color=\"#aa0000\">S</font></b>{{c1::higella spp.}}</i></div></div></div>", "time": null}, {"id": 1514434693948, "note": "The <b>benzathine</b> forms of <u>Pencillin V/G</u> make them {{c1::long}}-acting", "time": null}, {"id": 1514434849844, "note": "<b>Penicillins </b>and their derivatives are {{c2::<u>D-ala-D-ala</u>}} structural analogs which bind and inhibit {{c1::<b>transpeptidases</b>}} ", "time": null}, {"id": 1514435402463, "note": "Does inhibition of transpeptidases <u>directly</u> kill bacteria?<div><br /></div><div>{{c1::No}} </div>", "time": null}, {"id": 1514436096099, "note": "Which <u>Penicillinase-resistant penicillin</u> is commonly used to treat <b>Staph Aureus</b>?<div><br />{{c1::Nafcillin}}</div>", "time": null}, {"id": 1514436260830, "note": "<b>Penicillin V/G</b> are mostly used for Gram-{{c1::Positive}} organisms", "time": null}, {"id": 1514436347961, "note": "Besides <i>Gram + organisms</i>, <u>Penicillin V/G</u> are used to treat {{c1::<b>Neisseria meningitidis</b>::Gram Negative organism}} and {{c2::<b>Treponema pallidum</b>::Spirochete organism}}", "time": null}, {"id": 1514436496585, "note": "<div>Pregnant patients with a <i>positive</i> culture of what microbe receive&nbsp;<u>intrapartum</u> penicillin&nbsp;<b>prophylaxis</b>?</div><div><br></div><div>{{c1::Streptococcus agalactiae}}</div>", "time": null}, {"id": 1514436919577, "note": "<div>Patients who have been exposed to what <i>STD</i> should be given&nbsp;<b>prophylactic</b> <u>Benzathine Penicillin G</u></div><div><u><br></u></div><div>{{c1::Treponema pallidum}}</div>", "time": null}, {"id": 1514437403760, "note": "<i>Children</i> who have been previously been exposed to <u>what bacterial complication</u>&nbsp;and are now manifesting with <b>oropharyngeal symptoms </b>should be given <b>prophylaxis</b> with <u>Penicillin G or V</u>?<div><br></div><div>{{c1::Rheumatic Fever}}</div>", "time": null}, {"id": 1514437669394, "note": "If a patient taking <u>penicillin</u> manifests with <i>nausea</i>, <i>hives</i>, or <i>wheezing</i>, and the following <i>rash</i>, they are demonstrating what side effect?<br /><div><br /></div><div>{{c1::Type I Hypersensitivity}}</div><div><br /></div><div><img src=\"paste-335153477976065.jpg\" /></div>", "time": null}, {"id": 1514438709754, "note": "If a patient taking <u>penicillin</u> manifests with <i>mild fever</i>, <i>myalgia or</i> <i>arthralagias</i>, and the following <i>rash</i>, they are demonstrating what side effect?<br /><div><br /></div><div>{{c1::Hypersensitivity Vasculitis (Cutaneous Small Vessel Vasculitis)}}</div><div><br /></div><div><img src=\"paste-335965226795009.jpg\" /></div>", "time": null}, {"id": 1514439095781, "note": "Patients taking <u>Penicillin G/V</u> can develop a(n) {{c1::<b>hemolytic</b>}} anemia ", "time": null}, {"id": 1514439182774, "note": "Is the <b>hemolytic</b> <b>anemia</b> caused by penicillin G/V <u>coombs</u> <b>positive</b> or <b>negative</b>?<div><br /></div><div>{{c1::Coombs positive}}</div>", "time": null}, {"id": 1514439774614, "note": "<div>Between patients taking <b>Ampicillin </b>and <b>Amoxicillin</b>, which group has a higher risk of developing a <u>Pseudomembranous Colitis</u>?</div><div><br /></div><div>{{c1::Ampicillin}}</div>", "time": null}, {"id": 1514440129037, "note": "In patients receiving <u>Triple Therapy</u> for H Pylori that have an <b>amoxicillin</b> allergy, what drug should replace it?<div><br /></div><div>{{c1::Metronidazole}}</div>", "time": null}, {"id": 1514440460727, "note": "In <u>pregnant women and children</u> who have been infected with <b>Borrelia</b> <b>Burgdorferi</b>, they should receive {{c1::amoxicillin}} and {{c1::cefuroxime}}", "time": null}, {"id": 1514440546690, "note": "<b>Penicillins</b> {{c1::are NOT::are or are not}} indicated with <i>Mycoplasma pneumoniae</i>", "time": null}, {"id": 1514440711339, "note": "Are penicillins <u>bactericidal</u> or <u>bacteriostatic</u>?<div><br /></div><div>{{c1::Bactericidal}}</div>", "time": null}, {"id": 1514440791493, "note": "In patients with <b>streptococcal infections</b> who are allergic to <i>penicillin</i>, they should be given what class of <u>antibiotics</u> instead?<div><br /></div><div>{{c1::Macrolides}}</div>", "time": null}, {"id": 1514440977413, "note": "Patients who are <b>high</b> risk for <u>endocarditis</u> and are undergoing<u> surgical or dental procedures</u> should be given {{c1::Amoxicillin}} prophylaxis", "time": null}, {"id": 1514441153062, "note": "Can <b>penicillins / derivatives</b> cause <b>sloughing of skin</b> at the <b>dermal-epidermal junction</b>? <div><br /></div><div>{{c1::Yes}}</div>", "time": null}, {"id": 1514441376218, "note": "What <u>gout drug</u> can precipitate the side effects of <b>penicillins</b>?<div><br /></div><div>{{c1::Probenecid}}</div>", "time": null}, {"id": 1514441738287, "note": "What structural feature of <b>Penicillins</b> give them their activity?<div><br></div><div>{{c1::B-lactam ring}}</div>", "time": null}, {"id": 1514442928641, "note": "Which generation of <u>Cephalosporins</u> are <b>Cefazolin </b>and<b> Cephalexin?</b><div><b><br /></b></div><div><b>{{c1::1st Generation}}</b></div>", "time": null}, {"id": 1514443210018, "note": "<div>To prevent <i>post-surgical</i> <b>wound infections</b> by <u>Staph aureus</u>, what <b>Cephalosporin</b> is indicated?</div><div><br /></div><div>{{c1::Cefazolin}}</div>", "time": null}, {"id": 1514443273175, "note": "<div>Which generation of <u>Cephalosporins</u> are <b>Cefaclor,</b> <b>Cefoxetin</b>, <b>Cefuroxime?</b><div><br></div><div>{{c1::2nd Generation}}</div></div>", "time": null}, {"id": 1514443647682, "note": "All generations of <b>Cephalosporins</b> can be used for <u>Gram-</u>{{c1::<u>positive cocci</u>::stain and shape}}", "time": null}, {"id": 1514443819523, "note": "<i>Non-gram + cocci </i>coverage of <u>2nd generation Cephalosporins</u> includes 1st generation (<b><i><font color=\"#aa0000\">PEcK</font></i></b>) as well as <b><font color=\"#aa0000\">HENS</font></b><div><b><br></b></div><div><i>- <font color=\"#aa0000\"><b>H</b></font>{{c1::aemophilus influenzae}}</i></div><div><i></i><i>- <font color=\"#aa0000\"><b>E</b></font>{{c2::nterobacter aerogenes}}</i></div><div><i>- <b><font color=\"#aa0000\">N</font></b></i>{{c3::<i>eisseria spp.</i>}}</div><div><i>- <b><font color=\"#aa0000\">S</font></b>{{c4::erratia marscescens}}</i></div>", "time": null}, {"id": 1514444587887, "note": "<b>3rd generation cephalosporins</b> are used for <u>meningitis</u> vs other generations of cephalosporins due to their ability to {{c1::cross the Blood Brain Barrier}}", "time": null}, {"id": 1514445508453, "note": "Which generation of <u>Cephalosporins</u> is <b>Cefepime</b><b>?</b><div><b><br /></b></div><div><b>{{c1::4th Generation}}</b></div>", "time": null}, {"id": 1514445573219, "note": "<b>Cefepime</b> is primarily used to treat <u>multiple drug resistant</u> <i>{{c1::Pseudomonas aeruginosa}}</i>", "time": null}, {"id": 1514445882123, "note": "Which generation of <u>Cephalosporins</u> is <b>Ceftaroline</b><b>?</b><div><b><br /></b></div><div><b>{{c1::5th Generation}}</b></div>", "time": null}, {"id": 1514446686718, "note": "Can <b>Cephalosporins</b> cause the same hypersensitivity reactions as <u>Penicillin V/G</u>?<div><br /></div><div>{{c1::Yes}}</div>", "time": null}, {"id": 1514447214681, "note": "<b>Cephalosporins</b> are associated with a(n) {{c1::<u>Disulfiram like</u>}} reaction", "time": null}, {"id": 1514447541492, "note": "<b>Cephalosporins</b> can cause a Vitamin {{c1::K}} deficiency", "time": null}, {"id": 1514447747690, "note": "Which step (<font color=\"#aa0000\"><b>[A] - [E]</b></font>) of Bacterial Protein Synthesis does <b>Chloramphenicol</b> inhibit?<div><br /></div><div><b>{{c1::</b><b><font color=\"#aa0000\">[C]</font></b>}}</div><div><br /><div><img src=\"paste-668301206224897.jpg\" /></div></div>", "time": null}, {"id": 1514450415516, "note": "<b>Nitrofurantoin</b> is used to treat patients who have <u>UTIs</u> and are currently {{c1::<b>pregnant</b>}}", "time": null}, {"id": 1514450530846, "note": "<b>Nitrofurantoin</b> is contraindicated in patients with a deficiency of the enzyme {{c1::<b>Glucose-6-Phosphate Dehydrogenase</b>}}", "time": null}, {"id": 1514450756049, "note": "<b>Metronidazole</b> is used to treat <u>anaerobic</u> infections <b>{{c1::below}}</b> the diaphragm", "time": null}, {"id": 1514450844855, "note": "The <b>important</b> coverage of <u>Metronidazole</u> can be remembered with the mnemonic: \"<i><font color=\"#aa0000\"><b>GET GAP</b> </font>on the <b><font color=\"#aa0000\">Metro</font></b> with <b><font color=\"#aa0000\">metro</font></b>nidazole</i>\"<div style=\"centerbox\"><div class=\"mnemonics\"><div><br/></div><div>- <b><font color=\"#aa0000\">G</font></b><i>{{c1::iardia lamblia}}</i></div><div>- <b><font color=\"#aa0000\">E</font></b><i>{{c2::ntamoeba histolytica}}</i></div><div>- <b><font color=\"#aa0000\">T</font></b><i>{{c3::richomonas vaginalis}}</i></div><div><br/></div><div>- <b><font color=\"#aa0000\">G</font></b><i>{{c4::ardnerella vaginalis}}</i></div><div>- <b><font color=\"#aa0000\">A</font></b><i>{{c5::naerobes}}</i></div><div>- {{c6::<i>Helicobacter</i>}} <b><font color=\"#aa0000\">P</font></b><i>{{c6::ylori triple therapy replacement}}</i></div></div></div>", "time": null}, {"id": 1514451291382, "note": "Patients taking <b>Metronidazole</b> can report side effects of <u>headache</u> as well as a(n) {{c1::metallic}} taste", "time": null}, {"id": 1514451796998, "note": "Which step (<font color=\"#aa0000\"><b>[A] - [F]</b></font>) of Fungal homeostasis do <b>Echinocandins</b> impact?<div><br /><div><b>{{c1::<font color=\"#aa0000\">[A]</font>}}</b></div><div><br /></div><div><img src=\"paste-4587025072129.jpg\" /></div></div>", "time": null}, {"id": 1514452140645, "note": "<div>Which step (<font color=\"#aa0000\"><b>[A] - [E]</b></font>) of the HIV life cycle does <b>Maraviroc</b> target?<div><br><div><b>{{c1::<font color=\"#aa0000\">[A]</font>}}</b></div></div></div><div><br></div><div><img src=\"paste-45157286150145.jpg\"></div>", "time": null}, {"id": 1514452792616, "note": "Which step (<font color=\"#aa0000\"><b>[A] - [D]</b></font>) of the viral life cycle does <b>Oseltamivir </b>and <b>Zanamivir</b> target?<div><br></div><div><div><b>{{c1::</b><b><font color=\"#aa0000\">[D]</font>}}</b></div><div><b></b><b><br></b></div><div><img src=\"paste-26190710571009.jpg\"></div></div>", "time": null}, {"id": 1514456914237, "note": "Which step (<font color=\"#aa0000\"><b>[A] - [E]</b></font>) of Bacterial Protein Synthesis do <b>Aminoglycosides</b> inhibit?<div><br /></div><div>{{c1::<b><font color=\"#aa0000\">[B]</font></b>}}</div><div><br /><div><img src=\"paste-668301206224897.jpg\" /></div></div>", "time": null}, {"id": 1514457054810, "note": "What class of antimicrobials are the following drugs?<div><br /></div><div>{{c1::Aminoglycosides}}</div><div><br /></div><div><img src=\"paste-243743689015297.jpg\" /></div>", "time": null}, {"id": 1514457179721, "note": "Are <b>aminoglycosides</b> bactericidal or bacteriostatic?<div><br /></div><div>{{c1::Bactericidal}} </div>", "time": null}, {"id": 1514457221062, "note": "Can <b>aminoglycosides</b> be used for both <u>aerobic</u> and <u>anaerobic</u> infections?<div><br /></div><div>{{c1::No}}</div>", "time": null}, {"id": 1514457306321, "note": "Besides inhibiting the formation of the initiation complex, <b>Aminoglycosides</b> can damage protein synthesis by causing {{c1::<b>misreading</b>}} of mRNA", "time": null}, {"id": 1514457672217, "note": "<u>Aminoglycosides</u> are primarily indicated for <b>severe</b> Gram-{{c1::Negative Rod::Stain and Shape?}} infections", "time": null}, {"id": 1514457851724, "note": "<u>Paromomycin</u> is used as a luminal agent against {{c1::parasites}} of the GI tract", "time": null}, {"id": 1514457925286, "note": "Aminoglycosides are <b>synergistic</b> with&nbsp;\u03b2-lactams and Vancomycin since they increase {{c1::cell wall permeability}}", "time": null}, {"id": 1514458114358, "note": "Are <u>aminoglycosides</u> absorbed effectively from the alimentary / GI tract?<div><br /></div><div>{{c1::No}} </div>", "time": null}, {"id": 1514458257172, "note": "Resistance to <b>Aminoglycosides</b> is encoded by bacterial {{c1::transferase}} enzymes", "time": null}, {"id": 1514458295721, "note": "<u>Aminoglycosides</u> cause <b>nephrotoxicity</b> by damaging the {{c1::proximal convoluted tubule}}", "time": null}, {"id": 1514458460580, "note": "<u>Aminoglycosides</u> can impact the neuromuscular junction, blocking {{c1::post::pre or post?}} synaptic {{c1:: Nm}} receptors", "time": null}, {"id": 1514458682574, "note": "Patients taking <b>aminoglycosides</b> can present with <u>vertigo</u>,&nbsp;<u>ataxia</u>, and <u>nausea</u>  due to damage to the {{c1::vestibulocochlear apparatus}}", "time": null}, {"id": 1514458860048, "note": "Patients are at much greater risk of developing <u>ototoxicity</u> while taking <b>Aminoglycosides</b> if they are used with a(n) {{c1::Loop Diuretic}}", "time": null}, {"id": 1514458901383, "note": "<b>Aminoglycosides</b> act as a <u>teratogen</u> by causing congenital {{c1::deafness}}", "time": null}, {"id": 1514459034165, "note": "Do bacterial ribosomal inhibitors affect the human ribosome (80S)? <div><br /></div><div>{{c1::No}}</div>", "time": null}, {"id": 1514461757411, "note": "Which step (<font color=\"#aa0000\"><b>[A] - [E]</b></font>) of Bacterial Protein Synthesis do <b>Tetracyclines</b> inhibit?<div><br></div><div>{{c1::<b><font color=\"#aa0000\">[E]</font></b>}}</div><div><br><div><img src=\"paste-668301206224897.jpg\"></div></div>", "time": null}, {"id": 1514461927723, "note": "Are <b>Tetracyclines</b> indicated for patients who are experiencing symptoms of Meningitis?<div><br></div><div>{{c1::No}}</div>", "time": null}, {"id": 1514462049753, "note": "<b>Doxycycline</b> is safe to use in patients with <u>renal failure</u> as it is {{c1::fecally}} eliminated", "time": null}, {"id": 1514462133220, "note": "Patients should not consume <u>Milk</u>, <u>Antacids</u>, or <u>Iron-containing preparations</u> with <b>Tetracyclines</b> as they prevent the drugs {{c1::absorption}}", "time": null}, {"id": 1514462275608, "note": "If a patient presents to you with <u>Lyme disease</u>, your first line drug is {{c1::Doxycycline}}", "time": null}, {"id": 1514462342356, "note": "<b>Tetracyclines</b> are used to treat what cause of <u>atypical pneumonia</u>?<div><br /></div><div>{{c1::Mycoplasma pneumoniae}}</div>", "time": null}, {"id": 1514462478138, "note": "<b>Doxycycline</b> and <b>Clindamycin </b>can be used as a treatment for what <u>infectious</u> <i>skin</i> condition<div><br /></div><div>{{c1::Acne vulgaris}}</div>", "time": null}, {"id": 1514462781191, "note": "Patients taking <b>Tetracyclines</b> can manifest symptoms of skin sensitivity to {{c1::light}} and {{c2::GI}} distress", "time": null}, {"id": 1514463121926, "note": "<b>Tetracyclines</b> are contraindicated in <u>pregnancy</u> and in <u>children</u> due to their ability to:<div>1) discolor / deposit in {{c1::teeth}}</div><div>2) inhibit {{c2::bone}} growth</div>", "time": null}, {"id": 1514463180331, "note": "<div>Resistance to <b>Tetracyclines</b> occurs in two primary ways</div><div><br /><div>1) Decreasing <b>{{c1::uptake}}</b></div><div>2) Increasing <b>{{c2::efflux}} </b></div></div>", "time": null}, {"id": 1514463267259, "note": "<b>Tigecycline</b> is a(n) {{c1::<b>tetracycline</b>}} derivative that is resistant to bacterial {{c2::<u>efflux pumps</u>}}", "time": null}, {"id": 1514463449579, "note": "<b>Tigecycline</b> is useful for infections that have {{c1::deep}} tissue penetration", "time": null}, {"id": 1514463629792, "note": "<b>Tigecycline</b> is primarily used for bacteria that are {{c1::multiple-drug resistant}}", "time": null}, {"id": 1514492150873, "note": "<b>Chloramphenicol</b> prevents <u>peptidyl bond formation</u> by inhibiting the enzyme {{c1::peptidyltransferase}}", "time": null}, {"id": 1514492742100, "note": "<b>Chloramphenicol</b> is <u>hepatically</u> metabolized by {{c1::UDP-glucuronyltransferase}}", "time": null}, {"id": 1514492832526, "note": "<b>Chloramphenicol</b> is primarily used to treat {{c2::<b>meningitis</b>}} and {{c1::<b>rocky mountain spotted</b>}} fever", "time": null}, {"id": 1514492916695, "note": "<b>Chloramphenicol</b> causes a dose-{{c1::dependent}} anemia and a dose-{{c1::<b>independent</b>}} aplastic-anemia", "time": null}, {"id": 1514493073982, "note": "<b>Chloramphenicol</b> is contraindicated in <u>infants</u> as they havent developed enough {{c1::UDP-glucuronyltransferase}}", "time": null}, {"id": 1514493401381, "note": "If <b>Chloramphenicol</b> levels build up in infants before liver enzymes have developed, this manifests with {{c1::Gray-Baby Syndrome}}", "time": null}, {"id": 1514493539465, "note": "<div>Resistance to <b>Chloramphenicol</b> is encoded via a <u>plasmid</u>-encoded {{c1::acetyltransferase}} enzyme</div>", "time": null}, {"id": 1514500997298, "note": "Which step (<font color=\"#aa0000\"><b>[A] - [E]</b></font>) of Bacterial Protein Synthesis does <b>Clindamycin</b> inhibit?<div><br /></div><div><b>{{c1::</b><b><font color=\"#aa0000\">[D]</font></b>}}</div><div><br /><div><img src=\"paste-668301206224897.jpg\" /></div></div>", "time": null}, {"id": 1514502587908, "note": "<div><b>Clindamycin</b> prevents <u>translocation</u> by binding the 50S ribosome and <u>sterically hindering</u> {{c1::peptidyl transfer}}</div>", "time": null}, {"id": 1514502725358, "note": "<b>Clindamycin</b> is used to treat <u>anaerobic</u> infections <b>{{c1::above}}</b> the diaphragm", "time": null}, {"id": 1514502973036, "note": "<b>Clindamycin</b> is effective against <u>invasive</u> <b>Group A Strep</b><i> </i>and <b>Staph Aureus </b>infection as it is a potent suppressor of the synthesis of their {{c1::<b>toxins</b>}} ", "time": null}, {"id": 1514503148965, "note": "<b>Clindamycin</b> can cause a mild self-limited {{c1::diarrhea}} and fever", "time": null}, {"id": 1514504167162, "note": "<b>Clindamycin </b>use can unintentionally cause an overgrowth of {{c1::Clostridioides difficile}}", "time": null}, {"id": 1514504342380, "note": "Which step (<font color=\"#aa0000\"><b>[A] - [E]</b></font>) of Bacterial Protein Synthesis does <b>Linezolid</b> inhibit?<div><br /></div><div><b>{{c1::<font color=\"#aa0000\">[</font></b><b><font color=\"#aa0000\">A]</font></b>}}</div><div><br /><div><img src=\"paste-668301206224897.jpg\" /></div></div>", "time": null}, {"id": 1514504704391, "note": "Is<b> Linezolid </b><u>bacteriostatic</u><b> </b>or<b> </b><u>bactericidal</u><b>?</b><div><b><br /></b></div><div>{{c1::Both :)}}</div>", "time": null}, {"id": 1514504777486, "note": "<b>Linezolid</b> is a drug of <u>last resort</u> used primarily for {{c1::<b>MRSA</b>}} and {{c2::<b>VRE</b>}}", "time": null}, {"id": 1514504854424, "note": "<b>Linezolid</b> can suppress the {{c1::bone marrow}}, often manifesting with thrombocytopenia", "time": null}, {"id": 1514504972100, "note": "<b>Linezolid</b> can cause a(n) {{c1::peripheral}} and {{c2::optic}} neuropathy ", "time": null}, {"id": 1514505123470, "note": "Use of <b>Linezolid</b> is contraindicated in patients taking drugs that<i> increase</i> {{c1::<b>seroto</b>}}-<b>nergic</b> transmission", "time": null}, {"id": 1514505673938, "note": "<div>Resistance to <b>Linezolid</b> is developed via a <u>point mutation</u> of {{c1::ribosomal RNA}}</div>", "time": null}, {"id": 1514505922565, "note": "Which step (<font color=\"#aa0000\"><b>[A] - [E]</b></font>) of Bacterial Protein Synthesis do <b>Macrolides</b> inhibit?<div><br /></div><div><b>{{c1::<font color=\"#aa0000\">[D</font></b><b><font color=\"#aa0000\">]</font></b>}}</div><div><br /><div><img src=\"paste-668301206224897.jpg\" /></div></div>", "time": null}, {"id": 1514506028657, "note": "<b>Macrolides</b> prevents <u>translocation</u> by binding the 50S ribosome and <u>sterically hindering</u> {{c1::peptidyl transfer}}", "time": null}, {"id": 1514506042798, "note": "What class of antimicrobials are the following drugs?<div><br /></div><div>{{c1::Macrolides}}</div><div><br /></div><div><img src=\"paste-225064876244993.jpg\" /></div>", "time": null}, {"id": 1514506682583, "note": "<b>Tetracyclines</b> are very effective against <i>Rickettsia</i> and<i> Chlamydophila</i> because these drugs {{c1::accumulate intracellularly}}", "time": null}, {"id": 1514506918332, "note": "What macrolide is used for Chlamydia (and thus for Chlamydia-Gonorrhea empirical therapy)?<div><br /></div><div>{{c1::Azithromycin}}</div>", "time": null}, {"id": 1514507424195, "note": "When treating Chlamydia Trachomatis, when would you use Azithromycin over Doxycycline?<div><br /></div><div>- Patients who are {{c1::pregnant}}<div>- Chlamydia Trachomatis serotypes {{c2::A-C (eye drop ointment)}}, {{c2::D-K (STI)}}</div></div>", "time": null}, {"id": 1514507708785, "note": "Prominent side effects of macrolides can be remembered with the mnemonic <b><font color=\"#aa0000\">MACRO</font>:</b><div style=\"centerbox\"><div class=\"mnemonics\"><div><b><br/></b><div><b>- <font color=\"#aa0000\">M</font></b>{{c1::otility issues of the GI tract}}</div><div>- <b><font color=\"#aa0000\">A</font></b>{{c2::rrhythmia\u00a0due to prolonged QT}}</div><div>- <b><font color=\"#aa0000\">C</font></b>{{c3::holestatic Hepatitis}}</div><div>- <b><font color=\"#aa0000\">R</font></b>{{c4::ash}}</div><div>- {{c5::e}}<b><font color=\"#aa0000\">O</font></b>{{c5::sinophilia}}</div></div></div></div>", "time": null}, {"id": 1514508220274, "note": "<b>Macrolides</b> cause <u>GI motility issues</u> as they agonize the {{c1::motilin}} receptor", "time": null}, {"id": 1514508361101, "note": "<b>Macrolides</b> are often used for {{c1::atypical}}-pneumonias", "time": null}, {"id": 1514508906862, "note": "<b>Macrolides</b> can be used to treat <u>Pertussis</u> as long as it is still in the {{c1::catarrhal}} phase", "time": null}, {"id": 1514509313238, "note": "<b>Azithromycin</b> can be used as an antiprotozoal in the treatment of {{c1::Babesiosis}}", "time": null}, {"id": 1514510079046, "note": "<b>Erythromycin</b> eye ointment is indicated as prophylaxis for {{c1::gonococcal}} conjunctivitis in the newborn", "time": null}, {"id": 1514510192071, "note": "Which of the following macrolides <u>inhibit</u> cytochrome p450 enzymes?<div><br /><div>{{c1::Clarithromycin, Erythromycin}}</div><div><br /></div><div><img src=\"paste-291688408940545.jpg\" /></div></div>", "time": null}, {"id": 1514511075948, "note": "<b>Erythromycin</b> is used off-label for the treatment of gastro-{{c1::paresis}}", "time": null}, {"id": 1514513195576, "note": "Which step (<font color=\"#aa0000\"><b>[A] - [E]</b></font>) of Bacterial Protein Synthesis does the <b>Quinupristin-Dalfopristin</b> (<i>Streptogramins</i>) combination inhibit?<div><br /></div><div><b>{{c1::<font color=\"#aa0000\">[C</font></b><b><font color=\"#aa0000\">]</font></b>}}</div><div><br /><div><img src=\"paste-668301206224897.jpg\" /></div></div>", "time": null}, {"id": 1514513787208, "note": "<b>Quinupristin / Dalfopristin</b> is used to treat vancomycin {{c1::resistant::sensitive or resistant}} enterococci", "time": null}, {"id": 1514514182817, "note": "Which Topoisomerases do Fluoroquinolones inhibit?<div><br /></div><div>{{c1::II and IV}}</div>", "time": null}, {"id": 1514514329720, "note": "<b>Fluoroquinolones</b> that are known as \"<u>Respiratory Fluoroquinolones</u>\" are known as such because they exhibit <b>enhanced</b> activity against {{c1::Strep pneumoniae}}", "time": null}, {"id": 1514515200640, "note": "<b>Fluoroquinolones</b> cannot be taken with {{c1::antacids}} as they inhibit the <u>absorption</u> of these drugs", "time": null}, {"id": 1514515544308, "note": "Are <b>Fluoroquinolones </b>bactericidal or bacteriostatic?<div><br /></div><div>{{c1::Bactericidal}}</div>", "time": null}, {"id": 1514515963174, "note": "<b>Fluoroquinolones</b> are indicated for treatment of<b> Otitis</b> <b>{{c1::Externa}}</b>", "time": null}, {"id": 1514516107224, "note": "Fluoroquinolones can be used for {{c1::atypical}}-pneumonias", "time": null}, {"id": 1514517938935, "note": "<b>Fluoroquinolones</b> are contraindicated in the following groups due to damage to {{c1::cartilage}}<div><br /><div>- pregnant women</div><div>- nursing mothers</div><div>- children &lt; 18 years old </div></div>", "time": null}, {"id": 1514518131379, "note": "<b>Fluoroquinolones</b> are contraindicated in the following groups due to damage to {{c1::tendons}}<div><br /><div>- people &gt; 60 years old</div><div>- patients taking prednisone</div></div>", "time": null}, {"id": 1514518208243, "note": "Some <b>Fluoroquinolones</b> can prolong the {{c1::QT}} interval", "time": null}, {"id": 1514518348409, "note": "Resistance to <b>Fluoroquinolones</b> is primarily encoded by chromosome-encoded mutations in {{c1::DNA Gyrase}}", "time": null}, {"id": 1514518646731, "note": "Which step (<font color=\"#aa0000\"><b>[A] - [F]</b></font>) of Bacterial Genetics do <b>Sulfonamides</b> impact?<div><br /><div><b>{{c1::<font color=\"#aa0000\">[A]</font>}}</b></div><div><br /></div><div><img src=\"paste-573073191337985.jpg\" /></div></div>", "time": null}, {"id": 1514518822228, "note": "<b>Sulfonamides</b> are <i>{{c2::competitive}}</i> inhibitors of the enzyme {{c1::<b>Dihydropteroate Synth</b><b>ase</b>}}", "time": null}, {"id": 1514518932937, "note": "<div><b>Sulfonamides </b>are contraindicated in patients with a deficiency of the enzyme {{c1::<b>Glucose-6-Phosphate Dehydrogenase</b>}}</div>", "time": null}, {"id": 1514519133165, "note": "<b>Sulfonamides</b> cause skin sensitivity to {{c1::light}}", "time": null}, {"id": 1514521800603, "note": "<i>Infants</i> who are taking <b>sulfonamides</b> are at risk for {{c1::Kernicterus}}", "time": null}, {"id": 1514521859322, "note": "Drugs that bind to {{c1::Albumin}} are displaced by Sulfonamides", "time": null}, {"id": 1514522018491, "note": "Resistance to <b>Sulfonamides</b> is primarily developed via a <u>mutation</u> of {{c1::bacterial dihydropteroate synthase}}", "time": null}, {"id": 1514522127441, "note": "Which step (<font color=\"#aa0000\"><b>[A] - [F]</b></font>) of Bacterial Genetics does <b>Trimethoprim</b> impact?<div><br /><div><b>{{c1::<font color=\"#aa0000\">[B]</font>}}</b></div><div><br /></div><div><img src=\"paste-573073191337985.jpg\" /></div></div>", "time": null}, {"id": 1514522324681, "note": "<b>Trimethoprim</b> inhibits the enzyme {{c1::<b>Dihydrofolate Reductase</b>}}", "time": null}, {"id": 1514522445038, "note": "<b>Sulfonamides </b>can cause a Type {{c1::IV}} Renal Tubular Acidosis", "time": null}, {"id": 1514522558258, "note": "<b>Trimethoprim</b> is often combined with {{c1::Sulfamethoxazole}}", "time": null}, {"id": 1514523193580, "note": "At less than CD4 count of <u><b>200</b></u> in <i>AIDS patients</i>, <b>TMP-SMX</b> is indicated for treatment of and prophylaxis for {{c1::Pneumocystis Jirovecii}}", "time": null}, {"id": 1514523406956, "note": "Because <b>Trimethoprim</b> blocks the reduction of <u>DHF Reductase</u>, it is associated with a(n) {{c1::<b>Megaloblastic</b>}} <b>anemia</b> and well as increased susceptibility to infections", "time": null}, {"id": 1514523695666, "note": "The bone marrow toxicity effects of <b>Trimethoprim</b> treatment may be avoided with coadminstration of {{c1::folinic acid}}", "time": null}, {"id": 1514523741386, "note": "<div>When taken during <u>early pregnancy</u>, <b>Trimethoprim</b> can cause the baby to develop {{c1::neural tube defects}}</div>", "time": null}, {"id": 1514569391561, "note": "<b>Rifampin</b> is used for close-contact prophylaxis of the following non-<u>mycobacterial</u> species<div><br /></div><div>1 - {{c1::Neisseria Meningitidis}}</div><div>2 - {{c2::Haemophilus Influenzae B}}</div>", "time": null}, {"id": 1514572172444, "note": "If a patient on <b>Isoniazid</b> develops <u>arthralgias</u> and a <u>rash</u>, you should suspect the patient has developed {{c1::Drug Induced Lupus}}", "time": null}, {"id": 1514572717164, "note": "Patients that <u>overdose</u> on <b>Isoniazid</b> can develop a(n) {{c1::high}} anion gap metabolic acidosis ", "time": null}, {"id": 1514574631336, "note": "Which step (<font color=\"#aa0000\"><b>[A] - [F]</b></font>) of Bacterial Genetics does <b>Dapsone</b> impact?<div><br><div><b>{{c1::<font color=\"#aa0000\">[A]</font>}}</b></div><div><br></div><div><img src=\"paste-573073191337985.jpg\" style=\"width: 800px;\"></div></div>", "time": null}, {"id": 1514574764466, "note": "<b>Dapsone</b> is used to treat Mycobacterium {{c1::<b>leprae</b>}}", "time": null}, {"id": 1514574918297, "note": "Which form of <u>Leprosy</u> is <b>Dapsone</b> used to treat? Lepromatous or Tuberculoid?<div><br /></div><div>{{c1::Both :)}}</div>", "time": null}, {"id": 1514575408582, "note": "<b>Dapsone</b> can be used for <u>prophylaxis</u> of {{c1::Pneumocystis Jirovecii}}", "time": null}, {"id": 1514575870809, "note": "<b>Clofazimine</b> is used to treat Mycobacterium {{c1::<b>leprae</b>}}", "time": null}, {"id": 1514575990602, "note": "Which form of <u>Leprosy</u> is <b>Clofazimine</b>&nbsp;used to treat? Lepromatous or Tuberculoid?<div><br></div><div>{{c1::Lepromatous)}}</div>", "time": null}, {"id": 1514576626207, "note": "<b>Echinocandins</b> inhibit <u>cell wall synthesis</u> by inhibiting synthesis of <b>{{c1::B-glucan}}</b>", "time": null}, {"id": 1514576673430, "note": "<b>Echinocandins</b> are primarily indicated for {{c1::invasive}} infections of <i>Aspergillosis</i> and <i>Candida</i>", "time": null}, {"id": 1514576736235, "note": "<b>Echinocandins</b> cause <u>flushing</u> and <u>GI upset</u> by stimulating {{c1::Histamine}} release", "time": null}, {"id": 1514577306242, "note": "What class of antimicrobials are the following drugs?<div><br /></div><div>{{c1::Echinocandins}}</div><div><br /></div><div><img src=\"paste-900809260793857.jpg\" /></div>", "time": null}, {"id": 1514577409259, "note": "Which step (<font color=\"#aa0000\"><b>[A] - [F]</b></font>) of Fungal homeostasis does <b>Flucytosine</b> impact?<div><br /><div><b>{{c1::<font color=\"#aa0000\">[C]</font>}}</b></div><div><br /></div><div><img src=\"paste-4587025072129.jpg\" /></div></div>", "time": null}, {"id": 1514577482891, "note": "<b>Flucytosine </b>is activated intracellularly to {{c1::<b>5-fluorouracil</b> (<b>5-FU</b>)}} by <u>cytosine deaminase</u>", "time": null}, {"id": 1514578318921, "note": "<b>Flucytosine</b> is given for {{c1::<b>systemic</b>}} fungal infections", "time": null}, {"id": 1514578395739, "note": "<b>Flucytosine</b> is primarily used for {{c1::cryptococcal}} meningitis", "time": null}, {"id": 1514578479296, "note": "<b>Flucytosine</b> has significant {{c1::bone marrow}} toxicity", "time": null}, {"id": 1514578565465, "note": "Which step (<font color=\"#aa0000\"><b>[A] - [F]</b></font>) of Fungal homeostasis do <b>Polyenes</b> impact?<div><br /><div><b>{{c1::<font color=\"#aa0000\">[B]</font>}}</b></div><div><br /></div><div><img src=\"paste-4587025072129.jpg\" /></div></div>", "time": null}, {"id": 1514578726359, "note": "What class of antimicrobials are the following drugs?<div><br /></div><div>{{c1::Polyenes}}</div><div><br /></div><div><img src=\"paste-935396632428545.jpg\" /></div>", "time": null}, {"id": 1514578761759, "note": "<b>Polyenes</b> disrupt cell membrane stability by binding {{c1::<br><img src=\"paste-940121096454145.jpg\">}}", "time": null}, {"id": 1514578874673, "note": "<b>Amphotericin B</b> is given for <u>serious</u> {{c1::<b>systemic</b>}} fungal infections", "time": null}, {"id": 1514578972476, "note": "When <b>Amphotericin B</b> is used for <u>Meningitis</u> it is given {{c1::intrathecally}}", "time": null}, {"id": 1514580145115, "note": "To decrease toxicity of amphotericin B, use a(n) {{c1::liposomal}} formulation and give with IV {{c2::normal saline}}", "time": null}, {"id": 1514580346966, "note": "<b>Amphotericin B</b> increases the renal tubule permeability, resulting in {{c1::K+}} and {{c2::Mg2+}} <u>wasting</u>", "time": null}, {"id": 1514580519023, "note": "Upon <b>{{c1::IV}}</b> infusion of <b>Amphotericin B</b>, patients can present with <u>fever and chills</u>, <u>hypotension</u>, and <u>headache</u>", "time": null}, {"id": 1514581115897, "note": "At the <u>infusion site</u> of the <b>IV</b>, Amphotericin B can cause a(n) {{c1::thrombophlebitis}}", "time": null}, {"id": 1514581268628, "note": "Upon <b>{{c1::Intrathecal}}</b> infusion of <b>Amphotericin B</b>, patients can present with <u>seizures</u> and <u>headache</u>", "time": null}, {"id": 1514581311427, "note": "<b>Amphotericin B</b> causes a <i>dose-dependent / slow-accumulated</i> <u>Type</u> {{c1::1}} <u>Renal Tubular Acidosis</u>", "time": null}, {"id": 1514581770673, "note": "<b>Amphotericin B</b> causes a <i>dose-dependent / slow-accumulated</i> <u>reversible </u>{{c1::<b>nephro</b>}}<b>toxicity</b>", "time": null}, {"id": 1514581913540, "note": "<b>Amphotericin B</b> suppresses renal {{c1::<b>EPO</b>}} synthesis", "time": null}, {"id": 1514582271830, "note": "Can <b>Nystatin </b>be given for systemic fungal infections?<div><br /></div><div>{{c1::No}}</div>", "time": null}, {"id": 1514582320489, "note": "<b>Nystatin</b> is used to treat non-systemic infections by {{c1::Candida albicans}}", "time": null}, {"id": 1514582716438, "note": "Which step (<font color=\"#aa0000\"><b>[A] - [F]</b></font>) of Fungal homeostasis does <b>Terbinafine</b> impact?<div><br /><div><b>{{c1::<font color=\"#aa0000\">[E]</font>}}</b></div></div><div><b><br /></b></div><div><b><img src=\"paste-4587025072129.jpg\" /></b></div>", "time": null}, {"id": 1514582953537, "note": "<b>Terbinafine</b> is mainly used to treat {{c1::dermatophytoses}}", "time": null}, {"id": 1514583111655, "note": "<b>Terbinafine </b>is associated with side effects of GI upset, headaches, hepatotoxicity, and {{c1::taste::type of sensation}} disturbance", "time": null}, {"id": 1514583362638, "note": "Which step (<font color=\"#aa0000\"><b>[A] - [F]</b></font>) of Fungal homeostasis do<b> Azoles</b> impact?<div><br /><div><b>{{c1::<font color=\"#aa0000\">[D]</font>}}</b></div></div><div><b><br /></b></div><div><b><img src=\"paste-4587025072129.jpg\" /></b></div>", "time": null}, {"id": 1514583416438, "note": "<b>Azoles </b>work by inhibiting {{c1::cytochrome P450}} enzymes in the Fungi", "time": null}, {"id": 1514583836151, "note": "Are <b>Azoles</b> used for <u>local</u> AND <u>systemic</u> fungal infections? <div><br></div><div>{{c1::Yes}}</div>", "time": null}, {"id": 1514584124803, "note": "{{c1::Flucon}}<b>azole</b> is used for:<div><br /><div>- chronic suppression of cryptococcal meningitis in AIDS patients</div><div>- candidal infections of all types</div></div>", "time": null}, {"id": 1514584175090, "note": "{{c1::<b>Itracon</b>}}<b>azole</b> is used for <u>systemic</u> infections with {{c2::<u>dimorphic</u>}} fungi ", "time": null}, {"id": 1514584232919, "note": "{{c1::Clotrim}}<b>azole</b> and {{c1::Micon}}<b>azole</b> are commonly used for <u>topical</u> fungal infections such as Tinea", "time": null}, {"id": 1514584343410, "note": "{{c1::Voricon}}<b>azole</b> is used for <u>Invasive Aspergillosis</u> and <u>Candida Esophagitis</u> in AIDS patients", "time": null}, {"id": 1514584507672, "note": "{{c1::Isavucon}}<b>azole</b> is used for <u>serious</u> <i>Aspergillus </i>and <i>Mucor</i> infections", "time": null}, {"id": 1514584631941, "note": "<b>Azoles</b> can inhibit cytochrome p450 enzymes involved in synthesis of {{c1::steroids}} in humans", "time": null}, {"id": 1514584967942, "note": "<b>Ketoconazole</b> can be used a <u>second line</u> treatment for <b>{{c1::advanced prostate}} </b><b>cancer</b>", "time": null}, {"id": 1514585115060, "note": "<b>Ketoconazole</b> can be used to treat patients with <b>{{c1::Cushing}} </b><b>Syndrome</b>", "time": null}, {"id": 1514585420700, "note": "<b>Azoles </b>can cause side effects of dizziness, nausea, vomiting, and {{c1::hepato}}toxicity", "time": null}, {"id": 1514585930718, "note": "<b>Azoles</b> can cause <u>anti-androgenic</u> side effects, most commonly resulting in {{c1::gynecomastia}}", "time": null}, {"id": 1514587038741, "note": "<b>Pyrimethamine</b> + <b>Dapsone</b> is used as a second line option to prevent {{c1::Pneumocystis Jirovecii Pneumonia}} in patients with HIV/AIDS", "time": null}, {"id": 1514587044928, "note": "<b>Amphotericin B</b> can be used for certain <u>protozoal</u> infections, particularly <b>{{c1::Leishmaniasis}}</b> and <b>{{c2::Naegleria Fowleri}}</b>", "time": null}, {"id": 1514588824901, "note": "For life threatening <b>Malaria</b>, use {{c1::<b>quinidine</b>}} or <b>{{c2::artesunate}}</b>", "time": null}, {"id": 1514594020539, "note": "<u>Long term use</u>  / <u>high-doses</u> of <b>Chloroquine</b> can cause an irreversible {{c1::retino}}<b>pathy</b>", "time": null}, {"id": 1514658082445, "note": "<b>Maraviroc</b> works by binding {{c1::CCR-5}} on the surface of Monocytes / T cells", "time": null}, {"id": 1514659435421, "note": "<b>Maraviroc</b> prevents HIV infection by <b>preventing</b> host cell interaction with what <u>glycoprotein</u>?<div><br /></div><div><div>{{c1::gp120}}</div><div><br /></div><div><img src=\"paste-29759828393985.jpg\" /></div></div>", "time": null}, {"id": 1514659848604, "note": "<b>Maraviroc</b> carries a significant risk of {{c1::<b>hepato</b>}}<b>toxicity</b>", "time": null}, {"id": 1514661153544, "note": "<div>Which step (<font color=\"#aa0000\"><b>[A] - [E]</b></font>) of the HIV life cycle does <b>Enfuvirtide</b> target?<div><br><div><b>{{c1::<font color=\"#aa0000\">[B]</font>}}</b></div></div></div><div><br></div><div><img src=\"paste-45157286150145.jpg\"></div>", "time": null}, {"id": 1514661846196, "note": "<b>Enfuvirtide</b> prevents HIV infection by <b>binding </b>what HIV <u>glycoprotein</u>?<div><br /></div><div><div>{{c1::gp41}}</div><div><br /></div><div><img src=\"paste-29759828393985.jpg\" /></div></div>", "time": null}, {"id": 1514662042031, "note": "<b>Enfuvirtide</b> causes a <u>skin reaction</u> at {{c1::injection sites}}", "time": null}, {"id": 1514662177557, "note": "What class of antimicrobials are the following drugs?<div><br /></div><div>{{c1::Nucleoside Reverse Transcriptase Inhibitor (NRTI)}}<br /><div><br /></div><div><img src=\"paste-56053618180097.jpg\" /></div></div>", "time": null}, {"id": 1514662572193, "note": "<div>Which step (<font color=\"#aa0000\"><b>[A] - [E]</b></font>) of the HIV life cycle do <b>NRTIs</b> target?<div><br><div><b>{{c1::<font color=\"#aa0000\">[C]</font>}}</b></div></div></div><br><div><img src=\"paste-45157286150145.jpg\"></div>", "time": null}, {"id": 1514662665451, "note": "<b>NRTIs</b> are {{c1::competitive}} inhibitors of the HIV <u>Reverse Transcriptase</u>", "time": null}, {"id": 1514662961439, "note": "<b>NRTIs</b> are <i>mostly</i> {{c1::nucleoside}} analogs", "time": null}, {"id": 1514663186262, "note": "Do <i>most</i> <b>NRTIs</b> need to be <u>phosphorylated</u> to be active?<div><br /></div><div>{{c1::Yes}}</div>", "time": null}, {"id": 1514663343487, "note": "When incorporated into the nascent DNA chain, <b>NRTI</b>s<b> </b>cause <u>chain termination</u> as they lack a(n) {{c1::3 OH group}}", "time": null}, {"id": 1514664090379, "note": "<b>Tenofovir (TDF)</b> and <b>Emtricitabine</b> (<b>FTC</b>) are given as a <u>combination drug</u> for {{c1::pre-exposure prophylaxis}} of HIV", "time": null}, {"id": 1514664228275, "note": "In treating HIV, {{c1::<b>Zidovudine (ZDV)</b>::<b>NRTI</b>}} is used for <u>general prophylaxis</u> as well as <u>decreasing risk of fetal transmission during pregnancy</u> ", "time": null}, {"id": 1514665046693, "note": "<b>Abacavir (ABC)</b> is <i>contraindicated</i> for HIV treatment if patient has an <b>HLA-</b>{{c1::<b>B*5701</b>}} mutation", "time": null}, {"id": 1514665175231, "note": "Patients taking <b>NRTIs</b> suffer from {{c1::bone marrow}} suppression", "time": null}, {"id": 1514665411921, "note": "<div><div>Which <b>NRTIs</b> are <i>particularly</i> associated with <u>peripheral neuropathy?</u></div><div><u><br /></u></div><div style=\"font-weight: bold; \">{{c1::Didanosine (ddl), Lamivudine (3TC), Stavudine (d4T)}}<br /><div><br /></div><div><img src=\"paste-56053618180097.jpg\" /></div></div></div>", "time": null}, {"id": 1514665566871, "note": "Patients taking <u>nucleoside</u> <b>NRTIs</b> can develop a(n) {{c1::lactic}} <b>acidosis</b>", "time": null}, {"id": 1514665641707, "note": "<b>Zidovudine (ZDV/AZT)</b> can cause a(n) {{c1::<b>megaloblastic</b>}}<b> anemia </b>and <b>{{c2::agranulo}}cytosis</b>", "time": null}, {"id": 1514665762770, "note": "<b>Didanosine (ddl)</b> can cause {{c1::<b>pancreat</b>}}<b>itis</b>", "time": null}, {"id": 1514665825334, "note": "What class of antimicrobials are the following drugs?<div><br /></div><div>{{c1::Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI)}}<br /><div><br /></div><div><img src=\"paste-114246130073601 (1).jpg\" /></div></div>", "time": null}, {"id": 1514665922889, "note": "<div>Which step (<font color=\"#aa0000\"><b>[A] - [E]</b></font>) of the HIV life cycle does <b>NNRTIs</b> target?<div><br><div><b>{{c1::<font color=\"#aa0000\">[C]</font>}}</b></div></div></div><div><br></div><div><img src=\"paste-45157286150145.jpg\"></div>", "time": null}, {"id": 1514666303506, "note": "<b>NNRTIs</b> are {{c1::non-competitive}} inhibitors of the HIV <u>Reverse Transcriptase</u>", "time": null}, {"id": 1514666743430, "note": "Do <b>NNRTIs</b> need to be <u>phosphorylated</u> to be active?<div><br /></div><div>{{c1::No}}</div>", "time": null}, {"id": 1514666847402, "note": "<u>Rash</u> and <u>hepatotoxicity</u> are common to which <b>NNRTIs</b>?<div><br /></div><div><div>{{c1::All :)}}</div><div style=\"font-weight: bold; \"><br /></div><div style=\"font-weight: bold; \"><img src=\"paste-151298812936193.jpg\" /></div></div>", "time": null}, {"id": 1514667292361, "note": "<u>Vivid dreams / Nightmares</u> and <u>CNS symptoms</u> are side effects seen with which <b>NNRTI?</b><div><b><br /></b></div><div><div>{{c1::Efavirenz}}</div><div style=\"font-weight: bold; \"><br /></div><div style=\"font-weight: bold; \"><img src=\"paste-151298812936193.jpg\" /></div></div>", "time": null}, {"id": 1514668032144, "note": "Which <b>NNRTIs</b> are contraindicated in pregnancy?<div><br /></div><div>{{c1::Delaviridine, Efavirenz}}</div><div><br /></div><div><img src=\"paste-151298812936193.jpg\" /></div>", "time": null}, {"id": 1514668384320, "note": "<b>Nevirapine</b> is associated with {{c1::induction}} of <u>cytochrome p450 enzymes</u>", "time": null}, {"id": 1514669001886, "note": "<div><div>What class of antimicrobials are the following drugs?<div><br /></div><div>{{c1::<b>HIV Protease Inhibitors</b>}}</div></div></div><div><br /></div><div><img src=\"paste-203001629245441.jpg\" /></div>", "time": null}, {"id": 1514669165526, "note": "<div>Which step (<font color=\"#aa0000\"><b>[A] - [E]</b></font>) of the HIV life cycle do<b> </b>drugs with the suffix <b>-navir</b> target?<div><br><div><b>{{c1::<font color=\"#aa0000\">[E]</font>}}</b></div></div></div><div><br></div><div><img src=\"paste-45157286150145.jpg\"></div>", "time": null}, {"id": 1514669484484, "note": "<b>HIV Protease Inhibitors</b> inhibit the {{c1::maturation}} of new viruses", "time": null}, {"id": 1514670037825, "note": "<b>HIV Protease Inhibitors </b>are metabolized by {{c1::Cytochrome P450}}", "time": null}, {"id": 1514670410940, "note": "<b>Ritonavir </b>is a cytochrome p450 {{c1::inhibitor}}", "time": null}, {"id": 1514670434695, "note": "<div>Which <b>HIV Protease Inhibitor</b> is <i>especially</i> associated with <u>Nephropathy/Nephrolithiasis</u>, <u>Hematuria</u>, and <u>Thrombocytopenia</u></div><div><div><div style=\"font-weight: bold; \"><b><br /></b></div><div style=\"font-weight: bold; \"><div>{{c1::Indinavir}}</div><div style=\"font-weight: bold; \"><br /></div><div style=\"font-weight: bold; \"><img src=\"paste-228307576553473.jpg\" /></div></div></div></div>", "time": null}, {"id": 1514670570704, "note": "<div>Which <b>HIV</b> <b>Protease Inhibitor</b> is <i>especially</i> associated with <u>GI intolerance (<i>Nausea, Diarrhea</i>)</u></div><div><div><div style=\"font-weight: bold; \"><b><br /></b></div><div style=\"font-weight: bold; \"><div>{{c1::Saquinavir}}</div><div style=\"font-weight: bold; \"><br /></div><div style=\"font-weight: bold; \"><img src=\"paste-228307576553473.jpg\" /></div></div></div></div>", "time": null}, {"id": 1514670597544, "note": "<div>All<b> HIV</b> <b>Protease Inhibitors</b> cause {{c1::insulin}} resistance and {{c2::dyslipid}}emia</div>", "time": null}, {"id": 1514671047073, "note": "Patients taking<b> HIV</b> <b>Protease inhibitors </b>for awhile can resemble patients on chronic <u>Glucocorticoid therapy</u> due to their ability to cause {{c1::Lipodystrophy}}", "time": null}, {"id": 1514671566113, "note": "<b>Enfuvirtide </b>and <b>Maraviroc</b> are used for {{c1::treatment-resistant}} patients with HIV", "time": null}, {"id": 1514672013629, "note": "<u>Highly Active Anti-Retroviral Therapy</u> (<b>HAART</b>) is often initiated at the time of {{c1::HIV Diagnosis}} ", "time": null}, {"id": 1514672344717, "note": "A <b>HAART</b> regimen typically consists of <b>3 drugs</b> to prevent <u>resistance</u>: <b>2</b> {{c1::<b>NRTIs</b>}} and preferably a(n) {{c2::<b>Integrase Inhibitor</b>}}", "time": null}, {"id": 1514672518972, "note": "What class of antimicrobials are the following drugs?<div><br /></div><div>{{c1::Integrase Inhibitors}}</div><div><br /></div><div><img src=\"paste-261026637414401.jpg\" /></div>", "time": null}, {"id": 1514672754597, "note": "<div>Which step (<font color=\"#aa0000\"><b>[A] - [E]</b></font>) of the HIV life cycle do<b> </b>drugs with the infix <b>-tegra-</b> target?<div><br><div><b>{{c1::<font color=\"#aa0000\">[D]</font>}}</b></div></div></div><br><div><img src=\"paste-45157286150145.jpg\"></div>", "time": null}, {"id": 1514672868031, "note": "Drugs like <b>Dolutegravir</b>, <b>Elvitegravir</b>, and <b>Raltegravir</b> reversibly inhibit {{c1::HIV integrase}}", "time": null}, {"id": 1514678528038, "note": "If a patient taking  <b>Integrase Inhibitors </b>can develops elevated Creatine Kinase levels, what should you suspect is occurring?<div><br></div><div>{{c1::Rhabdomyolysis}}</div>", "time": null}, {"id": 1514736654381, "note": "Is therapy for <b>Hepatitis Viruses</b> indicated for <u>acute</u> or <u>chronic</u> infection?<div><br /></div><div>{{c1::Chronic}}</div>", "time": null}, {"id": 1514737744464, "note": "The direct acting <b>antiretroviral HCV drugs</b> work by targeting {{c1::RNA}} synthesis", "time": null}, {"id": 1514740606355, "note": "<b>Ribavirin </b>is an antiviral that works by inhibiting the synthesis of {{c1::<b>guanine</b>}} nucleotides", "time": null}, {"id": 1514740864172, "note": "<b>Ribavirin </b>is a(n) {{c2::<b>guanosine</b>}} nucleoside analog that acts by <u>competitively</u> inhibiting <b>{{c1::Inosine Monophosphate Dehydrogenase}}</b>", "time": null}, {"id": 1514740926267, "note": "Patients taking <b>Ribavirin</b> can develop a(n) {{c1::hemolytic}} <b>anemia</b>", "time": null}, {"id": 1514740967212, "note": "<b>Ribavirin</b> is <u>extremely</u> contraindicated in what patient population?<div><br /></div><div>{{c1::Pregnant patients}}</div>", "time": null}, {"id": 1514741107116, "note": "<b>Ribavirin</b> is used to treat {{c1::RSV}} in <u>adults</u>", "time": null}, {"id": 1514900969301, "note": "Which step (<font color=\"#aa0000\"><b>[A] - [D]</b></font>) of the viral life cycle does <b>Ribavirin</b> target?<div><br /></div><div><div><b>{{c1::</b><b><font color=\"#aa0000\">[C]</font>}}</b></div><div><b></b><b><br /></b></div><div><img src=\"paste-26190710571009.jpg\" /></div></div>", "time": null}, {"id": 1514901294546, "note": "What class of antivirals are the following drugs?<div><br /></div><div><b>{{c1::</b><b>Guanosine</b> analogs}}</div><div><br /></div><div><b><font color=\"#0055ff\">Acyclovir, Famciclovir, Valacyclovir, Ganciclovir, Valganciclovir</font></b></div>", "time": null}, {"id": 1514903337446, "note": "Which step (<font color=\"#aa0000\"><b>[A] - [D]</b></font>) of the viral life cycle do<b> Acyclovir, Famciclovir, Valacyclovir, Ganciclovir, Valganciclovir</b> target?<div><br /></div><div><div><b>{{c1::</b><b><font color=\"#aa0000\">[C]</font>}}</b></div><div><b></b><b><br /></b></div><div><img src=\"paste-26190710571009.jpg\" /></div></div>", "time": null}, {"id": 1514903513766, "note": "In their <u>first</u> step of <u>bioactivation</u>, <b>-cyclovirs</b> are converted to the {{c1::<b>monophosphate</b>}}<b> form</b> by specific {{c2::<b>herpesvirus</b>}} <b>kinases</b>", "time": null}, {"id": 1514904884948, "note": "<div>Which group of -<b>cyclovirs</b> is bioactivated by <b>HSV/VZV</b> <u>thymidine kinase</u> and indicated for <u>treatment</u> of them?</div><div><b><font color=\"#0055ff\"><br /></font></b></div><div><b><font color=\"#0055ff\"><div></div></font></b><b><font color=\"#0055ff\">{{c1::Acyclovir, Famciclovir, Valacyclovir}}</font></b></div><div><b><font color=\"#0055ff\"><br /></font></b></div><div><b><font color=\"#0055ff\">Acyclovir, Famciclovir, Valacyclovir</font></b></div><div><b><font color=\"#0055ff\"><br /></font></b></div><div><b>OR</b></div><div><b><font color=\"#0055ff\"><br /></font></b></div><div><b><font color=\"#0055ff\">Ganciclovir, Valganciclovir</font></b></div>", "time": null}, {"id": 1514905046744, "note": "<div>Which group of -<b>cyclovirs</b> is bioactivated by a <b>CMV</b> <u>viral kinase</u> and indicated for <u>treatment</u> of them?</div><div><b><font color=\"#0055ff\"><br /></font></b></div><div><b><font color=\"#0055ff\"><div></div></font></b><b><font color=\"#0055ff\">{{c1::</font></b><b><font color=\"#0055ff\">Ganciclovir, Valganciclovir</font></b>}}</div><div><b><font color=\"#0055ff\"><br /></font></b></div><div><b><font color=\"#0055ff\">Acyclovir, Famciclovir, Valacyclovir</font></b></div><div><b><font color=\"#0055ff\"><br /></font></b></div><div><b>OR</b></div><div><b><font color=\"#0055ff\"><br /></font></b></div><div><b><font color=\"#0055ff\">Ganciclovir, Valganciclovir</font></b></div>", "time": null}, {"id": 1514905658978, "note": "Do any of the following antivirals have activity against CMV?<div><br /></div><div>{{c1::No}}</div><div><br /></div><div><img src=\"paste-125593433669633.jpg\" /></div>", "time": null}, {"id": 1514906008748, "note": "Are <b>Acyclovir, Famciclovir, Valacyclovir</b> used to treat both HSV-induced <u>mucocutaneous and genital lesions</u> as well as for <u>encephalitis</u>?<div><br /></div><div>{{c1::Yes}}</div>", "time": null}, {"id": 1514906638562, "note": "<div><b>Valacyclovir</b>, a prodrug of <u>acyclovir</u>, has better oral {{c1::bioavailability}}</div>", "time": null}, {"id": 1514906806931, "note": "Patients taking <b>acyclovir, famciclovir, valacyclovir</b> are at risk of <u>obstructive crystalline nephropathy</u> and <u>acute renal failure</u> if not adequately {{c1::hydrated}}", "time": null}, {"id": 1514907033786, "note": "<b>Ganciclovir</b>&nbsp;and&nbsp;<b>Valganciclovir</b> are used to treat <u>CMV</u>, especially in {{c1::immunocompromised}} patients", "time": null}, {"id": 1514907741886, "note": "<b>Valganciclovir</b>, a prodrug of <u>ganciclovir</u>, has better oral {{c1::bioavailability}}", "time": null}, {"id": 1514907784721, "note": "<b>Ganciclovir</b> causes toxicity at the {{c1::<u>bone marrow</u>}} and the {{c2::<u>kidneys</u>}}", "time": null}, {"id": 1514907961244, "note": "<b>Foscarnet</b> and <b>Cidofovir </b>are used for {{c1::<b>CMV retinitis</b>}} in immunocompromised patients", "time": null}, {"id": 1514910155365, "note": "<b>Foscarnet</b> and <b>Cidofovir </b>can cause damage to the {{c1::kidneys}}", "time": null}, {"id": 1514910275399, "note": "Patients taking <b>Foscarnet </b>can experience various {{c1::electrolyte}} abnormalities ", "time": null}, {"id": 1515380277519, "note": "<b>Pegloticase</b> is used for <u>severe, refractory</u><b> {{c1::gout}}</b> ", "time": null}, {"id": 1515380457962, "note": "<div>If initiated without NSAIDS / Colchicine, <b>Allopurinol / Febuxostat</b> may precipitate a(n) {{c1::gout attack}}</div>", "time": null}, {"id": 1515380545942, "note": "<b>Rasburicase</b> is a non-PEGylated uricase used for prophylaxis and treatment of <u>{{c1::Tumor Lysis}} Syndrome</u> ", "time": null}, {"id": 1515380666089, "note": "<b>Allopurinol</b> can irritate the {{c1::GI}} tract", "time": null}, {"id": 1515382789312, "note": "<b>Griseofulvin</b> inhibits the action of fungal cell {{c1::microtubules}}", "time": null}, {"id": 1515382899368, "note": "<b>Griseofulvin </b>deposits in {{c1::keratin}}-containing tissues", "time": null}, {"id": 1515382928401, "note": "<b>Griseofulvin </b>is an oral treatment that is most often used to inhibit the growth of {{c1::dermatophytes}}", "time": null}, {"id": 1515383023301, "note": "<b>Griseofulvin </b>is contraindicated in patients who are {{c1::pregnant}}", "time": null}, {"id": 1515383145273, "note": "Patients taking <b>Griseofulvin</b> can develop {{c1::neuro}}toxicity", "time": null}, {"id": 1515383317269, "note": "Patients taking <b>Griseofulvin</b> should not consume {{c1::alcohol}} as they can develop Flushing and GI Upset", "time": null}, {"id": 1515383425443, "note": "<b>Griseofulvin</b> is a cytochrome p450 {{c1::inducer}}", "time": null}, {"id": 1515383927567, "note": "The <b>fungal cell membrane</b> is composed of {{c1::Ergosterol}} as opposed to cholesterol", "time": null}, {"id": 1515385207192, "note": "{{c1::Voriconazole}} is an antifungal that can produce <b>blurred vision </b>and<b> changes in color vision</b>", "time": null}, {"id": 1515539993315, "note": "Patients with <b>Systemic Juvenile Idiopathic Arthritis </b>often develop&nbsp;<u>{{c1::uveitis}}</u> in their eye", "time": null}, {"id": 1515556520483, "note": "<b>NNRTIs</b> can cause {{c1::Stevens-Johnson Syndrome::Dermatologic Syndrome}} as a side effect", "time": null}, {"id": 1515557739749, "note": "Can <b>Acyclovir</b> be used to treat <u>neonatal</u> HSV?<div><br /></div><div>{{c1::Yes}}</div>", "time": null}, {"id": 1515559898214, "note": "<div><div>Which <b>NRTIs</b> cause <u>lipodystrophy?</u></div><div><u><br /></u></div><div style=\"font-weight: bold; \">{{c1::<b>Zidovudine (ZDV),</b> <b>Stavudine (d4T)</b>}}<br /><div><br /></div><div><img src=\"paste-56053618180097.jpg\" /></div></div></div>", "time": null}, {"id": 1515560045767, "note": "The <u>toxicities</u> that result from <b>NRTIs</b> are based in part by the <b>inhibition</b> of {{c1::Mitochondrial}} DNA synthesis", "time": null}, {"id": 1515722455837, "note": "<b>Rhabdomyolysis</b> is a syndrome caused by {{c1::muscle necrosis}} that can lead to <u>renal failure</u> and <u>death</u>", "time": null}, {"id": 1515722563357, "note": "<b>Rhabdomyolysis</b> is most commonly caused by a(n)&nbsp;<u>{{c1::crush}} injury</u> or <u>strenuous {{c2::exercise}}</u>", "time": null}, {"id": 1515722684226, "note": "What two <u>cholesterol modulating</u> medications should not be combined due to a high risk of causing <b>rhabdomyolysis</b>?<div><br /></div><div>{{c1::Statins + Fibrates}}</div>", "time": null}, {"id": 1515722770836, "note": "Destroyed muscle cells release large amounts of {{c1::<b>myoglobin</b>}} and {{c2::<b>purines</b>}}, which lead to <u>acute tubular necrosis</u>", "time": null}, {"id": 1515722911357, "note": "<b>Rhabdomyolysis </b>typically presents with muscle pains, weakness, vomiting, and {{c1::hypo}}calcemia", "time": null}, {"id": 1515723006671, "note": "Destroyed muscle cells in <b>Rhabdomyolysis</b> release large amounts of {{c1::potassium}}, causing arrhythmias", "time": null}, {"id": 1515723070213, "note": "Patients who have <b>Rhabdomyolysis</b> are diagnosed by observing a(n) {{c2::<u>creatine kinase</u>}} level greater than {{c1::<b>1000</b>}} <b>u/L</b>", "time": null}, {"id": 1515727009006, "note": "Which <b>renal tubular defect syndrome</b> is associated with the use of <i><u>expired</u> </i>tetracyclines?<div><br /></div><div>{{c1::Fanconi Syndrome}}</div>", "time": null}, {"id": 1515775028345, "note": "If a patient has a <u>swollen, painful knee</u> that cannot extend their knee <b>against gravity</b>, what condition should you <u>first</u> suspect?<div><br></div><div>{{c1::Patellar fracture}}</div>", "time": null}, {"id": 1515780219071, "note": "<b>Metronidazole </b>can be used for what colitis causing infection?<div><br></div><div>{{c1::Clostridioides difficile}}</div>", "time": null}, {"id": 1515780468007, "note": "Patients on chronic {{c1::steroid}} therapy should not be prescribed fluoroquinolones due to a <b>significantly</b> increased risk of <u>tendon / cartilage damage</u>", "time": null}, {"id": 1516031999666, "note": "<b>Paragangliomas </b>are tumors of {{c1::glomus cells}}", "time": null}, {"id": 1516052301971, "note": "<b>Sialolithiasis</b> is the presence of stones in the {{c1::salivary gland}} duct", "time": null}, {"id": 1516052413276, "note": "In <b>sialolithiasis</b>, a single stone is more common in the {{c2::<b>submandibular gland</b>}}, specifically in the {{c1::<u>wharton</u>}}<u> duct</u>", "time": null}, {"id": 1516052568445, "note": "<b>Sialolithiasis</b> presents as recurrent {{c1::pre-/peri}}-prandial pain and swelling in affected gland", "time": null}, {"id": 1516052611991, "note": "<b>Sialolithiasis</b> is typically caused by {{c1::dehydration}} or {{c2::trauma}}", "time": null}, {"id": 1516052726388, "note": "<div><b>Sialolithiasis</b> is typically treated conservatively with NSAIDs, gland massage, warm compresses, and {{c1::sialogogues}}</div>", "time": null}, {"id": 1516060754864, "note": "What unique antibodies in plasma do patients with the <b>A</b> blood type have?<div><br /></div><div>{{c1::<img src=\"paste-32822140076033.jpg\" />::name and isotype}}</div>", "time": null}, {"id": 1516060882936, "note": "<div><div>Patients with the <b>A </b>blood type cannot receive which <u>blood types</u>?</div></div><div><br /></div><div>{{c1::<img src=\"paste-56573309222913.jpg\" /><img src=\"paste-32946694127617.jpg\" />}}</div>", "time": null}, {"id": 1516060998624, "note": "What unique antibodies in plasma do patients with the <b>B</b> blood type have?<div><br /></div><div>{{c1::<img src=\"paste-46849503264769 (1).jpg\" />::name and isotype}}</div>", "time": null}, {"id": 1516061091978, "note": "What unique antibodies in plasma do patients with the <b>AB</b> blood type have?<div><br /></div><div>{{c1::none}}</div>", "time": null}, {"id": 1516061108309, "note": "Which blood type does not have any group antigens on RBC surfaces?<div><br /></div><div>{{c1::<img src=\"paste-52106543235073.jpg\" />}}</div>", "time": null}, {"id": 1516061198725, "note": "<div>Patients with the <b>B</b> blood type cannot receive which <u>blood types</u>?</div><div><br /></div><div>{{c1::<img src=\"paste-32933809225729.jpg\" /><img src=\"paste-32946694127617.jpg\" />}}</div>", "time": null}, {"id": 1516061255284, "note": "What unique antibodies in plasma do patients with the <b>O</b> blood type have?<div><br /></div><div>{{c1::<img src=\"paste-60017872994305.jpg\" />::name and isotype}}</div>", "time": null}, {"id": 1516061313616, "note": "<div>Patients with the <b>AB</b> blood type cannot receive which <u>blood types</u>?</div><div><br /></div><div>{{c1::None}}</div>", "time": null}, {"id": 1516061368613, "note": "<div>Patients with the <b>O</b> blood type cannot receive which <u>blood types</u>?</div><div><br /></div><div>{{c1::<img src=\"paste-32933809225729.jpg\" /><img src=\"paste-56573309222913.jpg\" /><img src=\"paste-32946694127617.jpg\" />}}</div>", "time": null}, {"id": 1516061489817, "note": "What unique antibodies in plasma do patients with the <b>Rh+ </b>blood type have?<div><br /></div><div>{{c1::none}}</div>", "time": null}, {"id": 1516061554788, "note": "What unique antibodies in plasma do patients with the <b>Rh- </b>blood type have?<div><br /></div><div>{{c1::<img src=\"paste-76201309765633.jpg\" />}}</div>", "time": null}, {"id": 1516061727087, "note": "<b>Rh- mothers</b> must be treated during pregnancy with {{c1::anti-D}} Immunoglobulin (<i>RhoGAM) </i>to prevent {{c2::anti-D}} IgG formation", "time": null}, {"id": 1516061829690, "note": "During the immediate / early postpartum period after delivering an Rh+ fetus, must <b>Rh- mothers</b> be given <u>anti-D Ig</u>?<div><br></div><div>{{c1::Yes}}</div>", "time": null}, {"id": 1516061921946, "note": "<b>Rh hemolytic disease of the newborn</b> has the potential to occur when a <b>Rh{{c1::-}} </b>mother has a <b>Rh{{c1::+}}</b> fetus", "time": null}, {"id": 1516062099732, "note": "Assuming <i>RhoGam</i> is not given, the first time a <u>mother</u> is <b>Rh-</b> and delivers a <b>Rh+</b> <u>fetus</u>, the mother will form what substance?<div><br /></div><div>{{c1::<img src=\"paste-86324547682305.jpg\" />}}</div>", "time": null}, {"id": 1516062222140, "note": "If an <b>Rh- mother</b> with anti-D IgG antibodies has a subsequent pregnancy with an <b>Rh+ fetus</b>, the fetus can develop {{c1::hydrops fetalis}} ", "time": null}, {"id": 1516062395011, "note": "If an <b>Rh- mother</b> with anti-D IgG antibodies has a subsequent pregnancy with an <b>Rh+ fetus</b> and the baby survives to delivery, the newborn can develop {{c1::<b>Jaundice</b>}}; which in serious cases can also manifest with {{c2::<u>Kernicterus</u>}}", "time": null}, {"id": 1516062551867, "note": "<b>ABO hemolytic disease of the newborn</b> has the potential to occur when a <b>Type {{c1::O}} mother</b> has a <b>Type {{c1::A or B}}</b> <b>fetus</b>", "time": null}, {"id": 1516062832584, "note": "Will <b>ABO hemolytic disease of the newborn</b> occur on the first pregnancy?<div><br /></div><div>{{c1::Yes}}</div>", "time": null}, {"id": 1516062859864, "note": "Will <b>Rh hemolytic disease of the newborn</b> occur on the first pregnancy?<div><br /></div><div>{{c1::No}}</div>", "time": null}, {"id": 1516063061822, "note": "Newborns that are suffering from <b>ABO hemolytic disease of the newborn</b> can be treated with:<div><br /></div><div>{{c1::Phototherapy}}</div><div>{{c2::Exchange transfusion}}</div>", "time": null}, {"id": 1516115769450, "note": "<div>Which blood transfusion reaction is caused by&nbsp;</div><div>1)&nbsp;<b>cytokines</b> that are created by WBCs and accumulate during the <b>storage of blood products&nbsp;</b></div><div>&nbsp; &nbsp; &nbsp;-or-&nbsp;</div><div>2) host antibodies against<b> donor HLA antigens/WBCs? </b></div><div><br></div><div><div>{{c1::Febrile nonhemolytic transfusion reaction}}</div></div>", "time": null}, {"id": 1516246417073, "note": "<b>{{c1::Mesenchyme}} </b>is the embryonic connective tissue", "time": null}, {"id": 1516246473563, "note": "The <b>Mesenchyme </b>gives rise to <i>most</i> <b>{{c1::connective tissue}}</b>", "time": null}, {"id": 1516246515683, "note": "A <b>mesenchymal</b> tumor is a(n) {{c1::sarcoma}}", "time": null}, {"id": 1516407555842, "note": "If a patient presents with an <i>undulating fever</i>, what antimicrobial can be used to treat the organism in question?<div><br /></div><div>{{c1::Doxycycline}}</div>", "time": null}, {"id": 1516408114642, "note": "Can <b>Clindamycin</b> be used to treat <u>Gardnerella Vaginalis?</u><div><br /></div><div>{{c1::Yes}}</div>", "time": null}, {"id": 1516408256568, "note": "A patient has recently been scratched by a <u>cat</u> and develops a <b>febrile lymphadenitis,</b> what two classes of drugs can you use?<div><br /></div><div>{{c1::Tetracyclines and Macrolides}}</div>", "time": null}, {"id": 1516408630312, "note": "The <b>triple therapy regimen</b> for <u>Helicobacter Pylori</u> can be remembered with the mnemonic: <i><b><font color=\"#aa0000\">A</font></b>ntibiotics<b> <font color=\"#aa0000\">C</font></b>ure <b><font color=\"#aa0000\">P</font></b>ylori</i><div style=\"centerbox\"><div class=\"mnemonics\"><div><br></div><div><b><font color=\"#aa0000\">A</font></b>{{c1::moxicillin}}</div><div><b><font color=\"#aa0000\">C</font></b>{{c2::larithromycin}}</div><div><b><font color=\"#aa0000\">P</font></b>{{c3::roton Pump Inhibitor}}<br></div></div></div>", "time": null}, {"id": 1516408959617, "note": "<b>Erythromycin</b> can be used to treat <u>Neonatal Conjunctivitis</u> caused by what two microbes?<div><br /></div><div>{{c1::Neisseria Gonorrhae, Chlamydophila Trachomatis}}</div>", "time": null}, {"id": 1516409371505, "note": "A patient develops <u>severe lymphadenopathy, fever, and a painful throat</u>; upon examination of the throat you notice <b>grayish-white membranes</b> - what <i>bacterial protein synthesis inhibitor</i> can be used to treat this condition?<br><br><div>{{c1::Erythromycin}}</div>", "time": null}, {"id": 1516409545340, "note": "Before a patient gets a <b>C-section</b>, what combination of drugs should be given prophylactically?<div><br /></div><div>{{c1::Gentamicin + Clindamycin}}</div>", "time": null}, {"id": 1516409786109, "note": "A teenage girl has recently gotten an <u>IUD</u>, but comes back to your office complaining of <b>pelvic pain</b> and on pelvic exam you notice she has <b>uterine bleeding</b> and the tissue looks slightly necrotic in a focal area - what medications can you prescribe?<div><br /></div><div>{{c1::Gentamicin + Clindamicin}}</div>", "time": null}, {"id": 1516410198146, "note": "Which <u>HIV gene</u> encodes for the <b>gp120</b> and <b>gp41</b> surface glycoproteins?<br /><div><br /></div><div><b><i>{{c1::env}}</i></b></div><div><br /></div><div><img src=\"paste-377738078715905.jpg\" /></div>", "time": null}, {"id": 1516410362011, "note": "Which <u>HIV gene</u> encodes for the virion <b>p24 (Capsid)</b> and <b>p17 (Matrix)</b> core proteins?<br /><div><br /></div><div><b><i>{{c1::gag}}</i></b></div><div><br /></div><div><img src=\"paste-377738078715905.jpg\" /></div>", "time": null}, {"id": 1516410436420, "note": "Which <u>HIV gene</u> encodes <b>Reverse Transcriptase</b>, <b>Aspartate Protease</b>, and <b>Integrase</b><br /><div><br /></div><div><b><i>{{c1::pol}}</i></b></div><div><br /></div><div><img src=\"paste-377738078715905.jpg\" /></div>", "time": null}, {"id": 1516467886379, "note": "<b>Radial Head Subluxation </b>is also known by the name \"{{c1::Nursemaids Elbow}}\"", "time": null}, {"id": 1516552228242, "note": "<b>Osgood-Schlatter Disease</b> is an <u>overuse injury</u> caused by inflammation of the apophysis located on the {{c1::<b>Tibial Tuberosity</b>}}", "time": null}, {"id": 1516552434126, "note": "<b>Osgood-Schlatter Disease</b> is commonly seen in patients after their {{c1::pubertal growth spurt}}", "time": null}, {"id": 1516552577663, "note": "An <u>apophysis</u> is a(n) {{c1::secondary ossification center}} which serves as an attachment for a tendon", "time": null}, {"id": 1516552882272, "note": "In <b>Osgood Schlatter</b>, healed microavulsions can be noted on physical exam by the presence of a pronounced/enlarged {{c1::tibial tubercle}}", "time": null}, {"id": 1516553476487, "note": "<b>Osgood-Schlatter Disease</b> is commonly seen in which demographic?<br><br>{{c1::Childhood athletes}}", "time": null}, {"id": 1516553657699, "note": "In patients with <b>Osgood-Schlatter Disease</b>, patients report pain on <u>resisted</u> knee {{c1::extension}}", "time": null}, {"id": 1516721154487, "note": "<b>Heyde syndrome</b> is a situation where a <u>severely</u> calcific &amp; stenotic {{c1::<b>aortic</b>}} <b>valve</b> causes increased rupture of <u>{{c2::angiodysplasias}}</u>", "time": null}, {"id": 1516721343853, "note": "In <b>Heyde syndrome</b>, the stenotic aortic valve causes passing <u>vWF</u> to {{c1::<b>uncoil</b>}}, making it available to be degraded by <u>{{c2::ADAMTS13}}</u> in the vasculature", "time": null}, {"id": 1516721582011, "note": "Without active <b>vWF</b>, {{c1::intestinal angiodysplasias}} will rupture much more easily, resulting in <u>GI bleeding</u> and <u>Iron Deficiency Anemia</u>", "time": null}, {"id": 1516743281813, "note": "Patients with <b>Xeroderma Pigmentosum</b> often present with <u>freckled and dry</u> skin, <u>extreme</u> <b>{{c1::sunlight}} sensitivity, </b>and {{c2::<b>corneal</b>}} <b>ulcers</b>", "time": null}, {"id": 1516743462756, "note": "Patients with <b>xeroderma&nbsp;pigmentosum</b>&nbsp;are at risk for which type/s of skin cancer?<div><br></div><div>{{c1::All :)}}</div>", "time": null}, {"id": 1516743593919, "note": "Patients with <b>Xeroderma Pigmentosum</b> cannot repair {{c1::Thymidine Dimers}} formed as a result of <u>UV-B</u> exposure", "time": null}, {"id": 1516938061553, "note": "<b>Nonhomologous End Joining (NHEJ)</b> occurs {{c1::before::before/after?}} S phase of the cell cycle", "time": null}, {"id": 1516938350345, "note": "Is <b>Nonhomologous End Joining </b><u>error prone</u>?<div><br /></div><div>{{c1::Yes}}</div>", "time": null}, {"id": 1516939735510, "note": "<u>Nonhomologous End Joining</u> is defective in {{c1::<b>SCID</b>}} and {{c2::<b>Ataxia Telangiectasia</b>}}", "time": null}, {"id": 1517771826170, "note": "<b>Chronic mucocutaneous candidiasis</b> can result from congenital genetic defects in {{c1::IL-17}} or its <u>receptor</u>", "time": null}, {"id": 1517790399681, "note": "<b>Prematurity</b> and <b>low-birth weight</b>&nbsp;are major risk factors for&nbsp;{{c1::Necrotizing Enterocolitis::which congenital GI disorder?}}", "time": 1660105347804.0}, {"id": 1518122485549, "note": "<div><b>Sacubitril </b>is an antihypertensive that may be combined with <b>{{c2::ARBs}}</b> for the treatment of <b>chronic {{c1::systolic}} heart failure</b></div>", "time": null}, {"id": 1518122617043, "note": "<b>Sacubitril</b> is a(n) {{c1::neprilysin}} inhibitor", "time": null}, {"id": 1518122653976, "note": "<b>ANP </b>and <b>BNP</b> are endogenously metabolized by the enzyme {{c1::neprilysin}}", "time": null}, {"id": 1518312585956, "note": "In <b>Central cyanosis</b>, there is {{c1::<u>normal</u>}} blood flow, and patients will have {{c2::warm::temperature}} extremities", "time": null}, {"id": 1518312666690, "note": "<b>Central cyanosis </b>typically manifests in the {{c1::lips}}, nail beds, and conjunctiva, and other mucosal surfaces", "time": null}, {"id": 1518312689465, "note": "In <b>peripheral cyanosis</b>, there is {{c1::low}} blood flow, and patients will have {{c2::cold::temperature}} extremities", "time": null}, {"id": 1518312715637, "note": "<b>Right-to-left shunts</b> typically require urgent surgical treatment and/or maintenance of a(n) {{c1::PDA}}", "time": null}, {"id": 1518313163667, "note": "The <b>5 Ts</b> of <u>Right-to-Left</u> Shunts:<div><br></div><div>1. {{c1::Truncus Arteriosus::1 vessel}}</div><div><div>2. {{c2::Transposition::2 switched vessels}}</div><div>3. {{c3::Tricuspid atresia::3 = Tri}}</div><div>4. {{c4::Tetralogy of Fallot::4 = Tetra}}</div><div>5. {{c5::TAPVR::5 letters in the name}}</div></div>", "time": null}, {"id": 1518313213243, "note": "<b>Ebsteins Anomaly</b> is associated with {{c1::Wolff-Parkinson-White}}, which can lead to arrhythmias ", "time": null}, {"id": 1518315720736, "note": "<b>{{c1::Pulmonary Atresia}}</b> is the <u>failure</u> of the <b>pulmonic valve orifice</b> to develop ", "time": null}, {"id": 1518315850491, "note": "<div><b>Pulmonary atresia</b> results in no flow from {{c1::right ventricle}} to {{c1::lungs}}</div>", "time": null}, {"id": 1518315922723, "note": "<b>Pulmonary Atresia</b> often co-exists with {{c1::VSD}} for outflow of RV", "time": null}, {"id": 1518634532822, "note": "Which MEN syndrome can have multiple angiofibromas, collagenomas, meningiomas, and lipomas?<div><br></div><div>{{c1::MEN1}}</div>", "time": null}, {"id": 1518657439710, "note": "In teenagers, the most common anatomic deformity that increases the risk of<b> testicular</b> <b>torsion</b> is the {{c1::Bell Clapper deformity}}", "time": null}, {"id": 1518661740894, "note": "Testicular torsion may lead to <u>infertility</u> and thus is treated with urgent {{c1::surgery}}", "time": null}, {"id": 1518661822920, "note": "The palpable \"bag of worms\" on physical exam in a patient who has a <b>varicocele</b> may be augmented by the {{c1::Valsalva}} maneuver", "time": null}, {"id": 1518663407728, "note": "If a patient has a <b>varicocele</b>, consider surgical ligation or {{c1::catheter embolization}} if associated with <u>pain or infertility</u>", "time": null}, {"id": 1518929163207, "note": "A(n)&nbsp;<b>{{c1::penile fracture}}</b> presents with a \"popping/snap\" sound during sexual intercourse; resulting in penile pain, swelling, and ecchymosis ", "time": null}, {"id": 1518929541738, "note": "<b>Ischemia priapism</b> may lead to permanent erectile dysfunction and {{c1::penile necrosis}}", "time": null}, {"id": 1518930938093, "note": "<b>Ischemic priapism </b>is treated with corporal aspiration, intracavernosal {{c1::phenylephrine}}, or surgical decompression to prevent ischemia", "time": null}, {"id": 1518963117783, "note": "Patients with <b>spinal shock</b> may develop <u>autonomic dysreflexia</u> in those with spinal cord injuries <i>typically</i> above {{c1::T6}}", "time": null}, {"id": 1518964489211, "note": "{{c1::<b>Arterial Insufficiency</b> (Peripheral Artery Disease)}} is due to occlusion of arteries, most commonly due to {{c2::atherosclerosis}} or other artery specific inflammatory processes", "time": null}, {"id": 1518964961692, "note": "<b>Peripheral Arterial Disease</b> is most commonly caused by occlusion of the {{c1::popliteal artery}}", "time": null}, {"id": 1518965428572, "note": "Patients with <b>short bowel syndrome</b> often develop an increased frequency of {{c1::calcium oxalate}} kidney stones", "time": null}, {"id": 1518987469596, "note": "Extragonadal germ cell tumors arise in {{c1::midline}} locations", "time": null}, {"id": 1518987600370, "note": "Are <b>extragonadal germ cell tumors</b> in the <u>retroperitoneum</u> and&nbsp;<u>mediastinum</u> regions most commonly associated with <b>adults</b> or <b>infants / young children?</b><div><b><br></b></div><div><b>{{c1::Adults}}</b></div>", "time": null}, {"id": 1518987661842, "note": "Are extragonadal germ cell tumors in the <u>sacrococcygeal</u> and <u>intracranial&nbsp;</u>regions most commonly associated with <b>adults</b> or <b>infants / young children?</b><div><b><br></b></div><div><b>{{c1::Infants / Young Children}}</b></div>", "time": null}, {"id": 1518987705256, "note": "<b>Benign prostatic hyperplasia</b> may be treated with surgical resection, with the gold standard being the {{c1::TURP}} procedure", "time": null}, {"id": 1518989205267, "note": "Which of the following is a discrete tumor mass arising from lymph nodes?<br /><div><br /></div><div>{{c1::Lymphoma}}</div><div><br /></div><div><img src=\"paste-521263000846337.jpg\" /></div>", "time": null}, {"id": 1518989287340, "note": "Do patients with Leukemia typically present with decreased, normal, or increased circulating WBCs?<div><br /></div><div>{{c1::Usually increased}}</div>", "time": null}, {"id": 1519059049099, "note": "<b>Palbociclib</b> is used to treat <u>Breast Cancer</u> that is ER {{c1::+}} and HER2 {{c1::-}}", "time": null}, {"id": 1519081483502, "note": "<b>\"Broken Heart Syndrome\"</b> is also known as {{c1::Takotsubo cardiomyopathy}}", "time": null}, {"id": 1519081550408, "note": "In <b>Takotsubo Cardiomyopathy</b>, there is <u>ventricular apical ballooning</u> due to increased {{c1::sympathetic stimulation}}", "time": null}, {"id": 1519182327659, "note": "Hodgkins Lymphoma can be classified as <u>Classical</u> or more rarely, {{c1::Nodular Lymphocyte Predominant}}", "time": null}, {"id": 1519182406936, "note": "<b>Nodular Lymphocyte Predominant Hodgkins Lymphoma </b>is a rare variant that is characterized by \"{{c1::popcorn}} cells\"", "time": null}, {"id": 1519182507447, "note": "<b>Nodular Lymphocyte Predominant Hodgkin Lymphoma</b> has unusual surface marker expression in that it usually lacks <b>CD15</b> and <b>CD30</b> but expresses <b>CD-{{c1::19}}</b>&nbsp;and&nbsp;<b>CD{{c1::20}}</b>", "time": null}, {"id": 1519267270847, "note": "<b>Waldeyers Ring</b> is lymphoid tissue in the pharynx that is often involved in {{c1::non-Hodgkins lymphoma}}", "time": null}, {"id": 1519267330463, "note": "<b>Diffuse Large B-Cell Lymphoma</b> is most commonly caused by alterations in {{c1::<u>Bcl-2</u>}} or {{c2::<u>Bcl-6</u>}}", "time": null}, {"id": 1519401770185, "note": "<div><b>Achlorhydria</b> can cause a <b>vitamin B12 deficiency</b> by preventing <u>release</u> of B12 from {{c1::food particles}}</div>", "time": null}, {"id": 1519402577402, "note": "One cause of <b>vitamin </b>{{c2::<b>B</b><sub style=\"font-weight: bold; \">12</sub>}} <u>deficiency</u> is <b>{{c1::(SIBO) small intestinal bacterial}} overgrowth</b>", "time": null}, {"id": 1519404926368, "note": "<b>Ifosfamide</b> can cause neurotoxicity due to buildup of its metabolite {{c1::<b>chloroacetaldehyde (CAA)</b>}}, which can be treated with {{c2::<u>methylene blue</u>}}", "time": null}, {"id": 1519585463878, "note": "The <u>{{c1::recurrent laryngeal}} nerve</u> may be transected during ligation of the {{c2::inferior thyroid}} artery during thyroid surgery", "time": null}, {"id": 1519675717558, "note": "<b>{{c1::Euthyroid sick}} syndrome </b>is an apparent alteration of thyroid hormone level with <u>normal thyroid gland function</u> seen in <b>{{c2::critically ill}} patients</b>", "time": null}, {"id": 1519675855589, "note": "Most commonly, patients with <b>euthyroid sick syndrome </b>will have:<div><br /></div><div>- serum TSH {{c1::normal}}</div><div>- total serum T4 {{c1::normal}}</div><div>- total serum T3 {{c1::\u2193}}</div><div>- reverse T3 {{c1::\u2191}}</div>", "time": null}, {"id": 1519675970024, "note": "Should you start thyroid hormone replacement in a patient with <b>euthyroid sick syndrome</b>?<div><br /></div><div>{{c1::No*}}</div>", "time": null}, {"id": 1519706900037, "note": "<div>Which <b>thyroid imbalance</b> presents with <b>hyponatremia</b>?</div><div><br /></div><div>{{c1::Hypothyroidism}}</div>", "time": null}, {"id": 1519709275091, "note": "<div>Which <b>thyroid imbalance</b> presents with <b>puffy facies </b>and <b>generalized nonpitting edema</b>?</div><div><br /></div><div>{{c1::Hypothyroidism}}</div>", "time": null}, {"id": 1519710247930, "note": "<div>Which <b>thyroid imbalance</b> presents with <b>hypoactivity, lethargy, and fatigue</b>?</div><div><br></div><div>{{c1::Hypothyroidism}}</div>", "time": null}, {"id": 1519710406151, "note": "<div>Which <b>thyroid imbalance</b> presents with <b>hyperactivity, restlessness, </b>and<b> insomnia</b>?</div><div><br /></div><div>{{c1::Hyperthyroidism}}</div>", "time": null}, {"id": 1519710452983, "note": "What is the most common arrhythmia seen in <b>Hyperthyroidism</b>?<div><br></div><div>{{c1::Atrial Fibrillation}}</div>", "time": null}, {"id": 1519710900798, "note": "<div>Which <b>thyroid imbalance</b> presents with <b>increased TSH </b>(if 1*) and <b>decreased free T3 / T4</b>?</div><div><br /></div><div>{{c1::Hypothyroidism}}</div>", "time": null}, {"id": 1519711142577, "note": "<div>Which <b>thyroid imbalance</b> presents with <b>decreased TSH </b>(if 1*) and <b>increased free T3 / T4</b>?</div><div><br /></div><div>{{c1::Hyperthyroidism}}</div>", "time": null}, {"id": 1519711156220, "note": "<div>Which <b>thyroid imbalance</b> presents with <b>osteoporosis / increased fracture rate</b>?</div><div><br></div><div>{{c1::Hyperthyroidism}}</div>", "time": null}, {"id": 1519711653829, "note": "What is the most common cause of hyperthyroidism?<div><br /></div><div>{{c1::Graves disease}}</div>", "time": null}, {"id": 1519712508964, "note": "One cause of <b>cretinism</b> is {{c1::antibody}} mediated maternal hypothyroidism", "time": null}, {"id": 1519712635103, "note": "One cause of <b>cretinism</b> is thyroid {{c1::agenesis::embryological defect}}", "time": null}, {"id": 1519786017644, "note": "Do Graves ophthalmopathy symptoms often improve when you treat the hyperthyroidism?<div><br></div><div>{{c1::No}}</div>", "time": null}, {"id": 1519786106768, "note": "What <b>Graves associated</b> <u>condition</u> is made worse by cold air, wind, and bright lights?<div><br></div><div>{{c1::Graves ophthalmopathy}}</div>", "time": null}, {"id": 1519786159085, "note": "{{c1::Toxic Adenomas}} are <u>palpable</u> nodules in the thyroid that function independently", "time": null}, {"id": 1519786357173, "note": "The <b>{{c1::Jod-Basedow}} phenomenon </b>often occurs in patients with<b> toxic adenomas </b>and a drug administered with a <u>high iodine content</u>", "time": null}, {"id": 1519786900541, "note": "The most common cause of <b>cretinism</b>&nbsp;<u>worldwide</u> is <b>{{c1::Iodine Deficiency}}</b>", "time": null}, {"id": 1519788323050, "note": "<b>{{c1::Lymphocytic Thyroiditis}}</b> is a variant of hashimotos that presents with <u>transient hyperthyroidism</u> followed sometimes by <u>hypothyroidism</u>", "time": null}, {"id": 1519852994405, "note": "What cardiac complication do Kawasaki disease, sarcoidosis, SLE, and poly/dermatomyositis share?<div><br></div><div>{{c1::Myocarditis}}</div>", "time": null}, {"id": 1519853206841, "note": "Complications of <b>myocarditis</b> include arrhythmias, heart failure, {{c2::cardiogenic}} shock and {{c1::dilated}} cardiomyopathy", "time": null}, {"id": 1519858800572, "note": "What type of <b>upper airway obstruction</b> is depicted by the following flow-volume loop?<div><br /></div><div>{{c1::Variable extrathoracic obstruction}}</div><div><br /></div><div><img src=\"paste-315048736063489.jpg\" /></div>", "time": null}, {"id": 1519859133377, "note": "What type of <b>upper airway obstruction</b> is seen in<i> </i><u>vocal cord paralysis / dysfunction</u> and <u>laryngeal tumors</u>?<div><br /></div><div>{{c1::Variable extrathoracic obstruction}}</div>", "time": null}, {"id": 1519859487329, "note": "What type of <b>upper airway obstruction </b>is depicted by the following flow-volume loop?<div><br /></div><div>{{c1::Variable intrathoracic obstruction}}</div><div><br /></div><div><img src=\"paste-321705935372289.jpg\" /></div>", "time": null}, {"id": 1519860412778, "note": "What type of <b>upper airway obstruction</b> is seen in <u>tracheomalacia</u> and <u>bronchogenic cysts</u>?<div><br /></div><div>{{c1::Variable intrathoracic obstruction}}</div>", "time": null}, {"id": 1519860747841, "note": "What type of <b>upper airway obstruction</b> is depicted by the following flow-volume loop?<div><br /></div><div>{{c1::Fixed upper airway obstruction}}</div><div><br /></div><div><img src=\"paste-336751205810177.jpg\" /></div>", "time": null}, {"id": 1519861036511, "note": "What type of <b>upper airway obstruction</b> is seen in <u>tracheal stenosis</u>, <u>extraluminal goiter</u> and <u>mediastinal mass</u>?<div><br /></div><div>{{c1::Fixed upper airway obstruction}}</div>", "time": null}, {"id": 1519861613333, "note": "<b>Central sleep apnea</b> may be also caused by delayed detection / response to changes in {{c1::PaCO2}} resulting in <b>cyclic </b>({{c2::cheyne-stokes}})<b> </b>breathing", "time": null}, {"id": 1519861941136, "note": "<b>Central sleep apnea</b> is treated with {{c1::positive airway pressure}}", "time": null}, {"id": 1520274561035, "note": "<b>Histones</b> are {{c1::positively}} charged because they have a large quantity of <u>lysine</u> and <u>arginine</u> amino acids", "time": null}, {"id": 1520274742115, "note": "What process is used embryologically to cause \"Lyonization\"<div><br /></div><div>{{c1::DNA Methylation}}</div>", "time": null}, {"id": 1520275652643, "note": "\"Barr bodies\" formed by lyonization may be visible where in the cell?<div><br /></div><div>{{c1::Periphery of the nucleus}}</div>", "time": null}, {"id": 1520275730946, "note": "<b>Deamination</b> of <b>adenine</b> ultimately makes {{c1::<b>hypoxanthine</b>}}", "time": null}, {"id": 1520275767649, "note": "<b>Deamination</b> of <b>guanine</b> makes {{c1::<b>xanthine</b>}}", "time": null}, {"id": 1520277707475, "note": "In regards to <b>wrinkles of aging</b>, there is <u>{{c1::decreased}}</u> synthesis of collagen fibrils and <u>{{c2::increased}}</u> crosslinking of collagen", "time": null}, {"id": 1520277897542, "note": "A <b>direct ELISA</b> tests for a(n) {{c1::antigen}}, whereas the <b>indirect ELISA</b> tests for a(n) {{c2::antibody against an antigen}}", "time": null}, {"id": 1520278360870, "note": "Females with Turner Syndrome due to an (45,XO genotype) are more likely to have what type of concurrent disorders?<div><br /></div><div>{{c1::X-linked recessive disorders}}</div>", "time": null}, {"id": 1520278629964, "note": "What trinucleotide repeat disorder is associated with autism?<div><br />{{c1::Fragile X syndrome}}</div>", "time": null}, {"id": 1520278762361, "note": "The <b><font color=\"#aa0000\">5As</font></b> of <u>down syndrome</u> are:<div><br /></div><div><b><font color=\"#aa0000\">A</font></b>{{c1::dvanced maternal age}}</div><div><b><font color=\"#aa0000\">A</font></b>{{c2::tresia (Duodenal)}}</div><div><b><font color=\"#aa0000\">A</font></b>{{c3::trioventricular septal defect}}</div><div><b><font color=\"#aa0000\">A</font></b>{{c4::lzheimers (early onset)}}</div><div><b><font color=\"#aa0000\">A</font></b>{{c5::ML}}/<b><font color=\"#aa0000\">A</font></b>{{c5::LL}}</div>", "time": null}, {"id": 1520278995120, "note": "What microdeletion syndrome is associated with <u>supravalvular</u> aortic stenosis and renal artery stenosis?<div><br></div><div>{{c1::Williams syndrome}}</div>", "time": null}, {"id": 1520279328940, "note": "In a patient with a <b>Vitamin B12 (Cobalamin) </b>deficiency, <b>B9 (Folate)</b> supplementation will mask {{c1::hematological}} but not {{c1::neurological}} symptoms", "time": null}, {"id": 1520279394016, "note": "Vitamin {{c1::D}} deficiency is seen in patients with <u>malabsorption</u>, <u>decreased sun exposure</u>, <u>poor diet</u>, and <u>chronic kidney disease</u> ", "time": null}, {"id": 1520279913508, "note": "Vitamin {{c1::E}} <u>excess</u> increases risk of necrotizing enterocolitis in infants", "time": null}, {"id": 1520280145649, "note": "Nicotinamides (NAD+, NADP+) come from Vitamin {{c1::B3}}", "time": null}, {"id": 1520280240826, "note": "Flavin nucleotides (FAD+) come from Vitamin {{c1::B2}}", "time": null}, {"id": 1520296943511, "note": "Rupture of the thoracic duct can cause {{c1::chylothorax}}", "time": null}, {"id": 1520298958244, "note": "The <i>normal</i> neonatal thymus appears \"{{c1::sail}}-shaped\" on a Chest X-Ray", "time": null}, {"id": 1520299088400, "note": "<div>In which type of <u>immunity</u>&nbsp;is <b>microbial resistance not heritable</b>?</div><div><br></div><div>{{c1::Adaptive immunity::innate or adaptive}}</div>", "time": null}, {"id": 1520299291738, "note": "<div>In which type of <u>immunity</u> (innate or adaptive) does <b>microbial resistance persist through generations</b>?</div><div><br></div><div>{{c1::Innate immunity}}</div>", "time": null}, {"id": 1520299391760, "note": "<div>Which type of <u>immunity</u>&nbsp;utilizes <b>C-Reactive Protein</b> and <b>complement</b>?</div><div><br></div><div>{{c1::Innate immunity::innate or adaptive}}</div>", "time": null}, {"id": 1520299451730, "note": "LPS, bacterial flagellin, and viral nucleic acids are detected by the innate immune system via {{c1::<b>Pattern-Recognition</b>}} <b>Receptors</b>", "time": null}, {"id": 1520299562982, "note": "<i>NF-kB activation pathway: </i>Pattern-Recognition Receptors recognize <u>PAMPs</u> which leads to activation of {{c1::IKB}} kinase", "time": null}, {"id": 1520300013308, "note": "<div>What <i>class</i> of <u>helper T cell</u> secretes <b>IL-17, -21, and -22</b>? </div><div><br></div><div>{{c1::Th<sub>17</sub>}} </div><div><br></div><div>*<i>What does each do?</i></div>", "time": null}, {"id": 1520300267643, "note": "<div>What <i>class</i> of <u>helper T cell</u> when deficient results in mendelian susceptibility to mycobacterial disease?</div><div><br /></div><div>{{c1::Th<sub>1</sub>}} </div>", "time": null}, {"id": 1520300296240, "note": "<div>What <i>class</i> of <u>helper T cell</u> promotes immunity against extracellular microbes</div><div><br /></div><div>{{c1::Th<sub>17</sub>}} </div>", "time": null}, {"id": 1520300403523, "note": "Differentiation of <u>helper T cells</u> to <b>{{c2::Th<sub>17</sub>}}</b> is <i>inhibited</i> by {{c1::<b>IFN-\u03b3</b>}} and {{c1::<b>IL-4</b>}} (from Th1 and Th2 cells)", "time": null}, {"id": 1520300435789, "note": "<div>What <i>class</i> of <u>helper T cell</u> when deficient results in Hyper-IgE syndrome?</div><div><br /></div><div>{{c1::Th<sub>17</sub>}} </div>", "time": null}, {"id": 1520300460306, "note": "<div>What <i>class</i> of <u>helper T cell</u> secretes <b>TGF-B, IL-10, and IL-35</b>? </div><div><br></div><div>{{c1::Regulatory T cell}} </div>", "time": null}, {"id": 1520300810177, "note": "The <u>macrophage-lymphocyte interaction</u> is also enhanced by interaction of T cell {{c1::CD40L}} with {{c1::CD40}} on macrophages", "time": null}, {"id": 1520301453074, "note": "Type I Interferons increase cell surface expression of {{c1::MHC}} proteins to facilitate recognition of infected cells", "time": null}, {"id": 1520348845643, "note": "<div>What <u>type of vaccine</u> is the <b>Adenovirus vaccine</b>? </div><div><br /></div><div>{{c1::Live non-attenuated}}</div>", "time": null}, {"id": 1520349090462, "note": "<div>In what sole <u>population</u> is the <b>Adenovirus vaccine </b>indicated?</div><div><br /></div><div>{{c1::Military recruits}}</div>", "time": null}, {"id": 1520349342170, "note": "<div>Which type of <u>vaccine</u> has the <u>lowest</u> chance of <b>adverse reactions?</b></div><div><br /></div><div>{{c1::Subunit}}</div>", "time": null}, {"id": 1520349496885, "note": "<div>Which types of <u>vaccines</u> <b>usually</b> requires <b>booster shots</b>?</div><div><br /></div><div>{{c1::Killed/inactivated vaccine}}</div>", "time": null}, {"id": 1520349610883, "note": "<div>Which type of <u>vaccine</u> is typically the <b>most expensive</b>?</div><div><br /></div><div>{{c1::Subunit}}</div>", "time": null}, {"id": 1520349635265, "note": "<div>Which type of <u>vaccine</u> includes only the antigens which <b>best stimulate the immune system</b>? </div><div><br /></div><div>{{c1::Subunit}}</div>", "time": null}, {"id": 1520349768071, "note": "<div>What <u>type of vaccine</u> is the <b>HBV vaccine</b>? </div><div><br /></div><div>{{c1::Subunit}}</div>", "time": null}, {"id": 1520349810324, "note": "<div>What <u>type of vaccine</u> is the <b>HPV vaccine</b>? </div><div><br /></div><div>{{c1::Subunit}}</div>", "time": null}, {"id": 1520349838418, "note": "<div>What <u>type of vaccine</u> is the <b>acellular pertussis (aP) vaccine</b>? </div><div><br /></div><div>{{c1::Subunit}}</div>", "time": null}, {"id": 1520350020005, "note": "<div>What <u>type of vaccine</u> are the <b>Meningococcal vaccines</b>? </div><div><br /></div><div>{{c1::Subunit}}</div>", "time": null}, {"id": 1520350299216, "note": "Is the <u>conjugate vaccine</u> or the <u>polysaccharide vaccine</u> the only meningococcal vaccine indicated for <b>people older than 55</b>?<div><br></div><div>{{c1::*Conjugate}}</div>", "time": null}, {"id": 1520350346925, "note": "<div>What <u>type of vaccine</u> are the <b>pneumococcal vaccines</b>? </div><div><br /></div><div>{{c1::Subunit}}</div>", "time": null}, {"id": 1520350497804, "note": "<div>What <u>type of vaccine</u> is the <b>Hib vaccine</b>? </div><div><br /></div><div>{{c1::Subunit}}</div>", "time": null}, {"id": 1520350606644, "note": "<div>Which type of <u>vaccine</u> protects against <b>bacterial toxins?</b></div><div><br /></div><div>{{c1::Toxoid}}</div>", "time": null}, {"id": 1520350649105, "note": "<div><div>Which type of <u>vaccine</u> <b>may</b> require a <b>booster</b>?</div><div><br /></div><div>{{c1::Toxoid}}</div></div>", "time": null}, {"id": 1520350698792, "note": "<b>Toxoid vaccines</b> are composed of a <u>denatured</u> bacterial toxin with an intact {{c1::receptor binding site}}", "time": null}, {"id": 1520350737368, "note": "Does administration of the Toxoid vaccine itself have any potential for causing disease?<div><br /></div><div>{{c1::No}}</div>", "time": null}, {"id": 1520350800405, "note": "<div>What <u>type of vaccine</u> is the <b>Tetanus vaccine</b>? </div><div><br /></div><div>{{c1::Toxoid}}</div>", "time": null}, {"id": 1520351096121, "note": "<div>What <u>type of vaccine</u> is the <b>Diphtheriae vaccine</b>? </div><div><br /></div><div>{{c1::Toxoid}}</div>", "time": null}, {"id": 1520351135706, "note": "<div>What type of <u>hypersensitivity reaction</u> is the <b><i>Candida</i> extract test</b>? </div><div><br /></div><div>{{c1::Type IV HSR (CD4 Mediated)}}</div>", "time": null}, {"id": 1520354097521, "note": "<div>Which <u>blood transfusion reaction</u> can be caused by <b>cytokines</b> which are created and accumulate during the <u>storage of blood products</u><br></div><div><br></div><div>{{c1::Febrile nonhemolytic transfusion reaction}}</div>", "time": null}, {"id": 1520440331083, "note": "Which <u>cellular adaptation</u> is usually preceded by persistent metaplasia or pathologic hyperplasia?<div><br /></div><div>{{c1::Dysplasia}}</div>", "time": null}, {"id": 1520443329636, "note": "Ischemia can occur due to {{c1::hypoperfusion}} (ex. shock)", "time": null}, {"id": 1520443344519, "note": "What are anatomical locations that receive blood supply from the most distal branches of 2 arteries with <u>limited</u> collateral vascularity known as?<div><br></div><div>{{c1::Watershed areas (border zones)}}</div>", "time": null}, {"id": 1520443529180, "note": "One cardinal sign of <u>inflammation</u> is <b>{{c1::Functio laesa}}</b>, or <b>loss of function</b>", "time": null}, {"id": 1520444046369, "note": "{{c1::Acute phase reactants}} are {{c2::liver}} produced factors whose serum concentrations change significantly in response to inflammation", "time": null}, {"id": 1520444181815, "note": "Are acute phase reactants produced by liver in acute or chronic inflammatory states?<div><br></div><div>{{c1::Both :)}}</div>", "time": null}, {"id": 1520444212406, "note": "What <b>acute phase reactant</b> is <u>upregulated</u> during inflammation to bind and sequester iron to inhibit microbial iron scavenging?<div><br /></div><div>{{c1::Ferritin}}</div>", "time": null}, {"id": 1520444263822, "note": "What <b>acute phase reactant</b> is <u>upregulated</u> during inflammation to promote endothelial repair?<div><br /></div><div>{{c1::Fibrinogen}}</div>", "time": null}, {"id": 1520444298927, "note": "What <b>acute phase reactant</b> is <u>upregulated</u> during inflammation that correlates with ESR<div><br /></div><div>{{c1::Fibrinogen}}</div>", "time": null}, {"id": 1520444509518, "note": "What class of <b>acute phase reactant</b> that when <u>upregulated</u> during <u>chronic</u> inflammation can lead to amyloidosis?<div><br /></div><div>{{c1::serum amyloid A proteins}}</div>", "time": null}, {"id": 1520444679068, "note": "What <b>acute phase reactant</b> is <u>upregulated</u> during inflammation to prevent iron release from macrophages and enterocytes?<div><br /></div><div>{{c1::Hepcidin}}</div>", "time": null}, {"id": 1520445108362, "note": "What <b>acute phase reactant</b> is <u>upregulated</u> during inflammation to opsonize targets, fix complement and facilitate phagocytosis?<div><br></div><div>{{c1::C-reactive protein}}</div>", "time": null}, {"id": 1520445157941, "note": "What <b>acute phase reactant</b> can be measured clinically as a nonspecific sign of ongoing inflammation?<div><br /></div><div>{{c1::C-reactive protein}}</div>", "time": null}, {"id": 1520445172196, "note": "What <b>acute phase reactant</b> is <u>downregulated</u> during inflammation to conserve amino acids for positive reactants?<div><br /></div><div>{{c1::Albumin}}</div>", "time": null}, {"id": 1520445197524, "note": "What <b>acute phase reactant</b> is <u>downregulated</u> during inflammation by being internalized into macrophages to sequester iron?<div><br /></div><div>{{c1::Transferrin}}</div>", "time": null}, {"id": 1520633332152, "note": "<b>Diffuse esophageal spasm</b> is associated with {{c1::GERD}}", "time": null}, {"id": 1520701430032, "note": "<b>Homatropine</b> is {{c1::muscarinic::general class}} antagonist used as a <u>cycloplegic / mydriatic</u>", "time": null}, {"id": 1520701559102, "note": "<b>Tropicamide</b> is a(n) {{c1::muscarinic::general class}} antagonist used as a <u>cycloplegic / mydriatic</u>", "time": null}, {"id": 1520709291667, "note": "When <u>total myocardial ischemia</u> lasts less than 30 minutes, restoration of blood flow leads to {{c1::reversible contractile}}&nbsp;dysfunction", "time": null}, {"id": 1520709411746, "note": "Patients with <b>{{c1::carotid sinus}} hypersensitivity</b> are at increased risk of <u>syncope / lightheadedness</u> when pressure is applied around the neck (ex. a tight shirt collar)", "time": null}, {"id": 1520709952510, "note": "Enteric bacteria (Gut flora) produce vitamins, <u>particularly</u> Vitamins {{c1::K}} and {{c1::B9}}", "time": null}, {"id": 1520711589397, "note": "Does the following <b>cardiac/vascular function</b> graph reflect a patient with <u>chronic anemia</u> or <u>anaphylaxis</u>?<div><br /></div><div>{{c1::Chronic Anemia}}</div><div><br /></div><div><img src=\"paste-862004231274497.jpg\" /></div>", "time": null}, {"id": 1520712861176, "note": "The <b>{{c1::ilioinguinal}}</b> <b>nerve</b> (<b>{{c2::L1}}</b>) carries sensation from the skin of medial upper thigh, root of the penis, and upper part of the scrotum / mons pubis + labia major", "time": null}, {"id": 1520713697891, "note": "The <b>{{c1::inferior hypogastric}} plexus</b> innervates internal pelvic viscera", "time": null}, {"id": 1520713733324, "note": "<b>SMA syndrome </b>can occur due to pronounced <u>lordosis</u> or surgical correction of {{c1::scoliosis}}", "time": null}, {"id": 1520714239512, "note": "On CT, <b>{{c1::constrictive pericarditis}}</b> presents with <u>calcification</u> and <u>thickening</u> of the pericardium", "time": null}, {"id": 1520714481780, "note": "What vertebral level is this CT image taken at?<div><br></div><div>{{c1::T12/L1}}</div><div><br></div><div><img src=\"paste-884170557489153.jpg\" style=\"width: 626px;\"></div>", "time": null}, {"id": 1520717134280, "note": "<b>Systemic amyloidosis</b> can have <u>hematologic manifestations</u>, including splenomegaly and <b>{{c1::periorbital}}</b> <b>purpura</b>", "time": null}, {"id": 1520717469155, "note": "<b>Systemic amyloidosis</b> can have <u>gastrointestinal manifestations</u>, including hepatomegaly, malabsorption and <b>{{c1::macro}}glossia</b>", "time": null}, {"id": 1520717686972, "note": "<div>Does the adrenal medulla have postganglionic sympathetic fibers?</div><div><br /></div><div>{{c1::No}}</div>", "time": null}, {"id": 1520717768604, "note": "Sweat glands are part of the sympathetic pathway, but the innervating postganglionic sympathetic fibers release {{c1::acetylcholine}}", "time": null}, {"id": 1520717800484, "note": "The renal vasculature smooth muscle is part of the sympathetic pathway, but the innervating postganglionic sympathetic fibers release {{c1::dopamine}} instead of norepinephrine", "time": null}, {"id": 1520718033975, "note": "<b>\u03b2-blockers</b> are useful in the <u>prophylactic</u> management of <b>variceal bleeding</b> by decreasing the hepatic {{c2::venous pressure}} gradient and {{c1::portal}} hypertension", "time": null}, {"id": 1520718315885, "note": "Activation of which sympathetic receptor leads to <u>increased lipolysis</u>, <u>increased thermogenesis</u> in skeletal muscle, and <u>increased bladder relaxation</u>?<div><br></div><div>{{c1::\u03b23}}</div>", "time": null}, {"id": 1520718423027, "note": "<b>Nebivolol</b> <u>blocks</u> \u03b2{{c1::1}} receptors and <u>stimulates</u> \u03b2{{c1::3}} receptors", "time": null}, {"id": 1520718485657, "note": "The <b>Beers criteria</b> are used to reduce potential inappropriate prescribing and harmful polypharmacy in the {{c1::geriatric}} population", "time": null}, {"id": 1520719709530, "note": "<div><div>What does <b>\u03c3 </b>represent in regards to capillary fluid exchange?</div><div><br></div><div>{{c1::Reflection coefficient}}</div></div>", "time": null}, {"id": 1520720062422, "note": "In regards to <u>myocardial infarction complications</u>, LV hypertrophy and previous MI protect against {{c1::ventricular free wall}} rupture", "time": null}, {"id": 1520720709904, "note": "The <u>acute</u> form of <b>ventricular free wall rupture</b> usually leads to {{c1::sudden death}}", "time": null}, {"id": 1520723677811, "note": "<div><div>The following drugs are good for Hypertension and Heart Failure as they help prevent {{c1::cardiac remodeling}}</div></div><div><br></div><div>ACE inhibitors,&nbsp;\u03b2-blockers (compensated HF), and Aldosterone Antagonists</div>", "time": null}, {"id": 1520723775776, "note": "<div>Patients with hypertension and what comorbidity should replace ACE inhibitors with ARBs and nonselective \u03b2-blockers with cardioselective \u03b2-blockers?</div><div><br></div><div>{{c1::Obstructive Lung Disease}}<br><div><br></div><div><img src=\"paste-395149876133889.jpg\"></div></div>", "time": null}, {"id": 1520723840491, "note": "<div>To remember the drugs that are safe to treat hypertension in pregnancy: <img src=\"paste-395965919920129.jpg\"></div><div><br></div><div>H{{c1::ydralazine}}</div><div>L{{c1::abetalol}}</div><div>M{{c1::ethyldopa}}</div><div>N{{c1::ifedipine}}<br></div>", "time": null}, {"id": 1520724862215, "note": "The osmotic diuresis in diabetic ketoacidosis may lead to fatal arrhythmias by causing {{c1::total body K+}} depletion", "time": null}, {"id": 1520725702188, "note": "Patients taking <b>sevelamer </b>can develop <u>hypophosphatemia</u> and {{c1::GI upset::GI side effect}}", "time": null}, {"id": 1520726028342, "note": "Is <b>Gastroschisis</b> associated with chromosomal abnormalities?<div><br /></div><div>{{c1::No}}</div>", "time": null}, {"id": 1520726155922, "note": "Is <b>omphalocele</b> associated with chromosomal abnormalities?<div><br /></div><div>{{c1::Yes}}</div>", "time": null}, {"id": 1520726177396, "note": "Which ventral wall defect is associated with <b>Beckwith Wiedemann Syndrome</b>?<div><br /></div><div>{{c1::Omphalocele}}</div>", "time": null}, {"id": 1520726204602, "note": "Which ventral wall defect is associated with cardiac, GU, neural tube based structural abnormalities?<div><br /></div><div>{{c1::Omphalocele}}</div>", "time": null}, {"id": 1520726228244, "note": "An ultrasound of a patient with <b>hypertrophic pyloric stenosis</b> shows a(n) {{c1::thickened}} and {{c1::lengthened}} pylorus", "time": null}, {"id": 1520726299596, "note": "Injuries to the displayed structures can cause an accumulation of <b>blood</b> or <b>gas </b>in the {{c1::retroperitoneal space (<b>Retroperitoneal Hematoma</b>)}}<div><br /></div><div><img src=\"paste-447170520023041.jpg\" /></div>", "time": null}, {"id": 1520726446562, "note": "The <b>rectosigmoid junction (sudeck point)</b> is a watershed region supplied by the last sigmoid arterial branch from the {{c1::IMA}} and the {{c2::superior rectal artery}}", "time": null}, {"id": 1520727088485, "note": "<b>M\u00e9n\u00e9trier</b>&nbsp;<b>disease </b>presents with {{c1::epigastric}} pain, anorexia, weight loss, vomiting, and edema (due to {{c2::protein loss}})", "time": null}, {"id": 1520728409770, "note": "<b>{{c1::Non-alcoholic steatohepatitis}}</b> is the most severe form of <b>Nonalcoholic fatty liver disease</b>", "time": null}, {"id": 1520728891667, "note": "<b>Spontaneous bacterial peritonitis </b>is treated empirically with a(n) {{c1::3rd generation cephalosporin}}", "time": null}, {"id": 1520729012293, "note": "What is the curative treatment for Crigler-Najjar syndrome?<div><br /></div><div>{{c1::Liver transplant}}</div>", "time": null}, {"id": 1520729160540, "note": "Thrombopoietin stimulates {{c1::megakaryocyte}} proliferation and is <i>made</i> in the {{c1::liver}}", "time": null}, {"id": 1520730688999, "note": "Initially <b>immune thrombocytopenia</b> can be treated with steroids, but if it becomes refractory the patient can be given {{c1::rituxi}}mab <div><br /></div><div><i>Bonus*- what drug inhibits the macrophages? </i></div>", "time": null}, {"id": 1520813115603, "note": "A needle should be positioned for a <u>tension pneumothorax</u> at the {{c1::5th*}} ICS along the {{c1::anterior-axillary}} line", "time": null}, {"id": 1520813884614, "note": "Depending on heart size, the <b>point</b> of <b>maximal</b> apical<b> impulse</b> can be felt at the <u>{{c1::5th}} left ICS</u>", "time": null}, {"id": 1520814510779, "note": "In the normal heart, the aorta is {{c2::<u>posterior</u>}} and to the {{c2::<u>right</u>}} of the pulmonary artery; whereas in <b>D-transposition of the great vessels</b>, the aorta is {{c1::<u>anterior</u>}} and to the {{c1::<u>right</u>}} of the pulmonary artery", "time": null}, {"id": 1520815355947, "note": "When placing a <b>biventricular pacemaker</b>, the three leads are placed in the:<div><br /></div><div>- right atrium </div><div>- right ventricle</div><div>- {{c1::coronary sinus}}</div>", "time": null}, {"id": 1520899975915, "note": "Is the <b>external iliac artery</b> intraperitoneal, extraperitoneal, or retroperitoneal?<div><br></div><div>{{c1::Retroperitoneal}}</div>", "time": null}, {"id": 1520900253563, "note": "The external iliac artery becomes the femoral artery as it crosses the {{c1::inguinal ligament}}", "time": null}, {"id": 1520900503633, "note": "Because <b>Class IC antiarrhythmics</b> have a <u>strong</u> binding affinity and dissociate primarily during <u>diastole</u>, a(n) {{c2::increased}} heart rate results in a longer {{c1::QRS}} complex", "time": null}, {"id": 1520900992240, "note": "What class of <b>anti</b><b style=\"\">arrhythmics</b>&nbsp;will prolong <u>QRS duratio</u>n?<div><br></div><div>{{c1::Class I antiarrhythmics::I, II, III, or IV}}</div>", "time": null}, {"id": 1520901090909, "note": "Characteristic histological findings of <b>GERD </b>include {{c3::<u>basal zone</u>}} <u>hyperplasia</u>, elongation of the {{c2::<u>lamina propria papillae</u>}}, and scattered {{c1::<u>eosinophils</u>}} and <u>neutrophils</u>", "time": null}, {"id": 1520901347807, "note": "{{c3::<b>Dihydroergotamine</b>}}&nbsp;is not frequently used for migraine treatment due to its significant side effect profile, including {{c1::gangrene}} and {{c2::vasospastic (prinzmetal) angina}}", "time": null}, {"id": 1520903002174, "note": "A<b> bicuspid aortic valve</b> presents with a <u>soft</u> systolic early ejection murmur that radiates to the {{c1::neck}} with a high frequency {{c2::<u>ejection click</u>::extra sound}}", "time": null}, {"id": 1520903285210, "note": "Which lymph node cluster drains the splenic flexure and the upper descending colon?<div><br></div><div>{{c1::Left colic lymph nodes}}</div>", "time": null}, {"id": 1520905674180, "note": "Is pulmonary hypertension due to left heart disease usually at least partially reversible following correction of underlying abnormality?<div><br></div><div>{{c1::Yes}}</div>", "time": null}, {"id": 1520906706487, "note": "Does renal function change with age?<div><br /></div><div>{{c1::Yes}}</div>", "time": null}, {"id": 1520947799743, "note": "<b>Methotrexate</b> <u>rarely</u> causes a(n) {{c1::nephro}}toxicity", "time": null}, {"id": 1520948020649, "note": "<b>Procarbazine</b> is a chemotherapeutic {{c1::alkylating}} agent used to treat Hodgkins lymphoma and brain tumors", "time": null}, {"id": 1520948242706, "note": "<b>Procarbazine</b> has notable side effects; including {{c2::pulmonary}} toxicity and {{c1::leuk}}emia<div><br></div><div>*<i>bonus: pts shouldnt eat what food?</i></div>", "time": null}, {"id": 1520948267256, "note": "In a(n)&nbsp;<b>{{c1::greenstick::greenstick or torus}}</b> <b>fracture,&nbsp;</b>the&nbsp;<u>compression</u> side is intact, bone fails on <u>tension</u> side", "time": null}, {"id": 1520948678127, "note": "In a(n) {{c1::<b>torus (buckle)</b>::<b>greenstick or torus (buckle)</b>}} <b>fracture,</b>&nbsp;the <u>compression</u> side cortex fails while the bone remains intact on <u>tension</u> side", "time": null}, {"id": 1520973386455, "note": "How long does it take for <b>constrictive pericarditis</b> to occur?<div><br /></div><div>{{c1::Several weeks to months}}</div>", "time": null}, {"id": 1520973569166, "note": "Is <b>pulsus paradoxus</b> typically seen in patients with myocarditis?<div><br /></div><div>{{c1::No}}</div>", "time": null}, {"id": 1520973601210, "note": "Patients with <b>Cardiac Tamponade</b> have an enlarged \"{{c1::water bottle}}\" shaped heart on chest x-ray", "time": null}, {"id": 1520973784131, "note": "<b>Cardiac tamponade</b> may be caused by malignancies / {{c3::radiation}} therapy; infections (most commonly {{c1::viral}}), drugs, and {{c2::connective}} tissue diseases", "time": null}, {"id": 1520974064907, "note": "Absolute contraindications to OCPs include:<div>- prior / family history of {{c1::stroke}}</div><div>- history of a(n) {{c2::estrogen}} dependent tumor</div><div>- women over 35 who {{c3::smoke}} heavily</div>", "time": null}, {"id": 1521069443308, "note": "What effect does <b>carotid massage </b>have on <b>AV node refractory period</b>?<div><br /></div><div>{{c1::Prolongation}}</div>", "time": null}, {"id": 1521069633928, "note": "A <b>carotid massage</b> temporarily inhibits the activity of the {{c1::SA}} node", "time": null}, {"id": 1521070575911, "note": "<b>Vagal maneuvers</b> can be used to acutely terminate which arrhythmia?<div><br /></div><div>{{c1::Paroxysmal Supraventricular Tachycardia (PSVT)}}</div>", "time": null}, {"id": 1521070746065, "note": "<b>Fidaxomicin </b>is indicated for recurrent cases of infection by <b>{{c1::<i>Clostridioides difficile</i>}} </b>", "time": null}, {"id": 1521071051694, "note": "Is the recurrence rate of C<i>. difficile </i>colitis lower or higher when taking<b> Fidaxomicin</b> than with vancomycin?<div><br></div><div>{{c1::Significantly lower}}</div>", "time": null}, {"id": 1521071262903, "note": "Does <b>fidaxomicin</b> have a weaker or stronger effect on normal colonic flora than metronidazole or vancomycin? <div><br /></div><div>{{c1::weaker}}</div>", "time": null}, {"id": 1521071357761, "note": "On a CT of the <b>thorax</b>, the <b>{{c1::trachea}}</b> is a good landmark to localize the <u>esophagus</u> (located posteriorly) and the <u>great vessels</u> (located anteriorly)", "time": null}, {"id": 1521071732308, "note": "If compression of the hepatoduodenal ligament via a <b>Pringle maneuver</b> does not cease bleeding, the source of the <b>RUQ bleed </b>is most likely the {{c1::<u>inferior vena cava</u>}} or the {{c2::<u>hepatic vein</u>}}", "time": null}, {"id": 1521073354169, "note": "Approximately 90% of left atrial thrombi are found within the <b>{{c1::left atrial appendage}}</b> in patients with nonvalvular <b>atrial fibrillation</b>", "time": null}, {"id": 1521073580598, "note": "<b>Atrial</b> {{c1::<b>flutter</b>}} is most often caused by a <u>re-entrant</u> current that rotates around the {{c2::<b>tricuspid annulus</b>}}", "time": null}, {"id": 1521075844350, "note": "Patients who are being infused with <b>norepinephrine</b> and develop <u>rigid induration</u> and <u>pallor</u> around the IV site can be treated with a local injection of {{c1::phentolamine}}", "time": null}, {"id": 1521077870349, "note": "Patients with <b>pericarditis </b>present with <b>{{c1::pleuritic}} </b>chest pain and is relieved by <b>{{c2::postural}} changes</b>", "time": null}, {"id": 1521079313083, "note": "The anastomosis of what arteries allows perfusion of the <b>celiac trunk</b> and the <b>SMA</b> by each other in cases where either is <u>thrombosed</u> or <u>ligated</u>?<div><br></div><div>{{c1::Superior and inferior pancreaticoduodenal arteries}}</div>", "time": null}, {"id": 1521135744299, "note": "<div><b>Juvenile polyps</b> are <u>benign</u> with {{c1::some}} <b>malignant potential</b> </div>", "time": null}, {"id": 1521156441953, "note": "<b>{{c2::Gastric (fundal) varices}}</b> result from <u>portosystemic shunting</u> between the <b>{{c1::short gastric veins}}</b> (portal) and <b>{{c1::inferior phrenic}}</b> (systemic)<b> vein</b>", "time": null}, {"id": 1521156796178, "note": "<b>{{c2::Descending colon varices}}</b> result from <u>portosystemic shunting</u> between the <b>{{c1::left colic vein}}</b> (portal) and <b>{{c1::retroperitoneal (of Retzius)}}</b> (systemic)<b> veins</b>", "time": null}, {"id": 1521168066019, "note": "A deficiency in <b>{{c1::methylene tetrahydrofolate reductase (MTHFR)}} </b>is the most common genetic cause of <b>hyperhomocysteinemia</b>", "time": null}, {"id": 1521168535183, "note": "A <b>pericardial knock </b>is a brief, high frequency, precordial sound heard in early {{c2::diastole}} in patients with <b>{{c1::constrictive pericarditis}}</b>", "time": null}, {"id": 1521169448163, "note": "<b>Edema</b> may be caused by {{c1::sodium}} and {{c1::water}} retention", "time": null}, {"id": 1521170266917, "note": "On an <u>abdominal CT scan</u>, the <b>pancreas</b> can be identified by:<div>- its head in close association with the {{c1::2nd}} part of the duodenum</div><div>- its body overlying the {{c1::abdominal aorta::vasculature}}</div>", "time": null}, {"id": 1521171381704, "note": "What pathology presents with mid-anterior chest wall pain, shortness of breath, persistent tachycardia, and new conduction defects on ECG (ex. bundle branch block)<div><br /></div><div><b>{{c1::Blunt cardiac injury</b><b>}}</b></div>", "time": null}, {"id": 1521171476528, "note": "<b>Breast milk jaundice</b> causes a(n) {{c1::indirect}} <b>hyperbilirubinemia</b> that peaks at age 2", "time": null}, {"id": 1521171636462, "note": "<b>Breast milk jaundice </b>is likely caused by the presence of {{c1::\u03b2-glucuronidase}} in breast milk", "time": null}, {"id": 1521219262065, "note": "<b>Biliary atresia </b>is treated with <u>Kasai</u> liver procedure, which attaches the {{c1::distal duodenum}} to the liver", "time": null}, {"id": 1521260466186, "note": "Because <b>milrinone</b> causes both systemic <u>arteriolar</u> and <u>venous</u> dilation, it should not be used in severely {{c1::hypotensive}} patients", "time": null}, {"id": 1521260945563, "note": "Due to the <u>high degree of oxygen extraction</u> by the <b>myocardium</b>, increases in myocardial oxygen demand can only be met by an increase in {{c1::coronary blood flow}}", "time": null}, {"id": 1521261347590, "note": "Patients with <b>Nutcracker syndrome </b>can develop a left sided {{c1::varicocele}}", "time": null}, {"id": 1521262212406, "note": "<b>{{c2::Reye}} syndrome</b> is characterized by <u>{{c1::micro}}-vesicular</u> <b>fatty change</b>", "time": null}, {"id": 1521264391869, "note": "<b>Costosternal syndrome (costochondritis)</b> typically presents after <u>repetitive activity</u> and involves the upper costal cartilage at the {{c1::costochondral}} or {{c1::costosternal}} junctions", "time": null}, {"id": 1521421074806, "note": "<b>Pulsus paradoxus </b>is quantified by measuring the variation of <b>{{c1::systolic}} </b>pressure during expiration and inspiration", "time": null}, {"id": 1521423123567, "note": "Patients who have been hit by <b>lightning </b>will present with a characteristic {{c1::lichtenburg figure}} skin finding", "time": null}, {"id": 1521423417543, "note": "While <b>lightning injuries</b> are <u>rare</u>, the most common cause of death is a(n) {{c1::arrhythmia}}", "time": null}, {"id": 1521423729086, "note": "Patients with <b>renal artery stenosis</b> may eventually develop renal {{c1::atrophy}}", "time": null}, {"id": 1521424037362, "note": "The hallmark histologic findings of acute {{c1::viral}} hepatitis include <u>hepatocyte necrosis</u> and apoptosis with <b>mononuclear</b> infiltration", "time": null}, {"id": 1521424595880, "note": "In severe cases of acute viral hepatitis, adjacent lobules are interconnected by swaths of dead hepatocytes called \"{{c1::bridging necrosis}}\"", "time": null}, {"id": 1521425420243, "note": "The <u>major determinant</u> of whether or not a coronary artery plaque will cause ischemic myocardial injury is the <b>rate of </b>{{c1::arterial occlusion}}", "time": null}, {"id": 1521427798951, "note": "Both polymyositis and dermatomyositis are associated with {{c1::interstitial lung}} disease", "time": null}, {"id": 1521498851107, "note": "Isolated <b>gastric fundal varices</b> are seen in <b>{{c1::splenic vein}} thrombosis</b>", "time": null}, {"id": 1521499586481, "note": "<b>Umbilical hernias </b>are specifically due to a defect in the {{c1::linea alba::anatomical structure}}", "time": null}, {"id": 1521500510750, "note": "{{c1::<b>Hiatal</b>}} <b>hernias</b> are found in about half of patients with <u>Mallory Weiss syndrome</u> and are considered a strong predisposing factor", "time": null}, {"id": 1521501908794, "note": "Patients with <b>acute viral hepatitis</b> present with a(n) {{c1::prodrome}} of fever, malaise, anorexia, nausea and vomiting", "time": null}, {"id": 1521503280286, "note": "After several days (up to 1 week) of <b>acute viral hepatitis prodrome</b>, signs of cholestasis develop; jaundice, pruritus, {{c1::dark}}-colored urine, and {{c2::acholic}} stool", "time": null}, {"id": 1521503816382, "note": "<b>Phlegmasia alba dolens</b> (painful white \"milk\" leg) is a result of massive {{c1::common iliac}} vein occlusion", "time": null}, {"id": 1521570177833, "note": "<div>What <u>leads</u> (1) show <b>ST elevations</b> or <b>Q waves</b> in a&nbsp;<b>Left Main (LCA)</b> myocardial infarction? </div><div><br></div><div>{{c1::aVR}}</div>", "time": null}, {"id": 1521573734382, "note": "Because <i>Vibrio vulnificus</i>, <i>Yersinia spp</i>, and <i>Listeria</i> are {{c1::siderophilic}}, they more commonly infect patients with <b>Hemochromatosis</b>", "time": null}, {"id": 1521591610410, "note": "In regards to the development of <b>infective endocarditis;</b> {{c1::mitral valve prolapse}} is the most common underlying valvular disease in <u>developed countries</u>, whereas {{c1::rheumatic heart disease}} is the most common underlying valvular disease in <u>non-developed countries</u>", "time": null}, {"id": 1521591883921, "note": "<b>Gallbladder hypomotility</b> is associated with what kind of gallstone?<div><br /></div><div>{{c1::Cholesterol gallstones}}</div>", "time": null}, {"id": 1521596607286, "note": "The primary way unabsorbed copper is eliminated is by excretion into {{c1::bile}}", "time": null}, {"id": 1521597449484, "note": "<b>Intussusception</b> is most common in patients under {{c1::2}} years old", "time": null}, {"id": 1521680301551, "note": "The <b>great saphenous vein</b> joins the femoral vein in the {{c1::femoral triangle}}", "time": null}, {"id": 1521680487909, "note": "The {{c1::right ventricle}} composes the majority of the anterior surface of the heart", "time": null}, {"id": 1521681348591, "note": "During <u>systole</u>, is there relatively constant blood flow in the left ventricles coronary arteries?<div><br></div><div>{{c1::No}}</div>", "time": null}, {"id": 1521681443682, "note": "<b>Myxomatous degeneration </b>in the tunica media is found in {{c1::cystic medial degeneration}}, which predisposes to the development of aortic {{c2::dissections}} / aortic {{c2::aneurysms}}", "time": null}, {"id": 1521682607614, "note": "<b>Supine hypotension syndrome</b> occurs when a pregnant woman lies on her back, and is due to the gravid uterus compressing the {{c1::inferior vena cava}}", "time": null}, {"id": 1521683025324, "note": "One complication of <u>Crohn disease</u> is a(n) <b>{{c1::enterocutaneous}}&nbsp;</b><b>fistula</b>, which can cause bowel contents to drain to the surface of the skin", "time": null}, {"id": 1521683773931, "note": "Which cardiac tumor often causes systemic / constitutional symptoms (fevers, chills, sweats)?<div><br /></div><div>{{c1::Myxoma}}</div>", "time": null}, {"id": 1521765720666, "note": "Patients with <b>severe aortic stenosis</b> depend upon {{c1::atrial contraction}} for maintenance of <u>preload</u>", "time": null}, {"id": 1521765959144, "note": "<b>Mesenteric adenitis</b> is most commonly associated with {{c1::Yersinia enterocolitica}}", "time": null}, {"id": 1521766804955, "note": "The presence of a <b>fluid filled cavity</b> in the <u>liver</u> in conjunction with fevers, chills, and RUQ pain is suggestive of a(n) {{c1::hepatic abscess}}", "time": null}, {"id": 1521767844229, "note": "In developed countries, <b>hepatic abscesses</b> have a(n) {{c1::low}} incidence and are caused by {{c1::bacterial}} infection in 80% of cases", "time": null}, {"id": 1521767902862, "note": "<b>Pyogenic bacteria</b> <i>typically</i> gain access to the <u>liver</u> through either a(n) {{c1::biliary tract infection (ascending cholangitis)}} or {{c2::portal vein pyemia}}", "time": null}, {"id": 1521768379649, "note": "Obstruction of the {{c1::<b>brachiocephalic vein</b>}} causes symptoms similar to those seen in <u>SVC syndrome</u>, but only on one side of the body", "time": null}, {"id": 1521768713296, "note": "Is the incidence of <u>torsades de pointes</u>&nbsp;with&nbsp;<u>amiodarone</u> higher or lower than other drugs that prolong the QT?<div><br></div><div>{{c1::Much lower}}</div>", "time": null}, {"id": 1521770300052, "note": "Patients with <b>acute</b> {{c1::<b>decompensated</b>}} <b>heart failure</b> typically present with progressive {{c3::dyspnea}}, orthopnea, lower extremity edema, along with bilateral crackles / wheezing (known as {{c2::cardiac asthma}})", "time": null}, {"id": 1521770693590, "note": "{{c1::<b>Kerley B</b>}} lines may also be seen on a <u>chest x-ray</u> of a patient with <b>acute</b> <b>decompensated heart failure</b>", "time": null}, {"id": 1521770739776, "note": "<div>The following CXR is highly suggestive of what pulmonary pathology?</div><div><br /></div><div> {{c1::Pneumothorax}}</div><div><br /></div><div><img src=\"paste-18000207937537.jpg\" /></div>", "time": null}, {"id": 1521770922392, "note": "<div><div>The following CXR is highly suggestive of what restrictive pulmonary pathology in a ~ 50 year old man?</div><div><br></div><div>{{c1::Idiopathic Pulmonary Fibrosis}}</div></div><div><br></div><div><img src=\"paste-395368919465985.jpg\"></div>", "time": null}, {"id": 1521770989953, "note": "<b>Villous adenomas</b> can cause {{c1::secretory}} diarrhea, hypovolemia, and electrolyte abnormalities", "time": null}, {"id": 1521917653168, "note": "A bifid carotid pulse with a brisk upstroke is characteristic of {{c1::hypertrophic cardiomyopathy}}", "time": null}, {"id": 1521917877679, "note": "<b>Holiday Heart Syndrome </b>describes the precipitation of {{c1::atrial fibrillation}} after excessive alcohol consumption", "time": null}, {"id": 1521918626073, "note": "Patients with <b>recurrent DVTs</b> can be given a(n) {{c1::IVC filter}} if they have contraindications to anticoagulation", "time": null}, {"id": 1521918876939, "note": "<b>Achalasia</b> may be treated with <b>{{c1::botulinum toxin}}</b> injections", "time": null}, {"id": 1521919569399, "note": "A patient with abdominal pain and distension, bloody diarrhea, fever and shock in the setting of <u>ulcerative colitis</u> or <i><u>Clostridioides difficile</u></i> is most likely presenting with <b>{{c1::Toxic megacolon}}</b>", "time": null}, {"id": 1521922082231, "note": "What is the most common malignant hepatic lesion?<div><br /></div><div>{{c1::Liver metastasis}}</div>", "time": null}, {"id": 1521932145933, "note": "Cardiovascular manifestations of lupus include accelerated {{c1::atherosclerosis}}, small-vessel necrotizing {{c2::vasculitis}}, pericarditis, and libman-sacks endocarditis", "time": null}, {"id": 1521932192299, "note": "Examples of the <b>beers criteria </b>include drugs that increase the risk of {{c1::hypotension}} (alpha blockers)", "time": null}, {"id": 1521932648240, "note": "Examples of the <b>beers criteria</b> include drugs that increase the risk of anti-{{c1::cholinergic}} activity (antihistamines, GI antispasmodics)", "time": null}, {"id": 1521933499544, "note": "A mitral valve with diffuse fibrous thickening and distortion, commisural fusion at the leaflet edges, and narrowing of the mitral valve orifice is highly suggestive of what pathology?<div><br /></div><div>{{c1::Mitral stenosis}}</div>", "time": null}, {"id": 1521933757465, "note": "Does a <b>portal vein thrombosis </b>cause histologic changes to the hepatic parenchyma?<div><br></div><div>{{c1::No}}</div>", "time": null}, {"id": 1522033658225, "note": "In the setting of <b>gestational diabetes</b> with poor control, fetal hyperglycemia leads to fetal hyperinsulinism and {{c1::\u03b2&nbsp;cell}} hyperplasia", "time": null}, {"id": 1522034862029, "note": "Recurrence of genital HSV can be suppressed or minimized with a(n) {{c1::daily}} administration of {{c3::valacyclovir}}", "time": null}, {"id": 1522035146116, "note": "Will a short (7-10 day) course of treatment with <b>acyclovir</b> during the primary genital HSV infection alter recurrence rates? <div><br></div><div>{{c1::No}}</div>", "time": null}, {"id": 1522106010887, "note": "<b>Accessory nipples</b> are typically asymptomatic but may <b>swell </b>or<b> become tender</b> during times of {{c1::hormonal}} fluctuation", "time": null}, {"id": 1522108771352, "note": "Masses (ex retroperitoneal hematoma / abscess) that involve the <b>iliopsoas</b> / <b>iliacus</b> muscle can result in {{c1::femoral nerve}} palsy", "time": null}, {"id": 1522201866086, "note": "What intoxicant causes spasms of the sphincter of oddi and has a direct toxic effect on acinar cells of the pancreas?<div><br /></div><div>{{c1::Ethanol}}</div>", "time": null}, {"id": 1522297996898, "note": "What psychological disorder is characterized by increased intake of free water, leading to <u>hyponatremia</u> and production of a volume of dilute urine?<div><br></div><div>{{c1::Primary psychogenic polydipsia}}</div>", "time": null}, {"id": 1522344837754, "note": "To gauge the degree of {{c1::paralysis}} induced by neuromuscular junction blocking agents, <b>train of four</b> stimulation can be used during <u>anesthesia</u>", "time": null}, {"id": 1522345575124, "note": "The duration of action of <b>Succinylcholine </b>is determined by its metabolism by {{c1::plasma cholinesterase}}", "time": null}, {"id": 1522350837813, "note": "<b>Myocardial infarction</b> induced <u>acute</u> left ventricular failure can result in rapid onset {{c1::pulmonary venous hypertension}} and {{c2::acute pulmonary edema}}", "time": null}, {"id": 1522351981808, "note": "<b>Aminoglycosides</b> can lead to severe decreases in <b>{{c1::Mg2+}} </b>serum concentration, which in prolonged use can eventually precipitate {{c2::tetany}}", "time": null}, {"id": 1522419532686, "note": "<b>Cryoglobulinemic vasculitis </b>is a(n) {{c1::small}} vessel vasculitis that can be seen in patients with <b>{{c2::HCV}}</b>", "time": null}, {"id": 1522419607177, "note": "Patients with <b>cryoglobulinemic vasculitis</b> have deposition of immune complexes in the {{c1::skin}}, {{c2::peripheral}} nervous system, and the {{c3::kidney}}", "time": null}, {"id": 1522419681104, "note": "The main symptomatic difference between <b>cryoglobulinemic vasculitis </b>and <b>henoch-schonlein purpura</b> is a lack of {{c1::gastrointestinal}} symptoms", "time": null}, {"id": 1522424293535, "note": "<b>Diazepam</b>, <b>Chlordiazepoxide</b>, and <b>Flurazepam</b> are benzodiazepines that have {{c1::long}} half-lives", "time": null}, {"id": 1522427952831, "note": "<b>Thoracic outlet syndrome</b> most commonly occurs due to compression of structures within the <b>{{c1::scalene triangle}}</b>", "time": null}, {"id": 1522428732333, "note": "The trunks of the brachial plexus and subclavian artery pass through the <u>anterior</u> and <u>middle</u> <b>{{c1::scalenes (scalene triangle)}}</b>", "time": null}, {"id": 1522430086941, "note": "Increased urinary frequency in pregnancy is due to <b>\u03b2-hCG </b>stimulated production of <b>{{c1::relaxin}}</b>, which increases<b> </b><u>GFR</u> by increasing renal {{c2::circulation}}", "time": null}, {"id": 1522430444424, "note": "Histopathology of <b>mesothelioma</b> will show tumor cells with numerous, long slender {{c1::microvilli}} and abundant {{c2::tonofilaments}}", "time": null}, {"id": 1522430614557, "note": "Grossly, <b>mesothelioma </b>most commonly presents with <b>nodular / smooth pleural {{c1::thickening}}</b>", "time": null}, {"id": 1522522620802, "note": "Lithium CNS toxicity can lead to slurred speech, as well as hyperreflexia and {{c1::seizures}}", "time": null}, {"id": 1522522630686, "note": "Patients experiencing lithium toxicity should first discontinue lithium, then be treated aggressively with {{c1::isotonic saline}}", "time": null}, {"id": 1522523216788, "note": "Prolonged <b>methamphetamine</b> usage may be noticed on physical exam due to {{c1::skin excoriations::derm finding}}", "time": null}, {"id": 1522524251630, "note": "Patients on stimulants may develop {{c1::tics::movement disorder}}", "time": null}, {"id": 1522524388741, "note": "What features of extrapyramidal symptoms may be treated with <b>benztropine</b> and <b>diphenhydramine</b>?<div><br></div><div>{{c1::Acute Dystonia}}</div>", "time": null}, {"id": 1522524516442, "note": "What features of extrapyramidal symptoms may be treated with \u03b2-blockers, benzodiazepines, and benztropine?<div><br></div><div>{{c1::Akathisia}}</div>", "time": null}, {"id": 1522524540457, "note": "What features of extrapyramidal symptoms may be treated with benztropine and amantadine?<div><br /></div><div>{{c1::Parkinsonism}}</div>", "time": null}, {"id": 1522524557688, "note": "What features of extrapyramidal symptoms may be treated with reserpine, tetrabenazine, or a switch to an atypical antipsychotic?<div><br /></div><div>{{c1::Tardive Dyskinesia}}</div>", "time": null}, {"id": 1522524591305, "note": "Is <b>bupropion</b> associated with sexual side-effects?<div><br /></div><div>{{c1::No}}</div>", "time": null}, {"id": 1522528763868, "note": "Angiotensin II acts on the<u> hypothalamus</u> to increase {{c1::thirst}}", "time": null}, {"id": 1522528970723, "note": "<div>Which <u>renal tubular acidosis</u> is highly associated with congenital anomalies (obstruction) of urinary tract?</div><div><br /></div><div>{{c1::Distal RTA (type 1)}}</div>", "time": null}, {"id": 1522543003481, "note": "Patients with renal osteodystrophy present with <b>calciphylaxis</b>, due to high serum {{c1::phosphate}} binding with Ca<sup>2+</sup> leading to <u>metastatic deposits</u> and {{c2::lowered}} serum Ca<sup>2+</sup>", "time": null}, {"id": 1522544797357, "note": "Is it possible for dizygotic twins to have different biological sexes?<div><br />{{c1::Yes}}</div>", "time": null}, {"id": 1522545918379, "note": "Is it possible for monozygotic twins to have two different biological sexes?<div><br /></div><div>{{c1::No}}</div>", "time": null}, {"id": 1522546037015, "note": "<b>Diabetes mellitus</b> may result in {{c1::overflow}} incontinence", "time": null}, {"id": 1522550552770, "note": "Patients with <b>diabetic neuropathy</b> present with a slowly progressive decrease in vibratory sensation, {{c1::proprioception}}, and {{c2::temperature}} sensation", "time": null}, {"id": 1522550673436, "note": "Patients with <u>early</u> <b>diabetic neuropathy</b> typically have decreased {{c1::ankle}} reflexes", "time": null}, {"id": 1522550767866, "note": "Patients with <u>late</u> diabetic neuropathy have widespread loss of reflexes with motor {{c1::weakness}}", "time": null}, {"id": 1522596053069, "note": "Examples of the <b>beers criteria </b>include drugs that increase the risk of {{c1::falls}} (benzodiazepines, opioids)", "time": null}, {"id": 1522596676916, "note": "Examples of the <b>beers criteria </b>include drugs that increase the risk of {{c1::C. difficile}} infections (PPIs)", "time": null}, {"id": 1522765670865, "note": "<div>In a baby whose mother had untreated <b>gestational diabetes</b>, upon delivery neonates can develop transient <b>{{c1::hypoglycemia}}</b></div>", "time": null}, {"id": 1522766784686, "note": "<b>Gestational diabetes</b> is the onset of <u>{{c1::maternal}}</u> insulin resistance during pregnancy", "time": null}, {"id": 1522766862787, "note": "<b>Human placental lactogen</b> increases maternal {{c1::lipolysis}}", "time": null}, {"id": 1522767130070, "note": "Neonatal hyperinsulinism in the setting of uncontrolled <b>gestational diabetes</b> can lead to <b>macro</b>{{c1::<b>somia</b>}}", "time": null}, {"id": 1522767252576, "note": "If a patient has hyper/hypogonadotropic hypogonadism, will they have:<div>- Uterus? {{c1::+::+/-?}}</div><div>- Breasts? {{c1::-::+/-?}}</div>", "time": null}, {"id": 1522767538297, "note": "If a patient has uterovaginal agenesis in genotypic female OR androgen insensitivity in genotypic male, will they have:<div>- Breasts? {{c1::+::+/-?}}</div><div>- Uterus? {{c1::-::+/-?}}</div>", "time": null}, {"id": 1522767585641, "note": "If a patient has insufficient production of testosterone and is a male genotype, will they have:<div>- Breasts? {{c1::-::+/-?}}</div><div>- Uterus? {{c1::-::+/-?}}</div>", "time": null}, {"id": 1522767618093, "note": "The <u>prognosis</u> of gynecologic tumor epidemiology can be remembered with the mnemonic:<i> <font color=\"#aa0000\" style=\"font-weight: bold; \">CEO</font>s often go from <b><font color=\"#aa0000\">best</font></b> to <b><font color=\"#aa0000\">worst</font></b> as they get older</i><div><i><br /></i></div><div><i><font color=\"#aa0000\"><b>C</b></font>{{c1::ervical}} &gt; <b><font color=\"#aa0000\">E</font></b>{{c2::ndometrial}} &gt; <b><font color=\"#aa0000\">O</font></b>{{c3::varian}}</i></div>", "time": null}, {"id": 1522767968780, "note": "<b>Primary ovarian insufficiency</b> is associated with <u>{{c1::chromosomal}} abnormalities</u>, especially in those younger than {{c2::30}}", "time": null}, {"id": 1522768182082, "note": "Patients with <b>primary ovarian insufficiency</b> have the following serology:<br><br><div>- Estrogen - {{c1::decreased}}</div><div>- LH - {{c1::increased}}</div><div>- FSH - {{c1::increased}}</div>", "time": null}, {"id": 1522858621380, "note": "Patients with <u>long standing</u> <b>COPD</b> who are administered <u>excessive</u> oxygen can develop <b>{{c1::hypercapnia}}</b> ", "time": null}, {"id": 1522858909314, "note": "COPD patients with <b>oxygen induced hypercapnia </b>suffer from excess oxygen induced generation of increased {{c1::physiologic dead space}}", "time": null}, {"id": 1522885879666, "note": "Which <b>ENaC inhibitor</b><i> </i><u>increases</u> calcium reabsorption?<div><br></div><div>{{c1::Amiloride}}</div>", "time": null}, {"id": 1522886746355, "note": "All organisms in the {{c1::mycoplasma}} genus (ex ureaplasma urealyticum) lack {{c2::cell walls}} and thus are resistant to agents that target the {{c2::cell wall}}", "time": null}, {"id": 1522891819566, "note": "What is the effect of <b>bicornuate uterus</b> on <b>fertility</b>?<div><br /></div><div>{{c1::Decreased}}</div>", "time": null}, {"id": 1522978084595, "note": "An <b>intraductal papilloma</b> is a proliferation of <u>papillary cells</u> that develop in {{c1::ducts}} or cyst wall with a(n) {{c2::fibrovascular}} core", "time": null}, {"id": 1522978826683, "note": "<b>Fibrocystic changes</b> frequently cause <b>{{c1::cyclic}} breast pain</b> without nipple discharge", "time": null}, {"id": 1522978929448, "note": "On histology, the stromal proliferation in <b>fibroadenomas </b>compresses the {{c1::ducts}}", "time": null}, {"id": 1522986512395, "note": "Compression / neuropathy of the phrenic nerve results in {{c1::uniform weak}} inspirations during maximal voluntary ventilation", "time": null}, {"id": 1523153755717, "note": "<b>{{c1::Chronic}} interstitial nephritis</b> is typically seen with patients whove been taking {{c2::NSAIDs}} for a long time", "time": null}, {"id": 1523153827410, "note": "Patients with <b>chronic interstitial nephritis</b> have a(n) {{c2::mild}} elevation of BUN and creatinine due to a(n) {{c1::mononuclear}} infiltrate of tubules causing fibrosis and atrophy", "time": null}, {"id": 1523153962275, "note": "Sulfonamides, methotrexate, IV acyclovir, and triameterene are agents that can {{c1::precipitate}} in renal tubules, causing renal failure", "time": null}, {"id": 1523155250898, "note": "What is the most common complication of Turner Syndrome?<div><br /></div><div>{{c1::Bicuspid aortic valve (20-30%)}}</div>", "time": null}, {"id": 1523196495913, "note": "Patients with <b>asherman syndrome</b> will present with {{c1::decreased}} fertility", "time": null}, {"id": 1523198507740, "note": "<b>Tocolytics</b> are generally used to decrease contraction frequency in {{c1::preterm}} labor", "time": null}, {"id": 1523240302504, "note": "What flow-volume pattern would <b>diffuse intraalveolar hemorrhage </b>cause?<div><br /></div><div>{{c1::Restrictive}}</div>", "time": null}, {"id": 1523240406190, "note": "What kind of flow volume pattern would <b>compression atelectasis</b> cause?<div><br></div><div>{{c1::Restrictive}}</div>", "time": null}, {"id": 1523240453446, "note": "What flow volume pattern would <b>alveolar hyaline membranes (ARDS)</b> cause?<div><br></div><div>{{c1::Restrictive}}</div>", "time": null}, {"id": 1523297766679, "note": "<b>Glycogenolysis</b> and <b>skeletal muscle contraction</b> are synchronized via intracellular accumulation of {{c1::Ca2+}} following neuromuscular stimulation", "time": null}, {"id": 1523302344176, "note": "To prevent the development of <b>oral thrush</b> after using inhaled corticosteroids, what <u>two</u> interventions can be used?<div><br /></div><div>{{c1::Spacer, Rinsing Mouth}}</div>", "time": null}, {"id": 1523303019600, "note": "What vitamin can be prescribed for Alzheimers disease to slow functional losses?<div><br></div><div>{{c1::Vitamin E (tocopherol)}}</div>", "time": null}, {"id": 1523321743572, "note": "During the <b>Canalicular phase</b> of lung development<b>,</b> <u>pneumocytes</u> develop starting at {{c1::20}} weeks", "time": null}, {"id": 1523409710031, "note": "Loss of <b>ATIII</b> in nephrotic syndrome can predispose patients to <b>{{c1::renal vein}} thrombosis</b>", "time": null}, {"id": 1523409774775, "note": "Patients with left sided <b>renal vein thrombosis</b> can develop a left sided {{c1::varicocele}} due to the \"nutcracker\" effect", "time": null}, {"id": 1523409819271, "note": "Patients with nephrotic syndrome are especially vulnerable to {{c1::pneumococcal}} infections", "time": null}, {"id": 1523411825116, "note": "<b>Selective muscarinic antagonists</b> (ex. glycopyrrolate, hyoscyamine, propantheline) can be used to reduce side effects of {{c1::cholinesterase}} inhibitors where they are mediated by activation of muscarinic receptors", "time": null}, {"id": 1523414014382, "note": "Can normal aging cause a ventilation/perfusion mismatch?<div><br /></div><div>{{c1::Yes}}</div>", "time": null}, {"id": 1523414047330, "note": "How does normal aging change the A-a gradient?<div><br /></div><div>{{c1::Increased A-a gradient}}</div>", "time": null}, {"id": 1523414842071, "note": "<b>Ankylosing spondylitis</b> can cause <u>{{c2::restrictive}} lung disease</u> due to limited <b>{{c1::chest wall}} </b>expansion", "time": null}, {"id": 1523474895372, "note": "<b>Trisomy 13</b> {{c1::does not::does / does not}} have overlapping fingers", "time": null}, {"id": 1523475027630, "note": "The lung apices extend above the first {{c1::rib}} and <u>clavicle</u>", "time": null}, {"id": 1523478916168, "note": "Once methotrexate enters the target cell, it undergoes <b>{{c1::polyglutamation}}</b>, preventing the movement of MTX out of the cell", "time": null}, {"id": 1523586544673, "note": "Carbon monoxide poisoning can be treated with {{c1::100% O<sub>2</sub>}} or hyperbaric O<sub>2</sub>", "time": null}, {"id": 1523885609867, "note": "What is the best method of achieving pregnancy in a patient who has Turner Syndrome?<div><br /></div><div>{{c1::In Vitro Fertilization}}</div>", "time": null}, {"id": 1523889982310, "note": "A <b>vasectomy</b> is a male contraceptive surgical technique which transects the {{c2::vas deferens}}, preventing transport of <u>new sperm</u> from the {{c1::epididymis}}", "time": null}, {"id": 1523890702245, "note": "The most important steps in working up a <b>metabolic alkalosis </b>are:<div><br><div>- determining the patients {{c1::<b>volume status</b>}} for <u>saline responsiveness</u></div><div>- checking the<b> urine</b> {{c2::<b>chloride</b>}} levels</div></div>", "time": null}, {"id": 1523906955206, "note": "In a <b>blunt cardiac injury</b>, the {{c1::right ventricle}} is the most common <u>structure</u> to be injured, while the {{c2::aortic valve}} is the most common <u>valve</u> to be injured", "time": null}, {"id": 1524101686868, "note": "Patients with long-standing COPD have decreased sensitivity to {{c1::PaCO<sub>2</sub>}}", "time": null}, {"id": 1524101898555, "note": "In patients with long standing COPD, the main contributor to respiratory drive is arterial {{c1::PaO<sub>2</sub>}} levels", "time": null}, {"id": 1524102065748, "note": "When supplemental oxygen is administered to a patient with longstanding COPD, the rapid increase in PaO<sub>2</sub>&nbsp;can <u>reduce</u> {{c1::peripheral chemoreceptor}} stimulation", "time": null}, {"id": 1524104123475, "note": "Chronic hemolysis can lead to iron deposition in the kidney (this process is known as {{c1::hemosiderosis}})", "time": null}, {"id": 1524146563713, "note": "<b>Cyanide poisoning </b>is usually due to {{c1::<u>inhalation</u>}}<u> injury</u>", "time": null}, {"id": 1524146658690, "note": "Cyanide inhibits {{c1::aerobic}} metabolism, resulting in <b>hypoxia</b> unresponsive to {{c2::supplemental O<sub>2</sub>}}", "time": null}, {"id": 1524146884689, "note": "Patients with <b>cyanide poisoning</b> present with an \"<u>almond</u>\" breath odor and {{c1::reddish}} skin discoloration", "time": null}, {"id": 1524147764686, "note": "In <b>exercise</b>, blood is flowing faster through the pulmonary capillaries, resulting in it taking a(n) {{c1::longer::shorter or longer}} time for capillary O<sub>2</sub>&nbsp;concentration to <u>maximize</u>", "time": null}, {"id": 1524147915895, "note": "In a <u>healthy</u> patient, can exercise alone make patients hypoxemic?<div><br /></div><div>{{c1::No}}</div>", "time": null}, {"id": 1524148184617, "note": "Infections in the <u>sphenoid</u> or <u>ethmoid sinus</u> may extend to the {{c1::<b>cavernous</b>}} <b>sinus </b>and cause complications", "time": null}, {"id": 1524148427060, "note": "Because the <b>facial vein </b>is valveless, infections of the face can spread to the {{c1::cavernous sinus}}", "time": null}, {"id": 1524148715978, "note": "Rhinosinusitis most commonly affects the {{c1::ethmoid}} sinus in children", "time": null}, {"id": 1524148797489, "note": "Patients who develop <b>pulmonary emboli&nbsp;</b>may develop <u>right heart strain</u> that generates a(n) {{c1::S1Q3T3}} ECG finding", "time": null}, {"id": 1524149251024, "note": "In <b>chronic bronchitis</b>, the DLCO is usually {{c1::normal}}", "time": null}, {"id": 1524149644141, "note": "In <b>emphysema</b>, the D<sub>LCO</sub> is usually {{c1::decreased}}", "time": null}, {"id": 1524149690650, "note": "In <b>asthma</b>, the D<sub>LCO</sub> is {{c1::normal or increased}}", "time": null}, {"id": 1524149763277, "note": "Which cause of <b>crescentic glomerulonephritis</b> may also cause a restrictive lung disease?<div><br /></div><div>{{c1::Goodpasture syndrome}}</div>", "time": null}, {"id": 1524150034457, "note": "<b>Sarcoidosis</b> may present with a(n) {{c1::rheumatoid arthritis}}-like arthropathy", "time": null}, {"id": 1524150515716, "note": "On physical exam, many patients with inhalation injury have singed {{c1::nasal hairs}}", "time": null}, {"id": 1524150690333, "note": "Which three&nbsp;<b>pneumoconioses</b> increase the risk for <u>Caplan syndrome</u>?<div><br></div><div>{{c1::Coal workers pneumoconiosis, Asbestosis and Silicosis}}</div>", "time": null}, {"id": 1524151287448, "note": "One <u>complication</u> associated with <b>lung cancer</b> is {{c1::pericardial effusion}}, which can lead to <u>obstructive shock</u>", "time": null}, {"id": 1524151749002, "note": "During which phase of the natural history of lobar pneumonia is the exudate composed of mostly bacteria?<div><br /></div><div>{{c1::Congestion}}</div>", "time": null}, {"id": 1524151971478, "note": "During which phase of the natural history of lobar pneumonia is the exudate composed of fibrin, bacteria, RBCs, and WBCs?<div><br /></div><div>{{c1::Red hepatization}}</div>", "time": null}, {"id": 1524152032953, "note": "During which phase of the natural history of<b> lobar pneumonia</b> is the exudate composed of <b>WBCs</b>, <u>lysed</u> <b>RBCs</b>, and <b>fibrin?</b><div><br /></div><div>{{c1::Gray hepatization}}</div>", "time": null}, {"id": 1524152048128, "note": "A tension pneumothorax may lead to {{c1::increased}} intrathoracic pressure, leading to <u>{{c2::decreased}}</u> cardiac function", "time": null}, {"id": 1524165274446, "note": "Patients with prolonged, untreated <b>obstructive sleep apnea</b> can develop {{c1::pulmonary hypertension}} and a resultant right heart failure", "time": null}, {"id": 1524167427513, "note": "Patients with <b>cryptorchidism</b> typically have the testis remain in the abdomen or the {{c1::inguinal canal}}", "time": null}, {"id": 1524247235026, "note": "Stimulation of the <b>{{c1::hypoglossal}} nerve</b> can be used as a therapy for <b>obstructive sleep apnea </b>by increasing the {{c2::diameter}} of the oropharyngeal airway", "time": null}, {"id": 1524248123764, "note": "<b>Obstructive sleep apnea </b>is due to relaxation of <b>{{c1::pharyngeal muscle tone}} </b>during sleep", "time": null}, {"id": 1524248435216, "note": "What is the treatment for <b>Tetrodotoxin </b>and <b>Ciguatoxin</b> poisoning?<div><br /></div><div>{{c1::Supportive care}}</div>", "time": null}, {"id": 1524249723352, "note": "<b>Adenomyosis </b>grossly presents with a uniformly enlarged, soft, {{c1::globular}} uterus", "time": null}, {"id": 1524258762201, "note": "In a nonmedical setting, severe hypoglycemia is <u>ideally</u> treated with intramuscular {{c1::glucagon}}", "time": null}, {"id": 1524259092731, "note": "In a medical setting, severe hypoglycemia is treated with IV {{c1::glucose}}", "time": null}, {"id": 1524325496003, "note": "Besides hyaline membranes, loss of {{c1::surfactant}} contributes to alveolar collapse in <b>ARDS</b>", "time": null}, {"id": 1524327729226, "note": "<b>Cheyne-Stokes breathing</b> is defined by respirations that oscillate between <u>{{c1::apnea}}</u> and <u>{{c1::hyperpnea}}</u> in response ", "time": null}, {"id": 1524328886574, "note": "<b>Sleep apnea</b> is diagnosed via {{c1::polysomnography}}, where a patient sleeps in a monitored setting and a number of related measurements are taken", "time": null}, {"id": 1524526728679, "note": "<i>Exogenous</i> <b>testosterone</b> causes {{c1::increased}} <b>hematocrit</b>", "time": null}, {"id": 1524527865392, "note": "Patients taking <i>exogenous</i><b> testosterone </b>can develop hormone imbalances, resulting in {{c1::small}} testes, low sperm count, and {{c2::gynecomastia}}", "time": null}, {"id": 1524609033483, "note": "If undiagnosed at birth, an <b>imperforate hymen</b> presents with {{c1::<u>primary amenorrhea</u>}} and <u>cyclic abdominal / pelvic pain</u> due to accumulation of {{c2::<b>menstrual bloo</b>d}} in the vagina / uterus", "time": null}, {"id": 1524609197643, "note": "Do patients with an <b>imperforate hymen</b> typically have abnormal <b>secondary sexual development</b>?<div><br /></div><div>{{c1::No}}</div>", "time": null}, {"id": 1524699712797, "note": "Patients with cyanide poisoning have a(n) {{c1::narrowing}} of the <b>venous-arterial PO2 gradient</b>", "time": null}, {"id": 1524700826965, "note": "Irritation of the <u>phrenic nerve</u> can refer pain to the <u>C3-C5</u>&nbsp;shoulder region (<i>Kehr sign</i>) and cause {{c2::<u>hiccups</u>}}", "time": null}, {"id": 1524705541467, "note": "<b>Glucagon</b>, <b>cortisol</b>, and <b>epinephrine</b> induce {{c1::<b>insulin</b> <b>resistance</b>}} leading to phosphorylation of {{c1::serine}} / {{c2::threonine}} residues of the <u>insulin receptor</u> and <u>IRS-1</u>", "time": null}, {"id": 1524798283046, "note": "<u>Increased</u> lung volumes result in {{c1::increased}} <u>pulmonary vascular resistance</u>", "time": null}, {"id": 1524798399322, "note": "During expiration, <u>decreased</u> lung volumes result in a(n) {{c1::increase}} in extra-alveolar vessel resistance", "time": null}, {"id": 1524798554422, "note": "Pulmonary vascular resistance is lowest is near the {{c1::<b>Functional Residual Capacity</b>::which lung parameter}}", "time": null}, {"id": 1524800758410, "note": "An <b>adrenal crisis </b>should be treated with <u>immediate</u> {{c1::glucocorticoid}} supplementation and aggressive fluid resuscitation", "time": null}, {"id": 1525043744165, "note": "<b>Pulmonary alveolar proteinosis </b>is a(n) {{c1::restrictive}} lung disease where proteinaceous material fills the alveoli", "time": null}, {"id": 1525112016641, "note": "Are the following <u>protective</u> factors or <u>risk</u> factors for surface epithelial ovarian cancer?<div><br></div><div>{{c1::Risk factors}}<br><div><br></div><div><font color=\"#aa0000\">- Infertility </font></div><div><font color=\"#aa0000\">- Nulliparity</font></div><div><font color=\"#aa0000\">- Postmenopausal hormone therapy</font></div></div>", "time": null}, {"id": 1525112237560, "note": "Are the following <u>protective</u> factors or <u>risk</u> factors for surface epithelial ovarian cancer?<div><br /></div><div>{{c1::Protective factors}}<br /><div><br /></div><div><font color=\"#aa0000\">- Combined oral contraceptives</font></div><div><font color=\"#aa0000\">- Multiparity</font></div><div><font color=\"#aa0000\">- Breast feeding</font></div></div>", "time": null}, {"id": 1525112432441, "note": "What is the most common pediatric elbow fracture?<div><br /></div><div>{{c1::Supracondylar fracture of the humerus}}</div>", "time": null}, {"id": 1525112850711, "note": "In a <b>supracondylar fracture</b> of the humerus, <u>anteromedial</u> displacement of the proximal fracture fragment typically results in damage to the {{c1::median nerve}}", "time": null}, {"id": 1525116053327, "note": "Patients with <b>kallmann syndrome</b> most commonly have mutations in the {{c1::KAL-1}} or FGFR-1 genes", "time": null}, {"id": 1525137303328, "note": "The <b>bleeding time</b> test has been replaced by the {{c1::platelet function analyzer (PFA-100)}}", "time": null}, {"id": 1525138104051, "note": "The {{c2::<u>thrombin</u>}}<u> time</u> is prolonged in patients with deficient or defective {{c1::<b>fibrinogen</b>}}", "time": null}, {"id": 1525220854667, "note": "Patients with <b>hydatiform moles</b> may present with pelvic discomfort, vaginal bleeding, and hyper{{c1::emesis}}", "time": null}, {"id": 1525228314739, "note": "Resistance to <b>cephalosporins </b>and <b>aztreonam</b> is typically accomplished by <b>{{c1::Extended-Spectrum&nbsp;</b><b>\u03b2</b><b>-Lactamases (ESBL)::specific}}</b> that are encoded on <u>plasmids</u>", "time": null}, {"id": 1525305295646, "note": "Severe diabetic acidosis can cause {{c1::respiratory}} failure", "time": null}, {"id": 1525312075824, "note": "Histologically, patients with diabetic neuropathy will have endoneural arteriole {{c1::hyalinization}}", "time": null}, {"id": 1525389426486, "note": "Major risk factors for <b>parotitis</b> include dehydration, {{c1::intubation}} (elderly postoperative patients), and anti-{{c2::cholinergics}}", "time": null}, {"id": 1525397303331, "note": "<b>Parotitis</b> usually presents with <u>acute</u> onset of firm and erythematous pre/postauricular {{c1::swelling}}", "time": null}, {"id": 1525397379771, "note": "<b>Parotitis</b> can present with elevated serum {{c1::amylase}}", "time": null}, {"id": 1525397414333, "note": "A diagnosis of parotitis is confirmed by {{c1::imaging (ultrasound / CT)}}", "time": null}, {"id": 1525441121649, "note": "In the context of a metabolic acidosis; the <b>delta-delta ratio </b>to determine the presence of a <u>secondary metabolic disorder</u> = {{c1::<sup>(AG-12)</sup>/<sub>(24-[HCO3])</sub>}}", "time": null}, {"id": 1525465852258, "note": "<b>Cystic fibrosis </b>may present with <b>{{c1::hypo}}natremia</b>", "time": null}, {"id": 1525530732814, "note": "What is the <u>treatment</u> for <b>cryptogenic organizing pneumonia (COP)</b>?<div><br></div><div>{{c1::Oral corticosteroids}}</div>", "time": 1660105341733.0}, {"id": 1525534447417, "note": "In female infertility testing: a <b>hysterosalpingogram</b> <b>(HSG)</b> is primarily used to determine {{c1::fallopian tube patency}} ", "time": null}, {"id": 1525534618298, "note": "In female infertility testing; <u>saline infusion sonohysterography</u> is the preferred method of diagnosing abnormalities of the {{c1::uterine cavity}}", "time": null}, {"id": 1525564242390, "note": "Are <b>cavernous hemangiomas</b> typically symptomatic or asymptomatic?<div><br /></div><div>{{c1::Asymptomatic}}</div>", "time": null}, {"id": 1525565689288, "note": "A good rule of thumb for the relationship between GFR and serum creatinine is that everytime GFR {{c1::halves}}, serum creatinine {{c1::doubles}}", "time": null}, {"id": 1525667625301, "note": "Endometriosis spread to the <b>uterosacral ligaments</b>&nbsp;can result in a fixed, {{c1::retroverted}} uterus", "time": null}, {"id": 1525832074892, "note": "Patients with <b>Lambert-Eaton Syndrome </b>present with {{c1::autonomic}} symptoms (dry mouth, constipation, impotence)", "time": null}, {"id": 1525898817417, "note": "In the following group of diseases, what is the most likely ratio of conjugated bilirubin : total bilirubin?<div><br /></div><div>{{c1::&lt;20}}%</div><div><br /></div><div><font color=\"#aa0000\">Gilbert Syndrome / Crigler-Najjar</font></div><div><font color=\"#aa0000\">Physiologic Jaundice of Newborn</font></div><div><font color=\"#aa0000\">Hemolysis</font></div>", "time": null}, {"id": 1525899000205, "note": "In the following group of diseases, what is the most likely ratio of conjugated bilirubin : total bilirubin?<div><br /></div><div>{{c1::20-50}}%</div><div><br /></div><div><font color=\"#aa0000\">Viral Hepatitis</font></div>", "time": null}, {"id": 1525899048575, "note": "In the following group of diseases, what is the most likely ratio of <u>conjugated bilirubin : total bilirubin</u>?<div><br></div><div>{{c1::&gt;50}}%</div><div><br></div><div><font color=\"#aa0000\">Drugs (ex. OCPs)</font></div><div><font color=\"#aa0000\">Dubin-Johnson / Rotor</font></div><div><font color=\"#aa0000\">Primary Biliary Cholangitis</font></div><div><font color=\"#aa0000\">Obstruction (ex. gallstone)</font></div>", "time": null}, {"id": 1525915981730, "note": "High iron levels and inflammatory conditions {{c1::increase}} the synthesis of hepcidin", "time": null}, {"id": 1526001460758, "note": "Most of the venous drainage from the myocardium traverses the <b>{{c1::coronary sinus (CS)}}</b>, which delivers deoxygenated blood to right atrium", "time": null}, {"id": 1526001579813, "note": "Any factor that causes increased {{c1::right atrial}} pressure will cause <b>coronary sinus</b> dilation", "time": null}, {"id": 1526071398931, "note": "The presence of {{c1::glandular endocervical cells}} in a pap smear indicates <u>adequate</u> sampling", "time": null}, {"id": 1526164971905, "note": "Patients with <b>infective endocarditis</b> can develop a <u>nephritic syndrome</u> due to deposition of {{c1::circulating immune complexes}}", "time": null}, {"id": 1526169384687, "note": "Patients with <b>sarcoidosis</b> may have scattered granulomas in their <u>liver</u>; most commonly affecting the {{c1::portal triads}}", "time": null}, {"id": 1526260615005, "note": "Indications for acute dialysis may be remembered with the mnemonic <b>AEIOU</b>:<div style=\"centerbox\"><div class=\"mnemonics\"><div><br/></div><div><b>A</b> - {{c1::<b>A</b>cidosis}}</div><div><b>E</b> - {{c2::severe <b>E</b>lectrolyte abnormalities}}</div><div><b>I</b> - {{c3::substance <b>I</b>ntoxication}}</div><div><b>O</b> - {{c4::volume <b>O</b>verload}}</div><div><b>U</b> - {{c5::<b>U</b>remic symptoms}}</div></div></div>", "time": null}, {"id": 1526313925730, "note": "The major risk factor for <b>renal artery stenosis</b> is {{c1::atherosclerosis}}", "time": null}, {"id": 1526328755862, "note": "Patients with <b>cavernous hemangiomas</b> in the <u>brain</u> are at risk of developing an  {{c1::intraparenchymal hemorrhage}}", "time": null}, {"id": 1526328901920, "note": "Patients with an <b>intervertebral disc herniation</b> affecting the {{c2::L5}} or {{c1::S1}} nerve roots will have a positive {{c1::<u>straight leg raise</u>}} test", "time": null}, {"id": 1526330773665, "note": "<b>Granulosa cell tumors</b> have a scattering of {{c1::theca}} cells, which give the mass a <b>yellow</b> color on gross inspection", "time": null}, {"id": 1526340598707, "note": "Patients with <b>granulosa cell tumors</b> can develop a(n) {{c1::endometrial}} carcinoma", "time": null}, {"id": 1536696017301, "note": "Decreasing V<sub>A</sub>/Q may be due to a(n) {{c1::R to L}} shunt", "time": null}, {"id": 1547607494657, "note": "<b>Erythrocyte Sedimentation Rate </b>{{c1::increases::increases or decreases}} in inflammatory conditions", "time": null}, {"id": 1547940439819, "note": "<b>Slippage</b> in a template strand will cause a(n) {{c1::deletion}}", "time": null}, {"id": 1547940537506, "note": "<b>Slippage</b> in a replicated strand will cause a(n) {{c1::insertion}}", "time": null}, {"id": 1547940805273, "note": "<b>Depurination</b> results in the loss of {{c1::purine}} bases", "time": null}, {"id": 1548363898504, "note": "<b>Capecitabine</b> is the prodrug of {{c1::5-FU}}", "time": null}, {"id": 1552605404493, "note": "The <u>S</u>ystemic <u>I</u>nflammatory <u>R</u>esponse <u>S</u>yndrome (SIRS) is defined by \u22652 of the following:<div><br></div><div><b>Temp</b>: &gt;{{c1::38}}\u2103 <u>or</u> &lt;{{c1::36}}\u2103</div><div><b>HR</b>: &gt;{{c2::90}} bpm</div><div><b>WBC</b>: &gt;{{c3::12,000}} <u>or</u> &lt;{{c3::4000}} <u>or</u> immature forms &gt;{{c3::10}}%</div><div><b>RR</b>: &gt;{{c4::20}} breaths/min <u>or</u> P<sub>a</sub>CO<sub>2</sub> &lt;{{c4::32}} mmHg</div>", "time": null}, {"id": 1566505820778, "note": "{{c1::Heavier menstrual bleeding}} is a <u>side effect</u> associated with <b>copper intrauterine devices</b>", "time": null}, {"id": 1566572487165, "note": "<div>What effect does the <b>passive leg raise</b>&nbsp;maneuver&nbsp;have on the&nbsp;<u>intensity</u>&nbsp;of&nbsp;<b>hypertrophic cardiomyopathy&nbsp;murmurs</b>?</div><div><br></div><div>{{c1::Decreased intensity}}</div>", "time": null}, {"id": 1502305191940, "note": "<div><b>Disulfiram </b>works by inhibiting <b>acetaldehyde dehydrogenase</b>, resulting in a build up of {{c2::<i><u>acetaldehyde</u></i>}}</div>", "time": null}, {"id": 1569959162322, "note": "<div>Which&nbsp;<i>pulmonary disorder</i> is characterized by inflammation and fibrosis of <u>small airways</u> with <b>connective tissue plugs</b>?</div><b><div><b><br></b></div></b><div>{{c1::<b>Cryptogenic organizing pneumonia</b>}}&nbsp;<br></div>", "time": null}, {"id": 1570487202656, "note": "Systemic<b> </b>inflammation<b> </b>in<b>&nbsp;RA</b>&nbsp;may present with&nbsp;{{c1::<b>interstitial&nbsp;</b><b>lung</b>&nbsp;<b>fibrosis</b>::lung}}, {{c1::<b>pericarditis</b>::heart}}, {{c1::<b>vasculitis</b>::vascular}} and {{c1::<b>anemia of chronic disease</b>::heme}}", "time": null}, {"id": 1574312847337, "note": "<b>Posterior urethral valve</b> may cause {{c1::<b>oligohydramnios</b>}} due to obstruction of fetal urinary output and severe amniotic fluid reduction&nbsp;", "time": null}, {"id": 1575175432797, "note": "<b>COPD</b>&nbsp;may cause {{c1::<b>respiratory</b>&nbsp;<b>acidosis</b>::what acid-base disorder?}}&nbsp;", "time": null}, {"id": 1576815160851, "note": "<div><b>Digitalis</b> and <b>milrinone</b> are <u>contraindicated</u> in&nbsp;<span style=\"color: var(--text-fg);\">{{c1::hypertrophic obstructive cardiomyopathy</span><span style=\"color: var(--text-fg);\">::heart condition</span><span style=\"color: var(--text-fg);\">}}</span></div>", "time": null}, {"id": 1577063387755, "note": "What is the likely&nbsp;<i>diagnosis</i>&nbsp;in a patient with&nbsp;<b>pain</b>,&nbsp;<b>pallor</b>,&nbsp;<b>paresthesias</b>,&nbsp;<b>paralysis</b>,&nbsp;<b>poikilothermia</b>&nbsp;and&nbsp;<b>pulselessness</b>&nbsp;in one limb?<div><br></div><div>{{c1::Acute limb ischemia}}</div>", "time": null}, {"id": 1577640860927, "note": "What is the most common cause of&nbsp;<b>secondary spontaneous pneumothorax</b>?<div><br></div><div>{{c1::COPD (due to parenchymal destruction)}}</div>", "time": null}, {"id": 1577641901105, "note": "{{c1::<b>Tension</b>}}&nbsp;<b>pneumothorax</b>&nbsp;may restrict venous return resulting in&nbsp;<b>hypotension</b>&nbsp;and {{c2::<b>obstructive</b>}}&nbsp;<b>shock</b>", "time": null}, {"id": 1578107897849, "note": "<b>Dermatomyositis</b>&nbsp;and&nbsp;<b>polymyositis</b>&nbsp;are more common in {{c1::<u>women</u>::demographic}}", "time": null}, {"id": 1578107966397, "note": "Pathogenesis of <b>polymyositis</b>&nbsp;begins with <u>increased</u> expression of {{c1::<i>MHC I</i>}} on the <u>sarcolemma</u>", "time": null}, {"id": 1578108101510, "note": "<div>Do&nbsp;<b>polymyositis</b>&nbsp;and&nbsp;<b>dermatomyositis </b>present with <i>myalgias</i>?</div><div><br></div><div>{{c1::Yes}}</div>", "time": null}, {"id": 1578248007976, "note": "<div>Which&nbsp;<u>complement proteins</u>&nbsp;are&nbsp;<i>increased</i>&nbsp;in&nbsp;<b>C1 esterase inhibitor deficiency</b>?</div><div><br></div><div>{{c1::C3a, C4a, and C5a}}</div>", "time": null}, {"id": 1578248124988, "note": "<div><u>Nausea/vomiting</u>, <u>abdominal pain</u>, and <u>diarrhea</u>&nbsp;may present in {{c1::<b>hereditary angioedema</b>}}<b>&nbsp;</b>due to&nbsp;submucosal swelling&nbsp;in the&nbsp;<i>GI tract</i><br></div>", "time": null}, {"id": 1578248499297, "note": "<b>C1esterase inhibitor deficiency</b>&nbsp;is a(n) {{c1::<b>autosomal dominant</b>::inheritance pattern}} <i>primary immunodeficiency</i>&nbsp;that presents with <u>widespread</u> <b>angioedema</b>", "time": null}, {"id": 1578627140675, "note": "<b>Aortic regurgitation murmurs</b>&nbsp;due to <u>{{c1::aortic root dilation}}</u>&nbsp;are best heard at the <u>{{c2::base (aortic area 2nd ICS)}}</u>", "time": null}, {"id": 1578627436807, "note": "<b>Aortic regurgitation murmurs</b>&nbsp;due to <u>{{c1::valvular disease}}</u>&nbsp;are best heard at the <u>{{c2::left sternal border (3rd ICS)}}</u>", "time": null}, {"id": 1579056793018, "note": "An <b>entire leg </b>burn is {{c1::18}}% of the body surface area", "time": null}, {"id": 1579056838484, "note": "An <b>entire arm&nbsp;</b>burn is {{c1::9}}% of the body surface area", "time": null}, {"id": 1579056849831, "note": "An <b>entire head&nbsp;</b>burn is {{c1::9}}% of the body surface area", "time": null}, {"id": 1579056859576, "note": "An <b>entire torso&nbsp;</b>burn is {{c1::18}}% of the body surface area", "time": null}, {"id": 1579056878964, "note": "An <b>entire abdomen&nbsp;</b>burn is {{c1::18}}% of the body surface area", "time": null}, {"id": 1579056887286, "note": "A <b>perineum&nbsp;</b>burn is {{c1::1}}% of the body surface area", "time": null}, {"id": 1579655931955, "note": "<i>{{c1::Cyanide}} poisoning</i> may occur through the ingestion of <b>{{c2::amygdalin}}</b>, which is a <u>glucoside</u> found in <b>apricot seeds</b>", "time": null}, {"id": 1579657087867, "note": "<i>{{c2::Carbon monoxide}} poisoning</i> is classically associated with <u>bilateral</u> <b>{{c1::globus pallidus}}</b> lesions on MRI", "time": null}, {"id": 1579658911817, "note": "{{c1::<b>Tension pneumothorax</b>::Respiratory}}&nbsp;may cause <u>kinking </u>of the <b>IVC</b>&nbsp;which results in a <b><i>decreased</i>&nbsp;{{c2::cardiac output}}</b>", "time": null}, {"id": 1579659387360, "note": "<b>Cryptogenic organizing</b>&nbsp;<b>pneumonia </b>is treated with {{c1::steroids}} as it does <b>not</b>&nbsp;respond to antibiotics", "time": null}, {"id": 1580077441757, "note": "<b>Breast</b> {{c1::<b>feeding</b>}} <b>jaundice</b> is due to lack of enteral feeding, which leads to slow bile excretion and causes a(n) {{c2::<b>unconjugated (indirect)</b>}} <b>hyperbilirubinemia</b> that appears in the<b> 1st&nbsp;</b><u>week</u>&nbsp;of life", "time": null}, {"id": 1580783543931, "note": "<b>Cardiogenic shock</b>,&nbsp;<b>septic shock</b>, and&nbsp;<b>hypovolemia</b>&nbsp;may cause {{c1::acute colonic ischemia (Ischemic colitis)}}&nbsp;due to to poor perfusion of the <u>colon</u>&nbsp;", "time": null}, {"id": 1581636897059, "note": "<b>Emphysema</b>&nbsp;presents with diffuse <u>bi</u><u>lateral</u>&nbsp;{{c1::<b>wheezing</b>::lung sound}}", "time": null}, {"id": 1581636990676, "note": "<b>COPD</b>&nbsp;causes {{c1::<u>irre</u>}}<u>versible</u>&nbsp;<b>obstruction</b>", "time": null}, {"id": 1581637061745, "note": "<b>Emphysema</b>&nbsp;may present with&nbsp;{{c1::distant/diminished}}&nbsp;<u>heart</u> and&nbsp;<u>lung</u>&nbsp;sounds", "time": null}, {"id": 1581706459775, "note": "<b>Newborns</b>&nbsp;are routinely given a(n)&nbsp;{{c2::<b>vitamin&nbsp;</b><b>K</b>}}<b>&nbsp;injection </b>in the hospital, thus a risk factor for {{c3::<b>hemorrhagic disease of the newborn</b>}} is {{c1::<u>home birth</u>}}&nbsp;", "time": null}, {"id": 1581877072982, "note": "<div><b>Massive pulmonary embolism</b>&nbsp;may result in&nbsp;<u>{{c1::</u>obstructive<u>}} shock</u>&nbsp;and <u>cor pulmonale</u></div>", "time": null}, {"id": 1581878151605, "note": "<div><b>DVT</b>, <b>PE</b>&nbsp;and <b>ischemic stroke&nbsp;</b>are complications that may occur in&nbsp;<u>antiphospholipid syndrome<br></u><br>{{c1::T::T/F}}</div>", "time": null}, {"id": 1582766838962, "note": "The <b>external urethral sphincter</b>&nbsp;predominantly expresses {{c1::nicotinic}}&nbsp;receptors", "time": null}, {"id": 1582767810149, "note": "{{c1::Roflumilast}} is a <u>PDE-4 inhibitor</u> that is used in&nbsp;<b>severe COPD</b>&nbsp;and may cause <i>abdominal pain</i>, <i>weight loss</i>, and <i>depression</i>", "time": null}, {"id": 1583374187570, "note": "<div><b>Bronchiectasis</b> primarily affects the {{c1::<u>lower</u>}} lobes of the lung&nbsp;</div><div></div>", "time": null}, {"id": 1583376230438, "note": "Prolonged&nbsp;<b>interstitial lung disease</b>&nbsp;may lead to respiratory failure secondary to {{c1::pulmonary arterial hypertension}}", "time": null}, {"id": 1583381849275, "note": "<b>ARDS</b> presents with&nbsp;<u>bilateral</u>&nbsp;{{c1::diffuse&nbsp;<u>crackles</u>::lung sound}}", "time": null}, {"id": 1588168677810, "note": "<b>Endometrial</b>&nbsp;<b>polyps</b>&nbsp;are&nbsp;<u>benign</u>&nbsp;polyps that&nbsp;often present with {{c1::intermenstrual spotting::bleeding characteristic}}&nbsp;<u>without</u>&nbsp;uterine enlargement", "time": null}, {"id": 1588168744525, "note": "<div><!--anki-->Which form of <b>cervical intraepithelial neoplasia (CIN)</b> is at the highest risk of progressing to <b>cervical cancer</b>?<br></div><div><br></div><div>{{c1::CIN2/3 (HSIL)}}</div>", "time": null}, {"id": 1588253076377, "note": "What cause of <u>abnormal uterine bleeding</u> has a small risk of underlying <b>endometrial cancer</b>?<div><br></div><div>{{c1::Endometrial polyps}}<br></div>", "time": null}, {"id": 1588254875223, "note": "<b>PCOS</b>,&nbsp;<b>e</b><span style=\"color: var(--text-fg);\"><b>arly menarche</b>,&nbsp;<b>l</b></span><span style=\"color: var(--text-fg);\"><b>ate menopause</b>,&nbsp;<b>n</b></span><span style=\"color: var(--text-fg);\"><b>ulliparity&nbsp;</b></span>are&nbsp;<u>ovulatory cycle-related</u> risk factors for endometrial<b>&nbsp;</b>{{c1::hyperplasia}}", "time": null}, {"id": 1588294953536, "note": "What treatment for <b>PCOS</b> <u>decreases</u> the risk of hyperplasia and cancer?<div><br></div><div>{{c1::OCPs}}</div>", "time": null}, {"id": 1588296032690, "note": "Patients with&nbsp;<b>PCOS</b>&nbsp;may have {{c1::infertility}} and {{c1::irregular menses}} due to&nbsp;<u>anovulation</u>&nbsp;from&nbsp;<b>failed follicular maturation</b>", "time": null}, {"id": 1588297919063, "note": "Which reproductive pathology is the most common cause of anovulation?<div><br></div><div>{{c1::PCOS}}</div>", "time": null}, {"id": 1588298925573, "note": "Why is <i>weight loss</i> a <u>first-line</u> treatment for <b>PCOS</b>?<div><br></div><div>{{c1::Decreases insulin resistance}}</div>", "time": null}, {"id": 1588299062516, "note": "Why does PCOS <u>increase</u> the risk of <b>endometrial hyperplasia</b> and <b>cancer</b>?<div><br></div><div>{{c1::Exposure to estrogen only, without progesterone}}<br></div>", "time": null}, {"id": 1588299171436, "note": "<div>What <u style=\"\">medication</u> is used to reverse <i>hyperinsulinism</i> caused by <b>PCOS</b>?<br></div><div><br></div>{{c1::Metformin}}", "time": null}, {"id": 1588299386693, "note": "In&nbsp;<b>PCOS</b>, <i>weight loss</i> treatment can decrease androgen levels resulting in what benefit?<div><br></div><div>{{c1::Restored fertility (ovulatory cycles start)}}</div>", "time": null}, {"id": 1514434392334, "note": "<u>Penicillin G</u> is given <b>IV</b> and <b>IM,</b> whereas <u>Penicillin V</u> is given {{c2::<b>Orally</b>}}", "time": null}, {"id": 1588873321021, "note": "What is the <i>likely</i>&nbsp;<i>diagnosis</i>&nbsp;in a 6-month postpartum woman that presents with&nbsp;<b>irregular</b>&nbsp;<b>vaginal</b>&nbsp;<b>bleeding</b>, an&nbsp;<b>enlarged</b>&nbsp;<b>uterus</b>, and&nbsp;<b>dyspnea</b>&nbsp;with&nbsp;<u>multiple infiltrates</u>&nbsp;on CXR?<div><br></div><div>{{c1::Choriocarcinoma}}</div>", "time": null}, {"id": 1589045940690, "note": "<div>Exposure to what <u>medication</u> in utero increases the risk of <b>ectopic pregnancy</b>?<br></div><div><br></div>{{c1::Diethylstilbestrol (DES)}}", "time": null}, {"id": 1589047150162, "note": "<div><i>Maternal</i>&nbsp;complications associated with&nbsp;<u>placental abruption</u>&nbsp;include&nbsp;<b>{{c1::DIC}}</b>&nbsp;and {{c2::<b>hypovolemic</b>&nbsp;<b>shock</b>}}</div><div></div>", "time": null}, {"id": 1589050671556, "note": "Exposure to {{c1::ACE inhibitors/ARBs::drug class}}&nbsp;<i>in utero</i> may cause <b>oligohydramnios</b>", "time": null}], "links": [{"source": 1391740893804, "target": 1405141731050}, {"source": 1391740893804, "target": 1405141770453}, {"source": 1391740893804, "target": 1405722949047}, {"source": 1391740893804, "target": 1461597220648}, {"source": 1391740893804, "target": 1461597313002}, {"source": 1391740893804, "target": 1461597592228}, {"source": 1391740893804, "target": 1461597624636}, {"source": 1391740893804, "target": 1461597712293}, {"source": 1391740893804, "target": 1461597740971}, {"source": 1391740893804, "target": 1461598594612}, {"source": 1391740893804, "target": 1461598623075}, {"source": 1391740893804, "target": 1461598684331}, {"source": 1391740893804, "target": 1461599476879}, {"source": 1391740893804, "target": 1461599508630}, {"source": 1391740893804, "target": 1461599525155}, {"source": 1391740893804, "target": 1461599540100}, {"source": 1391740893804, "target": 1461600845716}, {"source": 1391740893804, "target": 1461600965249}, {"source": 1391740893804, "target": 1461601445180}, {"source": 1391740893804, "target": 1461601568244}, {"source": 1391740893804, "target": 1461601928376}, {"source": 1391740893804, "target": 1461615074564}, {"source": 1391740893804, "target": 1461615595492}, {"source": 1391740893804, "target": 1461615646774}, {"source": 1391740893804, "target": 1461616559615}, {"source": 1391740893804, "target": 1461616635772}, {"source": 1391740893804, "target": 1461616648667}, {"source": 1391740893804, "target": 1461616743909}, {"source": 1391740893804, "target": 1461624946809}, {"source": 1391740893804, "target": 1461624955031}, {"source": 1391740893804, "target": 1461624994016}, {"source": 1391740893804, "target": 1461625004593}, {"source": 1391740893804, "target": 1461625020267}, {"source": 1391740893804, "target": 1461625032072}, {"source": 1391740893804, "target": 1461625057796}, {"source": 1391740893804, "target": 1461625078700}, {"source": 1391740893804, "target": 1461634577602}, {"source": 1391740893804, "target": 1461634588075}, {"source": 1391740893804, "target": 1461634601250}, {"source": 1391740893804, "target": 1461634613345}, {"source": 1391740893804, "target": 1461634642138}, {"source": 1391740893804, "target": 1461634716202}, {"source": 1391740893804, "target": 1461634763574}, {"source": 1391740893804, "target": 1461634814863}, {"source": 1391740893804, "target": 1461634826340}, {"source": 1391740893804, "target": 1461634834294}, {"source": 1391740893804, "target": 1461806819909}, {"source": 1391740893804, "target": 1461806838245}, {"source": 1391740893804, "target": 1461806905197}, {"source": 1391740893804, "target": 1461806919056}, {"source": 1391740893804, "target": 1461852697255}, {"source": 1391740893804, "target": 1461857141003}, {"source": 1391740893804, "target": 1461857237570}, {"source": 1391740893804, "target": 1461857273344}, {"source": 1391740893804, "target": 1461857288204}, {"source": 1391740893804, "target": 1461857325591}, {"source": 1391740893804, "target": 1461857362486}, {"source": 1391740893804, "target": 1461857387477}, {"source": 1391740893804, "target": 1461864718849}, {"source": 1391740893804, "target": 1461865790194}, {"source": 1391740893804, "target": 1461865801747}, {"source": 1391740893804, "target": 1461865838545}, {"source": 1391740893804, "target": 1461865844254}, {"source": 1391740893804, "target": 1461865849072}, {"source": 1391740893804, "target": 1461865862798}, {"source": 1391740893804, "target": 1461866207939}, {"source": 1391740893804, "target": 1461866913033}, {"source": 1391740893804, "target": 1461866992917}, {"source": 1391740893804, "target": 1461867008556}, {"source": 1391740893804, "target": 1461867010914}, {"source": 1391740893804, "target": 1461867085192}, {"source": 1391740893804, "target": 1461867864150}, {"source": 1391740893804, "target": 1461867909640}, {"source": 1391740893804, "target": 1461869987440}, {"source": 1391740893804, "target": 1461869991748}, {"source": 1391740893804, "target": 1461870006406}, {"source": 1391740893804, "target": 1461870015336}, {"source": 1391740893804, "target": 1461870027148}, {"source": 1391740893804, "target": 1461870077108}, {"source": 1391740893804, "target": 1461870083093}, {"source": 1391740893804, "target": 1461870088700}, {"source": 1391740893804, "target": 1461870100824}, {"source": 1391740893804, "target": 1461870110912}, {"source": 1391740893804, "target": 1461870128102}, {"source": 1391740893804, "target": 1461870794373}, {"source": 1391740893804, "target": 1461871639955}, {"source": 1391740893804, "target": 1461871660443}, {"source": 1391740893804, "target": 1461871703220}, {"source": 1391740893804, "target": 1461871735495}, {"source": 1391740893804, "target": 1461871756747}, {"source": 1391740893804, "target": 1461871803920}, {"source": 1391740893804, "target": 1461875768373}, {"source": 1391740893804, "target": 1461875782791}, {"source": 1391740893804, "target": 1461875806897}, {"source": 1391740893804, "target": 1461875813135}, {"source": 1391740893804, "target": 1461875836893}, {"source": 1391740893804, "target": 1461875856182}, {"source": 1391740893804, "target": 1461875931305}, {"source": 1391740893804, "target": 1461875941713}, {"source": 1391740893804, "target": 1461875953752}, {"source": 1391740893804, "target": 1461875965165}, {"source": 1391740893804, "target": 1461875973910}, {"source": 1391740893804, "target": 1461875983115}, {"source": 1391740893804, "target": 1461876028006}, {"source": 1391740893804, "target": 1461876075319}, {"source": 1391740893804, "target": 1461876115915}, {"source": 1391740893804, "target": 1461876152346}, {"source": 1391740893804, "target": 1461876217426}, {"source": 1391740893804, "target": 1461876244688}, {"source": 1391740893804, "target": 1461876367336}, {"source": 1391740893804, "target": 1461877961265}, {"source": 1391740893804, "target": 1461877968926}, {"source": 1391740893804, "target": 1461877995639}, {"source": 1391740893804, "target": 1461878001216}, {"source": 1391740893804, "target": 1461878021280}, {"source": 1391740893804, "target": 1461878037901}, {"source": 1391740893804, "target": 1461878049146}, {"source": 1391740893804, "target": 1461878103457}, {"source": 1391740893804, "target": 1461878115218}, {"source": 1391740893804, "target": 1461878128995}, {"source": 1391740893804, "target": 1461878157516}, {"source": 1391740893804, "target": 1461878460770}, {"source": 1391740893804, "target": 1461878628938}, {"source": 1391740893804, "target": 1461878671855}, {"source": 1391740893804, "target": 1461880415237}, {"source": 1391740893804, "target": 1461880431253}, {"source": 1391740893804, "target": 1461880437675}, {"source": 1391740893804, "target": 1461880451899}, {"source": 1391740893804, "target": 1461880484814}, {"source": 1391740893804, "target": 1461880499776}, {"source": 1391740893804, "target": 1461880512032}, {"source": 1391740893804, "target": 1461880526100}, {"source": 1391740893804, "target": 1461880545687}, {"source": 1391740893804, "target": 1461880555092}, {"source": 1391740893804, "target": 1461880563805}, {"source": 1391740893804, "target": 1461880585745}, {"source": 1391740893804, "target": 1461880606750}, {"source": 1391740893804, "target": 1461880625384}, {"source": 1391740893804, "target": 1461880651296}, {"source": 1391740893804, "target": 1461880672430}, {"source": 1391740893804, "target": 1461880683894}, {"source": 1391740893804, "target": 1461883823047}, {"source": 1391740893804, "target": 1461884702127}, {"source": 1391740893804, "target": 1461884717288}, {"source": 1391740893804, "target": 1461884723914}, {"source": 1391740893804, "target": 1461884730279}, {"source": 1391740893804, "target": 1461884747560}, {"source": 1391740893804, "target": 1461884755574}, {"source": 1391740893804, "target": 1461884763062}, {"source": 1391740893804, "target": 1461884779583}, {"source": 1391740893804, "target": 1461884800688}, {"source": 1391740893804, "target": 1461884807843}, {"source": 1391740893804, "target": 1461884819979}, {"source": 1391740893804, "target": 1461884838662}, {"source": 1391740893804, "target": 1461884846394}, {"source": 1391740893804, "target": 1461884855032}, {"source": 1391740893804, "target": 1461884861116}, {"source": 1391740893804, "target": 1461884867388}, {"source": 1391740893804, "target": 1461884871184}, {"source": 1391740893804, "target": 1461884917022}, {"source": 1391740893804, "target": 1461884921465}, {"source": 1391740893804, "target": 1461884927872}, {"source": 1391740893804, "target": 1461884968628}, {"source": 1391740893804, "target": 1461884982922}, {"source": 1391740893804, "target": 1461884987103}, {"source": 1391740893804, "target": 1461885006895}, {"source": 1391740893804, "target": 1461885010270}, {"source": 1391740893804, "target": 1461976397557}, {"source": 1391740893804, "target": 1461978083695}, {"source": 1391740893804, "target": 1461978094215}, {"source": 1391740893804, "target": 1461978101467}, {"source": 1391740893804, "target": 1461978108106}, {"source": 1391740893804, "target": 1461978112272}, {"source": 1391740893804, "target": 1461978118121}, {"source": 1391740893804, "target": 1461978145086}, {"source": 1391740893804, "target": 1461978156443}, {"source": 1391740893804, "target": 1461978165029}, {"source": 1391740893804, "target": 1461978184061}, {"source": 1391740893804, "target": 1461978191219}, {"source": 1391740893804, "target": 1461978531598}, {"source": 1391740893804, "target": 1461979320393}, {"source": 1391740893804, "target": 1461979329468}, {"source": 1391740893804, "target": 1461979376290}, {"source": 1391740893804, "target": 1461979481956}, {"source": 1391740893804, "target": 1461979495589}, {"source": 1391740893804, "target": 1461979522595}, {"source": 1391740893804, "target": 1461979552822}, {"source": 1391740893804, "target": 1461979698536}, {"source": 1391740893804, "target": 1461984633531}, {"source": 1391740893804, "target": 1461984643617}, {"source": 1391740893804, "target": 1461984665340}, {"source": 1391740893804, "target": 1461984695705}, {"source": 1391740893804, "target": 1461984713642}, {"source": 1391740893804, "target": 1461984729677}, {"source": 1391740893804, "target": 1461984744498}, {"source": 1391740893804, "target": 1461984762666}, {"source": 1391740893804, "target": 1461984815252}, {"source": 1391740893804, "target": 1461984963965}, {"source": 1391740893804, "target": 1461985089349}, {"source": 1391740893804, "target": 1461985157595}, {"source": 1391740893804, "target": 1461985179436}, {"source": 1391740893804, "target": 1461985266429}, {"source": 1391740893804, "target": 1461985304582}, {"source": 1391740893804, "target": 1461985394124}, {"source": 1391740893804, "target": 1461985436986}, {"source": 1391740893804, "target": 1461985501857}, {"source": 1391740893804, "target": 1461985522739}, {"source": 1391740893804, "target": 1461985542858}, {"source": 1391740893804, "target": 1461985573952}, {"source": 1391740893804, "target": 1461985599113}, {"source": 1391740893804, "target": 1461985625347}, {"source": 1391740893804, "target": 1461985640145}, {"source": 1391740893804, "target": 1461985675479}, {"source": 1391740893804, "target": 1461985737790}, {"source": 1391740893804, "target": 1461985749010}, {"source": 1391740893804, "target": 1461986013689}, {"source": 1391740893804, "target": 1461986072634}, {"source": 1391740893804, "target": 1462032410674}, {"source": 1391740893804, "target": 1462037942264}, {"source": 1391740893804, "target": 1462038045403}, {"source": 1391740893804, "target": 1462038123541}, {"source": 1391740893804, "target": 1462038128069}, {"source": 1391740893804, "target": 1462038150878}, {"source": 1391740893804, "target": 1462038188179}, {"source": 1391740893804, "target": 1462038296160}, {"source": 1391740893804, "target": 1462038317147}, {"source": 1391740893804, "target": 1462038359619}, {"source": 1391740893804, "target": 1462038445101}, {"source": 1391740893804, "target": 1462038493029}, {"source": 1391740893804, "target": 1462038514628}, {"source": 1391740893804, "target": 1462038533263}, {"source": 1391740893804, "target": 1462038554234}, {"source": 1391740893804, "target": 1462038565107}, {"source": 1391740893804, "target": 1462038586217}, {"source": 1391740893804, "target": 1462038610838}, {"source": 1391740893804, "target": 1462038624500}, {"source": 1391740893804, "target": 1462038633475}, {"source": 1391740893804, "target": 1462038652698}, {"source": 1391740893804, "target": 1462038674313}, {"source": 1391740893804, "target": 1462038682267}, {"source": 1391740893804, "target": 1462038696517}, {"source": 1391740893804, "target": 1462038763651}, {"source": 1391740893804, "target": 1462038777530}, {"source": 1391740893804, "target": 1462038815493}, {"source": 1391740893804, "target": 1462038836551}, {"source": 1391740893804, "target": 1462038854701}, {"source": 1391740893804, "target": 1462038872057}, {"source": 1391740893804, "target": 1462038910568}, {"source": 1391740893804, "target": 1462038986297}, {"source": 1391740893804, "target": 1462039003966}, {"source": 1391740893804, "target": 1462039023178}, {"source": 1391740893804, "target": 1462039030033}, {"source": 1391740893804, "target": 1462039045912}, {"source": 1391740893804, "target": 1462039119063}, {"source": 1391740893804, "target": 1462039124289}, {"source": 1391740893804, "target": 1462039139240}, {"source": 1391740893804, "target": 1462043406009}, {"source": 1391740893804, "target": 1462043410108}, {"source": 1391740893804, "target": 1462043412770}, {"source": 1391740893804, "target": 1462049653810}, {"source": 1391740893804, "target": 1462049673226}, {"source": 1391740893804, "target": 1462049687559}, {"source": 1391740893804, "target": 1462049697854}, {"source": 1391740893804, "target": 1462049746964}, {"source": 1391740893804, "target": 1462049756266}, {"source": 1391740893804, "target": 1462049766892}, {"source": 1391740893804, "target": 1462049776032}, {"source": 1391740893804, "target": 1462049892666}, {"source": 1391740893804, "target": 1462049935679}, {"source": 1391740893804, "target": 1462049962406}, {"source": 1391740893804, "target": 1462050002651}, {"source": 1391740893804, "target": 1462050158143}, {"source": 1391740893804, "target": 1462050188336}, {"source": 1391740893804, "target": 1462050210541}, {"source": 1391740893804, "target": 1462050232929}, {"source": 1391740893804, "target": 1462050264981}, {"source": 1391740893804, "target": 1462050406060}, {"source": 1391740893804, "target": 1462050444853}, {"source": 1391740893804, "target": 1462050458149}, {"source": 1391740893804, "target": 1462050477056}, {"source": 1391740893804, "target": 1462050602375}, {"source": 1391740893804, "target": 1462051340374}, {"source": 1391740893804, "target": 1462053126605}, {"source": 1391740893804, "target": 1462053144091}, {"source": 1391740893804, "target": 1462053147855}, {"source": 1391740893804, "target": 1462053248848}, {"source": 1391740893804, "target": 1462053298193}, {"source": 1391740893804, "target": 1462053314382}, {"source": 1391740893804, "target": 1462053341905}, {"source": 1391740893804, "target": 1462053376290}, {"source": 1391740893804, "target": 1462053392778}, {"source": 1391740893804, "target": 1462053424992}, {"source": 1391740893804, "target": 1462053437992}, {"source": 1391740893804, "target": 1462053455853}, {"source": 1391740893804, "target": 1462061124035}, {"source": 1391740893804, "target": 1462061140097}, {"source": 1391740893804, "target": 1462061153036}, {"source": 1391740893804, "target": 1462061159065}, {"source": 1391740893804, "target": 1462061167732}, {"source": 1391740893804, "target": 1462061181462}, {"source": 1391740893804, "target": 1462061188088}, {"source": 1391740893804, "target": 1462061208539}, {"source": 1391740893804, "target": 1462061251872}, {"source": 1391740893804, "target": 1462061261772}, {"source": 1391740893804, "target": 1462061271080}, {"source": 1391740893804, "target": 1462061287878}, {"source": 1391740893804, "target": 1462061303113}, {"source": 1391740893804, "target": 1462061338886}, {"source": 1391740893804, "target": 1462061368360}, {"source": 1391740893804, "target": 1462061455299}, {"source": 1391740893804, "target": 1462061483238}, {"source": 1391740893804, "target": 1462061496172}, {"source": 1391740893804, "target": 1462061507179}, {"source": 1391740893804, "target": 1462062116806}, {"source": 1391740893804, "target": 1462066630531}, {"source": 1391740893804, "target": 1462066714314}, {"source": 1391740893804, "target": 1462066758910}, {"source": 1391740893804, "target": 1462066777580}, {"source": 1391740893804, "target": 1462066785696}, {"source": 1391740893804, "target": 1462066801144}, {"source": 1391740893804, "target": 1462066845454}, {"source": 1391740893804, "target": 1462066866385}, {"source": 1391740893804, "target": 1462066906674}, {"source": 1391740893804, "target": 1462066978901}, {"source": 1391740893804, "target": 1462066985374}, {"source": 1391740893804, "target": 1462067017399}, {"source": 1391740893804, "target": 1462067036959}, {"source": 1391740893804, "target": 1462067057504}, {"source": 1391740893804, "target": 1462067070469}, {"source": 1391740893804, "target": 1462067091584}, {"source": 1391740893804, "target": 1462067106848}, {"source": 1391740893804, "target": 1462067121558}, {"source": 1391740893804, "target": 1462067182134}, {"source": 1391740893804, "target": 1462067204039}, {"source": 1391740893804, "target": 1462067218581}, {"source": 1391740893804, "target": 1462067231521}, {"source": 1391740893804, "target": 1462067240205}, {"source": 1391740893804, "target": 1462120796565}, {"source": 1391740893804, "target": 1462121444354}, {"source": 1391740893804, "target": 1462121459429}, {"source": 1391740893804, "target": 1462121467886}, {"source": 1391740893804, "target": 1462121476788}, {"source": 1391740893804, "target": 1462121485588}, {"source": 1391740893804, "target": 1462121501158}, {"source": 1391740893804, "target": 1462121526915}, {"source": 1391740893804, "target": 1462121552008}, {"source": 1391740893804, "target": 1462121565140}, {"source": 1391740893804, "target": 1462121573747}, {"source": 1391740893804, "target": 1462122572408}, {"source": 1391740893804, "target": 1462122608618}, {"source": 1391740893804, "target": 1462122640848}, {"source": 1391740893804, "target": 1462122652771}, {"source": 1391740893804, "target": 1462122670792}, {"source": 1391740893804, "target": 1462122681020}, {"source": 1391740893804, "target": 1462122701249}, {"source": 1391740893804, "target": 1462122709023}, {"source": 1391740893804, "target": 1462123239655}, {"source": 1391740893804, "target": 1462127745460}, {"source": 1391740893804, "target": 1462127759504}, {"source": 1391740893804, "target": 1462127781248}, {"source": 1391740893804, "target": 1462127805913}, {"source": 1391740893804, "target": 1462127846011}, {"source": 1391740893804, "target": 1462127869624}, {"source": 1391740893804, "target": 1462127903018}, {"source": 1391740893804, "target": 1462127929691}, {"source": 1391740893804, "target": 1462127967528}, {"source": 1391740893804, "target": 1462128017601}, {"source": 1391740893804, "target": 1462128028823}, {"source": 1391740893804, "target": 1462128036872}, {"source": 1391740893804, "target": 1462128089182}, {"source": 1391740893804, "target": 1462128108324}, {"source": 1391740893804, "target": 1462128120927}, {"source": 1391740893804, "target": 1462128178981}, {"source": 1391740893804, "target": 1462128186045}, {"source": 1391740893804, "target": 1462128205014}, {"source": 1391740893804, "target": 1462128231420}, {"source": 1391740893804, "target": 1462128243453}, {"source": 1391740893804, "target": 1462128277353}, {"source": 1391740893804, "target": 1462128347237}, {"source": 1391740893804, "target": 1462128367235}, {"source": 1391740893804, "target": 1462128384469}, {"source": 1391740893804, "target": 1462128398864}, {"source": 1391740893804, "target": 1462128449086}, {"source": 1391740893804, "target": 1462128459898}, {"source": 1391740893804, "target": 1462130433532}, {"source": 1391740893804, "target": 1462131701878}, {"source": 1391740893804, "target": 1462131726115}, {"source": 1391740893804, "target": 1462131783153}, {"source": 1391740893804, "target": 1462131799037}, {"source": 1391740893804, "target": 1462131802276}, {"source": 1391740893804, "target": 1462131823875}, {"source": 1391740893804, "target": 1462131831506}, {"source": 1391740893804, "target": 1462131878424}, {"source": 1391740893804, "target": 1462133663173}, {"source": 1391740893804, "target": 1462133670703}, {"source": 1391740893804, "target": 1462133693905}, {"source": 1391740893804, "target": 1462133704288}, {"source": 1391740893804, "target": 1462133718268}, {"source": 1391740893804, "target": 1462133746777}, {"source": 1391740893804, "target": 1462133757332}, {"source": 1391740893804, "target": 1462133789803}, {"source": 1391740893804, "target": 1462135442737}, {"source": 1391740893804, "target": 1462137178939}, {"source": 1391740893804, "target": 1462137188759}, {"source": 1391740893804, "target": 1462137205163}, {"source": 1391740893804, "target": 1462137262732}, {"source": 1391740893804, "target": 1462137282272}, {"source": 1391740893804, "target": 1462137305372}, {"source": 1391740893804, "target": 1462137316417}, {"source": 1391740893804, "target": 1462137345946}, {"source": 1391740893804, "target": 1462137433796}, {"source": 1391740893804, "target": 1462137441428}, {"source": 1391740893804, "target": 1462137452070}, {"source": 1391740893804, "target": 1462137465195}, {"source": 1391740893804, "target": 1462137479145}, {"source": 1391740893804, "target": 1462137508465}, {"source": 1391740893804, "target": 1462137531146}, {"source": 1391740893804, "target": 1462137593301}, {"source": 1391740893804, "target": 1462137601866}, {"source": 1391740893804, "target": 1462137618041}, {"source": 1391740893804, "target": 1462137679566}, {"source": 1391740893804, "target": 1462137711715}, {"source": 1391740893804, "target": 1462137714771}, {"source": 1391740893804, "target": 1462140487757}, {"source": 1391740893804, "target": 1462140496889}, {"source": 1391740893804, "target": 1462140513830}, {"source": 1391740893804, "target": 1462140522357}, {"source": 1391740893804, "target": 1462140530307}, {"source": 1391740893804, "target": 1462140537123}, {"source": 1391740893804, "target": 1462140542758}, {"source": 1391740893804, "target": 1462140548057}, {"source": 1391740893804, "target": 1462140559401}, {"source": 1391740893804, "target": 1462140572238}, {"source": 1391740893804, "target": 1462140587560}, {"source": 1391740893804, "target": 1462140593524}, {"source": 1391740893804, "target": 1462140635772}, {"source": 1391740893804, "target": 1462140680959}, {"source": 1391740893804, "target": 1462140694887}, {"source": 1391740893804, "target": 1462140768683}, {"source": 1391740893804, "target": 1462140786768}, {"source": 1391740893804, "target": 1462140791464}, {"source": 1391740893804, "target": 1462140817380}, {"source": 1391740893804, "target": 1462140837741}, {"source": 1391740893804, "target": 1462140850494}, {"source": 1391740893804, "target": 1462143914867}, {"source": 1391740893804, "target": 1462145992988}, {"source": 1391740893804, "target": 1462146092249}, {"source": 1391740893804, "target": 1462146106409}, {"source": 1391740893804, "target": 1462146190722}, {"source": 1391740893804, "target": 1462146204556}, {"source": 1391740893804, "target": 1462146232681}, {"source": 1391740893804, "target": 1462146277040}, {"source": 1391740893804, "target": 1462146288515}, {"source": 1391740893804, "target": 1462146297915}, {"source": 1391740893804, "target": 1462204521643}, {"source": 1391740893804, "target": 1462206107219}, {"source": 1391740893804, "target": 1462206113339}, {"source": 1391740893804, "target": 1462206153513}, {"source": 1391740893804, "target": 1462206162910}, {"source": 1391740893804, "target": 1462206168906}, {"source": 1391740893804, "target": 1462206173395}, {"source": 1391740893804, "target": 1462206536742}, {"source": 1391740893804, "target": 1462207418792}, {"source": 1391740893804, "target": 1462207447904}, {"source": 1391740893804, "target": 1462207540805}, {"source": 1391740893804, "target": 1462207566120}, {"source": 1391740893804, "target": 1462208336313}, {"source": 1391740893804, "target": 1462209828585}, {"source": 1391740893804, "target": 1462209855035}, {"source": 1391740893804, "target": 1462209861777}, {"source": 1391740893804, "target": 1462209877358}, {"source": 1391740893804, "target": 1462209898939}, {"source": 1391740893804, "target": 1462210021520}, {"source": 1391740893804, "target": 1462210030535}, {"source": 1391740893804, "target": 1462210050114}, {"source": 1391740893804, "target": 1462210111594}, {"source": 1391740893804, "target": 1462210119948}, {"source": 1391740893804, "target": 1462210128881}, {"source": 1391740893804, "target": 1462210181914}, {"source": 1391740893804, "target": 1462210183851}, {"source": 1391740893804, "target": 1462210190761}, {"source": 1391740893804, "target": 1462210209207}, {"source": 1391740893804, "target": 1462210245186}, {"source": 1391740893804, "target": 1462210250618}, {"source": 1391740893804, "target": 1462210256039}, {"source": 1391740893804, "target": 1462210267018}, {"source": 1391740893804, "target": 1462210280338}, {"source": 1391740893804, "target": 1462210386904}, {"source": 1391740893804, "target": 1462210406620}, {"source": 1391740893804, "target": 1462210416123}, {"source": 1391740893804, "target": 1462210486818}, {"source": 1391740893804, "target": 1462211176329}, {"source": 1391740893804, "target": 1462211180559}, {"source": 1391740893804, "target": 1462211182904}, {"source": 1391740893804, "target": 1462211192914}, {"source": 1391740893804, "target": 1462218872220}, {"source": 1391740893804, "target": 1462219774801}, {"source": 1391740893804, "target": 1462219782959}, {"source": 1391740893804, "target": 1462219790083}, {"source": 1391740893804, "target": 1462219795034}, {"source": 1391740893804, "target": 1462219844221}, {"source": 1391740893804, "target": 1462219845577}, {"source": 1391740893804, "target": 1462219856267}, {"source": 1391740893804, "target": 1462219862784}, {"source": 1391740893804, "target": 1462219876107}, {"source": 1391740893804, "target": 1462219894892}, {"source": 1391740893804, "target": 1462219903584}, {"source": 1391740893804, "target": 1462219909563}, {"source": 1391740893804, "target": 1462219919701}, {"source": 1391740893804, "target": 1462219943721}, {"source": 1391740893804, "target": 1462219961995}, {"source": 1391740893804, "target": 1462220165879}, {"source": 1391740893804, "target": 1462220185774}, {"source": 1391740893804, "target": 1462220276669}, {"source": 1391740893804, "target": 1462220285179}, {"source": 1391740893804, "target": 1462220327470}, {"source": 1391740893804, "target": 1462223715564}, {"source": 1391740893804, "target": 1462223763124}, {"source": 1391740893804, "target": 1462223781267}, {"source": 1391740893804, "target": 1462223793144}, {"source": 1391740893804, "target": 1462223802155}, {"source": 1391740893804, "target": 1462223809215}, {"source": 1391740893804, "target": 1462223812155}, {"source": 1391740893804, "target": 1462223814642}, {"source": 1391740893804, "target": 1462223819821}, {"source": 1391740893804, "target": 1462223846795}, {"source": 1391740893804, "target": 1462223862805}, {"source": 1391740893804, "target": 1462223891730}, {"source": 1391740893804, "target": 1462223900918}, {"source": 1391740893804, "target": 1462223916411}, {"source": 1391740893804, "target": 1462223924118}, {"source": 1391740893804, "target": 1462223933107}, {"source": 1391740893804, "target": 1462223953253}, {"source": 1391740893804, "target": 1462223990721}, {"source": 1391740893804, "target": 1462224001342}, {"source": 1391740893804, "target": 1462224038691}, {"source": 1391740893804, "target": 1462224076734}, {"source": 1391740893804, "target": 1462224106274}, {"source": 1391740893804, "target": 1462224134179}, {"source": 1391740893804, "target": 1462224141565}, {"source": 1391740893804, "target": 1462228482324}, {"source": 1391740893804, "target": 1462228497868}, {"source": 1391740893804, "target": 1462228511124}, {"source": 1391740893804, "target": 1462228521890}, {"source": 1391740893804, "target": 1462228531057}, {"source": 1391740893804, "target": 1462228546625}, {"source": 1391740893804, "target": 1462228554222}, {"source": 1391740893804, "target": 1462228578176}, {"source": 1391740893804, "target": 1462228594968}, {"source": 1391740893804, "target": 1462228629278}, {"source": 1391740893804, "target": 1462228661599}, {"source": 1391740893804, "target": 1462228665661}, {"source": 1391740893804, "target": 1462228694838}, {"source": 1391740893804, "target": 1462228925054}, {"source": 1391740893804, "target": 1462228968675}, {"source": 1391740893804, "target": 1462228988545}, {"source": 1391740893804, "target": 1462228992508}, {"source": 1391740893804, "target": 1462229017040}, {"source": 1391740893804, "target": 1462229039299}, {"source": 1391740893804, "target": 1462229047807}, {"source": 1391740893804, "target": 1462229061096}, {"source": 1391740893804, "target": 1462229067351}, {"source": 1391740893804, "target": 1462229072601}, {"source": 1391740893804, "target": 1462229092555}, {"source": 1391740893804, "target": 1462229198876}, {"source": 1391740893804, "target": 1462229233459}, {"source": 1391740893804, "target": 1462229255450}, {"source": 1391740893804, "target": 1462229270613}, {"source": 1391740893804, "target": 1462229277074}, {"source": 1391740893804, "target": 1462229286041}, {"source": 1391740893804, "target": 1462232001565}, {"source": 1391740893804, "target": 1462232007760}, {"source": 1391740893804, "target": 1462232033989}, {"source": 1391740893804, "target": 1462232060525}, {"source": 1391740893804, "target": 1462232077763}, {"source": 1391740893804, "target": 1462232142704}, {"source": 1391740893804, "target": 1462232161465}, {"source": 1391740893804, "target": 1462232179503}, {"source": 1391740893804, "target": 1462232204692}, {"source": 1391740893804, "target": 1462232219341}, {"source": 1391740893804, "target": 1462232225257}, {"source": 1391740893804, "target": 1462232232348}, {"source": 1391740893804, "target": 1462232288770}, {"source": 1391740893804, "target": 1462232307555}, {"source": 1391740893804, "target": 1462308715423}, {"source": 1391740893804, "target": 1462326105448}, {"source": 1391740893804, "target": 1462326951145}, {"source": 1391740893804, "target": 1462326961450}, {"source": 1391740893804, "target": 1462326990404}, {"source": 1391740893804, "target": 1462326996658}, {"source": 1391740893804, "target": 1462327011039}, {"source": 1391740893804, "target": 1462327016536}, {"source": 1391740893804, "target": 1462327023070}, {"source": 1391740893804, "target": 1462327031605}, {"source": 1391740893804, "target": 1462327043159}, {"source": 1391740893804, "target": 1462327053167}, {"source": 1391740893804, "target": 1462327061414}, {"source": 1391740893804, "target": 1462327073683}, {"source": 1391740893804, "target": 1462327089156}, {"source": 1391740893804, "target": 1462327127564}, {"source": 1391740893804, "target": 1462327139204}, {"source": 1391740893804, "target": 1462327161497}, {"source": 1391740893804, "target": 1462327170017}, {"source": 1391740893804, "target": 1462327178225}, {"source": 1391740893804, "target": 1462327189114}, {"source": 1391740893804, "target": 1462327203603}, {"source": 1391740893804, "target": 1462327211125}, {"source": 1391740893804, "target": 1462327224889}, {"source": 1391740893804, "target": 1462327286091}, {"source": 1391740893804, "target": 1462327309654}, {"source": 1391740893804, "target": 1462327320519}, {"source": 1391740893804, "target": 1462327329868}, {"source": 1391740893804, "target": 1462327341080}, {"source": 1391740893804, "target": 1462327346466}, {"source": 1391740893804, "target": 1462327363797}, {"source": 1391740893804, "target": 1462327370877}, {"source": 1391740893804, "target": 1462327377004}, {"source": 1391740893804, "target": 1462327382493}, {"source": 1391740893804, "target": 1462327389480}, {"source": 1391740893804, "target": 1462327432810}, {"source": 1391740893804, "target": 1462327441833}, {"source": 1391740893804, "target": 1462327461738}, {"source": 1391740893804, "target": 1462327473707}, {"source": 1391740893804, "target": 1462327481691}, {"source": 1391740893804, "target": 1462327545263}, {"source": 1391740893804, "target": 1462327558597}, {"source": 1391740893804, "target": 1462327570500}, {"source": 1391740893804, "target": 1462327588618}, {"source": 1391740893804, "target": 1462327605465}, {"source": 1391740893804, "target": 1462327641370}, {"source": 1391740893804, "target": 1462327651340}, {"source": 1391740893804, "target": 1462327670273}, {"source": 1391740893804, "target": 1462327681826}, {"source": 1391740893804, "target": 1462327695261}, {"source": 1391740893804, "target": 1462327732727}, {"source": 1391740893804, "target": 1462327744491}, {"source": 1391740893804, "target": 1462327755265}, {"source": 1391740893804, "target": 1462327759863}, {"source": 1391740893804, "target": 1462327767445}, {"source": 1391740893804, "target": 1462327792664}, {"source": 1391740893804, "target": 1462327808151}, {"source": 1391740893804, "target": 1462327847781}, {"source": 1391740893804, "target": 1462327862046}, {"source": 1391740893804, "target": 1462327872883}, {"source": 1391740893804, "target": 1462327883792}, {"source": 1391740893804, "target": 1462327891062}, {"source": 1391740893804, "target": 1462327899426}, {"source": 1391740893804, "target": 1462327929517}, {"source": 1391740893804, "target": 1462327941682}, {"source": 1391740893804, "target": 1462327945336}, {"source": 1391740893804, "target": 1462327957226}, {"source": 1391740893804, "target": 1462327963475}, {"source": 1391740893804, "target": 1462327969304}, {"source": 1391740893804, "target": 1462377691686}, {"source": 1391740893804, "target": 1462380546437}, {"source": 1391740893804, "target": 1462380557261}, {"source": 1391740893804, "target": 1462380573238}, {"source": 1391740893804, "target": 1462380580332}, {"source": 1391740893804, "target": 1462380591634}, {"source": 1391740893804, "target": 1462380612148}, {"source": 1391740893804, "target": 1462380628768}, {"source": 1391740893804, "target": 1462380649800}, {"source": 1391740893804, "target": 1462380658695}, {"source": 1391740893804, "target": 1462380664504}, {"source": 1391740893804, "target": 1462380676531}, {"source": 1391740893804, "target": 1462380707702}, {"source": 1391740893804, "target": 1462380769945}, {"source": 1391740893804, "target": 1462380781251}, {"source": 1391740893804, "target": 1462380786286}, {"source": 1391740893804, "target": 1462380873616}, {"source": 1391740893804, "target": 1462380876557}, {"source": 1391740893804, "target": 1462380908389}, {"source": 1391740893804, "target": 1462380962582}, {"source": 1391740893804, "target": 1462381626652}, {"source": 1391740893804, "target": 1462381638330}, {"source": 1391740893804, "target": 1462381654555}, {"source": 1391740893804, "target": 1462381664335}, {"source": 1391740893804, "target": 1462383708003}, {"source": 1391740893804, "target": 1462383833553}, {"source": 1391740893804, "target": 1462383836128}, {"source": 1391740893804, "target": 1462383838903}, {"source": 1391740893804, "target": 1462383841425}, {"source": 1391740893804, "target": 1462383843747}, {"source": 1391740893804, "target": 1462383846293}, {"source": 1391740893804, "target": 1462383852650}, {"source": 1391740893804, "target": 1462383855049}, {"source": 1391740893804, "target": 1462389760356}, {"source": 1391740893804, "target": 1462390236322}, {"source": 1391740893804, "target": 1462390426081}, {"source": 1391740893804, "target": 1462390432656}, {"source": 1391740893804, "target": 1462390449708}, {"source": 1391740893804, "target": 1462390476322}, {"source": 1391740893804, "target": 1462390501771}, {"source": 1391740893804, "target": 1462390507327}, {"source": 1391740893804, "target": 1462390512342}, {"source": 1391740893804, "target": 1462390533401}, {"source": 1391740893804, "target": 1462390543517}, {"source": 1391740893804, "target": 1462390604502}, {"source": 1391740893804, "target": 1462390609512}, {"source": 1391740893804, "target": 1462390622705}, {"source": 1391740893804, "target": 1462390641726}, {"source": 1391740893804, "target": 1462391904909}, {"source": 1391740893804, "target": 1462391919306}, {"source": 1391740893804, "target": 1462391926278}, {"source": 1391740893804, "target": 1462391951908}, {"source": 1391740893804, "target": 1462391963610}, {"source": 1391740893804, "target": 1462392011163}, {"source": 1391740893804, "target": 1462392039342}, {"source": 1391740893804, "target": 1462392047911}, {"source": 1391740893804, "target": 1462808901843}, {"source": 1391740893804, "target": 1462808976733}, {"source": 1391740893804, "target": 1462809000922}, {"source": 1391740893804, "target": 1462809037538}, {"source": 1391740893804, "target": 1462809038273}, {"source": 1391740893804, "target": 1462809195840}, {"source": 1391740893804, "target": 1462809232452}, {"source": 1391740893804, "target": 1462809498251}, {"source": 1391740893804, "target": 1462809621604}, {"source": 1391740893804, "target": 1462809735089}, {"source": 1391740893804, "target": 1462809895863}, {"source": 1391740893804, "target": 1462810051900}, {"source": 1391740893804, "target": 1462810342552}, {"source": 1391740893804, "target": 1462810386376}, {"source": 1391740893804, "target": 1462810615371}, {"source": 1391740893804, "target": 1462810965063}, {"source": 1391740893804, "target": 1462811101121}, {"source": 1391740893804, "target": 1462811140825}, {"source": 1391740893804, "target": 1462811217109}, {"source": 1391740893804, "target": 1462811651513}, {"source": 1391740893804, "target": 1462811666951}, {"source": 1391740893804, "target": 1462811683463}, {"source": 1391740893804, "target": 1462811818195}, {"source": 1391740893804, "target": 1462812278781}, {"source": 1391740893804, "target": 1462812673994}, {"source": 1391740893804, "target": 1462818005716}, {"source": 1391740893804, "target": 1462818046641}, {"source": 1391740893804, "target": 1462818125916}, {"source": 1391740893804, "target": 1462818332334}, {"source": 1391740893804, "target": 1462818499640}, {"source": 1391740893804, "target": 1462818806593}, {"source": 1391740893804, "target": 1462831927912}, {"source": 1391740893804, "target": 1462833649683}, {"source": 1391740893804, "target": 1462834082547}, {"source": 1391740893804, "target": 1462834177306}, {"source": 1391740893804, "target": 1462834193700}, {"source": 1391740893804, "target": 1462834233055}, {"source": 1391740893804, "target": 1462834249353}, {"source": 1391740893804, "target": 1462834349642}, {"source": 1391740893804, "target": 1462834690894}, {"source": 1391740893804, "target": 1462834697458}, {"source": 1391740893804, "target": 1462834724504}, {"source": 1391740893804, "target": 1462834732857}, {"source": 1391740893804, "target": 1462834769845}, {"source": 1391740893804, "target": 1462834777985}, {"source": 1391740893804, "target": 1462834810746}, {"source": 1391740893804, "target": 1462844350121}, {"source": 1391740893804, "target": 1462844554684}, {"source": 1391740893804, "target": 1462845596752}, {"source": 1391740893804, "target": 1462849092193}, {"source": 1391740893804, "target": 1462849100249}, {"source": 1391740893804, "target": 1462849107376}, {"source": 1391740893804, "target": 1462849116753}, {"source": 1391740893804, "target": 1462849123696}, {"source": 1391740893804, "target": 1462849133349}, {"source": 1391740893804, "target": 1462849140370}, {"source": 1391740893804, "target": 1462849149554}, {"source": 1391740893804, "target": 1462849159965}, {"source": 1391740893804, "target": 1462849196492}, {"source": 1391740893804, "target": 1462849213386}, {"source": 1391740893804, "target": 1462849233061}, {"source": 1391740893804, "target": 1462849240470}, {"source": 1391740893804, "target": 1462849248763}, {"source": 1391740893804, "target": 1462849277484}, {"source": 1391740893804, "target": 1462849289458}, {"source": 1391740893804, "target": 1462849297574}, {"source": 1391740893804, "target": 1462849313819}, {"source": 1391740893804, "target": 1462849345929}, {"source": 1391740893804, "target": 1462849353569}, {"source": 1391740893804, "target": 1462849360434}, {"source": 1391740893804, "target": 1462849367468}, {"source": 1391740893804, "target": 1462849374890}, {"source": 1391740893804, "target": 1462849382382}, {"source": 1391740893804, "target": 1462849387815}, {"source": 1391740893804, "target": 1462849394748}, {"source": 1391740893804, "target": 1462849402751}, {"source": 1391740893804, "target": 1462849410036}, {"source": 1391740893804, "target": 1462849421840}, {"source": 1391740893804, "target": 1462849428163}, {"source": 1391740893804, "target": 1462849434995}, {"source": 1391740893804, "target": 1462849442061}, {"source": 1391740893804, "target": 1462849448833}, {"source": 1391740893804, "target": 1462849457192}, {"source": 1391740893804, "target": 1462849475077}, {"source": 1391740893804, "target": 1462849488980}, {"source": 1391740893804, "target": 1462879506170}, {"source": 1391740893804, "target": 1462913151403}, {"source": 1391740893804, "target": 1462913162803}, {"source": 1391740893804, "target": 1462913170662}, {"source": 1391740893804, "target": 1462913225002}, {"source": 1391740893804, "target": 1462913228518}, {"source": 1391740893804, "target": 1462913238244}, {"source": 1391740893804, "target": 1462913246058}, {"source": 1391740893804, "target": 1462913257878}, {"source": 1391740893804, "target": 1462913267342}, {"source": 1391740893804, "target": 1462913285372}, {"source": 1391740893804, "target": 1462913300610}, {"source": 1391740893804, "target": 1462913309820}, {"source": 1391740893804, "target": 1462913323101}, {"source": 1391740893804, "target": 1462913355567}, {"source": 1391740893804, "target": 1462913390177}, {"source": 1391740893804, "target": 1462913407963}, {"source": 1391740893804, "target": 1462913437726}, {"source": 1391740893804, "target": 1462913442939}, {"source": 1391740893804, "target": 1462913454503}, {"source": 1391740893804, "target": 1462913462613}, {"source": 1391740893804, "target": 1462913505933}, {"source": 1391740893804, "target": 1462913533718}, {"source": 1391740893804, "target": 1462913541311}, {"source": 1391740893804, "target": 1462913552133}, {"source": 1391740893804, "target": 1462913584874}, {"source": 1391740893804, "target": 1462913605177}, {"source": 1391740893804, "target": 1462913613399}, {"source": 1391740893804, "target": 1462913625624}, {"source": 1391740893804, "target": 1462913640957}, {"source": 1391740893804, "target": 1462913649966}, {"source": 1391740893804, "target": 1462913659830}, {"source": 1391740893804, "target": 1462913664323}, {"source": 1391740893804, "target": 1462913681590}, {"source": 1391740893804, "target": 1462913702538}, {"source": 1391740893804, "target": 1462913711724}, {"source": 1391740893804, "target": 1462913732310}, {"source": 1391740893804, "target": 1462913747084}, {"source": 1391740893804, "target": 1462913773816}, {"source": 1391740893804, "target": 1462913780255}, {"source": 1391740893804, "target": 1462913801840}, {"source": 1391740893804, "target": 1462913811151}, {"source": 1391740893804, "target": 1462913833610}, {"source": 1391740893804, "target": 1462913839886}, {"source": 1391740893804, "target": 1462933166502}, {"source": 1391740893804, "target": 1462933184944}, {"source": 1391740893804, "target": 1462981484465}, {"source": 1391740893804, "target": 1462981781486}, {"source": 1391740893804, "target": 1462981797259}, {"source": 1391740893804, "target": 1462981887544}, {"source": 1391740893804, "target": 1462982073243}, {"source": 1391740893804, "target": 1462986895220}, {"source": 1391740893804, "target": 1462996327469}, {"source": 1391740893804, "target": 1463141251045}, {"source": 1391740893804, "target": 1463172352600}, {"source": 1391740893804, "target": 1463346003581}, {"source": 1391740893804, "target": 1463346102353}, {"source": 1391740893804, "target": 1463442971546}, {"source": 1391740893804, "target": 1463675545974}, {"source": 1391740893804, "target": 1463675562411}, {"source": 1391740893804, "target": 1463844501109}, {"source": 1391740893804, "target": 1463844524624}, {"source": 1391740893804, "target": 1463844549067}, {"source": 1391740893804, "target": 1463844555620}, {"source": 1391740893804, "target": 1463844566230}, {"source": 1391740893804, "target": 1463844574977}, {"source": 1391740893804, "target": 1463844595293}, {"source": 1391740893804, "target": 1463844954526}, {"source": 1391740893804, "target": 1463845068497}, {"source": 1391740893804, "target": 1463845088254}, {"source": 1391740893804, "target": 1463845129097}, {"source": 1391740893804, "target": 1463845154729}, {"source": 1391740893804, "target": 1463845174869}, {"source": 1391740893804, "target": 1463845182983}, {"source": 1391740893804, "target": 1463845189086}, {"source": 1391740893804, "target": 1463845202003}, {"source": 1391740893804, "target": 1463845210814}, {"source": 1391740893804, "target": 1463875484080}, {"source": 1391740893804, "target": 1463875780951}, {"source": 1391740893804, "target": 1463875845927}, {"source": 1391740893804, "target": 1463875853686}, {"source": 1391740893804, "target": 1463875860762}, {"source": 1391740893804, "target": 1463875872656}, {"source": 1391740893804, "target": 1463875952548}, {"source": 1391740893804, "target": 1463881872804}, {"source": 1391740893804, "target": 1463883728414}, {"source": 1391740893804, "target": 1463883738825}, {"source": 1391740893804, "target": 1463883746350}, {"source": 1391740893804, "target": 1463883753623}, {"source": 1391740893804, "target": 1463883777608}, {"source": 1391740893804, "target": 1463883894010}, {"source": 1391740893804, "target": 1463883932504}, {"source": 1391740893804, "target": 1463883941617}, {"source": 1391740893804, "target": 1463884000084}, {"source": 1391740893804, "target": 1463884018201}, {"source": 1391740893804, "target": 1463930142523}, {"source": 1391740893804, "target": 1464061546338}, {"source": 1391740893804, "target": 1464061625945}, {"source": 1391740893804, "target": 1464300429805}, {"source": 1391740893804, "target": 1464300798101}, {"source": 1391740893804, "target": 1464300810389}, {"source": 1391740893804, "target": 1464300847477}, {"source": 1391740893804, "target": 1464300876421}, {"source": 1391740893804, "target": 1464300976080}, {"source": 1391740893804, "target": 1464478354579}, {"source": 1391740893804, "target": 1464478365999}, {"source": 1391740893804, "target": 1464478389699}, {"source": 1391740893804, "target": 1464478399061}, {"source": 1391740893804, "target": 1464478432028}, {"source": 1391740893804, "target": 1464478461799}, {"source": 1391740893804, "target": 1464478477613}, {"source": 1391740893804, "target": 1464478493034}, {"source": 1391740893804, "target": 1464478523728}, {"source": 1391740893804, "target": 1464478542649}, {"source": 1391740893804, "target": 1464524897579}, {"source": 1391740893804, "target": 1467833823409}, {"source": 1391740893804, "target": 1471176273250}, {"source": 1391740893804, "target": 1471809049354}, {"source": 1391740893804, "target": 1471995423922}, {"source": 1391740893804, "target": 1471999839826}, {"source": 1391740893804, "target": 1471999854180}, {"source": 1391740893804, "target": 1471999865945}, {"source": 1391740893804, "target": 1471999885871}, {"source": 1391740893804, "target": 1471999893105}, {"source": 1391740893804, "target": 1471999905712}, {"source": 1391740893804, "target": 1471999913609}, {"source": 1391740893804, "target": 1471999921983}, {"source": 1391740893804, "target": 1471999929658}, {"source": 1391740893804, "target": 1471999936258}, {"source": 1391740893804, "target": 1471999942205}, {"source": 1391740893804, "target": 1471999949472}, {"source": 1391740893804, "target": 1471999956293}, {"source": 1391740893804, "target": 1471999991212}, {"source": 1391740893804, "target": 1471999998145}, {"source": 1391740893804, "target": 1472000006974}, {"source": 1391740893804, "target": 1472000019446}, {"source": 1391740893804, "target": 1472000027736}, {"source": 1391740893804, "target": 1472000038292}, {"source": 1391740893804, "target": 1472000042817}, {"source": 1391740893804, "target": 1472000056279}, {"source": 1391740893804, "target": 1472000064700}, {"source": 1391740893804, "target": 1472000071465}, {"source": 1391740893804, "target": 1472000097100}, {"source": 1391740893804, "target": 1472000103258}, {"source": 1391740893804, "target": 1472000114229}, {"source": 1391740893804, "target": 1472000124224}, {"source": 1391740893804, "target": 1472000134782}, {"source": 1391740893804, "target": 1472000138222}, {"source": 1391740893804, "target": 1472000146226}, {"source": 1391740893804, "target": 1472000153006}, {"source": 1391740893804, "target": 1472000170602}, {"source": 1391740893804, "target": 1472000179397}, {"source": 1391740893804, "target": 1472000189983}, {"source": 1391740893804, "target": 1472000196513}, {"source": 1391740893804, "target": 1472000199963}, {"source": 1391740893804, "target": 1472000205998}, {"source": 1391740893804, "target": 1472000211302}, {"source": 1391740893804, "target": 1472000217588}, {"source": 1391740893804, "target": 1472078824458}, {"source": 1391740893804, "target": 1472085339918}, {"source": 1391740893804, "target": 1472087000322}, {"source": 1391740893804, "target": 1472087004432}, {"source": 1391740893804, "target": 1472087007504}, {"source": 1391740893804, "target": 1472087015704}, {"source": 1391740893804, "target": 1472087022065}, {"source": 1391740893804, "target": 1472087031632}, {"source": 1391740893804, "target": 1472087041816}, {"source": 1391740893804, "target": 1472087051517}, {"source": 1391740893804, "target": 1472087069469}, {"source": 1391740893804, "target": 1472087079663}, {"source": 1391740893804, "target": 1472087092128}, {"source": 1391740893804, "target": 1472087101965}, {"source": 1391740893804, "target": 1472087110025}, {"source": 1391740893804, "target": 1472087115813}, {"source": 1391740893804, "target": 1472090596497}, {"source": 1391740893804, "target": 1472091023576}, {"source": 1391740893804, "target": 1472091031357}, {"source": 1391740893804, "target": 1472091039542}, {"source": 1391740893804, "target": 1472091045601}, {"source": 1391740893804, "target": 1472091073131}, {"source": 1391740893804, "target": 1472091088106}, {"source": 1391740893804, "target": 1472091094963}, {"source": 1391740893804, "target": 1472091101662}, {"source": 1391740893804, "target": 1472091107732}, {"source": 1391740893804, "target": 1472091129744}, {"source": 1391740893804, "target": 1472091136098}, {"source": 1391740893804, "target": 1472091142763}, {"source": 1391740893804, "target": 1472091153400}, {"source": 1391740893804, "target": 1472091162700}, {"source": 1391740893804, "target": 1472091171892}, {"source": 1391740893804, "target": 1472091178381}, {"source": 1391740893804, "target": 1472091184661}, {"source": 1391740893804, "target": 1472091193755}, {"source": 1391740893804, "target": 1472091209218}, {"source": 1391740893804, "target": 1472091220986}, {"source": 1391740893804, "target": 1472091227884}, {"source": 1391740893804, "target": 1472091234421}, {"source": 1391740893804, "target": 1472091238059}, {"source": 1391740893804, "target": 1472091242088}, {"source": 1391740893804, "target": 1472261539021}, {"source": 1391740893804, "target": 1472261849467}, {"source": 1391740893804, "target": 1472261858159}, {"source": 1391740893804, "target": 1472261861671}, {"source": 1391740893804, "target": 1472261870063}, {"source": 1391740893804, "target": 1472261876215}, {"source": 1391740893804, "target": 1472261886034}, {"source": 1391740893804, "target": 1472261890259}, {"source": 1391740893804, "target": 1472261896454}, {"source": 1391740893804, "target": 1472261904555}, {"source": 1391740893804, "target": 1472261910467}, {"source": 1391740893804, "target": 1472261919635}, {"source": 1391740893804, "target": 1472261925853}, {"source": 1391740893804, "target": 1472264798618}, {"source": 1391740893804, "target": 1472265205487}, {"source": 1391740893804, "target": 1472265213940}, {"source": 1391740893804, "target": 1472265219508}, {"source": 1391740893804, "target": 1472265226228}, {"source": 1391740893804, "target": 1472265258266}, {"source": 1391740893804, "target": 1472265265781}, {"source": 1391740893804, "target": 1472265271998}, {"source": 1391740893804, "target": 1472265278073}, {"source": 1391740893804, "target": 1472265283602}, {"source": 1391740893804, "target": 1472265289730}, {"source": 1391740893804, "target": 1472265296216}, {"source": 1391740893804, "target": 1472265318747}, {"source": 1391740893804, "target": 1472265327630}, {"source": 1391740893804, "target": 1472265335516}, {"source": 1391740893804, "target": 1472265342000}, {"source": 1391740893804, "target": 1472265350914}, {"source": 1391740893804, "target": 1472265363911}, {"source": 1391740893804, "target": 1472265374376}, {"source": 1391740893804, "target": 1472265381679}, {"source": 1391740893804, "target": 1472265388511}, {"source": 1391740893804, "target": 1472265402899}, {"source": 1391740893804, "target": 1472265413515}, {"source": 1391740893804, "target": 1472265424130}, {"source": 1391740893804, "target": 1472487541747}, {"source": 1391740893804, "target": 1472487550752}, {"source": 1391740893804, "target": 1472487557798}, {"source": 1391740893804, "target": 1472487609656}, {"source": 1391740893804, "target": 1472487655906}, {"source": 1391740893804, "target": 1472487663906}, {"source": 1391740893804, "target": 1472487670528}, {"source": 1391740893804, "target": 1472500374903}, {"source": 1391740893804, "target": 1472502461817}, {"source": 1391740893804, "target": 1472502468924}, {"source": 1391740893804, "target": 1472502477608}, {"source": 1391740893804, "target": 1472502484635}, {"source": 1391740893804, "target": 1472502493911}, {"source": 1391740893804, "target": 1472502505405}, {"source": 1391740893804, "target": 1472502520244}, {"source": 1391740893804, "target": 1472502529886}, {"source": 1391740893804, "target": 1472502538202}, {"source": 1391740893804, "target": 1472502559313}, {"source": 1391740893804, "target": 1472502565616}, {"source": 1391740893804, "target": 1472502574081}, {"source": 1391740893804, "target": 1472502594120}, {"source": 1391740893804, "target": 1472502605856}, {"source": 1391740893804, "target": 1472502616617}, {"source": 1391740893804, "target": 1472502628127}, {"source": 1391740893804, "target": 1472502634353}, {"source": 1391740893804, "target": 1472502649352}, {"source": 1391740893804, "target": 1472502659342}, {"source": 1391740893804, "target": 1472502678171}, {"source": 1391740893804, "target": 1472502689964}, {"source": 1391740893804, "target": 1472502698548}, {"source": 1391740893804, "target": 1472502704876}, {"source": 1391740893804, "target": 1472502710529}, {"source": 1391740893804, "target": 1472502721143}, {"source": 1391740893804, "target": 1472502750542}, {"source": 1391740893804, "target": 1472502758634}, {"source": 1391740893804, "target": 1472502761294}, {"source": 1391740893804, "target": 1472611837810}, {"source": 1391740893804, "target": 1472611912290}, {"source": 1391740893804, "target": 1472611938769}, {"source": 1391740893804, "target": 1472611979581}, {"source": 1391740893804, "target": 1472611989012}, {"source": 1391740893804, "target": 1472612013495}, {"source": 1391740893804, "target": 1472612051677}, {"source": 1391740893804, "target": 1472668144393}, {"source": 1391740893804, "target": 1472668157311}, {"source": 1391740893804, "target": 1472668181157}, {"source": 1391740893804, "target": 1472668189982}, {"source": 1391740893804, "target": 1472668212125}, {"source": 1391740893804, "target": 1472668221441}, {"source": 1391740893804, "target": 1472668230564}, {"source": 1391740893804, "target": 1472668244713}, {"source": 1391740893804, "target": 1472668252970}, {"source": 1391740893804, "target": 1472668261580}, {"source": 1391740893804, "target": 1472668268533}, {"source": 1391740893804, "target": 1472668276020}, {"source": 1391740893804, "target": 1472668287227}, {"source": 1391740893804, "target": 1472668297518}, {"source": 1391740893804, "target": 1472668314490}, {"source": 1391740893804, "target": 1472668322150}, {"source": 1391740893804, "target": 1472668346297}, {"source": 1391740893804, "target": 1472668354811}, {"source": 1391740893804, "target": 1472668367901}, {"source": 1391740893804, "target": 1472668380549}, {"source": 1391740893804, "target": 1472668407920}, {"source": 1391740893804, "target": 1472668415239}, {"source": 1391740893804, "target": 1472668423640}, {"source": 1391740893804, "target": 1472668437183}, {"source": 1391740893804, "target": 1472668445184}, {"source": 1391740893804, "target": 1472668453090}, {"source": 1391740893804, "target": 1472668462268}, {"source": 1391740893804, "target": 1472668470653}, {"source": 1391740893804, "target": 1472668485114}, {"source": 1391740893804, "target": 1472668510022}, {"source": 1391740893804, "target": 1472668519019}, {"source": 1391740893804, "target": 1472668526554}, {"source": 1391740893804, "target": 1472668552198}, {"source": 1391740893804, "target": 1472668562134}, {"source": 1391740893804, "target": 1472672275670}, {"source": 1391740893804, "target": 1472673094113}, {"source": 1391740893804, "target": 1472673105758}, {"source": 1391740893804, "target": 1472673121602}, {"source": 1391740893804, "target": 1472673129980}, {"source": 1391740893804, "target": 1472673137003}, {"source": 1391740893804, "target": 1472673150221}, {"source": 1391740893804, "target": 1472673161686}, {"source": 1391740893804, "target": 1472673168254}, {"source": 1391740893804, "target": 1472673197430}, {"source": 1391740893804, "target": 1472673210697}, {"source": 1391740893804, "target": 1472673225907}, {"source": 1391740893804, "target": 1472673233193}, {"source": 1391740893804, "target": 1472673237351}, {"source": 1391740893804, "target": 1472673244066}, {"source": 1391740893804, "target": 1472673251212}, {"source": 1391740893804, "target": 1472673261352}, {"source": 1391740893804, "target": 1472673269032}, {"source": 1391740893804, "target": 1472676030952}, {"source": 1391740893804, "target": 1472676524788}, {"source": 1391740893804, "target": 1472676532297}, {"source": 1391740893804, "target": 1472676541571}, {"source": 1391740893804, "target": 1472676549097}, {"source": 1391740893804, "target": 1472676561710}, {"source": 1391740893804, "target": 1472676568535}, {"source": 1391740893804, "target": 1472676576760}, {"source": 1391740893804, "target": 1472676616697}, {"source": 1391740893804, "target": 1472676626963}, {"source": 1391740893804, "target": 1472676636114}, {"source": 1391740893804, "target": 1472676642388}, {"source": 1391740893804, "target": 1472676648720}, {"source": 1391740893804, "target": 1472676654480}, {"source": 1391740893804, "target": 1472676659959}, {"source": 1391740893804, "target": 1472676674981}, {"source": 1391740893804, "target": 1472743774495}, {"source": 1391740893804, "target": 1472747773497}, {"source": 1391740893804, "target": 1472747780684}, {"source": 1391740893804, "target": 1472747787801}, {"source": 1391740893804, "target": 1472747798559}, {"source": 1391740893804, "target": 1472747806470}, {"source": 1391740893804, "target": 1472747814325}, {"source": 1391740893804, "target": 1472747820905}, {"source": 1391740893804, "target": 1472747829983}, {"source": 1391740893804, "target": 1472747837737}, {"source": 1391740893804, "target": 1472747844000}, {"source": 1391740893804, "target": 1472747850067}, {"source": 1391740893804, "target": 1472747857568}, {"source": 1391740893804, "target": 1472747866517}, {"source": 1391740893804, "target": 1472747873373}, {"source": 1391740893804, "target": 1472747882582}, {"source": 1391740893804, "target": 1472747888604}, {"source": 1391740893804, "target": 1472747894757}, {"source": 1391740893804, "target": 1472747901922}, {"source": 1391740893804, "target": 1472747910012}, {"source": 1391740893804, "target": 1472747916455}, {"source": 1391740893804, "target": 1472747925827}, {"source": 1391740893804, "target": 1472747933027}, {"source": 1391740893804, "target": 1472747945251}, {"source": 1391740893804, "target": 1472747953733}, {"source": 1391740893804, "target": 1472782086749}, {"source": 1391740893804, "target": 1472782285156}, {"source": 1391740893804, "target": 1472782289232}, {"source": 1391740893804, "target": 1472782313881}, {"source": 1391740893804, "target": 1472782319515}, {"source": 1391740893804, "target": 1472782322699}, {"source": 1391740893804, "target": 1472782338409}, {"source": 1391740893804, "target": 1472782344403}, {"source": 1391740893804, "target": 1472782350788}, {"source": 1391740893804, "target": 1472782356991}, {"source": 1391740893804, "target": 1472782364657}, {"source": 1391740893804, "target": 1472782371240}, {"source": 1391740893804, "target": 1472782379809}, {"source": 1391740893804, "target": 1472782387702}, {"source": 1391740893804, "target": 1473695370768}, {"source": 1391740893804, "target": 1473697145352}, {"source": 1391740893804, "target": 1473732995433}, {"source": 1391740893804, "target": 1473733000524}, {"source": 1391740893804, "target": 1473733149553}, {"source": 1391740893804, "target": 1473733154474}, {"source": 1391740893804, "target": 1473733164970}, {"source": 1391740893804, "target": 1473733173413}, {"source": 1391740893804, "target": 1473733179458}, {"source": 1391740893804, "target": 1473986316038}, {"source": 1391740893804, "target": 1474306785104}, {"source": 1391740893804, "target": 1474340730687}, {"source": 1391740893804, "target": 1474503607320}, {"source": 1391740893804, "target": 1474571591865}, {"source": 1391740893804, "target": 1474571599295}, {"source": 1391740893804, "target": 1474571698024}, {"source": 1391740893804, "target": 1474571737889}, {"source": 1391740893804, "target": 1474580628339}, {"source": 1391740893804, "target": 1474580639757}, {"source": 1391740893804, "target": 1474580657593}, {"source": 1391740893804, "target": 1474580671870}, {"source": 1391740893804, "target": 1474580678183}, {"source": 1391740893804, "target": 1474580686903}, {"source": 1391740893804, "target": 1474580694965}, {"source": 1391740893804, "target": 1474580700023}, {"source": 1391740893804, "target": 1474580710779}, {"source": 1391740893804, "target": 1474580716506}, {"source": 1391740893804, "target": 1474580722813}, {"source": 1391740893804, "target": 1474580731345}, {"source": 1391740893804, "target": 1474580736503}, {"source": 1391740893804, "target": 1474580780060}, {"source": 1391740893804, "target": 1474580787193}, {"source": 1391740893804, "target": 1474580796645}, {"source": 1391740893804, "target": 1474580803822}, {"source": 1391740893804, "target": 1474580819655}, {"source": 1391740893804, "target": 1474580830221}, {"source": 1391740893804, "target": 1474580850378}, {"source": 1391740893804, "target": 1474580865425}, {"source": 1391740893804, "target": 1474580870148}, {"source": 1391740893804, "target": 1474580874963}, {"source": 1391740893804, "target": 1474580882205}, {"source": 1391740893804, "target": 1474580885688}, {"source": 1391740893804, "target": 1474580890382}, {"source": 1391740893804, "target": 1474580895509}, {"source": 1391740893804, "target": 1474580900802}, {"source": 1391740893804, "target": 1474580908969}, {"source": 1391740893804, "target": 1474580915632}, {"source": 1391740893804, "target": 1474580923255}, {"source": 1391740893804, "target": 1474580928334}, {"source": 1391740893804, "target": 1474580933087}, {"source": 1391740893804, "target": 1474580937969}, {"source": 1391740893804, "target": 1474580948335}, {"source": 1391740893804, "target": 1474580958073}, {"source": 1391740893804, "target": 1474580960989}, {"source": 1391740893804, "target": 1474580971787}, {"source": 1391740893804, "target": 1474580978865}, {"source": 1391740893804, "target": 1474580987952}, {"source": 1391740893804, "target": 1474580993401}, {"source": 1391740893804, "target": 1474580997112}, {"source": 1391740893804, "target": 1474580999867}, {"source": 1391740893804, "target": 1474581002805}, {"source": 1391740893804, "target": 1474581007757}, {"source": 1391740893804, "target": 1474581020542}, {"source": 1391740893804, "target": 1474581024632}, {"source": 1391740893804, "target": 1474651327123}, {"source": 1391740893804, "target": 1474651458513}, {"source": 1391740893804, "target": 1474666007192}, {"source": 1391740893804, "target": 1474666075079}, {"source": 1391740893804, "target": 1474666078223}, {"source": 1391740893804, "target": 1474666085564}, {"source": 1391740893804, "target": 1474666102186}, {"source": 1391740893804, "target": 1474666104617}, {"source": 1391740893804, "target": 1474666115096}, {"source": 1391740893804, "target": 1474666117993}, {"source": 1391740893804, "target": 1474666128784}, {"source": 1391740893804, "target": 1474684616177}, {"source": 1391740893804, "target": 1474686171007}, {"source": 1391740893804, "target": 1474686176874}, {"source": 1391740893804, "target": 1474686182224}, {"source": 1391740893804, "target": 1474686187282}, {"source": 1391740893804, "target": 1474686197574}, {"source": 1391740893804, "target": 1474686203572}, {"source": 1391740893804, "target": 1474686213041}, {"source": 1391740893804, "target": 1474686218949}, {"source": 1391740893804, "target": 1474686227756}, {"source": 1391740893804, "target": 1474686237808}, {"source": 1391740893804, "target": 1474686246072}, {"source": 1391740893804, "target": 1474686254735}, {"source": 1391740893804, "target": 1474686260264}, {"source": 1391740893804, "target": 1474686265216}, {"source": 1391740893804, "target": 1474686269926}, {"source": 1391740893804, "target": 1474686274500}, {"source": 1391740893804, "target": 1474686279261}, {"source": 1391740893804, "target": 1474686309779}, {"source": 1391740893804, "target": 1474686320085}, {"source": 1391740893804, "target": 1474686325582}, {"source": 1391740893804, "target": 1474686333322}, {"source": 1391740893804, "target": 1474686338336}, {"source": 1391740893804, "target": 1474686349415}, {"source": 1391740893804, "target": 1474686354906}, {"source": 1391740893804, "target": 1474686363427}, {"source": 1391740893804, "target": 1474686367174}, {"source": 1391740893804, "target": 1474686384532}, {"source": 1391740893804, "target": 1474686391197}, {"source": 1391740893804, "target": 1474686405380}, {"source": 1391740893804, "target": 1474686417807}, {"source": 1391740893804, "target": 1474686431809}, {"source": 1391740893804, "target": 1474686441354}, {"source": 1391740893804, "target": 1474686451558}, {"source": 1391740893804, "target": 1474686460035}, {"source": 1391740893804, "target": 1474686473276}, {"source": 1391740893804, "target": 1474686477331}, {"source": 1391740893804, "target": 1474686494629}, {"source": 1391740893804, "target": 1474686499750}, {"source": 1391740893804, "target": 1474686508267}, {"source": 1391740893804, "target": 1474686517153}, {"source": 1391740893804, "target": 1474686521925}, {"source": 1391740893804, "target": 1474686526636}, {"source": 1391740893804, "target": 1474686556381}, {"source": 1391740893804, "target": 1474686559492}, {"source": 1391740893804, "target": 1474686569024}, {"source": 1391740893804, "target": 1474686581015}, {"source": 1391740893804, "target": 1474686586573}, {"source": 1391740893804, "target": 1474686590025}, {"source": 1391740893804, "target": 1474686599248}, {"source": 1391740893804, "target": 1474746837185}, {"source": 1391740893804, "target": 1474746866845}, {"source": 1391740893804, "target": 1474747042640}, {"source": 1391740893804, "target": 1474747048093}, {"source": 1391740893804, "target": 1474747052320}, {"source": 1391740893804, "target": 1474747057898}, {"source": 1391740893804, "target": 1474747062216}, {"source": 1391740893804, "target": 1474747066410}, {"source": 1391740893804, "target": 1474922506786}, {"source": 1391740893804, "target": 1475082841154}, {"source": 1391740893804, "target": 1475082848928}, {"source": 1391740893804, "target": 1475082866378}, {"source": 1391740893804, "target": 1475082877166}, {"source": 1391740893804, "target": 1475082883967}, {"source": 1391740893804, "target": 1475082893857}, {"source": 1391740893804, "target": 1475101620253}, {"source": 1391740893804, "target": 1475101841972}, {"source": 1391740893804, "target": 1475453457502}, {"source": 1391740893804, "target": 1475453463080}, {"source": 1391740893804, "target": 1475453469868}, {"source": 1391740893804, "target": 1475453482604}, {"source": 1391740893804, "target": 1475633629850}, {"source": 1391740893804, "target": 1475636680103}, {"source": 1391740893804, "target": 1475636693655}, {"source": 1391740893804, "target": 1475636698521}, {"source": 1391740893804, "target": 1475636703092}, {"source": 1391740893804, "target": 1475636707510}, {"source": 1391740893804, "target": 1475636718966}, {"source": 1391740893804, "target": 1475636736138}, {"source": 1391740893804, "target": 1475636740566}, {"source": 1391740893804, "target": 1475636748549}, {"source": 1391740893804, "target": 1475636756999}, {"source": 1391740893804, "target": 1475636781037}, {"source": 1391740893804, "target": 1475636789652}, {"source": 1391740893804, "target": 1475636800490}, {"source": 1391740893804, "target": 1475636808667}, {"source": 1391740893804, "target": 1475636814661}, {"source": 1391740893804, "target": 1475636822384}, {"source": 1391740893804, "target": 1475636846425}, {"source": 1391740893804, "target": 1475636854602}, {"source": 1391740893804, "target": 1475636859252}, {"source": 1391740893804, "target": 1475636863433}, {"source": 1391740893804, "target": 1475636873747}, {"source": 1391740893804, "target": 1475636883017}, {"source": 1391740893804, "target": 1475636887796}, {"source": 1391740893804, "target": 1475636894121}, {"source": 1391740893804, "target": 1475636899144}, {"source": 1391740893804, "target": 1475636902047}, {"source": 1391740893804, "target": 1475636904715}, {"source": 1391740893804, "target": 1475636907165}, {"source": 1391740893804, "target": 1475636911457}, {"source": 1391740893804, "target": 1475636920964}, {"source": 1391740893804, "target": 1475636929548}, {"source": 1391740893804, "target": 1475636932784}, {"source": 1391740893804, "target": 1475636941924}, {"source": 1391740893804, "target": 1475636949706}, {"source": 1391740893804, "target": 1475636960046}, {"source": 1391740893804, "target": 1475636975592}, {"source": 1391740893804, "target": 1475636978710}, {"source": 1391740893804, "target": 1475704581729}, {"source": 1391740893804, "target": 1475704590710}, {"source": 1391740893804, "target": 1475723610576}, {"source": 1391740893804, "target": 1475777525494}, {"source": 1391740893804, "target": 1475777624874}, {"source": 1391740893804, "target": 1475783631493}, {"source": 1391740893804, "target": 1475784185212}, {"source": 1391740893804, "target": 1475784195387}, {"source": 1391740893804, "target": 1475784202796}, {"source": 1391740893804, "target": 1475784210709}, {"source": 1391740893804, "target": 1475784215796}, {"source": 1391740893804, "target": 1475784338773}, {"source": 1391740893804, "target": 1475784344811}, {"source": 1391740893804, "target": 1475784350728}, {"source": 1391740893804, "target": 1475784355251}, {"source": 1391740893804, "target": 1475784363717}, {"source": 1391740893804, "target": 1475784371054}, {"source": 1391740893804, "target": 1475784382760}, {"source": 1391740893804, "target": 1475784390789}, {"source": 1391740893804, "target": 1475784396602}, {"source": 1391740893804, "target": 1475784401111}, {"source": 1391740893804, "target": 1475784405822}, {"source": 1391740893804, "target": 1475784411856}, {"source": 1391740893804, "target": 1475784417761}, {"source": 1391740893804, "target": 1475784424384}, {"source": 1391740893804, "target": 1475784427405}, {"source": 1391740893804, "target": 1475784430813}, {"source": 1391740893804, "target": 1475784439679}, {"source": 1391740893804, "target": 1475784443986}, {"source": 1391740893804, "target": 1475784447029}, {"source": 1391740893804, "target": 1475784453952}, {"source": 1391740893804, "target": 1475784458619}, {"source": 1391740893804, "target": 1475784462835}, {"source": 1391740893804, "target": 1475784475612}, {"source": 1391740893804, "target": 1475784492646}, {"source": 1391740893804, "target": 1475784496637}, {"source": 1391740893804, "target": 1475784499514}, {"source": 1391740893804, "target": 1475784501981}, {"source": 1391740893804, "target": 1475791011290}, {"source": 1391740893804, "target": 1475791111932}, {"source": 1391740893804, "target": 1475791118882}, {"source": 1391740893804, "target": 1475791126171}, {"source": 1391740893804, "target": 1475791129554}, {"source": 1391740893804, "target": 1475791132047}, {"source": 1391740893804, "target": 1475791136404}, {"source": 1391740893804, "target": 1475791141009}, {"source": 1391740893804, "target": 1475791149563}, {"source": 1391740893804, "target": 1475791156865}, {"source": 1391740893804, "target": 1475791163490}, {"source": 1391740893804, "target": 1475791167738}, {"source": 1391740893804, "target": 1475791181523}, {"source": 1391740893804, "target": 1475791191571}, {"source": 1391740893804, "target": 1475791196190}, {"source": 1391740893804, "target": 1475791201574}, {"source": 1391740893804, "target": 1475791212125}, {"source": 1391740893804, "target": 1475791218107}, {"source": 1391740893804, "target": 1475791231974}, {"source": 1391740893804, "target": 1475791241993}, {"source": 1391740893804, "target": 1475791264227}, {"source": 1391740893804, "target": 1475791272897}, {"source": 1391740893804, "target": 1475791277370}, {"source": 1391740893804, "target": 1475801251542}, {"source": 1391740893804, "target": 1475803054465}, {"source": 1391740893804, "target": 1475803060109}, {"source": 1391740893804, "target": 1475803064583}, {"source": 1391740893804, "target": 1475803069011}, {"source": 1391740893804, "target": 1475803073708}, {"source": 1391740893804, "target": 1475803081654}, {"source": 1391740893804, "target": 1475803087346}, {"source": 1391740893804, "target": 1475803092399}, {"source": 1391740893804, "target": 1475803096851}, {"source": 1391740893804, "target": 1475803101293}, {"source": 1391740893804, "target": 1475803107428}, {"source": 1391740893804, "target": 1475803114431}, {"source": 1391740893804, "target": 1475803118764}, {"source": 1391740893804, "target": 1475803122988}, {"source": 1391740893804, "target": 1475803132593}, {"source": 1391740893804, "target": 1475803141549}, {"source": 1391740893804, "target": 1475803146531}, {"source": 1391740893804, "target": 1475803154405}, {"source": 1391740893804, "target": 1475803159454}, {"source": 1391740893804, "target": 1475803165151}, {"source": 1391740893804, "target": 1475803169856}, {"source": 1391740893804, "target": 1475803172814}, {"source": 1391740893804, "target": 1475803175228}, {"source": 1391740893804, "target": 1475803179794}, {"source": 1391740893804, "target": 1475803187344}, {"source": 1391740893804, "target": 1475803191500}, {"source": 1391740893804, "target": 1475803196244}, {"source": 1391740893804, "target": 1475803200843}, {"source": 1391740893804, "target": 1475803205680}, {"source": 1391740893804, "target": 1475803210175}, {"source": 1391740893804, "target": 1475803214768}, {"source": 1391740893804, "target": 1475803220048}, {"source": 1391740893804, "target": 1475803224182}, {"source": 1391740893804, "target": 1475803236058}, {"source": 1391740893804, "target": 1475803245775}, {"source": 1391740893804, "target": 1475803252097}, {"source": 1391740893804, "target": 1475803258402}, {"source": 1391740893804, "target": 1475803267195}, {"source": 1391740893804, "target": 1475803274064}, {"source": 1391740893804, "target": 1476583497529}, {"source": 1391740893804, "target": 1476583926797}, {"source": 1391740893804, "target": 1476583956651}, {"source": 1391740893804, "target": 1476583959014}, {"source": 1391740893804, "target": 1476583961748}, {"source": 1391740893804, "target": 1476583966601}, {"source": 1391740893804, "target": 1476583969633}, {"source": 1391740893804, "target": 1476583982749}, {"source": 1391740893804, "target": 1477011581106}, {"source": 1391740893804, "target": 1477011611143}, {"source": 1391740893804, "target": 1477011616347}, {"source": 1391740893804, "target": 1477011621149}, {"source": 1391740893804, "target": 1477433035666}, {"source": 1391740893804, "target": 1477433039808}, {"source": 1391740893804, "target": 1477433048360}, {"source": 1391740893804, "target": 1477433068590}, {"source": 1391740893804, "target": 1477447038671}, {"source": 1391740893804, "target": 1477447048175}, {"source": 1391740893804, "target": 1479248816088}, {"source": 1391740893804, "target": 1479248835296}, {"source": 1391740893804, "target": 1480563925641}, {"source": 1391740893804, "target": 1481335343183}, {"source": 1391740893804, "target": 1481477282577}, {"source": 1391740893804, "target": 1482021770777}, {"source": 1391740893804, "target": 1482021774604}, {"source": 1391740893804, "target": 1482021777590}, {"source": 1391740893804, "target": 1482021780663}, {"source": 1391740893804, "target": 1482021783566}, {"source": 1391740893804, "target": 1482021793271}, {"source": 1391740893804, "target": 1482021814068}, {"source": 1391740893804, "target": 1482021822196}, {"source": 1391740893804, "target": 1482022023195}, {"source": 1391740893804, "target": 1482022044624}, {"source": 1391740893804, "target": 1482022047169}, {"source": 1391740893804, "target": 1482276001326}, {"source": 1391740893804, "target": 1482359673641}, {"source": 1391740893804, "target": 1482359685945}, {"source": 1391740893804, "target": 1482359694412}, {"source": 1391740893804, "target": 1482359699735}, {"source": 1391740893804, "target": 1482359707088}, {"source": 1391740893804, "target": 1482359719029}, {"source": 1391740893804, "target": 1482359724826}, {"source": 1391740893804, "target": 1482359729870}, {"source": 1391740893804, "target": 1482359732401}, {"source": 1391740893804, "target": 1482359734855}, {"source": 1391740893804, "target": 1482359737045}, {"source": 1391740893804, "target": 1482359742565}, {"source": 1391740893804, "target": 1482359750696}, {"source": 1391740893804, "target": 1482978436457}, {"source": 1391740893804, "target": 1485037239547}, {"source": 1391740893804, "target": 1485127261259}, {"source": 1391740893804, "target": 1486857456886}, {"source": 1391740893804, "target": 1487207158134}, {"source": 1391740893804, "target": 1487207236838}, {"source": 1391740893804, "target": 1487550549393}, {"source": 1391740893804, "target": 1487983956917}, {"source": 1391740893804, "target": 1488154358646}, {"source": 1391740893804, "target": 1488763721560}, {"source": 1391740893804, "target": 1488765214688}, {"source": 1391740893804, "target": 1488765219096}, {"source": 1391740893804, "target": 1488765222541}, {"source": 1391740893804, "target": 1488765226036}, {"source": 1391740893804, "target": 1488765231664}, {"source": 1391740893804, "target": 1488765233649}, {"source": 1391740893804, "target": 1488765239779}, {"source": 1391740893804, "target": 1488765243586}, {"source": 1391740893804, "target": 1488765248074}, {"source": 1391740893804, "target": 1488765251203}, {"source": 1391740893804, "target": 1488765255379}, {"source": 1391740893804, "target": 1488765259902}, {"source": 1391740893804, "target": 1488765273230}, {"source": 1391740893804, "target": 1488765277192}, {"source": 1391740893804, "target": 1488765280375}, {"source": 1391740893804, "target": 1488765287344}, {"source": 1391740893804, "target": 1488765290929}, {"source": 1391740893804, "target": 1488765296661}, {"source": 1391740893804, "target": 1488765299956}, {"source": 1391740893804, "target": 1488765303577}, {"source": 1391740893804, "target": 1488765308661}, {"source": 1391740893804, "target": 1488765310513}, {"source": 1391740893804, "target": 1488765314397}, {"source": 1391740893804, "target": 1488767760913}, {"source": 1391740893804, "target": 1488767918819}, {"source": 1391740893804, "target": 1488767923559}, {"source": 1391740893804, "target": 1488767931946}, {"source": 1391740893804, "target": 1488767936242}, {"source": 1391740893804, "target": 1488767948376}, {"source": 1391740893804, "target": 1488767952273}, {"source": 1391740893804, "target": 1488767955829}, {"source": 1391740893804, "target": 1488767964396}, {"source": 1391740893804, "target": 1488767968330}, {"source": 1391740893804, "target": 1488767971727}, {"source": 1391740893804, "target": 1488767980272}, {"source": 1391740893804, "target": 1488767982990}, {"source": 1391740893804, "target": 1488767991453}, {"source": 1391740893804, "target": 1488767999794}, {"source": 1391740893804, "target": 1488768006143}, {"source": 1391740893804, "target": 1488768009809}, {"source": 1391740893804, "target": 1488768013791}, {"source": 1391740893804, "target": 1488768017315}, {"source": 1391740893804, "target": 1488768020833}, {"source": 1391740893804, "target": 1488768024175}, {"source": 1391740893804, "target": 1488768028936}, {"source": 1391740893804, "target": 1488768031507}, {"source": 1391740893804, "target": 1488768038717}, {"source": 1391740893804, "target": 1488768047036}, {"source": 1391740893804, "target": 1488768050748}, {"source": 1391740893804, "target": 1488768053179}, {"source": 1391740893804, "target": 1488768055086}, {"source": 1391740893804, "target": 1488768061994}, {"source": 1391740893804, "target": 1488768067383}, {"source": 1391740893804, "target": 1488768070741}, {"source": 1391740893804, "target": 1488768080149}, {"source": 1391740893804, "target": 1488768082952}, {"source": 1391740893804, "target": 1488768088581}, {"source": 1391740893804, "target": 1488768090306}, {"source": 1391740893804, "target": 1488847654792}, {"source": 1391740893804, "target": 1488847683296}, {"source": 1391740893804, "target": 1488847688890}, {"source": 1391740893804, "target": 1488847696894}, {"source": 1391740893804, "target": 1488847719405}, {"source": 1391740893804, "target": 1488847725986}, {"source": 1391740893804, "target": 1488847733019}, {"source": 1391740893804, "target": 1488847735973}, {"source": 1391740893804, "target": 1488847739545}, {"source": 1391740893804, "target": 1488847742908}, {"source": 1391740893804, "target": 1488847747227}, {"source": 1391740893804, "target": 1488847752152}, {"source": 1391740893804, "target": 1488847755836}, {"source": 1391740893804, "target": 1488847759567}, {"source": 1391740893804, "target": 1488847763094}, {"source": 1391740893804, "target": 1488847766303}, {"source": 1391740893804, "target": 1488847772054}, {"source": 1391740893804, "target": 1488847776527}, {"source": 1391740893804, "target": 1488847779733}, {"source": 1391740893804, "target": 1488847783222}, {"source": 1391740893804, "target": 1488847786464}, {"source": 1391740893804, "target": 1488847795901}, {"source": 1391740893804, "target": 1488847800266}, {"source": 1391740893804, "target": 1488847803714}, {"source": 1391740893804, "target": 1488847807658}, {"source": 1391740893804, "target": 1488847813320}, {"source": 1391740893804, "target": 1488847815337}, {"source": 1391740893804, "target": 1488847817311}, {"source": 1391740893804, "target": 1488847818071}, {"source": 1391740893804, "target": 1488850148851}, {"source": 1391740893804, "target": 1488850153355}, {"source": 1391740893804, "target": 1488850156616}, {"source": 1391740893804, "target": 1488850159719}, {"source": 1391740893804, "target": 1488850164208}, {"source": 1391740893804, "target": 1488850166683}, {"source": 1391740893804, "target": 1488850174871}, {"source": 1391740893804, "target": 1488850179982}, {"source": 1391740893804, "target": 1488850183623}, {"source": 1391740893804, "target": 1488850186903}, {"source": 1391740893804, "target": 1488850191723}, {"source": 1391740893804, "target": 1488850198140}, {"source": 1391740893804, "target": 1488850201821}, {"source": 1391740893804, "target": 1488850205070}, {"source": 1391740893804, "target": 1488850208041}, {"source": 1391740893804, "target": 1488850212066}, {"source": 1391740893804, "target": 1488850223642}, {"source": 1391740893804, "target": 1489959879323}, {"source": 1391740893804, "target": 1489959933371}, {"source": 1391740893804, "target": 1489959955843}, {"source": 1391740893804, "target": 1489959968219}, {"source": 1391740893804, "target": 1489960158679}, {"source": 1391740893804, "target": 1489960223722}, {"source": 1391740893804, "target": 1489960388465}, {"source": 1391740893804, "target": 1489960412415}, {"source": 1391740893804, "target": 1489960574435}, {"source": 1391740893804, "target": 1489960590736}, {"source": 1391740893804, "target": 1489960648168}, {"source": 1391740893804, "target": 1489960668479}, {"source": 1391740893804, "target": 1489960697759}, {"source": 1391740893804, "target": 1489960770811}, {"source": 1391740893804, "target": 1489960782243}, {"source": 1391740893804, "target": 1489960803160}, {"source": 1391740893804, "target": 1489961021618}, {"source": 1391740893804, "target": 1489961117310}, {"source": 1391740893804, "target": 1489961443667}, {"source": 1391740893804, "target": 1489961592450}, {"source": 1391740893804, "target": 1489961629334}, {"source": 1391740893804, "target": 1489961756380}, {"source": 1391740893804, "target": 1489961819194}, {"source": 1391740893804, "target": 1489961987539}, {"source": 1391740893804, "target": 1489962009550}, {"source": 1391740893804, "target": 1489962071630}, {"source": 1391740893804, "target": 1489962489701}, {"source": 1391740893804, "target": 1489962636797}, {"source": 1391740893804, "target": 1489962921146}, {"source": 1391740893804, "target": 1489962998004}, {"source": 1391740893804, "target": 1489963051870}, {"source": 1391740893804, "target": 1489963073192}, {"source": 1391740893804, "target": 1489963125560}, {"source": 1391740893804, "target": 1489963136856}, {"source": 1391740893804, "target": 1489963378120}, {"source": 1391740893804, "target": 1489963412373}, {"source": 1391740893804, "target": 1489963471375}, {"source": 1391740893804, "target": 1489963587014}, {"source": 1391740893804, "target": 1489963603993}, {"source": 1391740893804, "target": 1489963707884}, {"source": 1391740893804, "target": 1489963760474}, {"source": 1391740893804, "target": 1489963793297}, {"source": 1391740893804, "target": 1489963845288}, {"source": 1391740893804, "target": 1489967613940}, {"source": 1391740893804, "target": 1489967649130}, {"source": 1391740893804, "target": 1489967671487}, {"source": 1391740893804, "target": 1489967703514}, {"source": 1391740893804, "target": 1489968578286}, {"source": 1391740893804, "target": 1489968613360}, {"source": 1391740893804, "target": 1493667013610}, {"source": 1391740893804, "target": 1493667164347}, {"source": 1391740893804, "target": 1493667650847}, {"source": 1391740893804, "target": 1493667933442}, {"source": 1391740893804, "target": 1493668150043}, {"source": 1391740893804, "target": 1493668310033}, {"source": 1391740893804, "target": 1493668383937}, {"source": 1391740893804, "target": 1493668504290}, {"source": 1391740893804, "target": 1493668592362}, {"source": 1391740893804, "target": 1493669075416}, {"source": 1391740893804, "target": 1493669227162}, {"source": 1391740893804, "target": 1493669357997}, {"source": 1391740893804, "target": 1493669552068}, {"source": 1391740893804, "target": 1493669920128}, {"source": 1391740893804, "target": 1493670305294}, {"source": 1391740893804, "target": 1493670479272}, {"source": 1391740893804, "target": 1493670550338}, {"source": 1391740893804, "target": 1493670587112}, {"source": 1391740893804, "target": 1493670643676}, {"source": 1391740893804, "target": 1493670833040}, {"source": 1391740893804, "target": 1493670899237}, {"source": 1391740893804, "target": 1493670936385}, {"source": 1391740893804, "target": 1493673847368}, {"source": 1391740893804, "target": 1493674159991}, {"source": 1391740893804, "target": 1493674222596}, {"source": 1391740893804, "target": 1493674452979}, {"source": 1391740893804, "target": 1493675054335}, {"source": 1391740893804, "target": 1493675300258}, {"source": 1391740893804, "target": 1493675532373}, {"source": 1391740893804, "target": 1493675721609}, {"source": 1391740893804, "target": 1493675950331}, {"source": 1391740893804, "target": 1493676625806}, {"source": 1391740893804, "target": 1493676957977}, {"source": 1391740893804, "target": 1493677691853}, {"source": 1391740893804, "target": 1494988042360}, {"source": 1391740893804, "target": 1494988372076}, {"source": 1391740893804, "target": 1494988814923}, {"source": 1391740893804, "target": 1494988913959}, {"source": 1391740893804, "target": 1494989429488}, {"source": 1391740893804, "target": 1494989545970}, {"source": 1391740893804, "target": 1494989779751}, {"source": 1391740893804, "target": 1494989968462}, {"source": 1391740893804, "target": 1494990443406}, {"source": 1391740893804, "target": 1494990648090}, {"source": 1391740893804, "target": 1494990718449}, {"source": 1391740893804, "target": 1494990866419}, {"source": 1391740893804, "target": 1494990914793}, {"source": 1391740893804, "target": 1494991061174}, {"source": 1391740893804, "target": 1494991141787}, {"source": 1391740893804, "target": 1494991205221}, {"source": 1391740893804, "target": 1495734704148}, {"source": 1391740893804, "target": 1495734830497}, {"source": 1391740893804, "target": 1495735188904}, {"source": 1391740893804, "target": 1495735796199}, {"source": 1391740893804, "target": 1495735940631}, {"source": 1391740893804, "target": 1495736131793}, {"source": 1391740893804, "target": 1495736987476}, {"source": 1391740893804, "target": 1495737138512}, {"source": 1391740893804, "target": 1495737396886}, {"source": 1391740893804, "target": 1495737442417}, {"source": 1391740893804, "target": 1495737635396}, {"source": 1391740893804, "target": 1495737981969}, {"source": 1391740893804, "target": 1495738163681}, {"source": 1391740893804, "target": 1495738313876}, {"source": 1391740893804, "target": 1495738392776}, {"source": 1391740893804, "target": 1495738626939}, {"source": 1391740893804, "target": 1495738972701}, {"source": 1391740893804, "target": 1495739124907}, {"source": 1391740893804, "target": 1495739747156}, {"source": 1391740893804, "target": 1495740017108}, {"source": 1391740893804, "target": 1495740310438}, {"source": 1391740893804, "target": 1495740615760}, {"source": 1391740893804, "target": 1495741163975}, {"source": 1391740893804, "target": 1495741324392}, {"source": 1391740893804, "target": 1495741480727}, {"source": 1391740893804, "target": 1495812512415}, {"source": 1391740893804, "target": 1495812700726}, {"source": 1391740893804, "target": 1495812852349}, {"source": 1391740893804, "target": 1495823589233}, {"source": 1391740893804, "target": 1495823891256}, {"source": 1391740893804, "target": 1495824428159}, {"source": 1391740893804, "target": 1495824863345}, {"source": 1391740893804, "target": 1495997958989}, {"source": 1391740893804, "target": 1496006981334}, {"source": 1391740893804, "target": 1496007126465}, {"source": 1391740893804, "target": 1496007192285}, {"source": 1391740893804, "target": 1496007393595}, {"source": 1391740893804, "target": 1496007679100}, {"source": 1391740893804, "target": 1496008326942}, {"source": 1391740893804, "target": 1496008463840}, {"source": 1391740893804, "target": 1496008597519}, {"source": 1391740893804, "target": 1496008817614}, {"source": 1391740893804, "target": 1496008854211}, {"source": 1391740893804, "target": 1496029410295}, {"source": 1391740893804, "target": 1496029620681}, {"source": 1391740893804, "target": 1496032276945}, {"source": 1391740893804, "target": 1496032306714}, {"source": 1391740893804, "target": 1496032495928}, {"source": 1391740893804, "target": 1496033290669}, {"source": 1391740893804, "target": 1496105405364}, {"source": 1391740893804, "target": 1496105536532}, {"source": 1391740893804, "target": 1496107918481}, {"source": 1391740893804, "target": 1496109644674}, {"source": 1391740893804, "target": 1496109782853}, {"source": 1391740893804, "target": 1496110017365}, {"source": 1391740893804, "target": 1496110133728}, {"source": 1391740893804, "target": 1496110442979}, {"source": 1391740893804, "target": 1496110895116}, {"source": 1391740893804, "target": 1496111092713}, {"source": 1391740893804, "target": 1496111134927}, {"source": 1391740893804, "target": 1496864057677}, {"source": 1391740893804, "target": 1496864352035}, {"source": 1391740893804, "target": 1496864658353}, {"source": 1391740893804, "target": 1496864694059}, {"source": 1391740893804, "target": 1497058728715}, {"source": 1391740893804, "target": 1497058899081}, {"source": 1391740893804, "target": 1497059151626}, {"source": 1391740893804, "target": 1497062011770}, {"source": 1391740893804, "target": 1497066613995}, {"source": 1391740893804, "target": 1497067317568}, {"source": 1391740893804, "target": 1496110237401}, {"source": 1391740893804, "target": 1497103900248}, {"source": 1391740893804, "target": 1497104700095}, {"source": 1391740893804, "target": 1497106587707}, {"source": 1391740893804, "target": 1497107684861}, {"source": 1391740893804, "target": 1497190430173}, {"source": 1391740893804, "target": 1497192238111}, {"source": 1391740893804, "target": 1497194200908}, {"source": 1391740893804, "target": 1497194465060}, {"source": 1391740893804, "target": 1497194736626}, {"source": 1391740893804, "target": 1497195019610}, {"source": 1391740893804, "target": 1497195076845}, {"source": 1391740893804, "target": 1497195266866}, {"source": 1391740893804, "target": 1497195404174}, {"source": 1391740893804, "target": 1497195561019}, {"source": 1391740893804, "target": 1497195651522}, {"source": 1391740893804, "target": 1497195751879}, {"source": 1391740893804, "target": 1497196077139}, {"source": 1391740893804, "target": 1497196361185}, {"source": 1391740893804, "target": 1497196451810}, {"source": 1391740893804, "target": 1497196510573}, {"source": 1391740893804, "target": 1497197031696}, {"source": 1391740893804, "target": 1497197274253}, {"source": 1391740893804, "target": 1497197397389}, {"source": 1391740893804, "target": 1497197449113}, {"source": 1391740893804, "target": 1497197625933}, {"source": 1391740893804, "target": 1497197748300}, {"source": 1391740893804, "target": 1497197947379}, {"source": 1391740893804, "target": 1497198087623}, {"source": 1391740893804, "target": 1497200095459}, {"source": 1391740893804, "target": 1497200296622}, {"source": 1391740893804, "target": 1497200375971}, {"source": 1391740893804, "target": 1497200675738}, {"source": 1391740893804, "target": 1497203185934}, {"source": 1391740893804, "target": 1497205206181}, {"source": 1391740893804, "target": 1497205982738}, {"source": 1391740893804, "target": 1497210532542}, {"source": 1391740893804, "target": 1497366822289}, {"source": 1391740893804, "target": 1497366871349}, {"source": 1391740893804, "target": 1497367283882}, {"source": 1391740893804, "target": 1497369123409}, {"source": 1391740893804, "target": 1497369809745}, {"source": 1391740893804, "target": 1497370604817}, {"source": 1391740893804, "target": 1497381706399}, {"source": 1391740893804, "target": 1497381915590}, {"source": 1391740893804, "target": 1497382264588}, {"source": 1391740893804, "target": 1497383292545}, {"source": 1391740893804, "target": 1497383561163}, {"source": 1391740893804, "target": 1497383843374}, {"source": 1391740893804, "target": 1497383992830}, {"source": 1391740893804, "target": 1497384216002}, {"source": 1391740893804, "target": 1497384375909}, {"source": 1391740893804, "target": 1497384877982}, {"source": 1391740893804, "target": 1497385088901}, {"source": 1391740893804, "target": 1497385527399}, {"source": 1391740893804, "target": 1497385631398}, {"source": 1391740893804, "target": 1497494664062}, {"source": 1391740893804, "target": 1497494695202}, {"source": 1391740893804, "target": 1497495357753}, {"source": 1391740893804, "target": 1499356681125}, {"source": 1391740893804, "target": 1499356681269}, {"source": 1391740893804, "target": 1499356681293}, {"source": 1391740893804, "target": 1499356681316}, {"source": 1391740893804, "target": 1499356681339}, {"source": 1391740893804, "target": 1499356681362}, {"source": 1391740893804, "target": 1499356681385}, {"source": 1391740893804, "target": 1499356681502}, {"source": 1391740893804, "target": 1499356681525}, {"source": 1391740893804, "target": 1499356681548}, {"source": 1391740893804, "target": 1499358257645}, {"source": 1391740893804, "target": 1499358446751}, {"source": 1391740893804, "target": 1500229455013}, {"source": 1391740893804, "target": 1500230234909}, {"source": 1391740893804, "target": 1502086858589}, {"source": 1391740893804, "target": 1502086944102}, {"source": 1391740893804, "target": 1502086979437}, {"source": 1391740893804, "target": 1502087058246}, {"source": 1391740893804, "target": 1502087136496}, {"source": 1391740893804, "target": 1502087323174}, {"source": 1391740893804, "target": 1502087343188}, {"source": 1391740893804, "target": 1502087562746}, {"source": 1391740893804, "target": 1502411653744}, {"source": 1391740893804, "target": 1502414496794}, {"source": 1391740893804, "target": 1512516717343}, {"source": 1391740893804, "target": 1514584967942}, {"source": 1391740893804, "target": 1514671047073}, {"source": 1391740893804, "target": 1515380545942}, {"source": 1391740893804, "target": 1515722684226}, {"source": 1391740893804, "target": 1516031999666}, {"source": 1391740893804, "target": 1518122485549}, {"source": 1391740893804, "target": 1518122617043}, {"source": 1391740893804, "target": 1518122653976}, {"source": 1391740893804, "target": 1518634532822}, {"source": 1391740893804, "target": 1519059049099}, {"source": 1391740893804, "target": 1519404926368}, {"source": 1391740893804, "target": 1519585463878}, {"source": 1391740893804, "target": 1519675717558}, {"source": 1391740893804, "target": 1519675855589}, {"source": 1391740893804, "target": 1519675970024}, {"source": 1391740893804, "target": 1519706900037}, {"source": 1391740893804, "target": 1519709275091}, {"source": 1391740893804, "target": 1519710247930}, {"source": 1391740893804, "target": 1519710406151}, {"source": 1391740893804, "target": 1519710452983}, {"source": 1391740893804, "target": 1519710900798}, {"source": 1391740893804, "target": 1519711142577}, {"source": 1391740893804, "target": 1519711156220}, {"source": 1391740893804, "target": 1519711653829}, {"source": 1391740893804, "target": 1519712508964}, {"source": 1391740893804, "target": 1519712635103}, {"source": 1391740893804, "target": 1519786017644}, {"source": 1391740893804, "target": 1519786106768}, {"source": 1391740893804, "target": 1519786159085}, {"source": 1391740893804, "target": 1519786357173}, {"source": 1391740893804, "target": 1519786900541}, {"source": 1391740893804, "target": 1519788323050}, {"source": 1391740893804, "target": 1520723677811}, {"source": 1391740893804, "target": 1520723775776}, {"source": 1391740893804, "target": 1520723840491}, {"source": 1391740893804, "target": 1520724862215}, {"source": 1391740893804, "target": 1520725702188}, {"source": 1391740893804, "target": 1520730688999}, {"source": 1391740893804, "target": 1520900503633}, {"source": 1391740893804, "target": 1520900992240}, {"source": 1391740893804, "target": 1520947799743}, {"source": 1391740893804, "target": 1520948020649}, {"source": 1391740893804, "target": 1520948242706}, {"source": 1391740893804, "target": 1520974064907}, {"source": 1391740893804, "target": 1521260466186}, {"source": 1391740893804, "target": 1521768713296}, {"source": 1391740893804, "target": 1522297996898}, {"source": 1391740893804, "target": 1522546037015}, {"source": 1391740893804, "target": 1522550552770}, {"source": 1391740893804, "target": 1522550673436}, {"source": 1391740893804, "target": 1522550767866}, {"source": 1391740893804, "target": 1522885879666}, {"source": 1391740893804, "target": 1523198507740}, {"source": 1391740893804, "target": 1523302344176}, {"source": 1391740893804, "target": 1523478916168}, {"source": 1391740893804, "target": 1524258762201}, {"source": 1391740893804, "target": 1524259092731}, {"source": 1391740893804, "target": 1524526728679}, {"source": 1391740893804, "target": 1524527865392}, {"source": 1391740893804, "target": 1524705541467}, {"source": 1391740893804, "target": 1524800758410}, {"source": 1391740893804, "target": 1525305295646}, {"source": 1391740893804, "target": 1525312075824}, {"source": 1391740893804, "target": 1548363898504}, {"source": 1391740893804, "target": 1566505820778}, {"source": 1405141770453, "target": 1462982009231}, {"source": 1405141770453, "target": 1463078721869}, {"source": 1405141770453, "target": 1463078730041}, {"source": 1405141770453, "target": 1463078734022}, {"source": 1405141770453, "target": 1463078751694}, {"source": 1405141770453, "target": 1463078773984}, {"source": 1405141770453, "target": 1463078784640}, {"source": 1405141770453, "target": 1463078903785}, {"source": 1405141770453, "target": 1463078915955}, {"source": 1405141770453, "target": 1463078929014}, {"source": 1405141770453, "target": 1463078936768}, {"source": 1405141770453, "target": 1463078942355}, {"source": 1405141770453, "target": 1463082333416}, {"source": 1405141770453, "target": 1463094023779}, {"source": 1405141770453, "target": 1463094049348}, {"source": 1405141770453, "target": 1463094074203}, {"source": 1405141770453, "target": 1463094084820}, {"source": 1405141770453, "target": 1463094394076}, {"source": 1405141770453, "target": 1463094505791}, {"source": 1405141770453, "target": 1463101150767}, {"source": 1405141770453, "target": 1463101160605}, {"source": 1405141770453, "target": 1463101171957}, {"source": 1405141770453, "target": 1463101175620}, {"source": 1405141770453, "target": 1463101179451}, {"source": 1405141770453, "target": 1463101187418}, {"source": 1405141770453, "target": 1463101200000}, {"source": 1405141770453, "target": 1463101204259}, {"source": 1405141770453, "target": 1463101220961}, {"source": 1405141770453, "target": 1463101224904}, {"source": 1405141770453, "target": 1463101228831}, {"source": 1405141770453, "target": 1463101246153}, {"source": 1405141770453, "target": 1463101266778}, {"source": 1405141770453, "target": 1463101295333}, {"source": 1405141770453, "target": 1463101300781}, {"source": 1405141770453, "target": 1463101305391}, {"source": 1405141770453, "target": 1463101308955}, {"source": 1405141770453, "target": 1463101311443}, {"source": 1405141770453, "target": 1463105824837}, {"source": 1405141770453, "target": 1463105840341}, {"source": 1405141770453, "target": 1463105881914}, {"source": 1405141770453, "target": 1463105909117}, {"source": 1405141770453, "target": 1463105915437}, {"source": 1405141770453, "target": 1463105924097}, {"source": 1405141770453, "target": 1463105947626}, {"source": 1405141770453, "target": 1463105972862}, {"source": 1405141770453, "target": 1463105976747}, {"source": 1405141770453, "target": 1463105983927}, {"source": 1405141770453, "target": 1463105992062}, {"source": 1405141770453, "target": 1463105999636}, {"source": 1405141770453, "target": 1463106003755}, {"source": 1405141770453, "target": 1463106007081}, {"source": 1405141770453, "target": 1463106011070}, {"source": 1405141770453, "target": 1463106014708}, {"source": 1405141770453, "target": 1463106018043}, {"source": 1405141770453, "target": 1463106021207}, {"source": 1405141770453, "target": 1463106029685}, {"source": 1405141770453, "target": 1463106033552}, {"source": 1405141770453, "target": 1463106055950}, {"source": 1405141770453, "target": 1463106062110}, {"source": 1405141770453, "target": 1463106074503}, {"source": 1405141770453, "target": 1463106081948}, {"source": 1405141770453, "target": 1463106094001}, {"source": 1405141770453, "target": 1463150148468}, {"source": 1405141770453, "target": 1463163260222}, {"source": 1405141770453, "target": 1463163500200}, {"source": 1405141770453, "target": 1463163507048}, {"source": 1405141770453, "target": 1463172079616}, {"source": 1405141770453, "target": 1463172089555}, {"source": 1405141770453, "target": 1463172095708}, {"source": 1405141770453, "target": 1463172100364}, {"source": 1405141770453, "target": 1463172108621}, {"source": 1405141770453, "target": 1463172112650}, {"source": 1405141770453, "target": 1463172117522}, {"source": 1405141770453, "target": 1463172122482}, {"source": 1405141770453, "target": 1463172137015}, {"source": 1405141770453, "target": 1463172143887}, {"source": 1405141770453, "target": 1463172156994}, {"source": 1405141770453, "target": 1463172169695}, {"source": 1405141770453, "target": 1463172179641}, {"source": 1405141770453, "target": 1463172186799}, {"source": 1405141770453, "target": 1463172198813}, {"source": 1405141770453, "target": 1463172225574}, {"source": 1405141770453, "target": 1463172226538}, {"source": 1405141770453, "target": 1463172236433}, {"source": 1405141770453, "target": 1463172247043}, {"source": 1405141770453, "target": 1463172253954}, {"source": 1405141770453, "target": 1463172258965}, {"source": 1405141770453, "target": 1463172263963}, {"source": 1405141770453, "target": 1463172268325}, {"source": 1405141770453, "target": 1463172272323}, {"source": 1405141770453, "target": 1463172280966}, {"source": 1405141770453, "target": 1463172289630}, {"source": 1405141770453, "target": 1463172294631}, {"source": 1405141770453, "target": 1463172298323}, {"source": 1405141770453, "target": 1463172301905}, {"source": 1405141770453, "target": 1463172307168}, {"source": 1405141770453, "target": 1463172319857}, {"source": 1405141770453, "target": 1463172327723}, {"source": 1405141770453, "target": 1463172336780}, {"source": 1405141770453, "target": 1463172359613}, {"source": 1405141770453, "target": 1463172379407}, {"source": 1405141770453, "target": 1463172386929}, {"source": 1405141770453, "target": 1463172390498}, {"source": 1405141770453, "target": 1463172394153}, {"source": 1405141770453, "target": 1463172398226}, {"source": 1405141770453, "target": 1463172401877}, {"source": 1405141770453, "target": 1463172406630}, {"source": 1405141770453, "target": 1463172415056}, {"source": 1405141770453, "target": 1463172439331}, {"source": 1405141770453, "target": 1463172445552}, {"source": 1405141770453, "target": 1463172460286}, {"source": 1405141770453, "target": 1463172476562}, {"source": 1405141770453, "target": 1463172499947}, {"source": 1405141770453, "target": 1463172503888}, {"source": 1405141770453, "target": 1463172506951}, {"source": 1405141770453, "target": 1463172510273}, {"source": 1405141770453, "target": 1463172517382}, {"source": 1405141770453, "target": 1463172529545}, {"source": 1405141770453, "target": 1463172533352}, {"source": 1405141770453, "target": 1463172536516}, {"source": 1405141770453, "target": 1463172540111}, {"source": 1405141770453, "target": 1463172544045}, {"source": 1405141770453, "target": 1463172547912}, {"source": 1405141770453, "target": 1463172572838}, {"source": 1405141770453, "target": 1463172594564}, {"source": 1405141770453, "target": 1463172598605}, {"source": 1405141770453, "target": 1463172608516}, {"source": 1405141770453, "target": 1463172618384}, {"source": 1405141770453, "target": 1463172633135}, {"source": 1405141770453, "target": 1463172638754}, {"source": 1405141770453, "target": 1463174905508}, {"source": 1405141770453, "target": 1463176730505}, {"source": 1405141770453, "target": 1463176746263}, {"source": 1405141770453, "target": 1463176758271}, {"source": 1405141770453, "target": 1463176773349}, {"source": 1405141770453, "target": 1463176777704}, {"source": 1405141770453, "target": 1463176780906}, {"source": 1405141770453, "target": 1463176783939}, {"source": 1405141770453, "target": 1463176787073}, {"source": 1405141770453, "target": 1463176789917}, {"source": 1405141770453, "target": 1463176792455}, {"source": 1405141770453, "target": 1463176795022}, {"source": 1405141770453, "target": 1463176802048}, {"source": 1405141770453, "target": 1463176881592}, {"source": 1405141770453, "target": 1463177010540}, {"source": 1405141770453, "target": 1463178466775}, {"source": 1405141770453, "target": 1463187644766}, {"source": 1405141770453, "target": 1463187654764}, {"source": 1405141770453, "target": 1463187666186}, {"source": 1405141770453, "target": 1463187677022}, {"source": 1405141770453, "target": 1463187698743}, {"source": 1405141770453, "target": 1463187709198}, {"source": 1405141770453, "target": 1463187720272}, {"source": 1405141770453, "target": 1463187726002}, {"source": 1405141770453, "target": 1463187736885}, {"source": 1405141770453, "target": 1463187744728}, {"source": 1405141770453, "target": 1463187754886}, {"source": 1405141770453, "target": 1463187760102}, {"source": 1405141770453, "target": 1463187763929}, {"source": 1405141770453, "target": 1463187773649}, {"source": 1405141770453, "target": 1463187806662}, {"source": 1405141770453, "target": 1463187812239}, {"source": 1405141770453, "target": 1463187820455}, {"source": 1405141770453, "target": 1463187827285}, {"source": 1405141770453, "target": 1463187832044}, {"source": 1405141770453, "target": 1463187844705}, {"source": 1405141770453, "target": 1463187881126}, {"source": 1405141770453, "target": 1463187887033}, {"source": 1405141770453, "target": 1463187894899}, {"source": 1405141770453, "target": 1463187899305}, {"source": 1405141770453, "target": 1463187910218}, {"source": 1405141770453, "target": 1463187920919}, {"source": 1405141770453, "target": 1463187929584}, {"source": 1405141770453, "target": 1463187934796}, {"source": 1405141770453, "target": 1463187938130}, {"source": 1405141770453, "target": 1463187941201}, {"source": 1405141770453, "target": 1463187950548}, {"source": 1405141770453, "target": 1463187954433}, {"source": 1405141770453, "target": 1463187961223}, {"source": 1405141770453, "target": 1463187968614}, {"source": 1405141770453, "target": 1463188002544}, {"source": 1405141770453, "target": 1463188008567}, {"source": 1405141770453, "target": 1463188017836}, {"source": 1405141770453, "target": 1463188027127}, {"source": 1405141770453, "target": 1463188032640}, {"source": 1405141770453, "target": 1463188061833}, {"source": 1405141770453, "target": 1463188066226}, {"source": 1405141770453, "target": 1463188070821}, {"source": 1405141770453, "target": 1463188084024}, {"source": 1405141770453, "target": 1463188088647}, {"source": 1405141770453, "target": 1463188095823}, {"source": 1405141770453, "target": 1463188103442}, {"source": 1405141770453, "target": 1463188119098}, {"source": 1405141770453, "target": 1463188127235}, {"source": 1405141770453, "target": 1463188130876}, {"source": 1405141770453, "target": 1463188165692}, {"source": 1405141770453, "target": 1463188169675}, {"source": 1405141770453, "target": 1463188185291}, {"source": 1405141770453, "target": 1463188216971}, {"source": 1405141770453, "target": 1463188227727}, {"source": 1405141770453, "target": 1463188237072}, {"source": 1405141770453, "target": 1463188240255}, {"source": 1405141770453, "target": 1463188251805}, {"source": 1405141770453, "target": 1463188255248}, {"source": 1405141770453, "target": 1463191075841}, {"source": 1405141770453, "target": 1463279445274}, {"source": 1405141770453, "target": 1463279616645}, {"source": 1405141770453, "target": 1463279622440}, {"source": 1405141770453, "target": 1463279630622}, {"source": 1405141770453, "target": 1463279639694}, {"source": 1405141770453, "target": 1463279646698}, {"source": 1405141770453, "target": 1463279658641}, {"source": 1405141770453, "target": 1463279666723}, {"source": 1405141770453, "target": 1463279672655}, {"source": 1405141770453, "target": 1463279676639}, {"source": 1405141770453, "target": 1463279681310}, {"source": 1405141770453, "target": 1463279694569}, {"source": 1405141770453, "target": 1463279705406}, {"source": 1405141770453, "target": 1463279711383}, {"source": 1405141770453, "target": 1463279718206}, {"source": 1405141770453, "target": 1463279724957}, {"source": 1405141770453, "target": 1463279745525}, {"source": 1405141770453, "target": 1463279752475}, {"source": 1405141770453, "target": 1463279757292}, {"source": 1405141770453, "target": 1463279770692}, {"source": 1405141770453, "target": 1463279774717}, {"source": 1405141770453, "target": 1463279790203}, {"source": 1405141770453, "target": 1463279800156}, {"source": 1405141770453, "target": 1463279816657}, {"source": 1405141770453, "target": 1463279826371}, {"source": 1405141770453, "target": 1463279835082}, {"source": 1405141770453, "target": 1463279839010}, {"source": 1405141770453, "target": 1463279861371}, {"source": 1405141770453, "target": 1463279871354}, {"source": 1405141770453, "target": 1463279881373}, {"source": 1405141770453, "target": 1463279885403}, {"source": 1405141770453, "target": 1463279890224}, {"source": 1405141770453, "target": 1463279901977}, {"source": 1405141770453, "target": 1463279905770}, {"source": 1405141770453, "target": 1463279909190}, {"source": 1405141770453, "target": 1463279912679}, {"source": 1405141770453, "target": 1463279930319}, {"source": 1405141770453, "target": 1463279938999}, {"source": 1405141770453, "target": 1463279946159}, {"source": 1405141770453, "target": 1463279956478}, {"source": 1405141770453, "target": 1463279967084}, {"source": 1405141770453, "target": 1463279978747}, {"source": 1405141770453, "target": 1463279979722}, {"source": 1405141770453, "target": 1463279988164}, {"source": 1405141770453, "target": 1463279995059}, {"source": 1405141770453, "target": 1463280001660}, {"source": 1405141770453, "target": 1463280009357}, {"source": 1405141770453, "target": 1463280027026}, {"source": 1405141770453, "target": 1463280032221}, {"source": 1405141770453, "target": 1463280035157}, {"source": 1405141770453, "target": 1463280038717}, {"source": 1405141770453, "target": 1463280041950}, {"source": 1405141770453, "target": 1463280044881}, {"source": 1405141770453, "target": 1463280058681}, {"source": 1405141770453, "target": 1463280070337}, {"source": 1405141770453, "target": 1463280075288}, {"source": 1405141770453, "target": 1463280078411}, {"source": 1405141770453, "target": 1463280088789}, {"source": 1405141770453, "target": 1463280093289}, {"source": 1405141770453, "target": 1463280096234}, {"source": 1405141770453, "target": 1463280098824}, {"source": 1405141770453, "target": 1463280101481}, {"source": 1405141770453, "target": 1463280103792}, {"source": 1405141770453, "target": 1463280612433}, {"source": 1405141770453, "target": 1463330337199}, {"source": 1405141770453, "target": 1463331296522}, {"source": 1405141770453, "target": 1463331315899}, {"source": 1405141770453, "target": 1463331318605}, {"source": 1405141770453, "target": 1463331321726}, {"source": 1405141770453, "target": 1463331324884}, {"source": 1405141770453, "target": 1463331339443}, {"source": 1405141770453, "target": 1463331360156}, {"source": 1405141770453, "target": 1463331364573}, {"source": 1405141770453, "target": 1463331372090}, {"source": 1405141770453, "target": 1463331383138}, {"source": 1405141770453, "target": 1463334066900}, {"source": 1405141770453, "target": 1463334088123}, {"source": 1405141770453, "target": 1463334097647}, {"source": 1405141770453, "target": 1463334101161}, {"source": 1405141770453, "target": 1463334104014}, {"source": 1405141770453, "target": 1463334107038}, {"source": 1405141770453, "target": 1463334134563}, {"source": 1405141770453, "target": 1463334145617}, {"source": 1405141770453, "target": 1463334152127}, {"source": 1405141770453, "target": 1463334158805}, {"source": 1405141770453, "target": 1463334161746}, {"source": 1405141770453, "target": 1463334164527}, {"source": 1405141770453, "target": 1463334171326}, {"source": 1405141770453, "target": 1463334174816}, {"source": 1405141770453, "target": 1463334184167}, {"source": 1405141770453, "target": 1463334193640}, {"source": 1405141770453, "target": 1463334197478}, {"source": 1405141770453, "target": 1463334201001}, {"source": 1405141770453, "target": 1463334207231}, {"source": 1405141770453, "target": 1463334225957}, {"source": 1405141770453, "target": 1463334264578}, {"source": 1405141770453, "target": 1463334269994}, {"source": 1405141770453, "target": 1463339050251}, {"source": 1405141770453, "target": 1463339928621}, {"source": 1405141770453, "target": 1463339955533}, {"source": 1405141770453, "target": 1463339968803}, {"source": 1405141770453, "target": 1463339972200}, {"source": 1405141770453, "target": 1463339975628}, {"source": 1405141770453, "target": 1463339978379}, {"source": 1405141770453, "target": 1463339983674}, {"source": 1405141770453, "target": 1463339990695}, {"source": 1405141770453, "target": 1463339998840}, {"source": 1405141770453, "target": 1463340004334}, {"source": 1405141770453, "target": 1463340008364}, {"source": 1405141770453, "target": 1463340056503}, {"source": 1405141770453, "target": 1463340062541}, {"source": 1405141770453, "target": 1463340066021}, {"source": 1405141770453, "target": 1463340075489}, {"source": 1405141770453, "target": 1463340099569}, {"source": 1405141770453, "target": 1463340102943}, {"source": 1405141770453, "target": 1463340118784}, {"source": 1405141770453, "target": 1463340121839}, {"source": 1405141770453, "target": 1463340128491}, {"source": 1405141770453, "target": 1463340132352}, {"source": 1405141770453, "target": 1463340155475}, {"source": 1405141770453, "target": 1463343838534}, {"source": 1405141770453, "target": 1463345914020}, {"source": 1405141770453, "target": 1463345919229}, {"source": 1405141770453, "target": 1463345922819}, {"source": 1405141770453, "target": 1463345925967}, {"source": 1405141770453, "target": 1463345928964}, {"source": 1405141770453, "target": 1463345931564}, {"source": 1405141770453, "target": 1463345936419}, {"source": 1405141770453, "target": 1463345940337}, {"source": 1405141770453, "target": 1463345947474}, {"source": 1405141770453, "target": 1463345952079}, {"source": 1405141770453, "target": 1463345960314}, {"source": 1405141770453, "target": 1463345963883}, {"source": 1405141770453, "target": 1463345985953}, {"source": 1405141770453, "target": 1463346010918}, {"source": 1405141770453, "target": 1463346015128}, {"source": 1405141770453, "target": 1463346018491}, {"source": 1405141770453, "target": 1463346024760}, {"source": 1405141770453, "target": 1463346050168}, {"source": 1405141770453, "target": 1463346053358}, {"source": 1405141770453, "target": 1463346056481}, {"source": 1405141770453, "target": 1463346061489}, {"source": 1405141770453, "target": 1463346071188}, {"source": 1405141770453, "target": 1463346081917}, {"source": 1405141770453, "target": 1463346088119}, {"source": 1405141770453, "target": 1463346091406}, {"source": 1405141770453, "target": 1463346099788}, {"source": 1405141770453, "target": 1463349512978}, {"source": 1405141770453, "target": 1463356243674}, {"source": 1405141770453, "target": 1463356248081}, {"source": 1405141770453, "target": 1463356256794}, {"source": 1405141770453, "target": 1463356260645}, {"source": 1405141770453, "target": 1463356264902}, {"source": 1405141770453, "target": 1463356268349}, {"source": 1405141770453, "target": 1463356271940}, {"source": 1405141770453, "target": 1463356275732}, {"source": 1405141770453, "target": 1463356283395}, {"source": 1405141770453, "target": 1463356287240}, {"source": 1405141770453, "target": 1463356293665}, {"source": 1405141770453, "target": 1463356301740}, {"source": 1405141770453, "target": 1463356305554}, {"source": 1405141770453, "target": 1463356309150}, {"source": 1405141770453, "target": 1463356317440}, {"source": 1405141770453, "target": 1463356325517}, {"source": 1405141770453, "target": 1463356329258}, {"source": 1405141770453, "target": 1463356342414}, {"source": 1405141770453, "target": 1463356347799}, {"source": 1405141770453, "target": 1463356369801}, {"source": 1405141770453, "target": 1463356374053}, {"source": 1405141770453, "target": 1463356377704}, {"source": 1405141770453, "target": 1463356381503}, {"source": 1405141770453, "target": 1463356385294}, {"source": 1405141770453, "target": 1463356394363}, {"source": 1405141770453, "target": 1463356413365}, {"source": 1405141770453, "target": 1463356420839}, {"source": 1405141770453, "target": 1463356429101}, {"source": 1405141770453, "target": 1463356432441}, {"source": 1405141770453, "target": 1463356441715}, {"source": 1405141770453, "target": 1463356453700}, {"source": 1405141770453, "target": 1463356457000}, {"source": 1405141770453, "target": 1463356461093}, {"source": 1405141770453, "target": 1463356464886}, {"source": 1405141770453, "target": 1463356469862}, {"source": 1405141770453, "target": 1463356483258}, {"source": 1405141770453, "target": 1463356487232}, {"source": 1405141770453, "target": 1463356491082}, {"source": 1405141770453, "target": 1463356494886}, {"source": 1405141770453, "target": 1463356498416}, {"source": 1405141770453, "target": 1463356501464}, {"source": 1405141770453, "target": 1463356505756}, {"source": 1405141770453, "target": 1463356514499}, {"source": 1405141770453, "target": 1463356532940}, {"source": 1405141770453, "target": 1463356558172}, {"source": 1405141770453, "target": 1463356564936}, {"source": 1405141770453, "target": 1463356568833}, {"source": 1405141770453, "target": 1463356577083}, {"source": 1405141770453, "target": 1463356589606}, {"source": 1405141770453, "target": 1463356597398}, {"source": 1405141770453, "target": 1463356606383}, {"source": 1405141770453, "target": 1463356609999}, {"source": 1405141770453, "target": 1463356615982}, {"source": 1405141770453, "target": 1463356622263}, {"source": 1405141770453, "target": 1463442436474}, {"source": 1405141770453, "target": 1463442475910}, {"source": 1405141770453, "target": 1463442490849}, {"source": 1405141770453, "target": 1463442496649}, {"source": 1405141770453, "target": 1463442505682}, {"source": 1405141770453, "target": 1463442510727}, {"source": 1405141770453, "target": 1463442521792}, {"source": 1405141770453, "target": 1463442529940}, {"source": 1405141770453, "target": 1463442541618}, {"source": 1405141770453, "target": 1463442550257}, {"source": 1405141770453, "target": 1463442563224}, {"source": 1405141770453, "target": 1463442568414}, {"source": 1405141770453, "target": 1463442577876}, {"source": 1405141770453, "target": 1463442582429}, {"source": 1405141770453, "target": 1463442589618}, {"source": 1405141770453, "target": 1463442596495}, {"source": 1405141770453, "target": 1463442600788}, {"source": 1405141770453, "target": 1463442609662}, {"source": 1405141770453, "target": 1463442614906}, {"source": 1405141770453, "target": 1463442623228}, {"source": 1405141770453, "target": 1463442627581}, {"source": 1405141770453, "target": 1463442637836}, {"source": 1405141770453, "target": 1463442654763}, {"source": 1405141770453, "target": 1463442661997}, {"source": 1405141770453, "target": 1463442682381}, {"source": 1405141770453, "target": 1463442690482}, {"source": 1405141770453, "target": 1463442696094}, {"source": 1405141770453, "target": 1463442700607}, {"source": 1405141770453, "target": 1463442712804}, {"source": 1405141770453, "target": 1463442718625}, {"source": 1405141770453, "target": 1463442730408}, {"source": 1405141770453, "target": 1463442739985}, {"source": 1405141770453, "target": 1463442752880}, {"source": 1405141770453, "target": 1463442763210}, {"source": 1405141770453, "target": 1463442771028}, {"source": 1405141770453, "target": 1463442780091}, {"source": 1405141770453, "target": 1463442789976}, {"source": 1405141770453, "target": 1463442802064}, {"source": 1405141770453, "target": 1463442810974}, {"source": 1405141770453, "target": 1463442814795}, {"source": 1405141770453, "target": 1463442840892}, {"source": 1405141770453, "target": 1463442860197}, {"source": 1405141770453, "target": 1463442868302}, {"source": 1405141770453, "target": 1463442877717}, {"source": 1405141770453, "target": 1463442895605}, {"source": 1405141770453, "target": 1463442900258}, {"source": 1405141770453, "target": 1463442917303}, {"source": 1405141770453, "target": 1463442924234}, {"source": 1405141770453, "target": 1463442943662}, {"source": 1405141770453, "target": 1463442982359}, {"source": 1405141770453, "target": 1463443025598}, {"source": 1405141770453, "target": 1463443062226}, {"source": 1405141770453, "target": 1463443068528}, {"source": 1405141770453, "target": 1463443071372}, {"source": 1405141770453, "target": 1463443074631}, {"source": 1405141770453, "target": 1463443078086}, {"source": 1405141770453, "target": 1463443081183}, {"source": 1405141770453, "target": 1463443083596}, {"source": 1405141770453, "target": 1463443090416}, {"source": 1405141770453, "target": 1463443100523}, {"source": 1405141770453, "target": 1463526404611}, {"source": 1405141770453, "target": 1463526408165}, {"source": 1405141770453, "target": 1463526412603}, {"source": 1405141770453, "target": 1463529021317}, {"source": 1405141770453, "target": 1463529453311}, {"source": 1405141770453, "target": 1463529461225}, {"source": 1405141770453, "target": 1463529464624}, {"source": 1405141770453, "target": 1463529468266}, {"source": 1405141770453, "target": 1463529471830}, {"source": 1405141770453, "target": 1463529479421}, {"source": 1405141770453, "target": 1463529483683}, {"source": 1405141770453, "target": 1463529488559}, {"source": 1405141770453, "target": 1463529510813}, {"source": 1405141770453, "target": 1463529514333}, {"source": 1405141770453, "target": 1463529518094}, {"source": 1405141770453, "target": 1463529526162}, {"source": 1405141770453, "target": 1463529534214}, {"source": 1405141770453, "target": 1463529538028}, {"source": 1405141770453, "target": 1463529541032}, {"source": 1405141770453, "target": 1463529546124}, {"source": 1405141770453, "target": 1463529568699}, {"source": 1405141770453, "target": 1463529575275}, {"source": 1405141770453, "target": 1463529580634}, {"source": 1405141770453, "target": 1463529584173}, {"source": 1405141770453, "target": 1463529587147}, {"source": 1405141770453, "target": 1463530651952}, {"source": 1405141770453, "target": 1463534046490}, {"source": 1405141770453, "target": 1463675427032}, {"source": 1405141770453, "target": 1463675434980}, {"source": 1405141770453, "target": 1463944239303}, {"source": 1405141770453, "target": 1463947013821}, {"source": 1405141770453, "target": 1463947088822}, {"source": 1405141770453, "target": 1463947774175}, {"source": 1405141770453, "target": 1463947812898}, {"source": 1405141770453, "target": 1463947850134}, {"source": 1405141770453, "target": 1463947881893}, {"source": 1405141770453, "target": 1463947911732}, {"source": 1405141770453, "target": 1463950513482}, {"source": 1405141770453, "target": 1463951406234}, {"source": 1405141770453, "target": 1463951418297}, {"source": 1405141770453, "target": 1463951426347}, {"source": 1405141770453, "target": 1463951456776}, {"source": 1405141770453, "target": 1463951475639}, {"source": 1405141770453, "target": 1463951480447}, {"source": 1405141770453, "target": 1463951489067}, {"source": 1405141770453, "target": 1463951492922}, {"source": 1405141770453, "target": 1463951500613}, {"source": 1405141770453, "target": 1463951509378}, {"source": 1405141770453, "target": 1463954126962}, {"source": 1405141770453, "target": 1463955278825}, {"source": 1405141770453, "target": 1463956522023}, {"source": 1405141770453, "target": 1463957692573}, {"source": 1405141770453, "target": 1463957763047}, {"source": 1405141770453, "target": 1463957794588}, {"source": 1405141770453, "target": 1463957828496}, {"source": 1405141770453, "target": 1463957933297}, {"source": 1405141770453, "target": 1463958394262}, {"source": 1405141770453, "target": 1463958628607}, {"source": 1405141770453, "target": 1463958668258}, {"source": 1405141770453, "target": 1463958744601}, {"source": 1405141770453, "target": 1468250280385}, {"source": 1405141770453, "target": 1468250283753}, {"source": 1405141770453, "target": 1468531923039}, {"source": 1405141770453, "target": 1471461070808}, {"source": 1405141770453, "target": 1471461086122}, {"source": 1405141770453, "target": 1471541327679}, {"source": 1405141770453, "target": 1471541598687}, {"source": 1405141770453, "target": 1471558840954}, {"source": 1405141770453, "target": 1471558846888}, {"source": 1405141770453, "target": 1471558899790}, {"source": 1405141770453, "target": 1471558905659}, {"source": 1405141770453, "target": 1471558934765}, {"source": 1405141770453, "target": 1471797120815}, {"source": 1405141770453, "target": 1471806043495}, {"source": 1405141770453, "target": 1471806048024}, {"source": 1405141770453, "target": 1471806052273}, {"source": 1405141770453, "target": 1471806055812}, {"source": 1405141770453, "target": 1471806065717}, {"source": 1405141770453, "target": 1471806069386}, {"source": 1405141770453, "target": 1471806073709}, {"source": 1405141770453, "target": 1471806078219}, {"source": 1405141770453, "target": 1471806086201}, {"source": 1405141770453, "target": 1471806095511}, {"source": 1405141770453, "target": 1471806099065}, {"source": 1405141770453, "target": 1471806103006}, {"source": 1405141770453, "target": 1471806107034}, {"source": 1405141770453, "target": 1471806114242}, {"source": 1405141770453, "target": 1471806124315}, {"source": 1405141770453, "target": 1471806132559}, {"source": 1405141770453, "target": 1471806136985}, {"source": 1405141770453, "target": 1471806144718}, {"source": 1405141770453, "target": 1471806149857}, {"source": 1405141770453, "target": 1471806157855}, {"source": 1405141770453, "target": 1471806162437}, {"source": 1405141770453, "target": 1471806170265}, {"source": 1405141770453, "target": 1471806180799}, {"source": 1405141770453, "target": 1471806184543}, {"source": 1405141770453, "target": 1471806188325}, {"source": 1405141770453, "target": 1471806197883}, {"source": 1405141770453, "target": 1471806201823}, {"source": 1405141770453, "target": 1471806210220}, {"source": 1405141770453, "target": 1471806217861}, {"source": 1405141770453, "target": 1471806231010}, {"source": 1405141770453, "target": 1471806235020}, {"source": 1405141770453, "target": 1471806240278}, {"source": 1405141770453, "target": 1471806250450}, {"source": 1405141770453, "target": 1471806263616}, {"source": 1405141770453, "target": 1471806267906}, {"source": 1405141770453, "target": 1471806277667}, {"source": 1405141770453, "target": 1471806287761}, {"source": 1405141770453, "target": 1471806302661}, {"source": 1405141770453, "target": 1471806307755}, {"source": 1405141770453, "target": 1471806312069}, {"source": 1405141770453, "target": 1471806318041}, {"source": 1405141770453, "target": 1471806325942}, {"source": 1405141770453, "target": 1471806330955}, {"source": 1405141770453, "target": 1471806351580}, {"source": 1405141770453, "target": 1471806359114}, {"source": 1405141770453, "target": 1471806363393}, {"source": 1405141770453, "target": 1471806368819}, {"source": 1405141770453, "target": 1471806373361}, {"source": 1405141770453, "target": 1471806381549}, {"source": 1405141770453, "target": 1471806387188}, {"source": 1405141770453, "target": 1471806392633}, {"source": 1405141770453, "target": 1471806409036}, {"source": 1405141770453, "target": 1471806421346}, {"source": 1405141770453, "target": 1471806426564}, {"source": 1405141770453, "target": 1471806432657}, {"source": 1405141770453, "target": 1471806436773}, {"source": 1405141770453, "target": 1471806442258}, {"source": 1405141770453, "target": 1471806471000}, {"source": 1405141770453, "target": 1471806482193}, {"source": 1405141770453, "target": 1471806493817}, {"source": 1405141770453, "target": 1471806497406}, {"source": 1405141770453, "target": 1471806500932}, {"source": 1405141770453, "target": 1471806505942}, {"source": 1405141770453, "target": 1471806519835}, {"source": 1405141770453, "target": 1471806531097}, {"source": 1405141770453, "target": 1471806534652}, {"source": 1405141770453, "target": 1471806538201}, {"source": 1405141770453, "target": 1471806541451}, {"source": 1405141770453, "target": 1471806584678}, {"source": 1405141770453, "target": 1471806603801}, {"source": 1405141770453, "target": 1471806621695}, {"source": 1405141770453, "target": 1471806636140}, {"source": 1405141770453, "target": 1471806647224}, {"source": 1405141770453, "target": 1471806659451}, {"source": 1405141770453, "target": 1471806663894}, {"source": 1405141770453, "target": 1471806671662}, {"source": 1405141770453, "target": 1471806675606}, {"source": 1405141770453, "target": 1471806684970}, {"source": 1405141770453, "target": 1471806688179}, {"source": 1405141770453, "target": 1471806691032}, {"source": 1405141770453, "target": 1471806692855}, {"source": 1405141770453, "target": 1471808946236}, {"source": 1405141770453, "target": 1471808954153}, {"source": 1405141770453, "target": 1471808962781}, {"source": 1405141770453, "target": 1471808998460}, {"source": 1405141770453, "target": 1471809005658}, {"source": 1405141770453, "target": 1471809011732}, {"source": 1405141770453, "target": 1471809020140}, {"source": 1405141770453, "target": 1471809042124}, {"source": 1405141770453, "target": 1471809045876}, {"source": 1405141770453, "target": 1471809055703}, {"source": 1405141770453, "target": 1471811875076}, {"source": 1405141770453, "target": 1471811878742}, {"source": 1405141770453, "target": 1471811882841}, {"source": 1405141770453, "target": 1471811944476}, {"source": 1405141770453, "target": 1471811951779}, {"source": 1405141770453, "target": 1471811955341}, {"source": 1405141770453, "target": 1471811960008}, {"source": 1405141770453, "target": 1471811965337}, {"source": 1405141770453, "target": 1471811968814}, {"source": 1405141770453, "target": 1471811979298}, {"source": 1405141770453, "target": 1471811989477}, {"source": 1405141770453, "target": 1471811997810}, {"source": 1405141770453, "target": 1471812008532}, {"source": 1405141770453, "target": 1471812024737}, {"source": 1405141770453, "target": 1471812042722}, {"source": 1405141770453, "target": 1471812048776}, {"source": 1405141770453, "target": 1471812052582}, {"source": 1405141770453, "target": 1471812055612}, {"source": 1405141770453, "target": 1471812058036}, {"source": 1405141770453, "target": 1471812061940}, {"source": 1405141770453, "target": 1471812074715}, {"source": 1405141770453, "target": 1471817954249}, {"source": 1405141770453, "target": 1471819176314}, {"source": 1405141770453, "target": 1471819183136}, {"source": 1405141770453, "target": 1471819186977}, {"source": 1405141770453, "target": 1471819191084}, {"source": 1405141770453, "target": 1471819210293}, {"source": 1405141770453, "target": 1471819217429}, {"source": 1405141770453, "target": 1471819222194}, {"source": 1405141770453, "target": 1471819229180}, {"source": 1405141770453, "target": 1471819233373}, {"source": 1405141770453, "target": 1471819245705}, {"source": 1405141770453, "target": 1471819276926}, {"source": 1405141770453, "target": 1471819317034}, {"source": 1405141770453, "target": 1471824752378}, {"source": 1405141770453, "target": 1471824768225}, {"source": 1405141770453, "target": 1471824783780}, {"source": 1405141770453, "target": 1471824793615}, {"source": 1405141770453, "target": 1471824801037}, {"source": 1405141770453, "target": 1471824804069}, {"source": 1405141770453, "target": 1471824809572}, {"source": 1405141770453, "target": 1471824821986}, {"source": 1405141770453, "target": 1471824831028}, {"source": 1405141770453, "target": 1471824836707}, {"source": 1405141770453, "target": 1471824839446}, {"source": 1405141770453, "target": 1471824842252}, {"source": 1405141770453, "target": 1471824848914}, {"source": 1405141770453, "target": 1471824852175}, {"source": 1405141770453, "target": 1471824868294}, {"source": 1405141770453, "target": 1471824872055}, {"source": 1405141770453, "target": 1471824876607}, {"source": 1405141770453, "target": 1471824884869}, {"source": 1405141770453, "target": 1471824895480}, {"source": 1405141770453, "target": 1471824901308}, {"source": 1405141770453, "target": 1471824910294}, {"source": 1405141770453, "target": 1471824913480}, {"source": 1405141770453, "target": 1471824920983}, {"source": 1405141770453, "target": 1471824932558}, {"source": 1405141770453, "target": 1471878007808}, {"source": 1405141770453, "target": 1471878017218}, {"source": 1405141770453, "target": 1471878055898}, {"source": 1405141770453, "target": 1471880376461}, {"source": 1405141770453, "target": 1471880379381}, {"source": 1405141770453, "target": 1471880381847}, {"source": 1405141770453, "target": 1471880384775}, {"source": 1405141770453, "target": 1471880402055}, {"source": 1405141770453, "target": 1471880414063}, {"source": 1405141770453, "target": 1471880418039}, {"source": 1405141770453, "target": 1471880428703}, {"source": 1405141770453, "target": 1471880433632}, {"source": 1405141770453, "target": 1471880441143}, {"source": 1405141770453, "target": 1471880448151}, {"source": 1405141770453, "target": 1471880451252}, {"source": 1405141770453, "target": 1471880453940}, {"source": 1405141770453, "target": 1471880459924}, {"source": 1405141770453, "target": 1471880462751}, {"source": 1405141770453, "target": 1471880467615}, {"source": 1405141770453, "target": 1471880481754}, {"source": 1405141770453, "target": 1471880947815}, {"source": 1405141770453, "target": 1471880956835}, {"source": 1405141770453, "target": 1471898845279}, {"source": 1405141770453, "target": 1471898867686}, {"source": 1405141770453, "target": 1471898879429}, {"source": 1405141770453, "target": 1471898887090}, {"source": 1405141770453, "target": 1471898892065}, {"source": 1405141770453, "target": 1471898896955}, {"source": 1405141770453, "target": 1471898912568}, {"source": 1405141770453, "target": 1471898932776}, {"source": 1405141770453, "target": 1471898945857}, {"source": 1405141770453, "target": 1471899020561}, {"source": 1405141770453, "target": 1471899029714}, {"source": 1405141770453, "target": 1471899040750}, {"source": 1405141770453, "target": 1471899048022}, {"source": 1405141770453, "target": 1471899057863}, {"source": 1405141770453, "target": 1471899068548}, {"source": 1405141770453, "target": 1471899071838}, {"source": 1405141770453, "target": 1471899075220}, {"source": 1405141770453, "target": 1471899082910}, {"source": 1405141770453, "target": 1471899090660}, {"source": 1405141770453, "target": 1471899095578}, {"source": 1405141770453, "target": 1471899134297}, {"source": 1405141770453, "target": 1471899140737}, {"source": 1405141770453, "target": 1471899144372}, {"source": 1405141770453, "target": 1471899149384}, {"source": 1405141770453, "target": 1471899154660}, {"source": 1405141770453, "target": 1471899158974}, {"source": 1405141770453, "target": 1471899174061}, {"source": 1405141770453, "target": 1471899180531}, {"source": 1405141770453, "target": 1471899192663}, {"source": 1405141770453, "target": 1471899202241}, {"source": 1405141770453, "target": 1471899212336}, {"source": 1405141770453, "target": 1471899221722}, {"source": 1405141770453, "target": 1471899234512}, {"source": 1405141770453, "target": 1471899256655}, {"source": 1405141770453, "target": 1471899267904}, {"source": 1405141770453, "target": 1471899271006}, {"source": 1405141770453, "target": 1471899275408}, {"source": 1405141770453, "target": 1471899290606}, {"source": 1405141770453, "target": 1471899319397}, {"source": 1405141770453, "target": 1471899328126}, {"source": 1405141770453, "target": 1471899336939}, {"source": 1405141770453, "target": 1471899339995}, {"source": 1405141770453, "target": 1471899346321}, {"source": 1405141770453, "target": 1471899349727}, {"source": 1405141770453, "target": 1471899362336}, {"source": 1405141770453, "target": 1471899371687}, {"source": 1405141770453, "target": 1471899376283}, {"source": 1405141770453, "target": 1471899388138}, {"source": 1405141770453, "target": 1471899395392}, {"source": 1405141770453, "target": 1471899404681}, {"source": 1405141770453, "target": 1471899409106}, {"source": 1405141770453, "target": 1471899412796}, {"source": 1405141770453, "target": 1471899419610}, {"source": 1405141770453, "target": 1471899426119}, {"source": 1405141770453, "target": 1471899435178}, {"source": 1405141770453, "target": 1471899439284}, {"source": 1405141770453, "target": 1471899450039}, {"source": 1405141770453, "target": 1471899459296}, {"source": 1405141770453, "target": 1471899462236}, {"source": 1405141770453, "target": 1471899464553}, {"source": 1405141770453, "target": 1471899472721}, {"source": 1405141770453, "target": 1471909359002}, {"source": 1405141770453, "target": 1471909453754}, {"source": 1405141770453, "target": 1471910984242}, {"source": 1405141770453, "target": 1471910987924}, {"source": 1405141770453, "target": 1471910994276}, {"source": 1405141770453, "target": 1471910997263}, {"source": 1405141770453, "target": 1471911002718}, {"source": 1405141770453, "target": 1471911005725}, {"source": 1405141770453, "target": 1471911012149}, {"source": 1405141770453, "target": 1471911016577}, {"source": 1405141770453, "target": 1471911022900}, {"source": 1405141770453, "target": 1471911025659}, {"source": 1405141770453, "target": 1471911032392}, {"source": 1405141770453, "target": 1471911062062}, {"source": 1405141770453, "target": 1471914909206}, {"source": 1405141770453, "target": 1471914912128}, {"source": 1405141770453, "target": 1471914914774}, {"source": 1405141770453, "target": 1471914917436}, {"source": 1405141770453, "target": 1471914919931}, {"source": 1405141770453, "target": 1471914922825}, {"source": 1405141770453, "target": 1471914925586}, {"source": 1405141770453, "target": 1471914928516}, {"source": 1405141770453, "target": 1471914931976}, {"source": 1405141770453, "target": 1471914938644}, {"source": 1405141770453, "target": 1471914942128}, {"source": 1405141770453, "target": 1471914954685}, {"source": 1405141770453, "target": 1471914969111}, {"source": 1405141770453, "target": 1471914979068}, {"source": 1405141770453, "target": 1471914992993}, {"source": 1405141770453, "target": 1471914999950}, {"source": 1405141770453, "target": 1471915003682}, {"source": 1405141770453, "target": 1471915035278}, {"source": 1405141770453, "target": 1471915047213}, {"source": 1405141770453, "target": 1471915101703}, {"source": 1405141770453, "target": 1471915155178}, {"source": 1405141770453, "target": 1471989960544}, {"source": 1405141770453, "target": 1471989967288}, {"source": 1405141770453, "target": 1471989976175}, {"source": 1405141770453, "target": 1471989983590}, {"source": 1405141770453, "target": 1471989989842}, {"source": 1405141770453, "target": 1471990007665}, {"source": 1405141770453, "target": 1471990027733}, {"source": 1405141770453, "target": 1471990035729}, {"source": 1405141770453, "target": 1471990069494}, {"source": 1405141770453, "target": 1471990077514}, {"source": 1405141770453, "target": 1471990122978}, {"source": 1405141770453, "target": 1471990129054}, {"source": 1405141770453, "target": 1471990184418}, {"source": 1405141770453, "target": 1471990192539}, {"source": 1405141770453, "target": 1471990196725}, {"source": 1405141770453, "target": 1471990231482}, {"source": 1405141770453, "target": 1471990236088}, {"source": 1405141770453, "target": 1471990251073}, {"source": 1405141770453, "target": 1471990273033}, {"source": 1405141770453, "target": 1471990276789}, {"source": 1405141770453, "target": 1471990316141}, {"source": 1405141770453, "target": 1471990321620}, {"source": 1405141770453, "target": 1471990336202}, {"source": 1405141770453, "target": 1471990345570}, {"source": 1405141770453, "target": 1471990360540}, {"source": 1405141770453, "target": 1471990372693}, {"source": 1405141770453, "target": 1471990378964}, {"source": 1405141770453, "target": 1471990386790}, {"source": 1405141770453, "target": 1471990402261}, {"source": 1405141770453, "target": 1471990415098}, {"source": 1405141770453, "target": 1471990419337}, {"source": 1405141770453, "target": 1471990424324}, {"source": 1405141770453, "target": 1471990429400}, {"source": 1405141770453, "target": 1471990434324}, {"source": 1405141770453, "target": 1471990439469}, {"source": 1405141770453, "target": 1471990453854}, {"source": 1405141770453, "target": 1471990482138}, {"source": 1405141770453, "target": 1471990492863}, {"source": 1405141770453, "target": 1471990497672}, {"source": 1405141770453, "target": 1471990527868}, {"source": 1405141770453, "target": 1471990537720}, {"source": 1405141770453, "target": 1471990555821}, {"source": 1405141770453, "target": 1471990559381}, {"source": 1405141770453, "target": 1471990562850}, {"source": 1405141770453, "target": 1471990568385}, {"source": 1405141770453, "target": 1471990572291}, {"source": 1405141770453, "target": 1471990580271}, {"source": 1405141770453, "target": 1471990586601}, {"source": 1405141770453, "target": 1471990597653}, {"source": 1405141770453, "target": 1471990603994}, {"source": 1405141770453, "target": 1471990607962}, {"source": 1405141770453, "target": 1471990627889}, {"source": 1405141770453, "target": 1471990657613}, {"source": 1405141770453, "target": 1471990672697}, {"source": 1405141770453, "target": 1471990678892}, {"source": 1405141770453, "target": 1471990683814}, {"source": 1405141770453, "target": 1471990688317}, {"source": 1405141770453, "target": 1471990692243}, {"source": 1405141770453, "target": 1471990716491}, {"source": 1405141770453, "target": 1471990724475}, {"source": 1405141770453, "target": 1472058591254}, {"source": 1405141770453, "target": 1472058599074}, {"source": 1405141770453, "target": 1472058602540}, {"source": 1405141770453, "target": 1472058606797}, {"source": 1405141770453, "target": 1472058609956}, {"source": 1405141770453, "target": 1472058617422}, {"source": 1405141770453, "target": 1472058620746}, {"source": 1405141770453, "target": 1472058624751}, {"source": 1405141770453, "target": 1472058634105}, {"source": 1405141770453, "target": 1472058638817}, {"source": 1405141770453, "target": 1472058647432}, {"source": 1405141770453, "target": 1472058667580}, {"source": 1405141770453, "target": 1472058674176}, {"source": 1405141770453, "target": 1472058685014}, {"source": 1405141770453, "target": 1472058698775}, {"source": 1405141770453, "target": 1472058703254}, {"source": 1405141770453, "target": 1472058706949}, {"source": 1405141770453, "target": 1472058715982}, {"source": 1405141770453, "target": 1472058725470}, {"source": 1405141770453, "target": 1472058734186}, {"source": 1405141770453, "target": 1472058738488}, {"source": 1405141770453, "target": 1472058744043}, {"source": 1405141770453, "target": 1472058746912}, {"source": 1405141770453, "target": 1472058750504}, {"source": 1405141770453, "target": 1472058753870}, {"source": 1405141770453, "target": 1472058762429}, {"source": 1405141770453, "target": 1472058770262}, {"source": 1405141770453, "target": 1472058830036}, {"source": 1405141770453, "target": 1472058878308}, {"source": 1405141770453, "target": 1472058984977}, {"source": 1405141770453, "target": 1472068006982}, {"source": 1405141770453, "target": 1472072078325}, {"source": 1405141770453, "target": 1472072081949}, {"source": 1405141770453, "target": 1472072085534}, {"source": 1405141770453, "target": 1472072090577}, {"source": 1405141770453, "target": 1472072097648}, {"source": 1405141770453, "target": 1472072104808}, {"source": 1405141770453, "target": 1472072107763}, {"source": 1405141770453, "target": 1472072110576}, {"source": 1405141770453, "target": 1472072115600}, {"source": 1405141770453, "target": 1472072126853}, {"source": 1405141770453, "target": 1472072130618}, {"source": 1405141770453, "target": 1472072137356}, {"source": 1405141770453, "target": 1472072140715}, {"source": 1405141770453, "target": 1472072149708}, {"source": 1405141770453, "target": 1472072154881}, {"source": 1405141770453, "target": 1472072157675}, {"source": 1405141770453, "target": 1472072164834}, {"source": 1405141770453, "target": 1472072173442}, {"source": 1405141770453, "target": 1472072182113}, {"source": 1405141770453, "target": 1472072190993}, {"source": 1405141770453, "target": 1472072198097}, {"source": 1405141770453, "target": 1472072206743}, {"source": 1405141770453, "target": 1472072219254}, {"source": 1405141770453, "target": 1472072229216}, {"source": 1405141770453, "target": 1472072237422}, {"source": 1405141770453, "target": 1472072242222}, {"source": 1405141770453, "target": 1472072245370}, {"source": 1405141770453, "target": 1472072263603}, {"source": 1405141770453, "target": 1472072268519}, {"source": 1405141770453, "target": 1472072271446}, {"source": 1405141770453, "target": 1472077123190}, {"source": 1405141770453, "target": 1472078675445}, {"source": 1405141770453, "target": 1472078681367}, {"source": 1405141770453, "target": 1472078716563}, {"source": 1405141770453, "target": 1472078731516}, {"source": 1405141770453, "target": 1472078743516}, {"source": 1405141770453, "target": 1472078813364}, {"source": 1405141770453, "target": 1472078821022}, {"source": 1405141770453, "target": 1472078827800}, {"source": 1405141770453, "target": 1472078831731}, {"source": 1405141770453, "target": 1472078835137}, {"source": 1405141770453, "target": 1472078876824}, {"source": 1405141770453, "target": 1472078884074}, {"source": 1405141770453, "target": 1472078891926}, {"source": 1405141770453, "target": 1472078900076}, {"source": 1405141770453, "target": 1472078903517}, {"source": 1405141770453, "target": 1472078910305}, {"source": 1405141770453, "target": 1472078917744}, {"source": 1405141770453, "target": 1472078921019}, {"source": 1405141770453, "target": 1472078933976}, {"source": 1405141770453, "target": 1472078947637}, {"source": 1405141770453, "target": 1472078951203}, {"source": 1405141770453, "target": 1472078955281}, {"source": 1405141770453, "target": 1472078958506}, {"source": 1405141770453, "target": 1472078965806}, {"source": 1405141770453, "target": 1472078969410}, {"source": 1405141770453, "target": 1472078973457}, {"source": 1405141770453, "target": 1472078981815}, {"source": 1405141770453, "target": 1472079020079}, {"source": 1405141770453, "target": 1472079023283}, {"source": 1405141770453, "target": 1472079064044}, {"source": 1405141770453, "target": 1472079071768}, {"source": 1405141770453, "target": 1472079075375}, {"source": 1405141770453, "target": 1472079078709}, {"source": 1405141770453, "target": 1472147014014}, {"source": 1405141770453, "target": 1472147029631}, {"source": 1405141770453, "target": 1472147055139}, {"source": 1405141770453, "target": 1472147062479}, {"source": 1405141770453, "target": 1472147158498}, {"source": 1405141770453, "target": 1472147168894}, {"source": 1405141770453, "target": 1472147174414}, {"source": 1405141770453, "target": 1472147273188}, {"source": 1405141770453, "target": 1472147355240}, {"source": 1405141770453, "target": 1472147380828}, {"source": 1405141770453, "target": 1472147393835}, {"source": 1405141770453, "target": 1472160921721}, {"source": 1405141770453, "target": 1472160925535}, {"source": 1405141770453, "target": 1472160934383}, {"source": 1405141770453, "target": 1472160945385}, {"source": 1405141770453, "target": 1472160960255}, {"source": 1405141770453, "target": 1472160971843}, {"source": 1405141770453, "target": 1472160976855}, {"source": 1405141770453, "target": 1472160983526}, {"source": 1405141770453, "target": 1472160991017}, {"source": 1405141770453, "target": 1472161006747}, {"source": 1405141770453, "target": 1472161014695}, {"source": 1405141770453, "target": 1472161017955}, {"source": 1405141770453, "target": 1472161020896}, {"source": 1405141770453, "target": 1472161027631}, {"source": 1405141770453, "target": 1472161030560}, {"source": 1405141770453, "target": 1472161037446}, {"source": 1405141770453, "target": 1472161040604}, {"source": 1405141770453, "target": 1472161046165}, {"source": 1405141770453, "target": 1472161049375}, {"source": 1405141770453, "target": 1472161052097}, {"source": 1405141770453, "target": 1472161054773}, {"source": 1405141770453, "target": 1472161058426}, {"source": 1405141770453, "target": 1472161064901}, {"source": 1405141770453, "target": 1472161069279}, {"source": 1405141770453, "target": 1472161073961}, {"source": 1405141770453, "target": 1472161083979}, {"source": 1405141770453, "target": 1472161087300}, {"source": 1405141770453, "target": 1472161090368}, {"source": 1405141770453, "target": 1472161094503}, {"source": 1405141770453, "target": 1472161128581}, {"source": 1405141770453, "target": 1472161140070}, {"source": 1405141770453, "target": 1472161149689}, {"source": 1405141770453, "target": 1472161153409}, {"source": 1405141770453, "target": 1472161162928}, {"source": 1405141770453, "target": 1472161172593}, {"source": 1405141770453, "target": 1472161182633}, {"source": 1405141770453, "target": 1472161190792}, {"source": 1405141770453, "target": 1472161197399}, {"source": 1405141770453, "target": 1472161209479}, {"source": 1405141770453, "target": 1472161218711}, {"source": 1405141770453, "target": 1472161223823}, {"source": 1405141770453, "target": 1472161230528}, {"source": 1405141770453, "target": 1472161233950}, {"source": 1405141770453, "target": 1472161242542}, {"source": 1405141770453, "target": 1472161250447}, {"source": 1405141770453, "target": 1472161253998}, {"source": 1405141770453, "target": 1472161256779}, {"source": 1405141770453, "target": 1472161263980}, {"source": 1405141770453, "target": 1472161271695}, {"source": 1405141770453, "target": 1472161282900}, {"source": 1405141770453, "target": 1472161298149}, {"source": 1405141770453, "target": 1472267102887}, {"source": 1405141770453, "target": 1472267164385}, {"source": 1405141770453, "target": 1472317625805}, {"source": 1405141770453, "target": 1472317632103}, {"source": 1405141770453, "target": 1472317635740}, {"source": 1405141770453, "target": 1472319935401}, {"source": 1405141770453, "target": 1472319957308}, {"source": 1405141770453, "target": 1472426456195}, {"source": 1405141770453, "target": 1472426481431}, {"source": 1405141770453, "target": 1472426485090}, {"source": 1405141770453, "target": 1472426491309}, {"source": 1405141770453, "target": 1472426494725}, {"source": 1405141770453, "target": 1472426501144}, {"source": 1405141770453, "target": 1472426513341}, {"source": 1405141770453, "target": 1472426521266}, {"source": 1405141770453, "target": 1472426529103}, {"source": 1405141770453, "target": 1472426537468}, {"source": 1405141770453, "target": 1472426541101}, {"source": 1405141770453, "target": 1472426549510}, {"source": 1405141770453, "target": 1472426560728}, {"source": 1405141770453, "target": 1472426576894}, {"source": 1405141770453, "target": 1472426585896}, {"source": 1405141770453, "target": 1472426600174}, {"source": 1405141770453, "target": 1472426609949}, {"source": 1405141770453, "target": 1472426614133}, {"source": 1405141770453, "target": 1472426616871}, {"source": 1405141770453, "target": 1472426619514}, {"source": 1405141770453, "target": 1472426621969}, {"source": 1405141770453, "target": 1472426624361}, {"source": 1405141770453, "target": 1472426626716}, {"source": 1405141770453, "target": 1472426629660}, {"source": 1405141770453, "target": 1472426631686}, {"source": 1405141770453, "target": 1472426633744}, {"source": 1405141770453, "target": 1473283703470}, {"source": 1405141770453, "target": 1473289622374}, {"source": 1405141770453, "target": 1473300703893}, {"source": 1405141770453, "target": 1473300709116}, {"source": 1405141770453, "target": 1473300713413}, {"source": 1405141770453, "target": 1473300721069}, {"source": 1405141770453, "target": 1473300758449}, {"source": 1405141770453, "target": 1473359792359}, {"source": 1405141770453, "target": 1473359810332}, {"source": 1405141770453, "target": 1473359817001}, {"source": 1405141770453, "target": 1473359947453}, {"source": 1405141770453, "target": 1473375572544}, {"source": 1405141770453, "target": 1473375631091}, {"source": 1405141770453, "target": 1473375643425}, {"source": 1405141770453, "target": 1473375653665}, {"source": 1405141770453, "target": 1473375657305}, {"source": 1405141770453, "target": 1473375660370}, {"source": 1405141770453, "target": 1473388710737}, {"source": 1405141770453, "target": 1473388953084}, {"source": 1405141770453, "target": 1473456927662}, {"source": 1405141770453, "target": 1473456935083}, {"source": 1405141770453, "target": 1473456943998}, {"source": 1405141770453, "target": 1473456949116}, {"source": 1405141770453, "target": 1473466761107}, {"source": 1405141770453, "target": 1473536763671}, {"source": 1405141770453, "target": 1473536775019}, {"source": 1405141770453, "target": 1473536778562}, {"source": 1405141770453, "target": 1473536833722}, {"source": 1405141770453, "target": 1473547676650}, {"source": 1405141770453, "target": 1473548355407}, {"source": 1405141770453, "target": 1473548369834}, {"source": 1405141770453, "target": 1473548378667}, {"source": 1405141770453, "target": 1473548385834}, {"source": 1405141770453, "target": 1473548398439}, {"source": 1405141770453, "target": 1473548408491}, {"source": 1405141770453, "target": 1473548430236}, {"source": 1405141770453, "target": 1473548436921}, {"source": 1405141770453, "target": 1473548445520}, {"source": 1405141770453, "target": 1473548457637}, {"source": 1405141770453, "target": 1473548462128}, {"source": 1405141770453, "target": 1473548472722}, {"source": 1405141770453, "target": 1473548476620}, {"source": 1405141770453, "target": 1473548483092}, {"source": 1405141770453, "target": 1473548494127}, {"source": 1405141770453, "target": 1473548504699}, {"source": 1405141770453, "target": 1473548512472}, {"source": 1405141770453, "target": 1473548517793}, {"source": 1405141770453, "target": 1473548523852}, {"source": 1405141770453, "target": 1473548530340}, {"source": 1405141770453, "target": 1473548541545}, {"source": 1405141770453, "target": 1473548558814}, {"source": 1405141770453, "target": 1473548565827}, {"source": 1405141770453, "target": 1473548575017}, {"source": 1405141770453, "target": 1473548585240}, {"source": 1405141770453, "target": 1473548603861}, {"source": 1405141770453, "target": 1473548608652}, {"source": 1405141770453, "target": 1473548613652}, {"source": 1405141770453, "target": 1473548626793}, {"source": 1405141770453, "target": 1473548638343}, {"source": 1405141770453, "target": 1473548642198}, {"source": 1405141770453, "target": 1473548655128}, {"source": 1405141770453, "target": 1473548659199}, {"source": 1405141770453, "target": 1473548663216}, {"source": 1405141770453, "target": 1473548667856}, {"source": 1405141770453, "target": 1473548674277}, {"source": 1405141770453, "target": 1473548678001}, {"source": 1405141770453, "target": 1473548691306}, {"source": 1405141770453, "target": 1473548696191}, {"source": 1405141770453, "target": 1473548706867}, {"source": 1405141770453, "target": 1473548728383}, {"source": 1405141770453, "target": 1473548750523}, {"source": 1405141770453, "target": 1473548771424}, {"source": 1405141770453, "target": 1473548777192}, {"source": 1405141770453, "target": 1473548780668}, {"source": 1405141770453, "target": 1473548786106}, {"source": 1405141770453, "target": 1473548789577}, {"source": 1405141770453, "target": 1473548800206}, {"source": 1405141770453, "target": 1473548807864}, {"source": 1405141770453, "target": 1473548811354}, {"source": 1405141770453, "target": 1473548850675}, {"source": 1405141770453, "target": 1473548885497}, {"source": 1405141770453, "target": 1473548941011}, {"source": 1405141770453, "target": 1473623659476}, {"source": 1405141770453, "target": 1473627804555}, {"source": 1405141770453, "target": 1473627813737}, {"source": 1405141770453, "target": 1473627818097}, {"source": 1405141770453, "target": 1473627826312}, {"source": 1405141770453, "target": 1473627834849}, {"source": 1405141770453, "target": 1473627839070}, {"source": 1405141770453, "target": 1473627847403}, {"source": 1405141770453, "target": 1473627856119}, {"source": 1405141770453, "target": 1473627865232}, {"source": 1405141770453, "target": 1473627874563}, {"source": 1405141770453, "target": 1473627897399}, {"source": 1405141770453, "target": 1473627902758}, {"source": 1405141770453, "target": 1473627906832}, {"source": 1405141770453, "target": 1473627910628}, {"source": 1405141770453, "target": 1473627914429}, {"source": 1405141770453, "target": 1473627921275}, {"source": 1405141770453, "target": 1473627929151}, {"source": 1405141770453, "target": 1473627940622}, {"source": 1405141770453, "target": 1473627946233}, {"source": 1405141770453, "target": 1473627951855}, {"source": 1405141770453, "target": 1473627957778}, {"source": 1405141770453, "target": 1473627965295}, {"source": 1405141770453, "target": 1473627969067}, {"source": 1405141770453, "target": 1473627972140}, {"source": 1405141770453, "target": 1473627980218}, {"source": 1405141770453, "target": 1473627988643}, {"source": 1405141770453, "target": 1473627994933}, {"source": 1405141770453, "target": 1473627997824}, {"source": 1405141770453, "target": 1473628000924}, {"source": 1405141770453, "target": 1473628007883}, {"source": 1405141770453, "target": 1473628011248}, {"source": 1405141770453, "target": 1473628016236}, {"source": 1405141770453, "target": 1473628019626}, {"source": 1405141770453, "target": 1473628022683}, {"source": 1405141770453, "target": 1473628025370}, {"source": 1405141770453, "target": 1473628028243}, {"source": 1405141770453, "target": 1473628031956}, {"source": 1405141770453, "target": 1473628043600}, {"source": 1405141770453, "target": 1473628051921}, {"source": 1405141770453, "target": 1473628054935}, {"source": 1405141770453, "target": 1473628062986}, {"source": 1405141770453, "target": 1473628066058}, {"source": 1405141770453, "target": 1473628069197}, {"source": 1405141770453, "target": 1473628085810}, {"source": 1405141770453, "target": 1473628088962}, {"source": 1405141770453, "target": 1473628091738}, {"source": 1405141770453, "target": 1473628105781}, {"source": 1405141770453, "target": 1473628107938}, {"source": 1405141770453, "target": 1473628116213}, {"source": 1405141770453, "target": 1473628122928}, {"source": 1405141770453, "target": 1473628127344}, {"source": 1405141770453, "target": 1473628137176}, {"source": 1405141770453, "target": 1473628139761}, {"source": 1405141770453, "target": 1473628142291}, {"source": 1405141770453, "target": 1473628148888}, {"source": 1405141770453, "target": 1473628151513}, {"source": 1405141770453, "target": 1473628154652}, {"source": 1405141770453, "target": 1473628157851}, {"source": 1405141770453, "target": 1473628163192}, {"source": 1405141770453, "target": 1473628168408}, {"source": 1405141770453, "target": 1473628171767}, {"source": 1405141770453, "target": 1473628182439}, {"source": 1405141770453, "target": 1473628185048}, {"source": 1405141770453, "target": 1473628189728}, {"source": 1405141770453, "target": 1473628192986}, {"source": 1405141770453, "target": 1473628195686}, {"source": 1405141770453, "target": 1473628198040}, {"source": 1405141770453, "target": 1473628200497}, {"source": 1405141770453, "target": 1473628203353}, {"source": 1405141770453, "target": 1473628206194}, {"source": 1405141770453, "target": 1473628208445}, {"source": 1405141770453, "target": 1473628210480}, {"source": 1405141770453, "target": 1473628212871}, {"source": 1405141770453, "target": 1473628215176}, {"source": 1405141770453, "target": 1473636186485}, {"source": 1405141770453, "target": 1473638382739}, {"source": 1405141770453, "target": 1473638386511}, {"source": 1405141770453, "target": 1473638390443}, {"source": 1405141770453, "target": 1473638399297}, {"source": 1405141770453, "target": 1473638408068}, {"source": 1405141770453, "target": 1473638411680}, {"source": 1405141770453, "target": 1473638414516}, {"source": 1405141770453, "target": 1473638417423}, {"source": 1405141770453, "target": 1473638423778}, {"source": 1405141770453, "target": 1473638435532}, {"source": 1405141770453, "target": 1473638438470}, {"source": 1405141770453, "target": 1473638441447}, {"source": 1405141770453, "target": 1473638444755}, {"source": 1405141770453, "target": 1473638448026}, {"source": 1405141770453, "target": 1473638455081}, {"source": 1405141770453, "target": 1473638462376}, {"source": 1405141770453, "target": 1473638465183}, {"source": 1405141770453, "target": 1473638467997}, {"source": 1405141770453, "target": 1473638470562}, {"source": 1405141770453, "target": 1473638477155}, {"source": 1405141770453, "target": 1473638480163}, {"source": 1405141770453, "target": 1473638482935}, {"source": 1405141770453, "target": 1473638486962}, {"source": 1405141770453, "target": 1473638516753}, {"source": 1405141770453, "target": 1473638519694}, {"source": 1405141770453, "target": 1473638522436}, {"source": 1405141770453, "target": 1473638525340}, {"source": 1405141770453, "target": 1473638531675}, {"source": 1405141770453, "target": 1473638538360}, {"source": 1405141770453, "target": 1473638546856}, {"source": 1405141770453, "target": 1473638553635}, {"source": 1405141770453, "target": 1473638557173}, {"source": 1405141770453, "target": 1473638562607}, {"source": 1405141770453, "target": 1473638564977}, {"source": 1405141770453, "target": 1473638571391}, {"source": 1405141770453, "target": 1473638578406}, {"source": 1405141770453, "target": 1473638593118}, {"source": 1405141770453, "target": 1473638595730}, {"source": 1405141770453, "target": 1473638601304}, {"source": 1405141770453, "target": 1473638623505}, {"source": 1405141770453, "target": 1473638627379}, {"source": 1405141770453, "target": 1473638629779}, {"source": 1405141770453, "target": 1473638633433}, {"source": 1405141770453, "target": 1473638638181}, {"source": 1405141770453, "target": 1473638644560}, {"source": 1405141770453, "target": 1473638647238}, {"source": 1405141770453, "target": 1473638659728}, {"source": 1405141770453, "target": 1473638662414}, {"source": 1405141770453, "target": 1473638669380}, {"source": 1405141770453, "target": 1473638676765}, {"source": 1405141770453, "target": 1473638685349}, {"source": 1405141770453, "target": 1473638690056}, {"source": 1405141770453, "target": 1473638702772}, {"source": 1405141770453, "target": 1473638705750}, {"source": 1405141770453, "target": 1473638707900}, {"source": 1405141770453, "target": 1473638710349}, {"source": 1405141770453, "target": 1473638717615}, {"source": 1405141770453, "target": 1473699393521}, {"source": 1405141770453, "target": 1473707197132}, {"source": 1405141770453, "target": 1473707200636}, {"source": 1405141770453, "target": 1473707203064}, {"source": 1405141770453, "target": 1473707208537}, {"source": 1405141770453, "target": 1473707219852}, {"source": 1405141770453, "target": 1473707226820}, {"source": 1405141770453, "target": 1473707229598}, {"source": 1405141770453, "target": 1473707232059}, {"source": 1405141770453, "target": 1473707239661}, {"source": 1405141770453, "target": 1473707246767}, {"source": 1405141770453, "target": 1473707250397}, {"source": 1405141770453, "target": 1473707263928}, {"source": 1405141770453, "target": 1473707272647}, {"source": 1405141770453, "target": 1473707275903}, {"source": 1405141770453, "target": 1473707283021}, {"source": 1405141770453, "target": 1473707286558}, {"source": 1405141770453, "target": 1473707295145}, {"source": 1405141770453, "target": 1473707300427}, {"source": 1405141770453, "target": 1473707313998}, {"source": 1405141770453, "target": 1473707322300}, {"source": 1405141770453, "target": 1473707340741}, {"source": 1405141770453, "target": 1473707356801}, {"source": 1405141770453, "target": 1473707363543}, {"source": 1405141770453, "target": 1473707387439}, {"source": 1405141770453, "target": 1473707392350}, {"source": 1405141770453, "target": 1473707401320}, {"source": 1405141770453, "target": 1473707408559}, {"source": 1405141770453, "target": 1473707412227}, {"source": 1405141770453, "target": 1473707419762}, {"source": 1405141770453, "target": 1473707526525}, {"source": 1405141770453, "target": 1473707532037}, {"source": 1405141770453, "target": 1473729868523}, {"source": 1405141770453, "target": 1473732867211}, {"source": 1405141770453, "target": 1473732871582}, {"source": 1405141770453, "target": 1473732879162}, {"source": 1405141770453, "target": 1473732882092}, {"source": 1405141770453, "target": 1473732886065}, {"source": 1405141770453, "target": 1473732889878}, {"source": 1405141770453, "target": 1473732893483}, {"source": 1405141770453, "target": 1473732897393}, {"source": 1405141770453, "target": 1473732900803}, {"source": 1405141770453, "target": 1473732904737}, {"source": 1405141770453, "target": 1473732908452}, {"source": 1405141770453, "target": 1473732927285}, {"source": 1405141770453, "target": 1473732940578}, {"source": 1405141770453, "target": 1473732948560}, {"source": 1405141770453, "target": 1473732954556}, {"source": 1405141770453, "target": 1473732957912}, {"source": 1405141770453, "target": 1473732968862}, {"source": 1405141770453, "target": 1473732979677}, {"source": 1405141770453, "target": 1473732983559}, {"source": 1405141770453, "target": 1473732987672}, {"source": 1405141770453, "target": 1473733003619}, {"source": 1405141770453, "target": 1473733007224}, {"source": 1405141770453, "target": 1473733010517}, {"source": 1405141770453, "target": 1473733014124}, {"source": 1405141770453, "target": 1473733017715}, {"source": 1405141770453, "target": 1473733024243}, {"source": 1405141770453, "target": 1473733036646}, {"source": 1405141770453, "target": 1473733041796}, {"source": 1405141770453, "target": 1473733050108}, {"source": 1405141770453, "target": 1473733061158}, {"source": 1405141770453, "target": 1473733068249}, {"source": 1405141770453, "target": 1473733074371}, {"source": 1405141770453, "target": 1473733078186}, {"source": 1405141770453, "target": 1473733081498}, {"source": 1405141770453, "target": 1473733091369}, {"source": 1405141770453, "target": 1473733098785}, {"source": 1405141770453, "target": 1473733105069}, {"source": 1405141770453, "target": 1473733108775}, {"source": 1405141770453, "target": 1473733111997}, {"source": 1405141770453, "target": 1473733119649}, {"source": 1405141770453, "target": 1473733123279}, {"source": 1405141770453, "target": 1473733134696}, {"source": 1405141770453, "target": 1473733138296}, {"source": 1405141770453, "target": 1473733140777}, {"source": 1405141770453, "target": 1473733143670}, {"source": 1405141770453, "target": 1473733146291}, {"source": 1405141770453, "target": 1473733160737}, {"source": 1405141770453, "target": 1473733183165}, {"source": 1405141770453, "target": 1473733186393}, {"source": 1405141770453, "target": 1473733189446}, {"source": 1405141770453, "target": 1473733192635}, {"source": 1405141770453, "target": 1473733196263}, {"source": 1405141770453, "target": 1473733206246}, {"source": 1405141770453, "target": 1473733209170}, {"source": 1405141770453, "target": 1473733212850}, {"source": 1405141770453, "target": 1473733215939}, {"source": 1405141770453, "target": 1473733221545}, {"source": 1405141770453, "target": 1473733226192}, {"source": 1405141770453, "target": 1473733237107}, {"source": 1405141770453, "target": 1473733243986}, {"source": 1405141770453, "target": 1473733249792}, {"source": 1405141770453, "target": 1473733256463}, {"source": 1405141770453, "target": 1473733260207}, {"source": 1405141770453, "target": 1473733262505}, {"source": 1405141770453, "target": 1473733268223}, {"source": 1405141770453, "target": 1473733270888}, {"source": 1405141770453, "target": 1473733277472}, {"source": 1405141770453, "target": 1473733280489}, {"source": 1405141770453, "target": 1473733286454}, {"source": 1405141770453, "target": 1473733289550}, {"source": 1405141770453, "target": 1473733299333}, {"source": 1405141770453, "target": 1473733352058}, {"source": 1405141770453, "target": 1473733368795}, {"source": 1405141770453, "target": 1473733371846}, {"source": 1405141770453, "target": 1473733374147}, {"source": 1405141770453, "target": 1473733376492}, {"source": 1405141770453, "target": 1473733378847}, {"source": 1405141770453, "target": 1473733380981}, {"source": 1405141770453, "target": 1473733383452}, {"source": 1405141770453, "target": 1473733391294}, {"source": 1405141770453, "target": 1473733419784}, {"source": 1405141770453, "target": 1473733428329}, {"source": 1405141770453, "target": 1473733430633}, {"source": 1405141770453, "target": 1473733439317}, {"source": 1405141770453, "target": 1473733441882}, {"source": 1405141770453, "target": 1473733443878}, {"source": 1405141770453, "target": 1473733445739}, {"source": 1405141770453, "target": 1473733448257}, {"source": 1405141770453, "target": 1473793980276}, {"source": 1405141770453, "target": 1473985980516}, {"source": 1405141770453, "target": 1473985992028}, {"source": 1405141770453, "target": 1473985997545}, {"source": 1405141770453, "target": 1473986001040}, {"source": 1405141770453, "target": 1473986009866}, {"source": 1405141770453, "target": 1473986015897}, {"source": 1405141770453, "target": 1473986020742}, {"source": 1405141770453, "target": 1473986024573}, {"source": 1405141770453, "target": 1473986028528}, {"source": 1405141770453, "target": 1473986031590}, {"source": 1405141770453, "target": 1473986034094}, {"source": 1405141770453, "target": 1473986036899}, {"source": 1405141770453, "target": 1473986040113}, {"source": 1405141770453, "target": 1473986043060}, {"source": 1405141770453, "target": 1473986052600}, {"source": 1405141770453, "target": 1473986059652}, {"source": 1405141770453, "target": 1473986065214}, {"source": 1405141770453, "target": 1473986117229}, {"source": 1405141770453, "target": 1473986130048}, {"source": 1405141770453, "target": 1473986132369}, {"source": 1405141770453, "target": 1473986144525}, {"source": 1405141770453, "target": 1473986166644}, {"source": 1405141770453, "target": 1473986174744}, {"source": 1405141770453, "target": 1473986177028}, {"source": 1405141770453, "target": 1473986179822}, {"source": 1405141770453, "target": 1473986197639}, {"source": 1405141770453, "target": 1473986200310}, {"source": 1405141770453, "target": 1473986210187}, {"source": 1405141770453, "target": 1473986222009}, {"source": 1405141770453, "target": 1473986243860}, {"source": 1405141770453, "target": 1473986262035}, {"source": 1405141770453, "target": 1473986269261}, {"source": 1405141770453, "target": 1473986274259}, {"source": 1405141770453, "target": 1473986277129}, {"source": 1405141770453, "target": 1473986283695}, {"source": 1405141770453, "target": 1473986289344}, {"source": 1405141770453, "target": 1473986295017}, {"source": 1405141770453, "target": 1473986300420}, {"source": 1405141770453, "target": 1473986303656}, {"source": 1405141770453, "target": 1473986318863}, {"source": 1405141770453, "target": 1473986325018}, {"source": 1405141770453, "target": 1473986338200}, {"source": 1405141770453, "target": 1473986341252}, {"source": 1405141770453, "target": 1473986344268}, {"source": 1405141770453, "target": 1473986353147}, {"source": 1405141770453, "target": 1473986356940}, {"source": 1405141770453, "target": 1473986359554}, {"source": 1405141770453, "target": 1473986362035}, {"source": 1405141770453, "target": 1473986370477}, {"source": 1405141770453, "target": 1473986373335}, {"source": 1405141770453, "target": 1473986381071}, {"source": 1405141770453, "target": 1473986384164}, {"source": 1405141770453, "target": 1473986386705}, {"source": 1405141770453, "target": 1473986393277}, {"source": 1405141770453, "target": 1473986396022}, {"source": 1405141770453, "target": 1473986398130}, {"source": 1405141770453, "target": 1473995163159}, {"source": 1405141770453, "target": 1473995444571}, {"source": 1405141770453, "target": 1473995463276}, {"source": 1405141770453, "target": 1473995466091}, {"source": 1405141770453, "target": 1473995468409}, {"source": 1405141770453, "target": 1473995471069}, {"source": 1405141770453, "target": 1473995480416}, {"source": 1405141770453, "target": 1473995486704}, {"source": 1405141770453, "target": 1473995492923}, {"source": 1405141770453, "target": 1473995504794}, {"source": 1405141770453, "target": 1473995508259}, {"source": 1405141770453, "target": 1473995525861}, {"source": 1405141770453, "target": 1473995528007}, {"source": 1405141770453, "target": 1473995532126}, {"source": 1405141770453, "target": 1473995552377}, {"source": 1405141770453, "target": 1473995557603}, {"source": 1405141770453, "target": 1473995562419}, {"source": 1405141770453, "target": 1473995568285}, {"source": 1405141770453, "target": 1473995572360}, {"source": 1405141770453, "target": 1473995574937}, {"source": 1405141770453, "target": 1473995578050}, {"source": 1405141770453, "target": 1473995580618}, {"source": 1405141770453, "target": 1473995583272}, {"source": 1405141770453, "target": 1473995592393}, {"source": 1405141770453, "target": 1473995595810}, {"source": 1405141770453, "target": 1473995598601}, {"source": 1405141770453, "target": 1473995601545}, {"source": 1405141770453, "target": 1473995604345}, {"source": 1405141770453, "target": 1473995618552}, {"source": 1405141770453, "target": 1473995622762}, {"source": 1405141770453, "target": 1473995625622}, {"source": 1405141770453, "target": 1473995633243}, {"source": 1405141770453, "target": 1473995638003}, {"source": 1405141770453, "target": 1473995650654}, {"source": 1405141770453, "target": 1473995657596}, {"source": 1405141770453, "target": 1473995665744}, {"source": 1405141770453, "target": 1473995668705}, {"source": 1405141770453, "target": 1473995671286}, {"source": 1405141770453, "target": 1473995674176}, {"source": 1405141770453, "target": 1473995676873}, {"source": 1405141770453, "target": 1473995679341}, {"source": 1405141770453, "target": 1473995681855}, {"source": 1405141770453, "target": 1473995684086}, {"source": 1405141770453, "target": 1473995687424}, {"source": 1405141770453, "target": 1473995695173}, {"source": 1405141770453, "target": 1473995698255}, {"source": 1405141770453, "target": 1473995704528}, {"source": 1405141770453, "target": 1473995711586}, {"source": 1405141770453, "target": 1473995714094}, {"source": 1405141770453, "target": 1473995720927}, {"source": 1405141770453, "target": 1473995736635}, {"source": 1405141770453, "target": 1473995740705}, {"source": 1405141770453, "target": 1473995743024}, {"source": 1405141770453, "target": 1473995752044}, {"source": 1405141770453, "target": 1473995754384}, {"source": 1405141770453, "target": 1473995756839}, {"source": 1405141770453, "target": 1473995759027}, {"source": 1405141770453, "target": 1473995761090}, {"source": 1405141770453, "target": 1473995763371}, {"source": 1405141770453, "target": 1473995775866}, {"source": 1405141770453, "target": 1474056842486}, {"source": 1405141770453, "target": 1474059949481}, {"source": 1405141770453, "target": 1474059951940}, {"source": 1405141770453, "target": 1474059954350}, {"source": 1405141770453, "target": 1474059956808}, {"source": 1405141770453, "target": 1474059964300}, {"source": 1405141770453, "target": 1474059967657}, {"source": 1405141770453, "target": 1474059969452}, {"source": 1405141770453, "target": 1474059974027}, {"source": 1405141770453, "target": 1474059977107}, {"source": 1405141770453, "target": 1474059980809}, {"source": 1405141770453, "target": 1474059992945}, {"source": 1405141770453, "target": 1474059996043}, {"source": 1405141770453, "target": 1474060008420}, {"source": 1405141770453, "target": 1474060012250}, {"source": 1405141770453, "target": 1474060020070}, {"source": 1405141770453, "target": 1474060025715}, {"source": 1405141770453, "target": 1474060032363}, {"source": 1405141770453, "target": 1474060036899}, {"source": 1405141770453, "target": 1474060042847}, {"source": 1405141770453, "target": 1474060045108}, {"source": 1405141770453, "target": 1474060049763}, {"source": 1405141770453, "target": 1474060051855}, {"source": 1405141770453, "target": 1474060054176}, {"source": 1405141770453, "target": 1474060056086}, {"source": 1405141770453, "target": 1474060058035}, {"source": 1405141770453, "target": 1474060061828}, {"source": 1405141770453, "target": 1474060067792}, {"source": 1405141770453, "target": 1474060070226}, {"source": 1405141770453, "target": 1474060075606}, {"source": 1405141770453, "target": 1474060077809}, {"source": 1405141770453, "target": 1474060080077}, {"source": 1405141770453, "target": 1474060088165}, {"source": 1405141770453, "target": 1474132397341}, {"source": 1405141770453, "target": 1474132602716}, {"source": 1405141770453, "target": 1474132844495}, {"source": 1405141770453, "target": 1474340518305}, {"source": 1405141770453, "target": 1474340536548}, {"source": 1405141770453, "target": 1474340552038}, {"source": 1405141770453, "target": 1474340554238}, {"source": 1405141770453, "target": 1474340556572}, {"source": 1405141770453, "target": 1474340559882}, {"source": 1405141770453, "target": 1474340567887}, {"source": 1405141770453, "target": 1474340571288}, {"source": 1405141770453, "target": 1474340580166}, {"source": 1405141770453, "target": 1474340588031}, {"source": 1405141770453, "target": 1474340594888}, {"source": 1405141770453, "target": 1474340602053}, {"source": 1405141770453, "target": 1474340609370}, {"source": 1405141770453, "target": 1474340622747}, {"source": 1405141770453, "target": 1474340632913}, {"source": 1405141770453, "target": 1474340637819}, {"source": 1405141770453, "target": 1474340647578}, {"source": 1405141770453, "target": 1474340658912}, {"source": 1405141770453, "target": 1474340665996}, {"source": 1405141770453, "target": 1474340669130}, {"source": 1405141770453, "target": 1474340675609}, {"source": 1405141770453, "target": 1474340678804}, {"source": 1405141770453, "target": 1474340685900}, {"source": 1405141770453, "target": 1474340691384}, {"source": 1405141770453, "target": 1474340700648}, {"source": 1405141770453, "target": 1474340703084}, {"source": 1405141770453, "target": 1474340712036}, {"source": 1405141770453, "target": 1474340718532}, {"source": 1405141770453, "target": 1474340722065}, {"source": 1405141770453, "target": 1474340733586}, {"source": 1405141770453, "target": 1474340749040}, {"source": 1405141770453, "target": 1474340751953}, {"source": 1405141770453, "target": 1474340754145}, {"source": 1405141770453, "target": 1474340756655}, {"source": 1405141770453, "target": 1474340758802}, {"source": 1405141770453, "target": 1474340761077}, {"source": 1405141770453, "target": 1474426134617}, {"source": 1405141770453, "target": 1474426138087}, {"source": 1405141770453, "target": 1474426144108}, {"source": 1405141770453, "target": 1474426146952}, {"source": 1405141770453, "target": 1474426149485}, {"source": 1405141770453, "target": 1474426151822}, {"source": 1405141770453, "target": 1474426154857}, {"source": 1405141770453, "target": 1474426179963}, {"source": 1405141770453, "target": 1474426182572}, {"source": 1405141770453, "target": 1474426188868}, {"source": 1405141770453, "target": 1474426192275}, {"source": 1405141770453, "target": 1474426211966}, {"source": 1405141770453, "target": 1474426229341}, {"source": 1405141770453, "target": 1474426236322}, {"source": 1405141770453, "target": 1474426238805}, {"source": 1405141770453, "target": 1474426241278}, {"source": 1405141770453, "target": 1474426251470}, {"source": 1405141770453, "target": 1474426253893}, {"source": 1405141770453, "target": 1474426256653}, {"source": 1405141770453, "target": 1474426259158}, {"source": 1405141770453, "target": 1474426261606}, {"source": 1405141770453, "target": 1474426264636}, {"source": 1405141770453, "target": 1474426282700}, {"source": 1405141770453, "target": 1474426307667}, {"source": 1405141770453, "target": 1474426314905}, {"source": 1405141770453, "target": 1474426326611}, {"source": 1405141770453, "target": 1474426331306}, {"source": 1405141770453, "target": 1474426382395}, {"source": 1405141770453, "target": 1474426389805}, {"source": 1405141770453, "target": 1474503563246}, {"source": 1405141770453, "target": 1474503570416}, {"source": 1405141770453, "target": 1474503577858}, {"source": 1405141770453, "target": 1474503594259}, {"source": 1405141770453, "target": 1474503597137}, {"source": 1405141770453, "target": 1474503600195}, {"source": 1405141770453, "target": 1474503602651}, {"source": 1405141770453, "target": 1474503605052}, {"source": 1405141770453, "target": 1474503614121}, {"source": 1405141770453, "target": 1474503616777}, {"source": 1405141770453, "target": 1474503628397}, {"source": 1405141770453, "target": 1474503640158}, {"source": 1405141770453, "target": 1474503645336}, {"source": 1405141770453, "target": 1474503663945}, {"source": 1405141770453, "target": 1474503668169}, {"source": 1405141770453, "target": 1474503671817}, {"source": 1405141770453, "target": 1474503674681}, {"source": 1405141770453, "target": 1474503686803}, {"source": 1405141770453, "target": 1474503699805}, {"source": 1405141770453, "target": 1474503706819}, {"source": 1405141770453, "target": 1474503709638}, {"source": 1405141770453, "target": 1474503712016}, {"source": 1405141770453, "target": 1474503714558}, {"source": 1405141770453, "target": 1474503716932}, {"source": 1405141770453, "target": 1474503739822}, {"source": 1405141770453, "target": 1474503743647}, {"source": 1405141770453, "target": 1474503746119}, {"source": 1405141770453, "target": 1474503749896}, {"source": 1405141770453, "target": 1474503752869}, {"source": 1405141770453, "target": 1474503757152}, {"source": 1405141770453, "target": 1474503760222}, {"source": 1405141770453, "target": 1474503768203}, {"source": 1405141770453, "target": 1474503771577}, {"source": 1405141770453, "target": 1474503781327}, {"source": 1405141770453, "target": 1474503784942}, {"source": 1405141770453, "target": 1474503787648}, {"source": 1405141770453, "target": 1474503790995}, {"source": 1405141770453, "target": 1474503793223}, {"source": 1405141770453, "target": 1474503795880}, {"source": 1405141770453, "target": 1474503798243}, {"source": 1405141770453, "target": 1474503805629}, {"source": 1405141770453, "target": 1474503812564}, {"source": 1405141770453, "target": 1474503817940}, {"source": 1405141770453, "target": 1474503822233}, {"source": 1405141770453, "target": 1474503835126}, {"source": 1405141770453, "target": 1474503845229}, {"source": 1405141770453, "target": 1474503853594}, {"source": 1405141770453, "target": 1474503857395}, {"source": 1405141770453, "target": 1474512820505}, {"source": 1405141770453, "target": 1474763338334}, {"source": 1405141770453, "target": 1474763665591}, {"source": 1405141770453, "target": 1474763667904}, {"source": 1405141770453, "target": 1474763670263}, {"source": 1405141770453, "target": 1475028620304}, {"source": 1405141770453, "target": 1475107702619}, {"source": 1405141770453, "target": 1475114939718}, {"source": 1405141770453, "target": 1475114947006}, {"source": 1405141770453, "target": 1475114951816}, {"source": 1405141770453, "target": 1475114956456}, {"source": 1405141770453, "target": 1475114962355}, {"source": 1405141770453, "target": 1475114968608}, {"source": 1405141770453, "target": 1475114975445}, {"source": 1405141770453, "target": 1475114980575}, {"source": 1405141770453, "target": 1475114985396}, {"source": 1405141770453, "target": 1475114989915}, {"source": 1405141770453, "target": 1475114999119}, {"source": 1405141770453, "target": 1475115012652}, {"source": 1405141770453, "target": 1475115054784}, {"source": 1405141770453, "target": 1475115086383}, {"source": 1405141770453, "target": 1475115092818}, {"source": 1405141770453, "target": 1475115097360}, {"source": 1405141770453, "target": 1475115110904}, {"source": 1405141770453, "target": 1475115136486}, {"source": 1405141770453, "target": 1475115173540}, {"source": 1405141770453, "target": 1475115182305}, {"source": 1405141770453, "target": 1475115200115}, {"source": 1405141770453, "target": 1475115228977}, {"source": 1405141770453, "target": 1475115245082}, {"source": 1405141770453, "target": 1475115252741}, {"source": 1405141770453, "target": 1475115290102}, {"source": 1405141770453, "target": 1475115335100}, {"source": 1405141770453, "target": 1475115343012}, {"source": 1405141770453, "target": 1475115369043}, {"source": 1405141770453, "target": 1475115373568}, {"source": 1405141770453, "target": 1475115379443}, {"source": 1405141770453, "target": 1475287319984}, {"source": 1405141770453, "target": 1475287322161}, {"source": 1405141770453, "target": 1475287324745}, {"source": 1405141770453, "target": 1475287335371}, {"source": 1405141770453, "target": 1475287343372}, {"source": 1405141770453, "target": 1475287350418}, {"source": 1405141770453, "target": 1475287371253}, {"source": 1405141770453, "target": 1475287374579}, {"source": 1405141770453, "target": 1475287384441}, {"source": 1405141770453, "target": 1475287386660}, {"source": 1405141770453, "target": 1475287388509}, {"source": 1405141770453, "target": 1475287390592}, {"source": 1405141770453, "target": 1475287392656}, {"source": 1405141770453, "target": 1475287401222}, {"source": 1405141770453, "target": 1475287417725}, {"source": 1405141770453, "target": 1475287434487}, {"source": 1405141770453, "target": 1475287436376}, {"source": 1405141770453, "target": 1475287438868}, {"source": 1405141770453, "target": 1475287443246}, {"source": 1405141770453, "target": 1475287445404}, {"source": 1405141770453, "target": 1475348251414}, {"source": 1405141770453, "target": 1475353363846}, {"source": 1405141770453, "target": 1475353497496}, {"source": 1405141770453, "target": 1475353500632}, {"source": 1405141770453, "target": 1475353514062}, {"source": 1405141770453, "target": 1475353547607}, {"source": 1405141770453, "target": 1475353550626}, {"source": 1405141770453, "target": 1475353557014}, {"source": 1405141770453, "target": 1475353560007}, {"source": 1405141770453, "target": 1475353563417}, {"source": 1405141770453, "target": 1475353567041}, {"source": 1405141770453, "target": 1475353569831}, {"source": 1405141770453, "target": 1475353572575}, {"source": 1405141770453, "target": 1475353575640}, {"source": 1405141770453, "target": 1475353578336}, {"source": 1405141770453, "target": 1475353585796}, {"source": 1405141770453, "target": 1475353588313}, {"source": 1405141770453, "target": 1475353590850}, {"source": 1405141770453, "target": 1475353595370}, {"source": 1405141770453, "target": 1475353600577}, {"source": 1405141770453, "target": 1475353603518}, {"source": 1405141770453, "target": 1475353605696}, {"source": 1405141770453, "target": 1475353608030}, {"source": 1405141770453, "target": 1475353615732}, {"source": 1405141770453, "target": 1475353630743}, {"source": 1405141770453, "target": 1475353637083}, {"source": 1405141770453, "target": 1475353639796}, {"source": 1405141770453, "target": 1475353642142}, {"source": 1405141770453, "target": 1475353650203}, {"source": 1405141770453, "target": 1475353652841}, {"source": 1405141770453, "target": 1475353660130}, {"source": 1405141770453, "target": 1475353671175}, {"source": 1405141770453, "target": 1475353678694}, {"source": 1405141770453, "target": 1475353689389}, {"source": 1405141770453, "target": 1475353700927}, {"source": 1405141770453, "target": 1475353703566}, {"source": 1405141770453, "target": 1475353706251}, {"source": 1405141770453, "target": 1475353712670}, {"source": 1405141770453, "target": 1475353717012}, {"source": 1405141770453, "target": 1475353719884}, {"source": 1405141770453, "target": 1475353722104}, {"source": 1405141770453, "target": 1475353724586}, {"source": 1405141770453, "target": 1475353729635}, {"source": 1405141770453, "target": 1475353732476}, {"source": 1405141770453, "target": 1475353735142}, {"source": 1405141770453, "target": 1475353745252}, {"source": 1405141770453, "target": 1475353749867}, {"source": 1405141770453, "target": 1475353753903}, {"source": 1405141770453, "target": 1475354642973}, {"source": 1405141770453, "target": 1475363769043}, {"source": 1405141770453, "target": 1475363772593}, {"source": 1405141770453, "target": 1475363774930}, {"source": 1405141770453, "target": 1475363777148}, {"source": 1405141770453, "target": 1475363783582}, {"source": 1405141770453, "target": 1475363791450}, {"source": 1405141770453, "target": 1475363800217}, {"source": 1405141770453, "target": 1475363803106}, {"source": 1405141770453, "target": 1475363809585}, {"source": 1405141770453, "target": 1475363812524}, {"source": 1405141770453, "target": 1475363817507}, {"source": 1405141770453, "target": 1475363820412}, {"source": 1405141770453, "target": 1475363825579}, {"source": 1405141770453, "target": 1475363828294}, {"source": 1405141770453, "target": 1475363831349}, {"source": 1405141770453, "target": 1475363838997}, {"source": 1405141770453, "target": 1475363841815}, {"source": 1405141770453, "target": 1475363844810}, {"source": 1405141770453, "target": 1475363847722}, {"source": 1405141770453, "target": 1475363849731}, {"source": 1405141770453, "target": 1475363852586}, {"source": 1405141770453, "target": 1475363857060}, {"source": 1405141770453, "target": 1475363863959}, {"source": 1405141770453, "target": 1475363870196}, {"source": 1405141770453, "target": 1475363877947}, {"source": 1405141770453, "target": 1475363880707}, {"source": 1405141770453, "target": 1475363888352}, {"source": 1405141770453, "target": 1475363908883}, {"source": 1405141770453, "target": 1475363911361}, {"source": 1405141770453, "target": 1475363980691}, {"source": 1405141770453, "target": 1475363985178}, {"source": 1405141770453, "target": 1475363987466}, {"source": 1405141770453, "target": 1475363999923}, {"source": 1405141770453, "target": 1475364023607}, {"source": 1405141770453, "target": 1475364024753}, {"source": 1405141770453, "target": 1475364027546}, {"source": 1405141770453, "target": 1475364030028}, {"source": 1405141770453, "target": 1475364039224}, {"source": 1405141770453, "target": 1475364052433}, {"source": 1405141770453, "target": 1475364057523}, {"source": 1405141770453, "target": 1475364061773}, {"source": 1405141770453, "target": 1475364074152}, {"source": 1405141770453, "target": 1475364079016}, {"source": 1405141770453, "target": 1475364082942}, {"source": 1405141770453, "target": 1475364095466}, {"source": 1405141770453, "target": 1475364102374}, {"source": 1405141770453, "target": 1475364107707}, {"source": 1405141770453, "target": 1475364110524}, {"source": 1405141770453, "target": 1475364112776}, {"source": 1405141770453, "target": 1475364115656}, {"source": 1405141770453, "target": 1475364120802}, {"source": 1405141770453, "target": 1475364123204}, {"source": 1405141770453, "target": 1475364125638}, {"source": 1405141770453, "target": 1475364129715}, {"source": 1405141770453, "target": 1475364137399}, {"source": 1405141770453, "target": 1475364140189}, {"source": 1405141770453, "target": 1475364142714}, {"source": 1405141770453, "target": 1475364147786}, {"source": 1405141770453, "target": 1475364150468}, {"source": 1405141770453, "target": 1475364152379}, {"source": 1405141770453, "target": 1475375262667}, {"source": 1405141770453, "target": 1475376381122}, {"source": 1405141770453, "target": 1475376384474}, {"source": 1405141770453, "target": 1475376387061}, {"source": 1405141770453, "target": 1475376389469}, {"source": 1405141770453, "target": 1475376396532}, {"source": 1405141770453, "target": 1475376399619}, {"source": 1405141770453, "target": 1475376402452}, {"source": 1405141770453, "target": 1475376406771}, {"source": 1405141770453, "target": 1475376412860}, {"source": 1405141770453, "target": 1475376417766}, {"source": 1405141770453, "target": 1475376425582}, {"source": 1405141770453, "target": 1475376428519}, {"source": 1405141770453, "target": 1475376431328}, {"source": 1405141770453, "target": 1475376433919}, {"source": 1405141770453, "target": 1475376436296}, {"source": 1405141770453, "target": 1475376438517}, {"source": 1405141770453, "target": 1475376445664}, {"source": 1405141770453, "target": 1475376486636}, {"source": 1405141770453, "target": 1475376496099}, {"source": 1405141770453, "target": 1475376498638}, {"source": 1405141770453, "target": 1475376503087}, {"source": 1405141770453, "target": 1475376506084}, {"source": 1405141770453, "target": 1475376509836}, {"source": 1405141770453, "target": 1475376511780}, {"source": 1405141770453, "target": 1475376514149}, {"source": 1405141770453, "target": 1475376520112}, {"source": 1405141770453, "target": 1475376526888}, {"source": 1405141770453, "target": 1475376529252}, {"source": 1405141770453, "target": 1475376545116}, {"source": 1405141770453, "target": 1475376552582}, {"source": 1405141770453, "target": 1475376572176}, {"source": 1405141770453, "target": 1475376574700}, {"source": 1405141770453, "target": 1475376577258}, {"source": 1405141770453, "target": 1475376579559}, {"source": 1405141770453, "target": 1475376581661}, {"source": 1405141770453, "target": 1475376583593}, {"source": 1405141770453, "target": 1475376585950}, {"source": 1405141770453, "target": 1475376588139}, {"source": 1405141770453, "target": 1475376595559}, {"source": 1405141770453, "target": 1475376597881}, {"source": 1405141770453, "target": 1475376608583}, {"source": 1405141770453, "target": 1475376612128}, {"source": 1405141770453, "target": 1475376614336}, {"source": 1405141770453, "target": 1475376617622}, {"source": 1405141770453, "target": 1475376623320}, {"source": 1405141770453, "target": 1475376628335}, {"source": 1405141770453, "target": 1475376633607}, {"source": 1405141770453, "target": 1475376636033}, {"source": 1405141770453, "target": 1475376641804}, {"source": 1405141770453, "target": 1475376644933}, {"source": 1405141770453, "target": 1475376651770}, {"source": 1405141770453, "target": 1475376654031}, {"source": 1405141770453, "target": 1475376667877}, {"source": 1405141770453, "target": 1475376674749}, {"source": 1405141770453, "target": 1475376677237}, {"source": 1405141770453, "target": 1475376678987}, {"source": 1405141770453, "target": 1475376681509}, {"source": 1405141770453, "target": 1475376683275}, {"source": 1405141770453, "target": 1475376695635}, {"source": 1405141770453, "target": 1475452920961}, {"source": 1405141770453, "target": 1475452925539}, {"source": 1405141770453, "target": 1475452928405}, {"source": 1405141770453, "target": 1475452931321}, {"source": 1405141770453, "target": 1475452937544}, {"source": 1405141770453, "target": 1475452940682}, {"source": 1405141770453, "target": 1475452943180}, {"source": 1405141770453, "target": 1475452946092}, {"source": 1405141770453, "target": 1475452948886}, {"source": 1405141770453, "target": 1475452951914}, {"source": 1405141770453, "target": 1475452960076}, {"source": 1405141770453, "target": 1475452963347}, {"source": 1405141770453, "target": 1475452971352}, {"source": 1405141770453, "target": 1475452975778}, {"source": 1405141770453, "target": 1475452989103}, {"source": 1405141770453, "target": 1475453004269}, {"source": 1405141770453, "target": 1475453007566}, {"source": 1405141770453, "target": 1475453013894}, {"source": 1405141770453, "target": 1475453031438}, {"source": 1405141770453, "target": 1475453035006}, {"source": 1405141770453, "target": 1475453038069}, {"source": 1405141770453, "target": 1475453045695}, {"source": 1405141770453, "target": 1475453051645}, {"source": 1405141770453, "target": 1475453058518}, {"source": 1405141770453, "target": 1475453079620}, {"source": 1405141770453, "target": 1475453091066}, {"source": 1405141770453, "target": 1475453110289}, {"source": 1405141770453, "target": 1475453116797}, {"source": 1405141770453, "target": 1475453132862}, {"source": 1405141770453, "target": 1475453135801}, {"source": 1405141770453, "target": 1475453139770}, {"source": 1405141770453, "target": 1475453142267}, {"source": 1405141770453, "target": 1475453150219}, {"source": 1405141770453, "target": 1475453157187}, {"source": 1405141770453, "target": 1475453160043}, {"source": 1405141770453, "target": 1475453162870}, {"source": 1405141770453, "target": 1475453168385}, {"source": 1405141770453, "target": 1475453171165}, {"source": 1405141770453, "target": 1475453181509}, {"source": 1405141770453, "target": 1475453188699}, {"source": 1405141770453, "target": 1475453191411}, {"source": 1405141770453, "target": 1475453205490}, {"source": 1405141770453, "target": 1475453213234}, {"source": 1405141770453, "target": 1475453216091}, {"source": 1405141770453, "target": 1475453220280}, {"source": 1405141770453, "target": 1475453223270}, {"source": 1405141770453, "target": 1475453226283}, {"source": 1405141770453, "target": 1475453229159}, {"source": 1405141770453, "target": 1475453236620}, {"source": 1405141770453, "target": 1475453243182}, {"source": 1405141770453, "target": 1475453246064}, {"source": 1405141770453, "target": 1475453250507}, {"source": 1405141770453, "target": 1475453253604}, {"source": 1405141770453, "target": 1475453256310}, {"source": 1405141770453, "target": 1475453259650}, {"source": 1405141770453, "target": 1475453262176}, {"source": 1405141770453, "target": 1475453264320}, {"source": 1405141770453, "target": 1475453266868}, {"source": 1405141770453, "target": 1475453274131}, {"source": 1405141770453, "target": 1475453276934}, {"source": 1405141770453, "target": 1475453283377}, {"source": 1405141770453, "target": 1475453286069}, {"source": 1405141770453, "target": 1475453294639}, {"source": 1405141770453, "target": 1475453297299}, {"source": 1405141770453, "target": 1475453301458}, {"source": 1405141770453, "target": 1475453303765}, {"source": 1405141770453, "target": 1475453306198}, {"source": 1405141770453, "target": 1475453308606}, {"source": 1405141770453, "target": 1475453310825}, {"source": 1405141770453, "target": 1475453318914}, {"source": 1405141770453, "target": 1475453326357}, {"source": 1405141770453, "target": 1475453340355}, {"source": 1405141770453, "target": 1475453343743}, {"source": 1405141770453, "target": 1475453348135}, {"source": 1405141770453, "target": 1475453356821}, {"source": 1405141770453, "target": 1475453375270}, {"source": 1405141770453, "target": 1475453378032}, {"source": 1405141770453, "target": 1475453397652}, {"source": 1405141770453, "target": 1475453400568}, {"source": 1405141770453, "target": 1475453406023}, {"source": 1405141770453, "target": 1475453422378}, {"source": 1405141770453, "target": 1475453425482}, {"source": 1405141770453, "target": 1475453429411}, {"source": 1405141770453, "target": 1475453432034}, {"source": 1405141770453, "target": 1475453434812}, {"source": 1405141770453, "target": 1475453437333}, {"source": 1405141770453, "target": 1475453442348}, {"source": 1405141770453, "target": 1475453444576}, {"source": 1405141770453, "target": 1475453446887}, {"source": 1405141770453, "target": 1475453489899}, {"source": 1405141770453, "target": 1475453498841}, {"source": 1405141770453, "target": 1475460297979}, {"source": 1405141770453, "target": 1475462959571}, {"source": 1405141770453, "target": 1475462966975}, {"source": 1405141770453, "target": 1475462971484}, {"source": 1405141770453, "target": 1475462978025}, {"source": 1405141770453, "target": 1475462983332}, {"source": 1405141770453, "target": 1475462988602}, {"source": 1405141770453, "target": 1475462995684}, {"source": 1405141770453, "target": 1475463012039}, {"source": 1405141770453, "target": 1475463018940}, {"source": 1405141770453, "target": 1475463021894}, {"source": 1405141770453, "target": 1475463026584}, {"source": 1405141770453, "target": 1475463031790}, {"source": 1405141770453, "target": 1475463054501}, {"source": 1405141770453, "target": 1475463065054}, {"source": 1405141770453, "target": 1475463067676}, {"source": 1405141770453, "target": 1475463069917}, {"source": 1405141770453, "target": 1475463113190}, {"source": 1405141770453, "target": 1475463191861}, {"source": 1405141770453, "target": 1475463194050}, {"source": 1405141770453, "target": 1475463196563}, {"source": 1405141770453, "target": 1475463199257}, {"source": 1405141770453, "target": 1475463201591}, {"source": 1405141770453, "target": 1475463212199}, {"source": 1405141770453, "target": 1475463214665}, {"source": 1405141770453, "target": 1475463223057}, {"source": 1405141770453, "target": 1475463225676}, {"source": 1405141770453, "target": 1475463227868}, {"source": 1405141770453, "target": 1475463252650}, {"source": 1405141770453, "target": 1475463257882}, {"source": 1405141770453, "target": 1475463260501}, {"source": 1405141770453, "target": 1475463272947}, {"source": 1405141770453, "target": 1475463297879}, {"source": 1405141770453, "target": 1475463318609}, {"source": 1405141770453, "target": 1475463326724}, {"source": 1405141770453, "target": 1475463329357}, {"source": 1405141770453, "target": 1475463344628}, {"source": 1405141770453, "target": 1475463348604}, {"source": 1405141770453, "target": 1475463375703}, {"source": 1405141770453, "target": 1475463381699}, {"source": 1405141770453, "target": 1475463383859}, {"source": 1405141770453, "target": 1475463386114}, {"source": 1405141770453, "target": 1475463392967}, {"source": 1405141770453, "target": 1475463395276}, {"source": 1405141770453, "target": 1475463397773}, {"source": 1405141770453, "target": 1475463401818}, {"source": 1405141770453, "target": 1475463404054}, {"source": 1405141770453, "target": 1475463406185}, {"source": 1405141770453, "target": 1475463407823}, {"source": 1405141770453, "target": 1475463409814}, {"source": 1405141770453, "target": 1475704810517}, {"source": 1405141770453, "target": 1475713336232}, {"source": 1405141770453, "target": 1475713346285}, {"source": 1405141770453, "target": 1475713351153}, {"source": 1405141770453, "target": 1475713357154}, {"source": 1405141770453, "target": 1475713382619}, {"source": 1405141770453, "target": 1475713386294}, {"source": 1405141770453, "target": 1475713396454}, {"source": 1405141770453, "target": 1475713408598}, {"source": 1405141770453, "target": 1475713435737}, {"source": 1405141770453, "target": 1475713438166}, {"source": 1405141770453, "target": 1475713440191}, {"source": 1405141770453, "target": 1475713487440}, {"source": 1405141770453, "target": 1475721654515}, {"source": 1405141770453, "target": 1475721772882}, {"source": 1405141770453, "target": 1475721775046}, {"source": 1405141770453, "target": 1475721778747}, {"source": 1405141770453, "target": 1475874265007}, {"source": 1405141770453, "target": 1475874402725}, {"source": 1405141770453, "target": 1476233142595}, {"source": 1405141770453, "target": 1476383467230}, {"source": 1405141770453, "target": 1476487955126}, {"source": 1405141770453, "target": 1476583187105}, {"source": 1405141770453, "target": 1476584021092}, {"source": 1405141770453, "target": 1476661073431}, {"source": 1405141770453, "target": 1476661087790}, {"source": 1405141770453, "target": 1476661104838}, {"source": 1405141770453, "target": 1476661113645}, {"source": 1405141770453, "target": 1476661119016}, {"source": 1405141770453, "target": 1476665733378}, {"source": 1405141770453, "target": 1476666792202}, {"source": 1405141770453, "target": 1476666798893}, {"source": 1405141770453, "target": 1476666803925}, {"source": 1405141770453, "target": 1476666810819}, {"source": 1405141770453, "target": 1476666815134}, {"source": 1405141770453, "target": 1476666821658}, {"source": 1405141770453, "target": 1476666825837}, {"source": 1405141770453, "target": 1476666829827}, {"source": 1405141770453, "target": 1476666833848}, {"source": 1405141770453, "target": 1476666837592}, {"source": 1405141770453, "target": 1476669580948}, {"source": 1405141770453, "target": 1476669582662}, {"source": 1405141770453, "target": 1476733477668}, {"source": 1405141770453, "target": 1476915318326}, {"source": 1405141770453, "target": 1476919613381}, {"source": 1405141770453, "target": 1476919620070}, {"source": 1405141770453, "target": 1476919625787}, {"source": 1405141770453, "target": 1476919634500}, {"source": 1405141770453, "target": 1476919643870}, {"source": 1405141770453, "target": 1476919648352}, {"source": 1405141770453, "target": 1476919655451}, {"source": 1405141770453, "target": 1476919664478}, {"source": 1405141770453, "target": 1476919674183}, {"source": 1405141770453, "target": 1476919680971}, {"source": 1405141770453, "target": 1476919685377}, {"source": 1405141770453, "target": 1476919693433}, {"source": 1405141770453, "target": 1476919698402}, {"source": 1405141770453, "target": 1476919709210}, {"source": 1405141770453, "target": 1476919714833}, {"source": 1405141770453, "target": 1476919724945}, {"source": 1405141770453, "target": 1476919734213}, {"source": 1405141770453, "target": 1476919744186}, {"source": 1405141770453, "target": 1476919757743}, {"source": 1405141770453, "target": 1476919769431}, {"source": 1405141770453, "target": 1476919773069}, {"source": 1405141770453, "target": 1476919776519}, {"source": 1405141770453, "target": 1476919779333}, {"source": 1405141770453, "target": 1476919782385}, {"source": 1405141770453, "target": 1476919789412}, {"source": 1405141770453, "target": 1476919793674}, {"source": 1405141770453, "target": 1476919800993}, {"source": 1405141770453, "target": 1476919810379}, {"source": 1405141770453, "target": 1476919819600}, {"source": 1405141770453, "target": 1476919831441}, {"source": 1405141770453, "target": 1476919839290}, {"source": 1405141770453, "target": 1476919841793}, {"source": 1405141770453, "target": 1476919848901}, {"source": 1405141770453, "target": 1476919851460}, {"source": 1405141770453, "target": 1477005434793}, {"source": 1405141770453, "target": 1477011377426}, {"source": 1405141770453, "target": 1477011384108}, {"source": 1405141770453, "target": 1477011401729}, {"source": 1405141770453, "target": 1477011409317}, {"source": 1405141770453, "target": 1477011414189}, {"source": 1405141770453, "target": 1477011423804}, {"source": 1405141770453, "target": 1477011431858}, {"source": 1405141770453, "target": 1477011437200}, {"source": 1405141770453, "target": 1477011451449}, {"source": 1405141770453, "target": 1477011456345}, {"source": 1405141770453, "target": 1477011463650}, {"source": 1405141770453, "target": 1477011469772}, {"source": 1405141770453, "target": 1477011480660}, {"source": 1405141770453, "target": 1477011485721}, {"source": 1405141770453, "target": 1477011497450}, {"source": 1405141770453, "target": 1477011505650}, {"source": 1405141770453, "target": 1477011511428}, {"source": 1405141770453, "target": 1477011516755}, {"source": 1405141770453, "target": 1477011522197}, {"source": 1405141770453, "target": 1477011528602}, {"source": 1405141770453, "target": 1477011534590}, {"source": 1405141770453, "target": 1477011539335}, {"source": 1405141770453, "target": 1477011544513}, {"source": 1405141770453, "target": 1477011550067}, {"source": 1405141770453, "target": 1477011554587}, {"source": 1405141770453, "target": 1477011561690}, {"source": 1405141770453, "target": 1477011567163}, {"source": 1405141770453, "target": 1477011576752}, {"source": 1405141770453, "target": 1477011629194}, {"source": 1405141770453, "target": 1477011634030}, {"source": 1405141770453, "target": 1477011641203}, {"source": 1405141770453, "target": 1477011649586}, {"source": 1405141770453, "target": 1477011656570}, {"source": 1405141770453, "target": 1477011664436}, {"source": 1405141770453, "target": 1477011672952}, {"source": 1405141770453, "target": 1477011680427}, {"source": 1405141770453, "target": 1477011688658}, {"source": 1405141770453, "target": 1477011693487}, {"source": 1405141770453, "target": 1477011701404}, {"source": 1405141770453, "target": 1477011709231}, {"source": 1405141770453, "target": 1477011718005}, {"source": 1405141770453, "target": 1477011725670}, {"source": 1405141770453, "target": 1477011732949}, {"source": 1405141770453, "target": 1477011740581}, {"source": 1405141770453, "target": 1477011748932}, {"source": 1405141770453, "target": 1477011753866}, {"source": 1405141770453, "target": 1477011760995}, {"source": 1405141770453, "target": 1477011767340}, {"source": 1405141770453, "target": 1477011774822}, {"source": 1405141770453, "target": 1477011782938}, {"source": 1405141770453, "target": 1477011790487}, {"source": 1405141770453, "target": 1477011798304}, {"source": 1405141770453, "target": 1477011808646}, {"source": 1405141770453, "target": 1477011839741}, {"source": 1405141770453, "target": 1477011851812}, {"source": 1405141770453, "target": 1477011859852}, {"source": 1405141770453, "target": 1477011869612}, {"source": 1405141770453, "target": 1477011876587}, {"source": 1405141770453, "target": 1477011883318}, {"source": 1405141770453, "target": 1477089705684}, {"source": 1405141770453, "target": 1477089715178}, {"source": 1405141770453, "target": 1477089726093}, {"source": 1405141770453, "target": 1477089745741}, {"source": 1405141770453, "target": 1477089750537}, {"source": 1405141770453, "target": 1477089761426}, {"source": 1405141770453, "target": 1477089771285}, {"source": 1405141770453, "target": 1477089775518}, {"source": 1405141770453, "target": 1477089780610}, {"source": 1405141770453, "target": 1477089795846}, {"source": 1405141770453, "target": 1477089800068}, {"source": 1405141770453, "target": 1477089830734}, {"source": 1405141770453, "target": 1477089837439}, {"source": 1405141770453, "target": 1477089841730}, {"source": 1405141770453, "target": 1477089846070}, {"source": 1405141770453, "target": 1477089852913}, {"source": 1405141770453, "target": 1477089867198}, {"source": 1405141770453, "target": 1477089906455}, {"source": 1405141770453, "target": 1477089913242}, {"source": 1405141770453, "target": 1477089918154}, {"source": 1405141770453, "target": 1477432063653}, {"source": 1405141770453, "target": 1477432855650}, {"source": 1405141770453, "target": 1477432861773}, {"source": 1405141770453, "target": 1477432866507}, {"source": 1405141770453, "target": 1477432872252}, {"source": 1405141770453, "target": 1477432878321}, {"source": 1405141770453, "target": 1477432887267}, {"source": 1405141770453, "target": 1477432891952}, {"source": 1405141770453, "target": 1477432895849}, {"source": 1405141770453, "target": 1477432899027}, {"source": 1405141770453, "target": 1477432903955}, {"source": 1405141770453, "target": 1477432909389}, {"source": 1405141770453, "target": 1477432914191}, {"source": 1405141770453, "target": 1477432920598}, {"source": 1405141770453, "target": 1477432925746}, {"source": 1405141770453, "target": 1477432936752}, {"source": 1405141770453, "target": 1477432942049}, {"source": 1405141770453, "target": 1477432947868}, {"source": 1405141770453, "target": 1477432955952}, {"source": 1405141770453, "target": 1477432963694}, {"source": 1405141770453, "target": 1477432971129}, {"source": 1405141770453, "target": 1477432981161}, {"source": 1405141770453, "target": 1477432989137}, {"source": 1405141770453, "target": 1477433000882}, {"source": 1405141770453, "target": 1477433005679}, {"source": 1405141770453, "target": 1477433010779}, {"source": 1405141770453, "target": 1477433015124}, {"source": 1405141770453, "target": 1477433020046}, {"source": 1405141770453, "target": 1477433027612}, {"source": 1405141770453, "target": 1477433031722}, {"source": 1405141770453, "target": 1477433060866}, {"source": 1405141770453, "target": 1477433075625}, {"source": 1405141770453, "target": 1477433079711}, {"source": 1405141770453, "target": 1477433089246}, {"source": 1405141770453, "target": 1477433097831}, {"source": 1405141770453, "target": 1477440510272}, {"source": 1405141770453, "target": 1477447015004}, {"source": 1405141770453, "target": 1477447024779}, {"source": 1405141770453, "target": 1477447031885}, {"source": 1405141770453, "target": 1477447053586}, {"source": 1405141770453, "target": 1477447065294}, {"source": 1405141770453, "target": 1477447074073}, {"source": 1405141770453, "target": 1477447082664}, {"source": 1405141770453, "target": 1477447100980}, {"source": 1405141770453, "target": 1477447111426}, {"source": 1405141770453, "target": 1477447115841}, {"source": 1405141770453, "target": 1477447120151}, {"source": 1405141770453, "target": 1477447131807}, {"source": 1405141770453, "target": 1477447140175}, {"source": 1405141770453, "target": 1477447145086}, {"source": 1405141770453, "target": 1477447155287}, {"source": 1405141770453, "target": 1477447161132}, {"source": 1405141770453, "target": 1477447170888}, {"source": 1405141770453, "target": 1477447177436}, {"source": 1405141770453, "target": 1477447188460}, {"source": 1405141770453, "target": 1477447196321}, {"source": 1405141770453, "target": 1477447205759}, {"source": 1405141770453, "target": 1477447210587}, {"source": 1405141770453, "target": 1477447224578}, {"source": 1405141770453, "target": 1477447228893}, {"source": 1405141770453, "target": 1477447235549}, {"source": 1405141770453, "target": 1477447248845}, {"source": 1405141770453, "target": 1477447256308}, {"source": 1405141770453, "target": 1477447260399}, {"source": 1405141770453, "target": 1477447267775}, {"source": 1405141770453, "target": 1477447276445}, {"source": 1405141770453, "target": 1477447288622}, {"source": 1405141770453, "target": 1477447295771}, {"source": 1405141770453, "target": 1477447306507}, {"source": 1405141770453, "target": 1477447313512}, {"source": 1405141770453, "target": 1477447319676}, {"source": 1405141770453, "target": 1477447324180}, {"source": 1405141770453, "target": 1477447327155}, {"source": 1405141770453, "target": 1477447329463}, {"source": 1405141770453, "target": 1477447331862}, {"source": 1405141770453, "target": 1477447337864}, {"source": 1405141770453, "target": 1478644623569}, {"source": 1405141770453, "target": 1478741474828}, {"source": 1405141770453, "target": 1478915661684}, {"source": 1405141770453, "target": 1479267261208}, {"source": 1405141770453, "target": 1479267263688}, {"source": 1405141770453, "target": 1479267268809}, {"source": 1405141770453, "target": 1479267275681}, {"source": 1405141770453, "target": 1479267324516}, {"source": 1405141770453, "target": 1479267329028}, {"source": 1405141770453, "target": 1479267335124}, {"source": 1405141770453, "target": 1479267337680}, {"source": 1405141770453, "target": 1479267340667}, {"source": 1405141770453, "target": 1479267358567}, {"source": 1405141770453, "target": 1479267395454}, {"source": 1405141770453, "target": 1479267461227}, {"source": 1405141770453, "target": 1479267463438}, {"source": 1405141770453, "target": 1479267465747}, {"source": 1405141770453, "target": 1479267524420}, {"source": 1405141770453, "target": 1480563883544}, {"source": 1405141770453, "target": 1480563962378}, {"source": 1405141770453, "target": 1480563965313}, {"source": 1405141770453, "target": 1480563969014}, {"source": 1405141770453, "target": 1480563971359}, {"source": 1405141770453, "target": 1480563978323}, {"source": 1405141770453, "target": 1480563995713}, {"source": 1405141770453, "target": 1480563998173}, {"source": 1405141770453, "target": 1480564003760}, {"source": 1405141770453, "target": 1480564118993}, {"source": 1405141770453, "target": 1480564133291}, {"source": 1405141770453, "target": 1480564138898}, {"source": 1405141770453, "target": 1480564145214}, {"source": 1405141770453, "target": 1480564150230}, {"source": 1405141770453, "target": 1480564153998}, {"source": 1405141770453, "target": 1480564160094}, {"source": 1405141770453, "target": 1480564165697}, {"source": 1405141770453, "target": 1480564168105}, {"source": 1405141770453, "target": 1480564170393}, {"source": 1405141770453, "target": 1480564172520}, {"source": 1405141770453, "target": 1480564174659}, {"source": 1405141770453, "target": 1480564182494}, {"source": 1405141770453, "target": 1480564186735}, {"source": 1405141770453, "target": 1480564193542}, {"source": 1405141770453, "target": 1480564195911}, {"source": 1405141770453, "target": 1480564207407}, {"source": 1405141770453, "target": 1480564210396}, {"source": 1405141770453, "target": 1480564217692}, {"source": 1405141770453, "target": 1480564222986}, {"source": 1405141770453, "target": 1480564228511}, {"source": 1405141770453, "target": 1480564230781}, {"source": 1405141770453, "target": 1480564236828}, {"source": 1405141770453, "target": 1480564239574}, {"source": 1405141770453, "target": 1480564244694}, {"source": 1405141770453, "target": 1480564250886}, {"source": 1405141770453, "target": 1480564261082}, {"source": 1405141770453, "target": 1480564270476}, {"source": 1405141770453, "target": 1480564273556}, {"source": 1405141770453, "target": 1480564275517}, {"source": 1405141770453, "target": 1480564277903}, {"source": 1405141770453, "target": 1480564283123}, {"source": 1405141770453, "target": 1480564288709}, {"source": 1405141770453, "target": 1480564291439}, {"source": 1405141770453, "target": 1480564293791}, {"source": 1405141770453, "target": 1480564302943}, {"source": 1405141770453, "target": 1480564318772}, {"source": 1405141770453, "target": 1480564325491}, {"source": 1405141770453, "target": 1480645785025}, {"source": 1405141770453, "target": 1480646882826}, {"source": 1405141770453, "target": 1480646887685}, {"source": 1405141770453, "target": 1480646912185}, {"source": 1405141770453, "target": 1480646945096}, {"source": 1405141770453, "target": 1480646959040}, {"source": 1405141770453, "target": 1480646962226}, {"source": 1405141770453, "target": 1480646964715}, {"source": 1405141770453, "target": 1480646969997}, {"source": 1405141770453, "target": 1480646976277}, {"source": 1405141770453, "target": 1480646978863}, {"source": 1405141770453, "target": 1480646982068}, {"source": 1405141770453, "target": 1480646984927}, {"source": 1405141770453, "target": 1480646987166}, {"source": 1405141770453, "target": 1480646989390}, {"source": 1405141770453, "target": 1480646994730}, {"source": 1405141770453, "target": 1480647002481}, {"source": 1405141770453, "target": 1480647005122}, {"source": 1405141770453, "target": 1480647007606}, {"source": 1405141770453, "target": 1480647009765}, {"source": 1405141770453, "target": 1480647012122}, {"source": 1405141770453, "target": 1480647018232}, {"source": 1405141770453, "target": 1480647021973}, {"source": 1405141770453, "target": 1480647024386}, {"source": 1405141770453, "target": 1480647026937}, {"source": 1405141770453, "target": 1480647032473}, {"source": 1405141770453, "target": 1480647044946}, {"source": 1405141770453, "target": 1480647048466}, {"source": 1405141770453, "target": 1480647054826}, {"source": 1405141770453, "target": 1480647061759}, {"source": 1405141770453, "target": 1480647079747}, {"source": 1405141770453, "target": 1480647082705}, {"source": 1405141770453, "target": 1480647110727}, {"source": 1405141770453, "target": 1480647113251}, {"source": 1405141770453, "target": 1480647115492}, {"source": 1405141770453, "target": 1481328893539}, {"source": 1405141770453, "target": 1481330544018}, {"source": 1405141770453, "target": 1481330549403}, {"source": 1405141770453, "target": 1481330631625}, {"source": 1405141770453, "target": 1481330642022}, {"source": 1405141770453, "target": 1481330666330}, {"source": 1405141770453, "target": 1481330673147}, {"source": 1405141770453, "target": 1481330725065}, {"source": 1405141770453, "target": 1481330729767}, {"source": 1405141770453, "target": 1481330733274}, {"source": 1405141770453, "target": 1481330742359}, {"source": 1405141770453, "target": 1481330745789}, {"source": 1405141770453, "target": 1481330754322}, {"source": 1405141770453, "target": 1481330763737}, {"source": 1405141770453, "target": 1481330777811}, {"source": 1405141770453, "target": 1481330821240}, {"source": 1405141770453, "target": 1481330825790}, {"source": 1405141770453, "target": 1481330830284}, {"source": 1405141770453, "target": 1481330836353}, {"source": 1405141770453, "target": 1481330858659}, {"source": 1405141770453, "target": 1481330867563}, {"source": 1405141770453, "target": 1481330876863}, {"source": 1405141770453, "target": 1481330882808}, {"source": 1405141770453, "target": 1481330888341}, {"source": 1405141770453, "target": 1481330892847}, {"source": 1405141770453, "target": 1481330900853}, {"source": 1405141770453, "target": 1481330908501}, {"source": 1405141770453, "target": 1481330918238}, {"source": 1405141770453, "target": 1481330923869}, {"source": 1405141770453, "target": 1481330931835}, {"source": 1405141770453, "target": 1481330936897}, {"source": 1405141770453, "target": 1481330945063}, {"source": 1405141770453, "target": 1481330955321}, {"source": 1405141770453, "target": 1481330964938}, {"source": 1405141770453, "target": 1481330970263}, {"source": 1405141770453, "target": 1481330979815}, {"source": 1405141770453, "target": 1481330987282}, {"source": 1405141770453, "target": 1481330995569}, {"source": 1405141770453, "target": 1481331004185}, {"source": 1405141770453, "target": 1481331011775}, {"source": 1405141770453, "target": 1481331037844}, {"source": 1405141770453, "target": 1481331042288}, {"source": 1405141770453, "target": 1481331070297}, {"source": 1405141770453, "target": 1481331073466}, {"source": 1405141770453, "target": 1481331078662}, {"source": 1405141770453, "target": 1481331081640}, {"source": 1405141770453, "target": 1481331108533}, {"source": 1405141770453, "target": 1481331118988}, {"source": 1405141770453, "target": 1481331123263}, {"source": 1405141770453, "target": 1481331128938}, {"source": 1405141770453, "target": 1481331132964}, {"source": 1405141770453, "target": 1481331137093}, {"source": 1405141770453, "target": 1481331141117}, {"source": 1405141770453, "target": 1481331145178}, {"source": 1405141770453, "target": 1481335274780}, {"source": 1405141770453, "target": 1481335285928}, {"source": 1405141770453, "target": 1481335297272}, {"source": 1405141770453, "target": 1481335309127}, {"source": 1405141770453, "target": 1481335315008}, {"source": 1405141770453, "target": 1481335322052}, {"source": 1405141770453, "target": 1481335336072}, {"source": 1405141770453, "target": 1481335391975}, {"source": 1405141770453, "target": 1481335403145}, {"source": 1405141770453, "target": 1481335444447}, {"source": 1405141770453, "target": 1481335448184}, {"source": 1405141770453, "target": 1481335461024}, {"source": 1405141770453, "target": 1481335465309}, {"source": 1405141770453, "target": 1481335477349}, {"source": 1405141770453, "target": 1481335494405}, {"source": 1405141770453, "target": 1481335499955}, {"source": 1405141770453, "target": 1481335508438}, {"source": 1405141770453, "target": 1481335519028}, {"source": 1405141770453, "target": 1481335522400}, {"source": 1405141770453, "target": 1481335525711}, {"source": 1405141770453, "target": 1481335529915}, {"source": 1405141770453, "target": 1481335541845}, {"source": 1405141770453, "target": 1481335552189}, {"source": 1405141770453, "target": 1481335558657}, {"source": 1405141770453, "target": 1481335568359}, {"source": 1405141770453, "target": 1481335576291}, {"source": 1405141770453, "target": 1481335589184}, {"source": 1405141770453, "target": 1481335618613}, {"source": 1405141770453, "target": 1481335625688}, {"source": 1405141770453, "target": 1481335636086}, {"source": 1405141770453, "target": 1481335641858}, {"source": 1405141770453, "target": 1481335649637}, {"source": 1405141770453, "target": 1481335671459}, {"source": 1405141770453, "target": 1481335674660}, {"source": 1405141770453, "target": 1481335677363}, {"source": 1405141770453, "target": 1481335711535}, {"source": 1405141770453, "target": 1481335718073}, {"source": 1405141770453, "target": 1481335728332}, {"source": 1405141770453, "target": 1481335745043}, {"source": 1405141770453, "target": 1481335759164}, {"source": 1405141770453, "target": 1481335777145}, {"source": 1405141770453, "target": 1481335785451}, {"source": 1405141770453, "target": 1481335790026}, {"source": 1405141770453, "target": 1481335796685}, {"source": 1405141770453, "target": 1481335799700}, {"source": 1405141770453, "target": 1481335802501}, {"source": 1405141770453, "target": 1481335824161}, {"source": 1405141770453, "target": 1481335826686}, {"source": 1405141770453, "target": 1481335833182}, {"source": 1405141770453, "target": 1481335848197}, {"source": 1405141770453, "target": 1481335857397}, {"source": 1405141770453, "target": 1481335874189}, {"source": 1405141770453, "target": 1481335878353}, {"source": 1405141770453, "target": 1481335881007}, {"source": 1405141770453, "target": 1481335888586}, {"source": 1405141770453, "target": 1481335896023}, {"source": 1405141770453, "target": 1481335899225}, {"source": 1405141770453, "target": 1481335901819}, {"source": 1405141770453, "target": 1481335904978}, {"source": 1405141770453, "target": 1481335919116}, {"source": 1405141770453, "target": 1481335921954}, {"source": 1405141770453, "target": 1481335924365}, {"source": 1405141770453, "target": 1481335930440}, {"source": 1405141770453, "target": 1481335936093}, {"source": 1405141770453, "target": 1481335943404}, {"source": 1405141770453, "target": 1481335953050}, {"source": 1405141770453, "target": 1481336059289}, {"source": 1405141770453, "target": 1481477106660}, {"source": 1405141770453, "target": 1482030352837}, {"source": 1405141770453, "target": 1482115195503}, {"source": 1405141770453, "target": 1482191425845}, {"source": 1405141770453, "target": 1482191438195}, {"source": 1405141770453, "target": 1482191440593}, {"source": 1405141770453, "target": 1482191442957}, {"source": 1405141770453, "target": 1482191446032}, {"source": 1405141770453, "target": 1482191452207}, {"source": 1405141770453, "target": 1482191454667}, {"source": 1405141770453, "target": 1482191457090}, {"source": 1405141770453, "target": 1482191460328}, {"source": 1405141770453, "target": 1482191462733}, {"source": 1405141770453, "target": 1482191464785}, {"source": 1405141770453, "target": 1482191475157}, {"source": 1405141770453, "target": 1482191477668}, {"source": 1405141770453, "target": 1482191484730}, {"source": 1405141770453, "target": 1482191486924}, {"source": 1405141770453, "target": 1482191495929}, {"source": 1405141770453, "target": 1482191498808}, {"source": 1405141770453, "target": 1482191504196}, {"source": 1405141770453, "target": 1482191506425}, {"source": 1405141770453, "target": 1482191508179}, {"source": 1405141770453, "target": 1482191509975}, {"source": 1405141770453, "target": 1482203680744}, {"source": 1405141770453, "target": 1482203684060}, {"source": 1405141770453, "target": 1482203686941}, {"source": 1405141770453, "target": 1482203693998}, {"source": 1405141770453, "target": 1482203696957}, {"source": 1405141770453, "target": 1482203703271}, {"source": 1405141770453, "target": 1482203712090}, {"source": 1405141770453, "target": 1482203718520}, {"source": 1405141770453, "target": 1482203721241}, {"source": 1405141770453, "target": 1482203723630}, {"source": 1405141770453, "target": 1482203725950}, {"source": 1405141770453, "target": 1482203728689}, {"source": 1405141770453, "target": 1482203731228}, {"source": 1405141770453, "target": 1482203737378}, {"source": 1405141770453, "target": 1482203740366}, {"source": 1405141770453, "target": 1482203748553}, {"source": 1405141770453, "target": 1482203751576}, {"source": 1405141770453, "target": 1482203756188}, {"source": 1405141770453, "target": 1482203764406}, {"source": 1405141770453, "target": 1482203769705}, {"source": 1405141770453, "target": 1482203772064}, {"source": 1405141770453, "target": 1482203779331}, {"source": 1405141770453, "target": 1482203787030}, {"source": 1405141770453, "target": 1482203793099}, {"source": 1405141770453, "target": 1482203795669}, {"source": 1405141770453, "target": 1482203801315}, {"source": 1405141770453, "target": 1482203808143}, {"source": 1405141770453, "target": 1482203810412}, {"source": 1405141770453, "target": 1482203812587}, {"source": 1405141770453, "target": 1482203821480}, {"source": 1405141770453, "target": 1482203823643}, {"source": 1405141770453, "target": 1482203830526}, {"source": 1405141770453, "target": 1482203833062}, {"source": 1405141770453, "target": 1482203843738}, {"source": 1405141770453, "target": 1482203845945}, {"source": 1405141770453, "target": 1482203852076}, {"source": 1405141770453, "target": 1482203855096}, {"source": 1405141770453, "target": 1482203859036}, {"source": 1405141770453, "target": 1482203866292}, {"source": 1405141770453, "target": 1482203868576}, {"source": 1405141770453, "target": 1482203956292}, {"source": 1405141770453, "target": 1482203977242}, {"source": 1405141770453, "target": 1482203979595}, {"source": 1405141770453, "target": 1482203981622}, {"source": 1405141770453, "target": 1482203983569}, {"source": 1405141770453, "target": 1482255441749}, {"source": 1405141770453, "target": 1482255679162}, {"source": 1405141770453, "target": 1482255682101}, {"source": 1405141770453, "target": 1482255686225}, {"source": 1405141770453, "target": 1482255688470}, {"source": 1405141770453, "target": 1482255690220}, {"source": 1405141770453, "target": 1482255696148}, {"source": 1405141770453, "target": 1482255701661}, {"source": 1405141770453, "target": 1482255704031}, {"source": 1405141770453, "target": 1482255713833}, {"source": 1405141770453, "target": 1482275713023}, {"source": 1405141770453, "target": 1482275724899}, {"source": 1405141770453, "target": 1482275730166}, {"source": 1405141770453, "target": 1482275734722}, {"source": 1405141770453, "target": 1482275738780}, {"source": 1405141770453, "target": 1482275742402}, {"source": 1405141770453, "target": 1482275748424}, {"source": 1405141770453, "target": 1482275755769}, {"source": 1405141770453, "target": 1482275763392}, {"source": 1405141770453, "target": 1482275770410}, {"source": 1405141770453, "target": 1482275773896}, {"source": 1405141770453, "target": 1482275776638}, {"source": 1405141770453, "target": 1482275780185}, {"source": 1405141770453, "target": 1482275786649}, {"source": 1405141770453, "target": 1482275789570}, {"source": 1405141770453, "target": 1482275792478}, {"source": 1405141770453, "target": 1482275800941}, {"source": 1405141770453, "target": 1482275848739}, {"source": 1405141770453, "target": 1482275855469}, {"source": 1405141770453, "target": 1482275866688}, {"source": 1405141770453, "target": 1482275879352}, {"source": 1405141770453, "target": 1482275885978}, {"source": 1405141770453, "target": 1482275889027}, {"source": 1405141770453, "target": 1482275895589}, {"source": 1405141770453, "target": 1482275928004}, {"source": 1405141770453, "target": 1482275937923}, {"source": 1405141770453, "target": 1482275947242}, {"source": 1405141770453, "target": 1482275950328}, {"source": 1405141770453, "target": 1482275966286}, {"source": 1405141770453, "target": 1482275969327}, {"source": 1405141770453, "target": 1482275980698}, {"source": 1405141770453, "target": 1482275983368}, {"source": 1405141770453, "target": 1482275986228}, {"source": 1405141770453, "target": 1482275993431}, {"source": 1405141770453, "target": 1482275998890}, {"source": 1405141770453, "target": 1482276003791}, {"source": 1405141770453, "target": 1482276009311}, {"source": 1405141770453, "target": 1482276012228}, {"source": 1405141770453, "target": 1482276015731}, {"source": 1405141770453, "target": 1482276022637}, {"source": 1405141770453, "target": 1482276026606}, {"source": 1405141770453, "target": 1482276029805}, {"source": 1405141770453, "target": 1482276032069}, {"source": 1405141770453, "target": 1482276034749}, {"source": 1405141770453, "target": 1482276036848}, {"source": 1405141770453, "target": 1482276044316}, {"source": 1405141770453, "target": 1482276059851}, {"source": 1405141770453, "target": 1482276062753}, {"source": 1405141770453, "target": 1482276069472}, {"source": 1405141770453, "target": 1482276071848}, {"source": 1405141770453, "target": 1482276076924}, {"source": 1405141770453, "target": 1482276113524}, {"source": 1405141770453, "target": 1482276121561}, {"source": 1405141770453, "target": 1482276124111}, {"source": 1405141770453, "target": 1482276126544}, {"source": 1405141770453, "target": 1482276131945}, {"source": 1405141770453, "target": 1482276134378}, {"source": 1405141770453, "target": 1482276145668}, {"source": 1405141770453, "target": 1482276148696}, {"source": 1405141770453, "target": 1482276151528}, {"source": 1405141770453, "target": 1482276167916}, {"source": 1405141770453, "target": 1482276174562}, {"source": 1405141770453, "target": 1482276177874}, {"source": 1405141770453, "target": 1482276182309}, {"source": 1405141770453, "target": 1482276186550}, {"source": 1405141770453, "target": 1482276188994}, {"source": 1405141770453, "target": 1482276190926}, {"source": 1405141770453, "target": 1482276192890}, {"source": 1405141770453, "target": 1482276194946}, {"source": 1405141770453, "target": 1482276209786}, {"source": 1405141770453, "target": 1482276212675}, {"source": 1405141770453, "target": 1482276216481}, {"source": 1405141770453, "target": 1482276224000}, {"source": 1405141770453, "target": 1482276226091}, {"source": 1405141770453, "target": 1482289491610}, {"source": 1405141770453, "target": 1482289494494}, {"source": 1405141770453, "target": 1482289502594}, {"source": 1405141770453, "target": 1482289505425}, {"source": 1405141770453, "target": 1482289510964}, {"source": 1405141770453, "target": 1482289515105}, {"source": 1405141770453, "target": 1482289518360}, {"source": 1405141770453, "target": 1482289520748}, {"source": 1405141770453, "target": 1482289524478}, {"source": 1405141770453, "target": 1482289539018}, {"source": 1405141770453, "target": 1482289546088}, {"source": 1405141770453, "target": 1482289549128}, {"source": 1405141770453, "target": 1482289554846}, {"source": 1405141770453, "target": 1482289557764}, {"source": 1405141770453, "target": 1482289560054}, {"source": 1405141770453, "target": 1482289564582}, {"source": 1405141770453, "target": 1482289568991}, {"source": 1405141770453, "target": 1482289579274}, {"source": 1405141770453, "target": 1482289593587}, {"source": 1405141770453, "target": 1482289603147}, {"source": 1405141770453, "target": 1482289610928}, {"source": 1405141770453, "target": 1482289615950}, {"source": 1405141770453, "target": 1482289623508}, {"source": 1405141770453, "target": 1482289625777}, {"source": 1405141770453, "target": 1482289634672}, {"source": 1405141770453, "target": 1482289637050}, {"source": 1405141770453, "target": 1482289647560}, {"source": 1405141770453, "target": 1482289650424}, {"source": 1405141770453, "target": 1482289652565}, {"source": 1405141770453, "target": 1482289654584}, {"source": 1405141770453, "target": 1482289659677}, {"source": 1405141770453, "target": 1482289661873}, {"source": 1405141770453, "target": 1482289667898}, {"source": 1405141770453, "target": 1482289670432}, {"source": 1405141770453, "target": 1482289672114}, {"source": 1405141770453, "target": 1482342409102}, {"source": 1405141770453, "target": 1482342465607}, {"source": 1405141770453, "target": 1482342792702}, {"source": 1405141770453, "target": 1482343170021}, {"source": 1405141770453, "target": 1482343779218}, {"source": 1405141770453, "target": 1482355178454}, {"source": 1405141770453, "target": 1482359254980}, {"source": 1405141770453, "target": 1482359266484}, {"source": 1405141770453, "target": 1482359303783}, {"source": 1405141770453, "target": 1482359312751}, {"source": 1405141770453, "target": 1482359318969}, {"source": 1405141770453, "target": 1482359326233}, {"source": 1405141770453, "target": 1482359329829}, {"source": 1405141770453, "target": 1482359348837}, {"source": 1405141770453, "target": 1482359355658}, {"source": 1405141770453, "target": 1482359358577}, {"source": 1405141770453, "target": 1482359361688}, {"source": 1405141770453, "target": 1482359364200}, {"source": 1405141770453, "target": 1482359382839}, {"source": 1405141770453, "target": 1482359386135}, {"source": 1405141770453, "target": 1482359389310}, {"source": 1405141770453, "target": 1482359407331}, {"source": 1405141770453, "target": 1482359431570}, {"source": 1405141770453, "target": 1482359449381}, {"source": 1405141770453, "target": 1482359464147}, {"source": 1405141770453, "target": 1482359472741}, {"source": 1405141770453, "target": 1482359478387}, {"source": 1405141770453, "target": 1482359486208}, {"source": 1405141770453, "target": 1482359500680}, {"source": 1405141770453, "target": 1482359512506}, {"source": 1405141770453, "target": 1482359538706}, {"source": 1405141770453, "target": 1482359541727}, {"source": 1405141770453, "target": 1482359544432}, {"source": 1405141770453, "target": 1482359552377}, {"source": 1405141770453, "target": 1482359555074}, {"source": 1405141770453, "target": 1482359564811}, {"source": 1405141770453, "target": 1482359572977}, {"source": 1405141770453, "target": 1482359576029}, {"source": 1405141770453, "target": 1482359578671}, {"source": 1405141770453, "target": 1482359589330}, {"source": 1405141770453, "target": 1482359593949}, {"source": 1405141770453, "target": 1482359601319}, {"source": 1405141770453, "target": 1482359607083}, {"source": 1405141770453, "target": 1482359609528}, {"source": 1405141770453, "target": 1482359618134}, {"source": 1405141770453, "target": 1482359621598}, {"source": 1405141770453, "target": 1482359631696}, {"source": 1405141770453, "target": 1482359635387}, {"source": 1405141770453, "target": 1482359642469}, {"source": 1405141770453, "target": 1482359650137}, {"source": 1405141770453, "target": 1482359656396}, {"source": 1405141770453, "target": 1482359666657}, {"source": 1405141770453, "target": 1482359668798}, {"source": 1405141770453, "target": 1482359671335}, {"source": 1405141770453, "target": 1482361493392}, {"source": 1405141770453, "target": 1482361852062}, {"source": 1405141770453, "target": 1482361855147}, {"source": 1405141770453, "target": 1482361859692}, {"source": 1405141770453, "target": 1482361866370}, {"source": 1405141770453, "target": 1482361886695}, {"source": 1405141770453, "target": 1482369554930}, {"source": 1405141770453, "target": 1482374179075}, {"source": 1405141770453, "target": 1482374185613}, {"source": 1405141770453, "target": 1482374188222}, {"source": 1405141770453, "target": 1482374191830}, {"source": 1405141770453, "target": 1482374194811}, {"source": 1405141770453, "target": 1482374199572}, {"source": 1405141770453, "target": 1482374205403}, {"source": 1405141770453, "target": 1482374207721}, {"source": 1405141770453, "target": 1482374210189}, {"source": 1405141770453, "target": 1482374212224}, {"source": 1405141770453, "target": 1482374214379}, {"source": 1405141770453, "target": 1482374216336}, {"source": 1405141770453, "target": 1482374223031}, {"source": 1405141770453, "target": 1482374229026}, {"source": 1405141770453, "target": 1482374233392}, {"source": 1405141770453, "target": 1482374237153}, {"source": 1405141770453, "target": 1482374240195}, {"source": 1405141770453, "target": 1482374241957}, {"source": 1405141770453, "target": 1482374247553}, {"source": 1405141770453, "target": 1482374264661}, {"source": 1405141770453, "target": 1482374270272}, {"source": 1405141770453, "target": 1482374274606}, {"source": 1405141770453, "target": 1482374278670}, {"source": 1405141770453, "target": 1482374290962}, {"source": 1405141770453, "target": 1482374300933}, {"source": 1405141770453, "target": 1482374303437}, {"source": 1405141770453, "target": 1482374309968}, {"source": 1405141770453, "target": 1482374312007}, {"source": 1405141770453, "target": 1482374315198}, {"source": 1405141770453, "target": 1482374319570}, {"source": 1405141770453, "target": 1482374325812}, {"source": 1405141770453, "target": 1482374327719}, {"source": 1405141770453, "target": 1482374332046}, {"source": 1405141770453, "target": 1482374334033}, {"source": 1405141770453, "target": 1482374336057}, {"source": 1405141770453, "target": 1482374337911}, {"source": 1405141770453, "target": 1482374341463}, {"source": 1405141770453, "target": 1482374343955}, {"source": 1405141770453, "target": 1482374345667}, {"source": 1405141770453, "target": 1482374347418}, {"source": 1405141770453, "target": 1482374349436}, {"source": 1405141770453, "target": 1482878964408}, {"source": 1405141770453, "target": 1482886562931}, {"source": 1405141770453, "target": 1482886567135}, {"source": 1405141770453, "target": 1482886572434}, {"source": 1405141770453, "target": 1482886579365}, {"source": 1405141770453, "target": 1482886582123}, {"source": 1405141770453, "target": 1482886587921}, {"source": 1405141770453, "target": 1482886599402}, {"source": 1405141770453, "target": 1482886603327}, {"source": 1405141770453, "target": 1482886606125}, {"source": 1405141770453, "target": 1482886616052}, {"source": 1405141770453, "target": 1482886621730}, {"source": 1405141770453, "target": 1482886631055}, {"source": 1405141770453, "target": 1482886634613}, {"source": 1405141770453, "target": 1482886637639}, {"source": 1405141770453, "target": 1482886640351}, {"source": 1405141770453, "target": 1482886642816}, {"source": 1405141770453, "target": 1482886645144}, {"source": 1405141770453, "target": 1482886650853}, {"source": 1405141770453, "target": 1482886656445}, {"source": 1405141770453, "target": 1482886658640}, {"source": 1405141770453, "target": 1482886661006}, {"source": 1405141770453, "target": 1482886663862}, {"source": 1405141770453, "target": 1482886666544}, {"source": 1405141770453, "target": 1482886670766}, {"source": 1405141770453, "target": 1482886682972}, {"source": 1405141770453, "target": 1482886689929}, {"source": 1405141770453, "target": 1482886692839}, {"source": 1405141770453, "target": 1482886696163}, {"source": 1405141770453, "target": 1482886699064}, {"source": 1405141770453, "target": 1482886706398}, {"source": 1405141770453, "target": 1482886711096}, {"source": 1405141770453, "target": 1482886714520}, {"source": 1405141770453, "target": 1482886717185}, {"source": 1405141770453, "target": 1482886719758}, {"source": 1405141770453, "target": 1482886726114}, {"source": 1405141770453, "target": 1482886730980}, {"source": 1405141770453, "target": 1482886738291}, {"source": 1405141770453, "target": 1482886740929}, {"source": 1405141770453, "target": 1482886747788}, {"source": 1405141770453, "target": 1482886766452}, {"source": 1405141770453, "target": 1482886768778}, {"source": 1405141770453, "target": 1482886771508}, {"source": 1405141770453, "target": 1482886774073}, {"source": 1405141770453, "target": 1482886776621}, {"source": 1405141770453, "target": 1482886779367}, {"source": 1405141770453, "target": 1482886781952}, {"source": 1405141770453, "target": 1482886790385}, {"source": 1405141770453, "target": 1482886798598}, {"source": 1405141770453, "target": 1482886802591}, {"source": 1405141770453, "target": 1482886805436}, {"source": 1405141770453, "target": 1482886811614}, {"source": 1405141770453, "target": 1482886819280}, {"source": 1405141770453, "target": 1482886825934}, {"source": 1405141770453, "target": 1482886835161}, {"source": 1405141770453, "target": 1482886841409}, {"source": 1405141770453, "target": 1482886851249}, {"source": 1405141770453, "target": 1482886858693}, {"source": 1405141770453, "target": 1482886861200}, {"source": 1405141770453, "target": 1482886867250}, {"source": 1405141770453, "target": 1482886874458}, {"source": 1405141770453, "target": 1482886876931}, {"source": 1405141770453, "target": 1482886879171}, {"source": 1405141770453, "target": 1482886882093}, {"source": 1405141770453, "target": 1482886888524}, {"source": 1405141770453, "target": 1482886892911}, {"source": 1405141770453, "target": 1482886895750}, {"source": 1405141770453, "target": 1482886898188}, {"source": 1405141770453, "target": 1482886900348}, {"source": 1405141770453, "target": 1482886906383}, {"source": 1405141770453, "target": 1482886913645}, {"source": 1405141770453, "target": 1482886915797}, {"source": 1405141770453, "target": 1482886917754}, {"source": 1405141770453, "target": 1482886920226}, {"source": 1405141770453, "target": 1482886922545}, {"source": 1405141770453, "target": 1482886924531}, {"source": 1405141770453, "target": 1482886927273}, {"source": 1405141770453, "target": 1482886932317}, {"source": 1405141770453, "target": 1482959670270}, {"source": 1405141770453, "target": 1482959678760}, {"source": 1405141770453, "target": 1482959684979}, {"source": 1405141770453, "target": 1482959688086}, {"source": 1405141770453, "target": 1482959695838}, {"source": 1405141770453, "target": 1482959698585}, {"source": 1405141770453, "target": 1482959701217}, {"source": 1405141770453, "target": 1482959705416}, {"source": 1405141770453, "target": 1482959710127}, {"source": 1405141770453, "target": 1482959713090}, {"source": 1405141770453, "target": 1482959736746}, {"source": 1405141770453, "target": 1482959764813}, {"source": 1405141770453, "target": 1482959775157}, {"source": 1405141770453, "target": 1482959777469}, {"source": 1405141770453, "target": 1482959816004}, {"source": 1405141770453, "target": 1482959837664}, {"source": 1405141770453, "target": 1482959842224}, {"source": 1405141770453, "target": 1482959849039}, {"source": 1405141770453, "target": 1482959859744}, {"source": 1405141770453, "target": 1482959865798}, {"source": 1405141770453, "target": 1482959868268}, {"source": 1405141770453, "target": 1482959873096}, {"source": 1405141770453, "target": 1482959885274}, {"source": 1405141770453, "target": 1482959890209}, {"source": 1405141770453, "target": 1482971281074}, {"source": 1405141770453, "target": 1482971291518}, {"source": 1405141770453, "target": 1482971294770}, {"source": 1405141770453, "target": 1482971299269}, {"source": 1405141770453, "target": 1482971305143}, {"source": 1405141770453, "target": 1482971311075}, {"source": 1405141770453, "target": 1482971320837}, {"source": 1405141770453, "target": 1482971324970}, {"source": 1405141770453, "target": 1482971327560}, {"source": 1405141770453, "target": 1482971330625}, {"source": 1405141770453, "target": 1482971339275}, {"source": 1405141770453, "target": 1482971345397}, {"source": 1405141770453, "target": 1482971357054}, {"source": 1405141770453, "target": 1482971374440}, {"source": 1405141770453, "target": 1482971413468}, {"source": 1405141770453, "target": 1482971425744}, {"source": 1405141770453, "target": 1482971428188}, {"source": 1405141770453, "target": 1482971431015}, {"source": 1405141770453, "target": 1482971433304}, {"source": 1405141770453, "target": 1482971435786}, {"source": 1405141770453, "target": 1482971438364}, {"source": 1405141770453, "target": 1482971441031}, {"source": 1405141770453, "target": 1482971466635}, {"source": 1405141770453, "target": 1482971514575}, {"source": 1405141770453, "target": 1482971533067}, {"source": 1405141770453, "target": 1482971536512}, {"source": 1405141770453, "target": 1482971548645}, {"source": 1405141770453, "target": 1482971561533}, {"source": 1405141770453, "target": 1482971569395}, {"source": 1405141770453, "target": 1482971572502}, {"source": 1405141770453, "target": 1482971578611}, {"source": 1405141770453, "target": 1482971585507}, {"source": 1405141770453, "target": 1482971593747}, {"source": 1405141770453, "target": 1482971596285}, {"source": 1405141770453, "target": 1482971607268}, {"source": 1405141770453, "target": 1482976984253}, {"source": 1405141770453, "target": 1482978349044}, {"source": 1405141770453, "target": 1482978351848}, {"source": 1405141770453, "target": 1482978360365}, {"source": 1405141770453, "target": 1482978396966}, {"source": 1405141770453, "target": 1482978405717}, {"source": 1405141770453, "target": 1482978433575}, {"source": 1405141770453, "target": 1482978465432}, {"source": 1405141770453, "target": 1482978479026}, {"source": 1405141770453, "target": 1482978481610}, {"source": 1405141770453, "target": 1482978486307}, {"source": 1405141770453, "target": 1482978489497}, {"source": 1405141770453, "target": 1482978492202}, {"source": 1405141770453, "target": 1482978497438}, {"source": 1405141770453, "target": 1482978507215}, {"source": 1405141770453, "target": 1482978510390}, {"source": 1405141770453, "target": 1482978530310}, {"source": 1405141770453, "target": 1482978542274}, {"source": 1405141770453, "target": 1482978566629}, {"source": 1405141770453, "target": 1482978569217}, {"source": 1405141770453, "target": 1482978576781}, {"source": 1405141770453, "target": 1482978588423}, {"source": 1405141770453, "target": 1482978622860}, {"source": 1405141770453, "target": 1482978625107}, {"source": 1405141770453, "target": 1482978629409}, {"source": 1405141770453, "target": 1482978658105}, {"source": 1405141770453, "target": 1482978661462}, {"source": 1405141770453, "target": 1482978704303}, {"source": 1405141770453, "target": 1482978710341}, {"source": 1405141770453, "target": 1482978770329}, {"source": 1405141770453, "target": 1482978790539}, {"source": 1405141770453, "target": 1482978793159}, {"source": 1405141770453, "target": 1482978795501}, {"source": 1405141770453, "target": 1482978797522}, {"source": 1405141770453, "target": 1482978799790}, {"source": 1405141770453, "target": 1482978801797}, {"source": 1405141770453, "target": 1482978803774}, {"source": 1405141770453, "target": 1482978805608}, {"source": 1405141770453, "target": 1482978807812}, {"source": 1405141770453, "target": 1482978812166}, {"source": 1405141770453, "target": 1482978820391}, {"source": 1405141770453, "target": 1482978823034}, {"source": 1405141770453, "target": 1482978825065}, {"source": 1405141770453, "target": 1483825140079}, {"source": 1405141770453, "target": 1483825263574}, {"source": 1405141770453, "target": 1483825588255}, {"source": 1405141770453, "target": 1483826505573}, {"source": 1405141770453, "target": 1484768634230}, {"source": 1405141770453, "target": 1484778037232}, {"source": 1405141770453, "target": 1484778142057}, {"source": 1405141770453, "target": 1484778257280}, {"source": 1405141770453, "target": 1484879626510}, {"source": 1405141770453, "target": 1484879756877}, {"source": 1405141770453, "target": 1484879771973}, {"source": 1405141770453, "target": 1484879804223}, {"source": 1405141770453, "target": 1484950307243}, {"source": 1405141770453, "target": 1484950312081}, {"source": 1405141770453, "target": 1484950340052}, {"source": 1405141770453, "target": 1484950422509}, {"source": 1405141770453, "target": 1484950599425}, {"source": 1405141770453, "target": 1485036804882}, {"source": 1405141770453, "target": 1485037133108}, {"source": 1405141770453, "target": 1485037139844}, {"source": 1405141770453, "target": 1485037144597}, {"source": 1405141770453, "target": 1485037149846}, {"source": 1405141770453, "target": 1485037154999}, {"source": 1405141770453, "target": 1485037267655}, {"source": 1405141770453, "target": 1485037272604}, {"source": 1405141770453, "target": 1485037275907}, {"source": 1405141770453, "target": 1485037278052}, {"source": 1405141770453, "target": 1485037306763}, {"source": 1405141770453, "target": 1485042171728}, {"source": 1405141770453, "target": 1485042550553}, {"source": 1405141770453, "target": 1485042556613}, {"source": 1405141770453, "target": 1485042663916}, {"source": 1405141770453, "target": 1485047130408}, {"source": 1405141770453, "target": 1485048768062}, {"source": 1405141770453, "target": 1485048774787}, {"source": 1405141770453, "target": 1485048790993}, {"source": 1405141770453, "target": 1485048847611}, {"source": 1405141770453, "target": 1485048861175}, {"source": 1405141770453, "target": 1485048869407}, {"source": 1405141770453, "target": 1485048874704}, {"source": 1405141770453, "target": 1485053499537}, {"source": 1405141770453, "target": 1485053657195}, {"source": 1405141770453, "target": 1485053661725}, {"source": 1405141770453, "target": 1485053679920}, {"source": 1405141770453, "target": 1485053727919}, {"source": 1405141770453, "target": 1485053779530}, {"source": 1405141770453, "target": 1485053794810}, {"source": 1405141770453, "target": 1485126756268}, {"source": 1405141770453, "target": 1485126807025}, {"source": 1405141770453, "target": 1485126995875}, {"source": 1405141770453, "target": 1485127038618}, {"source": 1405141770453, "target": 1485127168406}, {"source": 1405141770453, "target": 1485127267582}, {"source": 1405141770453, "target": 1485127300673}, {"source": 1405141770453, "target": 1485127371710}, {"source": 1405141770453, "target": 1485127376385}, {"source": 1405141770453, "target": 1485127384075}, {"source": 1405141770453, "target": 1485127393577}, {"source": 1405141770453, "target": 1485127433105}, {"source": 1405141770453, "target": 1485127512595}, {"source": 1405141770453, "target": 1485127633487}, {"source": 1405141770453, "target": 1485195927119}, {"source": 1405141770453, "target": 1485197156148}, {"source": 1405141770453, "target": 1485197319661}, {"source": 1405141770453, "target": 1485197324724}, {"source": 1405141770453, "target": 1485197328694}, {"source": 1405141770453, "target": 1485197342483}, {"source": 1405141770453, "target": 1485197356773}, {"source": 1405141770453, "target": 1485197367877}, {"source": 1405141770453, "target": 1485197383550}, {"source": 1405141770453, "target": 1485197420808}, {"source": 1405141770453, "target": 1485216299549}, {"source": 1405141770453, "target": 1485218502063}, {"source": 1405141770453, "target": 1485219964898}, {"source": 1405141770453, "target": 1485219972311}, {"source": 1405141770453, "target": 1485220063037}, {"source": 1405141770453, "target": 1485220069870}, {"source": 1405141770453, "target": 1485220074250}, {"source": 1405141770453, "target": 1485220091213}, {"source": 1405141770453, "target": 1485227020903}, {"source": 1405141770453, "target": 1485227034713}, {"source": 1405141770453, "target": 1485227039136}, {"source": 1405141770453, "target": 1485373632124}, {"source": 1405141770453, "target": 1485382064127}, {"source": 1405141770453, "target": 1485382069799}, {"source": 1405141770453, "target": 1485382077657}, {"source": 1405141770453, "target": 1485382082442}, {"source": 1405141770453, "target": 1485382087191}, {"source": 1405141770453, "target": 1485382112355}, {"source": 1405141770453, "target": 1485382151977}, {"source": 1405141770453, "target": 1485382157192}, {"source": 1405141770453, "target": 1485382166758}, {"source": 1405141770453, "target": 1485382170346}, {"source": 1405141770453, "target": 1485382175324}, {"source": 1405141770453, "target": 1485382179934}, {"source": 1405141770453, "target": 1485382187439}, {"source": 1405141770453, "target": 1485382192161}, {"source": 1405141770453, "target": 1485382199836}, {"source": 1405141770453, "target": 1485382205594}, {"source": 1405141770453, "target": 1485382210373}, {"source": 1405141770453, "target": 1485382213384}, {"source": 1405141770453, "target": 1485382218297}, {"source": 1405141770453, "target": 1485382222368}, {"source": 1405141770453, "target": 1485382227392}, {"source": 1405141770453, "target": 1485382232847}, {"source": 1405141770453, "target": 1485382239959}, {"source": 1405141770453, "target": 1485382248027}, {"source": 1405141770453, "target": 1485382251441}, {"source": 1405141770453, "target": 1485382278118}, {"source": 1405141770453, "target": 1485382282570}, {"source": 1405141770453, "target": 1485382286527}, {"source": 1405141770453, "target": 1485382321484}, {"source": 1405141770453, "target": 1485382329569}, {"source": 1405141770453, "target": 1485382335147}, {"source": 1405141770453, "target": 1485382339718}, {"source": 1405141770453, "target": 1485382351047}, {"source": 1405141770453, "target": 1485382362549}, {"source": 1405141770453, "target": 1485382365415}, {"source": 1405141770453, "target": 1485382369795}, {"source": 1405141770453, "target": 1485382373819}, {"source": 1405141770453, "target": 1485382377464}, {"source": 1405141770453, "target": 1485389816164}, {"source": 1405141770453, "target": 1485389832478}, {"source": 1405141770453, "target": 1486519322563}, {"source": 1405141770453, "target": 1486522380118}, {"source": 1405141770453, "target": 1486522390591}, {"source": 1405141770453, "target": 1486522395177}, {"source": 1405141770453, "target": 1486522403872}, {"source": 1405141770453, "target": 1486522418951}, {"source": 1405141770453, "target": 1486522422740}, {"source": 1405141770453, "target": 1486522426162}, {"source": 1405141770453, "target": 1486522430052}, {"source": 1405141770453, "target": 1486522451470}, {"source": 1405141770453, "target": 1486522459317}, {"source": 1405141770453, "target": 1486522466249}, {"source": 1405141770453, "target": 1486522470445}, {"source": 1405141770453, "target": 1486522473729}, {"source": 1405141770453, "target": 1486522477137}, {"source": 1405141770453, "target": 1486522482841}, {"source": 1405141770453, "target": 1486522486856}, {"source": 1405141770453, "target": 1486522491958}, {"source": 1405141770453, "target": 1486522498103}, {"source": 1405141770453, "target": 1486522501087}, {"source": 1405141770453, "target": 1486522504599}, {"source": 1405141770453, "target": 1486522508003}, {"source": 1405141770453, "target": 1486522515284}, {"source": 1405141770453, "target": 1486522521355}, {"source": 1405141770453, "target": 1486522525618}, {"source": 1405141770453, "target": 1486522528709}, {"source": 1405141770453, "target": 1486522534230}, {"source": 1405141770453, "target": 1486522543509}, {"source": 1405141770453, "target": 1486522549639}, {"source": 1405141770453, "target": 1486522556268}, {"source": 1405141770453, "target": 1486522563815}, {"source": 1405141770453, "target": 1486522566796}, {"source": 1405141770453, "target": 1486522573745}, {"source": 1405141770453, "target": 1486522580002}, {"source": 1405141770453, "target": 1486522586117}, {"source": 1405141770453, "target": 1486522593205}, {"source": 1405141770453, "target": 1486522596363}, {"source": 1405141770453, "target": 1486522599412}, {"source": 1405141770453, "target": 1486522611061}, {"source": 1405141770453, "target": 1486522618128}, {"source": 1405141770453, "target": 1486522630094}, {"source": 1405141770453, "target": 1486522637384}, {"source": 1405141770453, "target": 1486522654540}, {"source": 1405141770453, "target": 1486522662626}, {"source": 1405141770453, "target": 1486522667060}, {"source": 1405141770453, "target": 1486522670366}, {"source": 1405141770453, "target": 1486522673379}, {"source": 1405141770453, "target": 1486522676151}, {"source": 1405141770453, "target": 1486522681611}, {"source": 1405141770453, "target": 1486522684741}, {"source": 1405141770453, "target": 1486522690115}, {"source": 1405141770453, "target": 1486522693430}, {"source": 1405141770453, "target": 1486522695665}, {"source": 1405141770453, "target": 1486522702734}, {"source": 1405141770453, "target": 1486522729229}, {"source": 1405141770453, "target": 1486522744760}, {"source": 1405141770453, "target": 1486522750998}, {"source": 1405141770453, "target": 1486522758122}, {"source": 1405141770453, "target": 1486522762686}, {"source": 1405141770453, "target": 1486522767302}, {"source": 1405141770453, "target": 1486522771132}, {"source": 1405141770453, "target": 1486522786197}, {"source": 1405141770453, "target": 1486522799728}, {"source": 1405141770453, "target": 1486522804267}, {"source": 1405141770453, "target": 1486522813431}, {"source": 1405141770453, "target": 1486522818318}, {"source": 1405141770453, "target": 1486522822101}, {"source": 1405141770453, "target": 1486522825676}, {"source": 1405141770453, "target": 1486522828840}, {"source": 1405141770453, "target": 1486522836510}, {"source": 1405141770453, "target": 1486522847427}, {"source": 1405141770453, "target": 1486589932110}, {"source": 1405141770453, "target": 1486590791883}, {"source": 1405141770453, "target": 1486590795841}, {"source": 1405141770453, "target": 1486590798588}, {"source": 1405141770453, "target": 1486590801692}, {"source": 1405141770453, "target": 1486590804231}, {"source": 1405141770453, "target": 1486590807272}, {"source": 1405141770453, "target": 1486590815608}, {"source": 1405141770453, "target": 1486590827098}, {"source": 1405141770453, "target": 1486590830745}, {"source": 1405141770453, "target": 1486590838863}, {"source": 1405141770453, "target": 1486590846162}, {"source": 1405141770453, "target": 1486590946128}, {"source": 1405141770453, "target": 1486590949959}, {"source": 1405141770453, "target": 1486590953002}, {"source": 1405141770453, "target": 1486590955789}, {"source": 1405141770453, "target": 1486590958876}, {"source": 1405141770453, "target": 1486590962252}, {"source": 1405141770453, "target": 1486590965296}, {"source": 1405141770453, "target": 1486590968007}, {"source": 1405141770453, "target": 1486590976651}, {"source": 1405141770453, "target": 1486590985316}, {"source": 1405141770453, "target": 1486590994020}, {"source": 1405141770453, "target": 1486590997246}, {"source": 1405141770453, "target": 1486591001987}, {"source": 1405141770453, "target": 1486591020624}, {"source": 1405141770453, "target": 1486591023980}, {"source": 1405141770453, "target": 1486591026992}, {"source": 1405141770453, "target": 1486591033652}, {"source": 1405141770453, "target": 1486591040947}, {"source": 1405141770453, "target": 1486591044900}, {"source": 1405141770453, "target": 1486591055752}, {"source": 1405141770453, "target": 1486591059081}, {"source": 1405141770453, "target": 1486591065991}, {"source": 1405141770453, "target": 1486591074378}, {"source": 1405141770453, "target": 1486591077740}, {"source": 1405141770453, "target": 1486591083934}, {"source": 1405141770453, "target": 1486591086855}, {"source": 1405141770453, "target": 1486591093197}, {"source": 1405141770453, "target": 1486591099796}, {"source": 1405141770453, "target": 1486591119547}, {"source": 1405141770453, "target": 1486591132401}, {"source": 1405141770453, "target": 1486591144511}, {"source": 1405141770453, "target": 1486591147885}, {"source": 1405141770453, "target": 1486591150476}, {"source": 1405141770453, "target": 1486591153191}, {"source": 1405141770453, "target": 1486591157840}, {"source": 1405141770453, "target": 1486591167720}, {"source": 1405141770453, "target": 1486591173784}, {"source": 1405141770453, "target": 1486591176052}, {"source": 1405141770453, "target": 1486591222024}, {"source": 1405141770453, "target": 1486591227249}, {"source": 1405141770453, "target": 1486591239941}, {"source": 1405141770453, "target": 1486591245629}, {"source": 1405141770453, "target": 1486591248468}, {"source": 1405141770453, "target": 1486591251230}, {"source": 1405141770453, "target": 1486591253645}, {"source": 1405141770453, "target": 1486591255795}, {"source": 1405141770453, "target": 1486591262323}, {"source": 1405141770453, "target": 1486591265100}, {"source": 1405141770453, "target": 1486591267339}, {"source": 1405141770453, "target": 1486591272185}, {"source": 1405141770453, "target": 1486591276598}, {"source": 1405141770453, "target": 1486591284504}, {"source": 1405141770453, "target": 1486591287399}, {"source": 1405141770453, "target": 1486591295606}, {"source": 1405141770453, "target": 1486591298584}, {"source": 1405141770453, "target": 1486591301294}, {"source": 1405141770453, "target": 1486591304104}, {"source": 1405141770453, "target": 1486591314813}, {"source": 1405141770453, "target": 1486591317696}, {"source": 1405141770453, "target": 1486591320386}, {"source": 1405141770453, "target": 1486591326494}, {"source": 1405141770453, "target": 1486591329503}, {"source": 1405141770453, "target": 1486591331907}, {"source": 1405141770453, "target": 1486591357720}, {"source": 1405141770453, "target": 1486591369680}, {"source": 1405141770453, "target": 1486591372327}, {"source": 1405141770453, "target": 1486591374938}, {"source": 1405141770453, "target": 1486591387909}, {"source": 1405141770453, "target": 1486591392171}, {"source": 1405141770453, "target": 1486591396296}, {"source": 1405141770453, "target": 1486591400578}, {"source": 1405141770453, "target": 1486770898373}, {"source": 1405141770453, "target": 1486771318902}, {"source": 1405141770453, "target": 1486771339520}, {"source": 1405141770453, "target": 1486771369403}, {"source": 1405141770453, "target": 1486776332176}, {"source": 1405141770453, "target": 1486777658795}, {"source": 1405141770453, "target": 1486857369632}, {"source": 1405141770453, "target": 1486867654077}, {"source": 1405141770453, "target": 1486867704942}, {"source": 1405141770453, "target": 1486945125504}, {"source": 1405141770453, "target": 1486945351084}, {"source": 1405141770453, "target": 1486945360655}, {"source": 1405141770453, "target": 1486952589995}, {"source": 1405141770453, "target": 1486952594655}, {"source": 1405141770453, "target": 1486952598683}, {"source": 1405141770453, "target": 1486952603043}, {"source": 1405141770453, "target": 1486952607566}, {"source": 1405141770453, "target": 1487116841407}, {"source": 1405141770453, "target": 1487116849895}, {"source": 1405141770453, "target": 1487116858814}, {"source": 1405141770453, "target": 1487116864321}, {"source": 1405141770453, "target": 1487116869316}, {"source": 1405141770453, "target": 1487116873670}, {"source": 1405141770453, "target": 1487116878738}, {"source": 1405141770453, "target": 1487116883398}, {"source": 1405141770453, "target": 1487116888778}, {"source": 1405141770453, "target": 1487116895205}, {"source": 1405141770453, "target": 1487116917001}, {"source": 1405141770453, "target": 1487116922978}, {"source": 1405141770453, "target": 1487116928027}, {"source": 1405141770453, "target": 1487116948156}, {"source": 1405141770453, "target": 1487116955601}, {"source": 1405141770453, "target": 1487116960234}, {"source": 1405141770453, "target": 1487116967325}, {"source": 1405141770453, "target": 1487116971703}, {"source": 1405141770453, "target": 1487116975048}, {"source": 1405141770453, "target": 1487116982311}, {"source": 1405141770453, "target": 1487116986135}, {"source": 1405141770453, "target": 1487116989319}, {"source": 1405141770453, "target": 1487116993218}, {"source": 1405141770453, "target": 1487116998408}, {"source": 1405141770453, "target": 1487117002637}, {"source": 1405141770453, "target": 1487117143873}, {"source": 1405141770453, "target": 1487117152018}, {"source": 1405141770453, "target": 1487117156031}, {"source": 1405141770453, "target": 1487117161213}, {"source": 1405141770453, "target": 1487117260690}, {"source": 1405141770453, "target": 1487117263860}, {"source": 1405141770453, "target": 1487117266817}, {"source": 1405141770453, "target": 1487117272282}, {"source": 1405141770453, "target": 1487117286060}, {"source": 1405141770453, "target": 1487117288751}, {"source": 1405141770453, "target": 1487117291271}, {"source": 1405141770453, "target": 1487117293576}, {"source": 1405141770453, "target": 1487117295752}, {"source": 1405141770453, "target": 1487117300306}, {"source": 1405141770453, "target": 1487117304665}, {"source": 1405141770453, "target": 1487117308213}, {"source": 1405141770453, "target": 1487117310594}, {"source": 1405141770453, "target": 1487117312582}, {"source": 1405141770453, "target": 1487117314403}, {"source": 1405141770453, "target": 1487117321802}, {"source": 1405141770453, "target": 1487117328797}, {"source": 1405141770453, "target": 1487117336631}, {"source": 1405141770453, "target": 1487117356804}, {"source": 1405141770453, "target": 1487207079363}, {"source": 1405141770453, "target": 1487207084334}, {"source": 1405141770453, "target": 1487207091819}, {"source": 1405141770453, "target": 1487207141168}, {"source": 1405141770453, "target": 1487207145930}, {"source": 1405141770453, "target": 1487207162179}, {"source": 1405141770453, "target": 1487207213102}, {"source": 1405141770453, "target": 1487458829921}, {"source": 1405141770453, "target": 1487460256729}, {"source": 1405141770453, "target": 1487460262238}, {"source": 1405141770453, "target": 1487460265531}, {"source": 1405141770453, "target": 1487460268378}, {"source": 1405141770453, "target": 1487460276914}, {"source": 1405141770453, "target": 1487461041752}, {"source": 1405141770453, "target": 1487461046220}, {"source": 1405141770453, "target": 1487461053514}, {"source": 1405141770453, "target": 1487461060183}, {"source": 1405141770453, "target": 1487461064842}, {"source": 1405141770453, "target": 1487461072030}, {"source": 1405141770453, "target": 1487461075476}, {"source": 1405141770453, "target": 1487461083189}, {"source": 1405141770453, "target": 1487461089160}, {"source": 1405141770453, "target": 1487461096732}, {"source": 1405141770453, "target": 1487461107256}, {"source": 1405141770453, "target": 1487461112379}, {"source": 1405141770453, "target": 1487463879752}, {"source": 1405141770453, "target": 1487463887140}, {"source": 1405141770453, "target": 1487463894466}, {"source": 1405141770453, "target": 1487463900987}, {"source": 1405141770453, "target": 1487463907439}, {"source": 1405141770453, "target": 1487463918664}, {"source": 1405141770453, "target": 1487463922315}, {"source": 1405141770453, "target": 1487463924702}, {"source": 1405141770453, "target": 1487467497291}, {"source": 1405141770453, "target": 1487469733350}, {"source": 1405141770453, "target": 1487469750801}, {"source": 1405141770453, "target": 1487469755479}, {"source": 1405141770453, "target": 1487469759701}, {"source": 1405141770453, "target": 1487469763555}, {"source": 1405141770453, "target": 1487469766823}, {"source": 1405141770453, "target": 1487469774152}, {"source": 1405141770453, "target": 1487469778711}, {"source": 1405141770453, "target": 1487469783753}, {"source": 1405141770453, "target": 1487469807276}, {"source": 1405141770453, "target": 1487469816961}, {"source": 1405141770453, "target": 1487469825199}, {"source": 1405141770453, "target": 1487469864434}, {"source": 1405141770453, "target": 1487469868022}, {"source": 1405141770453, "target": 1487469877849}, {"source": 1405141770453, "target": 1487469880635}, {"source": 1405141770453, "target": 1487469883647}, {"source": 1405141770453, "target": 1487469886411}, {"source": 1405141770453, "target": 1487469894582}, {"source": 1405141770453, "target": 1487469931164}, {"source": 1405141770453, "target": 1487469935766}, {"source": 1405141770453, "target": 1487469938790}, {"source": 1405141770453, "target": 1487469944925}, {"source": 1405141770453, "target": 1487469959674}, {"source": 1405141770453, "target": 1487469962274}, {"source": 1405141770453, "target": 1487469968141}, {"source": 1405141770453, "target": 1487469971218}, {"source": 1405141770453, "target": 1487469975903}, {"source": 1405141770453, "target": 1487469981667}, {"source": 1405141770453, "target": 1487469993914}, {"source": 1405141770453, "target": 1487470008820}, {"source": 1405141770453, "target": 1487470017343}, {"source": 1405141770453, "target": 1487470065053}, {"source": 1405141770453, "target": 1487470068885}, {"source": 1405141770453, "target": 1487470072763}, {"source": 1405141770453, "target": 1487470077436}, {"source": 1405141770453, "target": 1487470084914}, {"source": 1405141770453, "target": 1487470094124}, {"source": 1405141770453, "target": 1487470100826}, {"source": 1405141770453, "target": 1487470105872}, {"source": 1405141770453, "target": 1487470115450}, {"source": 1405141770453, "target": 1487470119549}, {"source": 1405141770453, "target": 1487470122628}, {"source": 1405141770453, "target": 1487470125519}, {"source": 1405141770453, "target": 1487470128060}, {"source": 1405141770453, "target": 1487470134272}, {"source": 1405141770453, "target": 1487470141075}, {"source": 1405141770453, "target": 1487470148526}, {"source": 1405141770453, "target": 1487470154743}, {"source": 1405141770453, "target": 1487470156809}, {"source": 1405141770453, "target": 1487470158626}, {"source": 1405141770453, "target": 1487470164855}, {"source": 1405141770453, "target": 1487470180854}, {"source": 1405141770453, "target": 1487470201031}, {"source": 1405141770453, "target": 1487470208377}, {"source": 1405141770453, "target": 1487470222716}, {"source": 1405141770453, "target": 1487470225207}, {"source": 1405141770453, "target": 1487470227188}, {"source": 1405141770453, "target": 1487470229408}, {"source": 1405141770453, "target": 1487470231445}, {"source": 1405141770453, "target": 1487470234455}, {"source": 1405141770453, "target": 1487470236560}, {"source": 1405141770453, "target": 1487470238614}, {"source": 1405141770453, "target": 1487470244885}, {"source": 1405141770453, "target": 1487470250734}, {"source": 1405141770453, "target": 1487470252945}, {"source": 1405141770453, "target": 1487470255062}, {"source": 1405141770453, "target": 1487470260293}, {"source": 1405141770453, "target": 1487470262097}, {"source": 1405141770453, "target": 1487470267945}, {"source": 1405141770453, "target": 1487470274721}, {"source": 1405141770453, "target": 1487470280583}, {"source": 1405141770453, "target": 1487470289670}, {"source": 1405141770453, "target": 1487547577420}, {"source": 1405141770453, "target": 1487550474201}, {"source": 1405141770453, "target": 1487550483703}, {"source": 1405141770453, "target": 1487550493244}, {"source": 1405141770453, "target": 1487550496659}, {"source": 1405141770453, "target": 1487550501974}, {"source": 1405141770453, "target": 1487550504664}, {"source": 1405141770453, "target": 1487550507064}, {"source": 1405141770453, "target": 1487550515135}, {"source": 1405141770453, "target": 1487550521082}, {"source": 1405141770453, "target": 1487550527095}, {"source": 1405141770453, "target": 1487550534131}, {"source": 1405141770453, "target": 1487550541119}, {"source": 1405141770453, "target": 1487550547055}, {"source": 1405141770453, "target": 1487550555569}, {"source": 1405141770453, "target": 1487550566447}, {"source": 1405141770453, "target": 1487550571778}, {"source": 1405141770453, "target": 1487550585393}, {"source": 1405141770453, "target": 1487986335122}, {"source": 1405141770453, "target": 1487986370184}, {"source": 1405141770453, "target": 1487988649958}, {"source": 1405141770453, "target": 1488154095903}, {"source": 1405141770453, "target": 1488154186768}, {"source": 1405141770453, "target": 1488154264011}, {"source": 1405141770453, "target": 1488158472215}, {"source": 1405141770453, "target": 1488158700582}, {"source": 1405141770453, "target": 1488158723205}, {"source": 1405141770453, "target": 1488158724693}, {"source": 1405141770453, "target": 1488158726384}, {"source": 1405141770453, "target": 1488418330232}, {"source": 1405141770453, "target": 1488418385131}, {"source": 1405141770453, "target": 1488418638300}, {"source": 1405141770453, "target": 1488418643668}, {"source": 1405141770453, "target": 1488418645713}, {"source": 1405141770453, "target": 1488418653159}, {"source": 1405141770453, "target": 1488680746086}, {"source": 1405141770453, "target": 1488843272212}, {"source": 1405141770453, "target": 1488847659723}, {"source": 1405141770453, "target": 1488847667802}, {"source": 1405141770453, "target": 1488847671701}, {"source": 1405141770453, "target": 1488847674991}, {"source": 1405141770453, "target": 1488847679422}, {"source": 1405141770453, "target": 1488854981835}, {"source": 1405141770453, "target": 1488854985772}, {"source": 1405141770453, "target": 1488854994112}, {"source": 1405141770453, "target": 1488855057580}, {"source": 1405141770453, "target": 1488855106673}, {"source": 1405141770453, "target": 1488855114769}, {"source": 1405141770453, "target": 1488855196597}, {"source": 1405141770453, "target": 1488855200902}, {"source": 1405141770453, "target": 1488855207253}, {"source": 1405141770453, "target": 1488855211120}, {"source": 1405141770453, "target": 1489113044939}, {"source": 1405141770453, "target": 1489113049381}, {"source": 1405141770453, "target": 1489966943274}, {"source": 1405141770453, "target": 1489966986129}, {"source": 1405141770453, "target": 1489970022577}, {"source": 1405141770453, "target": 1489970026548}, {"source": 1405141770453, "target": 1489970054827}, {"source": 1405141770453, "target": 1489970060543}, {"source": 1405141770453, "target": 1489970091921}, {"source": 1405141770453, "target": 1489970137869}, {"source": 1405141770453, "target": 1489970181312}, {"source": 1405141770453, "target": 1489970247629}, {"source": 1405141770453, "target": 1489970364081}, {"source": 1405141770453, "target": 1489970862017}, {"source": 1405141770453, "target": 1489970960324}, {"source": 1405141770453, "target": 1489970973404}, {"source": 1405141770453, "target": 1489970994844}, {"source": 1405141770453, "target": 1489971004003}, {"source": 1405141770453, "target": 1489971019097}, {"source": 1405141770453, "target": 1489971106127}, {"source": 1405141770453, "target": 1489971140322}, {"source": 1405141770453, "target": 1489973170226}, {"source": 1405141770453, "target": 1489973370208}, {"source": 1405141770453, "target": 1489973375825}, {"source": 1405141770453, "target": 1489973382717}, {"source": 1405141770453, "target": 1489973497370}, {"source": 1405141770453, "target": 1489973764289}, {"source": 1405141770453, "target": 1489974240036}, {"source": 1405141770453, "target": 1489974306219}, {"source": 1405141770453, "target": 1489974326402}, {"source": 1405141770453, "target": 1489974984676}, {"source": 1405141770453, "target": 1489975359321}, {"source": 1405141770453, "target": 1489976304767}, {"source": 1405141770453, "target": 1489976307289}, {"source": 1405141770453, "target": 1489976310507}, {"source": 1405141770453, "target": 1489976313229}, {"source": 1405141770453, "target": 1489976320594}, {"source": 1405141770453, "target": 1489976327304}, {"source": 1405141770453, "target": 1489976330654}, {"source": 1405141770453, "target": 1489976334964}, {"source": 1405141770453, "target": 1489976337608}, {"source": 1405141770453, "target": 1489976344162}, {"source": 1405141770453, "target": 1489976366312}, {"source": 1405141770453, "target": 1489976373103}, {"source": 1405141770453, "target": 1489976379576}, {"source": 1405141770453, "target": 1489976392823}, {"source": 1405141770453, "target": 1490061652098}, {"source": 1405141770453, "target": 1490066159100}, {"source": 1405141770453, "target": 1490066162567}, {"source": 1405141770453, "target": 1490066166158}, {"source": 1405141770453, "target": 1490066171169}, {"source": 1405141770453, "target": 1490066174929}, {"source": 1405141770453, "target": 1490066178586}, {"source": 1405141770453, "target": 1490066181877}, {"source": 1405141770453, "target": 1490066185604}, {"source": 1405141770453, "target": 1490066192922}, {"source": 1405141770453, "target": 1490066195477}, {"source": 1405141770453, "target": 1490066198198}, {"source": 1405141770453, "target": 1490066204599}, {"source": 1405141770453, "target": 1490066207488}, {"source": 1405141770453, "target": 1490066209783}, {"source": 1405141770453, "target": 1490066212502}, {"source": 1405141770453, "target": 1490066214478}, {"source": 1405141770453, "target": 1490066217772}, {"source": 1405141770453, "target": 1490066222678}, {"source": 1405141770453, "target": 1490066226073}, {"source": 1405141770453, "target": 1490066229194}, {"source": 1405141770453, "target": 1490066232397}, {"source": 1405141770453, "target": 1490066236446}, {"source": 1405141770453, "target": 1490066239613}, {"source": 1405141770453, "target": 1490066244440}, {"source": 1405141770453, "target": 1490066246680}, {"source": 1405141770453, "target": 1490066253471}, {"source": 1405141770453, "target": 1490066257140}, {"source": 1405141770453, "target": 1490066261471}, {"source": 1405141770453, "target": 1490066263554}, {"source": 1405141770453, "target": 1490066265387}, {"source": 1405141770453, "target": 1490066268966}, {"source": 1405141770453, "target": 1490066271518}, {"source": 1405141770453, "target": 1490066273472}, {"source": 1405141770453, "target": 1490066276769}, {"source": 1405141770453, "target": 1490066280055}, {"source": 1405141770453, "target": 1490066286562}, {"source": 1405141770453, "target": 1490066290359}, {"source": 1405141770453, "target": 1490066293330}, {"source": 1405141770453, "target": 1490066300391}, {"source": 1405141770453, "target": 1490066305390}, {"source": 1405141770453, "target": 1490066308677}, {"source": 1405141770453, "target": 1490066311609}, {"source": 1405141770453, "target": 1490066314616}, {"source": 1405141770453, "target": 1490066320396}, {"source": 1405141770453, "target": 1490066323578}, {"source": 1405141770453, "target": 1490066326802}, {"source": 1405141770453, "target": 1490137213363}, {"source": 1405141770453, "target": 1490137861396}, {"source": 1405141770453, "target": 1490137865783}, {"source": 1405141770453, "target": 1490137911734}, {"source": 1405141770453, "target": 1490137920397}, {"source": 1405141770453, "target": 1490137924125}, {"source": 1405141770453, "target": 1490137930957}, {"source": 1405141770453, "target": 1490137935086}, {"source": 1405141770453, "target": 1490137960049}, {"source": 1405141770453, "target": 1490137963044}, {"source": 1405141770453, "target": 1490137966107}, {"source": 1405141770453, "target": 1490137969292}, {"source": 1405141770453, "target": 1493070807467}, {"source": 1405141770453, "target": 1495818993477}, {"source": 1405141770453, "target": 1496352237286}, {"source": 1405141770453, "target": 1496511618237}, {"source": 1405141770453, "target": 1496873297074}, {"source": 1405141770453, "target": 1497060843469}, {"source": 1405141770453, "target": 1497061915081}, {"source": 1405141770453, "target": 1497199809850}, {"source": 1405141770453, "target": 1497202218758}, {"source": 1405141770453, "target": 1497203002753}, {"source": 1405141770453, "target": 1497209375497}, {"source": 1405141770453, "target": 1497310670150}, {"source": 1405141770453, "target": 1499356681150}, {"source": 1405141770453, "target": 1499356681173}, {"source": 1405141770453, "target": 1502301024958}, {"source": 1405141770453, "target": 1502301446592}, {"source": 1405141770453, "target": 1502301498513}, {"source": 1405141770453, "target": 1502301522582}, {"source": 1405141770453, "target": 1502301670964}, {"source": 1405141770453, "target": 1502301735723}, {"source": 1405141770453, "target": 1502302124791}, {"source": 1405141770453, "target": 1502302298317}, {"source": 1405141770453, "target": 1502302569404}, {"source": 1405141770453, "target": 1502303951839}, {"source": 1405141770453, "target": 1502304299735}, {"source": 1405141770453, "target": 1502305079611}, {"source": 1405141770453, "target": 1502306084477}, {"source": 1405141770453, "target": 1502306590401}, {"source": 1405141770453, "target": 1502410275869}, {"source": 1405141770453, "target": 1502412510405}, {"source": 1405141770453, "target": 1502413141027}, {"source": 1405141770453, "target": 1514420605938}, {"source": 1405141770453, "target": 1514421809620}, {"source": 1405141770453, "target": 1514438709754}, {"source": 1405141770453, "target": 1514439182774}, {"source": 1405141770453, "target": 1514439774614}, {"source": 1405141770453, "target": 1514441153062}, {"source": 1405141770453, "target": 1514447214681}, {"source": 1405141770453, "target": 1514458295721}, {"source": 1405141770453, "target": 1514458860048}, {"source": 1405141770453, "target": 1514463121926}, {"source": 1405141770453, "target": 1514492916695}, {"source": 1405141770453, "target": 1514493401381}, {"source": 1405141770453, "target": 1514503148965}, {"source": 1405141770453, "target": 1514504167162}, {"source": 1405141770453, "target": 1514504854424}, {"source": 1405141770453, "target": 1514504972100}, {"source": 1405141770453, "target": 1514505123470}, {"source": 1405141770453, "target": 1514506042798}, {"source": 1405141770453, "target": 1514507708785}, {"source": 1405141770453, "target": 1514508220274}, {"source": 1405141770453, "target": 1514517938935}, {"source": 1405141770453, "target": 1514518131379}, {"source": 1405141770453, "target": 1514518822228}, {"source": 1405141770453, "target": 1514518932937}, {"source": 1405141770453, "target": 1514519133165}, {"source": 1405141770453, "target": 1514521800603}, {"source": 1405141770453, "target": 1514521859322}, {"source": 1405141770453, "target": 1514522018491}, {"source": 1405141770453, "target": 1514522445038}, {"source": 1405141770453, "target": 1514523406956}, {"source": 1405141770453, "target": 1514523695666}, {"source": 1405141770453, "target": 1514572172444}, {"source": 1405141770453, "target": 1514572717164}, {"source": 1405141770453, "target": 1514577306242}, {"source": 1405141770453, "target": 1514580145115}, {"source": 1405141770453, "target": 1514581268628}, {"source": 1405141770453, "target": 1514662177557}, {"source": 1405141770453, "target": 1514665411921}, {"source": 1405141770453, "target": 1514665641707}, {"source": 1405141770453, "target": 1514669001886}, {"source": 1405141770453, "target": 1514670434695}, {"source": 1405141770453, "target": 1514670570704}, {"source": 1405141770453, "target": 1514901294546}, {"source": 1405141770453, "target": 1514907784721}, {"source": 1405141770453, "target": 1514910275399}, {"source": 1405141770453, "target": 1515380666089}, {"source": 1405141770453, "target": 1515383317269}, {"source": 1405141770453, "target": 1515556520483}, {"source": 1405141770453, "target": 1515559898214}, {"source": 1405141770453, "target": 1515722455837}, {"source": 1405141770453, "target": 1515722563357}, {"source": 1405141770453, "target": 1515722770836}, {"source": 1405141770453, "target": 1515722911357}, {"source": 1405141770453, "target": 1515723006671}, {"source": 1405141770453, "target": 1515723070213}, {"source": 1405141770453, "target": 1515780468007}, {"source": 1405141770453, "target": 1516052301971}, {"source": 1405141770453, "target": 1516052413276}, {"source": 1405141770453, "target": 1516052568445}, {"source": 1405141770453, "target": 1516052611991}, {"source": 1405141770453, "target": 1516052726388}, {"source": 1405141770453, "target": 1516060754864}, {"source": 1405141770453, "target": 1516060882936}, {"source": 1405141770453, "target": 1516060998624}, {"source": 1405141770453, "target": 1516061091978}, {"source": 1405141770453, "target": 1516061108309}, {"source": 1405141770453, "target": 1516061198725}, {"source": 1405141770453, "target": 1516061255284}, {"source": 1405141770453, "target": 1516061313616}, {"source": 1405141770453, "target": 1516061368613}, {"source": 1405141770453, "target": 1516061489817}, {"source": 1405141770453, "target": 1516061554788}, {"source": 1405141770453, "target": 1516061727087}, {"source": 1405141770453, "target": 1516061829690}, {"source": 1405141770453, "target": 1516061921946}, {"source": 1405141770453, "target": 1516062099732}, {"source": 1405141770453, "target": 1516062222140}, {"source": 1405141770453, "target": 1516062395011}, {"source": 1405141770453, "target": 1516062551867}, {"source": 1405141770453, "target": 1516062832584}, {"source": 1405141770453, "target": 1516062859864}, {"source": 1405141770453, "target": 1516063061822}, {"source": 1405141770453, "target": 1516246417073}, {"source": 1405141770453, "target": 1516246473563}, {"source": 1405141770453, "target": 1516246515683}, {"source": 1405141770453, "target": 1516721154487}, {"source": 1405141770453, "target": 1516721343853}, {"source": 1405141770453, "target": 1516721582011}, {"source": 1405141770453, "target": 1517790399681}, {"source": 1405141770453, "target": 1518312585956}, {"source": 1405141770453, "target": 1518312666690}, {"source": 1405141770453, "target": 1518312689465}, {"source": 1405141770453, "target": 1518312715637}, {"source": 1405141770453, "target": 1518313163667}, {"source": 1405141770453, "target": 1518313213243}, {"source": 1405141770453, "target": 1518315720736}, {"source": 1405141770453, "target": 1518315850491}, {"source": 1405141770453, "target": 1518315922723}, {"source": 1405141770453, "target": 1518657439710}, {"source": 1405141770453, "target": 1518661740894}, {"source": 1405141770453, "target": 1518661822920}, {"source": 1405141770453, "target": 1518663407728}, {"source": 1405141770453, "target": 1518929163207}, {"source": 1405141770453, "target": 1518929541738}, {"source": 1405141770453, "target": 1518930938093}, {"source": 1405141770453, "target": 1518964489211}, {"source": 1405141770453, "target": 1518964961692}, {"source": 1405141770453, "target": 1518965428572}, {"source": 1405141770453, "target": 1518987469596}, {"source": 1405141770453, "target": 1518987600370}, {"source": 1405141770453, "target": 1518987661842}, {"source": 1405141770453, "target": 1518987705256}, {"source": 1405141770453, "target": 1518989205267}, {"source": 1405141770453, "target": 1518989287340}, {"source": 1405141770453, "target": 1519081483502}, {"source": 1405141770453, "target": 1519081550408}, {"source": 1405141770453, "target": 1519182327659}, {"source": 1405141770453, "target": 1519182406936}, {"source": 1405141770453, "target": 1519182507447}, {"source": 1405141770453, "target": 1519267270847}, {"source": 1405141770453, "target": 1519267330463}, {"source": 1405141770453, "target": 1519852994405}, {"source": 1405141770453, "target": 1519853206841}, {"source": 1405141770453, "target": 1519858800572}, {"source": 1405141770453, "target": 1519859133377}, {"source": 1405141770453, "target": 1519859487329}, {"source": 1405141770453, "target": 1519860412778}, {"source": 1405141770453, "target": 1519860747841}, {"source": 1405141770453, "target": 1519861036511}, {"source": 1405141770453, "target": 1519861613333}, {"source": 1405141770453, "target": 1519861941136}, {"source": 1405141770453, "target": 1520278360870}, {"source": 1405141770453, "target": 1520278995120}, {"source": 1405141770453, "target": 1520296943511}, {"source": 1405141770453, "target": 1520300013308}, {"source": 1405141770453, "target": 1520300267643}, {"source": 1405141770453, "target": 1520300296240}, {"source": 1405141770453, "target": 1520300403523}, {"source": 1405141770453, "target": 1520300435789}, {"source": 1405141770453, "target": 1520300460306}, {"source": 1405141770453, "target": 1520300810177}, {"source": 1405141770453, "target": 1520440331083}, {"source": 1405141770453, "target": 1520443329636}, {"source": 1405141770453, "target": 1520443344519}, {"source": 1405141770453, "target": 1520443529180}, {"source": 1405141770453, "target": 1520444046369}, {"source": 1405141770453, "target": 1520444181815}, {"source": 1405141770453, "target": 1520444212406}, {"source": 1405141770453, "target": 1520444263822}, {"source": 1405141770453, "target": 1520444298927}, {"source": 1405141770453, "target": 1520444509518}, {"source": 1405141770453, "target": 1520444679068}, {"source": 1405141770453, "target": 1520445108362}, {"source": 1405141770453, "target": 1520445157941}, {"source": 1405141770453, "target": 1520445172196}, {"source": 1405141770453, "target": 1520445197524}, {"source": 1405141770453, "target": 1520633332152}, {"source": 1405141770453, "target": 1520701430032}, {"source": 1405141770453, "target": 1520701559102}, {"source": 1405141770453, "target": 1520709291667}, {"source": 1405141770453, "target": 1520711589397}, {"source": 1405141770453, "target": 1520713697891}, {"source": 1405141770453, "target": 1520714239512}, {"source": 1405141770453, "target": 1520717134280}, {"source": 1405141770453, "target": 1520717469155}, {"source": 1405141770453, "target": 1520717686972}, {"source": 1405141770453, "target": 1520717768604}, {"source": 1405141770453, "target": 1520717800484}, {"source": 1405141770453, "target": 1520718033975}, {"source": 1405141770453, "target": 1520718315885}, {"source": 1405141770453, "target": 1520718423027}, {"source": 1405141770453, "target": 1520718485657}, {"source": 1405141770453, "target": 1520720062422}, {"source": 1405141770453, "target": 1520720709904}, {"source": 1405141770453, "target": 1520727088485}, {"source": 1405141770453, "target": 1520728409770}, {"source": 1405141770453, "target": 1520728891667}, {"source": 1405141770453, "target": 1520729012293}, {"source": 1405141770453, "target": 1520729160540}, {"source": 1405141770453, "target": 1520814510779}, {"source": 1405141770453, "target": 1520815355947}, {"source": 1405141770453, "target": 1520901090909}, {"source": 1405141770453, "target": 1520905674180}, {"source": 1405141770453, "target": 1520973386455}, {"source": 1405141770453, "target": 1520973569166}, {"source": 1405141770453, "target": 1520973601210}, {"source": 1405141770453, "target": 1520973784131}, {"source": 1405141770453, "target": 1521075844350}, {"source": 1405141770453, "target": 1521077870349}, {"source": 1405141770453, "target": 1521135744299}, {"source": 1405141770453, "target": 1521168535183}, {"source": 1405141770453, "target": 1521171476528}, {"source": 1405141770453, "target": 1521171636462}, {"source": 1405141770453, "target": 1521219262065}, {"source": 1405141770453, "target": 1521261347590}, {"source": 1405141770453, "target": 1521262212406}, {"source": 1405141770453, "target": 1521421074806}, {"source": 1405141770453, "target": 1521423729086}, {"source": 1405141770453, "target": 1521424037362}, {"source": 1405141770453, "target": 1521424595880}, {"source": 1405141770453, "target": 1521425420243}, {"source": 1405141770453, "target": 1521500510750}, {"source": 1405141770453, "target": 1521501908794}, {"source": 1405141770453, "target": 1521503280286}, {"source": 1405141770453, "target": 1521503816382}, {"source": 1405141770453, "target": 1521570177833}, {"source": 1405141770453, "target": 1521573734382}, {"source": 1405141770453, "target": 1521591610410}, {"source": 1405141770453, "target": 1521591883921}, {"source": 1405141770453, "target": 1521597449484}, {"source": 1405141770453, "target": 1521681443682}, {"source": 1405141770453, "target": 1521682607614}, {"source": 1405141770453, "target": 1521683025324}, {"source": 1405141770453, "target": 1521683773931}, {"source": 1405141770453, "target": 1521765959144}, {"source": 1405141770453, "target": 1521766804955}, {"source": 1405141770453, "target": 1521767844229}, {"source": 1405141770453, "target": 1521767902862}, {"source": 1405141770453, "target": 1521768379649}, {"source": 1405141770453, "target": 1521770300052}, {"source": 1405141770453, "target": 1521770693590}, {"source": 1405141770453, "target": 1521770739776}, {"source": 1405141770453, "target": 1521770922392}, {"source": 1405141770453, "target": 1521770989953}, {"source": 1405141770453, "target": 1521917653168}, {"source": 1405141770453, "target": 1521918626073}, {"source": 1405141770453, "target": 1521918876939}, {"source": 1405141770453, "target": 1521919569399}, {"source": 1405141770453, "target": 1521922082231}, {"source": 1405141770453, "target": 1521932145933}, {"source": 1405141770453, "target": 1521932192299}, {"source": 1405141770453, "target": 1521932648240}, {"source": 1405141770453, "target": 1521933757465}, {"source": 1405141770453, "target": 1522033658225}, {"source": 1405141770453, "target": 1522106010887}, {"source": 1405141770453, "target": 1522344837754}, {"source": 1405141770453, "target": 1522345575124}, {"source": 1405141770453, "target": 1522350837813}, {"source": 1405141770453, "target": 1522419532686}, {"source": 1405141770453, "target": 1522419607177}, {"source": 1405141770453, "target": 1522419681104}, {"source": 1405141770453, "target": 1522430086941}, {"source": 1405141770453, "target": 1522430444424}, {"source": 1405141770453, "target": 1522430614557}, {"source": 1405141770453, "target": 1522522620802}, {"source": 1405141770453, "target": 1522523216788}, {"source": 1405141770453, "target": 1522524557688}, {"source": 1405141770453, "target": 1522543003481}, {"source": 1405141770453, "target": 1522596053069}, {"source": 1405141770453, "target": 1522596676916}, {"source": 1405141770453, "target": 1522765670865}, {"source": 1405141770453, "target": 1522766784686}, {"source": 1405141770453, "target": 1522767130070}, {"source": 1405141770453, "target": 1522767252576}, {"source": 1405141770453, "target": 1522767538297}, {"source": 1405141770453, "target": 1522767585641}, {"source": 1405141770453, "target": 1522767618093}, {"source": 1405141770453, "target": 1522767968780}, {"source": 1405141770453, "target": 1522768182082}, {"source": 1405141770453, "target": 1522858621380}, {"source": 1405141770453, "target": 1522858909314}, {"source": 1405141770453, "target": 1522978084595}, {"source": 1405141770453, "target": 1522978826683}, {"source": 1405141770453, "target": 1522978929448}, {"source": 1405141770453, "target": 1523153755717}, {"source": 1405141770453, "target": 1523153827410}, {"source": 1405141770453, "target": 1523153962275}, {"source": 1405141770453, "target": 1523155250898}, {"source": 1405141770453, "target": 1523196495913}, {"source": 1405141770453, "target": 1523240302504}, {"source": 1405141770453, "target": 1523240406190}, {"source": 1405141770453, "target": 1523240453446}, {"source": 1405141770453, "target": 1523409710031}, {"source": 1405141770453, "target": 1523409774775}, {"source": 1405141770453, "target": 1523409819271}, {"source": 1405141770453, "target": 1523411825116}, {"source": 1405141770453, "target": 1523586544673}, {"source": 1405141770453, "target": 1523885609867}, {"source": 1405141770453, "target": 1524101686868}, {"source": 1405141770453, "target": 1524101898555}, {"source": 1405141770453, "target": 1524102065748}, {"source": 1405141770453, "target": 1524104123475}, {"source": 1405141770453, "target": 1524148184617}, {"source": 1405141770453, "target": 1524148715978}, {"source": 1405141770453, "target": 1524148797489}, {"source": 1405141770453, "target": 1524149251024}, {"source": 1405141770453, "target": 1524149644141}, {"source": 1405141770453, "target": 1524149690650}, {"source": 1405141770453, "target": 1524149763277}, {"source": 1405141770453, "target": 1524150034457}, {"source": 1405141770453, "target": 1524150515716}, {"source": 1405141770453, "target": 1524150690333}, {"source": 1405141770453, "target": 1524151287448}, {"source": 1405141770453, "target": 1524151749002}, {"source": 1405141770453, "target": 1524151971478}, {"source": 1405141770453, "target": 1524152032953}, {"source": 1405141770453, "target": 1524152048128}, {"source": 1405141770453, "target": 1524165274446}, {"source": 1405141770453, "target": 1524167427513}, {"source": 1405141770453, "target": 1524247235026}, {"source": 1405141770453, "target": 1524248123764}, {"source": 1405141770453, "target": 1524248435216}, {"source": 1405141770453, "target": 1524249723352}, {"source": 1405141770453, "target": 1524325496003}, {"source": 1405141770453, "target": 1524327729226}, {"source": 1405141770453, "target": 1524328886574}, {"source": 1405141770453, "target": 1524609033483}, {"source": 1405141770453, "target": 1524609197643}, {"source": 1405141770453, "target": 1525043744165}, {"source": 1405141770453, "target": 1525112016641}, {"source": 1405141770453, "target": 1525112237560}, {"source": 1405141770453, "target": 1525116053327}, {"source": 1405141770453, "target": 1525137303328}, {"source": 1405141770453, "target": 1525138104051}, {"source": 1405141770453, "target": 1525220854667}, {"source": 1405141770453, "target": 1525389426486}, {"source": 1405141770453, "target": 1525397303331}, {"source": 1405141770453, "target": 1525397379771}, {"source": 1405141770453, "target": 1525397414333}, {"source": 1405141770453, "target": 1525530732814}, {"source": 1405141770453, "target": 1525564242390}, {"source": 1405141770453, "target": 1525667625301}, {"source": 1405141770453, "target": 1525898817417}, {"source": 1405141770453, "target": 1525899000205}, {"source": 1405141770453, "target": 1525899048575}, {"source": 1405141770453, "target": 1525915981730}, {"source": 1405141770453, "target": 1526071398931}, {"source": 1405141770453, "target": 1526164971905}, {"source": 1405141770453, "target": 1526169384687}, {"source": 1405141770453, "target": 1526313925730}, {"source": 1405141770453, "target": 1526328755862}, {"source": 1405141770453, "target": 1526330773665}, {"source": 1405141770453, "target": 1526340598707}, {"source": 1405141770453, "target": 1547607494657}, {"source": 1405141770453, "target": 1552605404493}, {"source": 1405141770453, "target": 1566572487165}, {"source": 1405141770453, "target": 1502305191940}, {"source": 1405141770453, "target": 1569959162322}, {"source": 1405141770453, "target": 1574312847337}, {"source": 1405141770453, "target": 1576815160851}, {"source": 1405141770453, "target": 1577063387755}, {"source": 1405141770453, "target": 1577640860927}, {"source": 1405141770453, "target": 1577641901105}, {"source": 1405141770453, "target": 1579658911817}, {"source": 1405141770453, "target": 1579659387360}, {"source": 1405141770453, "target": 1580077441757}, {"source": 1405141770453, "target": 1580783543931}, {"source": 1405141770453, "target": 1581636897059}, {"source": 1405141770453, "target": 1581636990676}, {"source": 1405141770453, "target": 1581637061745}, {"source": 1405141770453, "target": 1581706459775}, {"source": 1405141770453, "target": 1581877072982}, {"source": 1405141770453, "target": 1582766838962}, {"source": 1405141770453, "target": 1582767810149}, {"source": 1405141770453, "target": 1583374187570}, {"source": 1405141770453, "target": 1583376230438}, {"source": 1405141770453, "target": 1583381849275}, {"source": 1405141770453, "target": 1588168677810}, {"source": 1405141770453, "target": 1588168744525}, {"source": 1405141770453, "target": 1588253076377}, {"source": 1405141770453, "target": 1588254875223}, {"source": 1405141770453, "target": 1588294953536}, {"source": 1405141770453, "target": 1588296032690}, {"source": 1405141770453, "target": 1588297919063}, {"source": 1405141770453, "target": 1588298925573}, {"source": 1405141770453, "target": 1588299062516}, {"source": 1405141770453, "target": 1588299171436}, {"source": 1405141770453, "target": 1588299386693}, {"source": 1405141770453, "target": 1588873321021}, {"source": 1405141770453, "target": 1589045940690}, {"source": 1405141770453, "target": 1589047150162}, {"source": 1405189423019, "target": 1405189449032}, {"source": 1405189423019, "target": 1405189616150}, {"source": 1405189423019, "target": 1405189748896}, {"source": 1405189423019, "target": 1405189766131}, {"source": 1405189423019, "target": 1461871639955}, {"source": 1405189423019, "target": 1461871685256}, {"source": 1405189423019, "target": 1462932018812}, {"source": 1405189423019, "target": 1462932142648}, {"source": 1405189423019, "target": 1462932191528}, {"source": 1405189423019, "target": 1462932197787}, {"source": 1405189423019, "target": 1462932210004}, {"source": 1405189423019, "target": 1462932222605}, {"source": 1405189423019, "target": 1462932252114}, {"source": 1405189423019, "target": 1462932310717}, {"source": 1405189423019, "target": 1462932318824}, {"source": 1405189423019, "target": 1462933136208}, {"source": 1405189423019, "target": 1462933237929}, {"source": 1405189423019, "target": 1462935407964}, {"source": 1405189423019, "target": 1462935430927}, {"source": 1405189423019, "target": 1462935441365}, {"source": 1405189423019, "target": 1462935476863}, {"source": 1405189423019, "target": 1462935563125}, {"source": 1405189423019, "target": 1462935591927}, {"source": 1405189423019, "target": 1462935608373}, {"source": 1405189423019, "target": 1462935620453}, {"source": 1405189423019, "target": 1462935633329}, {"source": 1405189423019, "target": 1462935652670}, {"source": 1405189423019, "target": 1462935662591}, {"source": 1405189423019, "target": 1462935678981}, {"source": 1405189423019, "target": 1462935686800}, {"source": 1405189423019, "target": 1462979504741}, {"source": 1405189423019, "target": 1462979571197}, {"source": 1405189423019, "target": 1462979605920}, {"source": 1405189423019, "target": 1462981814472}, {"source": 1405189423019, "target": 1462981851888}, {"source": 1405189423019, "target": 1462981895638}, {"source": 1405189423019, "target": 1462981903167}, {"source": 1405189423019, "target": 1462981916104}, {"source": 1405189423019, "target": 1462981928631}, {"source": 1405189423019, "target": 1462981933728}, {"source": 1405189423019, "target": 1462981937884}, {"source": 1405189423019, "target": 1462981942283}, {"source": 1405189423019, "target": 1462981954788}, {"source": 1405189423019, "target": 1462982032546}, {"source": 1405189423019, "target": 1462982091710}, {"source": 1405189423019, "target": 1462984377331}, {"source": 1405189423019, "target": 1462984387058}, {"source": 1405189423019, "target": 1462984399517}, {"source": 1405189423019, "target": 1462984451980}, {"source": 1405189423019, "target": 1462984460832}, {"source": 1405189423019, "target": 1462984486053}, {"source": 1405189423019, "target": 1462984495155}, {"source": 1405189423019, "target": 1462984508078}, {"source": 1405189423019, "target": 1462984522924}, {"source": 1405189423019, "target": 1462984641273}, {"source": 1405189423019, "target": 1462986779904}, {"source": 1405189423019, "target": 1462986796333}, {"source": 1405189423019, "target": 1462986834932}, {"source": 1405189423019, "target": 1462987312318}, {"source": 1405189423019, "target": 1462989742904}, {"source": 1405189423019, "target": 1462989745991}, {"source": 1405189423019, "target": 1462989749371}, {"source": 1405189423019, "target": 1462989752426}, {"source": 1405189423019, "target": 1462989755828}, {"source": 1405189423019, "target": 1462989759896}, {"source": 1405189423019, "target": 1462989763064}, {"source": 1405189423019, "target": 1462989766626}, {"source": 1405189423019, "target": 1462989771729}, {"source": 1405189423019, "target": 1462989774805}, {"source": 1405189423019, "target": 1462989824446}, {"source": 1405189423019, "target": 1462989833021}, {"source": 1405189423019, "target": 1462989855687}, {"source": 1405189423019, "target": 1462992500901}, {"source": 1405189423019, "target": 1462992616794}, {"source": 1405189423019, "target": 1462992655373}, {"source": 1405189423019, "target": 1462992670874}, {"source": 1405189423019, "target": 1462992912807}, {"source": 1405189423019, "target": 1462993011096}, {"source": 1405189423019, "target": 1462993044137}, {"source": 1405189423019, "target": 1462993071890}, {"source": 1405189423019, "target": 1462993208165}, {"source": 1405189423019, "target": 1462993212425}, {"source": 1405189423019, "target": 1462993228629}, {"source": 1405189423019, "target": 1462993233054}, {"source": 1405189423019, "target": 1462995824386}, {"source": 1405189423019, "target": 1462995830556}, {"source": 1405189423019, "target": 1462995840692}, {"source": 1405189423019, "target": 1462995889625}, {"source": 1405189423019, "target": 1462995922829}, {"source": 1405189423019, "target": 1462995934823}, {"source": 1405189423019, "target": 1462995967981}, {"source": 1405189423019, "target": 1462996151862}, {"source": 1405189423019, "target": 1462996238719}, {"source": 1405189423019, "target": 1462996297369}, {"source": 1405189423019, "target": 1463075650855}, {"source": 1405189423019, "target": 1463078557201}, {"source": 1405189423019, "target": 1463078577289}, {"source": 1405189423019, "target": 1463078581596}, {"source": 1405189423019, "target": 1463078620627}, {"source": 1405189423019, "target": 1463078634375}, {"source": 1405189423019, "target": 1463078659617}, {"source": 1405189423019, "target": 1463078682536}, {"source": 1405189423019, "target": 1463078795879}, {"source": 1405189423019, "target": 1463078810052}, {"source": 1405189423019, "target": 1463078836498}, {"source": 1405189423019, "target": 1463078866733}, {"source": 1405189423019, "target": 1463078878506}, {"source": 1405189423019, "target": 1463078891051}, {"source": 1405189423019, "target": 1463078958759}, {"source": 1405189423019, "target": 1463078965308}, {"source": 1405189423019, "target": 1463078977459}, {"source": 1405189423019, "target": 1463078997361}, {"source": 1405189423019, "target": 1463081027332}, {"source": 1405189423019, "target": 1463081222466}, {"source": 1405189423019, "target": 1463081611935}, {"source": 1405189423019, "target": 1463081757542}, {"source": 1405189423019, "target": 1463081820748}, {"source": 1405189423019, "target": 1463081859526}, {"source": 1405189423019, "target": 1463081896488}, {"source": 1405189423019, "target": 1463081930386}, {"source": 1405189423019, "target": 1463081956910}, {"source": 1405189423019, "target": 1463082529466}, {"source": 1405189423019, "target": 1463082620879}, {"source": 1405189423019, "target": 1463082697879}, {"source": 1405189423019, "target": 1463082721843}, {"source": 1405189423019, "target": 1463082787001}, {"source": 1405189423019, "target": 1463082815704}, {"source": 1405189423019, "target": 1463082847360}, {"source": 1405189423019, "target": 1463083035387}, {"source": 1405189423019, "target": 1463083069015}, {"source": 1405189423019, "target": 1463083081562}, {"source": 1405189423019, "target": 1463083925825}, {"source": 1405189423019, "target": 1463084161585}, {"source": 1405189423019, "target": 1463084175199}, {"source": 1405189423019, "target": 1463084186996}, {"source": 1405189423019, "target": 1463084244802}, {"source": 1405189423019, "target": 1463279918927}, {"source": 1405189423019, "target": 1463279926558}, {"source": 1405189423019, "target": 1463520710247}, {"source": 1405189423019, "target": 1463526102619}, {"source": 1405189423019, "target": 1463526113458}, {"source": 1405189423019, "target": 1463526118760}, {"source": 1405189423019, "target": 1463526124762}, {"source": 1405189423019, "target": 1463526131353}, {"source": 1405189423019, "target": 1463526137463}, {"source": 1405189423019, "target": 1463526145718}, {"source": 1405189423019, "target": 1463526209818}, {"source": 1405189423019, "target": 1463526248482}, {"source": 1405189423019, "target": 1463526252752}, {"source": 1405189423019, "target": 1463526258452}, {"source": 1405189423019, "target": 1463526262145}, {"source": 1405189423019, "target": 1463526266052}, {"source": 1405189423019, "target": 1463526385372}, {"source": 1405189423019, "target": 1463526393047}, {"source": 1405189423019, "target": 1463526400180}, {"source": 1405189423019, "target": 1463943419326}, {"source": 1405189423019, "target": 1463944180575}, {"source": 1405189423019, "target": 1463944198038}, {"source": 1405189423019, "target": 1463944202361}, {"source": 1405189423019, "target": 1463944209580}, {"source": 1405189423019, "target": 1463944212861}, {"source": 1405189423019, "target": 1463944216868}, {"source": 1405189423019, "target": 1463944224537}, {"source": 1405189423019, "target": 1463944228821}, {"source": 1405189423019, "target": 1463944253517}, {"source": 1405189423019, "target": 1463944257343}, {"source": 1405189423019, "target": 1463944261135}, {"source": 1405189423019, "target": 1463944269114}, {"source": 1405189423019, "target": 1463944272827}, {"source": 1405189423019, "target": 1463944277580}, {"source": 1405189423019, "target": 1463944339139}, {"source": 1405189423019, "target": 1463944348904}, {"source": 1405189423019, "target": 1463944355918}, {"source": 1405189423019, "target": 1463944359553}, {"source": 1405189423019, "target": 1463944364170}, {"source": 1405189423019, "target": 1463944368984}, {"source": 1405189423019, "target": 1463944377495}, {"source": 1405189423019, "target": 1463944389120}, {"source": 1405189423019, "target": 1463944398823}, {"source": 1405189423019, "target": 1463944402230}, {"source": 1405189423019, "target": 1463944405911}, {"source": 1405189423019, "target": 1463944408999}, {"source": 1405189423019, "target": 1463944414541}, {"source": 1405189423019, "target": 1463945063263}, {"source": 1405189423019, "target": 1463945251338}, {"source": 1405189423019, "target": 1463945257858}, {"source": 1405189423019, "target": 1463945263919}, {"source": 1405189423019, "target": 1463945273041}, {"source": 1405189423019, "target": 1463945278650}, {"source": 1405189423019, "target": 1463946079893}, {"source": 1405189423019, "target": 1463951464989}, {"source": 1405189423019, "target": 1469212054829}, {"source": 1405189423019, "target": 1470793965216}, {"source": 1405189423019, "target": 1470794037896}, {"source": 1405189423019, "target": 1472310814145}, {"source": 1405189423019, "target": 1472311600246}, {"source": 1405189423019, "target": 1472311628946}, {"source": 1405189423019, "target": 1472311644323}, {"source": 1405189423019, "target": 1472311744141}, {"source": 1405189423019, "target": 1472311765491}, {"source": 1405189423019, "target": 1472311783046}, {"source": 1405189423019, "target": 1472311809283}, {"source": 1405189423019, "target": 1472311842456}, {"source": 1405189423019, "target": 1472311914172}, {"source": 1405189423019, "target": 1472312509202}, {"source": 1405189423019, "target": 1472317574681}, {"source": 1405189423019, "target": 1472317585511}, {"source": 1405189423019, "target": 1472317591569}, {"source": 1405189423019, "target": 1472317600504}, {"source": 1405189423019, "target": 1472317610340}, {"source": 1405189423019, "target": 1472317616453}, {"source": 1405189423019, "target": 1472317622098}, {"source": 1405189423019, "target": 1472317639354}, {"source": 1405189423019, "target": 1472317652793}, {"source": 1405189423019, "target": 1472317662259}, {"source": 1405189423019, "target": 1472317718259}, {"source": 1405189423019, "target": 1472317725558}, {"source": 1405189423019, "target": 1472317734577}, {"source": 1405189423019, "target": 1472317743442}, {"source": 1405189423019, "target": 1472317746227}, {"source": 1405189423019, "target": 1472318680807}, {"source": 1405189423019, "target": 1472319906177}, {"source": 1405189423019, "target": 1472319909035}, {"source": 1405189423019, "target": 1472319911691}, {"source": 1405189423019, "target": 1472319917363}, {"source": 1405189423019, "target": 1472319923606}, {"source": 1405189423019, "target": 1472319929389}, {"source": 1405189423019, "target": 1472319948100}, {"source": 1405189423019, "target": 1472319954680}, {"source": 1405189423019, "target": 1472319983044}, {"source": 1405189423019, "target": 1473289602247}, {"source": 1405189423019, "target": 1473289611174}, {"source": 1405189423019, "target": 1473289619233}, {"source": 1405189423019, "target": 1473359937703}, {"source": 1405189423019, "target": 1473359951494}, {"source": 1405189423019, "target": 1473359954555}, {"source": 1405189423019, "target": 1473359957928}, {"source": 1405189423019, "target": 1473466966183}, {"source": 1405189423019, "target": 1473707426029}, {"source": 1405189423019, "target": 1473707428913}, {"source": 1405189423019, "target": 1473707435818}, {"source": 1405189423019, "target": 1473707444911}, {"source": 1405189423019, "target": 1473707491540}, {"source": 1405189423019, "target": 1473707500365}, {"source": 1405189423019, "target": 1473707511363}, {"source": 1405189423019, "target": 1473707517311}, {"source": 1405189423019, "target": 1473707553199}, {"source": 1405189423019, "target": 1473707561353}, {"source": 1405189423019, "target": 1473707568629}, {"source": 1405189423019, "target": 1473707574858}, {"source": 1405189423019, "target": 1473707579754}, {"source": 1405189423019, "target": 1473707585027}, {"source": 1405189423019, "target": 1473707587717}, {"source": 1405189423019, "target": 1473707595473}, {"source": 1405189423019, "target": 1473707603639}, {"source": 1405189423019, "target": 1473707606392}, {"source": 1405189423019, "target": 1473707608661}, {"source": 1405189423019, "target": 1474505838759}, {"source": 1405189423019, "target": 1474509336827}, {"source": 1405189423019, "target": 1474509340674}, {"source": 1405189423019, "target": 1474509356802}, {"source": 1405189423019, "target": 1474509362273}, {"source": 1405189423019, "target": 1474509366500}, {"source": 1405189423019, "target": 1474509372412}, {"source": 1405189423019, "target": 1474509377202}, {"source": 1405189423019, "target": 1474509380518}, {"source": 1405189423019, "target": 1474509383752}, {"source": 1405189423019, "target": 1474509387818}, {"source": 1405189423019, "target": 1474509397005}, {"source": 1405189423019, "target": 1474509399773}, {"source": 1405189423019, "target": 1474509405173}, {"source": 1405189423019, "target": 1474509408245}, {"source": 1405189423019, "target": 1474509412679}, {"source": 1405189423019, "target": 1474509416897}, {"source": 1405189423019, "target": 1474509420919}, {"source": 1405189423019, "target": 1474509424160}, {"source": 1405189423019, "target": 1474509438311}, {"source": 1405189423019, "target": 1474509445288}, {"source": 1405189423019, "target": 1474509452822}, {"source": 1405189423019, "target": 1474509460829}, {"source": 1405189423019, "target": 1474509463396}, {"source": 1405189423019, "target": 1474509466150}, {"source": 1405189423019, "target": 1474509469020}, {"source": 1405189423019, "target": 1474509476315}, {"source": 1405189423019, "target": 1474509478829}, {"source": 1405189423019, "target": 1474509484893}, {"source": 1405189423019, "target": 1474509488862}, {"source": 1405189423019, "target": 1474509491676}, {"source": 1405189423019, "target": 1474509493954}, {"source": 1405189423019, "target": 1474509498627}, {"source": 1405189423019, "target": 1474563607979}, {"source": 1405189423019, "target": 1475280574693}, {"source": 1405189423019, "target": 1475287234425}, {"source": 1405189423019, "target": 1475287241814}, {"source": 1405189423019, "target": 1475287246977}, {"source": 1405189423019, "target": 1475287250177}, {"source": 1405189423019, "target": 1475287252831}, {"source": 1405189423019, "target": 1475287255781}, {"source": 1405189423019, "target": 1475287258523}, {"source": 1405189423019, "target": 1475287261393}, {"source": 1405189423019, "target": 1475287265217}, {"source": 1405189423019, "target": 1475287268030}, {"source": 1405189423019, "target": 1475287273153}, {"source": 1405189423019, "target": 1475287276309}, {"source": 1405189423019, "target": 1475287279212}, {"source": 1405189423019, "target": 1475287281585}, {"source": 1405189423019, "target": 1475287283862}, {"source": 1405189423019, "target": 1475287286742}, {"source": 1405189423019, "target": 1475287289082}, {"source": 1405189423019, "target": 1475287291157}, {"source": 1405189423019, "target": 1475287300322}, {"source": 1405189423019, "target": 1475287304702}, {"source": 1405189423019, "target": 1475287310437}, {"source": 1405189423019, "target": 1475287312836}, {"source": 1405189423019, "target": 1475287315208}, {"source": 1405189423019, "target": 1475287317666}, {"source": 1405189423019, "target": 1475287465054}, {"source": 1405189423019, "target": 1475287469624}, {"source": 1405189423019, "target": 1475287543397}, {"source": 1405189423019, "target": 1475290028338}, {"source": 1405189423019, "target": 1475290033702}, {"source": 1405189423019, "target": 1475290038364}, {"source": 1405189423019, "target": 1475290042667}, {"source": 1405189423019, "target": 1475290046517}, {"source": 1405189423019, "target": 1475290050454}, {"source": 1405189423019, "target": 1475290053332}, {"source": 1405189423019, "target": 1475290057493}, {"source": 1405189423019, "target": 1475290061747}, {"source": 1405189423019, "target": 1475290064936}, {"source": 1405189423019, "target": 1475290069310}, {"source": 1405189423019, "target": 1475290075603}, {"source": 1405189423019, "target": 1475290081562}, {"source": 1405189423019, "target": 1475290083779}, {"source": 1405189423019, "target": 1475290647432}, {"source": 1405189423019, "target": 1475290649782}, {"source": 1405189423019, "target": 1475290653474}, {"source": 1405189423019, "target": 1475290658728}, {"source": 1405189423019, "target": 1476487914649}, {"source": 1405189423019, "target": 1480550522376}, {"source": 1405189423019, "target": 1482203633368}, {"source": 1405189423019, "target": 1482203653741}, {"source": 1405189423019, "target": 1482203658544}, {"source": 1405189423019, "target": 1482203661732}, {"source": 1405189423019, "target": 1482203664232}, {"source": 1405189423019, "target": 1482203666996}, {"source": 1405189423019, "target": 1482203669616}, {"source": 1405189423019, "target": 1482203671978}, {"source": 1405189423019, "target": 1482203676681}, {"source": 1405189423019, "target": 1482273060226}, {"source": 1405189423019, "target": 1482274957988}, {"source": 1405189423019, "target": 1482274965376}, {"source": 1405189423019, "target": 1482274971453}, {"source": 1405189423019, "target": 1482274978199}, {"source": 1405189423019, "target": 1482274990793}, {"source": 1405189423019, "target": 1482274999896}, {"source": 1405189423019, "target": 1482275004042}, {"source": 1405189423019, "target": 1482275007962}, {"source": 1405189423019, "target": 1482275017818}, {"source": 1405189423019, "target": 1482275085375}, {"source": 1405189423019, "target": 1482275190191}, {"source": 1405189423019, "target": 1482275198622}, {"source": 1405189423019, "target": 1482275209765}, {"source": 1405189423019, "target": 1482275213721}, {"source": 1405189423019, "target": 1482275221585}, {"source": 1405189423019, "target": 1482275230016}, {"source": 1405189423019, "target": 1482284296442}, {"source": 1405189423019, "target": 1482289458987}, {"source": 1405189423019, "target": 1482289465469}, {"source": 1405189423019, "target": 1482289468295}, {"source": 1405189423019, "target": 1482289470259}, {"source": 1405189423019, "target": 1482289473221}, {"source": 1405189423019, "target": 1482289480639}, {"source": 1405189423019, "target": 1482289483439}, {"source": 1405189423019, "target": 1482965424718}, {"source": 1405189423019, "target": 1482971213105}, {"source": 1405189423019, "target": 1482971220318}, {"source": 1405189423019, "target": 1482971225208}, {"source": 1405189423019, "target": 1482971231424}, {"source": 1405189423019, "target": 1482971236131}, {"source": 1405189423019, "target": 1482971243363}, {"source": 1405189423019, "target": 1482971253882}, {"source": 1405189423019, "target": 1482971258399}, {"source": 1405189423019, "target": 1482971261818}, {"source": 1405189423019, "target": 1482971264299}, {"source": 1405189423019, "target": 1482971271910}, {"source": 1405189423019, "target": 1486596640365}, {"source": 1405189423019, "target": 1486596665570}, {"source": 1405189423019, "target": 1486596668900}, {"source": 1405189423019, "target": 1486596671662}, {"source": 1405189423019, "target": 1486596675590}, {"source": 1405189423019, "target": 1486596678532}, {"source": 1405189423019, "target": 1486596683598}, {"source": 1405189423019, "target": 1486857214573}, {"source": 1405189423019, "target": 1487117096735}, {"source": 1405189423019, "target": 1487117179318}, {"source": 1405189423019, "target": 1487117191334}, {"source": 1405189423019, "target": 1487117247126}, {"source": 1405189423019, "target": 1487121969591}, {"source": 1405189423019, "target": 1489112130810}, {"source": 1405189423019, "target": 1489112814280}, {"source": 1405189423019, "target": 1489112819759}, {"source": 1405189423019, "target": 1489112822671}, {"source": 1405189423019, "target": 1489112827721}, {"source": 1405189423019, "target": 1489112834939}, {"source": 1405189423019, "target": 1489112839753}, {"source": 1405189423019, "target": 1489112844796}, {"source": 1405189423019, "target": 1489112849260}, {"source": 1405189423019, "target": 1489112860211}, {"source": 1405189423019, "target": 1489112863785}, {"source": 1405189423019, "target": 1489112866359}, {"source": 1405189423019, "target": 1489112870762}, {"source": 1405189423019, "target": 1489112874704}, {"source": 1405189423019, "target": 1489112879936}, {"source": 1405189423019, "target": 1489112884330}, {"source": 1405189423019, "target": 1489112888493}, {"source": 1405189423019, "target": 1489112893990}, {"source": 1405189423019, "target": 1489112898394}, {"source": 1405189423019, "target": 1489112902130}, {"source": 1405189423019, "target": 1489112908133}, {"source": 1405189423019, "target": 1489112912399}, {"source": 1405189423019, "target": 1489112916155}, {"source": 1405189423019, "target": 1489112920379}, {"source": 1405189423019, "target": 1489112939263}, {"source": 1405189423019, "target": 1489112946562}, {"source": 1405189423019, "target": 1489112951090}, {"source": 1405189423019, "target": 1489112954716}, {"source": 1405189423019, "target": 1489112958770}, {"source": 1405189423019, "target": 1489112961336}, {"source": 1405189423019, "target": 1489112968862}, {"source": 1405189423019, "target": 1489112976992}, {"source": 1405189423019, "target": 1489112981171}, {"source": 1405189423019, "target": 1489112985969}, {"source": 1405189423019, "target": 1489112989862}, {"source": 1405189423019, "target": 1489112993482}, {"source": 1405189423019, "target": 1489112996871}, {"source": 1405189423019, "target": 1489113000682}, {"source": 1405189423019, "target": 1489113004877}, {"source": 1405189423019, "target": 1489113010886}, {"source": 1405189423019, "target": 1489113019621}, {"source": 1405189423019, "target": 1489113024476}, {"source": 1405189423019, "target": 1489113028145}, {"source": 1405189423019, "target": 1489113031112}, {"source": 1405189423019, "target": 1489113038495}, {"source": 1405189423019, "target": 1489113042237}, {"source": 1405189423019, "target": 1489113051598}, {"source": 1405189423019, "target": 1489113053591}, {"source": 1405189423019, "target": 1489113055432}, {"source": 1405189423019, "target": 1489113063884}, {"source": 1405189423019, "target": 1489113530157}, {"source": 1405189423019, "target": 1489115490800}, {"source": 1405189423019, "target": 1489115495506}, {"source": 1405189423019, "target": 1489115545454}, {"source": 1405189423019, "target": 1489115551467}, {"source": 1405189423019, "target": 1489115559922}, {"source": 1405189423019, "target": 1489115563908}, {"source": 1405189423019, "target": 1489115567302}, {"source": 1405189423019, "target": 1489115575905}, {"source": 1405189423019, "target": 1489115591365}, {"source": 1405189423019, "target": 1489115594180}, {"source": 1405189423019, "target": 1489115596258}, {"source": 1405189423019, "target": 1489115598560}, {"source": 1405189423019, "target": 1489115602387}, {"source": 1405189423019, "target": 1489115607905}, {"source": 1405189423019, "target": 1489115611968}, {"source": 1405189423019, "target": 1489115615390}, {"source": 1405189423019, "target": 1489115619593}, {"source": 1405189423019, "target": 1489115623221}, {"source": 1405189423019, "target": 1489115626516}, {"source": 1405189423019, "target": 1489115630036}, {"source": 1405189423019, "target": 1489115633644}, {"source": 1405189423019, "target": 1489115637266}, {"source": 1405189423019, "target": 1489115640609}, {"source": 1405189423019, "target": 1489115644530}, {"source": 1405189423019, "target": 1489115648711}, {"source": 1405189423019, "target": 1489115652171}, {"source": 1405189423019, "target": 1489115655836}, {"source": 1405189423019, "target": 1489115659200}, {"source": 1405189423019, "target": 1489115664354}, {"source": 1405189423019, "target": 1489115667759}, {"source": 1405189423019, "target": 1489115671098}, {"source": 1405189423019, "target": 1489115675284}, {"source": 1405189423019, "target": 1489115678326}, {"source": 1405189423019, "target": 1489115681641}, {"source": 1405189423019, "target": 1489115685280}, {"source": 1405189423019, "target": 1489115689647}, {"source": 1405189423019, "target": 1489115692629}, {"source": 1405189423019, "target": 1489115697533}, {"source": 1405189423019, "target": 1489115700761}, {"source": 1405189423019, "target": 1489115704079}, {"source": 1405189423019, "target": 1489115708123}, {"source": 1405189423019, "target": 1489115711910}, {"source": 1405189423019, "target": 1489115715080}, {"source": 1405189423019, "target": 1489115717318}, {"source": 1405189423019, "target": 1489115719007}, {"source": 1405189423019, "target": 1489115720740}, {"source": 1405189423019, "target": 1520726028342}, {"source": 1405189423019, "target": 1520726155922}, {"source": 1405189423019, "target": 1520726177396}, {"source": 1405189423019, "target": 1520726204602}, {"source": 1405189423019, "target": 1520726228244}, {"source": 1405189423019, "target": 1521499586481}, {"source": 1405189423019, "target": 1522544797357}, {"source": 1405189423019, "target": 1522545918379}, {"source": 1405189423019, "target": 1522766862787}, {"source": 1405189423019, "target": 1522891819566}, {"source": 1405189423019, "target": 1523321743572}, {"source": 1405189423019, "target": 1523889982310}, {"source": 1405189423019, "target": 1525534447417}, {"source": 1405189423019, "target": 1525534618298}, {"source": 1405189423019, "target": 1589050671556}, {"source": 1405189748896, "target": 1469211789678}, {"source": 1405189748896, "target": 1470793858352}, {"source": 1405189748896, "target": 1470793889603}, {"source": 1405189748896, "target": 1471378716219}, {"source": 1405189748896, "target": 1471378723785}, {"source": 1405189748896, "target": 1472147398832}, {"source": 1405189748896, "target": 1473375617796}, {"source": 1405189748896, "target": 1484768430296}, {"source": 1405189748896, "target": 1484768435794}, {"source": 1405189748896, "target": 1484768489461}, {"source": 1405189748896, "target": 1484768496791}, {"source": 1405189748896, "target": 1484768504506}, {"source": 1405189748896, "target": 1484768528915}, {"source": 1405189748896, "target": 1484768542523}, {"source": 1405189748896, "target": 1484768546903}, {"source": 1405189748896, "target": 1484768555637}, {"source": 1405189748896, "target": 1484768625035}, {"source": 1405189748896, "target": 1484768629105}, {"source": 1405189748896, "target": 1484768639953}, {"source": 1405189748896, "target": 1484778145187}, {"source": 1405189748896, "target": 1484778149500}, {"source": 1405189748896, "target": 1484778153479}, {"source": 1405189748896, "target": 1484778174517}, {"source": 1405189748896, "target": 1484778178394}, {"source": 1405189748896, "target": 1484778220705}, {"source": 1405189748896, "target": 1484778229455}, {"source": 1405189748896, "target": 1484778241451}, {"source": 1405189748896, "target": 1484778245242}, {"source": 1405189748896, "target": 1484862200866}, {"source": 1405189748896, "target": 1484862393206}, {"source": 1405189748896, "target": 1484862427507}, {"source": 1405189748896, "target": 1484862432889}, {"source": 1405189748896, "target": 1484862441642}, {"source": 1405189748896, "target": 1484862446206}, {"source": 1405189748896, "target": 1484862452178}, {"source": 1405189748896, "target": 1484862461322}, {"source": 1405189748896, "target": 1484862490045}, {"source": 1405189748896, "target": 1484862500798}, {"source": 1405189748896, "target": 1484862510434}, {"source": 1405189748896, "target": 1484862527140}, {"source": 1405189748896, "target": 1484879636730}, {"source": 1405189748896, "target": 1484879643351}, {"source": 1405189748896, "target": 1484879655591}, {"source": 1405189748896, "target": 1484879664445}, {"source": 1405189748896, "target": 1484879673290}, {"source": 1405189748896, "target": 1484879678492}, {"source": 1405189748896, "target": 1484879684118}, {"source": 1405189748896, "target": 1484879690560}, {"source": 1405189748896, "target": 1484879694825}, {"source": 1405189748896, "target": 1484879697741}, {"source": 1405189748896, "target": 1484879701855}, {"source": 1405189748896, "target": 1484879727067}, {"source": 1405189748896, "target": 1484879734307}, {"source": 1405189748896, "target": 1484879741939}, {"source": 1405189748896, "target": 1484879749641}, {"source": 1405189748896, "target": 1484879782041}, {"source": 1405189748896, "target": 1484879785546}, {"source": 1405189748896, "target": 1484879789460}, {"source": 1405189748896, "target": 1484879797391}, {"source": 1405189748896, "target": 1484879811416}, {"source": 1405189748896, "target": 1484950235435}, {"source": 1405189748896, "target": 1484950241378}, {"source": 1405189748896, "target": 1484950257380}, {"source": 1405189748896, "target": 1484950290832}, {"source": 1405189748896, "target": 1484950294343}, {"source": 1405189748896, "target": 1484950302359}, {"source": 1405189748896, "target": 1484950316241}, {"source": 1405189748896, "target": 1484950323983}, {"source": 1405189748896, "target": 1484950334879}, {"source": 1405189748896, "target": 1484950370258}, {"source": 1405189748896, "target": 1484950376874}, {"source": 1405189748896, "target": 1484950383414}, {"source": 1405189748896, "target": 1484950408050}, {"source": 1405189748896, "target": 1484950415236}, {"source": 1405189748896, "target": 1484950509959}, {"source": 1405189748896, "target": 1484950512131}, {"source": 1405189748896, "target": 1484950518844}, {"source": 1405189748896, "target": 1484950540514}, {"source": 1405189748896, "target": 1484950562122}, {"source": 1405189748896, "target": 1484950565258}, {"source": 1405189748896, "target": 1484950567327}, {"source": 1405189748896, "target": 1484950569362}, {"source": 1405189748896, "target": 1484950576373}, {"source": 1405189748896, "target": 1484950582585}, {"source": 1405189748896, "target": 1484950587301}, {"source": 1405189748896, "target": 1484950589278}, {"source": 1405189748896, "target": 1484950591778}, {"source": 1405189748896, "target": 1485048795602}, {"source": 1405189748896, "target": 1485048804453}, {"source": 1405189748896, "target": 1485048808436}, {"source": 1405189748896, "target": 1485048812402}, {"source": 1405189748896, "target": 1485048818628}, {"source": 1405189748896, "target": 1485048822971}, {"source": 1405189748896, "target": 1485126956476}, {"source": 1405189748896, "target": 1485126970109}, {"source": 1405189748896, "target": 1485126983586}, {"source": 1405189748896, "target": 1485126989139}, {"source": 1405189748896, "target": 1485127007445}, {"source": 1405189748896, "target": 1485127013968}, {"source": 1405189748896, "target": 1485127050894}, {"source": 1405189748896, "target": 1485127079406}, {"source": 1405189748896, "target": 1485127104969}, {"source": 1405189748896, "target": 1485127109814}, {"source": 1405189748896, "target": 1485127122076}, {"source": 1405189748896, "target": 1485127127238}, {"source": 1405189748896, "target": 1485127132019}, {"source": 1405189748896, "target": 1485127136888}, {"source": 1405189748896, "target": 1485127158928}, {"source": 1405189748896, "target": 1485127177693}, {"source": 1405189748896, "target": 1485127183182}, {"source": 1405189748896, "target": 1485127191097}, {"source": 1405189748896, "target": 1485127201063}, {"source": 1405189748896, "target": 1485127213919}, {"source": 1405189748896, "target": 1485127225427}, {"source": 1405189748896, "target": 1485127234705}, {"source": 1405189748896, "target": 1485127252070}, {"source": 1405189748896, "target": 1485127272816}, {"source": 1405189748896, "target": 1485127291177}, {"source": 1405189748896, "target": 1485127316123}, {"source": 1405189748896, "target": 1485127319429}, {"source": 1405189748896, "target": 1485127348698}, {"source": 1405189748896, "target": 1485127367254}, {"source": 1405189748896, "target": 1485127389322}, {"source": 1405189748896, "target": 1485127398074}, {"source": 1405189748896, "target": 1485127406267}, {"source": 1405189748896, "target": 1485127427576}, {"source": 1405189748896, "target": 1485127504259}, {"source": 1405189748896, "target": 1485127520616}, {"source": 1405189748896, "target": 1485127537767}, {"source": 1405189748896, "target": 1485127541726}, {"source": 1405189748896, "target": 1485127545269}, {"source": 1405189748896, "target": 1485127554282}, {"source": 1405189748896, "target": 1485127559293}, {"source": 1405189748896, "target": 1485127567796}, {"source": 1405189748896, "target": 1485127624016}, {"source": 1405189748896, "target": 1485127628996}, {"source": 1405189748896, "target": 1485127643105}, {"source": 1405189748896, "target": 1485197412342}, {"source": 1405189748896, "target": 1485225174374}, {"source": 1405189748896, "target": 1485226866177}, {"source": 1405189748896, "target": 1485226875275}, {"source": 1405189748896, "target": 1485226887033}, {"source": 1405189748896, "target": 1485226891209}, {"source": 1405189748896, "target": 1485226895684}, {"source": 1405189748896, "target": 1485226901711}, {"source": 1405189748896, "target": 1485226910732}, {"source": 1405189748896, "target": 1485226918038}, {"source": 1405189748896, "target": 1485226922398}, {"source": 1405189748896, "target": 1485226927627}, {"source": 1405189748896, "target": 1485226943316}, {"source": 1405189748896, "target": 1485226947581}, {"source": 1405189748896, "target": 1485226951657}, {"source": 1405189748896, "target": 1485226959311}, {"source": 1405189748896, "target": 1485226964020}, {"source": 1405189748896, "target": 1485226969948}, {"source": 1405189748896, "target": 1485226973026}, {"source": 1405189748896, "target": 1485226975107}, {"source": 1405189748896, "target": 1485226983749}, {"source": 1405189748896, "target": 1485226992623}, {"source": 1405189748896, "target": 1485227000677}, {"source": 1405189748896, "target": 1485227004646}, {"source": 1405189748896, "target": 1485227008690}, {"source": 1405189748896, "target": 1485382294582}, {"source": 1405189748896, "target": 1485382304579}, {"source": 1405189748896, "target": 1485382309642}, {"source": 1405189748896, "target": 1485382311895}, {"source": 1405189748896, "target": 1485389788956}, {"source": 1405189748896, "target": 1485389822615}, {"source": 1405189748896, "target": 1485389837206}, {"source": 1405189748896, "target": 1485389845221}, {"source": 1405189748896, "target": 1496772731140}, {"source": 1405189748896, "target": 1496775770544}, {"source": 1405189748896, "target": 1496775862689}, {"source": 1405189748896, "target": 1496775957800}, {"source": 1405189748896, "target": 1496776101268}, {"source": 1405189748896, "target": 1502344726854}, {"source": 1405189748896, "target": 1518963117783}, {"source": 1405189748896, "target": 1520901347807}, {"source": 1405189748896, "target": 1522424293535}, {"source": 1405189748896, "target": 1522524388741}, {"source": 1405189748896, "target": 1522524516442}, {"source": 1405189748896, "target": 1522524540457}, {"source": 1405189748896, "target": 1523303019600}, {"source": 1405189748896, "target": 1524148427060}, {"source": 1405189748896, "target": 1526328901920}, {"source": 1405189766131, "target": 1463526446923}, {"source": 1405189766131, "target": 1467682438089}, {"source": 1405189766131, "target": 1467683632126}, {"source": 1405189766131, "target": 1467683640354}, {"source": 1405189766131, "target": 1467771941535}, {"source": 1405189766131, "target": 1467771949843}, {"source": 1405189766131, "target": 1467771958669}, {"source": 1405189766131, "target": 1467771962365}, {"source": 1405189766131, "target": 1467771965298}, {"source": 1405189766131, "target": 1467833332774}, {"source": 1405189766131, "target": 1467833342686}, {"source": 1405189766131, "target": 1467833373021}, {"source": 1405189766131, "target": 1467833376501}, {"source": 1405189766131, "target": 1467833682877}, {"source": 1405189766131, "target": 1467833693475}, {"source": 1405189766131, "target": 1467833697927}, {"source": 1405189766131, "target": 1467833712322}, {"source": 1405189766131, "target": 1467833724957}, {"source": 1405189766131, "target": 1468086171259}, {"source": 1405189766131, "target": 1468089968464}, {"source": 1405189766131, "target": 1468089972385}, {"source": 1405189766131, "target": 1468089978978}, {"source": 1405189766131, "target": 1468089987696}, {"source": 1405189766131, "target": 1468089995767}, {"source": 1405189766131, "target": 1468101834431}, {"source": 1405189766131, "target": 1468248039828}, {"source": 1405189766131, "target": 1468250033324}, {"source": 1405189766131, "target": 1468250050173}, {"source": 1405189766131, "target": 1468250055072}, {"source": 1405189766131, "target": 1468250062063}, {"source": 1405189766131, "target": 1468250066742}, {"source": 1405189766131, "target": 1468250070151}, {"source": 1405189766131, "target": 1468250073774}, {"source": 1405189766131, "target": 1468250081218}, {"source": 1405189766131, "target": 1468250104716}, {"source": 1405189766131, "target": 1468250111962}, {"source": 1405189766131, "target": 1468250119090}, {"source": 1405189766131, "target": 1468531878098}, {"source": 1405189766131, "target": 1468531885671}, {"source": 1405189766131, "target": 1468531890730}, {"source": 1405189766131, "target": 1468531898082}, {"source": 1405189766131, "target": 1468531904527}, {"source": 1405189766131, "target": 1468531910983}, {"source": 1405189766131, "target": 1468531927104}, {"source": 1405189766131, "target": 1468549213267}, {"source": 1405189766131, "target": 1468549216900}, {"source": 1405189766131, "target": 1468549219948}, {"source": 1405189766131, "target": 1468549222931}, {"source": 1405189766131, "target": 1468549231401}, {"source": 1405189766131, "target": 1469146604758}, {"source": 1405189766131, "target": 1469146644218}, {"source": 1405189766131, "target": 1469146651628}, {"source": 1405189766131, "target": 1469146656814}, {"source": 1405189766131, "target": 1469146662039}, {"source": 1405189766131, "target": 1469146780202}, {"source": 1405189766131, "target": 1469146794988}, {"source": 1405189766131, "target": 1469146805489}, {"source": 1405189766131, "target": 1469146927480}, {"source": 1405189766131, "target": 1469146935257}, {"source": 1405189766131, "target": 1469211793467}, {"source": 1405189766131, "target": 1469211908690}, {"source": 1405189766131, "target": 1469212036244}, {"source": 1405189766131, "target": 1469212039940}, {"source": 1405189766131, "target": 1470793816352}, {"source": 1405189766131, "target": 1470793844592}, {"source": 1405189766131, "target": 1470793865617}, {"source": 1405189766131, "target": 1470793873507}, {"source": 1405189766131, "target": 1470793881136}, {"source": 1405189766131, "target": 1470793896802}, {"source": 1405189766131, "target": 1470850181542}, {"source": 1405189766131, "target": 1470850200353}, {"source": 1405189766131, "target": 1470850231818}, {"source": 1405189766131, "target": 1471466918687}, {"source": 1405189766131, "target": 1471468263016}, {"source": 1405189766131, "target": 1471551647075}, {"source": 1405189766131, "target": 1471552222169}, {"source": 1405189766131, "target": 1471552239888}, {"source": 1405189766131, "target": 1471552244931}, {"source": 1405189766131, "target": 1471552248534}, {"source": 1405189766131, "target": 1471552267287}, {"source": 1405189766131, "target": 1473289801695}, {"source": 1405189766131, "target": 1473289822632}, {"source": 1405189766131, "target": 1473293220506}, {"source": 1405189766131, "target": 1473293242577}, {"source": 1405189766131, "target": 1473293251581}, {"source": 1405189766131, "target": 1473293260136}, {"source": 1405189766131, "target": 1473293268513}, {"source": 1405189766131, "target": 1473293272040}, {"source": 1405189766131, "target": 1473293278261}, {"source": 1405189766131, "target": 1473293285727}, {"source": 1405189766131, "target": 1473293294683}, {"source": 1405189766131, "target": 1473293303131}, {"source": 1405189766131, "target": 1473293310827}, {"source": 1405189766131, "target": 1473293316303}, {"source": 1405189766131, "target": 1473293322063}, {"source": 1405189766131, "target": 1473293330615}, {"source": 1405189766131, "target": 1473293337113}, {"source": 1405189766131, "target": 1473293343603}, {"source": 1405189766131, "target": 1473293347301}, {"source": 1405189766131, "target": 1473293369230}, {"source": 1405189766131, "target": 1473293375437}, {"source": 1405189766131, "target": 1473293379509}, {"source": 1405189766131, "target": 1473293387558}, {"source": 1405189766131, "target": 1473293394920}, {"source": 1405189766131, "target": 1473297224976}, {"source": 1405189766131, "target": 1473300336904}, {"source": 1405189766131, "target": 1473300352378}, {"source": 1405189766131, "target": 1473300359071}, {"source": 1405189766131, "target": 1473300362617}, {"source": 1405189766131, "target": 1473300367115}, {"source": 1405189766131, "target": 1473300408446}, {"source": 1405189766131, "target": 1473300428992}, {"source": 1405189766131, "target": 1473300442300}, {"source": 1405189766131, "target": 1473300454880}, {"source": 1405189766131, "target": 1473300651450}, {"source": 1405189766131, "target": 1473300687105}, {"source": 1405189766131, "target": 1473300694950}, {"source": 1405189766131, "target": 1473303039851}, {"source": 1405189766131, "target": 1473303058193}, {"source": 1405189766131, "target": 1473303061719}, {"source": 1405189766131, "target": 1473303064461}, {"source": 1405189766131, "target": 1473303068390}, {"source": 1405189766131, "target": 1473303075690}, {"source": 1405189766131, "target": 1473357081053}, {"source": 1405189766131, "target": 1473359649088}, {"source": 1405189766131, "target": 1473359656628}, {"source": 1405189766131, "target": 1473359664721}, {"source": 1405189766131, "target": 1473359676593}, {"source": 1405189766131, "target": 1473359681224}, {"source": 1405189766131, "target": 1473359694352}, {"source": 1405189766131, "target": 1473359711985}, {"source": 1405189766131, "target": 1473359718241}, {"source": 1405189766131, "target": 1473359727133}, {"source": 1405189766131, "target": 1473359737393}, {"source": 1405189766131, "target": 1473359748313}, {"source": 1405189766131, "target": 1473359754715}, {"source": 1405189766131, "target": 1473359773067}, {"source": 1405189766131, "target": 1473359784908}, {"source": 1405189766131, "target": 1473359800095}, {"source": 1405189766131, "target": 1473359822159}, {"source": 1405189766131, "target": 1473359825264}, {"source": 1405189766131, "target": 1473359831675}, {"source": 1405189766131, "target": 1473359840004}, {"source": 1405189766131, "target": 1473359848012}, {"source": 1405189766131, "target": 1473359903608}, {"source": 1405189766131, "target": 1473359913501}, {"source": 1405189766131, "target": 1473359922418}, {"source": 1405189766131, "target": 1473359929731}, {"source": 1405189766131, "target": 1473360086947}, {"source": 1405189766131, "target": 1473360178198}, {"source": 1405189766131, "target": 1473360181189}, {"source": 1405189766131, "target": 1473360187634}, {"source": 1405189766131, "target": 1473360199275}, {"source": 1405189766131, "target": 1473360208446}, {"source": 1405189766131, "target": 1473360216545}, {"source": 1405189766131, "target": 1473360223014}, {"source": 1405189766131, "target": 1473360233264}, {"source": 1405189766131, "target": 1473360243258}, {"source": 1405189766131, "target": 1473360254783}, {"source": 1405189766131, "target": 1473368934391}, {"source": 1405189766131, "target": 1473368940054}, {"source": 1405189766131, "target": 1473368992990}, {"source": 1405189766131, "target": 1473369003612}, {"source": 1405189766131, "target": 1473369013245}, {"source": 1405189766131, "target": 1473369023362}, {"source": 1405189766131, "target": 1473369029753}, {"source": 1405189766131, "target": 1473369083915}, {"source": 1405189766131, "target": 1473369124027}, {"source": 1405189766131, "target": 1473369137331}, {"source": 1405189766131, "target": 1473369142474}, {"source": 1405189766131, "target": 1473369146920}, {"source": 1405189766131, "target": 1473369155271}, {"source": 1405189766131, "target": 1473369165633}, {"source": 1405189766131, "target": 1473369177431}, {"source": 1405189766131, "target": 1473369189318}, {"source": 1405189766131, "target": 1473369196549}, {"source": 1405189766131, "target": 1473369204016}, {"source": 1405189766131, "target": 1473369219302}, {"source": 1405189766131, "target": 1473369227483}, {"source": 1405189766131, "target": 1473369231234}, {"source": 1405189766131, "target": 1473369240326}, {"source": 1405189766131, "target": 1473369251416}, {"source": 1405189766131, "target": 1473369278925}, {"source": 1405189766131, "target": 1473369288604}, {"source": 1405189766131, "target": 1473369295710}, {"source": 1405189766131, "target": 1473369299476}, {"source": 1405189766131, "target": 1473369303496}, {"source": 1405189766131, "target": 1473369308294}, {"source": 1405189766131, "target": 1473369312966}, {"source": 1405189766131, "target": 1473369317123}, {"source": 1405189766131, "target": 1473369331388}, {"source": 1405189766131, "target": 1473369344215}, {"source": 1405189766131, "target": 1473375478702}, {"source": 1405189766131, "target": 1473375500147}, {"source": 1405189766131, "target": 1473375503319}, {"source": 1405189766131, "target": 1473375506777}, {"source": 1405189766131, "target": 1473375535170}, {"source": 1405189766131, "target": 1473375550384}, {"source": 1405189766131, "target": 1473375560175}, {"source": 1405189766131, "target": 1473375565346}, {"source": 1405189766131, "target": 1473375576711}, {"source": 1405189766131, "target": 1473375599442}, {"source": 1405189766131, "target": 1473375621493}, {"source": 1405189766131, "target": 1473375666330}, {"source": 1405189766131, "target": 1473375670335}, {"source": 1405189766131, "target": 1473375678641}, {"source": 1405189766131, "target": 1473375704144}, {"source": 1405189766131, "target": 1473375731135}, {"source": 1405189766131, "target": 1473375752214}, {"source": 1405189766131, "target": 1473375755860}, {"source": 1405189766131, "target": 1473375759207}, {"source": 1405189766131, "target": 1473375766028}, {"source": 1405189766131, "target": 1473375774093}, {"source": 1405189766131, "target": 1473375777918}, {"source": 1405189766131, "target": 1473382505498}, {"source": 1405189766131, "target": 1473384968406}, {"source": 1405189766131, "target": 1473384972708}, {"source": 1405189766131, "target": 1473384976677}, {"source": 1405189766131, "target": 1473384984006}, {"source": 1405189766131, "target": 1473384994044}, {"source": 1405189766131, "target": 1473385001562}, {"source": 1405189766131, "target": 1473385008578}, {"source": 1405189766131, "target": 1473385014843}, {"source": 1405189766131, "target": 1473385085081}, {"source": 1405189766131, "target": 1473385093236}, {"source": 1405189766131, "target": 1473385100104}, {"source": 1405189766131, "target": 1473385107205}, {"source": 1405189766131, "target": 1473385120151}, {"source": 1405189766131, "target": 1473385124486}, {"source": 1405189766131, "target": 1473385132024}, {"source": 1405189766131, "target": 1473385135804}, {"source": 1405189766131, "target": 1473385149693}, {"source": 1405189766131, "target": 1473385162124}, {"source": 1405189766131, "target": 1473385182147}, {"source": 1405189766131, "target": 1473385189444}, {"source": 1405189766131, "target": 1473385207458}, {"source": 1405189766131, "target": 1473385216220}, {"source": 1405189766131, "target": 1473385224779}, {"source": 1405189766131, "target": 1473385231162}, {"source": 1405189766131, "target": 1473385249608}, {"source": 1405189766131, "target": 1473385253436}, {"source": 1405189766131, "target": 1473385257949}, {"source": 1405189766131, "target": 1473385267297}, {"source": 1405189766131, "target": 1473385273967}, {"source": 1405189766131, "target": 1473385280374}, {"source": 1405189766131, "target": 1473385283630}, {"source": 1405189766131, "target": 1473385287565}, {"source": 1405189766131, "target": 1473385295319}, {"source": 1405189766131, "target": 1473385302273}, {"source": 1405189766131, "target": 1473385309456}, {"source": 1405189766131, "target": 1473385326286}, {"source": 1405189766131, "target": 1473385338969}, {"source": 1405189766131, "target": 1473385372338}, {"source": 1405189766131, "target": 1473385383326}, {"source": 1405189766131, "target": 1473388334713}, {"source": 1405189766131, "target": 1473388343171}, {"source": 1405189766131, "target": 1473388346421}, {"source": 1405189766131, "target": 1473388349273}, {"source": 1405189766131, "target": 1473388363119}, {"source": 1405189766131, "target": 1473388366794}, {"source": 1405189766131, "target": 1473388374224}, {"source": 1405189766131, "target": 1473388382342}, {"source": 1405189766131, "target": 1473388388973}, {"source": 1405189766131, "target": 1473388394383}, {"source": 1405189766131, "target": 1473388399336}, {"source": 1405189766131, "target": 1473388404748}, {"source": 1405189766131, "target": 1473388409501}, {"source": 1405189766131, "target": 1473388413857}, {"source": 1405189766131, "target": 1473388418050}, {"source": 1405189766131, "target": 1473449619050}, {"source": 1405189766131, "target": 1473451548444}, {"source": 1405189766131, "target": 1473456816180}, {"source": 1405189766131, "target": 1473456819619}, {"source": 1405189766131, "target": 1473456823056}, {"source": 1405189766131, "target": 1473456825860}, {"source": 1405189766131, "target": 1473456828566}, {"source": 1405189766131, "target": 1473456831203}, {"source": 1405189766131, "target": 1473456833834}, {"source": 1405189766131, "target": 1473456846940}, {"source": 1405189766131, "target": 1473456875333}, {"source": 1405189766131, "target": 1473456888262}, {"source": 1405189766131, "target": 1473456895792}, {"source": 1405189766131, "target": 1473456902368}, {"source": 1405189766131, "target": 1473456910717}, {"source": 1405189766131, "target": 1473456920567}, {"source": 1405189766131, "target": 1473456958647}, {"source": 1405189766131, "target": 1473456964441}, {"source": 1405189766131, "target": 1473456980055}, {"source": 1405189766131, "target": 1473456999177}, {"source": 1405189766131, "target": 1473457013179}, {"source": 1405189766131, "target": 1473457019242}, {"source": 1405189766131, "target": 1473457024978}, {"source": 1405189766131, "target": 1473457030849}, {"source": 1405189766131, "target": 1473457042626}, {"source": 1405189766131, "target": 1473457052548}, {"source": 1405189766131, "target": 1473457056485}, {"source": 1405189766131, "target": 1473457064016}, {"source": 1405189766131, "target": 1473457082593}, {"source": 1405189766131, "target": 1473457089774}, {"source": 1405189766131, "target": 1473457103123}, {"source": 1405189766131, "target": 1473457111077}, {"source": 1405189766131, "target": 1473457119672}, {"source": 1405189766131, "target": 1473457123360}, {"source": 1405189766131, "target": 1473457126772}, {"source": 1405189766131, "target": 1473457135988}, {"source": 1405189766131, "target": 1473457167822}, {"source": 1405189766131, "target": 1473462191670}, {"source": 1405189766131, "target": 1473462194805}, {"source": 1405189766131, "target": 1473462198021}, {"source": 1405189766131, "target": 1473462201615}, {"source": 1405189766131, "target": 1473462213152}, {"source": 1405189766131, "target": 1473462227997}, {"source": 1405189766131, "target": 1473462233981}, {"source": 1405189766131, "target": 1473462237789}, {"source": 1405189766131, "target": 1473462247915}, {"source": 1405189766131, "target": 1473462256883}, {"source": 1405189766131, "target": 1473462260997}, {"source": 1405189766131, "target": 1473462263825}, {"source": 1405189766131, "target": 1473462274943}, {"source": 1405189766131, "target": 1473462296454}, {"source": 1405189766131, "target": 1473462305431}, {"source": 1405189766131, "target": 1473462316560}, {"source": 1405189766131, "target": 1473462323490}, {"source": 1405189766131, "target": 1473462329921}, {"source": 1405189766131, "target": 1473462342206}, {"source": 1405189766131, "target": 1473462353971}, {"source": 1405189766131, "target": 1473462358150}, {"source": 1405189766131, "target": 1473462361340}, {"source": 1405189766131, "target": 1473462364075}, {"source": 1405189766131, "target": 1473462366827}, {"source": 1405189766131, "target": 1473465950356}, {"source": 1405189766131, "target": 1473466696206}, {"source": 1405189766131, "target": 1473466699874}, {"source": 1405189766131, "target": 1473466702995}, {"source": 1405189766131, "target": 1473466705886}, {"source": 1405189766131, "target": 1473466716293}, {"source": 1405189766131, "target": 1473466719274}, {"source": 1405189766131, "target": 1473466722005}, {"source": 1405189766131, "target": 1473466724430}, {"source": 1405189766131, "target": 1473466726760}, {"source": 1405189766131, "target": 1473466729435}, {"source": 1405189766131, "target": 1473466732375}, {"source": 1405189766131, "target": 1473466739900}, {"source": 1405189766131, "target": 1473466743100}, {"source": 1405189766131, "target": 1473466750305}, {"source": 1405189766131, "target": 1473466753404}, {"source": 1405189766131, "target": 1473466783990}, {"source": 1405189766131, "target": 1473466790168}, {"source": 1405189766131, "target": 1473466796836}, {"source": 1405189766131, "target": 1473466799950}, {"source": 1405189766131, "target": 1473466803191}, {"source": 1405189766131, "target": 1473466810863}, {"source": 1405189766131, "target": 1473466822938}, {"source": 1405189766131, "target": 1473466827229}, {"source": 1405189766131, "target": 1473466830217}, {"source": 1405189766131, "target": 1473466832973}, {"source": 1405189766131, "target": 1473466841624}, {"source": 1405189766131, "target": 1473466844481}, {"source": 1405189766131, "target": 1473466847506}, {"source": 1405189766131, "target": 1473466854672}, {"source": 1405189766131, "target": 1473466860013}, {"source": 1405189766131, "target": 1473466862672}, {"source": 1405189766131, "target": 1473548962473}, {"source": 1405189766131, "target": 1474509558350}, {"source": 1405189766131, "target": 1474511888849}, {"source": 1405189766131, "target": 1474511892721}, {"source": 1405189766131, "target": 1474511897736}, {"source": 1405189766131, "target": 1474511912687}, {"source": 1405189766131, "target": 1474511918491}, {"source": 1405189766131, "target": 1474511925850}, {"source": 1405189766131, "target": 1474511934874}, {"source": 1405189766131, "target": 1474511944771}, {"source": 1405189766131, "target": 1474511953060}, {"source": 1405189766131, "target": 1474511955568}, {"source": 1405189766131, "target": 1474511963068}, {"source": 1405189766131, "target": 1474746842357}, {"source": 1405189766131, "target": 1474746852860}, {"source": 1405189766131, "target": 1474746855917}, {"source": 1405189766131, "target": 1474746862902}, {"source": 1405189766131, "target": 1474746870596}, {"source": 1405189766131, "target": 1474746873791}, {"source": 1405189766131, "target": 1474758510704}, {"source": 1405189766131, "target": 1474932502315}, {"source": 1405189766131, "target": 1474932505066}, {"source": 1405189766131, "target": 1474932507699}, {"source": 1405189766131, "target": 1475177759507}, {"source": 1405189766131, "target": 1475178054448}, {"source": 1405189766131, "target": 1475200506347}, {"source": 1405189766131, "target": 1475203838374}, {"source": 1405189766131, "target": 1475203846579}, {"source": 1405189766131, "target": 1475203856328}, {"source": 1405189766131, "target": 1475203858939}, {"source": 1405189766131, "target": 1475203864870}, {"source": 1405189766131, "target": 1475203871268}, {"source": 1405189766131, "target": 1475203886147}, {"source": 1405189766131, "target": 1475203888674}, {"source": 1405189766131, "target": 1475203890936}, {"source": 1405189766131, "target": 1475203892902}, {"source": 1405189766131, "target": 1475203895050}, {"source": 1405189766131, "target": 1475203898709}, {"source": 1405189766131, "target": 1475203900994}, {"source": 1405189766131, "target": 1475204034580}, {"source": 1405189766131, "target": 1475703937935}, {"source": 1405189766131, "target": 1475704474957}, {"source": 1405189766131, "target": 1475704670335}, {"source": 1405189766131, "target": 1476583297365}, {"source": 1405189766131, "target": 1476583304479}, {"source": 1405189766131, "target": 1476583308513}, {"source": 1405189766131, "target": 1476583312048}, {"source": 1405189766131, "target": 1476583349919}, {"source": 1405189766131, "target": 1482115275376}, {"source": 1405189766131, "target": 1482115280312}, {"source": 1405189766131, "target": 1482115284201}, {"source": 1405189766131, "target": 1482115290110}, {"source": 1405189766131, "target": 1482115296382}, {"source": 1405189766131, "target": 1482115305907}, {"source": 1405189766131, "target": 1482115311272}, {"source": 1405189766131, "target": 1482115316095}, {"source": 1405189766131, "target": 1482115326502}, {"source": 1405189766131, "target": 1482115337224}, {"source": 1405189766131, "target": 1486608749626}, {"source": 1405189766131, "target": 1486608754106}, {"source": 1405189766131, "target": 1486608758394}, {"source": 1405189766131, "target": 1486608763486}, {"source": 1405189766131, "target": 1486608768857}, {"source": 1405189766131, "target": 1486771325323}, {"source": 1405189766131, "target": 1486781853443}, {"source": 1405189766131, "target": 1486781856708}, {"source": 1405189766131, "target": 1486781859461}, {"source": 1405189766131, "target": 1486831373970}, {"source": 1405189766131, "target": 1486831388932}, {"source": 1405189766131, "target": 1486945301523}, {"source": 1405189766131, "target": 1486945306178}, {"source": 1405189766131, "target": 1486945310167}, {"source": 1405189766131, "target": 1486945344711}, {"source": 1405189766131, "target": 1486945363228}, {"source": 1405189766131, "target": 1486945368306}, {"source": 1405189766131, "target": 1486952617561}, {"source": 1405189766131, "target": 1486952620697}, {"source": 1405189766131, "target": 1487117070760}, {"source": 1405189766131, "target": 1487117108862}, {"source": 1405189766131, "target": 1487117112350}, {"source": 1405189766131, "target": 1487117115624}, {"source": 1405189766131, "target": 1487117118637}, {"source": 1405189766131, "target": 1487292580228}, {"source": 1405189766131, "target": 1487462195051}, {"source": 1405189766131, "target": 1487983926461}, {"source": 1405189766131, "target": 1488418428735}, {"source": 1405189766131, "target": 1488418436183}, {"source": 1405189766131, "target": 1488418438908}, {"source": 1405189766131, "target": 1488418445475}, {"source": 1405189766131, "target": 1488418447737}, {"source": 1405189766131, "target": 1488418449967}, {"source": 1405189766131, "target": 1496079065704}, {"source": 1405189766131, "target": 1496183277033}, {"source": 1405189766131, "target": 1496183407992}, {"source": 1405189766131, "target": 1496620320182}, {"source": 1405189766131, "target": 1496620388047}, {"source": 1405189766131, "target": 1496620614167}, {"source": 1405189766131, "target": 1496620892610}, {"source": 1405189766131, "target": 1496870175137}, {"source": 1405189766131, "target": 1496870429879}, {"source": 1405189766131, "target": 1496870508969}, {"source": 1405189766131, "target": 1496871132816}, {"source": 1405189766131, "target": 1496872303888}, {"source": 1405189766131, "target": 1520301453074}, {"source": 1405189766131, "target": 1520813115603}, {"source": 1405189766131, "target": 1520906706487}, {"source": 1405189766131, "target": 1521071357761}, {"source": 1405189766131, "target": 1521264391869}, {"source": 1405189766131, "target": 1522524251630}, {"source": 1405189766131, "target": 1522986512395}, {"source": 1405189766131, "target": 1523414014382}, {"source": 1405189766131, "target": 1523414047330}, {"source": 1405189766131, "target": 1523475027630}, {"source": 1405189766131, "target": 1524146563713}, {"source": 1405189766131, "target": 1524146658690}, {"source": 1405189766131, "target": 1524146884689}, {"source": 1405189766131, "target": 1524147764686}, {"source": 1405189766131, "target": 1524147915895}, {"source": 1405189766131, "target": 1524699712797}, {"source": 1405189766131, "target": 1524700826965}, {"source": 1405189766131, "target": 1524798283046}, {"source": 1405189766131, "target": 1524798399322}, {"source": 1405189766131, "target": 1524798554422}, {"source": 1405189766131, "target": 1525441121649}, {"source": 1405189766131, "target": 1536696017301}, {"source": 1405189766131, "target": 1579655931955}, {"source": 1405189766131, "target": 1579657087867}, {"source": 1405722949047, "target": 1476667635005}, {"source": 1405722949047, "target": 1476669535017}, {"source": 1405722949047, "target": 1476669538969}, {"source": 1405722949047, "target": 1476669544873}, {"source": 1405722949047, "target": 1476669549324}, {"source": 1405722949047, "target": 1476669552837}, {"source": 1405722949047, "target": 1476669559297}, {"source": 1405722949047, "target": 1476669563594}, {"source": 1405722949047, "target": 1476669567633}, {"source": 1405722949047, "target": 1476669572157}, {"source": 1405722949047, "target": 1476669576211}, {"source": 1405722949047, "target": 1476669579159}, {"source": 1405722949047, "target": 1482014886764}, {"source": 1405722949047, "target": 1482021549752}, {"source": 1405722949047, "target": 1482021556058}, {"source": 1405722949047, "target": 1482021561377}, {"source": 1405722949047, "target": 1482021567159}, {"source": 1405722949047, "target": 1482021572867}, {"source": 1405722949047, "target": 1482021579186}, {"source": 1405722949047, "target": 1482021584289}, {"source": 1405722949047, "target": 1482021589803}, {"source": 1405722949047, "target": 1482021594676}, {"source": 1405722949047, "target": 1482021603417}, {"source": 1405722949047, "target": 1482021663832}, {"source": 1405722949047, "target": 1482021669311}, {"source": 1405722949047, "target": 1482021680972}, {"source": 1405722949047, "target": 1482021684208}, {"source": 1405722949047, "target": 1482021686946}, {"source": 1405722949047, "target": 1482021696583}, {"source": 1405722949047, "target": 1482021700392}, {"source": 1405722949047, "target": 1482021707646}, {"source": 1405722949047, "target": 1482021710999}, {"source": 1405722949047, "target": 1482021715220}, {"source": 1405722949047, "target": 1482021723937}, {"source": 1405722949047, "target": 1482021728193}, {"source": 1405722949047, "target": 1482021739745}, {"source": 1405722949047, "target": 1482021742911}, {"source": 1405722949047, "target": 1482021746495}, {"source": 1405722949047, "target": 1482021753483}, {"source": 1405722949047, "target": 1482021756852}, {"source": 1405722949047, "target": 1482021762704}, {"source": 1405722949047, "target": 1482021827543}, {"source": 1405722949047, "target": 1482021831523}, {"source": 1405722949047, "target": 1482021838448}, {"source": 1405722949047, "target": 1482021846216}, {"source": 1405722949047, "target": 1482021853417}, {"source": 1405722949047, "target": 1482021864452}, {"source": 1405722949047, "target": 1482021870350}, {"source": 1405722949047, "target": 1482021883479}, {"source": 1405722949047, "target": 1482021886990}, {"source": 1405722949047, "target": 1482021894404}, {"source": 1405722949047, "target": 1482021903019}, {"source": 1405722949047, "target": 1482021911657}, {"source": 1405722949047, "target": 1482021920866}, {"source": 1405722949047, "target": 1482021939459}, {"source": 1405722949047, "target": 1482021949414}, {"source": 1405722949047, "target": 1482021953235}, {"source": 1405722949047, "target": 1482021955784}, {"source": 1405722949047, "target": 1482021961866}, {"source": 1405722949047, "target": 1482021967948}, {"source": 1405722949047, "target": 1482021971578}, {"source": 1405722949047, "target": 1482022001682}, {"source": 1405722949047, "target": 1482022005886}, {"source": 1405722949047, "target": 1482022008299}, {"source": 1405722949047, "target": 1482022010871}, {"source": 1405722949047, "target": 1482022027494}, {"source": 1405722949047, "target": 1482022030441}, {"source": 1405722949047, "target": 1482022036640}, {"source": 1405722949047, "target": 1482022069057}, {"source": 1405722949047, "target": 1482022076569}, {"source": 1405722949047, "target": 1482022079663}, {"source": 1405722949047, "target": 1482022081983}, {"source": 1405722949047, "target": 1482022084524}, {"source": 1405722949047, "target": 1482022097240}, {"source": 1405722949047, "target": 1482022105272}, {"source": 1405722949047, "target": 1482022108336}, {"source": 1405722949047, "target": 1482022126258}, {"source": 1405722949047, "target": 1482022129277}, {"source": 1405722949047, "target": 1482022140828}, {"source": 1405722949047, "target": 1482022147543}, {"source": 1405722949047, "target": 1482022152555}, {"source": 1405722949047, "target": 1482028018965}, {"source": 1405722949047, "target": 1482030234278}, {"source": 1405722949047, "target": 1482030242022}, {"source": 1405722949047, "target": 1482030247113}, {"source": 1405722949047, "target": 1482030251800}, {"source": 1405722949047, "target": 1482030256371}, {"source": 1405722949047, "target": 1482030261006}, {"source": 1405722949047, "target": 1482030269123}, {"source": 1405722949047, "target": 1482030273275}, {"source": 1405722949047, "target": 1482030275598}, {"source": 1405722949047, "target": 1482030278629}, {"source": 1405722949047, "target": 1482030283165}, {"source": 1405722949047, "target": 1482030287042}, {"source": 1405722949047, "target": 1482030295480}, {"source": 1405722949047, "target": 1482030303363}, {"source": 1405722949047, "target": 1482030311506}, {"source": 1405722949047, "target": 1482030315536}, {"source": 1405722949047, "target": 1482030319798}, {"source": 1405722949047, "target": 1482030322556}, {"source": 1405722949047, "target": 1482030326785}, {"source": 1405722949047, "target": 1482030330644}, {"source": 1405722949047, "target": 1482030334468}, {"source": 1405722949047, "target": 1482030339793}, {"source": 1405722949047, "target": 1482030348639}, {"source": 1405722949047, "target": 1482030356723}, {"source": 1405722949047, "target": 1482030364936}, {"source": 1405722949047, "target": 1482030372145}, {"source": 1405722949047, "target": 1482030376868}, {"source": 1405722949047, "target": 1482030383962}, {"source": 1405722949047, "target": 1482030391388}, {"source": 1405722949047, "target": 1482030396859}, {"source": 1405722949047, "target": 1482114769717}, {"source": 1405722949047, "target": 1482115200729}, {"source": 1405722949047, "target": 1482115208173}, {"source": 1405722949047, "target": 1482115213179}, {"source": 1405722949047, "target": 1482115220459}, {"source": 1405722949047, "target": 1482115226227}, {"source": 1405722949047, "target": 1482115229293}, {"source": 1405722949047, "target": 1482115237070}, {"source": 1405722949047, "target": 1482115240121}, {"source": 1405722949047, "target": 1482115252126}, {"source": 1405722949047, "target": 1482115268611}, {"source": 1405722949047, "target": 1482115342571}, {"source": 1405722949047, "target": 1482115345843}, {"source": 1405722949047, "target": 1482115348463}, {"source": 1405722949047, "target": 1482115351278}, {"source": 1405722949047, "target": 1482115357618}, {"source": 1405722949047, "target": 1482115360476}, {"source": 1405722949047, "target": 1482115362763}, {"source": 1405722949047, "target": 1482115365440}, {"source": 1405722949047, "target": 1482115378077}, {"source": 1405722949047, "target": 1482115382071}, {"source": 1405722949047, "target": 1482115388869}, {"source": 1405722949047, "target": 1482115391361}, {"source": 1405722949047, "target": 1482115393714}, {"source": 1405722949047, "target": 1482115395969}, {"source": 1405722949047, "target": 1482115403409}, {"source": 1405722949047, "target": 1482115408306}, {"source": 1405722949047, "target": 1482115420919}, {"source": 1405722949047, "target": 1482115427771}, {"source": 1405722949047, "target": 1482115432496}, {"source": 1405722949047, "target": 1482115442644}, {"source": 1405722949047, "target": 1482115445612}, {"source": 1405722949047, "target": 1482115451005}, {"source": 1405722949047, "target": 1482115455383}, {"source": 1405722949047, "target": 1482115460996}, {"source": 1405722949047, "target": 1482115465581}, {"source": 1405722949047, "target": 1482115473217}, {"source": 1405722949047, "target": 1482115477908}, {"source": 1405722949047, "target": 1482115481615}, {"source": 1405722949047, "target": 1482115484108}, {"source": 1405722949047, "target": 1482115490061}, {"source": 1405722949047, "target": 1482115492876}, {"source": 1405722949047, "target": 1482115500165}, {"source": 1405722949047, "target": 1482115504921}, {"source": 1405722949047, "target": 1482115509710}, {"source": 1405722949047, "target": 1482115513922}, {"source": 1405722949047, "target": 1482115518484}, {"source": 1405722949047, "target": 1482115525140}, {"source": 1405722949047, "target": 1482115541696}, {"source": 1405722949047, "target": 1482115547887}, {"source": 1405722949047, "target": 1482115554891}, {"source": 1405722949047, "target": 1482115575316}, {"source": 1405722949047, "target": 1482115579210}, {"source": 1405722949047, "target": 1486596689685}, {"source": 1405722949047, "target": 1486596693761}, {"source": 1405722949047, "target": 1486605111359}, {"source": 1405722949047, "target": 1486605702844}, {"source": 1405722949047, "target": 1486605708937}, {"source": 1405722949047, "target": 1486605712112}, {"source": 1405722949047, "target": 1486605714923}, {"source": 1405722949047, "target": 1486605719941}, {"source": 1405722949047, "target": 1486605724453}, {"source": 1405722949047, "target": 1486605727740}, {"source": 1405722949047, "target": 1486605759797}, {"source": 1405722949047, "target": 1486605773525}, {"source": 1405722949047, "target": 1486605777827}, {"source": 1405722949047, "target": 1486605781009}, {"source": 1405722949047, "target": 1486605785335}, {"source": 1405722949047, "target": 1486605789747}, {"source": 1405722949047, "target": 1486605794937}, {"source": 1405722949047, "target": 1486608389324}, {"source": 1405722949047, "target": 1486608728772}, {"source": 1405722949047, "target": 1486608734803}, {"source": 1405722949047, "target": 1486608739171}, {"source": 1405722949047, "target": 1486608745216}, {"source": 1405722949047, "target": 1486608774946}, {"source": 1405722949047, "target": 1486608779650}, {"source": 1405722949047, "target": 1486608782562}, {"source": 1405722949047, "target": 1486608789738}, {"source": 1405722949047, "target": 1486608796832}, {"source": 1405722949047, "target": 1486608800197}, {"source": 1405722949047, "target": 1486608805821}, {"source": 1405722949047, "target": 1486608813182}, {"source": 1405722949047, "target": 1486767143966}, {"source": 1405722949047, "target": 1486767150807}, {"source": 1405722949047, "target": 1486767159823}, {"source": 1405722949047, "target": 1486767163689}, {"source": 1405722949047, "target": 1486767179344}, {"source": 1405722949047, "target": 1486767185215}, {"source": 1405722949047, "target": 1486767214155}, {"source": 1405722949047, "target": 1486767222611}, {"source": 1405722949047, "target": 1486767231234}, {"source": 1405722949047, "target": 1486767235675}, {"source": 1405722949047, "target": 1486767238872}, {"source": 1405722949047, "target": 1486767243259}, {"source": 1405722949047, "target": 1486767250072}, {"source": 1405722949047, "target": 1486767254523}, {"source": 1405722949047, "target": 1486767263733}, {"source": 1405722949047, "target": 1486767268255}, {"source": 1405722949047, "target": 1486767276770}, {"source": 1405722949047, "target": 1486767287058}, {"source": 1405722949047, "target": 1486767295417}, {"source": 1405722949047, "target": 1486767304293}, {"source": 1405722949047, "target": 1486767314237}, {"source": 1405722949047, "target": 1486767323251}, {"source": 1405722949047, "target": 1486767327881}, {"source": 1405722949047, "target": 1486767330571}, {"source": 1405722949047, "target": 1486767333068}, {"source": 1405722949047, "target": 1486767335503}, {"source": 1405722949047, "target": 1486767337959}, {"source": 1405722949047, "target": 1486767341284}, {"source": 1405722949047, "target": 1486767346792}, {"source": 1405722949047, "target": 1486767395683}, {"source": 1405722949047, "target": 1486771285047}, {"source": 1405722949047, "target": 1486771299461}, {"source": 1405722949047, "target": 1486771310689}, {"source": 1405722949047, "target": 1486771334237}, {"source": 1405722949047, "target": 1486771343412}, {"source": 1405722949047, "target": 1486771346144}, {"source": 1405722949047, "target": 1486771351448}, {"source": 1405722949047, "target": 1486771357327}, {"source": 1405722949047, "target": 1486771359798}, {"source": 1405722949047, "target": 1486771365392}, {"source": 1405722949047, "target": 1486771372707}, {"source": 1405722949047, "target": 1486771374861}, {"source": 1405722949047, "target": 1486771380083}, {"source": 1405722949047, "target": 1486771387643}, {"source": 1405722949047, "target": 1486771390217}, {"source": 1405722949047, "target": 1486771396183}, {"source": 1405722949047, "target": 1486775502282}, {"source": 1405722949047, "target": 1486776235726}, {"source": 1405722949047, "target": 1486776242882}, {"source": 1405722949047, "target": 1486776248771}, {"source": 1405722949047, "target": 1486776254440}, {"source": 1405722949047, "target": 1486776257809}, {"source": 1405722949047, "target": 1486776304662}, {"source": 1405722949047, "target": 1486776314995}, {"source": 1405722949047, "target": 1486776358379}, {"source": 1405722949047, "target": 1486776364876}, {"source": 1405722949047, "target": 1486776370260}, {"source": 1405722949047, "target": 1486776374938}, {"source": 1405722949047, "target": 1486776378880}, {"source": 1405722949047, "target": 1486776382915}, {"source": 1405722949047, "target": 1486776386641}, {"source": 1405722949047, "target": 1486776390497}, {"source": 1405722949047, "target": 1486776394241}, {"source": 1405722949047, "target": 1486776399210}, {"source": 1405722949047, "target": 1486776403243}, {"source": 1405722949047, "target": 1486777451032}, {"source": 1405722949047, "target": 1486777651171}, {"source": 1405722949047, "target": 1486777654795}, {"source": 1405722949047, "target": 1486778497083}, {"source": 1405722949047, "target": 1486778696654}, {"source": 1405722949047, "target": 1486778702275}, {"source": 1405722949047, "target": 1486778710282}, {"source": 1405722949047, "target": 1486778716772}, {"source": 1405722949047, "target": 1486778720937}, {"source": 1405722949047, "target": 1486778725100}, {"source": 1405722949047, "target": 1486780884702}, {"source": 1405722949047, "target": 1486781809597}, {"source": 1405722949047, "target": 1486781824679}, {"source": 1405722949047, "target": 1486781865305}, {"source": 1405722949047, "target": 1486781873705}, {"source": 1405722949047, "target": 1486781877894}, {"source": 1405722949047, "target": 1486781885770}, {"source": 1405722949047, "target": 1486781908212}, {"source": 1405722949047, "target": 1486781913076}, {"source": 1405722949047, "target": 1486781921099}, {"source": 1405722949047, "target": 1486781925444}, {"source": 1405722949047, "target": 1486781932848}, {"source": 1405722949047, "target": 1486781953253}, {"source": 1405722949047, "target": 1486781957705}, {"source": 1405722949047, "target": 1486781960267}, {"source": 1405722949047, "target": 1486781963213}, {"source": 1405722949047, "target": 1486781967050}, {"source": 1405722949047, "target": 1486781970730}, {"source": 1405722949047, "target": 1486830193952}, {"source": 1405722949047, "target": 1486831365896}, {"source": 1405722949047, "target": 1486831370373}, {"source": 1405722949047, "target": 1486831380213}, {"source": 1405722949047, "target": 1486831385390}, {"source": 1405722949047, "target": 1486831395587}, {"source": 1405722949047, "target": 1486831402485}, {"source": 1405722949047, "target": 1486831407877}, {"source": 1405722949047, "target": 1486831412480}, {"source": 1405722949047, "target": 1486831418335}, {"source": 1405722949047, "target": 1486831422868}, {"source": 1405722949047, "target": 1486831427477}, {"source": 1405722949047, "target": 1486831445995}, {"source": 1405722949047, "target": 1486831448616}, {"source": 1405722949047, "target": 1486945227191}, {"source": 1405722949047, "target": 1486945231564}, {"source": 1405722949047, "target": 1486945235222}, {"source": 1405722949047, "target": 1486945239368}, {"source": 1405722949047, "target": 1486945243332}, {"source": 1405722949047, "target": 1486945247167}, {"source": 1405722949047, "target": 1486945252224}, {"source": 1405722949047, "target": 1486945288206}, {"source": 1405722949047, "target": 1520713733324}, {"source": 1405722949047, "target": 1520714481780}, {"source": 1405722949047, "target": 1520726299596}, {"source": 1405722949047, "target": 1520726446562}, {"source": 1405722949047, "target": 1520899975915}, {"source": 1405722949047, "target": 1520900253563}, {"source": 1405722949047, "target": 1520903285210}, {"source": 1405722949047, "target": 1521071732308}, {"source": 1405722949047, "target": 1521079313083}, {"source": 1405722949047, "target": 1521156441953}, {"source": 1405722949047, "target": 1521156796178}, {"source": 1405722949047, "target": 1521170266917}, {"source": 1405722949047, "target": 1521498851107}, {"source": 1405722949047, "target": 1521596607286}, {"source": 1405722949047, "target": 1522201866086}, {"source": 1461598684331, "target": 1467927138618}, {"source": 1461598684331, "target": 1467927142028}, {"source": 1461598684331, "target": 1475704608986}, {"source": 1461598684331, "target": 1476583315863}, {"source": 1461598684331, "target": 1476583320663}, {"source": 1461598684331, "target": 1476583335376}, {"source": 1461598684331, "target": 1476583972242}, {"source": 1461598684331, "target": 1476583976799}, {"source": 1461598684331, "target": 1476583985260}, {"source": 1461598684331, "target": 1484950427352}, {"source": 1461598684331, "target": 1485037158388}, {"source": 1461598684331, "target": 1485037163106}, {"source": 1461598684331, "target": 1485037181746}, {"source": 1461598684331, "target": 1485037195286}, {"source": 1461598684331, "target": 1485037215079}, {"source": 1461598684331, "target": 1485037217772}, {"source": 1461598684331, "target": 1485037220962}, {"source": 1461598684331, "target": 1485037225784}, {"source": 1461598684331, "target": 1485037230598}, {"source": 1461598684331, "target": 1485037235169}, {"source": 1461598684331, "target": 1485037244915}, {"source": 1461598684331, "target": 1485037249011}, {"source": 1461598684331, "target": 1485037254163}, {"source": 1461598684331, "target": 1485037287564}, {"source": 1461598684331, "target": 1485037294850}, {"source": 1461598684331, "target": 1485037302273}, {"source": 1461598684331, "target": 1485037314388}, {"source": 1461598684331, "target": 1485042559919}, {"source": 1461598684331, "target": 1485042569716}, {"source": 1461598684331, "target": 1485042574055}, {"source": 1461598684331, "target": 1485042578061}, {"source": 1461598684331, "target": 1485042581970}, {"source": 1461598684331, "target": 1485042585717}, {"source": 1461598684331, "target": 1485042589665}, {"source": 1461598684331, "target": 1485042592432}, {"source": 1461598684331, "target": 1485042600488}, {"source": 1461598684331, "target": 1485042610619}, {"source": 1461598684331, "target": 1485042614659}, {"source": 1461598684331, "target": 1485042620859}, {"source": 1461598684331, "target": 1485042636608}, {"source": 1461598684331, "target": 1485042644988}, {"source": 1461598684331, "target": 1485042649443}, {"source": 1461598684331, "target": 1485042653577}, {"source": 1461598684331, "target": 1485042659288}, {"source": 1461598684331, "target": 1485042672407}, {"source": 1461598684331, "target": 1485042676367}, {"source": 1461598684331, "target": 1485042680339}, {"source": 1461598684331, "target": 1485048800051}, {"source": 1461598684331, "target": 1485048831798}, {"source": 1461598684331, "target": 1485048836271}, {"source": 1461598684331, "target": 1485048840582}, {"source": 1461598684331, "target": 1485048854935}, {"source": 1461598684331, "target": 1485048858768}, {"source": 1461598684331, "target": 1485048880722}, {"source": 1461598684331, "target": 1485053638174}, {"source": 1461598684331, "target": 1485053644033}, {"source": 1461598684331, "target": 1485053652441}, {"source": 1461598684331, "target": 1485053683098}, {"source": 1461598684331, "target": 1485053688514}, {"source": 1461598684331, "target": 1485053698756}, {"source": 1461598684331, "target": 1485053703584}, {"source": 1461598684331, "target": 1485053707855}, {"source": 1461598684331, "target": 1485053712014}, {"source": 1461598684331, "target": 1485053716394}, {"source": 1461598684331, "target": 1485053720833}, {"source": 1461598684331, "target": 1485053725170}, {"source": 1461598684331, "target": 1485053731302}, {"source": 1461598684331, "target": 1485053736113}, {"source": 1461598684331, "target": 1485053741166}, {"source": 1461598684331, "target": 1485053745807}, {"source": 1461598684331, "target": 1485053753326}, {"source": 1461598684331, "target": 1485053760622}, {"source": 1461598684331, "target": 1485053767451}, {"source": 1461598684331, "target": 1485053774666}, {"source": 1461598684331, "target": 1485053782197}, {"source": 1461598684331, "target": 1485053784465}, {"source": 1461598684331, "target": 1485053797165}, {"source": 1461598684331, "target": 1485053799258}, {"source": 1461598684331, "target": 1485053801271}, {"source": 1461598684331, "target": 1485126703491}, {"source": 1461598684331, "target": 1485126718528}, {"source": 1461598684331, "target": 1485126742965}, {"source": 1461598684331, "target": 1485126747494}, {"source": 1461598684331, "target": 1485126765245}, {"source": 1461598684331, "target": 1485126788211}, {"source": 1461598684331, "target": 1485126797804}, {"source": 1461598684331, "target": 1485126830237}, {"source": 1461598684331, "target": 1485126835875}, {"source": 1461598684331, "target": 1485126841513}, {"source": 1461598684331, "target": 1485126851799}, {"source": 1461598684331, "target": 1485197167577}, {"source": 1461598684331, "target": 1485197173976}, {"source": 1461598684331, "target": 1485197183364}, {"source": 1461598684331, "target": 1485197196524}, {"source": 1461598684331, "target": 1485197204480}, {"source": 1461598684331, "target": 1485197240608}, {"source": 1461598684331, "target": 1485197255331}, {"source": 1461598684331, "target": 1485197266380}, {"source": 1461598684331, "target": 1485197270482}, {"source": 1461598684331, "target": 1485197279658}, {"source": 1461598684331, "target": 1485197284770}, {"source": 1461598684331, "target": 1485197289010}, {"source": 1461598684331, "target": 1485197293102}, {"source": 1461598684331, "target": 1485197376704}, {"source": 1461598684331, "target": 1485197389304}, {"source": 1461598684331, "target": 1485197406891}, {"source": 1461598684331, "target": 1485197432205}, {"source": 1461598684331, "target": 1485197436210}, {"source": 1461598684331, "target": 1485219977212}, {"source": 1461598684331, "target": 1485219981783}, {"source": 1461598684331, "target": 1485219985329}, {"source": 1461598684331, "target": 1485219990010}, {"source": 1461598684331, "target": 1485220015721}, {"source": 1461598684331, "target": 1485220018582}, {"source": 1461598684331, "target": 1485220020967}, {"source": 1461598684331, "target": 1485220028997}, {"source": 1461598684331, "target": 1485220035986}, {"source": 1461598684331, "target": 1485220042805}, {"source": 1461598684331, "target": 1485220045231}, {"source": 1461598684331, "target": 1485220060480}, {"source": 1461598684331, "target": 1485220077925}, {"source": 1461598684331, "target": 1485220084231}, {"source": 1461598684331, "target": 1486952585000}, {"source": 1461598684331, "target": 1488153925598}, {"source": 1461598684331, "target": 1488153943084}, {"source": 1461598684331, "target": 1488153977297}, {"source": 1461598684331, "target": 1488153980776}, {"source": 1461598684331, "target": 1488153984198}, {"source": 1461598684331, "target": 1488153987056}, {"source": 1461598684331, "target": 1488153992586}, {"source": 1461598684331, "target": 1488153999516}, {"source": 1461598684331, "target": 1488154002188}, {"source": 1461598684331, "target": 1488154005344}, {"source": 1461598684331, "target": 1488154008256}, {"source": 1461598684331, "target": 1488154011659}, {"source": 1461598684331, "target": 1488154018652}, {"source": 1461598684331, "target": 1488154025451}, {"source": 1461598684331, "target": 1488154036143}, {"source": 1461598684331, "target": 1488154044058}, {"source": 1461598684331, "target": 1488154051712}, {"source": 1461598684331, "target": 1488154057387}, {"source": 1461598684331, "target": 1488154063767}, {"source": 1461598684331, "target": 1488154067058}, {"source": 1461598684331, "target": 1488154072070}, {"source": 1461598684331, "target": 1488154079433}, {"source": 1461598684331, "target": 1488154087019}, {"source": 1461598684331, "target": 1488154103442}, {"source": 1461598684331, "target": 1488154106594}, {"source": 1461598684331, "target": 1488154123080}, {"source": 1461598684331, "target": 1488154130432}, {"source": 1461598684331, "target": 1488154132833}, {"source": 1461598684331, "target": 1488154134900}, {"source": 1461598684331, "target": 1488154141116}, {"source": 1461598684331, "target": 1488154151078}, {"source": 1461598684331, "target": 1488154155508}, {"source": 1461598684331, "target": 1488154158429}, {"source": 1461598684331, "target": 1488154162983}, {"source": 1461598684331, "target": 1488154165735}, {"source": 1461598684331, "target": 1488154172718}, {"source": 1461598684331, "target": 1488154179748}, {"source": 1461598684331, "target": 1488154194187}, {"source": 1461598684331, "target": 1488154197821}, {"source": 1461598684331, "target": 1488154203814}, {"source": 1461598684331, "target": 1488154205844}, {"source": 1461598684331, "target": 1488154207969}, {"source": 1461598684331, "target": 1488154209988}, {"source": 1461598684331, "target": 1488154212025}, {"source": 1461598684331, "target": 1488154214573}, {"source": 1461598684331, "target": 1488154222514}, {"source": 1461598684331, "target": 1488154239414}, {"source": 1461598684331, "target": 1488154244383}, {"source": 1461598684331, "target": 1488154250806}, {"source": 1461598684331, "target": 1488154254526}, {"source": 1461598684331, "target": 1488154260436}, {"source": 1461598684331, "target": 1488154271167}, {"source": 1461598684331, "target": 1488154273351}, {"source": 1461598684331, "target": 1488154275283}, {"source": 1461598684331, "target": 1488154310043}, {"source": 1461598684331, "target": 1488154346725}, {"source": 1461598684331, "target": 1488156362804}, {"source": 1461598684331, "target": 1488158468885}, {"source": 1461598684331, "target": 1488158478382}, {"source": 1461598684331, "target": 1488158483806}, {"source": 1461598684331, "target": 1488158491025}, {"source": 1461598684331, "target": 1488158498635}, {"source": 1461598684331, "target": 1488158505167}, {"source": 1461598684331, "target": 1488158509358}, {"source": 1461598684331, "target": 1488158515445}, {"source": 1461598684331, "target": 1488158521582}, {"source": 1461598684331, "target": 1488158587363}, {"source": 1461598684331, "target": 1488158592417}, {"source": 1461598684331, "target": 1488158594625}, {"source": 1461598684331, "target": 1488158604836}, {"source": 1461598684331, "target": 1488158607454}, {"source": 1461598684331, "target": 1488158609741}, {"source": 1461598684331, "target": 1488158616564}, {"source": 1461598684331, "target": 1488158618692}, {"source": 1461598684331, "target": 1488158624515}, {"source": 1461598684331, "target": 1488158626909}, {"source": 1461598684331, "target": 1488158629480}, {"source": 1461598684331, "target": 1488158632507}, {"source": 1461598684331, "target": 1488158639613}, {"source": 1461598684331, "target": 1488158642264}, {"source": 1461598684331, "target": 1488158647681}, {"source": 1461598684331, "target": 1488158653008}, {"source": 1461598684331, "target": 1488158657810}, {"source": 1461598684331, "target": 1488158661194}, {"source": 1461598684331, "target": 1488158663647}, {"source": 1461598684331, "target": 1488158666195}, {"source": 1461598684331, "target": 1488158668157}, {"source": 1461598684331, "target": 1488158671971}, {"source": 1461598684331, "target": 1488158675153}, {"source": 1461598684331, "target": 1488158677710}, {"source": 1461598684331, "target": 1488158679387}, {"source": 1461598684331, "target": 1488158681260}, {"source": 1461598684331, "target": 1488158684257}, {"source": 1461598684331, "target": 1488158686006}, {"source": 1461598684331, "target": 1488158689770}, {"source": 1461598684331, "target": 1488158691886}, {"source": 1461598684331, "target": 1488158694088}, {"source": 1461598684331, "target": 1488158706465}, {"source": 1461598684331, "target": 1488158711866}, {"source": 1461598684331, "target": 1488158715215}, {"source": 1461598684331, "target": 1488158719240}, {"source": 1461598684331, "target": 1488158721404}, {"source": 1461598684331, "target": 1488247922730}, {"source": 1461598684331, "target": 1488247975880}, {"source": 1461598684331, "target": 1488248086324}, {"source": 1461598684331, "target": 1488409952800}, {"source": 1461598684331, "target": 1488418087875}, {"source": 1461598684331, "target": 1488418093751}, {"source": 1461598684331, "target": 1488418096970}, {"source": 1461598684331, "target": 1488418099220}, {"source": 1461598684331, "target": 1488418106813}, {"source": 1461598684331, "target": 1488418224075}, {"source": 1461598684331, "target": 1488418271395}, {"source": 1461598684331, "target": 1488418278945}, {"source": 1461598684331, "target": 1488418284913}, {"source": 1461598684331, "target": 1488418289795}, {"source": 1461598684331, "target": 1488418293440}, {"source": 1461598684331, "target": 1488418299612}, {"source": 1461598684331, "target": 1488418305850}, {"source": 1461598684331, "target": 1488418308296}, {"source": 1461598684331, "target": 1488418310891}, {"source": 1461598684331, "target": 1488418318763}, {"source": 1461598684331, "target": 1488418321113}, {"source": 1461598684331, "target": 1488418324096}, {"source": 1461598684331, "target": 1488418347812}, {"source": 1461598684331, "target": 1488418351291}, {"source": 1461598684331, "target": 1488418358285}, {"source": 1461598684331, "target": 1488418414137}, {"source": 1461598684331, "target": 1488418416727}, {"source": 1461598684331, "target": 1488418426461}, {"source": 1461598684331, "target": 1488418525490}, {"source": 1461598684331, "target": 1488418535769}, {"source": 1461598684331, "target": 1488418538322}, {"source": 1461598684331, "target": 1488418541862}, {"source": 1461598684331, "target": 1488418545172}, {"source": 1461598684331, "target": 1488418548933}, {"source": 1461598684331, "target": 1488418555043}, {"source": 1461598684331, "target": 1488418562282}, {"source": 1461598684331, "target": 1488418565940}, {"source": 1461598684331, "target": 1488418572449}, {"source": 1461598684331, "target": 1488418576187}, {"source": 1461598684331, "target": 1494989899824}, {"source": 1461598684331, "target": 1496080089180}, {"source": 1461598684331, "target": 1496095496392}, {"source": 1461598684331, "target": 1496095543376}, {"source": 1461598684331, "target": 1496182184553}, {"source": 1461598684331, "target": 1496182685275}, {"source": 1461598684331, "target": 1496182766150}, {"source": 1461598684331, "target": 1496182848127}, {"source": 1461598684331, "target": 1496182886253}, {"source": 1461598684331, "target": 1496182934811}, {"source": 1461598684331, "target": 1496182963245}, {"source": 1461598684331, "target": 1496182982505}, {"source": 1461598684331, "target": 1496183168055}, {"source": 1461598684331, "target": 1496183230856}, {"source": 1461598684331, "target": 1496351444482}, {"source": 1461598684331, "target": 1496351602377}, {"source": 1461598684331, "target": 1496351983459}, {"source": 1461598684331, "target": 1496352026512}, {"source": 1461598684331, "target": 1496352086585}, {"source": 1461598684331, "target": 1496352128311}, {"source": 1461598684331, "target": 1496352355479}, {"source": 1461598684331, "target": 1496352395527}, {"source": 1461598684331, "target": 1496352430998}, {"source": 1461598684331, "target": 1496352456455}, {"source": 1461598684331, "target": 1496352500581}, {"source": 1461598684331, "target": 1496701796676}, {"source": 1461598684331, "target": 1497373274959}, {"source": 1461598684331, "target": 1497378912089}, {"source": 1461598684331, "target": 1497379168285}, {"source": 1461598684331, "target": 1514458460580}, {"source": 1461598684331, "target": 1515539993315}, {"source": 1461598684331, "target": 1515775028345}, {"source": 1461598684331, "target": 1516467886379}, {"source": 1461598684331, "target": 1516552228242}, {"source": 1461598684331, "target": 1516552434126}, {"source": 1461598684331, "target": 1516552577663}, {"source": 1461598684331, "target": 1516552882272}, {"source": 1461598684331, "target": 1516553476487}, {"source": 1461598684331, "target": 1516553657699}, {"source": 1461598684331, "target": 1520279394016}, {"source": 1461598684331, "target": 1520948267256}, {"source": 1461598684331, "target": 1520948678127}, {"source": 1461598684331, "target": 1521427798951}, {"source": 1461598684331, "target": 1522108771352}, {"source": 1461598684331, "target": 1522522630686}, {"source": 1461598684331, "target": 1522524591305}, {"source": 1461598684331, "target": 1523414842071}, {"source": 1461598684331, "target": 1525112432441}, {"source": 1461598684331, "target": 1525112850711}, {"source": 1461598684331, "target": 1525832074892}, {"source": 1461598684331, "target": 1570487202656}, {"source": 1461598684331, "target": 1578107897849}, {"source": 1461598684331, "target": 1578107966397}, {"source": 1461598684331, "target": 1578108101510}, {"source": 1461598684331, "target": 1581878151605}, {"source": 1461792762468, "target": 1461794607480}, {"source": 1461792762468, "target": 1461794779174}, {"source": 1461792762468, "target": 1461797617523}, {"source": 1461792762468, "target": 1461797629482}, {"source": 1461792762468, "target": 1461797649771}, {"source": 1461792762468, "target": 1461797660332}, {"source": 1461792762468, "target": 1461797674252}, {"source": 1461792762468, "target": 1462061251872}, {"source": 1461792762468, "target": 1463675445325}, {"source": 1461792762468, "target": 1463675586235}, {"source": 1461792762468, "target": 1468250242901}, {"source": 1461792762468, "target": 1486866351517}, {"source": 1461792762468, "target": 1486867490403}, {"source": 1461792762468, "target": 1486867495023}, {"source": 1461792762468, "target": 1486867499358}, {"source": 1461792762468, "target": 1486867503989}, {"source": 1461792762468, "target": 1486867509134}, {"source": 1461792762468, "target": 1486867513384}, {"source": 1461792762468, "target": 1486867518070}, {"source": 1461792762468, "target": 1486867532110}, {"source": 1461792762468, "target": 1486867606359}, {"source": 1461792762468, "target": 1486867612235}, {"source": 1461792762468, "target": 1486867618953}, {"source": 1461792762468, "target": 1486867623104}, {"source": 1461792762468, "target": 1486867628723}, {"source": 1461792762468, "target": 1486867633025}, {"source": 1461792762468, "target": 1486867644687}, {"source": 1461792762468, "target": 1486867649389}, {"source": 1461792762468, "target": 1486867658485}, {"source": 1461792762468, "target": 1486867662727}, {"source": 1461792762468, "target": 1486867667014}, {"source": 1461792762468, "target": 1486867676959}, {"source": 1461792762468, "target": 1486867685826}, {"source": 1461792762468, "target": 1486867696248}, {"source": 1461792762468, "target": 1486867700749}, {"source": 1461792762468, "target": 1486867708925}, {"source": 1461792762468, "target": 1486867712651}, {"source": 1461792762468, "target": 1486867718130}, {"source": 1461792762468, "target": 1486945028810}, {"source": 1461792762468, "target": 1486945095844}, {"source": 1461792762468, "target": 1486945100917}, {"source": 1461792762468, "target": 1486945105493}, {"source": 1461792762468, "target": 1486945114357}, {"source": 1461792762468, "target": 1486945119290}, {"source": 1461792762468, "target": 1486945122632}, {"source": 1461792762468, "target": 1486945128758}, {"source": 1461792762468, "target": 1486945131833}, {"source": 1461792762468, "target": 1486945137995}, {"source": 1461792762468, "target": 1486945149721}, {"source": 1461792762468, "target": 1486945155220}, {"source": 1461792762468, "target": 1486945159596}, {"source": 1461792762468, "target": 1486945164044}, {"source": 1461792762468, "target": 1486945168998}, {"source": 1461792762468, "target": 1486945173671}, {"source": 1461792762468, "target": 1486945178237}, {"source": 1461792762468, "target": 1486945186009}, {"source": 1461792762468, "target": 1486945189088}, {"source": 1461792762468, "target": 1486945192340}, {"source": 1461792762468, "target": 1486945196492}, {"source": 1461792762468, "target": 1486945200481}, {"source": 1461792762468, "target": 1486945204408}, {"source": 1461792762468, "target": 1486945209483}, {"source": 1461792762468, "target": 1486945213450}, {"source": 1461792762468, "target": 1486945217222}, {"source": 1461792762468, "target": 1486945222161}, {"source": 1461792762468, "target": 1486945256449}, {"source": 1461792762468, "target": 1486945260294}, {"source": 1461792762468, "target": 1486945264004}, {"source": 1461792762468, "target": 1486945267724}, {"source": 1461792762468, "target": 1486945272965}, {"source": 1461792762468, "target": 1486945280637}, {"source": 1461792762468, "target": 1486945284156}, {"source": 1461792762468, "target": 1486945292519}, {"source": 1461792762468, "target": 1486945297046}, {"source": 1461792762468, "target": 1486945314023}, {"source": 1461792762468, "target": 1486945318448}, {"source": 1461792762468, "target": 1486945322037}, {"source": 1461792762468, "target": 1486945327076}, {"source": 1461792762468, "target": 1486945331281}, {"source": 1461792762468, "target": 1486945335969}, {"source": 1461792762468, "target": 1486945340214}, {"source": 1461792762468, "target": 1486952361607}, {"source": 1461792762468, "target": 1486952565694}, {"source": 1461792762468, "target": 1486952569377}, {"source": 1461792762468, "target": 1486952572343}, {"source": 1461792762468, "target": 1486952576797}, {"source": 1461792762468, "target": 1486952580934}, {"source": 1461792762468, "target": 1486952612312}, {"source": 1461792762468, "target": 1486952615115}, {"source": 1461792762468, "target": 1486952623418}, {"source": 1461792762468, "target": 1486952630150}, {"source": 1461792762468, "target": 1486952638474}, {"source": 1461792762468, "target": 1486952644614}, {"source": 1461792762468, "target": 1486952649215}, {"source": 1461792762468, "target": 1486952653362}, {"source": 1461792762468, "target": 1486952657292}, {"source": 1461792762468, "target": 1486952664370}, {"source": 1461792762468, "target": 1486952670744}, {"source": 1461792762468, "target": 1486952677289}, {"source": 1461792762468, "target": 1486952681913}, {"source": 1461792762468, "target": 1486952685707}, {"source": 1461792762468, "target": 1486952689393}, {"source": 1461792762468, "target": 1486952695243}, {"source": 1461792762468, "target": 1486952700865}, {"source": 1461792762468, "target": 1486952708867}, {"source": 1461792762468, "target": 1486952713234}, {"source": 1461792762468, "target": 1486952717741}, {"source": 1461792762468, "target": 1486952720521}, {"source": 1461792762468, "target": 1486952724628}, {"source": 1461792762468, "target": 1486952730716}, {"source": 1461792762468, "target": 1486952733427}, {"source": 1461792762468, "target": 1486952739648}, {"source": 1461792762468, "target": 1486956337697}, {"source": 1461792762468, "target": 1487115889320}, {"source": 1461792762468, "target": 1487116826422}, {"source": 1461792762468, "target": 1487116831797}, {"source": 1461792762468, "target": 1487116836334}, {"source": 1461792762468, "target": 1487117011573}, {"source": 1461792762468, "target": 1487117018684}, {"source": 1461792762468, "target": 1487117025756}, {"source": 1461792762468, "target": 1487117038124}, {"source": 1461792762468, "target": 1487117045399}, {"source": 1461792762468, "target": 1487117055356}, {"source": 1461792762468, "target": 1487117063416}, {"source": 1461792762468, "target": 1487117074086}, {"source": 1461792762468, "target": 1487117077263}, {"source": 1461792762468, "target": 1487117081885}, {"source": 1461792762468, "target": 1487117090100}, {"source": 1461792762468, "target": 1487117100809}, {"source": 1461792762468, "target": 1487117104655}, {"source": 1461792762468, "target": 1487117121383}, {"source": 1461792762468, "target": 1487117165317}, {"source": 1461792762468, "target": 1487117169828}, {"source": 1461792762468, "target": 1487117174952}, {"source": 1461792762468, "target": 1487117187498}, {"source": 1461792762468, "target": 1487117197858}, {"source": 1461792762468, "target": 1487117209824}, {"source": 1461792762468, "target": 1487117216624}, {"source": 1461792762468, "target": 1487117219869}, {"source": 1461792762468, "target": 1487117223955}, {"source": 1461792762468, "target": 1487117227757}, {"source": 1461792762468, "target": 1487117234083}, {"source": 1461792762468, "target": 1487117238120}, {"source": 1461792762468, "target": 1487117240890}, {"source": 1461792762468, "target": 1487117251418}, {"source": 1461792762468, "target": 1487117255825}, {"source": 1461792762468, "target": 1487117269713}, {"source": 1461792762468, "target": 1487117363961}, {"source": 1461792762468, "target": 1487117366290}, {"source": 1461792762468, "target": 1487121752455}, {"source": 1461792762468, "target": 1487121953944}, {"source": 1461792762468, "target": 1487121958371}, {"source": 1461792762468, "target": 1487121965148}, {"source": 1461792762468, "target": 1487121973551}, {"source": 1461792762468, "target": 1487121978005}, {"source": 1461792762468, "target": 1487121984540}, {"source": 1461792762468, "target": 1487121991618}, {"source": 1461792762468, "target": 1487121995626}, {"source": 1461792762468, "target": 1487121999722}, {"source": 1461792762468, "target": 1487122003310}, {"source": 1461792762468, "target": 1487122006764}, {"source": 1461792762468, "target": 1487122010297}, {"source": 1461792762468, "target": 1487122014689}, {"source": 1461792762468, "target": 1487122020805}, {"source": 1461792762468, "target": 1487122023570}, {"source": 1461792762468, "target": 1487122030428}, {"source": 1461792762468, "target": 1487122032935}, {"source": 1461792762468, "target": 1487122035576}, {"source": 1461792762468, "target": 1487122042028}, {"source": 1461792762468, "target": 1487122045686}, {"source": 1461792762468, "target": 1487122048949}, {"source": 1461792762468, "target": 1487122053213}, {"source": 1461792762468, "target": 1487122056375}, {"source": 1461792762468, "target": 1487122060289}, {"source": 1461792762468, "target": 1487122064154}, {"source": 1461792762468, "target": 1487122067345}, {"source": 1461792762468, "target": 1487122070185}, {"source": 1461792762468, "target": 1487122077594}, {"source": 1461792762468, "target": 1487122080060}, {"source": 1461792762468, "target": 1487122086575}, {"source": 1461792762468, "target": 1487122089996}, {"source": 1461792762468, "target": 1487122093207}, {"source": 1461792762468, "target": 1487122099697}, {"source": 1461792762468, "target": 1487122104176}, {"source": 1461792762468, "target": 1487122107982}, {"source": 1461792762468, "target": 1487122111408}, {"source": 1461792762468, "target": 1487122118000}, {"source": 1461792762468, "target": 1487122124336}, {"source": 1461792762468, "target": 1487207094725}, {"source": 1461792762468, "target": 1487207097572}, {"source": 1461792762468, "target": 1487207100136}, {"source": 1461792762468, "target": 1487207102783}, {"source": 1461792762468, "target": 1487207105743}, {"source": 1461792762468, "target": 1487207112553}, {"source": 1461792762468, "target": 1487207119666}, {"source": 1461792762468, "target": 1487207122541}, {"source": 1461792762468, "target": 1487207142388}, {"source": 1461792762468, "target": 1487207151765}, {"source": 1461792762468, "target": 1487207154426}, {"source": 1461792762468, "target": 1487207156353}, {"source": 1461792762468, "target": 1487207160372}, {"source": 1461792762468, "target": 1487207167794}, {"source": 1461792762468, "target": 1487207175248}, {"source": 1461792762468, "target": 1487207181602}, {"source": 1461792762468, "target": 1487207184256}, {"source": 1461792762468, "target": 1487207190223}, {"source": 1461792762468, "target": 1487207192567}, {"source": 1461792762468, "target": 1487207194698}, {"source": 1461792762468, "target": 1487207200447}, {"source": 1461792762468, "target": 1487207203586}, {"source": 1461792762468, "target": 1487207210931}, {"source": 1461792762468, "target": 1487207216546}, {"source": 1461792762468, "target": 1487207218837}, {"source": 1461792762468, "target": 1487207220752}, {"source": 1461792762468, "target": 1487207229813}, {"source": 1461792762468, "target": 1487207238825}, {"source": 1461792762468, "target": 1487207240713}, {"source": 1461792762468, "target": 1487207242473}, {"source": 1461792762468, "target": 1487207244285}, {"source": 1461792762468, "target": 1487207248593}, {"source": 1461792762468, "target": 1487208643200}, {"source": 1461792762468, "target": 1487214787212}, {"source": 1461792762468, "target": 1487214790550}, {"source": 1461792762468, "target": 1487214792960}, {"source": 1461792762468, "target": 1487214863091}, {"source": 1461792762468, "target": 1487470217383}, {"source": 1461792762468, "target": 1487982311235}, {"source": 1461792762468, "target": 1487983915856}, {"source": 1461792762468, "target": 1487983919927}, {"source": 1461792762468, "target": 1487983938140}, {"source": 1461792762468, "target": 1487983941570}, {"source": 1461792762468, "target": 1487983947972}, {"source": 1461792762468, "target": 1487983954783}, {"source": 1461792762468, "target": 1487983958998}, {"source": 1461792762468, "target": 1487983965276}, {"source": 1461792762468, "target": 1487983968953}, {"source": 1461792762468, "target": 1489966658123}, {"source": 1461792762468, "target": 1489966869972}, {"source": 1461792762468, "target": 1489966899449}, {"source": 1461792762468, "target": 1489967019558}, {"source": 1461792762468, "target": 1489967103370}, {"source": 1461792762468, "target": 1489967393730}, {"source": 1461792762468, "target": 1489967395455}, {"source": 1461792762468, "target": 1489967499767}, {"source": 1461792762468, "target": 1489968369893}, {"source": 1461792762468, "target": 1489968431221}, {"source": 1461792762468, "target": 1489968436766}, {"source": 1461792762468, "target": 1489968442057}, {"source": 1461792762468, "target": 1489968446315}, {"source": 1461792762468, "target": 1489969950421}, {"source": 1461792762468, "target": 1489970103277}, {"source": 1461792762468, "target": 1489970288745}, {"source": 1461792762468, "target": 1489970329566}, {"source": 1461792762468, "target": 1489970333367}, {"source": 1461792762468, "target": 1489970360784}, {"source": 1461792762468, "target": 1489970456186}, {"source": 1461792762468, "target": 1489970516941}, {"source": 1461792762468, "target": 1489970519207}, {"source": 1461792762468, "target": 1489970582544}, {"source": 1461792762468, "target": 1489970595226}, {"source": 1461792762468, "target": 1489970609617}, {"source": 1461792762468, "target": 1489970615786}, {"source": 1461792762468, "target": 1489970693302}, {"source": 1461792762468, "target": 1489971265225}, {"source": 1461792762468, "target": 1489972334508}, {"source": 1461792762468, "target": 1489972338045}, {"source": 1461792762468, "target": 1489972341669}, {"source": 1461792762468, "target": 1489972344892}, {"source": 1461792762468, "target": 1489972348185}, {"source": 1461792762468, "target": 1489972355594}, {"source": 1461792762468, "target": 1489972384117}, {"source": 1461792762468, "target": 1489972385073}, {"source": 1461792762468, "target": 1489972389668}, {"source": 1461792762468, "target": 1489972393455}, {"source": 1461792762468, "target": 1401387108466}, {"source": 1461792762468, "target": 1495633577748}, {"source": 1461792762468, "target": 1495634939970}, {"source": 1461792762468, "target": 1495635392036}, {"source": 1461792762468, "target": 1495635688466}, {"source": 1461792762468, "target": 1495731198988}, {"source": 1461792762468, "target": 1495734114619}, {"source": 1461792762468, "target": 1497198981442}, {"source": 1461792762468, "target": 1497199116233}, {"source": 1461792762468, "target": 1497199647386}, {"source": 1461792762468, "target": 1497199947288}, {"source": 1461792762468, "target": 1497200014755}, {"source": 1461792762468, "target": 1497202892232}, {"source": 1461792762468, "target": 1497203886624}, {"source": 1461792762468, "target": 1497205397644}, {"source": 1461792762468, "target": 1497205776676}, {"source": 1461792762468, "target": 1497212066546}, {"source": 1461792762468, "target": 1497372323184}, {"source": 1461792762468, "target": 1497385969520}, {"source": 1461792762468, "target": 1501511684746}, {"source": 1461792762468, "target": 1514737744464}, {"source": 1461792762468, "target": 1514740606355}, {"source": 1461792762468, "target": 1514740864172}, {"source": 1461792762468, "target": 1514740926267}, {"source": 1461792762468, "target": 1514740967212}, {"source": 1461792762468, "target": 1514741107116}, {"source": 1461792762468, "target": 1514900969301}, {"source": 1461792762468, "target": 1516115769450}, {"source": 1461792762468, "target": 1516939735510}, {"source": 1461792762468, "target": 1517771826170}, {"source": 1461792762468, "target": 1520298958244}, {"source": 1461792762468, "target": 1520299088400}, {"source": 1461792762468, "target": 1520299291738}, {"source": 1461792762468, "target": 1520299391760}, {"source": 1461792762468, "target": 1520299451730}, {"source": 1461792762468, "target": 1520299562982}, {"source": 1461792762468, "target": 1520348845643}, {"source": 1461792762468, "target": 1520349090462}, {"source": 1461792762468, "target": 1520349342170}, {"source": 1461792762468, "target": 1520349496885}, {"source": 1461792762468, "target": 1520349610883}, {"source": 1461792762468, "target": 1520349635265}, {"source": 1461792762468, "target": 1520349768071}, {"source": 1461792762468, "target": 1520349810324}, {"source": 1461792762468, "target": 1520349838418}, {"source": 1461792762468, "target": 1520350020005}, {"source": 1461792762468, "target": 1520350299216}, {"source": 1461792762468, "target": 1520350346925}, {"source": 1461792762468, "target": 1520350497804}, {"source": 1461792762468, "target": 1520350606644}, {"source": 1461792762468, "target": 1520350649105}, {"source": 1461792762468, "target": 1520350698792}, {"source": 1461792762468, "target": 1520350737368}, {"source": 1461792762468, "target": 1520350800405}, {"source": 1461792762468, "target": 1520351096121}, {"source": 1461792762468, "target": 1520351135706}, {"source": 1461792762468, "target": 1520354097521}, {"source": 1461792762468, "target": 1578248007976}, {"source": 1461792762468, "target": 1578248124988}, {"source": 1461792762468, "target": 1578248499297}, {"source": 1461797617523, "target": 1461797689978}, {"source": 1461797617523, "target": 1474670586711}, {"source": 1461797617523, "target": 1489873889112}, {"source": 1461797617523, "target": 1500763927138}, {"source": 1461797617523, "target": 1514419633547}, {"source": 1461797617523, "target": 1514420887416}, {"source": 1461797617523, "target": 1514422215928}, {"source": 1461797617523, "target": 1514422659811}, {"source": 1461797617523, "target": 1514423519338}, {"source": 1461797617523, "target": 1514423999681}, {"source": 1461797617523, "target": 1514424401527}, {"source": 1461797617523, "target": 1514424617556}, {"source": 1461797617523, "target": 1514425801856}, {"source": 1461797617523, "target": 1514426162645}, {"source": 1461797617523, "target": 1514426584201}, {"source": 1461797617523, "target": 1514427712564}, {"source": 1461797617523, "target": 1514430258982}, {"source": 1461797617523, "target": 1514430526440}, {"source": 1461797617523, "target": 1514430905153}, {"source": 1461797617523, "target": 1514431283782}, {"source": 1461797617523, "target": 1514431666907}, {"source": 1461797617523, "target": 1514431768534}, {"source": 1461797617523, "target": 1514432045338}, {"source": 1461797617523, "target": 1514432711133}, {"source": 1461797617523, "target": 1514433076091}, {"source": 1461797617523, "target": 1514433987345}, {"source": 1461797617523, "target": 1514434693948}, {"source": 1461797617523, "target": 1514434849844}, {"source": 1461797617523, "target": 1514435402463}, {"source": 1461797617523, "target": 1514436096099}, {"source": 1461797617523, "target": 1514436260830}, {"source": 1461797617523, "target": 1514436347961}, {"source": 1461797617523, "target": 1514436496585}, {"source": 1461797617523, "target": 1514436919577}, {"source": 1461797617523, "target": 1514437403760}, {"source": 1461797617523, "target": 1514437669394}, {"source": 1461797617523, "target": 1514439095781}, {"source": 1461797617523, "target": 1514440129037}, {"source": 1461797617523, "target": 1514440460727}, {"source": 1461797617523, "target": 1514440546690}, {"source": 1461797617523, "target": 1514440711339}, {"source": 1461797617523, "target": 1514440791493}, {"source": 1461797617523, "target": 1514440977413}, {"source": 1461797617523, "target": 1514441376218}, {"source": 1461797617523, "target": 1514441738287}, {"source": 1461797617523, "target": 1514442928641}, {"source": 1461797617523, "target": 1514443210018}, {"source": 1461797617523, "target": 1514443273175}, {"source": 1461797617523, "target": 1514443647682}, {"source": 1461797617523, "target": 1514443819523}, {"source": 1461797617523, "target": 1514444587887}, {"source": 1461797617523, "target": 1514445508453}, {"source": 1461797617523, "target": 1514445573219}, {"source": 1461797617523, "target": 1514445882123}, {"source": 1461797617523, "target": 1514446686718}, {"source": 1461797617523, "target": 1514447541492}, {"source": 1461797617523, "target": 1514447747690}, {"source": 1461797617523, "target": 1514450415516}, {"source": 1461797617523, "target": 1514450530846}, {"source": 1461797617523, "target": 1514450756049}, {"source": 1461797617523, "target": 1514450844855}, {"source": 1461797617523, "target": 1514451291382}, {"source": 1461797617523, "target": 1514451796998}, {"source": 1461797617523, "target": 1514452140645}, {"source": 1461797617523, "target": 1514452792616}, {"source": 1461797617523, "target": 1514456914237}, {"source": 1461797617523, "target": 1514457054810}, {"source": 1461797617523, "target": 1514457179721}, {"source": 1461797617523, "target": 1514457221062}, {"source": 1461797617523, "target": 1514457306321}, {"source": 1461797617523, "target": 1514457672217}, {"source": 1461797617523, "target": 1514457851724}, {"source": 1461797617523, "target": 1514457925286}, {"source": 1461797617523, "target": 1514458114358}, {"source": 1461797617523, "target": 1514458257172}, {"source": 1461797617523, "target": 1514458682574}, {"source": 1461797617523, "target": 1514458901383}, {"source": 1461797617523, "target": 1514459034165}, {"source": 1461797617523, "target": 1514461757411}, {"source": 1461797617523, "target": 1514461927723}, {"source": 1461797617523, "target": 1514462049753}, {"source": 1461797617523, "target": 1514462133220}, {"source": 1461797617523, "target": 1514462275608}, {"source": 1461797617523, "target": 1514462342356}, {"source": 1461797617523, "target": 1514462478138}, {"source": 1461797617523, "target": 1514462781191}, {"source": 1461797617523, "target": 1514463180331}, {"source": 1461797617523, "target": 1514463267259}, {"source": 1461797617523, "target": 1514463449579}, {"source": 1461797617523, "target": 1514463629792}, {"source": 1461797617523, "target": 1514492150873}, {"source": 1461797617523, "target": 1514492742100}, {"source": 1461797617523, "target": 1514492832526}, {"source": 1461797617523, "target": 1514493073982}, {"source": 1461797617523, "target": 1514493539465}, {"source": 1461797617523, "target": 1514500997298}, {"source": 1461797617523, "target": 1514502587908}, {"source": 1461797617523, "target": 1514502725358}, {"source": 1461797617523, "target": 1514502973036}, {"source": 1461797617523, "target": 1514504342380}, {"source": 1461797617523, "target": 1514504704391}, {"source": 1461797617523, "target": 1514504777486}, {"source": 1461797617523, "target": 1514505673938}, {"source": 1461797617523, "target": 1514505922565}, {"source": 1461797617523, "target": 1514506028657}, {"source": 1461797617523, "target": 1514506682583}, {"source": 1461797617523, "target": 1514506918332}, {"source": 1461797617523, "target": 1514507424195}, {"source": 1461797617523, "target": 1514508361101}, {"source": 1461797617523, "target": 1514508906862}, {"source": 1461797617523, "target": 1514509313238}, {"source": 1461797617523, "target": 1514510079046}, {"source": 1461797617523, "target": 1514510192071}, {"source": 1461797617523, "target": 1514511075948}, {"source": 1461797617523, "target": 1514513195576}, {"source": 1461797617523, "target": 1514513787208}, {"source": 1461797617523, "target": 1514514182817}, {"source": 1461797617523, "target": 1514514329720}, {"source": 1461797617523, "target": 1514515200640}, {"source": 1461797617523, "target": 1514515544308}, {"source": 1461797617523, "target": 1514515963174}, {"source": 1461797617523, "target": 1514516107224}, {"source": 1461797617523, "target": 1514518208243}, {"source": 1461797617523, "target": 1514518348409}, {"source": 1461797617523, "target": 1514518646731}, {"source": 1461797617523, "target": 1514522127441}, {"source": 1461797617523, "target": 1514522324681}, {"source": 1461797617523, "target": 1514522558258}, {"source": 1461797617523, "target": 1514523193580}, {"source": 1461797617523, "target": 1514523741386}, {"source": 1461797617523, "target": 1514569391561}, {"source": 1461797617523, "target": 1514574631336}, {"source": 1461797617523, "target": 1514574764466}, {"source": 1461797617523, "target": 1514574918297}, {"source": 1461797617523, "target": 1514575408582}, {"source": 1461797617523, "target": 1514575870809}, {"source": 1461797617523, "target": 1514575990602}, {"source": 1461797617523, "target": 1514576626207}, {"source": 1461797617523, "target": 1514576673430}, {"source": 1461797617523, "target": 1514576736235}, {"source": 1461797617523, "target": 1514577409259}, {"source": 1461797617523, "target": 1514577482891}, {"source": 1461797617523, "target": 1514578318921}, {"source": 1461797617523, "target": 1514578395739}, {"source": 1461797617523, "target": 1514578479296}, {"source": 1461797617523, "target": 1514578565465}, {"source": 1461797617523, "target": 1514578726359}, {"source": 1461797617523, "target": 1514578761759}, {"source": 1461797617523, "target": 1514578874673}, {"source": 1461797617523, "target": 1514578972476}, {"source": 1461797617523, "target": 1514580346966}, {"source": 1461797617523, "target": 1514580519023}, {"source": 1461797617523, "target": 1514581115897}, {"source": 1461797617523, "target": 1514581311427}, {"source": 1461797617523, "target": 1514581770673}, {"source": 1461797617523, "target": 1514581913540}, {"source": 1461797617523, "target": 1514582271830}, {"source": 1461797617523, "target": 1514582320489}, {"source": 1461797617523, "target": 1514582716438}, {"source": 1461797617523, "target": 1514582953537}, {"source": 1461797617523, "target": 1514583111655}, {"source": 1461797617523, "target": 1514583362638}, {"source": 1461797617523, "target": 1514583416438}, {"source": 1461797617523, "target": 1514583836151}, {"source": 1461797617523, "target": 1514584124803}, {"source": 1461797617523, "target": 1514584175090}, {"source": 1461797617523, "target": 1514584232919}, {"source": 1461797617523, "target": 1514584343410}, {"source": 1461797617523, "target": 1514584507672}, {"source": 1461797617523, "target": 1514584631941}, {"source": 1461797617523, "target": 1514585115060}, {"source": 1461797617523, "target": 1514585420700}, {"source": 1461797617523, "target": 1514585930718}, {"source": 1461797617523, "target": 1514587038741}, {"source": 1461797617523, "target": 1514587044928}, {"source": 1461797617523, "target": 1514588824901}, {"source": 1461797617523, "target": 1514594020539}, {"source": 1461797617523, "target": 1514658082445}, {"source": 1461797617523, "target": 1514659435421}, {"source": 1461797617523, "target": 1514659848604}, {"source": 1461797617523, "target": 1514661153544}, {"source": 1461797617523, "target": 1514661846196}, {"source": 1461797617523, "target": 1514662042031}, {"source": 1461797617523, "target": 1514662572193}, {"source": 1461797617523, "target": 1514662665451}, {"source": 1461797617523, "target": 1514662961439}, {"source": 1461797617523, "target": 1514663186262}, {"source": 1461797617523, "target": 1514663343487}, {"source": 1461797617523, "target": 1514664090379}, {"source": 1461797617523, "target": 1514664228275}, {"source": 1461797617523, "target": 1514665046693}, {"source": 1461797617523, "target": 1514665175231}, {"source": 1461797617523, "target": 1514665566871}, {"source": 1461797617523, "target": 1514665762770}, {"source": 1461797617523, "target": 1514665825334}, {"source": 1461797617523, "target": 1514665922889}, {"source": 1461797617523, "target": 1514666303506}, {"source": 1461797617523, "target": 1514666743430}, {"source": 1461797617523, "target": 1514666847402}, {"source": 1461797617523, "target": 1514667292361}, {"source": 1461797617523, "target": 1514668032144}, {"source": 1461797617523, "target": 1514668384320}, {"source": 1461797617523, "target": 1514669165526}, {"source": 1461797617523, "target": 1514669484484}, {"source": 1461797617523, "target": 1514670037825}, {"source": 1461797617523, "target": 1514670410940}, {"source": 1461797617523, "target": 1514670597544}, {"source": 1461797617523, "target": 1514671566113}, {"source": 1461797617523, "target": 1514672013629}, {"source": 1461797617523, "target": 1514672344717}, {"source": 1461797617523, "target": 1514672518972}, {"source": 1461797617523, "target": 1514672754597}, {"source": 1461797617523, "target": 1514672868031}, {"source": 1461797617523, "target": 1514678528038}, {"source": 1461797617523, "target": 1514736654381}, {"source": 1461797617523, "target": 1514903337446}, {"source": 1461797617523, "target": 1514903513766}, {"source": 1461797617523, "target": 1514904884948}, {"source": 1461797617523, "target": 1514905046744}, {"source": 1461797617523, "target": 1514905658978}, {"source": 1461797617523, "target": 1514906008748}, {"source": 1461797617523, "target": 1514906638562}, {"source": 1461797617523, "target": 1514906806931}, {"source": 1461797617523, "target": 1514907033786}, {"source": 1461797617523, "target": 1514907741886}, {"source": 1461797617523, "target": 1514907961244}, {"source": 1461797617523, "target": 1514910155365}, {"source": 1461797617523, "target": 1515382789312}, {"source": 1461797617523, "target": 1515382899368}, {"source": 1461797617523, "target": 1515382928401}, {"source": 1461797617523, "target": 1515383023301}, {"source": 1461797617523, "target": 1515383145273}, {"source": 1461797617523, "target": 1515383425443}, {"source": 1461797617523, "target": 1515383927567}, {"source": 1461797617523, "target": 1515385207192}, {"source": 1461797617523, "target": 1515557739749}, {"source": 1461797617523, "target": 1515560045767}, {"source": 1461797617523, "target": 1515727009006}, {"source": 1461797617523, "target": 1515780219071}, {"source": 1461797617523, "target": 1516407555842}, {"source": 1461797617523, "target": 1516408114642}, {"source": 1461797617523, "target": 1516408256568}, {"source": 1461797617523, "target": 1516408630312}, {"source": 1461797617523, "target": 1516408959617}, {"source": 1461797617523, "target": 1516409371505}, {"source": 1461797617523, "target": 1516409545340}, {"source": 1461797617523, "target": 1516409786109}, {"source": 1461797617523, "target": 1516410198146}, {"source": 1461797617523, "target": 1516410362011}, {"source": 1461797617523, "target": 1516410436420}, {"source": 1461797617523, "target": 1521070746065}, {"source": 1461797617523, "target": 1521071051694}, {"source": 1461797617523, "target": 1521071262903}, {"source": 1461797617523, "target": 1522034862029}, {"source": 1461797617523, "target": 1522035146116}, {"source": 1461797617523, "target": 1522351981808}, {"source": 1461797617523, "target": 1522886746355}, {"source": 1461797617523, "target": 1525228314739}, {"source": 1461797617523, "target": 1514434392334}, {"source": 1461852697255, "target": 1462054352273}, {"source": 1461852697255, "target": 1462054697841}, {"source": 1461852697255, "target": 1462054771296}, {"source": 1461852697255, "target": 1462054797990}, {"source": 1461852697255, "target": 1462054808914}, {"source": 1461852697255, "target": 1462054825483}, {"source": 1461852697255, "target": 1462054842563}, {"source": 1461852697255, "target": 1462054857059}, {"source": 1461852697255, "target": 1462054869905}, {"source": 1461852697255, "target": 1462054872908}, {"source": 1461852697255, "target": 1462381603797}, {"source": 1461852697255, "target": 1470836378217}, {"source": 1461852697255, "target": 1470839277805}, {"source": 1461852697255, "target": 1470839413539}, {"source": 1461852697255, "target": 1470839420946}, {"source": 1461852697255, "target": 1470839425004}, {"source": 1461852697255, "target": 1470840588805}, {"source": 1461852697255, "target": 1470841597433}, {"source": 1461852697255, "target": 1470841601855}, {"source": 1461852697255, "target": 1470841606399}, {"source": 1461852697255, "target": 1470841609507}, {"source": 1461852697255, "target": 1470841612811}, {"source": 1461852697255, "target": 1470841620766}, {"source": 1461852697255, "target": 1470841628690}, {"source": 1461852697255, "target": 1470844049174}, {"source": 1461852697255, "target": 1470849959523}, {"source": 1461852697255, "target": 1470849965601}, {"source": 1461852697255, "target": 1470849985857}, {"source": 1461852697255, "target": 1470849997969}, {"source": 1461852697255, "target": 1470850006526}, {"source": 1461852697255, "target": 1470850010829}, {"source": 1461852697255, "target": 1470850014562}, {"source": 1461852697255, "target": 1470850018953}, {"source": 1461852697255, "target": 1470850028855}, {"source": 1461852697255, "target": 1470850036482}, {"source": 1461852697255, "target": 1470850047974}, {"source": 1461852697255, "target": 1470850056888}, {"source": 1461852697255, "target": 1470850068583}, {"source": 1461852697255, "target": 1470850073410}, {"source": 1461852697255, "target": 1470850077204}, {"source": 1461852697255, "target": 1470850085634}, {"source": 1461852697255, "target": 1470850095408}, {"source": 1461852697255, "target": 1470850104686}, {"source": 1461852697255, "target": 1470850110081}, {"source": 1461852697255, "target": 1470850113012}, {"source": 1461852697255, "target": 1470850129966}, {"source": 1461852697255, "target": 1470850142433}, {"source": 1461852697255, "target": 1470850169002}, {"source": 1461852697255, "target": 1470850208869}, {"source": 1461852697255, "target": 1470850212324}, {"source": 1461852697255, "target": 1470850222414}, {"source": 1461852697255, "target": 1470875818432}, {"source": 1461852697255, "target": 1470880127116}, {"source": 1461852697255, "target": 1470880131797}, {"source": 1461852697255, "target": 1470880140148}, {"source": 1461852697255, "target": 1470880151989}, {"source": 1461852697255, "target": 1470880181246}, {"source": 1461852697255, "target": 1470880187380}, {"source": 1461852697255, "target": 1470880197051}, {"source": 1461852697255, "target": 1470880209864}, {"source": 1461852697255, "target": 1470880214095}, {"source": 1461852697255, "target": 1470880221588}, {"source": 1461852697255, "target": 1470880226184}, {"source": 1461852697255, "target": 1470880235448}, {"source": 1461852697255, "target": 1470880238653}, {"source": 1461852697255, "target": 1470880245555}, {"source": 1461852697255, "target": 1470880260476}, {"source": 1461852697255, "target": 1470880302437}, {"source": 1461852697255, "target": 1470880306206}, {"source": 1461852697255, "target": 1470880314839}, {"source": 1461852697255, "target": 1470880328100}, {"source": 1461852697255, "target": 1470880332043}, {"source": 1461852697255, "target": 1470880335411}, {"source": 1461852697255, "target": 1470880346050}, {"source": 1461852697255, "target": 1470880350208}, {"source": 1461852697255, "target": 1470880353973}, {"source": 1461852697255, "target": 1470880356909}, {"source": 1461852697255, "target": 1470880360279}, {"source": 1461852697255, "target": 1470880367589}, {"source": 1461852697255, "target": 1470880383058}, {"source": 1461852697255, "target": 1470880386392}, {"source": 1461852697255, "target": 1470880389765}, {"source": 1461852697255, "target": 1470880397079}, {"source": 1461852697255, "target": 1470926668365}, {"source": 1461852697255, "target": 1470929277154}, {"source": 1461852697255, "target": 1470929280700}, {"source": 1461852697255, "target": 1470929283601}, {"source": 1461852697255, "target": 1470929301100}, {"source": 1461852697255, "target": 1470929313168}, {"source": 1461852697255, "target": 1470929320966}, {"source": 1461852697255, "target": 1470929327082}, {"source": 1461852697255, "target": 1470929337627}, {"source": 1461852697255, "target": 1470929344743}, {"source": 1461852697255, "target": 1470929348967}, {"source": 1461852697255, "target": 1470929360626}, {"source": 1461852697255, "target": 1470929367727}, {"source": 1461852697255, "target": 1470929371036}, {"source": 1461852697255, "target": 1470929374412}, {"source": 1461852697255, "target": 1470929377630}, {"source": 1461852697255, "target": 1470929422314}, {"source": 1461852697255, "target": 1470929429000}, {"source": 1461852697255, "target": 1470929470761}, {"source": 1461852697255, "target": 1470929475929}, {"source": 1461852697255, "target": 1470929480095}, {"source": 1461852697255, "target": 1470929487277}, {"source": 1461852697255, "target": 1470944202275}, {"source": 1461852697255, "target": 1470945292566}, {"source": 1461852697255, "target": 1470945298200}, {"source": 1461852697255, "target": 1470945305914}, {"source": 1461852697255, "target": 1470945329001}, {"source": 1461852697255, "target": 1470945336792}, {"source": 1461852697255, "target": 1470945344201}, {"source": 1461852697255, "target": 1470945364274}, {"source": 1461852697255, "target": 1470945367685}, {"source": 1461852697255, "target": 1470945381155}, {"source": 1461852697255, "target": 1470945400750}, {"source": 1461852697255, "target": 1470945441886}, {"source": 1461852697255, "target": 1470945494610}, {"source": 1461852697255, "target": 1470945501724}, {"source": 1461852697255, "target": 1470945656630}, {"source": 1461852697255, "target": 1471218464015}, {"source": 1461852697255, "target": 1471224396681}, {"source": 1461852697255, "target": 1471224401820}, {"source": 1461852697255, "target": 1471224406413}, {"source": 1461852697255, "target": 1471224415440}, {"source": 1461852697255, "target": 1471224440268}, {"source": 1461852697255, "target": 1471224467806}, {"source": 1461852697255, "target": 1471224477196}, {"source": 1461852697255, "target": 1471224490686}, {"source": 1461852697255, "target": 1471224508109}, {"source": 1461852697255, "target": 1471224512101}, {"source": 1461852697255, "target": 1471224515467}, {"source": 1461852697255, "target": 1471224519538}, {"source": 1461852697255, "target": 1471224536944}, {"source": 1461852697255, "target": 1471224590406}, {"source": 1461852697255, "target": 1471224663028}, {"source": 1461852697255, "target": 1471224677046}, {"source": 1461852697255, "target": 1471224680488}, {"source": 1461852697255, "target": 1471224684457}, {"source": 1461852697255, "target": 1471224689513}, {"source": 1461852697255, "target": 1471224698015}, {"source": 1461852697255, "target": 1471224723342}, {"source": 1461852697255, "target": 1471224754332}, {"source": 1461852697255, "target": 1471224757056}, {"source": 1461852697255, "target": 1471224759732}, {"source": 1461852697255, "target": 1471224766592}, {"source": 1461852697255, "target": 1471224770350}, {"source": 1461852697255, "target": 1471224774091}, {"source": 1461852697255, "target": 1471224777726}, {"source": 1461852697255, "target": 1471224780838}, {"source": 1461852697255, "target": 1471224803014}, {"source": 1461852697255, "target": 1471224807904}, {"source": 1461852697255, "target": 1471224820932}, {"source": 1461852697255, "target": 1471224827913}, {"source": 1461852697255, "target": 1471273372497}, {"source": 1461852697255, "target": 1471274287185}, {"source": 1461852697255, "target": 1471274292765}, {"source": 1461852697255, "target": 1471274300627}, {"source": 1461852697255, "target": 1471274306843}, {"source": 1461852697255, "target": 1471274312788}, {"source": 1461852697255, "target": 1471274319093}, {"source": 1461852697255, "target": 1471274322460}, {"source": 1461852697255, "target": 1471274325193}, {"source": 1461852697255, "target": 1471274328220}, {"source": 1461852697255, "target": 1471274331054}, {"source": 1461852697255, "target": 1471274338690}, {"source": 1461852697255, "target": 1471274345796}, {"source": 1461852697255, "target": 1471274352443}, {"source": 1461852697255, "target": 1471274358522}, {"source": 1461852697255, "target": 1471274365484}, {"source": 1461852697255, "target": 1471274371357}, {"source": 1461852697255, "target": 1471274377554}, {"source": 1461852697255, "target": 1471274390554}, {"source": 1461852697255, "target": 1471276670263}, {"source": 1461852697255, "target": 1471276934361}, {"source": 1461852697255, "target": 1471276938496}, {"source": 1461852697255, "target": 1471276943049}, {"source": 1461852697255, "target": 1471276945706}, {"source": 1461852697255, "target": 1471276948595}, {"source": 1461852697255, "target": 1471276953481}, {"source": 1461852697255, "target": 1471276964931}, {"source": 1461852697255, "target": 1471276982372}, {"source": 1461852697255, "target": 1471276994963}, {"source": 1461852697255, "target": 1471277020049}, {"source": 1461852697255, "target": 1471277046566}, {"source": 1461852697255, "target": 1471289939766}, {"source": 1461852697255, "target": 1471294040253}, {"source": 1461852697255, "target": 1471294044110}, {"source": 1461852697255, "target": 1471294048001}, {"source": 1461852697255, "target": 1471294052806}, {"source": 1461852697255, "target": 1471294064499}, {"source": 1461852697255, "target": 1471294075331}, {"source": 1461852697255, "target": 1471294080868}, {"source": 1461852697255, "target": 1471294084533}, {"source": 1461852697255, "target": 1471294104386}, {"source": 1461852697255, "target": 1471294113945}, {"source": 1461852697255, "target": 1471294123323}, {"source": 1461852697255, "target": 1471294159863}, {"source": 1461852697255, "target": 1471294222786}, {"source": 1461852697255, "target": 1471294229720}, {"source": 1461852697255, "target": 1471294240036}, {"source": 1461852697255, "target": 1471294257021}, {"source": 1461852697255, "target": 1471294272870}, {"source": 1461852697255, "target": 1471294282027}, {"source": 1461852697255, "target": 1471294310881}, {"source": 1461852697255, "target": 1471294321159}, {"source": 1461852697255, "target": 1471294329467}, {"source": 1461852697255, "target": 1471294336923}, {"source": 1461852697255, "target": 1471294340099}, {"source": 1461852697255, "target": 1471294355563}, {"source": 1461852697255, "target": 1471294363464}, {"source": 1461852697255, "target": 1471294366999}, {"source": 1461852697255, "target": 1471294403135}, {"source": 1461852697255, "target": 1471367445517}, {"source": 1461852697255, "target": 1471373941915}, {"source": 1461852697255, "target": 1471373949478}, {"source": 1461852697255, "target": 1471373957839}, {"source": 1461852697255, "target": 1471373965595}, {"source": 1461852697255, "target": 1471373973842}, {"source": 1461852697255, "target": 1471373980396}, {"source": 1461852697255, "target": 1471373987266}, {"source": 1461852697255, "target": 1471373995806}, {"source": 1461852697255, "target": 1471373999704}, {"source": 1461852697255, "target": 1471374002850}, {"source": 1461852697255, "target": 1471374017183}, {"source": 1461852697255, "target": 1471374026509}, {"source": 1461852697255, "target": 1471374038161}, {"source": 1461852697255, "target": 1471374043606}, {"source": 1461852697255, "target": 1471374049722}, {"source": 1461852697255, "target": 1471374056483}, {"source": 1461852697255, "target": 1471374064088}, {"source": 1461852697255, "target": 1471374073636}, {"source": 1461852697255, "target": 1471374083626}, {"source": 1461852697255, "target": 1471374093096}, {"source": 1461852697255, "target": 1471374102211}, {"source": 1461852697255, "target": 1471374108833}, {"source": 1461852697255, "target": 1471375678230}, {"source": 1461852697255, "target": 1471378696248}, {"source": 1461852697255, "target": 1471378707376}, {"source": 1461852697255, "target": 1471378710022}, {"source": 1461852697255, "target": 1471378712791}, {"source": 1461852697255, "target": 1471378777627}, {"source": 1461852697255, "target": 1471378785447}, {"source": 1461852697255, "target": 1471378793470}, {"source": 1461852697255, "target": 1471378832213}, {"source": 1461852697255, "target": 1471447132876}, {"source": 1461852697255, "target": 1471447242243}, {"source": 1461852697255, "target": 1471447244666}, {"source": 1461852697255, "target": 1471447248110}, {"source": 1461852697255, "target": 1471447254224}, {"source": 1461852697255, "target": 1471456202579}, {"source": 1461852697255, "target": 1471457755859}, {"source": 1461852697255, "target": 1471457759434}, {"source": 1461852697255, "target": 1471457762153}, {"source": 1461852697255, "target": 1471457764858}, {"source": 1461852697255, "target": 1471457767523}, {"source": 1461852697255, "target": 1471457770358}, {"source": 1461852697255, "target": 1471457773070}, {"source": 1461852697255, "target": 1471457792149}, {"source": 1461852697255, "target": 1471457806709}, {"source": 1461852697255, "target": 1471457814120}, {"source": 1461852697255, "target": 1471461030608}, {"source": 1461852697255, "target": 1471461042542}, {"source": 1461852697255, "target": 1471461045449}, {"source": 1461852697255, "target": 1471461048669}, {"source": 1461852697255, "target": 1471461053719}, {"source": 1461852697255, "target": 1471461067682}, {"source": 1461852697255, "target": 1471466733838}, {"source": 1461852697255, "target": 1471466751292}, {"source": 1461852697255, "target": 1471466801870}, {"source": 1461852697255, "target": 1471466805806}, {"source": 1461852697255, "target": 1471466824360}, {"source": 1461852697255, "target": 1471466831564}, {"source": 1461852697255, "target": 1471466834322}, {"source": 1461852697255, "target": 1471466840948}, {"source": 1461852697255, "target": 1471466846426}, {"source": 1461852697255, "target": 1471466849804}, {"source": 1461852697255, "target": 1471466857351}, {"source": 1461852697255, "target": 1471466860825}, {"source": 1461852697255, "target": 1471466884199}, {"source": 1461852697255, "target": 1471466893190}, {"source": 1461852697255, "target": 1471466900946}, {"source": 1461852697255, "target": 1471466908876}, {"source": 1461852697255, "target": 1471468280928}, {"source": 1461852697255, "target": 1471541616944}, {"source": 1461852697255, "target": 1471541620768}, {"source": 1461852697255, "target": 1471541638699}, {"source": 1461852697255, "target": 1471541651238}, {"source": 1461852697255, "target": 1471541666800}, {"source": 1461852697255, "target": 1471541670022}, {"source": 1461852697255, "target": 1471541699437}, {"source": 1461852697255, "target": 1471541716832}, {"source": 1461852697255, "target": 1471541719710}, {"source": 1461852697255, "target": 1471541722579}, {"source": 1461852697255, "target": 1471541725222}, {"source": 1461852697255, "target": 1471541734275}, {"source": 1461852697255, "target": 1471541737371}, {"source": 1461852697255, "target": 1471541760900}, {"source": 1461852697255, "target": 1471541806006}, {"source": 1461852697255, "target": 1471541811425}, {"source": 1461852697255, "target": 1471544858459}, {"source": 1461852697255, "target": 1471547618307}, {"source": 1461852697255, "target": 1471548037554}, {"source": 1461852697255, "target": 1471548040375}, {"source": 1461852697255, "target": 1471548046791}, {"source": 1461852697255, "target": 1471548053272}, {"source": 1461852697255, "target": 1471548060543}, {"source": 1461852697255, "target": 1471548066974}, {"source": 1461852697255, "target": 1471548073385}, {"source": 1461852697255, "target": 1471548079484}, {"source": 1461852697255, "target": 1471548095656}, {"source": 1461852697255, "target": 1471552293942}, {"source": 1461852697255, "target": 1471552302491}, {"source": 1461852697255, "target": 1471552306515}, {"source": 1461852697255, "target": 1471552310851}, {"source": 1461852697255, "target": 1471552321632}, {"source": 1461852697255, "target": 1471552328358}, {"source": 1461852697255, "target": 1471552336078}, {"source": 1461852697255, "target": 1471552346413}, {"source": 1461852697255, "target": 1471552353438}, {"source": 1461852697255, "target": 1471552359997}, {"source": 1461852697255, "target": 1471552366885}, {"source": 1461852697255, "target": 1471552372903}, {"source": 1461852697255, "target": 1471552388799}, {"source": 1461852697255, "target": 1471552411732}, {"source": 1461852697255, "target": 1471552429751}, {"source": 1461852697255, "target": 1471552434882}, {"source": 1461852697255, "target": 1471552444449}, {"source": 1461852697255, "target": 1471552454947}, {"source": 1461852697255, "target": 1471554803766}, {"source": 1461852697255, "target": 1471558760048}, {"source": 1461852697255, "target": 1471558768276}, {"source": 1461852697255, "target": 1471558771660}, {"source": 1461852697255, "target": 1471558774734}, {"source": 1461852697255, "target": 1471558780451}, {"source": 1461852697255, "target": 1471558786536}, {"source": 1461852697255, "target": 1471558789622}, {"source": 1461852697255, "target": 1471558794566}, {"source": 1461852697255, "target": 1471558799120}, {"source": 1461852697255, "target": 1471558805917}, {"source": 1461852697255, "target": 1471558813597}, {"source": 1461852697255, "target": 1471558819797}, {"source": 1461852697255, "target": 1471558825957}, {"source": 1461852697255, "target": 1471558832322}, {"source": 1461852697255, "target": 1471558836726}, {"source": 1461852697255, "target": 1471558855981}, {"source": 1461852697255, "target": 1471558860873}, {"source": 1461852697255, "target": 1471558869916}, {"source": 1461852697255, "target": 1471558880219}, {"source": 1461852697255, "target": 1471558889414}, {"source": 1461852697255, "target": 1471558916902}, {"source": 1461852697255, "target": 1471558921194}, {"source": 1461852697255, "target": 1471558924603}, {"source": 1461852697255, "target": 1471558930347}, {"source": 1461852697255, "target": 1471558932772}, {"source": 1461852697255, "target": 1471877601145}, {"source": 1461852697255, "target": 1472058775498}, {"source": 1461852697255, "target": 1472058782489}, {"source": 1461852697255, "target": 1472058786068}, {"source": 1461852697255, "target": 1472058794493}, {"source": 1461852697255, "target": 1472058799078}, {"source": 1461852697255, "target": 1472058810169}, {"source": 1461852697255, "target": 1472058817318}, {"source": 1461852697255, "target": 1472058826585}, {"source": 1461852697255, "target": 1472058834697}, {"source": 1461852697255, "target": 1472058867617}, {"source": 1461852697255, "target": 1472058871043}, {"source": 1461852697255, "target": 1472058882618}, {"source": 1461852697255, "target": 1472058888270}, {"source": 1461852697255, "target": 1472058891600}, {"source": 1461852697255, "target": 1472058895186}, {"source": 1461852697255, "target": 1472058898774}, {"source": 1461852697255, "target": 1472058901939}, {"source": 1461852697255, "target": 1472058912445}, {"source": 1461852697255, "target": 1472058920968}, {"source": 1461852697255, "target": 1472058929720}, {"source": 1461852697255, "target": 1472058950915}, {"source": 1461852697255, "target": 1472058957758}, {"source": 1461852697255, "target": 1472058967059}, {"source": 1461852697255, "target": 1472058981260}, {"source": 1461852697255, "target": 1472058988829}, {"source": 1461852697255, "target": 1472058992255}, {"source": 1461852697255, "target": 1472058995902}, {"source": 1461852697255, "target": 1472058998627}, {"source": 1461852697255, "target": 1472059003077}, {"source": 1461852697255, "target": 1472139199092}, {"source": 1461852697255, "target": 1472146993792}, {"source": 1461852697255, "target": 1472146997848}, {"source": 1461852697255, "target": 1472147021015}, {"source": 1461852697255, "target": 1472147065831}, {"source": 1461852697255, "target": 1472147111730}, {"source": 1461852697255, "target": 1472147180171}, {"source": 1461852697255, "target": 1472147244957}, {"source": 1461852697255, "target": 1472147255373}, {"source": 1461852697255, "target": 1472147261637}, {"source": 1461852697255, "target": 1472147290407}, {"source": 1461852697255, "target": 1472147314850}, {"source": 1461852697255, "target": 1472147334578}, {"source": 1461852697255, "target": 1472147363872}, {"source": 1461852697255, "target": 1472147368524}, {"source": 1461852697255, "target": 1472147376594}, {"source": 1461852697255, "target": 1472147388954}, {"source": 1461852697255, "target": 1472147442231}, {"source": 1461852697255, "target": 1472147549163}, {"source": 1461852697255, "target": 1472147564017}, {"source": 1461852697255, "target": 1472147572504}, {"source": 1461852697255, "target": 1472147594834}, {"source": 1461852697255, "target": 1472147631824}, {"source": 1461852697255, "target": 1472147658939}, {"source": 1461852697255, "target": 1472147672143}, {"source": 1461852697255, "target": 1472147679613}, {"source": 1461852697255, "target": 1472147692713}, {"source": 1461852697255, "target": 1472147713025}, {"source": 1461852697255, "target": 1472147724188}, {"source": 1461852697255, "target": 1472147731220}, {"source": 1461852697255, "target": 1472147778461}, {"source": 1461852697255, "target": 1472147788517}, {"source": 1461852697255, "target": 1472147800542}, {"source": 1461852697255, "target": 1472147819483}, {"source": 1461852697255, "target": 1472147823286}, {"source": 1461852697255, "target": 1472147826598}, {"source": 1461852697255, "target": 1472147840361}, {"source": 1461852697255, "target": 1472147847318}, {"source": 1461852697255, "target": 1472147853249}, {"source": 1461852697255, "target": 1472147859678}, {"source": 1461852697255, "target": 1472147916281}, {"source": 1461852697255, "target": 1472147925256}, {"source": 1461852697255, "target": 1473609295329}, {"source": 1461852697255, "target": 1473957534401}, {"source": 1461852697255, "target": 1474740478683}, {"source": 1461852697255, "target": 1474746760064}, {"source": 1461852697255, "target": 1474746765591}, {"source": 1461852697255, "target": 1474746769550}, {"source": 1461852697255, "target": 1474746774149}, {"source": 1461852697255, "target": 1474746781048}, {"source": 1461852697255, "target": 1474746797999}, {"source": 1461852697255, "target": 1474746802754}, {"source": 1461852697255, "target": 1474746821687}, {"source": 1461852697255, "target": 1474746882207}, {"source": 1461852697255, "target": 1474746958406}, {"source": 1461852697255, "target": 1474746962963}, {"source": 1461852697255, "target": 1474746967542}, {"source": 1461852697255, "target": 1474746972150}, {"source": 1461852697255, "target": 1474746977041}, {"source": 1461852697255, "target": 1474747015054}, {"source": 1461852697255, "target": 1474747019160}, {"source": 1461852697255, "target": 1474747022806}, {"source": 1461852697255, "target": 1474747026681}, {"source": 1461852697255, "target": 1474763251887}, {"source": 1461852697255, "target": 1474763274094}, {"source": 1461852697255, "target": 1474763277556}, {"source": 1461852697255, "target": 1474763284717}, {"source": 1461852697255, "target": 1474763288960}, {"source": 1461852697255, "target": 1474763292268}, {"source": 1461852697255, "target": 1474763298610}, {"source": 1461852697255, "target": 1474763305428}, {"source": 1461852697255, "target": 1474763321835}, {"source": 1461852697255, "target": 1474763341992}, {"source": 1461852697255, "target": 1474763351178}, {"source": 1461852697255, "target": 1474763357561}, {"source": 1461852697255, "target": 1474763361773}, {"source": 1461852697255, "target": 1474763369869}, {"source": 1461852697255, "target": 1474763375647}, {"source": 1461852697255, "target": 1474763386216}, {"source": 1461852697255, "target": 1474763400180}, {"source": 1461852697255, "target": 1474763407997}, {"source": 1461852697255, "target": 1474763416138}, {"source": 1461852697255, "target": 1474763419291}, {"source": 1461852697255, "target": 1474763422931}, {"source": 1461852697255, "target": 1474763431029}, {"source": 1461852697255, "target": 1474763437090}, {"source": 1461852697255, "target": 1474763450879}, {"source": 1461852697255, "target": 1474763455361}, {"source": 1461852697255, "target": 1474763467088}, {"source": 1461852697255, "target": 1474763473389}, {"source": 1461852697255, "target": 1474763499282}, {"source": 1461852697255, "target": 1474763506441}, {"source": 1461852697255, "target": 1474763514561}, {"source": 1461852697255, "target": 1474763550482}, {"source": 1461852697255, "target": 1474763558205}, {"source": 1461852697255, "target": 1474763565664}, {"source": 1461852697255, "target": 1474763572604}, {"source": 1461852697255, "target": 1474763579120}, {"source": 1461852697255, "target": 1474763584176}, {"source": 1461852697255, "target": 1474763588567}, {"source": 1461852697255, "target": 1474763593293}, {"source": 1461852697255, "target": 1474763597673}, {"source": 1461852697255, "target": 1474763604888}, {"source": 1461852697255, "target": 1474763614010}, {"source": 1461852697255, "target": 1474763631111}, {"source": 1461852697255, "target": 1474763658246}, {"source": 1461852697255, "target": 1474763662554}, {"source": 1461852697255, "target": 1474763686814}, {"source": 1461852697255, "target": 1474763698514}, {"source": 1461852697255, "target": 1474763701856}, {"source": 1461852697255, "target": 1474763704210}, {"source": 1461852697255, "target": 1474763708724}, {"source": 1461852697255, "target": 1474763713169}, {"source": 1461852697255, "target": 1474913501954}, {"source": 1461852697255, "target": 1474922296785}, {"source": 1461852697255, "target": 1474922302177}, {"source": 1461852697255, "target": 1474922326239}, {"source": 1461852697255, "target": 1474922330649}, {"source": 1461852697255, "target": 1474922337108}, {"source": 1461852697255, "target": 1474922347730}, {"source": 1461852697255, "target": 1474922357406}, {"source": 1461852697255, "target": 1474922362704}, {"source": 1461852697255, "target": 1474922367295}, {"source": 1461852697255, "target": 1474922371104}, {"source": 1461852697255, "target": 1474922374083}, {"source": 1461852697255, "target": 1474922401297}, {"source": 1461852697255, "target": 1474922409905}, {"source": 1461852697255, "target": 1474922413517}, {"source": 1461852697255, "target": 1474922449467}, {"source": 1461852697255, "target": 1474922509502}, {"source": 1461852697255, "target": 1474922517443}, {"source": 1461852697255, "target": 1474922524410}, {"source": 1461852697255, "target": 1474922538417}, {"source": 1461852697255, "target": 1474922547709}, {"source": 1461852697255, "target": 1474922553494}, {"source": 1461852697255, "target": 1474922639637}, {"source": 1461852697255, "target": 1474929447261}, {"source": 1461852697255, "target": 1474932384686}, {"source": 1461852697255, "target": 1474932395460}, {"source": 1461852697255, "target": 1474932398773}, {"source": 1461852697255, "target": 1474932405759}, {"source": 1461852697255, "target": 1474932426910}, {"source": 1461852697255, "target": 1474932431909}, {"source": 1461852697255, "target": 1474932437772}, {"source": 1461852697255, "target": 1474932447019}, {"source": 1461852697255, "target": 1474932451499}, {"source": 1461852697255, "target": 1474932460152}, {"source": 1461852697255, "target": 1474932476571}, {"source": 1461852697255, "target": 1474932479975}, {"source": 1461852697255, "target": 1474932485458}, {"source": 1461852697255, "target": 1474932490408}, {"source": 1461852697255, "target": 1475023030947}, {"source": 1461852697255, "target": 1475023145072}, {"source": 1461852697255, "target": 1475023148576}, {"source": 1461852697255, "target": 1475023151338}, {"source": 1461852697255, "target": 1475023156885}, {"source": 1461852697255, "target": 1475023164702}, {"source": 1461852697255, "target": 1475023167601}, {"source": 1461852697255, "target": 1475023170258}, {"source": 1461852697255, "target": 1475023173253}, {"source": 1461852697255, "target": 1475023179496}, {"source": 1461852697255, "target": 1475023188432}, {"source": 1461852697255, "target": 1475023207285}, {"source": 1461852697255, "target": 1475023212490}, {"source": 1461852697255, "target": 1475023223476}, {"source": 1461852697255, "target": 1475023231313}, {"source": 1461852697255, "target": 1475023236542}, {"source": 1461852697255, "target": 1475023241238}, {"source": 1461852697255, "target": 1475023249022}, {"source": 1461852697255, "target": 1475023267133}, {"source": 1461852697255, "target": 1475023281268}, {"source": 1461852697255, "target": 1475023288799}, {"source": 1461852697255, "target": 1475023293960}, {"source": 1461852697255, "target": 1475023301582}, {"source": 1461852697255, "target": 1475023319279}, {"source": 1461852697255, "target": 1475023324120}, {"source": 1461852697255, "target": 1475023348879}, {"source": 1461852697255, "target": 1475023354853}, {"source": 1461852697255, "target": 1475023360479}, {"source": 1461852697255, "target": 1475023371223}, {"source": 1461852697255, "target": 1475023376859}, {"source": 1461852697255, "target": 1475023386260}, {"source": 1461852697255, "target": 1475023394742}, {"source": 1461852697255, "target": 1475023399522}, {"source": 1461852697255, "target": 1475023402435}, {"source": 1461852697255, "target": 1475023404978}, {"source": 1461852697255, "target": 1475023407328}, {"source": 1461852697255, "target": 1475024177732}, {"source": 1461852697255, "target": 1475024469081}, {"source": 1461852697255, "target": 1475024491494}, {"source": 1461852697255, "target": 1475024501313}, {"source": 1461852697255, "target": 1475026494378}, {"source": 1461852697255, "target": 1475028551112}, {"source": 1461852697255, "target": 1475028554589}, {"source": 1461852697255, "target": 1475028559369}, {"source": 1461852697255, "target": 1475028564158}, {"source": 1461852697255, "target": 1475028568425}, {"source": 1461852697255, "target": 1475028580006}, {"source": 1461852697255, "target": 1475028584708}, {"source": 1461852697255, "target": 1475028595175}, {"source": 1461852697255, "target": 1475028599544}, {"source": 1461852697255, "target": 1475028603588}, {"source": 1461852697255, "target": 1475028611617}, {"source": 1461852697255, "target": 1475028616230}, {"source": 1461852697255, "target": 1475028718697}, {"source": 1461852697255, "target": 1475028795710}, {"source": 1461852697255, "target": 1475028803355}, {"source": 1461852697255, "target": 1475028806030}, {"source": 1461852697255, "target": 1475028815097}, {"source": 1461852697255, "target": 1475028821432}, {"source": 1461852697255, "target": 1475028830285}, {"source": 1461852697255, "target": 1475082776569}, {"source": 1461852697255, "target": 1475082795028}, {"source": 1461852697255, "target": 1475082900558}, {"source": 1461852697255, "target": 1475082906040}, {"source": 1461852697255, "target": 1475082921853}, {"source": 1461852697255, "target": 1475101582942}, {"source": 1461852697255, "target": 1475101596275}, {"source": 1461852697255, "target": 1475101601179}, {"source": 1461852697255, "target": 1475101605375}, {"source": 1461852697255, "target": 1475101609569}, {"source": 1461852697255, "target": 1475101613908}, {"source": 1461852697255, "target": 1475101707272}, {"source": 1461852697255, "target": 1475101798210}, {"source": 1461852697255, "target": 1475101822187}, {"source": 1461852697255, "target": 1475101835618}, {"source": 1461852697255, "target": 1475178058540}, {"source": 1461852697255, "target": 1475178061443}, {"source": 1461852697255, "target": 1475178067413}, {"source": 1461852697255, "target": 1475178073034}, {"source": 1461852697255, "target": 1475178078505}, {"source": 1461852697255, "target": 1475178085760}, {"source": 1461852697255, "target": 1475178090922}, {"source": 1461852697255, "target": 1475178094848}, {"source": 1461852697255, "target": 1475178097569}, {"source": 1461852697255, "target": 1475178100183}, {"source": 1461852697255, "target": 1475178102547}, {"source": 1461852697255, "target": 1475178112018}, {"source": 1461852697255, "target": 1475178159080}, {"source": 1461852697255, "target": 1475178177038}, {"source": 1461852697255, "target": 1475178204508}, {"source": 1461852697255, "target": 1475178208291}, {"source": 1461852697255, "target": 1475195251454}, {"source": 1461852697255, "target": 1475196483035}, {"source": 1461852697255, "target": 1475196487814}, {"source": 1461852697255, "target": 1475196524399}, {"source": 1461852697255, "target": 1475196531489}, {"source": 1461852697255, "target": 1475196534698}, {"source": 1461852697255, "target": 1475196542262}, {"source": 1461852697255, "target": 1475196548894}, {"source": 1461852697255, "target": 1475196555715}, {"source": 1461852697255, "target": 1475196558711}, {"source": 1461852697255, "target": 1475196564387}, {"source": 1461852697255, "target": 1475196569576}, {"source": 1461852697255, "target": 1475196572668}, {"source": 1461852697255, "target": 1475196577241}, {"source": 1461852697255, "target": 1475196585261}, {"source": 1461852697255, "target": 1475196592003}, {"source": 1461852697255, "target": 1475196615386}, {"source": 1461852697255, "target": 1475196625077}, {"source": 1461852697255, "target": 1475196649798}, {"source": 1461852697255, "target": 1475196678184}, {"source": 1461852697255, "target": 1475196684550}, {"source": 1461852697255, "target": 1475196693528}, {"source": 1461852697255, "target": 1475203903176}, {"source": 1461852697255, "target": 1475203905213}, {"source": 1461852697255, "target": 1475203914725}, {"source": 1461852697255, "target": 1475203917075}, {"source": 1461852697255, "target": 1475203919206}, {"source": 1461852697255, "target": 1475203933773}, {"source": 1461852697255, "target": 1475203952057}, {"source": 1461852697255, "target": 1475204000469}, {"source": 1461852697255, "target": 1475204002830}, {"source": 1461852697255, "target": 1475204005291}, {"source": 1461852697255, "target": 1475204008958}, {"source": 1461852697255, "target": 1475204011514}, {"source": 1461852697255, "target": 1475204013495}, {"source": 1461852697255, "target": 1475204019349}, {"source": 1461852697255, "target": 1475204021869}, {"source": 1461852697255, "target": 1475204024006}, {"source": 1461852697255, "target": 1475204026032}, {"source": 1461852697255, "target": 1475204042122}, {"source": 1461852697255, "target": 1475204047599}, {"source": 1461852697255, "target": 1475204055693}, {"source": 1461852697255, "target": 1475204057826}, {"source": 1461852697255, "target": 1475700465425}, {"source": 1461852697255, "target": 1475703918707}, {"source": 1461852697255, "target": 1475703929983}, {"source": 1461852697255, "target": 1475703958925}, {"source": 1461852697255, "target": 1475703963364}, {"source": 1461852697255, "target": 1475703966647}, {"source": 1461852697255, "target": 1475703973341}, {"source": 1461852697255, "target": 1475703980557}, {"source": 1461852697255, "target": 1475703984646}, {"source": 1461852697255, "target": 1475703988155}, {"source": 1461852697255, "target": 1475703998743}, {"source": 1461852697255, "target": 1475704002070}, {"source": 1461852697255, "target": 1475704008931}, {"source": 1461852697255, "target": 1475704018591}, {"source": 1461852697255, "target": 1475704021775}, {"source": 1461852697255, "target": 1475704028171}, {"source": 1461852697255, "target": 1475704041042}, {"source": 1461852697255, "target": 1475704044425}, {"source": 1461852697255, "target": 1475704063331}, {"source": 1461852697255, "target": 1475704073991}, {"source": 1461852697255, "target": 1475704077390}, {"source": 1461852697255, "target": 1475704083741}, {"source": 1461852697255, "target": 1475704101275}, {"source": 1461852697255, "target": 1475704104542}, {"source": 1461852697255, "target": 1475704128000}, {"source": 1461852697255, "target": 1475704130805}, {"source": 1461852697255, "target": 1475704133477}, {"source": 1461852697255, "target": 1475704136294}, {"source": 1461852697255, "target": 1475704143410}, {"source": 1461852697255, "target": 1475704153938}, {"source": 1461852697255, "target": 1475704157554}, {"source": 1461852697255, "target": 1475704160922}, {"source": 1461852697255, "target": 1475704171437}, {"source": 1461852697255, "target": 1475704175095}, {"source": 1461852697255, "target": 1475704178937}, {"source": 1461852697255, "target": 1475704189323}, {"source": 1461852697255, "target": 1475704197940}, {"source": 1461852697255, "target": 1475704204931}, {"source": 1461852697255, "target": 1475704208186}, {"source": 1461852697255, "target": 1475704215805}, {"source": 1461852697255, "target": 1475704230009}, {"source": 1461852697255, "target": 1475704272711}, {"source": 1461852697255, "target": 1475704275956}, {"source": 1461852697255, "target": 1475704278837}, {"source": 1461852697255, "target": 1475704282043}, {"source": 1461852697255, "target": 1475704284898}, {"source": 1461852697255, "target": 1475704353903}, {"source": 1461852697255, "target": 1475704392767}, {"source": 1461852697255, "target": 1475704403088}, {"source": 1461852697255, "target": 1475704406483}, {"source": 1461852697255, "target": 1475704409635}, {"source": 1461852697255, "target": 1475704416680}, {"source": 1461852697255, "target": 1475704420146}, {"source": 1461852697255, "target": 1475704424077}, {"source": 1461852697255, "target": 1475704431337}, {"source": 1461852697255, "target": 1475704434755}, {"source": 1461852697255, "target": 1475704437176}, {"source": 1461852697255, "target": 1475704439941}, {"source": 1461852697255, "target": 1475704448153}, {"source": 1461852697255, "target": 1475704456046}, {"source": 1461852697255, "target": 1475704465797}, {"source": 1461852697255, "target": 1475704481414}, {"source": 1461852697255, "target": 1475704502915}, {"source": 1461852697255, "target": 1475704505649}, {"source": 1461852697255, "target": 1475704511587}, {"source": 1461852697255, "target": 1475704516937}, {"source": 1461852697255, "target": 1475704524115}, {"source": 1461852697255, "target": 1475704531155}, {"source": 1461852697255, "target": 1475704537873}, {"source": 1461852697255, "target": 1475704550752}, {"source": 1461852697255, "target": 1475704555994}, {"source": 1461852697255, "target": 1475704559983}, {"source": 1461852697255, "target": 1475704571141}, {"source": 1461852697255, "target": 1475704576856}, {"source": 1461852697255, "target": 1475704598208}, {"source": 1461852697255, "target": 1475704604597}, {"source": 1461852697255, "target": 1475704613413}, {"source": 1461852697255, "target": 1475704618623}, {"source": 1461852697255, "target": 1475704621284}, {"source": 1461852697255, "target": 1475704667950}, {"source": 1461852697255, "target": 1475704672372}, {"source": 1461852697255, "target": 1475704749667}, {"source": 1461852697255, "target": 1475704753633}, {"source": 1461852697255, "target": 1475704756049}, {"source": 1461852697255, "target": 1475704764670}, {"source": 1461852697255, "target": 1475704766893}, {"source": 1461852697255, "target": 1475704774908}, {"source": 1461852697255, "target": 1475704777400}, {"source": 1461852697255, "target": 1475704779656}, {"source": 1461852697255, "target": 1475704782078}, {"source": 1461852697255, "target": 1475704784428}, {"source": 1461852697255, "target": 1475704791214}, {"source": 1461852697255, "target": 1475704797793}, {"source": 1461852697255, "target": 1475704801446}, {"source": 1461852697255, "target": 1475704808555}, {"source": 1461852697255, "target": 1475704812592}, {"source": 1461852697255, "target": 1475704814610}, {"source": 1461852697255, "target": 1475704820088}, {"source": 1461852697255, "target": 1475704823914}, {"source": 1461852697255, "target": 1475704826799}, {"source": 1461852697255, "target": 1475704828727}, {"source": 1461852697255, "target": 1475704834291}, {"source": 1461852697255, "target": 1475704844392}, {"source": 1461852697255, "target": 1520709411746}, {"source": 1461852697255, "target": 1520719709530}, {"source": 1461852697255, "target": 1520813884614}, {"source": 1461852697255, "target": 1520903002174}, {"source": 1461852697255, "target": 1521069443308}, {"source": 1461852697255, "target": 1521069633928}, {"source": 1461852697255, "target": 1521070575911}, {"source": 1461852697255, "target": 1521073354169}, {"source": 1461852697255, "target": 1521073580598}, {"source": 1461852697255, "target": 1521169448163}, {"source": 1461852697255, "target": 1521260945563}, {"source": 1461852697255, "target": 1521423123567}, {"source": 1461852697255, "target": 1521423417543}, {"source": 1461852697255, "target": 1521681348591}, {"source": 1461852697255, "target": 1521765720666}, {"source": 1461852697255, "target": 1521917877679}, {"source": 1461852697255, "target": 1521933499544}, {"source": 1461852697255, "target": 1522528763868}, {"source": 1461852697255, "target": 1522528970723}, {"source": 1461852697255, "target": 1523890702245}, {"source": 1461852697255, "target": 1525565689288}, {"source": 1461852697255, "target": 1526260615005}, {"source": 1461852697255, "target": 1575175432797}, {"source": 1461852697255, "target": 1578627140675}, {"source": 1461852697255, "target": 1578627436807}, {"source": 1461867909640, "target": 1470839280347}, {"source": 1461867909640, "target": 1470839287077}, {"source": 1461867909640, "target": 1470839294833}, {"source": 1461867909640, "target": 1470839303346}, {"source": 1461867909640, "target": 1470839310425}, {"source": 1461867909640, "target": 1470839316273}, {"source": 1461867909640, "target": 1470839322331}, {"source": 1461867909640, "target": 1470839328752}, {"source": 1461867909640, "target": 1470839334989}, {"source": 1461867909640, "target": 1470839351508}, {"source": 1461867909640, "target": 1470839383062}, {"source": 1461867909640, "target": 1472320389702}, {"source": 1461867909640, "target": 1472320579969}, {"source": 1461867909640, "target": 1472321222872}, {"source": 1461867909640, "target": 1472321225527}, {"source": 1461867909640, "target": 1472321229002}, {"source": 1461867909640, "target": 1472321235661}, {"source": 1461867909640, "target": 1472321238353}, {"source": 1461867909640, "target": 1472321253969}, {"source": 1461867909640, "target": 1472321256473}, {"source": 1461867909640, "target": 1472321259575}, {"source": 1461867909640, "target": 1472321262004}, {"source": 1461867909640, "target": 1472321269968}, {"source": 1461867909640, "target": 1472321276735}, {"source": 1461867909640, "target": 1474735479535}, {"source": 1461867909640, "target": 1474740118606}, {"source": 1461867909640, "target": 1474740124096}, {"source": 1461867909640, "target": 1474740128563}, {"source": 1461867909640, "target": 1474740134057}, {"source": 1461867909640, "target": 1474740138099}, {"source": 1461867909640, "target": 1474740154600}, {"source": 1461867909640, "target": 1474740165098}, {"source": 1461867909640, "target": 1474740367558}, {"source": 1461867909640, "target": 1474740373043}, {"source": 1461867909640, "target": 1474740377221}, {"source": 1461867909640, "target": 1474740381345}, {"source": 1461867909640, "target": 1474740385466}, {"source": 1461867909640, "target": 1474740392746}, {"source": 1461867909640, "target": 1474740410456}, {"source": 1461867909640, "target": 1474740414745}, {"source": 1461867909640, "target": 1474740420064}, {"source": 1461867909640, "target": 1474740424347}, {"source": 1461867909640, "target": 1474740432266}, {"source": 1461867909640, "target": 1474740436322}, {"source": 1461867909640, "target": 1474740440380}, {"source": 1461867909640, "target": 1474740445704}, {"source": 1461867909640, "target": 1474740455628}, {"source": 1461867909640, "target": 1521171381704}, {"source": 1461867909640, "target": 1521680487909}, {"source": 1461867909640, "target": 1523906955206}, {"source": 1461867909640, "target": 1526001460758}, {"source": 1461867909640, "target": 1526001579813}, {"source": 1461871639955, "target": 1467927195193}, {"source": 1461871639955, "target": 1467927201468}, {"source": 1461871639955, "target": 1467927212415}, {"source": 1461871639955, "target": 1467927222859}, {"source": 1461871639955, "target": 1467927230738}, {"source": 1461871639955, "target": 1467927236628}, {"source": 1461871639955, "target": 1467927244831}, {"source": 1461871803920, "target": 1476583128453}, {"source": 1461871803920, "target": 1476583132273}, {"source": 1461871803920, "target": 1476583135570}, {"source": 1461871803920, "target": 1476583140069}, {"source": 1461871803920, "target": 1476583144320}, {"source": 1461871803920, "target": 1476583148423}, {"source": 1461871803920, "target": 1476583157140}, {"source": 1461871803920, "target": 1476583171440}, {"source": 1461871803920, "target": 1476583175080}, {"source": 1461871803920, "target": 1476583275422}, {"source": 1461871803920, "target": 1476583280119}, {"source": 1461871803920, "target": 1476583284038}, {"source": 1461871803920, "target": 1476583287550}, {"source": 1461871803920, "target": 1476583290698}, {"source": 1461871803920, "target": 1476583293810}, {"source": 1461871803920, "target": 1476583353894}, {"source": 1461871803920, "target": 1476583358077}, {"source": 1461871803920, "target": 1476583361519}, {"source": 1461871803920, "target": 1476583445937}, {"source": 1461871803920, "target": 1476583449997}, {"source": 1461871803920, "target": 1476583453669}, {"source": 1461871803920, "target": 1476583456788}, {"source": 1461871803920, "target": 1476583459860}, {"source": 1461871803920, "target": 1476583463074}, {"source": 1461871803920, "target": 1476583576619}, {"source": 1461871803920, "target": 1476583580011}, {"source": 1461871803920, "target": 1476583586358}, {"source": 1461871803920, "target": 1476583589562}, {"source": 1461871803920, "target": 1476583592918}, {"source": 1461871803920, "target": 1476583596111}, {"source": 1461871803920, "target": 1476583632124}, {"source": 1461871803920, "target": 1476583635491}, {"source": 1461871803920, "target": 1476583642059}, {"source": 1461871803920, "target": 1476583648794}, {"source": 1461871803920, "target": 1476583656234}, {"source": 1461871803920, "target": 1476583675506}, {"source": 1461871803920, "target": 1476583678630}, {"source": 1461871803920, "target": 1476583681489}, {"source": 1461871803920, "target": 1476583684909}, {"source": 1461871803920, "target": 1476583687853}, {"source": 1461871803920, "target": 1476583690602}, {"source": 1461871803920, "target": 1476583693485}, {"source": 1461871803920, "target": 1476583696264}, {"source": 1461871803920, "target": 1476583699009}, {"source": 1461871803920, "target": 1476583741652}, {"source": 1461871803920, "target": 1476583744866}, {"source": 1461871803920, "target": 1476583753540}, {"source": 1461871803920, "target": 1476583756773}, {"source": 1461871803920, "target": 1476583759387}, {"source": 1461871803920, "target": 1476583827458}, {"source": 1461871803920, "target": 1476583830053}, {"source": 1461871803920, "target": 1476583833764}, {"source": 1461871803920, "target": 1476583836527}, {"source": 1461871803920, "target": 1476583840567}, {"source": 1461871803920, "target": 1476583843502}, {"source": 1461871803920, "target": 1476584002542}, {"source": 1461871803920, "target": 1476584005032}, {"source": 1461871803920, "target": 1476584009973}, {"source": 1461871803920, "target": 1476584033358}, {"source": 1461871803920, "target": 1476584036426}, {"source": 1461871803920, "target": 1476584038859}, {"source": 1461871803920, "target": 1476584041597}, {"source": 1461871803920, "target": 1476584044171}, {"source": 1461871803920, "target": 1476584071161}, {"source": 1461871803920, "target": 1476584073597}, {"source": 1461871803920, "target": 1476584076865}, {"source": 1461871803920, "target": 1520280145649}, {"source": 1461871803920, "target": 1520280240826}, {"source": 1461871803920, "target": 1520709952510}, {"source": 1461880606750, "target": 1468250408492}, {"source": 1461880606750, "target": 1476583190763}, {"source": 1461880606750, "target": 1476583194711}, {"source": 1461880606750, "target": 1476583200157}, {"source": 1461880606750, "target": 1476583206549}, {"source": 1461880606750, "target": 1476583223750}, {"source": 1461880606750, "target": 1476583339113}, {"source": 1461880606750, "target": 1476583342751}, {"source": 1461880606750, "target": 1476583346666}, {"source": 1461880606750, "target": 1476583368603}, {"source": 1461880606750, "target": 1476583374378}, {"source": 1461880606750, "target": 1476583439941}, {"source": 1461880606750, "target": 1476583470387}, {"source": 1461880606750, "target": 1476583475548}, {"source": 1461880606750, "target": 1476583479638}, {"source": 1461880606750, "target": 1476583483635}, {"source": 1461880606750, "target": 1476583487158}, {"source": 1461880606750, "target": 1476583490418}, {"source": 1461880606750, "target": 1476583493926}, {"source": 1461880606750, "target": 1476583501488}, {"source": 1461880606750, "target": 1476583510666}, {"source": 1461880606750, "target": 1476583519576}, {"source": 1461880606750, "target": 1476583526759}, {"source": 1461880606750, "target": 1476583546693}, {"source": 1461880606750, "target": 1476583583262}, {"source": 1461880606750, "target": 1476583603375}, {"source": 1461880606750, "target": 1476583613878}, {"source": 1461880606750, "target": 1476583663367}, {"source": 1461880606750, "target": 1476583668245}, {"source": 1461880606750, "target": 1476583672286}, {"source": 1461880606750, "target": 1476583701831}, {"source": 1461880606750, "target": 1476583707008}, {"source": 1461880606750, "target": 1476583713668}, {"source": 1461880606750, "target": 1476583726304}, {"source": 1461880606750, "target": 1476583733748}, {"source": 1461880606750, "target": 1476583738293}, {"source": 1461880606750, "target": 1476583763287}, {"source": 1461880606750, "target": 1476583766716}, {"source": 1461880606750, "target": 1476583770861}, {"source": 1461880606750, "target": 1476583774604}, {"source": 1461880606750, "target": 1476583778314}, {"source": 1461880606750, "target": 1476583781350}, {"source": 1461880606750, "target": 1476583784272}, {"source": 1461880606750, "target": 1476583793394}, {"source": 1461880606750, "target": 1476583796722}, {"source": 1461880606750, "target": 1476583799809}, {"source": 1461880606750, "target": 1476583805176}, {"source": 1461880606750, "target": 1476583812900}, {"source": 1461880606750, "target": 1476583821628}, {"source": 1461880606750, "target": 1476583824625}, {"source": 1461880606750, "target": 1476583846055}, {"source": 1461880606750, "target": 1476583848657}, {"source": 1461880606750, "target": 1476583854343}, {"source": 1461880606750, "target": 1476583864279}, {"source": 1461880606750, "target": 1476583869493}, {"source": 1461880606750, "target": 1476583874664}, {"source": 1461880606750, "target": 1476583878006}, {"source": 1461880606750, "target": 1476583887901}, {"source": 1461880606750, "target": 1476583979683}, {"source": 1461880606750, "target": 1476584023882}, {"source": 1461880606750, "target": 1476584026341}, {"source": 1461880606750, "target": 1476584046114}, {"source": 1461880606750, "target": 1476584054368}, {"source": 1461880606750, "target": 1476584060864}, {"source": 1461880606750, "target": 1476584068209}, {"source": 1461880606750, "target": 1476584079267}, {"source": 1461880606750, "target": 1476584081608}, {"source": 1461880606750, "target": 1476584083742}, {"source": 1461880606750, "target": 1476584085965}, {"source": 1461880606750, "target": 1476584088411}, {"source": 1461880606750, "target": 1476584099738}, {"source": 1461880606750, "target": 1476584180434}, {"source": 1461880606750, "target": 1476584182319}, {"source": 1461880606750, "target": 1476584184074}, {"source": 1461880606750, "target": 1476584185817}, {"source": 1461880606750, "target": 1519401770185}, {"source": 1461880606750, "target": 1519402577402}, {"source": 1461880606750, "target": 1520279328940}, {"source": 1461880606750, "target": 1521168066019}, {"source": 1461880625384, "target": 1476583239260}, {"source": 1461880625384, "target": 1476583242805}, {"source": 1461880625384, "target": 1476583246104}, {"source": 1461880625384, "target": 1476583249637}, {"source": 1461880625384, "target": 1476583253097}, {"source": 1461880625384, "target": 1476583258340}, {"source": 1461880625384, "target": 1476583262023}, {"source": 1461880625384, "target": 1476583265854}, {"source": 1461880625384, "target": 1476583271416}, {"source": 1461880625384, "target": 1476583557608}, {"source": 1461880625384, "target": 1476583565822}, {"source": 1461880625384, "target": 1476583573298}, {"source": 1461880625384, "target": 1476583896012}, {"source": 1461880625384, "target": 1476583908192}, {"source": 1461880625384, "target": 1476583987989}, {"source": 1461880625384, "target": 1476583995605}, {"source": 1461880625384, "target": 1476583999750}, {"source": 1461880625384, "target": 1520279913508}, {"source": 1461978191219, "target": 1474670625781}, {"source": 1461978191219, "target": 1474670628112}, {"source": 1461978191219, "target": 1474670632979}, {"source": 1461978191219, "target": 1474670635112}, {"source": 1461978191219, "target": 1474670637480}, {"source": 1461978191219, "target": 1474670639442}, {"source": 1461978191219, "target": 1502407946079}, {"source": 1461978191219, "target": 1502408261996}, {"source": 1461978191219, "target": 1502409162952}, {"source": 1461978191219, "target": 1502409507103}, {"source": 1461978191219, "target": 1502409605020}, {"source": 1461978191219, "target": 1502409764224}, {"source": 1461978191219, "target": 1502409864610}, {"source": 1462053376290, "target": 1474670560955}, {"source": 1462053376290, "target": 1474670570161}, {"source": 1462053376290, "target": 1474670572492}, {"source": 1462053376290, "target": 1474670578507}, {"source": 1462053376290, "target": 1474670581496}, {"source": 1462137531146, "target": 1463671526250}, {"source": 1462137531146, "target": 1463675323435}, {"source": 1462137531146, "target": 1463675409153}, {"source": 1462137531146, "target": 1463675416618}, {"source": 1462137531146, "target": 1463675577271}, {"source": 1462137531146, "target": 1463675593790}, {"source": 1462137531146, "target": 1463675621016}, {"source": 1462137531146, "target": 1483491954571}, {"source": 1462137531146, "target": 1483491997459}, {"source": 1462137531146, "target": 1483492000077}, {"source": 1462137531146, "target": 1483492003622}, {"source": 1462137531146, "target": 1483492118063}, {"source": 1462137531146, "target": 1483492134876}, {"source": 1462137531146, "target": 1483492137748}, {"source": 1462137531146, "target": 1488854891621}, {"source": 1462137531146, "target": 1488854917707}, {"source": 1462137531146, "target": 1488854939810}, {"source": 1462137531146, "target": 1488854944270}, {"source": 1462137531146, "target": 1488854949157}, {"source": 1462137531146, "target": 1488854955037}, {"source": 1462137531146, "target": 1488854972928}, {"source": 1462137531146, "target": 1488854977018}, {"source": 1462137531146, "target": 1488855002412}, {"source": 1462137531146, "target": 1488855006967}, {"source": 1462137531146, "target": 1488855011000}, {"source": 1462137531146, "target": 1488855018926}, {"source": 1462137531146, "target": 1488855030418}, {"source": 1462137531146, "target": 1488855034510}, {"source": 1462137531146, "target": 1488855061452}, {"source": 1462137531146, "target": 1488855069021}, {"source": 1462137531146, "target": 1488855073013}, {"source": 1462137531146, "target": 1488855076686}, {"source": 1462137531146, "target": 1488855129317}, {"source": 1462137531146, "target": 1488855131940}, {"source": 1462137531146, "target": 1488855193129}, {"source": 1462137531146, "target": 1488855204009}, {"source": 1462137531146, "target": 1494985583129}, {"source": 1462137531146, "target": 1494985784198}, {"source": 1462137531146, "target": 1494986039913}, {"source": 1462137531146, "target": 1494986156445}, {"source": 1462137531146, "target": 1494987311932}, {"source": 1462137531146, "target": 1494987409779}, {"source": 1462137531146, "target": 1494987503240}, {"source": 1462137531146, "target": 1496078911270}, {"source": 1462137531146, "target": 1496079030878}, {"source": 1462137531146, "target": 1496079084819}, {"source": 1462137531146, "target": 1496079121879}, {"source": 1462137531146, "target": 1496079183047}, {"source": 1462137531146, "target": 1496079235885}, {"source": 1462137531146, "target": 1496079298796}, {"source": 1462137531146, "target": 1496079360132}, {"source": 1462137531146, "target": 1496079390352}, {"source": 1462137531146, "target": 1496079472104}, {"source": 1462137531146, "target": 1496079535070}, {"source": 1462137531146, "target": 1496079584387}, {"source": 1462137531146, "target": 1496079654765}, {"source": 1462137531146, "target": 1496079698921}, {"source": 1462137531146, "target": 1496079737499}, {"source": 1462137531146, "target": 1496079792660}, {"source": 1462137531146, "target": 1496079916740}, {"source": 1462137531146, "target": 1496080025321}, {"source": 1462137531146, "target": 1496080042295}, {"source": 1462137531146, "target": 1496183466501}, {"source": 1462137531146, "target": 1496183537336}, {"source": 1462137531146, "target": 1496183572876}, {"source": 1462137531146, "target": 1496183610893}, {"source": 1462137531146, "target": 1496183699185}, {"source": 1462137531146, "target": 1496183761507}, {"source": 1462137531146, "target": 1496183985115}, {"source": 1462137531146, "target": 1496184039415}, {"source": 1462137531146, "target": 1496184112410}, {"source": 1462137531146, "target": 1496184163665}, {"source": 1462137531146, "target": 1496184249316}, {"source": 1462137531146, "target": 1496184367512}, {"source": 1462137531146, "target": 1496184402000}, {"source": 1462137531146, "target": 1496184441665}, {"source": 1462137531146, "target": 1496351643415}, {"source": 1462137531146, "target": 1496351847486}, {"source": 1462137531146, "target": 1496351900511}, {"source": 1462137531146, "target": 1496351944625}, {"source": 1462137531146, "target": 1496598817658}, {"source": 1462137531146, "target": 1496599021042}, {"source": 1462137531146, "target": 1496599147883}, {"source": 1462137531146, "target": 1496599296288}, {"source": 1462137531146, "target": 1496599433184}, {"source": 1462137531146, "target": 1496599521790}, {"source": 1462137531146, "target": 1496599851964}, {"source": 1462137531146, "target": 1496599885855}, {"source": 1462137531146, "target": 1496600043781}, {"source": 1462137531146, "target": 1496602297377}, {"source": 1462137531146, "target": 1496602403049}, {"source": 1462137531146, "target": 1496602511480}, {"source": 1462137531146, "target": 1496602982182}, {"source": 1462137531146, "target": 1496603035538}, {"source": 1462137531146, "target": 1496603132543}, {"source": 1462137531146, "target": 1496603266265}, {"source": 1462137531146, "target": 1496603308878}, {"source": 1462137531146, "target": 1496603354258}, {"source": 1462137531146, "target": 1496604023388}, {"source": 1462137531146, "target": 1496604104524}, {"source": 1462137531146, "target": 1496604136916}, {"source": 1462137531146, "target": 1496604155753}, {"source": 1462137531146, "target": 1496604196287}, {"source": 1462137531146, "target": 1496604209709}, {"source": 1462137531146, "target": 1496604284088}, {"source": 1462137531146, "target": 1496604372859}, {"source": 1462137531146, "target": 1496604490473}, {"source": 1462137531146, "target": 1496607698945}, {"source": 1462137531146, "target": 1496607841823}, {"source": 1462137531146, "target": 1496607898058}, {"source": 1462137531146, "target": 1496608039683}, {"source": 1462137531146, "target": 1496608084837}, {"source": 1462137531146, "target": 1496608174130}, {"source": 1462137531146, "target": 1496608251089}, {"source": 1462137531146, "target": 1496608357490}, {"source": 1462137531146, "target": 1496608419803}, {"source": 1462137531146, "target": 1496608483471}, {"source": 1462137531146, "target": 1496608604412}, {"source": 1462137531146, "target": 1496608680946}, {"source": 1462137531146, "target": 1496608737895}, {"source": 1462137531146, "target": 1496608819674}, {"source": 1462137531146, "target": 1496609031353}, {"source": 1462137531146, "target": 1496609065391}, {"source": 1462137531146, "target": 1496609138175}, {"source": 1462137531146, "target": 1496609204321}, {"source": 1462137531146, "target": 1496620665242}, {"source": 1462137531146, "target": 1496620776631}, {"source": 1462137531146, "target": 1496620827971}, {"source": 1462137531146, "target": 1496620859698}, {"source": 1462137531146, "target": 1496621109895}, {"source": 1462137531146, "target": 1496621207173}, {"source": 1462137531146, "target": 1496621247538}, {"source": 1462137531146, "target": 1496621272603}, {"source": 1462137531146, "target": 1496621295705}, {"source": 1462137531146, "target": 1496621546579}, {"source": 1462137531146, "target": 1496700685629}, {"source": 1462137531146, "target": 1496700900655}, {"source": 1462137531146, "target": 1496700975215}, {"source": 1462137531146, "target": 1496701039754}, {"source": 1462137531146, "target": 1496701112919}, {"source": 1462137531146, "target": 1496701138350}, {"source": 1462137531146, "target": 1496701201756}, {"source": 1462137531146, "target": 1496701381425}, {"source": 1462137531146, "target": 1496701430117}, {"source": 1462137531146, "target": 1496701553014}, {"source": 1462137531146, "target": 1496701661112}, {"source": 1462137531146, "target": 1496701677325}, {"source": 1462137531146, "target": 1496701710041}, {"source": 1462137531146, "target": 1496701812693}, {"source": 1462137531146, "target": 1496701847029}, {"source": 1462137531146, "target": 1496702069894}, {"source": 1462137531146, "target": 1496702221940}, {"source": 1462137531146, "target": 1496702292763}, {"source": 1462137531146, "target": 1496702407111}, {"source": 1462137531146, "target": 1496702476086}, {"source": 1462137531146, "target": 1496702526966}, {"source": 1462137531146, "target": 1496702617032}, {"source": 1462137531146, "target": 1496702661944}, {"source": 1462137531146, "target": 1496702679664}, {"source": 1462137531146, "target": 1496702925212}, {"source": 1462137531146, "target": 1496702960191}, {"source": 1462137531146, "target": 1496766684762}, {"source": 1462137531146, "target": 1496766876963}, {"source": 1462137531146, "target": 1496766930062}, {"source": 1462137531146, "target": 1496767001191}, {"source": 1462137531146, "target": 1496767187973}, {"source": 1462137531146, "target": 1496767287691}, {"source": 1462137531146, "target": 1496767480804}, {"source": 1462137531146, "target": 1496767510858}, {"source": 1462137531146, "target": 1496767587979}, {"source": 1462137531146, "target": 1496767683204}, {"source": 1462137531146, "target": 1496767707806}, {"source": 1462137531146, "target": 1496767830867}, {"source": 1462137531146, "target": 1496767941258}, {"source": 1462137531146, "target": 1496768101304}, {"source": 1462137531146, "target": 1496768851595}, {"source": 1462137531146, "target": 1496768984202}, {"source": 1462137531146, "target": 1496776223147}, {"source": 1462137531146, "target": 1496776398551}, {"source": 1462137531146, "target": 1496776445185}, {"source": 1462137531146, "target": 1496776632236}, {"source": 1462137531146, "target": 1496776718708}, {"source": 1462137531146, "target": 1496776770417}, {"source": 1462137531146, "target": 1496870788981}, {"source": 1462137531146, "target": 1496871875707}, {"source": 1462137531146, "target": 1496872585684}, {"source": 1462137531146, "target": 1496872912455}, {"source": 1462137531146, "target": 1496872960311}, {"source": 1462137531146, "target": 1496873123942}, {"source": 1462137531146, "target": 1497061073470}, {"source": 1462137531146, "target": 1497309558948}, {"source": 1462137531146, "target": 1497310034167}, {"source": 1462137531146, "target": 1497310570418}, {"source": 1462137531146, "target": 1497371447076}, {"source": 1462137531146, "target": 1497371660910}, {"source": 1462137531146, "target": 1497371691198}, {"source": 1462137531146, "target": 1497371847593}, {"source": 1462137531146, "target": 1497371909985}, {"source": 1462137531146, "target": 1497374236198}, {"source": 1462137531146, "target": 1497374410076}, {"source": 1462137531146, "target": 1497374547981}, {"source": 1462137531146, "target": 1497374668330}, {"source": 1462137531146, "target": 1497375563385}, {"source": 1462137531146, "target": 1497375666132}, {"source": 1462137531146, "target": 1497375793588}, {"source": 1462137531146, "target": 1497375956453}, {"source": 1462137531146, "target": 1497375984494}, {"source": 1462137531146, "target": 1497376022921}, {"source": 1462137531146, "target": 1497376040736}, {"source": 1462137531146, "target": 1497376071663}, {"source": 1462137531146, "target": 1497376103826}, {"source": 1462137531146, "target": 1497376126592}, {"source": 1462137531146, "target": 1497376183041}, {"source": 1462137531146, "target": 1497372723105}, {"source": 1462137531146, "target": 1497376209411}, {"source": 1462137531146, "target": 1497378092823}, {"source": 1462137531146, "target": 1497378148913}, {"source": 1462137531146, "target": 1497378335881}, {"source": 1462137531146, "target": 1497378395390}, {"source": 1462137531146, "target": 1497378477763}, {"source": 1462137531146, "target": 1497378575778}, {"source": 1462137531146, "target": 1497378642558}, {"source": 1462137531146, "target": 1497378692922}, {"source": 1462137531146, "target": 1497378883453}, {"source": 1462137531146, "target": 1497378973098}, {"source": 1462137531146, "target": 1497379005837}, {"source": 1462137531146, "target": 1497379370911}, {"source": 1462137531146, "target": 1497379444722}, {"source": 1462137531146, "target": 1497379531634}, {"source": 1462137531146, "target": 1497379561184}, {"source": 1462137531146, "target": 1497379643141}, {"source": 1462137531146, "target": 1497379783371}, {"source": 1462137531146, "target": 1497379834486}, {"source": 1462137531146, "target": 1497379898641}, {"source": 1462137531146, "target": 1497379939080}, {"source": 1462137531146, "target": 1501555295479}, {"source": 1462137531146, "target": 1515380277519}, {"source": 1462137531146, "target": 1515380457962}, {"source": 1462137531146, "target": 1516743462756}, {"source": 1462137531146, "target": 1520712861176}, {"source": 1462137531146, "target": 1521680301551}, {"source": 1462137531146, "target": 1522427952831}, {"source": 1462137531146, "target": 1522428732333}, {"source": 1462137531146, "target": 1523297766679}, {"source": 1462137531146, "target": 1579056793018}, {"source": 1462137531146, "target": 1579056838484}, {"source": 1462137531146, "target": 1579056849831}, {"source": 1462137531146, "target": 1579056859576}, {"source": 1462137531146, "target": 1579056878964}, {"source": 1462137531146, "target": 1579056887286}, {"source": 1462145992988, "target": 1462327705715}, {"source": 1462145992988, "target": 1464371990594}, {"source": 1462145992988, "target": 1467680889892}, {"source": 1462145992988, "target": 1467682100570}, {"source": 1462145992988, "target": 1467682104886}, {"source": 1462145992988, "target": 1467682112238}, {"source": 1462145992988, "target": 1467682119151}, {"source": 1462145992988, "target": 1467682127205}, {"source": 1462145992988, "target": 1467682132293}, {"source": 1462145992988, "target": 1467682141963}, {"source": 1462145992988, "target": 1467682151814}, {"source": 1462145992988, "target": 1467682160443}, {"source": 1462145992988, "target": 1467682164864}, {"source": 1462145992988, "target": 1467682168594}, {"source": 1462145992988, "target": 1467682176839}, {"source": 1462145992988, "target": 1467682184880}, {"source": 1462145992988, "target": 1467682191339}, {"source": 1462145992988, "target": 1467682203692}, {"source": 1462145992988, "target": 1467682210281}, {"source": 1462145992988, "target": 1467682218464}, {"source": 1462145992988, "target": 1467682225986}, {"source": 1462145992988, "target": 1467682230375}, {"source": 1462145992988, "target": 1467682236755}, {"source": 1462145992988, "target": 1467682246440}, {"source": 1462145992988, "target": 1467683671375}, {"source": 1462145992988, "target": 1467683685406}, {"source": 1462145992988, "target": 1467683698106}, {"source": 1462145992988, "target": 1467683705831}, {"source": 1462145992988, "target": 1467683713918}, {"source": 1462145992988, "target": 1467683722745}, {"source": 1462145992988, "target": 1467683729345}, {"source": 1462145992988, "target": 1467683736978}, {"source": 1462145992988, "target": 1467683748989}, {"source": 1462145992988, "target": 1467683757507}, {"source": 1462145992988, "target": 1467683773187}, {"source": 1462145992988, "target": 1467683782311}, {"source": 1462145992988, "target": 1467683785823}, {"source": 1462145992988, "target": 1467683821663}, {"source": 1462145992988, "target": 1467683827712}, {"source": 1462145992988, "target": 1467683837488}, {"source": 1462145992988, "target": 1467683840789}, {"source": 1462145992988, "target": 1467683857613}, {"source": 1462145992988, "target": 1467771663505}, {"source": 1462145992988, "target": 1467771674094}, {"source": 1462145992988, "target": 1467771685074}, {"source": 1462145992988, "target": 1467771694239}, {"source": 1462145992988, "target": 1467771708980}, {"source": 1462145992988, "target": 1467771721122}, {"source": 1462145992988, "target": 1467771730067}, {"source": 1462145992988, "target": 1467771738865}, {"source": 1462145992988, "target": 1467771753315}, {"source": 1462145992988, "target": 1467771762899}, {"source": 1462145992988, "target": 1467771772782}, {"source": 1462145992988, "target": 1467771777297}, {"source": 1462145992988, "target": 1467771785512}, {"source": 1462145992988, "target": 1467771793359}, {"source": 1462145992988, "target": 1467771801123}, {"source": 1462145992988, "target": 1467771810893}, {"source": 1462145992988, "target": 1467771816667}, {"source": 1462145992988, "target": 1467771829884}, {"source": 1462145992988, "target": 1467771834622}, {"source": 1462145992988, "target": 1467771842612}, {"source": 1462145992988, "target": 1467771853847}, {"source": 1462145992988, "target": 1467771862566}, {"source": 1462145992988, "target": 1467771867525}, {"source": 1462145992988, "target": 1467771872364}, {"source": 1462145992988, "target": 1467771886505}, {"source": 1462145992988, "target": 1467771897291}, {"source": 1462145992988, "target": 1467771904154}, {"source": 1462145992988, "target": 1467771911742}, {"source": 1462145992988, "target": 1467771917029}, {"source": 1462145992988, "target": 1467771922095}, {"source": 1462145992988, "target": 1467771928859}, {"source": 1462145992988, "target": 1467771968226}, {"source": 1462145992988, "target": 1467771977177}, {"source": 1462145992988, "target": 1467771988825}, {"source": 1462145992988, "target": 1467771998020}, {"source": 1462145992988, "target": 1467772007821}, {"source": 1462145992988, "target": 1467818125623}, {"source": 1462145992988, "target": 1467819685605}, {"source": 1462145992988, "target": 1467819699712}, {"source": 1462145992988, "target": 1467819708854}, {"source": 1462145992988, "target": 1467819713749}, {"source": 1462145992988, "target": 1467819717437}, {"source": 1462145992988, "target": 1467819733331}, {"source": 1462145992988, "target": 1467819736477}, {"source": 1462145992988, "target": 1467819747337}, {"source": 1462145992988, "target": 1467819753003}, {"source": 1462145992988, "target": 1467819757446}, {"source": 1462145992988, "target": 1467819760893}, {"source": 1462145992988, "target": 1467819790375}, {"source": 1462145992988, "target": 1467819793606}, {"source": 1462145992988, "target": 1467819801792}, {"source": 1462145992988, "target": 1467819810778}, {"source": 1462145992988, "target": 1467819815746}, {"source": 1462145992988, "target": 1467819819593}, {"source": 1462145992988, "target": 1467819823153}, {"source": 1462145992988, "target": 1467819833068}, {"source": 1462145992988, "target": 1467819843271}, {"source": 1462145992988, "target": 1467833317937}, {"source": 1462145992988, "target": 1467833327674}, {"source": 1462145992988, "target": 1467833390571}, {"source": 1462145992988, "target": 1467833411276}, {"source": 1462145992988, "target": 1467833441597}, {"source": 1462145992988, "target": 1467833642875}, {"source": 1462145992988, "target": 1467833651277}, {"source": 1462145992988, "target": 1467833654903}, {"source": 1462145992988, "target": 1467833662315}, {"source": 1462145992988, "target": 1467833666692}, {"source": 1462145992988, "target": 1467833689549}, {"source": 1462145992988, "target": 1467833758513}, {"source": 1462145992988, "target": 1467833798088}, {"source": 1462145992988, "target": 1467833814403}, {"source": 1462145992988, "target": 1467833820283}, {"source": 1462145992988, "target": 1467833832000}, {"source": 1462145992988, "target": 1467833839824}, {"source": 1462145992988, "target": 1467833846822}, {"source": 1462145992988, "target": 1467833855389}, {"source": 1462145992988, "target": 1467833857831}, {"source": 1462145992988, "target": 1467833865131}, {"source": 1462145992988, "target": 1467833873415}, {"source": 1462145992988, "target": 1467927049625}, {"source": 1462145992988, "target": 1467927060428}, {"source": 1462145992988, "target": 1467927065057}, {"source": 1462145992988, "target": 1467927070095}, {"source": 1462145992988, "target": 1467927073318}, {"source": 1462145992988, "target": 1467927076561}, {"source": 1462145992988, "target": 1467927083137}, {"source": 1462145992988, "target": 1467927088995}, {"source": 1462145992988, "target": 1467927092663}, {"source": 1462145992988, "target": 1467927099760}, {"source": 1462145992988, "target": 1467927104082}, {"source": 1462145992988, "target": 1467927108504}, {"source": 1462145992988, "target": 1467927114300}, {"source": 1462145992988, "target": 1467927124490}, {"source": 1462145992988, "target": 1467927131738}, {"source": 1462145992988, "target": 1467927145086}, {"source": 1462145992988, "target": 1467927147874}, {"source": 1462145992988, "target": 1467927150999}, {"source": 1462145992988, "target": 1467927153960}, {"source": 1462145992988, "target": 1467927163875}, {"source": 1462145992988, "target": 1467927177492}, {"source": 1462145992988, "target": 1467927184068}, {"source": 1462145992988, "target": 1467927248193}, {"source": 1462145992988, "target": 1467927251462}, {"source": 1462145992988, "target": 1467927284412}, {"source": 1462145992988, "target": 1467927301604}, {"source": 1462145992988, "target": 1467927310137}, {"source": 1462145992988, "target": 1467927337792}, {"source": 1462145992988, "target": 1468090003178}, {"source": 1462145992988, "target": 1468090015858}, {"source": 1462145992988, "target": 1468090020332}, {"source": 1462145992988, "target": 1468090037888}, {"source": 1462145992988, "target": 1468090041618}, {"source": 1462145992988, "target": 1468090047136}, {"source": 1462145992988, "target": 1468090054335}, {"source": 1462145992988, "target": 1468090071594}, {"source": 1462145992988, "target": 1468090084627}, {"source": 1462145992988, "target": 1468090100922}, {"source": 1462145992988, "target": 1468090112926}, {"source": 1462145992988, "target": 1468090131838}, {"source": 1462145992988, "target": 1468090142327}, {"source": 1462145992988, "target": 1468090145602}, {"source": 1462145992988, "target": 1468090162890}, {"source": 1462145992988, "target": 1468090181130}, {"source": 1462145992988, "target": 1468101648191}, {"source": 1462145992988, "target": 1468101677524}, {"source": 1462145992988, "target": 1468101687731}, {"source": 1462145992988, "target": 1468101697168}, {"source": 1462145992988, "target": 1468101709109}, {"source": 1462145992988, "target": 1468101717082}, {"source": 1462145992988, "target": 1468101721156}, {"source": 1462145992988, "target": 1468101731577}, {"source": 1462145992988, "target": 1468101734699}, {"source": 1462145992988, "target": 1468101742045}, {"source": 1462145992988, "target": 1468101754043}, {"source": 1462145992988, "target": 1468101760456}, {"source": 1462145992988, "target": 1468101763616}, {"source": 1462145992988, "target": 1468101766794}, {"source": 1462145992988, "target": 1468101769990}, {"source": 1462145992988, "target": 1468101772387}, {"source": 1462145992988, "target": 1468101790635}, {"source": 1462145992988, "target": 1468101794395}, {"source": 1462145992988, "target": 1468101797682}, {"source": 1462145992988, "target": 1468101807071}, {"source": 1462145992988, "target": 1468101810757}, {"source": 1462145992988, "target": 1468101821842}, {"source": 1462145992988, "target": 1468101828318}, {"source": 1462145992988, "target": 1468101831208}, {"source": 1462145992988, "target": 1468178553079}, {"source": 1462145992988, "target": 1468180458898}, {"source": 1462145992988, "target": 1468180469796}, {"source": 1462145992988, "target": 1468180482606}, {"source": 1462145992988, "target": 1468180488383}, {"source": 1462145992988, "target": 1468180493048}, {"source": 1462145992988, "target": 1468180496024}, {"source": 1462145992988, "target": 1468180498878}, {"source": 1462145992988, "target": 1468180509631}, {"source": 1462145992988, "target": 1468180513115}, {"source": 1462145992988, "target": 1468180522245}, {"source": 1462145992988, "target": 1468180527863}, {"source": 1462145992988, "target": 1468180535736}, {"source": 1462145992988, "target": 1468180544636}, {"source": 1462145992988, "target": 1468180547712}, {"source": 1462145992988, "target": 1468180554504}, {"source": 1462145992988, "target": 1468180562100}, {"source": 1462145992988, "target": 1468180570221}, {"source": 1462145992988, "target": 1468250019616}, {"source": 1462145992988, "target": 1468250023076}, {"source": 1462145992988, "target": 1468250042681}, {"source": 1462145992988, "target": 1468250046217}, {"source": 1462145992988, "target": 1468250087836}, {"source": 1462145992988, "target": 1468250126050}, {"source": 1462145992988, "target": 1468250135385}, {"source": 1462145992988, "target": 1468250145227}, {"source": 1462145992988, "target": 1468250205492}, {"source": 1462145992988, "target": 1468250215718}, {"source": 1462145992988, "target": 1468250231270}, {"source": 1462145992988, "target": 1468250234549}, {"source": 1462145992988, "target": 1468250259504}, {"source": 1462145992988, "target": 1468250262595}, {"source": 1462145992988, "target": 1468250274117}, {"source": 1462145992988, "target": 1468250287632}, {"source": 1462145992988, "target": 1468250298127}, {"source": 1462145992988, "target": 1468250306701}, {"source": 1462145992988, "target": 1468250310013}, {"source": 1462145992988, "target": 1468250319201}, {"source": 1462145992988, "target": 1468250327871}, {"source": 1462145992988, "target": 1468250335702}, {"source": 1462145992988, "target": 1468250346923}, {"source": 1462145992988, "target": 1468250370572}, {"source": 1462145992988, "target": 1468250377043}, {"source": 1462145992988, "target": 1468250383192}, {"source": 1462145992988, "target": 1468250390306}, {"source": 1462145992988, "target": 1468250399707}, {"source": 1462145992988, "target": 1468531236213}, {"source": 1462145992988, "target": 1468531735700}, {"source": 1462145992988, "target": 1468531744239}, {"source": 1462145992988, "target": 1468531751986}, {"source": 1462145992988, "target": 1468531755586}, {"source": 1462145992988, "target": 1468531768449}, {"source": 1462145992988, "target": 1468531779548}, {"source": 1462145992988, "target": 1468531784089}, {"source": 1462145992988, "target": 1468531846102}, {"source": 1462145992988, "target": 1468531853450}, {"source": 1462145992988, "target": 1468531860753}, {"source": 1462145992988, "target": 1468531867985}, {"source": 1462145992988, "target": 1468531871497}, {"source": 1462145992988, "target": 1468531918216}, {"source": 1462145992988, "target": 1468549239653}, {"source": 1462145992988, "target": 1468549248441}, {"source": 1462145992988, "target": 1468549256100}, {"source": 1462145992988, "target": 1468549263734}, {"source": 1462145992988, "target": 1468549269015}, {"source": 1462145992988, "target": 1468549285757}, {"source": 1462145992988, "target": 1468549288868}, {"source": 1462145992988, "target": 1468549297186}, {"source": 1462145992988, "target": 1468549304489}, {"source": 1462145992988, "target": 1468549318455}, {"source": 1462145992988, "target": 1468597206819}, {"source": 1462145992988, "target": 1468605422972}, {"source": 1462145992988, "target": 1468605428299}, {"source": 1462145992988, "target": 1468605437554}, {"source": 1462145992988, "target": 1468605447110}, {"source": 1462145992988, "target": 1468605460088}, {"source": 1462145992988, "target": 1468605476084}, {"source": 1462145992988, "target": 1468605486456}, {"source": 1462145992988, "target": 1468605494779}, {"source": 1462145992988, "target": 1468605505369}, {"source": 1462145992988, "target": 1468605516940}, {"source": 1462145992988, "target": 1468605522020}, {"source": 1462145992988, "target": 1468605530742}, {"source": 1462145992988, "target": 1468605551769}, {"source": 1462145992988, "target": 1468605561743}, {"source": 1462145992988, "target": 1468605570593}, {"source": 1462145992988, "target": 1468605605193}, {"source": 1462145992988, "target": 1468605614335}, {"source": 1462145992988, "target": 1468605624923}, {"source": 1462145992988, "target": 1468605629127}, {"source": 1462145992988, "target": 1468605635616}, {"source": 1462145992988, "target": 1468605640090}, {"source": 1462145992988, "target": 1468605649044}, {"source": 1462145992988, "target": 1468605672126}, {"source": 1462145992988, "target": 1468605679141}, {"source": 1462145992988, "target": 1468605683908}, {"source": 1462145992988, "target": 1468605700819}, {"source": 1462145992988, "target": 1468605710555}, {"source": 1462145992988, "target": 1469146690171}, {"source": 1462145992988, "target": 1469146700915}, {"source": 1462145992988, "target": 1469146704776}, {"source": 1462145992988, "target": 1469146716026}, {"source": 1462145992988, "target": 1469146725917}, {"source": 1462145992988, "target": 1469146729264}, {"source": 1462145992988, "target": 1469146736550}, {"source": 1462145992988, "target": 1469146744041}, {"source": 1462145992988, "target": 1469146750767}, {"source": 1462145992988, "target": 1469146757336}, {"source": 1462145992988, "target": 1469146766774}, {"source": 1462145992988, "target": 1469146770793}, {"source": 1462145992988, "target": 1469146833164}, {"source": 1462145992988, "target": 1469146882653}, {"source": 1462145992988, "target": 1469146891130}, {"source": 1462145992988, "target": 1469211731057}, {"source": 1462145992988, "target": 1469211758510}, {"source": 1462145992988, "target": 1469211768096}, {"source": 1462145992988, "target": 1469211776297}, {"source": 1462145992988, "target": 1469211821192}, {"source": 1462145992988, "target": 1469211866990}, {"source": 1462145992988, "target": 1469211878818}, {"source": 1462145992988, "target": 1469211888271}, {"source": 1462145992988, "target": 1469211895990}, {"source": 1462145992988, "target": 1469211901148}, {"source": 1462145992988, "target": 1469211918414}, {"source": 1462145992988, "target": 1469211922943}, {"source": 1462145992988, "target": 1469211930007}, {"source": 1462145992988, "target": 1469211936591}, {"source": 1462145992988, "target": 1469211945421}, {"source": 1462145992988, "target": 1469211952966}, {"source": 1462145992988, "target": 1469211959736}, {"source": 1462145992988, "target": 1469211963576}, {"source": 1462145992988, "target": 1469211967494}, {"source": 1462145992988, "target": 1469211975821}, {"source": 1462145992988, "target": 1469211979735}, {"source": 1462145992988, "target": 1469211982873}, {"source": 1462145992988, "target": 1469211985793}, {"source": 1462145992988, "target": 1469211988593}, {"source": 1462145992988, "target": 1469211992261}, {"source": 1462145992988, "target": 1469211995409}, {"source": 1462145992988, "target": 1469211998842}, {"source": 1462145992988, "target": 1469212001931}, {"source": 1462145992988, "target": 1469212006870}, {"source": 1462145992988, "target": 1469212015433}, {"source": 1462145992988, "target": 1469212046884}, {"source": 1462145992988, "target": 1469212049845}, {"source": 1462145992988, "target": 1469212079676}, {"source": 1462145992988, "target": 1469212082998}, {"source": 1462145992988, "target": 1469212097066}, {"source": 1462145992988, "target": 1469212105987}, {"source": 1462145992988, "target": 1469212128488}, {"source": 1462145992988, "target": 1469212132977}, {"source": 1462145992988, "target": 1469212140064}, {"source": 1462145992988, "target": 1469212143200}, {"source": 1462145992988, "target": 1469212160390}, {"source": 1462145992988, "target": 1469212163391}, {"source": 1462145992988, "target": 1469212172401}, {"source": 1462145992988, "target": 1469212174648}, {"source": 1462145992988, "target": 1469212177328}, {"source": 1462145992988, "target": 1469212183553}, {"source": 1462145992988, "target": 1469212191737}, {"source": 1462145992988, "target": 1469212200495}, {"source": 1462145992988, "target": 1470790711337}, {"source": 1462145992988, "target": 1470793765181}, {"source": 1462145992988, "target": 1470793772715}, {"source": 1462145992988, "target": 1470793786718}, {"source": 1462145992988, "target": 1470793801012}, {"source": 1462145992988, "target": 1470793810006}, {"source": 1462145992988, "target": 1470793813508}, {"source": 1462145992988, "target": 1470793824126}, {"source": 1462145992988, "target": 1470793834168}, {"source": 1462145992988, "target": 1470793854315}, {"source": 1462145992988, "target": 1470793906545}, {"source": 1462145992988, "target": 1470793913138}, {"source": 1462145992988, "target": 1470793917200}, {"source": 1462145992988, "target": 1470793930160}, {"source": 1462145992988, "target": 1470793948768}, {"source": 1462145992988, "target": 1470793956764}, {"source": 1462145992988, "target": 1470793975737}, {"source": 1462145992988, "target": 1470793982266}, {"source": 1462145992988, "target": 1470793987719}, {"source": 1462145992988, "target": 1470793994021}, {"source": 1462145992988, "target": 1470794002045}, {"source": 1462145992988, "target": 1470794005067}, {"source": 1462145992988, "target": 1470794011584}, {"source": 1462145992988, "target": 1470794018583}, {"source": 1462145992988, "target": 1470794026061}, {"source": 1462145992988, "target": 1470794029882}, {"source": 1462145992988, "target": 1470794041447}, {"source": 1462145992988, "target": 1470794054199}, {"source": 1462145992988, "target": 1470794058884}, {"source": 1462145992988, "target": 1470794061543}, {"source": 1462145992988, "target": 1474670081186}, {"source": 1462145992988, "target": 1474670490438}, {"source": 1462145992988, "target": 1474670493718}, {"source": 1462145992988, "target": 1474670495829}, {"source": 1462145992988, "target": 1474670498150}, {"source": 1462145992988, "target": 1474670500145}, {"source": 1462145992988, "target": 1474670502201}, {"source": 1462145992988, "target": 1474670504167}, {"source": 1462145992988, "target": 1474670506237}, {"source": 1462145992988, "target": 1474670521374}, {"source": 1462145992988, "target": 1474670530324}, {"source": 1462145992988, "target": 1474670536188}, {"source": 1462145992988, "target": 1474670546156}, {"source": 1462145992988, "target": 1474670584017}, {"source": 1462145992988, "target": 1474670589163}, {"source": 1462145992988, "target": 1474670595105}, {"source": 1462145992988, "target": 1474670598330}, {"source": 1462145992988, "target": 1474670601646}, {"source": 1462145992988, "target": 1474670612056}, {"source": 1462145992988, "target": 1474670615748}, {"source": 1462145992988, "target": 1474670618209}, {"source": 1462145992988, "target": 1474670620491}, {"source": 1462145992988, "target": 1474670622536}, {"source": 1462145992988, "target": 1476580396674}, {"source": 1462145992988, "target": 1476583107452}, {"source": 1462145992988, "target": 1476583116285}, {"source": 1462145992988, "target": 1476583120594}, {"source": 1462145992988, "target": 1476583124449}, {"source": 1462145992988, "target": 1476584103099}, {"source": 1462145992988, "target": 1476584105090}, {"source": 1462145992988, "target": 1476584108843}, {"source": 1462145992988, "target": 1476584154333}, {"source": 1462145992988, "target": 1476584161540}, {"source": 1462145992988, "target": 1476584164425}, {"source": 1462145992988, "target": 1488418455323}, {"source": 1462145992988, "target": 1488418461029}, {"source": 1462145992988, "target": 1488418466511}, {"source": 1462145992988, "target": 1488418468638}, {"source": 1462145992988, "target": 1488418470779}, {"source": 1462145992988, "target": 1488418478717}, {"source": 1462145992988, "target": 1488418480898}, {"source": 1462145992988, "target": 1488418482714}, {"source": 1462145992988, "target": 1488418489582}, {"source": 1462145992988, "target": 1488418495512}, {"source": 1462145992988, "target": 1488418502329}, {"source": 1462145992988, "target": 1488418515177}, {"source": 1462145992988, "target": 1488418518286}, {"source": 1462145992988, "target": 1488418521622}, {"source": 1462145992988, "target": 1401384439188}, {"source": 1462145992988, "target": 1401383464593}, {"source": 1462145992988, "target": 1495595300874}, {"source": 1462145992988, "target": 1497306717842}, {"source": 1462145992988, "target": 1497306842176}, {"source": 1462145992988, "target": 1497307004297}, {"source": 1462145992988, "target": 1497307127909}, {"source": 1462145992988, "target": 1497307205371}, {"source": 1462145992988, "target": 1516743281813}, {"source": 1462145992988, "target": 1516743593919}, {"source": 1462145992988, "target": 1516938061553}, {"source": 1462145992988, "target": 1516938350345}, {"source": 1462145992988, "target": 1520274561035}, {"source": 1462145992988, "target": 1520274742115}, {"source": 1462145992988, "target": 1520275652643}, {"source": 1462145992988, "target": 1520275730946}, {"source": 1462145992988, "target": 1520275767649}, {"source": 1462145992988, "target": 1520277707475}, {"source": 1462145992988, "target": 1520277897542}, {"source": 1462145992988, "target": 1520278629964}, {"source": 1462145992988, "target": 1520278762361}, {"source": 1462145992988, "target": 1523474895372}, {"source": 1462145992988, "target": 1525465852258}, {"source": 1462145992988, "target": 1547940439819}, {"source": 1462145992988, "target": 1547940537506}, {"source": 1462145992988, "target": 1547940805273}]}